PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sacco, F; Tinti, M; Palma, A; Ferrari, E; Nardozza, AP; van Huijsduijnen, RH; Takahashi, T; Castagnoli, L; Cesareni, G				Sacco, Francesca; Tinti, Michele; Palma, Anita; Ferrari, Emanuela; Nardozza, Aurelio P.; van Huijsduijnen, Rob Hooft; Takahashi, Takamune; Castagnoli, Luisa; Cesareni, Gianni			Tumor Suppressor Density-enhanced Phosphatase-1 (DEP-1) Inhibits the RAS Pathway by Direct Dephosphorylation of ERK1/2 Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; MAP-KINASE; SUBSTRATE-SPECIFICITY; PHOSPHORYLATION SITES; CELL-MIGRATION; IN-VIVO; PTP-SL; RECEPTOR; GROWTH; ERK2	Density-enhanced phosphatase-1 (DEP-1) is a trans-membrane receptor protein-tyrosine phosphatase that plays a recognized prominent role as a tumor suppressor. However, the mechanistic details underlying its function are poorly understood because its primary physiological substrate(s) have not been firmly established. To shed light on the mechanisms underlying the anti-proliferative role of this phosphatase, we set out to identify new DEP-1 substrates by a novel approach based on screening of high density peptide arrays. The results of the array experiment were combined with a bioinformatics filter to identify eight potential DEP-1 targets among the proteins annotated in the MAPK pathway. In this study we show that one of these potential targets, the ERK1/2, is indeed a direct DEP-1 substrate in vivo. Pulldown and in vitro dephosphorylation assays confirmed our prediction and demonstrated an overall specificity of DEP-1 in targeting the phosphorylated tyrosine 204 of ERK1/2. After epidermal growth factor stimulation, the phosphorylation of the activation loop of ERK1/2 can be modulated by changing the concentration of DEP-1, without affecting the activity of the upstream kinase MEK. In addition, we show that DEP-1 contains a KIM-like motif to recruit ERK1/2 proteins by a docking mechanism mediated by the common docking domain in ERK1/2. ERK proteins that are mutated in the conserved docking domain become insensitive to DEP-1 de-phosphorylation. Overall this study provides novel insights into the anti-proliferative role of this phosphatase and proposes a new mechanism that may also be relevant for the regulation of density-dependent growth inhibition.	[Sacco, Francesca; Tinti, Michele; Palma, Anita; Ferrari, Emanuela; Nardozza, Aurelio P.; Castagnoli, Luisa; Cesareni, Gianni] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Cesareni, Gianni] Ist Ricovero, I-00143 Rome, Italy; [Cesareni, Gianni] Cura Carattere Sci Fdn St Lucia, I-00143 Rome, Italy; [van Huijsduijnen, Rob Hooft] Merck Serono Int SA, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Takahashi, Takamune] Vanderbilt Univ, Med Ctr, Div Nephrol, Nashville, TN 37232 USA; [Takahashi, Takamune] Vanderbilt Univ, Med Ctr, Ctr Vasc Biol, Nashville, TN 37232 USA	University of Rome Tor Vergata; IRCCS Santa Lucia; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.; Vanderbilt University; Vanderbilt University	Castagnoli, L (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy.	castagnoli@uniroma2.it; cesareni@uniroma2.it	van Huijsduijnen, Rob A.M. Hooft/B-3653-2009; Palma, Anita/K-7656-2016; Sacco, Francesca/AAB-4231-2021; Cesareni, Gianni/AAW-1382-2020	van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424; Palma, Anita/0000-0002-5971-3676; Sacco, Francesca/0000-0001-5586-9529; Tinti, Michele/0000-0002-0051-017X; Takahashi, Takamune/0000-0002-4841-2499; Castagnoli, Luisa/0000-0001-5283-8671	Italian Association for Cancer Research; ENFIN Network of Excellence; European Union	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); ENFIN Network of Excellence; European Union(European Commission)	This work was supported by a grant from the Italian Association for Cancer Research, by the ENFIN Network of Excellence, and by the Interaction Proteome Integrated Project of the European Union FP6.	Ahmed N, 2002, ONCOGENE, V21, P1370, DOI 10.1038/sj.onc.1205286; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Arvind R, 2005, INT J ONCOL, V27, P1499; Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Holsinger LJ, 2002, ONCOGENE, V21, P7067, DOI 10.1038/sj.onc.1205858; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Iervolino A, 2006, CANCER RES, V66, P6280, DOI 10.1158/0008-5472.CAN-06-0228; Jallal B, 1997, J BIOL CHEM, V272, P12158, DOI 10.1074/jbc.272.18.12158; Jandt E, 2003, ONCOGENE, V22, P4175, DOI 10.1038/sj.onc.1206652; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Keane MM, 1996, CANCER RES, V56, P4236; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Nelson Peter J, 2002, Kidney Int, V61, pS99; Orchard S, 2007, NAT BIOTECHNOL, V25, P894, DOI 10.1038/nbt1324; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pestana M, 1999, TRANSPLANT P, V31, P306, DOI 10.1016/S0041-1345(98)01638-8; Pettiford SM, 2000, ONCOGENE, V19, P858, DOI 10.1038/sj.onc.1203408; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; SARCEVIC B, 1993, J BIOL CHEM, V268, P25075; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Trapasso F, 2004, CARCINOGENESIS, V25, P2107, DOI 10.1093/carcin/bgh224; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; Walchli S, 2004, J BIOL CHEM, V279, P311, DOI 10.1074/jbc.M307617200; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	50	61	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22048	22058		10.1074/jbc.M109.002758	http://dx.doi.org/10.1074/jbc.M109.002758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19494114	hybrid, Green Published			2022-12-27	WOS:000268783700029
J	Zhang, J; Zhang, XF; Guo, YQ; Xu, LL; Pei, DQ				Zhang, Juan; Zhang, Xiaofei; Guo, Yunqian; Xu, Liangliang; Pei, Duanqing			Sorting Nexin 33 Induces Mammalian Cell Micronucleated Phenotype and Actin Polymerization by Interacting with Wiskott-Aldrich Syndrome Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ARP2/3 COMPLEX; WASP; DOMAINS; SH3PX1; PHOSPHORYLATION; DEGRADATION; ACTIVATION; BINDING; ACK2	Sorting nexin 33 (SNX33) is a novel member of the sorting nexin superfamily with three predicted structural domains, SH3-PX-BAR. Very little is known about the cellular function of SNX33. In an effort to analyze its structure/function relationship, we attempted but failed to generate stable cell lines for short hairpin RNA or overexpression SNX33. Transient knockdown of SNX33 induces both HeLa and MCF7 cells to grow multiple long processes, delay the G(1)/M transition, and become more apoptotic, implying that SNX33 may control cell cycle process through influence the cytoskeleton. In vitro cell lineage analysis revealed that cells transfected with SNX33 failed to divide and became micronucleated, suggesting a specific defect in cytokinesis. Further analysis revealed that SNX33 induced the accumulation of actin at the perinuclear space, which might have disabled the cytokinetic machinery. However, SNX33 appears to mediate actin polymerization indirectly, as they do not interact with each other. SNX33 interacts with itself and SNX9. Interestingly, it also interacts with VCA domain of Wiskott-Aldrich syndrome protein (WASp), a protein known to be involved in actin polymerization. Indeed, cells overexpressing WASp failed to divide and form stable colonies as SNX33, consistent with the notion that SNX33 may interfere with cytokinesis. On the other hand, knockdown of WASp alleviates the phenotype induced by SNX33. Taken together, our results suggest that SNX33 plays a role in maintaining cell shape and cell cycle progression through its interaction with WASp.	[Zhang, Juan; Zhang, Xiaofei; Guo, Yunqian; Xu, Liangliang; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou 510663, Guangdong, Peoples R China; [Zhang, Juan; Zhang, Xiaofei; Guo, Yunqian; Xu, Liangliang; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Hlth, Guangzhou 510663, Guangdong, Peoples R China; [Zhang, Juan; Guo, Yunqian; Xu, Liangliang] Tsinghua Univ, Sch Med, Inst Biomed, Dept Biol Sci & Biotechnol,Lab Stem Cell Biol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Tsinghua University	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Zhang, Xiafoei/C-8471-2014; Guo, Yunqian/L-4716-2013; zhou, xingru/G-4442-2012		National Natural Science Foundation of China [30630039, 30725012, 30700410, 30871404, 90813033]; Knowledge Innovation Project of The Chinese Academy of Sciences [KSCX2-YW-R-48, KSCX1-YW-02-1]; Bureau of Science and Technology of Guangzhou Municipality, China [2008A1-E4011]; 973 Program of China [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of The Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Bureau of Science and Technology of Guangzhou Municipality, China; 973 Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30630039, 30725012, 30700410, 30871404, and 90813033; by Knowledge Innovation Project of The Chinese Academy of Sciences Grants KSCX2-YW-R-48 and KSCX1-YW-02-1; by Bureau of Science and Technology of Guangzhou Municipality, China, Grant 2008A1-E4011; and by 973 Program of China Grants 2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102 and 2009CB940902.	Badour K, 2007, P NATL ACAD SCI USA, V104, P1593, DOI 10.1073/pnas.0610543104; Childress C, 2006, BIOCHEM J, V394, P693, DOI 10.1042/BJ20050576; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Heiseke A, 2008, TRAFFIC, V9, P1116, DOI 10.1111/j.1600-0854.2008.00750.x; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Jiang AX, 2003, J BIOL CHEM, V278, P38765, DOI 10.1074/jbc.M306618200; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Kurten RC, 2001, J CELL SCI, V114, P1743; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Macaulay SL, 2003, BIOCHEM J, V376, P123, DOI 10.1042/BJ20030130; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; Olivier A, 2006, MOL THER, V13, P729, DOI 10.1016/j.ymthe.2005.11.003; Otsuki M, 2003, J BIOL CHEM, V278, P6461, DOI 10.1074/jbc.M207433200; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Qin BM, 2006, J BIOL CHEM, V281, P36891, DOI 10.1074/jbc.M608884200; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; Tsuboi S, 2006, EMBO REP, V7, P506, DOI 10.1038/sj.embor.7400665; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x	31	24	26	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21659	21669		10.1074/jbc.M109.007278	http://dx.doi.org/10.1074/jbc.M109.007278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19487689	Green Published, hybrid			2022-12-27	WOS:000268564400059
J	Kobayashi, T; Patrick, SE; Kobayashi, M				Kobayashi, Tomoyoshi; Patrick, Stacey E.; Kobayashi, Minae			Ala Scanning of the Inhibitory Region of Cardiac Troponin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MUSCLE THIN-FILAMENTS; REGULATORY PROPERTIES; STRUCTURAL BASIS; CALCIUM-BINDING; TROPOMYOSIN; ACTIN; MYOSIN; SITES	In skeletal and cardiac muscles, troponin (Tn), which resides on the thin filament, senses a change in intracellular Ca2+ concentration. Tn is composed of TnC, TnI, and TnT. Ca2+ binding to the regulatory domain of TnC removes the inhibitory effect by TnI on the contraction. The inhibitory region of cardiac TnI spans from residue 138 to 149. Upon Ca2+ activation, the inhibitory region is believed to be released from actin, thus triggering actin-activation of myosin ATPase. In this study, we created a series of Ala-substitution mutants of cTnI to delineate the functional contribution of each amino acid in the inhibitory region to myofilament regulation. We found that most of the point mutations in the inhibitory region reduced the ATPase activity in the presence of Ca2+, which suggests the same region also acts as an activator of the ATPase. The thin filaments can also be activated by strong myosin head (S1)-actin interactions. The binding of N-ethylmaleimide-treated myosin subfragment 1 (NEM-S1) to actin filaments mimics such strong interactions. Interestingly, in the absence of Ca2+ NEM-S1-induced activation of S1 ATPase was significantly less with the thin filaments containing TnI(T144A) than that with the wild-type TnI. However, in the presence of Ca2+, there was little difference in the activation of ATPase activity between these preparations.	[Kobayashi, Tomoyoshi] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kobayashi, T (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott Ave,M-C 901, Chicago, IL 60612 USA.	tkoba@uic.edu			National Institutes of Health [R01 HL082923]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL082923.	Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Burton D, 2002, BIOCHEM J, V362, P443, DOI 10.1042/0264-6021:3620443; Chang AN, 2008, BIOCHEM BIOPH RES CO, V369, P74, DOI 10.1016/j.bbrc.2007.12.081; Craig R, 2001, J MOL BIOL, V311, P1027, DOI 10.1006/jmbi.2001.4897; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gomes AV, 2004, J BIOL CHEM, V279, P49579, DOI 10.1074/jbc.M407340200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GREENE LE, 1987, P NATL ACAD SCI USA, V84, P3102, DOI 10.1073/pnas.84.10.3102; Harada K, 2004, JPN J PHYSIOL, V54, P307, DOI 10.2170/jjphysiol.54.307; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HILL LE, 1992, J BIOL CHEM, V267, P16106; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 2005, J MOL CELL CARDIOL, V38, P213, DOI 10.1016/j.yjmcc.2004.10.014; Kobayashi T, 2000, BIOCHEMISTRY-US, V39, P86, DOI 10.1021/bi991903b; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Kohler J, 2003, PHYSIOL GENOMICS, V14, P117, DOI 10.1152/physiolgenomics.00101.2002; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Malnic B, 1998, J BIOL CHEM, V273, P10594, DOI 10.1074/jbc.273.17.10594; Mathur MC, 2008, BIOPHYS J, V94, P542, DOI 10.1529/biophysj.107.113944; Mathur MC, 2009, BIOPHYS J, V96, P2237, DOI 10.1016/j.bpj.2008.12.3909; Matsumoto F, 2004, J MOL BIOL, V342, P1209, DOI 10.1016/j.jmb.2004.07.086; Maxwell SE, 2003, DESIGNING EXPT ANAL, DOI DOI 10.1158/2159-8290.CD-16-0040; Maytum R, 2003, J BIOL CHEM, V278, P6696, DOI 10.1074/jbc.M210690200; McKay RT, 1998, BIOCHEMISTRY-US, V37, P12419, DOI 10.1021/bi9809019; McKay RT, 1999, BIOCHEMISTRY-US, V38, P5478; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Narolska NA, 2006, CIRC RES, V99, P1012, DOI 10.1161/01.RES.0000248753.30340.af; PAN BS, 1987, J BIOL CHEM, V262, P7839; PAN BS, 1992, J BIOL CHEM, V267, P23052; Patchell VB, 2005, J BIOL CHEM, V280, P14469, DOI 10.1074/jbc.M414202200; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; Robinson JM, 2008, BIOPHYS J, V95, P4772, DOI 10.1529/biophysj.108.131318; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; Tachampa K, 2008, J BIOL CHEM, V283, P15114, DOI 10.1074/jbc.M801636200; Tachampa K, 2007, CIRC RES, V101, P1081, DOI 10.1161/CIRCRESAHA.107.165258; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; VANEYK JE, 1988, J BIOL CHEM, V263, P1726; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x	54	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20052	20060		10.1074/jbc.M109.001396	http://dx.doi.org/10.1074/jbc.M109.001396			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19483081	hybrid, Green Published			2022-12-27	WOS:000268097400032
J	Singer, D; Camargo, SMR; Huggel, K; Romeo, E; Danilczyk, U; Kuba, K; Chesnov, S; Caron, MG; Penninger, JM; Verrey, F				Singer, Dustin; Camargo, Simone M. R.; Huggel, Katja; Romeo, Elisa; Danilczyk, Ursula; Kuba, Keiji; Chesnov, Serge; Caron, Marc G.; Penninger, Josef M.; Verrey, Francois			Orphan Transporter SLC6A18 Is Renal Neutral Amino Acid Transporter B(0)AT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; MICE; KIDNEY; EXPRESSION; MOUSE; COTRANSPORTER; HYPERTENSION; GLYCINE; CELLS; GENE	The orphan transporter Slc6a18 (XT2) is highly expressed at the luminal membrane of kidney proximal tubules and displays similar to 50% identity with Slc6a19 (B(0)AT1), which is the main neutral amino acid transporter in both kidney and small intestine. As yet, the amino acid transport function of XT2 has only been experimentally supported by the urinary glycine loss observed in xt2 null mice. We report here that in Xenopus laevis oocytes, co-expressed ACE2 (angiotensin-converting enzyme 2) associates with XT2 and reveals its function as a Na+- and Cl--dependent neutral amino acid transporter. In contrast to its association with ACE2 observed in Xenopus laevis oocytes, our experiments with ace2 and collectrin null mice demonstrate that in vivo it is Collectrin, a smaller homologue of ACE2, that is required for functional expression of XT2 in kidney. To assess the function of XT2 in vivo, we reanalyzed its knock-out mouse model after more than 10 generations of backcrossing into C57BL/6 background. In addition to the previously published glycinuria, we observed a urinary loss of several other amino acids, in particular beta-branched and small neutral ones. Using telemetry, we confirmed the previously described link of XT2 absence with hypertension but only in physically restrained animals. Taken together, our data indicate that the formerly orphan transporter XT2 functions as a sodium and chloride-dependent neutral amino acid transporter that we propose to rename B(0)AT3.	[Verrey, Francois] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Verrey, Francois] Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Danilczyk, Ursula; Kuba, Keiji; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Chesnov, Serge] Univ & ETH Zurich, Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol Med & Neurobiol, Durham, NC 27710 USA	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Swiss Federal Institutes of Technology Domain; ETH Zurich; Duke University	Verrey, F (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Verrey@access.uzh.ch	Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Camargo, Simone/0000-0003-0091-7380; Verrey, Francois/0000-0003-3250-9824	Swiss National Science Foundation [31-59141.02]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by Swiss National Science Foundation Grant 31-59141.02 (to F.V.).	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Babu S V Suresh, 2002, Indian J Clin Biochem, V17, P7, DOI 10.1007/BF02867967; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Camargo SMR, 2005, PFLUG ARCH EUR J PHY, V451, P338, DOI 10.1007/s00424-005-1455-x; COHEN SA, 1994, J CHROMATOGR A, V661, P25, DOI 10.1016/0021-9673(93)E0821-B; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; Ehnes C, 2004, J GEN PHYSIOL, V124, P475, DOI 10.1085/jgp.200409060; Eslami B, 2006, TOHOKU J EXP MED, V208, P25, DOI 10.1620/tjem.208.25; Lum C, 2004, HYPERTENSION, V43, P79, DOI 10.1161/01.HYP.0000107401.72456.50; Mills PA, 2000, J APPL PHYSIOL, V88, P1537, DOI 10.1152/jappl.2000.88.5.1537; Nash SR, 1998, RECEPTOR CHANNEL, V6, P113; Parks LD, 2002, AM J PHYSIOL-RENAL, V283, pF1208, DOI 10.1152/ajprenal.00021.2002; Paunescu TG, 2004, AM J PHYSIOL-CELL PH, V287, pC149, DOI 10.1152/ajpcell.00464.2003; Pfeiffer R, 1999, MOL BIOL CELL, V10, P4135, DOI 10.1091/mbc.10.12.4135; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Quan H, 2004, MOL CELL BIOL, V24, P4166, DOI 10.1128/MCB.24.10.4166-4173.2004; Ristic Z, 2006, AM J PHYSIOL-RENAL, V290, pF880, DOI 10.1152/ajprenal.00319.2005; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; SEATON B, 1984, MED LAB SCI, V41, P327; Van Abel M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022423.34922.2A; Van Vliet BN, 2003, J PHYSIOL-LONDON, V549, P313, DOI 10.1113/jphysiol.2003.041897; WASSERMAN JC, 1994, AM J PHYSIOL-RENAL, V267, pF688, DOI 10.1152/ajprenal.1994.267.4.F688; Wysocki J, 2006, DIABETES, V55, P2132, DOI 10.2337/db06-0033; Zecevic M, 2004, PFLUG ARCH EUR J PHY, V448, P29, DOI 10.1007/s00424-003-1222-9	26	39	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19953	19960		10.1074/jbc.M109.011171	http://dx.doi.org/10.1074/jbc.M109.011171			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19478081	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000268097400022
J	Barth, MC; Ahluwalia, N; Anderson, TJT; Hardy, GJ; Sinha, S; Alvarez-Cardona, JA; Pruitt, IE; Rhee, EP; Colvin, RA; Gerszten, RE				Barth, Marita C.; Ahluwalia, Neil; Anderson, Thomas J. T.; Hardy, Gregory J.; Sinha, Sumita; Alvarez-Cardona, Jose A.; Pruitt, Ivy E.; Rhee, Eugene P.; Colvin, Richard A.; Gerszten, Robert E.			Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; FUNCTIONAL EXPRESSION; CHEMOTACTIC FACTORS; PATHWAY METABOLISM; MOLECULAR-CLONING; DENDRITIC CELLS; MICE REVEALS; ADHESION; TRYPTOPHAN	Recent studies have demonstrated that kynurenic acid (KYNA), a compound produced endogenously by the interferon-gamma-induced degradation of tryptophan by indoleamine 2,3-dioxygenase, activates the previously orphaned G protein-coupled receptor, GPR35. This receptor is expressed in immune tissues, although its potential function in immunomodulation remains to be explored. We determined that GPR35 was most highly expressed on human peripheral monocytes. In an in vitro vascular flow model, KYNA triggered the firm arrest of monocytes to both fibronectin and ICAM-1, via beta(1) integrin- and beta(2) integrin-mediated mechanisms, respectively. Incubation of monocytes with pertussis toxin prior to use in flow experiments significantly reduced the KYNA-induced monocyte adhesion, suggesting that adhesion is triggered by a G(i)-mediated process. Furthermore, KYNA-triggered adhesion of monocytic cells was reduced by short hairpin RNA-mediated silencing of GPR35. Although GPR35 is expressed at slightly lower levels on neutrophils, KYNA induced firm adhesion of these cells to an ICAM-1-expressing monolayer as well. KYNA also elicited neutrophil shedding of surface L-selectin, another indicator of leukocyte activation. Taken together, these data suggest that KYNA could be an important early mediator of leukocyte recruitment.	[Gerszten, Robert E.] Massachusetts Gen Hosp, Div Cardiol, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gerszten, RE (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Charlestown, MA 02129 USA.	Gerszten.Robert@mgh.harvard.edu		Anderson, Thomas/0000-0002-2762-6703	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065584] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL065584, HL65584] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amirkhani A, 2002, J CHROMATOGR B, V780, P381, DOI 10.1016/S1570-0232(02)00572-X; Baran H, 1997, PEDIATR RES, V41, P404, DOI 10.1203/00006450-199703000-00017; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; BURNS DL, 1988, MICROBIOL SCI, V5, P285; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Chen JC, 2003, EUR J PHARMACOL, V467, P57, DOI 10.1016/S0014-2999(03)01635-2; CLARK RA, 1996, CURRENT PROTOCOLS IM; Forrest CM, 2006, CLIN EXP PHARMACOL P, V33, P1078, DOI 10.1111/j.1440-1681.2006.04490.x; Forrest CM, 2003, ADV EXP MED BIOL, V527, P395; Forrest CM, 2002, J BIOMED SCI, V9, P436, DOI 10.1007/BF02256538; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gerszten RE, 2001, J BIOL CHEM, V276, P26846, DOI 10.1074/jbc.M011235200; Hartai Z, 2007, NEUROCHEM INT, V50, P308, DOI 10.1016/j.neuint.2006.08.012; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; King VL, 2009, CIRCULATION, V119, P426, DOI 10.1161/CIRCULATIONAHA.108.785949; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; KOO C, 1983, J CLIN INVEST, V72, P748, DOI 10.1172/JCI111045; Kuang YN, 1996, J BIOL CHEM, V271, P3975; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Liu CL, 2001, J PHARMACOL EXP THER, V299, P121; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Maes M, 2007, NEUROENDOCRINOL LETT, V28, P826; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Papadopoulou C, 2008, CYTOKINE, V43, P181, DOI 10.1016/j.cyto.2008.05.009; Parsons CG, 1997, J PHARMACOL EXP THER, V283, P1264; Pawlak D., 2001, International Urology and Nephrology, V33, P399, DOI 10.1023/A:1015238418500; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; SMITH CW, 1991, J CLIN INVEST, V87, P609, DOI 10.1172/JCI115037; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stazka J, 2002, EUR J PHARMACOL, V448, P133, DOI 10.1016/S0014-2999(02)01943-X; STONE TW, 1993, PHARMACOL REV, V45, P309; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	41	103	106	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19189	19195		10.1074/jbc.M109.024042	http://dx.doi.org/10.1074/jbc.M109.024042			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473985	Green Published, hybrid			2022-12-27	WOS:000267908300008
J	Castro, MO; Pomin, VH; Santos, LL; Vilela-Silva, ACES; Hirohashi, N; Pol-Fachin, L; Verli, H; Mourao, PAS				Castro, Michelle O.; Pomin, Vitor H.; Santos, Livia L.; Vilela-Silva, Ana-Cristina E. S.; Hirohashi, Noritaka; Pol-Fachin, Laercio; Verli, Hugo; Mourao, Paulo A. S.			A Unique 2-Sulfated beta-Galactan from the Egg Jelly of the Sea Urchin Glyptocidaris crenularis CONFORMATION FLEXIBILITY VERSUS INDUCTION OF THE SPERM ACROSOME REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BASED MECHANISM; PLICATA CHORDATA-TUNICATA; FUCOSE SULFATE POLYMER; MILD ACID-HYDROLYSIS; ACROSOME REACTION; SPECIES RECOGNITION; MOLECULAR-DYNAMICS; AQUEOUS-SOLUTIONS; HEPARIN; FERTILIZATION	Sulfated polysaccharides from the egg jelly of sea urchins act as species-specific inducers of the sperm acrosome reaction, which is a rare molecular mechanism of carbohydrate-induced signal-transduction event in animal cells. The sea urchin polysaccharides differ in monosaccharide composition (L-fucose or L-galactose), glycosylation, and sulfation sites, but they are always in the alpha-anomeric configuration. Herein, structural analysis of the polysaccharide from the sea urchin Glyptocidaris crenularis surprisingly revealed a unique sulfated beta-D-galactan composed by (3-beta-D-Galp-2(OSO3)-1 -> 3-beta-D-Galp-1)(n) repeating units. Subsequently, we used the G. crenularis galactan to compare different 2-sulfated polysaccharides as inducers of the acrosome reaction using homologous and heterologous sperm. We also tested the effect of chemically over-sulfated galactans. Intriguingly, the anomeric configuration of the glycosidic linkage rather than the monosaccharide composition (galactose or fucose) is the preferential structural requirement for the effect of these polysaccharides on sea urchin fertilization. Nuclear magnetic resonance and molecular dynamics indicate that sulfated alpha-galactan or alpha-fucan have less dynamic structural behavior, exhibiting fewer conformational populations, with an almost exclusive conformational state with glycosidic dihedral angles Phi/Psi = -102 degrees/131 degrees. The preponderant conformer observed in the sulfated alpha-galactan or alpha-fucan is not observed among populations in the beta-form despite its more flexible structure in solution. Possibly, a proper spatial arrangement is required for interaction of the sea urchin-sulfated polysaccharides with the specific sperm receptor.	[Castro, Michelle O.; Pomin, Vitor H.; Santos, Livia L.; Mourao, Paulo A. S.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Vilela-Silva, Ana-Cristina E. S.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941590 Rio De Janeiro, Brazil; [Castro, Michelle O.; Pomin, Vitor H.; Santos, Livia L.; Vilela-Silva, Ana-Cristina E. S.; Verli, Hugo; Mourao, Paulo A. S.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Tecido Conjunt, BR-21941590 Rio De Janeiro, Brazil; [Hirohashi, Noritaka] Ochanomizu Univ, Grad Sch Humanities & Sci, Genet Counseling Course, Tokyo 1128610, Japan; [Verli, Hugo] Univ Fed Rio Grande do Sul, Fac Farm, BR-91500970 Porto Alegre, RS, Brazil; [Pol-Fachin, Laercio; Verli, Hugo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, BR-91500970 Porto Alegre, RS, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Ochanomizu University; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Mourao, PAS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Caixa Postal 68041, BR-21941590 Rio De Janeiro, Brazil.	pmourao@hucff.ufrj.br	Verli, Hugo/G-8703-2012; Verli, Hugo/AAZ-2148-2021; Mourao, Paulo/AAA-5386-2020	Verli, Hugo/0000-0002-4796-8620; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	ALBANO RM, 1986, J BIOL CHEM, V261, P758; Alves AP, 1997, J BIOL CHEM, V272, P6965, DOI 10.1074/jbc.272.11.6965; Alves AP, 1998, GLYCOBIOLOGY, V8, P939, DOI 10.1093/glycob/8.9.939; Amornrut C, 1999, CARBOHYD RES, V321, P121, DOI 10.1016/S0008-6215(99)00188-3; Becker CF, 2007, J MOL GRAPH MODEL, V26, P391, DOI 10.1016/j.jmgm.2007.01.008; Becker CF, 2005, CARBOHYD RES, V340, P1499, DOI 10.1016/j.carres.2005.03.018; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Biermann CH, 2004, EVOL DEV, V6, P353, DOI 10.1111/j.1525-142X.2004.04043.x; Bilan MI, 2007, CARBOHYD RES, V342, P586, DOI 10.1016/j.carres.2006.11.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Farias EHC, 2008, GLYCOBIOLOGY, V18, P250, DOI 10.1093/glycob/cwm139; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hirai E., 1963, Science Reports of the Tohoku University, V29, P369; Hirohashi N, 2003, BIOCHEM BIOPH RES CO, V304, P285, DOI 10.1016/S0006-291X(03)00587-4; Hirohashi N, 2002, BIOCHEM BIOPH RES CO, V296, P833, DOI 10.1016/S0006-291X(02)00941-5; Hirohashi N, 2002, BIOCHEM BIOPH RES CO, V298, P403, DOI 10.1016/S0006-291X(02)02441-5; Hirohashi N, 2002, J BIOL CHEM, V277, P8041, DOI 10.1074/jbc.M110661200; Hirohashi N, 2002, J BIOL CHEM, V277, P1182, DOI 10.1074/jbc.M108046200; KABAT EA, 1971, EXPT IMMUNOCHEMISTRY, P505; KIRCHER HW, 1960, ANAL CHEM, V32, P1103, DOI 10.1021/ac60165a016; Mourao PAS, 2007, BRAZ J MED BIOL RES, V40, P5, DOI 10.1590/S0100-879X2007000100002; MOURAO PAS, 1987, EUR J BIOCHEM, V166, P431, DOI 10.1111/j.1432-1033.1987.tb13534.x; MULLOY B, 1994, J BIOL CHEM, V269, P22113; Pereira MS, 2002, CARBOHYD RES, V337, P2231, DOI 10.1016/S0008-6215(02)00215-X; Pol-Fachin L, 2008, CARBOHYD RES, V343, P1435, DOI 10.1016/j.carres.2008.04.016; Pomin VH, 2005, GLYCOBIOLOGY, V15, P1376, DOI 10.1093/glycob/cwj030; Pomin VH, 2005, GLYCOBIOLOGY, V15, P369, DOI 10.1093/glycob/cwi021; RAVENSCROFT N, 1995, EUR J BIOCHEM, V227, P889, DOI 10.1111/j.1432-1033.1995.tb20215.x; SAITO H, 1968, J BIOL CHEM, V243, P1536; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Su YH, 2006, MOL BIOL CELL, V17, P114, DOI 10.1091/mbc.e05-08-0820; Usov AI, 1997, CARBOHYD RES, V303, P93, DOI 10.1016/S0008-6215(97)00136-5; VACQUIER VD, 1977, P NATL ACAD SCI USA, V74, P2456, DOI 10.1073/pnas.74.6.2456; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Verli H, 2005, J MOL GRAPH MODEL, V24, P203, DOI 10.1016/j.jmgm.2005.07.002; Verli H, 2004, CARBOHYD RES, V339, P281, DOI 10.1016/j.carres.2003.09.026; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; Vilela-Silva ACES, 2002, J BIOL CHEM, V277, P379, DOI 10.1074/jbc.M108496200; Vilela-Silva ACES, 1999, GLYCOBIOLOGY, V9, P927, DOI 10.1093/glycob/9.9.927; Vilela-Silva ACES, 2008, INT J DEV BIOL, V52, P551, DOI 10.1387/ijdb.072531av; WOODS RJ, 1995, CURR OPIN STRUC BIOL, V5, P591, DOI 10.1016/0959-440X(95)80049-2	45	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18790	18800		10.1074/jbc.M109.005702	http://dx.doi.org/10.1074/jbc.M109.005702			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19403528	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000267711500028
J	Martins, M; Rodrigues-Lima, F; Dairou, J; Lamouri, A; Malagnac, F; Silar, P; Dupret, JM				Martins, Marta; Rodrigues-Lima, Fernando; Dairou, Julien; Lamouri, Aazdine; Malagnac, Fabienne; Silar, Philippe; Dupret, Jean-Marie			An Acetyltransferase Conferring Tolerance to Toxic Aromatic Amine Chemicals MOLECULAR AND FUNCTIONAL STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYLAMINE N-ACETYLTRANSFERASES; PODOSPORA-ANSERINA; FILAMENTOUS FUNGI; GENOME SEQUENCE; SOIL; DIURON; MICE; METABOLISM; EXPRESSION; GENERATION	Aromatic amines (AA) are a major class of environmental pollutants that have been shown to have genotoxic and cytotoxic potentials toward most living organisms. Fungi are able to tolerate a diverse range of chemical compounds including certain AA and have long been used as models to understand general biological processes. Deciphering the mechanisms underlying this tolerance may improve our understanding of the adaptation of organisms to stressful environments and pave the way for novel pharmaceutical and/or biotechnological applications. We have identified and characterized two arylamine N-acetyltransferase (NAT) enzymes (PaNAT1 and PaNAT2) from the model fungus Podospora anserina that acetylate a wide range of AA. Targeted gene disruption experiments revealed that PaNAT2 was required for the growth and survival of the fungus in the presence of toxic AA. Functional studies using the knock-out strains and chemically acetylated AA indicated that tolerance of P. anserina to toxic AA was due to the N-acetylation of these chemicals by PaNAT2. Moreover, we provide proof-of-concept remediation experiments where P. anserina, through its PaNAT2 enzyme, is able to detoxify the highly toxic pesticide residue 3,4-dichloroaniline in experimentally contaminated soil samples. Overall, our data show that a single xenobiotic-metabolizing enzyme can mediate tolerance to a major class of pollutants in a eukaryotic species. These findings expand the understanding of the role of xenobiotic-metabolizing enzyme and in particular of NATs in the adaptation of organisms to their chemical environment and provide a basis for new systems for the bioremediation of contaminated soils.	[Martins, Marta; Rodrigues-Lima, Fernando; Dairou, Julien; Dupret, Jean-Marie] Univ Paris 07, Lab Reponses Mol & Cellulaires Xenobiot, CNRS, Unite Biol Fonct & Adaptat,EAC 7059, F-75205 Paris 13, France; [Martins, Marta; Rodrigues-Lima, Fernando; Dairou, Julien; Malagnac, Fabienne; Silar, Philippe; Dupret, Jean-Marie] Univ Paris 07, UFR Sci Vivant, F-75013 Paris, France; [Lamouri, Aazdine] Univ Paris 07, Lab Interfaces Traitements Org & Dynam Syst, CNRS, UMR 7086, F-75013 Paris, France; [Lamouri, Aazdine] Univ Paris 07, UFR Chim, F-75013 Paris, France; [Malagnac, Fabienne; Silar, Philippe] Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Dupret, JM (corresponding author), Univ Paris 07, Lab Reponses Mol & Cellulaires Xenobiot, CNRS, Unite Biol Fonct & Adaptat,EAC 7059, Batiment Buffon,3Eme Etage,4 Rue Marie Andree Lag, F-75205 Paris 13, France.	jean-marie.dupret@univ-paris-diderot.fr	Martins, Marta/A-9905-2013	Martins, Marta/0000-0003-0429-9380; silar, philippe/0000-0003-0104-987X; Malagnac, Fabienne/0000-0003-1139-7691	Association pour la Recherche sur le Cancer (ARC); la Caisse d'Assurance Maladie des Professions Liberales de Province; Universite Paris Diderot- Paris 7; Universite Paris 11-Sud	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); la Caisse d'Assurance Maladie des Professions Liberales de Province; Universite Paris Diderot- Paris 7; Universite Paris 11-Sud	This work was supported by grants from the Association pour la Recherche sur le Cancer (ARC) and la Caisse d'Assurance Maladie des Professions Liberales de Province and running grants from Universite Paris Diderot- Paris 7 and Universite Paris 11-Sud.	[Anonymous], 2005, 11 US DEP HLTH HUM S; Brazier-Hicks M, 2005, PLANT J, V42, P556, DOI 10.1111/j.1365-313X.2005.02398.x; Brooke EW, 2003, BIOORGAN MED CHEM, V11, P1227, DOI 10.1016/S0968-0896(02)00642-9; Cornish VA, 2003, PHARMACOGENOMICS J, V3, P169, DOI 10.1038/sj.tpj.6500170; D'Annibale A, 2006, APPL ENVIRON MICROB, V72, P28, DOI 10.1128/AEM.72.1.28-36.2006; DUPRET JM, 1992, J BIOL CHEM, V267, P7381; Dupret JM, 2005, CURR MED CHEM, V12, P311, DOI 10.2174/0929867053363289; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Gan JP, 2004, JNCI-J NATL CANCER I, V96, P1425, DOI 10.1093/jnci/djh274; Giacomazzi S, 2004, CHEMOSPHERE, V56, P1021, DOI 10.1016/j.chemosphere.2004.04.061; GLENN AE, 2009, J APPL MICR IN PRESS; Gooddy DC, 2002, SCI TOTAL ENVIRON, V297, P67, DOI 10.1016/S0048-9697(02)00079-7; Hein DW, 2000, TOXICOL LETT, V112, P349, DOI 10.1016/S0378-4274(99)00226-X; HULZEBOS EM, 1993, ENVIRON TOXICOL CHEM, V12, P1079, DOI 10.1002/etc.5620120614; Kim D, 2005, ANNU REV PHARMACOL, V45, P27, DOI 10.1146/annurev.pharmtox.45.120403.100010; Malagnac F, 2007, EUKARYOT CELL, V6, P2323, DOI 10.1128/EC.00083-07; Martins M, 2008, J MOL BIOL, V383, P549, DOI 10.1016/j.jmb.2008.08.035; Palmiotto G, 2001, CHEMOSPHERE, V43, P355, DOI 10.1016/S0045-6535(00)00109-0; RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51; Rodrigues-Lima F, 2006, MOL MICROBIOL, V60, P505, DOI 10.1111/j.1365-2958.2006.05114.x; Rodrigues-Lima F, 2002, BIOCHEM BIOPH RES CO, V293, P783, DOI 10.1016/S0006-291X(02)00299-1; Silar P, 1999, GENETICS, V151, P87; Silar P, 2005, MYCOL RES, V109, P137, DOI 10.1017/S0953756204002230; Silar P, 2001, GENETICS, V158, P1477; Silar P, 1995, FUNG GENET NEWSLETT, V42, P73, DOI DOI 10.4148/1941-4765.1353; Sim E, 2008, DRUG METAB REV, V40, P479, DOI [10.1080/03602530802186603, 10.1080/03602530802186603 ]; Stadler M, 2008, MYCOL RES, V112, P127, DOI 10.1016/j.mycres.2007.12.002; Sugamori KS, 2006, DRUG METAB DISPOS, V34, P1697, DOI 10.1124/dmd.106.010819; Sugamori KS, 2003, MOL PHARMACOL, V64, P170, DOI 10.1124/mol.64.1.170; Teeri TT, 2004, NAT BIOTECHNOL, V22, P679, DOI 10.1038/nbt0604-679; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Tixier C, 2002, CHEMOSPHERE, V46, P519, DOI 10.1016/S0045-6535(01)00193-X; Tortella GR, 2005, CRIT REV MICROBIOL, V31, P197, DOI 10.1080/10408410500304066; Voelker D, 2008, AQUAT TOXICOL, V86, P112, DOI 10.1016/j.aquatox.2007.10.007; Westwood IM, 2005, BIOCHEM J, V385, P605, DOI 10.1042/BJ20041330	35	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18726	18733		10.1074/jbc.M109.015230	http://dx.doi.org/10.1074/jbc.M109.015230			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19416981	Green Published, hybrid			2022-12-27	WOS:000267711500022
J	Shiozaki, K; Koseki, K; Yamaguchi, K; Shiozaki, M; Narimatsu, H; Miyagi, T				Shiozaki, Kazuhiro; Koseki, Koichi; Yamaguchi, Kazunori; Shiozaki, Momo; Narimatsu, Hisashi; Miyagi, Taeko			Developmental Change of Sialidase Neu4 Expression in Murine Brain and Its Involvement in the Regulation of Neuronal Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; GANGLIOSIDE SIALIDASE; MOLECULAR-CLONING; SUPPRESSION; GLYCOGENES; PHENOTYPE; CANCERS; MICE	Sialidase Neu4 is reported to be dominantly expressed in the mouse brain, but its functional significance is not fully understood. We previously demonstrated that sialidase Neu3, also rich in mouse brain, is up-regulated during neuronal differentiation with involvement in acceleration of neurite formation. To elucidate physiological functions of Neu4, as well as Neu3, we determined expression during mouse brain development by quantitative RT-PCR. Expression was relatively low in the embryonic stage and then rapidly increased at 3-14 days after birth, whereas Neu3 demonstrated high levels in the embryonic stage and down-regulation after birth. Murine Neu4 was found to possess two isoforms differing in expression levels, developmental pattern, and enzymatic character. Distinct from the human isoforms, the murine forms, to a different extent, both catalyzed the removal of sialic acid from gangliosides as well as glycoproteins, and one isoform seemed to act on polysialylated NCAM efficiently, despite the low activity toward ordinary substrates. In situ hybridization demonstrated Neu4 mRNA to be present mainly in the hippocampus in which NCAM is rich and decreases after birth. During retinoic acid-induced differentiation, Neu4 expression was down-regulated in Neuro2a cells. Overexpression of Neu4 resulted in suppression of neurite formation, and its knockdown showed the acceleration. Thin layer chromatography of the glycolipids from Neu4-transfected cells showed ganglioside compositions to be only slightly affected, although lectin blot analysis revealed increased binding to Ricinus communis agglutinin (RCA) lectin of a similar to 95-kDa glycoprotein, which decreased with cell differentiation. These results suggest that mouse Neu4 plays an important regulatory role in neurite formation, possibly through desialylation of glycoproteins.	[Shiozaki, Kazuhiro; Koseki, Koichi; Yamaguchi, Kazunori; Shiozaki, Momo; Miyagi, Taeko] Miyagi Canc Ctr, Res Inst, Div Biochem, Natori, Miyagi 9811293, Japan; [Shiozaki, Kazuhiro; Koseki, Koichi; Miyagi, Taeko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan	Miyagi Cancer Center; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Miyagi, T (corresponding author), Miyagi Canc Ctr, Res Inst, Div Biochem, 47-1 Aza Nodayama, Natori, Miyagi 9811293, Japan.	miyagi-ta173@pref.miyagi.jp	Narimatsu, Hisashi/M-4757-2018	Narimatsu, Hisashi/0000-0002-8402-133X; Shiozaki, Kazuhiro/0000-0002-0523-838X	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Exploratory Research and Scientific Research on Priority Areas Cancer from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Fanzani A, 2004, FEBS LETT, V566, P178, DOI 10.1016/j.febslet.2004.03.115; Hasegawa T, 2001, BIOCHEM BIOPH RES CO, V280, P726, DOI 10.1006/bbrc.2000.4186; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Hasegawa T, 2007, FEBS LETT, V581, P406, DOI 10.1016/j.febslet.2006.12.046; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kato T, 2001, INT J CANCER, V92, P797, DOI 10.1002/ijc.1268; Magesh S, 2006, J MOL GRAPH MODEL, V25, P196, DOI 10.1016/j.jmgm.2005.12.006; Miyagi T., 2007, COMPREHENSIVE GLYCOS, P297; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; Monti E, 2004, GENOMICS, V83, P445, DOI 10.1016/j.ygeno.2003.08.019; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Proshin S, 2002, NEUROCHEM RES, V27, P841, DOI 10.1023/A:1020269326825; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Valaperta R, 2007, J NEUROCHEM, V100, P708, DOI 10.1111/j.1471-4159.2006.04279.x; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; Yamanami H, 2007, CANCER SCI, V98, P299, DOI 10.1111/j.1349-7006.2007.00403.x	24	43	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21157	21164		10.1074/jbc.M109.012708	http://dx.doi.org/10.1074/jbc.M109.012708			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506080	Green Published, hybrid			2022-12-27	WOS:000268564400008
J	Seminario-Vidal, L; Kreda, S; Jones, L; O'Neal, W; Trejo, J; Boucher, RC; Lazarowski, ER				Seminario-Vidal, Lucia; Kreda, Silvia; Jones, Lisa; O'Neal, Wanda; Trejo, Joann; Boucher, Richard C.; Lazarowski, Eduardo R.			Thrombin Promotes Release of ATP from Lung Epithelial Cells through Coordinated Activation of Rho- and Ca2+-dependent Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE LIQUID HOMEOSTASIS; HUMAN AIRWAY EPITHELIA; PROTEIN-KINASE-C; CYSTIC-FIBROSIS; INTRACELLULAR CALCIUM; ION-TRANSPORT; EXTRACELLULAR ATP; P2Y(2) RECEPTOR; FAMILY GTPASES; CALU-3 CELLS	Extracellular ATP controls key aspects of lung function via activation of epithelial cell purinergic receptors, but how ATP is released from cells remains poorly understood. To identify mechanistic components upstream of ATP release, we examined the effect of selected G protein coupled-receptor activation on ATP release from lung epithelial cells. The protease-activated receptor ( PAR) agonist thrombin elicited a rapid Ca2+-dependent release of ATP from A549 cells. In contrast, the P2Y(2) receptor agonist UTP caused negligible ATP release, despite promoting a robust Ca2+ response. Agonist-elicited ATP release was associated with Rho activation and was reduced in cells transfected with dominant negative mutants of p115-Rho GEF or RhoA, and by inhibitors of Rho kinase ( ROCK). However, RhoA activation alone did not promote ATP release if temporally separated from Ca2+ mobilization. PAR3 was the only PAR subtype detected in A549 cells by reverse transcription-PCR. Transfection of cells with human PAR3 cDNA increased thrombin-promoted ATP release, inositol phosphate formation, and RhoA activation. Conversely, small interference RNA against PAR3 diminished thrombin-evoked responses. Thrombin-elicited ATP release was accompanied by an enhanced cellular uptake of propidium iodide in a Ca2+- and ROCK-dependent manner and was inhibited by connexin/pannexin hemichannel blockers. Our data suggest that thrombin promotes ATP release from A549 cells via Rho- and Ca2+-dependent activation of connexin/pannexin hemichannels. The relevance of these findings is highlighted by the observation that exposure of primary cultures of well differentiated human bronchial epithelial cells to thrombin resulted in robust ATP release, which was inhibited by ROCK inhibitors and by connexin/pannexin hemichannel blockers.	[Lazarowski, Eduardo R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Dept Med, Chapel Hill, NC 27599 USA; [Seminario-Vidal, Lucia] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Trejo, Joann] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego	Lazarowski, ER (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Dept Med, 7017 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	eduardo_lazarowski@med.unc.edu	Seminario-Vidal, Lucia/AAR-3314-2020	Seminario-Vidal, Lucia/0000-0002-6004-2451; TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [P01-HL034322]; Cystic Fibrosis Foundation [CFF-SEMINA08FO]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322, R01HL073328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL034322. This work was also supported by Cystic Fibrosis Foundation Grant CFF-SEMINA08FO ( to L. S. V.).	Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Blum AE, 2008, AM J PHYSIOL-CELL PH, V295, pC231, DOI 10.1152/ajpcell.00175.2008; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Boudreault F, 2004, J PHYSIOL-LONDON, V561, P499, DOI 10.1113/jphysiol.2004.072306; Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cressman VL, 1999, J BIOL CHEM, V274, P26461, DOI 10.1074/jbc.274.37.26461; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; Danahay H, 2001, AM J PHYSIOL-CELL PH, V280, pC1455, DOI 10.1152/ajpcell.2001.280.6.C1455; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; Devor DC, 1999, AM J PHYSIOL-CELL PH, V276, pC827, DOI 10.1152/ajpcell.1999.276.4.C827; Factor P, 2007, P NATL ACAD SCI USA, V104, P4083, DOI 10.1073/pnas.0601117104; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Furstenau CR, 2004, CHEM-BIOL INTERACT, V148, P93, DOI 10.1016/j.cbi.2004.04.003; Gavard J, 2008, J BIOL CHEM, V283, P29888, DOI 10.1074/jbc.M803880200; Goel R, 2004, J BIOL CHEM, V279, P6701, DOI 10.1074/jbc.M308753200; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Hains MD, 2004, METHOD ENZYMOL, V389, P71; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Hirakawa M, 2004, J PHYSIOL-LONDON, V558, P479, DOI 10.1113/jphysiol.2004.065334; HUNG DT, 1992, J BIOL CHEM, V267, P20831; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; Joseph SM, 2004, BRIT J PHARMACOL, V142, P1002, DOI 10.1038/sj.bjp.0705865; Joseph SM, 2003, J BIOL CHEM, V278, P23331, DOI 10.1074/jbc.M302680200; Koyama T, 2001, J PHYSIOL-LONDON, V532, P759, DOI 10.1111/j.1469-7793.2001.0759e.x; Kreda SM, 2008, BRIT J PHARMACOL, V153, P1528, DOI 10.1038/sj.bjp.0707692; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Kunzelmann K, 2002, CELL BIOCHEM BIOPHYS, V36, P209, DOI 10.1385/CBB:36:2-3:209; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lazarowski ER, 2003, MOL PHARMACOL, V63, P1190, DOI 10.1124/mol.63.5.1190; Lazarowski ER, 1997, P NATL ACAD SCI USA, V94, P2599, DOI 10.1073/pnas.94.6.2599; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Ostrowska E, 2008, CELL MOL LIFE SCI, V65, P970, DOI 10.1007/s00018-008-7555-y; Palmer ML, 2006, AM J PHYSIOL-CELL PH, V290, pC1189, DOI 10.1152/ajpcell.00464.2005; PARADISO AM, 1995, NATURE, V377, P643, DOI 10.1038/377643a0; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Picher M, 2004, J BIOL CHEM, V279, P20234, DOI 10.1074/jbc.M400305200; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; SAITOH M, 1987, J BIOL CHEM, V262, P7796; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Sesma JI, 2009, J BIOL CHEM, V284, P12572, DOI 10.1074/jbc.M806759200; Seye CI, 2004, J BIOL CHEM, V279, P35679, DOI 10.1074/jbc.M401799200; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tatur S, 2008, PURINERG SIGNAL, V4, P139, DOI 10.1007/s11302-007-9059-x; Tatur S, 2007, J PHYSIOL-LONDON, V584, P419, DOI 10.1113/jphysiol.2007.133314; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zsembery A, 2004, J BIOL CHEM, V279, P10720, DOI 10.1074/jbc.M313391200	65	86	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20638	20648		10.1074/jbc.M109.004762	http://dx.doi.org/10.1074/jbc.M109.004762			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19439413	Green Published, hybrid			2022-12-27	WOS:000268316100025
J	Van Themsche, C; Leblanc, V; Parent, S; Asselin, E				Van Themsche, Celine; Leblanc, Valerie; Parent, Sophie; Asselin, Eric			X-linked Inhibitor of Apoptosis Protein (XIAP) Regulates PTEN Ubiquitination, Content, and Compartmentalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; CELL-DEATH; PROSTATE-CANCER; LIGASE ACTIVITY; DEGRADATION; MONOUBIQUITINATION; LOCALIZATION; INDUCTION; STABILITY; CASPASE-9	Apoptotic cell death plays a normal role in various physiological processes, and deregulated apoptosis is a hallmark of several diseases, including cancer. Cell fate is dictated by the balance between pro- and antiapoptotic factors. Akt is one of these antiapoptotic factors, which must be activated through phosphorylation. The phosphorylation of Akt has previously been shown to be promoted by X-linked inhibitor of apoptosis protein (XIAP), another antiapoptotic protein dictating the fate of normal and cancer cells. However, the underlying mechanisms are poorly understood. We have observed that XIAP associates with PTEN (phosphatase and tensin homolog deleted on chromosome ten), the best characterized negative regulator of Akt phosphorylation, in vitro and in vivo. XIAP knockdown reduces constitutive mono- and polyubiquitination of PTEN, increases PTEN protein levels, and prevents nuclear accumulation of PTEN. Overexpression of XIAP induces polyubiquitination of PTEN and proteasome-dependent decrease of PTEN protein levels. RNA interference experiments showed that XIAP-induced regulation of Akt phosphorylation is PTEN-dependent. Additional experiments confirmed that XIAP also regulates PTEN in vivo; primary mouse embryonic fibroblasts derived from XIAP(-/-) mice contain higher levels of PTEN protein, less mono- and polyubiquitinated PTEN, and less nuclear PTEN than primary mouse embryonic fibroblasts derived from XIAP(+/+) mice. Finally, we found that XIAP can directly ubiquitinate PTEN in vitro. We thus propose that XIAP acts as an E3 ubiquitin ligase for PTEN and promotes Akt activity by regulating PTEN content and compartmentalization.	[Van Themsche, Celine; Leblanc, Valerie; Parent, Sophie; Asselin, Eric] Univ Quebec, Dept Biol Chem, Trois Rivieres, PQ G9A 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Asselin, E (corresponding author), Univ Quebec, Dept Biol Chem, 3351 Boul Des Forges,CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	eric.asselin@uqtr.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a research grant from the Canadian Institute of Health Research and a grant from Natural Sciences and Engineering Research Council of Canada.	Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Asselin E, 2001, ENDOCRINOLOGY, V142, P2451, DOI 10.1210/en.142.6.2451; Asselin E, 2001, CANCER RES, V61, P1862; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Dai Y, 2008, INT J CANCER, V122, P2858, DOI 10.1002/ijc.23443; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Huang HK, 2000, J BIOL CHEM, V275, P26661; Hwang C, 2008, CELL DEATH DIFFER, V15, P831, DOI 10.1038/cdd.2008.15; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Schwab M, 2008, CARCINOGENESIS, V29, P1407, DOI 10.1093/carcin/bgn118; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Themsche C, 2007, J BIOL CHEM, V282, P4794, DOI 10.1074/jbc.M608497200; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	26	112	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20462	20466		10.1074/jbc.C109.009522	http://dx.doi.org/10.1074/jbc.C109.009522			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19473982	Green Published, hybrid			2022-12-27	WOS:000268316100007
J	Xu, JF; Testa, JR				Xu, Jinfei; Testa, Joseph R.			DLX5 (Distal-less Homeobox 5) Promotes Tumor Cell Proliferation by Transcriptionally Regulating MYC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN C-MYC; ONCOGENE EXPRESSION; GENE-EXPRESSION; LUNG-CANCER; APOPTOSIS; DIFFERENTIATION; IDENTIFICATION; ACTIVATION; INHIBITION; 10058-F4	The human DLX homeobox genes, which are related to Dll (Drosophila distal-less gene), encode transcription factors that are expressed primarily in embryonic development. Recently, DLX5 was reported to act as an oncogene in lymphomas and lung cancers, although the mechanism is not known. The identification of target genes of DLX5 can facilitate our understanding of oncogenic mechanisms driven by overexpression of DLX5. The MYC oncogene is aberrantly expressed in many human cancers and regulates transcription of numerous target genes involved in tumorigenesis. Here we demonstrate by luciferase assay that the MYC promoter is specifically activated by overexpression of DLX5 and that two DLX5 binding sites in the MYC promoter are important for transcriptional activation of MYC. We also show that DLX5 binds to the MYC promoter both in vitro and in vivo and that transfection of a DLX5 expression plasmid promotes the expression of MYC in a dose-dependent manner in mammalian cells. Furthermore, overexpression of DLX5 results in increased cell proliferation by up-regulating MYC. Knockdown of DLX5 in lung cancer cells overexpressing DLX5 resulted in decreased expression of MYC and reduced cell proliferation, which was rescued by overexpression of MYC. Because DLX5 has a restricted pattern of expression in adult tissues, it may serve as a potential therapeutic target for the treatment of cancers that overexpress DLX5.	[Xu, Jinfei; Testa, Joseph R.] Fox Chase Canc Ctr, Canc Signaling & Genet Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Testa, JR (corresponding author), Fox Chase Canc Ctr, Canc Signaling & Genet Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Joseph.Testa@fccc.edu			National Institutes of Health [CA77429, CA06927]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA077429, P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77429 and CA06927. This work was also supported by an appropriation from the Commonwealth of Pennsylvania.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Benson MD, 2000, J BIOL CHEM, V275, P13907, DOI 10.1074/jbc.275.18.13907; CLINE MJ, 1987, CANCER, V60, P2669, DOI 10.1002/1097-0142(19871201)60:11<2669::AID-CNCR2820601116>3.0.CO;2-4; Dang CV, 1999, MOL CELL BIOL, V19, P1; DAVIS M, 1984, NATURE, V308, P286, DOI 10.1038/308286a0; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; DUBIK D, 1987, CANCER RES, V47, P6517; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Han YQ, 2004, ONCOGENE, V23, P6933, DOI 10.1038/sj.onc.1207609; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hennessy BT, 2006, INT J BIOCHEM CELL B, V38, P1450, DOI 10.1016/j.biocel.2006.01.009; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Kato T, 2008, CLIN CANCER RES, V14, P2363, DOI 10.1158/1078-0432.CCR-07-1523; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Kraus P, 2006, AM J MED GENET A, V140A, P1366, DOI 10.1002/ajmg.a.31252; Kubokura H, 1999, Nihon Ika Daigaku Zasshi, V66, P107, DOI 10.1272/jnms.66.107; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lin CP, 2007, ANTI-CANCER DRUG, V18, P161, DOI 10.1097/CAD.0b013e3280109424; Marinkovic D, 2004, INT J CANCER, V110, P336, DOI 10.1002/ijc.20099; MASTERS JRW, 1988, UROL RES, V16, P341; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; NOWELL P, 1983, NATURE, V306, P494, DOI 10.1038/306494a0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; SCHERER SW, 1994, HUM MOL GENET, V3, P1345; Shimamoto T, 1997, P NATL ACAD SCI USA, V94, P3245, DOI 10.1073/pnas.94.7.3245; SIKORA K, 1987, CANCER-AM CANCER SOC, V59, P1289, DOI 10.1002/1097-0142(19870401)59:7<1289::AID-CNCR2820590710>3.0.CO;2-O; SIKORA K, 1985, BRIT J CANCER, V52, P171, DOI 10.1038/bjc.1985.174; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Suzuki K, 2008, EUR J HUM GENET, V16, P36, DOI 10.1038/sj.ejhg.5201925; Tan YF, 2008, CANCER RES, V68, P1296, DOI 10.1158/0008-5472.CAN-07-3218; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wierstra I, 2006, FEBS J, V273, P4645, DOI 10.1111/j.1742-4658.2006.05468.x; YAMADA H, 1986, JPN J CANCER RES, V77, P370	40	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20593	20601		10.1074/jbc.M109.021477	http://dx.doi.org/10.1074/jbc.M109.021477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497851	hybrid, Green Published			2022-12-27	WOS:000268316100021
J	Yi, L; Jenkins, PM; Leichert, LI; Jakob, U; Martens, JR; Ragsdale, SW				Yi, Li; Jenkins, Paul M.; Leichert, Lars I.; Jakob, Ursula; Martens, Jeffrey R.; Ragsdale, Stephen W.			Heme Regulatory Motifs in Heme Oxygenase-2 Form a Thiol/Disulfide Redox Switch That Responds to the Cellular Redox State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-MONOXIDE; BIOLOGICAL SIGNIFICANCE; IRR PROTEIN; DEGRADATION; SYSTEM; THIOREDOXIN; ENVIRONMENT; ACTIVATION; MOLECULE; BINDING	Heme oxygenase (HO) catalyzes the rate-limiting step in heme catabolism to generate CO, biliverdin, and free iron. Two isoforms of HO have been identified in mammals: inducible HO-1 and constitutively expressed HO-2. HO-1 and HO-2 share similar physical and kinetic properties but have different physiological roles and tissue distributions. Unlike HO-1, which lacks cysteine residues, HO-2 contains three Cys-Pro signatures, known as heme regulatory motifs (HRMs), which are known to control processes related to iron and oxidative metabolism in organisms from bacteria to humans. In HO-2, the C-terminal HRMs constitute a thiol/disulfide redox switch that regulates affinity of the enzyme for heme (Yi, L., and Ragsdale, S. W. (2007) J. Biol. Chem. 282, 20156-21067). Here, we demonstrate that the thiol/disulfide switch in human HO-2 is physiologically relevant. Its redox potential was measured to be -200 mV, which is near the ambient intracellular redox potential. We expressed HO-2 in bacterial and human cells and measured the redox state of the C-terminal HRMs in growing cells by thiol-trapping experiments using the isotope-coded affinity tag technique. Under normal growth conditions, the HRMs are 60-70% reduced, whereas oxidative stress conditions convert most (86-89%) of the HRMs to the disulfide state. Treatment with reductants converts the HRMs largely (81-87%) to the reduced dithiol state. Thus, the thiol/disulfide switch in HO-2 responds to cellular oxidative stress and reductive conditions, representing a paradigm for how HRMs can integrate heme homeostasis with CO signaling and redox regulation of cellular metabolism.	[Ragsdale, Stephen W.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Jenkins, Paul M.; Martens, Jeffrey R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Leichert, Lars I.; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu	Jenkins, Paul/C-9098-2015; Leichert, Lars I./B-4762-2009; Yi, Li/A-3967-2013	Jenkins, Paul/0000-0002-4207-5823; Leichert, Lars I./0000-0002-5666-9681; 	National Institutes of Health [R21HL089837, GM065318, AG027349]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R21HL089837 ( to S. W. R. and J. R. M.) and GM065318 and AG027349 ( to U. J.).	Bauer M, 2008, INTENS CARE MED, V34, P640, DOI 10.1007/s00134-008-1010-2; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; Boehning D, 2002, SCIENCE, V298, P2339, DOI 10.1126/science.1080339; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Einstein RS, 1998, J NUTR, V128, P2295, DOI 10.1093/jn/128.12.2295; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hen T, 2000, BIOCHEM BIOPH RES CO, V273, P584, DOI 10.1006/bbrc.2000.2995; Huang TJ, 2001, ANTIOXID REDOX SIGN, V3, P685, DOI 10.1089/15230860152543023; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Lee HC, 2003, MOL CELL BIOL, V23, P5857, DOI 10.1128/MCB.23.16.5857-5866.2003; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Maines MD, 2005, BIOCHEM BIOPH RES CO, V338, P568, DOI 10.1016/j.bbrc.2005.08.121; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Maines MD, 2004, ANTIOXID REDOX SIGN, V6, P797, DOI 10.1089/1523086041798105; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Parfenova H, 2008, CURR PHARM DESIGN, V14, P443, DOI 10.2174/138161208783597380; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Qiu WH, 2007, P NATL ACAD SCI USA, V104, P5366, DOI 10.1073/pnas.0608498104; Ragsdale S.W., 2008, REDOX BIOCH, P131; Rivera M, 2005, J INORG BIOCHEM, V99, P337, DOI 10.1016/j.jinorgbio.2004.09.016; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Uma S, 2000, EUR J BIOCHEM, V267, P498, DOI 10.1046/j.1432-1327.2000.01021.x; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yoshino K, 2007, J BIOCHEM, V142, P453, DOI 10.1093/jb/mvm159	37	66	67	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20556	20561		10.1074/jbc.M109.015651	http://dx.doi.org/10.1074/jbc.M109.015651			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19473966	hybrid, Green Published			2022-12-27	WOS:000268316100017
J	Drury, JE; Di Costanzo, L; Penning, TM; Christianson, DW				Drury, Jason E.; Di Costanzo, Luigi; Penning, Trevor M.; Christianson, David W.			Inhibition of Human Steroid 5 beta-Reductase (AKR1D1) by Finasteride and Structure of the Enzyme-Inhibitor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; PROSTATE-CANCER; 5-ALPHA-REDUCTASE; MECHANISM; RECEPTOR; IDENTIFICATION; REDUCTASE; DEFINES; BINDING	The Delta(4)-3-ketosteroid functionality is present in nearly all steroid hormones apart from estrogens. The first step in functionalization of the A-ring is mediated in humans by steroid 5 alpha- or 5 beta-reductase. Finasteride is a mechanism-based inactivator of 5 alpha-reductase type 2 with subnanomolar affinity and is widely used as a therapeutic for the treatment of benign prostatic hyperplasia. It is also used for androgen deprivation in hormone-dependent prostate carcinoma, and it has been examined as a chemopreventive agent in prostate cancer. The effect of finasteride on steroid 5 beta-reductase (AKR1D1) has not been previously reported. We show that finasteride competitively inhibits AKR1D1 with low micromolar affinity but does not act as a mechanism-based inactivator. The structure of the AKR1D1.NADP(+).finasteride complex determined at 1.7 angstrom resolution shows that it is not possible for NADPH to reduce the Delta(1-2)-ene of finasteride because the cofactor and steroid are not proximal to each other. The C3-ketone of finasteride accepts hydrogen bonds from the catalytic residues Tyr-58 and Glu-120 in the active site of AKR1D1, providing an explanation for the competitive inhibition observed. This is the first reported structure of finasteride bound to an enzyme involved in steroid hormone metabolism.	[Drury, Jason E.; Penning, Trevor M.] Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA; [Penning, Trevor M.] Univ Penn, Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Di Costanzo, Luigi; Christianson, David W.] Univ Penn, Roy Lab, Dept Chem, Philadelphia, PA 19104 USA; [Di Costanzo, Luigi; Christianson, David W.] Univ Penn, Dlana Vagelos Lab, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Penning, TM (corresponding author), Univ Penn, Dept Pharmacol, Sch Med, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@mail.med.upenn.edu; chris@sas.upenn.edu	Di Costanzo, Luigi Franklin/AAL-6761-2020	Di Costanzo, Luigi Franklin/0000-0002-4795-2573; Penning, Trevor/0000-0002-3937-1066	National Institutes of Health [R01-DK47015, P30-ES013508, R01-GM56838]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK47015 and P30-ES013508 (to T.M.P.) and R01-GM56838 (to D.W.C.).	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; ANDERSSON S, 1990, P NATL ACAD SCI USA, V87, P3640, DOI 10.1073/pnas.87.10.3640; ANDRIOLE G, 1995, UROLOGY, V45, P491, DOI 10.1016/S0090-4295(99)80021-1; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Di Costanzo L, 2009, MOL CELL ENDOCRINOL, V301, P191, DOI 10.1016/j.mce.2008.09.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faucher F, 2008, BIOCHEMISTRY-US, V47, P8261, DOI 10.1021/bi800572s; Faucher F, 2008, BIOCHEMISTRY-US, V47, P13537, DOI 10.1021/bi801276h; Gormley G J, 1996, Semin Urol Oncol, V14, P139; Habib FK, 1997, CLIN ENDOCRINOL, V46, P137, DOI 10.1046/j.1365-2265.1997.950908.x; HERZBERG O, 1991, PROTEINS, V11, P223, DOI 10.1002/prot.340110307; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; HUSKEY SEW, 1995, DRUG METAB DISPOS, V23, P1126; JENKINS EP, 1992, J CLIN INVEST, V89, P293, DOI 10.1172/JCI115574; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Shimada T, 1996, DRUG METAB DISPOS, V24, P515; STONER E, 1990, J STEROID BIOCHEM, V37, P375, DOI 10.1016/0960-0760(90)90487-6; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Wawrzycka I, 1999, J MOL STRUCT, V474, P157, DOI 10.1016/S0022-2860(98)00569-9	27	38	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19786	19790		10.1074/jbc.C109.016931	http://dx.doi.org/10.1074/jbc.C109.016931			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19515843	Green Published, hybrid			2022-12-27	WOS:000268097400004
J	Agarwal, V; Hammerschmidt, S				Agarwal, Vaibhav; Hammerschmidt, Sven			Cdc42 and the Phosphatidylinositol 3-Kinase-Akt Pathway Are Essential for PspC-mediated Internalization of Pneumococci by Respiratory Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; CANINE KIDNEY-CELLS; INTEGRIN-LINKED KINASE; EPSTEIN-BARR-VIRUS; COMPLEMENT FACTOR-H; STREPTOCOCCUS-PNEUMONIAE; RHO-GTPASES; IG RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; SECRETORY COMPONENT	The pneumococcal surface protein C (PspC) is a major adhesin of Streptococcus pneumoniae, the cause of lobar pneumonia and invasive diseases. PspC interacts in a human-specific manner with the ectodomain of the human polymeric immunoglobulin receptor (pIgR) produced by respiratory epithelial cells. By adopting the retrograde machinery of human pIgR, this protein-protein interaction promotes colonization and transcytosis across the epithelial layer. Here, we explored the role of Rho family guanosine triphosphatases (GTPases), phosphatidylinositol 3-kinase (PI3K) and protein kinase B (Akt) for ingestion of pneumococci via the human pIgR. Inhibition experiments suggested that the host-cell actin microfilaments and microtubules are essential for this pneumococcal uptake mechanism. By using specific GTPase-modifying toxins, inhibitors, and GTPase expression constructs we demonstrate that Cdc42, but not Rac1 and RhoA are involved in PspC-mediated invasion of pneumococci into host cells. Accordingly, Cdc42 is time-dependently activated during ingestion of pneumococci. In addition, PI3K and Akt are essential for ingestion of pneumococci by respiratory epithelial cells via the PspC-pIgR interaction. The subunit p85 alpha of PI3K and Akt was activated during the infection process. Moreover, Akt activation upon pneumococcal invasion depends on PI3K. In conclusion, our results illustrate for the first time key signaling molecules of host cells that are required for PspC-pIgR-mediated invasion of pneumococci into epithelial cells. This unique and specific bacterial entry process is dependent on the cooperation and activation of Rho family GTPase Cdc42, PI3K, and Akt.	[Agarwal, Vaibhav; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Agarwal, Vaibhav; Hammerschmidt, Sven] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Agarwal, Vaibhav; Hammerschmidt, Sven] Univ Wurzburg, Res Ctr Infect Dis, D-97070 Wurzburg, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Munich; University of Wurzburg	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Inst Genet & Funct Genom, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681	Deutsche Forschungsgemeinschaft [Ha 3125/4-1]; Sonderforschungsbereich [479]; Teilprojekt [A7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Teilprojekt	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG, Sonderforschungsbereich 479, Teilprojekt A7 ( to S. H.) and DFG Ha 3125/4-1).	Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Burnham CAD, 2007, FEMS MICROBIOL LETT, V272, P8, DOI 10.1111/j.1574-6968.2007.00768.x; Cardone MH, 1996, J CELL BIOL, V133, P997, DOI 10.1083/jcb.133.5.997; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dave S, 2004, J IMMUNOL, V173, P471, DOI 10.4049/jimmunol.173.1.471; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Finlay BB, 2005, CURR TOP MICROBIOL, V291, P1; Gan YJ, 1997, J VIROL, V71, P519, DOI 10.1128/JVI.71.1.519-526.1997; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Giffroy D, 1998, INT IMMUNOL, V10, P347, DOI 10.1093/intimm/10.3.347; Giffroy D, 2001, SCAND J IMMUNOL, V53, P56, DOI 10.1046/j.1365-3083.2001.00843.x; Godding V, 1998, EUR RESPIR J, V11, P1043, DOI 10.1183/09031936.98.11051043; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; HANSEN SH, 1995, J BIOL CHEM, V270, P28425; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hippenstiel S, 2000, BLOOD, V95, P3044; Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Jou TS, 2000, MOL BIOL CELL, V11, P287, DOI 10.1091/mbc.11.1.287; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Kazmierczak BI, 2001, CELL MICROBIOL, V3, P85, DOI 10.1046/j.1462-5822.2001.00091.x; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Lawlor MA, 2001, J CELL SCI, V114, P2903; Leung SM, 1999, MOL BIOL CELL, V10, P4369, DOI 10.1091/mbc.10.12.4369; Lin CT, 1997, AM J PATHOL, V150, P1745; Lu L, 2003, J BIOL CHEM, V278, P48178, DOI 10.1074/jbc.M306906200; Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138; Lu L, 2006, J BIOL CHEM, V281, P15464, DOI 10.1074/jbc.M602404200; Luo RS, 2005, EMBO J, V24, P34, DOI 10.1038/sj.emboj.7600490; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; Luton F, 1999, MOL BIOL CELL, V10, P1409, DOI 10.1091/mbc.10.5.1409; Luton F, 1998, MOL BIOL CELL, V9, P1787, DOI 10.1091/mbc.9.7.1787; Lynch DK, 1999, ONCOGENE, V18, P8024, DOI 10.1038/sj.onc.1203258; Maples CJ, 1997, J BIOL CHEM, V272, P6741, DOI 10.1074/jbc.272.10.6741; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Purushothaman SS, 2003, INFECT IMMUN, V71, P5823, DOI 10.1128/IAI.71.10.5823-5830.2003; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Rottner K, 2004, J PATHOL, V204, P396, DOI 10.1002/path.1638; Sangari FJ, 2000, CELL MICROBIOL, V2, P561, DOI 10.1046/j.1462-5822.2000.00080.x; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Schmeck B, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-98; SIXBEY JW, 1992, SCIENCE, V255, P1578, DOI 10.1126/science.1312750; SONG WX, 1994, P NATL ACAD SCI USA, V91, P163, DOI 10.1073/pnas.91.1.163; Stokoe David, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009361; TAMER CM, 1995, J IMMUNOL, V155, P707; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Xu B, 2006, ORG BIOMOL CHEM, V4, P4149, DOI 10.1039/b609143a; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	68	41	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19427	19436		10.1074/jbc.M109.003442	http://dx.doi.org/10.1074/jbc.M109.003442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473971	Green Published, hybrid			2022-12-27	WOS:000267908300034
J	Gavalda, S; Leger, M; van der Rest, B; Stella, A; Bardou, F; Montrozier, H; Chalut, C; Burlet-Schiltz, O; Marrakchi, H; Daffe, M; Quemard, A				Gavalda, Sabine; Leger, Mathieu; van der Rest, Benoit; Stella, Alexandre; Bardou, Fabienne; Montrozier, Henri; Chalut, Christian; Burlet-Schiltz, Odile; Marrakchi, Hedia; Daffe, Mamadou; Quemard, Annaik			The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA CARBOXYLASE; FATTY-ACID; CORYNEBACTERIUM-GLUTAMICUM; OUTER-MEMBRANE; COENZYME-A; IDENTIFICATION; GENE; CATALYZES	The last steps of the biosynthesis of mycolic acids, essential and specific lipids of Mycobacterium tuberculosis and related bacteria, are catalyzed by proteins encoded by the fadD32-pks13-accD4 cluster. Here, we produced and purified an active form of the Pks13 polyketide synthase, with a phosphopantetheinyl (P-pant) arm at both positions Ser-55 and Ser-1266 of its two acyl carrier protein (ACP) domains. Combination of liquid chromatography-tandem mass spectrometry of protein tryptic digests and radiolabeling experiments showed that, in vitro, the enzyme specifically loads long-chain 2-carboxyacyl-CoA substrates onto the P-pant arm of its C-terminal ACP domain via the acyltransferase domain. The acyl-AMPs produced by the FadD32 enzyme are specifically transferred onto the ketosynthase domain after binding to the P-pant moiety of the N-terminal ACP domain of Pks13 (N-ACP(Pks13)). Unexpectedly, however, the latter step requires the presence of active FadD32. Thus, the couple FadD32-(N-ACP(Pks13)) composes the initiation module of the mycolic condensation system. Pks13 ultimately condenses the two loaded fatty acyl chains to produce alpha-alkyl beta-ketoacids, the precursors of mycolic acids. The developed in vitro assay will constitute a strategic tool for antimycobacterial drug screening.	[Gavalda, Sabine; Leger, Mathieu; van der Rest, Benoit; Bardou, Fabienne; Montrozier, Henri; Chalut, Christian; Marrakchi, Hedia; Daffe, Mamadou; Quemard, Annaik] CNRS, IPBS, Dept Mecanismes Mol Infect Mycobacteriennes, F-31077 Toulouse, France; [Stella, Alexandre; Burlet-Schiltz, Odile] CNRS, IPBS, Dept Canc Biol, F-31077 Toulouse, France; [Gavalda, Sabine; Leger, Mathieu; van der Rest, Benoit; Stella, Alexandre; Bardou, Fabienne; Montrozier, Henri; Chalut, Christian; Burlet-Schiltz, Odile; Marrakchi, Hedia; Daffe, Mamadou; Quemard, Annaik] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Daffe, M (corresponding author), CNRS, IPBS, Dept Mecanismes Mol Infect Mycobacteriennes, 205 Route Narbonne, F-31077 Toulouse, France.	Mamadou.Daffe@ipbs.fr; Annaik.Quemard@ipbs.fr	Marrakchi, Hedia/AAF-2657-2020	Chalut, Christian/0000-0002-4849-1369; Quemard, Annaik/0000-0002-5545-3424; Marrakchi, Hedia/0000-0003-2749-5966; Schiltz, Odile/0000-0002-3606-2356	CNRS (France); Vaincre la Mucoviscidose [IC0716]; European Community [LSHP-CT-2006-037217]; Region Midi-Pyrenees; Fondation pour la Recherche Medicale ( France)	CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Vaincre la Mucoviscidose; European Community(European Commission); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Fondation pour la Recherche Medicale ( France)(Fondation pour la Recherche Medicale)	This work was supported by post-doctoral fellowships ( to S. G. and B. v. d. R.) from the CNRS ( France), the "Vaincre la Mucoviscidose" (IC0716, France), European Community Grant LSHP-CT-2006-037217, the Region Midi-Pyrenees, and the Fondation pour la Recherche Medicale ( France).	ADAMS R, 1941, ORG SYNTH, V1, P250; AHIBOCOFFY A, 1978, CHEM PHYS LIPIDS, V22, P185, DOI 10.1016/0009-3084(78)90025-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chalut C, 2006, P NATL ACAD SCI USA, V103, P8511, DOI 10.1073/pnas.0511129103; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Gande R, 2007, J BACTERIOL, V189, P5257, DOI 10.1128/JB.00254-07; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P11637, DOI 10.1021/bi9812571; GOLDMAN P, 1961, J BIOL CHEM, V236, P2620; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Marrakchi H, 2008, MYCOBACTERIAL CELL ENVELOPE, P41; Morsczeck C, 2001, BBA-GENE STRUCT EXPR, V1521, P59, DOI 10.1016/S0167-4781(01)00287-1; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Oh TJ, 2006, J BIOL CHEM, V281, P3899, DOI 10.1074/jbc.M511761200; PADMAKUMAR R, 1993, ANAL BIOCHEM, V214, P318, DOI 10.1006/abio.1993.1494; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Revill WP, 1996, J BACTERIOL, V178, P5660, DOI 10.1128/jb.178.19.5660-5667.1996; Schmoock G, 2005, J BIOL CHEM, V280, P4339, DOI 10.1074/jbc.M411026200; SHIMAKATA T, 1984, ARCH BIOCHEM BIOPHYS, V229, P329, DOI 10.1016/0003-9861(84)90159-0; SHIMAKATA T, 1986, ARCH BIOCHEM BIOPHYS, V247, P302, DOI 10.1016/0003-9861(86)90588-6; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; WALKER RW, 1973, BIOCHIM BIOPHYS ACTA, V326, P52, DOI 10.1016/0005-2760(73)90027-1; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	27	80	83	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19255	19264		10.1074/jbc.M109.006940	http://dx.doi.org/10.1074/jbc.M109.006940			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19436070	Green Published, hybrid			2022-12-27	WOS:000267908300016
J	Liu, J; Rasul, I; Sun, YN; Wu, GS; Li, LX; Premont, RT; Suo, WZ				Liu, Jun; Rasul, Imtiaz; Sun, Yuning; Wu, Guisheng; Li, Longxuan; Premont, Richard T.; Suo, William Z.			GRK5 Deficiency Leads to Reduced Hippocampal Acetylcholine Level via Impaired Presynaptic M2/M4 Autoreceptor Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED-RECEPTOR KINASES; INDUCED MICROGLIAL ACTIVATION; NERVE-CELL DEATH; ALZHEIMERS-DISEASE; KNOCKOUT MICE; SUPERSENSITIVITY; EXPRESSION; ARRESTINS; RAT	G protein-coupled receptor kinase 5 (GRK5) deficiency has been linked recently to early Alzheimer disease (AD), but the mechanism by which GRK5 deficiency may contribute to AD pathogenesis remains elusive. Here we report that overexpression of dominant negative mutant of GRK5 (dnGRK5) in a cholinergic neuronal cell line led to decreased acetylcholine (ACh) release. This reduction was fully corrected by pertussis toxin, atropine (a nonselective muscarinic antagonist), or methoctramine(a selective M2/M4 muscarinic receptor antagonist). Consistent with results in cultured cells, high potassium-evoked ACh release in hippocampal slices from young GRK5 knock-out mice was significantly reduced compared with wild type littermates, and this reduced ACh release was also fully corrected by methoctramine. In addition, following treatment with the nonselective muscarinic agonist oxotremorine-M, M2, and M4 receptors underwent significantly reduced internalization in GRK5KO slices compared with wild type slices, as assessed by plasma membrane retention of receptor immunoreactivity, whereas M1 receptor internalization was not affected by loss of GRK5 expression. Moreover, Western blotting revealed no synaptic or cholinergic degenerative changes in young GRK5 knock-out mice. Altogether, these results suggest that GRK5 deficiency leads to a reduced hippocampal ACh release and cholinergic hypofunction by selective impairment of desensitization of presynaptic M2/M4 autoreceptors. Because this nonstructural cholinergic hypofunction precedes the hippocampal cholinergic hypofunction associated with structural cholinergic degeneration and cognitive decline in aged GRK5 knock-out mice, this nonstructural alteration may be an early event contributing to cholinergic degeneration in AD.	[Liu, Jun; Rasul, Imtiaz; Sun, Yuning; Wu, Guisheng; Li, Longxuan; Suo, William Z.] Kansas City Vet Affairs Med Ctr, Lab Alzheimers Dis & Aging Res, Kansas City, MO 64128 USA; [Liu, Jun] Sun Yat Sen Univ, Dept Neurol, Affiliated Hosp 2, Guangzhou 510120, Guangdong, Peoples R China; [Suo, William Z.] Univ Kansas, Dept Neurol, Coll Med, Kansas City, KS 66170 USA; [Suo, William Z.] Univ Kansas, Dept Physiol, Coll Med, Kansas City, KS 66170 USA; [Li, Longxuan] Affiliated Hosp, Guangdong Med Coll, Dept Neurol, Zhanjian 524001, Guangdong, Peoples R China; [Sun, Yuning] Ningxia Med Univ, Dept Biochem & Mol Biol, Ningxia 750004, Peoples R China; [Premont, Richard T.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Sun Yat Sen University; University of Kansas; University of Kansas; Guangdong Medical University; Ningxia Medical University; Duke University	Suo, WZ (corresponding author), Vet Affairs Med Ctr, Lab Alzheimers Dis & Aging Res, 4801 Linwood Blvd, KS City, MO 64128 USA.	william.suo@va.gov		Premont, Richard/0000-0002-8053-5026	Medical Research and Development Service; Department of Veterans Affairs; American Federation for Aging Research; Midwest Biomedical Research Foundation	Medical Research and Development Service(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); American Federation for Aging Research; Midwest Biomedical Research Foundation	This work was supported by grants ( to W. Z. S.) from the Medical Research and Development Service, Department of Veterans Affairs, the American Federation for Aging Research, and resources from the Midwest Biomedical Research Foundation.	AMADEO A, 1995, NEUROSCI LETT, V184, P161, DOI 10.1016/0304-3940(94)11196-P; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gifford AN, 1999, J PHARMACOL EXP THER, V288, P478; Guidry G, 2005, AUTON NEUROSCI-BASIC, V123, P54, DOI 10.1016/j.autneu.2005.10.001; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541; Li LX, 2009, BRAIN RES BULL, V78, P145, DOI 10.1016/j.brainresbull.2008.09.019; Li L, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-24; Li YH, 1998, P NATL ACAD SCI USA, V95, P7748, DOI 10.1073/pnas.95.13.7748; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Matsui M, 2004, LIFE SCI, V75, P2971, DOI 10.1016/j.lfs.2004.05.034; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; PITTEL Z, 1990, J NEUROCHEM, V55, P665, DOI 10.1111/j.1471-4159.1990.tb04185.x; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; ROGERS SW, 1991, J NEUROSCI, V11, P2713; SUO Z, 2005, NEUROBIOL AGING, V25, pS2; Suo Z, 2007, NEUROBIOL AGING, V28, P1873, DOI 10.1016/j.neurobiolaging.2006.08.013; Suo ZM, 2004, J NEUROSCI, V24, P3444, DOI 10.1523/JNEUROSCI.4856-03.2004; Suo ZM, 2003, J BIOL CHEM, V278, P37681, DOI 10.1074/jbc.M301406200; Suo ZM, 2003, J BIOL CHEM, V278, P31177, DOI 10.1074/jbc.M302137200; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Walker JKL, 2004, AM J PHYSIOL-LUNG C, V286, pL312, DOI 10.1152/ajplung.00255.2003; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Zhang WL, 2002, J NEUROSCI, V22, P1709, DOI 10.1523/JNEUROSCI.22-05-01709.2002	29	37	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19564	19571		10.1074/jbc.M109.005959	http://dx.doi.org/10.1074/jbc.M109.005959			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19478075	Green Published, hybrid			2022-12-27	WOS:000267908300048
J	Kojima, K; Motohashi, K; Morota, T; Oshita, M; Hisabori, T; Hayashi, H; Nishiyama, Y				Kojima, Kouji; Motohashi, Ken; Morota, Takuya; Oshita, Masaru; Hisabori, Toru; Hayashi, Hidenori; Nishiyama, Yoshitaka			Regulation of Translation by the Redox State of Elongation Factor G in the Cyanobacterium Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODED D1 PROTEIN; PHOTOSYSTEM-II; TARGET PROTEINS; CALVIN CYCLE; THIOREDOXIN; PHOTOINHIBITION; REPAIR; PHOTODAMAGE; MEMBRANE; PSBA	Elongation factor G (EF-G), a key protein in translational elongation, was identified as a primary target of inactivation by reactive oxygen species within the translational machinery of the cyanobacterium Synechocystis sp. PCC 6803 (Kojima, K., Oshita, M., Nanjo, Y., Kasai, K., Tozawa, Y., Hayashi, H., and Nishiyama, Y. (2007) Mol. Microbiol. 65, 936-947). In the present study, we found that inactivation of EF-G (Slr1463) by H2O2 was attributable to the oxidation of two specific cysteine residues and formation of a disulfide bond. Substitution of these cysteine residues by serine residues protected EF-G from inactivation by H2O2 and allowed the EF-G to mediate translation in a translation system in vitro that had been prepared from Synechocystis. The disulfide bond in oxidized EF-G was reduced by thioredoxin, and the resultant reduced form of EF-G regained the activity to mediate translation in vitro. Western blotting analysis showed that levels of the oxidized form of EF-G increased under strong light in a mutant that lacked NADPH-thioredoxin reductase, indicating that EF-G is reduced by thioredoxin in vivo. These observations suggest that the translational machinery is regulated by the redox state of EF-G, which is oxidized by reactive oxygen species and reduced by thioredoxin, a transmitter of reducing signals generated by the photosynthetic transport of electrons.	[Kojima, Kouji; Morota, Takuya; Nishiyama, Yoshitaka] Saitama Univ, Dept Biochem & Mol Biol, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Kojima, Kouji; Hayashi, Hidenori] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Oshita, Masaru; Hayashi, Hidenori] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Hayashi, Hidenori] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan	Saitama University; Tokyo Institute of Technology; Ehime University; Ehime University; Ehime University	Nishiyama, Y (corresponding author), Saitama Univ, Dept Biochem & Mol Biol, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	nishiyama@molbiol.saitama-u.ac.jp	Motohashi, Ken/I-4970-2019; Nishiyama, Yoshitaka/K-3825-2012; Kojima, Kouji/L-8180-2013; Hisabori, Toru/E-5205-2014	Motohashi, Ken/0000-0002-8414-2836; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19570043]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research 19570043 ( to Y. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Research Project of Saitama University.	Allakhverdiev SI, 2005, PLANT PHYSIOL, V137, P263, DOI 10.1104/pp.104.054478; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; GLAZER AN, 1975, CHEM MODIFICATION PR, P21; Green R, 2000, CURR BIOL, V10, pR369, DOI 10.1016/S0960-9822(00)00481-4; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; Hisabori T, 2005, J EXP BOT, V56, P1463, DOI 10.1093/jxb/eri170; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; Hishiya S, 2008, PLANT CELL PHYSIOL, V49, P11, DOI 10.1093/pcp/pcm158; Hosoya-Matsuda N, 2005, J BIOL CHEM, V280, P840, DOI 10.1074/jbc.M411493200; Jacquot JP, 1997, NEW PHYTOL, V136, P543, DOI 10.1046/j.1469-8137.1997.00784.x; KLEIN RR, 1987, J BIOL CHEM, V262, P4341; Kojima K, 2007, MOL MICROBIOL, V65, P936, DOI 10.1111/j.1365-2958.2007.05836.x; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Kuroda H, 1996, PLANT CELL PHYSIOL, V37, P754, DOI 10.1093/oxfordjournals.pcp.a029010; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; Motohashi K, 2006, J BIOL CHEM, V281, P35039, DOI 10.1074/jbc.M605938200; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nishiyama Y, 2004, BIOCHEMISTRY-US, V43, P11321, DOI 10.1021/bi036178q; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Ohnishi N, 2005, BIOCHEMISTRY-US, V44, P8494, DOI 10.1021/bi047518q; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Takahashi S, 2006, BBA-BIOENERGETICS, V1757, P198, DOI 10.1016/j.bbabio.2006.02.002; Takahashi S, 2005, BBA-BIOENERGETICS, V1708, P352, DOI 10.1016/j.bbabio.2005.04.003; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2007, PLANT PHYSIOL, V144, P487, DOI 10.1104/pp.107.097253; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; Trebitsh T, 2001, P NATL ACAD SCI USA, V98, P12289, DOI 10.1073/pnas.211440698; Tyystjarvi T, 2001, MOL MICROBIOL, V40, P476, DOI 10.1046/j.1365-2958.2001.02402.x; Tyystjarvi T, 2004, FEBS LETT, V576, P211, DOI 10.1016/j.febslet.2004.08.083; Ueoka-Nakanishi H, 2004, J BIOL CHEM, V279, P16272, DOI 10.1074/jbc.M400607200; Yamazaki D, 2004, PLANT CELL PHYSIOL, V45, P18, DOI 10.1093/pcp/pch019; Zhang LX, 2002, FEBS LETT, V512, P13, DOI 10.1016/S0014-5793(02)02218-4; Zhang LX, 2000, PLANT CELL, V12, P1769, DOI 10.1105/tpc.12.9.1769; Zsiros O, 2006, BBA-BIOENERGETICS, V1757, P123, DOI 10.1016/j.bbabio.2006.01.004	43	51	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18685	18691		10.1074/jbc.M109.015131	http://dx.doi.org/10.1074/jbc.M109.015131			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19447882	Green Published, hybrid			2022-12-27	WOS:000267711500017
J	Wong, SG; Tom-Yew, SAL; Lewin, A; Le Brun, NE; Moore, GR; Murphy, MEP; Mauk, AG				Wong, Steve G.; Tom-Yew, Stacey A. L.; Lewin, Allison; Le Brun, Nick E.; Moore, Geoffrey R.; Murphy, Michael E. P.; Mauk, A. Grant			Structural and Mechanistic Studies of a Stabilized Subunit Dimer Variant of Escherichia coli Bacterioferritin Identify Residues Required for Core Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-CAPSULATUS BACTERIOFERRITIN; IRON; HEME; SITE; BINDING; FERROXIDASE; MUTANTS	Bacterioferritin (BFR) is a bacterial member of the ferritin family that functions in iron metabolism and protects against oxidative stress. BFR differs from the mammalian protein in that it is comprised of 24 identical subunits and is able to bind 12 equivalents of heme at sites located between adjacent pairs of subunits. The mechanism by which iron enters the protein to form the dinuclear (ferroxidase) catalytic site present in every subunit and the mineralized iron core housed within the 24-mer is not well understood. To address this issue, the properties of a catalytically functional assembly variant (E128R/E135R) of Escherichia coli BFR are characterized by a combination of crystallography, site-directed mutagenesis, and kinetics. The three-dimensional structure of the protein (1.8 angstrom resolution) includes two ethylene glycol molecules located on either side of the dinuclear iron site. One of these ethylene glycol molecules is integrated into the surface of the protein that would normally be exposed to solvent, and the other is integrated into the surface of the protein that would normally face the iron core where it is surrounded by the anionic residues Glu(47), Asp(50), and Asp(126). We propose that the sites occupied by these ethylene glycol molecules define regions where iron interacts with the protein, and, in keeping with this proposal, ferroxidase activity decreases significantly when they are replaced with the corresponding amides.	[Wong, Steve G.; Mauk, A. Grant] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Tom-Yew, Stacey A. L.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Wong, Steve G.; Mauk, A. Grant] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Lewin, Allison; Le Brun, Nick E.; Moore, Geoffrey R.] Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England	University of British Columbia; University of British Columbia; University of British Columbia; University of East Anglia	Mauk, AG (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	mauk@interchange.ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Le Brun, Nick/0000-0001-9780-4061	Canadian Institutes of Health Research/Canadian Blood Services; Canadian Institutes of Health Research [MOP-49597, 83/B14704, BB/D001943/1]; Biotechnology and Biological Sciences Research Council; Canadian Foundation for Innovation to the University of British Columbia Laboratory of Molecular Biophysics; Michael Smith Foundation for Health Sciences; University of British Columbia Laboratory of Molecular Biophysics; United States Department of Energy Office of Basic Energy Sciences and Office of Biological and Environmental Research; National Institutes of Health; National Center for Research Resources; Biomedical Technology Program; National Institute of General Medical Sciences; Biotechnology and Biological Sciences Research Council [BB/D001943/1] Funding Source: researchfish; BBSRC [BB/D001943/1] Funding Source: UKRI	Canadian Institutes of Health Research/Canadian Blood Services(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Foundation for Innovation to the University of British Columbia Laboratory of Molecular Biophysics; Michael Smith Foundation for Health Sciences(Michael Smith Foundation for Health Research); University of British Columbia Laboratory of Molecular Biophysics; United States Department of Energy Office of Basic Energy Sciences and Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Canadian Institutes of Health Research/Canadian Blood Services partnership grant (to A.G.M.), Canadian Institutes of Health Research Grant MOP-49597 (to M.E.P.M.), and Grants 83/B14704 and BB/D001943/1 from the Biotechnology and Biological Sciences Research Council (to G.R. M. and N.E.L.). This work was also supported in part by a grant from the Canadian Foundation for Innovation to the University of British Columbia Laboratory of Molecular Biophysics, an infrastructure support grant from the Michael Smith Foundation for Health Sciences to the University of British Columbia Centre for Blood Research and the University of British Columbia Laboratory of Molecular Biophysics, and funds from the United States Department of Energy Office of Basic Energy Sciences and Office of Biological and Environmental Research, the National Institutes of Health, the National Center for Research Resources, the Biomedical Technology Program, and the National Institute of General Medical Sciences.	Aitken-Rogers H, 2004, J BIOL INORG CHEM, V9, P161, DOI 10.1007/s00775-003-0504-1; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bou-Abdallah F, 2002, J BIOL CHEM, V277, P37064, DOI 10.1074/jbc.M205712200; CHEESMAN MR, 1990, NATURE, V346, P771, DOI 10.1038/346771a0; Cobessi D, 2002, ACTA CRYSTALLOGR D, V58, P29, DOI 10.1107/S0907444901017267; Dautant A, 1998, ACTA CRYSTALLOGR D, V54, P16, DOI 10.1107/S0907444997006811; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; FROLOW F, 2001, HDB METALLOPROTEINS, P782; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kilic MA, 2003, PROTEIN SCI, V12, P1663, DOI 10.1110/ps.0301903; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEBRUN NE, 1993, FEBS LETT, V333, P197, DOI 10.1016/0014-5793(93)80404-I; LeBrun NE, 1996, FEBS LETT, V397, P159; LEBRUN NE, 1995, BIOCHEM J, V312, P385, DOI 10.1042/bj3120385; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Liu HL, 2004, FEBS LETT, V573, P93, DOI 10.1016/j.febslet.2004.07.054; Liu JL, 2004, J BIOL CHEM, V279, P42794, DOI 10.1074/jbc.M405008200; Macedo S, 2003, NAT STRUCT BIOL, V10, P285, DOI 10.1038/nsb909; Malone SA, 2004, J AM CHEM SOC, V126, P496, DOI 10.1021/ja036483z; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; STIEFEL EI, 1979, NATURE, V279, P81, DOI 10.1038/279081a0; STIEFEL EI, 1994, ADV EXP MED BIOL, V356, P157; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Swartz L, 2006, BIOCHEMISTRY-US, V45, P4421, DOI 10.1021/bi060146w; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Eerde A, 2006, ACTA CRYSTALLOGR F, V62, P1061, DOI 10.1107/S1744309106039583; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f	35	19	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18873	18881		10.1074/jbc.M901747200	http://dx.doi.org/10.1074/jbc.M901747200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19439409	Green Published, hybrid			2022-12-27	WOS:000267711500037
J	Gao, ZG; Yin, J; Zhang, J; He, Q; McGuinness, OP; Ye, JP				Gao, Zhanguo; Yin, Jun; Zhang, Jin; He, Qing; McGuinness, Owen P.; Ye, Jianping			Inactivation of NF-kappa B p50 Leads to Insulin Sensitization in Liver through Post-translational Inhibition of p70S6K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR INHIBITION; BETA LINKS INFLAMMATION; IKK-BETA; RECEPTOR SUBSTRATE-1; MAMMALIAN TARGET; TRANSCRIPTIONAL ACTIVATOR; SERINE PHOSPHORYLATION; CELL-PROLIFERATION; RAPAMYCIN PATHWAY; SKELETAL-MUSCLE	In this study, we investigated the metabolic phenotype of the NF-kappa B p50 knock-out (p50-KO) mice. Compared with wild type mice, the p50-KO mice had an increase in food intake, but a decrease in body fat content. On chow diet, their blood glucose dropped much more than the wild type (WT) mice in the insulin tolerance test. Their glucose infusion rate was 30% higher than that of the WT mice in the hyperinsulinemic-euglycemic clamp. Their hepatic glucose production was suppressed more actively by insulin, and their insulin-induced glucose uptake was not altered in skeletal muscle or adipose tissue. In the liver, their p70S6K (S6K1) protein was significantly lower, and tumor necrosis factor-alpha (TNF-alpha) expression was much higher. Their S6K1 protein was reduced by TNF-alpha treatment in the primary culture of hepatocytes. S6K1 reduction was blocked by the proteasome inhibitor MG132. In their livers, IKK2 (IKK beta) activity was reduced together with IKK gamma. Their S6K1 degradation was dependent on IKK2 deficiency. Reconstitution of the S6K1 protein in their liver blocked the increase in insulin sensitivity. S6K1 degradation was not observed in hepatocytes of the WT mice. The data suggest that inactivation of NF-kappa B p50 leads to suppression of IKK2 activity in the liver. IKK2 deficiency leads to S6K1 inhibition through TNF-induced protein degradation. The S6K1 reduction may contribute to insulin sensitivity in p50-KO mice. This study suggests that hepatic S6K1 may be a drug target in the treatment of insulin resistance.	[Gao, Zhanguo; Yin, Jun; Zhang, Jin; He, Qing; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [McGuinness, Owen P.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Vanderbilt University	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	yej@pbrc.edu	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X	National Institutes of Health [DK68036]; American Diabetes Association Research [7-07-RA-189]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078188, P30DK072476, R56DK068036, U24DK059637, R01DK068036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Research(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK68036 ( to J. Y.). This work was also supported by the American Diabetes Association Research Award 7-07-RA-189 ( to J.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Jhaveri KA, 2006, AM J PHYSIOL-REG I, V291, pR1516, DOI 10.1152/ajpregu.00262.2006; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Lu ZY, 2006, NEUROSCIENCE, V139, P965, DOI 10.1016/j.neuroscience.2005.12.062; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Panasyuk G, 2008, BIOCHEM BIOPH RES CO, V369, P339, DOI 10.1016/j.bbrc.2008.02.016; Patti ME, 2004, NAT MED, V10, P1049, DOI 10.1038/nm1004-1049; RUBEN SM, 1992, MOL CELL BIOL, V12, P444, DOI 10.1128/MCB.12.2.444; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Tharappel JC, 2003, TOXICOL SCI, V75, P300, DOI 10.1093/toxsci/kfg201; Tharappel JC, 2008, TOXICOL APPL PHARM, V226, P338, DOI 10.1016/j.taap.2007.09.019; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wang ML, 2008, BIOCHEM BIOPH RES CO, V369, P382, DOI 10.1016/j.bbrc.2008.02.032; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	46	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18368	18376		10.1074/jbc.M109.007260	http://dx.doi.org/10.1074/jbc.M109.007260			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433583	Green Published, hybrid			2022-12-27	WOS:000267712400049
J	Sava, IG; Zhang, FM; Toma, I; Theilacker, C; Li, BZ; Baumert, TF; Holst, O; Linhardt, RJ; Huebner, J				Sava, Irina G.; Zhang, Fuming; Toma, Ioana; Theilacker, Christian; Li, Boyangzhi; Baumert, Thomas F.; Holst, Otto; Linhardt, Robert J.; Huebner, Johannes			Novel Interactions of Glycosaminoglycans and Bacterial Glycolipids Mediate Binding of Enterococci to Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; ALPHA-C-PROTEIN; LIPOTEICHOIC ACID; STAPHYLOCOCCUS-AUREUS; CAPSULAR POLYSACCHARIDE; STREPTOCOCCUS-PYOGENES; EPITHELIAL-CELLS; HOST-CELLS; FAECALIS; INFECTIONS	Enterococcus faecalis is among the most important nosocomial pathogens. The intestinal mucosa is considered to be the main site used by these bacteria for entrance and dissemination. A better understanding of the mechanisms involved in colonization and invasion of enterococci may help to devise methods to prevent infections in hospitalized patients. Glycosaminoglycans, which are present on the surface of all eukaryotic cells, were investigated with regard to their role as host receptors for adhesion of E. faecalis. Competitive binding assays, enzymatic digestion, and reduction of the sulfation of the glycosaminoglycan chains indicated that heparin and heparan sulfate, but not chondroitin sulfate B, played important roles in adhesion of E. faecalis 12030 to Caco2 cells. By using proteinases and carbohydrate oxidation by sodium meta-periodate to modify the bacterial surface, it could be demonstrated that a sugar-containing molecule rather than a protein is the bacterial ligand mediating adhesion to eukaryotic cells. Preincubation of Caco2 cells with the enterococcal glycolipid diglucosyldiacylglycerol but not other carbohydrate cell wall components inhibited bacterial binding. These results may indicate that heparin and/or heparan sulfate on host epithelial cells and diglucosyldiacylglycerol, either itself or as a partial structure of lipoteichoic acid, are involved in enterococcal adhesion to colonic epithelia, the first step in translocation from the intestinal tract.	[Huebner, Johannes] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, D-79106 Freiburg, Germany; [Zhang, Fuming; Li, Boyangzhi; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Zhang, Fuming; Li, Boyangzhi; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol & Chem & Biol Engn, Troy, NY 12180 USA; [Baumert, Thomas F.] INSERM, U748, Strasbourg, France; [Baumert, Thomas F.] Univ Strasbourg, F-67000 Strasbourg, France; [Baumert, Thomas F.] Hop Univ Strasbourg, Serv Hepatogastroenterol, F-67000 Strasbourg, France; [Holst, Otto] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr, D-23845 Borstel, Germany	University of Freiburg; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Forschungszentrum Borstel	Huebner, J (corresponding author), Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Hugstetter Str 55, D-79106 Freiburg, Germany.	johannes.huebner@uniklinik-freiburg.de	Li, Boyangzi/B-4813-2012; Baumert, Thomas/ABF-4718-2020	Baumert, Thomas/0000-0002-8864-2168; Theilacker, Christian/0000-0003-0821-9202; Huebner, Johannes/0000-0003-1232-4646	National Institutes of Health [AI050667, GM-38060]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI050667 ( to J. H.) and GM-38060 ( to R. J. L.).	AlvarezDominguez C, 1997, INFECT IMMUN, V65, P78; Auperin TC, 2005, J BIOL CHEM, V280, P18245, DOI 10.1074/jbc.M412391200; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Baldassarri L, 2006, INT J ARTIF ORGANS, V29, P402, DOI 10.1177/039139880602900410; Baldassarri L, 2005, J INFECT DIS, V191, P1253, DOI 10.1086/428778; BANERJEE SN, 1991, AM J MED S3B, V0091, P00086; Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; BEACHEY EH, 1979, J IMMUNOL, V122, P189; BEACHEY EH, 1979, INFECT IMMUN, V23, P618, DOI 10.1128/IAI.23.3.618-625.1979; Behling-Kelly E, 2006, INFECT IMMUN, V74, P5311, DOI 10.1128/IAI.00614-06; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bocharova TV, 2001, GLASS PHYS CHEM+, V27, P48, DOI 10.1023/A:1009559820794; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; CHOI SH, 1989, INFECT IMMUN, V57, P3834, DOI 10.1128/IAI.57.12.3834-3840.1989; COURTNEY HS, 1992, MICROB PATHOGENESIS, V12, P199, DOI 10.1016/0882-4010(92)90054-R; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fallgren C, 2001, CURR MICROBIOL, V43, P57, DOI 10.1007/s002840010260; FISCHER W, 1990, GLYCOLIPIDS PHOSPHOG, P123; Fleckenstein JM, 2002, INFECT IMMUN, V70, P1530, DOI 10.1128/IAI.70.3.1530-1537.2002; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Gu L, 2008, BIOCHEM BIOPH RES CO, V369, P1061, DOI 10.1016/j.bbrc.2008.02.160; GUZMAN CA, 1991, MICROB PATHOGENESIS, V11, P399, DOI 10.1016/0882-4010(91)90036-A; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Hess DJ, 2006, MED MICROBIOL IMMUN, V195, P133, DOI 10.1007/s00430-005-0007-5; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; LANDRY SL, 1989, AM J INFECT CONTROL, V17, P323, DOI 10.1016/0196-6553(89)90001-1; MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; OFEK I, 1982, J BACTERIOL, V149, P426, DOI 10.1128/JB.149.2.426-433.1982; OFEK I, 2003, BACTERIAL ADHESION A, P177; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Rostand KS, 1997, INFECT IMMUN, V65, P1; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Tonnaer ELGM, 2006, MICROBES INFECT, V8, P316, DOI 10.1016/j.micinf.2005.06.028; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	47	42	42	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18194	18201		10.1074/jbc.M901460200	http://dx.doi.org/10.1074/jbc.M901460200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19395379	hybrid, Green Published			2022-12-27	WOS:000267712400031
J	Formentini, L; Macchiarulo, A; Cipriani, G; Camaioni, E; Rapizzi, E; Pellicciari, R; Moroni, F; Chiarugi, A				Formentini, Laura; Macchiarulo, Antonio; Cipriani, Giulia; Camaioni, Emidio; Rapizzi, Elena; Pellicciari, Roberto; Moroni, Flavio; Chiarugi, Alberto			Poly(ADP-ribose) Catabolism Triggers AMP-dependent Mitochondrial Energy Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; INDUCED CELL-DEATH; ADP/ATP CARRIER; PAR POLYMER; ADP-RIBOSE; GLYCOHYDROLASE; NUCLEAR; NAD(+); METABOLISM; INHIBITORS	Upon massive DNA damage, hyperactivation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP)-1 causes severe depletion of intracellular NAD and ATP pools as well as mitochondrial dysfunction. Thus far, the molecular mechanisms contributing to PARP-1-dependent impairment of mitochondrial functioning have not been identified. We found that degradation of the PARP-1 product poly(ADP-ribose) through the concerted actions of poly(ADP-ribose) glycohydrolase and NUDIX (nucleoside diphosphate-X) hydrolases leads to accumulation of AMP. The latter, in turn, inhibits the ADP/ATP translocator, prompting mitochondrial energy failure. For the first time, our findings identify NUDIX hydrolases as key enzymes involved in energy derangement during PARP-1 hyperactivity. Also, these data disclose unanticipated AMP-dependent impairment of mitochondrial exchange of adenine nucleotides, which can be of relevance to organelle functioning and disease pathogenesis.	[Moroni, Flavio; Chiarugi, Alberto] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Macchiarulo, Antonio; Camaioni, Emidio; Pellicciari, Roberto] Univ Perugia, Dept Med Chem & Drug Technol, I-06100 Perugia, Italy; [Rapizzi, Elena] Univ Florence, Dept Biochem Sci, I-50139 Florence, Italy	University of Florence; University of Perugia; University of Florence	Chiarugi, A (corresponding author), Univ Florence, Dept Pharmacol, Viale Pieraccini 6, I-50139 Florence, Italy.	alberto.chiarugi@unifi.it	Macchiarulo, Antonio/L-2846-2017; Camaioni, Emidio/AAK-3138-2020	Macchiarulo, Antonio/0000-0001-9535-4183; Camaioni, Emidio/0000-0002-8529-0849; Formentini, Laura/0000-0001-5641-821X	Italian Ministry of University and Research PRIN; Fondazione Italiana Sclerosi Multipla; Ente Cassa di Risparmio di Firenze	Italian Ministry of University and Research PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This study was supported by grants from the Italian Ministry of University and Research PRIN 2007, Fondazione Italiana Sclerosi Multipla, and Ente Cassa di Risparmio di Firenze.	Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Cohausz O, 2008, CELL MOL LIFE SCI, V65, P644, DOI 10.1007/s00018-008-7516-5; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Cozzi A, 2006, J CEREBR BLOOD F MET, V26, P684, DOI 10.1038/sj.jcbfm.9600222; Cuzzocrea S, 2005, FASEB J, V19, P558, DOI 10.1096/fj.04-3117com; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Formentini L, 2008, BRIT J PHARMACOL, V155, P1235, DOI 10.1038/bjp.2008.370; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; JACOBSON EL, 1994, MOL CELL BIOCHEM, V138, P207, DOI 10.1007/BF00928463; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kennedy HJ, 1999, BIOCHEM J, V342, P275, DOI 10.1042/0264-6021:3420275; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Klingenberg M, 2007, BIOCHIMIE, V89, P1042, DOI 10.1016/j.biochi.2007.02.010; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kroemer G, 1997, CELL DEATH DIFFER, V4, P443, DOI 10.1038/sj.cdd.4400266; Lu XCM, 2003, BRAIN RES, V978, P99, DOI 10.1016/S0006-8993(03)02774-4; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Murphy MP, 2001, BBA-BIOENERGETICS, V1504, P1, DOI 10.1016/S0005-2728(00)00234-6; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Oei SL, 2000, J BIOL CHEM, V275, P23234, DOI 10.1074/jbc.M002429200; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Rapizzi E, 2004, MOL PHARMACOL, V66, P890, DOI 10.1124/mol.104.000968; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Rossi L, 2002, BIOCHIMIE, V84, P1229; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; TANUMA S, 1989, BIOCHEM BIOPH RES CO, V163, P1047, DOI 10.1016/0006-291X(89)92327-9; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; WEIDEMAN.MJ, 1970, EUR J BIOCHEM, V16, P313, DOI 10.1111/j.1432-1033.1970.tb01086.x; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zha MW, 2006, J MOL BIOL, V364, P1021, DOI 10.1016/j.jmb.2006.09.078; Zhang J, 2002, DRUG FUTURE, V27, P371, DOI 10.1358/dof.2002.027.04.669101	50	77	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17668	17676		10.1074/jbc.M109.002931	http://dx.doi.org/10.1074/jbc.M109.002931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19411252	hybrid, Green Published			2022-12-27	WOS:000267202500033
J	Cheong, SM; Kim, H; Han, JK				Cheong, Seong-Moon; Kim, Hyunjoon; Han, Jin-Kwan			Identification of a Novel Negative Regulator of Activin/Nodal Signaling in Mesendodermal Formation of Xenopus Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; GERM-LAYER SPECIFICATION; E3 UBIQUITIN LIGASE; TGF-BETA RECEPTOR; FATE SPECIFICATION; PTB DOMAINS; I RECEPTOR; GROWTH; SMAD7; DEGRADATION	Phosphotyrosine binding (PTB) domains, which are found in a large number of proteins, have been implicated in signal transduction mediated by growth factor receptors. However, the in vivo roles of these PTB-containing proteins remain to be investigated. Here, we show that Xdpcp (Xenopus dok-PTB containing protein) has a pivotal role in regulating mesendoderm formation in Xenopus, and negatively regulates the activin/nodal signaling pathway. We isolated cDNA for xdpcp and examined its potential role in Xenopus embryogenesis. We found that Xdpcp is strongly expressed in the animal hemisphere at the cleavage and blastula stages. The overexpression of xdpcp RNA affects activin/nodal signaling, which causes defects in mesendoderm formation. In addition, loss of Xdpcp function by injection of morpholino oligonucleotides leads to the expansion of the mesodermal territory. Moreover, we found that axis duplication by ventrally forced expression of activin is recovered by coexpression with Xdpcp. In addition, Xdpcp inhibits the phosphorylation and nuclear translocation of Smad2. Furthermore, we also found that Xdpcp interacts with Alk4, a type I activin receptor, and inhibits activin/nodal signaling by disturbing the interaction between Smad2 and Alk4. Taken together, these results indicate that Xdpcp regulates activin/nodal signaling that is essential for mesendoderm specification.	[Cheong, Seong-Moon; Kim, Hyunjoon; Han, Jin-Kwan] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea	Pohang University of Science & Technology (POSTECH)	Han, JK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, San 31, Pohang 790784, Kyungbuk, South Korea.	jkh@postech.ac.kr	Kim, Hyunjoon/AAK-3154-2021	Kim, Hyunjoon/0000-0002-0207-1190	National RD Program; Ministry of Health Welfare; Republic of Korea [0720150]; Brain Korea	National RD Program; Ministry of Health Welfare; Republic of Korea; Brain Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea Grant 0720150, and the Brain Korea 21 project.	Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; Cheong SM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-63; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Funaba M, 2000, MOL ENDOCRINOL, V14, P1583, DOI 10.1210/me.14.10.1583; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Margolis B, 1999, KIDNEY INT, V56, P1230, DOI 10.1046/j.1523-1755.1999.00700.x; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Munoz-Sanjuan I, 2001, DEV BIOL, V237, P1, DOI 10.1006/dbio.2001.0350; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NIEUWKOOP PD, 1994, NORMAL TABLE XENOPUS, P163; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Sasai N, 2008, CELL, V133, P878, DOI 10.1016/j.cell.2008.03.035; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Suri C, 2005, DEVELOPMENT, V132, P2733, DOI 10.1242/dev.01865; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Valdimarsdottir G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-16; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; Yamakawa N, 2002, EMBO J, V21, P1684, DOI 10.1093/emboj/21.7.1684; Yun CH, 2007, DEVELOPMENT, V134, P769, DOI 10.1242/dev.02778; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	41	2	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17052	17060		10.1074/jbc.M109.007443	http://dx.doi.org/10.1074/jbc.M109.007443			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19389709	Green Published, hybrid			2022-12-27	WOS:000266962400043
J	Bugge, TH; Antalis, TM; Wu, QY				Bugge, Thomas H.; Antalis, Toni M.; Wu, Qingyu			Type II Transmembrane Serine Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR-1B; PROSTATE-CANCER PROGRESSION; EPITHELIAL SODIUM-CHANNEL; CELL-SURFACE; GENE FUSION; PLASMINOGEN-ACTIVATOR; MATRIPTASE-2 TMPRSS6; FUNCTIONAL-ANALYSIS; IRON-DEFICIENCY	Analysis of genome and expressed sequence tag data bases at the turn of the millennium unveiled a new protease family named the type II transmembrane serine proteases (TTSPs) in a Journal of Biological Chemistry minireview (Hooper, J. D., Clements, J. A., Quigley, J. P., and Antalis, T. M. (2001) J. Biol. Chem. 276, 857-860). Since then, the number of known TTSPs has more than doubled, and more importantly, our understanding of the physiological functions of individual TTSPs and their contribution to human disease has greatly increased. Progress has also been made in identifying molecular substrates and endogenous inhibitors. This minireview summarizes the current knowledge of the rapidly advancing TTSP field.	[Bugge, Thomas H.] NIH, Proteases & Tissue Remodeling Sect, NIDCR, Bethesda, MD 20892 USA; [Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Wu, Qingyu] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Wu, Qingyu] Cleveland Clin, Lerner Res Inst, Dept Nephrol, Cleveland, OH 44195 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Bugge, TH (corresponding author), NIH, Proteases & Tissue Remodeling Sect, NIDCR, Bldg 10, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov		Wu, Qingyu/0000-0003-0561-9315	National Institutes of Health Intramural Program; National Institutes of Health [CA098369, HL084387, HL089298]; Mary Kay Ash Charitable Foundation [075-07]; NATIONAL CANCER INSTITUTE [R01CA098369, R56CA098369, P30CA134274] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084387, R01HL089298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081376] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Kay Ash Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in wholeor in part, by the National Institutes of Health Intramural Program (to T. H. B.) and National Institutes of Health Grants CA098369 and HL084387 (to T. M. A.) and HL089298 (to Q. W.). This work was also supported by the Mary Kay Ash Charitable Foundation (075-07). This is the sixth article in the Thematic Minireview Series on Proteolytic Enzymes. The first article was published in the November 7, 2008 issue; the second and third articles were published in the May 22, 2009 issue; and the fourth and fifth articles were published in the July 31, 2009 issue. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Afar DEH, 2001, CANCER RES, V61, P1686; Alef T, 2009, J INVEST DERMATOL, V129, P862, DOI 10.1038/jid.2008.311; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Bugge TH, 2007, FRONT BIOSCI-LANDMRK, V12, P5060, DOI 10.2741/2448; Cerveira N, 2006, NEOPLASIA, V8, P826, DOI 10.1593/neo.06427; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enshell-Seijffers D, 2008, DEVELOPMENT, V135, P217, DOI 10.1242/dev.011031; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Guipponi M, 2008, FRONT BIOSCI-LANDMRK, V13, P1557, DOI 10.2741/2780; Guipponi M, 2008, HUM MUTAT, V29, P130, DOI 10.1002/humu.20617; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Knappe S, 2003, J BIOL CHEM, V278, P52363, DOI 10.1074/jbc.M309991200; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin BY, 1999, CANCER RES, V59, P4180; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Miao JY, 2008, INT J CANCER, V123, P2041, DOI 10.1002/ijc.23726; Nam RK, 2007, BRIT J CANCER, V97, P1690, DOI 10.1038/sj.bjc.6604054; Nam RK, 2007, CANCER BIOL THER, V6, P40, DOI 10.4161/cbt.6.1.3489; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Okumura Y, 2006, BIOCHEM J, V400, P551, DOI 10.1042/BJ20060212; Qiu D, 2007, BIOCHEM SOC T, V35, P583, DOI 10.1042/BST0350583; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Stallmach R, 2008, BIOCHEM J, V412, P81, DOI 10.1042/BJ20071432; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Szabo R, 2003, THROMB HAEMOSTASIS, V90, P185, DOI 10.1160/TH03-02-0071; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tripathi M, 2008, J BIOL CHEM, V283, P30576, DOI 10.1074/jbc.M802312200; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P5052, DOI 10.2741/2447; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P4179, DOI 10.2741/2379; Wu QY, 2003, CURR TOP DEV BIOL, V54, P167, DOI 10.1016/S0070-2153(03)54009-1	61	237	240	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23177	23181		10.1074/jbc.R109.021006	http://dx.doi.org/10.1074/jbc.R109.021006			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19487698	hybrid, Green Published			2022-12-27	WOS:000269180000001
J	Das, R; Chowdhury, S; Mazhab-Jafari, MT; SilDas, S; Selvaratnam, R; Melacini, G				Das, Rahul; Chowdhury, Somenath; Mazhab-Jafari, Mohammad T.; SilDas, Soumita; Selvaratnam, Rajeevan; Melacini, Giuseppe			Dynamically Driven Ligand Selectivity in Cyclic Nucleotide Binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; N-15 NMR RELAXATION; CHEMICAL-EXCHANGE; REGULATORY SUBUNIT; GLOBULAR-PROTEINS; STRUCTURE REVEALS; STRUCTURAL BASIS; CAMP; ACTIVATION; MECHANISM	One of the mechanisms that minimize the aberrant cross-talk between cAMP-and cGMP-dependent signaling pathways relies on the selectivity of cAMP binding domains (CBDs). For instance, the CBDs of two critical eukaryotic cAMP receptors, i.e. protein kinase A (PKA) and the exchange protein activated by cAMP (EPAC), are both selectively activated by cAMP. However, the mechanisms underlying their cAMP versus cGMP selectivity are quite distinct. In PKA this selectivity is controlled mainly at the level of ligand affinity, whereas in EPAC it is mostly determined at the level of allostery. Currently, the molecular basis for these different selectivity mechanisms is not fully understood. We have therefore comparatively analyzed by NMR the cGMP-bound states of the essential CBDs of PKA and EPAC, revealing key differences between them. Specifically, cGMP binds PKA preserving the same syn base orientation as cAMP at the price of local steric clashes, which lead to a reduced affinity for cGMP. Unlike PKA, cGMP is recognized by EPAC in an anti conformation and generates several short and long range perturbations. Although these effects do not alter significantly the structure of the EPAC CBD investigated, remarkable differences in dynamics between the cAMP-and cGMP-bound states are detected for the ionic latch region. These observations suggest that one of the determinants of cGMP antagonism in EPAC is the modulation of the entropic control of inhibitory interactions and illustrate the pivotal role of allostery in determining signaling selectivity as a function of dynamic changes, even in the absence of significant affinity variations.	[Melacini, Giuseppe] McMaster Univ, Dept Chem & Biochem, Hamilton, ON L8S 4M1, Canada; McMaster Univ, Dept Biomed Sci, Hamilton, ON L8S 4M1, Canada	McMaster University; McMaster University	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Biochem, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Chowdhury, Somenath/I-7846-2015; Das, Rahul/AAU-5123-2020; SELVARATNAM, RAJEEVAN/H-5289-2011	Das, Rahul/0000-0001-7841-8229; SELVARATNAM, RAJEEVAN/0000-0003-4457-616X; Chowdhury, Somenath/0000-0002-3693-1427; Mazhab-Jafari, Mohammad T./0000-0003-0207-5877	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research. This paper is dedicated to the memory of Professor Richard Haslam.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Aden J, 2007, J AM CHEM SOC, V129, P14003, DOI 10.1021/ja075055g; Atkinson RA, 2004, PROG NUCL MAG RES SP, V44, P141, DOI 10.1016/j.pnmrs.2004.01.001; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bernado P, 2002, J BIOMOL NMR, V23, P139, DOI 10.1023/A:1016359412284; CAVANAGH J, 1996, PROTEIN NMR SPECTROS, P100; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; de la Torre JG, 2001, BIOPHYS CHEM, V93, P159, DOI 10.1016/S0301-4622(01)00218-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desvaux H, 1999, PROG NUCL MAG RES SP, V35, P295, DOI 10.1016/S0079-6565(99)00011-4; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P219, DOI 10.1007/s10858-005-7944-6; Esposito V, 2006, J BIOMOL NMR, V36, P64, DOI 10.1007/s10858-006-9050-9; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fischer MWF, 1998, PROG NUCL MAG RES SP, V33, P207, DOI 10.1016/S0079-6565(98)00023-5; Goddard T. D., 2006, SPARKY VERSION 3; GRONENBORN AM, 1981, FEBS LETT, V136, P160, DOI 10.1016/0014-5793(81)81237-9; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Houben K, 2005, J MOL BIOL, V349, P621, DOI 10.1016/j.jmb.2005.04.007; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim C, 2006, EUR J CELL BIOL, V85, P651, DOI 10.1016/j.ejcb.2006.02.004; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)90000-0; OTTING G, 1989, J MAGN RESON, V85, P586, DOI 10.1016/0022-2364(89)90249-7; PALMER AG, 1998, CURVEFIT; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Rodriguez JC, 2004, J BIOMOL NMR, V30, P155, DOI 10.1023/B:JNMR.0000048857.44219.c3; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Segui-Lines G, 2007, ANALYST, V132, P741, DOI 10.1039/b705469f; SHABB JB, 1991, J BIOL CHEM, V266, P24320; SHABB JB, 1990, J BIOL CHEM, V265, P16031; Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Vialle-Printems C, 2000, J MAGN RESON, V142, P276, DOI 10.1006/jmre.1999.1954; VONDEVEN FJM, 1995, MULTIDIMENSIONAL NMR, P99; Wang X, 1997, J NEUROCHEM, V68, P443; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	57	66	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23682	23696		10.1074/jbc.M109.011700	http://dx.doi.org/10.1074/jbc.M109.011700			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19403523	Green Published, hybrid			2022-12-27	WOS:000269180000054
J	D'Arco, M; Giniatullin, R; Leone, V; Carloni, P; Birsa, N; Nair, A; Nistri, A; Fabbretti, E				D'Arco, Marianna; Giniatullin, Rashid; Leone, Vanessa; Carloni, Paolo; Birsa, Nicol; Nair, Asha; Nistri, Andrea; Fabbretti, Elsa			The C-terminal Src Inhibitory Kinase (Csk)-mediated Tyrosine Phosphorylation Is a Novel Molecular Mechanism to Limit P2X(3) Receptor Function in Mouse Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; NEGATIVE REGULATOR; FAMILY KINASES; CSK; ACTIVATION; PAIN; COMPLEX; PHOSPHOINOSITIDES; MEDIATORS; MICE	On sensory neurons, sensitization of P2X(3) receptors gated by extracellular ATP contributes to chronic pain. We explored the possibility that receptor sensitization may arise from down-regulation of an intracellular signal negatively controlling receptor function. In view of the structural modeling between the Src region phosphorylated by the C-terminal Src inhibitory kinase (Csk) and the intracellular C terminus domain of the P2X(3) receptor, we investigated how Csk might regulate receptor activity. Using HEK cells and the in vitro kinase assay, we observed that Csk directly phosphorylated the tyrosine 393 residue of the P2X(3) receptor and strongly inhibited receptor currents. On mouse trigeminal sensory neurons, the role of Csk was tightly controlled by the extracellular level of nerve growth factor, a known algogen. Furthermore, silencing endogenous Csk in HEK or trigeminal cells potentiated P2X(3) receptor responses, confirming constitutive Csk-mediated inhibition. The present study provides the first demonstration of an original molecular mechanism responsible for negative control over P2X(3) receptor function and outlines a potential new target for trigeminal pain suppression.	[D'Arco, Marianna; Leone, Vanessa; Carloni, Paolo; Birsa, Nicol; Nair, Asha; Nistri, Andrea; Fabbretti, Elsa] SISSA, Int Sch Adv Studies, Neurobiol Sector, I-34014 Trieste, Italy; [D'Arco, Marianna; Leone, Vanessa; Carloni, Paolo; Birsa, Nicol; Nair, Asha; Nistri, Andrea; Fabbretti, Elsa] SISSA, Int Sch Adv Studies, Italian Inst Technol Unit, I-34014 Trieste, Italy; [Leone, Vanessa; Carloni, Paolo] INFM DEMOCRITOS, Modelling Ctr Res Atomist Simulat, I-34014 Trieste, Italy; [Giniatullin, Rashid] Univ Kuopio, AI Virtanen Inst, FIN-70211 Kuopio, Finland; [Fabbretti, Elsa] Univ Nova Gorica, SI-5000 Nova Gorica, Slovenia	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; University of Eastern Finland; University of Nova Gorica	Fabbretti, E (corresponding author), SISSA, Int Sch Adv Studies, Neurobiol Sector, I-34014 Trieste, Italy.	fabbre@sissa.it	Giniatullin, Rashid/Y-9687-2018; Carloni, Paolo/H-8736-2013; Leone, Vanessa/AGZ-1133-2022	Leone, Vanessa/0000-0001-7017-4020; Birsa, Nicol/0000-0002-8271-540X; Giniatullin, Rashid/0000-0002-1580-6280	Telethon Foundation [GGP07032]; Italian Institute of Technology (IIT); Fondi per gli Investimenti della Ricerca di; Slovenian Research Agency	Telethon Foundation(Fondazione Telethon); Italian Institute of Technology (IIT)(Istituto Italiano di Tecnologia - IIT); Fondi per gli Investimenti della Ricerca di; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants from the Telethon Foundation (GGP07032), the Italian Institute of Technology (IIT), Fondi per gli Investimenti della Ricerca di Base project (to A. Nistri), and the Slovenian Research Agency ARRS project (to E. F.).	Abrahamsen H, 2003, J BIOL CHEM, V278, P17170, DOI 10.1074/jbc.M211426200; Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Bernier LP, 2008, J NEUROSCI, V28, P12938, DOI 10.1523/JNEUROSCI.3038-08.2008; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; D'Arco M, 2007, J NEUROSCI, V27, P8190, DOI 10.1523/JNEUROSCI.0713-07.2007; Donnelly-Roberts D, 2008, J PHARMACOL EXP THER, V324, P409, DOI 10.1124/jpet.106.105890; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Giniatullin R, 2008, MOL NEUROBIOL, V37, P83, DOI 10.1007/s12035-008-8020-5; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Kalia LV, 2006, EMBO J, V25, P4971, DOI 10.1038/sj.emboj.7601342; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; LESK AM, 2002, INTRO BIOINFORMATICS, P160; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; Mager PP, 2004, CURR TOP MED CHEM, V4, P1657, DOI 10.2174/1568026043387197; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vacca F, 2009, J NEUROCHEM, V109, P1031, DOI 10.1111/j.1471-4159.2009.06029.x; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Wang DX, 2001, BIOCHEMISTRY-US, V40, P2004, DOI 10.1021/bi002342n; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	34	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21393	21401		10.1074/jbc.M109.023051	http://dx.doi.org/10.1074/jbc.M109.023051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509283	hybrid, Green Published			2022-12-27	WOS:000268564400034
J	Shan, JX; Ord, D; Ord, T; Kilberg, MS				Shan, Jixiu; Oerd, Daima; Oerd, Tonis; Kilberg, Michael S.			Elevated ATF4 Expression, in the Absence of Other Signals, Is Sufficient for Transcriptional Induction via CCAAT Enhancer-binding Protein-activating Transcription Factor Response Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID LIMITATION; ASPARAGINE SYNTHETASE GENE; INTEGRATED STRESS-RESPONSE; MESSENGER-RNA TRANSLATION; HUMAN HEPATOMA-CELLS; ENDOPLASMIC-RETICULUM; SYSTEM-A; MAMMALIAN-CELLS; HEPG2 CELLS; DEPRIVATION	Protein limitation in vivo or amino acid deprivation of cells in culture causes a signal transduction cascade consisting of activation of the kinase GCN2 (general control nonderepressible 2), phosphorylation of eukaryotic initiation factor 2, and increased synthesis of activating transcription factor (ATF) 4 by a translational control mechanism. In a self-limiting transcriptional program, ATF4 transiently activates a wide range of downstream target genes involved in transport, cellular metabolism, and other cell functions. Simultaneous activation of other signal transduction pathways by amino acid deprivation led to the question of whether or not the increased abundance of ATF4 alone was sufficient to trigger the transcriptional control mechanisms. Using 293 cells that ectopically express ATF4 in a tetracycline-inducible manner showed that ATF4 target genes were activated in the absence of amino acid deprivation. Ectopic expression of ATF4 alone resulted in effective recruitment of the general transcription machinery, but some reduction in histone modification was observed. These data document that ATF4 alone is sufficient to trigger the amino acid-responsive transcriptional control program. However, the absolute amount of ectopic ATF4 required to achieve the same degree of transcriptional activation observed after amino acid limitation was greater, suggesting that other factors may serve to enhance ATF4 function.	[Shan, Jixiu; Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr,Genet Inst, Gainesville, FL 32610 USA; [Shan, Jixiu; Kilberg, Michael S.] Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA; [Oerd, Daima; Oerd, Tonis] Estonina Bioctr, EE-51010 Tartu, Estonia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Estonian Biocentre	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr,Genet Inst, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu	Örd, Daima/H-4467-2012; Örd, Tõnis/G-8113-2012	Örd, Tõnis/0000-0001-8778-2508	National Institutes of Health [DK-59315, DK-52064]; Estonian Science Foundation [7683]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059315, R01DK052064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estonian Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-59315 and DK-52064 (to M. S. K.).; Supported by Grant 7683 from the Estonian Science Foundation.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Averous J, 2005, FEBS LETT, V579, P2609, DOI 10.1016/j.febslet.2005.03.077; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Cibelli G, 1999, EUR J CELL BIOL, V78, P642, DOI 10.1016/S0171-9335(99)80049-1; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Gjymishka A, 2008, J BIOL CHEM, V283, P27736, DOI 10.1074/jbc.M803781200; Hamamura K, 2008, J BONE MINER METAB, V26, P231, DOI 10.1007/s00774-007-0825-1; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KILBERG MS, 2009, TRENDS ENDO IN PRESS, V20; Kimball SR, 2002, J NUTR, V132, P883; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lopez-Fontanals M, 2003, J GEN PHYSIOL, V122, P5, DOI 10.1085/jgp.200308800; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Matsukawa T, 2001, ENDOCRINOLOGY, V142, P4643, DOI 10.1210/en.142.11.4643; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	34	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21241	21248		10.1074/jbc.M109.011338	http://dx.doi.org/10.1074/jbc.M109.011338			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509279	Green Published, hybrid			2022-12-27	WOS:000268564400017
J	Alaimo, A; Gomez-Posada, JC; Aivar, P; Etxeberria, A; Rodriguez-Alfaro, JA; Areso, P; Villarroel, A				Alaimo, Alessandro; Gomez-Posada, Juan Camilo; Aivar, Paloma; Etxeberria, Ainhoa; Rodriguez-Alfaro, Jose Angel; Areso, Pilar; Villarroel, Alvaro			Calmodulin Activation Limits the Rate of KCNQ2 K+ Channel Exit from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; SURFACE EXPRESSION; TRAFFICKING; EPILEPSY; SUBUNIT; BINDING	The potential regulation of protein trafficking by calmodulin (CaM) is a novel concept that remains to be substantiated. We proposed that KCNQ2 K+ channel trafficking is regulated by CaM binding to the C-terminal A and B helices. Here we show that the L339R mutation in helix A, which is linked to human benign neonatal convulsions, perturbs CaM binding to KCNQ2 channels and prevents their correct trafficking to the plasma membrane. We used glutathione S-transferase fused to helices A and B to examine the impact of this and other mutations in helix A (I340A, I340E, A343D, and R353G) on the interaction with CaM. The process appears to require at least two steps; the first involves the transient association of CaM with KCNQ2, and in the second, the complex adopts an "active" conformation that is more stable and is that which confers the capacity to exit the endoplasmic reticulum. Significantly, the mutations that we have analyzed mainly affect the stability of the active configuration of the complex, whereas Ca2+ alone appears to affect the initial binding step. The spectrum of responses from this collection of mutants revealed a strong correlation between adopting the active conformation and channel trafficking in mammalian cells. These data are entirely consistent with the concept that CaM bound to KCNQ2 acts as a Ca2+ sensor, conferring Ca2+ dependence to the trafficking of the channel to the plasma membrane and fully explaining the requirement of CaM binding for KCNQ2 function.	[Alaimo, Alessandro; Gomez-Posada, Juan Camilo; Aivar, Paloma; Etxeberria, Ainhoa; Rodriguez-Alfaro, Jose Angel; Villarroel, Alvaro] Univ Basque Country, CSIC UPV EHU, Unidad Biofis, Leioa 48940, Spain; [Areso, Pilar] Univ Basque Country, UPV EHU, Dept Farmacol, Leioa 48940, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Villarroel, A (corresponding author), Univ Basque Country, CSIC UPV EHU, Unidad Biofis, Leioa 48940, Spain.	gbxvimua@ehu.es	Villarroel, Alvaro/H-5580-2015; Messier, Claude/A-2322-2008; Alaimo, Alessandro/C-6334-2016	Messier, Claude/0000-0002-4791-1763; Alaimo, Alessandro/0000-0002-5888-6268	VII European Framework Program [PI071316]; Spanish Ministry of Education [SAF2006-13450]; Consolider Project [CSD2008-00005]	VII European Framework Program; Spanish Ministry of Education(Spanish Government); Consolider Project(Spanish Government)	This work was supported by Grant PI071316 from the VII European Framework Program, Spanish Ministry of Education Grant SAF2006-13450, and Consolider Project Grant CSD2008-00005.	Bal M, 2008, J PHYSIOL-LONDON, V586, P2307, DOI 10.1113/jphysiol.2008.152777; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; MANDERS EMM, 1992, J CELL SCI, V103, P857; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	18	51	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20668	20675		10.1074/jbc.M109.019539	http://dx.doi.org/10.1074/jbc.M109.019539			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19494108	Green Published, hybrid			2022-12-27	WOS:000268316100028
J	Fazal, F; Bijli, KM; Minhajuddin, M; Rein, T; Finkelstein, JN; Rahman, A				Fazal, Fabeha; Bijli, Kaiser M.; Minhajuddin, Mohd; Rein, Theo; Finkelstein, Jacob N.; Rahman, Arshad			Essential Role of Cofilin-1 in Regulating Thrombin-induced RelA/p65 Nuclear Translocation and Intercellular Adhesion Molecule 1 (ICAM-1) Expression in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIN DYNAMICS; PROTEIN-KINASE; TRANSCRIPTIONAL REGULATION; LIM-KINASE; F-ACTIN; BINDING PROTEINS; IN-VIVO; ACTIVATION; PHOSPHORYLATION	Activation of RhoA/Rho-associated kinase ( ROCK) pathway and the associated changes in actin cytoskeleton induced by thrombin are crucial for activation of NF-kappa B and expression of its target gene ICAM-1 in endothelial cells. However, the events acting downstream of RhoA/ROCK to mediate these responses remain unclear. Here, we show a central role of cofilin-1, an actin-binding protein that promotes actin depolymerization, in linking RhoA/ROCK pathway to dynamic alterations in actin cytoskeleton that are necessary for activation of NF-kappa B and thereby expression of ICAM-1 in these cells. Stimulation of human umbilical vein endothelial cells with thrombin resulted in Ser(3) phosphorylation/inactivation of cofilin and formation of actin stress fibers in a ROCK-dependent manner. RNA interference knockdown of cofilin-1 stabilized the actin filaments and inhibited thrombin- and RhoA-induced NF-kappa B activity. Similarly, constitutively inactive mutant of cofilin-1 (Cof1-S3D), known to stabilize the actin cytoskeleton, inhibited NF-kappa B activity by thrombin. Overexpression of wild type cofilin-1 or constitutively active cofilin-1 mutant (Cof1-S3A), known to destabilize the actin cytoskeleton, also impaired thrombin- induced NF-kappa B activity. Additionally, depletion of cofilin-1 was associated with a marked reduction in ICAM-1 expression induced by thrombin. The effect of cofilin-1 depletion on NF-kappa B activity and ICAM-1 expression occurred downstream of I kappa B alpha degradation and was a result of impaired RelA/p65 nuclear translocation and consequently, RelA/p65 binding to DNA. Together, these data show that cofilin-1 occupies a central position in RhoA-actin pathway mediating nuclear translocation of RelA/p65 and expression of ICAM-1 in endothelial cells.	[Fazal, Fabeha; Bijli, Kaiser M.; Minhajuddin, Mohd; Finkelstein, Jacob N.; Rahman, Arshad] Univ Rochester, Sch Med & Dent, Dept Pediat Neonatol, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Rein, Theo] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Rochester; Max Planck Society	Fazal, F (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	Fabeha_Fazal@urmc.rochester.edu		Rein, Theo/0000-0003-2850-4289	National Institutes of Health [HL67424, ES-01247]; American Lung Association [FA9550-04-1-0430]; Environmental Protection Agency [R-827354]; National Science Foundation [EEC-0506968]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Environmental Protection Agency(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67424 and ES-01247. This work was also supported by a biomedical research grant from the American Lung Association, Air Force Office of Scientific Research Grant FA9550-04-1-0430, Environmental Protection Agency Science to Achieve Results Particulate Matter Center Grant R-827354, and National Science Foundation Grant EEC-0506968.	Aird WC, 2005, CRIT CARE CLIN, V21, P417, DOI 10.1016/j.ccc.2005.04.004; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Doerschuk CM, 2000, AM J RESP CELL MOL, V23, P133, DOI 10.1165/ajrcmb.23.2.f193; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Gorovoy M, 2005, J BIOL CHEM, V280, P26533, DOI 10.1074/jbc.M502921200; Hatziapostolou M, 2008, CANCER RES, V68, P1851, DOI 10.1158/0008-5472.CAN-07-5793; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Laroche G, 2005, J BIOL CHEM, V280, P23215, DOI 10.1074/jbc.M414071200; Lawler S, 1999, CURR BIOL, V9, pR800, DOI 10.1016/S0960-9822(99)80493-X; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Lin T, 2003, CIRC RES, V92, P1296, DOI 10.1161/01.RES.0000078780.65824.8B; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Mayo MW, 2003, J BIOL CHEM, V278, P18980, DOI 10.1074/jbc.M211695200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Pandey D, 2006, BLOOD, V107, P575, DOI 10.1182/blood-2004-11-4377; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Rahman A, 1999, J IMMUNOL, V162, P5466; Rahman A, 1999, MOL PHARMACOL, V55, P575; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Redondo PC, 2006, BLOOD, V107, P973, DOI 10.1182/blood-2005-05-2015; Ruegg J, 2004, MOL CELL BIOL, V24, P9371, DOI 10.1128/MCB.24.21.9371-9382.2004; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Volovyk ZM, 2006, J BIOL CHEM, V281, P9773, DOI 10.1074/jbc.M511435200; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003	62	50	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21047	21056		10.1074/jbc.M109.016444	http://dx.doi.org/10.1074/jbc.M109.016444			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19483084	Green Published, hybrid			2022-12-27	WOS:000268316100067
J	Garcia, MC; Ray, DM; Lackford, B; Rubino, M; Olden, K; Roberts, JD				Garcia, Melissa C.; Ray, Denise M.; Lackford, Brad; Rubino, Mark; Olden, Kenneth; Roberts, John D.			Arachidonic Acid Stimulates Cell Adhesion through a Novel p38 MAPK-RhoA Signaling Pathway That Involves Heat Shock Protein 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; NUCLEOTIDE EXCHANGE FACTOR; HETEROTRIMERIC G-PROTEINS; KINASE-DEPENDENT PATHWAY; BREAST-CARCINOMA CELLS; FACTOR-KAPPA-B; ACTIN CYTOSKELETON; PROSTATE-CANCER; CYCLOOXYGENASE-2 EXPRESSION; ACTIVATING PROTEIN	Rho GTPases are critical components of cellular signal transduction pathways. Both hyperactivity and overexpression of these proteins have been observed in human cancers and have been implicated as important factors in metastasis. We previously showed that dietary n-6 fatty acids increase cancer cell adhesion to extracellular matrix proteins, such as type IV collagen. Here we report that in MDA-MB-435 human melanoma cells, arachidonic acid activates RhoA, and inhibition of RhoA signaling with either C3 exoenzyme or dominant negative Rho blocked arachidonic acid-induced cell adhesion. Inhibition of the Rho kinase (ROCK) with either small molecule inhibitors or ROCK II-specific small interfering RNA (siRNA) blocked the fatty acid-induced adhesion. However, unlike other systems, inhibition of ROCK did not block the activation of p38 mitogen-activated protein kinase (MAPK); instead, Rho activation depended on p38 MAPK activity and the presence of heat shock protein 27 (HSP27), which is phosphorylated downstream of p38 after arachidonic acid treatment. HSP27 associated with p115RhoGEF in fatty acid-treated cells, and this association was blocked when p38 was inhibited. Furthermore, siRNA knockdown of HSP27 blocked the fatty acid-stimulated Rho activity. Expression of dominant negative p115-RhoGEF or p115RhoGEF-specific siRNA inhibited both RhoA activation and adhesion on type IV collagen, whereas a constitutively active p115RhoGEF restored the arachidonic acid stimulation in cells in which the p38 MAPK had been inhibited. These data suggest that n-6 dietary fatty acids stimulate a set of interactions that regulates cell adhesion through RhoA and ROCK II via a p38 MAPK-dependent association of HSP27 and p115RhoGEF.	[Garcia, Melissa C.; Ray, Denise M.; Lackford, Brad; Rubino, Mark; Olden, Kenneth; Roberts, John D.] NIEHS, NIH, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Roberts, JD (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	roberts1@niehs.nih.gov		Garcia-Sherman, Melissa/0000-0003-1409-4397	National Institutes of Health (NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES023018] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the National Institutes of Health (NIEHS).	Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; Attiga FA, 2000, CANCER RES, V60, P4629; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Benitah SA, 2003, MOL BIOL CELL, V14, P3041, DOI 10.1091/mbc.E03-01-0016; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; Dong QH, 2006, CANCER LETT, V240, P9, DOI 10.1016/j.canlet.2005.08.012; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; FIDLER IJ, 1978, CANCER RES, V38, P2651; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; GARRETT MD, 1989, J BIOL CHEM, V264, P10; Hahn A, 2002, BIOCHEM J, V362, P33, DOI 10.1042/0264-6021:3620033; Harbige LS, 2003, LIPIDS, V38, P323, DOI 10.1007/s11745-003-1067-z; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Jiang JG, 2007, CANCER RES, V67, P6665, DOI 10.1158/0008-5472.CAN-06-3643; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kim BC, 1997, FEBS LETT, V415, P325, DOI 10.1016/S0014-5793(97)01152-6; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Landry J, 1999, BIOCHEM SOC SYMP, P79; Lee JW, 2008, EUR J CELL BIOL, V87, P377, DOI 10.1016/j.ejcb.2008.03.006; Lemieux P, 1998, INVAS METAST, V17, P113; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu XH, 1996, CANCER LETT, V109, P223, DOI 10.1016/S0304-3835(96)04462-X; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Nony PA, 2005, J BIOL CHEM, V280, P31413, DOI 10.1074/jbc.M500418200; Nwariaku FE, 2003, J APPL PHYSIOL, V95, P1889, DOI 10.1152/japplphysiol.00225.2003; Paine E, 2000, J BIOL CHEM, V275, P11284, DOI 10.1074/jbc.275.15.11284; Palmantier R, 1996, CANCER RES, V56, P2206; Palmantier R, 2001, CANCER RES, V61, P2445; PEPPELENBOSCH MP, 1995, CELL, V81, P849, DOI 10.1016/0092-8674(95)90005-5; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roberts LA, 2003, J CELL PHYSIOL, V196, P196, DOI 10.1002/jcp.10303; ROSE DP, 1993, CANCER RES, V53, P4686; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Schmeck B, 2003, INFLAMMATION, V27, P89, DOI 10.1023/A:1023278600596; Slice LW, 2003, J CELL PHYSIOL, V194, P127, DOI 10.1002/jcp.10195; Sugarbaker E V, 1979, Curr Probl Cancer, V3, P1, DOI 10.1016/S0147-0272(79)80008-2; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; UEDA T, 1990, J BIOL CHEM, V265, P9373; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wu R, 2007, J BIOL CHEM, V282, P21598, DOI 10.1074/jbc.M611316200; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yoshioka K, 1999, CANCER RES, V59, P2004; Zheng CL, 2006, J BIOL CHEM, V281, P37215, DOI 10.1074/jbc.M603622200	76	42	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20936	20945		10.1074/jbc.M109.020271	http://dx.doi.org/10.1074/jbc.M109.020271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19506078	Green Published, hybrid			2022-12-27	WOS:000268316100057
J	Patrick, AN; Schiemann, BJ; Yang, K; Zhao, R; Ford, HL				Patrick, Aaron N.; Schiemann, Barbara J.; Yang, Kui; Zhao, Rui; Ford, Heide L.			Biochemical and Functional Characterization of Six SIX1 Branchio-oto-renal Syndrome Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; EYES-ABSENT; BOR SYNDROME; DNA-BINDING; DROSOPHILA; EYA; GENES; ACTIVATION; EXPRESSION; DEFECTS	Branchio-oto-renal syndrome (BOR) is an autosomal dominant developmental disorder characterized by hearing loss, branchial arch defects, and renal anomalies. Recently, eight mutations in the SIX1 homeobox gene were discovered in BOR patients. To characterize the effect of SIX1 BOR mutations on the EYA-SIX1-DNA complex, we expressed and purified six of the eight mutants in Escherichia coli. We demonstrate that only the most N-terminal mutation in SIX1 (V17E) completely abolishes SIX1-EYA complex formation, whereas all of the other mutants are able to form a stable complex with EYA. We further show that only the V17E mutant fails to localize EYA to the nucleus and cannot be stabilized by EYA in the cell. The remaining five SIX1 mutants are instead all deficient in DNA binding. In contrast, V17E alone has a DNA binding affinity similar to that of wild type SIX1 in complex with the EYA co-factor. Finally, we show that all SIX1 BOR mutants are defective in transcriptional activation using luciferase reporter assays. Taken together, our experiments demonstrate that the SIX1 BOR mutations contribute to the pathology of the disease through at least two different mechanisms that involve: 1) abolishing the formation of the SIX1-EYA complex or 2) diminishing the ability of SIX1 to bind DNA. Furthermore, our data demonstrate for the first time that EYA: 1) requires the N-terminal region of the SIX1 Six domain for its interaction, 2) increases the level of the SIX1 protein within the cell, and 3) increases the DNA binding affinity of SIX1.	[Patrick, Aaron N.; Zhao, Rui; Ford, Heide L.] Univ Colorado Denver, Sch Med, Program Mol Biol, Aurora, CO 80045 USA; [Schiemann, Barbara J.; Ford, Heide L.] Univ Colorado Denver, Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA; [Yang, Kui; Zhao, Rui; Ford, Heide L.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhao, R (corresponding author), Univ Colorado Denver, Sch Med, Program Mol Biol, Anschutz Med Campus,12800 E 17th Ave,Mail Stop 81, Aurora, CO 80045 USA.	rui.zhao@ucdenver.edu; heide.ford@ucdenver.edu			National Institutes of Health [2RO1-CA095277]; American Cancer Society [RSG-07-183-01-DDC]; V Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Department of Defense Breast Cancer Research [W81XWH-06-1-0396]; Thorkildsen postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA095277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); V Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Department of Defense Breast Cancer Research(United States Department of Defense); Thorkildsen postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 2RO1-CA095277 (to H. L. F.). This work was also supported by American Cancer Society Grant RSG-07-183-01-DDC (to H. L. F.), a V Scholar award from the V Foundation for Cancer Research, and a Kimmel scholar award from the Sidney Kimmel Foundation for Cancer Research (to R.Z.).; Supported by Department of Defense Breast Cancer Research Program Pre-doctoral Fellowship W81XWH-06-1-0396.; Supported by a Thorkildsen postdoctoral fellowship.	Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; ADES SE, 1994, BIOCHEMISTRY-US, V33, P9187, DOI 10.1021/bi00197a022; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Bui QT, 2000, GENETICS, V155, P709; Buller C, 2001, HUM MOL GENET, V10, P2775, DOI 10.1093/hmg/10.24.2775; Chang EH, 2004, HUM MUTAT, V23, P582, DOI 10.1002/humu.20048; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Christensen KL, 2007, ONCOGENE, V26, P3406, DOI 10.1038/sj.onc.1210122; FRASER FC, 1980, AM J MED GENET, V7, P341, DOI 10.1002/ajmg.1320070316; Hoskins BE, 2007, AM J HUM GENET, V80, P800, DOI 10.1086/513322; Hu SY, 2008, BIOCHEMISTRY-US, V47, P3586, DOI 10.1021/bi702186s; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kawakami K, 1996, NUCLEIC ACIDS RES, V24, P303, DOI 10.1093/nar/24.2.303; Kochhar A, 2008, HUM MUTAT, V29, P565, DOI 10.1002/humu.20714; Kochhar A, 2007, AM J MED GENET A, V143A, P1671, DOI 10.1002/ajmg.a.31561; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Ruf RG, 2003, J MED GENET, V40, P515, DOI 10.1136/jmg.40.7.515; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974	25	31	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20781	20790		10.1074/jbc.M109.016832	http://dx.doi.org/10.1074/jbc.M109.016832			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497856	hybrid, Green Published			2022-12-27	WOS:000268316100040
J	Rucktaschel, R; Thoms, S; Sidorovitch, V; Halbach, A; Pechlivanis, M; Volkmer, R; Alexandrov, K; Kuhlmann, J; Rottensteiner, H; Erdmann, R				Rucktaeschel, Robert; Thoms, Sven; Sidorovitch, Vadim; Halbach, Andre; Pechlivanis, Markos; Volkmer, Rudolf; Alexandrov, Kirill; Kuhlmann, Juergen; Rottensteiner, Hanspeter; Erdmann, Ralf			Farnesylation of Pex19p Is Required for Its Structural Integrity and Function in Peroxisome Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; MEMBRANE-PROTEINS; MOLECULAR CHARACTERIZATION; ENDOPLASMIC-RETICULUM; IMPORT RECEPTOR; POTENTIAL ROLE; LOCALIZATION; YEAST; IDENTIFICATION	The conserved CaaX box peroxin Pex19p is known to be modified by farnesylation. The possible involvement of this lipid modification in peroxisome biogenesis, the degree to which Pex19p is farnesylated, and its molecular function are unknown or controversial. We resolve these issues by first showing that the complete pool of Pex19p is processed by farnesyltransferase in vivo and that this modification is independent of peroxisome induction or the Pex19p membrane anchor Pex3p. Furthermore, genomic mutations of PEX19 prove that farnesylation is essential for proper matrix protein import into peroxisomes, which is supposed to be caused indirectly by a defect in peroxisomal membrane protein (PMP) targeting or stability. This assumption is corroborated by the observation that mutants defective in Pex19p farnesylation are characterized by a significantly reduced steady-state concentration of prominent PMPs (Pex11p, Ant1p) but also of essential components of the peroxisomal import machinery, especially the RING peroxins, which were almost depleted from the importomer. In vivo and in vitro, PMP recognition is only efficient when Pex19p is farnesylated with affinities differing by a factor of 10 between the non-modified and wild-type forms of Pex19p. Farnesylation is likely to induce a conformational change in Pex19p. Thus, isoprenylation of Pex19p contributes to substrate membrane protein recognition for the topogenesis of PMPs, and our results highlight the importance of lipid modifications in protein-protein interactions.	[Erdmann, Ralf] Ruhr Univ Bochum, Inst Physiol Chem, Dept Syst Biochem, Abt Syst Biochem, D-44780 Bochum, Germany; [Sidorovitch, Vadim; Alexandrov, Kirill] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Volkmer, Rudolf] Inst Med Immunol, Charite, Dept Mol Lib, D-10115 Berlin, Germany	Ruhr University Bochum; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, Dept Syst Biochem, Abt Syst Biochem, Univ Str 150, D-44780 Bochum, Germany.	ralf.erdmann@rub.de	Thoms, Sven/K-4530-2019; Thoms, Sven/B-5763-2013; Alexandrov, Kirill/A-5830-2013	Thoms, Sven/0000-0003-3018-6363; Alexandrov, Kirill/0000-0002-0957-6511; Volkmer, Rudolf/0000-0003-4710-1143	Deutsche Forschungsgemeinschaft [SFB642]; FP6 EU Project [LSHG-CT-2004-512018]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FP6 EU Project; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB642, by FP6 EU Project LSHG-CT-2004-512018, and by the Fonds der Chemischen Industrie.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Ausubel FM, 1988, MOL REPROD DEV; Banerjee SK, 2005, MOL BIOCHEM PARASIT, V142, P47, DOI 10.1016/j.molbiopara.2005.03.008; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Boudeau J, 2003, FEBS LETT, V546, P159, DOI 10.1016/S0014-5793(03)00642-2; BRAUN A, 1994, GENE, V146, P291, DOI 10.1016/0378-1119(94)90308-5; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Dursina B, 2006, J AM CHEM SOC, V128, P2822, DOI 10.1021/ja052196e; Eckert JH, 2003, REV PHYSIOL BIOCH P, V147, P75, DOI 10.1007/s10254-003-0007-z; ERDMANN R, 1994, YEAST, V10, P1173, DOI 10.1002/yea.320100905; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Fransen M, 2004, J BIOL CHEM, V279, P12615, DOI 10.1074/jbc.M304941200; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Gotte K, 1998, MOL CELL BIOL, V18, P616; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; HOHFELD J, 1991, J CELL BIOL, V114, P1167, DOI 10.1083/jcb.114.6.1167; JAMES GL, 1994, J BIOL CHEM, V269, P14182; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kals M, 2005, YEAST, V22, P213, DOI 10.1002/yea.1204; Kammerer S, 1997, GENOMICS, V45, P200, DOI 10.1006/geno.1997.4914; Keeling PJ, 2000, NATURE, V405, P635, DOI 10.1038/35015167; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; KUNAU WH, 1988, BIOCHEM SOC T, V16, P418, DOI 10.1042/bst0160418; Lambkin GR, 2001, MOL BIOL CELL, V12, P3353, DOI 10.1091/mbc.12.11.3353; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Mayerhofer PU, 2002, BIOCHEM BIOPH RES CO, V291, P1180, DOI 10.1006/bbrc.2002.6568; Muntau AC, 2003, EUR J CELL BIOL, V82, P333, DOI 10.1078/0171-9335-00325; Otzen M, 2004, J BIOL CHEM, V279, P19181, DOI 10.1074/jbc.M314275200; PARK K, 1992, PROTEIN SCI, V1, P1032, DOI 10.1002/pro.5560010809; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Rost B, 1996, METHOD ENZYMOL, V266, P525; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 2004, CURR BIOL, V14, pR397, DOI 10.1016/j.cub.2004.05.017; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; SIMON HU, 1994, BIOCHEM J, V297, P389, DOI 10.1042/bj2970389; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1529, P203, DOI 10.1016/S1388-1981(00)00149-9; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; Snyder WB, 1999, MOL BIOL CELL, V10, P1745, DOI 10.1091/mbc.10.6.1745; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Thoms S, 2005, MOL B INT U, P125; Vastiau IMK, 2006, CELL MOL LIFE SCI, V63, P1686, DOI 10.1007/s00018-006-6110-y; Yalovsky S, 1999, TRENDS PLANT SCI, V4, P439, DOI 10.1016/S1360-1385(99)01492-2; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	66	37	37	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20885	20896		10.1074/jbc.M109.016584	http://dx.doi.org/10.1074/jbc.M109.016584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19451657	Green Published, hybrid			2022-12-27	WOS:000268316100052
J	Tallack, MR; Keys, JR; Humbert, PO; Perkins, AC				Tallack, Michael R.; Keys, Janelle R.; Humbert, Patrick O.; Perkins, Andrew C.			EKLF/KLF1 Controls Cell Cycle Entry via Direct Regulation of E2f2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; HEMOGLOBIN-STABILIZING PROTEIN; KINASE INHIBITOR P18(INK4C); TRANSCRIPTION FACTOR GATA-1; EMBRYONIC STEM-CELLS; EKLF-DEFICIENT MICE; BETA-THALASSEMIA; GENE-EXPRESSION; NULL MICE; ERYTHROPOIESIS	Differentiation of erythroid cells requires precise control over the cell cycle to regulate the balance between cell proliferation and differentiation. The zinc finger transcription factor, erythroid Kruppel-like factor (EKLF/KLF1), is essential for proper erythroid cell differentiation and regulates many erythroid genes. Here we show that loss of EKLF leads to aberrant entry into S-phase of the cell cycle during both primitive and definitive erythropoiesis. This cell cycle defect was associated with a significant reduction in the expression levels of E2f2 and E2f4, key factors necessary for the induction of S-phase gene expression and erythropoiesis. We found and validated novel intronic enhancers in both the E2f2 and E2f4 genes, which contain conserved CACC, GATA, and E-BOX elements. The E2f2 enhancer was occupied by EKLF in vivo. Furthermore, we were able to partially restore cell cycle dynamics in EKLF-/- fetal liver upon additional genetic depletion of Rb, establishing a genetic causal link between reduced E2f2 and the EKLF cell cycle defect. Finally, we propose direct regulation of the E2f2 enhancer is a generic mechanism by which many KLFs regulate proliferation and differentiation.	[Tallack, Michael R.; Keys, Janelle R.; Perkins, Andrew C.] Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, Brisbane, Qld 4072, Australia; [Humbert, Patrick O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, Melbourne, Vic 3002, Australia	University of Queensland; Peter Maccallum Cancer Center	Perkins, AC (corresponding author), Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, St Lucia, Qld 4072, Australia.	a.perkins@imb.uq.edu.au	Tallack, Michael/A-4760-2010; Perkins, Andrew C/M-3216-2014; Humbert, Patrick O/L-4264-2016; Perkins, Andrew/X-4180-2019; Perkins, Andrew/AAJ-9696-2020	Perkins, Andrew C/0000-0003-3644-7093; Humbert, Patrick O/0000-0002-1366-6691; Perkins, Andrew/0000-0003-3644-7093; Tallack, Michael/0000-0002-9991-670X	Cancer Council Queensland [519718]; Australian Research Council [DP0770471]	Cancer Council Queensland(Cancer Council Queensland); Australian Research Council(Australian Research Council)	This work was supported by Cancer Council Queensland Grant 519718 (to A.C.P.) and Australian Research Council Discovery Grant DP0770471 (to A.C.P.).	Blais A, 2002, J BIOL CHEM, V277, P31679, DOI 10.1074/jbc.M204554200; Bouilloux F, 2008, BLOOD, V112, P576, DOI 10.1182/blood-2007-07-098996; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clark AJ, 2004, BLOOD, V104, P1324, DOI 10.1182/blood-2004-02-0618; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Coghill E, 2001, BLOOD, V97, P1861, DOI 10.1182/blood.V97.6.1861; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Dirlam A, 2007, MOL CELL BIOL, V27, P8713, DOI 10.1128/MCB.01118-07; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; FENG WC, 1994, J BIOL CHEM, V269, P1493; Frontelo P, 2007, BLOOD, V110, P3871, DOI 10.1182/blood-2007-03-082065; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; Gordon CT, 2005, BBA-GENE STRUCT EXPR, V1729, P74, DOI 10.1016/j.bbaexp.2005.03.004; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Keys JR, 2007, BRIT J HAEMATOL, V136, P150, DOI 10.1111/j.1365-2141.2006.06381.x; Kinross KM, 2006, BLOOD, V108, P886, DOI 10.1182/blood-2005-09-008656; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Lavia P, 1999, BIOESSAYS, V21, P221; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Li FX, 2003, MOL CELL BIOL, V23, P3607, DOI 10.1128/MCB.23.10.3607-3622.2003; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Nilson DG, 2006, EXP HEMATOL, V34, P705, DOI 10.1016/j.exphem.2006.02.018; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; PERKINS AC, 1995, NATURE, V375, P318; Pilon AM, 2006, MOL CELL BIOL, V26, P4368, DOI 10.1128/MCB.02216-05; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Rempel RE, 2000, MOL CELL, V6, P293, DOI 10.1016/S1097-2765(00)00030-7; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Siatecka M, 2007, MOL CELL BIOL, V27, P8547, DOI 10.1128/MCB.00589-07; Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tallack MR, 2007, J MOL BIOL, V369, P313, DOI 10.1016/j.jmb.2007.02.109; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wang H, 2006, GENOME RES, V16, P1480, DOI 10.1101/gr.5353806; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417	48	56	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20966	20974		10.1074/jbc.M109.006346	http://dx.doi.org/10.1074/jbc.M109.006346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19457859	Green Published, hybrid			2022-12-27	WOS:000268316100060
J	Dickey, DM; Yoder, AR; Potter, LR				Dickey, Deborah M.; Yoder, Andrea R.; Potter, Lincoln R.			A Familial Mutation Renders Atrial Natriuretic Peptide Resistant to Proteolytic Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL NEUTRAL ENDOPEPTIDASE; CLEARANCE RECEPTOR; HEART-FAILURE; RAT-KIDNEY; CYCLASE; EXPRESSION; MEMBRANES; DEPHOSPHORYLATION; FIBRILLATION; SELECTIVITY	A heterozygous frameshift mutation causing a 12-amino acid extension to the C terminus of atrial natriuretic peptide (ANP) was recently genetically linked to patients with familial atrial fibrillation (Hodgson-Zingman, D. M., Karst, M. L., Zingman, L. V., Heublein, D. M., Darbar, D., Herron, K. J., Ballew, J. D., de Andrade, M., Burnett, J. C., Jr., and Olson, T. M. ( 2008) N. Engl. J. Med. 359, 158-165). The frameshift product (fsANP), but not wild-type ANP (wtANP), was elevated in the serum of affected patients, but the molecular basis for the elevated peptide concentrations was not determined. Here, we measured the ability of fsANP to interact with natriuretic peptide receptors and to be proteolytically degraded. fsANP and wtANP bound and activated human NPR-A and NPR-C similarly, whereas fsANP had a slightly increased efficacy for human NPR-B. Proteolytic susceptibility was addressed with novel bioassays that measure the time required for kidney membranes or purified neutral endopeptidase to abolish ANP-dependent activation of NPR-A. The half-life of fsANP was markedly greater than that of wtANP in both assays. Additional membrane proteolysis studies indicated that wtANP and fsANP are preferentially degraded by neutral endopeptidase and serine peptidases, respectively. These data indicate that the familial ANP mutation associated with atrial fibrillation has only minor effects on natriuretic peptide receptor interactions but markedly modifies peptide proteolysis.	[Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Yoder, Andrea R.; Potter, Lincoln R.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Potter, LR (corresponding author), Univ Minnesota Twin Cities, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	potter@umn.edu			Graduate School of the University of Minnesota; 3M Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066397] Funding Source: NIH RePORTER	Graduate School of the University of Minnesota(University of Minnesota System); 3M Corporation(3M); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant-in-aid from the Graduate School of the University of Minnesota ( to L. R. P.) and in part by a fellowship from the 3M Corporation ( to A. R. Y.).	Bryan PM, 2007, AM J PHYSIOL-RENAL, V292, pF1636, DOI 10.1152/ajprenal.00418.2006; Bryan PM, 2002, J BIOL CHEM, V277, P16041, DOI 10.1074/jbc.M110626200; Bukowska A, 2008, EUROPACE, V10, P1212, DOI 10.1093/europace/eun206; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CROZIER I, 1993, PACE, V16, P738, DOI 10.1111/j.1540-8159.1993.tb01653.x; Dickey DM, 2008, J BIOL CHEM, V283, P35003, DOI 10.1074/jbc.M804538200; FULLER F, 1988, J BIOL CHEM, V263, P9395; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; KENNY AJ, 1988, FEBS LETT, V232, P1, DOI 10.1016/0014-5793(88)80375-2; KENNY AJ, 1987, BIOCHEM J, V245, P515, DOI 10.1042/bj2450515; Kishimoto I, 2001, CAN J PHYSIOL PHARM, V79, P715, DOI 10.1139/cjpp-79-8-715; Kishimoto I, 1996, P NATL ACAD SCI USA, V93, P6215, DOI 10.1073/pnas.93.12.6215; Knecht M, 2002, LIFE SCI, V71, P2701, DOI 10.1016/S0024-3205(02)01990-2; KOEHN JA, 1987, J BIOL CHEM, V262, P11623; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; Langenickel TH, 2006, P NATL ACAD SCI USA, V103, P4735, DOI 10.1073/pnas.0510019103; Lopez MJ, 1997, J BIOL CHEM, V272, P23064, DOI 10.1074/jbc.272.37.23064; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; MAACK T, 1992, ANNU REV PHYSIOL, V54, P11, DOI 10.1146/annurev.physiol.54.1.11; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; OKOLICANY J, 1992, AM J PHYSIOL, V263, pF546, DOI 10.1152/ajprenal.1992.263.3.F546; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; POTTER LR, 1992, J BIOL CHEM, V267, P14531; Potthast R, 2004, J BIOL CHEM, V279, P48513, DOI 10.1074/jbc.M408247200; Rose RA, 2008, J PHYSIOL-LONDON, V586, P353, DOI 10.1113/jphysiol.2007.144253; SONNENBERG JL, 1988, PEPTIDES, V9, P173, DOI 10.1016/0196-9781(88)90024-1; Stambler BS, 2005, J CARDIOVASC ELECTR, V16, P1341, DOI 10.1111/j.1540-8167.2005.00259.x; STEPHENSON SL, 1987, BIOCHEM J, V243, P183, DOI 10.1042/bj2430183; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; Thomas CJ, 2008, HYPERTENSION, V52, P696, DOI 10.1161/HYPERTENSIONAHA.108.111302; VANNESTE Y, 1988, BIOCHEM J, V254, P531, DOI 10.1042/bj2540531; VANNESTE Y, 1990, BIOCHEM J, V269, P801, DOI 10.1042/bj2690801; YANDLE TG, 1989, PEPTIDES, V10, P891, DOI 10.1016/0196-9781(89)90131-9	33	48	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19196	19202		10.1074/jbc.M109.010777	http://dx.doi.org/10.1074/jbc.M109.010777			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19458086	hybrid, Green Published			2022-12-27	WOS:000267908300009
J	Phelan, MM; Thai, CT; Soares, DC; Ogata, RT; Barlow, PN; Bramham, J				Phelan, Marie M.; Thai, Chuong-Thu; Soares, Dinesh C.; Ogata, Ronald T.; Barlow, Paul N.; Bramham, Janice			Solution Structure of Factor I-like Modules from Complement C7 Reveals a Pair of Follistatin Domains in Compact Pseudosymmetric Arrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEIN-SEQUENCE; CHEMICAL-SHIFT; C345C DOMAIN; BINDING; COMPONENT; NMR; MECHANISM; SOFTWARE; INSIGHTS	Factor I-like modules (FIMs) of complement proteins C6, C7, and factor I participate in protein-protein interactions critical to the progress of a complement-mediated immune response to infections and other trauma. For instance, the carboxyl-terminal FIM pair of C7 (C7-FIMs) binds to the C345C domain of C5 and its activated product, C5b, during self-assembly of the cytolytic membrane-attack complex. FIMs share sequence similarity with follistatin domains (FDs) of known three-dimensional structure, suggesting that FIM structures could be reliably modeled. However, conflicting disulfide maps, inconsistent orientations of subdomains within FDs, and the presence of binding partners in all FD structures led us to determine the three-dimensional structure of C7-FIMs by NMR spectroscopy. The solution structure reveals that each FIM within C7 contains a small amino-terminal FOLN subdomain connected to a larger carboxyl-terminal KAZAL domain. The open arrangement of the subdomains within FIMs resembles that of first FDs within structures of tandem FDs but differs from the more compact subdomain arrangement of second or third FDs. Unexpectedly, the two C7-FIMs pack closely together with an approximate 2-fold rotational symmetry that is rarely seen in module pairs and has not been observed in FD-containing proteins. Interfaces between subdomains and between modules include numerous hydrophobic and electrostatic contributions, suggesting that this is a physiologically relevant conformation that persists in the context of the parent protein. Similar interfaces were predicted in a homology-based model of the C6-FIM pair. The C7-FIM structures also facilitated construction of a model of the single FIM of factor I.	[Phelan, Marie M.; Soares, Dinesh C.; Barlow, Paul N.; Bramham, Janice] Univ Edinburgh, Edinburgh Biomol NMR Unit, Edinburgh EH9 3JJ, Midlothian, Scotland; [Barlow, Paul N.; Bramham, Janice] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Thai, Chuong-Thu; Ogata, Ronald T.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Soares, Dinesh C.] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Torrey Pines Institute for Molecular Studies, California; University of Edinburgh	Bramham, J (corresponding author), Univ Edinburgh, Edinburgh Biomol NMR Unit, W Mains Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.	janice.bramham@ed.ac.uk	Barlow, Paul N/G-2853-2011; Soares, Dinesh C/A-4425-2012	Soares, Dinesh C/0000-0001-7557-0495	National Institutes of Health; Medical Research Council of the United Kingdom; Wellcome Trust and Scottish Universities Life Sciences Alliance; MRC [G0500940] Funding Source: UKRI; Medical Research Council [G0500940] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust and Scottish Universities Life Sciences Alliance; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by a National Institutes of Health grant (to R.T.O.). This work was also supported by a Medical Research Council of the United Kingdom grant (to M. M. P.) and funds from the Wellcome Trust and Scottish Universities Life Sciences Alliance (to J.B.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bohana-Kashtan O, 2004, MOL IMMUNOL, V41, P583, DOI 10.1016/j.molimm.2004.04.007; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bramham J, 2005, J BIOL CHEM, V280, P10636, DOI 10.1074/jbc.M413126200; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; BUNGER AT, 1998, ACTA CRYSTALLOGR D, V54, P905; Chamberlain D, 1998, BIOCHEMISTRY-US, V37, P13918, DOI 10.1021/bi9805184; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; COOPER NR, 1970, J EXP MED, V132, P775, DOI 10.1084/jem.132.4.775; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DISCIPIO RG, 1988, J BIOL CHEM, V263, P549; DiScipio RG, 1999, J BIOL CHEM, V274, P31811, DOI 10.1074/jbc.274.45.31811; DISCIPIO RG, 1983, J BIOL CHEM, V258, P629; DISCIPIO RG, 1989, J BIOL CHEM, V264, P16197; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gabdoulline RR, 2003, NUCLEIC ACIDS RES, V31, P3349, DOI 10.1093/nar/gkg588; Gabdoulline RR, 1999, TRENDS BIOCHEM SCI, V24, P285, DOI 10.1016/S0968-0004(99)01412-7; GOLDLUST MB, 1974, J IMMUNOL, V113, P998; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; GOTZE O, 1970, J EXP MED, V132, P898, DOI 10.1084/jem.132.5.898; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HAMMER CH, 1975, P NATL ACAD SCI USA, V72, P5076, DOI 10.1073/pnas.72.12.5076; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison PM, 1996, J MOL BIOL, V264, P603, DOI 10.1006/jmbi.1996.0664; HEIDEN W, 1993, J COMPUT AID MOL DES, V7, P503, DOI 10.1007/BF00124359; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HIGGINS JMG, 1995, J IMMUNOL, V155, P5777; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; Husler T, 1996, BIOCHEMISTRY-US, V35, P3263, DOI 10.1021/bi952862w; Innis CA, 2003, J BIOL CHEM, V278, P39969, DOI 10.1074/jbc.M211284200; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lengweiler S, 1997, BBA-PROTEIN STRUCT M, V1342, P13, DOI 10.1016/S0167-4838(97)00072-1; Lerch TF, 2007, J BIOL CHEM, V282, P15930, DOI 10.1074/jbc.M700737200; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; PEITSCH MC, 1990, MOL IMMUNOL, V27, P589, DOI 10.1016/0161-5890(90)90001-G; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Phelan MM, 2009, BIOMOL NMR ASSIGN, V3, P49, DOI 10.1007/s12104-008-9139-z; PODACK ER, 1978, J IMMUNOL, V121, P484; Ponting CP, 1999, CURR BIOL, V9, pR911, DOI 10.1016/S0960-9822(00)80102-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Stamler R, 2008, J BIOL CHEM, V283, P32831, DOI 10.1074/jbc.M801266200; Thai CT, 2005, J IMMUNOL, V174, P6227, DOI 10.4049/jimmunol.174.10.6227; Thai CT, 2004, J IMMUNOL, V173, P4547, DOI 10.4049/jimmunol.173.7.4547; Thai CT, 2003, J IMMUNOL, V171, P6565, DOI 10.4049/jimmunol.171.12.6565; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Ullman CG, 1997, BIOCHEM J, V326, P939, DOI 10.1042/bj3260929v; Varret M, 1998, NUCLEIC ACIDS RES, V26, P248, DOI 10.1093/nar/26.1.248; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803	77	11	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19637	19649		10.1074/jbc.M901993200	http://dx.doi.org/10.1074/jbc.M901993200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19419965	hybrid, Green Published			2022-12-27	WOS:000267908300055
J	Talabot-Ayer, D; Lamacchia, C; Gabay, C; Palmer, G				Talabot-Ayer, Dominique; Lamacchia, Celine; Gabay, Cem; Palmer, Gaby			Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ANTAGONIST; IL-33; INFLAMMASOME; ACTIVATION; EXPRESSION; SUBSTRATE; CYTOKINE; CELLS; ST2	The new interleukin (IL)-1 family cytokine IL-33 is synthesized as a 30-kDa precursor. Like pro-IL-1 beta, human pro-IL-33 was reported to be cleaved by caspase-1 to generate an 18-kDa fragment, which is sufficient to activate signaling by the IL-33 receptor T1/ST2. However, the proposed caspase-1 cleavage site is poorly conserved between species. In addition, it is not clear whether caspase-1 cleavage of pro-IL-33 occurs in vivo and whether, as for IL-1 beta, this cleavage is a prerequisite for IL-33 secretion and bioactivity. In this study, we further investigated caspase-1 cleavage of mouse and human pro-IL-33 and assessed the potential bioactivity of the IL-33 precursor. We observed the generation of a 20-kDa IL-33 fragment in cell lysates, which was enhanced by incubation with caspase-1. However, in vitro assays of mouse and human pro-IL-33 indicated that IL-33 is not a direct substrate for this enzyme. Consistently, caspase-1 activation in THP-1 cells induced cleavage of pro-IL-1 beta but not of pro-IL-33, and activated THP-1 cells released full-length pro-IL-33 into culture supernatants. Finally, addition of full-length pro-IL-33 induced T1/ST2-dependent IL-6 secretion in mast cells. However, we observed in situ processing of pro-IL-33 in mast cell cultures, and it remains to be determined whether full-length pro-IL-33 itself indeed represents the bioactive species. In conclusion, our data indicate that pro-IL-33 is not a direct substrate for caspase-1. In addition, our results clearly show that caspase-1 cleavage is not required for pro-IL-33 secretion and bioactivity, highlighting major differences between IL-1 beta and IL-33.	[Palmer, Gaby] Univ Hosp, Div Rheumatol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Palmer, G (corresponding author), Ctr Med Univ Geneva, Dept Pathol & Immunol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	gaby.palmer@unige.ch	palmer, gaby/AAA-7117-2021	palmer, gaby/0000-0001-7567-1798	Swiss National Science Foundation Grants [320000-120319, 3200-107592]; Rheumasearch Foundation; Lotterie Romande	Swiss National Science Foundation Grants(Swiss National Science Foundation (SNSF)); Rheumasearch Foundation; Lotterie Romande	This work was supported by Swiss National Science Foundation Grants 320000-120319 ( to G. P.) and 3200-107592 ( to C. G.) and by the Rheumasearch Foundation and the Lotterie Romande.	Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Dunand-Sauthier I, 2005, J BIOL CHEM, V280, P7030, DOI 10.1074/jbc.M412228200; Fennewald SM, 2002, J VIROL, V76, P1154, DOI 10.1128/JVI.76.3.1154-1162.2002; Gabay C, 2001, EUR J IMMUNOL, V31, P490, DOI 10.1002/1521-4141(200102)31:2<490::AID-IMMU490>3.0.CO;2-H; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Hudson CA, 2008, J LEUKOCYTE BIOL, V84, P631, DOI 10.1189/jlb.1207830; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Luschen S, 1998, BIOCHEM BIOPH RES CO, V253, P92, DOI 10.1006/bbrc.1998.9754; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Palmer G, 2005, CYTOKINE, V31, P153, DOI 10.1016/j.cyto.2005.03.007; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Vaisid T, 2005, BBA-MOL CELL RES, V1743, P223, DOI 10.1016/j.bbamcr.2005.01.001; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003	19	193	207	3	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19420	19426		10.1074/jbc.M901744200	http://dx.doi.org/10.1074/jbc.M901744200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19465481	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000267908300033
J	Zachos, NC; van Rossum, DB; Li, XH; Caraveo, G; Sarker, R; Cha, BY; Mohan, S; Desiderio, S; Patterson, RL; Donowitz, M				Zachos, Nicholas C.; van Rossum, Damian B.; Li, Xuhang; Caraveo, Gabriela; Sarker, Rafiquel; Cha, Boyoung; Mohan, Sachin; Desiderio, Stephen; Patterson, Randen L.; Donowitz, Mark			Phospholipase C-gamma Binds Directly to the Na+/H+ Exchanger 3 and Is Required for Calcium Regulation of Exchange Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BRUSH-BORDER; MOLECULAR PHYSIOLOGY; NHE3 TRAFFICKING; TERMINAL DOMAINS; ABSORBING CELLS; INHIBITION; C-GAMMA-1; TRANSPORT; EZRIN	Multiple studies suggest that phospholipase C-gamma(PLC-gamma) contributes to regulation of sodium/hydrogen exchanger 3 (NHE3) in the small intestine, although the mechanism(s) for this regulation remain unknown. We demonstrate here that PLC-gamma binds directly to the C terminus of NHE3 and exists in similar sized multiprotein complexes as NHE3. This binding is dynamic and decreases with elevated [Ca2+](i). The PLC-gamma-binding site in NHE3 was identified (amino acids 586-605) and shown to be a critical regulatory domain for protein complex formation, because when it is mutated, NHE3 binding to PLC-gamma as well as NHERF2 is lost. An inhibitory peptide, which binds to the Src homology 2 domains contained in PLC-gamma without interrupting binding of PLC-gamma to NHE3, was used to probe a non-lipase-dependent role of PLC-gamma. In the presence of this peptide, carbachol-stimulated calcium inhibition of NHE3 was lost. These results mirror previous studies with the transient receptor potential channel and suggest that PLC-gamma may play a common role in regulating the cell-surface expression of ion transporters.	[Zachos, Nicholas C.; Li, Xuhang; Sarker, Rafiquel; Cha, Boyoung; Mohan, Sachin; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Caraveo, Gabriela; Desiderio, Stephen] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol & Med, Baltimore, MD 21205 USA; [van Rossum, Damian B.; Patterson, Randen L.] Penn State Univ, Dept Biol, Ctr Computat Prote, University Pk, PA 16802 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Donowitz, M (corresponding author), 720 Rutland Ave,925 Ross Res Bldg, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Zachos, Nicholas/GWC-7914-2022; mohan, sachin/H-4017-2015	van Rossum, Damian/0000-0003-1011-2586; Mohan, Sachin/0000-0002-6798-4767	National Institutes of Health Grants [R01-DK26523, R01-DK61765, PO1-DK72084, R24-DK64388]; The Hopkins Center for Epithelial Disorders Grants [T32-DK07632, K01-DK080930]; Searle Young Investigators award; Pennsylvania State University; Huck Life Science Institute Center for Computational Proteomics; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026523, T32DK007632, R01DK061765, K01DK080930, R24DK064388, P01DK072084] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hopkins Center for Epithelial Disorders Grants; Searle Young Investigators award; Pennsylvania State University; Huck Life Science Institute Center for Computational Proteomics; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK26523, R01-DK61765, PO1-DK72084, and R24-DK64388 ( The Hopkins Basic Research Digestive Diseases Development Core Center) from NIDDK. This work was also supported by The Hopkins Center for Epithelial Disorders Grants T32-DK07632 and K01-DK080930, Searle Young Investigators award, start-up monies from Pennsylvania State University ( to R. L. P.), funds from the Huck Life Science Institute Center for Computational Proteomics ( to R. L. P. and D. B. v. R.), and a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds ( to D. B. v. R.).	Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chang JS, 2005, J BIOL CHEM, V280, P6897, DOI 10.1074/jbc.M406350200; Choi JH, 2004, J CELL SCI, V117, P3785, DOI 10.1242/jcs.01220; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; DEBER CM, 1986, BIOCHEM BIOPH RES CO, V134, P731, DOI 10.1016/S0006-291X(86)80481-8; DONOWITZ M, 1989, J CLIN INVEST, V83, P1953, DOI 10.1172/JCI114104; DONOWITZ M, 1986, ANNU REV PHYSIOL, V48, P135, DOI 10.1146/annurev.ph.48.030186.001031; Donowitz M, 2001, CURR TOP MEMBR, V50, P437; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; EMMER E, 1989, J MEMBRANE BIOL, V108, P207, DOI 10.1007/BF01871735; Janecki AJ, 1999, AM J PHYSIOL-GASTR L, V277, pG292, DOI 10.1152/ajpgi.1999.277.2.G292; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Khurana S, 1996, BIOCHEM J, V313, P509, DOI 10.1042/bj3130509; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Morris AP, 2001, AM J PHYSIOL-GASTR L, V281, pG303, DOI 10.1152/ajpgi.2001.281.2.G303; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; TAPPER EJ, 1978, AM J PHYSIOL, V235, pE402, DOI 10.1152/ajpendo.1978.235.4.E402; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	35	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19437	19444		10.1074/jbc.M109.006098	http://dx.doi.org/10.1074/jbc.M109.006098			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473983	Green Published, hybrid			2022-12-27	WOS:000267908300035
J	Bour, T; Akaddar, A; Lorber, B; Blais, S; Balg, C; Candolfi, E; Frugier, M				Bour, Tania; Akaddar, Aziza; Lorber, Bernard; Blais, Sebastien; Balg, Christian; Candolfi, Ermanno; Frugier, Magali			Plasmodial Aspartyl-tRNA Synthetases and Peculiarities in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL EXTENSION; DYNAMIC LIGHT-SCATTERING; PLASTID-LIKE DNA; ESCHERICHIA-COLI; ACTIVE-SITE; YEAST; MALARIA; ADENYLATE; SEQUENCE; AMINOACYLATION	Distinctive features of aspartyl-transfer RNA (tRNA) synthetases (AspRS) from the protozoan Plasmodium genus are described. These apicomplexan AspRSs contain 29-31 amino acid insertions in their anticodon binding domains, a remarkably long N-terminal appendix that varies in size from 110 to 165 amino acids and two potential initiation codons. This article focuses on the atypical functional and structural properties of Plasmodium falciparum cytosolic AspRS, the causative parasite of human malaria. This species encodes a 626 or 577 amino acids AspRS depending on whether initiation starts on the first or second in-frame initiation codon. The longer protein has poor solubility and a propensity to aggregate. Production of the short version was favored as shown by the comparison of the recombinant protein with endogenous AspRS. Comparison of the tRNA aminoacylation activity of wild-type and mutant parasite AspRSs with those of yeast and human AspRSs revealed unique properties. The N-terminal extension contains a motif that provides unexpectedly strong RNA binding to plasmodial AspRS. Furthermore, experiments demonstrated the requirement of the plasmodial insertion for AspRS dimerization and, therefore, tRNA aminoacylation and other putative functions. Implications for the parasite biology are proposed. These data provide a robust background for unraveling the precise functional properties of the parasite AspRS and for developing novel lead compounds against malaria, targeting its idiosyncratic domains.	[Bour, Tania; Lorber, Bernard; Frugier, Magali] Univ Strasbourg, Architecture & Reactivite ARN, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Akaddar, Aziza; Candolfi, Ermanno] Univ Strasbourg, Inst Parasitol & Pathol Trop, F-67000 Strasbourg, France; [Blais, Sebastien] Univ Laval, Dept Biochim & Microbiol, Quebec City, PQ G1V 0A6, Canada; [Balg, Christian] Univ Laval, Fac Sci & Genie, Dept Chim, Quebec City, PQ G1V 0A6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Laval University; Laval University	Frugier, M (corresponding author), Univ Strasbourg, Architecture & Reactivite ARN, CNRS, Inst Biol Mol & Cellulaire, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	M.Frugier@ibmc.u-strasbg.fr			Universite Louis Pasteur; Agence Nationale de la Recherche [ANR-07-BLAN-006901]	Universite Louis Pasteur; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS including a PICS project, the Universite Louis Pasteur, the Agence Nationale de la Recherche (ANR-07-BLAN-006901), and a "Bourse Formation Recherche" from Luxembourg (to T.B.).	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; AGOU F, 1995, BIOCHEMISTRY-US, V34, P569, DOI 10.1021/bi00002a023; Ataide SF, 2006, ACS CHEM BIOL, V1, P285, DOI 10.1021/cb600200k; Balg C, 2007, BIOORGAN MED CHEM, V15, P295, DOI 10.1016/j.bmc.2006.09.056; Becker HD, 2000, BIOCHEMISTRY-US, V39, P3216, DOI 10.1021/bi992573y; Bernard D, 2007, J ENZYM INHIB MED CH, V22, P77, DOI 10.1080/14756360600952316; Bernier S, 2005, BIOORGAN MED CHEM, V13, P69, DOI 10.1016/j.bmc.2004.09.055; BONNET J, 1972, EUR J BIOCHEM, V31, P335, DOI 10.1111/j.1432-1033.1972.tb02538.x; Campanacci V, 2004, J MOL BIOL, V337, P273, DOI 10.1016/j.jmb.2004.01.027; CAVARELLI J, 1993, NATURE, V362, P181, DOI 10.1038/362181a0; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chayen N, 2004, ANN NY ACAD SCI, V1027, P20, DOI 10.1196/annals.1324.003; Choi H, 2003, RNA, V9, P386, DOI 10.1261/rna.2139703; Depledge DP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-122; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ERIANI G, 1991, EUR J BIOCHEM, V200, P337, DOI 10.1111/j.1432-1033.1991.tb16190.x; ERIANI G, 1995, J MOL EVOL, V40, P499; ERIANI G, 1993, P NATL ACAD SCI USA, V90, P10816, DOI 10.1073/pnas.90.22.10816; ESCALANTE C, 1993, J BIOL CHEM, V268, P6014; Feagin JE, 2000, INT J PARASITOL, V30, P371, DOI 10.1016/S0020-7519(99)00190-3; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Feng L, 2005, J BIOL CHEM, V280, P20638, DOI 10.1074/jbc.M500874200; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; FRUGIER M, 1994, BIOCHEMISTRY-US, V33, P9912, DOI 10.1021/bi00199a013; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giege R, 1996, BIOCHIMIE, V78, P605, DOI 10.1016/S0300-9084(96)80007-1; GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7; GIEGE R, 1982, BIOCHIMIE, V64, P357, DOI 10.1016/S0300-9084(82)80440-9; Giege R., 2005, AMINOACYL TRNA SYNTH, P210; Giege R, 2008, NAT STRUCT MOL BIOL, V15, P1007, DOI 10.1038/nsmb.1498; Ibba M., 2005, AMINOACYL TRNA SYNTH; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Martin D, 2000, MOL BIOCHEM PARASIT, V110, P93, DOI 10.1016/S0166-6851(00)00260-7; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Messmer M, 2009, BIOCHIMIE, V91, P596, DOI 10.1016/j.biochi.2009.02.005; Metlitskaya A, 2006, J BIOL CHEM, V281, P18033, DOI 10.1074/jbc.M513174200; MIKOL V, 1991, J CRYST GROWTH, V110, P195, DOI 10.1016/0022-0248(91)90885-9; Moras D, 1992, CURR OPIN STRUC BIOL, V2, P138; Moulinier L, 2001, EMBO J, V20, P5290, DOI 10.1093/emboj/20.18.5290; Mourier T, 2005, RNA, V11, P119, DOI 10.1261/rna.7185605; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pizzi E, 2001, GENOME RES, V11, P218, DOI 10.1101/gr.GR-1522R; PREISER P, 1995, NUCLEIC ACIDS RES, V23, P4329, DOI 10.1093/nar/23.21.4329; PUTZ J, 1991, SCIENCE, V252, P1696, DOI 10.1126/science.2047878; Rees B, 2000, J MOL BIOL, V299, P1157, DOI 10.1006/jmbi.2000.3792; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Ryckelynck M, 2003, J BIOL CHEM, V278, P9683, DOI 10.1074/jbc.M211035200; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Sauter C, 2000, J MOL BIOL, V299, P1313, DOI 10.1006/jmbi.2000.3791; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; SELLAMI M, 1986, NUCLEIC ACIDS RES, V14, P1657, DOI 10.1093/nar/14.4.1657; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; THIBAULT F, 1992, J MOL BIOL, V225, P185, DOI 10.1016/0022-2836(92)91035-N; Trager W, 1997, INT J PARASITOL, V27, P989, DOI 10.1016/S0020-7519(97)00080-5; Tuteja R, 2007, FEBS J, V274, P4670, DOI 10.1111/j.1742-4658.2007.05997.x; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449	59	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18893	18903		10.1074/jbc.M109.015297	http://dx.doi.org/10.1074/jbc.M109.015297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19443655	Green Published, hybrid			2022-12-27	WOS:000267711500039
J	Kleiner, S; Nguyen-Tran, V; Bare, O; Huang, XM; Spiegelman, B; Wu, ZD				Kleiner, Sandra; Nguyen-Tran, Van; Bare, Olivia; Huang, Xueming; Spiegelman, Bruce; Wu, Zhidan			PPAR delta Agonism Activates Fatty Acid Oxidation via PGC-1 alpha but Does Not Increase Mitochondrial Gene Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; COACTIVATOR PGC-1-ALPHA; TRANSCRIPTIONAL CONTROL; METABOLIC SYNDROME; ENERGY-METABOLISM; RECEPTOR; CELLS; GAMMA; OBESITY; ALPHA	PPAR delta (peroxisome proliferator-activated receptor delta) is a regulator of lipid metabolism and has been shown to induce fatty acid oxidation (FAO). PPAR delta transgenic and knock-out mice indicate an involvement of PPAR delta in regulating mitochondrial biogenesis and oxidative capacity; however, the precise mechanisms by which PPAR delta regulates these pathways in skeletal muscle remain unclear. In this study, we determined the effect of selective PPAR delta agonism with the synthetic ligand, GW501516, on FAO and mitochondrial gene expression in vitro and in vivo. Our results show that activation of PPAR delta by GW501516 led to a robust increase in mRNA levels of key lipid metabolism genes. Mitochondrial gene expression and function were not induced under the same conditions. Additionally, the activation of Pdk4 transcription by PPAR delta was coactivated by PGC-1 alpha. PGC-1 alpha, but not PGC-1 beta, was essential for full activation of Cpt-1b and Pdk4 gene expression via PPAR beta agonism. Furthermore, the induction of FAO by PPAR delta agonism was completely abolished in the absence of both PGC-1 alpha and PGC-1 beta Conversely, PGC-1 alpha-driven FAO was independent of PPAR delta. Neither GW501516 treatment nor knockdown of PPAR delta affects PGC-1 alpha-induced mitochondrial gene expression in primary myotubes. These results demonstrate that pharmacological activation of PPAR delta induces FAO via PGC-1 alpha. However, PPAR delta agonism does not induce mitochondrial gene expression and function. PGC-1 alpha-induced FAO and mitochondrial biogenesis appear to be independent of PPAR delta.	[Nguyen-Tran, Van] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Kleiner, Sandra; Spiegelman, Bruce] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Kleiner, Sandra; Spiegelman, Bruce] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kleiner, Sandra; Bare, Olivia; Huang, Xueming; Wu, Zhidan] Novartis Inst Biomed Res Inc, Cardiovasc & Metab Dis Area, Cambridge, MA 02139 USA	Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Novartis	Wu, ZD (corresponding author), 100 Technol Sq, Cambridge, MA 02139 USA.	zhidan.wu@novartis.com		Wu, Zhidan/0000-0001-7289-9420				Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; LUQUET S, 2003, FASEB J; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Semple RK, 2004, INT J OBESITY, V28, P176, DOI 10.1038/sj.ijo.0802482; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Takahashi S, 2007, ENDOCR J, V54, P347, DOI 10.1507/endocrj.KR-99; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103	25	109	113	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18624	18633		10.1074/jbc.M109.008797	http://dx.doi.org/10.1074/jbc.M109.008797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19435887	Green Published, hybrid			2022-12-27	WOS:000267711500011
J	Tarrago, L; Laugier, E; Zaffagnini, M; Marchand, C; Le Marechal, P; Rouhier, N; Lemaire, SD; Rey, P				Tarrago, Lionel; Laugier, Edith; Zaffagnini, Mirko; Marchand, Christophe; Le Marechal, Pierre; Rouhier, Nicolas; Lemaire, Stephane D.; Rey, Pascal			Regeneration Mechanisms of Arabidopsis thaliana Methionine Sulfoxide Reductases B by Glutaredoxins and Thioredoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; S-GLUTATHIONYLATION; CATALYTIC MECHANISM; REDOX REGULATION; REDUCING AGENT; ACTIVE-SITE; PROTEIN; PEROXIREDOXIN; POPLAR	Methionine oxidation leads to the formation of S- and R-diastereomers of methionine sulfoxide (MetSO), which are reduced back to methionine by methionine sulfoxide reductases (MSRs) A and B, respectively. MSRBs are classified in two groups depending on the conservation of one or two redox-active Cys; 2-Cys MSRBs possess a catalytic Cys-reducing MetSO and a resolving Cys, allowing regeneration by thioredoxins. The second type, 1-Cys MSRBs, possess only the catalytic Cys. The biochemical mechanisms involved in activity regeneration of 1-Cys MSRBs remain largely elusive. In the present work we used recombinant plastidial Arabidopsis thaliana MSRB1 and MSRB2 as models for 1-Cys and 2-Cys MSRBs, respectively, to delineate the Trx- and glutaredoxin-dependent reduction mechanisms. Activity assays carried out using a series of cysteine mutants and various reductants combined with measurements of free thiols under distinct oxidation conditions and mass spectrometry experiments show that the 2-Cys MSRB2 is reduced by Trx through a dithiol-disulfide exchange involving both redox-active Cys of the two partners. Regarding 1-Cys MSRB1, oxidation of the enzyme after substrate reduction leads to the formation of a stable sulfenic acid on the catalytic Cys, which is subsequently glutathionylated. The deglutathionylation of MSRB1 is achieved by both mono- and dithiol glutaredoxins and involves only their N-terminal conserved catalytic Cys. This study proposes a detailed mechanism of the regeneration of 1-Cys MSRB activity by glutaredoxins, which likely constitute physiological reductants for this type of MSR.	[Tarrago, Lionel; Laugier, Edith; Rey, Pascal] CEN Cadarache, Lab Ecophysiol Mol Plantes, Inst Biol Environm & Biotechnol, Direct Sci Vivant, F-13108 St Paul Les Durance, France; [Zaffagnini, Mirko; Lemaire, Stephane D.] Univ Paris 11, Inst Biotechnol Plantes, Unite Mixte Rech 8618, F-91405 Orsay, France; [Marchand, Christophe; Le Marechal, Pierre] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, Unite Mixte Rech 8619, F-91405 Orsay, France; [Rouhier, Nicolas] Nancy Univ Interact Arbres Microorganismes, Inst Natl Rech Agron, Unite Mixte Rech 1136, IFR Genom Ecophysiol & Ecol Fonct 110, F-54506 Vandoeuvre Les Nancy, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Lorraine	Rey, P (corresponding author), CEN Cadarache, Lab Ecophysiol Mol Plantes, Inst Biol Environm & Biotechnol, Direct Sci Vivant, Batiment 158, F-13108 St Paul Les Durance, France.	pascal.rey@cea.fr	REY, Pascal/E-5794-2019; Lemaire, Stéphane D/A-3530-2008; Tarrago, Lionel/CAH-1308-2022; MARCHAND, Christophe H/B-5854-2008; Tarrago, Lionel/N-3534-2016	REY, Pascal/0000-0001-6512-1418; Lemaire, Stéphane D/0000-0001-6442-0547; Tarrago, Lionel/0000-0001-7115-8137; MARCHAND, Christophe H/0000-0002-0729-3841; Tarrago, Lionel/0000-0001-7115-8137; Zaffagnini, Mirko/0000-0001-5115-0859	Agence Nationale de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche, ANR-Geno-plante Grants GNP05010G (to P.R., E.L., and N.R.) and ANR-JC45751 (to M.Z. and S.D.L.). Financial support (to L.T.) from Region Provence-Alpes-Cotes-d'Azur is acknowledged.	Augusto LA, 2003, BIOCHEMISTRY-US, V42, P3929, DOI 10.1021/bi0268394; Behm M, 2000, PLANT PHYSIOL BIOCH, V38, P363, DOI 10.1016/S0981-9428(00)00760-9; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Broin M, 2002, PLANT CELL, V14, P1417, DOI 10.1105/tpc.001644; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Ding D, 2007, BIOCHEM BIOPH RES CO, V361, P629, DOI 10.1016/j.bbrc.2007.07.072; Dixon DP, 2005, BIOCHEMISTRY-US, V44, P7696, DOI 10.1021/bi047324a; Dos Santos CV, 2007, FEBS LETT, V581, P4371, DOI 10.1016/j.febslet.2007.07.081; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Neiers F, 2004, J BIOL CHEM, V279, P42462, DOI 10.1074/jbc.M407464200; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Rey P, 2005, PLANT J, V41, P31, DOI 10.1111/j.1365-313X.2004.02271.x; Rey P, 1998, PLANT J, V13, P97, DOI 10.1046/j.1365-313X.1998.00015.x; Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Ruegg U T, 1977, Methods Enzymol, V47, P111; Sagher D, 2006, J BIOL CHEM, V281, P31184, DOI 10.1074/jbc.M606962200; Saghert D, 2006, P NATL ACAD SCI USA, V103, P8656, DOI 10.1073/pnas.0602826103; Shelton MD, 2008, MOL CELLS, V25, P332; Silva GM, 2008, FEBS J, V275, P2942, DOI 10.1111/j.1742-4658.2008.06441.x; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; Tarrago L, 2009, MOL PLANT, V2, P202, DOI 10.1093/mp/ssn067; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x	44	107	113	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18963	18971		10.1074/jbc.M109.015487	http://dx.doi.org/10.1074/jbc.M109.015487			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19457862	Green Published, hybrid			2022-12-27	WOS:000267711500046
J	Vankemmelbeke, M; Zhang, Y; Moore, GR; Kleanthous, C; Penfold, CN; James, R				Vankemmelbeke, Mireille; Zhang, Ying; Moore, Geoffrey R.; Kleanthous, Colin; Penfold, Christopher N.; James, Richard			Energy-dependent Immunity Protein Release during tol-dependent Nuclease Colicin Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; PROTON MOTIVE FORCE; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; RECEPTOR-BINDING; INNER MEMBRANE; CELL-DIVISION; EVOLUTIONARY RELATIONSHIP; COMPETITIVE RECRUITMENT; MUTATIONAL ANALYSIS	Nuclease colicins bind their target receptor in the outer membrane of sensitive cells in the form of a high affinity complex with their cognate immunity proteins. Upon cell entry the immunity protein is lost from the complex by means that are poorly understood. We have developed a sensitive fluorescence assay that has enabled us to study the molecular requirements for immunity protein release. Nuclease colicins use members of the tol operon for their translocation across the outer membrane. We have demonstrated that the amino-terminal 80 residues of the colicin E9 molecule, which is the region that interacts with TolB, are essential for immunity protein release. Using tol deletion strains we analyzed the cellular components necessary for immunity protein release and found that in addition to a requirement for tolB, the tolA deletion strain was most affected. Complementation studies showed that the mutation H22A, within the transmembrane segment of TolA, abolishes immunity protein release. Investigation of the energy requirements demonstrated that the proton motive force of the cytoplasmic membrane is critical. Taken together these results demonstrate for the first time a clear energy requirement for the uptake of a nuclease colicin complex and suggest that energy transduced from the cytoplasmic membrane to the outer membrane by TolA could be the driving force for immunity protein release and concomitant translocation of the nuclease domain.	[Vankemmelbeke, Mireille; Zhang, Ying; Penfold, Christopher N.; James, Richard] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Vankemmelbeke, Mireille; Zhang, Ying; Penfold, Christopher N.; James, Richard] Univ Nottingham, Ctr Biomol Sci, Inst Infect Immun & Inflammat, Nottingham NG7 2RD, England; [Moore, Geoffrey R.] Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England; [Kleanthous, Colin] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of Nottingham; University of Nottingham; University of East Anglia; University of York - UK	Vankemmelbeke, M (corresponding author), Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England.	mireille.vankemmelbeke@nottingham.ac.uk	James, Richard/B-2252-2009; zhang, ying/E-2718-2017	Penfold, Christopher/0000-0003-3251-5650; Zhang, Ying/0000-0003-3074-9998; James, Richard/0000-0002-5086-788X; Vankemmelbeke, Mireille/0000-0002-8100-813X	Wellcome Trust; University of Nottingham; Biotechnology and Biological Sciences Research Council [BB/C516236/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); University of Nottingham; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a program grant from The Wellcome Trust and by the University of Nottingham.	Baboolal TG, 2008, STRUCTURE, V16, P371, DOI 10.1016/j.str.2007.12.023; BASSFORD PJ, 1977, J BACTERIOL, V129, P265, DOI 10.1128/JB.129.1.265-275.1977; BAYER ME, 1968, J VIROL, V2, P346, DOI 10.1128/JVI.2.4.346-356.1968; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bonsor DA, 2007, J AM CHEM SOC, V129, P4800, DOI 10.1021/ja070153n; BRAUN V, 1993, MOL MICROBIOL, V8, P261, DOI 10.1111/j.1365-2958.1993.tb01570.x; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Clavel T, 1998, MOL MICROBIOL, V29, P359, DOI 10.1046/j.1365-2958.1998.00945.x; Collins ES, 2002, J MOL BIOL, V318, P787, DOI 10.1016/S0022-2836(02)00036-0; Davidov Y, 2000, MUTAT RES-GEN TOX EN, V466, P97, DOI 10.1016/S1383-5718(99)00233-8; de Zamaroczy M, 2002, BIOCHIMIE, V84, P423, DOI 10.1016/S0300-9084(02)01426-8; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; Dubuisson JF, 2002, J BACTERIOL, V184, P4620, DOI 10.1128/JB.184.16.4620-4625.2002; DUCHE D, 1994, J BIOL CHEM, V269, P24820; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; Duche D, 2006, J BACTERIOL, V188, P8593, DOI 10.1128/JB.00941-06; Edgar R, 2008, MOL MICROBIOL, V68, P1107, DOI 10.1111/j.1365-2958.2008.06205.x; GarinotSchneider C, 1997, MICROBIOL-SGM, V143, P2931, DOI 10.1099/00221287-143-9-2931; Gaspar JA, 2000, MOL MICROBIOL, V38, P262, DOI 10.1046/j.1365-2958.2000.02094.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Germon P, 1998, J BACTERIOL, V180, P6433, DOI 10.1128/JB.180.24.6433-6439.1998; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; GUDMUNDSDOTTIR A, 1988, J BIOL CHEM, V263, P14224; GUIHARD G, 1994, J BIOL CHEM, V269, P5874; Hands SL, 2005, J BACTERIOL, V187, P6733, DOI 10.1128/JB.187.19.6733-6741.2005; Hann E, 2007, BIOPHYS J, V92, pL79, DOI 10.1529/biophysj.106.102475; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; JETTEN AM, 1975, BIOCHIM BIOPHYS ACTA, V387, P12, DOI 10.1016/0005-2728(75)90048-1; KRONCKE KD, 1990, J BACTERIOL, V172, P3469; Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199; Larsen RA, 1999, MOL MICROBIOL, V31, P1809, DOI 10.1046/j.1365-2958.1999.01317.x; Larsen RA, 2001, J BIOL CHEM, V276, P8111, DOI 10.1074/jbc.M007479200; Larsen RA, 2007, J BACTERIOL, V189, P2825, DOI 10.1128/JB.01925-06; Lazzaroni JC, 2002, BIOCHIMIE, V84, P391, DOI 10.1016/S0300-9084(02)01419-0; LEVENGOOD SK, 1991, P NATL ACAD SCI USA, V88, P5939, DOI 10.1073/pnas.88.14.5939; Li W, 1998, BIOCHEMISTRY-US, V37, P11771, DOI 10.1021/bi9808621; Lim JH, 2001, EMBO J, V20, P941, DOI 10.1093/emboj/20.5.941; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Loftus SR, 2006, P NATL ACAD SCI USA, V103, P12353, DOI 10.1073/pnas.0603433103; MARTIN J, 1991, J BIOL CHEM, V266, P18051; Meury J, 1999, BIOL CELL, V91, P67, DOI 10.1016/S0248-4900(99)80032-X; Mokranjac D, 2008, BBA-BIOENERGETICS, V1777, P758, DOI 10.1016/j.bbabio.2008.04.009; Penfold CN, 2004, J BACTERIOL, V186, P4520, DOI 10.1128/JB.186.14.4520-4527.2004; PFANNER N, 1990, BIOCHIM BIOPHYS ACTA, V1018, P239, DOI 10.1016/0005-2728(90)90257-5; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; ROTHFIELD LI, 1988, MICROBIOL SCI, V5, P182; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Sharma O, 2007, J BIOL CHEM, V282, P23163, DOI 10.1074/jbc.M703004200; Sharma O, 2007, J BACTERIOL, V189, P363, DOI 10.1128/JB.01344-06; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; Tefsen B, 2005, J BIOL CHEM, V280, P4504, DOI 10.1074/jbc.M409259200; Vankemmelbeke M, 2005, J BACTERIOL, V187, P4900, DOI 10.1128/JB.187.14.4900-4907.2005; Vianney A, 1996, J BACTERIOL, V178, P4031, DOI 10.1128/jb.178.14.4031-4038.1996; Walburger A, 2002, MOL MICROBIOL, V44, P695, DOI 10.1046/j.1365-2958.2002.02895.x; Walker D, 2007, J BIOL CHEM, V282, P31389, DOI 10.1074/jbc.M705883200; WALLIS R, 1992, EUR J BIOCHEM, V207, P687, DOI 10.1111/j.1432-1033.1992.tb17096.x; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x; Witty M, 2002, EMBO J, V21, P4207, DOI 10.1093/emboj/cdf417; YAMANE K, 1987, J BIOL CHEM, V262, P2358; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137; Zakharov SD, 2004, BIOPHYS J, V87, P3901, DOI 10.1529/biophysj.104.046151; Zakharov SD, 2006, BIOCHEMISTRY-US, V45, P10199, DOI 10.1021/bi060694+; Zhai YF, 2003, BBA-BIOMEMBRANES, V1614, P201, DOI 10.1016/S0005-2736(03)00176-7; Zhang Y, 2008, J BACTERIOL, V190, P4342, DOI 10.1128/JB.00047-08	71	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18932	18941		10.1074/jbc.M806149200	http://dx.doi.org/10.1074/jbc.M806149200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19458090	Green Published, hybrid			2022-12-27	WOS:000267711500043
J	Fabrick, J; Oppert, C; Lorenzen, MD; Morris, K; Oppert, B; Jurat-Fuentes, JL				Fabrick, Jeff; Oppert, Cris; Lorenzen, Marce D.; Morris, Kaley; Oppert, Brenda; Jurat-Fuentes, Juan Luis			A Novel Tenebrio molitor Cadherin Is a Functional Receptor for Bacillus thuringiensis Cry3Aa Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER MEMBRANE-VESICLES; DROSOPHILA S2 CELLS; DELTA-ENDOTOXIN; HELIOTHIS-VIRESCENS; MANDUCA-SEXTA; CRY1A TOXINS; INSECT RESISTANCE; PORE FORMATION; LARVAL MIDGUT; HELICOVERPA-ARMIGERA	Cry toxins produced by the bacterium Bacillus thuringiensis are effective biological insecticides. Cadherin-like proteins have been reported as functional Cry1A toxin receptors in Lepidoptera. Here we present data that demonstrate that a coleopteran cadherin is a functional Cry3Aa toxin receptor. The Cry3Aa receptor cadherin was cloned from Tenebrio molitor larval midgut mRNA, and the predicted protein, TmCad1, has domain structure and a putative toxin binding region similar to those in lepidopteran cadherin B. thuringiensis receptors. A peptide containing the putative toxin binding region from TmCad1 bound specifically to Cry3Aa and promoted the formation of Cry3Aa toxin oligomers, proposed to be mediators of toxicity in lepidopterans. Injection of TmCad1-specific double-stranded RNA into T. molitor larvae resulted in knockdown of the TmCad1 transcript and conferred resistance to Cry3Aa toxicity. These data demonstrate the functional role of TmCad1 as a Cry3Aa receptor in T. molitor and reveal similarities between the mode of action of Cry toxins in Lepidoptera and Coleoptera.	[Lorenzen, Marce D.; Oppert, Brenda] ARS, USDA, GMPRC, Manhattan, KS 66502 USA; [Fabrick, Jeff] ARS, USDA, US Arid Land Agr Res Ctr, Maricopa, AZ 85238 USA; [Oppert, Cris; Jurat-Fuentes, Juan Luis] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37996 USA; [Morris, Kaley] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Kansas State University	Oppert, B (corresponding author), ARS, USDA, GMPRC, 1515 Coll Ave, Manhattan, KS 66502 USA.	bso@ksu.edu	Jurat-Fuentes, Juan Luis/A-5104-2014	Jurat-Fuentes, Juan Luis/0000-0002-8945-1814; Fabrick, Jeffrey/0000-0002-3893-9545; Lorenzen, Marce/0000-0003-2318-1388				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BELFIORE CJ, 1994, BIOCHEM BIOPH RES CO, V200, P359, DOI 10.1006/bbrc.1994.1456; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Carroll J, 1997, J INVERTEBR PATHOL, V70, P41, DOI 10.1006/jipa.1997.4656; CARROLL J, 1989, BIOCHEM J, V261, P99, DOI 10.1042/bj2610099; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gomez I, 2007, PEPTIDES, V28, P169, DOI 10.1016/j.peptides.2006.06.013; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Hara H, 2003, FEBS LETT, V538, P29, DOI 10.1016/S0014-5793(03)00117-0; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Hua G, 2004, INSECT BIOCHEM MOLEC, V34, P193, DOI 10.1016/j.ibmb.2003.10.006; Hua G, 2008, BIOCHEMISTRY-US, V47, P5101, DOI 10.1021/bi7023578; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2001, APPL ENVIRON MICROB, V67, P323, DOI 10.1128/AEM.67.1.323-329.2001; Jurat-Fuentes JL, 2006, BIOCHEMISTRY-US, V45, P9688, DOI 10.1021/bi0606703; KOLLER CN, 1992, BIOCHEM BIOPH RES CO, V184, P692, DOI 10.1016/0006-291X(92)90645-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Ochoa-Campuzano C, 2007, BIOCHEM BIOPH RES CO, V362, P437, DOI 10.1016/j.bbrc.2007.07.197; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Park Y, 2009, APPL ENVIRON MICROB, V75, P3086, DOI 10.1128/AEM.00268-09; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Prabhakar S, 2007, INSECT MOL BIOL, V16, P455, DOI 10.1111/j.1365-2583.2007.00740.x; Rausell C, 2007, BBA-BIOMEMBRANES, V1768, P2293, DOI 10.1016/j.bbamem.2007.06.014; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; Rice ME., 2004, PLANT HLTH PROG, DOI [10.1094/PHP-2004-0301-01-RV, DOI 10.1094/PHP-2004-0301-01-RV]; Sayed A, 2007, INSECT MOL BIOL, V16, P591, DOI 10.1111/j.1365-2583.2007.00755.x; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tsuda Y, 2003, BIOCHEM J, V369, P697, DOI 10.1042/BJ20021401; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2008, J INVERTEBR PATHOL, V97, P27, DOI 10.1016/j.jip.2007.04.009; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; XU Z, 2009, PEST MANAG IN PRESS; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	47	86	97	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18401	18410		10.1074/jbc.M109.001651	http://dx.doi.org/10.1074/jbc.M109.001651			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416969	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000267712400052
J	Bottova, I; Hehl, AB; Stefanic, S; Fabrias, G; Casas, J; Schraner, E; Pieters, J; Sonda, S				Bottova, Iveta; Hehl, Adrian B.; Stefanic, Sasa; Fabrias, Gemma; Casas, Josefina; Schraner, Elisabeth; Pieters, Jean; Sonda, Sabrina			Host Cell P-glycoprotein Is Essential for Cholesterol Uptake and Replication of Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; NEOSPORA-CANINUM; DENSITY-LIPOPROTEIN; ESTERIFICATION; MEMBRANE; ACCUMULATION; TRANSPORTERS; VACUOLE; SPHINGOMYELIN; SPHINGOLIPIDS	P-glycoprotein (P-gp) is a membrane-bound efflux pump that actively exports a wide range of compounds from the cell and is associated with the phenomenon of multidrug resistance. However, the role of P-gp in normal physiological processes remains elusive. Using P-gp-deficient fibroblasts, we showed that P-gp was critical for the replication of the intracellular parasite Toxoplasma gondii but was not involved in invasion of host cells by the parasite. Importantly, we found that the protein participated in the transport of host-derived cholesterol to the intracellular parasite. T. gondii replication in P-gp-deficient host cells not only resulted in reduced cholesterol content in the parasite but also altered its sphingolipid metabolism. In addition, we found that different levels of P-gp expression modified the cholesterol metabolism in uninfected fibroblasts. Collectively our findings reveal a key and previously undocumented role of P-gp in host-parasite interaction and suggest a physiological role for P-gp in cholesterol trafficking in mammalian cells.	[Bottova, Iveta; Hehl, Adrian B.; Stefanic, Sasa; Sonda, Sabrina] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Schraner, Elisabeth] Univ Zurich, Inst Vet Anat, CH-8057 Zurich, Switzerland; [Fabrias, Gemma; Casas, Josefina] CSIC, Inst Quim Avancada Catalunya, ES-08034 Barcelona, Spain; [Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Zurich; University of Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Basel	Sonda, S (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.	sabrina.sonda@vetparas.uzh.ch	Casas, Josefina/L-7934-2014; Stefanic, Sasa/AAF-3063-2020	Fabrias, Gemma/0000-0001-7162-3772; Hehl, Adrian/0000-0002-2110-4445; Pieters, Jean/0000-0002-5284-9757; Stefanic, Sasa/0000-0001-7367-1831	Marie Heim-Vogtlin Foundation; Fondation Pierre Mercier pour la Science; Roche and Novartis; Bundesamt fur Bildung and Wissenschaft [C03.0007]; Swiss National Foundation	Marie Heim-Vogtlin Foundation; Fondation Pierre Mercier pour la Science; Roche and Novartis; Bundesamt fur Bildung and Wissenschaft; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Marie Heim-Vogtlin Foundation, Fondation Pierre Mercier pour la Science, Roche and Novartis (to S. S.), Bundesamt fur Bildung and Wissenschaft C03.0007 COST Action 857 (to A. B. H.), and the Swiss National Foundation (to J. P.).	Aleman C, 2003, CANCER RES, V63, P3084; Blackmore CG, 2001, MOL MEMBR BIOL, V18, P97, DOI 10.1080/09687680010030200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown RE, 1998, J CELL SCI, V111, P1; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; CURRIER SJ, 1992, J BIOL CHEM, V267, P25153; Debry P, 1997, J BIOL CHEM, V272, P1026, DOI 10.1074/jbc.272.2.1026; Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006; Fuchs N, 1998, J PARASITOL, V84, P753, DOI 10.2307/3284583; Garrigues A, 2002, P NATL ACAD SCI USA, V99, P10347, DOI 10.1073/pnas.162366399; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hemphill A, 1996, INFECT IMMUN, V64, P4279, DOI 10.1128/IAI.64.10.4279-4287.1996; Hemphill A, 1996, PARASITOLOGY, V112, P183, DOI 10.1017/S0031182000084754; Kim H, 1997, AM J PHYSIOL-CELL PH, V273, pC687, DOI 10.1152/ajpcell.1997.273.2.C687; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Leppimaki P, 1998, BIOCHEM J, V335, P285, DOI 10.1042/bj3350285; Lerch PG, 1996, VOX SANG, V71, P155, DOI 10.1046/j.1423-0410.1996.7130155.x; Liscovitch M, 2000, TRENDS BIOCHEM SCI, V25, P530, DOI 10.1016/S0968-0004(00)01668-6; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Loo TW, 1999, BIOCHEM CELL BIOL, V77, P11, DOI 10.1139/bcb-77-1-11; Luker GD, 1999, J BIOL CHEM, V274, P6979, DOI 10.1074/jbc.274.11.6979; Luker GD, 2001, J LIPID RES, V42, P1389; Martin AM, 2007, J EUKARYOT MICROBIOL, V54, P25, DOI 10.1111/j.1550-7408.2006.00230.x; Maubon D, 2008, TRENDS PARASITOL, V24, P299, DOI 10.1016/j.pt.2008.03.012; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; McFadden DC, 1997, ANTIMICROB AGENTS CH, V41, P1849, DOI 10.1128/AAC.41.9.1849; Monaghan P, 2003, J MICROSC-OXFORD, V212, P62, DOI 10.1046/j.1365-2818.2003.01245.x; Mordue DG, 1999, EXP PARASITOL, V92, P87, DOI 10.1006/expr.1999.4412; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8; Santini MT, 2001, BBA-MOL CELL BIOL L, V1531, P111, DOI 10.1016/S1388-1981(01)00093-2; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Sehgal A, 2005, TRAFFIC, V6, P1125, DOI 10.1111/j.1600-0854.2005.00348.x; Silverman JA, 1997, ANTIMICROB AGENTS CH, V41, P1859, DOI 10.1128/AAC.41.9.1859; Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200; Underwood KW, 1996, J LIPID RES, V37, P1556; van Veen HW, 1998, BBA-BIOENERGETICS, V1365, P31, DOI 10.1016/S0005-2728(98)00039-5; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Wijnholds J, 2000, J CLIN INVEST, V105, P279, DOI 10.1172/JCI8267; Wild P, 2001, MICROSC RES TECHNIQ, V53, P313, DOI 10.1002/jemt.1098; Zhang M, 2001, J BIOL CHEM, V276, P3417, DOI 10.1074/jbc.M005393200	46	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17438	17448		10.1074/jbc.M809420200	http://dx.doi.org/10.1074/jbc.M809420200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19389707	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000267202500010
J	Karytinos, A; Forneris, F; Profumo, A; Ciossani, G; Battaglioli, E; Binda, C; Mattevi, A				Karytinos, Aristotele; Forneris, Federico; Profumo, Antonella; Ciossani, Giuseppe; Battaglioli, Elena; Binda, Claudia; Mattevi, Andrea			A Novel Mammalian Flavin-dependent Histone Demethylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOAMINE-OXIDASE; CHROMATIN MODIFICATIONS; MODIFYING ENZYMES; STRUCTURAL BASIS; LSD1; MECHANISM; RECOGNITION; DOMAIN; COREST; CODE	Methylation of Lys residues on histone proteins is a well known and extensively characterized epigenetic mark. The recent discovery of lysine-specific demethylase 1 (LSD1) demonstrated that lysine methylation can be dynamically controlled. Among the histone demethylases so far identified, LSD1 has the unique feature of functioning through a flavin-dependent amine oxidation reaction. Data base analysis reveals that mammalian genomes contain a gene (AOF1, for amine-oxidase flavin-containing domain 1) that is homologous to the LSD1-coding gene. Here, we demonstrate that the protein encoded by AOF1 represents a second mammalian flavin-dependent histone demethylase, named LSD2. The new demethylase is strictly specific for mono-and dimethylated Lys(4) of histone H3, recognizes a long stretch of the H3 N-terminal tail, senses the presence of additional epigenetic marks on the histone substrate, and is covalently inhibited by tranylcypromine. As opposed to LSD1, LSD2 does not form a biochemically stable complex with the C-terminal domain of the corepressor protein CoREST. Furthermore, LSD2 contains a CW-type zinc finger motif with potential zinc-binding sites that are not present in LSD1. We conclude that mammalian LSD2 represents a new flavin-dependent H3-Lys(4) demethylase that features substrate specificity properties highly similar to those of LSD1 but is very likely to be part of chromatin-remodeling complexes that are distinct from those involving LSD1.	[Karytinos, Aristotele; Forneris, Federico; Ciossani, Giuseppe; Binda, Claudia; Mattevi, Andrea] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Profumo, Antonella] Univ Pavia, Dipartimento Chim Gen, I-27100 Pavia, Italy; [Battaglioli, Elena] Univ Milan, Dipartimento Biol & Genet Sci Med, I-20133 Milan, Italy	University of Pavia; University of Pavia; University of Milan	Binda, C (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	binda@ipvgen.unipv.it; mattevi@ipvgen.unipv.it	battaglioli, elena/H-9350-2017; Forneris, Federico/B-1145-2011; Forneris, Federico/AAL-5361-2020; mattevi, andrea/K-5464-2012; Mattevi, Andrea/R-4469-2019	Forneris, Federico/0000-0002-7818-1804; Forneris, Federico/0000-0002-7818-1804; mattevi, andrea/0000-0002-9523-7128; Mattevi, Andrea/0000-0002-9523-7128; Ciossani, Giuseppe/0000-0001-5293-4292; Binda, Claudia/0000-0003-2038-9845; Battaglioli, Elena/0000-0001-9168-7212	Italian Ministry of Science; FIRB programs; Fondazione Cariplo; Italian Association for Cancer Research	Italian Ministry of Science(Ministry of Education, Universities and Research (MIUR)); FIRB programs; Fondazione Cariplo(Fondazione Cariplo); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Ministry of Science PRIN06 and FIRB programs, Fondazione Cariplo, and the Italian Association for Cancer Research.	Aliverti A, 1999, METH MOL B, V131, P9; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Anand R, 2007, J BIOL CHEM, V282, P35425, DOI 10.1074/jbc.R700027200; Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2008, TRENDS BIOCHEM SCI, V33, P181, DOI 10.1016/j.tibs.2008.01.003; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lall S, 2007, NAT STRUCT MOL BIOL, V14, P1110, DOI 10.1038/nsmb1107-1110; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lizcano JM, 2000, ANAL BIOCHEM, V286, P75, DOI 10.1006/abio.2000.4782; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Mimasu S, 2008, BIOCHEM BIOPH RES CO, V366, P15, DOI 10.1016/j.bbrc.2007.11.066; Perry J, 2003, TRENDS BIOCHEM SCI, V28, P576, DOI 10.1016/j.tibs.2003.09.007; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schmidt DMZ, 2007, BIOCHEMISTRY-US, V46, P4408, DOI 10.1021/bi0618621; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; SMITH TA, 1988, PROGR POLYAMINE RES; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Zhou XF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-294; Zlatanova J, 2009, STRUCTURE, V17, P160, DOI 10.1016/j.str.2008.12.016	34	193	229	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17775	17782		10.1074/jbc.M109.003087	http://dx.doi.org/10.1074/jbc.M109.003087			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19407342	Green Published, hybrid			2022-12-27	WOS:000267202500043
J	Wu, JB; Chen, K; Ou, XM; Shih, JC				Wu, Jason B.; Chen, Kevin; Ou, Xiao-Ming; Shih, Jean C.			Retinoic Acid Activates Monoamine Oxidase B Promoter in Human Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-RELATED-CHANGES; MAO ACTIVITY; TRANSCRIPTION FACTORS; NUCLEAR RECEPTORS; RESPONSE-ELEMENT; GENE-EXPRESSION; RAT-BRAIN; SP1; DIFFERENTIATION; LOCALIZATION	Monoamine oxidase (MAO) B deaminates a number of biogenic and dietary amines and plays an important role in many biological processes. Among hormonal regulations of MAO B, we have recently found that retinoic acid (RA) significantly activates both MAOB promoter activity and mRNA expression in a human neuroblastoma BE(2) C cell line. RA activates MAO B promoter in both concentration- and time-dependent manners, which is mediated through retinoic acid receptor alpha (RAR alpha) and retinoid X receptor alpha (RXR alpha). There are four retinoic acid response elements (RAREs) as identified in the MAO B 2-kb promoter, and mutation of the third RARE reduced RA-induced MAO B promoter activation by 50%, suggesting this element is important. Electrophoretic mobility shift analysis and chromatin immunoprecipitation assay demonstrated that RAR alpha specifically binds to the third RARE both in vitro and in vivo. Moreover, transient transfection and luciferase assays revealed that Sp1 enhances but not essentially required for the RA activation of MAO B through two clusters of Sp1-binding sites in the MAO B promoter. RAR alpha physically interacts with Sp1 via zinc finger domains in Sp1 as determined by co-immunoprecipitation assay. Further, RAR alpha was shown to be recruited by Sp1 and to form a transcriptional regulation complex with Sp1 in the Sp1-binding sites of natural MAO B promoter. Taken together, this study provides evidence for the first time showing the stimulating effect of RA on MAO B and new insight into the molecular mechanisms of MAO B regulation by hormones.	[Shih, Jean C.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Shih, Jean C.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Ou, Xiao-Ming] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA	University of Southern California; University of Southern California; University of Mississippi; University of Mississippi Medical Center	Shih, JC (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, PSC 518,1985 Zonal Ave, Los Angeles, CA 90089 USA.	jcshih@usc.edu	Chen, Kevin/GYU-8963-2022; Wu, Jason Boyang/I-5780-2013		National Institute of Mental Health [R0 1MH67968, R01 MH39085]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039085, R01MH067968] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institute of Mental Health Grants R0 1MH67968 and R01 MH39085. This work was also supported by the Boyd and Elsie Welin Professorship.	Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1; ARAI Y, 1988, J NEURAL TRANSM, V72, P99, DOI 10.1007/BF01250233; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Cheng YH, 2008, J CLIN ENDOCR METAB, V93, P1915, DOI 10.1210/jc.2007-1536; DEKLOET ER, 1990, J STEROID BIOCHEM, V37, P387, DOI 10.1016/0960-0760(90)90489-8; DESAIYAJNIK V, 1993, MOL CELL BIOL, V13, P5057, DOI 10.1128/MCB.13.8.5057; DEVOR EJ, 1993, AM J MED GENET, V48, P209, DOI 10.1002/ajmg.1320480407; Ekici M, 2008, J BIOL CHEM, V283, P9257, DOI 10.1074/jbc.M709388200; FARAJ BA, 1994, ALCOHOL CLIN EXP RES, V18, P1114, DOI 10.1111/j.1530-0277.1994.tb00090.x; Fazi F, 2005, ONCOGENE, V24, P1820, DOI 10.1038/sj.onc.1208286; FOWLER CJ, 1980, J NEURAL TRANSM, V49, P1, DOI 10.1007/BF01249185; Hao H, 2003, BLOOD, V101, P4551, DOI 10.1182/blood-2002-10-3174; HOLSCHNEIDER DP, 1998, PSYCHOPHARMOCOLOGY 4; Hong JS, 2008, BIOCHEM J, V410, P49, DOI 10.1042/BJ20070904; HUGGENVIK JI, 1993, MOL ENDOCRINOL, V7, P543, DOI 10.1210/me.7.4.543; Husmann M, 2000, BIOCHEM J, V352, P763, DOI 10.1042/0264-6021:3520763; Jahng JW, 1997, SYNAPSE, V25, P30; Jiang HB, 2006, J BIOL CHEM, V281, P8591, DOI 10.1074/jbc.M510926200; JOHNSTON JP, 1968, BIOCHEM PHARMACOL, V17, P1285, DOI 10.1016/0006-2952(68)90066-X; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Knoll J, 1972, Adv Biochem Psychopharmacol, V5, P393; LEW AM, 1994, J BIOL CHEM, V269, P12007; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luque JM, 1995, J COMP NEUROL, V363, P665, DOI 10.1002/cne.903630410; Nicotra A, 2002, CELL BIOCHEM FUNCT, V20, P87, DOI 10.1002/cbf.955; Oreland L., 1993, MONOAMINE OXIDASE BA, P219; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Prochazka H, 2003, WORLD J BIOL PSYCHIA, V4, P35, DOI 10.3109/15622970309167909; Ren MQ, 2005, MOL CELL BIOL, V25, P10591, DOI 10.1128/MCB.25.23.10591-10603.2005; RIEDERER P, 1983, ACTA NEUROL SCAND, V68, P43, DOI 10.1111/j.1600-0404.1983.tb01516.x; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Salahpour A, 2007, BIOL PSYCHIAT, V61, P65, DOI 10.1016/j.biopsych.2006.03.020; SAURA J, 1994, J NEURAL TRANSM-SUPP, P89; SAURA J, 1994, NEUROBIOL AGING, V15, P399, DOI 10.1016/0197-4580(94)90071-X; SCHNEIDER G, 1981, ARCH PSYCHIAT NERVEN, V230, P5, DOI 10.1007/BF00343762; SHIH JC, 1991, NEUROPSYCHOPHARMACOL, V4, P1; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Subramaniam N, 2003, BIOCHEM J, V370, P1087, DOI 10.1042/BJ20020471; Suzuki Y, 1999, BLOOD, V93, P4264, DOI 10.1182/blood.V93.12.4264.412k27_4264_4276; Van der Burg B, 1999, INT J DEV BIOL, V43, P735; van Wageningen S, 2008, BLOOD, V111, P1634, DOI 10.1182/blood-2007-04-081125; VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229; WESTLUND KN, 1988, NEUROSCIENCE, V25, P439, DOI 10.1016/0306-4522(88)90250-3; WILLOUGHBY J, 1988, J NEURAL TRANSM, V74, P29, DOI 10.1007/BF01243573; Wong WK, 2003, J BIOL CHEM, V278, P36227, DOI 10.1074/jbc.M305549200; Wong WK, 2002, J BIOL CHEM, V277, P22222, DOI 10.1074/jbc.M202844200; Wong WK, 2001, MOL PHARMACOL, V59, P852, DOI 10.1124/mol.59.4.852; Yen A, 1998, CANCER RES, V58, P3163; Zhang ZP, 2006, MOL ENDOCRINOL, V20, P1547, DOI 10.1210/me.2005-0252; ZHU QS, 1992, J NEUROSCI, V12, P4437	54	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16723	16735		10.1074/jbc.M901779200	http://dx.doi.org/10.1074/jbc.M901779200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19401466	hybrid, Green Published			2022-12-27	WOS:000266962400007
J	Neuhaus, EM; Zhang, WY; Gelis, L; Deng, Y; Noldus, J; Hatt, H				Neuhaus, Eva M.; Zhang, Weiyi; Gelis, Lian; Deng, Ying; Noldus, Joachim; Hatt, Hanns			Activation of an Olfactory Receptor Inhibits Proliferation of Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MULTIGENE FAMILY; GENE FAMILY; EXPRESSION; ANDROGEN; PSGR; TESTOSTERONE; PROGRESSION; MICROARRAY; MOUSE	Olfactory receptors (ORs) are expressed not only in the sensory neurons of the olfactory epithelium, where they detect volatile substances, but also in various other tissues where their potential functions are largely unknown. Here, we report the physiological characterization of human OR51E2, also named prostate-specific G-protein-coupled receptor (PSGR) due to its reported up-regulation in prostate cancer. We identified androstenone derivatives as ligands for the recombinant receptor. PSGR can also be activated with the odorant beta-ionone. Activation of the endogenous receptor in prostate cancer cells by the identified ligands evoked an intracellular Ca2+ increase. Exposure to beta-ionone resulted in the activation of members of the MAPK family and inhibition of cell proliferation. Our data give support to the hypothesis that because PSGR signaling could reduce growth of prostate cancer cells, specific receptor ligands might therefore be potential candidates for prostate cancer treatment.	[Neuhaus, Eva M.; Zhang, Weiyi; Gelis, Lian; Deng, Ying; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, D-44780 Bochum, Germany; [Noldus, Joachim] Ruhr Univ Bochum, Marienhosp Herne, Dept Urol, D-44627 Herne, Germany	Ruhr University Bochum; Ruhr University Bochum; St. Marien Hospital	Neuhaus, EM (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, D-44780 Bochum, Germany.	eva.neuhaus@rub.de	Neuhaus, Eva M./L-1428-2015	Neuhaus, Eva M./0000-0003-3363-1231	Deutsche Forschungsgemeinschaft [SFB642]; Max-Planck-Research School for Chemical Biology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Research School for Chemical Biology	This study was supported by Grant SFB642 from the Deutsche Forschungsgemeinschaft (to E. M. N. and H. H.) and a grant from the Max-Planck-Research School for Chemical Biology.	Ben-Josef E, 1999, J UROLOGY, V161, P970, DOI 10.1016/S0022-5347(01)61831-7; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BRODIE AMH, 1983, J STEROID BIOCHEM, V19, P53, DOI 10.1016/S0022-4731(83)80006-5; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck L B, 1992, Curr Opin Neurobiol, V2, P282, DOI 10.1016/0959-4388(92)90116-3; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Cooper CR, 2003, CANCER-AM CANCER SOC, V97, P739, DOI 10.1002/cncr.11181; Dai J, 2002, CLIN CANCER RES, V8, P2399; DANZO BJ, 1991, ENDOCRINOLOGY, V129, P690, DOI 10.1210/endo-129-2-690; Duncan RE, 2004, BIOCHEM PHARMACOL, V68, P1739, DOI 10.1016/j.bcp.2004.06.022; Elson CE, 1999, P SOC EXP BIOL MED, V221, P294, DOI 10.1046/j.1525-1373.1999.d01-87.x; Falkenstein E, 2000, J CLIN ENDOCR METAB, V85, P2072, DOI 10.1210/jc.85.5.2072; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Firestein Stuart, 2004, Sci STKE, V2004, ppe15; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Godara G, 2005, PROSTATE, V65, P27, DOI 10.1002/pros.20252; HALVORSON M, 1990, ARCH BIOCHEM BIOPHYS, V277, P166, DOI 10.1016/0003-9861(90)90566-H; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Mo HB, 1999, J NUTR, V129, P804, DOI 10.1093/jn/129.4.804; NAGATA K, 1986, DRUG METAB DISPOS, V14, P559; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Taub JS, 2003, CANCER RES, V63, P2037; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; Wang JH, 2006, PROSTATE, V66, P847, DOI 10.1002/pros.20389; Weng JS, 2005, INT J CANCER, V113, P811, DOI 10.1002/ijc.20635; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Xu LL, 2000, CANCER RES, V60, P6568; Xu LL, 2006, PROSTATE CANCER P D, V9, P56, DOI 10.1038/sj.pcan.4500836; Yuan TTT, 2001, GENE, V278, P41, DOI 10.1016/S0378-1119(01)00709-0; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101	37	170	177	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16218	16225		10.1074/jbc.M109.012096	http://dx.doi.org/10.1074/jbc.M109.012096			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19389702	Green Published, hybrid			2022-12-27	WOS:000266730900019
J	Narayan, V; Eckert, M; Zylicz, A; Zylicz, M; Ball, KL				Narayan, Vikram; Eckert, Mirjam; Zylicz, Alicja; Zylicz, Maciej; Ball, Kathryn L.			Cooperative Regulation of the Interferon Regulatory Factor-1 Tumor Suppressor Protein by Core Components of the Molecular Chaperone Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR IRF-1; HSP90 CHAPERONE; SUBSTRATE-SPECIFICITY; DNAK CHAPERONE; P53; BINDING; DEGRADATION; ACTIVATION; EXPRESSION; INDUCTION	Our understanding of the post-translational processes involved in regulating the interferon regulatory factor-1 (IRF-1) tumor suppressor protein is limited. The introduction of mutations within the C-terminal Mf1 domain (amino acids 301-325) impacts on IRF-1-mediated gene repression and growth suppression as well as the rate of IRF-1 degradation. However, nothing is known about the proteins that interact with this region to modulate IRF-1 function. A biochemical screen for Mf1-interacting proteins has identified an LXXLL motif that is required for binding of Hsp70 family members and cooperation with Hsp90 to regulate IRF-1 turnover and activity. These conclusions are supported by the finding that Hsp90 inhibitors suppress IRF-1-dependent transcription shortly after treatment, although at later time points inhibition of Hsp90 leads to an Hsp70-dependent depletion of nuclear IRF-1. Conversely, the half-life of IRF-1 is increased by Hsp90 in an ATPase-dependent manner leading to the accumulation of nuclear but not cytoplasmic IRF-1. This study begins to elucidate the role of the Mf1 domain of IRF-1 in orchestrating the recruitment of regulatory factors that can impact on both its turnover and transcriptional activity.	[Ball, Kathryn L.] Univ Edinburgh, Canc Res Ctr, Cell Signalling Unit, Inst Genet & Mol Med,Canc Res UK Interferon & Cel, Edinburgh EH4 2XR, Midlothian, Scotland; [Zylicz, Alicja; Zylicz, Maciej] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland	University of Edinburgh; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Ball, KL (corresponding author), Univ Edinburgh, Canc Res Ctr, Cell Signalling Unit, Inst Genet & Mol Med,Canc Res UK Interferon & Cel, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	kathryn.ball@ed.ac.uk	Narayan, Vikram/AAF-3964-2020	Eckert, Mirjam/0000-0001-8641-8763; Narayan, Vikram/0000-0002-6128-7944; Zylicz, Alicja/0000-0003-4174-3073	Cancer Research UK [C377/A6355]; Polish Ministry of Science and Higher Education	Cancer Research UK(Cancer Research UK); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Programme Grant C377/A6355 (to K. L. B.) from Cancer Research UK and a grant from the Polish Ministry of Science and Higher Education (to A. Z. and M. Z.).	DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; Eckert M, 2006, J BIOL CHEM, V281, P23092, DOI 10.1074/jbc.M512589200; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Hansen S, 1996, J BIOL CHEM, V271, P3917; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Kirchhoff S, 2000, EUR J BIOCHEM, V267, P6753, DOI 10.1046/j.1432-1327.2000.01750.x; Klucken J, 2004, BIOCHEM BIOPH RES CO, V325, P367, DOI 10.1016/j.bbrc.2004.10.037; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Liu M, 2008, J BIOL CHEM, V283, P35783, DOI 10.1074/jbc.M806860200; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Neckers L, 1999, INVEST NEW DRUG, V17, P361, DOI 10.1023/A:1006382320697; Neckers L, 1999, DRUG RESIST UPDATE, V2, P165, DOI 10.1054/drup.1999.0082; Nozawa H, 1998, INT J CANCER, V77, P522, DOI 10.1002/(SICI)1097-0215(19980812)77:4<522::AID-IJC8>3.0.CO;2-W; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Passioura T, 2005, CANCER RES, V65, P797; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pion E, 2009, CELL SIGNAL, V21, P1479, DOI 10.1016/j.cellsig.2009.05.004; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Tamura G, 1996, J PATHOL, V180, P371, DOI 10.1002/(SICI)1096-9896(199612)180:4<371::AID-PATH704>3.0.CO;2-2; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Tendler DS, 2001, CANCER RES, V61, P3682; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27	50	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25889	25899		10.1074/jbc.M109.019505	http://dx.doi.org/10.1074/jbc.M109.019505			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19502235	Green Published, hybrid			2022-12-27	WOS:000269738000046
J	Tabarani, G; Thepaut, M; Stroebel, D; Ebel, C; Vives, C; Vachette, P; Durand, D; Fieschi, F				Tabarani, Georges; Thepaut, Michel; Stroebel, David; Ebel, Christine; Vives, Corinne; Vachette, Patrice; Durand, Dominique; Fieschi, Franck			DC-SIGN Neck Domain Is a pH-sensor Controlling Oligomerization SAXS AND HYDRODYNAMIC STUDIES OF EXTRACELLULAR DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DENDRITIC CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL-ANGLE SCATTERING; ICAM3-GRABBING NONINTEGRIN; CARBOHYDRATE-RECOGNITION; MEDIATED INTERNALIZATION; STRUCTURAL BASIS; TRANS-INFECTION; HIGH-RESOLUTION; T-CELLS	DC-SIGN is a C- type lectin receptor of dendritic cells and is involved in the early stages of numerous infectious diseases. DC-SIGN is organized into a tetramer enabling multivalent interaction with pathogens. Once formed, the DC-SIGN-pathogen complex can be internalized into compartments of increasing acidity. We have studied the pH dependence of the oligomerization state and conformation of the entire extracellular domain and neck region. We present evidence for equilibrium between the monomeric and tetrameric states of the extracellular domain, which exhibits a marked dependence with respect to both pH and ionic strength. Using solution x-ray scattering we have obtained a molecular envelope of the extracellular domain in which a model has been built. Our results highlight the central role of the neck domain in the pH-sensitive control of the oligomerization state, in the extended conformation of the protein, and in carbohydrate recognition domain organization and presentation. This work opens new insight into the molecular mechanism of ligand release and points to new avenues to block the first step of this important infection pathway.	[Tabarani, Georges; Thepaut, Michel; Stroebel, David; Vives, Corinne; Fieschi, Franck] Inst Biol Struct, Lab Prot Membranaires, F-38027 Grenoble 1, France; [Ebel, Christine] Inst Biol Struct, DSV, CEA, Lab Mol Biophys, F-38027 Grenoble 1, France; [Tabarani, Georges; Thepaut, Michel; Stroebel, David; Ebel, Christine; Vives, Corinne; Fieschi, Franck] CNRS, UMR 5075, F-38000 Grenoble, France; [Tabarani, Georges; Thepaut, Michel; Stroebel, David; Ebel, Christine; Vives, Corinne; Fieschi, Franck] Univ Grenoble 1, F-38000 Grenoble, France; [Vachette, Patrice; Durand, Dominique] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; [Vachette, Patrice; Durand, Dominique] CNRS, UMR 8619, F-91405 Orsay, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Fieschi, F (corresponding author), Inst Biol Struct, Lab Prot Membranaires, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	fieschi@ibs.fr	Fieschi, Franck/W-2748-2019; t, m/GXF-8560-2022; T, M/GRO-7072-2022	Ebel, Christine/0000-0002-6912-500X; FIESCHI, Franck/0000-0003-1194-8107	B. & M. Gates Foundation; Sidaction-Ensemble contre le Sida	B. & M. Gates Foundation; Sidaction-Ensemble contre le Sida	This work was supported by a post-doctoral grant from the B. & M. Gates Foundation (to M. T.) and the "Sidaction-Ensemble contre le Sida" (to F. F. and M. T.).	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; de Bakker BI, 2007, CHEMPHYSCHEM, V8, P1473, DOI 10.1002/cphc.200700169; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Gramberg T, 2008, VIROLOGY, V373, P189, DOI 10.1016/j.virol.2007.11.001; Guinier A., 1955, SMALL ANGLE SCATTERI; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; INOUE M, 1992, BIOCHEMISTRY-US, V31, P5545, DOI 10.1021/bi00139a017; Jelesarov I, 1998, BIOCHEMISTRY-US, V37, P7539, DOI 10.1021/bi972977v; Kohn WD, 1997, J MOL BIOL, V267, P1039, DOI 10.1006/jmbi.1997.0930; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Meier M, 2002, J STRUCT BIOL, V137, P65, DOI 10.1006/jsbi.2002.4467; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Reina JJ, 2007, CHEMMEDCHEM, V2, P1030, DOI 10.1002/cmdc.200700047; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Serrano-Gomez D, 2005, IMMUNOBIOLOGY, V210, P175, DOI 10.1016/j.imbio.2005.05.011; Serrano-Gomez D, 2008, J BIOL CHEM, V283, P3889, DOI 10.1074/jbc.M706004200; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Snyder GA, 2005, J MOL BIOL, V347, P979, DOI 10.1016/j.jmb.2005.01.063; Steeghs L, 2006, CELL MICROBIOL, V8, P316, DOI 10.1111/j.1462-5822.2005.00623.x; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tabarani G, 2006, FEBS LETT, V580, P2402, DOI 10.1016/j.febslet.2006.03.061; Thepaut M, 2008, ACTA CRYSTALLOGR F, V64, P115, DOI 10.1107/S1744309108001000; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Timpano G, 2008, CHEMBIOCHEM, V9, P1921, DOI 10.1002/cbic.200800139; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105	55	87	87	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21229	21240		10.1074/jbc.M109.021204	http://dx.doi.org/10.1074/jbc.M109.021204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19502234	hybrid, Green Published			2022-12-27	WOS:000268564400016
J	de Lavalette, AD; Barucq, L; Alric, J; Rappaport, F; Zito, F				de Lavalette, Agnes de Lacroix; Barucq, Lise; Alric, Jean; Rappaport, Fabrice; Zito, Francesca			Is the Redox State of the c(i) Heme of the Cytochrome b(6)f Complex Dependent on the Occupation and Structure of the Q(i) Site and Vice Versa?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ELECTRON-TRANSFER; CD(1) NITRITE REDUCTASE; CHLAMYDOMONAS-REINHARDTII; OXYGENIC PHOTOSYNTHESIS; BC(1) COMPLEX; DIRECTED MUTAGENESIS; PROXIMAL HISTIDINE; TRANSFER CHAIN; PHOTOSYSTEM-I; B/F COMPLEX	Oxidoreductases of the cytochrome bc(1)/b(6)f family transfer electrons from a liposoluble quinol to a soluble acceptor protein and contribute to the formation of a transmembrane electrochemical potential. The crystal structure of cyt b(6)f has revealed the presence in the Q(i) site of an atypical c-type heme, heme c(i). Surprisingly, the protein does not provide any axial ligand to the iron of this heme, and its surrounding structure suggests it can be accessed by exogenous ligand. In this work we describe a mutagenesis approach aimed at characterizing the c(i) heme and its interaction with the Q(i) site environment. We engineered a mutant of Chlamydomonas reinhardtii in which Phe(40) from subunit IV was substituted by a tyrosine. This results in a dramatic slowing down of the reoxidation of the b hemes under single flash excitation, suggesting hindered accessibility of the heme to its quinone substrate. This modified accessibility likely originates from the ligation of the heme iron by the phenol(ate) side chain introduced by the mutation. Indeed, it also results in a marked downshift of the c(i) heme midpoint potential (from +100 mV to -200 mV at pH 7). Yet the overall turnover rate of the mutant cytochrome b(6)f complex under continuous illumination was found similar to the wild type one, both in vitro and in vivo. We propose that, in the mutant, a change in the ligation state of the heme upon its reduction could act as a redox switch that would control the accessibility of the substrate to the heme and trigger the catalysis.	[Alric, Jean; Rappaport, Fabrice] Univ Paris 06, CNRS, UMR7141, F-75005 Paris, France; [de Lavalette, Agnes de Lacroix; Barucq, Lise; Zito, Francesca] Univ Paris 07, CNRS, UMR7099, Inst Biol Physicochim, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Rappaport, F (corresponding author), Univ Paris 06, CNRS, UMR7141, 13 Rue Curie, F-75005 Paris, France.	Fabrice.Rappaport@ibpc.fr; Francesca.Zito@ibpc.fr	Alric, Jean/E-3538-2013	Alric, Jean/0000-0003-3574-2234; Rappaport, Fabrice/0000-0001-9377-4934; Zito, Francesca/0000-0003-1783-5090				ADACHI S, 1993, BIOCHEMISTRY-US, V32, P241, DOI 10.1021/bi00052a031; Allen JF, 2004, TRENDS PLANT SCI, V9, P130, DOI 10.1016/j.tplants.2004.01.009; Alric J, 2005, P NATL ACAD SCI USA, V102, P15860, DOI 10.1073/pnas.0508102102; Andrew CR, 2005, BIOCHEMISTRY-US, V44, P8664, DOI 10.1021/bi050428g; Baniulis D, 2009, J BIOL CHEM, V284, P9861, DOI 10.1074/jbc.M809196200; Baymann F, 2007, P NATL ACAD SCI USA, V104, P519, DOI 10.1073/pnas.0606369104; Bennoun P, 1982, METHODS CHLOROPLAST, P25; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Choquet Y, 2003, PLANT CELL, V15, P1443, DOI 10.1105/tpc.011692; CORNFORTH JW, 1956, BIOCHEM J, V63, P124, DOI 10.1042/bj0630124; Cramer WA, 2005, PHOTOSYNTH RES, V85, P133, DOI 10.1007/s11120-004-2149-5; Crofts AR, 2004, PHOTOSYNTH RES, V80, P223, DOI 10.1023/B:PRES.0000030444.52579.10; CROFTS AR, 1982, BIOCHEM SOC T, V10, P201, DOI 10.1042/bst0100201; Darrouzet E, 2004, PHOTOSYNTH RES, V79, P25, DOI 10.1023/B:PRES.0000011926.47778.4e; Das TK, 2001, BIOCHEMISTRY-US, V40, P10774, DOI 10.1021/bi002327i; de Lavalette AD, 2008, CR BIOL, V331, P510, DOI 10.1016/j.crvi.2008.04.003; de Vitry C, 2004, BIOCHEMISTRY-US, V43, P3956, DOI 10.1021/bi036093p; Ducluzeau AL, 2008, BBA-BIOENERGETICS, V1777, P1140, DOI 10.1016/j.bbabio.2008.04.026; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HILDEBRAND DP, 1995, BIOCHEMISTRY-US, V34, P1997, DOI 10.1021/bi00006a021; HUANG D, 1994, BIOCHEMISTRY-US, V33, P4401, DOI 10.1021/bi00180a038; JOLIOT P, 1974, BIOCHIM BIOPHYS ACTA, V357, P267, DOI 10.1016/0005-2728(74)90066-8; JOLIOT P, 1988, BIOCHIM BIOPHYS ACTA, V933, P319, DOI 10.1016/0005-2728(88)90039-4; JOLIOT P, 1980, J CHIM PHYS PCB, V77, P209, DOI 10.1051/jcp/1980770209; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; JUNGE W, 1968, Z NATURFORSCH PT B, VB 23, P244, DOI 10.1515/znb-1968-0222; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; KURAS R, 1994, EMBO J, V13, P1019, DOI 10.1002/j.1460-2075.1994.tb06350.x; Kuras R, 2007, P NATL ACAD SCI USA, V104, P9906, DOI 10.1073/pnas.0702340104; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; LAVERGNE J, 1983, BIOCHIM BIOPHYS ACTA, V725, P25, DOI 10.1016/0005-2728(83)90220-7; LEMAIRE C, 1987, PROGR PHOTOSYNTHESIS, V4, P655; Lezhneva L, 2008, J BIOL CHEM, V283, P24608, DOI 10.1074/jbc.M803869200; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Musser SM, 1997, BIOCHEMISTRY-US, V36, P894, DOI 10.1021/bi961723r; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; PIERRE Y, 1995, J BIOL CHEM, V270, P29342, DOI 10.1074/jbc.270.49.29342; RICH PR, 1991, BIOCHIM BIOPHYS ACTA, V1058, P312, DOI 10.1016/S0005-2728(05)80252-X; Sacksteder CA, 2000, PHOTOSYNTH RES, V66, P145, DOI 10.1023/A:1010785912271; SELAK MA, 1984, PHOTOCHEM PHOTOBIOL, V39, P485; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; STREKAS TC, 1974, BIOCHIM BIOPHYS ACTA, V351, P237, DOI 10.1016/0005-2795(74)90186-X; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Wilson EK, 1999, BIOCHEMISTRY-US, V38, P7556, DOI 10.1021/bi990179u; Yamashita E, 2007, J MOL BIOL, V370, P39, DOI 10.1016/j.jmb.2007.04.011; Zhang HM, 2004, BIOCHEMISTRY-US, V43, P16329, DOI 10.1021/bi048363p; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zito F, 1997, PLANT MOL BIOL, V33, P79, DOI 10.1023/A:1005734809834	54	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20822	20829		10.1074/jbc.M109.016709	http://dx.doi.org/10.1074/jbc.M109.016709			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19478086	Green Published, hybrid			2022-12-27	WOS:000268316100045
J	Henry, BL; Connell, J; Liang, AY; Krishnasamy, C; Desai, UR				Henry, Brian L.; Connell, Justin; Liang, Aiye; Krishnasamy, Chandravel; Desai, Umesh R.			Interaction of Antithrombin with Sulfated, Low Molecular Weight Lignins OPPORTUNITIES FOR POTENT, SELECTIVE MODULATION OF ANTITHROMBIN FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-VIIA; ANTICOAGULANT ACTIVITY; HEPARIN ACCELERATION; PROTEINASE REACTIONS; BINDING; INHIBITION; ACTIVATION; MECHANISM; THROMBIN; AFFINITY	Antithrombin, a major regulator of coagulation and angiogenesis, is known to interact with several natural sulfated polysaccharides. Previously, we prepared sulfated low molecular weight variants of natural lignins, called sulfated dehydrogenation polymers (DHPs) (Henry, B. L., Monien, B. H., Bock, P. E., and Desai, U. R. (2007) J. Biol. Chem. 282, 31891 31899), which have now been found to exhibit interesting antithrombin binding properties. Sulfated DHPs represent a library of diverse noncarbohydrate aromatic scaffolds that possess structures completely different from heparin and heparan sulfate. Fluorescence binding studies indicate that sulfated DHPs bind to antithrombin with micromolar affinity under physiological conditions. Salt dependence of binding affinity indicates that the antithrombin-sulfated DHP interaction involves a massive 80-87% non-ionic component to the free energy of binding. Competitive binding studies with heparin pentasaccharide, epicatechin sulfate, and full-length heparin indicate that sulfated DHPs bind to both the pentasaccharide-binding site and extended heparin-binding site of antithrombin. Affinity capillary electrophoresis resolves a limited number of peaks of antithrombin co-complexes suggesting preferential binding of selected DHP structures to the serpin. Computational genetic algorithm-based virtual screening study shows that only one sulfated DHP structure, out of the 11 present in a library of plausible sequences, bound in the heparin-binding site with a high calculated score supporting selectivity of recognition. Enzyme inhibition studies indicate that only one of the three sulfated DHPs studied is a potent inhibitor of free factor VIIa in the presence of antithrombin. Overall, the chemo-enzymatic origin and antithrombin binding properties of sulfated DHPs present novel opportunities for potent and selective modulation of the serpin function, especially for inhibiting the initiation phase of hemostasis.	Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Desai, UR (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, 800 E Leigh St,Ste 212,POB 980133, Richmond, VA 23219 USA.	urdesai@vcu.edu	Desai, Umesh/D-3741-2013; Connell, Justin/AAZ-9638-2020	Desai, Umesh/0000-0002-1976-6597; Connell, Justin/0000-0002-2979-2131	National Institutes of Health [HL069975, HL090586]; American Heart Association National Center [EIA 0640053N]; A. D. Williams Foundation [6-46064]; Mizutani Foundation for Glycoscience, Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090586, R01HL069975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association National Center(American Heart Association); A. D. Williams Foundation; Mizutani Foundation for Glycoscience, Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL069975 and HL090586. This work was also supported by Grant EIA 0640053N from the American Heart Association National Center, Grant 6-46064 from the A. D. Williams Foundation, and a grant from the Mizutani Foundation for Glycoscience, Japan.	Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Blick SKA, 2008, AM J CARDIOVASC DRUG, V8, P113, DOI 10.1007/BF03256588; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gray E, 2008, THROMB HAEMOSTASIS, V99, P807, DOI 10.1160/TH08-01-0032; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Gunnarsson GT, 2003, BIOORG MED CHEM LETT, V13, P679, DOI 10.1016/S0960-894X(02)01055-7; Gunnarsson GT, 2002, J MED CHEM, V45, P1233, DOI 10.1021/jm020012q; Gunnarsson GT, 2002, J MED CHEM, V45, P4460, DOI 10.1021/jm020132y; Henry BL, 2007, J BIOL CHEM, V282, P31891, DOI 10.1074/jbc.M704257200; Henry BL, 2009, BLOOD COAGUL FIBRIN, V20, P27, DOI 10.1097/MBC.0b013e328304e077; Henry Brian L., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P323, DOI 10.2174/187152508785909519; Janin S, 2009, J THROMB THROMBOLYS, V28, P320, DOI 10.1007/s11239-008-0288-9; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; LAWSON JH, 1993, J BIOL CHEM, V268, P767; Le Saux T, 2006, J CHROMATOGR A, V1132, P289, DOI 10.1016/j.chroma.2006.07.092; Liang AY, 2009, ELECTROPHORESIS, V30, P1544, DOI 10.1002/elps.200800642; Lin PH, 2001, BBA-GEN SUBJECTS, V1526, P105, DOI 10.1016/S0304-4165(01)00117-9; LUTZ HP, 1983, HELV CHIM ACTA, V66, P1929, DOI 10.1002/hlca.19830660704; MASCOTTI DP, 1995, BIOCHEMISTRY-US, V34, P2908, DOI 10.1021/bi00009a022; Melo FR, 2008, BBA-GEN SUBJECTS, V1780, P1047, DOI 10.1016/j.bbagen.2008.05.006; Monien BH, 2006, BIOORGAN MED CHEM, V14, P7988, DOI 10.1016/j.bmc.2006.07.066; Monien BH, 2005, J MED CHEM, V48, P5360, DOI 10.1021/jm0503648; Monien BH, 2005, BIOCHEMISTRY-US, V44, P11660, DOI 10.1021/bi050741i; Monien BH, 2005, J MED CHEM, V48, P1269, DOI 10.1021/jm0492960; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; NEUENSCHWANDER PF, 1993, THROMB HAEMOSTASIS, V70, P970; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1991, J BIOL CHEM, V266, P6353; Pereira MG, 2005, CARBOHYD RES, V340, P2015, DOI 10.1016/j.carres.2005.05.018; PIXLEY RA, 1985, J BIOL CHEM, V260, P1723; PIXLEY RA, 1985, BLOOD, V66, P198; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Raghuraman A, 2006, J MED CHEM, V49, P3553, DOI 10.1021/jm060092o; Raghuraman A, 2009, EUR J MED CHEM, V44, P2626, DOI 10.1016/j.ejmech.2008.09.042; RAO LVM, 1993, BLOOD, V81, P2600; Reale S, 2004, MASS SPECTROM REV, V23, P87, DOI 10.1002/mas.10072; Richard B, 2008, J BIOL CHEM, V283, P14417, DOI 10.1074/jbc.M710327200; Schedin-Weiss S, 2008, BIOCHEMISTRY-US, V47, P13610, DOI 10.1021/bi801656u; Seyrek E, 2007, BIOPOLYMERS, V86, P249, DOI 10.1002/bip.20731; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; Varenne A, 2003, ANAL BIOCHEM, V315, P152, DOI 10.1016/S0003-2697(02)00687-5; Yang LK, 2009, BIOCHEMISTRY-US, V48, P1517, DOI 10.1021/bi802298r	50	29	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20897	20908		10.1074/jbc.M109.013359	http://dx.doi.org/10.1074/jbc.M109.013359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497853	Green Published, hybrid			2022-12-27	WOS:000268316100053
J	Huang, YH; Colgrave, ML; Daly, NL; Keleshian, A; Martinac, B; Craik, DJ				Huang, Yen-Hua; Colgrave, Michelle L.; Daly, Norelle L.; Keleshian, Asbed; Martinac, Boris; Craik, David J.			The Biological Activity of the Prototypic Cyclotide Kalata B1 Is Modulated by the Formation of Multimeric Pores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANOSENSITIVE ION-CHANNEL; CYCLIC CYSTINE KNOT; PLANT CYCLOTIDES; ANTIMICROBIAL PEPTIDES; MACROCYCLIC PEPTIDES; MEMBRANE INTERACTION; OLDENLANDIA-AFFINIS; SPATIAL STRUCTURE; STRUCTURAL MOTIF; ESCHERICHIA-COLI	The cyclotides are a large family of circular mini-proteins containing a cystine knot motif. They are expressed in plants as defense-related proteins, with insecticidal activity. Here we investigate their role in membrane interaction and disruption. Kalata B1, a prototypic cyclotide, was found to induce leakage of the self-quenching fluorophore, carboxyfluorescein, from phospholipid vesicles. Alanine-scanning mutagenesis of kalata B1 showed that residues essential for lytic activity are clustered, forming a bioactive face. Kalata B1 was sequestered at the membrane surface and showed slow dissociation from vesicles. Electrophysiological experiments showed that conductive pores were induced in liposome patches on incubation with kalata B1. The conductance calculated from the current-voltage relationship indicated that the diameter of the pores formed in the bilayer patches is 41-47 angstrom. Collectively, the findings provide a mechanistic explanation for the diversity of biological functions ascribed to this fascinating family of ultrastable macrocyclic peptides.	[Huang, Yen-Hua; Colgrave, Michelle L.; Daly, Norelle L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Keleshian, Asbed; Martinac, Boris] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Colgrave, Michelle L.] CSIRO, Div Livestock Ind, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@uq.edu.au	Craik, David/B-1695-2010; Martinac, Boris/A-7178-2018; Colgrave, Michelle/A-5710-2012; Huang, Yen-Hua/J-9056-2014; Daly, Norelle L/D-4302-2013	Craik, David/0000-0003-0007-6796; Martinac, Boris/0000-0001-8422-7082; Colgrave, Michelle/0000-0001-8463-805X; Huang, Yen-Hua/0000-0001-6937-2660; Daly, Norelle L/0000-0002-4697-6602	Australian Research Council; Australian Research Council-Commonwealth Scientific and Industrial Research Organization (CSIRO); Institute for Molecular Bioscience-CSIRO Ph.D. Scholarship	Australian Research Council(Australian Research Council); Australian Research Council-Commonwealth Scientific and Industrial Research Organization (CSIRO)(Australian Research CouncilCommonwealth Scientific & Industrial Research Organisation (CSIRO)); Institute for Molecular Bioscience-CSIRO Ph.D. Scholarship	This work was supported in part by grants from the Australian Research Council (to D. J.C. and B. M.) and by an Australian Research Council-Commonwealth Scientific and Industrial Research Organization (CSIRO) Linkage Grant (to M. L. C.).; Supported by an Institute for Molecular Bioscience-CSIRO Ph.D. Scholarship.	AIDLEY DJ, 1996, ION CHANNELS MOL ACT, P33; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; Colgrave ML, 2008, CHEMBIOCHEM, V9, P1939, DOI 10.1002/cbic.200800174; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2009, ACTA TROP, V109, P163, DOI 10.1016/j.actatropica.2008.11.003; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2001, TOXICON, V39, P1809, DOI 10.1016/S0041-0101(01)00129-5; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Daly NL, 2000, J BIOL CHEM, V275, P19068, DOI 10.1074/jbc.M000450200; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; De los Rios V, 1998, EUR J BIOCHEM, V252, P284, DOI 10.1046/j.1432-1327.1998.2520284.x; EHRENSTEIN G, 1977, Q REV BIOPHYS, V10, P1, DOI 10.1017/S0033583500000123; Goransson U, 2004, J NAT PROD, V67, P1287, DOI 10.1021/np0499719; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASE CC, 1995, J BIOL CHEM, V270, P18329, DOI 10.1074/jbc.270.31.18329; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Martinac B, 2002, P NATL ACAD SCI USA, V99, P4308, DOI 10.1073/pnas.072632899; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; MOLLEMAN A, 2002, PATCH CLAMPING INTRO, P1; NEHER E, 1978, PFLUG ARCH EUR J PHY, V375, P219, DOI 10.1007/BF00584247; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Nourse A, 2004, J BIOL CHEM, V279, P562, DOI 10.1074/jbc.M306826200; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Rex S, 1996, BIOPHYS CHEM, V58, P75, DOI 10.1016/0301-4622(95)00087-9; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SCHWARZ G, 1990, BIOPHYS J, V58, P577, DOI 10.1016/S0006-3495(90)82401-2; SCHWARZ G, 1992, BIOPHYS CHEM, V42, P291, DOI 10.1016/0301-4622(92)80021-V; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shenkarev ZO, 2008, J INORG BIOCHEM, V102, P1246, DOI 10.1016/j.jinorgbio.2008.01.018; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Svangard E, 2007, J NAT PROD, V70, P643, DOI 10.1021/np070007v; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	47	125	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20699	20707		10.1074/jbc.M109.003384	http://dx.doi.org/10.1074/jbc.M109.003384			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19491108	Green Published, hybrid			2022-12-27	WOS:000268316100032
J	Kahn, R; Karbat, I; Ilan, N; Cohen, L; Sokolov, S; Catterall, WA; Gordon, D; Gurevitz, M				Kahn, Roy; Karbat, Izhar; Ilan, Nitza; Cohen, Lior; Sokolov, Stanislav; Catterall, William A.; Gordon, Dalia; Gurevitz, Michael			Molecular Requirements for Recognition of Brain Voltage-gated Sodium Channels by Scorpion alpha-Toxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEIURUS-QUINQUESTRIATUS-HEBRAEUS; ANDROCTONUS-AUSTRALIS HECTOR; SEA-ANEMONE TOXIN; RECEPTOR-SITE; SKELETAL-MUSCLE; BETA-TOXINS; CRYSTAL-STRUCTURES; DOMAIN IV; BMK M1; BINDING	The scorpion alpha-toxin Lqh2 (from Leiurus quinquestriatus hebraeus) is active at various mammalian voltage-gated sodium channels (Na(v)s) and is inactive at insect Na(v)s. To resolve the molecular basis of this preference we used the following strategy: 1) Lqh2 was expressed in recombinant form and key residues important for activity at the rat brain channel rNa(v)1.2a were identified by mutagenesis. These residues form a bipartite functional surface made of a conserved "core domain" (residues of the loops connecting the secondary structure elements of the molecule core), and a variable "NC domain" (five-residue turn and the C-tail) as was reported for other scorpion alpha-toxins. 2) The functional role of the two domains was validated by their stepwise construction on the similar scaffold of the anti-insect toxin Lqh alpha IT. Analysis of the activity of the intermediate constructs highlighted the critical role of Phe(15) of the core domain in toxin potency at rNa(v)1.2a, and has suggested that the shape of the NC-domain is important for toxin efficacy. 3) Based on these findings and by comparison with other scorpion alpha-toxins we were able to eliminate the activity of Lqh2 at rNa(v)1.4 (skeletal muscle), hNa(v)1.5 (cardiac), and rNa(v)1.6 channels, with no hindrance of its activity at Na(v)1.1-1.3. These results suggest that by employing a similar approach the design of further target-selective sodium channel modifiers is imminent.	[Kahn, Roy; Karbat, Izhar; Ilan, Nitza; Cohen, Lior; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Sokolov, Stanislav; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Tel Aviv University; University of Washington; University of Washington Seattle	Gordon, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel.	dgordon@post.tau.ac.il; mamgur@post.tau.ac.il			National Institutes of Health [1 U01 NS058039-01]; United States-Israel Binational Agricultural Research and Development [IS-3928-06, IS-4066-07]; Israeli Science Foundation [909/04, 1008/05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development; Israeli Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 U01 NS058039-01 (to M. G. and W. A. C.). This work was also supported by United States-Israel Binational Agricultural Research and Development Grants IS-3928-06 (to M. G. and D. G.) and IS-4066-07 (to D. G. and M. G.), and Israeli Science Foundation Grants 909/04 (to M. G. and D. G.) and 1008/05 (to D. G. and M. G.).	Alami M, 2003, BIOCHEM J, V375, P551, DOI 10.1042/BJ20030688; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1978, J BIOL CHEM, V253, P7393; CATTERALL WA, 1979, J BIOL CHEM, V254, P1379; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chen H, 2001, J GEN PHYSIOL, V117, P505, DOI 10.1085/jgp.117.6.505; Chen HJ, 2002, EUR J NEUROSCI, V16, P767, DOI 10.1046/j.1460-9568.2002.02142.x; Chen HJ, 2000, PFLUG ARCH EUR J PHY, V439, P423, DOI 10.1007/s004240050959; Clare JJ, 2000, DRUG DISCOV TODAY, V5, P506, DOI 10.1016/S1359-6446(00)01570-1; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; DARBON H, 1983, INT J PEPT PROT RES, V22, P179; ELAYEB M, 1986, EUR J BIOCHEM, V155, P289; FONTECILLACAMPS JC, 1988, P NATL ACAD SCI USA, V85, P7443, DOI 10.1073/pnas.85.20.7443; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Gilles N, 2000, EUR J NEUROSCI, V12, P2823, DOI 10.1046/j.1460-9568.2000.00168.x; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Gordon D, 2003, TOXICON, V41, P125, DOI 10.1016/S0041-0101(02)00294-5; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Guan RJ, 2004, J MOL BIOL, V341, P1189, DOI 10.1016/j.jmb.2004.06.067; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; He XL, 1999, J MOL BIOL, V292, P125, DOI 10.1006/jmbi.1999.3036; HOUSSET D, 1994, J MOL BIOL, V238, P88, DOI 10.1006/jmbi.1994.1270; JOHO RH, 1990, MOL BRAIN RES, V7, P105, DOI 10.1016/0169-328X(90)90087-T; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; Karbat I, 2007, FEBS J, V274, P1918, DOI 10.1111/j.1742-4658.2007.05737.x; KEYNES RD, 1990, PROC R SOC SER B-BIO, V240, P411, DOI 10.1098/rspb.1990.0045; Legros C, 2005, BBA-GEN SUBJECTS, V1723, P91, DOI 10.1016/j.bbagen.2005.01.008; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Little MJ, 1998, J BIOL CHEM, V273, P27076, DOI 10.1074/jbc.273.42.27076; Liu LH, 2005, FASEB J, V19, P594, DOI 10.1096/fj.04-2485fje; Martin-Eauclaire M. F., 1995, Handbook of neurotoxicology., P683; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Sautiere P, 1998, TOXICON, V36, P1141, DOI 10.1016/S0041-0101(98)00080-4; Scalmani P, 2006, J NEUROSCI, V26, P10100, DOI 10.1523/JNEUROSCI.2476-06.2006; Schnur E, 2008, BIOCHEMISTRY-US, V47, P911, DOI 10.1021/bi701323k; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; Shichor I, 2002, J NEUROSCI, V22, P4364, DOI 10.1523/JNEUROSCI.22-11-04364.2002; TEJEDOR FJ, 1990, CELL MOL NEUROBIOL, V10, P257, DOI 10.1007/BF00734578; THOMSEN WJ, 1989, P NATL ACAD SCI USA, V86, P10161, DOI 10.1073/pnas.86.24.10161; Tugarinov V, 1997, BIOCHEMISTRY-US, V36, P2414, DOI 10.1021/bi961497l; WALLNER M, 1993, FEBS LETT, V336, P535, DOI 10.1016/0014-5793(93)80871-Q; Wang CG, 2003, BIOCHEMISTRY-US, V42, P4699, DOI 10.1021/bi0270438; Waxman SG, 2001, NAT REV NEUROSCI, V2, P652, DOI 10.1038/35090026; Whitaker WRJ, 2001, MOL BRAIN RES, V88, P37, DOI 10.1016/S0169-328X(00)00289-8; Yang YC, 2003, J NEUROSCI, V23, P4922; Ye X, 2005, J MOL BIOL, V353, P788, DOI 10.1016/j.jmb.2005.08.068; ZILBERBERG N, 1992, INSECT BIOCHEM MOLEC, V22, P199, DOI 10.1016/0965-1748(92)90160-G; Zilberberg N, 1997, J BIOL CHEM, V272, P14810, DOI 10.1074/jbc.272.23.14810	51	44	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20684	20691		10.1074/jbc.M109.021303	http://dx.doi.org/10.1074/jbc.M109.021303			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509294	hybrid, Green Published			2022-12-27	WOS:000268316100030
J	Li, D; Molldrem, JJ; Ma, Q				Li, Dan; Molldrem, Jeffrey J.; Ma, Qing			LFA-1 Regulates CD8(+) T Cell Activation via T Cell Receptor-mediated and LFA-1-mediated Erk1/2 Signal Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ORGANIZING CENTER; IMMUNOLOGICAL SYNAPSE; TYROSINE KINASE; LIPID RAFTS; ADHESION; ANTIGEN; LYMPHOCYTES; POLARIZATION; CYTOSKELETON; MIGRATION	LFA-1 regulates T cell activation and signal transduction through the immunological synapse. T cell receptor (TCR) stimulation rapidly activates LFA-1, which provides unique LFA-1-dependent signals to promote T cell activation. However, the detailed molecular pathways that regulate these processes and the precise mechanism by which LFA-1 contributes to TCR activation remain unclear. We found LFA-1 directly participates in Erk1/2 signaling upon TCR stimulation in CD8(+) T cells. The presence of LFA-1, not ligand binding, is required for the TCR-mediated Erk1/2 signal pathway. LFA-1-deficient T cells have defects in sustained Erk1/2 signaling and TCR/CD3 clustering, which subsequently prevents MTOC reorientation, cell cycle progression, and mitosis. LFA-1 regulates the TCR-mediated Erk1/2 signal pathway in the context of immunological synapse for recruitment and amplification of the Erk1/2 signal. In addition, LFA-1 ligation with ICAM-1 generates an additional Erk1/2 signal, which synergizes with the existing TCR-mediated Erk1/2 signal to enhance T cell activation. Thus, LFA-1 contributes to CD8(+) T cell activation through two distinct signal pathways. We demonstrated that the function of LFA-1 is to enhance TCR signaling through the immunological synapse and deliver distinct signals in CD8(+) T cell activation.	[Li, Dan; Molldrem, Jeffrey J.; Ma, Qing] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Sect Transplantat Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Ma, Q (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Sect Transplantat Immunol, Unit 900,1515 Holcombe Blvd, Houston, TX 77030 USA.	qma@mdanderson.org			American Cancer Society [RSG-08-183-01]	American Cancer Society(American Cancer Society)	This work was supported by American Cancer Society Grant RSG-08-183-01 LIB (to Q. M.).	Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bossi G, 1998, EUR J HISTOCHEM, V42, P277; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Ding ZM, 1999, J IMMUNOL, V163, P5029; Dustin ML, 2002, ARTHRITIS RES THER, V4, pS119, DOI 10.1186/ar559; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Dustin ML, 2003, ANN NY ACAD SCI, V987, P51, DOI 10.1111/j.1749-6632.2003.tb06032.x; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Endl E, 1997, CYTOMETRY, V29, P233, DOI 10.1002/(SICI)1097-0320(19971101)29:3<233::AID-CYTO6>3.0.CO;2-C; Fagerholm S, 2002, EUR J IMMUNOL, V32, P1670, DOI 10.1002/1521-4141(200206)32:6<1670::AID-IMMU1670>3.0.CO;2-M; GERDES J, 1984, J IMMUNOL, V133, P1710; Goda S, 2004, J IMMUNOL, V172, P5379, DOI 10.4049/jimmunol.172.9.5379; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hogg N, 2004, IMMUNOL LETT, V92, P51, DOI 10.1016/j.imlet.2003.10.014; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Hynes RO, 2003, SCIENCE, V300, P755, DOI 10.1126/science.1084854; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; Leitinger B, 2002, J CELL SCI, V115, P963; Lin J, 2005, J CELL BIOL, V170, P177, DOI 10.1083/jcb.200503032; Marwali MR, 2004, J IMMUNOL, V173, P2960, DOI 10.4049/jimmunol.173.5.2960; MAZEROLLES F, 1994, J IMMUNOL, V152, P5670; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Mueller KL, 2004, J IMMUNOL, V173, P2222, DOI 10.4049/jimmunol.173.4.2222; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Sims TN, 2002, IMMUNOL REV, V186, P100, DOI 10.1034/j.1600-065X.2002.18610.x; Smits HH, 2002, J IMMUNOL, V168, P1710, DOI 10.4049/jimmunol.168.4.1710; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Suzuki J, 1999, TRANSPL IMMUNOL, V7, P65, DOI 10.1016/S0966-3274(99)80021-5; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232	45	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21001	21010		10.1074/jbc.M109.002865	http://dx.doi.org/10.1074/jbc.M109.002865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19483086	hybrid, Green Published			2022-12-27	WOS:000268316100063
J	Vielemeyer, O; Yuan, H; Moutel, S; Saint-Fort, R; Tang, DM; Nizak, C; Goud, B; Wang, YZ; Perez, F				Vielemeyer, Ole; Yuan, Hebao; Moutel, Sandrine; Saint-Fort, Renette; Tang, Danming; Nizak, Clement; Goud, Bruno; Wang, Yanzhuang; Perez, Franck			Direct Selection of Monoclonal Phosphospecific Antibodies without Prior Phosphoamino Acid Mapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI STACKING FACTOR; CELL-FREE SYSTEM; RECOMBINANT ANTIBODIES; IN-VIVO; GRASP65; PROTEINS; RESOURCE	In the current post-genomic era, large scale efforts are under-way to functionally explore the proteome by assembling large antibody libraries. However, because many proteins are modified post-translationally to regulate their function, collections of modification-specific sensors are also needed. Here we applied a novel approach to select monoclonal phosphospecific antibodies directly from the full-length protein and without up-front phosphoamino acid identification. We chose as antigen GRASP65, a well studied Golgi phosphoprotein. Bacterially produced full-length protein was first incubated with mitotic cytosol, thus allowing modification by naturally occurring kinases, and then used directly for affinity-based antibody selection using a single chain variable fragment phagemid library. In less than 1 week, three distinct and highly functional monoclonal phosphospecific antibodies against two GRASP65 epitopes were obtained and subsequently characterized. The presented approach is carried out fully in vitro, requires no prior knowledge of the phosphoamino acid identity, and is fast and inexpensive. It therefore has great potential to be an attractive alternative to classic animal-based protocols for the selection of post-translation modification sensors and thus to become an invaluable tool in our quest to understand the proteome in all its complexity.	[Yuan, Hebao; Tang, Danming; Wang, Yanzhuang] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Vielemeyer, Ole; Moutel, Sandrine; Saint-Fort, Renette; Nizak, Clement; Goud, Bruno; Perez, Franck] Inst Curie, Res Sect, F-75248 Paris 5, France; [Moutel, Sandrine] Inst Curie, Translat Dept, F-75248 Paris 5, France; [Vielemeyer, Ole; Saint-Fort, Renette; Nizak, Clement; Goud, Bruno; Perez, Franck] Inst Curie, CNRS, UMR144, F-75248 Paris 5, France	University of Michigan System; University of Michigan; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Wang, YZ (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	yzwang@umich.edu; franck.perez@curie.fr	Nizak, Clement/HGV-1085-2022; Goud, Bruno/GWC-4807-2022; Wang, Yanzhuang/AAE-5299-2019; Perez, Franck/A-1558-2014; Yuan, Hebao/E-2032-2011; Nizak, Clement/L-1334-2013	Nizak, Clement/0000-0002-4591-8240; Wang, Yanzhuang/0000-0002-1864-7094; Perez, Franck/0000-0002-9129-9401; Yuan, Hebao/0000-0003-4425-3678; Nizak, Clement/0000-0002-4591-8240; Moutel, Sandrine/0000-0002-9585-4855	National Institutes of Health [GM087364]; Pardee Cancer Research Foundation; Curie Institute; CNRS; Agence National de la Recherche; Association pour la Recherche Contre le Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Cancer Research Foundation; Curie Institute; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087364 (to Y.W.). This work was also supported by the Pardee Cancer Research Foundation, the Curie Institute, CNRS, and by grants from the "Agence National de la Recherche" and the "Association pour la Recherche Contre le Cancer" (to F. P.).	DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Haab BB, 2006, MOL CELL PROTEOMICS, V5, P1996, DOI 10.1074/mcp.T600020-MCP200; Johnson L, 2007, BIOCHEM SOC T, V35, P7, DOI 10.1042/BST0350007; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Moutel S, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-14; NAIRN AC, 1982, NATURE, V299, P734, DOI 10.1038/299734a0; Nizak C, 2003, TRAFFIC, V4, P739, DOI 10.1034/j.1600-0854.2003.00132.x; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; ROSS AH, 1981, NATURE, V294, P654, DOI 10.1038/294654a0; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; Ventura Juan-Jose, 2006, Clin Transl Oncol, V8, P153, DOI 10.1007/s12094-006-0005-0; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Yoshimura S, 2005, J BIOL CHEM, V280, P23048, DOI 10.1074/jbc.M502442200	19	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20791	20795		10.1074/jbc.M109.008730	http://dx.doi.org/10.1074/jbc.M109.008730			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19473967	Green Published, hybrid			2022-12-27	WOS:000268316100041
J	Wojtal, KA; Diskar, M; Herberg, FW; Hoekstra, D; van Ijzendoorn, SCD				Wojtal, Kacper A.; Diskar, Mandy; Herberg, Friedrich W.; Hoekstra, Dick; van Ijzendoorn, Sven C. D.			Regulatory Subunit I-controlled Protein Kinase A Activity Is Required for Apical Bile Canalicular Lumen Development in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED SPHINGOLIPID TRANSPORT; FETAL LIVER DEVELOPMENT; ENERGY-TRANSFER BRET; CELL POLARITY; ONCOSTATIN-M; CYCLIC-AMP; HEPG2 CELLS; CAMP-KINASE; SUBAPICAL COMPARTMENT; MEMBRANE BIOGENESIS	Signaling via cAMP plays an important role in apical cell surface dynamics in epithelial cells. In hepatocytes, elevated levels of cAMP as well as extracellular oncostatin M stimulate apical lumen development in a manner that depends on protein kinase A (PKA) activity. However, neither the identity of PKA isoforms involved nor the mechanisms of the cross-talk between oncostatin M and cAMP/PKA signaling pathways have been elucidated. Here we demonstrate that oncostatin M and PKA signaling converge at the level of the PKA holoenzyme downstream of oncostatin M-stimulated MAPK activation. Experiments were performed with chemically modified cAMP analogues that preferentially target regulatory subunit (R) I or RII holoenzymes, respectively, in hepatocytes. The data suggest that the dissociation of RI- but not RII-containing holoenzymes, as well as catalytic activity of PKA, is required for apical lumen development in response to elevated levels of cAMP and oncostatin M. However, oncostatin M signaling does not stimulate PKA holoenzyme dissociation in living cells. Based on pharmacological and cell biological studies, it is concluded that RI-controlled PKA activity is essential for cAMP- and oncostatin M-stimulated development of apical bile canalicular lumens.	[Wojtal, Kacper A.; Hoekstra, Dick; van Ijzendoorn, Sven C. D.] Univ Groningen, Univ Med Ctr Groningen, Sect Membrane Cell Biol, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Diskar, Mandy; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, D-34109 Kassel, Germany	University of Groningen; Universitat Kassel	van Ijzendoorn, SCD (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Sect Membrane Cell Biol, Dept Cell Biol, NL-9713 AV Groningen, Netherlands.	s.c.d.van.ijzendoorn@med.umcg.nl	Herberg, Friedrich W/B-5572-2015	Herberg, Friedrich W/0000-0001-7117-7653	Otto Braun Fund; European Union [LSHB-CT-2006-037189]; Royal Dutch Academy of Sciences	Otto Braun Fund; European Union(European Commission); Royal Dutch Academy of Sciences	Supported by the Otto Braun Fund.; Supported by European Union Grant LSHB-CT-2006-037189.; Supported by the Royal Dutch Academy of Sciences.	Abu-Absi SF, 2005, TISSUE ENG, V11, P415, DOI 10.1089/ten.2005.11.415; Alvarez-Curto E, 2007, BIOCHEM J, V401, P309, DOI 10.1042/BJ20060880; Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; BRIGNONI M, 1995, J CELL SCI, V108, P1931; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; CHIU JH, 1990, HEPATOLOGY, V11, P834, DOI 10.1002/hep.1840110519; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Cibrian-Uhalte E, 2007, J CELL BIOL, V176, P223, DOI 10.1083/jcb.200606116; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Decaens C, 2008, BIOL CELL, V100, P387, DOI 10.1042/BC20070127; Dong J, 2008, CYTOTECHNOLOGY, V57, P251, DOI 10.1007/s10616-008-9168-6; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Falasca L, 2001, CELLS TISSUES ORGANS, V168, P126, DOI 10.1159/000047828; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; Herrema H, 2006, MOL BIOL CELL, V17, P3291, DOI 10.1091/mbc.E06-01-0067; IHRKE G, 1993, J CELL BIOL, V123, P1761, DOI 10.1083/jcb.123.6.1761; Imamura M, 2007, EXP CELL RES, V313, P1951, DOI 10.1016/j.yexcr.2007.03.010; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; KELLY JH, 1989, IN VITRO CELL DEV B, V25, P217; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; LECLUYSE EL, 1994, AM J PHYSIOL, V266, pC1764, DOI 10.1152/ajpcell.1994.266.6.C1764; Matsui T, 2002, EMBO J, V21, P1021, DOI 10.1093/emboj/21.5.1021; Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100; MUSAT AI, 1993, HEPATOLOGY, V18, P198, DOI 10.1002/hep.1840180129; OGREID D, 1989, EUR J BIOCHEM, V181, P19; Peng X, 2006, CELL TISSUE RES, V323, P233, DOI 10.1007/s00441-005-0067-2; Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406; Prinz A, 2006, CHEMBIOCHEM, V7, P1007, DOI 10.1002/cbic.200600048; Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013; Roelofsen H, 1998, J CELL SCI, V111, P1137; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Schwede F, 2000, BIOCHEMISTRY-US, V39, P8803, DOI 10.1021/bi000304y; SORMUNEN R, 1993, LAB INVEST, V68, P652; Sudo R, 2005, FASEB J, V19, P1695, DOI 10.1096/fj.04-3269fje; van der Wouden JM, 2002, EMBO J, V21, P6409, DOI 10.1093/emboj/cdf629; van Ijzendoorn SCD, 2004, MOL BIOL CELL, V15, P4115, DOI 10.1091/mbc.E04-04-0290; van IJzendoorn SCD, 2004, MOL BIOL CELL, V15, P4105, DOI 10.1091/mbc.e04-03-0201; van Ijzendoorn SCD, 1999, MOL BIOL CELL, V10, P3449, DOI 10.1091/mbc.10.10.3449; van Ijzendoorn SCD, 2000, MOL BIOL CELL, V11, P1093, DOI 10.1091/mbc.11.3.1093; Wang W, 2006, GASTROENTEROLOGY, V131, P878, DOI 10.1053/j.gastro.2006.06.013; Wojtal KA, 2008, BIOESSAYS, V30, P146, DOI 10.1002/bies.20705; Wojtal KA, 2007, MOL BIOL CELL, V18, P2745, DOI 10.1091/mbc.E06-08-0732; Zegers MMP, 1998, BIOCHEM J, V336, P257, DOI 10.1042/bj3360257; Zegers MMP, 1997, J CELL BIOL, V138, P307, DOI 10.1083/jcb.138.2.307	49	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20773	20780		10.1074/jbc.M109.013599	http://dx.doi.org/10.1074/jbc.M109.013599			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19465483	Green Published, hybrid			2022-12-27	WOS:000268316100039
J	Johnson, BS; Snead, D; Lee, JJ; McCaffery, JM; Shorter, J; Gitler, AD				Johnson, Brian S.; Snead, David; Lee, Jonathan J.; McCaffery, J. Michael; Shorter, James; Gitler, Aaron D.			TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEIC-ACID BINDING; ALPHA-SYNUCLEIN; TARDBP MUTATIONS; IN-VITRO; NEURODEGENERATIVE DISEASES; CYTOPLASMIC INCLUSIONS; PARKINSONS-DISEASE; AMYLOID PORES; YEAST	Non-amyloid, ubiquitinated cytoplasmic inclusions containing TDP-43 and its C-terminal fragments are pathological hallmarks of amyotrophic lateral sclerosis (ALS), a fatal motor neuron disorder, and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U). Importantly, TDP-43 mutations are linked to sporadic and non-SOD1 familial ALS. However, TDP-43 is not the only protein in disease-associated inclusions, and whether TDP-43 misfolds or is merely sequestered by other aggregated components is unclear. Here, we report that, in the absence of other components, TDP-43 spontaneously forms aggregates bearing remarkable ultrastructural similarities to TDP-43 deposits in degenerating neurons of ALS FTLD-U patients. The C-terminal domain of TDP-43 is critical for spontaneous aggregation. Several ALS-linked TDP-43 mutations within this domain (Q331K, M337V, Q343R, N345K, R361S, and N390D) increase the number of TDP-43 aggregates and promote toxicity in vivo. Importantly, mutations that promote toxicity in vivo accelerate aggregation of pure TDP-43 in vitro. Thus, TDP-43 is intrinsically aggregation-prone, and its propensity for toxic misfolding trajectories is accentuated by specific ALS-linked mutations.	[Johnson, Brian S.; Lee, Jonathan J.; Gitler, Aaron D.] Univ Penn, Dept Cell & Dev Biol, Sch Med, Philadelphia, PA 19104 USA; [Snead, David; Shorter, James] Univ Penn, Dept Biochem & Biophys, Sch Med, Philadelphia, PA 19104 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Integrated Imaging Ctr, Baltimore, MD 21218 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University	Shorter, J (corresponding author), 805B Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu; gitler@mail.med.upenn.edu	Shorter, James/E-8207-2011	Johnson, Brian/0000-0003-3711-5920; Gitler, Aaron/0000-0001-8603-1526; Shorter, James/0000-0001-5269-8533	National Institutes of Health [1DP2OD004417-01, 1DP2OD002177-01]; University of Pennsylvania Institute on Aging; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065317] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004417, DP2OD002177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Institute on Aging; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants 1DP2OD004417-01 (Director's New Innovator Award to A. D. G.) and 1DP2OD002177-01 (Director's New Innovator Award to J.S.). This work was also supported by a pilot grant from the University of Pennsylvania Institute on Aging (to A. D. G.).	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Daoud H, 2009, J MED GENET, V46, P112, DOI 10.1136/jmg.2008.062463; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Kwong LK, 2008, NEUROSIGNALS, V16, P41, DOI 10.1159/000109758; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Mori F, 2008, ACTA NEUROPATHOL, V116, P193, DOI 10.1007/s00401-008-0396-9; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishihira Y, 2008, ACTA NEUROPATHOL, V116, P169, DOI 10.1007/s00401-008-0385-z; Pamphlett R, 2009, NEUROPATH APPL NEURO, V35, P222, DOI 10.1111/j.1365-2990.2008.00982.x; Pamphlett R, 2008, ACTA NEUROPATHOL, V116, P221, DOI 10.1007/s00401-008-0392-0; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; Rothstein JD, 2007, ANN NEUROL, V61, P382, DOI 10.1002/ana.21155; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sanelli T, 2007, J NEUROPATH EXP NEUR, V66, P1147, DOI 10.1097/nen.0b013e31815c5edd; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Xiao S, 2008, J NEUROSCI, V28, P1833, DOI 10.1523/JNEUROSCI.3222-07.2008; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392	46	501	513	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20329	20339		10.1074/jbc.M109.010264	http://dx.doi.org/10.1074/jbc.M109.010264			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19465477	Green Published, hybrid			2022-12-27	WOS:000268097400059
J	Ali, F; Zakkar, M; Karu, K; Lidington, EA; Hamdulay, SS; Boyle, JJ; Zloh, M; Bauer, A; Haskard, DO; Evans, PC; Mason, JC				Ali, Faisal; Zakkar, Mustafa; Karu, Kersti; Lidington, Elaine A.; Hamdulay, Shahir S.; Boyle, Joseph J.; Zloh, Mire; Bauer, Andrea; Haskard, Dorian O.; Evans, Paul C.; Mason, Justin C.			Induction of the Cytoprotective Enzyme Heme Oxygenase-1 by Statins Is Enhanced in Vascular Endothelium Exposed to Laminar Shear Stress and Impaired by Disturbed Flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ATHEROSCLEROTIC LESION FORMATION; COMPLEMENT-MEDIATED INJURY; TRANSCRIPTION FACTOR NRF2; KRUPPEL-LIKE FACTOR-2; C-REACTIVE PROTEIN; HMG-COA REDUCTASE; INDUCED EXPRESSION; SIGNALING PATHWAY; GENE-EXPRESSION	In addition to cholesterol-lowering properties, statins exhibit lipid-independent immunomodulatory, anti-inflammatory actions. However, high concentrations are typically required to induce these effects in vitro, raising questions concerning therapeutic relevance. We present evidence that endothelial cell sensitivity to statins depends upon shear stress. Using heme oxygenase-1 expression as a model, we demonstrate differential heme oxygenase-1 induction by atorvastatin in athero-resistant compared with atheroprone sites of the murine aorta. In vitro, exposure of human endothelial cells to laminar shear stress significantly reduced the statin concentration required to induce heme oxygenase-1 and protect against H2O2-mediated injury. Synergy was observed between laminar shear stress and atorvastatin, resulting in optimal expression of heme oxygenase-1 and resistance to oxidative stress, a response inhibited by heme oxygenase-1 small interfering RNA. Moreover, treatment of laminar shear stress-exposed endothelial cells resulted in a significant fall in intracellular cholesterol. Mechanistically, synergy required Akt phosphorylation, activation of Kruppel-like factor 2, NF-E2-related factor-2 (Nrf2), increased nitric-oxide synthase activity, and enhanced HO-1 mRNA stability. In contrast, heme oxygenase-1 induction by atorvastatin in endothelial cells exposed to oscillatory flow was markedly attenuated. We have identified a novel relationship between laminar shear stress and statins, demonstrating that atorvastatin-mediated heme oxygenase-1-dependent antioxidant effects are laminar shear stress-dependent, proving the principle that biomechanical signaling contributes significantly to endothelial responsiveness to pharmacological agents. Our findings suggest statin pleiotropy may be suboptimal at disturbed flow atherosusceptible sites, emphasizing the need for more specific therapeutic agents, such as those targeting Kruppel-like factor 2 or Nrf2.	[Ali, Faisal; Zakkar, Mustafa; Lidington, Elaine A.; Hamdulay, Shahir S.; Boyle, Joseph J.; Bauer, Andrea; Haskard, Dorian O.; Evans, Paul C.; Mason, Justin C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Bywaters Ctr Vasc Inflammat, Hammersmith Hosp, London W12 0NN, England; [Karu, Kersti; Zloh, Mire] Univ London, Sch Pharm, London WC1N 1AX, England	Imperial College London; University of London; University College London; University of London School of Pharmacy	Mason, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Bywaters Ctr Vasc Inflammat, Hammersmith Hosp, London W12 0NN, England.	justin.mason@imperial.ac.uk	Zloh, Mire/A-8124-2008; Ali, Faisal/I-4250-2018; Zloh, Mire/M-5597-2018	Zloh, Mire/0000-0002-4848-2737; Evans, Paul/0000-0001-7975-681X; Mason, Justin/0000-0001-7783-1660	British Heart Foundation [PG/06/026/20419]	British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Project Grant PG/06/026/20419.	Ali F, 2007, J THROMB HAEMOST, V5, P2537, DOI 10.1111/j.1538-7836.2007.02787.x; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Berk BC, 2008, CIRCULATION, V117, P1082, DOI 10.1161/CIRCULATIONAHA.107.720730; Bouton C, 2000, J BIOL CHEM, V275, P32688, DOI 10.1074/jbc.275.42.32688; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Cilla DD, 1996, CLIN PHARMACOL THER, V60, P687, DOI 10.1016/S0009-9236(96)90218-0; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Dulak J, 2005, ENDOTHELIUM-J ENDOTH, V12, P233, DOI 10.1080/10623320500476559; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Feron O, 2001, CIRCULATION, V103, P113; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; Hermann C, 1997, ARTERIOSCL THROM VAS, V17, P3588, DOI 10.1161/01.ATV.17.12.3588; Huddleson JP, 2005, J BIOL CHEM, V280, P23371, DOI 10.1074/jbc.M413839200; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Juan SH, 2001, CIRCULATION, V104, P1519, DOI 10.1161/hc3801.095663; Kinderlerer AR, 2008, J BIOL CHEM, V283, P14636, DOI 10.1074/jbc.M800362200; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Landmesser U, 2005, CIRCULATION, V111, P2356, DOI 10.1161/01.CIR.0000164260.82417.3F; Lee TS, 2004, CIRCULATION, V110, P1296, DOI 10.1161/01.CIR.0000140694.67251.9C; Leonard MO, 2006, FASEB J, V20, P2624, DOI 10.1096/fj.06-5097fje; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; Loboda A, 2006, ATHEROSCLEROSIS, V187, P26, DOI 10.1016/j.atherosclerosis.2006.03.015; Lungu AO, 2004, J BIOL CHEM, V279, P48794, DOI 10.1074/jbc.M313897200; Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200; Mason JC, 2003, CLIN SCI, V105, P251, DOI 10.1042/CS20030148; Mason JC, 2002, CIRC RES, V91, P696, DOI 10.1161/01.RES.0000038151.57577.19; Muchova L, 2007, CAN J PHYSIOL PHARM, V85, P800, DOI 10.1139/Y07-077; Ni CW, 2004, AM J PHYSIOL-CELL PH, V287, pC771, DOI 10.1152/ajpcell.00532.2003; Park H, 1998, J BIOL CHEM, V273, P32304, DOI 10.1074/jbc.273.48.32304; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Pelat M, 2003, CIRCULATION, V107, P2480, DOI 10.1161/01.CIR.0000065601.83526.3E; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Tsai CT, 2008, CIRCULATION, V117, P344, DOI 10.1161/CIRCULATIONAHA.107.695346; Uchiyama T, 2006, ATHEROSCLEROSIS, V188, P265, DOI 10.1016/j.atherosclerosis.2005.10.045; van Thienen JV, 2006, CARDIOVASC RES, V72, P231, DOI 10.1016/j.cardiores.2006.07.008; Wang LJ, 1998, AM J PATHOL, V152, P711; Wang YQ, 2007, BIOCHIMIE, V89, P182, DOI 10.1016/j.biochi.2006.10.008; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje; Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje	54	83	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18882	18892		10.1074/jbc.M109.009886	http://dx.doi.org/10.1074/jbc.M109.009886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19457866	Green Published, hybrid			2022-12-27	WOS:000267711500038
J	Bomberger, JM; Barnaby, RL; Stanton, BA				Bomberger, Jennifer M.; Barnaby, Roxanna L.; Stanton, Bruce A.			The Deubiquitinating Enzyme USP10 Regulates the Post-endocytic Sorting of Cystic Fibrosis Transmembrane Conductance Regulator in Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; REVERSIBLE UBIQUITINATION; GENE-PRODUCT; PROTEIN; CFTR; TRAFFICKING; MEMBRANE; TRANSPORT; PATHWAY; DOMAIN	The cystic fibrosis transmembrane conductance regulator (CFTR), a member of the ABC transporter superfamily, is a cyclic AMP-regulated chloride channel and a regulator of other ion channels and transporters. In epithelial cells CFTR is rapidly endocytosed from the apical plasma membrane and efficiently recycles back to the plasma membrane. Because ubiquitination targets endocytosed CFTR for degradation in the lysosome, deubiquitinating enzymes (DUBs) are likely to facilitate CFTR recycling. Accordingly, the aim of this study was to identify DUBs that regulate the post-endocytic sorting of CFTR. Using an activity-based chemical screen to identify active DUBs in human airway epithelial cells, we demonstrated that Ubiquitin Specific Protease-10 (USP10) is located in early endosomes and regulates the deubiquitination of CFTR and its trafficking in the post-endocytic compartment. small interference RNA-mediated knockdown of USP10 increased the amount of ubiquitinated CFTR and its degradation in lysosomes, and reduced both apical membrane CFTR and CFTR-mediated chloride secretion. Moreover, a dominant negative USP10 (USP10-C424A) increased the amount of ubiquitinated CFTR and its degradation, whereas overexpression of wt-USP10 decreased the amount of ubiquitinated CFTR and increased the abundance of CFTR. These studies demonstrate a novel function for USP10 in facilitating the deubiquitination of CFTR in early endosomes and thereby enhancing the endocytic recycling of CFTR.	[Bomberger, Jennifer M.; Barnaby, Roxanna L.; Stanton, Bruce A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Physiol, Hanover, NH 03755 USA	Dartmouth College	Bomberger, JM (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Physiol, 604 Remsen Bldg, Hanover, NH 03755 USA.	jbomberger@dartmouth.edu			National Institutes of Health [5T32DK007301, 5R01DK45581]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5T32DK007301 and 5R01DK45581 (to B. A. S.). This work was also supported by Cystic Fibrosis Foundation Grants BOMBER08F0 (to J.M.B.) and STANTO07R0 (to B. A. S.).	Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bomberger JM, 2005, J BIOL CHEM, V280, P9297, DOI 10.1074/jbc.M413786200; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Boulkroun S, 2008, AM J PHYSIOL-RENAL, V295, pF889, DOI 10.1152/ajprenal.00001.2008; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Chang CT, 2005, J PHYSIOL-LONDON, V562, P271, DOI 10.1113/jphysiol.2004.077933; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cohen M, 2003, J BIOL CHEM, V278, P51989, DOI 10.1074/jbc.C300451200; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Gesbert F, 2005, BIOCHEM BIOPH RES CO, V334, P474, DOI 10.1016/j.bbrc.2005.06.121; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lahr TF, 2000, PFLUG ARCH EUR J PHY, V439, P610, DOI 10.1007/s004240050984; Lorenzo ME, 2002, J VIROL, V76, P5522, DOI 10.1128/JVI.76.11.5522-5531.2002; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Saxena S, 2005, BIOCHEM BIOPH RES CO, V337, P1219, DOI 10.1016/j.bbrc.2005.09.186; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V346, P259, DOI 10.1016/j.bbrc.2006.05.102; Schlieker C, 2005, J VIROL, V79, P15582, DOI 10.1128/JVI.79.24.15582-15585.2005; Schmitz C, 2005, MOL BIOL CELL, V16, P1319, DOI 10.1091/mbc.E04-05-0425; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Wicks SJ, 2006, BIOCHEM SOC T, V34, P761, DOI 10.1042/BST0340761; Wicks SJ, 2005, ONCOGENE, V24, P8080, DOI 10.1038/sj.onc.1208944; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200	44	82	90	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18778	18789		10.1074/jbc.M109.001685	http://dx.doi.org/10.1074/jbc.M109.001685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19398555	Green Published, hybrid			2022-12-27	WOS:000267711500027
J	Fiermonte, G; Paradies, E; Todisco, S; Marobbio, CMT; Palmieri, F				Fiermonte, Giuseppe; Paradies, Eleonora; Todisco, Simona; Marobbio, Carlo M. T.; Palmieri, Ferdinando			A Novel Member of Solute Carrier Family 25 (SLC25A42) Is a Transporter of Coenzyme A and Adenosine 3 ',5 '-Diphosphate in Human Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; TISSUE DISTRIBUTION; MAMMALIAN MITOCHONDRIA; ENDOPLASMIC-RETICULUM; BOVINE MITOCHONDRIA; PHOSPHATE CARRIER; ADP/ATP CARRIER	Mitochondrial carriers are a family of proteins that transport metabolites, nucleotides, and cofactors across the inner mitochondrial membrane thereby connecting cytosolic and matrix functions. The essential cofactor coenzyme A (CoA) is synthesized outside the mitochondrial matrix and therefore must be transported into mitochondria where it is required for a number of fundamental processes. In this work we have functionally identified and characterized SLC25A42, a novel human member of the mitochondrial carrier family. The SLC25A42 gene (Haitina, T., Lindblom, J., Renstrom, T., and Fredriksson, R., 2006, Genomics 88, 779-790) was overexpressed in Escherichia coli, purified, and reconstituted into phospholipid vesicles. Its transport properties, kinetic parameters, and targeting to mitochondria demonstrate that SLC25A42 protein is a mitochondrial transporter for CoA and adenosine 3',5'-diphosphate. SLC25A42 catalyzed only a counter-exchange transport, exhibited a high transport affinity for CoA, dephospho-CoA, ADP, and adenosine 3',5'-diphosphate, was saturable and inhibited by bongkrekic acid and other inhibitors of mitochondrial carriers to various degrees. The main physiological role of SLC25A42 is to import CoA into mitochondria in exchange for intramitochondrial (deoxy) adenine nucleotides and adenosine 3',5'-diphosphate. This is the first time that a mitochondrial carrier for CoA and adenosine 3',5'-diphosphate has been characterized biochemically.	[Fiermonte, Giuseppe; Paradies, Eleonora; Todisco, Simona; Marobbio, Carlo M. T.; Palmieri, Ferdinando] Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; [Fiermonte, Giuseppe; Palmieri, Ferdinando] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Palmieri, F (corresponding author), Via Orabona 4, I-70125 Bari, Italy.	fpalm@farmbiol.uniba.it	Paradies, Eleonora/K-4606-2014; Fiermonte, Giuseppe/D-3680-2018; MAROBBIO, Carlo/G-5775-2015; Todisco, Simona/AAU-2091-2021	Paradies, Eleonora/0000-0002-1668-7148; Fiermonte, Giuseppe/0000-0002-6764-9395; MAROBBIO, Carlo/0000-0002-2516-0321; 	Ministero dell'Universitae della Ricerca (MIUR); Center of Excellence in Genomics, Apulia Region; University of Bari; Italian Human ProteomeNet [RBRN07BMCT_009]	Ministero dell'Universitae della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Center of Excellence in Genomics, Apulia Region; University of Bari; Italian Human ProteomeNet	This work was supported by grants from the Ministero dell'Universitae della Ricerca (MIUR), the Center of Excellence in Genomics, Apulia Region, the University of Bari, and the Italian Human ProteomeNet no. RBRN07BMCT_009 (MIUR).	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; BREMER J, 1972, EUR J BIOCHEM, V25, P90, DOI 10.1111/j.1432-1033.1972.tb01684.x; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Chiesa A, 2001, BIOCHEM J, V355, P1, DOI 10.1042/0264-6021:3550001; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fiermonte G, 1992, DNA Seq, V3, P71, DOI 10.3109/10425179209033999; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; HADDOCK BA, 1970, BIOCHEM J, V119, P565, DOI 10.1042/bj1190565; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; HELDT HW, 1965, BIOCHEM Z, V343, P433; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; KRAMER R, 1980, BIOCHEMISTRY-US, V19, P556; Leonardi R, 2007, P NATL ACAD SCI USA, V104, P1494, DOI 10.1073/pnas.0607621104; Leroch M, 2008, PLANT CELL, V20, P438, DOI 10.1105/tpc.107.057554; NEUBURGER M, 1984, ARCH BIOCHEM BIOPHYS, V229, P253, DOI 10.1016/0003-9861(84)90151-6; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; PFAFF E, 1968, EUR J BIOCHEM, V6, P66, DOI 10.1111/j.1432-1033.1968.tb00420.x; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Prohl C, 2001, MOL CELL BIOL, V21, P1089, DOI 10.1128/MCB.21.4.1089-1097.2001; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; SIKORSKI RS, 1989, GENETICS, V122, P19; TAHILIANI AG, 1987, J BIOL CHEM, V262, P11607; TAHILIANI AG, 1987, J MOL CELL CARDIOL, V19, P1161, DOI 10.1016/S0022-2828(87)80526-6; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Traba J, 2009, BIOCHEM J, V418, P125, DOI 10.1042/BJ20081262; Visser WF, 2002, BIOCHEM BIOPH RES CO, V299, P494, DOI 10.1016/S0006-291X(02)02663-3; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; ZARA V, 1992, J BIOL CHEM, V267, P12077; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200	47	104	106	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18152	18159		10.1074/jbc.M109.014118	http://dx.doi.org/10.1074/jbc.M109.014118			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19429682	hybrid, Green Published			2022-12-27	WOS:000267712400026
J	Graham, SA; Jegouzo, SAF; Yan, S; Powlesland, AS; Brady, JP; Taylor, ME; Drickamer, K				Graham, Sarah A.; Jegouzo, Sabine A. F.; Yan, Sheng; Powlesland, Alex S.; Brady, Jacob P.; Taylor, Maureen E.; Drickamer, Kurt			Prolectin, a Glycan-binding Receptor on Dividing B Cells in Germinal Centers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; DC-SIGN; CARBOHYDRATE-RECOGNITION; STRUCTURAL BASIS; IMMUNE-RESPONSES; LANGERHANS CELLS; LIGAND-BINDING; IDENTIFICATION; PROTEINS; ORGANIZATION	Prolectin, a previously undescribed glycan-binding receptor, has been identified by re-screening of the human genome for genes encoding proteins containing potential C-type carbohydrate-recognition domains. Glycan array analysis revealed that the carbohydrate-recognition domain in the extracellular domain of the receptor binds glycans with terminal alpha-linked mannose or fucose residues. Prolectin expressed in fibroblasts is found at the cell surface, but unlike many glycan-binding receptors it does not mediate endocytosis of a neoglycoprotein ligand. However, compared with other known glycan-binding receptors, the receptor contains an unusually large intracellular domain that consists of multiple sequence motifs, including phosphorylated tyrosine residues, that allow it to interact with signaling molecules such as Grb2. Immunohistochemistry has been used to demonstrate that prolectin is expressed on a specialized population of proliferating B cells in germinal centers. Thus, this novel receptor has the potential to function in carbohydrate-mediated communication between cells in the germinal center.	[Graham, Sarah A.; Jegouzo, Sabine A. F.; Yan, Sheng; Powlesland, Alex S.; Brady, Jacob P.; Taylor, Maureen E.; Drickamer, Kurt] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Drickamer, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, Biochem Bldg, London SW7 2AZ, England.	k.drickamer@imperial.ac.uk	Graham, Sarah/G-7765-2014; Brady, Jacob/AAB-3738-2019	Graham, Sarah/0000-0003-2521-2416; Brady, Jacob/0000-0002-9316-7226; Jegouzo, Sabine/0000-0001-7768-0102; Yan, Sheng/0000-0003-2308-6540; Taylor, Maureen/0000-0001-8300-4987; Drickamer, Kurt/0000-0001-5026-5996	Wellcome Trust [075565]; National Institutes of Health [GM062116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 075565 from the Wellcome Trust (to M. E. T. and K. D.). This work was also supported, in part, by National Institutes of Health Grant GM062116 to the Consortium for Functional Glycomics.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; Coombs PJ, 2005, J BIOL CHEM, V280, P22993, DOI 10.1074/jbc.M504197200; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dam TK, 2008, BIOCHEMISTRY-US, V47, P8470, DOI 10.1021/bi801208b; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Drickamer K, 2003, METHOD ENZYMOL, V362, P560; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wragg S, 1999, J BIOL CHEM, V274, P35400, DOI 10.1074/jbc.274.50.35400; Wurzburg BA, 2006, STRUCTURE, V14, P1049, DOI 10.1016/j.str.2006.03.017	31	19	20	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18537	18544		10.1074/jbc.M109.012807	http://dx.doi.org/10.1074/jbc.M109.012807			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419970	Green Published, hybrid			2022-12-27	WOS:000267712400064
J	Guo, P; Zhao, KW; Dong, XY; Sun, XD; Dong, JT				Guo, Peng; Zhao, Ke-Wen; Dong, Xue-Yuan; Sun, Xiaodong; Dong, Jin-Tang			Acetylation of KLF5 Alters the Assembly of p15 Transcription Factors in Transforming Growth Factor-beta-mediated Induction in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK INHIBITOR P15(INK4B); KRUPPEL-LIKE FACTOR-5; TGF-BETA; TUMOR-SUPPRESSOR; BREAST-CANCER; C-MYC; SMAD; COACTIVATORS; HOMEOSTASIS; EXPRESSION	KLF5 plays important roles in a variety of cellular processes including proliferation and differentiation. Recently KLF5 was shown to reverse its function in proliferative and p15 regulation upon transforming growth factor-beta (TGF beta)-mediated acetylation. To understand how KLF5 acetylation functions in TGF beta-induced p15 transcription, we characterized the interactions of KLF5 with other transcription factors and promoter DNA elements in the context of TGF beta. KLF5 interacted with Smad2-4 and Miz-1 in a TGF beta-independent manner, but interacted with Myc only when TGF beta was activated, and at least some of the interactions had an additive effect on TGF beta-induced p15 transcription. Oligo pulldown assays showed that binding of Myc to the Inr element was KLF5-dependent, and TGF beta could enhance the binding when more KLF5 was available. Furthermore, TGF beta-induced an interaction between KLF5 and the p300 acetylase, and acetylation of KLF5 was necessary for Smad4 to associate with p300. Failure in KLF5 acetylation not only prevented p300-assembled Smad4-KLF5 complex formation on p15 promoter but also affected the binding of Smad4 and FOXO3 on the p15 promoter in vivo. These findings suggest that without TGF beta, some KLF5 associates with Smads in the nucleus and other KLF5 associates with Miz-1 on the p15 promoter to repress its transcription. Activation of TGF beta recruits p300 to the KLF5-Smad complex to acetylate KLF5, and the complex with acetylated KLF5 binds to the Smad binding element and alters the binding of other factors to p15 promoter to induce its transcription.	Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Dong, JT (corresponding author), 1365-C Clifton Rd,Rm C4080, Atlanta, GA 30322 USA.	jdong2@emory.edu	Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019	Guo, Peng/0000-0002-4575-8443; Dong, Jin-Tang/0000-0003-2349-5782	National Institutes of Health [R01CA087921]; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA087921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA087921. This work was also supported by the Georgia Cancer Coalition.	Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; LI JM, 1995, J BIOL CHEM, V270, P26750, DOI 10.1074/jbc.270.45.26750; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	32	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18184	18193		10.1074/jbc.M109.007096	http://dx.doi.org/10.1074/jbc.M109.007096			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419955	Green Published, hybrid			2022-12-27	WOS:000267712400030
J	Zhang, XX; Dowd, DR; Moore, MC; Kranenburg, TA; Meester-Smoor, MA; Zwarthoff, EC; MacDonald, PN				Zhang, Xiaoxue; Dowd, Diane R.; Moore, Meika C.; Kranenburg, Tanya A.; Meester-Smoor, Magda A.; Zwarthoff, Ellen C.; MacDonald, Paul N.			Meningioma 1 Is Required for Appropriate Osteoblast Proliferation, Motility, Differentiation, and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; VITAMIN-D-RECEPTOR; NF-KAPPA-B; OSTEOCLAST DIFFERENTIATION; ANIMAL-MODEL; MN1; EXPRESSION; GENE; OSTEOPROTEGERIN; TRANSCRIPTION	The vitamin D endocrine system is essential for calcium and phosphate homeostasis and skeletal mineralization. The 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) hormone binds to the vitamin D receptor (VDR) to regulate gene expression. These gene products in turn mediate the actions of 1,25(OH) D-2(3) in mineral-regulating target cells such as the osteoblast. We showed previously that meningioma 1 (MN1) is a novel target of 1,25(OH)(2)D-3 in MG-63 osteoblastic cells and that it is a coactivator for VDR-mediated transcription (Sutton, A. L., Zhang, X., Ellison, T. I., and MacDonald, P. N. (2005) Mol. Endocrinol. 19, 2234-2244). However, the functional significance of MN1 in osteoblastic cell biology is largely unknown. Here, we demonstrate that MN1 expression is increased dramatically during differentiation of primary osteoblastic cells. Using calvarial osteoblasts derived from wild-type and MN1 knock-out mice, we provide data supporting an essential role of MN1 in maintaining appropriate osteoblast proliferation, differentiation, and function. MN1 knock-out osteoblasts displayed altered morphology, decreased growth rate, impaired motility, and attenuated 1,25(OH)(2)D-3/VDR-mediated transcription as well as reduced alkaline phosphatase activity and mineralized nodule formation. MN1 null osteoblasts were also impaired in supporting osteoclastogenesis in co-culture studies presumably because of marked reduction in the RANKL: OPG ratio in the MN1 null cells. Mechanistic studies supported a transcriptional role for MN1 in controlling RANKL gene expression through activation of the RANKL promoter. Cumulatively, these studies indicate an important role for MN1 in maintaining the appropriate maturation and function of calvarial osteoblasts.	[Zhang, Xiaoxue; Dowd, Diane R.; Moore, Meika C.; MacDonald, Paul N.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Kranenburg, Tanya A.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Meester-Smoor, Magda A.; Zwarthoff, Ellen C.] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, NL-3000 DR Rotterdam, Netherlands	Case Western Reserve University; St Jude Children's Research Hospital; Erasmus University Rotterdam; Erasmus MC	MacDonald, PN (corresponding author), Case Western Reserve Univ, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	paul.macdonald@case.edu	Kranenburg, Tanya/F-7138-2012	Kranenburg, Tanya/0000-0002-5329-4968	National Institutes of Health [RO1DK53980, RO1DK071769]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053980, R01DK071769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DK53980 and RO1DK071769 ( to P. N. M.).	Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Bove PF, 2008, J BIOL CHEM, V283, P17919, DOI 10.1074/jbc.M709914200; BUIJS A, 1995, ONCOGENE, V10, P1511; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; Carella C, 2006, LEUKEMIA, V20, P1582, DOI 10.1038/sj.leu.2404298; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; DEPREZ RHL, 1995, ONCOGENE, V10, P1521; Divieti P, 1998, J BONE MINER RES, V13, P1835, DOI 10.1359/jbmr.1998.13.12.1835; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Ellison TI, 2007, J BIOL CHEM, V282, P10953, DOI 10.1074/jbc.M609717200; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Heuser M, 2007, BLOOD, V110, P1639, DOI 10.1182/blood-2007-03-080523; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Jurutka PW, 2007, J BONE MINER RES, V22, pV2, DOI 10.1359/JBMR.07S216; Kassem M, 2008, ARCH BIOCHEM BIOPHYS, V473, P183, DOI 10.1016/j.abb.2008.03.028; Kawagoe H, 2005, BLOOD, V106, P4278, DOI 10.1182/blood-2005-04-1674; Kawagoe H, 2005, BLOOD, V106, P4269, DOI 10.1182/blood-2005-04-1679; Kawai S, 2007, J BONE MINER RES, V22, P1362, DOI 10.1359/JBMR.070602; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Meester-Smoor MA, 2005, MOL CELL BIOL, V25, P4229, DOI 10.1128/MCB.25.10.4229-4236.2005; Meester-Smoor MA, 2008, CARCINOGENESIS, V29, P2025, DOI 10.1093/carcin/bgn168; Meester-Smoor MA, 2007, J MOL ENDOCRINOL, V38, P113, DOI 10.1677/jme.1.02110; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Mrak E, 2007, J ENDOCRINOL, V192, P639, DOI 10.1677/joe.1.07073; Mrozek K, 2007, CURR OPIN HEMATOL, V14, P106, DOI 10.1097/MOH.0b013e32801684c7; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Samee N, 2007, CRIT REV EUKAR GENE, V17, P173, DOI 10.1615/CritRevEukarGeneExpr.v17.i3.10; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Sutton ALM, 2005, MOL ENDOCRINOL, V19, P2234, DOI 10.1210/me.2005-0081; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; Sutton ALM, 2008, MOL ENDOCRINOL, V22, P1370, DOI 10.1210/me.2007-0363; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; van Wely KHM, 2003, ONCOGENE, V22, P699, DOI 10.1038/sj.onc.1206124; Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	46	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18174	18183		10.1074/jbc.M109.001354	http://dx.doi.org/10.1074/jbc.M109.001354			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19386590	hybrid, Green Published			2022-12-27	WOS:000267712400029
J	Nishida, A; Andoh, A; Inatomi, O; Fujiyama, Y				Nishida, Atsushi; Andoh, Akira; Inatomi, Osamu; Fujiyama, Yoshihide			Interleukin-32 Expression in the Pancreas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PERIACINAR MYOFIBROBLASTS; IL-6 PRODUCTION; CELL-DEATH; TNF-ALPHA; IN-VITRO; GENE	Interleukin (IL)-32 is a recently described proinflammatory cytokine characterized by the induction of nuclear factor (NF)-kappa B activation. We studied IL-32 expression in human pancreatic tissue and pancreatic cancer cell lines. Tissue samples were obtained surgically. IL-32 expression was evaluated by standard immunohistochemical procedures. IL-32 mRNA expression was analyzed by Northern blotting and real time PCR analyses. IL-32 was weakly immunoexpressed by pancreatic duct cells. In the inflamed lesions of chronic pancreas, the ductal expression of IL-32 was markedly increased. A strong expression of IL-32 alpha was detected in the pancreatic cancer cells. In pancreatic cancer cell lines (PANC-1, MIA PaCa-2, and BxPC-3 cells), the expression of IL-32 mRNA and protein was enhanced by IL-1 beta, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha. An inhibitor of phosphatidylinositol 3-kinase (LY294002) significantly suppressed the IL-1 beta-, IFN-gamma- and TNF-alpha-induced IL-32 mRNA expression. The blockade of NF-kappa B and activated protein-1 activation markedly suppressed the IL-1 beta-, IFN-gamma-, and/or TNF-alpha-induced IL-32 mRNA expression. Furthermore, IL-32-specific small interfering RNA significantly decreased the uptake of [H-3] thymidine and increased the annexin V-positive population (apoptotic cells) in PANC-1 cells. IL-32 knockdown also suppressed the mRNA expression of antiapoptotic proteins (Bcl-2, Bcl-xL, and Mcl-1). Pancreatic duct cells are the local source of IL-32, and IL-32 may play an important role in inflammatory responses and pancreatic cancer growth.	[Nishida, Atsushi; Andoh, Akira; Inatomi, Osamu; Fujiyama, Yoshihide] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan	Shiga University of Medical Science	Nishida, A (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan.	andoh@belle.shiga-med.ac.jp	Andoh, Akira/AAB-9303-2022	Inatomi, Osamu/0000-0002-5837-6575				Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Andoh A, 2000, GASTROENTEROLOGY, V119, P211, DOI 10.1053/gast.2000.8538; Andoh A, 2002, BBA-MOL CELL RES, V1591, P69, DOI 10.1016/S0167-4889(02)00250-1; APTE SS, 1995, GENOMICS, V26, P592, DOI 10.1016/0888-7543(95)80180-T; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Cagnard N, 2005, EUR CYTOKINE NETW, V16, P289; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen Q, 2006, VITAM HORM, V74, P207, DOI 10.1016/S0083-6729(06)74008-0; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Choi JD, 2009, IMMUNOLOGY, V126, P535, DOI 10.1111/j.1365-2567.2008.02917.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DAHL CA, 1992, J IMMUNOL, V148, P597; Detlefsen S, 2008, AM J SURG PATHOL, V32, P986, DOI 10.1097/PAS.0b013e31815d2583; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Hata K, 2002, AM J PHYSIOL-GASTR L, V282, pG1035, DOI 10.1152/ajpgi.00494.2001; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Kundu M, 2006, PLOS MED, V3, P1210, DOI 10.1371/journal.pmed.0030274; Li JX, 2004, J CELL BIOL, V165, P77, DOI 10.1083/jcb.200401004; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Obara H, 2000, ARTERIOSCL THROM VAS, V20, P2198, DOI 10.1161/01.ATV.20.10.2198; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Satoh K, 1998, PANCREAS, V16, P468, DOI 10.1097/00006676-199805000-00002; Shimada M, 2002, J IMMUNOL, V168, P861, DOI 10.4049/jimmunol.168.2.861; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Shoda H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2074; Singh VP, 2001, J CLIN INVEST, V108, P1387, DOI 10.1172/JCI200112874; Sinicrope FA, 2008, CLIN CANCER RES, V14, P4128, DOI 10.1158/1078-0432.CCR-07-5160; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tang CH, 2007, J IMMUNOL, V179, P1292, DOI 10.4049/jimmunol.179.2.1292; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gastro.2005.03.016; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yasumoto H, 2001, GENE THER, V8, P1682, DOI 10.1038/sj.gt.3301590; YUNIS AA, 1977, INT J CANCER, V19, P128, DOI 10.1002/ijc.2910190118; Zawalich WS, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740247	50	86	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17868	17876		10.1074/jbc.M900368200	http://dx.doi.org/10.1074/jbc.M900368200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19386602	hybrid, Green Published			2022-12-27	WOS:000267202500052
J	Struewing, IT; Durham, SN; Barnett, CD; Mao, CD				Struewing, Ian T.; Durham, Samuel N.; Barnett, Corey D.; Mao, Catherine D.			Enhanced Endothelial Cell Senescence by Lithium-induced Matrix Metalloproteinase-1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; GLYCOGEN-SYNTHASE KINASE-3-BETA; ONCOGENE-INDUCED SENESCENCE; BETA-CATENIN; TRANSCRIPTIONAL ACTIVATION; EXTRACELLULAR-MATRIX; GENE; TARGET; MMP-1; WNT	Endothelial cell (EC) senescence and dysfunction occurring after chronic injury and inflammation are highly associated with the development and progression of cardiovascular diseases. However, the factors involved in the establishment of EC senescence remain poorly understood. We have previously shown that lithium, an inhibitor of glycogen synthase kinase (GSK)-3 beta and activator of the Wnt/beta-catenin signaling pathway, induces an EC senescent-like phenotype. Herein, we show that lithium induces a rapid and pronounced up-regulation of the matrix metalloproteinase (MMP)-1, an inflammation and senescent cell marker, at the mRNA and protein levels, whereas the induction of two other senescent cell markers is either weak (interleukin-8) or delayed ( plasminogen activator inhibitor-1). Lithium effect on MMP-1 expression is also specific among other MMPs and not mediated by GSK3 beta inhibition. Lithium affects MMP-1 expression mainly at the transcriptional level but neither the AP1/Ets regulatory sites nor the redox sensitive (-1607/2G) site in MMP-1 promoter are involved in lithium-dependent MMP-1 regulation. However, down-regulation of p53, a target of lithium in EC, dampens both basal and lithium-induced MMP-1 expression, which further links MMP-1 up-regulation with the establishment of cell senescence. Although increased MMP-1 levels are usually associated with angiogenesis in enabled proliferative EC, the exogenous addition of activated MMP-1 on lithium-arrested EC increases the number of EC positive for the senescent-associated-beta-galactosidase marker. Conversely, down-regulation of MMP-1 expression by small interfering RNAs blunts the lithium-dependent increase in senescent-associated-beta-galactosidase positive cells. Altogether our data indicate that lithium-induced MMP-1 may participate in the reinforcement of EC senescence and reveal a novel mechanism for lithium-induced tissue remodeling.	[Struewing, Ian T.; Durham, Samuel N.; Barnett, Corey D.; Mao, Catherine D.] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40506 USA	University of Kentucky	Mao, CD (corresponding author), Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40506 USA.	cdmao2@uky.edu			National Institutes of Health [HL68698]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL68698 (to C. D. M.).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BELMAKER R H, 1990, Pharmacology and Toxicology Supplement, V66, P76; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bertram C, 2008, EXP GERONTOL, V43, P209, DOI 10.1016/j.exger.2007.11.007; Binder BR, 2008, IMMUNOL LETT, V118, P116, DOI 10.1016/j.imlet.2008.03.017; Bower KE, 2004, ONCOGENE, V23, P8805, DOI 10.1038/sj.onc.1208109; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Brenneisen P, 1998, J BIOL CHEM, V273, P5279, DOI 10.1074/jbc.273.9.5279; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1729, DOI 10.1152/ajpheart.01103.2005; COMI P, 1995, EXP CELL RES, V219, P304, DOI 10.1006/excr.1995.1232; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Cui J, 2007, NEUROSCIENCE, V144, P1447, DOI 10.1016/j.neuroscience.2006.11.010; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; De Freitas DM, 2006, ACCOUNTS CHEM RES, V39, P283, DOI 10.1021/ar030197a; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Frederiks WM, 2004, J HISTOCHEM CYTOCHEM, V52, P711, DOI 10.1369/jhc.4R6251.2004; Freeman MP, 2006, AM J MED, V119, P478, DOI 10.1016/j.amjmed.2005.11.003; Gustavson MD, 2004, MOL CARCINOGEN, V41, P125, DOI 10.1002/mc.20049; Hampel B, 2006, EXP GERONTOL, V41, P474, DOI 10.1016/j.exger.2006.03.001; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kang MK, 2003, EXP CELL RES, V287, P272, DOI 10.1016/S0014-4827(03)00061-2; Kim MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004864; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lee RT, 1996, ARTERIOSCL THROM VAS, V16, P1070, DOI 10.1161/01.ATV.16.8.1070; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Mao CD, 2001, J BIOL CHEM, V276, P26180, DOI 10.1074/jbc.M101188200; Marchenko GN, 2002, BIOCHEM J, V363, P253, DOI 10.1042/0264-6021:3630253; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Mu XC, 1998, J CELL PHYSIOL, V174, P90, DOI 10.1002/(SICI)1097-4652(199801)174:1<90::AID-JCP10>3.0.CO;2-S; Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008; Nelson KK, 2006, J BIOL CHEM, V281, P14100, DOI 10.1074/jbc.M601820200; Nemeth ZH, 2002, J BIOL CHEM, V277, P7713, DOI 10.1074/jbc.M109711200; NIKKARI ST, 1995, CIRCULATION, V92, P1393, DOI 10.1161/01.CIR.92.6.1393; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Pilcher HR, 2003, NATURE, V425, P118, DOI 10.1038/425118a; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rao JS, 2007, CANCER RES, V67, P4956, DOI 10.1158/0008-5472.CAN-07-0380; Rutter JL, 1997, J CELL BIOCHEM, V66, P322, DOI 10.1002/(SICI)1097-4644(19970901)66:3<322::AID-JCB5>3.3.CO;2-D; Rutter JL, 1998, CANCER RES, V58, P5321; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Sobel BE, 2003, ARTERIOSCL THROM VAS, V23, P1979, DOI 10.1161/01.ATV.0000091250.53231.4D; Struewing IT, 2007, FEBS J, V274, P2749, DOI 10.1111/j.1742-4658.2007.05809.x; Sun YB, 2004, J CELL BIOCHEM, V92, P258, DOI 10.1002/jcb.20044; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; Vines A, 2006, J BIOL CHEM, V281, P16985, DOI 10.1074/jbc.M602446200; Wenk J, 1999, J BIOL CHEM, V274, P25869, DOI 10.1074/jbc.274.36.25869; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Xu M, 2008, MOL CELL BIOL, V28, P1713, DOI 10.1128/MCB.01360-07; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	72	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17595	17606		10.1074/jbc.M109.001735	http://dx.doi.org/10.1074/jbc.M109.001735			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19407340	Green Published, hybrid			2022-12-27	WOS:000267202500025
J	Csomos, RA; Brady, GF; Duckett, CS				Csomos, Rebecca A.; Brady, Graham F.; Duckett, Colin S.			Enhanced Cytoprotective Effects of the Inhibitor of Apoptosis Protein Cellular IAP1 through Stabilization with TRAF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; NECROSIS-FACTOR-ALPHA; X-LINKED INHIBITOR; SIGNALING COMPLEX; LIGASE ACTIVITY; CYTOCHROME-C; ACTIVATION; C-IAP1; CASPASES	Inhibitor of apoptosis (IAP) proteins are key regulators of intracellular signaling that interact with tumor necrosis factor (TNF) receptor superfamily members as well as proapoptotic molecules such as Smac/DIABLO and caspases. Whereas the X-linked IAP is an established caspase inhibitor, the protective mechanisms utilized by the cellular IAP (c-IAP) proteins are less clear because c-IAPs bind to but do not inhibit the enzymatic activities of caspases. In this study, c-IAPs are shown to be highly unstable molecules that undergo autoubiquitination. The autoubiquitination of c-IAP1 is blocked upon coexpression with TNF receptor-associated factor (TRAF) 2, and this is achieved by inhibition of the E3 ubiquitin ligase activity intrinsic to the RING of c-IAP1. Consistent with these observations, loss of TRAF2 results in a decrease in c-IAP1 levels. Stabilized c-IAP1 was found to sequester and prevent Smac/DIABLO from antagonizing X-linked IAP and protect against cell death. Therefore, this study describes an intriguing cytoprotective mechanism utilized by c-IAP1 and provides critical insight into how IAP proteins function to alter the apoptotic threshold.	[Csomos, Rebecca A.; Brady, Graham F.; Duckett, Colin S.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Duckett, Colin S.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Duckett, CS (corresponding author), BSRB,Rm 2057,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	colind@umich.edu		Duckett, Colin/0000-0001-9413-2263	National Institutes of Health [T32 CA09676, R01 GM067827]; Department of Defense Pre-doctoral Award [W81XWH08-1-0211]; American Asthma Foundation; NATIONAL CANCER INSTITUTE [T32CA009676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Pre-doctoral Award(United States Department of Defense); American Asthma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 CA09676 ( to R. A. C.) and R01 GM067827 ( to C. S. D.). This work was also supported by Department of Defense Pre-doctoral Award W81XWH08-1-0211 ( to G. F. B.) and by an award from the American Asthma Foundation ( to C. S. D.).	Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Clem RJ, 2001, J BIOL CHEM, V276, P7602, DOI 10.1074/jbc.M010259200; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Duckett CS, 1998, MOL CELL BIOL, V18, P608, DOI 10.1128/MCB.18.1.608; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Imoto I, 2001, CANCER RES, V61, P6629; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tenev T, 2005, NAT CELL BIOL, V7, P70, DOI 10.1038/ncb1204; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wilkinson JC, 2004, J BIOL CHEM, V279, P51082, DOI 10.1074/jbc.M408655200; Xu L, 2007, MOL CELL, V28, P914, DOI 10.1016/j.molcel.2007.10.027; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	34	32	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20531	20539		10.1074/jbc.M109.029983	http://dx.doi.org/10.1074/jbc.M109.029983			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19506082	Green Published, hybrid			2022-12-27	WOS:000268316100014
J	Zhang, DY; Li, SY; Cruz, P; Kone, BC				Zhang, Dongyu; Li, Shiyu; Cruz, Pedro; Kone, Bruce C.			Sirtuin 1 Functionally and Physically Interacts with Disruptor of Telomeric Silencing-1 to Regulate alpha-ENaC Transcription in Collecting Duct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 METHYLTRANSFERASE; EPITHELIAL SODIUM-CHANNEL; SACCHAROMYCES-CEREVISIAE; CELL-SURVIVAL; METHYLATION; DEACETYLASE; REPRESSION; COMPLEX; PROTEIN; GENE	Aldosterone increases renal tubular Na+ absorption in large part by increasing transcription of the epithelial Na+ channel alpha-subunit (alpha-ENaC) expressed in the apical membrane of collecting duct principal cells. We recently reported that a complex containing the histone H3K79 methyltransferase disruptor of telomeric silencing-1 (Dot1) associates with and represses the alpha-ENaC promoter in mouse inner medullary collecting duct mIMCD3 cells, and that aldosterone acts to disrupt this complex and its inhibitory effects (Zhang, W., Xia, X., Reisenauer, M. R., Rieg, T., Lang, F., Kuhl, D., Vallon, V., and Kone, B. C. ( 2007) J. Clin. Invest. 117, 773-783). Here we demonstrate that the NAD(+)-dependent deacetylase sirtuin 1 (Sirt1) functionally and physically interacts with Dot1 to enhance the distributive activity of Dot1 on H3K79 methylation and thereby represses alpha-ENaC transcription in mIMCD3 cells. Sirt1 overexpression inhibited basal alpha-ENaC mRNA expression and alpha-ENaC promoter activity, surprisingly in a deacetylase-independent manner. The ability of Sirt1 to inhibit alpha-ENaC transcription was retained in a truncated Sirt1 construct expressing only its N-terminal domain. Conversely, Sirt1 knockdown enhanced alpha-ENaC mRNA levels and alpha-ENaC promoter activity, and inhibited global H3K79 methylation, particularly H3K79 trimethylation, in chromatin associated with the alpha-ENaC promoter. Sirt1 and Dot1 co-immunoprecipitated from mIMCD3 cells and colocalized in the nucleus. Sirt1 immunoprecipitated from chromatin associated with regions of the alpha-ENaC promoter known to associate with Dot1. Aldosterone inhibited Sirt1 association at two of these regions, as well as Sirt1 mRNA expression, in a coordinate manner with induction of alpha-ENaC transcription. Overexpressed Sirt1 inhibited aldosterone induction of alpha-ENaC transcription independent of effects on mineralocorticoid receptor trans-activation. These data identify Sirt1 as a novel modulator of alpha-ENaC, Dot1, and the aldosterone signaling pathway.	[Zhang, Dongyu; Li, Shiyu; Cruz, Pedro; Kone, Bruce C.] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA; [Kone, Bruce C.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kone, BC (corresponding author), Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA.	Bruce.C.Kone@uth.tmc.edu			National Institutes of Health [DK075565]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant DK075565 (to B. C. K.).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Amat R, 2007, J BIOL CHEM, V282, P34066, DOI 10.1074/jbc.M707114200; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Frederiks F, 2008, NAT STRUCT MOL BIOL, V15, P550, DOI 10.1038/nsmb.1432; Husted RF, 2007, AM J PHYSIOL-RENAL, V293, pF813, DOI 10.1152/ajprenal.00225.2007; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mick VE, 2001, MOL ENDOCRINOL, V15, P575, DOI 10.1210/me.15.4.575; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Schild L, 1996, NEPHROLOGIE, V17, P395; Singer MS, 1998, GENETICS, V150, P613; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yang B, 2008, J MOL BIOL, V381, P826, DOI 10.1016/j.jmb.2008.06.059; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	35	57	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20917	20926		10.1074/jbc.M109.020073	http://dx.doi.org/10.1074/jbc.M109.020073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19491102	Green Published, hybrid			2022-12-27	WOS:000268316100055
J	Moss, NM; Wu, YI; Liu, YY; Munshi, HG; Stack, MS				Moss, Natalie M.; Wu, Yi I.; Liu, Yueying; Munshi, H. G.; Stack, M. Sharon			Modulation of the Membrane Type 1 Matrix Metalloproteinase Cytoplasmic Tail Enhances Tumor Cell Invasion and Proliferation in Three-dimensional Collagen Matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE-C; PHOSPHORYLATION; ACTIVATION; PROGELATINASE; MT1-MMP; DOMAIN; CD44; INVADOPODIA; EXPRESSION	Increasing evidence suggests that the cytoplasmic tail of membrane type 1 matrix metalloproteinase (MT1-MMP) is subject to phosphorylation and that this modification may influence its enzymatic activity at the cell surface. In this study, phosphorylated MT1-MMP is detected using a phospho-specific antibody recognizing a protein kinase C consensus sequence (phospho-TXR), and a MT1-MMP tail peptide is phosphorylated by exogenous protein kinase C. To characterize the potential role of cytoplasmic residue Thr(567) in these processes, mutants that mimic a state of either constitutive (T567E) or defective phosphorylation (T567A) were expressed and analyzed for their functional effects on MT1-MMP activity and cellular behavior. Phospho-mimetic mutants of Thr(567) exhibit enhanced matrix invasion as well as more extensive growth within a three-dimensional type I collagen matrix. Together, these findings suggest that MT1-MMP surface action is regulated by phosphorylation at cytoplasmic tail residue Thr(567) and that this modification plays a critical role in processes that are linked to tumor progression.	[Liu, Yueying; Stack, M. Sharon] Univ Missouri, Dept Pathol & Anat Sci, Sch Med, Columbia, MO 65212 USA; [Moss, Natalie M.] Northwestern Univ, Feinberg Med Sch, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Munshi, H. G.] Northwestern Univ, Feinberg Med Sch, Div Hematol Oncol, Chicago, IL 60611 USA; [Wu, Yi I.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of Missouri System; University of Missouri Columbia; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Stack, MS (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, Sch Med, 1 Hosp Dr,M214E Med Sci Bldg, Columbia, MO 65212 USA.	stackm@health.missouri.edu			National Institutes of Health, NCI [RO1 CA86984, RO1 CA109545, CA86984-07S1]; NATIONAL CANCER INSTITUTE [R01CA086984, R01CA109545] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant RO1 CA86984 (to M. S. S.), RO1 CA109545 (to M. S. S.), and CA86984-07S1 (to M. S. S. and N.M.M.).	ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; BOWEN S, 1991, J BIOL CHEM, V266, P1162; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; CHEN JD, 1994, DERMATOLOGY, V188, P6, DOI 10.1159/000247076; DAVIS RJ, 1985, P NATL ACAD SCI USA, V82, P4080, DOI 10.1073/pnas.82.12.4080; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; GALLIS B, 1986, J BIOL CHEM, V261, P5075; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; LEWIS RE, 1990, BIOCHEMISTRY-US, V29, P1807, DOI 10.1021/bi00459a020; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Maizels ET, 1998, BIOCHEM J, V332, P703, DOI 10.1042/bj3320703; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SHACKELFORD DA, 1986, J BIOL CHEM, V261, P8334; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Tjia JS, 2002, ANN BIOMED ENG, V30, P851, DOI 10.1114/1.1492814; Tsunezuka Y, 1996, CANCER RES, V56, P5678; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200; Yana I, 2002, CLIN EXP METASTAS, V19, P209, DOI 10.1023/A:1015527220537; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	42	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19791	19799		10.1074/jbc.M109.020362	http://dx.doi.org/10.1074/jbc.M109.020362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19458085	Green Published, hybrid			2022-12-27	WOS:000268097400005
J	Ono, T; Kaneda, T; Muto, A; Yoshida, T				Ono, Takeshi; Kaneda, Toshio; Muto, Akihiro; Yoshida, Tadashi			Positive Transcriptional Regulation of the Human mu Opioid Receptor Gene by Poly(ADP-ribose) Polymerase-1 and Increase of Its DNA Binding Affinity Based on Polymorphism of G(-172) -> T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; NF-KAPPA-B; ALLELIC VARIATION; NEURONAL CELLS; EXPRESSION; PROTEIN; PARP-1; COACTIVATOR; ACTIVATION; DESENSITIZATION	mu opioid receptor (MOR) agonists such as morphine are applied widely in clinical practice as pain therapy. The effects of morphine through MOR, such as analgesia and development of tolerance and dependence, are influenced by individual specificity. Recently, we analyzed single nucleotide polymorphisms on the human MOR gene to investigate the factors that contribute to individual specificity. In process of single nucleotide polymorphisms analysis, we found that specific nuclear proteins bound to G(-172) -> T region in exon 1 in MOR gene, and its affinity to DNA was increased by base substitution from G(-172) to T-172. The isolated protein was identified by mass spectrometry and was confirmed by Western blotting to be poly(ADPribose) polymerase-1 (PARP-1). The overexpressed PARP-1 bound to G(-172) -> T and enhanced the transcription of reporter vectors containing G(-172) and T-172. Furthermore, PARP-1 inhibitor (benzamide) decreased PARP-1 binding to G(-172) -> T without affecting mRNA or protein expression level of PARP-1 and down-regulated the subsequent MOR gene expression in SH-SY5Y cells. Moreover, we found that tumor necrosis factor-alpha enhanced MOR gene expression as well as increased PARP-1 binding to the G(-172) -> T region and G(-172) -> T-dependent transcription in SH-SY5Y cells. These effects were also inhibited by benzamide. In this study, our data suggest that PARP-1 positively regulates MOR gene transcription via G(-172) -> T, which might influence individual specificity in therapeutic opioid effects.	[Ono, Takeshi; Kaneda, Toshio; Muto, Akihiro; Yoshida, Tadashi] Hoshi Univ, Fac Pharmaceut Sci, Dept Pathophysiol, Shinagawa Ku, Tokyo 1420063, Japan	Hoshi University	Yoshida, T (corresponding author), Hoshi Univ, Fac Pharmaceut Sci, Dept Pathophysiol, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1420063, Japan.	tyoshida@hoshi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	AGARWAL S, 1988, J IMMUNOL, V140, P4187; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; BAILEY DW, 1971, TRANSPLANTATION, V11, P419, DOI 10.1097/00007890-197104000-00014; Bayerer B, 2007, EUR J PAIN, V11, P421, DOI 10.1016/j.ejpain.2006.06.004; Bedini A, 2008, J NEUROCHEM, V105, P2166, DOI 10.1111/j.1471-4159.2008.05303.x; Beranger GE, 2006, J BONE MINER RES, V21, P1757, DOI 10.1359/JBMR.060809; Bergen AW, 1997, MOL PSYCHIATR, V2, P490, DOI 10.1038/sj.mp.4000331; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Chiba-Falek O, 2005, AM J HUM GENET, V76, P478, DOI 10.1086/428655; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Choi HS, 2008, J CELL MOL MED, V12, P2319, DOI 10.1111/j.1582-4934.2008.00259.x; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hattori Y, 2007, J CONTROL RELEASE, V120, P122, DOI 10.1016/j.jconrel.2007.04.012; Hoehe MR, 2000, HUM MOL GENET, V9, P2895, DOI 10.1093/hmg/9.19.2895; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Koch T, 2000, MOL PHARMACOL, V58, P328, DOI 10.1124/mol.58.2.328; Kraus J, 2003, MOL PHARMACOL, V64, P876, DOI 10.1124/mol.64.4.876; Kraus J, 2001, J BIOL CHEM, V276, P43901, DOI 10.1074/jbc.M107543200; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Law PY, 2000, MOL PHARMACOL, V58, P388, DOI 10.1124/mol.58.2.388; Lee PW, 2004, MOL PHARMACOL, V66, P1580, DOI 10.1124/mol.66.6.; Lotsch J, 2002, PHARMACOGENETICS, V12, P3, DOI 10.1097/00008571-200201000-00002; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; Ono T, 2009, BIOL PHARM BULL, V32, P721, DOI 10.1248/bpb.32.721; Pottier N, 2007, HUM MOL GENET, V16, P2261, DOI 10.1093/hmg/ddm178; Shiokawa M, 2005, JPN J CLIN ONCOL, V35, P97, DOI 10.1093/jjco/hyi028; Soldatenkov VA, 2002, J BIOL CHEM, V277, P665, DOI 10.1074/jbc.M108551200; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang DX, 2001, J BIOL CHEM, V276, P34624, DOI 10.1074/jbc.M104083200; WANG JB, 1994, FEBS LETT, V338, P217, DOI 10.1016/0014-5793(94)80368-4; Yu ZY, 2006, J BIOL CHEM, V281, P9101, DOI 10.1074/jbc.M511049200; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	40	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20175	20183		10.1074/jbc.M109.019414	http://dx.doi.org/10.1074/jbc.M109.019414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19447888	Green Published, hybrid			2022-12-27	WOS:000268097400045
J	Zhang, J; Walk, SF; Ravichandran, KS; Garrison, JC				Zhang, Jun; Walk, Scott F.; Ravichandran, Kodi S.; Garrison, James C.			Regulation of the Src Homology 2 Domain-containing Inositol 5 '-Phosphatase (SHIP1) by the Cyclic AMP-dependent Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE; IN-VIVO; TYROSINE PHOSPHORYLATION; ADENOSINE RECEPTORS; PHOSPHATASE SHIP; PTEN; CELLS; PATHWAY; MACROPHAGES; ASSOCIATION	Many agents that activate hematopoietic cells use phosphatidylinositol 3,4,5-trisphosphate (PtdIns 3,4,5-P-3) to initiate signaling cascades. The SH2 domain-containing inositol 5' phosphatase, SHIP1, regulates hematopoietic cell function by opposing the action of phosphatidylinositol 3-kinase and reducing the levels of PtdIns 3,4,5-P-3. Activation of the cyclic AMP-dependent protein kinase (PKA) also opposes many of the proinflammatory responses of hematopoietic cells. We tested to see whether the activity of SHIP1 was regulated via phosphorylation with PKA. We prepared pure recombinant SHIP1 from HEK293 cells and found it can be rapidly phosphorylated by PKA to a stoichiometry of 0.6 mol of PO4/mol of SHIP1. In P-32-labeled HEK-293 cells transfected with SHIP1, stimulation with Spadenosine 3',5'-cyclic monophosphorothioate triethylammonium salt hydrate (Sp-cAMPS) or activation of the beta-adrenergic receptor increased the phosphorylation state of SHIP1. Inhibition of protein phosphatase activity with okadaic acid also increased the phosphorylation of SHIP1. Phosphorylation of SHIP1 in vitro or in cells by PKA increased the 5' phosphatase activity of SHIP1 by 2-3-fold. Elevation of Ca2+ in DT40 cells in response to B cell receptor cross-linking, an indicator of PtdIns 3,4,5-P3 levels, was markedly blunted by pretreatment with Sp-cAMPS. This effect was absent in SHIP-/- DT40 cells showing that the effect of Sp-cAMPS in DT40 cells is SHIP1-dependent. Sp-cAMPS also blunted the ability of the B cell receptor to increase the phosphorylation of Akt in DT40 and A20 cells. Overall, activation of G protein-coupled receptors that raise cyclic AMP cause SHIP1 to be phosphorylated and stimulate its inositol phosphatase activity. These results outline a novel mechanism of SHIP1 regulation.	[Zhang, Jun; Garrison, James C.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Walk, Scott F.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Garrison, JC (corresponding author), Univ Virginia, Dept Pharmacol, POB 800735, Charlottesville, VA 22908 USA.	jcg8w@virginia.edu		Zhang, Jun/0000-0002-3339-0346; Ravichandran, Kodi/0000-0001-9049-1410	National Institutes of Health [R01 GM076236, DK199520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM076236 and DK199520.	Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; Aman MJ, 2001, J BIOL CHEM, V276, P46371, DOI 10.1074/jbc.M104069200; Artemenko Y, 2007, J CELL PHYSIOL, V211, P598, DOI 10.1002/jcp.20965; Barbour SE, 1998, MOL IMMUNOL, V35, P977, DOI 10.1016/S0161-5890(98)00070-4; Batty IH, 2007, BIOCHEM J, V407, P255, DOI 10.1042/BJ20070558; Blero D, 2001, BIOCHEM BIOPH RES CO, V282, P839, DOI 10.1006/bbrc.2001.4639; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Braun MC, 2001, MICROBES INFECT, V3, P99, DOI 10.1016/S1286-4579(00)01357-5; Brauweiler A, 2000, J EXP MED, V191, P1545, DOI 10.1084/jem.191.9.1545; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Giembycz MA, 2000, PULM PHARMACOL THER, V13, P195, DOI 10.1006/pupt.2000.0250; Giuriato S, 1997, J BIOL CHEM, V272, P26857, DOI 10.1074/jbc.272.43.26857; Gold MR, 1999, J IMMUNOL, V163, P1894; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hikida M, 2005, ADV IMMUNOL, V88, P73, DOI 10.1016/S0065-2776(05)88003-4; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Horn S, 2001, LEUKEMIA, V15, P112, DOI 10.1038/sj.leu.2401990; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222; Lamkin TD, 1997, J BIOL CHEM, V272, P10396; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; March ME, 2000, J BIOL CHEM, V275, P29960, DOI 10.1074/jbc.M003714200; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Okada H, 1998, J IMMUNOL, V161, P5129; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Sly LM, 2003, EXP HEMATOL, V31, P1170, DOI 10.1016/j.exphem.2003.09.011; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; Sun WC, 2008, VET IMMUNOL IMMUNOP, V121, P91, DOI 10.1016/j.vetimm.2007.08.011; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; ZHUO S, 1993, J BIOL CHEM, V268, P17754	46	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20070	20078		10.1074/jbc.M109.016865	http://dx.doi.org/10.1074/jbc.M109.016865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494109	hybrid, Green Published			2022-12-27	WOS:000268097400034
J	Jiang, YJ; Uchida, Y; Lu, B; Kim, P; Mao, C; Akiyama, M; Elias, PM; Holleran, WM; Grunfeld, C; Feingold, KR				Jiang, Yan J.; Uchida, Yoshikazu; Lu, Biao; Kim, Peggy; Mao, Cungui; Akiyama, Masashi; Elias, Peter M.; Holleran, Walter M.; Grunfeld, Carl; Feingold, Kenneth R.			Ceramide Stimulates ABCA12 Expression via Peroxisome Proliferator-activated Receptor delta in Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY BARRIER HOMEOSTASIS; CULTURED HUMAN KERATINOCYTES; PROTEIN-KINASE PATHWAYS; CASSETTE TRANSPORTER 1; HARLEQUIN ICHTHYOSIS; TANGIER-DISEASE; INDUCED APOPTOSIS; GENE-EXPRESSION; EPIDERMAL LIPIDS; LXR ACTIVATORS	ABCA12 (ATP binding cassette transporter, family 12) is a cellular membrane transporter that facilitates the delivery of glucosylceramides to epidermal lamellar bodies in keratinocytes, a process that is critical for permeability barrier formation. Following secretion of lamellar bodies into the stratum corneum, glucosylceramides are metabolized to ceramides, which comprise similar to 50% of the lipid in stratum corneum. Gene mutations of ABCA12 underlie harlequin ichthyosis, a devastating skin disorder characterized by abnormal lamellar bodies and a severe barrier abnormality. Recently we reported that peroxisome proliferator-activated receptor (PPAR) and liver X receptor activators increase ABCA12 expression in human keratinocytes. Here we demonstrate that ceramide (C-2-Cer and C-6-Cer), but not C-8-glucosylceramides, sphingosine, or ceramide 1-phosphate, increases ABCA12 mRNA expression in a dose- and time-dependent manner. Inhibitors of glucosylceramide synthase, sphingomyelin synthase, and ceramidase and small interfering RNA knockdown of human alkaline ceramidase, which all increase endogenous ceramide levels, also increased ABCA12 mRNA levels. Moreover, simultaneous treatment with C-6-Cer and each of these same inhibitors additively increased ABCA12 expression, indicating that ceramide is an important inducer of ABCA12 expression and that the conversion of ceramide to other sphingolipids or metabolites is not required. Finally, both exogenous and endogenous ceramides preferentially stimulate PPAR delta expression (but not other PPARs or liver X receptors), whereas PPAR delta knockdown by siRNA transfection specifically diminished the ceramide-induced increase in ABCA12 mRNA levels, indicating that PPAR delta is a mediator of the ceramide effect. Together, these results show that ceramide, an important lipid component of epidermis, up-regulates ABCA12 expression via the PPAR delta-mediated signaling pathway, providing a substrate-driven, feed-forward mechanism for regulating this key lipid transporter.	[Jiang, Yan J.; Lu, Biao; Kim, Peggy; Grunfeld, Carl; Feingold, Kenneth R.] Univ Calif San Francisco, No Calif Inst Res & Educ, Vet Affairs Med Ctr, Metab Sect, San Francisco, CA 94121 USA; [Uchida, Yoshikazu; Elias, Peter M.; Holleran, Walter M.] Univ Calif San Francisco, No Calif Inst Res & Educ, Vet Affairs Med Ctr, Dermatol Res Unit, San Francisco, CA 94121 USA; [Mao, Cungui] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Akiyama, Masashi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan	Northern California Institute for Research & Education; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Northern California Institute for Research & Education; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical University of South Carolina; Hokkaido University	Jiang, YJ (corresponding author), Dept Vet Affairs Med Ctr, Metab Sect 111F, 4150 Clement St, San Francisco, CA 94121 USA.	yan.jiang@med.va.gov	Akiyama, Masashi/I-1122-2012	Uchida, Yoshikazu/0000-0002-4980-3416	National Institutes of Health [AR39448, AR049932]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049932, P01AR039448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR39448 and AR049932. This work was also supported by the Medical Research Service, Department of Veterans Affairs at San Francisco.	Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Akiyama M, 2007, J INVEST DERMATOL, V127, P568, DOI 10.1038/sj.jid.5700617; Akiyama M, 2006, ARCH DERMATOL, V142, P914, DOI 10.1001/archderm.142.7.914; Allikmets R, 1997, NAT GENET, V17, P122, DOI 10.1038/ng0997-122b; Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chang KCN, 2008, MOL ENDOCRINOL, V22, P2407, DOI 10.1210/me.2008-0232; Chen CC, 2001, MOL PHARMACOL, V59, P493, DOI 10.1124/mol.59.3.493; Deigner HP, 2001, FASEB J, V15, P807, DOI 10.1096/fj.15.3.807; Elias P. M., 2006, EPIDERMAL LAMELLAR B, P261; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Fishelevich R, 2006, J IMMUNOL, V176, P2590, DOI 10.4049/jimmunol.176.4.2590; Geilen GC, 1997, J BIOL CHEM, V272, P8997, DOI 10.1074/jbc.272.14.8997; GRAYSON S, 1985, J INVEST DERMATOL, V85, P289, DOI 10.1111/1523-1747.ep12276826; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Holleran WM, 2006, FEBS LETT, V580, P5456, DOI 10.1016/j.febslet.2006.08.039; HOLLERAN WM, 1991, J CLIN INVEST, V88, P1338, DOI 10.1172/JCI115439; HOLLERAN WM, 1990, J LIPID RES, V31, P1655; Houben E, 2006, J LIPID RES, V47, P1063, DOI 10.1194/jlr.M600001-JLR200; Hovnanian A, 2005, J CLIN INVEST, V115, P1708, DOI 10.1172/JCI25736; Jiang YJ, 2008, J INVEST DERMATOL, V128, P104, DOI 10.1038/sj.jid.5700944; Jiang YJ, 2006, J LIPID RES, V47, P2248, DOI 10.1194/jlr.M600163-JLR200; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Komori H, 2000, FEBS LETT, V475, P247, DOI 10.1016/S0014-5793(00)01696-3; LAMPE MA, 1983, J LIPID RES, V24, P131; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Man MQ, 2006, J INVEST DERMATOL, V126, P386, DOI 10.1038/sj.jid.5700046; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Moskowitz DG, 2004, J PEDIATR-US, V145, P82, DOI 10.1016/j.jpeds.2004.03.052; Murate T, 2002, J BIOL CHEM, V277, P9936, DOI 10.1074/jbc.M111594200; NEISH AS, 1995, J BIOL CHEM, V270, P28903, DOI 10.1074/jbc.270.48.28903; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schmuth M, 2008, J LIPID RES, V49, P499, DOI 10.1194/jlr.R800001-JLR200; Selzner M, 2001, CANCER RES, V61, P1233; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Uchida Y, 2003, J INVEST DERMATOL, V120, P662, DOI 10.1046/j.1523-1747.2003.12098.x; Uchida Y, 2002, J LIPID RES, V43, P1293, DOI 10.1194/jlr.M100442-JLR200; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Vielhaber G, 2001, J INVEST DERMATOL, V117, P1126, DOI 10.1046/j.0022-202x.2001.01527.x; WAKITA H, 1994, ARCH DERMATOL RES, V286, P350, DOI 10.1007/BF00402228; Westergaard M, 2001, J INVEST DERMATOL, V116, P702, DOI 10.1046/j.1523-1747.2001.01329.x; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; Yanagi T, 2008, HUM MOL GENET, V17, P3075, DOI 10.1093/hmg/ddn204; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350; Zuo Y, 2008, J BIOL CHEM, V283, P36624, DOI 10.1074/jbc.M807377200	58	36	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18942	18952		10.1074/jbc.M109.006973	http://dx.doi.org/10.1074/jbc.M109.006973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19429679	Green Published, hybrid			2022-12-27	WOS:000267711500044
J	Valdes, R; Arastu-Kapur, S; Landfear, SM; Shinde, U				Valdes, Raquel; Arastu-Kapur, Shirin; Landfear, Scott M.; Shinde, Ujwal			An ab Initio Structural Model of a Nucleoside Permease Predicts Functionally Important Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE-GUANOSINE TRANSPORTER; LEISHMANIA-DONOVANI; NUCLEOBASE TRANSPORT; CHIMERIC CONSTRUCTS; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; ESCHERICHIA-COLI; DEFICIENT MUTANT; PROTEIN	Permeases belonging to the equilibrative nucleoside transporter family promote uptake of nucleosides and/or nucleobases into a wide range of eukaryotes and mediate the uptake of a variety of drugs used in the treatment of cancer, heart disease, AIDS, and parasitic infections. No experimental three-dimensional structure exists for any of these permeases, and they are not present in prokaryotes, the source of many membrane proteins used in crystal structure determination. To generate a structural model for such a transporter, the LdNT1.1 nucleoside permease from the parasitic protozoan Leishmania donovani was modeled using ab initio computation. Site-directed mutations that strongly impair transport or that alter substrate specificity map to the central pore of the ab initio model, whereas mutations that have less pronounced phenotypes map to peripheral positions. The model suggests that aromatic residues present in transmembrane helices 1, 2, and 7 may interact to form an extracellular gate that closes the permeation pathway in the inward oriented conformation. Mutation of two of these three residues abrogated transport activity, consistent with the prediction of the model. The ab initio model is similar to one derived previously using threading analysis, a distinct computational approach, supporting the overall accuracy of both models. However, significant differences in helix orientation and residue position between the two models are apparent, and the mutagenesis data suggest that the ab initio model represents an improvement regarding structural details over the threading model. The putative gating interaction may also help explain differences in substrate specificity between members of this family.	[Valdes, Raquel; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Arastu-Kapur, Shirin; Shinde, Ujwal] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Landfear, SM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	landfear@ohsu.edu; shindeu@ohsu.edu		Landfear, Scott/0000-0002-1643-6664	National Institutes of Health [AI44138]; National Science Foundation [0746589]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI44138 (to S. M. L.). This work was also supported by National Science Foundation Grant 0746589 (to U. S.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Bradley P, 2005, PROTEINS, V61, P128, DOI 10.1002/prot.20729; Brooijmans N, 2003, ANNU REV BIOPH BIOM, V32, P335, DOI 10.1146/annurev.biophys.32.110601.142532; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; Carter NS, 2000, J BIOL CHEM, V275, P20935, DOI 10.1074/jbc.M002418200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Gschwend DA, 1996, J MOL RECOGNIT, V9, P175, DOI 10.1002/(SICI)1099-1352(199603)9:2<175::AID-JMR260>3.0.CO;2-D; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jones DT, 1998, FEBS LETT, V423, P281, DOI 10.1016/S0014-5793(98)00095-7; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; LEBOWITZ JH, 1994, METHOD CELL BIOL, V45, P65; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Liu W, 2006, MOL BIOCHEM PARASIT, V150, P300, DOI 10.1016/j.molbiopara.2006.09.002; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; MURRAY AW, 1971, ANNU REV BIOCHEM, V40, P811, DOI 10.1146/annurev.bi.40.070171.004115; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Rose JB, 2008, PHYSIOLOGY, V23, P41, DOI 10.1152/physiol.00036.2007; Sanchez MA, 2004, MOL MEMBR BIOL, V21, P11, DOI 10.1080/0968768031000140845; SenGupta DJ, 2004, BIOCHEM PHARMACOL, V67, P453, DOI 10.1016/j.bcp.2003.09.018; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sundaram M, 1998, J BIOL CHEM, V273, P21519, DOI 10.1074/jbc.273.34.21519; Sundaram M, 2001, BIOCHEMISTRY-US, V40, P8146, DOI 10.1021/bi0101805; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2006, J BIOL CHEM, V281, P22647, DOI 10.1074/jbc.M602366200; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873; Vasudevan G, 2001, P NATL ACAD SCI USA, V98, P6092, DOI 10.1073/pnas.101537298; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2005, MOL PHARMACOL, V67, P1291, DOI 10.1124/mol.104.005884; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; VISSER F, 2002, BIOCH CELL BIOL, V80, P701; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105	44	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19067	19076		10.1074/jbc.M109.017947	http://dx.doi.org/10.1074/jbc.M109.017947			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19429678	Green Published, hybrid			2022-12-27	WOS:000267711500055
J	Makkonen, KM; Pasonen-Seppanen, S; Torronen, K; Tammi, MI; Carlberg, C				Makkonen, Katri M.; Pasonen-Seppanen, Sanna; Torronen, Kari; Tammi, Markku I.; Carlberg, Carsten			Regulation of the Hyaluronan Synthase 2 Gene by Convergence in Cyclic AMP Response Element-binding Protein and Retinoid Acid Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; PHOSPHORYLATED CREB; SOMATOSTATIN GENE; NUCLEAR RECEPTORS; CELLS; ACTIVATION; EXPRESSION; COACTIVATORS; EPIDERMIS; PROMOTER	The human hyaluronan synthase 2 (HAS2) gene encodes for an enzyme making hyaluronan, altered concentrations of which are associated with many pathological situations including wounding, several inflammatory conditions, and malignant tumors. In this study we showed that HAS2 is a primary target of the cAMP activator forskolin and the nuclear hormone all-trans-retinoic acid ( RA). The first 2250 bp of the promoter contain three response elements (REs) for the transcription factor CREB1 as well as two REs for the nuclear receptor RAR. Chromatin immunoprecipitation and re-chromatin immunoprecipitation assays using selected fragments of the promoter containing the putative REs showed that forskolin and all-trans-RA modulate the formation of complexes between CREB1 and RAR with various co-regulators at the predicted sites. Interestingly, CREB1 complexes are regulated by all-trans-RA as are RAR complexes by forskolin. Reporter gene assays using nested promoter fragments supported these findings. Forskolin and all-trans-RA co-stimulation reduced the binding of CREB1, RAR, and the co-repressor nuclear receptor co-repressor 1 (NCoR1), but enhanced the association of co-activators MED1 and CREB-binding protein (CBP). RNA interference experiments suggested that MED1 and NCoR1 are central for the all-trans-RA induction of the HAS2 gene and CBP dominates its forskolin response. In general, our findings suggest a convergence of CREB1 and RAR signaling, and demonstrate the individual character of each RE in terms of co-regulator use.	[Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg; [Makkonen, Katri M.; Carlberg, Carsten] Univ Kuopio, Dept Biosci, FIN-70211 Kuopio, Finland; [Pasonen-Seppanen, Sanna; Torronen, Kari; Tammi, Markku I.] Univ Kuopio, Dept Biomed, FIN-70211 Kuopio, Finland	University of Luxembourg; University of Eastern Finland; University of Eastern Finland	Carlberg, C (corresponding author), Univ Luxembourg, Life Sci Res Unit, 162A,Ave Faiencerie, L-1511 Luxembourg, Luxembourg.	carsten.carlberg@uni.lu	Tammi, Markku/AAQ-7878-2021; Carlberg, Carsten/C-9075-2011	Carlberg, Carsten/0000-0003-2633-0684	Academy of Finland; Juselius Foundation; EVO Fund of Kuopio University Hospital	Academy of Finland(Academy of Finland); Juselius Foundation; EVO Fund of Kuopio University Hospital	This work was supported by grants from the Academy of Finland ( to C. C. and M. I. T.), the Juselius Foundation ( to C. C. and M. I. T.), and EVO Fund of Kuopio University Hospital ( to M. I. T.).	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Apostolou E, 2008, MOL CELL, V29, P154, DOI 10.1016/j.molcel.2008.01.008; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHAMBON P, 1993, GENE, V135, P223, DOI 10.1016/0378-1119(93)90069-F; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dunlop TW, 2004, J STEROID BIOCHEM, V89-90, P257, DOI 10.1016/j.jsbmb.2004.03.079; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Glass CK, 2000, GENE DEV, V14, P121; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Li J, 2008, ARCH ORAL BIOL, V53, P60, DOI 10.1016/j.archoralbio.2007.07.011; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Monslow J, 2004, J BIOL CHEM, V279, P20576, DOI 10.1074/jbc.M312666200; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Richards JP, 1996, J BIOL CHEM, V271, P13716, DOI 10.1074/jbc.271.23.13716; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; SCHRADER M, 1993, NUCLEIC ACIDS RES, V21, P1231, DOI 10.1093/nar/21.5.1231; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Si JT, 2002, BLOOD, V100, P4401, DOI 10.1182/blood-2001-12-0374; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang W, 2000, BIOCHEM J, V349, P91, DOI 10.1042/0264-6021:3490091	43	39	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18270	18281		10.1074/jbc.M109.012492	http://dx.doi.org/10.1074/jbc.M109.012492			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416972	Green Published, hybrid			2022-12-27	WOS:000267712400040
J	Jian, WY; Lee, SH; Williams, MV; Blair, IA				Jian, Wenying; Lee, Seon Hwa; Williams, Michelle V.; Blair, Ian A.			5-Lipoxygenase-mediated Endogenous DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; CHIRAL LIPIDOMICS ANALYSIS; ARACHIDONIC-ACID; ARTERIAL-WALL; CELL LINES; CANCER; EXPRESSION; ATHEROSCLEROSIS; PATHWAY; LIPOXYGENASE	Lipoxygenases (LOs) convert polyunsaturated fatty acids into lipid hydroperoxides. Homolytic decomposition of lipid hydroperoxides gives rise to endogenous genotoxins such as 4-oxo-2(E)-nonenal, which cause the formation of mutagenic DNA adducts. Chiral lipidomics analysis was employed to show that a 5-LO-derived lipid hydroperoxide was responsible for endogenous DNA-adduct formation. The study employed human lymphoblastoid CESS cells, which expressed both 5-LO and the required 5-LO-activating protein (FLAP). The major lipid peroxidation product was 5(S)-hydroperoxy-6,8,11,14-(E,Z,Z,Z)-eicosatetraenoic acid, which was analyzed as its reduction product, 5(S)-hydroxy-6,8,11,14-(E,Z,Z,Z)-eicosatetraenoic acid (5(S)-HETE)). Concentrations of 5(S)-HETE increased from 0.07 +/- 0.01 to 45.50 +/- 4.05 pmol/10(7) cells upon stimulation of the CESS cells with calcium ionophore A23187. There was a concomitant increase in the 4-oxo-2(E)-nonenal-derived DNA-adduct, heptanone-etheno-2'-deoxyguanosine (H epsilon dGuo) from 2.41 +/- 0.35 to 6.31 +/- 0.73 adducts/10(7) normal bases. Biosynthesis of prostaglandins, 11(R)-hydroxy-5,8,12,14-(Z,Z,E,Z)-eicosatetraenoic acid, and 15(R,S)-hydroxy-5,8,11,13-(Z,Z,Z,E)-eicosatetraenoic acid revealed that there was cyclooxygenase ( COX) activity in the CESS cells. Western blot analysis revealed that COX-1 was expressed by the cells, but there was no COX-2 or 15-LO-1. FLAP inhibitor reduced H epsilon dGuo-adducts and 5(S)-HETE to basal levels. In contrast, aspirin, which had no effect on 5(S)-HETE, blocked the formation of prostaglandins, 15-HETE, and 11-HETE but did not inhibit H epsilon dGuo-adduct formation. These data showed that 5-LO was the enzyme responsible for the generation of the H epsilon dGuo DNA-adduct in CESS cells.	[Blair, Ian A.] Univ Penn, Sch Med, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Blair, IA (corresponding author), Univ Penn, Sch Med, Ctr Canc Pharmacol, 854 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.		Blair, Ian A/B-3320-2010	Lee, Seon Hwa/0000-0003-1095-5516	National Institutes of Health [RO1CA091016, P30ES013508]; NATIONAL CANCER INSTITUTE [R01CA091016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA091016 and P30ES013508.	Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3; Blair IA, 2001, EXP GERONTOL, V36, P1473, DOI 10.1016/S0531-5565(01)00133-4; Blair IA, 2008, J BIOL CHEM, V283, P15545, DOI 10.1074/jbc.R700051200; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Chaitidis P, 1998, FEBS LETT, V434, P437, DOI 10.1016/S0014-5793(98)01024-2; Chen XX, 2006, CURR CANCER DRUG TAR, V6, P613, DOI 10.2174/156800906778742451; Cook-Moreau JM, 2007, IMMUNOLOGY, V122, P157, DOI 10.1111/j.1365-2567.2007.02621.x; ELMAKHOURHOJEIJ Y, 1994, PROSTAGLANDINS, V48, P21, DOI 10.1016/0090-6980(94)90093-0; Fairweather DeLisa, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P80, DOI 10.2174/187152908783884957; Goossens L, 2007, CURR TOP MED CHEM, V7, P283, DOI 10.2174/156802607779941369; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Hamberg M, 1998, ARCH BIOCHEM BIOPHYS, V349, P376, DOI 10.1006/abbi.1997.0443; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Hennig R, 2002, AM J PATHOL, V161, P421, DOI 10.1016/S0002-9440(10)64198-3; Hicks A, 2007, EXPERT OPIN INV DRUG, V16, P1909, DOI 10.1517/13543784.16.12.1909; Hong SH, 1999, CANCER RES, V59, P2223; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Jian WY, 2007, CHEM RES TOXICOL, V20, P1008, DOI 10.1021/tx700001t; Jian WY, 2005, FREE RADICAL BIO MED, V39, P1162, DOI 10.1016/j.freeradbiomed.2005.06.008; Jian WY, 2005, CHEM RES TOXICOL, V18, P599, DOI 10.1021/tx049693d; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1168, P73, DOI 10.1016/0005-2760(93)90268-E; Lee SH, 2007, CHEM RES TOXICOL, V20, P1665, DOI 10.1021/tx700130p; Lee SH, 2007, METHOD ENZYMOL, V433, P159, DOI 10.1016/S0076-6879(07)33009-7; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Lee SH, 2005, PROSTAG OTH LIPID M, V77, P141, DOI 10.1016/j.prostaglandins.2004.01.009; Lee SH, 2005, J BIOL CHEM, V280, P28337, DOI 10.1074/jbc.M504178200; Lee SH, 2003, RAPID COMMUN MASS SP, V17, P2168, DOI 10.1002/rcm.1170; Lee SH, 2001, TRENDS CARDIOVAS MED, V11, P148, DOI 10.1016/S1050-1738(01)00094-9; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Li N, 2005, CLIN CANCER RES, V11, P2089, DOI 10.1158/1078-0432.CCR-04-1684; Loft S, 2006, CARCINOGENESIS, V27, P1245, DOI 10.1093/carcin/bgi313; Lotzer K, 2005, BBA-MOL CELL BIOL L, V1736, P30, DOI 10.1016/j.bbalip.2005.07.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; Mehrabian M, 2003, CURR OPIN LIPIDOL, V14, P447, DOI 10.1097/00041433-200310000-00005; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Oe T, 2003, J BIOL CHEM, V278, P42098, DOI 10.1074/jbc.M308167200; Ohtsubo T, 2007, DNA REPAIR, V6, P760, DOI 10.1016/j.dnarep.2007.01.003; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Peters-Golden M, 2005, ANN ALLERG ASTHMA IM, V94, P609, DOI 10.1016/S1081-1206(10)61317-8; Peters-Golden M, 2008, CURR ALLERGY ASTHM R, V8, P367, DOI 10.1007/s11882-008-0057-z; Pollack M, 2006, CHEM RES TOXICOL, V19, P1074, DOI 10.1021/tx0600503; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Rioux N, 1998, CARCINOGENESIS, V19, P1393, DOI 10.1093/carcin/19.8.1393; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; SCHULAM PG, 1990, J IMMUNOL, V144, P2696; Serrano-Mollar Anna, 2005, Current Drug Targets - Inflammation and Allergy, V4, P151, DOI 10.2174/1568010053586354; Sharma J. N., 2006, Inflammopharmacology, V14, P10, DOI 10.1007/s10787-006-1496-6; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Steele VE, 1999, CANCER EPIDEM BIOMAR, V8, P467; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; Woodside JV, 2005, P NUTR SOC, V64, P543, DOI 10.1079/PNS2005464; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zhu PJ, 2008, RAPID COMMUN MASS SP, V22, P432, DOI 10.1002/rcm.3380	62	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16799	16807		10.1074/jbc.M109.011841	http://dx.doi.org/10.1074/jbc.M109.011841			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19390118	Green Published, hybrid			2022-12-27	WOS:000266962400016
J	Barroso-Gonzalez, J; El Jaber-Vazdekis, N; Garcia-Exposito, L; Machado, JD; Zarate, R; Ravelo, AG; Estevez-Braun, A; Valenzuela-Fernandez, A				Barroso-Gonzalez, Jonathan; El Jaber-Vazdekis, Nabil; Garcia-Exposito, Laura; Machado, Jose-David; Zarate, Rafael; Ravelo, Angel G.; Estevez-Braun, Ana; Valenzuela-Fernandez, Agustin			The Lupane-type Triterpene 30-Oxo-calenduladiol Is a CCR5 Antagonist with Anti-HIV-1 and Anti-chemotactic Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL MATURATION; C CHEMOKINE RECEPTOR-5; HIV-1 INFECTION; T-CELLS; THERAPEUTIC TARGETS; BETULINIC ACID; SMALL-MOLECULE; HIGHLY POTENT; INFLAMMATION; ENTRY	The existence of drug-resistant human immunodeficiency virus (HIV) viruses in patients receiving antiretroviral treatment urgently requires the characterization and development of new antiretroviral drugs designed to inhibit resistant viruses and to complement the existing antiretroviral strategies against AIDS. We assayed several natural or semi-synthetic lupane-type pentacyclic triterpenes in their ability to inhibit HIV-1 infection in permissive cells. We observed that the 30-oxo-calenduladiol triterpene, compound 1, specifically impaired R5-tropic HIV-1 envelope-mediated viral infection and cell fusion in permissive cells, without affecting X4-tropic virus. This lupane derivative competed for the binding of a specific anti-CCR5 monoclonal antibody or the natural CCL5 chemokine to the CCR5 viral coreceptor with high affinity. 30-Oxo-calenduladiol seems not to interact with the CD4 antigen, the main HIV receptor, or the CXCR4 viral coreceptor. Our results suggest that compound 1 is a specific CCR5 antagonist, because it binds to the CCR5 receptor without triggering cell signaling or receptor internalization, and inhibits RANTES (regulated on activation normal T cell expressed and secreted)-mediated CCR5 internalization, intracellular calcium mobilization, and cell chemotaxis. Furthermore, compound 1 appeared not to interact with beta-chemokine receptors CCR1, CCR2b, CCR3, or CCR4. Thereby, the 30-oxo-calenduladiol-associated anti-HIV-1 activity against R5-tropic virus appears to rely on the selective occupancy of the CCR5 receptor to inhibit CCR5-mediated HIV-1 infection. Therefore, it is plausible that the chemical structure of 30-oxo-calenduladiol or other related dihydroxylated lupane-type triterpenes could represent a good model to develop more potent anti-HIV-1 molecules to inhibit viral infection by interfering with early fusion and entry steps in the HIV life cycle.	[Barroso-Gonzalez, Jonathan; El Jaber-Vazdekis, Nabil; Zarate, Rafael; Ravelo, Angel G.; Estevez-Braun, Ana] Univ La Laguna, Inst Univ Bioorgan, San Cristobal la Laguna 38206, Spain; [Barroso-Gonzalez, Jonathan; Garcia-Exposito, Laura; Machado, Jose-David; Valenzuela-Fernandez, Agustin] Univ La Laguna, Fac Med, Inst Tecnol Biomed,Lab Inmunol Celular & Viral, Dept Med Fis & Farmacol,Unidad Farmacol, Tenerife 38071, Spain; [Barroso-Gonzalez, Jonathan; El Jaber-Vazdekis, Nabil; Garcia-Exposito, Laura; Zarate, Rafael; Ravelo, Angel G.; Estevez-Braun, Ana; Valenzuela-Fernandez, Agustin] Hosp Univ La Candelaria, ICIC, Tenerife 38010, Spain	Universidad de la Laguna; Universidad de la Laguna	Estevez-Braun, A (corresponding author), Univ La Laguna, Inst Univ Bioorgan, San Cristobal la Laguna 38206, Spain.	aestebra@ull.es; avalenzu@ull.es	el jaber vazdekis, nabil/J-8108-2014; Machado, José David/N-5210-2014; Valenzuela-Fernández, Agustín/B-6219-2014; Valenzuela-Fernández, Agustín/P-1638-2019; Barroso, Jonathan/T-9295-2017; Estevez-Braun, Ana/A-8122-2015	el jaber vazdekis, nabil/0000-0002-8669-4730; Machado, José David/0000-0003-3531-7051; Valenzuela-Fernández, Agustín/0000-0002-2585-8703; Valenzuela-Fernández, Agustín/0000-0002-2585-8703; Barroso, Jonathan/0000-0001-9167-6660; Estevez-Braun, Ana/0000-0001-5279-7099; Garcia Exposito, Laura/0000-0002-8172-7986	Ministerio de Ciencia e Innovacion, Spain [SAF2008-01729]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [24508/05, FIPSE-24661/07]; Consejeria de Industria; Comercio y Nuevas Tecnologias del Gobierno Autonomo de Canarias, Spain [IDT-TF-06/066]; Fundacion Mutua Madrilena, Spain; Canary Islands Cancer Research Institute (ICIC); Spanish Ministry of Education and Science (MEC) [SAF 2006-06720]; Fundacion Canaria de Investigacion y Salud (FUNCIS) [PI56/07]; CajaCanarias; Fondo Social Europeo [RYC2002-694, RYC2002-3018]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Consejeria de Industria; Comercio y Nuevas Tecnologias del Gobierno Autonomo de Canarias, Spain; Fundacion Mutua Madrilena, Spain; Canary Islands Cancer Research Institute (ICIC); Spanish Ministry of Education and Science (MEC)(Spanish Government); Fundacion Canaria de Investigacion y Salud (FUNCIS); CajaCanarias; Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported in part by Ministerio de Ciencia e Innovacion, Spain, Grant SAF2008-01729, Fundacion para la Investigacion y Prevencion del SIDA en Espana Grants Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE)-24508/05 and FIPSE-24661/07, Consejeria de Industria, Comercio y Nuevas Tecnologias del Gobierno Autonomo de Canarias, Spain, Grant IDT-TF-06/066, and the Fundacion Mutua Madrilena, Spain. This work was also supported by the Canary Islands Cancer Research Institute (ICIC), and project SAF 2006-06720 from the Spanish Ministry of Education and Science (MEC).; Supported by associated Fellowship Fundacion Canaria de Investigacion y Salud (FUNCIS)-PI56/07.; Supported by a predoctoral fellowship from CajaCanarias.; Supported Fondo Social Europeo Grant RYC2002-694.	Aiken C, 2005, TRENDS MOL MED, V11, P31, DOI 10.1016/j.molmed.2004.11.001; Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Azenshtein E, 2002, CANCER RES, V62, P1093; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Barrero-Villar M, 2008, J IMMUNOL, V181, P6882, DOI 10.4049/jimmunol.181.10.6882; Barroso-Gonzalez J, 2009, J BIOL CHEM, V284, P2419, DOI 10.1074/jbc.M805311200; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Cascieri MA, 2000, CURR OPIN CHEM BIOL, V4, P420, DOI 10.1016/S1367-5931(00)00113-7; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cichewicz RH, 2004, MED RES REV, V24, P90, DOI 10.1002/med.10053; Condra JH, 2002, ANNU REV MED, V53, P541, DOI 10.1146/annurev.med.53.082901.104110; Connolly JD, 2000, NAT PROD REP, V17, P463, DOI 10.1039/b003456h; Delgado-Mendez P, 2008, BIOORGAN MED CHEM, V16, P1425, DOI 10.1016/j.bmc.2007.10.071; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Gutierrez F, 2007, J NAT PROD, V70, P1049, DOI 10.1021/np070019g; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Horuk R, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000921; Inciardi JA, 2005, AIDS CARE, V17, pS1, DOI 10.1080/09540120500120435; Kallings LO, 2008, J INTERN MED, V263, P218, DOI 10.1111/j.1365-2796.2007.01910.x; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kuehn BM, 2006, JAMA-J AM MED ASSOC, V296, P29, DOI 10.1001/jama.296.1.29; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mesa-Siverio D, 2005, TETRAHEDRON, V61, P429, DOI 10.1016/j.tet.2004.10.074; Mesa-Siverio D, 2003, EUR J ORG CHEM, V2003, P4243, DOI 10.1002/ejoc.200300284; Neukirch H, 2005, CHEM BIODIVERS, V2, P657, DOI 10.1002/cbdv.200590042; Nunez MJ, 2005, J NAT PROD, V68, P1018, DOI 10.1021/np058016w; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Perrin D.D., 1988, PURIFICATION LAB CHE; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; Pohlmann S, 2006, CURR PHARM DESIGN, V12, P1963, DOI 10.2174/138161206777442155; Princen K, 2005, CYTOKINE GROWTH F R, V16, P659, DOI 10.1016/j.cytogfr.2005.05.009; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schroder C, 2007, J IMMUNOL, V179, P2289, DOI 10.4049/jimmunol.179.4.2289; Seto M, 2006, J MED CHEM, V49, P2037, DOI 10.1021/jm0509703; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Sozzani S, 1998, J IMMUNOL, V161, P1083; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Suzaki Y, 2008, EUR RESPIR J, V31, P783, DOI 10.1183/09031936.00111507; UNAIDS, 2008, REP GLOB AIDS EP; Valenzuela-Fernandez A, 2005, MOL BIOL CELL, V16, P5445, DOI 10.1091/mbc.e05-04-0354; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; van Deventer HW, 2008, AM J PATHOL, V173, P253, DOI 10.2353/ajpath.2008.070732; van Deventer HW, 2005, CANCER RES, V65, P3374, DOI 10.1158/0008-5472.CAN-04-2616; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wysocki CA, 2005, BLOOD, V106, P3300, DOI 10.1182/blood-2005-04-1632; Zhou YH, 1998, J IMMUNOL, V160, P4018	57	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16609	16620		10.1074/jbc.M109.005835	http://dx.doi.org/10.1074/jbc.M109.005835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386595	Green Published, hybrid			2022-12-27	WOS:000266730900057
J	Hickey, CM; Stroupe, C; Wickner, W				Hickey, Christopher M.; Stroupe, Christopher; Wickner, William			The Major Role of the Rab Ypt7p in Vacuole Fusion Is Supporting HOPS Membrane Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEX RING DOMAIN; SACCHAROMYCES-CEREVISIAE; YEAST VACUOLE; SNARE COMPLEX; REGULATORY LIPIDS; DOCKING; PROTEINS; REQUIRES; KINASE; GTPASE	Yeast vacuole fusion requires soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), the Rab GTPase Ypt7p, vacuolar lipids, Sec17p and Sec18p, and the homotypic fusion and vacuole protein sorting complex (HOPS). HOPS is a multisubunit protein with direct affinities for SNAREs, vacuolar lipids, and the GTP-bound form of Ypt7p; each of these affinities contributes to HOPS association with the organelle. Using all-purified components, we have reconstituted fusion, but the Rab Ypt7p was not required. We now report that phosphorylation of HOPS by the vacuolar kinase Yck3p blocks HOPS binding to vacuolar lipids, making HOPS membrane association and the ensuing fusion depend on the presence of Ypt7p. In accord with this finding in the reconstituted fusion reaction, the inactivation of Ypt7p by the GTPase-activating protein Gyp1-46p only blocks the fusion of purified vacuoles when Yck3p is present and active. Thus, although Ypt7p may contribute to other fusion functions, its central role is to bind HOPS to the membrane.	[Hickey, Christopher M.; Stroupe, Christopher; Wickner, William] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wickner, W (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.	Bill.Wickner@dartmouth.edu			National Institutes of Health [RO1GM23377]; National Institutes of Health Training Grants [T32GM008704, T32AR007576]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704, R01GM023377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM23377 through the NIGMS (to W. W) and by National Institutes of Health Training Grants T32GM008704 and T32AR007576 ( to C. M. H.).	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Anand VC, 2009, MOL BIOL CELL, V20, P1592, DOI 10.1091/mbc.E08-08-0819; Ballew N, 2005, MOL BIOL CELL, V16, P1839, DOI 10.1091/mbc.E04-08-0725; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Dirac-Svejstrup AB, 2000, J CELL BIOL, V150, P475, DOI 10.1083/jcb.150.3.475; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Eitzen G, 2000, EMBO J, V19, P6713, DOI 10.1093/emboj/19.24.6713; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Jones EW, 2002, METHOD ENZYMOL, V351, P127; JONES EW, 1991, METHOD ENZYMOL, V194, P428; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LYONS PD, 2009, BIOSCI REP IN PRESS; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Meiringer CTA, 2006, METHODS, V40, P171, DOI 10.1016/j.ymeth.2006.06.020; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Olesen K, 2000, YEAST, V16, P1035, DOI 10.1002/1097-0061(200008)16:11<1035::AID-YEA606>3.0.CO;2-P; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Price A, 2000, J CELL BIOL, V148, P1223, DOI 10.1083/jcb.148.6.1223; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Sun BM, 2004, MOL BIOL CELL, V15, P1397, DOI 10.1091/mbc.E03-09-0682; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	47	56	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16118	16125		10.1074/jbc.M109.000737	http://dx.doi.org/10.1074/jbc.M109.000737			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386605	hybrid, Green Published			2022-12-27	WOS:000266730900008
J	Sung, WK; Lu, YW; Lee, CWH; Zhang, DW; Ronaghi, M; Lee, CGL				Sung, Wing-Kin; Lu, Yiwei; Lee, Charlie W. H.; Zhang, Dongwei; Ronaghi, Mostafa; Lee, Caroline G. L.			Deregulated Direct Targets of the Hepatitis B Virus (HBV) Protein, HBx, Identified through Chromatin Immunoprecipitation and Expression Microarray Profiling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING-SITES; X-PROTEIN; HEPATOCELLULAR-CARCINOMA; DNA-BINDING; TRANSACTIVATOR PROTEIN; TRANSCRIPTIONAL ACTIVATOR; C-MYC; CELLS; GENE; HEPATOCARCINOGENESIS	The hepatitis B-X (HBx) protein is strongly associated with hepatocellular carcinoma. It is implicated not to directly cause cancer but to play a role in hepatocellular carcinoma as a cofactor. The oncogenic potential of HBx primarily lies in its interaction with transcriptional regulators resulting in aberrant gene expression and deregulated cellular pathways. Utilizing ultraviolet irradiation to simulate a tumor-initiating event, we integrated chip-based chromatin immunoprecipitation (ChIP-chip) with expression microarray profiling and identified 184 gene targets directly deregulated by HBx. One-hundred forty-four transcription factors interacting with HBx were computationally inferred. We experimentally validated that HBx interacts with some of the predicted transcription factors (pTF) as well as the promoters of the deregulated target genes of these pTFs. Significantly, we demonstrated that the pTF interacts with the promoters of the deregulated HBx target genes and that deregulation by HBx of these HBx target genes carrying the pTF consensus sequences can be reversed using pTF small interfering RNAs. The roles of these deregulated direct HBx target genes and their relevance in cancer was inferred via querying against biogroup/cancer-related microarray databases using web-based NextBio (TM) software. Six pathways, including the Jak-STAT pathway, were predicted to be significantly deregulated when HBx binds indirectly to direct target gene promoters. In conclusion, this study represents the first ever demonstration of the utilization of ChIP-chip to identify deregulated direct gene targets from indirect protein-DNA binding as well as transcriptional factors directly interacting with HBx. Increased knowledge of the gene/transcriptional factor targets of HBx will enhance our understanding of the role of HBx in hepatocellular carcinogenesis and facilitate the design of better strategies in combating hepatitis B virus-associated hepatocellular carcinoma.	[Lu, Yiwei; Zhang, Dongwei; Lee, Caroline G. L.] Natl Canc Ctr Singapore, Div Med Sci, Singapore 169610, Singapore; [Sung, Wing-Kin; Lee, Charlie W. H.] Natl Univ Singapore, Dept Comp Sci, Singapore 119077, Singapore; [Zhang, Dongwei; Lee, Caroline G. L.] Natl Univ Singapore, Dept Biochem, Singapore 119077, Singapore; [Sung, Wing-Kin; Lee, Charlie W. H.] Genome Inst Singapore, Singapore 138672, Singapore; [Ronaghi, Mostafa] Stanford Univ, Stanford Genome Technol Ctr, Dept Biochem, Stanford, CA 94305 USA; [Lee, Caroline G. L.] Duke NUS Grad Med Sch, Singapore 169547, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Stanford University; National University of Singapore	Lee, CGL (corresponding author), Natl Canc Ctr Singapore, Div Med Sci, Level 6,Lab 5,11 Hosp Dr, Singapore 169610, Singapore.	bchleec@nus.edu.sg	Lee, Caroline G/M-8918-2019	Lee, Caroline G/0000-0002-4323-3635; Sung, Wing-Kin/0000-0001-7806-7086	BioMedical Research Council (BMRC) of Singapore [BMRC06/1/21/19/449]; Singapore Millennium Foundation; National Cancer Centre; DUKE-NUS Graduate Medical School	BioMedical Research Council (BMRC) of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Millennium Foundation(Singapore Millennium Foundation); National Cancer Centre; DUKE-NUS Graduate Medical School(National University of Singapore)	This work was supported by BioMedical Research Council (BMRC) of Singapore Grant BMRC06/1/21/19/449 and the Singapore Millennium Foundation (to C. G. L.) through the National Cancer Center, Block Grants from the National Cancer Centre, and the DUKE-NUS Graduate Medical School.	Andrisani OM, 1999, INT J ONCOL, V15, P373; Barnabas S, 1997, J BIOL CHEM, V272, P20684, DOI 10.1074/jbc.272.33.20684; Becker SA, 1998, J VIROL, V72, P266, DOI 10.1128/JVI.72.1.266-272.1998; Brechot C, 2000, SEMIN CANCER BIOL, V10, P211, DOI 10.1006/scbi.2000.0321; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; CHEONG JH, 1995, EMBO J, V14, P143, DOI 10.1002/j.1460-2075.1995.tb06984.x; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Diao JY, 2001, CYTOKINE GROWTH F R, V12, P189, DOI 10.1016/S1359-6101(00)00034-4; Ganem D, 2001, SCIENCE, V294, P2299, DOI 10.1126/science.1067850; Groisman IJ, 1999, CARCINOGENESIS, V20, P479, DOI 10.1093/carcin/20.3.479; Kirmizis A, 2004, EXP BIOL MED, V229, P705, DOI 10.1177/153537020422900803; Lee ATC, 2007, FRONT BIOSCI-LANDMRK, V12, P234, DOI 10.2741/2061; Lee ATC, 2005, J BIOL CHEM, V280, P33525, DOI 10.1074/jbc.M506628200; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092; Lee YH, 1998, J BIOL CHEM, V273, P25510, DOI 10.1074/jbc.273.39.25510; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Madden CR, 2000, J VIROL, V74, P5266, DOI 10.1128/JVI.74.11.5266-5272.2000; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Martin-Lluesma S, 2008, HEPATOLOGY, V48, P1467, DOI 10.1002/hep.22542; Ng RK, 2004, BIOCHEM BIOPH RES CO, V322, P827, DOI 10.1016/j.bbrc.2004.07.188; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Qadri I, 1996, J BIOL CHEM, V271, P15443, DOI 10.1074/jbc.271.26.15443; QADRI I, 1995, P NATL ACAD SCI USA, V92, P1003, DOI 10.1073/pnas.92.4.1003; Qadri I, 1996, P NATL ACAD SCI USA, V93, P10578, DOI 10.1073/pnas.93.20.10578; ROSSNER MT, 1992, J MED VIROL, V36, P101, DOI 10.1002/jmv.1890360207; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; WILLIAMS JS, 1995, P NATL ACAD SCI USA, V92, P3819, DOI 10.1073/pnas.92.9.3819; Wu CG, 2002, FASEB J, V16, P1665, DOI 10.1096/fj.02-0074fje; Wu CG, 2001, ONCOGENE, V20, P3674, DOI 10.1038/sj.onc.1204481; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yeh CT, 2000, J GASTROEN HEPATOL, V15, P339, DOI 10.1046/j.1440-1746.2000.02166.x; Yu FL, 2005, J HEPATOL, V42, P520, DOI 10.1016/j.jhep.2004.11.031; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	40	37	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21941	21954		10.1074/jbc.M109.014563	http://dx.doi.org/10.1074/jbc.M109.014563			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19439406	Green Published, hybrid			2022-12-27	WOS:000268783700019
J	Norais, CA; Chitteni-Pattu, S; Wood, EA; Inman, RB; Cox, MM				Norais, Cedric A.; Chitteni-Pattu, Sindhu; Wood, Elizabeth A.; Inman, Ross B.; Cox, Michael M.			DdrB Protein, an Alternative Deinococcus radiodurans SSB Induced by Ionizing Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI-SSB; BINDING-PROTEIN; RECA PROTEIN; LIMITED PROTEOLYSIS; CRYSTAL-STRUCTURE; RADIORESISTANCE; COMPLEXES; REVEALS; DOMAIN	Deinococcus radiodurans exhibits an extraordinary resistance to the effects of exposure to ionizing radiation (IR). DdrB is one of five proteins induced to high levels in Deinococcus following extreme IR exposure and that play a demonstrable role in genome reconstitution. Although homology is limited, DdrB is a bacterial single-stranded DNA-binding protein. DdrB features a stable core with a putative OB-fold, and a C-terminal segment with properties consistent with other bacterial SSBs. In solution, the protein functions as a pentamer. The protein binds single-stranded DNA but not duplex DNA. Electron microscopy and assays with two RecA proteins provide further structural and functional identification with bacterial SSB. Overall, the results establish DdrB as the prototype of a new bacterial SSB family. Given the role of SSB as a mobilization scaffold for many processes in DNA metabolism, the induction of an alternative and quite novel SSB following irradiation has potentially broad significance for the organization of genome reconstitution functions.	[Norais, Cedric A.; Chitteni-Pattu, Sindhu; Wood, Elizabeth A.; Inman, Ross B.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@biochem.wisc.edu			National Institutes of Health [GM067085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067085.	Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; Frenkiel-Krispin D, 2006, J STRUCT BIOL, V156, P311, DOI 10.1016/j.jsb.2006.05.014; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; Gutsche I, 2008, BBA-PROTEINS PROTEOM, V1784, P1050, DOI 10.1016/j.bbapap.2008.03.009; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; HOSODA J, 1978, J BIOL CHEM, V253, P7547; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; Meima R, 2001, J BACTERIOL, V183, P3169, DOI 10.1128/JB.183.10.3169-3175.2001; Meima R, 2000, APPL ENVIRON MICROB, V66, P3856, DOI 10.1128/AEM.66.9.3856-3867.2000; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waterhouse TH, 2009, J BIOPHARM STAT, V19, P386, DOI 10.1080/10543400802677257; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zimmerman JM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-17	41	57	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21402	21411		10.1074/jbc.M109.010454	http://dx.doi.org/10.1074/jbc.M109.010454			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19515845	hybrid, Green Published			2022-12-27	WOS:000268564400035
J	Spirin, AS				Spirin, Alexander S.			The Ribosome as a Conveying Thermal Ratchet Machine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ELONGATION-FACTOR-G; POLYMER RIBONUCLEIC-ACID; TRANSFER-RNA TRANSLOCATION; FACTOR EF-TU; ANGSTROM RESOLUTION; MESSENGER-RNA; MACROMOLECULAR STRUCTURE; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS		Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia	Russian Academy of Sciences	Spirin, AS (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia.	spirin@vega.protres.ru	Spirin, Alexander/A-7307-2016					Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; Ait-Haddou R, 2003, CELL BIOCHEM BIOPHYS, V38, P191, DOI 10.1385/CBB:38:2:191; ARONSON AI, 1961, BIOPHYS J, V1, P215, DOI 10.1016/S0006-3495(61)86885-9; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baranov V I, 1979, Methods Enzymol, V59, P382; BELITSINA NV, 1975, FEBS LETT, V54, P35, DOI 10.1016/0014-5793(75)81062-3; BELITSINA NV, 1976, J MOL BIOL, V108, P609, DOI 10.1016/S0022-2836(76)80140-4; BELOZERSKII AN, 1936, BIOKHIMIYA, V1, P665; BELOZERSKY AN, 1947, COLD SPRING HARB SYM, V12, P1; BELOZERSKY AN, 1958, NATURE, V182, P111, DOI 10.1038/182111a0; BELOZERSKY AN, 1940, MICROBIOLOGY, V9, P107; BERTCHOLD H, 1993, NATURE, V365, P126; BOGDANOVA E. S., 1962, BIOKHIMIYA, V27, P387; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; BROWN RA, 1960, NATURE, V187, P509, DOI 10.1038/187509a0; CHARGAFF E, 1949, J BIOL CHEM, V177, P405; CHARGAFF E, 1950, J BIOL CHEM, V186, P51; CHETVERIN AB, 1982, BIOCHIM BIOPHYS ACTA, V683, P153, DOI 10.1016/0304-4173(82)90009-X; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; CORDOVA NJ, 1992, P NATL ACAD SCI USA, V89, P339, DOI 10.1073/pnas.89.1.339; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; CRICK F. H. C., 1959, BROOKHAVEN SYMPOSIA IN BIOLSTRUCTURE AND FUNCTION OF GENETIC ELEMENTS, V12, P35; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Feynman R., 1963, FEYNMAN LECT PHYS, V1; Finkelstein A. V., 2002, PROTEIN PHYS; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GAVRILOV.LP, 1971, FEBS LETT, V17, P324, DOI 10.1016/0014-5793(71)80177-1; GAVRILOV.LP, 1972, FEBS LETT, V22, P91, DOI 10.1016/0014-5793(72)80227-8; Gavrilova L P, 1974, Methods Enzymol, V30, P452; GAVRILOVA L P, 1971, Molekulyarnaya Biologiya (Moscow), V5, P883; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; GAVRILOVA LP, 1981, J MOL BIOL, V149, P69, DOI 10.1016/0022-2836(81)90260-6; GAVRILOVA LP, 1966, J MOL BIOL, V16, P473, DOI 10.1016/S0022-2836(66)80186-9; GAVRILOVA LP, 1974, FEBS LETT, V39, P13, DOI 10.1016/0014-5793(74)80005-0; GAVRILOVA LP, 1974, FEBS LETT, V45, P324, DOI 10.1016/0014-5793(74)80872-0; GIRSHOVICH AS, 1981, FEBS LETT, V130, P54, DOI 10.1016/0014-5793(81)80664-3; GIRSHOVICH AS, 1986, FEBS LETT, V197, P192, DOI 10.1016/0014-5793(86)80325-8; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; GONGADZE GM, 1984, DOKL AKAD NAUK SSSR+, V279, P230; GORDON J, 1967, J MOL BIOL, V23, P23, DOI 10.1016/S0022-2836(67)80064-0; GUDKOV AT, 1982, FEBS LETT, V138, P229, DOI 10.1016/0014-5793(82)80448-1; HALL BD, 1959, J MOL BIOL, V1, P111, DOI 10.1016/S0022-2836(59)80040-1; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Horan LH, 2007, P NATL ACAD SCI USA, V104, P4881, DOI 10.1073/pnas.0700762104; HOSOKAWA K, 1966, P NATL ACAD SCI USA, V55, P198, DOI 10.1073/pnas.55.1.198; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Kiesel A, 1934, H-S Z PHYSIOL CHEM, V229, P160, DOI 10.1515/bchm2.1934.229.4-6.160; KISSELEV NA, 1961, J MOL BIOL, V3, P778, DOI 10.1016/S0022-2836(61)80083-1; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Korostelev A, 2007, J MOL BIOL, V373, P1058, DOI 10.1016/j.jmb.2007.08.054; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; LERMAN MI, 1966, J MOL BIOL, V15, P268, DOI 10.1016/S0022-2836(66)80226-7; LIPMANN F, 1969, SCIENCE, V164, P1024, DOI 10.1126/science.164.3883.1024; MIDGLEY JEM, 1962, BIOCHIM BIOPHYS ACTA, V61, P513, DOI 10.1016/0926-6550(62)90102-0; MIURA KI, 1962, BIOCHIM BIOPHYS ACTA, V55, P62; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; NISHIZUKA Y, 1966, ARCH BIOCHEM BIOPHYS, V116, P344, DOI 10.1016/0003-9861(66)90040-3; NISHIZUKA Y, 1966, P NATL ACAD SCI USA, V55, P212, DOI 10.1073/pnas.55.1.212; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; PESTKA S, 1968, J BIOL CHEM, V243, P2810; PESTKA S, 1969, J BIOL CHEM, V244, P1533; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; Purich DL, 2001, TRENDS BIOCHEM SCI, V26, P417, DOI 10.1016/S0968-0004(01)01880-1; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; SERDYUK I, 1992, BIOCHIMIE, V74, P299, DOI 10.1016/0300-9084(92)90107-P; SERDYUK IN, 1986, STRUCTURE FUNCTION G, P425; SIGNER ER, 1961, COLD SPRING HARB SYM, V26, P31, DOI 10.1101/SQB.1961.026.01.008; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; SPIEGELMAN S, 1961, COLD SPRING HARB SYM, V26, P75, DOI 10.1101/SQB.1961.026.01.013; SPIRIN A S, 1957, Biokhimiia, V22, P744; SPIRIN A. S., 1968, CURR MOD BIOL, V2, P115; Spirin A S, 1978, Prog Nucleic Acid Res Mol Biol, V21, P39, DOI 10.1016/S0079-6603(08)60266-4; Spirin A. S., 1966, Current Topics in Developmental Biology, V1, P1; SPIRIN A. S., 1964, ZH OBSHCH BIOL, V25, P321; Spirin Alexander S, 2004, RNA Biol, V1, P3; SPIRIN AS, 1969, EUR J BIOCHEM, V10, P20; SPIRIN AS, 1960, J MOL BIOL, V2, P436, DOI 10.1016/S0022-2836(60)80054-X; SPIRIN AS, 1969, COLD SPRING HARB SYM, V34, P197, DOI 10.1101/SQB.1969.034.01.026; SPIRIN AS, 1987, J MOL BIOL, V194, P119, DOI 10.1016/0022-2836(87)90720-0; SPIRIN AS, 1963, BIOCHEMISTRY-MOSCOW+, V28, P920; SPIRIN AS, 1976, J MOL BIOL, V101, P553, DOI 10.1016/0022-2836(76)90244-8; SPIRIN AS, 1988, ROOTS OF MODERN BIOCHEMISTRY, P511; Spirin AS, 2002, FEBS LETT, V514, P2, DOI 10.1016/S0014-5793(02)02309-8; SPIRIN AS, 1968, DOKL AKAD NAUK SSSR+, V179, P1467; SPIRIN AS, 1985, PROG NUCLEIC ACID RE, V32, P75, DOI 10.1016/S0079-6603(08)60346-3; SPIRIN AS, 1960, DOKL AKAD NAUK SSSR+, V134, P717; SPIRIN AS, 1963, PROG NUCLEIC ACID RE, V1, P301; SPIRIN AS, 1963, COLD SPRING HARB SYM, V28, P267, DOI 10.1101/SQB.1963.028.01.042; SPIRIN AS, 1961, BIOCHEMISTRY-USSR+, V26, P511; SPIRIN AS, 1966, J MOL BIOL, V15, P282, DOI 10.1016/S0022-2836(66)80227-9; SPIRIN AS, 1965, J MOL BIOL, V14, P611, DOI 10.1016/S0022-2836(65)80213-3; SPIRIN AS, 1964, MACROMOLECULAR STRUC; SPIRIN AS, 1962, C INTRERNATIONAUX CN, V106, P75; Spirin AS, 1999, RIBOSOMES; STAEHELIN T, 1966, J MOL BIOL, V16, P245, DOI 10.1016/S0022-2836(66)80277-2; STANDART N, 1990, GENE DEV, V4, P2157, DOI 10.1101/gad.4.12a.2157; STANDART N, 1990, ENZYME, V44, P106, DOI 10.1159/000468751; TAKANAMI M, 1960, BIOCHIM BIOPHYS ACTA, V39, P152, DOI 10.1016/0006-3002(60)90133-5; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Vale R D, 1990, Adv Biophys, V26, P97, DOI 10.1016/0065-227X(90)90009-I; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vasiliev V. D., 1986, STRUCTURE FUNCTION G, P128; VASILIEV VD, 1980, FEBS LETT, V121, P101, DOI 10.1016/0014-5793(80)81275-0; VASILIEV VD, 1978, FEBS LETT, V95, P273, DOI 10.1016/0014-5793(78)81009-6; VISCHER E, 1949, J BIOL CHEM, V177, P429; VISCHER E, 1948, J BIOL CHEM, V176, P703; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1961, NATURE, V189, P920, DOI 10.1038/189920a0; Ycas M, 1969, BIOL CODE; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	128	60	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21103	21119		10.1074/jbc.X109.001552	http://dx.doi.org/10.1074/jbc.X109.001552			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19416977	Green Published, hybrid			2022-12-27	WOS:000268564400003
J	Eoff, RL; Sanchez-Ponce, R; Guengerich, FP				Eoff, Robert L.; Sanchez-Ponce, Raymundo; Guengerich, F. Peter			Conformational Changes during Nucleotide Selection by Sulfolobus solfataricus DNA Polymerase Dpo4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; Y-FAMILY; CRYSTAL-STRUCTURE; TRANSLESION SYNTHESIS; REPLICATION FIDELITY; HYDROGEN-EXCHANGE; STRUCTURAL BASIS; LESION-BYPASS; STEADY-STATE; ERROR-PRONE	The mechanism of nucleotide selection by Y-family DNA polymerases has been the subject of intense study, but significant structural contacts and/or conformational changes that relate to polymerase fidelity have been difficult to identify. Here we report on the conformational dynamics of a model Y-family polymerase Dpo4 from Sulfolobus solfataricus. Hydrogen-deuterium exchange in tandem with mass spectrometry was used to monitor changes in Dpo4 structure as a function of time and the presence or absence of specific substrates and ligands. Analysis of the data revealed previously unrecognized structural changes that accompany steps in the catalytic cycle leading up to phosphoryl transfer. For example, the solvent accessibility of the alpha B-loop-alpha C region in the finger domain decreased in the presence of all four dNTP insertion events, but the rate of deuterium exchange, an indicator of conformational flexibility, only decreased during an accurate insertion event. Of particular note is a change in the region surrounding the H-helix of the thumb domain. Upon binding DNA and Mg2+, the H-helix showed a decrease in solvent accessibility and flexibility that was relaxed only upon addition of dCTP, which forms a Watson-Crick base pair with template dG and not during mispairing events. The current study expands upon a previous report from our group that used a fluorescent probe located near the thumb domain to measure the kinetic properties of Dpo4 conformational changes. We now present a model for nucleotide selection by Dpo4 that arises from a synthesis of both structural and kinetic data.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	zhang, huidong/B-5667-2011		National Institutes of Health [R01 ES010375, F32 CA119776, P30 ES000267]; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F. P. G.), F32 CA119776 (to R. L. E.), and P30 ES000267 (to F. P. G.).	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Avkin S, 2002, MUTAT RES-FUND MOL M, V510, P81, DOI 10.1016/S0027-5107(02)00254-3; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Busenlehner LS, 2006, P NATL ACAD SCI USA, V103, P15398, DOI 10.1073/pnas.0601451103; Busenlehner LS, 2005, ARCH BIOCHEM BIOPHYS, V433, P34, DOI 10.1016/j.abb.2004.09.002; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; DeLano W.L, PYMOL MOL GRAPHICS S; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Lisal J, 2005, NAT STRUCT MOL BIOL, V12, P460, DOI 10.1038/nsmb927; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Sanchez-Ponce R, 2007, ANAL CHEM, V79, P3355, DOI 10.1021/ac0622781; Suzuki N, 2004, BIOCHEMISTRY-US, V43, P11312, DOI 10.1021/bi049273n; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Velasco-Miguel S, 2003, DNA REPAIR, V2, P91, DOI 10.1016/S1568-7864(02)00189-1; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Wong JH, 2008, J MOL BIOL, V379, P317, DOI 10.1016/j.jmb.2008.03.038; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Xing GX, 2009, MOL MICROBIOL, V71, P678, DOI 10.1111/j.1365-2958.2008.06553.x; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang HD, 2009, J BIOL CHEM, V284, P3563, DOI 10.1074/jbc.M807778200	44	22	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21090	21099		10.1074/jbc.M109.009506	http://dx.doi.org/10.1074/jbc.M109.009506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19515847	hybrid, Green Published			2022-12-27	WOS:000268316100071
J	Qi, JH; Dai, GY; Luthert, P; Chaurasia, S; Hollyfield, J; Weber, BHF; Stohr, H; Anand-Apte, B				Qi, Jian Hua; Dai, Ganying; Luthert, Philip; Chaurasia, Shyam; Hollyfield, Joe; Weber, Bernhard H. F.; Stoehr, Heidi; Anand-Apte, Bela			S156C Mutation in Tissue Inhibitor of Metalloproteinases-3 Induces Increased Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SORSBYS-FUNDUS-DYSTROPHY; UNUSUAL CLINICAL-FEATURES; PIGMENT EPITHELIAL-CELLS; CHOROIDAL NEOVASCULARIZATION; VEGF RECEPTOR-2; BRUCHS MEMBRANE; TIMP3; APOPTOSIS; DEATH; LOCALIZATION	Tissue Inhibitor of metalloproteinases-3 (TIMP-3) is a potent matrix-bound angiogenesis inhibitor. Mutations in TIMP-3 cause Sorsby Fundus Dystrophy, a dominant inherited, early onset macular degenerative disease, with choroidal neovascularization causing a loss of vision in the majority of patients. Here we report that expression of S156C TIMP-3 mutation in endothelial cells results in an abnormal localization of the protein, increased glycosylation, decreased matrix metalloproteinase inhibitory activity, and increased vascular endothelial growth factor (VEGF) binding with a consequent increase in VEGF-dependent migration and tube formation. These enhanced signaling events appear to be mediated as a consequence of a post-transcriptionally regulated increase in the expression of membrane-associated VEGFR-2 in endothelial cells of Timp-3(156/156) mutant mice as well as in human Sorsby fundus dystrophy eyes. Understanding the mechanism(s) by which mutant TIMP-3 can induce abnormal neovascularization provides important insight into the pathophysiology of a number of diseases with increased angiogenesis.	[Anand-Apte, Bela] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Opthalmol,Cole Eye Inst, Cleveland, OH 44195 USA; [Anand-Apte, Bela] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Biol, Cleveland, OH 44195 USA; [Luthert, Philip] Inst Ophthalmol, Dept Pathol, London, England; [Weber, Bernhard H. F.; Stoehr, Heidi] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University of London; University College London; University of Regensburg	Anand-Apte, B (corresponding author), Cleveland Clin, Dept Ophthalmol, Cole Eye Inst 13 161, 9500 Euclid Ave, Cleveland, OH 44195 USA.	anandab@ccf.org	Chaurasia, Shyam/AAB-4709-2019	Chaurasia, Shyam/0000-0001-8725-676X; Luthert, Philip/0000-0001-7276-6898; Weber, Bernhard H.F./0000-0002-8808-7723	National Institutes of Health [EY016490, CA106415, EY015638]; Foundation Fighting Blindness Center; Research to Prevent Blindness (RPB) Challenge; Ohio Biomedical Research and Technology Transfer Partnership Program [05-29]; RPB Lew Wasserman; Deutsche Forschungsgemeinschaft [STO 366/3-1]; NATIONAL CANCER INSTITUTE [R01CA106415] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY015638, R01EY016490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness Center; Research to Prevent Blindness (RPB) Challenge(Research to Prevent Blindness (RPB)); Ohio Biomedical Research and Technology Transfer Partnership Program; RPB Lew Wasserman; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016490, CA106415, and EY015638. This work was also supported by a Foundation Fighting Blindness Center grant, a Research to Prevent Blindness (RPB) Challenge grant, an Ohio Biomedical Research and Technology Transfer Partnership Program 05-29 and RPB Lew Wasserman award (to B.A.-A.), and Grant STO 366/3-1 from the Deutsche Forschungsgemeinschaft (to H. S.).	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584; Barbazetto IA, 2005, ARCH OPHTHALMOL-CHIC, V123, P542, DOI 10.1001/archopht.123.4.542; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; Boldicke T, 2007, J CELL MOL MED, V11, P54, DOI 10.1111/j.1582-4934.2007.00002.x; Boldicke T, 2005, J IMMUNOL METHODS, V300, P146, DOI 10.1016/j.jim.2005.03.007; Bond M, 2000, J BIOL CHEM, V275, P41358, DOI 10.1074/jbc.M007929200; Borland G, 1999, J BIOL CHEM, V274, P2810, DOI 10.1074/jbc.274.5.2810; Butler GS, 1999, J BIOL CHEM, V274, P10846, DOI 10.1074/jbc.274.16.10846; CAPON MRC, 1988, EYE, V2, P114, DOI 10.1038/eye.1988.23; Della NG, 1996, INVEST OPHTH VIS SCI, V37, P1921; Ebos JML, 2004, MOL CANCER RES, V2, P315; Fariss RN, 1998, BRIT J OPHTHALMOL, V82, P1329, DOI 10.1136/bjo.82.11.1329; Fariss RN, 1997, AM J PATHOL, V150, P323; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; FELBOR U, 1995, HUM MOL GENET, V4, P2415, DOI 10.1093/hmg/4.12.2415; Felbor U, 1997, ARCH OPHTHALMOL-CHIC, V115, P1569, DOI 10.1001/archopht.1997.01100160739011; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Fogarasi M, 2008, MATRIX BIOL, V27, P381, DOI 10.1016/j.matbio.2008.01.008; Hargreaves PG, 1998, BRIT J HAEMATOL, V101, P694, DOI 10.1046/j.1365-2141.1998.00754.x; HOLZ FG, 1994, RETINA-J RET VIT DIS, V14, P329, DOI 10.1097/00006982-199414040-00006; JACOBSON SG, 1995, NAT GENET, V11, P27, DOI 10.1038/ng0995-27; Janssen A, 2008, INVEST OPHTH VIS SCI, V49, P2812, DOI 10.1167/iovs.07-1444; KALMUS H, 1976, J MED GENET, V13, P271, DOI 10.1136/jmg.13.4.271; Kamei M, 1999, INVEST OPHTH VIS SCI, V40, P2367; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Langton KP, 1998, J BIOL CHEM, V273, P16778, DOI 10.1074/jbc.273.27.16778; Langton KP, 2000, J BIOL CHEM, V275, P27027; Langton KP, 2005, HUM MOL GENET, V14, P3579, DOI 10.1093/hmg/ddi385; Li Zheng, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010045; Lin RJ, 2006, AM J OPHTHALMOL, V142, P839, DOI 10.1016/j.ajo.2006.06.003; Majid MA, 2002, FEBS LETT, V529, P281, DOI 10.1016/S0014-5793(02)03359-8; Mannello F, 2001, APOPTOSIS, V6, P479, DOI 10.1023/A:1012493808790; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; POLKINGHORNE PJ, 1989, OPHTHALMOLOGY, V96, P1763; Prager F, 2007, ACTA OPHTHALMOL SCAN, V85, P904, DOI 10.1111/j.1600-0420.2007.00927.x; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Qi JH, 2002, J BIOL CHEM, V277, P13394, DOI 10.1074/jbc.M110870200; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Soboleva G, 2003, J CELL PHYSIOL, V197, P149, DOI 10.1002/jcp.10361; SORSBY A, 1949, BRIT J OPHTHALMOL, V33, P67, DOI 10.1136/bjo.33.2.67; Tabata Y, 1998, HUM GENET, V103, P179, DOI 10.1007/PL00008707; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647; Weber BHF, 2002, INVEST OPHTH VIS SCI, V43, P2732; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352	48	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19927	19936		10.1074/jbc.M109.013763	http://dx.doi.org/10.1074/jbc.M109.013763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19478078	Green Published, hybrid			2022-12-27	WOS:000268097400019
J	Chow, SY; Yu, CY; Guy, GR				Chow, Soah Yee; Yu, Chye Yun; Guy, Graeme R.			Sprouty2 Interacts with Protein Kinase C delta and Disrupts Phosphorylation of Protein Kinase D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR STIMULATION; PROSTATE-CANCER CELLS; PKC-DELTA; BREAST-CANCER; TYROSINE PHOSPHORYLATION; SIGNALING PATHWAYS; DROSOPHILA-SPROUTY; ESTROGEN-RECEPTOR; ACTIVATION	The Sprouty (Spry) proteins act as inhibitors of the Ras/ERK pathway downstream of receptor tyrosine kinases. In this study, we report a novel interaction between protein kinase C delta (PKC delta) and Spry2. Endogenous PKC delta and Spry2 interact in cells upon basic fibroblast growth factor stimulation, indicating a physiological relevance for the interaction. This interaction appeared to require the full-length Spry2 protein and was conformation-dependent. Conformational constraints were released upon FGFR1 activation, allowing the interaction to occur. Although this interaction did not affect the phosphorylation of PKC delta by another kinase, it reduced the phosphorylation of a PKC delta substrate, protein kinase D1 (PKD1). Spry2 was found to interact more strongly with PKC delta with increasing amounts of PKD1, which indicated that instead of competing with PKD1 for binding with PKC delta, it was more likely to form a trimeric complex with both PKC delta and PKD1. Formation of the complex was found to be dependent on an existing PKC delta-PKD1 interaction. By disrupting the interaction between PKC delta and PKD1, Spry2 was unable to associate with PKC delta to form the trimeric complex. As a consequence of this trimeric complex, the existing interaction between PKC delta and PKD1 was increased, and the transfer of phosphate groups from PKC delta to PKD1 was at least partly blocked by Spry2. The action of Spry2 on PKC delta resulted in the inhibition of both ERK phosphorylation and invasion of PC-3 cells via PKC delta signaling. By disrupting the capacity of PKC delta to phosphorylate its cognate substrates, Spry2 may serve to modulate PKC delta signaling downstream of receptor tyrosine kinases and to regulate the physiological outcome.	[Chow, Soah Yee; Guy, Graeme R.] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Yu, Chye Yun] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Guy, GR (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Proteos 138673, Singapore.	mcbgg@imcb.a-star.edu.sg			Agency of Science, Technology, and Research, Singapore	Agency of Science, Technology, and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency of Science, Technology, and Research, Singapore.	Aranda S, 2008, MOL CELL BIOL, V28, P5899, DOI 10.1128/MCB.00394-08; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Basu A, 2003, J CELL MOL MED, V7, P341, DOI 10.1111/j.1582-4934.2003.tb00237.x; Basu A, 2008, CANCER RES, V68, P5689, DOI 10.1158/0008-5472.CAN-07-6603; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bradford MD, 2002, BIOCHEM J, V366, P745, DOI 10.1042/BJ20020358; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chandramouli S, 2008, J BIOL CHEM, V283, P1679, DOI 10.1074/jbc.M705457200; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; De Servi B, 2005, ONCOGENE, V24, P4946, DOI 10.1038/sj.onc.1208676; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gliki G, 2001, BIOCHEM J, V353, P503, DOI 10.1042/0264-6021:3530503; Gomel R, 2007, MOL CANCER RES, V5, P627, DOI 10.1158/1541-7786.MCR-06-0255; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kronfeld I, 2000, J BIOL CHEM, V275, P35491, DOI 10.1074/jbc.M005991200; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Lito P, 2009, J BIOL CHEM, V284, P848, DOI 10.1074/jbc.M808045200; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Murakami M, 2002, J BIOL CHEM, V277, P20367, DOI 10.1074/jbc.M202501200; NAKAMOTO T, 1992, CANCER RES, V52, P571; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Qiu J, 2003, J NEUROSCI, V23, P9529; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robles-Flores M, 2002, J BIOL CHEM, V277, P5247, DOI 10.1074/jbc.M109333200; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schreiber KL, 2001, AM J PHYSIOL-HEART C, V281, pH2062, DOI 10.1152/ajpheart.2001.281.5.H2062; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Wert MM, 2000, BIOCHEM J, V352, P175, DOI 10.1042/0264-6021:3520175; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	57	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19623	19636		10.1074/jbc.M109.021600	http://dx.doi.org/10.1074/jbc.M109.021600			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19458088	Green Published, hybrid			2022-12-27	WOS:000267908300054
J	Ediger, B; Melman, SD; Pappas, DL; Finch, M; Applen, J; Parra, KJ				Ediger, Benjamin; Melman, Sandra D.; Pappas, Donald L., Jr.; Finch, Mark; Applen, Jeremy; Parra, Karlett J.			The Tether Connecting Cytosolic (N Terminus) and Membrane (C Terminus) Domains of Yeast V-ATPase Subunit a (Vph1) Is Required for Assembly of V-0 Subunit d	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; ELASTIC POWER TRANSMISSION; MEDIATED CROSS-LINKING; IN-VIVO DISSOCIATION; MUTATIONAL ANALYSIS; 3-DIMENSIONAL STRUCTURE; ENDOPLASMIC-RETICULUM; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE	V-ATPases are molecular motors that reversibly disassemble in vivo. Anchored in the membrane is subunit a. Subunit a has a movable N terminus that switches positions during disassembly and reassembly. Deletions were made at residues securing the N terminus of subunit a (yeast isoform Vph1) to its membrane-bound C-terminal domain in order to understand the role of this conserved region for V-ATPase function. Shrinking of the tether made cells pH-sensitive (vma phenotype) because assembly of V-0 subunit d was harmed. Subunit d did not co-immunoprecipitate with subunit a and the c-ring. Cells contained pools of V-1 and V-0(-d) that failed to form V1V0, and very low levels of V-ATPase subunits were found at the membrane. Although subunit d expression was stable and at wild-type levels, growth defects were rescued by exogenous VMA6 (subunit d). Stable V1V0 assembled after yeast cells were co-transformed with VMA6 and mutant VPH1. Tether-less V1V0 was delivered to the vacuole and active. It retained 63-71% of the wild-type activity and was responsive to glucose. Tether-less V1V0 disassembled and reassembled after brief glucose depletion and readdition. The N terminus retained binding to V-1 subunits and the C terminus to phosphofructokinase. Thus, no major structural change was generated at the N and C termini of subunit a. We concluded that early steps of V-0 assembly and trafficking were likely impaired by shorter tethers and rescued by VMA6.	[Ediger, Benjamin; Melman, Sandra D.; Pappas, Donald L., Jr.; Finch, Mark; Applen, Jeremy; Parra, Karlett J.] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA	University of New Mexico	Parra, KJ (corresponding author), Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu			National Science Foundation [MCB-0728833]; University of New Mexico School of Medicine	National Science Foundation(National Science Foundation (NSF)); University of New Mexico School of Medicine	This work was supported by National Science Foundation CAREER Award MCB-0728833 (to K. J. P.). This project was also supported, in part, by the Dedicated Health Research Funds of the University of New Mexico School of Medicine (to K. J. P.).	BAUERLE C, 1993, J BIOL CHEM, V268, P12749; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Dunn SD, 2000, J BIOENERG BIOMEMBR, V32, P347, DOI 10.1023/A:1005571818730; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kane PM, 1999, J BIOL CHEM, V274, P17275, DOI 10.1074/jbc.274.24.17275; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Karet FE, 2005, J BIOENERG BIOMEMBR, V37, P425, DOI 10.1007/s10863-005-9484-x; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P17941, DOI 10.1074/jbc.M010790200; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ouyang ZQ, 2008, J BIOENERG BIOMEMBR, V40, P569, DOI 10.1007/s10863-008-9193-3; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Owegi MA, 2006, J BIOL CHEM, V281, P30001, DOI 10.1074/jbc.M605006200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Ryan M, 2008, MOL BIOL CELL, V19, P5131, DOI 10.1091/mbc.E08-06-0629; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Sorgen PL, 1998, J BIOL CHEM, V273, P27873, DOI 10.1074/jbc.273.43.27873; Su Y, 2003, J BIOL CHEM, V278, P20013, DOI 10.1074/jbc.M210077200; Su Y, 2008, AM J PHYSIOL-RENAL, V295, pF950, DOI 10.1152/ajprenal.90258.2008; Taranta A, 2003, AM J PATHOL, V162, P57, DOI 10.1016/S0002-9440(10)63798-4; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wang Y, 2007, J BIOL CHEM, V282, P34058, DOI 10.1074/jbc.M704331200; Wilkens S, 2005, MICRON, V36, P109, DOI 10.1016/j.micron.2004.10.002; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Yao GF, 2007, BIOCHEM BIOPH RES CO, V357, P821, DOI 10.1016/j.bbrc.2007.04.082; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200	60	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19522	19532		10.1074/jbc.M109.013375	http://dx.doi.org/10.1074/jbc.M109.013375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473972	Green Published, hybrid			2022-12-27	WOS:000267908300044
J	Nojiri, M; Loyet, KM; Klenchin, VA; Kabachinski, G; Martin, TFJ				Nojiri, Mari; Loyet, Kelly M.; Klenchin, Vadim A.; Kabachinski, Gregory; Martin, Thomas F. J.			CAPS Activity in Priming Vesicle Exocytosis Requires CK2 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSE-CORE VESICLE; PROTEIN-KINASE CK2; SYNAPTOSOME-ASSOCIATED PROTEIN; DEPENDENT PHOSPHORYLATION; MEMBRANE-FUSION; INOSITOL PYROPHOSPHATES; PRESYNAPTIC PLASTICITY; SYNAPTIC VESICLES; CYTOSOLIC PROTEIN; SYNAPTOTAGMIN-I	CAPS (Ca2+-dependent activator protein for secretion) functions in priming Ca2+-dependent vesicle exocytosis, but the regulation of CAPS activity has not been characterized. Here we show that phosphorylation by protein kinase CK2 is required for CAPS activity. Dephosphorylation eliminated CAPS activity in reconstituting Ca2+-dependent vesicle exocytosis in permeable and intact PC12 cells. Ser-5, -6, and -7 and Ser-1281 were identified by mass spectrometry as the major phosphorylation sites in the 1289 residue protein. Ser-5, -6, and -7 but not Ser-1281 to Ala substitutions abolished CAPS activity. Protein kinase CK2 phosphorylated CAPS in vitro at these sites and restored the activity of dephosphorylated CAPS. CK2 is the likely in vivo CAPS protein kinase based on inhibition of phosphorylation by tetrabromo-2-benzotriazole in PC12 cells and by the identity of in vivo and in vitro phosphorylation sites. CAPS phosphorylation by CK2 was constitutive, but the elevation of Ca2+ in synaptosomes increased CAPS Ser-5 and -6 dephosphorylation, which terminates CAPS activity. These results identify a functionally important N-terminal phosphorylation site that regulates CAPS activity in priming vesicle exocytosis.	[Nojiri, Mari; Klenchin, Vadim A.; Kabachinski, Gregory; Martin, Thomas F. J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Loyet, Kelly M.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	University of Wisconsin System; University of Wisconsin Madison; Roche Holding; Genentech	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	tfmartin@wisc.edu	Loyet, Kelly/AAD-7544-2021		National Institutes of Health [DK25861, DK40428]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025861, R01DK040428, R01DK025861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK25861 and DK40428 ( to T. F. J. M.). This work was also supported by an American Heart Association fellowship ( to M. N.).	Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Arnott D, 2002, MOL CELL PROTEOMICS, V1, P148, DOI 10.1074/mcp.M100027-MCP200; Battistutta R, 2001, PROTEIN SCI, V10, P2200, DOI 10.1110/ps.19601; BENNETT MK, 1993, J NEUROSCI, V13, P1701; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Blanquet PR, 2000, PROG NEUROBIOL, V60, P211, DOI 10.1016/S0301-0082(99)00026-X; Blanquet PR, 1998, NEUROSCIENCE, V86, P739, DOI 10.1016/S0306-4522(98)00087-6; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brunk I, 2009, J BIOL CHEM, V284, P1050, DOI 10.1074/jbc.M805328200; CALVERT R, 1978, FEBS LETT, V86, P247, DOI 10.1016/0014-5793(78)80572-9; CHARRIAUTMARLANGUE C, 1991, P NATL ACAD SCI USA, V88, P10232, DOI 10.1073/pnas.88.22.10232; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; DAVLETOV B, 1993, J BIOL CHEM, V268, P6816; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; Korolchuk VI, 2005, J BIOL CHEM, V280, P40796, DOI 10.1074/jbc.M508988200; Leenders AGM, 2005, PHARMACOL THERAPEUT, V105, P69, DOI 10.1016/j.pharmthera.2004.10.012; LIAO PC, 1994, ANAL BIOCHEM, V219, P9, DOI 10.1006/abio.1994.1224; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; Lonart G, 2002, TRENDS NEUROSCI, V25, P329, DOI 10.1016/S0166-2236(02)02193-8; Loyet KM, 2005, J PROTEOME RES, V4, P400, DOI 10.1021/pr049810q; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Nagy G, 2002, J NEUROSCI, V22, P9278; NIELANDER HB, 1995, J NEUROCHEM, V65, P1712; NISHIZAKI T, 1992, J BIOL CHEM, V267, P23972; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8; Waites CL, 2001, J CELL BIOL, V152, P1159, DOI 10.1083/jcb.152.6.1159; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wassenberg JJ, 2002, ANN NY ACAD SCI, V971, P201, DOI 10.1111/j.1749-6632.2002.tb04464.x; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013	52	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18707	18714		10.1074/jbc.M109.017483	http://dx.doi.org/10.1074/jbc.M109.017483			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19460754	Green Published, hybrid			2022-12-27	WOS:000267711500020
J	Chigurupati, S; Wei, ZL; Belal, C; Vandermey, M; Kyriazis, GA; Arumugam, TV; Chan, SL				Chigurupati, Srinivasulu; Wei, Zelan; Belal, Cherine; Vandermey, Myriam; Kyriazis, George A.; Arumugam, Thiruma V.; Chan, Sic L.			The Homocysteine-inducible Endoplasmic Reticulum Stress Protein Counteracts Calcium Store Depletion and Induction of CCAAT Enhancer-binding Protein Homologous Protein in a Neurotoxin Model of Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; OXIDATIVE STRESS; PC12 CELLS; PERMEABILITY TRANSITION; SARCOPLASMIC-RETICULUM; DOPAMINERGIC-NEURONS; INDUCED APOPTOSIS; CA2+ HOMEOSTASIS; ER STRESS; HERP	The endoplasmic reticulum (ER) is a key organelle regulating intracellular Ca2+ homeostasis. Oxidants and mitochondria-derived free radicals can target ER-based Ca2+ regulatory proteins and cause uncontrolled Ca2+ release that may contribute to protracted ER stress and apoptosis. Several ER stress proteins have been suggested to counteract the deregulation of ER Ca2+ homeostasis and ER stress. Here we showed that knockdown of Herp, an ubiquitin-like domain containing ER stress protein, renders PC12 and MN9D cells vulnerable to 1-methyl-4-phenylpyridinium-induced cytotoxic cell death by a mechanism involving up-regulation of CHOP expression and ER Ca2+ depletion. Conversely, Herp overexpression confers protection by blocking 1-methyl-4-phenylpyridinium-induced CHOP upregulation, ER Ca2+ store depletion, and mitochondrial Ca2+ accumulation in a manner dependent on a functional ubiquitin-proteasomal protein degradation pathway. Deletion of the ubiquitin-like domain of Herp or treatment with a proteasomal inhibitor abolished the central function of Herp in ER Ca2+ homeostasis. Thus, elucidating the underlying molecular mechanism(s) whereby Herp counteracts Ca2+ disturbances will provide insights into the molecular cascade of cell death in dopaminergic neurons and may uncover novel therapeutic strategies to prevent and ameliorate Parkinson disease progression.	[Chigurupati, Srinivasulu; Wei, Zelan; Belal, Cherine; Vandermey, Myriam; Kyriazis, George A.; Chan, Sic L.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Arumugam, Thiruma V.] Texas Tech Univ Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX 79106 USA	State University System of Florida; University of Central Florida; Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Chan, SL (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.	schan@mail.ucf.edu	Arumugam, Thiruma Valavan/B-4898-2011; Arumugam, Thiruma/AAG-6958-2019; Arumugam, Thiruma/C-7969-2009	Kyriazis, George/0000-0001-9514-3482; Arumugam, Thiruma/0000-0002-3377-0939	American Federation on Aging Research	American Federation on Aging Research	This work was supported by funds from the American Federation on Aging Research ( to S. L. C.).	Benavides A, 2005, GLIA, V52, P261, DOI 10.1002/glia.20242; BORASO A, 1994, AM J PHYSIOL, V267, pH1010, DOI 10.1152/ajpheart.1994.267.3.H1010; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7; Chan SL, 2006, J BIOL CHEM, V281, P37391, DOI 10.1074/jbc.M605552200; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Choi WS, 2008, BIOCHEM BIOPH RES CO, V371, P127, DOI 10.1016/j.bbrc.2008.04.020; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Copanaki E, 2007, BBA-MOL CELL RES, V1773, P157, DOI 10.1016/j.bbamcr.2006.10.002; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Hajnoczky G, 2000, CELL CALCIUM, V28, P349, DOI 10.1054/ceca.2000.0169; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Holtz WA, 2006, J NEUROCHEM, V99, P54, DOI 10.1111/j.1471-4159.2006.04025.x; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Jacobson J, 2002, J CELL SCI, V115, P1175; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kahns S, 2003, J BIOL CHEM, V278, P23376, DOI 10.1074/jbc.M300495200; Kalivendi SV, 2003, BIOCHEM J, V371, P151, DOI 10.1042/BJ20021525; KASS GEN, 1988, ARCH BIOCHEM BIOPHYS, V260, P789, DOI 10.1016/0003-9861(88)90509-7; Kim J, 2008, J CELL SCI, V121, P3636, DOI 10.1242/jcs.028654; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lee CS, 2005, NEUROCHEM INT, V46, P169, DOI 10.1016/j.neuint.2004.07.007; Lee CS, 2003, NEUROCHEM INT, V43, P147, DOI 10.1016/S0197-0186(02)00214-0; Lee DH, 2006, NEUROCHEM RES, V31, P851, DOI 10.1007/s11064-006-9088-9; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lotharius J, 1999, J NEUROSCI, V19, P1284; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Packer MA, 1996, BIOCHEM PHARMACOL, V51, P267, DOI 10.1016/0006-2952(95)02165-5; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; SUZUKI YJ, 1992, AM J PHYSIOL, V262, pH114, DOI 10.1152/ajpheart.1992.262.1.H114; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wei HF, 1996, J NEUROCHEM, V67, P2390; Yamamuro A, 2006, NEUROCHEM RES, V31, P657, DOI 10.1007/s11064-006-9062-6; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200	58	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18323	18333		10.1074/jbc.M109.020891	http://dx.doi.org/10.1074/jbc.M109.020891			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19447887	hybrid, Green Published			2022-12-27	WOS:000267712400045
J	Coffin, SR; Reich, NO				Coffin, Stephanie R.; Reich, Norbert O.			Escherichia coli DNA Adenine Methyltransferase THE STRUCTURAL BASIS OF PROCESSIVE CATALYSIS AND INDIRECT READ-OUT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RESTRICTION ENDONUCLEASES; GATC-FLANKING SEQUENCES; ECORI ENDONUCLEASE; DAM METHYLTRANSFERASE; SUBSTRATE-RECOGNITION; PROTEIN INTERACTIONS; SITES; METHYLATION; SPECIFICITY; CONTACTS	We have investigated the structural basis of processive GATC methylation by the Escherichia coli DNA adenine methyltransferase, which is critical in chromosome replication and mismatch repair. We determined the contribution of the orthologically conserved phosphate interactions involving residues Arg(95), Asn(126), Asn(132), Arg(116), and Lys(139), which directly contact the DNA outside the cognate recognition site (GATC) to processive catalysis, and that of residue Arg(137), which is not conserved and contacts the DNA backbone within the GATC sequence. Alanine substitutions at the conserved positions have large impacts on processivity yet do not impact k(cat)/K-m(DNA) or DNA affinity (K-D(DNA)). However, these mutants cause large preferences for GATC sites varying in flanking sequences when considering the pre-steady state efficiency constant k(chem)/K-D(DNA). These changes occur mainly at the level of the methylation rate constant, which results in the observed decreases in processive catalysis. Thus, processivity and catalytic efficiency (k(cat)/K-m(DNA)) are uncoupled in these mutants. These results reveal that the binding energy involved in DNA recognition contributes to the assembly of the active site rather than tight binding. Furthermore, the conserved residues (Arg(95), Asn(126), Asn(132), and Arg(116)) repress the modulation of the response of the enzyme to flanking sequence effects. Processivity impacted mutants do not show substrate-induced dimerization as is observed for the wild type enzyme. This study describes the structural means by which an enzyme that does not completely enclose its substrate has evolved to achieve processive catalysis, and how interactions with DNA flanking the recognition site alter this processivity.	[Coffin, Stephanie R.; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Reich, Norbert O.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu						Alonso A, 2005, J BACTERIOL, V187, P7901, DOI 10.1128/JB.187.23.7901-7911.2005; BERGERAT A, 1989, J BIOL CHEM, V264, P4064; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; Bilcock DT, 1999, J BIOL CHEM, V274, P36379, DOI 10.1074/jbc.274.51.36379; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Coffin SR, 2008, J BIOL CHEM, V283, P20106, DOI 10.1074/jbc.M802502200; Gillette WK, 2000, J MOL BIOL, V299, P1245, DOI 10.1006/jmbi.2000.3827; Gormley NA, 2000, J BIOL CHEM, V275, P6928, DOI 10.1074/jbc.275.10.6928; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Handa V, 2005, J MOL BIOL, V348, P1103, DOI 10.1016/j.jmb.2005.02.044; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Horton JR, 2006, J MOL BIOL, V358, P559, DOI 10.1016/j.jmb.2006.02.028; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Hubscher U, 2000, TRENDS BIOCHEM SCI, V25, P143, DOI 10.1016/S0968-0004(99)01523-6; JACK WE, 1982, P NATL ACAD SCI-BIOL, V79, P4010, DOI 10.1073/pnas.79.13.4010; Jen-Jacobson Linda, 1997, Biopolymers, V44, P153, DOI 10.1002/(SICI)1097-0282(1997)44:2<153::AID-BIP4>3.0.CO;2-U; JenJacobson L, 1996, EMBO J, V15, P2870, DOI 10.1002/j.1460-2075.1996.tb00648.x; JENJACOBSON L, 1986, CELL, V45, P619, DOI 10.1016/0092-8674(86)90294-1; Jin LH, 1999, J MOL BIOL, V285, P361, DOI 10.1006/jmbi.1998.2311; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Joshi HK, 2006, J BIOL CHEM, V281, P23852, DOI 10.1074/jbc.M512339200; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; LOHMAN TM, 1980, BIOCHEMISTRY-US, V19, P3522, DOI 10.1021/bi00556a017; Mashhoon N, 2006, J BIOMOL SCREEN, V11, P497, DOI 10.1177/1087057106287933; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; Naumann TA, 2008, CHEMBIOCHEM, V9, P194, DOI 10.1002/cbic.200700561; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Pan CQ, 1996, J MOL BIOL, V264, P675, DOI 10.1006/jmbi.1996.0669; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; TAYLOR JD, 1992, BIOCHEMISTRY-US, V31, P90, DOI 10.1021/bi00116a014; Tchernaenko V, 2003, J MOL BIOL, V326, P737, DOI 10.1016/S0022-2836(02)01468-7; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; VANCLEVE MD, 1992, BIOCHEMISTRY-US, V31, P334, DOI 10.1021/bi00117a004; VONHIPPEL PH, 1994, ANN NY ACAD SCI, V726, P118; WANG MX, 1992, NATURE, V360, P606, DOI 10.1038/360606a0; Watson ME, 2004, MOL MICROBIOL, V53, P651, DOI 10.1111/j.1365-2958.2004.04140.x; Wenz C, 1996, J BIOL CHEM, V271, P5565, DOI 10.1074/jbc.271.10.5565; Wu H, 2006, ORAL MICROBIOL IMMUN, V21, P238, DOI 10.1111/j.1399-302X.2006.00284.x; WYMAN C, 1995, CURR BIOL, V5, P334, DOI 10.1016/S0960-9822(95)00065-0; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973; Zinoviev VV, 2007, BIOL CHEM, V388, P1199, DOI 10.1515/BC.2007.142; Zinoviev VV, 2004, MOL BIOL+, V38, P737, DOI 10.1023/B:MBIL.0000043943.07792.80	49	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18390	18400		10.1074/jbc.M109.005876	http://dx.doi.org/10.1074/jbc.M109.005876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419959	Green Published, hybrid			2022-12-27	WOS:000267712400051
J	Huang, TH; Wu, FT; Loeb, GB; Hsu, R; Heidersbach, A; Brincat, A; Horiuchi, D; Lebbink, RJ; Mo, YY; Goga, A; McManus, MT				Huang, Tzu-Hsuan; Wu, Fangting; Loeb, Gabriel B.; Hsu, Ruby; Heidersbach, Amy; Brincat, Allison; Horiuchi, Dai; Lebbink, Robert J.; Mo, Yin-Yuan; Goga, Andrei; McManus, Michael T.			Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TUMOR-SUPPRESSOR GENE; BREAST-CANCER; TRANSCRIPTION FACTOR; MICRORNA-21 TARGETS; PROSTATE-CANCER; EXPRESSION; ACTIVATION; OVEREXPRESSION; METASTASIS	The cell surface receptor tyrosine kinase HER2/neu enhances tumor metastasis. Recent studies suggest that deregulated microRNA (miRNA) expression promotes invasion and metastasis of cancer cells; we therefore explored the possibility that HER2/neu signaling induces the expression of specific miRNAs involved in this process. We identified a putative oncogenic miRNA, miR-21, whose expression is correlated with HER2/neu up-regulation and is functionally involved in HER2/neu-induced cell invasion. We show that miR-21 is up-regulated via the MAPK (ERK1/2) pathway upon stimulation of HER2/neu signaling in breast cancer cells, and overexpression of other ERK1/2 activators such as RASV12 or ID-1 is sufficient to induce miR-21 up-regulation in HER2/neu-negative breast cancer cells. Furthermore, the metastasis suppressor protein PDCD4(programmed cell death 4) is down-regulated by miR-21 in breast cancer cells expressing HER2/neu. Our data reveal a mechanism for HER2/neu-induced cancer cell invasion via miRNA deregulation. In addition, our results identify miR-21 as a potential therapeutic target for the prevention of breast cancer invasion and metastasis.	[Huang, Tzu-Hsuan; Loeb, Gabriel B.; Hsu, Ruby; Heidersbach, Amy; Brincat, Allison; Lebbink, Robert J.; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Horiuchi, Dai; Goga, Andrei] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Wu, Fangting; Mo, Yin-Yuan] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Southern Illinois University System; Southern Illinois University	McManus, MT (corresponding author), 513 Parnassus Ave,Box 0534,HSW Rm 1053A, San Francisco, CA 94143 USA.	michael.mcmanus@ucsf.edu	Mo, Yin-Yuan/B-6141-2011; Lebbink, Robert Jan/GNH-5209-2022; Mo, Yin-Yuan/R-8255-2019; mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Lebbink, Robert Jan/0000-0002-1981-0420	National Institutes of Health [P50-CA58207, K08-CA104032]; Susan G. Komen Foundation; Sandler Program in Biological Sciences; Sandler Family Foundation; NATIONAL CANCER INSTITUTE [P50CA058207, K08CA104032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Sandler Program in Biological Sciences; Sandler Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50-CA58207 and K08-CA104032. This work was also supported by funds from the Susan G. Komen Foundation and the Sandler Program in Biological Sciences (to A. G.). We thank the Sandler Family Foundation for the Sandler postdoctoral research fellowship award (to T. H. H.) for supporting this research.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chavez-Blanco A, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-59; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Desprez PY, 1998, MOL CELL BIOL, V18, P4577, DOI 10.1128/MCB.18.8.4577; Egeblad M, 2000, INT J CANCER, V86, P617, DOI 10.1002/(SICI)1097-0215(20000601)86:5<617::AID-IJC3>3.3.CO;2-Q; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hellawell GO, 2002, CANCER RES, V62, P2942; Huang TH, 2006, J PHARMACOL EXP THER, V316, P983, DOI 10.1124/jpet.105.095513; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Ling MT, 2002, ONCOGENE, V21, P8498, DOI 10.1038/sj.onc.1206007; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Nieves-Alicea R, 2009, BREAST CANCER RES TR, V114, P203, DOI 10.1007/s10549-008-9993-5; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Smalley KSM, 2003, INT J CANCER, V104, P527, DOI 10.1002/ijc.10978; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan M, 1997, CANCER RES, V57, P1199; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wu FT, 2007, MOL CANCER THER, V6, P1823, DOI 10.1158/1535-7163.MCT-06-0771; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	48	157	175	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18515	18524		10.1074/jbc.M109.006676	http://dx.doi.org/10.1074/jbc.M109.006676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419954	Green Published, hybrid			2022-12-27	WOS:000267712400062
J	Masoudi, R; Ioannou, MS; Coughlin, MD; Pagadala, P; Neet, KE; Clewes, O; Allen, SJ; Dawbarn, D; Fahnestock, M				Masoudi, Raheleh; Ioannou, Maria S.; Coughlin, Michael D.; Pagadala, Promila; Neet, Kenneth E.; Clewes, Oliver; Allen, Shelley J.; Dawbarn, David; Fahnestock, Margaret			Biological Activity of Nerve Growth Factor Precursor Is Dependent upon Relative Levels of Its Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; PROTEIN EXPRESSION; NEUROTROPHIN RECEPTOR; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; P75-MEDIATED DEATH; ESCHERICHIA-COLI; SENSORY NEURONS; FACTOR COMPLEX; CELL-SURVIVAL	Nerve growth factor (NGF) is produced as a precursor called pro-nerve growth factor (proNGF), which is secreted by many tissues and is the predominant form of NGF in the central nervous system. In Alzheimer disease brain, cholinergic neurons degenerate and can no longer transport NGF as efficiently, leading to an increase in untransported NGF in the target tissue. The protein that accumulates in the target tissue is proNGF, not the mature form. The role of this precursor is controversial, and both neurotrophic and apoptotic activities have been reported for recombinant proNGFs. Differences in the protein structures, protein expression systems, methods used for protein purification, and methods used for bioassay may affect the activity of these proteins. Here, we show that proNGF is neurotrophic regardless of mutations or tags, and no matter how it is purified or in which system it is expressed. However, although proNGF is neurotrophic under our assay conditions for primary sympathetic neurons and for pheochromocytoma (PC12) cells, it is apoptotic for unprimed PC12 cells when they are deprived of serum. The ratio of tropomyosin-related kinase A to p75 neurotrophin receptor is low in unprimed PC12 cells compared with primed PC12 cells and sympathetic neurons, altering the balance of proNGF-induced signaling to favor apoptosis. We conclude that the relative level of proNGF receptors determines whether this precursor exhibits neurotrophic or apoptotic activity.	[Masoudi, Raheleh; Fahnestock, Margaret] McMaster Univ, Dept Biol, Hamilton, ON L8N 3Z5, Canada; [Ioannou, Maria S.; Fahnestock, Margaret] McMaster Univ, Grad Program Neurosci, Hamilton, ON L8N 3Z5, Canada; [Coughlin, Michael D.; Fahnestock, Margaret] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada; [Pagadala, Promila; Neet, Kenneth E.] Rosalind Franklin Univ Med & Sci, N Chicago, IL 60064 USA; [Clewes, Oliver; Allen, Shelley J.; Dawbarn, David] Univ Bristol, Bristol BS1 3NY, Avon, England	McMaster University; McMaster University; McMaster University; Rosalind Franklin University Medical & Science; University of Bristol	Fahnestock, M (corresponding author), 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	fahnest@mcmaster.ca	Pagadala, Promila/AAA-3367-2020; Fahnestock, Margaret/I-3578-2017	Fahnestock, Margaret/0000-0002-6815-0529; Allen, Shelley/0000-0001-7870-740X	Canadian Institutes of Health Research [MOP-64382]; Ministry of Science of Iran; Natural Sciences and Engineering Research Council of Canada; United States Public Health Services [NS24380]; National Institutes of Health; Bristol Research into Alzheimer's and Care of the Elderly; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024380] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-PG2002-3] Funding Source: researchfish; Alzheimer&quot;s Society [106] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Science of Iran; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); United States Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol Research into Alzheimer's and Care of the Elderly; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Alzheimer&quot;s Society	This work was supported in part by Canadian Institutes of Health Research Grant MOP-64382 (to M. F.), a scholarship from the Ministry of Science of Iran (to R. M.), a scholarship from the Natural Sciences and Engineering Research Council of Canada (to M. S. I.), United States Public Health Services Grant NS24380 (to K. E. N.) from the National Institutes of Health, and the Bristol Research into Alzheimer's and Care of the Elderly.	Al-Samarrai TH, 2007, PROTEIN EXPRES PURIF, V53, P289, DOI 10.1016/j.pep.2007.01.008; Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Althaus HH, 2006, J NEUROCHEM, V98, P506, DOI 10.1111/j.1471-4159.2006.03891.x; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bierl MA, 2005, NEUROSCI LETT, V380, P133, DOI 10.1016/j.neulet.2005.01.029; Bierl MA, 2007, NEUROBIOL AGING, V28, P122, DOI 10.1016/j.neurobiolaging.2005.11.008; Boutilier J, 2008, J BIOL CHEM, V283, P12709, DOI 10.1074/jbc.M710018200; Brann AB, 2002, J BIOL CHEM, V277, P9812, DOI 10.1074/jbc.M109862200; Buttigieg H, 2007, EXP NEUROL, V204, P832, DOI 10.1016/j.expneurol.2006.12.011; Chen Y, 1997, MOL CELL ENDOCRINOL, V127, P129, DOI 10.1016/S0303-7207(96)04001-4; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; DARLING TLJ, 1983, COLD SPRING HARB SYM, V48, P427, DOI 10.1101/SQB.1983.048.01.047; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Delsite R, 1999, PROSTATE, V41, P39, DOI 10.1002/(SICI)1097-0045(19990915)41:1<39::AID-PROS6>3.0.CO;2-E; EDWARDS RH, 1988, J BIOL CHEM, V263, P6810; Fahnestock M, 2004, PROG BRAIN RES, V146, P101, DOI 10.1016/S0079-6123(03)46007-X; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hayashi K, 2007, EUR J ORAL SCI, V115, P344, DOI 10.1111/j.1600-0722.2007.00480.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hunt I, 2005, PROTEIN EXPRES PURIF, V40, P1, DOI 10.1016/j.pep.2004.10.018; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Ledent P, 1997, FEBS LETT, V413, P194, DOI 10.1016/S0014-5793(97)00908-3; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; Peng SY, 2004, J NEUROPATH EXP NEUR, V63, P641, DOI 10.1093/jnen/63.6.641; PETRIDES PE, 1986, J NEUROCHEM, V46, P721, DOI 10.1111/j.1471-4159.1986.tb13031.x; RAMAGE P, 2002, LIFE SCI NEWS, V11, P1; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yardley G, 2000, EXP DERMATOL, V9, P283, DOI 10.1034/j.1600-0625.2000.009004283.x; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zhukovsky EA, 2004, NATURE, V427, P413, DOI 10.1038/427413a	52	106	109	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18424	18433		10.1074/jbc.M109.007104	http://dx.doi.org/10.1074/jbc.M109.007104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19389705	hybrid, Green Published			2022-12-27	WOS:000267712400054
J	Lee, DS; Park, JT; Kim, HM; Ko, JS; Son, HH; Gronostajski, RM; Cho, MI; Choung, PH; Park, JC				Lee, Dong-Seol; Park, Jong-Tae; Kim, Hyun-Man; Ko, Jea Seung; Son, Ho-Hyun; Gronostajski, Richard M.; Cho, Moon-Il; Choung, Pill-Hoon; Park, Joo-Cheol			Nuclear Factor I-C Is Essential for Odontogenic Cell Proliferation and Odontoblast Differentiation during Tooth Root Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; DENTIN MATRIX PROTEINS; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; SMAD PROTEINS; GENE PROMOTER; APOPTOSIS; TRANSCRIPTION; EXPRESSION; MICE	Our previous studies have demonstrated that nuclear factor I-C (NFI-C) null mice developed short molar roots that contain aberrant odontoblasts and abnormal dentin formation. Based on these findings, we performed studies to elucidate the function of NFI-C in odontoblasts. Initial studies demonstrated that aberrant odontoblasts become dissociated and trapped in an osteodentin- like mineralized tissue. Abnormal odontoblasts exhibit strong bone sialoprotein expression but a decreased level of dentin sialophosphoprotein expression when compared with wild type odontoblasts. Loss of Nfic results in an increase in p-Smad2/3 expression in aberrant odontoblasts and pulp cells in the subodontoblastic layer in vivo and primary pulp cells from Nfic-deficient mice in vitro. Cell proliferation analysis of both cervical loop and ectomesenchymal cells of the Nfic-deficient mice revealed significantly decreased proliferative activity compared with wild type mice. In addition, Nfic-deficient primary pulp cells showed increased expression of p21 and p16 but decreased expression of cyclin D1 and cyclin B1, strongly suggesting cell growth arrest caused by a lack of Nfic activity. Analysis of the pulp and abnormal dentin in Nfic-deficient mice revealed an increase in apoptotic activity. Further, Nfic-deficient primary pulp cells exhibited an increase in caspase-8 and -3 activation, whereas the cleaved form of Bid was hardly detected. These results indicate that the loss of Nfic leads to the suppression of odontogenic cell proliferation and differentiation and induces apoptosis of aberrant odontoblasts during root formation, thereby contributing to the formation of short roots.	[Lee, Dong-Seol; Park, Jong-Tae; Kim, Hyun-Man; Ko, Jea Seung; Park, Joo-Cheol] Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, Dent Res Inst, Seoul 110749, South Korea; [Choung, Pill-Hoon] Seoul Natl Univ, Sch Dent, Tooth Bioengn Natl Res Lab, Seoul 110749, South Korea; [Gronostajski, Richard M.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14214 USA; [Gronostajski, Richard M.] SUNY Buffalo, Sch Med & Biomed Sci, Program Neurosci, Buffalo, NY 14214 USA; [Cho, Moon-Il] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA	Seoul National University (SNU); Seoul National University (SNU); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Park, JC (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, Dent Res Inst, 28 Yeonkun Dong, Seoul 110749, South Korea.	jcapark@snu.ac.kr	Self, Casey J/B-6871-2011; Park, Joo Cheol/D-6437-2012; Lee, Dong-Seol/GLN-3829-2022	Park, Joo Cheol/0000-0002-3162-7557; Gronostajski, Richard/0000-0003-4264-208X	Korea Science and Engineering Foundation [M1060000283-06J0000-28310]; Ministry of Science and Technology, Korea Science and Engineering Foundation [M1064601000206N4601-00210]; Korean government (MOST); Korea Research Foundation [KRF-2008-314-E00214]; Korean Government (MOEHRD, Basic Research Promotion Fund)	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Science and Technology, Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD, Basic Research Promotion Fund)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported in part by Grant M1060000283-06J0000-28310 from the Korea Science and Engineering Foundation through the National Research Laboratory Program funded by the Ministry of Science and Technology, Korea Science and Engineering Foundation Grant M1064601000206N4601-00210 funded by the Korean government (MOST), and Korea Research Foundation Grant KRF-2008-314-E00214 funded by the Korean Government (MOEHRD, Basic Research Promotion Fund).	Bronckers ALJJ, 2000, HISTOCHEM CELL BIOL, V113, P293, DOI 10.1007/s004180000137; Butler WT, 1998, EUR J ORAL SCI, V106, P204, DOI 10.1111/j.1600-0722.1998.tb02177.x; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Couble ML, 2000, CALCIFIED TISSUE INT, V66, P129, DOI 10.1007/PL00005833; Cox LS, 1997, J PATHOL, V183, P134, DOI 10.1002/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Gong JG, 2003, CANCER RES, V63, P3340; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Hanks CT, 1998, CONNECT TISSUE RES, V37, P233, DOI 10.3109/03008209809002442; Harada H, 2002, DEVELOPMENT, V129, P1533; He WX, 2005, ARCH ORAL BIOL, V50, P929, DOI 10.1016/j.archoralbio.2005.03.004; He WX, 2004, ARCH ORAL BIOL, V49, P911, DOI 10.1016/j.archoralbio.2004.05.005; Hwang YC, 2008, J MOL HISTOL, V39, P153, DOI 10.1007/s10735-007-9148-8; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; Kaneko H, 1999, CELL TISSUE RES, V298, P95, DOI 10.1007/s004419900061; Lee KY, 2002, J BIOCHEM MOL BIOL, V35, P47; Luan XH, 2006, DEV DYNAM, V235, P1167, DOI 10.1002/dvdy.20674; Matalova E, 2004, J DENT RES, V83, P11, DOI 10.1177/154405910408300103; Miyazaki T, 2008, ARCH HISTOL CYTOL, V71, P131, DOI 10.1679/aohc.71.131; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; NAGATA K, 1982, P NATL ACAD SCI-BIOL, V79, P6438, DOI 10.1073/pnas.79.21.6438; Ogata Y, 1997, J CELL BIOCHEM, V65, P501, DOI 10.1002/(SICI)1097-4644(19970615)65:4<501::AID-JCB6>3.0.CO;2-S; Ouellet S, 2006, NUCLEIC ACIDS RES, V34, P6472, DOI 10.1093/nar/gkl861; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Park JC, 2007, J PERIODONTOL, V78, P1795, DOI 10.1902/jop.2007.060363; Philchenkov AA, 2003, BIOCHEMISTRY-MOSCOW+, V68, P365, DOI 10.1023/A:1023635510363; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Schultz DR, 2003, SEMIN ARTHRITIS RHEU, V32, P345, DOI 10.1053/sarh.2003.50005; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Sharpe P T, 2001, Adv Dent Res, V15, P4; Shigemura N, 2001, HISTOCHEM J, V33, P253, DOI 10.1023/A:1017900305661; Shigemura N, 1999, HISTOCHEM J, V31, P367, DOI 10.1023/A:1003796023992; Shu TZ, 2003, J NEUROSCI, V23, P203; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Smith AJ, 1998, EUR J ORAL SCI, V106, P179, DOI 10.1111/j.1600-0722.1998.tb02173.x; SMITH AJ, 1990, J BIOL BUCCALE, V18, P123; Smith AJ, 2001, CRIT REV ORAL BIOL M, V12, P425, DOI 10.1177/10454411010120050501; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Stefancsik R, 2003, DNA SEQUENCE, V14, P233, DOI 10.1080/1085566031000141126; Sun ZL, 1998, CONNECT TISSUE RES, V37, P251, DOI 10.3109/03008209809002443; TENCATE AR, 1986, J DENT RES, V65, P1087, DOI 10.1177/00220345860650080901; Thyagarajan T, 2001, J BIOL CHEM, V276, P11016, DOI 10.1074/jbc.M010502200; Tomlinson DC, 2004, ENDOCRINOLOGY, V145, P1988, DOI 10.1210/en.2003-0842; Unterbrink A, 2002, CONNECT TISSUE RES, V43, P354, DOI 10.1080/03008200290000565; Vermelin L, 1996, EUR J ORAL SCI, V104, P547, DOI 10.1111/j.1600-0722.1996.tb00140.x; Yokohama-Tamaki T, 2006, DEVELOPMENT, V133, P1359, DOI 10.1242/dev.02307; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0; zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x	53	81	82	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17293	17303		10.1074/jbc.M109.009084	http://dx.doi.org/10.1074/jbc.M109.009084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386589	hybrid, Green Published			2022-12-27	WOS:000266962400065
J	Martinez-Nunez, RT; Louafi, F; Friedmann, PS; Sanchez-Elsner, T				Martinez-Nunez, Rocio T.; Louafi, Fethi; Friedmann, Peter S.; Sanchez-Elsner, Tilman			MicroRNA-155 Modulates the Pathogen Binding Ability of Dendritic Cells (DCs) by Down-regulation of DC-specific Intercellular Adhesion Molecule-3 Grabbing Non-integrin (DC-SIGN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; T-CELLS; (ICAM-3)-GRABBING NONINTEGRIN; TRANS-INFECTION; RECEPTOR; PU.1; TRANSCRIPTION; MACROPHAGE; EXPRESSION; ANTIGEN	MicroRNA-155 (miR-155) has been involved in the response to inflammation in macrophages and lymphocytes. Here we show how miR-155 participates in the maturation of human dendritic cells (DC) and modulates pathogen binding by down-regulating DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN), after directly targeting the transcription factor PU.1. During the maturation of DCs, miR-155 increases up to 130-fold, whereas PU.1 protein levels decrease accordingly. We establish that human PU.1 is a direct target for miR-155 and localize the target sequence for miR-155 in the 3'-untranslated region of PU.1. Also, overexpression of miR-155 in the THP1 monocytic cell line decreases PU.1 protein levels and DC-SIGN at both the mRNA and protein levels. We prove a link between the down-regulation of PU.1 and reduced transcriptional activity of the DC-SIGN promoter, which is likely to be the basis for its reduced mRNA expression, after miR-155 overexpression. Finally, we show that, by reducing DC-SIGN in the cellular membrane, miR-155 is involved in regulating pathogen binding as dendritic cells exhibited the lower binding capacity for fungi and HIV protein gp-120 when the levels of miR-155 were higher. Thus, our results suggest a mechanism by which miR-155 regulates proteins involved in the cellular immune response against pathogens that could have clinical implications in the way pathogens enter the human organism.	[Martinez-Nunez, Rocio T.; Louafi, Fethi; Friedmann, Peter S.; Sanchez-Elsner, Tilman] Univ Southampton, Sch Med, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton	Sanchez-Elsner, T (corresponding author), Gen Hosp MP 813, Tremona Rd, Southampton SO16 6YD, Hants, England.	T.Sanchez-Elsner@soton.ac.uk		Sanchez-Elsner, Tilman/0000-0003-1915-2410; Martinez-Nunez, Rocio Teresa/0000-0003-2507-4738	Wessex [M14]	Wessex	This work was supported by Wessex Medical Research Grant M14.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bulliard Y, 2006, J BIOL CHEM, V281, P35742, DOI 10.1074/jbc.M602843200; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Deiva K, 2006, AIDS RES HUM RETROV, V22, P1152, DOI 10.1089/aid.2006.22.1152; Dominguez-Soto A, 2005, J BIOL CHEM, V280, P33123, DOI 10.1074/jbc.M503401200; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Serrano-Gomez D, 2008, J BIOL CHEM, V283, P3889, DOI 10.1074/jbc.M706004200; Spear GT, 2003, IMMUNOLOGY, V110, P80, DOI 10.1046/j.1365-2567.2003.01707.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wallet MA, 2005, CLIN MED RES, V3, P166, DOI 10.3121/cmr.3.3.166; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018	45	175	197	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16334	16342		10.1074/jbc.M109.011601	http://dx.doi.org/10.1074/jbc.M109.011601			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386588	Green Published, hybrid			2022-12-27	WOS:000266730900031
J	Dong, MQ; Cox, RF; Miller, LJ				Dong, Maoqing; Cox, Richard F.; Miller, Laurence J.			Juxtamembranous Region of the Amino Terminus of the Family B G Protein-coupled Calcitonin Receptor Plays a Critical Role in Small-molecule Agonist Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; SECRETIN RECEPTOR; PEPTIDE-1 RECEPTOR; BINDING; DETERMINANTS; ANTAGONIST; ACTIVATION; AFFINITY; DOMAINS; LIGAND	The Family B G protein-coupled calcitonin receptor is an important drug target. The aim of this work was to elucidate the molecular mechanism of action of small-molecule agonist ligands acting at this receptor, comparing it with the action mechanism of the receptor's natural peptide ligand. cAMP responses to four non-peptidyl ligands and calcitonin were studied in COS-1 cells expressing wild-type and chimeric calcitonin-secretin receptors. All compounds were full agonists at the calcitonin receptor with no activity at the secretin receptor. Only chimeric constructs including the calcitonin receptor amino terminus exhibited responses to any of these ligands. We progressively truncated this domain and tested constructs for cAMP responses. Although calcitonin was able to activate the calcitonin receptor fully with the first 58 residues absent, its potency was 3 orders of magnitude lower than that at the wildtype receptor. After truncation of 114 residues, there was no response to calcitonin. In contrast, small-molecule ligands were fully active at receptors having up to 149 amino-terminal residues absent. Those compounds finally became inactive after truncation of 153 residues. Deletion and/or alanine replacement of the region of the calcitonin receptor between residues 150 and 153 resulted in marked reduction in cAMP responses to these compounds, with some compound-specific differences observed, supporting a critical role for this region. Binding studies further supported distinct sites of action of small molecules relative to that of calcitonin. These findings focus attention on the potential importance of the juxtamembranous region of the amino terminus of the Family B calcitonin receptor for agonist drug action.	[Dong, Maoqing; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Cox, Richard F.] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA	Mayo Clinic; Mayo Clinic Phoenix; GlaxoSmithKline	Dong, MQ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	dongmq@mayo.edu; miller@mayo.edu			National Institutes of Health [DK46577]; GlaxoSmithKline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577 (to L. J. M.). This work was also supported by a grant from GlaxoSmithKline (to L. J. M.).	Boros EE, 2005, J ORG CHEM, V70, P5331, DOI 10.1021/jo050370b; Brain Susan D., 2002, Trends in Pharmacological Sciences, V23, P51, DOI 10.1016/S0165-6147(02)01945-4; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Doods H, 2000, BRIT J PHARMACOL, V129, P420, DOI 10.1038/sj.bjp.0703110; FUNAHASHI Y, 1996, CHEM ABSTR 6553, V126; Ganguli SC, 1998, J PHARMACOL EXP THER, V286, P593; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Hoare SRJ, 2006, BIOCHEM PHARMACOL, V72, P244, DOI 10.1016/j.bcp.2006.04.007; Holtmann MH, 1996, J PHARMACOL EXP THER, V279, P555; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; Katayama T, 2001, BBA-GEN SUBJECTS, V1526, P183, DOI 10.1016/S0304-4165(01)00125-8; Kehne J, 2002, CNS NEUROL DISORD-DR, V1, P467, DOI 10.2174/1568007023339049; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Madsen P, 1999, CURR PHARM DESIGN, V5, P683; Mallee JJ, 2002, J BIOL CHEM, V277, P14294, DOI 10.1074/jbc.M109661200; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Purdue BW, 2002, RECEPTOR CHANNEL, V8, P243, DOI 10.1080/10606820213681; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Sexton PM, 1999, CURR MED CHEM, V6, P1067; Stroop SD, 1996, ENDOCRINOLOGY, V137, P4752, DOI 10.1210/en.137.11.4752; STROOP SD, 1995, BIOCHEMISTRY-US, V34, P1050, DOI 10.1021/bi00003a040; SU MH, 1998, CHEM ABSTR 239489, V128; Tibaduiza EC, 2001, J BIOL CHEM, V276, P37787; VILARDAGA JP, 1995, BIOCHEM BIOPH RES CO, V211, P885, DOI 10.1006/bbrc.1995.1895	34	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21839	21847		10.1074/jbc.M109.011924	http://dx.doi.org/10.1074/jbc.M109.011924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19447889	Green Published, hybrid			2022-12-27	WOS:000268783700007
J	Pop, C; Salvesen, GS				Pop, Cristina; Salvesen, Guy S.			Human Caspases: Activation, Specificity, and Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEOLYTIC CLEAVAGE SITES; NF-KAPPA-B; CELL-DEATH; SUBSTRATE-SPECIFICITY; INFLAMMATORY CASPASES; APOPTOSIS; IDENTIFICATION; MECHANISMS; INHIBITORS; PATHWAYS	Caspases are intracellular proteases that propagate programmed cell death, proliferation, and inflammation. Activation of caspases occurs by a conserved mechanism subject to strict cellular regulation. Once activated by a specific stimulus, caspases execute limited proteolysis of downstream substrates to trigger a cascade of events that culminates in the desired biological response. Much has been learned of the mechanisms that govern the activation and regulation of caspases, and this minireview provides an update of these areas. We also delineate substantial gaps in knowledge of caspase function, which can be approached by techniques and experimental paradigms that are currently undergoing development.	[Pop, Cristina; Salvesen, Guy S.] Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Salvesen, GS (corresponding author), Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA.	gsalvesen@burnham.org			NCI NIH HHS [CA069381, P01 CA069381] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; ALNEMRI ES, 1996, CELL, V87, pP171; Berger AB, 2006, CELL RES, V16, P961, DOI 10.1038/sj.cr.7310112; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Bredesen DE, 2008, CURR MOL MED, V8, P173, DOI 10.2174/156652408784221315; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; Denault JB, 2006, MOL CELL, V23, P523, DOI 10.1016/j.molcel.2006.06.020; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Eckhart L, 2008, MOL BIOL EVOL, V25, P831, DOI 10.1093/molbev/msn012; Enoksson M, 2007, J PROTEOME RES, V6, P2850, DOI 10.1021/pr0701052; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Frisch SM, 2008, CANCER RES, V68, P4491, DOI 10.1158/0008-5472.CAN-08-0952; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Geng X, 2008, NAT STRUCT MOL BIOL, V15, P1094, DOI 10.1038/nsmb.1488; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kersse K, 2007, BIOCHEM SOC T, V35, P1508, DOI 10.1042/BST0351508; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Mikolajczyk J, 2004, BIOCHEMISTRY-US, V43, P10560, DOI 10.1021/bi0498048; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Snipas SJ, 2008, CELL DEATH DIFFER, V15, P938, DOI 10.1038/cdd.2008.23; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stennicke HR, 2002, TRENDS BIOCHEM SCI, V27, P94, DOI 10.1016/S0968-0004(01)02045-X; Tawa P, 2004, CELL DEATH DIFFER, V11, P439, DOI 10.1038/sj.cdd.4401360; Taylor RC, 2007, J BIOL CHEM, V282, P15011, DOI 10.1074/jbc.M611051200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zmasek CM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r226	50	511	539	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21777	21781		10.1074/jbc.R800084200	http://dx.doi.org/10.1074/jbc.R800084200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19473994	Green Published, hybrid			2022-12-27	WOS:000268783700001
J	Geiger, D; Becker, D; Vosloh, D; Gambale, F; Palme, K; Rehers, M; Anschuetz, U; Dreyer, I; Kudla, J; Hedrich, R				Geiger, Dietmar; Becker, Dirk; Vosloh, Daniel; Gambale, Franco; Palme, Klaus; Rehers, Marion; Anschuetz, Uta; Dreyer, Ingo; Kudla, Joerg; Hedrich, Rainer			Heteromeric AtKC1.AKT1 Channels in Arabidopsis Roots Facilitate Growth under K+-limiting Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY POTASSIUM-TRANSPORT; PROTEIN-KINASE; AKT1; EXPRESSION; GENE; SUBUNIT; KAT1; STOICHIOMETRY; SENSITIVITY; AMMONIUM	Plant growth and development is driven by osmotic processes. Potassium represents the major osmotically active cation in plants cells. The uptake of this inorganic osmolyte from the soil in Arabidopsis involves a root K+ uptake module consisting of the two K+ channel alpha-subunits, AKT1 and AtKC1. AKT1-mediated potassium absorption from K+-depleted soil was shown to depend on the calcium-sensing proteins CBL1/9 and their interacting kinase CIPK23. Here we show that upon activation by the CBL.CIPK complex in low external potassium homomeric AKT1 channels open at voltages positive of E-K a condition resulting in cellular K+ leakage. Although at submillimolar external potassium an intrinsic K+ sensor reduces AKT1 channel cord conductance, loss of cytosolic potassium is not completely abolished under these conditions. Depending on channel activity and the actual potassium gradients, this channel-mediated K+ loss results in impaired plant growth in the atkc1 mutant. Incorporation of the AtKC1 subunit into the channel complex, however, modulates the properties of the K+ uptake module to prevent K+ loss. Upon assembly of AKT1 and AtKC1, the activation threshold of the root inward rectifier voltage gate is shifted negative by approximately -70 mV. Additionally, the channel conductance gains a hypersensitive K+ dependence. Together, these two processes appear to represent a safety strategy preventing K+ loss through the uptake channels under physiological conditions. Similar growth retardation phenotypes of akt1 and atkc1 loss-of-function mutants in response to limiting K+ supply further support such functional interdependence of AKT1 and AtKC1. Taken together, these findings suggest an essential role of AtKC1-like subunits for root K+ uptake and K+ homeostasis when plants experience conditions of K+ limitation.	[Hedrich, Rainer] Univ Wurzburg, Julius von Sachs Inst Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany; [Gambale, Franco] CNR, Ist Biofis, I-16149 Genoa, Italy; [Palme, Klaus] Univ Freiburg, Fac Biol, Dept Bot & Plant Physiol, D-79104 Freiburg, Germany; [Rehers, Marion; Kudla, Joerg] Univ Munster, Inst Bot, D-48149 Munster, Germany; [Rehers, Marion; Kudla, Joerg] Univ Munster, Bot Gardens, D-48149 Munster, Germany; [Dreyer, Ingo] Inst Biochem & Biol, Heisenberg Grp Biophys & Mol Plant Biol, D-14476 Potsdam, Germany	University of Wurzburg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Freiburg; University of Munster; University of Munster; University of Potsdam		dbecker@botanik.uni-wuerzburg.de	Dreyer, Ingo/N-4747-2014; Hedrich, Rainer/G-8771-2011; Becker, Dirk/F-7826-2010; Geiger, Dietmar/D-6914-2014; Palme, Klaus/A-9524-2013; Geiger, Dietmar/AAH-8140-2019; Kudla, Jörg/C-2174-2012	Dreyer, Ingo/0000-0002-2781-0359; Hedrich, Rainer/0000-0003-3224-1362; Geiger, Dietmar/0000-0003-0715-5710; Palme, Klaus/0000-0002-2728-3835; Geiger, Dietmar/0000-0003-0715-5710; Kudla, Jörg/0000-0002-8238-767X; Becker, Dirk/0000-0003-0723-4160	Deutsche Forschungsgemeinschaft [FOR964]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Heisenberg Fellowship from the Deutsche Forschungsgemeinschaft (to I. D.) and by Deutsche Forschungsgemeinschaft Research Group Grant FOR964 ( to R. H., J. K., and D. B.).	ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Basset M, 1995, PLANT MOL BIOL, V29, P947, DOI 10.1007/BF00014968; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; Bruggemann L, 1999, P NATL ACAD SCI USA, V96, P3298, DOI 10.1073/pnas.96.6.3298; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; Dennison KL, 2001, PLANT PHYSIOL, V127, P1012, DOI 10.1104/pp.010193; Dreyer I, 1997, BIOPHYS J, V72, P2143, DOI 10.1016/S0006-3495(97)78857-X; Duby G, 2008, PLANT J, V53, P115, DOI 10.1111/j.1365-313X.2007.03324.x; EPSTEIN E, 1963, P NATL ACAD SCI USA, V49, P684, DOI 10.1073/pnas.49.5.684; Formentin E, 2004, FEBS LETT, V573, P61, DOI 10.1016/j.febslet.2004.07.052; Fu HH, 1998, PLANT CELL, V10, P63, DOI 10.1105/tpc.10.1.63; Geiger D, 2002, PLANT CELL, V14, P1859, DOI 10.1105/tpc.003244; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Hertel B, 2005, J EXP BOT, V56, P3103, DOI 10.1093/jxb/eri307; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Ivashikina N, 2001, FEBS LETT, V508, P463, DOI 10.1016/S0014-5793(01)03114-3; James P, 1996, GENETICS, V144, P1425; Johansson I, 2006, PLANT J, V46, P269, DOI [10.1111/j.1365-313X.2006.02690.x, 10.1111/j.1365-313X.2006.02690.X]; Kim EJ, 1998, PLANT CELL, V10, P51, DOI 10.1105/tpc.10.1.51; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; Lebaudy A, 2007, FEBS LETT, V581, P2357, DOI 10.1016/j.febslet.2007.03.058; Lee SC, 2007, P NATL ACAD SCI USA, V104, P15959, DOI 10.1073/pnas.0707912104; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Naso A, 2006, BIOPHYS J, V91, P3673, DOI 10.1529/biophysj.106.091777; Ortega-Saenz P, 2000, J GEN PHYSIOL, V116, P181, DOI 10.1085/jgp.116.2.181; Pilot G, 2003, PLANT MOL BIOL, V51, P773, DOI 10.1023/A:1022597102282; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Reintanz B, 2002, P NATL ACAD SCI USA, V99, P4079, DOI 10.1073/pnas.052677799; Roux B, 2005, ANNU REV BIOPH BIOM, V34, P153, DOI 10.1146/annurev.biophys.34.040204.144655; Rubio F, 2000, PHYSIOL PLANTARUM, V109, P34, DOI 10.1034/j.1399-3054.2000.100106.x; Santa-Maria GE, 2000, PLANT PHYSIOL, V123, P297, DOI 10.1104/pp.123.1.297; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Spalding EP, 1999, J GEN PHYSIOL, V113, P909, DOI 10.1085/jgp.113.6.909; Szyroki A, 2001, P NATL ACAD SCI USA, V98, P2917, DOI 10.1073/pnas.051616698; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Xicluna J, 2007, J BIOL CHEM, V282, P486, DOI 10.1074/jbc.M607607200; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011	44	127	136	3	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21288	21295		10.1074/jbc.M109.017574	http://dx.doi.org/10.1074/jbc.M109.017574			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509299	hybrid, Green Published			2022-12-27	WOS:000268564400023
J	Malintan, NT; Nguyen, TH; Han, LP; Latham, CF; Osborne, SL; Wen, PJ; Lim, SJT; Sugita, S; Collins, BM; Meunier, FA				Malintan, Nancy T.; Nguyen, Tam H.; Han, Liping; Latham, Catherine F.; Osborne, Shona L.; Wen, Peter J.; Lim, Siew Joo Tiffany; Sugita, Shuzo; Collins, Brett M.; Meunier, Frederic A.			Abrogating Munc18-1-SNARE Complex Interaction Has Limited Impact on Exocytosis in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL SNARE COMPLEX; SEC1/MUNC18 PROTEINS; VESICLE DOCKING; FUSION; SYNTAXIN; BINDING; GOLGI; TRAFFICKING; NEUROTOXINS; SPECIFICITY	Neuronal communication relies on the fusion of neurotransmitter-containing vesicles with the plasma membrane. The soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor (SNARE) proteins initiate membrane fusion through the formation of the SNARE complex, a process tightly regulated by Sec1/Munc18-1 (SM) proteins. The emerging trend is that SM proteins promote SNARE-mediated membrane fusion by binding to a Syntaxin N-terminal motif. Here we report that mutations in the hydrophobic pocket of Munc18-1 (F115E and E132A), predicted to disrupt the N-terminal Sx1a interaction have a modest effect on binding to Sx1a in its free state, but abolish binding to the SNARE complex. Overexpression of the Munc18-1 mutant in PC12 cells lacking Munc18-1 rescues both neuroexocytosis and the plasma membrane localization of Syntaxin. However, total internal reflection fluorescence microscopy analysis reveals that expression of a Munc18-1 double mutant reduces the rate of vesicle fusion, an effect only detectable at the onset of stimulation. The Munc18-1 hydrophobic pocket is therefore critical for SNARE complex binding. However, mutations abrogating this interaction have a limited impact on Ca2+-dependent exocytosis in PC12 cells.	[Lim, Siew Joo Tiffany; Meunier, Frederic A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lim, Siew Joo Tiffany; Meunier, Frederic A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Han, Liping; Sugita, Shuzo] Univ Toronto, Dept Physiol, Univ Hlth Network, Toronto Western Res Inst,Div Fundamental Neurobio, Toronto, ON M5T 2S8, Canada	University of Queensland; University of Queensland; University of Queensland; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Meunier, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	f.meunier@uq.edu.au	Malintan, Nancy/U-8278-2018; Nguyen, Tam/H-3423-2011; Meunier, Frederic A/C-8161-2009; Collins, Brett/J-1563-2014; Osborne, Shona/C-8290-2009	Malintan, Nancy/0000-0002-1040-8021; Meunier, Frederic A/0000-0001-6400-1107; Collins, Brett/0000-0002-6070-3774; Sugita, Shuzo/0000-0002-9182-873X; Osborne, Shona/0000-0002-7012-9278	Australian National Health and Medical Research Council; Australian Research Council; Canadian Institute of Health Research [MOP-57825]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Australian National Health and Medical Research Council (to F. A. M.), a Linkage Infrastructure, Equipment and Facilities grant from the Australian Research Council (to F. A. M.), and Canadian Institute of Health Research Grant MOP-57825 (to S. S.).	Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Johnson JR, 2009, BIOCHEM J, V418, P73, DOI 10.1042/BJ20081956; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Latham CF, 2007, INT J BIOCHEM CELL B, V39, P1576, DOI 10.1016/j.biocel.2006.11.015; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Meunier FA, 2002, J PHYSIOL-PARIS, V96, P105, DOI 10.1016/S0928-4257(01)00086-9; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Osborne SL, 2008, J BIOL CHEM, V283, P2804, DOI 10.1074/jbc.M704856200; Peng RW, 2004, EMBO J, V23, P3939, DOI 10.1038/sj.emboj.7600410; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	42	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21637	21646		10.1074/jbc.M109.013508	http://dx.doi.org/10.1074/jbc.M109.013508			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19483085	Green Published, hybrid			2022-12-27	WOS:000268564400057
J	Gad, HH; Dellgren, C; Hamming, OJ; Vends, S; Paludan, SR; Hartmann, R				Gad, Hans Henrik; Dellgren, Christoffer; Hamming, Ole J.; Vends, Susanne; Paludan, Soren R.; Hartmann, Rune			Interferon-lambda Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-LAMBDA; CRYSTAL-STRUCTURE; IL-10R2 BINDING; HOST-DEFENSE; III IFN; IL-22; CRYSTALLOGRAPHY; CYTOKINES; SOFTWARE; COMPLEX	Interferon-lambda (IFN-lambda) is an antiviral cytokine that signals through a distinct receptor complex, composed of the IFN-lambda R1 and interleukin-10R2 (IL-10R2) receptor chains. We have determined the crystal structure of human IFN-lambda 3 and characterized the interaction with its receptor complex through structure-based site-directed mutagenesis. The ability of IFN-lambda 3 mutants to signal was determined by measuring the antiviral activity and induced STAT2 phosphorylation. In conclusion, our data show that, although IFN-lambda is functionally an interferon, it is clearly structurally related to members of the IL-10 family. In particular, we found an interesting similarity between IFN-lambda and IL-22, and we suggest that IFN-lambda and IL-22 possess parallel functions, protecting epithelial tissue against viral and bacterial infections, respectively.	[Gad, Hans Henrik; Dellgren, Christoffer; Hamming, Ole J.; Vends, Susanne; Hartmann, Rune] Aarhus Univ, Dept Mol Biol, Struct Biol Ctr, DK-8000 Aarhus C, Denmark; [Paludan, Soren R.] Aarhus Univ, Dept Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Hartmann, R (corresponding author), Aarhus Univ, Dept Mol Biol, Struct Biol Ctr, DK-8000 Aarhus C, Denmark.	rh@mb.au.dk		Hartmann, Rune/0000-0003-1159-066X; Dellgren, Christoffer Dalsgaard/0000-0003-4841-5187; Gad, Hans Henrik/0000-0001-8449-1115	Danscatt consortium; Novo Nordisk Foundation; Danish Medical Research Council [22-04-0704]; Carlsberg Foundation; Arne Hansen stipend	Danscatt consortium; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Carlsberg Foundation(Carlsberg Foundation); Arne Hansen stipend	Beamline access was funded partly via the Danscatt consortium.; Supported by a Novo Nordisk Foundation senior research grant, by grants from The Danish Medical Research Council (Grant 22-04-0704) and The Carlsberg Foundation, and by an Arne Hansen stipend.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bleicher L, 2008, FEBS LETT, V582, P2985, DOI 10.1016/j.febslet.2008.07.046; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jones BC, 2008, STRUCTURE, V16, P1333, DOI 10.1016/j.str.2008.06.005; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382; Jordan WJ, 2007, GENES IMMUN, V8, P13, DOI 10.1038/sj.gene.6364348; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Logsdon NJ, 2004, J MOL BIOL, V342, P503, DOI 10.1016/j.jmb.2004.07.069; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Mennechet FJD, 2006, BLOOD, V107, P4417, DOI 10.1182/blood-2005-10-4129; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Ursby T, 2004, AIP CONF PROC, V705, P1241, DOI 10.1063/1.1758025; Wu PW, 2008, J MOL BIOL, V382, P1168, DOI 10.1016/j.jmb.2008.07.046; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	36	155	174	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20869	20875		10.1074/jbc.M109.002923	http://dx.doi.org/10.1074/jbc.M109.002923			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19457860	hybrid, Green Published			2022-12-27	WOS:000268316100050
J	Strasser, R; Castilho, A; Stadlmann, J; Kunert, R; Quendler, H; Gattinger, P; Jez, J; Rademacher, T; Altmann, F; Mach, L; Steinkellner, H				Strasser, Richard; Castilho, Alexandra; Stadlmann, Johannes; Kunert, Renate; Quendler, Heribert; Gattinger, Pia; Jez, Jakub; Rademacher, Thomas; Altmann, Friedrich; Mach, Lukas; Steinkellner, Herta			Improved Virus Neutralization by Plant-produced Anti-HIV Antibodies with a Homogeneous beta 1,4-Galactosylated N-Glycan Profile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; MONOCLONAL-ANTIBODY; GOLGI-APPARATUS; FC GLYCANS; GLYCOSYLATION; EXPRESSION; CELLS; GLYCOFORMS; EPITOPES; RECEPTOR	It is well established that proper N-glycosylation significantly influences the efficacy of monoclonal antibodies (mAbs). However, the specific immunological relevance of individual mAb-associated N-glycan structures is currently largely unknown, because of the heterogeneous N-glycan profiles of mAbs when produced in mammalian cells. Here we report on the generation of a plant-based expression platform allowing the efficient production of mAbs with a homogeneous beta 1,4-galactosylated N-glycosylation structure, the major N-glycan species present on serum IgG. This was achieved by the expression of a highly active modified version of the human beta 1,4-galactosyl-transferase in glycoengineered plants lacking plant-specific glycosylation. Moreover, we demonstrate that two anti-human immunodeficiency virus mAbs with fully beta 1,4-galactosylated N-glycans display improved virus neutralization potency when compared with other glycoforms produced in plants and Chinese hamster ovary cells. These findings indicate that mAbs containing such homogeneous N-glycan structures should display improved in vivo activities. Our system, using expression of mAbs in tobacco plants engineered for post-translational protein processing, provides a new means of overcoming the two hurdles that limit the therapeutic use of anti-human immunodeficiency virus mAbs in global health initiatives, low biological potency and high production costs.	[Strasser, Richard; Castilho, Alexandra; Gattinger, Pia; Jez, Jakub; Mach, Lukas; Steinkellner, Herta] Univ Nat Resources & Appl Life Sci, Dept Appl Genet, A-1190 Vienna, Austria; [Stadlmann, Johannes; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci, Dept Chem, A-1190 Vienna, Austria; [Kunert, Renate] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, A-1190 Vienna, Austria; [Quendler, Heribert] Polymun Sci GmbH, A-1190 Vienna, Austria; [Quendler, Heribert] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Rademacher, Thomas] Rhein Westfal TH Aachen, D-52074 Aachen, Germany	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Scripps Research Institute; RWTH Aachen University	Steinkellner, H (corresponding author), Muthgasse 18, A-1190 Vienna, Austria.	herta.steinkellner@boku.ac.at	Strasser, Richard/AAD-2916-2020; Kunert, Renate E/B-9185-2018; Castilho, Alexandra/AAC-8927-2020; Steinkellner, Herta/N-4267-2016; Stadlmann, Johannes/AAC-3157-2021	Kunert, Renate E/0000-0002-3397-3621; Castilho, Alexandra/0000-0003-4114-7861; Steinkellner, Herta/0000-0003-4823-1505; Stadlmann, Johannes/0000-0001-5693-6690; Strasser, Richard/0000-0001-8764-6530; Altmann, Friedrich/0000-0002-0112-7877; Gattinger, Pia/0000-0001-6724-8543; Mach, Lukas/0000-0001-9013-5408; Jez, Jakub/0000-0002-6481-4383	Wiener Wissenschafts-, Forschungs-, und Technologiefonds [LS154]; Austrian Science Fund (FWF) [L 575] Funding Source: researchfish	Wiener Wissenschafts-, Forschungs-, und Technologiefonds; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Wiener Wissenschafts-, Forschungs-, und Technologiefonds Project LS154.	Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; Bakker H, 2006, P NATL ACAD SCI USA, V103, P7577, DOI 10.1073/pnas.0600879103; Berger EG, 2001, HISTOCHEM CELL BIOL, V115, P157, DOI 10.1007/s004180000231; Boevink P, 1998, PLANT J, V15, P441, DOI 10.1046/j.1365-313X.1998.00208.x; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Fujiyama K, 2007, BIOCHEM BIOPH RES CO, V358, P85, DOI 10.1016/j.bbrc.2007.04.054; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Huber M, 2008, CURR TOP MICROBIOL, V317, P39; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Leonard R, 2002, GLYCOBIOLOGY, V12, P299, DOI 10.1093/glycob/12.5.299; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; Palacpac NQ, 1999, P NATL ACAD SCI USA, V96, P4692, DOI 10.1073/pnas.96.8.4692; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; REED LJ, 1938, AM J HYG, V27; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Schweizer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000109; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2005, BIOCHEM J, V387, P385, DOI 10.1042/BJ20041686; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151	32	130	142	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20479	20485		10.1074/jbc.M109.014126	http://dx.doi.org/10.1074/jbc.M109.014126			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19478090	Green Published, hybrid			2022-12-27	WOS:000268316100009
J	Tsukamoto, H; Farrens, DL; Koyanagi, M; Terakita, A				Tsukamoto, Hisao; Farrens, David L.; Koyanagi, Mitsumasa; Terakita, Akihisa			The Magnitude of the Light-induced Conformational Change in Different Rhodopsins Correlates with Their Ability to Activate G Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE CROSS-LINKING; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; STRUCTURAL INSIGHTS; BOVINE RHODOPSIN; IN-SITU; FLUORESCENCE; TRANSDUCIN; OPSIN; FAMILY	Light converts rhodopsin, the prototypical G protein-coupled receptor, into a form capable of activating G proteins. Recent work has shown that the light-activated state of different rhodopsins can possess different molecular properties, especially different abilities to activate G protein. For example, bovine rhodopsin is similar to 20-fold more effective at activating G protein than parapinopsin, a non-visual rhodopsin, although these rhodopsins share relatively high sequence similarity. Here we have investigated possible structural aspects that might underlie this difference. Using a site-directed fluorescence labeling approach, we attached the fluorescent probe bimane to cysteine residues introduced in the cytoplasmic ends of transmembrane helices V and VI in both rhodopsins. The fluorescence spectra of these probes as well as their accessibility to aqueous quenching agents changed dramatically upon photoactivation in bovine rhodopsin but only moderately so in parapinopsin. We also compared the relative movement of helices V and VI upon photoactivation of both rhodopsins by introducing a bimane label and the bimane-quenching residue tryptophan into helices VI and V, respectively. Both receptors showed movement in this region upon activation, although the movement appears much greater in bovine rhodopsin than in parapinopsin. Together, these data suggest that a larger conformational change in helices V and VI of bovine rhodopsin explains why it has greater G protein activation ability than other rhodopsins. The different amplitude of the helix movement may also be responsible for functional diversity of G protein-coupled receptors.	[Tsukamoto, Hisao; Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 5588585, Japan; [Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Osaka Metropolitan University; Oregon Health & Science University	Terakita, A (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, 3-3-138,Sugimoto, Osaka 5588585, Japan.	terakita@sci.osaka-cu.ac.jp		Koyanagi, Mitsumasa/0000-0002-7741-918X; Terakita, Akihisa/0000-0002-8379-8913	National Institutes of Health [DA018169, EY015436]; Japanese Ministry of Education, Science, Sports, and Culture; Yamada Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025684] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA018169 and EY015436 (to D. L. F.). This work was also supported in part by grants-in-aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture (to A. T. and M. K.) and by the Yamada Science Foundation (to A. T.).	Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Bartl FJ, 2001, J BIOL CHEM, V276, P30161, DOI 10.1074/jbc.M101506200; Blackshaw S, 1997, J NEUROSCI, V17, P8083; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; JANZ JM, 2004, THESIS OREGON HLTH S; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KOUTALOS Y, 1989, BIOCHEMISTRY-US, V28, P2732, DOI 10.1021/bi00432a055; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Lefkowitz RJ, 2008, NAT BIOTECHNOL, V26, P189, DOI 10.1038/nbt0208-189; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mansoor SE, 2002, BIOCHEMISTRY-US, V41, P2475, DOI 10.1021/bi011198i; Mansoor SE, 1999, BIOCHEMISTRY-US, V38, P16383, DOI 10.1021/bi991331v; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Ritter E, 2004, J BIOL CHEM, V279, P48102, DOI 10.1074/jbc.M406857200; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010	42	40	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20676	20683		10.1074/jbc.M109.016212	http://dx.doi.org/10.1074/jbc.M109.016212			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497849	Green Published, hybrid			2022-12-27	WOS:000268316100029
J	Qiu, S; Zhang, XM; Cao, JY; Yang, W; Yan, YG; Shan, L; Zheng, J; Luo, JH				Qiu, Shuang; Zhang, Xiao-min; Cao, Jing-yuan; Yang, Wei; Yan, Ying-gang; Shan, Ling; Zheng, Jie; Luo, Jian-hong			An Endoplasmic Reticulum Retention Signal Located in the Extracellular Amino-terminal Domain of the NR2A Subunit of N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; LIGAND-BINDING DOMAIN; NMDA RECEPTOR; GLUTAMATE RECEPTORS; QUALITY-CONTROL; NR1; TRAFFICKING; AFFINITY; PROTEIN; LUMEN	N-Methyl-D-aspartate (NMDA) receptors play critical roles in complex brain functions as well as pathogenesis of neurodegenerative diseases. There are many NMDA isoforms and subunit types that, together with subtype-specific assembly, give rise to significant functional heterogeneity of NMDA receptors. Conventional NMDA receptors are obligatory heterotetramers composed of two glycine-binding NR1 subunits and two glutamate-binding NR2 subunits. When individually expressed in heterogeneous cells, most of the NR1 splice variants and the NR2 subunits remain in the endoplasmic reticulum (ER) and do not form homomeric channels. The mechanisms underlying NMDA receptor trafficking and functional expression remain uncertain. Using truncated and chimeric NMDA receptor subunits expressed in heterogeneous cells and hippocampal neurons, together with immunostaining, biochemical, and functional analyses, we found that the NR2A amino-terminal domain (ATD) contains an ER retention signal, which can be specifically masked by the NR1a ATD. Interestingly, no such signal was found in the ATD of the NR2B subunit. We further identified the A2 segment of the NR2A ATD to be the primary determinant of ER retention. These findings indicate that NR2A-containing NMDA receptors may undergo a different ER quality control process from NR2B-containing NMDA receptors.	[Qiu, Shuang; Zhang, Xiao-min; Cao, Jing-yuan; Yang, Wei; Yan, Ying-gang; Shan, Ling; Luo, Jian-hong] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China; [Zheng, Jie] Univ Calif Davis, Dept Physiol & Membrane Biol, Sch Med, Davis, CA 95616 USA	Zhejiang University; University of California System; University of California Davis	Luo, JH (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol, 388 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn	Shan, Ling/E-4281-2012; Luo, jian/HGE-7331-2022; Shan, Ling/N-7075-2019	Shan, Ling/0000-0002-4765-2474; Shan, Ling/0000-0002-4765-2474; Zhang, Xiaomin/0000-0002-1179-979X	National Natural Science Foundation of China [30730038, 30800308]; National Basic Research Program of China [G2002CB713808]; National Institutes of Health [REY016754A]; American Heart Association [0665201Y]; NATIONAL EYE INSTITUTE [R21EY016754] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Natural Science Foundation of China Grants 30730038 and 30800308 and National Basic Research Program of China Grant G2002CB713808 (to J. H. L.). This work was also supported by the National Institutes of Health Grant REY016754A and American Heart Association Grant 0665201Y (to J. Z.).	Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Flint AC, 1997, J NEUROSCI, V17, P2469; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Lee SJ, 1998, EXP MOL MED, V30, P159, DOI 10.1038/emm.1998.23; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; LYNCH DR, 1995, J NEUROCHEM, V64, P1462; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okabe S, 1999, J NEUROSCI, V19, P7781; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Pauly T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002681; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; SHIN J, 1993, SCIENCE, V259, P1901, DOI 10.1126/science.8456316; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; Szklarczyk A, 2008, FASEB J, V22, P3757, DOI 10.1096/fj.07-101402; Vacher H, 2007, FASEB J, V21, P906, DOI 10.1096/fj.06-7229com; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894	39	42	42	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20285	20298		10.1074/jbc.M109.004960	http://dx.doi.org/10.1074/jbc.M109.004960			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19487695	Green Published, hybrid			2022-12-27	WOS:000268097400055
J	Hong, CF; Chou, YT; Lin, YS; Wu, CW				Hong, Chun-Fu; Chou, Yu-Ting; Lin, Young-Sun; Wu, Cheng-Wen			MAD2B, a Novel TCF4-binding Protein, Modulates TCF4-mediated Epithelial-Mesenchymal Transdifferentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER PROGRESSION; BETA-CATENIN; COLON-CANCER; SPINDLE CHECKPOINT; EXPRESSION; CELLS; TRANSITION; INTERACTS; WNT; TRANSACTIVATION	T cell factor 4 (TCF4) interacts with beta-catenin in the WNT signaling pathway and transactivates downstream target genes involved in cancer progression. To identify proteins that regulate TCF4-mediated biological responses, we performed a yeast two-hybrid screen to search for a TCF4-binding protein(s) and found that MAD2B interacts with TCF4. We confirmed that MAD2B is a TCF4-binding protein by co-immunoprecipitation. Using the TOPFLASH reporter assay, we found that MAD2B blocks TCF4-mediated transactivation. The MAD2B binding regions of TCF4 were identified by TCF4 deletion mapping and electrophoretic mobility shift assay analysis. TCF4 and MAD2B interactions abolished the DNA binding ability of TCF4. Knockdown of MAD2B in SW480 colorectal cancer cells led to the conversion of epithelial cells to a mesenchymal fibroblastoid phenotype (epithelial-mesenchymal transdifferentiation). An E-cadherin promoter reporter analysis showed that MAD2B modulates TCF4-mediated E-cadherin expression. MAD2B knockdown blocked E-cadherin expression and significantly induced mesenchymal markers, such as N-cadherin and vimentin. Mesenchymal induction was accompanied by F-actin redistribution and the appearance of a fibroblastoid phenotype. MAD2B knockdown also increased both mRNA and protein levels of Slug, a known TCF4-induced E-cadherin transcriptional repressor. A chromatin immunoprecipitation assay showed that MAD2B silencing enhances the ability of TCF4 to bind the Slug promoter. Thus, MAD2B is a novel TCF4-interacting protein. This study provides the first evidence for the involvement of MAD2B in TCF4-mediated epithelial-mesenchymal transdifferentiation.	[Wu, Cheng-Wen] Natl Yang Ming Univ, Taipei 11221, Taiwan; [Hong, Chun-Fu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan; [Hong, Chun-Fu; Chou, Yu-Ting; Wu, Cheng-Wen] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Lin, Young-Sun] Dev Ctr Biotechnol, Taipei 22180, Taiwan	National Yang Ming Chiao Tung University; National Defense Medical Center; Academia Sinica - Taiwan	Wu, CW (corresponding author), Natl Yang Ming Univ, 155 Sec 2,Linong St, Taipei 11221, Taiwan.	cwwu@ym.edu.tw		Chou, Yu-Ting/0000-0001-9274-8603	Academia Sinica, Department of Health [DOH97-TD-G-111-023]; National Science Council, Executive Yuan, Taiwan [NSC97-3111-B-010-005]	Academia Sinica, Department of Health(Academia Sinica - Taiwan); National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by Academia Sinica, Department of Health Grant DOH97-TD-G-111-023, and National Science Council Grant NSC97-3111-B-010-005, Executive Yuan, Taiwan.	Bates RC, 2005, CANCER BIOL THER, V4, P365; Bright-Thomas RM, 2003, EUR J SURG ONCOL, V29, P107, DOI 10.1053/ejso.2002.1331; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Chan SH, 2001, EUR J BIOCHEM, V268, P2107, DOI 10.1046/j.1432-1327.2001.02091.x; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Chen SS, 2002, EMBO J, V21, P4491, DOI 10.1093/emboj/cdf409; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Gilles C, 2003, CANCER RES, V63, P2658; Held W, 2003, EUR J IMMUNOL, V33, P1393, DOI 10.1002/eji.200323840; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Katoh M, 2005, INT J ONCOL, V27, P1677; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Li L, 2007, MOL CELL BIOCHEM, V304, P297, DOI 10.1007/s11010-007-9512-8; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Naishiro Y, 2001, CANCER RES, V61, P2751; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Pinto M, 2007, VIRCHOWS ARCH, V450, P379, DOI 10.1007/s00428-007-0386-7; Rimkus C, 2007, INT J CANCER, V120, P207, DOI 10.1002/ijc.22155; Sakai D, 2005, DEV GROWTH DIFFER, V47, P471, DOI 10.1111/j.1440-169X.2005.00821.x; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tzeng SL, 2006, J BIOL CHEM, V281, P15405, DOI 10.1074/jbc.M601807200; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Ying BL, 2003, VIROLOGY, V313, P224, DOI 10.1016/S0042-6822(03)00287-3; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zhang L, 2007, MOL CELL BIOL, V27, P2861, DOI 10.1128/MCB.02276-06	40	33	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19613	19622		10.1074/jbc.M109.005017	http://dx.doi.org/10.1074/jbc.M109.005017			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19443654	hybrid, Green Published			2022-12-27	WOS:000267908300053
J	Privalsky, ML; Lee, SH; Hahm, JB; Young, BM; Fong, RNG; Chan, IH				Privalsky, Martin L.; Lee, Sangho; Hahm, Johnnie B.; Young, Briana M.; Fong, Rebecca N. G.; Chan, Ivan H.			The p160 Coactivator PAS-B Motif Stabilizes Nuclear Receptor Binding and Contributes to Isoform-specific Regulation by Thyroid Hormone Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; ANDROGEN RECEPTOR; LIGAND-BINDING; PITUITARY RESISTANCE; GENE-EXPRESSION; BETA-ISOFORMS; MUTANT MICE; LXXLL MOTIF; IN-VIVO; COMPLEX	Thyroid hormone receptors (TRs) are hormone-regulated transcription factors that play multiple roles in vertebrate endocrinology and development. TRs are expressed as a series of distinct receptor isoforms that mediate different biological functions. The TR beta 2 isoform is expressed primarily in the hypothalamus, pituitary, cochlea, and retina, and displays an enhanced response to hormone agonist relative to the other TR isoforms. We report here that the unusual transcriptional properties of TR beta 2 parallel the ability of this isoform to bind p160 coactivators cooperatively through multiple contact surfaces; the more broadly expressed TR beta 1 isoform, in contrast, utilizes a single contact mechanism. Intriguingly, the PAS-B domain in the p160 N terminus plays a previously unanticipated role in permitting TR beta 2 to recruit coactivator at limiting triiodothyronine concentrations. The PAS-B sequences also play an important role in coactivator binding by estrogen receptor-alpha. We propose that the PAS-B domain of the p160 coactivators is an important modulator of coactivator recruitment for a specific subset of nuclear receptors, permitting stronger transcriptional activation at lower hormone concentrations than would otherwise occur, and allowing isoform-specific mRNA splicing to customize the hormone response in different tissues.	[Privalsky, Martin L.; Lee, Sangho; Hahm, Johnnie B.; Young, Briana M.; Fong, Rebecca N. G.; Chan, Ivan H.] Univ Calif Davis, Dept Microbiol, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Privalsky, ML (corresponding author), Univ Calif Davis, Dept Microbiol, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	mlprivalsky@ucdavis.edu	Chan, Ivan/B-7922-2010	Chan, Ivan/0000-0003-2834-2574; Lee, Sangho/0000-0003-3771-7761	National Institutes of Health Grant from the NIDDK [R01DK53528]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK53528 from the NIDDK.	Abel ED, 1999, J CLIN INVEST, V103, P271, DOI 10.1172/JCI5205; Abel ED, 1999, J CLIN INVEST, V104, P291, DOI 10.1172/JCI6397; Abel ED, 2003, MOL ENDOCRINOL, V17, P1767, DOI 10.1210/me.2003-0109; Abel ED, 2001, J CLIN INVEST, V107, P1017, DOI 10.1172/JCI10858; Alen P, 1999, MOL CELL BIOL, V19, P6085; Apriletti JW, 1998, CLIN EXP PHARMACOL P, V25, pS2, DOI 10.1111/j.1440-1681.1998.tb02293.x; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Bhat MK, 1999, THYROID, V9, P411, DOI 10.1089/thy.1999.9.411; Brent G A, 2000, Rev Endocr Metab Disord, V1, P27, DOI 10.1023/A:1010056202122; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Cheng S Y, 2000, Rev Endocr Metab Disord, V1, P9, DOI 10.1023/A:1010052101214; Cheng SY, 2005, STEROIDS, V70, P450, DOI 10.1016/j.steroids.2005.02.003; Christiaens V, 2002, J BIOL CHEM, V277, P49230, DOI 10.1074/jbc.M209322200; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Farboud B, 2003, MOL CELL BIOL, V23, P2844, DOI 10.1128/MCB.23.8.2844-2858.2003; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Goodson Michael L, 2007, Nucl Recept Signal, V5, pe002; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hong H, 1999, J BIOL CHEM, V274, P3496, DOI 10.1074/jbc.274.6.3496; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Kamiya Y, 2003, ENDOCRINOLOGY, V144, P4144, DOI 10.1210/en.2003-0239; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Lee S, 2005, MOL ENDOCRINOL, V19, P863, DOI 10.1210/me.2004-0210; Leers J, 1998, MOL CELL BIOL, V18, P6001, DOI 10.1128/MCB.18.10.6001; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Lin BC, 1997, MOL CELL BIOL, V17, P6131, DOI 10.1128/MCB.17.10.6131; Lodrini M, 2008, NUCLEIC ACIDS RES, V36, P1847, DOI 10.1093/nar/gkn029; Ma H, 1999, MOL CELL BIOL, V19, P6164; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Mengeling BJ, 2005, MOL ENDOCRINOL, V19, P35, DOI 10.1210/me.2003-0289; Murata Y, 1998, Nagoya J Med Sci, V61, P103; NG L, 1995, MOL ENDOCRINOL, V9, P1202, DOI 10.1210/me.9.9.1202; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Northrop JP, 2000, MOL ENDOCRINOL, V14, P605, DOI 10.1210/me.14.5.605; Oberste-Berghaus C, 2000, J BIOL CHEM, V275, P1787, DOI 10.1074/jbc.275.3.1787; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Rachez C, 2000, MOL CELL BIOL, V20, P2718, DOI 10.1128/MCB.20.8.2718-2726.2000; Reed larsen P, 2003, WILLIAMS TXB ENDOCRI, P331; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; RUIZ MDMV, 1991, EMBO J, V10, P3829, DOI 10.1002/j.1460-2075.1991.tb04952.x; Safer JD, 1997, MOL ENDOCRINOL, V11, P16, DOI 10.1210/me.11.1.16; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Schmidt S, 1998, NUCLEIC ACIDS RES, V26, P1191, DOI 10.1093/nar/26.5.1191; SJOBERG M, 1995, MOL CELL BIOL, V15, P4718; SJOBERG M, 1992, DEVELOPMENT, V114, P39; Takeuchi Y, 2002, ENDOCRINOLOGY, V143, P1346, DOI 10.1210/en.143.4.1346; Tian HH, 2006, MOL ENDOCRINOL, V20, P2036, DOI 10.1210/me.2005-0437; Tsai CC, 2004, VITAM HORM, V68, P93; Tzagarakis-Foster C, 1998, J BIOL CHEM, V273, P10926, DOI 10.1074/jbc.273.18.10926; Wan W, 2005, MOL ENDOCRINOL, V19, P1529, DOI 10.1210/me.2005-0014; Warnmark A, 2003, MOL ENDOCRINOL, V17, P1901, DOI 10.1210/me.2002-0384; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Yang ZH, 1999, J BIOL CHEM, V274, P37131, DOI 10.1074/jbc.274.52.37131; Yang ZH, 2001, MOL ENDOCRINOL, V15, P1170, DOI 10.1210/me.15.7.1170; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439	68	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19554	19563		10.1074/jbc.M109.007542	http://dx.doi.org/10.1074/jbc.M109.007542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19487700	hybrid, Green Published			2022-12-27	WOS:000267908300047
J	Yu, Y; Cai, JP; Tu, B; Wu, LP; Zhao, Y; Liu, XY; Li, L; McNutt, MA; Feng, JN; He, QH; Yang, Y; Wang, HY; Sekiguchi, M; Zhu, WG				Yu, Yu; Cai, Jian-Ping; Tu, Bo; Wu, Lipeng; Zhao, Ying; Liu, Xiangyu; Li, Lian; McNutt, Michael A.; Feng, Jingnan; He, Qihua; Yang, Yang; Wang, Haiying; Sekiguchi, Mutsuo; Zhu, Wei-Guo			Proliferating Cell Nuclear Antigen Is Protected from Degradation by Forming a Complex with MutT Homolog2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-DELTA; MUTAGENIC SUBSTRATE; ESCHERICHIA-COLI; PCNA-BINDING; LUNG-CANCER; TYROSINE PHOSPHORYLATION; REPLICATION INVITRO; AUXILIARY PROTEIN; REPAIR; CYCLIN	Proliferating cell nuclear antigen ( PCNA) has been demonstrated to interact with multiple proteins involved in several metabolic pathways such as DNA replication and repair. However, there have been fewer reports about whether these PCNA-binding proteins influence stability of PCNA. Here, we observed a physical interaction between PCNA and MutT homolog2 (MTH2), a new member of the MutT-related proteins that hydrolyzes 8-oxo-7,8-dihydrodeoxyguanosine triphosphate (8-oxo-dGTP). In several unstressed human cancer cell lines and in normal human fibroblast cells, PCNA and MTH2 formed a complex and their mutual binding fragments were confirmed. It was intriguing that PCNA and MTH2 were dissociated dependent on acetylation of PCNA, which in turn induced degradation of PCNA in response to UV irradiation, but not in response to other forms of DNA-damaging stress. To further explore the link between dissociation of PCNA-MTH2 and degradation of PCNA, RNAi against MTH2 was performed to mimic the dissociated status of PCNA to evaluate changes in the half-life of PCNA. Knockdown of MTH2 significantly promoted degradation of PCNA, suggesting that the physiological interaction of PCNA-MTH2 may confer protection from degradation for PCNA, whereas UV irradiation accelerates PCNA degradation by inducing dissociation of PCNA-MTH2. Moreover, secondary to degradation of PCNA, UV-induced inhibition of DNA synthesis or cell cycle progression was enhanced. Collectively, our data demonstrate for the first time that PCNA is protected by this newly identified partner molecule MTH2, which is related to DNA synthesis and cell cycle progression.	[Yu, Yu; Tu, Bo; Wu, Lipeng; Zhao, Ying; Liu, Xiangyu; Li, Lian; Feng, Jingnan; Yang, Yang; Wang, Haiying; Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol, Key Lab Carcinogenesis & Translat Res,Educ Minist, Beijing 100191, Peoples R China; [McNutt, Michael A.] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100191, Peoples R China; [He, Qihua] Peking Univ, Hlth Sci Ctr, Biomed Teaching Lab Ctr, Beijing 100191, Peoples R China; [Cai, Jian-Ping] Beijing Hosp, Natl Ctr Clin Lab, Beijing 100730, Peoples R China; [Sekiguchi, Mutsuo] Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140193, Japan; [Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Canc Res Ctr, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Beijing Hospital; Fukuoka Dental College (FDC); Peking University	Zhu, WG (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol, Key Lab Carcinogenesis & Translat Res,Educ Minist, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	zhuweiguo@bjmu.edu	zhu, wei-guo/E-1334-2012; liu, xiangyu/D-8213-2014	Zhu, Wei-Guo/0000-0001-8385-6581; Yang, Yang/0000-0002-8737-590X	National Natural Science Foundation of China [90919030, 30425017, 30670417, 30621002]; Ministry of Science and Technology of China [2005CB522403, 2006CB910300, B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was supported by the National Natural Science Foundation of China ( No. 90919030, No. 30425017, 30670417, and 30621002) and Grants 2005CB522403, 2006CB910300, and B07001 from the Ministry of Science and Technology of China.	AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Cai JP, 2003, BIOCHEM BIOPH RES CO, V305, P1073, DOI 10.1016/S0006-291X(03)00864-7; Cai JP, 1997, NUCLEIC ACIDS RES, V25, P1170, DOI 10.1093/nar/25.6.1170; Cazzalini O, 2008, NUCLEIC ACIDS RES, V36, P1713, DOI 10.1093/nar/gkn014; Chodon D, 2007, MOL CELL BIOCHEM, V297, P73, DOI 10.1007/s11010-006-9324-2; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; COHEN B, 1990, P NATL ACAD SCI USA, V87, P4458, DOI 10.1073/pnas.87.12.4458; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Engel FB, 2003, MOL CELL BIOL, V23, P555, DOI 10.1128/MCB.23.2.555-565.2003; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Gniadecki R, 1997, J INVEST DERMATOL, V109, P163, DOI 10.1111/1523-1747.ep12319216; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Han LY, 2006, CANCER RES, V66, P8633, DOI 10.1158/0008-5472.CAN-06-1410; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Hiyama H, 1999, CELL DEATH DIFFER, V6, P565, DOI 10.1038/sj.cdd.4400524; Hong R, 2003, J BIOL CHEM, V278, P44505, DOI 10.1074/jbc.M303138200; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Ishibashi T, 2003, EMBO REP, V4, P479, DOI 10.1038/sj.embor.embor838; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; JASKULSKI D, 1988, SCIENCE, V240, P1544, DOI 10.1126/science.2897717; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kamat AA, 2007, CANCER RES, V67, P281, DOI 10.1158/0008-5472.CAN-06-3282; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Kobayashi M, 1998, J BIOL CHEM, V273, P26394, DOI 10.1074/jbc.273.41.26394; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Liebermann DA, 2007, BLOOD CELL MOL DIS, V39, P329, DOI 10.1016/j.bcmd.2007.06.006; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Maga G, 2002, J BIOL CHEM, V277, P48434, DOI 10.1074/jbc.M206889200; Magrini R, 2008, J CELL BIOCHEM, V104, P2363, DOI 10.1002/jcb.21794; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MARTIN SJ, 1991, INT J RADIAT BIOL, V59, P1001, DOI 10.1080/09553009114550891; Masih PJ, 2008, NUCLEIC ACIDS RES, V36, P67, DOI 10.1093/nar/gkm943; MATSUOKA S, 1994, J BIOL CHEM, V269, P11030; Matunis MJ, 2002, MOL CELL, V10, P441, DOI 10.1016/S1097-2765(02)00653-6; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Naryzhny SN, 2003, PROTEOMICS, V3, P930, DOI 10.1002/pmic.200300400; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; Scorah J, 2008, J BIOL CHEM, V283, P17250, DOI 10.1074/jbc.M800369200; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Volm M, 2000, ANTICANCER RES, V20, P3449; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; ZENG XR, 1994, J BIOL CHEM, V269, P24027; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200; Zhu WG, 2001, CANCER RES, V61, P1327	76	40	43	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19310	19320		10.1074/jbc.M109.015289	http://dx.doi.org/10.1074/jbc.M109.015289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19419956	Green Published, hybrid			2022-12-27	WOS:000267908300022
J	Dhar, SS; Ongwijitwat, S; Wong-Riley, MTT				Dhar, Shilpa S.; Ongwijitwat, Sakkapol; Wong-Riley, Margaret T. T.			Chromosome Conformation Capture of All 13 Genomic Loci in the Transcriptional Regulation of the Multisubunit Bigenomic Cytochrome c Oxidase in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RESPIRATORY FACTOR-2; CONTROLLING MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; FUNCTIONAL-ACTIVITY; ENERGY-METABOLISM; FACTOR-I; COACTIVATOR; SUBUNITS; NRF-2; TRANSMISSION	Cytochrome c oxidase (COX) is the terminal enzyme of the electron transport chain composed of 13 subunits; three are mitochondria-encoded, and 10 are nucleus-inscribed on nine different chromosomes within the mammalian genome. The transcriptional regulation of such a multisubunit, multichromosomal, and bigenomic enzyme is mechanistically challenging. Transcription factories have been proposed as one mechanism by which genes from different genomic loci congregate to transcribe functionally related genes, and chromosome conformation capture (3C) is a means by which such interactions can be revealed. Thus far, however, only loci from the same chromosome or at most two chromosomes have been co-localized by 3C. The present study used 3C to test our hypothesis that not only the 10 genomic loci from nine chromosomes encoding the 10 nuclear subunits of COX, but also genes from three chromosomes encoding mitochondrial transcription factors A and B (Tfam, Tfb1m, and Tfb2m) critical for the transcription of the three mitochondria-encoded COX subunit genes all occupy common intranuclear sites in the murine neuronal nuclei. The pairing of various COX subunit genes and Tf genes indicates that interactions are present among all of them. On the other hand, genes for a non-mitochondrial protein (calreticulin) as well as a mitochondrial enzyme (citrate synthase) did not interact with COX genes. Furthermore, interactions between COX subunit and Tf genes were up-regulated by depolarizing stimulation and down-regulated by impulse blockade in primary neurons. Thus, a viable mechanism is in place for a synchronized, coordinated transcriptional regulation of this multisubunit, bigenomic COX enzyme in neurons.	[Dhar, Shilpa S.; Ongwijitwat, Sakkapol; Wong-Riley, Margaret T. T.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Wong-Riley, MTT (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mwr@mcw.edu	Wong-Riley, Margaret/AGM-6202-2022		National Institutes of Health [R01 EY018441]; NATIONAL EYE INSTITUTE [R01EY018441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY018441.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; Dhar SS, 2009, J NEUROCHEM, V108, P1595, DOI 10.1111/j.1471-4159.2009.05929.x; Dhar SS, 2009, J NEUROSCI, V29, P483, DOI 10.1523/JNEUROSCI.3704-08.2009; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Escriva H, 1999, BIOCHIMIE, V81, P965, DOI 10.1016/S0300-9084(99)00223-0; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; HEVNER RF, 1993, J NEUROSCI, V13, P1805; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; KADENBACH B, 1986, J BIOENERG BIOMEMBR, V18, P39, DOI 10.1007/BF00743611; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Liang HL, 2006, NEUROSCIENCE, V140, P177, DOI 10.1016/j.neuroscience.2006.01.056; Liang HL, 2006, NEUROREPORT, V17, P401, DOI 10.1097/01.wnr.0000204980.98876.11; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Meng H, 2007, BRAIN RES, V1175, P10, DOI 10.1016/j.brainres.2007.07.063; Miele Adriana, 2008, V464, P105; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Nie F, 1999, J COMP NEUROL, V404, P310, DOI 10.1002/(SICI)1096-9861(19990215)404:3<310::AID-CNE3>3.0.CO;2-4; Ongwijitwat S, 2005, GENE, V360, P65, DOI 10.1016/j.gene.2005.06.015; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pequignot MO, 2001, HUM MUTAT, V17, P374, DOI 10.1002/humu.1112.abs; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TOPPER JN, 1989, MOL CELL BIOL, V9, P1200, DOI 10.1128/MCB.9.3.1200; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wikstrom M., 1981, CYTOCHROME OXIDASE S; Wong-Riley MTT, 1998, CYTOCHROME OXIDASE IN NEURONAL METABOLISM AND ALZHEIMER'S DISEASE, P1; WONGRILEY MT, 2008, UNDERSTANDING TRANSC, P209; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Yang SJ, 2006, NEUROSCIENCE, V141, P1181, DOI 10.1016/j.neuroscience.2006.04.063; Yang SJ, 2004, EUR J NEUROSCI, V19, P1153, DOI 10.1111/j.1460-9568.2004.03250.x; Zhou GL, 2006, MOL CELL BIOL, V26, P5096, DOI 10.1128/MCB.02454-05	43	25	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18644	18650		10.1074/jbc.M109.019976	http://dx.doi.org/10.1074/jbc.M109.019976			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19439416	hybrid, Green Published			2022-12-27	WOS:000267711500013
J	Goh, SL; Looi, Y; Shen, H; Fang, J; Bodner, C; Houle, M; Ng, ACH; Screaton, RA; Featherstone, M				Goh, Siew-Lee; Looi, Yvonne; Shen, Hui; Fang, Jun; Bodner, Caroline; Houle, Martin; Ng, Andy Cheuk-Him; Screaton, Robert A.; Featherstone, Mark			Transcriptional Activation by MEIS1A in Response to Protein Kinase A Signaling Requires the Transducers of Regulated CREB Family of CREB Co-activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOX-PBX COMPLEXES; DNA-BINDING; MYELOID-LEUKEMIA; GENE-EXPRESSION; SEQUENCE CRS1; CELL; INDUCTION; LEUKEMOGENESIS; ASSOCIATION; MECHANISM	The transcription factor encoded by the murine ecotropic integration site 1 gene (MEIS1) is a partner of HOX and PBX proteins. It has been implicated in embryonic patterning and leukemia, and causally linked to restless legs syndrome. The MEIS1A C terminus harbors a transcriptional activation domain that is stimulated by protein kinase A (PKA) in a manner dependent on the co-activator of cAMP response element-binding protein (CREB), CREB-binding protein (CBP). We explored the involvement of another mediator of PKA-inducible transcription, namely the CREB co-activators transducers of regulated CREB activity (TORCs). Overexpression of TORC1 or TORC2 bypassed PKA for activation by MEIS1A. Co-immunoprecipitation experiments demonstrated a physical interaction between MEIS1 and TORC2 that is dependent on the MEIS1AC terminus, whereas chromatin immunoprecipitation revealed PKA-inducible recruitment of MEIS1, PBX1, and TORC2 on the MEIS1 target genes Hoxb2 and Meis1. The MEIS1 interaction domain on TORC1 was mapped to the N-terminal coiled-coil region, and TORC1 mutants lacking this domain attenuated the response to PKA on a natural MEIS1A target enhancer. Thus, TORCs physically cooperate with MEIS1 to achieve PKA-inducible transactivation through the MEIS1A C terminus, suggesting a concerted action in developmental and oncogenic processes.	[Goh, Siew-Lee; Fang, Jun; Bodner, Caroline; Houle, Martin] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; [Goh, Siew-Lee; Looi, Yvonne; Shen, Hui; Featherstone, Mark] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Ng, Andy Cheuk-Him; Screaton, Robert A.] Univ Ottawa, Dept Pediat, Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Ng, Andy Cheuk-Him; Screaton, Robert A.] Univ Ottawa, Dept Biochem Immunol & Microbiol, Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada	McGill University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario	Featherstone, M (corresponding author), Rm 03n 41,60 Nanyang Dr, Singapore 637551, Singapore.	msfeatherstone@ntu.edu.sg	Featherstone, Mark/E-8057-2010	Featherstone, Mark/0000-0003-1576-046X	Canadian Institutes of Health Research and the Biomedical Research Council	Canadian Institutes of Health Research and the Biomedical Research Council(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Canadian Institutes of Health Research and the Biomedical Research Council (Singapore) (to M.F.).	Argiropoulos B, 2008, EXP HEMATOL, V36, P845, DOI 10.1016/j.exphem.2008.02.011; Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Bijlsma MF, 2004, BIOESSAYS, V26, P387, DOI 10.1002/bies.20007; Bischof LJ, 1998, J BIOL CHEM, V273, P7941, DOI 10.1074/jbc.273.14.7941; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Calvo KR, 1999, ONCOGENE, V18, P8033, DOI 10.1038/sj.onc.1203377; Canettieri G, 2009, P NATL ACAD SCI USA, V106, P1445, DOI 10.1073/pnas.0808749106; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Dibner C, 2001, DEVELOPMENT, V128, P3415; Featherstone M, 2003, AD DEV BIOL, V13, P1; Ferretti E, 2000, DEVELOPMENT, V127, P155; Fischbach NA, 2005, BLOOD, V105, P1456, DOI 10.1182/blood-2004-04-1583; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Huang H, 2005, J BIOL CHEM, V280, P10119, DOI 10.1074/jbc.M413963200; Huang H, 2003, MOL CELL BIOL, V23, P3636, DOI 10.1128/MCB.23.10.3636-3645.2003; Inbal A, 2001, DEVELOPMENT, V128, P3405; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; KAGAWA N, 1994, J BIOL CHEM, V269, P18716; Koga H, 2004, J BIOL CHEM, V279, P52978, DOI 10.1074/jbc.M409021200; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Li ZJ, 2009, CANCER RES, V69, P1109, DOI 10.1158/0008-5472.CAN-08-3381; Mamo A, 2006, BLOOD, V108, P622, DOI 10.1182/blood-2005-06-2244; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen WF, 2004, J BIOL CHEM, V279, P39895, DOI 10.1074/jbc.M404132200; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; Siu YT, 2006, J VIROL, V80, P7052, DOI 10.1128/JVI.00103-06; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Vlachakis N, 2001, DEVELOPMENT, V128, P1299; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Xiong L, 2009, HUM MOL GENET, V18, P1065, DOI 10.1093/hmg/ddn443	48	16	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18904	18912		10.1074/jbc.M109.005090	http://dx.doi.org/10.1074/jbc.M109.005090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19473990	hybrid, Green Published			2022-12-27	WOS:000267711500040
J	Loimaranta, V; Hytonen, J; Pulliainen, AT; Sharma, A; Tenovuo, J; Stromberg, N; Finne, J				Loimaranta, Vuokko; Hytonen, Jukka; Pulliainen, Arto T.; Sharma, Ashu; Tenovuo, Jorma; Stromberg, Nicklas; Finne, Jukka			Leucine-rich Repeats of Bacterial Surface Proteins Serve as Common Pattern Recognition Motifs of Human Scavenger Receptor gp340	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; INNATE IMMUNE PROTEINS; ANTIGEN-I/II FAMILY; TOLL-LIKE RECEPTORS; SALIVARY AGGLUTININ; CELL-SURFACE; ANTIINFLUENZA ACTIVITIES; GEL-ELECTROPHORESIS; SEQUENCE-ANALYSIS; EPITHELIAL-CELLS	Scavenger receptors are innate immune molecules recognizing and inducing the clearance of non-host as well as modified host molecules. To recognize a wide pattern of invading microbes, many scavenger receptors bind to common pathogen-associated molecular patterns, such as lipopolysaccharides and lipoteichoic acids. Similarly, the gp340/DMBT1 protein, a member of the human scavenger receptor cysteine-rich protein family, displays a wide ligand repertoire. The peptide motif VEVLXXXXW derived from its scavenger receptor cysteine-rich domains is involved in some of these interactions, but most of the recognition mechanisms are unknown. In this study, we used mass spectrometry sequencing, gene inactivation, and recombinant proteins to identify Streptococcus pyogenes protein Spy0843 as a recognition receptor of gp340. Antibodies against Spy0843 are shown to protect against S. pyogenes infection, but no function or host receptor have been identified for the protein. Spy0843 belongs to the leucine-rich repeat (Lrr) family of eukaryotic and prokaryotic proteins. Experiments with truncated forms of the recombinant proteins confirmed that the Lrr region is needed in the binding of Spy0843 to gp340. The same motif of two other Lrr proteins, LrrG from the Gram-positive S. agalactiae and BspA from the Gram-negative Tannerella forsythia, also mediated binding to gp340. Moreover, inhibition of Spy0843 binding occurred with peptides containing the VEVLXXXXW motif, but also peptides devoid of the XXXXW motif inhibited binding of Lrr proteins. These results thus suggest that the conserved Lrr motif in bacterial proteins serves as a novel pattern recognition motif for unique core peptides of human scavenger receptor gp340.	[Loimaranta, Vuokko; Hytonen, Jukka; Pulliainen, Arto T.; Finne, Jukka] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland; [Hytonen, Jukka] Univ Turku, Dept Med Microbiol & Immunol, FI-20520 Turku, Finland; [Tenovuo, Jorma] Univ Turku, Inst Dent, FI-20520 Turku, Finland; [Tenovuo, Jorma] Turku Univ Hosp, Dept Oral Dis, FI-20520 Turku, Finland; [Pulliainen, Arto T.] Univ Basel, Biozentrum, Basel, Switzerland; [Sharma, Ashu] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA; [Stromberg, Nicklas] Umea Univ, Dept Odontol, SE-90187 Umea, Sweden	University of Turku; University of Turku; University of Turku; University of Turku; University of Basel; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Umea University	Loimaranta, V (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FI-20520 Turku, Finland.	vuokko.loimaranta@utu.fi	Pulliainen, Arto/AAX-2052-2021; Abrams, William R/A-5782-2008; Finne, Jukka/B-6881-2008	Loimaranta, Vuokko/0000-0002-6873-2270; Hytonen, Jukka/0000-0002-0585-9338; Finne, Jukka/0000-0002-8076-3344; Pulliainen, Arto Tapio/0000-0002-9361-8963	Academy of Finland [114100]	Academy of Finland(Academy of Finland)	This work was supported by Grant 114100 from the Academy of Finland.	AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Brannstrom A, 2002, BIOCHEM BIOPH RES CO, V290, P1462, DOI 10.1006/bbrc.2002.6378; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; CROWLEY PJ, 1993, INFECT IMMUN, V61, P1547, DOI 10.1128/IAI.61.4.1547-1552.1993; Edwards AM, 2008, MOL MICROBIOL, V68, P1378, DOI 10.1111/j.1365-2958.2008.06220.x; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Hajishengallis G, 2002, CLIN DIAGN LAB IMMUN, V9, P403, DOI 10.1128/CDLI.9.2.403-411.2002; Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695; Hartshorn KL, 2003, AM J PHYSIOL-LUNG C, V285, pL1066, DOI 10.1152/ajplung.00057.2003; Holmes AR, 1998, INFECT IMMUN, V66, P4633, DOI 10.1128/IAI.66.10.4633-4639.1998; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; Holmskov U, 1999, P NATL ACAD SCI USA, V96, P10794, DOI 10.1073/pnas.96.19.10794; Hytonen J, 2003, INFECT IMMUN, V71, P784, DOI 10.1128/IAI.71.2.784-793.2003; Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; Jonasson A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-57; Kang W, 2002, CLIN EXP IMMUNOL, V130, P449, DOI 10.1046/j.1365-2249.2002.01992.x; Kang WQ, 2003, FEBS LETT, V540, P21, DOI 10.1016/S0014-5793(03)00217-5; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kussmann M, 1997, J MASS SPECTROM, V32, P483; Ligtenberg TJM, 2001, BIOCHEM J, V359, P243, DOI 10.1042/0264-6021:3590243; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; Mollenhauer J, 2000, CANCER RES, V60, P1704; Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699; Nyman TA, 2000, EUR J BIOCHEM, V267, P4011, DOI 10.1046/j.1432-1327.2000.01433.x; Oho T, 1998, INFECT IMMUN, V66, P115, DOI 10.1128/IAI.66.1.115-121.1998; Onishi S, 2008, INFECT IMMUN, V76, P198, DOI 10.1128/IAI.01139-07; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; Pulliainen AT, 2003, J BIOL CHEM, V278, P7996, DOI 10.1074/jbc.M210174200; Reid SD, 2003, INFECT IMMUN, V71, P7043, DOI 10.1128/IAI.71.12.7043-7052.2003; Reid SD, 2002, J BACTERIOL, V184, P6316, DOI 10.1128/JB.184.22.6316-6324.2002; Renner M, 2007, GASTROENTEROLOGY, V133, P1499, DOI 10.1053/j.gastro.2007.08.007; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Schulz BL, 2002, BIOCHEM J, V366, P511, DOI 10.1042/BJ20011876; Seepersaud R, 2005, INFECT IMMUN, V73, P1671, DOI 10.1128/IAI.73.3.1671-1683.2005; Segers RPAM, 1998, FEMS MICROBIOL LETT, V167, P255, DOI 10.1111/j.1574-6968.1998.tb13236.x; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Virtaneva K, 2003, INFECT IMMUN, V71, P2199, DOI 10.1128/IAI.71.4.2199-2207.2003; White MR, 2005, AM J PHYSIOL-LUNG C, V289, pL606, DOI 10.1152/ajplung.00130.2005; White MR, 2005, AM J PHYSIOL-LUNG C, V288, pL831, DOI 10.1152/ajplung.00365.2004; Wu ZW, 2003, AIDS RES HUM RETROV, V19, P201, DOI 10.1089/088922203763315704	50	38	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18614	18623		10.1074/jbc.M900581200	http://dx.doi.org/10.1074/jbc.M900581200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19465482	hybrid, Green Published			2022-12-27	WOS:000267711500010
J	Brazier-Hicks, M; Evans, KM; Gershater, MC; Puschmann, H; Steel, PG; Edwards, R				Brazier-Hicks, Melissa; Evans, Kathryn M.; Gershater, Markus C.; Puschmann, Horst; Steel, Patrick G.; Edwards, Robert			The C-Glycosylation of Flavonoids in Cereals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; IN-VITRO; IDENTIFICATION; BIOSYNTHESIS; GLYCOSYLTRANSFERASE; GLUCOSYLTRANSFERASE; METABOLISM; GLYCOSYLFLAVONES; ISOVITEXIN; GLYCOSIDES	Flavonoids normally accumulate in plants as O-glycosylated derivatives, but several species, including major cereal crops, predominantly synthesize flavone-C-glycosides, which are stable to hydrolysis and are biologically active both in planta and as dietary components. An enzyme (OsCGT) catalyzing the UDP-glucosedependent C-glucosylation of 2-hydroxyflavanone precursors of flavonoids has been identified and cloned from rice (Oryza sativa ssp. indica), with a similar protein characterized in wheat (Triticum aestivum L.). OsCGT is a 49-kDa family 1 glycosyltransferase related to known O-glucosyltransferases. The recombinant enzyme C-glucosylated 2-hydroxyflavanones but had negligible O-glucosyltransferase activity with flavonoid acceptors. Enzyme chemistry studies suggested that OsCGT preferentially C-glucosylated the dibenzoylmethane tautomers formed in equilibrium with 2-hydroxyflavanones. The resulting 2-hydroxyflavanone-C-glucosides were unstable and spontaneously dehydrated in vitro to yield a mixture of 6C-and 8C-glucosyl derivatives of the respective flavones. In contrast, in planta, only the respective 6C-glucosides accumulated. Consistent with this selectivity in glycosylation product, a dehydratase activity that preferentially converted 2-hydroxyflavanone-C-glucosides to the corresponding flavone-6C-glucosides was identified in both rice and wheat. Our results demonstrate that cereal crops synthesize C-glucosylated flavones through the concerted action of a CGT and dehydratase acting on activated 2-hydroxyflavanones, as an alternative means of generating flavonoid metabolites.	[Brazier-Hicks, Melissa; Evans, Kathryn M.; Gershater, Markus C.; Puschmann, Horst; Steel, Patrick G.; Edwards, Robert] Univ Durham, Ctr Bioact Chem, Durham DH1 3LE, England	Durham University	Edwards, R (corresponding author), Univ Durham, Ctr Bioact Chem, Durham DH1 3LE, England.	Robert.Edwards@durham.ac.uk	Steel, Patrick/G-3187-2012; Puschmann, Horst/L-3630-2018	Steel, Patrick/0000-0002-2493-5826; Brazier-Hicks, Melissa/0000-0001-5993-1940; Edwards, Robert/0000-0003-0809-5991; EVANS, KATE/0000-0002-2184-7433	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F01094X/1]; BBSRC [BB/F01094X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F01094X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/F01094X/1).	Akashi T, 1998, FEBS LETT, V431, P287, DOI 10.1016/S0014-5793(98)00781-9; Akashi T, 2005, PLANT PHYSIOL, V137, P882, DOI 10.1104/pp.104.056747; Akiyama K, 2002, MOL PLANT MICROBE IN, V15, P334, DOI 10.1094/MPMI.2002.15.4.334; AMINO S, 1985, PHYSIOL PLANTARUM, V64, P197, DOI 10.1111/j.1399-3054.1985.tb02335.x; BESSON E, 1985, PHYTOCHEMISTRY, V24, P1061, DOI 10.1016/S0031-9422(00)83183-0; Bililign T, 2005, NAT PROD REP, V22, P742, DOI 10.1039/b407364a; Brazier M, 2002, PHYTOCHEMISTRY, V59, P149, DOI 10.1016/S0031-9422(01)00458-7; Brazier-Hicks M, 2008, J BIOL CHEM, V283, P21102, DOI 10.1074/jbc.M801998200; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cone K., 1989, Maize Genetics Cooperation News Letter, P68; Cummins I, 2006, PHYTOCHEMISTRY, V67, P1722, DOI 10.1016/j.phytochem.2006.01.012; Dinda B, 2006, CHEM PHARM BULL, V54, P679, DOI 10.1248/cpb.54.679; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Durr C, 2004, ANGEW CHEM INT EDIT, V43, P2962, DOI 10.1002/anie.200453758; ELIX JA, 1990, AUST J CHEM, V43, P1745, DOI 10.1071/CH9901745; Faust B, 2000, MICROBIOL-UK, V146, P147, DOI 10.1099/00221287-146-1-147; Fischbach MA, 2005, P NATL ACAD SCI USA, V102, P571, DOI 10.1073/pnas.0408463102; FRANZ G, 1983, PLANTA MED, V47, P131, DOI 10.1055/s-2007-969972; GAITAN E, 1995, J CLIN ENDOCR METAB, V80, P1144, DOI 10.1210/jc.80.4.1144; Harborne J. B., 1993, FLAVONOIDS ADV RES 1, P57; Hultin PG, 2005, CURR TOP MED CHEM, V5, P1299, DOI 10.2174/156802605774643015; Kazuno S, 2005, ANAL BIOCHEM, V347, P182, DOI 10.1016/j.ab.2005.09.020; KERSCHER F, 1988, J PLANT PHYSIOL, V132, P110, DOI 10.1016/S0176-1617(88)80193-7; KERSCHER F, 1987, Z NATURFORSCH C, V42, P519; Kim JH, 2008, J PLANT BIOL, V51, P97, DOI 10.1007/BF03030717; KIM M, 1985, J CHEM ECOL, V11, P441, DOI 10.1007/BF00989555; Kim YC, 2005, J FOOD SCI, V70, pS575; KITTA K, 1992, J AGR FOOD CHEM, V40, P1843, DOI 10.1021/jf00022a023; LES DH, 1990, AM J BOT, V77, P453, DOI [10.1002/j.1537-2197.1990.tb13576.x, 10.2307/2444379]; Lim EK, 2005, FEBS LETT, V579, P2802, DOI 10.1016/j.febslet.2005.04.016; Loutre C, 2003, PLANT J, V34, P485, DOI 10.1046/j.1365-313X.2003.01742.x; Manthey JA, 2001, CURR MED CHEM, V8, P135, DOI 10.2174/0929867013373723; Markham KR, 1998, PHYTOCHEMISTRY, V49, P1913, DOI 10.1016/S0031-9422(98)00438-5; Markham KR, FLAVONOIDS, DOI 10.1016/0022-2860(71)87109-0; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mittler M, 2007, J MOL BIOL, V372, P67, DOI 10.1016/j.jmb.2007.06.005; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502; RAMARATHNAM N, 1989, J AGR FOOD CHEM, V37, P316, DOI 10.1021/jf00086a009; Rauter AP, 2005, J CHROMATOGR A, V1089, P59, DOI 10.1016/j.chroma.2005.06.046; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHEN CC, 1993, PHYTOCHEMISTRY, V34, P843, DOI 10.1016/0031-9422(93)85370-7	46	208	220	10	95	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17926	17934		10.1074/jbc.M109.009258	http://dx.doi.org/10.1074/jbc.M109.009258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19411659	Green Published, hybrid			2022-12-27	WOS:000267712400004
J	Montalbano, J; Lui, K; Sheikh, MS; Huang, Y				Montalbano, JoAnne; Lui, Ki; Sheikh, M. Saeed; Huang, Ying			Identification and Characterization of RBEL1 Subfamily of GTPases in the Ras Superfamily Involved in Cell Growth Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; GENE; TRANSPORT; CANCER; GAPS; ONCOGENES; NUCLEUS; CLONING; FAMILY; GEFS	Recently, we reported the identification of a novel gene named RBEL1 (Rab-like protein 1) and characterized its two encoded isoforms, RBEL1A and RBEL1B, that function as novel GTPases of Ras superfamily. Here we report the identification of two additional splice variants of RBEL1 that we have named RBEL1C and -D. All four RBEL1 isoforms (A, B, C, and D) have identical N termini harboring the Rab-like GTPase domains but contain variable C termini. Although all isoforms can be detected in both cytoplasm and nucleus, RBEL1A is predominantly cytoplasmic, whereas RBEL1B is mostly nuclear. RBEL1C and -D, by contrast, are evenly distributed between the cytoplasm and nucleus. Furthermore, all four RBEL1 proteins are also capable of associating with cellular membrane. The RBEL1 proteins also exhibit a unique nucleotide-binding potential and, whereas the larger A and B isoforms are mainly GTP-bound, the smaller C and D variants bind to both GTP and GDP. Furthermore, a regulatory region at amino acid position 236 - 302 immediately adjacent to the GTP-binding domain is important for GTP-binding potential of RBEL1A, because deletion of this region converts RBEL1A from predominantly GTP-bound to GDP-bound. RBEL1 knockdown via RNA interference results in marked cell growth suppression, which is associated with morphological and biochemical features of apoptosis as well as inhibition of extracellular signal-regulated kinase phosphorylation. Taken together, our results indicate that RBEL1 proteins are linked to cell growth and survival and possess unique biochemical, cellular, and functional characteristics and, therefore, appear to form a novel subfamily of GTPases within the Ras superfamily.	[Montalbano, JoAnne; Lui, Ki; Sheikh, M. Saeed; Huang, Ying] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Huang, Y (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	huangy@upstate.edu		Lui, Ki/0000-0002-1690-4616	National Institutes of Health [CA113868, DK067271, ES014489]; NATIONAL CANCER INSTITUTE [R21CA113868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA113868 (to Y. H.), DK067271 (to Y. H.), and ES014489 (to M. S. S.).	Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; BOS JL, 1989, CANCER RES, V49, P4682; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; Deneka M, 2003, CRIT REV BIOCHEM MOL, V38, P121, DOI 10.1080/713609214; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; HUANG Y, 1995, ONCOGENE, V11, P1255; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Luo XQ, 2005, CANCER RES, V65, P10725, DOI 10.1158/0008-5472.CAN-05-1132; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Montalbano J, 2007, J BIOL CHEM, V282, P37640, DOI 10.1074/jbc.M704760200; Pei L, 2002, CANCER RES, V62, P5420; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Stenmark H, 2001, GENOME BIOL, V2; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Yao RS, 2003, NEOPLASIA, V5, P41, DOI 10.1016/S1476-5586(03)80016-7; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	32	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18129	18142		10.1074/jbc.M109.009597	http://dx.doi.org/10.1074/jbc.M109.009597			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433581	hybrid, Green Published			2022-12-27	WOS:000267712400024
J	Rashid, S; Pilecka, I; Torun, A; Olchowik, M; Bielinska, B; Miaczynska, M				Rashid, Sajid; Pilecka, Iwona; Torun, Anna; Olchowik, Marta; Bielinska, Beata; Miaczynska, Marta			Endosomal Adaptor Proteins APPL1 and APPL2 Are Novel Activators of beta-Catenin/TCF-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-FACTOR; NEGATIVE REGULATOR; CYCLIN D1; TARGET; GENE; SIGNAL; LOCALIZATION; INHIBITION; RECEPTOR; COMPLEX	Canonical Wnt signaling regulates many aspects of cellular physiology and tissue homeostasis during development and in adult organisms. In molecular terms, stimulation by Wnt ligands leads to the stabilization of beta-catenin, its translocation to the nucleus, and stimulation of TCF (T-cell factor)-dependent transcription of targetgenes. This process is controlled at various stages by a number of regulatory proteins, including transcriptional activators and repressors. Here we demonstrate that the endosomal proteins APPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription. APPL proteins are multifunctional adaptors and effectors of the small GTPase Rab5, which localize to a subpopulation of early endosomes but are also capable of nucleo-cytoplasmic shuttling. Overexpression of APPL1 or APPL2 protein stimulates the activity of beta-catenin/TCF-dependent reporter construct, whereas silencing of APPL1 reduces it. Both APPL proteins interact directly with Reptin, a transcriptional repressor binding to beta-catenin and HDAC1(histone deacetylase 1), and this interaction was mapped to the pleckstrin homology domain of APPL1. Moreover, APPL proteins are present in an endogenous complex containing Reptin, beta-catenin, HDAC1, and HDAC2. Overexpression of either APPL protein relieves Reptin-dependent transcriptional repression and correlates with the reduced amounts of HDAC sand beta-catenin associated with Reptin as well as with the lower levels of Reptin and HDAC1 on the promoters of beta-catenin target genes. We propose that APPL proteins exert their stimulatory effects on beta-catenin/TCF-dependent transcription by decreasing the activity of a Reptin-containing repressive complex.	[Rashid, Sajid; Pilecka, Iwona; Torun, Anna; Olchowik, Marta; Bielinska, Beata; Miaczynska, Marta] Int Inst Mol & Cell Biol, Cell Biol Lab, PL-02109 Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Miaczynska, M (corresponding author), Int Inst Mol & Cell Biol, Cell Biol Lab, Ks Trojdena 4, PL-02109 Warsaw, Poland.	miaczynska@iimcb.gov.pl	Pilecka, Iwona/AAT-9114-2021; Rashid, Sajid/K-8640-2019	Pilecka, Iwona/0000-0002-5057-346X; Miaczynska, Marta/0000-0003-0031-5267; Brewinska-Olchowik, Marta/0000-0002-2135-6220	Howard Hughes Medical Institute; Wellcome Trust Senior Research Fellowship [076469/Z/05/Z]; European Union [LSHG-CT2006-019050]; Polish Ministry of Science and Higher Education [2P04A03828]; Max Planck Society	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust Senior Research Fellowship(Wellcome Trust); European Union(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported in part by an International Research Scholar Grant from the Howard Hughes Medical Institute, Wellcome Trust Senior Research Fellowship 076469/Z/05/Z, European Union Grant LSHG-CT2006-019050 (EndoTrack), Polish Ministry of Science and Higher Education Grant 2P04A03828 and the Mobilitas. pl network, and the Max Planck Society (Partner Group Program).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Chiari E, 2004, J VIROL, V78, P11823, DOI 10.1128/JVI.78.21.11823-11832.2004; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Cong F, 2003, MOL CELL BIOL, V23, P8462, DOI 10.1128/MCB.23.23.8462-8470.2003; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huber O, 2008, CANCER RES, V68, P6873, DOI 10.1158/0008-5472.CAN-08-0547; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Li FQ, 2007, MOL CELL BIOL, V27, P4347, DOI 10.1128/MCB.01640-06; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2002, J BIOL CHEM, V277, P26281, DOI 10.1074/jbc.M204679200; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Mulholland DJ, 2003, ONCOGENE, V22, P5602, DOI 10.1038/sj.onc.1206802; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Pilecka I, 2007, EUR J CELL BIOL, V86, P533, DOI 10.1016/j.ejcb.2007.04.004; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sigala B, 2005, EXP CELL RES, V310, P357, DOI 10.1016/j.yexcr.2005.07.030; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vietor I, 2005, J BIOL CHEM, V280, P39795, DOI 10.1074/jbc.M509836200; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wiechens N, 2004, J BIOL CHEM, V279, P5263, DOI 10.1074/jbc.M307253200; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006	63	51	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18115	18128		10.1074/jbc.M109.007237	http://dx.doi.org/10.1074/jbc.M109.007237			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433865	Green Published, hybrid			2022-12-27	WOS:000267712400023
J	Subramanya, AR; Liu, J; Ellison, DH; Wade, JB; Welling, PA				Subramanya, Arohan R.; Liu, Jie; Ellison, David H.; Wade, James B.; Welling, Paul A.			WNK4 Diverts the Thiazide-sensitive NaCl Cotransporter to the Lysosome and Stimulates AP-3 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; CL COTRANSPORTER; MOLECULAR PATHOGENESIS; SURFACE EXPRESSION; MEMBRANE-PROTEINS; BLOOD-PRESSURE; KINASES; COMPLEX; KIDNEY; CELLS	With-no-lysine kinase 4 (WNK4) inhibits electroneutral sodium chloride reabsorption by attenuating the cell surface expression of the thiazide-sensitive NaCl cotransporter (NCC). The underlying mechanism for this effect remains poorly understood. Here, we explore how WNK4 affects the trafficking of NCC through its interactions with intracellular sorting machinery. An analysis of NCC cell surface lifetime showed that WNK4 did not alter the net rate of cotransporter internalization. In contrast, direct measurements of forward trafficking revealed that WNK4 attenuated the rate of NCC surface delivery, inhibiting the anterograde movement of cotransporters traveling to the plasma membrane from the trans-Golgi network. The response was paralleled by a dramatic reduction in NCC protein abundance, an effect that was sensitive to the lysosomal protease inhibitor leupeptin, insensitive to proteasome inhibition, and attenuated by endogenous WNK4 knockdown. Subcellular localization studies performed in the presence of leupeptin revealed that WNK4 enhanced the accumulation of NCC in lysosomes. Moreover, NCC immunoprecipitated with endogenous AP-3 complexes, and WNK4 increased the fraction of cotransporters that associate with this adaptor, which facilitates cargo transport to lysosomes. WNK4 expression also increased LAMP-2-positive lysosomal content, indicating that the kinase may act by a general AP-3-dependent mechanism to promote cargo delivery into the lysosomal pathway. Taken together, these findings indicate that WNK4 inhibits NCC activity by diverting the cotransporter to the lysosome for degradation by way of an AP-3 transport carrier.	[Subramanya, Arohan R.; Liu, Jie; Wade, James B.; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Subramanya, Arohan R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Subramanya, Arohan R.] Dept Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Wade, James B.] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97239 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University	Subramanya, AR (corresponding author), 660 W Redwood St,HH517, Baltimore, MD 21201 USA.	asubr001@umaryland.edu	Subramanya, Arohan R./AAN-5217-2020; , David/X-5730-2019	Subramanya, Arohan R./0000-0002-2609-7643; Ellison, David/0000-0003-2915-265X	National Institutes of Health [DK072865, DK063049, DK054231, DK051496]; American Heart Association [0755503U]; United States Department of Veterans Affairs Mid-Level Career Development Award; National Kidney Foundation of Maryland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049, F32DK072865, R01DK051496, R01DK054231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Veterans Affairs Mid-Level Career Development Award(US Department of Veterans Affairs); National Kidney Foundation of Maryland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK072865 (to A. R. S.), DK063049 (to P. A. W.), DK054231 (to P. A. W.), and DK051496 (to D. H. E.). This work was also supported by American Heart Association Grant 0755503U (to J. B. W.), a United States Department of Veterans Affairs Mid-Level Career Development Award (to A. R. S.), and a Mini-Grant from the National Kidney Foundation of Maryland (to A. R. S.).	Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Bostonjoglo M, 1998, J AM SOC NEPHROL, V9, P1347; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; FANG L, 2008, FASEB J, V22; Golbang AP, 2006, AM J PHYSIOL-RENAL, V291, pF1369, DOI 10.1152/ajprenal.00468.2005; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Halperin ML, 2000, CAN J PHYSIOL PHARM, V78, P587, DOI 10.1139/cjpp-78-8-587; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Mason AK, 2008, J BIOL CHEM, V283, P5973, DOI 10.1074/jbc.M709756200; McCormick JA, 2008, HYPERTENSION, V51, P588, DOI 10.1161/HYPERTENSIONAHA.107.103788; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; Peng Y, 2001, AM J PHYSIOL-RENAL, V280, pF34, DOI 10.1152/ajprenal.2001.280.1.F34; PFEIFFER S, 1985, J CELL BIOL, V101, P470, DOI 10.1083/jcb.101.2.470; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Song J, 2006, AM J PHYSIOL-RENAL, V290, pF1055, DOI 10.1152/ajprenal.00108.2005; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Yang SS, 2005, BIOCHEM BIOPH RES CO, V330, P410, DOI 10.1016/j.bbrc.2005.02.172; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200	43	85	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18471	18480		10.1074/jbc.M109.008185	http://dx.doi.org/10.1074/jbc.M109.008185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19401467	Green Published, hybrid			2022-12-27	WOS:000267712400058
J	Gianni, T; Amasio, M; Campadelli-Fiume, G				Gianni, Tatiana; Amasio, Michele; Campadelli-Fiume, Gabriella			Herpes Simplex Virus gD Forms Distinct Complexes with Fusion Executors gB and gH/gL in Part through the C-terminal Profusion Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-D; RECEPTOR-BINDING; HERPES-SIMPLEX-VIRUS-1 GH; POLIOVIRUS RECEPTOR; CRYSTAL-STRUCTURE; HEPTAD-REPEAT; ALPHA-HELIX; TYPE-1; ENTRY; MEMBRANE	Herpes simplex virus entry into cells requires a multipartite fusion apparatus made of glycoprotein D (gD), gB, and heterodimer gH/gL. gD serves as a receptor-binding glycoprotein and trigger of fusion; its ectodomain is organized in an N-terminal domain carrying the receptor-binding sites and a C-terminal domain carrying the profusion domain, required for fusion but not receptor binding. gB and gH/gL execute fusion. To understand how the four glycoproteins cross-talk to each other, we searched for biochemical defined complexes in infected and transfected cells and in virions. Previously, interactions were detected in transfected whole cells by split green fluorescent protein complementation (Atanasiu, D., Whitbeck, J. C., Cairns, T. M., Reilly, B., Cohen, G. H., and Eisen-berg, R. J. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 18718-18723; Avitabile, E., Forghieri, C., and Campadelli-Fiume, G. (2007) J. Virol. 81, 11532-11537); it was not determined whether they led to biochemical complexes. Infected cells harbor a gD-gH complex (Perez-Romero, P., Perez, A., Capul, A., Montgomery, R., and Fuller, A. O. (2005) J. Virol. 79, 4540-4544). We report that gD formed complexes with gB in the absence of gH/gL and with gH/gL in the absence of gB. Complexes with similar composition were formed in infected and transfected cells. They were also present in virions prior to entry and did not increase at virus entry into the cell. A panel of gD mutants enabled the preliminary location of part of the binding site in gD to gB to the amino acids 240-260 portion and downstream with Thr(304)-Pro(305) as critical residues and of the binding site to gH/gL at the amino acids 260-310 portion with Pro(291)-Pro(292) as critical residues. The results indicate that gD carries composite-independent binding sites for gB and gH/gL, both of which are partly located in the profusion domain.	[Gianni, Tatiana; Amasio, Michele; Campadelli-Fiume, Gabriella] Univ Bologna, Dept Expt Pathol, Sect Microbiol & Virol, I-40126 Bologna, Italy	University of Bologna	Campadelli-Fiume, G (corresponding author), Univ Bologna, Dept Expt Pathol, Sect Microbiol & Virol, Via San Giacomo 12, I-40126 Bologna, Italy.	gabriella.campadelli@unibo.it		Campadelli-Fiume, Gabriella/0000-0002-6012-6081; GIANNI, TATIANA/0000-0003-1946-2064	TargetHerpes European Union Grant [LSHG-CT-2006-037517]; Fondi Pallotti; Progetti di Ricerca di Interesse Nazionale; Ministero dell'Istruzione Universita e Ricerca; University of Bologna Ricerca Fondamentale Orientata	TargetHerpes European Union Grant; Fondi Pallotti; Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero dell'Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Bologna Ricerca Fondamentale Orientata	This work was supported by TargetHerpes European Union Grant LSHG-CT-2006-037517 (we specifically acknowledge the contribution of IBA GmbH) and by our department through Fondi Pallotti, by Progetti di Ricerca di Interesse Nazionale, Ministero dell'Istruzione Universita e Ricerca, and by a University of Bologna Ricerca Fondamentale Orientata grant.	Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Avitabile E, 2003, J VIROL, V77, P6836, DOI 10.1128/JVI.77.12.6836-6844.2003; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; BAINES JD, 1993, J VIROL, V67, P1441, DOI 10.1128/JVI.67.3.1441-1452.1993; BRANDIMARTI R, 1994, P NATL ACAD SCI USA, V91, P5406, DOI 10.1073/pnas.91.12.5406; Browne H, 2003, J GEN VIROL, V84, P1085, DOI 10.1099/vir.0.19039-0; CAI WH, 1987, J VIROL, V61, P714, DOI 10.1128/JVI.61.3.714-721.1987; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Campadelli-Fiume G, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P93; Campadelli-Fiume G, 2007, REV MED VIROL, V17, P313, DOI 10.1002/rmv.546; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Cocchi F, 1998, J VIROL, V72, P9992, DOI 10.1128/JVI.72.12.9992-10002.1998; Cocchi F, 2004, P NATL ACAD SCI USA, V101, P7445, DOI 10.1073/pnas.0401883101; Cocchi F, 2004, J VIROL, V78, P4720, DOI 10.1128/JVI.78.9.4720-4729.2004; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; Fusco D, 2005, P NATL ACAD SCI USA, V102, P9323, DOI 10.1073/pnas.0503907102; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; Galdiero S, 2008, J BIOL CHEM, V283, P29993, DOI 10.1074/jbc.M803092200; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gianni T, 2006, J VIROL, V80, P2216, DOI 10.1128/JVI.80.5.2216-2224.2006; Gianni T, 2005, J VIROL, V79, P7042, DOI 10.1128/JVI.79.11.7042-7049.2005; Gianni T, 2005, J VIROL, V79, P2931, DOI 10.1128/JVI.79.5.2931-2940.2005; Gianni T, 2006, J VIROL, V80, P8190, DOI 10.1128/JVI.00504-06; Gillet L, 2007, J VIROL, V81, P13082, DOI 10.1128/JVI.01141-07; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Kirschner AN, 2007, J VIROL, V81, P9216, DOI 10.1128/JVI.00575-07; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Lazear E, 2008, J VIROL, V82, P700, DOI 10.1128/JVI.02192-07; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; Markert JM, 2000, REV MED VIROL, V10, P17, DOI 10.1002/(SICI)1099-1654(200001/02)10:1<17::AID-RMV258>3.0.CO;2-G; Menotti L, 2002, VIROLOGY, V301, P6, DOI 10.1006/viro.2002.1620; Menotti L, 2008, J VIROL, V82, P10153, DOI 10.1128/JVI.01133-08; Milne RSB, 2003, J VIROL, V77, P8962, DOI 10.1128/JVI.77.16.8962-8972.2003; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; PARA MF, 1980, J VIROL, V34, P512, DOI 10.1128/JVI.34.2.512-520.1980; Patrone M, 2007, J VIROL, V81, P11479, DOI 10.1128/JVI.00788-07; Perez-Romero P, 2005, J VIROL, V79, P4540, DOI 10.1128/JVI.79.7.4540-4544.2005; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Rey FA, 2006, EMBO REP, V7, P1000, DOI 10.1038/sj.embor.7400807; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; ROOP C, 1993, J VIROL, V67, P2285, DOI 10.1128/JVI.67.4.2285-2297.1993; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; SHOWALTER SD, 1981, INFECT IMMUN, V34, P684, DOI 10.1128/IAI.34.3.684-692.1981; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Stefan A, 1997, J VIROL, V71, P5758, DOI 10.1128/JVI.71.8.5758-5763.1997; STETAN A, 1999, J CLIN MICROBIOL, V37, P3980; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; TORRISI MR, 1992, J VIROL, V66, P554, DOI 10.1128/JVI.66.1.554-561.1992; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Zhou GY, 2007, P NATL ACAD SCI USA, V104, P4142, DOI 10.1073/pnas.0611565104; Zhou GY, 2000, J VIROL, V74, P11782, DOI 10.1128/JVI.74.24.11782-11791.2000	58	81	88	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17370	17382		10.1074/jbc.M109.005728	http://dx.doi.org/10.1074/jbc.M109.005728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19386594	Green Published, hybrid			2022-12-27	WOS:000267202500003
J	Luka, Z; Mudd, SH; Wagner, C				Luka, Zigmund; Mudd, S. Harvey; Wagner, Conrad			Glycine N-Methyltransferase and Regulation of S-Adenosylmethionine Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FOLATE-BINDING-PROTEIN; METHYL-GROUP DEFICIENCY; KNOCKOUT MOUSE MODEL; RAT-LIVER; HEPATOCELLULAR-CARCINOMA; COOPERATIVE BINDING; CRYSTAL-STRUCTURES; PHOSPHORYLATION; PURIFICATION; INHIBITION	Methylation is a major biological process. It has been shown to be important in formation of compounds such as phosphatidylcholine, creatine, and many others and also participates in epigenetic effects through methylation of histones and DNA. The donor of methyl groups for almost all cellular methylation reactions is S-adenosylmethionine. It seems that the level of S-adenosylmethionine must be regulated in response to developmental stages and metabolic changes, and the enzyme glycine N-methyltransferase has been shown to play a major role in such regulation in mammals. This minireview will focus on the latest discoveries in the elucidation of the mechanism of that regulation.	[Luka, Zigmund; Wagner, Conrad] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Mudd, S. Harvey] NIMH, Mol Biol Lab, Bethesda, MD 20892 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Wagner, C (corresponding author), Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA.	conrad.wagner@vanderbilt.edu			National Institutes of Health [R01 DK15289, DK080010]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080010, R01DK015289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK15289 and DK080010 and by a merit revue award from the Department of Veterans Affairs. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Augoustides-Savvopoulou P, 2003, J INHERIT METAB DIS, V26, P745, DOI 10.1023/B:BOLI.0000009978.17777.33; Bhat R, 1996, J BIOL CHEM, V271, P32551, DOI 10.1074/jbc.271.51.32551; CANTONI GL, 1951, J BIOL CHEM, V189, P203; Clarke R, 2003, KIDNEY INT, V63, pS131, DOI 10.1046/j.1523-1755.63.s84.7.x; COOK RJ, 1984, P NATL ACAD SCI-BIOL, V81, P3631, DOI 10.1073/pnas.81.12.3631; COOK RJ, 1989, J NUTR, V119, P612, DOI 10.1093/jn/119.4.612; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; HEADY JE, 1975, CANCER RES, V35, P640; HEADY JE, 1973, J BIOL CHEM, V248, P69; HORNE DW, 1989, J NUTR, V119, P618, DOI 10.1093/jn/119.4.618; Huang Y, 2000, J MOL BIOL, V298, P149, DOI 10.1006/jmbi.2000.3637; Huang YC, 2007, CLIN CANCER RES, V13, P1412, DOI 10.1158/1078-0432.CCR-06-1551; KONISHI K, 1988, J BIOL CHEM, V263, P13381; Krupenko NI, 1997, J BIOL CHEM, V272, P27140, DOI 10.1074/jbc.272.43.27140; Liao YJ, 2009, INT J CANCER, V124, P816, DOI 10.1002/ijc.23979; Liu SP, 2007, HEPATOLOGY, V46, P1413, DOI 10.1002/hep.21863; LOMBARDI B, 1968, J LIPID RES, V9, P437; Luka Z, 2006, PROTEIN SCI, V15, P785, DOI 10.1110/ps.051906706; Luka Z, 2003, BIOCHEM BIOPH RES CO, V312, P1067, DOI 10.1016/j.bbrc.2003.11.037; Luka Z, 2002, HUM GENET, V110, P68, DOI 10.1007/s00439-001-0648-4; Luka Z, 2008, VITAM HORM, V79, P325, DOI 10.1016/S0083-6729(08)00411-1; Luka Z, 2008, BBA-PROTEINS PROTEOM, V1784, P1342, DOI 10.1016/j.bbapap.2008.04.016; Luka Z, 2007, J BIOL CHEM, V282, P4069, DOI 10.1074/jbc.M610384200; Luka Z, 2006, TRANSGENIC RES, V15, P393, DOI 10.1007/s11248-006-0008-1; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; MUDD SH, 1980, METABOLISM, V29, P707, DOI 10.1016/0026-0495(80)90192-4; MUDD SH, 1963, J BIOL CHEM, V238, P2156; Mudd SH, 2001, J INHERIT METAB DIS, V24, P448, DOI 10.1023/A:1010577512912; OGAWA H, 1993, COMP BIOCHEM PHYS B, V106, P601, DOI 10.1016/0305-0491(93)90137-T; Ogawa H, 1997, BIOCHEM BIOPH RES CO, V233, P300, DOI 10.1006/bbrc.1997.6444; OGAWA H, 1982, J BIOL CHEM, V257, P3447; Ogawa H, 1997, BIOCHEM J, V327, P407, DOI 10.1042/bj3270407; Pakhomova S, 2004, PROTEINS, V57, P331, DOI 10.1002/prot.20209; Pattanayek R, 1998, PROTEIN SCI, V7, P1326, DOI 10.1002/pro.5560070608; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; WAGNER C, 1989, J BIOL CHEM, V264, P9638; WAGNER C, 1985, BIOCHEM BIOPH RES CO, V127, P746, DOI 10.1016/S0006-291X(85)80006-1; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Williams KT, 2007, J NUTR, V137, P311, DOI 10.1093/jn/137.2.311; YEO EJ, 1994, P NATL ACAD SCI USA, V91, P210, DOI 10.1073/pnas.91.1.210; YEO EJ, 1992, J BIOL CHEM, V267, P24669; ZAMIEROWSKI MM, 1977, J BIOL CHEM, V252, P933	43	134	136	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22507	22511		10.1074/jbc.R109.019273	http://dx.doi.org/10.1074/jbc.R109.019273			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19483083	Green Published, hybrid			2022-12-27	WOS:000268963100002
J	Kim, TS; Kim, HD; Shin, HS; Kim, J				Kim, Tae-Sung; Kim, Hag Dong; Shin, Hyun-Seock; Kim, Joon			Phosphorylation Status of Nuclear Ribosomal Protein S3 Is Reciprocally Regulated by Protein Kinase C delta and Protein Phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PP2A; MEDIATED PHOSPHORYLATION; FUNCTIONAL INTERACTION; GROWTH-FACTOR; DNA-DAMAGE; B-SUBUNITS; IDENTIFICATION; COMPLEXES; CELLS; ERK	It has been shown previously that ribosomal protein S3 (rpS3) has an endonuclease activity, which is increased by protein kinase C delta (PKC delta)-dependent phosphorylation. However, the reciprocal mechanism for rpS3 dephosphorylation is not known. In this study, we examined phosphatases involved in rpS3 dephosphorylation, and we determined that rpS3 is specifically dephosphorylated by protein phosphatase 2A (PP2A). By immunoprecipitation assay, rpS3 only interacted with PP2Ac but not with protein phosphatase 1. The interaction between rpS3 and PP2Ac occurred only in the nuclear fraction. Moreover, the PP2Ac association with rpS3 was identified in cells transfected with wild-type rpS3 but not with mutant rpS3 lacking PKC delta phosphorylation sites. PP2A inhibition using okadaic acid induced rpS3 phosphorylation. The level of phosphorylated rpS3 in cells was decreased by the overexpression of PP2Ac and was increased by the down-regulation of PP2Ac. Taken together, these results suggest that oxidative stress regulates the phosphorylation status of nonribosomal rpS3 by both activating PKC delta and blocking the PP2A interaction with rpS3.	[Kim, Joon] Korea Univ, Sch Life Sci & Biotechnol, Biochem Lab, Seoul 136701, South Korea; Korea Univ, BioInst, Seoul 136701, South Korea	Korea University; Korea University	Kim, J (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Biochem Lab, Seoul 136701, South Korea.	joonkim@korea.ac.kr			Proteomics [FPR05C2-390]; Korea Science and Engineering Foundation [09-74777]	Proteomics; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported in part by Proteomics Grant FPR05C2-390 and Korea Science and Engineering Foundation Grant 09-74777.	Andjelkovic N, 1996, EMBO J, V15, P7156, DOI 10.1002/j.1460-2075.1996.tb01107.x; Begum N, 1999, BIOCHEM J, V344, P895, DOI 10.1042/0264-6021:3440895; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bos CL, 2006, ONCOGENE, V25, P6447, DOI 10.1038/sj.onc.1209658; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Foley TD, 2004, BIOCHEM BIOPH RES CO, V315, P568, DOI 10.1016/j.bbrc.2004.01.096; Hashigasako A, 2004, J BIOL CHEM, V279, P26445, DOI 10.1074/jbc.M314254200; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Howe CJ, 2004, J BIOL CHEM, V279, P44573, DOI 10.1074/jbc.M404175200; Jang CY, 2004, FEBS LETT, V560, P81, DOI 10.1016/S0014-5793(04)00074-2; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; KAMIBAYASHI C, 1994, J BIOL CHEM, V269, P20139; Kawabe T, 1997, NATURE, V385, P454, DOI 10.1038/385454a0; Kiely PA, 2008, J BIOL CHEM, V283, P22952, DOI 10.1074/jbc.M800802200; Kim HD, 2005, BIOCHEM BIOPH RES CO, V333, P110, DOI 10.1016/j.bbrc.2005.05.079; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kim SH, 2006, BBA-MOL CELL RES, V1763, P823, DOI 10.1016/j.bbamcr.2006.03.011; Kim SH, 2005, BIOCHEM BIOPH RES CO, V328, P962, DOI 10.1016/j.bbrc.2005.01.045; Kim TS, 2009, BBA-MOL CELL RES, V1793, P395, DOI 10.1016/j.bbamcr.2008.10.017; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Lechward K, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1373; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Rao RK, 2002, BIOCHEM BIOPH RES CO, V293, P610, DOI 10.1016/S0006-291X(02)00268-1; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Strack S, 1998, J COMP NEUROL, V392, P515; Tehrani MA, 1996, J BIOL CHEM, V271, P5164; Voorhoeve PM, 1999, ONCOGENE, V18, P515, DOI 10.1038/sj.onc.1202316; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200	50	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21201	21208		10.1074/jbc.M109.018168	http://dx.doi.org/10.1074/jbc.M109.018168			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19458393	hybrid, Green Published			2022-12-27	WOS:000268564400013
J	Michaud-Levesque, J; Richard, S				Michaud-Levesque, Jonathan; Richard, Stephane			Thrombospondin-1 Is a Transcriptional Repression Target of PRMT6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ARGININE METHYLATION; HISTONE H3; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; SM PROTEINS; METHYLTRANSFERASE; GENE; BINDING; ACTIVATION; P53	Protein arginine methyltransferase 6 (PRMT6) is known to catalyze the generation of asymmetric dimethylarginine in polypeptides. Although the cellular role of PRMT6 is not well understood, it has been implicated in human immunodeficiency virus pathogenesis, DNA repair, and transcriptional regulation. PRMT6 is known to methylate histone H3 Arg-2 (H3R2), and this negatively regulates the lysine methylation of H3K4 resulting in gene repression. To identify in a nonbiased manner genes regulated by PRMT6 expression, we performed a microarray analysis on U2OS osteosarcoma cells transfected with control and PRMT6 small interfering RNAs. We identified thrombospondin-1 (TSP-1), a potent natural inhibitor of angiogenesis, as a transcriptional repression target of PRMT6. Moreover, we show that PRMT6-deficient U2OS cells exhibited cell migration defects that were rescued by blocking the secreted TSP-1 with a neutralizing peptide or blocking alpha-TSP-1 antibody. PRMT6 associates with the TSP-1 promoter and regulates the balance of methylation of H3R2 and H3K4, such that in PRMT6-deficient cells H3R2 was hypomethylated and H3K4 was trimethylated at the TSP-1 promoter. Using a TSP-1 promoter reporter gene, we further show that PRMT6 directly regulates the TSP-1 promoter activity. These findings show that TSP-1 is a transcriptional repression target of PRMT6 and suggest that neutralizing the activity of PRMT6 could inhibit tumor progression and therefore may be of cancer therapeutic significance.	McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University	Richard, S (corresponding author), Segal Canc Ctr, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	stephane.richard@mcgill.ca			Canadian Institutes of Health [MOP-93811]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Grant MOP-93811 from the Canadian Institutes of Health.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; ASCH AS, 1992, BIOCHEM BIOPH RES CO, V182, P1208, DOI 10.1016/0006-291X(92)91860-S; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; BAENZIGER NL, 1972, J BIOL CHEM, V247, P2723; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Dawson DW, 1999, MOL PHARMACOL, V55, P332, DOI 10.1124/mol.55.2.332; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; FRAMSON P, 1993, J BIOL CHEM, V268, P4989; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Invernizzi CF, 2007, AIDS, V21, P795, DOI 10.1097/QAD.0b013e32803277ae; Invernizzi CF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-93; JAFFE EA, 1983, P NATL ACAD SCI-BIOL, V80, P998, DOI 10.1073/pnas.80.4.998; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lawler J, 2008, CURR DRUG TARGETS, V9, P820, DOI 10.2174/138945008785909266; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Miranda TB, 2005, BIOCHEM BIOPH RES CO, V336, P831, DOI 10.1016/j.bbrc.2005.08.179; MOSHER DF, 1982, J CELL BIOL, V93, P343, DOI 10.1083/jcb.93.2.343; MOSHER DF, 1990, ANNU REV MED, V41, P85; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Rojas A, 2008, INT J CANCER, V123, P14, DOI 10.1002/ijc.23608; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; SHINGU T, 1994, J BIOL CHEM, V269, P32551; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; TUSZYNSKI GP, 1993, J CELL BIOL, V120, P513, DOI 10.1083/jcb.120.2.513; VARANI J, 1989, CLIN EXP METASTAS, V7, P265, DOI 10.1007/BF01753679; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhao HY, 2008, CANCER RES, V68, P7035, DOI 10.1158/0008-5472.CAN-07-6496; Zou Y, 2007, BIOCHEMISTRY-US, V46, P7896, DOI 10.1021/bi6024897	61	49	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21338	21346		10.1074/jbc.M109.005322	http://dx.doi.org/10.1074/jbc.M109.005322			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509293	hybrid, Green Published			2022-12-27	WOS:000268564400028
J	Li, ZC; Cai, T; Tian, J; Xie, JX; Zhao, XC; Liu, LJ; Shapiro, JI; Xie, ZJ				Li, Zhichuan; Cai, Ting; Tian, Jiang; Xie, Joe X.; Zhao, Xiaochen; Liu, Lijun; Shapiro, Joseph I.; Xie, Zijian			NaKtide, a Na/K-ATPase-derived Peptide Src Inhibitor, Antagonizes Ouabain-activated Signal Transduction in Cultured Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CARDIAC MYOCYTES; ALPHA-SUBUNIT; SARCOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; TYROSINE KINASES; NA+/K+-ATPASE; CALCIUM-PUMP; NA,K-ATPASE; BINDING	We have previously shown that the Na/K-ATPase binds and inhibits Src. Here, we report the molecular mechanism of Na/K-ATPase-mediated Src regulation and the generation of a novel peptide Src inhibitor that targets the Na/K-ATPase/Src receptor complex and antagonizes ouabain-induced protein kinase cascades. First, the Na/K-ATPase inhibits Src kinase through the N terminus of the nucleotide-binding domain of the alpha 1 subunit. Second, detailed mapping leads to the identification of a 20-amino acid peptide (NaKtide) that inhibits Src (IC50 = 70 nM) in an ATP concentration-independent manner. Moreover, NaKtide does not directly affect the ERK and protein kinase C family of kinases. It inhibits Lyn with a much lower potency (IC50 = 2.5 mu M). Third, highly positively charged leader peptide conjugates including HIV-Tat-NaKtide (pNaKtide) readily enter cultured cells. Finally, the following functional studies of pNaKtide demonstrate that this conjugate can specifically target the Na/K-ATPase-interacting pool of Src and act as a potent ouabain antagonist in cultured cells: 1) pNaKtide, unlike PP2, resides in the membranes. Consistently, it affects the basal Src activity much less than that of PP2. 2) pNaKtide is effective in disrupting the formation of the Na/K-ATPase/Src receptor complex in a dose-dependent manner. Consequently, it blocks ouabain-induced activation of Src, ERK, and hypertrophic growth in cardiac myocytes. 3) Unlike PP2, pNaKtide does not affect IGF-induced ERK activation in cardiac myocytes. Taken together, we suggest that pNaKtide may be used as a novel antagonist of ouabain for probing the physiological and pathological significance of the newly appreciated signaling function of Na/K-ATPase and cardiotonic steroids.	[Li, Zhichuan; Cai, Ting; Tian, Jiang; Xie, Joe X.; Zhao, Xiaochen; Liu, Lijun; Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Shapiro, Joseph I.] Univ Toledo, Coll Med, Dept Med, Toledo, OH 43614 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Mail Stop 1008,3000 Arlington Ave, Toledo, OH 43614 USA.	Zi-Jian.Xie@utoledo.edu	Li, Zhichuan/Q-7379-2017		NHLBI [HL-36573]; NIGMS [GM-78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573 from NHLBI and GM-78565 from NIGMS.	Aydemir-Koksoy A, 2001, J BIOL CHEM, V276, P46605, DOI 10.1074/jbc.M106178200; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Boyce BF, 2006, CLIN CANCER RES, V12, p6291S, DOI 10.1158/1078-0432.CCR-06-0991; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Imagawa T, 2003, J BIOL CHEM, V278, P50283, DOI 10.1074/jbc.M309833200; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; JORDAN C, 1995, J BIOL CHEM, V270, P29971; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Lee K, 2001, BIOCHEM J, V353, P377, DOI 10.1042/0264-6021:3530377; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Lou Q, 1997, CANCER RES, V57, P1877; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Miller LD, 2004, ONCOGENE, V23, P5682, DOI 10.1038/sj.onc.1207735; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Peng M, 1996, J BIOL CHEM, V271, P10372, DOI 10.1074/jbc.271.17.10372; Sawyer TK, 2007, TOP MED CHEM SER, V1, P383, DOI 10.1007/7355_2006_010; Schulte RJ, 2003, BIOCHEMISTRY-US, V42, P9424, DOI 10.1021/bi034519u; Shokolenko IN, 2005, DNA REPAIR, V4, P511, DOI 10.1016/j.dnarep.2004.11.009; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2001, AM J PHYSIOL-HEART C, V281, pH1899, DOI 10.1152/ajpheart.2001.281.5.H1899; TOYOFUKU T, 1994, J BIOL CHEM, V269, P22929; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200	37	97	107	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21066	21076		10.1074/jbc.M109.013821	http://dx.doi.org/10.1074/jbc.M109.013821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19506077	Green Published, hybrid			2022-12-27	WOS:000268316100069
J	Pedroja, BS; Kang, LE; Imas, AO; Carmeliet, P; Bernstein, AM				Pedroja, Benjamin S.; Kang, Leah E.; Imas, Alex O.; Carmeliet, Peter; Bernstein, Audrey M.			Plasminogen Activator Inhibitor-1 Regulates Integrin alpha v beta 3 Expression and Autocrine Transforming Growth Factor beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE RECEPTOR; LATENT TGF-BETA-1; FIBROBLASTS; FIBROSIS; MYOFIBROBLAST; DISEASE; CELLS; BINDING; INJURY; LIVER	Fibrosis is characterized by elevated transforming growth factor beta (TGF beta) signaling, resulting in extracellular matrix accumulation and increased PAI-1 (plasminogen activator inhibitor) expression. PAI-1 induces the internalization of urokinase plasminogen activator/receptor and integrin alpha v beta 3 from the cell surface. Since increased alpha v beta 3 expression correlates with increased TGF beta signaling, we hypothesized that aberrant PAI-1-mediated alpha v beta 3 endocytosis could initiate an autocrine loop of TGF beta activity. We found that in PAI-1 knock-out (KO) mouse embryonic fibroblasts), alpha v beta 3 endocytosis was reduced by similar to 75%, leaving alpha v beta 3 in enlarged focal adhesions, similar to wild type cells transfected with PAI-1 small interfering RNA. TGF beta signaling was significantly enhanced in PAI-1 KO cells, as demonstrated by a 3-fold increase in SMAD2/3-containing nuclei and a 2.9-fold increase in TGF beta activity that correlated with an increase in alpha v beta 3 and TGF beta receptor II expression. As expected, PAI-1 KO cells had unregulated plasmin activity, which was only partially responsible for TGF beta activation, as evidenced by a mere 25% reduction in TGF beta activity when plasmin was inhibited. Treatment of cells with an alpha v beta 3-specific cyclic RGD peptide (Gpen-GRGD) led to a more profound (59%) TGF beta inhibition; a nonspecific RGD peptide (GRGDNP) inhibited TGF beta by only 23%. Human primary fibroblasts were used to confirm that PAI-1 inhibition and beta 3 overexpression led to an increase in TGF beta activity. Consistent with a fibrotic phenotype, PAI-1 KO cells were constitutively myofibroblasts that had a 1.6-fold increase in collagen deposition over wild type cells. These data suggest that PAI-1-mediated regulation of alpha v beta 3 integrin is critical for the control of TGF beta signaling and the prevention of fibrotic disease.	[Pedroja, Benjamin S.; Kang, Leah E.; Imas, Alex O.; Bernstein, Audrey M.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA; [Carmeliet, Peter] Katholieke Univ Leuven, B-3000 Leuven, Belgium; [Carmeliet, Peter] Vlaams Inst Biotechnol, Vesalius Res Ctr, B-3000 Leuven, Belgium	Icahn School of Medicine at Mount Sinai; KU Leuven; Flanders Institute for Biotechnology (VIB)	Bernstein, AM (corresponding author), Mt Sinai Sch Med, Dept Ophthalmol, Box 1183,1 Gustave L Levy Pl, New York, NY 10029 USA.	audrey.bernstein@mssm.edu	Imas, Alex/J-3426-2016; Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821; Bernstein, Audrey/0000-0002-2537-2594	National Institutes of Health (NIH), NEI [R01 EYO17030, P30-EY01867]; Research to Prevent Blindness grant; NIH, NCI [5R24 CA095823-04]; National Science Foundation Major Research Instrumentation [DBI-9724504]; NIH Shared Instrumentation [1 S10 RR0 9145-01]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001867, R01EY017030] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness grant(Research to Prevent Blindness (RPB)); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); NIH Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NEI, Grant R01 EYO17030 (to A. M. B.), Core Grant P30-EY01867, and a Research to Prevent Blindness grant. Microscopy was performed at the Mount Sinai School of Medicine-Microscopy Shared Research Facility, supported, in part, with funding from NIH, NCI, Shared Resources Grant 5R24 CA095823-04, National Science Foundation Major Research Instrumentation Grant DBI-9724504, and NIH Shared Instrumentation Grant 1 S10 RR0 9145-01.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Arteel GE, 2008, J GASTROEN HEPATOL, V23, pS54, DOI 10.1111/j.1440-1746.2007.05285.x; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; DAVIDPFEUTY T, 1980, P NATL ACAD SCI-BIOL, V77, P6687, DOI 10.1073/pnas.77.11.6687; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Gharaee-Kermani M, 2008, EXPERT OPIN INV DRUG, V17, P905, DOI 10.1517/13543784.17.6.905 ; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Heng ECK, 2006, J CELL BIOCHEM, V98, P409, DOI 10.1002/jcb.20810; Hill C, 2000, ENDOCRINOLOGY, V141, P1196, DOI 10.1210/en.141.3.1196; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Huang YF, 2007, CURR DRUG TARGETS, V8, P1007, DOI 10.2174/138945007781662373; Kubo M, 2002, J RHEUMATOL, V29, P2558; Lassila M, 2007, DIABETOLOGIA, V50, P1315, DOI 10.1007/s00125-007-0652-x; Ludbrook SB, 2003, BIOCHEM J, V369, P311, DOI 10.1042/BJ20020809; LUND LR, 1987, EMBO J, V6, P1286; Mogford JE, 1997, J CLIN INVEST, V100, P1647, DOI 10.1172/JCI119689; Moriwaki H, 2004, CIRC RES, V95, P637, DOI 10.1161/01.RES.0000141427.61023.f4; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Roberts AB, 2001, CHEST, V120, p43S, DOI 10.1378/chest.120.1_suppl.S43-a; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Sieuwerts AM, 2002, THROMB HAEMOSTASIS, V87, P674; Sisson TH, 2007, CURR DRUG TARGETS, V8, P1016, DOI 10.2174/138945007781662319; Srivatsa SS, 1997, CARDIOVASC RES, V36, P408, DOI 10.1016/S0008-6363(97)00184-3; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan DE, 2007, CURR DRUG TARGETS, V8, P962, DOI 10.2174/138945007781662364; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	36	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20708	20717		10.1074/jbc.M109.018804	http://dx.doi.org/10.1074/jbc.M109.018804			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19487690	hybrid, Green Published			2022-12-27	WOS:000268316100033
J	Vaubourgeix, J; Bardou, F; Boissier, F; Julien, S; Constant, P; Ploux, O; Daffe, M; Quemard, A; Mourey, L				Vaubourgeix, Julien; Bardou, Fabienne; Boissier, Fanny; Julien, Sylviane; Constant, Patricia; Ploux, Olivier; Daffe, Mamadou; Quemard, Annaik; Mourey, Lionel			S-Adenosyl-N-decyl-aminoethyl, a Potent Bisubstrate Inhibitor of Mycobacterium tuberculosis Mycolic Acid Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; FATTY-ACIDS; CELL-WALL; BIOSYNTHESIS; SYNTHASE; REFINEMENT; SINEFUNGIN; VIRULENCE; PHASES; COLI	S-Adenosylmethionine- dependent methyltransferases (Ado-Met-MTs) constitute a large family of enzymes specifically transferring a methyl group to a range of biologically active molecules. Mycobacterium tuberculosis produces a set of paralogous AdoMet-MTs responsible for introducing key chemical modifications at defined positions of mycolic acids, which are essential and specific components of the mycobacterial cell envelope. We investigated the inhibition of these mycolic acid methyltransferases (MA-MTs) by structural analogs of the AdoMet cofactor. We found that S-adenosyl-N-decyl-aminoethyl, a molecule in which the amino acid moiety of AdoMet is substituted by a lipid chain, inhibited MA-MTs from Mycobacterium smegmatis and M. tuberculosis strains, both in vitro and in vivo, with IC50 values in the submicromolar range. By contrast, S-adenosylhomocysteine, the demethylated reaction product, and sinefungin, a general AdoMet-MT inhibitor, did not inhibit MA-MTs. The interaction between Hma (MmaA4), which is strictly required for the biosynthesis of oxygenated mycolic acids in M. tuberculosis, and the three cofactor analogs was investigated by x-ray crystallography. The high resolution crystal structures obtained illustrate the bisubstrate nature of S-adenosyl-N-decyl-aminoethyl and provide insight into its mode of action in the inhibition of MA-MTs. This study has potential implications for the design of new drugs effective against multidrug-resistant and persistent tubercle bacilli.	[Vaubourgeix, Julien; Bardou, Fabienne; Boissier, Fanny; Julien, Sylviane; Constant, Patricia; Daffe, Mamadou; Quemard, Annaik; Mourey, Lionel] CNRS, Inst Pharmacol & Biol Struct, Dept Mecanismes Mol Infect Mycobacteriennes, F-31077 Toulouse, France; [Vaubourgeix, Julien; Bardou, Fabienne; Boissier, Fanny; Julien, Sylviane; Constant, Patricia; Daffe, Mamadou; Quemard, Annaik; Mourey, Lionel] Univ Toulouse 3, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Ploux, Olivier] Ecole Natl Super Chim Paris, CNRS, UMR7573, Lab Biochim Microorganismes Enzymol,Metab & Anti, F-75231 Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech	Quemard, A (corresponding author), CNRS, Inst Pharmacol & Biol Struct, Dept Mecanismes Mol Infect Mycobacteriennes, 205 Route Narbonne, F-31077 Toulouse, France.	annaik.quemard@ipbs.fr; lionel.mourey@ipbs.fr	Mourey, Lionel/B-5662-2009	Mourey, Lionel/0000-0002-8259-1259; Vaubourgeix, Julien/0000-0003-4872-0464; Quemard, Annaik/0000-0002-5545-3424				Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Carr RAE, 2005, DRUG DISCOV TODAY, V10, P987, DOI 10.1016/S1359-6446(05)03511-7; DAFFE M, 1983, ANN INST PASTEUR MIC, VB134, P241, DOI 10.1016/S0769-2609(83)80037-4; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; DeLano W.L, PYMOL MOL GRAPHICS S; Dinadayala P, 2003, J BIOL CHEM, V278, P7310, DOI 10.1074/jbc.M210501200; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; GOMEZFLORES R, 1995, J CLIN MICROBIOL, V33, P1842, DOI 10.1128/JCM.33.7.1842-1846.1995; Guianvarc'h D, 2008, BBA-PROTEINS PROTEOM, V1784, P1652, DOI 10.1016/j.bbapap.2008.04.019; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; LACAVE C, 1990, BIOCHIM BIOPHYS ACTA, V1045, P58, DOI 10.1016/0005-2760(90)90203-A; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laval F, 2008, J BIOL CHEM, V283, P1419, DOI 10.1074/jbc.M708859200; LESLIE AGW, 1987, P CCP4 STUD WEEK SER, P39; Marrakchi H, 2008, MYCOBACTERIAL CELL ENVELOPE, P41; MCCAMMON MT, 1981, J BACTERIOL, V145, P106, DOI 10.1128/JB.145.1.106-112.1981; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; Sankar Manimuthu Mani, 2008, Ann Clin Microbiol Antimicrob, V7, P15, DOI 10.1186/1476-0711-7-15; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SMITH DD, 1980, BIOCHEM BIOPH RES CO, V94, P1458, DOI 10.1016/0006-291X(80)90583-5; WANG AY, 1992, BIOCHEMISTRY-US, V31, P11020, DOI 10.1021/bi00160a011; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Yuan Y, 1998, J BIOL CHEM, V273, P21282, DOI 10.1074/jbc.273.33.21282; Zheng SS, 2006, J BIOL CHEM, V281, P35904, DOI 10.1074/jbc.M607292200; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	44	23	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19321	19330		10.1074/jbc.M809599200	http://dx.doi.org/10.1074/jbc.M809599200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19439410	Green Published, hybrid			2022-12-27	WOS:000267908300023
J	Jouhet, J; Gray, JC				Jouhet, Juliette; Gray, John C.			Interaction of Actin and the Chloroplast Protein Import Apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYLAKOID MEMBRANE FORMATION; OUTER ENVELOPE; POLYACRYLAMIDE GELS; MESOPHYLL-CELLS; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; ROOT GRAVITROPISM; PLASTIDS; ARABIDOPSIS; PLANTS	Actin filaments are major components of the cytoskeleton and play numerous essential roles, including chloroplast positioning and plastid stromule movement, in plant cells. Actin is present in pea chloroplast envelope membrane preparations and is localized at the surface of the chloroplasts, as shown by agglutination of intact isolated chloroplasts by antibodies to actin. To identify chloroplast envelope proteins involved in actin binding, we have carried out actin co-immunoprecipitation and co-sedimentation experiments on detergent-solubilized pea chloroplast envelope membranes. Proteins co-immunoprecipitated with actin were identified by mass spectrometry and by Western blotting and included the Toc159, Toc75, Toc34, and Tic110 components of the TOC-TIC protein import apparatus. A direct interaction of actin with Escherichia coli-expressed Toc159, but not Toc33, was shown by co-sedimentation experiments, suggesting that Toc159 is the component of the TOC complex that interacts with actin on the cytosolic side of the outer envelope membrane. The physiological significance of this interaction is unknown, but it may play a role in the import of nuclear-encoded photosynthesis proteins.	[Jouhet, Juliette; Gray, John C.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Gray, JC (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	jcg2@cam.ac.uk			EMBO	EMBO(European Molecular Biology Organization (EMBO))	This project was supported by an EMBO long term fellowship.	Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Aseeva E, 2007, PLANT PHYSIOL BIOCH, V45, P119, DOI 10.1016/j.plaphy.2007.01.005; Balsera M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-43; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bolter B, 1999, EMBO J, V18, P5505, DOI 10.1093/emboj/18.20.5505; Boonsirichai K, 2002, ANNU REV PLANT BIOL, V53, P421, DOI 10.1146/annurev.arplant.53.100301.135158; Brautigam A, 2008, J BIOTECHNOL, V136, P44, DOI 10.1016/j.jbiotec.2008.02.007; BROGLIE RM, 1980, P NATL ACAD SCI-BIOL, V77, P87, DOI 10.1073/pnas.77.1.87; Chen KH, 2000, PLANT PHYSIOL, V122, P813, DOI 10.1104/pp.122.3.813; CLINE K, 1981, P NATL ACAD SCI-BIOL, V78, P3595, DOI 10.1073/pnas.78.6.3595; Gray JC, 2001, PLANT BIOLOGY, V3, P223, DOI 10.1055/s-2001-15204; Gutensohn M, 2006, J PLANT PHYSIOL, V163, P333, DOI 10.1016/j.jplph.2005.11.009; Hanson MR, 2008, PLANT CELL ENVIRON, V31, P646, DOI 10.1111/j.1365-3040.2007.01768.x; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Higaki T, 2007, CURR OPIN PLANT BIOL, V10, P549, DOI 10.1016/j.pbi.2007.08.012; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Holzinger A, 2007, PLANT BIOLOGY, V9, P400, DOI 10.1055/s-2006-924727; Hou GC, 2003, PLANT PHYSIOL, V131, P1360, DOI 10.1104/pp.014423; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kandasamy MK, 1999, CELL MOTIL CYTOSKEL, V44, P110, DOI 10.1002/(SICI)1097-0169(199910)44:2<110::AID-CM3>3.0.CO;2-O; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; Kessler F, 1996, P NATL ACAD SCI USA, V93, P7684, DOI 10.1073/pnas.93.15.7684; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Kumar NS, 2008, AM J BOT, V95, P177, DOI 10.3732/ajb.95.2.177; Kumatani T, 2006, PROTOPLASMA, V229, P45, DOI 10.1007/s00709-006-0189-8; Kwok EY, 2003, PLANT J, V35, P16, DOI 10.1046/j.1365-313X.2003.01777.x; Liebe S, 1995, BIOL CELL, V85, P207, DOI 10.1016/0248-4900(96)85282-8; Liu CM, 2005, MOL BIOL CELL, V16, P1165, DOI 10.1091/mbc.E04-08-0736; Liu CM, 2007, PLANT J, V50, P265, DOI 10.1111/j.1365-313X.2007.03047.x; Ma YK, 1996, J CELL BIOL, V134, P315, DOI 10.1083/jcb.134.2.315; Natesan SKA, 2005, J EXP BOT, V56, P787, DOI 10.1093/jxb/eri088; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Oikawa K, 2003, PLANT CELL, V15, P2805, DOI 10.1105/tpc.016428; Oikawa K, 2008, PLANT PHYSIOL, V148, P829, DOI 10.1104/pp.108.123075; Oreb M, 2008, TRENDS CELL BIOL, V18, P19, DOI 10.1016/j.tcb.2007.10.002; Palmieri M, 2007, PHYSIOL PLANTARUM, V130, P613, DOI 10.1111/j.1399-3054.2007.00926.x; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; Schnell DJ, 1997, TRENDS CELL BIOL, V7, P303, DOI 10.1016/S0962-8924(97)01111-2; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Sheahan MB, 2004, PLANT J, V37, P379, DOI 10.1046/j.1365-313X.2003.01967.x; Smith MD, 2004, J CELL BIOL, V165, P323, DOI 10.1083/jcb.200311074; Stanga JP, 2009, PLANT PHYSIOL, V149, P1896, DOI 10.1104/pp.109.135301; Suetsugu N, 2007, BIOL CHEM, V388, P927, DOI 10.1515/BC.2007.118; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; Takagi S, 2003, J EXP BIOL, V206, P1963, DOI 10.1242/jeb.00215; Teyssier E, 1996, PLANT J, V10, P903, DOI 10.1046/j.1365-313X.1996.10050903.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; von Braun SS, 2008, PLANTA, V227, P1151, DOI 10.1007/s00425-007-0688-7; Wang ZY, 2004, CELL MOTIL CYTOSKEL, V57, P218, DOI 10.1002/cm.10168; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Weibel P, 2003, J BIOL CHEM, V278, P37321, DOI 10.1074/jbc.M305946200; WERNERWASHBURNE M, 1983, PLANT PHYSIOL, V73, P569, DOI 10.1104/pp.73.3.569; Yamamoto K, 2002, PLANT PHYSIOL, V128, P669, DOI 10.1104/pp.010804	55	40	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19132	19141		10.1074/jbc.M109.012831	http://dx.doi.org/10.1074/jbc.M109.012831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19435889	hybrid, Green Published			2022-12-27	WOS:000267711500061
J	Tikhonov, DB; Zhorov, BS				Tikhonov, Denis B.; Zhorov, Boris S.			Structural Model for Dihydropyridine Binding to L-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMANENTLY CHARGED 1,4-DIHYDROPYRIDINES; CA2+ CHANNEL; SODIUM-CHANNEL; OPTICAL ISOMERS; DRUG-BINDING; K+ CHANNEL; MOLECULAR DETERMINANTS; SLOW INACTIVATION; POTASSIUM CHANNEL; LOCAL-ANESTHETICS	1,4-Dihydropyridines (DHPs) constitute a major class of ligands for L-type Ca2+ channels (LTCC). The DHPs have a boat-like, six-membered ring with an NH group at the stern, an aromatic moiety at the bow, and substituents at the port and starboard sides. Various DHPs exhibit antagonistic or agonistic activities, which were previously explained as stabilization or destabilization, respectively, of the closed activation gate by the portside substituents. Here we report a novel structural model in which agonist and antagonist activities are determined by different parts of the DHP molecule and have different mechanisms. In our model, which is based on Monte Carlo minimizations of DHP-LTCC complexes, the DHP moieties at the stern, bow, and starboard form H-bonds with side chains of the key DHP-sensing residues Tyr_IIIS6, Tyr_IVS6, and Gln_IIIS5, respectively. We propose that these H-bonds, which are common for agonists and antagonists, stabilize the LTCC conformation with the open activation gate. This explains why both agonists and antagonists increase probability of the long lasting channel openings and why even partial disruption of the contacts eliminates the agonistic action. In our model, the portside approaches the selectivity filter. Hydrophobic portside of antagonists may induce long lasting channel closings by destabilizing Ca2+ binding to the selectivity filter glutamates. Agonists have either hydrophilic substituents or a hydrogen atom at their portside, and thus lack this destabilizing effect. The predicted orientation of the DHP core allows accommodation of long substituents in the domain interface or in the inner pore. Our model may be useful for developing novel clinically relevant LTCC blockers.	[Tikhonov, Denis B.; Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Tikhonov, Denis B.] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia	McMaster University; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Zhorov, BS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	zhorov@mcmaster.ca	Zhorov, Boris/T-9892-2019; Tikhonov, Denis/AAK-9148-2020; Zhorov, Boris S./V-8072-2019	Zhorov, Boris/0000-0002-3630-7114; Tikhonov, Denis/0000-0001-8523-4305	Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to B. S.Z.).	ARROWSMITH JE, 1986, J MED CHEM, V29, P1696, DOI 10.1021/jm00159a022; BAINDUR N, 1993, J MED CHEM, V36, P3743, DOI 10.1021/jm00075a034; BANGALORE R, 1994, MOL PHARMACOL, V46, P660; Berjukow S, 2000, J BIOL CHEM, V275, P22114, DOI 10.1074/jbc.M908836199; Bodi I, 1997, J BIOL CHEM, V272, P24952, DOI 10.1074/jbc.272.40.24952; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Bruhova I, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-5; Bruhova I, 2009, BIOPHYS J, V96, p183A, DOI 10.1016/j.bpj.2008.12.854; CAHALAN MD, 1979, BIOPHYS J, V27, P39, DOI 10.1016/S0006-3495(79)85201-7; CERBAI E, 1990, J CARDIOVASC PHARM, V15, P604, DOI 10.1097/00005344-199004000-00013; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Chen ZH, 2000, J PHYSIOL-LONDON, V524, P37, DOI 10.1111/j.1469-7793.2000.t01-1-00037.x; Cosconati S, 2007, J MED CHEM, V50, P1504, DOI 10.1021/jm061245a; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; FRANCKOWIAK G, 1985, EUR J PHARMACOL, V114, P223, DOI 10.1016/0014-2999(85)90631-4; GOLDMANN S, 1991, ANGEW CHEM INT EDIT, V30, P1559, DOI 10.1002/anie.199115591; Grabner M, 1996, NEURON, V16, P207, DOI 10.1016/S0896-6273(00)80037-9; He M, 1997, J BIOL CHEM, V272, P2629, DOI 10.1074/jbc.272.5.2629; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Hockerman GH, 1997, P NATL ACAD SCI USA, V94, P14906, DOI 10.1073/pnas.94.26.14906; HOF RP, 1985, J CARDIOVASC PHARM, V7, P689, DOI 10.1097/00005344-198507000-00012; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Ito H, 1997, MOL PHARMACOL, V52, P735, DOI 10.1124/mol.52.4.735; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; KASS RS, 1987, CIRC RES, V61, P1; KASS RS, 1989, J GEN PHYSIOL, V93, P1109, DOI 10.1085/jgp.93.6.1109; KASS RS, 1991, J GEN PHYSIOL, V98, P63, DOI 10.1085/jgp.98.1.63; KOKUBUN S, 1984, P NATL ACAD SCI-BIOL, V81, P4824, DOI 10.1073/pnas.81.15.4824; KWAN YW, 1995, J MOL CELL CARDIOL, V27, P253, DOI 10.1016/S0022-2828(08)80024-7; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Lipkind GM, 2003, MOL PHARMACOL, V63, P499, DOI 10.1124/mol.63.3.499; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MITTERDORFER J, 1995, BIOCHEMISTRY-US, V34, P9350, DOI 10.1021/bi00029a010; Mitterdorfer J, 1996, J BIOL CHEM, V271, P30330, DOI 10.1074/jbc.271.48.30330; MUTO K, 1988, ARZNEIMITTEL-FORSCH, V38-2, P1662; Peri R, 2000, J MED CHEM, V43, P2906, DOI 10.1021/jm000028l; Peterson BZ, 2006, MOL PHARMACOL, V70, P667, DOI 10.1124/mol.105.020644; Peterson BZ, 1997, J BIOL CHEM, V272, P18752, DOI 10.1074/jbc.272.30.18752; PETERSON BZ, 1995, J BIOL CHEM, V270, P18201, DOI 10.1074/jbc.270.31.18201; Peterson BZ, 1996, J BIOL CHEM, V271, P5293, DOI 10.1074/jbc.271.10.5293; Schuster A, 1996, EMBO J, V15, P2365, DOI 10.1002/j.1460-2075.1996.tb00592.x; Tikhonov DB, 2005, FEBS LETT, V579, P4207, DOI 10.1016/j.febslet.2005.07.017; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2008, J BIOL CHEM, V283, P17594, DOI 10.1074/jbc.M800141200; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; TOWART R, 1982, ARZNEIMITTEL-FORSCH, V32-1, P338; Wang SY, 2007, CHANNELS, V1, pE1, DOI 10.4161/chan.4437; Wang SY, 2007, PFLUG ARCH EUR J PHY, V454, P277, DOI 10.1007/s00424-006-0202-2; Wang SY, 2006, MOL PHARMACOL, V69, P788, DOI 10.1124/mol.105.018200; Wanner-Olsen H, 2000, CHIRALITY, V12, P660, DOI 10.1002/1520-636X(2000)12:9<660::AID-CHIR3>3.0.CO;2-1; Wappl E, 2001, J BIOL CHEM, V276, P12730, DOI 10.1074/jbc.M010164200; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WILLIAMS JS, 1985, BIOCHEM BIOPH RES CO, V131, P13, DOI 10.1016/0006-291X(85)91763-2; Yamaguchi S, 2003, MOL PHARMACOL, V64, P235, DOI 10.1124/mol.64.2.235; Yamaguchi S, 2000, J BIOL CHEM, V275, P41504, DOI 10.1074/jbc.M007165200; Zhen XG, 2005, J GEN PHYSIOL, V126, P193, DOI 10.1085/jgp.200509292; Zhorov BS, 1996, BIOPHYS J, V70, P22, DOI 10.1016/S0006-3495(96)79561-9; Zhorov BS, 2001, ARCH BIOCHEM BIOPHYS, V393, P22, DOI 10.1006/abbi.2001.2484	65	61	65	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19006	19017		10.1074/jbc.M109.011296	http://dx.doi.org/10.1074/jbc.M109.011296			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19416978	Green Published, hybrid			2022-12-27	WOS:000267711500050
J	Toustrup-Jensen, MS; Holm, R; Einholm, AP; Schack, VR; Morth, JP; Nissen, P; Andersen, JP; Vilsen, B				Toustrup-Jensen, Mads S.; Holm, Rikke; Einholm, Anja Pernille; Schack, Vivien Rodacker; Morth, J. Preben; Nissen, Poul; Andersen, Jens Peter; Vilsen, Bente			The C Terminus of Na+, K+-ATPase Controls Na+ Affinity on Both Sides of the Membrane through Arg(935)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH TRANSMEMBRANE SEGMENT; SODIUM-PUMP; FUNCTIONAL CONSEQUENCES; ADENOSINE-TRIPHOSPHATE; CATION-BINDING; ADP EXCHANGE; NA,K-ATPASE; NA+,K+-ATPASE; TRANSPORT; SITES	The Na+, K+-ATPase C terminus has a unique location between transmembrane segments, appearing to participate in a network of interactions. We have examined the functional consequences of amino acid substitutions in this region and deletions of the C terminus of varying lengths. Assays revealing separately the mutational effects on internally and externally facing Na+ sites, as well as E-1-E-2 conformational changes, have been applied. The results pinpoint the two terminal tyrosines, Tyr(1017) and Tyr(1018), as well as putative interaction partners, Arg(935) in the loop between transmembrane segments M8 and M9 and Lys(768) in transmembrane segment M5, as crucial to Na+ activation of phosphorylation of E-1, a partial reaction reflecting Na+ interaction on the cytoplasmic side of the membrane. Tyr1017, Tyr1018, and Arg935 are furthermore indispensable to Na+ interaction on the extracellular side of the membrane, as revealed by inability of high Na+ concentrations to drive the transition from E1P to E2P backwards toward E1P and inhibit Na+-ATPase activity in mutants. Lys768 is not important for Na+ binding from the external side of the membrane but is involved in stabilization of the E-2 form. These data demonstrate that the C terminus controls Na+ affinity on both sides of the membrane and suggest that Arg935 constitutes an important link between the C terminus and the third Na+ site, involving an arginine-pi stacking interaction between Arg935 and the C-terminal tyrosines. Lys768 may interact preferentially with the C terminus in E1 and E1P forms and with the loop between transmembrane segments M6 and M7 in E-2 and E2P forms.	[Toustrup-Jensen, Mads S.; Holm, Rikke; Einholm, Anja Pernille; Schack, Vivien Rodacker; Andersen, Jens Peter; Vilsen, Bente] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Toustrup-Jensen, Mads S.; Holm, Rikke; Einholm, Anja Pernille; Schack, Vivien Rodacker; Morth, J. Preben; Nissen, Poul; Andersen, Jens Peter; Vilsen, Bente] Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, DK-8000 Aarhus C, Denmark; [Morth, J. Preben; Nissen, Poul] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Danmarks Grundforskningsfond; Aarhus University	Vilsen, B (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Ole Worms Alle 6,Blg 1180, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk	Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Vilsen, Bente/0000-0002-4727-9382; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861; Andersen, Jens Peter/0000-0003-0654-4300; Nissen, Poul/0000-0003-0948-6628; Schack, Vivien/0000-0002-1365-3938	Lundbeck Foundation, Denmark; Danish Medical Research Council; Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat), Denmark; Danish National Research Foundation (PUMPKIN Centre)	Lundbeck Foundation, Denmark(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat), Denmark(Novo Nordisk Foundation); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond)	This study was funded in part by grants from the Lundbeck Foundation, Denmark, the Danish Medical Research Council, the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat), Denmark, and the Danish National Research Foundation (PUMPKIN Centre).	BEAUGE LA, 1979, J PHYSIOL-LONDON, V289, P17, DOI 10.1113/jphysiol.1979.sp012722; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P159, DOI 10.1113/jphysiol.1967.sp008294; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; GLYNN IM, 1976, J PHYSIOL-LONDON, V256, P465, DOI 10.1113/jphysiol.1976.sp011333; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KAPLAN JH, 1982, J GEN PHYSIOL, V80, P915, DOI 10.1085/jgp.80.6.915; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; KAPLAN JH, 1985, J GEN PHYSIOL, V85, P123, DOI 10.1085/jgp.85.1.123; LAUGER P, 1991, ELECTROGENIC ION PUM, P27; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; POST RL, 1972, J BIOL CHEM, V247, P6530; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Schneeberger A, 1999, J MEMBRANE BIOL, V168, P221, DOI 10.1007/s002329900511; Skou J. C, 1991, SODIUM PUMP RECENT D, P317; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; TANIGUCHI K, 1975, J BIOL CHEM, V250, P3010; Therien AG, 1996, J BIOL CHEM, V271, P7104, DOI 10.1074/jbc.271.12.7104; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; Vilsen B, 1997, ANN NY ACAD SCI, V834, P297, DOI 10.1111/j.1749-6632.1997.tb52260.x; WUDDEL I, 1995, BIOPHYS J, V69, P909, DOI 10.1016/S0006-3495(95)79965-9; YODA S, 1986, J BIOL CHEM, V261, P1147	38	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18715	18725		10.1074/jbc.M109.015099	http://dx.doi.org/10.1074/jbc.M109.015099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19416970	Green Published, hybrid			2022-12-27	WOS:000267711500021
J	Kabra, N; Li, ZY; Chen, LH; Li, BZ; Zhang, XH; Wang, CG; Yeatman, T; Coppola, D; Chen, JD				Kabra, Neha; Li, Zhenyu; Chen, Lihong; Li, Baozong; Zhang, Xiaohong; Wang, Chuangui; Yeatman, Timothy; Coppola, Domenico; Chen, Jiandong			SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ACTIVATORS; PANCREATIC BETA-CELLS; DNA-DAMAGE; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; INSULIN-SECRETION; INCREASED DOSAGE; REGULATES SIRT1; SURVIVAL	The NAD-dependent deacetylase SirT1 regulates factors involved in stress response and cell survival and is a potential drug target of activators and inhibitors. Determination of SirT1 function in tumor cells is important for its targeting in cancer therapy. We found that SirT1 knockdown by short hairpin RNA accelerates tumor xenograft formation by HCT116 cells, whereas SirT1 overexpression inhibits tumor formation. Furthermore, pharmacological inhibition of SirT1 stimulates cell proliferation under conditions of growth factor deprivation. Paradoxically, SirT1 inhibition also sensitizes cells to apoptosis by chemotherapy drugs. Immunohistochemical staining revealed high level SirT1 in normal colon mucosa and benign adenomas. SirT1 overexpression was observed in similar to 25% of stage I/II/III colorectal adenocarcinomas but rarely found in advanced stage IV tumors. Furthermore, similar to 30% of carcinomas showed lower than normal SirT1 expression. This pattern is consistent with SirT1 having pleiotropic effects during cancer development (anti-proliferation and anti-apoptotic). These results suggest a rationale for the use of SirT1 activators and inhibitors in the prevention and treatment of colon cancer.	[Kabra, Neha; Li, Zhenyu; Chen, Lihong; Li, Baozong; Zhang, Xiaohong; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; [Yeatman, Timothy] H Lee Moffitt Canc Ctr & Res Inst, Dept Surg, Tampa, FL 33612 USA; [Coppola, Domenico] H Lee Moffitt Canc Ctr & Res Inst, Div Anat Pathol, Tampa, FL 33612 USA; [Zhang, Xiaohong] Univ S Florida, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Wang, Chuangui] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; East China Normal University	Chen, JD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA.	Jiandong.chen@moffitt.org	li, baozong/K-4176-2012; Li, Baozong/ABD-4742-2020		National Institutes of Health [CA121291]; NATIONAL CANCER INSTITUTE [R01CA121291, R01CA112215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA121291 ( to J. C.).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Guarante LP, 2005, ANN NY ACAD SCI, V1055, P222; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; LUONGO C, 1994, CANCER RES, V54, P5947; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	37	144	151	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18210	18217		10.1074/jbc.M109.000034	http://dx.doi.org/10.1074/jbc.M109.000034			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433578	Green Published, hybrid			2022-12-27	WOS:000267712400033
J	Schmidtchen, A; Pasupuleti, M; Morgelin, M; Davoudi, M; Alenfall, J; Chalupka, A; Malmsten, M				Schmidtchen, Artur; Pasupuleti, Mukesh; Morgelin, Matthias; Davoudi, Mina; Alenfall, Jan; Chalupka, Anna; Malmsten, Martin			Boosting Antimicrobial Peptides by Hydrophobic Oligopeptide End Tags	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING PEPTIDES; ANTIBACTERIAL PEPTIDES; WATER-INTERFACE; LIPID-BILAYERS; MEMBRANE; TRYPTOPHAN; BACTERIA; LIPOPEPTIDES; SELECTIVITY; RESISTANCE	A novel approach for boosting antimicrobial peptides through end tagging with hydrophobic oligopeptide stretches is demonstrated. Focusing on two peptides derived from kininogen, GKHKNKGKKNGKHNGWK (GKH17) and HKHGHGHGKHKNKGKKN (HKH17), tagging resulted in enhanced killing of Gram-positive Staphylococcus aureus, Gram-negative Escherichia coli, and fungal Candida albicans. Microbicidal potency increased with tag length, also in plasma, and was larger for Trp and Phe stretches than for aliphatic ones. The enhanced microbicidal effects correlated to a higher degree of bacterial wall rupture. Analogously, tagging promoted peptide binding to model phospholipid membranes and liposome rupture, particularly for anionic and cholesterol-void membranes. Tagged peptides displayed low toxicity, particularly in the presence of serum, and resisted degradation by human leukocyte elastase and by staphylococcal aureolysin and V8 proteinase. The biological relevance of these findings was demonstrated ex vivo and in vivo in porcine S. aureus skin infection models. The generality of end tagging for facile boosting of antimicrobial peptides without the need for post-synthesis modification was also demonstrated.	[Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden; [Schmidtchen, Artur; Pasupuleti, Mukesh; Davoudi, Mina; Chalupka, Anna] Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, SE-22184 Lund, Sweden; [Morgelin, Matthias; Alenfall, Jan] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Morgelin, Matthias; Alenfall, Jan] Dermagen AB, SE-22363 Lund, Sweden	Uppsala University; Lund University; Lund University	Malmsten, M (corresponding author), Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden.	martin.malmsten@farmaci.uu.se	Schmidtchen, Artur/F-9507-2015; Pasupuleti, Mukesh/AAF-4066-2020; Pasupuleti, Mukesh/H-7605-2013; Pasupuleti, Mukesh/AAD-9977-2020	Pasupuleti, Mukesh/0000-0001-6337-6257; Davoudi, Mina/0000-0002-4952-1099	Swedish Research Council [521-2006-2784, 621-2003-4022]; Royal Physiographic Society in Lund; Welander-Finsen; Soderberg; Schyberg; Crafoord; Alfred Osterlund; Kock Foundations; Swedish Government Funds for Clinical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Welander-Finsen; Soderberg; Schyberg; Crafoord; Alfred Osterlund; Kock Foundations; Swedish Government Funds for Clinical Research	This work was supported by Swedish Research Council Projects 521-2006-2784 and 621-2003-4022, the Royal Physiographic Society in Lund, the Welander-Finsen, Soderberg, Schyberg, Crafoord, Alfred Osterlund, and Kock Foundations, and the Swedish Government Funds for Clinical Research.	Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Avrahami D, 2004, J BIOL CHEM, V279, P12277, DOI 10.1074/jbc.M312260200; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; Bhonsle JB, 2007, J MED CHEM, V50, P6545, DOI 10.1021/jm070884y; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; de Planque MRR, 1999, J BIOL CHEM, V274, P20839, DOI 10.1074/jbc.274.30.20839; DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; EMBER JA, 1991, BIOCHEMISTRY-US, V30, P3603, DOI 10.1021/bi00229a003; Fimland G, 2002, BIOCHEMISTRY-US, V41, P9508, DOI 10.1021/bi025856q; French GL, 2005, ADV DRUG DELIVER REV, V57, P1514, DOI 10.1016/j.addr.2005.04.005; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haney EF, 2007, BBA-BIOMEMBRANES, V1768, P2355, DOI 10.1016/j.bbamem.2007.04.018; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Ishitsuka Y, 2006, BBA-BIOMEMBRANES, V1758, P1450, DOI 10.1016/j.bbamem.2006.08.001; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jerala R, 2007, EXPERT OPIN INV DRUG, V16, P1159, DOI 10.1517/13543784.16.8.1159; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li X, 2006, BBA-BIOMEMBRANES, V1758, P1203, DOI 10.1016/j.bbamem.2006.03.032; Lotte K, 2004, PHOTOCH PHOTOBIO SCI, V3, P348, DOI 10.1039/b312436c; MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P333, DOI 10.1006/jcis.1994.1303; Malmsten M., 2003, SURFACTANTS POLYM DR; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Masny A, 2001, BIOTECHNIQUES, V31, P930, DOI 10.2144/01314rr04; McDonnell G, 1999, J MICROBIOL METH, V35, P31, DOI 10.1016/S0167-7012(98)00094-3; McInturff JE, 2005, J INVEST DERMATOL, V125, P256, DOI 10.1111/j.0022-202X.2005.23805.x; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k; Ringstad L, 2007, BBA-BIOMEMBRANES, V1768, P715, DOI 10.1016/j.bbamem.2006.11.016; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Stromstedt AA, 2009, ANTIMICROB AGENTS CH, V53, P593, DOI 10.1128/AAC.00477-08; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; Tiberg F, 2000, EUR BIOPHYS J BIOPHY, V29, P196, DOI 10.1007/PL00006646; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tossi A, 2002, PEPTIDES 2002, P416; Wei SY, 2006, J BACTERIOL, V188, P328, DOI 10.1128/JB.188.1.328-334.2006; WILLIAMS.P, 1965, J INVEST DERMATOL, V45, P498, DOI 10.1038/jid.1965.164; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	55	108	112	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17584	17594		10.1074/jbc.M109.011650	http://dx.doi.org/10.1074/jbc.M109.011650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19398550	hybrid, Green Published			2022-12-27	WOS:000267202500024
J	Xia, Y; Ongusaha, P; Lee, SW; Liou, YC				Xia, Yun; Ongusaha, Pat; Lee, Sam W.; Liou, Yih-Cherng			Loss of Wip1 Sensitizes Cells to Stress- and DNA Damage-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; PROTEIN PHOSPHATASE; KINASE; P53; ACTIVATION; PATHWAYS; PPM1D; PHOSPHORYLATION	In response to various environmental stresses, the stress-responsive MAPKs p38 and JNK are activated and phosphorylate ATF2 and c-Jun transcription factors, thereby affecting cell-fate decision. Targeted gene disruption studies have established that JNK-c-Jun signaling plays a vital role in stress-induced apoptosis. The oncogenic phosphatase Wip1 acts as an important regulator in DNA damage pathway by dephosphorylating a spectrum of proteins including p53, p38, Chk1, Chk2, and ATM. In this study we show that Wip1 negatively regulates the activation of MKK4-JNK-c-Jun signaling during stress-induced apoptosis. The loss of Wip1 function sensitizes mouse embryonic fibroblasts to stress-induced apoptosis via the activation of both p38-ATF2 and JNK-c-Jun signaling. Here we reveal that Wip1 has dual roles in alternatively regulating stress- and DNA damage-induced apoptosis through p38/JNK MAPKs and p38/p53-dependent pathways, respectively. Our results point to Wip1 as a general regulator of apoptosis, which further supports its role in tumorigenesis.	[Xia, Yun; Liou, Yih-Cherng] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore; [Ongusaha, Pat; Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02129 USA; [Ongusaha, Pat; Lee, Sam W.] Harvard Univ, Sch Med, Boston, MA 02129 USA	National University of Singapore; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Liou, YC (corresponding author), 14 Sci Dr 4, Singapore 117543, Singapore.	dbslyc@nus.edu.sg	Xia, Yun/K-4128-2015	Xia, Yun/0000-0003-2184-4870	Biomedical Research Council [06/1/21/19/473]; Agency for Science, Research and Technology, Singapore	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science, Research and Technology, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported, in whole or in part, by Grant 06/1/21/19/473 from the Biomedical Research Council, the Agency for Science, Research and Technology, Singapore (to Y.C.L.).	Anderson SM, 1999, CELL DEATH DIFFER, V6, P454, DOI 10.1038/sj.cdd.4400507; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Chresta CM, 1996, CANCER RES, V56, P1834; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Demidov ON, 2007, ONCOGENE, V26, P2502, DOI 10.1038/sj.onc.1210032; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Hanada M, 1998, FEBS LETT, V437, P172, DOI 10.1016/S0014-5793(98)01229-0; Harrison M, 2004, TRENDS MOL MED, V10, P359, DOI 10.1016/j.molmed.2004.06.010; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; Hazzalin CA, 1996, CURR BIOL, V6, P1028, DOI 10.1016/S0960-9822(02)00649-8; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hildesheim J, 2002, CANCER RES, V62, P7305; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Manfredi JJ, 2003, MOL CELL, V11, P552, DOI 10.1016/S1097-2765(03)00106-0; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Rossi R, 2006, CANCER RES, V66, P1675, DOI 10.1158/0008-5472.CAN-05-2741; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	49	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17428	17437		10.1074/jbc.M109.007823	http://dx.doi.org/10.1074/jbc.M109.007823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19395378	hybrid, Green Published			2022-12-27	WOS:000267202500009
J	Li, CR; Fu, XP; Qi, X; Hu, XS; Chasteen, ND; Zhao, GH				Li, Chaorui; Fu, Xiaoping; Qi, Xin; Hu, Xiaosong; Chasteen, N. Dennis; Zhao, Guanghua			Protein Association and Dissociation Regulated by Ferric Ion A NOVEL PATHWAY FOR OXIDATIVE DEPOSITION OF IRON IN PEA SEED FERRITIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-CHAIN FERRITIN; HYDROGEN-PEROXIDE DETOXIFICATION; PISUM-SATIVUM FERRITIN; ESCHERICHIA-COLI; PLANT FERRITIN; STORAGE FUNCTION; CORE FORMATION; HORSE SPLEEN; BINDING; MECHANISM	Iron stored in phytoferritin plays an important role in the germination and early growth of seedlings. The protein is located in the amyloplast where it stores large amounts of iron as a hydrated ferric oxide mineral core within its shell-like structure. The present work was undertaken to study alternate mechanisms of core formation in pea seed ferritin (PSF). The data reveal a new mechanism for mineral core formation in PSF involving the binding and oxidation of iron at the extension peptide (EP) located on the outer surface of the protein shell. This binding induces aggregation of the protein into large assemblies of similar to 400 monomers. The bound iron is gradually translocated to the mineral core during which time the protein dissociates back into its monomeric state. Either the oxidative addition of Fe2+ to the apoprotein to form Fe3+ or the direct addition of Fe3+ to apoPSF causes protein aggregation once the binding capacity of the 24 ferroxidase centers (48 Fe3+ / shell) is exceeded. When the EP is enzymatically deleted from PSF, aggregation is not observed, and the rate of iron oxidation is significantly reduced, demonstrating that the EP is a critical structural component for iron binding, oxidation, and protein aggregation. These data point to a functional role for the extension peptide as an iron binding and ferroxidase center that contributes to mineralization of the iron core. As the iron core grows larger, the new pathway becomes less important, and Fe2+ oxidation and deposition occurs directly on the surface of the iron core.	[Li, Chaorui; Fu, Xiaoping; Hu, Xiaosong; Zhao, Guanghua] China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Fruits & Vegetables Proc, Minist Agr, Beijing 100083, Peoples R China; [Chasteen, N. Dennis] Univ New Hampshire, Dept Chem, Durham, NH 03824 USA; [Qi, Xin] Natl Inst Metrol, Beijing 100013, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; University System Of New Hampshire; University of New Hampshire; National Institute of Metrology China	Zhao, GH (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Fruits & Vegetables Proc, Minist Agr, Beijing 100083, Peoples R China.	gzhao1000@yahoo.com	Zhao, Guanghua/GSE-4215-2022		China High-Tech [2007AA10Z333]; National Key Technology RD Program [2006BAD27B04]; National Institutes of Health [R01-GM20294]	China High-Tech; National Key Technology RD Program(National Key Technology R&D Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by China High-Tech (863) Project 2007AA10Z333 (to G.Z.) and National Key Technology R&D Program 2006BAD27B04 (to G.Z.). This project was also supported by National Institutes of Health Grant R01-GM20294 (NIGMS, to N.D.C.).	Aitken-Rogers H, 2004, J BIOL INORG CHEM, V9, P161, DOI 10.1007/s00775-003-0504-1; BAUMINGER ER, 1991, P ROY SOC B-BIOL SCI, V244, P211, DOI 10.1098/rspb.1991.0073; BAUMINGER ER, 1991, BIOCHIM BIOPHYS ACTA, V1118, P48, DOI 10.1016/0167-4838(91)90440-B; BI X, 1991, J BIOL CHEM, V266, P19965; Bou-Abdallah F, 2005, J AM CHEM SOC, V127, P3885, DOI 10.1021/ja044355k; Bou-Abdallah F, 2005, J MOL BIOL, V347, P543, DOI 10.1016/j.jmb.2005.01.007; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Crichton RR, 1996, J BIOL INORG CHEM, V1, P567, DOI 10.1007/s007750050093; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Ivanova E, 2008, J MOL BIOL, V375, P229, DOI 10.1016/j.jmb.2007.10.037; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Kopp DA, 2002, CURR OPIN CHEM BIOL, V6, P568, DOI 10.1016/S1367-5931(02)00366-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAULHERE JP, 1989, J BIOL CHEM, V264, P3629; Lee J, 2002, J AM CHEM SOC, V124, P3042, DOI 10.1021/ja011447q; LESCURE AM, 1991, P NATL ACAD SCI USA, V88, P8222, DOI 10.1073/pnas.88.18.8222; Li CR, 2009, BIOCHIMIE, V91, P230, DOI 10.1016/j.biochi.2008.09.008; LOBREAUX S, 1992, BIOCHEM J, V288, P931, DOI 10.1042/bj2880931; Masuda T, 2001, J BIOL CHEM, V276, P19575, DOI 10.1074/jbc.M011399200; Masuda T, 2007, PROTEIN EXPRES PURIF, V56, P237, DOI 10.1016/j.pep.2007.07.011; NIITSU Y, 1973, BIOCHEMISTRY-US, V12, P4690, DOI 10.1021/bi00747a023; Pereira AS, 1998, BIOCHEMISTRY-US, V37, P9871, DOI 10.1021/bi980847w; Petsev DN, 2000, BIOPHYS J, V78, P2060, DOI 10.1016/S0006-3495(00)76753-1; RAGLAND M, 1990, J BIOL CHEM, V265, P18339; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; TONOMURA B, 1978, ANAL BIOCHEM, V84, P370, DOI 10.1016/0003-2697(78)90054-4; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; Treffry A, 1997, BIOCHEMISTRY-US, V36, P432, DOI 10.1021/bi961830l; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P253, DOI 10.1042/bj3050253; WALDO GS, 1995, PLANT PHYSIOL, V109, P797, DOI 10.1104/pp.109.3.797; Welch KD, 2001, FREE RADICAL BIO MED, V31, P999, DOI 10.1016/S0891-5849(01)00676-1; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200; Zhao GH, 2006, BIOCHEMISTRY-US, V45, P3429, DOI 10.1021/bi052443r; Zhao GH, 2005, J MOL BIOL, V352, P467, DOI 10.1016/j.jmb.2005.07.039; Zhao GH, 2003, BIOCHEMISTRY-US, V42, P3142, DOI 10.1021/bi027357v	38	47	55	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16743	16751		10.1074/jbc.M109.011528	http://dx.doi.org/10.1074/jbc.M109.011528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19398557	Green Published, hybrid			2022-12-27	WOS:000266962400009
J	Thurman, JM; Renner, B; Kunchithapautham, K; Ferreira, VP; Pangburn, MK; Ablonczy, Z; Tomlinson, S; Holers, VM; Rohrer, B				Thurman, Joshua M.; Renner, Brandon; Kunchithapautham, Kannan; Ferreira, Viviana P.; Pangburn, Michael K.; Ablonczy, Zsolt; Tomlinson, Stephen; Holers, V. Michael; Rohrer, Baerbel			Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; FUNDUS CHANGES; ACTIVATION; SECRETION; DRUSEN; RPE; RECEPTORS	Uncontrolled activation of the alternative pathway of complement is thought to be associated with age-related macular degeneration (AMD). The alternative pathway is continuously activated in the fluid phase, and tissue surfaces require continuous complement inhibition to prevent spontaneous autologous tissue injury. Here, we examined the effects of oxidative stress on the ability of immortalized human retinal pigment epithelial cells (ARPE-19) to regulate complement activation on their cell surface. Combined treatment with H2O2 (to induce oxidative stress) and complement-sufficient serum was found to disrupt the barrier function of stable ARPE-19 monolayers as determined by transepithelial resistance (TER) measurements. Neither treatment alone had any effect. TER reduction was correlated with increased cell surface deposition of C3, and could be prevented by using C7-depleted serum, an essential component of the terminal complement pathway. Treatment with H2O2 reduced surface expression of the complement inhibitors DAF, CD55, and CD59, and impaired regulation at the cell surface by factor H present within the serum. Combined treatment of the monolayers with H2O2 and serum elicited polarized secretion of vascular epidermal growth factor (VEGF). Both, secretion of VEGF and TER reduction could be attenuated using either an alternative pathway inhibitor or by blocking VEGF receptor-1/2 signaling. Regarded together, these studies demonstrate that oxidative stress reduces regulation of complement on the surface of ARPE-19 cells, increasing complement activation. This sublytic activation results in VEGF release, which mediates disruption of the cell monolayer. These findings link oxidative stress, complement activation, and apical VEGF release, which have all been associated with the pathogenesis of AMD.	[Holers, V. Michael] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO 80045 USA; [Kunchithapautham, Kannan; Ablonczy, Zsolt; Rohrer, Baerbel] Med Univ S Carolina, Dept Ophthalmol, Div Res, Charleston, SC 29425 USA; [Kunchithapautham, Kannan; Ablonczy, Zsolt; Rohrer, Baerbel] Med Univ S Carolina, Dept Neurosci, Div Res, Charleston, SC 29425 USA; [Tomlinson, Stephen] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Ferreira, Viviana P.; Pangburn, Michael K.] Univ Texas Hlth Ctr Tyler, Dept Biochem, Tyler, TX 75708 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Rohrer, B (corresponding author), 167 Ashley Ave,SEI 511, Charleston, SC 29425 USA.	rohrer@musc.edu		Thurman, Joshua Michael/0000-0002-3476-9956; Ferreira, Viviana/0000-0001-8923-5671	National Institutes of Health [DK077661, DK076690, DK035081, EY13520, EY017465, HL082485]; Vision Core [EY014793]; Foundation Fighting Blindness; American Heart Association [0735101N]; Medical University of South Carolina; NATIONAL EYE INSTITUTE [R01EY013520, R43EY017465, R24EY014793] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035081, R01DK035081, R01DK076690, R03DK077661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision Core; Foundation Fighting Blindness(European Commission); American Heart Association(American Heart Association); Medical University of South Carolina; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077661 and DK076690 (to J.M.T.), DK035081 (to M. K. P.), EY13520 and EY017465 (to B. R.), and HL082485 (to S. T.). This work was also supported by Vision Core Grant EY014793, the Foundation Fighting Blindness, American Heart Association Grant 0735101N (to V. P. F.), and an unrestricted grant to the Medical University of South Carolina from Research to Prevent Blindness, Inc., New York.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Ancelin M, 2004, LAB INVEST, V84, P502, DOI 10.1038/labinvest.3700053; Atkinson JP, 2007, J EXP MED, V204, P1245, DOI 10.1084/jem.20070664; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Cai JY, 2000, PROG RETIN EYE RES, V19, P205, DOI 10.1016/S1350-9462(99)00009-9; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; DUVALLYOUNG J, 1989, BRIT J OPHTHALMOL, V73, P297, DOI 10.1136/bjo.73.4.297; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HOGAN M J, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P64; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Kannan R, 2006, MOL VIS, V12, P1649; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; LEYS A, 1991, GRAEF ARCH CLIN EXP, V229, P406, DOI 10.1007/BF00166300; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P3492; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Vogt SD, 2006, EXP EYE RES, V83, P834, DOI 10.1016/j.exer.2006.04.002; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	32	136	142	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16939	16947		10.1074/jbc.M808166200	http://dx.doi.org/10.1074/jbc.M808166200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386604	Green Published, hybrid			2022-12-27	WOS:000266962400031
J	Xie, Y; Blanc, V; Kerr, TA; Kennedy, S; Luo, J; Newberry, EP; Davidson, NO				Xie, Yan; Blanc, Valerie; Kerr, Thomas A.; Kennedy, Susan; Luo, Jianyang; Newberry, Elizabeth P.; Davidson, Nicholas O.			Decreased Expression of Cholesterol 7 alpha-Hydroxylase and Altered Bile Acid Metabolism in Apobec-1(-/-) Mice Lead to Increased Gallstone Susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; 7 ALPHA-HYDROXYLASE; MESSENGER-RNA LEVELS; APOLIPOPROTEIN-B; POSTTRANSCRIPTIONAL REGULATION; ENDOGENOUS TRIGLYCERIDE; CHENODEOXYCHOLIC ACID; HORMONAL-REGULATION; BINDING PROTEIN; MOUSE	Quantitative trait mapping in mice identified a susceptibility locus for gallstones (Lith6) spanning the Apobec-1 locus, the structural gene encoding the RNA-specific cytidine deaminase responsible for production of apolipoprotein B48 in mammalian small intestine and rodent liver. This observation prompted us to compare dietary gallstone susceptibility in Apobec-1(-/-) mice and congenic C57BL/6 wild type controls. When fed a lithogenic diet (LD) for 2 weeks, 90% Apobec-1(-/-) mice developed solid gallstones in comparison with 16% wild type controls. LD-fed Apobec-1(-/-) mice demonstrated increased biliary cholesterol secretion as well as increased cholesterol saturation and bile acid hydrophobicity indices. These changes occurred despite a relative decrease in cholesterol absorption in LD-fed Apobec-1(-/-) mice. Among the possible mechanisms to account for this phenotype, expression of Cyp7a1 mRNA and protein were significantly decreased in chow-fed Apobec-1(-/-) mice, decreasing further in LD-fed animals. Cyp7a1 transcription in hepatocyte nuclei, however, was unchanged in Apobec-1(-/-) mice, excluding transcriptional repression as a potential mechanism for decreased Cyp7a1 expression. We demonstrated that APOBEC-1 binds to AU-rich regions of the 3'-untranslated region of the Cyp7a1 transcript, containing the UUUN(A/U)U consensus motif, using both UV cross-linking to recombinant APOBEC-1 and in vivo RNA co-immunoprecipitation. In vivo Apobec-1-dependent modulation of Cyp7a1 expression was further confirmed following adenovirus-Apobec-1 administration to chow-fed Apobec-1(-/-) mice, which rescued Cyp7a1 gene expression. Taken together, the findings suggest that the AU-rich RNA binding-protein Apobec-1 mediates post-transcriptional regulation of murine Cyp7a1 expression and influences susceptibility to diet-induced gallstone formation.	[Xie, Yan; Blanc, Valerie; Kerr, Thomas A.; Kennedy, Susan; Luo, Jianyang; Newberry, Elizabeth P.; Davidson, Nicholas O.] Washington Univ, GI Div, Sch Med, Dept Med, St Louis, MO 63110 USA; [Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Pharmacol & Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Davidson, NO (corresponding author), Washington Univ, GI Div, Sch Med, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	nod@wustl.edu	Kerr, Thomas/C-2190-2011	Kerr, Thomas/0000-0002-7432-3289	National Institutes of Health [R01 DK056260, R37 HL038180, P30 DK052574]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK056260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK056260 and R37 HL038180 (to N. O. D.) and P30 DK052574 (to N. O. D. and the Washington University Digestive Diseases Research Core Center, in particular the Morphology and Functional Genomics Cores).	Agellon LB, 1997, BIOCHEM J, V328, P393; Amigo L, 2006, GASTROENTEROLOGY, V131, P1870, DOI 10.1053/j.gastro.2006.08.029; Anant S, 2004, GASTROENTEROLOGY, V127, P1139, DOI 10.1053/j.gastro.2004.06.022; Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; ANGELIN B, 1978, J LIPID RES, V19, P1004; ANGELIN B, 1978, J LIPID RES, V19, P1017; Baker DM, 2000, J BIOL CHEM, V275, P19985, DOI 10.1074/jbc.M002351200; Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200; Blanc V, 2007, CANCER RES, V67, P8565, DOI 10.1158/0008-5472.CAN-07-1593; CAREY MC, 1978, J LIPID RES, V19, P945; Castro J, 2007, HEPATOLOGY, V45, P1261, DOI 10.1002/hep.21616; Chen CYA, 2007, RNA, V13, P1775, DOI 10.1261/rna.663507; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393; Feingold KR, 1996, J LIPID RES, V37, P223; HEUMAN DM, 1989, J LIPID RES, V30, P719; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887; Hirokane H, 2004, J BIOL CHEM, V279, P45685, DOI 10.1074/jbc.M404255200; HYLEMON PB, 1992, J BIOL CHEM, V267, P16866; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Lammert F, 2001, GASTROENTEROLOGY, V120, P221, DOI 10.1053/gast.2001.20878; LI YC, 1990, J BIOL CHEM, V265, P12012; Lyons MA, 2003, J LIPID RES, V44, P1763, DOI 10.1194/jlr.M300149-JLR200; Lyons MA, 2003, J LIPID RES, V44, P953, DOI 10.1194/jlr.M300002-JLR200; Lyons MA, 2006, GASTROENTEROLOGY, V131, P1943, DOI 10.1053/j.gastro.2006.10.024; MILLER NE, 1974, LANCET, V2, P929; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; NESS GC, 1990, BIOCHEM BIOPH RES CO, V172, P1150, DOI 10.1016/0006-291X(90)91568-D; NOSHIRO M, 1990, J BIOL CHEM, V265, P10036; Pandak WM, 1996, AM J PHYSIOL-GASTR L, V270, pG401, DOI 10.1152/ajpgi.1996.270.3.G401; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; ROSSI SS, 1987, J LIPID RES, V28, P589; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schwarz M, 1998, J LIPID RES, V39, P1833; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; SETCHELL KDR, 1983, J LIPID RES, V24, P1085; SHIELS BR, 1987, J BIOL CHEM, V262, P12826; Sowden MP, 2002, J CELL SCI, V115, P1027; STRAKA MS, 1990, J BIOL CHEM, V265, P7145; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Wang DQH, 2003, J LIPID RES, V44, P1042, DOI 10.1194/jlr.D200041-JLR200; Wang DQH, 2001, J LIPID RES, V42, P1820; Wang HH, 2005, HEPATOLOGY, V42, P894, DOI 10.1002/hep.20867; Wang YW, 1997, J BIOL CHEM, V272, P12272, DOI 10.1074/jbc.272.19.12272; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Zanlungo S, 2004, CURR OPIN LIPIDOL, V15, P279, DOI 10.1097/00041433-200406000-00007	49	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16860	16871		10.1074/jbc.M109.010173	http://dx.doi.org/10.1074/jbc.M109.010173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386592	Green Published, hybrid			2022-12-27	WOS:000266962400022
J	Nagpal, K; Plantinga, TS; Wong, J; Monks, BG; Gay, NJ; Netea, MG; Fitzgerald, KA; Golenbock, DT				Nagpal, Kamalpreet; Plantinga, Theo S.; Wong, Joyce; Monks, Brian G.; Gay, Nicholas J.; Netea, Mihai G.; Fitzgerald, Katherine A.; Golenbock, Douglas T.			A TIR Domain Variant of MyD88 Adapter-like (Mal)/TIRAP Results in Loss of MyD88 Binding and Reduced TLR2/TLR4 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PYOGENIC BACTERIAL-INFECTIONS; PROTEIN; TRANSDUCTION; ACTIVATION; HUMANS; TLR4; POLYMORPHISMS; SUBSTITUTION; RECOGNITION	The adapter protein MyD88 adapter-like (Mal), encoded by TIR-domain containing adapter protein (Tirap) (MIM 606252), is the most polymorphic of the five adapter proteins involved in Toll-like receptor signaling, harboring eight non-synonymous single nucleotide polymorphisms in its coding region. We screened reported mutations of Mal for activity in reporter assays to test the hypothesis that variants of Mal existed with altered signaling potential. A TIR domain variant, Mal D96N (rs8177400), was found to be inactive. In reconstituted cell lines, Mal D96N acted as a hypomorphic mutation, with impaired cytokine production and NF-kappa B activation upon lipopolysaccharide or PAM(2)CSK(4) stimulation. Moreover, co-immunoprecipitation studies revealed that Mal D96N is unable to interact with MyD88, a prerequisite for downstream signaling to occur. Computer modeling data suggested that residue 96 resides in the MyD88 binding site, further supporting these findings. Genotyping of Mal D96N in three different cohorts suggested that it is a rare mutation. We, thus, describe a rare variant in Mal that exerts its effect via its inability to bind MyD88.	[Nagpal, Kamalpreet; Monks, Brian G.; Fitzgerald, Katherine A.; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA; [Plantinga, Theo S.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HD Nijmegen, Netherlands; [Plantinga, Theo S.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HD Nijmegen, Netherlands; [Wong, Joyce; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1TN, England	University of Massachusetts System; University of Massachusetts Worcester; Radboud University Nijmegen; Radboud University Nijmegen; University of Cambridge	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA.	douglas.golenbock@umassmed.edu	Monks, Brian/B-8362-2015; Fitzgerald, Katherine/ABE-6317-2020; Plantinga, Theo S./A-6895-2015; Netea, Mihai/N-5155-2014	Monks, Brian/0000-0003-4008-3093; Plantinga, Theo S./0000-0003-4990-6084; Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [AI52455, GM54060, AI067497]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI052455, R37AI067497, R01AI052455, R01AI067497, R56AI067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060, R01GM054060] Funding Source: NIH RePORTER; BBSRC [BB/G002797/1, BB/G009295/1] Funding Source: UKRI; MRC [G0400007] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G009295/1, BB/G002797/1] Funding Source: researchfish; Medical Research Council [G0400007] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants AI52455 and GM54060 ( to D. T. G. and K. N.) and AI067497 ( to K. A. F.).	Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; DeLano W, 2002, PYMOL 0 99; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; HAWLEY RG, 1994, GENE THER, V1, P136; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hong-Geller Elizabeth, 2008, Curr Drug Discov Technol, V5, P29, DOI 10.2174/157016308783769441; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Schumann RR, 2007, EUR J IMMUNOL, V37, P2059, DOI 10.1002/eji.200737604; Seabury CM, 2007, GENOMICS, V90, P502, DOI 10.1016/j.ygeno.2007.07.001; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; Vasl J, 2008, J IMMUNOL, V180, P6107, DOI 10.4049/jimmunol.180.9.6107; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Worth Catherine L, 2007, J Bioinform Comput Biol, V5, P1297, DOI 10.1142/S0219720007003120; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	38	57	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25742	25748		10.1074/jbc.M109.014886	http://dx.doi.org/10.1074/jbc.M109.014886			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19509286	Green Published, hybrid			2022-12-27	WOS:000269738000032
J	Matthew, T; Zhou, WX; Rupprecht, J; Lim, L; Thomas-Hall, SR; Doebbe, A; Kruse, O; Hankamer, B; Marx, UC; Smith, SM; Schenk, PM				Matthew, Timmins; Zhou, Wenxu; Rupprecht, Jens; Lim, Lysha; Thomas-Hall, Skye R.; Doebbe, Anja; Kruse, Olaf; Hankamer, Ben; Marx, Ute C.; Smith, Steven M.; Schenk, Peer M.			The Metabolome of Chlamydomonas reinhardtii following Induction of Anaerobic H-2 Production by Sulfur Depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PRODUCTION; GENE-EXPRESSION; GREEN-ALGAE; ACCLIMATION; PHOTOPRODUCTION; DEPRIVATION; MECHANISM; PATHWAYS; INSIGHTS; STARCH	The metabolome of the model species Chlamydomonas reinhardtii has been analyzed during 120 h of sulfur depletion to induce anaerobic hydrogen (H-2) production, using NMR spectroscopy, gas chromatography coupled to mass spectrometry, and TLC. The results indicate that these unicellular green algae consume freshly supplied acetate in the medium to accumulate energy reserves during the first 24 h of sulfur depletion. In addition to the previously reported accumulation of starch, large amounts of triacylglycerides were deposited in the cells. During the early 24- to 72-h time period fermentative energy metabolism lowered the pH, H-2 was produced, and amino acid levels generally increased. In the final phase from 72 to 120 h, metabolism slowed down leading to a stabilization of pH, even though some starch and most triacylglycerides remained. We conclude that H-2 production does not slow down due to depletion of energy reserves but rather due to loss of essential functions resulting from sulfur depletion or due to a build-up of the toxic fermentative products formate and ethanol.	[Matthew, Timmins; Rupprecht, Jens; Lim, Lysha; Hankamer, Ben; Marx, Ute C.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Matthew, Timmins; Thomas-Hall, Skye R.; Schenk, Peer M.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Matthew, Timmins; Zhou, Wenxu; Smith, Steven M.] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Zhou, Wenxu; Smith, Steven M.] Univ Western Australia, Ctr Excellence Plant Metabol, Crawley, WA 6009, Australia; [Doebbe, Anja; Kruse, Olaf] Univ Bielefeld, Dept Biol, AlgaeBioTech Grp, D-33615 Bielefeld, Germany	University of Queensland; University of Queensland; University of Western Australia; University of Western Australia; University of Bielefeld	Hankamer, B (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	b.hankamer@imb.uq.edu.au; ute.marx@bruker-biospin.de; ssmith@cyllene.uwa.edu.au	Smith, Steven M/G-7183-2015; Kruse, Olaf/O-1127-2015; Hankamer, Ben D/C-9688-2015; Smith, Steven/HDM-9496-2022; Zhou, Wenxu/T-6917-2019; Schenk, Peer/B-7879-2016	Smith, Steven M/0000-0001-5661-9994; Hankamer, Ben D/0000-0001-9284-4929; Schenk, Peer/0000-0003-4878-3799; Thomas-Hall, Skye/0000-0002-4208-5992; Kruse, Olaf/0000-0001-9874-382X	Australian Research Council [FF0457721, CE0561495]; Solar Biofuels Consortium; Centres of Excellence Program of the Government of Western Australia; German Federal Ministry of Education and Science [0315165A]; Deutsche Bundesstiftung Umwelt [DBU 20006/828]; ARC [DP0877147]	Australian Research Council(Australian Research Council); Solar Biofuels Consortium; Centres of Excellence Program of the Government of Western Australia; German Federal Ministry of Education and Science(Federal Ministry of Education & Research (BMBF)); Deutsche Bundesstiftung Umwelt; ARC(Australian Research Council)	This work was supported in part by the Australian Research Council (ARC Grants FF0457721 and CE0561495). This work was also supported by the Solar Biofuels Consortium, the Centres of Excellence Program of the Government of Western Australia, the German Federal Ministry of Education and Science (BMBF-ForSys Partner 0315165A), and the Deutsche Bundesstiftung Umwelt (Grant DBU 20006/828).; Supported by ARC Grant DP0877147.	BALL SG, 1990, PLANT SCI, V66, P1, DOI 10.1016/0168-9452(90)90162-H; Bernard L, 2006, FEBS J, V273, P3625, DOI 10.1111/j.1742-4658.2006.05370.x; BOICHENKO VA, 1994, PHOTOSYNTHETICA, V30, P527; Dubini A, 2009, J BIOL CHEM, V284, P7201, DOI 10.1074/jbc.M803917200; Fernandez E, 2008, EUKARYOT CELL, V7, P555, DOI 10.1128/EC.00431-07; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; Greenway H, 2003, FUNCT PLANT BIOL, V30, P999, DOI 10.1071/PP98096; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P780; Hemschemeier A, 2008, PLANTA, V227, P397, DOI 10.1007/s00425-007-0626-8; Kosourov S, 2003, PLANT CELL PHYSIOL, V44, P146, DOI 10.1093/pcp/pcg020; Kruse O, 2005, J BIOL CHEM, V280, P34170, DOI 10.1074/jbc.M503840200; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2007, PLANTA, V226, P1075, DOI 10.1007/s00425-007-0609-9; MENEGUS F, 1991, PLANT PHYSIOL, V95, P760, DOI 10.1104/pp.95.3.760; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Nguyen AV, 2008, EUKARYOT CELL, V7, P1965, DOI 10.1128/EC.00418-07; Poerschmann J, 2004, MICROB ECOL, V48, P78, DOI 10.1007/s00248-003-0144-6; Pollock SV, 2005, PHOTOSYNTH RES, V86, P475, DOI 10.1007/s11120-005-4048-9; Posewitz MC, 2004, PLANT CELL, V16, P2151, DOI 10.1105/tpc.104.021972; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; STOOP JM, 1996, TRENDS PLANT SCI, P139; STUART TS, 1972, PLANTA, V106, P101, DOI 10.1007/BF00383990; Timmins M, 2009, J EXP BOT, V60, P1691, DOI 10.1093/jxb/erp052; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	28	111	113	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23415	23425		10.1074/jbc.M109.003541	http://dx.doi.org/10.1074/jbc.M109.003541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19478077	Green Published, hybrid			2022-12-27	WOS:000269180000026
J	Jin, SQ; Gao, H; Mazzacurati, L; Wang, Y; Fan, WH; Chen, Q; Yu, W; Wang, MR; Zhu, XL; Zhang, CM; Zhan, QM				Jin, Shunqian; Gao, Hua; Mazzacurati, Lucia; Wang, Yang; Fan, Wenhong; Chen, Qiang; Yu, Wei; Wang, Mingrong; Zhu, Xueliang; Zhang, Chuanmao; Zhan, Qimin			BRCA1 Interaction of Centrosomal Protein Nlp Is Required for Successful Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; GAMMA-TUBULIN; BRCA1-DEPENDENT UBIQUITINATION; MICROTUBULE NUCLEATION; KINASE; CANCER; INSTABILITY; AMPLIFICATION; DUPLICATION; EXPRESSION	Breast cancer susceptibility gene BRCA1 is implicated in the control of mitotic progression, although the underlying mechanism(s) remains to be further defined. Deficiency of BRCA1 function leads to disrupted mitotic machinery and genomic instability. Here, we show that BRCA1 physically interacts and colocalizes with Nlp, an important molecule involved in centrosome maturation and spindle formation. Interestingly, Nlp centrosomal localization and its protein stability are regulated by normal cellular BRCA1 function because cells containing BRCA1 mutations or silenced for endogenous BRCA1 exhibit disrupted Nlp colocalization to centrosomes and enhanced Nlp degradation. Its is likely that the BRCA1 regulation of Nlp stability involves Plk1 suppression. Inhibition of endogenous Nlp via the small interfering RNA approach results in aberrant spindle formation, aborted chromosomal segregation, and aneuploidy, which mimic the phenotypes of disrupted BRCA1. Thus, BRCA1 interaction of Nlp might be required for the successful mitotic progression, and abnormalities of Nlp lead to genomic instability.	[Jin, Shunqian; Gao, Hua; Wang, Yang; Wang, Mingrong; Zhan, Qimin] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Jin, Shunqian; Gao, Hua; Wang, Yang; Wang, Mingrong; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Mazzacurati, Lucia] Univ Pittsburgh, Sch Med, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; [Fan, Wenhong] Inst Basic Med Sci, Beijing 100850, Peoples R China; [Chen, Qiang; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Yu, Wei; Zhu, Xueliang] Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhan, QM (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	zhanqimin@pumc.edu.cn	Wang, Yang/A-1849-2010; yu, WEI/F-2826-2014; chen, qiang/G-5031-2016; yu, wei/A-2287-2013	Wang, Yang/0000-0001-9385-7393; mazzacurati, lucia/0000-0002-8336-8032	973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [30730046, 30721001]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the 973 National Key Fundamental Research Program of China (Grant 2009CB521801) and the National Natural Science Foundation of China (Grants 30730046 and 30721001).	Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Deng CX, 2002, ONCOGENE, V21, P6222, DOI 10.1038/sj.onc.1205713; Donaldson MM, 2001, J CELL SCI, V114, P2357; Doxsey SJ, 2001, NAT CELL BIOL, V3, pE105, DOI 10.1038/35074618; EASTON DF, 1995, AM J HUM GENET, V56, P265; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Goepfert TM, 2000, CURR TOP DEV BIOL, V49, P331; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hsu LC, 2001, CANCER RES, V61, P7713; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Marx J, 2001, SCIENCE, V292, P426, DOI 10.1126/science.292.5516.426; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Okada S, 2003, J BIOL CHEM, V278, P2015, DOI 10.1074/jbc.M208685200; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Ree AH, 2003, ONCOGENE, V22, P8952, DOI 10.1038/sj.onc.1207000; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Salisbury JL, 1999, BIOL CELL, V91, P451, DOI 10.1016/S0248-4900(99)80086-0; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; Somasundaram K, 1997, ONCOGENE, V14, P1047, DOI 10.1038/sj.onc.1201002; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; Wang Y, 2007, J BIOL CHEM, V282, P17712, DOI 10.1074/jbc.M701350200; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhang HB, 1998, CELL, V92, P433, DOI 10.1016/S0092-8674(00)80936-8	38	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22970	22977		10.1074/jbc.M109.009134	http://dx.doi.org/10.1074/jbc.M109.009134			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19509300	hybrid, Green Published			2022-12-27	WOS:000268963100050
J	Chrispell, JD; Feathers, KL; Kane, MA; Kim, CY; Brooks, M; Khanna, R; Kurth, I; Hubner, CA; Gal, A; Mears, AJ; Swaroop, A; Napoli, JL; Sparrow, JR; Thompson, DA				Chrispell, Jared D.; Feathers, Kecia L.; Kane, Maureen A.; Kim, Chul Y.; Brooks, Matthew; Khanna, Ritu; Kurth, Ingo; Huebner, Christian A.; Gal, Andreas; Mears, Alan J.; Swaroop, Anand; Napoli, Joseph L.; Sparrow, Janet R.; Thompson, Debra A.			Rdh12 Activity and Effects on Retinoid Processing in the Murine Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; ALL-TRANS-RETINOL; HUMAN RETINOL-DEHYDROGENASE-12 RDH12; SHORT-CHAIN DEHYDROGENASE/REDUCTASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; MANGANESE SUPEROXIDE-DISMUTASE; PHOTORECEPTOR OUTER SEGMENTS; LIGHT-INDUCED DEGENERATION; FALSE DISCOVERY RATE; VISUAL CYCLE	RDH12 mutations are responsible for early-onset autosomal recessive retinal dystrophy, which results in profound retinal pathology and severe visual handicap in patients. To investigate the function of RDH12 within the network of retinoid dehydrogenases/reductases (RDHs) present in retina, we studied the retinal phenotype of Rdh12-deficient mice. In vivo rates of all-trans-retinal reduction and 11-cis-retinal formation during recovery from bleaching were similar in Rdh12-deficient and wild-type mice matched for an Rpe65 polymorphism that impacts visual cycle efficiency. However, retinal homogenates from Rdh12-deficient mice exhibited markedly decreased capacity to reduce exogenous retinaldehydes in vitro. Furthermore, in vivo levels of the bisretinoid compound diretinoid-pyridinium-ethanolamine (A2E) were increased in Rdh12-deficient mice of various genetic backgrounds. Conversely, in vivo levels of retinoic acid and total retinol were significantly decreased. Rdh12 transcript levels in wild-type mice homozygous for the Rpe65-Leu(450) polymorphism were greater than in Rpe65-Met(450) mice and increased during postnatal development in wild-type mice and Nrl-deficient mice having an all-cone retina. Rdh12-deficient mice did not exhibit increased retinal degeneration relative to wild-type mice at advanced ages, when bred on the light-sensitive BALB/c background, or when heterozygous for a null allele of superoxide dismutase 2 (Sod2(+/-)). Our findings suggest that a critical function of RDH12 is the reduction of all-trans-retinal that exceeds the reductive capacity of the photoreceptor outer segments.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48105 USA; [Feathers, Kecia L.; Brooks, Matthew; Khanna, Ritu; Mears, Alan J.; Swaroop, Anand; Thompson, Debra A.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Kane, Maureen A.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Kim, Chul Y.; Sparrow, Janet R.] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; [Kim, Chul Y.; Sparrow, Janet R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Kurth, Ingo; Gal, Andreas] Univ Hamburg Eppendorf, Inst Human Genet, D-20251 Hamburg, Germany; [Huebner, Christian A.] Univ Jena, Dept Clin Chem, D-07747 Jena, Germany; [Mears, Alan J.] Univ Ottawa, Inst Eye, Ottawa, ON K1Y 4E9, Canada; [Mears, Alan J.] Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada; [Brooks, Matthew; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Berkeley; Columbia University; Columbia University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Thompson, DA (corresponding author), Kellogg Eye Ctr, Ann Arbor, MI 48105 USA.	dathom@med.umich.edu	Hübner, Christian/A-2950-2017	Hübner, Christian/0000-0002-1030-4943; Kurth, Ingo/0000-0002-5642-8378; Thompson, Debra/0000-0003-3485-0794; Swaroop, Anand/0000-0002-1975-1141	National Institutes of Health [P30-EY07003, P60-DK-20572, EY11115, AG13566, EY12951]; Functional Genomics of the Retina in Health and Disease (EVI-GENORET) [LSHG-CT-2005-512036]; Foundation Fighting Blindness; Research to Prevent Blindness; Midwest Eye Banks; Kaplan Foundation; NATIONAL EYE INSTITUTE [ZIAEY000473, P30EY007003, R01EY011115, R01EY012951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Functional Genomics of the Retina in Health and Disease (EVI-GENORET)(European Commission); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Midwest Eye Banks; Kaplan Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-EY07003 (Michigan Vision Core Grant) and P60-DK-20572 (Michigan Diabetes Research and Training Center). EY11115 (to A. S.), AG13566 (to J. L. N.), and EY12951 (to J. R. S.). This work was also supported by Functional Genomics of the Retina in Health and Disease (EVI-GENORET) Grant LSHG-CT-2005-512036 (to A. G.), the Foundation Fighting Blindness (to D. A. T. and A. S.), Research to Prevent Blindness (to D. A. T. and A. S.), Midwest Eye Banks (to J. D. C.), and the Kaplan Foundation (to J. R. S.).	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Argmann CA, 2005, CELL METAB, V2, P349, DOI 10.1016/j.cmet.2005.11.002; Barua AB, 1998, MOL BIOTECHNOL, V10, P167, DOI 10.1007/BF02760863; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chen CH, 2005, BIOPHYS J, V88, P2278, DOI 10.1529/biophysj.104.054254; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Jacobson SG, 2007, INVEST OPHTH VIS SCI, V48, P332, DOI 10.1167/iovs.06-0599; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kasus-Jacobi A, 2005, J BIOL CHEM, V280, P20413, DOI 10.1074/jbc.M413789200; Keller B, 2007, J STEROID BIOCHEM, V104, P190, DOI 10.1016/j.jsbmb.2007.03.015; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; LANDERS GM, 1990, METHOD ENZYMOL, V189, P70; LaVail M. M., 1997, HISTOLOGICAL METHOD, P369; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee SA, 2008, BBA-MOL BASIS DIS, V1782, P421, DOI 10.1016/j.bbadis.2008.03.004; Lee SA, 2007, J BIOL CHEM, V282, P35621, DOI 10.1074/jbc.M706372200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liden M, 2006, J BIOL CHEM, V281, P13001, DOI 10.1074/jbc.R500027200; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Napoli JL, 2001, MOL CELL ENDOCRINOL, V171, P103, DOI 10.1016/S0303-7207(00)00392-0; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Sandbach JM, 2001, INVEST OPHTH VIS SCI, V42, P2173; SCHUSTER A, 2007, INVEST OPHTH VIS SCI, V27, P1370; Schuster A, 2007, INVEST OPHTH VIS SCI, V48, P1824, DOI 10.1167/iovs.06-0628; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sun WY, 2007, VISION RES, V47, P2055, DOI 10.1016/j.visres.2007.04.005; Thompson DA, 2005, HUM MOL GENET, V14, P3865, DOI 10.1093/hmg/ddi411; Tsina E, 2004, J GEN PHYSIOL, V124, P429, DOI 10.1085/jgp.200409078; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; WICKER LD, 2008, INVEST OPHTHALMOL VI, V49; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Wu QQ, 2007, BIOCHEMISTRY-US, V46, P8669, DOI 10.1021/bi7004619; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160	58	40	40	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21468	21477		10.1074/jbc.M109.020966	http://dx.doi.org/10.1074/jbc.M109.020966			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506076	Green Published, hybrid			2022-12-27	WOS:000268564400041
J	Johnson, DE; Ai, HW; Wong, P; Young, JD; Campbell, RE; Casey, JR				Johnson, Danielle E.; Ai, Hui-wang; Wong, Peter; Young, James D.; Campbell, Robert E.; Casey, Joseph R.			Red Fluorescent Protein pH Biosensor to Detect Concentrative Nucleoside Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE RESIDUE CYS-561; CARBONIC-ANHYDRASE-II; STRUCTURAL-CHARACTERIZATION; FUNCTIONAL EXPRESSION; MEMBRANE TOPOLOGY; MOLECULAR-CLONING; INTRACELLULAR PH; MAMMALIAN-CELLS; MONOMERIC RED; GOLGI PH	Human concentrative nucleoside transporter, hCNT3, mediates Na+/nucleoside and H+/nucleoside co-transport. We describe a new approach to monitor H+/uridine co-transport in cultured mammalian cells, using a pH-sensitive monomeric red fluorescent protein variant, mNectarine, whose development and characterization are also reported here. A chimeric protein, mNectarine fused to the N terminus of hCNT3 (mNect.hCNT3), enabled measurement of pH at the intracellular surface of hCNT3. mNectarine fluorescence was monitored in HEK293 cells expressing mNect.hCNT3 or mNect. hCNT3-F563C, an inactive hCNT3 mutant. Free cytosolic mNect, mNect. hCNT3, and the traditional pH-sensitive dye, BCECF, reported cytosolic pH similarly in pH-clamped HEK293 cells. Cells were incubated at the permissive pH for H+-coupled nucleoside transport, pH 5.5, under both Na+-free and Na+-containing conditions. In mNect.hCNT3-expressing cells (but not under negative control conditions) the rate of acidification increased in media containing 0.5 mM uridine, providing the first direct evidence for H+-coupled uridine transport. At pH 5.5, there was no significant difference in uridine transport rates (coupled H+ flux) in the presence or absence of Na+ (1.09 +/- 0.11 or 1.18 +/- 0.32 mM min(-1), respectively). This suggests that in acidic Na+-containing conditions, 1 Na+ and 1 H+ are transported per uridine molecule, while in acidic Na+-free conditions, 1 H+ alone is transported/uridine. In acid environments, including renal proximal tubule, H+/nucleoside co-transport may drive nucleoside accumulation by hCNT3. Fusion of mNect to hCNT3 provided a simple, self-referencing, and effective way to monitor nucleoside transport, suggesting an approach that may have applications in assays of transport activity of other H+-coupled transport proteins.	[Johnson, Danielle E.; Young, James D.; Casey, Joseph R.] Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Ai, Hui-wang; Wong, Peter; Campbell, Robert E.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Alberta; University of Alberta	Casey, JR (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada.	joe.casey@ualberta.ca	Casey, Joseph/A-8888-2013; Ai, Huiwang/A-7790-2016	Casey, Joseph/0000-0002-9890-5056; Campbell, Robert E./0000-0003-0604-092X; Ai, Huiwang/0000-0002-5664-3270	Canadian Institutes of Health Research; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council; Alberta Ingenuity; National Cancer Institute of Canada; Alberta Heritage Foundation for Medical Research (AHFMR)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	This work was supported in part by a Canadian Institutes of Health Research operating grant ( to J. R. C.), by financial support from the Canada Foundation for Innovation, the Natural Sciences and Engineering Research Council, and Alberta Ingenuity ( to R. E. C.), and by support from the National Cancer Institute of Canada ( to J. D. Y.).; Supported by an Alberta Heritage Foundation for Medical Research (AHFMR) studentship.	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Ai HW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-13; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Bizzarri R, 2006, BIOPHYS J, V90, P3300, DOI 10.1529/biophysj.105.074708; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chandy G, 2001, AM J PHYSIOL-CELL PH, V281, pC908, DOI 10.1152/ajpcell.2001.281.3.C908; Chen XZ, 1999, J BIOL CHEM, V274, P2773, DOI 10.1074/jbc.274.5.2773; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Errasti-Murugarren E, 2007, J PHYSIOL-LONDON, V582, P1249, DOI 10.1113/jphysiol.2007.130138; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Hirayama BA, 1997, J BIOL CHEM, V272, P2110; HIRAYAMA BA, 1994, J BIOL CHEM, V269, P21407; Hu HK, 2006, MOL PHARMACOL, V69, P1542, DOI 10.1124/mol.105.018945; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Johnson DE, 2008, FASEB J, V22; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Mackenzie B, 1996, J BIOL CHEM, V271, P5430, DOI 10.1074/jbc.271.10.5430; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; Poole RC, 1996, BIOCHEM J, V320, P817, DOI 10.1042/bj3200817; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Romero MF, 2005, CURR OPIN NEPHROL HY, V14, P495, DOI 10.1097/01.mnh.0000168333.01831.2c; RUETZ S, 1993, J CELL BIOL, V121, P37, DOI 10.1083/jcb.121.1.37; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slugoski MD, 2008, J BIOL CHEM, V283, P24922, DOI 10.1074/jbc.M801793200; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Toan SV, 2003, PFLUG ARCH EUR J PHY, V447, P195, DOI 10.1007/s00424-003-1166-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Young J. D., 2000, CURRENT TOPICS MEMBR, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4	59	50	51	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20499	20511		10.1074/jbc.M109.019042	http://dx.doi.org/10.1074/jbc.M109.019042			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19494110	Green Published, hybrid			2022-12-27	WOS:000268316100011
J	Rombouts, Y; Burguiere, A; Maes, E; Coddeville, B; Elass, E; Guerardel, Y; Kremer, L				Rombouts, Yoann; Burguiere, Adeline; Maes, Emmanuel; Coddeville, Bernadette; Elass, Elisabeth; Guerardel, Yann; Kremer, Laurent			Mycobacterium marinum Lipooligosaccharides Are Unique Caryophyllose-containing Cell Wall Glycolipids That Inhibit Tumor Necrosis Factor-alpha Secretion in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREHALOSE-CONTAINING LIPOOLIGOSACCHARIDES; O-ACYLTREHALOSE CORE; BRANCHED-CHAIN SUGAR; IMMUNE-RESPONSE; GLYCOSYLATED ACYLTREHALOSE; TUBERCULOSIS; LIPOARABINOMANNAN; KANSASII; ANTIGENS; BIOSYNTHESIS	Earlier studies have reported a role for lipooligosaccharides (LOSs) in sliding motility, biofilm formation, and infection of host macrophages in Mycobacterium marinum. Although a LOS biosynthetic gene cluster has recently been identified in this species, many structural features of the different LOSs (LOS-I-IV) are still unknown. This clearly hampers assessing the contribution of each LOS in mycobacterial virulence as well as structure-function-based studies of these important cell wall-associated glycolipids. In this study, we have identified an M. marinum isolate, M. marinum 7 (Mma7), which failed to produce LOS-IV but instead accumulated large amounts of LOS-III. Local genomic comparison of the LOS biosynthetic cluster established the presence of a highly disorganized region in Mma7 compared with the standard M strain, characterized by multiple genetic lesions that are likely to be responsible for the defect in LOS-IV production in Mma7. Our results indicate that the glycosyltransferase LosA alone is not sufficient to ensure LOS-IV biosynthesis. The availability of different M. marinum strains allowed us to determine the precise structure of individual LOSs through the combination of mass spectrometric and NMR techniques. In particular, we established the presence of two related 4-C-branched monosaccharides within LOS-II to IV sequences, of which one was never identified before. In addition, we provided evidence that LOSs are capable of inhibiting the secretion of tumor necrosis factor-alpha in lipopolysaccharide-stimulated human macrophages. This unexpected finding suggests that these cell wall-associated glycolipids represent key effectors capable of interfering with the establishment of a pro-inflammatory response.	[Rombouts, Yoann; Maes, Emmanuel; Coddeville, Bernadette; Elass, Elisabeth; Guerardel, Yann] Univ Sci & Technol Lille, CNRS, UMR 8576, Unite Glycobiol Struct & Fonct,IFR 147, F-59655 Villeneuve Dascq, France; [Burguiere, Adeline; Kremer, Laurent] Univ Montpellier 2, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Burguiere, Adeline; Kremer, Laurent] Univ Montpellier 1, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Guerardel, Y (corresponding author), Univ Sci & Technol Lille, CNRS, UMR 8576, Unite Glycobiol Struct & Fonct,IFR 147, F-59655 Villeneuve Dascq, France.	yann.guerardel@univ-lille1.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Rombouts, Yoann/0000-0003-4482-2199; elass, elisabeth/0000-0002-2573-2959; Guerardel, Yann/0000-0003-4967-9512	French National Research Agency [ANR-05-MIIM-025]; Ministere de l'Enseignement Superieur; Universite des Sciences et Technologies de Lille; Institut Federatif de Recherche [IFR 147]	French National Research Agency(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur; Universite des Sciences et Technologies de Lille; Institut Federatif de Recherche	This work was supported by Grant ANR-05-MIIM-025 from the French National Research Agency (to Y.G. and L. K.), the Ministere de l'Enseignement Superieur (to Y.R.), Universite des Sciences et Technologies de Lille, and Institut Federatif de Recherche Grant (IFR 147).	ADINOLFI M, 1995, CARBOHYD RES, V274, P223, DOI 10.1016/0008-6215(95)00127-F; ADINOLFI M, 1995, CARBOHYD RES, V267, P307, DOI 10.1016/0008-6215(94)00302-V; Alexander DC, 2004, J BIOL CHEM, V279, P18824, DOI 10.1074/jbc.M400791200; Appelmelk BJ, 2008, CELL MICROBIOL, V10, P930, DOI 10.1111/j.1462-5822.2007.01097.x; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; BESRA GS, 1993, BIOCHEMISTRY-US, V32, P12705, DOI 10.1021/bi00210a020; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; COLLINS FM, 1981, INFECT IMMUN, V32, P614, DOI 10.1128/IAI.32.2.614-624.1981; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; DAFFE M, 1991, BIOCHEMISTRY-US, V30, P378, DOI 10.1021/bi00216a011; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; Etienne G, 2009, J BACTERIOL, V191, P2613, DOI 10.1128/JB.01235-08; GILLERON M, 1995, GLYCOCONJUGATE J, V12, P298, DOI 10.1007/BF00731333; GILLERON M, 1993, J BIOL CHEM, V268, P3168; GORSHKOVA RP, 1987, BIOORG KHIM+, V13, P1146; GORSHKOVA RP, 1984, CARBOHYD RES, V126, P308, DOI 10.1016/0008-6215(84)85389-6; Guerardel Y, 2003, J BIOL CHEM, V278, P36637, DOI 10.1074/jbc.M305427200; Guerardel Y, 2002, J BIOL CHEM, V277, P30635, DOI 10.1074/jbc.M204398200; HUNTER SW, 1984, J BIOL CHEM, V259, P9729; HUNTER SW, 1985, BIOCHEMISTRY-US, V24, P2798, DOI 10.1021/bi00332a030; HUNTER SW, 1988, BIOCHEMISTRY-US, V27, P1549, DOI 10.1021/bi00405a023; HUNTER SW, 1983, J BIOL CHEM, V258, P481; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; KHOO KH, 1995, CARBOHYD RES, V276, P449, DOI 10.1016/0008-6215(95)00184-U; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; LEMASSU A, 1992, J GEN MICROBIOL, V138, P1535, DOI 10.1099/00221287-138-7-1535; Malm S, 2008, INT J MED MICROBIOL, V298, P645, DOI 10.1016/j.ijmm.2008.03.010; Mattos KA, 2005, GLYCOBIOLOGY, V15, P313, DOI 10.1093/glycob/cwi009; MCNEIL M, 1987, J BACTERIOL, V169, P3312, DOI 10.1128/jb.169.7.3312-3320.1987; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Molinaro A, 2001, J AM CHEM SOC, V123, P12605, DOI 10.1021/ja016471i; Munoz M, 1998, MICROBIOL-SGM, V144, P137, DOI 10.1099/00221287-144-1-137; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Robinson N, 2008, TRAFFIC, V9, P1936, DOI 10.1111/j.1600-0854.2008.00804.x; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; van der Sar AM, 2004, INFECT IMMUN, V72, P6306, DOI 10.1128/IAI.72.11.6306-6312.2004; VEY E, 1992, J IMMUNOL, V149, P2040; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014	49	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20975	20988		10.1074/jbc.M109.011429	http://dx.doi.org/10.1074/jbc.M109.011429			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19491094	Green Published, hybrid			2022-12-27	WOS:000268316100061
J	Guerreiro, JR; Lameu, C; Oliveira, EF; Klitzke, CF; Melo, RL; Linares, E; Augusto, O; Fox, JW; Lebrun, I; Serrano, SMT; Camargo, ACM				Guerreiro, Juliano R.; Lameu, Claudiana; Oliveira, Eduardo F.; Klitzke, Clecio F.; Melo, Robson L.; Linares, Edlaine; Augusto, Ohara; Fox, Jay W.; Lebrun, Ivo; Serrano, Solange M. T.; Camargo, Antonio C. M.			Argininosuccinate Synthetase Is a Functional Target for a Snake Venom Anti-hypertensive Peptide ROLE IN ARGININE AND NITRIC OXIDE PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; BRADYKININ-POTENTIATING PEPTIDES; PERFORMANCE LIQUID-CHROMATOGRAPHY; SPONTANEOUSLY HYPERTENSIVE-RATS; VASCULAR SMOOTH-MUSCLE; CITRULLINE-NO CYCLE; AMINO-ACID-ANALYSIS; BOTHROPS-JARARACA; PROLINE-RICH; ENDOTHELIAL-CELLS	Bj-BPP-10c is a bioactive proline-rich decapeptide, part of the C-type natriuretic peptide precursor, expressed in the brain and in the venom gland of Bothrops jararaca. We recently showed that Bj-BPP-10c displays a strong, sustained anti-hypertensive effect in spontaneous hypertensive rats (SHR), without causing any effect in normotensive rats, by a pharmacological effect independent of angiotensin-converting enzyme inhibition. Therefore, we hypothesized that another mechanism should be involved in the peptide activity. Here we used affinity chromatography to search for kidney cytosolic proteins with affinity for Bj-BPP-10c and demonstrate that argininosuccinate synthetase (AsS) is the major protein binding to the peptide. More importantly, this interaction activates the catalytic activity of AsS in a dose-dependent manner. AsS is recognized as an important player of the citrulline-NO cycle that represents a potential limiting step in NO synthesis. Accordingly, the functional interaction of Bj-BPP-10c and AsS was evidenced by the following effects promoted by the peptide: (i) increase of NO metabolite production in human umbilical vein endothelial cell culture and of arginine in human embryonic kidney cells and (ii) increase of arginine plasma concentration in SHR. Moreover, alpha-methyl-DL-aspartic acid, a specific AsS inhibitor, significantly reduced the anti-hypertensive activity of Bj-BPP-10c in SHR. Taken together, these results suggest that AsS plays a role in the anti-hypertensive action of Bj-BPP-10c. Therefore, we propose the activation of AsS as a new mechanism for the anti-hypertensive effect of Bj-BPP-10c in SHR and AsS as a novel target for the therapy of hypertension-related diseases.	[Serrano, Solange M. T.] Inst Butantan, Lab Especial Toxicol Aplicada, CAT CEPID, BR-05503900 Sao Paulo, Brazil; [Guerreiro, Juliano R.; Lameu, Claudiana; Linares, Edlaine; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil; [Oliveira, Eduardo F.] Univ Fed Sao Paulo, Dept Biol Mol, BR-04044020 Sao Paulo, Brazil; [Fox, Jay W.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Lebrun, Ivo] Inst Butantan, Lab Bioquim & Biofis, BR-05503900 Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Virginia; Instituto Butantan	Serrano, SMT (corresponding author), Inst Butantan, Lab Especial Toxicol Aplicada, CAT CEPID, Ave Vital Brasil, BR-05503900 Sao Paulo, Brazil.	solangeserrano@butantan.gov.br; acmcamargo@butantan.gov.br	Lameu, Claudiana/B-9089-2012; Linares, Edlaine/AAR-8753-2020; Toxicologia aplicada, Cepid/I-4891-2013; Serrano, Solange M. T./A-7132-2008; Klitzke, Clecio Fernando/A-8920-2010; Serrano, Solange/ABB-7569-2021; Augusto, Ohara/D-3839-2012; Melo, Robson/B-5798-2013	Lameu, Claudiana/0000-0002-6874-5864; Linares, Edlaine/0000-0001-8164-3013; Serrano, Solange M. T./0000-0001-8994-1904; Klitzke, Clecio Fernando/0000-0001-5973-6088; Serrano, Solange/0000-0001-8994-1904; Augusto, Ohara/0000-0002-7220-4286; 	Brazilian agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [98/14307-9, 04/14250-0, 06/53139-2, 04/11359-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Brazilian agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 98/14307-9, 04/14250-0, 06/53139-2, and 04/11359-0 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Atherton E., 1990, SOLID PHASE PEPTIDE; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Corbin KD, 2008, BIOCHEM BIOPH RES CO, V377, P1042, DOI 10.1016/j.bbrc.2008.10.056; Cotton J, 2002, BIOCHEMISTRY-US, V41, P6065, DOI 10.1021/bi012121x; DHANAKOTI SN, 1992, BIOCHEM J, V282, P369, DOI 10.1042/bj2820369; EBERT RF, 1986, ANAL BIOCHEM, V154, P431, DOI 10.1016/0003-2697(86)90010-2; FAKLER CR, 1995, ACTA PAEDIATR, V84, P460, DOI 10.1111/j.1651-2227.1995.tb13673.x; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005; Flam BR, 2007, NITRIC OXIDE-BIOL CH, V17, P115, DOI 10.1016/j.niox.2007.07.001; Fox JW, 2007, CURR PHARM DESIGN, V13, P2927, DOI 10.2174/138161207782023739; GAVRAS H, 1974, NEW ENGL J MED, V291, P817, DOI 10.1056/NEJM197410172911603; GILES AR, 1987, THROMB HAEMOSTASIS, V58, P1078; Gomes CL, 2007, BIOCHEM PHARMACOL, V74, P1350, DOI 10.1016/j.bcp.2007.07.014; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Hao G, 2004, J BIOL CHEM, V279, P36192, DOI 10.1074/jbc.M404866200; HASEGAWA T, 1992, BIOCHEM INT, V26, P653; HATTORI Y, 1994, J BIOL CHEM, V269, P9405; Hayashi MAF, 2005, TOXICON, V45, P1163, DOI 10.1016/j.toxicon.2005.02.017; Hayashi MAF, 2003, J NEUROCHEM, V85, P969, DOI 10.1046/j.1471-4159.2003.01743.x; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; Husson A, 2003, EUR J BIOCHEM, V270, P1887, DOI 10.1046/j.1432-1033.2003.03559.x; Ianzer D, 2007, J PHARMACOL EXP THER, V322, P795, DOI 10.1124/jpet.107.120873; JONES MR, 1988, J NUTR, V118, P579, DOI 10.1093/jn/118.5.579; Karlberg T, 2008, ACTA CRYSTALLOGR D, V64, P279, DOI 10.1107/S0907444907067455; Koeners MP, 2007, HYPERTENSION, V50, P1077, DOI 10.1161/HYPERTENSIONAHA.107.095794; Kurz S, 1997, J CLIN INVEST, V99, P369, DOI 10.1172/JCI119166; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee Y, 2004, ANAL CHEM, V76, P545, DOI 10.1021/ac035065+; Lemke CT, 2002, J BIOL CHEM, V277, P13074, DOI 10.1074/jbc.M112436200; Linares E, 2008, FREE RADICAL BIO MED, V44, P1668, DOI 10.1016/j.freeradbiomed.2008.01.027; Menez A, 1998, TOXICON, V36, P1557, DOI 10.1016/S0041-0101(98)00148-2; Morris SM, 2004, J NUTR, V134, p2743S, DOI 10.1093/jn/134.10.2743S; NG KKF, 1970, NATURE, V225, P1142, DOI 10.1038/2251142b0; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; Pujals S, 2008, ADV DRUG DELIVER REV, V60, P473, DOI 10.1016/j.addr.2007.09.012; Ram CVS, 2008, CURR HYPERTENS REP, V10, P345, DOI 10.1007/s11906-008-0065-3; Shen LJ, 2005, BIOCHEM PHARMACOL, V69, P97, DOI 10.1016/j.bcp.2004.09.003; Silva CA, 2008, TOXICON, V51, P515, DOI 10.1016/j.toxicon.2007.11.003; SILVA MRE, 1949, AM J PHYSIOL, V156, P261, DOI 10.1152/ajplegacy.1949.156.2.261; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; TAYLOR PD, 1994, BRIT J PHARMACOL, V113, P801, DOI 10.1111/j.1476-5381.1994.tb17064.x; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Vukosavljevic N, 2006, MICROVASC RES, V71, P48, DOI 10.1016/j.mvr.2005.10.006; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xie LJ, 1997, J BIOL CHEM, V272, P16624, DOI 10.1074/jbc.272.26.16624	47	53	60	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20022	20033		10.1074/jbc.M109.021089	http://dx.doi.org/10.1074/jbc.M109.021089			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19491403	Green Published, hybrid			2022-12-27	WOS:000268097400029
J	Guo, L; Song, ZQ; Li, MT; Wu, QG; Wang, D; Feng, H; Bernard, P; Daugherty, A; Huang, B; Li, XA				Guo, Ling; Song, Zhiqing; Li, Mengting; Wu, Qingan; Wang, Dan; Feng, Hong; Bernard, Philip; Daugherty, Alan; Huang, Bin; Li, Xiang-An			Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; DENSITY-LIPOPROTEIN BINDING; SR-BI; HDL RECEPTOR; REDUCES ATHEROSCLEROSIS; APOLIPOPROTEIN-E; PREMATURE DEATH; UNITED-STATES; LIVER-INJURY; MICE	Sepsis is a leading cause of death that is characterized by uncontrolled inflammatory response. In this study, we report that scavenger receptor BI (SR-BI), a high density lipoprotein receptor, is a critical survival factor of sepsis. We induced sepsis using an established septic animal model, cecal ligation and puncture (CLP). CLP induced 100% fatality in SR-BI-null mice but only 21% fatality in wild type littermates. SR-BI-null mice exhibited aberrant inflammatory responses with delayed inflammatory cytokine generation at the early stage of sepsis and highly elevated inflammatory cytokine production 20 h after CLP treatment. To understand the mechanisms underlying SR-BI protection, we elucidated the effect of macrophage SR-BI on inflammatory cytokine generation. Macrophages from SR-BI-null mice produced significantly higher levels of inflammatory cytokines than those of wild type controls in response to LPS. Importantly, transgenic mice overexpressing SR-BI were more resistant to CLP-induced septic death. Using an HEK-Blue (TM) cell system, we demonstrated that expression of SR-BI suppressed TLR4-mediated NF-kappa B activation. To understand why SR-BI-null mice had a delayed inflammatory response, we elucidated the effect of SR-BI on LPS clearance during sepsis. Compared with wild type controls, SR-BI-null mice had lower plasma LPS levels in the early stage of sepsis and elevated plasma LPS levels 20 h following CLP treatment. In conclusion, our findings demonstrate that SR-BI is a critical protective modulator of sepsis in mice. SR-BI exerts its protective function through its role in modulating inflammatory response in macrophages and facilitating LPS recruitment and clearance.	[Li, Xiang-An] Univ Kentucky, Sch Med, Dept Pediat, Lexington, KY 40536 USA; [Daugherty, Alan] Univ Kentucky, Sch Med, Dept Internal Med, Lexington, KY 40536 USA; [Huang, Bin] Univ Kentucky, Sch Med, Kentucky Canc Registry, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky	Li, XA (corresponding author), BBSRB B365,741 S Limestone St, Lexington, KY 40536 USA.	xli2@uky.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775	National Institutes of Health [R01GM085231, 2P0RR015592]; American Heart Association [0530241N]; Children's Miracle Network; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954, P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Children's Miracle Network; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM085231 (to X.-A.L.) and 2P0RR015592 (to T. Curry). This work was also supported by American Heart Association Grant 0530241N (to X.-A.L.) and the Children's Miracle Network (to X.-A.L.).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Berwin B, 2003, EMBO J, V22, P6127, DOI 10.1093/emboj/cdg572; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; Gong M, 2003, J CLIN INVEST, V111, P1579, DOI 10.1172/JCI200316777; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Letourneau I, 2002, NEPHRON, V90, P408, DOI 10.1159/000054728; Li XA, 2006, CIRC RES, V98, pE60, DOI 10.1161/01.RES.0000219310.00308.10; Li XA, 2005, J BIOL CHEM, V280, P19087, DOI 10.1074/jbc.M500944200; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Sessler Curtis N, 2004, Curr Opin Crit Care, V10, P354, DOI 10.1097/01.ccx.0000139363.76068.7b; Steinman CR, 1997, ANAL BIOCHEM, V244, P328, DOI 10.1006/abio.1996.9896; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; ULEVITCH RJ, 1981, J CLIN INVEST, V67, P827, DOI 10.1172/JCI110100; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Wesche-Soldato DE, 2005, BLOOD, V106, P2295, DOI 10.1182/blood-2004-10-4086; Yu H, 2006, ARTERIOSCL THROM VAS, V26, P150, DOI 10.1161/01.ATV.0000194096.89476.73; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zhang WW, 2003, CIRCULATION, V108, P2258, DOI 10.1161/01.CIR.0000093189.97429.9D	46	78	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19826	19834		10.1074/jbc.M109.020933	http://dx.doi.org/10.1074/jbc.M109.020933			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19491399	Green Published, hybrid			2022-12-27	WOS:000268097400009
J	Halling, DB; Georgiou, DK; Black, DJ; Yang, GJ; Fallon, JL; Quiocho, FA; Pedersen, SE; Hamilton, SL				Halling, D. Brent; Georgiou, Dimitra K.; Black, D. J.; Yang, Guojun; Fallon, Jennifer L.; Quiocho, Florante A.; Pedersen, Steen E.; Hamilton, Susan L.			Determinants in Ca(V)1 Channels That Regulate the Ca2+ Sensitivity of Bound Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-DEPENDENT INACTIVATION; CRYSTAL-STRUCTURE; CA2+-DEPENDENT INACTIVATION; BINDING-SITES; IQ MOTIFS; COMPLEX; DOMAIN; RECOGNITION; KINASE; FACILITATION	Calmodulin binds to IQ motifs in the alpha(1) subunit of Ca(V)1.1 and Ca(V)1.2, but the affinities of calmodulin for the motif and for Ca2+ are higher when bound to Ca(V)1.2 IQ. The Ca(V)1.1 IQ and Ca(V)1.2 IQ sequences differ by four amino acids. We determined the structure of calmodulin bound to Ca(V)1.1 IQ and compared it with that of calmodulin bound to Ca(V)1.2 IQ. Four methionines in Ca2+-calmodulin form a hydrophobic binding pocket for the peptide, but only one of the four nonconserved amino acids (His-1532 of Ca(V)1.1 and Tyr-1675 of Ca(V)1.2) contacts this calmodulin pocket. However, Tyr-1675 in Ca(V)1.2 contributes only modestly to the higher affinity of this peptide for calmodulin; the other three amino acids in Ca(V)1.2 contribute significantly to the difference in the Ca2+ affinity of the bound calmodulin despite having no direct contact with calmodulin. Those residues appear to allow an interaction with calmodulin with one lobe Ca2+-bound and one lobe Ca2+-free. Our data also provide evidence for lobe-lobe interactions in calmodulin bound to Ca(V)1.2.	[Halling, D. Brent; Georgiou, Dimitra K.; Yang, Guojun; Fallon, Jennifer L.; Quiocho, Florante A.; Pedersen, Steen E.; Hamilton, Susan L.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Black, D. J.] Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Fallon, Jennifer L.; Quiocho, Florante A.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Missouri System; University of Missouri Kansas City; Baylor College of Medicine	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, 1 Baylor Plaza,410B, Houston, TX 77030 USA.	susanh@bcm.edu		Pedersen, Steen E./0000-0001-8755-8899; Hamilton, Susan/0000-0003-0241-9369	National Institutes of Health [AR44864, HL087099, GM021371]; Muscular Dystrophy Association; Welch Foundation [Q-0581]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR44864 (to S. L. H.), HL087099 (to S. E. P.), and GM021371 (to F. A. Q.). This work was also supported by the Muscular Dystrophy Association (to S. L. H.) and Welch Foundation Grant Q-0581 (to F. A. Q.).	Andre I, 2006, BIOPHYS J, V90, P2903, DOI 10.1529/biophysj.105.068718; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Black DJ, 2000, BIOCHEMISTRY-US, V39, P13831, DOI 10.1021/bi001106+; Black DJ, 2005, AM J PHYSIOL-CELL PH, V288, pC669, DOI 10.1152/ajpcell.00191.2004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Kobrinsky E, 2003, J BIOL CHEM, V278, P5021, DOI 10.1074/jbc.M211254200; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; Mouton J, 2001, FEBS LETT, V505, P441, DOI 10.1016/S0014-5793(01)02866-6; Mukherjea P, 1996, PROTEIN SCI, V5, P468; Ohrtman J, 2008, J BIOL CHEM, V283, P29301, DOI 10.1074/jbc.M805152200; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peersen OB, 1997, PROTEIN SCI, V6, P794; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; Rossmann M. G., 1972, MOL REPLACEMENT METH; ROVATI GE, 1994, TRENDS PHARMACOL SCI, V15, P140, DOI 10.1016/0165-6147(94)90073-6; Sack JS, 1997, METHOD ENZYMOL, V277, P158, DOI 10.1016/S0076-6879(97)77011-3; Saucerman JJ, 2008, BIOPHYS J, V95, P4597, DOI 10.1529/biophysj.108.128728; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Sencer S, 2001, J BIOL CHEM, V276, P38237; Stroffekova K, 2008, PFLUG ARCH EUR J PHY, V455, P873, DOI 10.1007/s00424-007-0344-x; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; WALKER SW, 1984, BIOCHEM J, V217, P827, DOI 10.1042/bj2170827; Xiong LW, 2006, BIOPHYS J, V90, P173, DOI 10.1529/biophysj.105.066092; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	48	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20041	20051		10.1074/jbc.M109.013326	http://dx.doi.org/10.1074/jbc.M109.013326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19473981	hybrid, Green Published			2022-12-27	WOS:000268097400031
J	Koh, DI; Choi, WI; Jeon, BN; Lee, CE; Yun, CO; Hur, MW				Koh, Dong-In; Choi, Won-Il; Jeon, Bu-Nam; Lee, Choong-Eun; Yun, Chae-Ok; Hur, Man-Wook			A Novel POK Family Transcription Factor, ZBTB5, Represses Transcription of p21CIP1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INTERACTION MOTIF; ACUTE PROMYELOCYTIC LEUKEMIA; DNA-BINDING DOMAIN; HISTONE DEACETYLASE; FINGER PROTEIN; SP1; FUSION; CELLS; BCL-6; P53	Transcriptional repression through chromatin remodeling and histone deacetylation has been postulated as a driving force for tumorigenesis. We isolated and characterized a novel POZ domain Kruppel-like zinc finger transcription repressor, ZBTB5 (zinc finger and BTB domain-containing 5). Serial analysis of gene expression (SAGE) analysis showed that ZBTB5 expression is higher in retinoblastoma and muscle cancer tissues. Immunocytochemistry showed that ZBTB5 was localized to the nucleus, particularly nuclear speckles. ZBTB5 directly repressed transcription of cell cycle arrest gene p21 by binding to the proximal GC-box 5/6 elements and the two distal p53-responsive elements (bp -2323 similar to -2299; bp -1416 similar to -1392). Chromatin immunoprecipitation assays showed that ZBTB5 and p53 competed with each other in occupying the p53 binding elements. ZBTB5 interacted with corepressor-histone deacetylase complexes such as BCoR(BCL-6-interacting corepressor), NCoR (nuclear receptor corepressor), and SMRT (silencing mediator for retinoid and thyroid receptors) via its POZ domain. These interactions resulted in deacetylation of histones Ac-H3 and Ac-H4 at the proximal promoter, which is important in the transcriptional repression of p21. MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays and fluorescent-activated cell sorter analysis revealed that ZBTB5 stimulated both cell proliferation and cell cycle progression, significantly increasing the number of cells in S-phase. Overall, our data suggest that ZBTB5 is a potent transcription repressor of cell cycle arrest gene p21 and a potential proto-oncogene stimulating cell proliferation.	[Koh, Dong-In; Choi, Won-Il; Jeon, Bu-Nam; Hur, Man-Wook] Yonsei Univ, Brain Korea Project Med Sci 21, Inst Genet Sci, Sch Med, Seoul 120752, South Korea; [Lee, Choong-Eun] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Yun, Chae-Ok] Yonsei Univ, Inst Canc Res, Sch Med, Seoul 120752, South Korea	Yonsei University; Sungkyunkwan University (SKKU); Yonsei University	Hur, MW (corresponding author), Yonsei Univ, Brain Korea Project Med Sci 21, Inst Genet Sci, Sch Med, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur2@yuhs.ac	Yun, Chae-Ok/P-3698-2015	Hur, Man-Wook/0000-0002-3416-1334; Yun, Chae-Ok/0000-0002-9466-4531; CHOI, WONIL/0000-0002-4837-0436	Korean Science and Engineering Foundation of the Korean Ministry of Science and Technology Medical Research Center [R13-2002-054-05002-0]	Korean Science and Engineering Foundation of the Korean Ministry of Science and Technology Medical Research Center	This work was supported by Korean Science and Engineering Foundation of the Korean Ministry of Science and Technology Medical Research Center Grant R13-2002-054-05002-0 (to M.-W.H.).	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; EL DW, 1993, CELL, V75, P817; ELDEIRY WS, 1994, CANCER RES, V54, P1169; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Huynh KD, 2000, GENE DEV, V14, P1810; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334	35	22	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19856	19866		10.1074/jbc.M109.025817	http://dx.doi.org/10.1074/jbc.M109.025817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19491398	Green Published, hybrid			2022-12-27	WOS:000268097400012
J	Perrine, CL; Ganguli, A; Wu, P; Bertozzi, CR; Fritz, TA; Raman, J; Tabak, LA; Gerken, TA				Perrine, Cynthia L.; Ganguli, Anjali; Wu, Peng; Bertozzi, Carolyn R.; Fritz, Timothy A.; Raman, Jayalakshmi; Tabak, Lawrence A.; Gerken, Thomas A.			Glycopeptide-preferring Polypeptide GalNAc Transferase 10 (ppGalNAc T10), Involved in Mucin-type O-Glycosylation, Has a Unique GalNAc-O-Ser/Thr-binding Site in Its Catalytic Domain Not Found in ppGalNAc T1 or T2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-D-GALACTOSAMINE; N-ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; NEIGHBORING RESIDUE GLYCOSYLATION; PEPTIDE ACCEPTOR PREFERENCES; UDP-GALNAC; TANDEM REPEAT; FUNCTIONAL-CHARACTERIZATION; DROSOPHILA-MELANOGASTER; LINKED GLYCOSYLATION; STAUDINGER LIGATION	Mucin-type O-glycosylation is initiated by a large family of UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases (ppGalNAc Ts) that transfer GalNAc from UDP-GalNAc to the Ser and Thr residues of polypeptide acceptors. Some members of the family prefer previously glycosylated peptides (ppGalNAc T7 and T10), whereas others are inhibited by neighboring glycosylation (ppGalNAc T1 and T2). Characterizing their peptide and glycopeptide substrate specificity is critical for understanding the biological role and significance of each isoform. Utilizing a series of random peptide and glycopeptide substrates, we have obtained the peptide and glycopeptide specificities of ppGalNAc T10 for comparison with ppGalNAc T1 and T2. For the glycopeptide substrates, ppGalNAc T10 exhibited a single large preference for Ser/Thr-O-GalNAc at the +1 (C-terminal) position relative to the Ser or Thr acceptor site. ppGalNAc T1 and T2 revealed no significant enhancements suggesting Ser/Thr-O-GalNAc was inhibitory at most positions for these isoforms. Against random peptide substrates, ppGalNAc T10 revealed no significant hydrophobic or hydrophilic residue enhancements, in contrast to what has been reported previously for ppGalNAc T1 and T2. Our results reveal that these transferases have unique peptide and glycopeptide preferences demonstrating their substrate diversity and their likely roles ranging from initiating transferases to filling-in transferases.	[Gerken, Thomas A.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Perrine, Cynthia L.; Gerken, Thomas A.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Gerken, Thomas A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Gerken, Thomas A.] Case Western Reserve Univ, WA Bernbaum Ctr Cyst Fibrosis Res, Cleveland, OH 44106 USA; [Ganguli, Anjali; Wu, Peng; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Fritz, Timothy A.; Raman, Jayalakshmi; Tabak, Lawrence A.] NIDDK, Sect Biol Chem, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gerken, TA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, BRB 823,2109 Adelbert Rd, Cleveland, OH 44106 USA.	txg2@cwru.edu			National Institutes of Health [CA-78834]; NCI [GM66047]; NIDDK; NATIONAL CANCER INSTITUTE [R01CA078834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK070012, P30DK027651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-78834 from NCI (to T. A. G.) and GM66047 (to C. R. B.) and an NIDDK intramural program grant (to L. A. T.).	Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Cheng LM, 2004, FEBS LETT, V566, P17, DOI 10.1016/j.febslet.2004.03.108; Cheng LM, 2002, FEBS LETT, V531, P115, DOI 10.1016/S0014-5793(02)03399-9; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; ELHAMMER AP, 1993, J BIOL CHEM, V268, P10029; Freire T, 2004, BIOCHEM J, V382, P501, DOI 10.1042/BJ20031877; Freire T, 2003, BIOCHEM BIOPH RES CO, V312, P1309, DOI 10.1016/j.bbrc.2003.11.060; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P9888, DOI 10.1021/bi049178e; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Gerken TA, 1997, J BIOL CHEM, V272, P9709; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Guo JM, 2002, FEBS LETT, V524, P211, DOI 10.1016/S0014-5793(02)03007-7; Hanisch FG, 2001, GLYCOBIOLOGY, V11, P731, DOI 10.1093/glycob/11.9.731; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Herr P, 2008, DEVELOPMENT, V135, P1813, DOI 10.1242/dev.019323; HUISGEN R, 1984, 1 3 DIPOLAR CYCLOADD, P1; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Koldas M, 2001, THROMB RES, V102, P221, DOI 10.1016/S0049-3848(01)00257-2; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Perrine C, 2009, GLYCOBIOLOGY, V19, P321, DOI 10.1093/glycob/cwn143; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Saxon E, 2002, J AM CHEM SOC, V124, P14893, DOI 10.1021/ja027748x; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Stwora-Wojczyk MM, 2004, ARCH BIOCHEM BIOPHYS, V426, P231, DOI 10.1016/j.abb.2004.02.013; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Toba S, 2000, BBA-GENE STRUCT EXPR, V1493, P264, DOI 10.1016/S0167-4781(00)00180-9; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wang H, 2003, BIOCHEM BIOPH RES CO, V300, P738, DOI 10.1016/S0006-291X(02)02908-X; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; White KE, 2000, GENE, V246, P347, DOI 10.1016/S0378-1119(00)00050-0; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	51	43	48	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20387	20397		10.1074/jbc.M109.017236	http://dx.doi.org/10.1074/jbc.M109.017236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19460755	Green Published, hybrid			2022-12-27	WOS:000268097400064
J	Fu, YX; Chang, A; Chang, L; Niessen, K; Eapen, S; Setiadi, A; Karsan, A				Fu, YangXin; Chang, Alex; Chang, Linda; Niessen, Kyle; Eapen, Shawn; Setiadi, Audi; Karsan, Aly			Differential Regulation of Transforming Growth Factor beta Signaling Pathways by Notch in Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL HEART-DEFECTS; TGF-BETA; MESENCHYMAL TRANSITION; CARDIAC DEVELOPMENT; TRANSCRIPTIONAL ACTIVATION; INTRACELLULAR DOMAIN; VASCULAR DEVELOPMENT; GENE-EXPRESSION; TARGET GENES; SMAD3	Notch and transforming growth factor beta (TGF beta) play critical roles in endothelial-to-mesenchymal transition (EndMT), a process that is essential for heart development. Previously, we have shown that Notch and TGF beta signaling synergistically induce Snail expression in endothelial cells, which is required for EndMT in cardiac cushion morphogenesis. Here, we report that Notch activation modulates TGF beta signaling pathways in a receptor-activated Smad (R-Smad)-specific manner. Notch activation inhibits TGF beta/Smad1 and TGF beta/Smad2 signaling pathways by decreasing the expression of Smad1 and Smad2 and their target genes. In contrast, Notch increases SMAD3 mRNA expression and protein half-life and regulates the expression of TGF beta/Smad3 target genes in a gene-specific manner. Inhibition of Notch in the cardiac cushion of mouse embryonic hearts reduces Smad3 expression. Notch and TGF beta synergistically upregulate a subset of genes by recruiting Smad3 to both Smad and CSL binding sites and cooperatively inducing histone H4 acetylation. This is the first evidence that Notch activation affects R-Smad expression and that cooperative induction of histone acetylation at specific promoters underlies the selective synergy between Notch and TGF beta signaling pathways.	[Karsan, Aly] Univ British Columbia, British Columbia Canc Agcy, British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Fu, YangXin; Karsan, Aly] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Karsan, A (corresponding author), Univ British Columbia, British Columbia Canc Agcy, British Columbia Canc Res Ctr, 675W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	akarsan@bccrc.ca	Karsan, Aly/K-2067-2015; Setiadi, Audi/AAD-2076-2022	Setiadi, Audi/0000-0002-2361-7391	Canadian Institutes of Health Research Grant [MOP-64354]; Heart and Stroke Foundation of British Columbia; Yukon; Canadian Cancer Society; Genome Canada; Genome British Columbia	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia; Yukon; Canadian Cancer Society(Canadian Cancer Society (CCS)); Genome Canada(Genome Canada); Genome British Columbia	This work was supported in part by Canadian Institutes of Health Research Grant MOP-64354 and grants from the Heart and Stroke Foundation of British Columbia and the Yukon, the Canadian Cancer Society, Genome Canada, and Genome British Columbia.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Cinquetti R, 2008, HUM MUTAT, V29, P468, DOI 10.1002/humu.20711; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Fu YX, 2001, J BIOL CHEM, V276, P43004, DOI 10.1074/jbc.M106946200; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Itoh S, 2000, NUCLEIC ACIDS RES, V28, P4291, DOI 10.1093/nar/28.21.4291; Kanai H, 2001, CIRC RES, V88, P30, DOI 10.1161/01.RES.88.1.30; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Masuda S, 2005, CANCER SCI, V96, P274, DOI 10.1111/j.1349-7006.2005.00048.x; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; Ono Y, 2007, J CELL PHYSIOL, V210, P358, DOI 10.1002/jcp.20838; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Sun YP, 2005, ONCOGENE, V24, P5365, DOI 10.1038/sj.onc.1208528; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	48	79	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19452	19462		10.1074/jbc.M109.011833	http://dx.doi.org/10.1074/jbc.M109.011833			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473993	Green Published, hybrid			2022-12-27	WOS:000267908300037
J	Kimple, AJ; Soundararajan, M; Hutsell, SQ; Roos, AK; Urban, DJ; Setola, V; Temple, BRS; Roth, BL; Knapp, S; Willard, FS; Siderovski, DP				Kimple, Adam J.; Soundararajan, Meera; Hutsell, Stephanie Q.; Roos, Annette K.; Urban, Daniel J.; Setola, Vincent; Temple, Brenda R. S.; Roth, Bryan L.; Knapp, Stefan; Willard, Francis S.; Siderovski, David P.			Structural Determinants of G-protein alpha Subunit Selectivity by Regulator of G-protein Signaling 2 (RGS2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; MYOCARDIAL HYPERTROPHY; CIONA-INTESTINALIS; SEQUENCE ALIGNMENT; PHOSPHOLIPASE-C; RECEPTOR; PRESSURE; ANXIETY; DOMAIN; HYPERTENSION	"Regulator of G-protein signaling" (RGS) proteins facilitate the termination of G protein-coupled receptor (GPCR) signaling via their ability to increase the intrinsic GTP hydrolysis rate of G alpha subunits (known as GTPase-accelerating protein or "GAP" activity). RGS2 is unique in its in vitro potency and selectivity as a GAP for G alpha(q) subunits. As many vasoconstrictive hormones signal via G(q) heterotrimer-coupled receptors, it is perhaps not surprising that RGS2-deficient mice exhibit constitutive hypertension. However, to date the particular structural features within RGS2 determining its selectivity for G alpha(q) over G alpha(i/o) substrates have not been completely characterized. Here, we examine a trio of point mutations to RGS2 that elicits G alpha(i)-directed binding and GAP activities without perturbing its association with G alpha(q). Using x-ray crystallography, we determined a model of the triple mutant RGS2 in complex with a transition state mimetic form of G alpha(i) at 2.8-angstrom resolution. Structural comparison with unliganded, wild type RGS2 and of other RGS domain/G alpha complexes highlighted the roles of these residues in wild type RGS2 that weaken G alpha(i) subunit association. Moreover, these three amino acids are seen to be evolutionarily conserved among organisms with modern cardiovascular systems, suggesting that RGS2 arose from the R4-subfamily of RGS proteins to have specialized activity as a potent and selective G alpha(q) GAP that modulates cardiovascular function.	[Kimple, Adam J.; Urban, Daniel J.; Setola, Vincent; Roth, Bryan L.; Willard, Francis S.; Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Hutsell, Stephanie Q.; Temple, Brenda R. S.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Setola, Vincent; Roth, Bryan L.] Univ N Carolina, NIMH, Psychoact Drug Screening Program, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Temple, Brenda R. S.] Univ N Carolina, RL Juliano Struct Bioinformat Core Facil, Chapel Hill, NC 27599 USA; [Soundararajan, Meera; Roos, Annette K.; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford; University of Oxford	Siderovski, DP (corresponding author), 4073 Genet Med Bldg,CB 7365, Chapel Hill, NC 27599 USA.	dsiderov@med.unc.edu	Roth, Bryan L/F-3928-2010; Knapp, Stefan/AAG-2347-2019; Siderovski, David Peter/AAA-9603-2019	Knapp, Stefan/0000-0001-5995-6494; Siderovski, David Peter/0000-0002-0688-8210; Setola, Vincent/0000-0002-9791-2270; Soundararajan, Meera/0000-0003-4687-0151; Kimple, Adam/0000-0003-1670-8401	National Institutes of Health [R01 GM082892, T32 GM008570, T32 GM008719, F30 MH074266]; American Heart Association Mid-Atlantic Affiliate Grant [0815239E]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719, R01GM082892, T32GM008570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, F30MH074266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Mid-Atlantic Affiliate Grant(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM082892 ( to D. P. S.), T32 GM008570 ( to S. Q. H.), and T32 GM008719 and F30 MH074266 ( to A. J. K.). This work was also supported by American Heart Association Mid-Atlantic Affiliate Grant 0815239E ( to D. J. U.).. S The on-line version of this article ( available at http://www.jbc.org) contains supplemental Figs. S1-S3 and Tables S1 and S2.	Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Chiba S, 2004, ZOOL SCI, V21, P285, DOI 10.2108/zsj.21.285; Cladman W, 2002, MOL PHARMACOL, V62, P654, DOI 10.1124/mol.62.3.654; Cui H, 2008, NEUROPSYCHOPHARMACOL, V33, P1537, DOI 10.1038/sj.npp.1301557; Davidson B, 2007, SEMIN CELL DEV BIOL, V18, P16, DOI 10.1016/j.semcdb.2006.12.007; DAVISON IG, 1995, J EXP BIOL, V198, P2185; Druey KM, 1997, P NATL ACAD SCI USA, V94, P12851, DOI 10.1073/pnas.94.24.12851; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans DH, 2006, PHYSL FISHES; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gu S, 2008, MOL PHARMACOL, V73, P1037, DOI 10.1124/mol.107.044214; Hains MD, 2004, METHOD ENZYMOL, V389, P71; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; HEXIMER SP, 2007, SCI STKE, pPE2; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingi T, 1998, J NEUROSCI, V18, P7178; Keys JR, 2002, HYPERTENSION, V40, P660, DOI 10.1161/01.HYP.0000035397.73223.CE; Kimple AJ, 2007, BBA-PROTEINS PROTEOM, V1774, P1213, DOI 10.1016/j.bbapap.2007.06.002; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; McKenzie DJ, 2007, FISH PHYSIOL, V26, P1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pancer Z, 2004, P NATL ACAD SCI USA, V101, P13273, DOI 10.1073/pnas.0405529101; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seack J, 1998, BBA-MOL CELL RES, V1401, P93, DOI 10.1016/S0167-4889(97)00121-3; Semplicini A, 2006, J HYPERTENS, V24, P1115, DOI 10.1097/01.hjh.0000226202.80689.8f; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Sierra DA, 2002, GENOMICS, V79, P177, DOI 10.1006/geno.2002.6693; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; Smoller JW, 2008, ARCH GEN PSYCHIAT, V65, P298, DOI 10.1001/archgenpsychiatry.2007.48; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Srinivasa SP, 1998, J BIOL CHEM, V273, P1529, DOI 10.1074/jbc.273.3.1529; Stols L, 2007, PROTEIN EXPRES PURIF, V53, P396, DOI 10.1016/j.pep.2007.01.013; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suga H, 1999, J MOL EVOL, V48, P646, DOI 10.1007/PL00006508; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wieland T, 2000, J BIOL CHEM, V275, P28500, DOI 10.1074/jbc.M004187200; Willard FS, 2007, CELL SIGNAL, V19, P428, DOI 10.1016/j.cellsig.2006.07.013; Willard FS, 2006, ANAL BIOCHEM, V353, P147, DOI 10.1016/j.ab.2006.02.004; Willard FS, 2005, ANAL BIOCHEM, V340, P341, DOI 10.1016/j.ab.2005.02.015; Willard FS, 2004, METHOD ENZYMOL, V389, P56; WILLARD MD, 2009, HDB CELL SI IN PRESS; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450	64	54	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19402	19411		10.1074/jbc.M109.024711	http://dx.doi.org/10.1074/jbc.M109.024711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19478087	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000267908300031
J	Miyake, T; Alli, NS; Aziz, A; Knudson, J; Fernando, P; Megeney, LA; McDermott, JC				Miyake, Tetsuaki; Alli, Nezeka S.; Aziz, Arif; Knudson, Jennifer; Fernando, Pasan; Megeney, Lynn A.; McDermott, John C.			Cardiotrophin-1 Maintains the Undifferentiated State in Skeletal Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MUSCLE DIFFERENTIATION; TRANSCRIPTION FACTORS; GROWTH-FACTOR; CELL-DIFFERENTIATION; GENE-TRANSCRIPTION; POPULATION CELLS; STEM-CELLS; IN-VIVO; MYOD	Skeletal myogenesis is potently regulated by the extracellular milieu of growth factors and cytokines. We observed that cardiotrophin-1 (CT-1), a member of the interleukin-6 (IL-6) family of cytokines, is a potent regulator of skeletal muscle differentiation. The normal up-regulation of myogenic marker genes, myosin heavy chain (MyHC), myogenic regulatory factors (MRFs), and myocyte enhancer factor 2s (MEF2s) were inhibited by CT-1 treatment. CT-1 also represses myogenin (MyoG) promoter activation. CT-1 activated two signaling pathways: signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein kinase kinase (MEK), a component of the extracellular signal-regulated MAPK (ERK) pathway. In view of the known connection between CT-1 and STAT3 activation, we surprisingly found that pharmacological blockade of STAT3 activity had no effect on the inhibition of myogenesis by CT-1 suggesting that STAT3 signaling is dispensable for myogenic repression. Conversely, MEK inhibition potently reversed the inhibition of myotube formation and attenuated the repression of MRF transcriptional activity mediated by CT-1. Taken together, these data indicate that CT-1 represses skeletal myogenesis through interference with MRF activity by activation of MEK/ERK signaling. In agreement with these in vitro observations, exogenous systemic expression of CT-1 mediated by adenoviral vector delivery increased the number of myonuclei in normal post-natal mouse skeletal muscle and also delayed skeletal muscle regeneration induced by cardiotoxin injection. The expression pattern of CT-1 in embryonic and post-natal skeletal muscle and in vivo effects of CT-1 on myogenesis implicate CT-1 in the maintenance of the undifferentiated state in muscle progenitor cells.	[Miyake, Tetsuaki; Alli, Nezeka S.; Aziz, Arif; McDermott, John C.] York Univ, Dept Biol, LSB, N York, ON M3J 1P3, Canada; [Knudson, Jennifer; Fernando, Pasan; Megeney, Lynn A.] Ottawa Hlth Res Inst, Regenerat Med Program, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada	York University - Canada; University of Ottawa; Ottawa Hospital Research Institute	McDermott, JC (corresponding author), York Univ, Dept Biol, LSB, 327 Farquharson,4700 Keele St, N York, ON M3J 1P3, Canada.	jmcderm@yorku.ca		Megeney, Lynn/0000-0002-6824-8569	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research (to J.C.M.).	ALLEN RE, 1987, J CELL PHYSIOL, V133, P567, DOI 10.1002/jcp.1041330319; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Bordet T, 1999, J CLIN INVEST, V104, P1077, DOI 10.1172/JCI6265; Brar BK, 2001, CYTOKINE, V16, P93, DOI 10.1006/cyto.2001.0951; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen CM, 2004, BLOOD, V104, P73, DOI 10.1182/blood-2003-04-1340; Cox DM, 2003, J BIOL CHEM, V278, P15297, DOI 10.1074/jbc.M211312200; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; Freed DH, 2005, CARDIOVASC RES, V65, P782, DOI 10.1016/j.cardiores.2004.11.026; Freed DH, 2003, MOL CELL BIOCHEM, V254, P247, DOI 10.1023/A:1027332504861; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Jackson JD, 2002, CELL TRANSPLANT, V11, P779; JARVIS EE, 1989, GENE DEV, V3, P936, DOI 10.1101/gad.3.7.936; Jin HK, 1996, CYTOKINE, V8, P920, DOI 10.1006/cyto.1996.0123; Jo C, 2005, BBA-MOL CELL RES, V1743, P187, DOI 10.1016/j.bbamcr.2004.11.002; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kataoka Y, 2003, J BIOL CHEM, V278, P44178, DOI 10.1074/jbc.M304884200; KAUSHAL S, 1994, SCIENCE, V266, P1236, DOI 10.1126/science.7973707; Kim CH, 2008, MOL CELL BIOL, V28, P2941, DOI 10.1128/MCB.01682-07; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Liao ZH, 2002, CARDIOVASC RES, V53, P902, DOI 10.1016/S0008-6363(01)00531-4; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Muskiewicz KR, 2005, J HISTOCHEM CYTOCHEM, V53, P861, DOI 10.1369/jhc.4A6573.2005; Myer A, 1997, DEV BIOL, V185, P127, DOI 10.1006/dbio.1997.8565; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; OLWIN BB, 1988, J CELL BIOL, V107, P761, DOI 10.1083/jcb.107.2.761; Page JL, 2004, J BIOL CHEM, V279, P30966, DOI 10.1074/jbc.M402224200; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Pennica D, 1996, CYTOKINE, V8, P183, DOI 10.1006/cyto.1996.0026; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; Ramocki MB, 1997, MOL CELL BIOL, V17, P3547, DOI 10.1128/MCB.17.7.3547; Reynaud EG, 2000, J BIOL CHEM, V275, P18767, DOI 10.1074/jbc.M907412199; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Sheng ZL, 1996, DEVELOPMENT, V122, P419; Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783; SOMMER H, 1990, EMBO J, V9, P605, DOI 10.1002/j.1460-2075.1990.tb08152.x; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TEMPLETON TJ, 1992, DEV BIOL, V154, P169, DOI 10.1016/0012-1606(92)90057-N; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; WALSH K, 1992, J BIOL CHEM, V267, P13714; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Winter B, 2000, J CELL SCI, V113, P4211; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yip-Schneider MT, 2009, J PHARMACOL EXP THER, V329, P1063, DOI 10.1124/jpet.108.147306; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	70	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19679	19693		10.1074/jbc.M109.017319	http://dx.doi.org/10.1074/jbc.M109.017319			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19439412	hybrid, Green Published			2022-12-27	WOS:000267908300059
J	Zou, W; Reeve, JL; Zhao, H; Ross, FP; Teitelbaum, SL				Zou, Wei; Reeve, Jennifer L.; Zhao, Haibo; Ross, F. Patrick; Teitelbaum, Steven L.			Syk Tyrosine 317 Negatively Regulates Osteoclast Function via the Ubiquitin-Protein Isopeptide Ligase Activity of Cbl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; LINKER REGION TYROSINES; C-CBL; MICE LACKING; KINASE SYK; IN-VITRO; SRC; ACTIVATION; PHOSPHORYLATION; INTEGRIN	Cytoskeletal organization of the osteoclast (OC), which is central to the capacity of the cell to resorb bone, is induced by occupancy of the alpha v beta 3 integrin or the macrophage colony-stimulating factor (M-CSF) receptor c-Fms. In both circumstances, the tyrosine kinase Syk is an essential signaling intermediary. We demonstrate that Cbl negatively regulates OC function by interacting with Syk(Y317). Expression of nonphosphorylatable Syk(Y317F) in primary Syk(-/-) OCs enhances M-CSF- and alpha v beta 3-induced phosphorylation of the cytoskeleton-organizing molecules, SLP76, Vav3, and PLC gamma 2, to levels greater than wild type, thereby accelerating the resorptive capacity of the cell. SykY317 suppresses cytoskeletal organization and function while binding the ubiquitin-protein isopeptide ligase Cbl. Consequently, SykY317F abolishes M-CSF- and integrin-stimulated Syk ubiquitination. Thus, Cbl/Syk(Y317) association negatively regulates OC function and therefore is essential for maintenance of skeletal homeostasis.	[Zou, Wei; Reeve, Jennifer L.; Zhao, Haibo; Ross, F. Patrick; Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Reeve, Jennifer L.] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Teitelbaum, SL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid Ave,4940 Parkview Pl, St Louis, MO 63110 USA.	teitelbs@wustl.edu	Zhao, Haibo/ABG-9729-2021	ZHAO, HAIBO/0000-0003-0836-7555; Zou, Wei/0000-0001-8081-268X; Teitelbaum, Steven/0000-0002-4054-6679	National Institutes of Health [AR046852, AR032788, AR046523, 1 F30 AG302802]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032788, R37AR046523, R01AR046523, R01AR046852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG030280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR046852 (to F.P.R.), AR032788 and AR046523 ( to S.L.T.), and 1 F30 AG302802 (to J.L.R.).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Faccio R, 2007, J BIOL CHEM, V282, P18991, DOI 10.1074/jbc.M610937200; Hitomi T, 2001, GENES CELLS, V6, P475, DOI 10.1046/j.1365-2443.2001.00434.x; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P2325, DOI 10.1073/pnas.0806963106; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Moon KD, 2005, J BIOL CHEM, V280, P1543, DOI 10.1074/jbc.M407805200; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Paolini R, 2002, J BIOL CHEM, V277, P36940, DOI 10.1074/jbc.M204948200; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; Reeve J, 2008, J BONE MINER RES, V23, pS4; Sada K, 2000, J IMMUNOL, V164, P338, DOI 10.4049/jimmunol.164.1.338; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Simon M, 2005, J BIOL CHEM, V280, P4510, DOI 10.1074/jbc.M410326200; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wonerow P, 2003, J BIOL CHEM, V278, P37520, DOI 10.1074/jbc.M305077200; Yankee TM, 1999, J IMMUNOL, V163, P5827; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	47	14	14	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18833	18839		10.1074/jbc.M109.012385	http://dx.doi.org/10.1074/jbc.M109.012385			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19419964	hybrid, Green Published			2022-12-27	WOS:000267711500033
J	Lian, M; Zheng, XF				Lian, Min; Zheng, Xiaofeng			HSCARG Regulates NF-kappa B Activation by Promoting the Ubiquitination of RelA or COMMD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE COPPER TOXICOSIS; NITRIC-OXIDE; TUMOR-SUPPRESSOR; SENSOR PROTEIN; ALPHA; DEHYDROEPIANDROSTERONE; TRANSCRIPTION; MURR1; GENE; TERMINATION	The redox sensor protein HSCARG translocates from the cytoplasm to the nucleus in response to decreased cellular NADPH or increased nitric oxide, and is involved in protein regulation. However, the regulatory mechanism of HSCARG has remained elusive. In this report, through a yeast two-hybrid screen, HSCARG was found to associate with the copper metabolism gene MURR1 domain containing protein 1 (COMMD1), an inhibitor of NF-kappa B, and negatively regulate COMMD1 by accelerating its ubiquitination and proteasome-dependent degradation. Interestingly, we observed that HSCARG also blocked basal and stimulus-coupled NF-kappa B activation by promoting ubiquitination and degradation of the NF-kappa B subunit RelA. Further analyses showed that in cells under normal conditions, HSCARG localized mainly in the cytoplasm and acted as a negative regulator of COMMD1, and was distributed in the nucleus in small quantities to inhibit NF-kappa B. Although in response to intracellular redox changes by dehydroepiandrosterone or S-nitroso-N-acetylpenicillamine treatment, a large amount of HSCARG translocated to the nucleus, which terminated NF-kappa B activation. Meanwhile, COMMD1 was restored due to decreased cytoplasmic HSCARG levels and negatively regulated NF-kappa B as well. Thus, NF-kappa B activation was terminated efficiently. Our results indicate that HSCARG plays critical roles in regulation of NF-kappa B in response to cellular redox changes by promoting ubiquitination and proteolysis of RelA or COMMD1.	[Lian, Min; Zheng, Xiaofeng] Peking Univ, Dept Biochem & Mol Biol, Natl Lab Prot Engn & Plant Genet Engn, Coll Life Sci, Beijing 100871, Peoples R China	Peking University	Zheng, XF (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Natl Lab Prot Engn & Plant Genet Engn, Coll Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn			National Science Foundation of China [30670416]; National High Technology and Development Program of China Program [863, 2006AA02A314, 973, 2007CB914303]; International Centre for Genetic Engineering and Biotechnology ( ICGEB) [CRP/CHN05-01]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology and Development Program of China Program(National High Technology Research and Development Program of China); International Centre for Genetic Engineering and Biotechnology ( ICGEB)	This work was supported by National Science Foundation of China Grant 30670416, the National High Technology and Development Program of China Program numbers 863, 2006AA02A314 and 973, 2007CB914303, and International Centre for Genetic Engineering and Biotechnology ( ICGEB) Project number CRP/CHN05-01.	Aragno M, 2002, ENDOCRINOLOGY, V143, P3250, DOI 10.1210/en.2002-220182; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; El Omari K, 2005, J BIOL CHEM, V280, P18229, DOI 10.1074/jbc.M501113200; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Garcia-Nogales P, 1999, J NEUROCHEM, V72, P1750, DOI 10.1046/j.1471-4159.1999.721750.x; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Green DR, 2003, MOL CELL, V11, P551, DOI 10.1016/S1097-2765(03)00107-2; Greene WC, 2004, NAT IMMUNOL, V5, P18, DOI 10.1038/ni0104-18; Gutierrez G, 2007, ATHEROSCLEROSIS, V190, P90, DOI 10.1016/j.atherosclerosis.2006.02.031; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang Y, 2008, J BIOL CHEM, V283, P11453, DOI 10.1074/jbc.M708544200; Iwasaki Y, 2004, J CLIN ENDOCR METAB, V89, P3449, DOI 10.1210/jc.2003-031441; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Lamb HK, 2004, PROTEIN SCI, V13, P3127, DOI 10.1110/ps.04958904; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, CELL CYCLE, V6, P672, DOI 10.4161/cc.6.6.3989; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Malek S, 1998, J BIOL CHEM, V273, P25427, DOI 10.1074/jbc.273.39.25427; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mulherkar N, 2006, ONCOGENE, V25, P6252, DOI 10.1038/sj.onc.1209650; Muller T, 2003, J HEPATOL, V38, P164, DOI 10.1016/S0168-8278(02)00356-2; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Reynaert NL, 2005, ANTIOXID REDOX SIGN, V7, P129, DOI 10.1089/ars.2005.7.129; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Schwartz AG, 2004, AGEING RES REV, V3, P171, DOI 10.1016/j.arr.2003.05.001; Stammers DK, 2001, EMBO J, V20, P6619, DOI 10.1093/emboj/20.23.6619; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; van de Sluis B, 2000, MAMM GENOME, V11, P455, DOI 10.1007/s003350010086; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Yamamoto Yumi, 2001, Current Molecular Medicine (Hilversum), V1, P287; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhao YM, 2008, J BIOL CHEM, V283, P11004, DOI 10.1074/jbc.M708697200; Zheng XF, 2007, P NATL ACAD SCI USA, V104, P8809, DOI 10.1073/pnas.0700480104	45	23	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17998	18006		10.1074/jbc.M809752200	http://dx.doi.org/10.1074/jbc.M809752200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433587	hybrid, Green Published			2022-12-27	WOS:000267712400011
J	Zhang, YW; Jones, TL; Martin, SE; Caplen, NJ; Pommier, Y				Zhang, Yong-Wei; Jones, Tamara L.; Martin, Scott E.; Caplen, Natasha J.; Pommier, Yves			Implication of Checkpoint Kinase-dependent Up-regulation of Ribonucleotide Reductase R2 in DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-I INHIBITORS; DOUBLE-STRAND BREAKS; S-PHASE CHECKPOINT; CANCER-CELL-LINES; PROTEIN-KINASE; MULTIDRUG-RESISTANCE; CLEAVABLE COMPLEXES; REPLICATION STRESS; CARCINOMA CELLS; CAMPTOTHECIN	To investigate drug mechanisms of action and identify molecular targets for the development of rational drug combinations, we conducted synthetic small interfering RNA (siRNA)-based RNAi screens to identify genes whose silencing affects anti-cancer drug responses. Silencing of RRM1 and RRM2, which encode the large and small subunits of the human ribonucleotide reductase complex, respectively, markedly enhanced the cytotoxicity of the topoisomerase I inhibitor camptothecin (CPT). Silencing of RRM2 was also found to enhance DNA damage as measured by histone gamma-H2AX. Further studies showed that CPT up-regulates both RRM1 and RRM2 mRNA and protein levels and induces the nuclear translocation of RRM2. The checkpoint kinase 1 (Chk1) was up-regulated and activated in response to CPT, and CHEK1 down-regulation by siRNA and small molecule inhibitors of Chk1 blocked RRM2 induction by CPT. CHEK1 siRNA also suppressed E2F1 up-regulation by CPT, and silencing of E2F1 suppressed the up-regulation of RRM2. Silencing of ATR or ATM and inhibition of ATM activity by KU-55933 blocked Chk1 activation and RRM2 up-regulation. This study links the known components of CPT-induced DNA damage response with proteins required for the synthesis of dNTPs and DNA repair. Specifically, we propose that upon DNA damage, Chk1 activation, mediated by ATM and ATR, up-regulates RRM2 expression through the E2F1 transcription factor. Upregulation in RRM2 expression levels coupled with its nuclear recruitment suggests an active role for ribonucleotide reductase in the cellular response to CPT-mediated DNA damage that could potentially be exploited as a strategy for enhancing the efficacy of topoisomerase I inhibitors.	[Zhang, Yong-Wei; Pommier, Yves] NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; [Jones, Tamara L.; Martin, Scott E.; Caplen, Natasha J.] NCI, Gene Silencing Sect, Genet Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), Bldg 37,Rm 5068,9000 Rockville Pike, Bethesda, MD 20892 USA.	pommier@nih.gov	ZHANG, YONGWEI/E-6252-2012; Caplen, Natasha J/H-2768-2016	Caplen, Natasha J/0000-0002-0001-9460; Zhang, Yongwei/0000-0003-2900-1149	National Institutes of Health Intramural Research Program; Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE [ZIABC010613, Z01BC006161, ZIABC010615, Z01BC010939, ZIABC006161, Z01BC006150, Z01BC010613, ZIABC006150, ZIABC010939] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, Center for Cancer Research, NCI.	ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Antony S, 2007, CANCER RES, V67, P10397, DOI 10.1158/0008-5472.CAN-07-0938; Bailly C, 2003, CRIT REV ONCOL HEMAT, V45, P91, DOI 10.1016/S1040-8428(02)00090-2; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brangi M, 1999, CANCER RES, V59, P5938; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; CHENG MF, 1994, ONCOL RES, V6, P269; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Desai AA, 2005, ANN ONCOL, V16, P958, DOI 10.1093/annonc/mdi178; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; ELLEDGE SJ, 1993, BIOESSAYS, V15, P333, DOI 10.1002/bies.950150507; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; ENGSTROM Y, 1984, EMBO J, V3, P863, DOI 10.1002/j.1460-2075.1984.tb01897.x; Fedier A, 2003, INT J ONCOL, V22, P1169; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Furuta T, 2006, ONCOGENE, V25, P2839, DOI 10.1038/sj.onc.1209313; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Fusaro G, 2002, ONCOGENE, V21, P4539, DOI 10.1038/sj.onc.1205551; Goldwasser F, 1996, CANCER RES, V56, P4430; Heidel JD, 2007, CLIN CANCER RES, V13, P2207, DOI 10.1158/1078-0432.CCR-06-2218; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Klisovic RB, 2008, CLIN CANCER RES, V14, P3889, DOI 10.1158/1078-0432.CCR-08-0109; Koc A, 2007, BIOCHEM BIOPH RES CO, V353, P527, DOI 10.1016/j.bbrc.2006.12.049; Kuo ML, 2003, CANCER J, V9, P277, DOI 10.1097/00130404-200307000-00010; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; Lee YD, 2006, GENE DEV, V20, P334, DOI 10.1101/gad.1380506; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lin WC, 2001, GENE DEV, V15, P1833; Lin ZP, 2007, BIOCHEM PHARMACOL, V73, P760, DOI 10.1016/j.bcp.2006.11.014; Lin ZP, 2004, J BIOL CHEM, V279, P27030, DOI 10.1074/jbc.M402056200; Liu QH, 2000, GENE DEV, V14, P1448; Lubelsky Y, 2005, MOL CELL BIOL, V25, P10665, DOI 10.1128/MCB.25.23.10665-10673.2005; Martin SE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm141; Naruyama H, 2008, BIOCHEM BIOPH RES CO, V374, P79, DOI 10.1016/j.bbrc.2008.06.112; Nieves-Neira W, 1999, INT J CANCER, V82, P396, DOI 10.1002/(SICI)1097-0215(19990730)82:3<396::AID-IJC13>3.0.CO;2-Z; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; O'Connor T, 2008, CANCER CHEMOTH PHARM, V61, P125, DOI 10.1007/s00280-007-0456-1; Pommier Y, 1996, ANN NY ACAD SCI, V803, P60, DOI 10.1111/j.1749-6632.1996.tb26377.x; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Shao RG, 1997, CANCER RES, V57, P4029; Stadler WM, 2008, CANCER CHEMOTH PHARM, V61, P689, DOI 10.1007/s00280-007-0524-6; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Teicher BA, 2008, BIOCHEM PHARMACOL, V75, P1262, DOI 10.1016/j.bcp.2007.10.016; TSAO YP, 1993, CANCER RES, V53, P5908; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Uchiki T, 2004, J BIOL CHEM, V279, P11293, DOI 10.1074/jbc.M309751200; Wang JL, 2002, CELL CYCLE, V1, P267, DOI 10.4161/cc.1.4.137; Woolstencroft RN, 2006, J CELL SCI, V119, P5178, DOI 10.1242/jcs.03221; Yamaguchi T, 2001, CANCER RES, V61, P8256; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; Zhou BS, 2003, CANCER RES, V63, P6583; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	66	101	103	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18085	18095		10.1074/jbc.M109.003020	http://dx.doi.org/10.1074/jbc.M109.003020			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416980	hybrid, Green Published			2022-12-27	WOS:000267712400020
J	Nadolski, MJ; Linder, ME				Nadolski, Marissa J.; Linder, Maurine E.			Molecular Recognition of the Palmitoylation Substrate Vac8 by Its Palmitoyltransferase Pfa3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARMADILLO REPEAT PROTEIN; HUNTINGTIN-INTERACTING PROTEIN-14; CYSTEINE-RICH DOMAIN; SACCHAROMYCES-CEREVISIAE; MEMBRANE LOCALIZATION; MENTAL-RETARDATION; ESCHERICHIA-COLI; N-MYRISTOYLATION; PLASMA-MEMBRANE; GLOBAL ANALYSIS	Palmitoylation of the yeast vacuolar protein Vac8 is important for its role in membrane-mediated events such as vacuole fusion. It has been established both in vivo and in vitro that Vac8 is palmitoylated by the Asp-His-His-Cys (DHHC) protein Pfa3. However, the determinants of Vac8 critical for recognition by Pfa3 have yet to be elucidated. This is of particular importance because of the lack of a consensus sequence for palmitoylation. Here we show that Pfa3 was capable of palmitoylating each of the three N-terminal cysteines of Vac8 and that this reaction was most efficient when Vac8 is N-myristoylated. Additionally, when we analyzed the Src homology 4 (SH4) domain of Vac8 independent of the rest of the protein, palmitoylation by Pfa3 still occurred. However, the specificity of palmitoylation seen for the full-length protein was lost, and the SH4 domain was palmitoylated by all five of the yeast DHHC proteins tested. These data suggested that a region of the protein C-terminal to the SH4 domain was important for conferring specificity of palmitoylation. This was confirmed by use of a chimeric protein in which the SH4 domain of Vac8 was swapped for that of Meh1, another palmitoylated and N-myristoylated protein in yeast. In this case we saw specificity mimic that of wild type Vac8. Competition experiments revealed that the 11th armadillo repeat of Vac8 is an important element for recognition by Pfa3. This demonstrates that regions distant from the palmitoylated cysteines are important for recognition by DHHC proteins.	[Nadolski, Marissa J.; Linder, Maurine E.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Linder, ME (corresponding author), Washington Univ, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	mlinder@wustl.edu	Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	National Institutes of Health [GM51466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466, T32GM007067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51466.	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Budde C, 2006, METHODS, V40, P143, DOI 10.1016/j.ymeth.2006.07.017; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; Draper JM, 2007, J LIPID RES, V48, P1873, DOI 10.1194/jlr.M700179-JLR200; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fleckenstein D, 1998, J CELL SCI, V111, P3109; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hou HT, 2005, P NATL ACAD SCI USA, V102, P17366, DOI 10.1073/pnas.0508885102; HUANG K, 2009, FASEB J IN PRESS; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KOEGL M, 1994, BIOCHEM J, V303, P749, DOI 10.1042/bj3030749; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MAGEE AI, 1985, EMBO J, V4, P1137, DOI 10.1002/j.1460-2075.1985.tb03751.x; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Pan XZ, 1998, J CELL SCI, V111, P2137; Peng YT, 2006, TRAFFIC, V7, P1378, DOI 10.1111/j.1600-0854.2006.00472.x; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Stowers RS, 2007, J NEUROSCI, V27, P12874, DOI 10.1523/JNEUROSCI.2464-07.2007; Subramanian K, 2006, J CELL SCI, V119, P2477, DOI 10.1242/jcs.02972; Tang FS, 2006, TRAFFIC, V7, P1368, DOI 10.1111/j.1600-0854.2006.00458.x; TOWLER DA, 1987, J BIOL CHEM, V262, P1030; Veit M, 2001, EMBO J, V20, P3145, DOI 10.1093/emboj/20.12.3145; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	54	41	43	4	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17720	17730		10.1074/jbc.M109.005447	http://dx.doi.org/10.1074/jbc.M109.005447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19416974	hybrid, Green Published			2022-12-27	WOS:000267202500038
J	Lee, SH; Hatakeyama, S; Yu, SY; Bao, XF; Ohyama, C; Khoo, KH; Fukuda, MN; Fukuda, M				Lee, Seung Ho; Hatakeyama, Shingo; Yu, Shin-Yi; Bao, Xingfeng; Ohyama, Chikara; Khoo, Kai-Hooi; Fukuda, Michiko N.; Fukuda, Minoru			Core3 O-Glycan Synthase Suppresses Tumor Formation and Metastasis of Prostate Carcinoma PC3 and LNCaP Cells through Down-regulation of alpha 2 beta 1 Integrin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-V; HAMSTER-KIDNEY CELLS; MOLECULAR-CLONING; ALPHA-3-BETA-1 INTEGRIN; LUNG COLONIZATION; BRANCH FORMATION; GENE-TRANSFER; CANCER-CELLS; UDP-GLCNAC; EXPRESSION	Although there are numerous reports of carbohydrates enriched in cancer cells, very few studies have addressed the functions of carbohydrates present in normal cells that decrease in cancer cells. It has been reported that core3 O-glycans are synthesized in normal gastrointestinal cells but are down-regulated in cancer cells. To determine the roles of core3 O-glycans, we transfected PC3 and LNCaP prostate cancer cells with beta 3-N-acetylglucosaminyltransferase-6 ( core3 synthase) required to synthesize core3 O-glycans. Both engineered cell lines exhibited reduced migration and invasion through extracellular matrix components compared with mock-transfected cells. Moreover we found that alpha 2 beta 1 integrin acquired core3 O-glycans in cells expressing core3 synthase with decreased maturation of beta 1 integrin, leading to decreased levels of the alpha 2 beta 1 integrin complex, decreased activation of focal adhesion kinase, and reduced lamellipodia formation. Upon inoculation into the prostate of nude mice, PC3 cells expressing core3 O-glycans produced much smaller tumors without metastasis to the surrounding lymph nodes in contrast to robust tumor formation and metastasis seen in mock-transfected PC3 cells. Similarly LNCaP cells expressing core3 O-glycans barely produced subcutaneous tumors in contrast to robust tumor formation by mock-transfected LNCaP cells. These findings indicate that addition of core3 O-glycans to beta 1 and alpha 2 integrin subunits in prostate cancer cells suppresses tumor formation and tumor metastasis.	[Lee, Seung Ho; Hatakeyama, Shingo; Bao, Xingfeng; Fukuda, Michiko N.; Fukuda, Minoru] Burnham Inst Med Res, Ctr Canc, Glycobiol Unit, Tumor Microenvironm Program, La Jolla, CA 92037 USA; [Yu, Shin-Yi; Khoo, Kai-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Ohyama, Chikara] Hirosaki Univ, Sch Med, Dept Urol, Hirosaki, Aomori 0362562, Japan	Sanford Burnham Prebys Medical Discovery Institute; Academia Sinica - Taiwan; Hirosaki University	Fukuda, M (corresponding author), Burnham Inst Med Res, Ctr Canc, Glycobiol Unit, Tumor Microenvironm Program, La Jolla, CA 92037 USA.	minoru@burnham.org	Khoo, Kay-Hooi/E-1989-2019; Hatakeyama, Shingo/AAQ-2583-2020; Hatakeyama, Shingo/E-9234-2013	Khoo, Kay-Hooi/0000-0003-2906-406X; Hatakeyama, Shingo/0000-0002-0026-4079; YU, Shin-Yi/0000-0003-0197-9575	National Institutes of Health [CA33000, CA48737, PO1CA71932]; Taiwan National Science Council; NATIONAL CANCER INSTITUTE [P01CA071932, R37CA033000, R01CA033000, R01CA048737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA33000 and in part by CA48737 ( to M. F.) and PO1CA71932 ( to M. F. and M. N. F.) and by grants from Taiwan National Science Council ( to K. H. K.).	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Bellis SL, 1999, J CELL PHYSIOL, V181, P33, DOI 10.1002/(SICI)1097-4652(199910)181:1<33::AID-JCP4>3.0.CO;2-#; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Bonaccorsi L, 2000, ENDOCRINOLOGY, V141, P3172, DOI 10.1210/en.141.9.3172; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chen SH, 2005, J EXP MED, V202, P1679, DOI 10.1084/jem.20051473; Clement M, 2004, J CELL SCI, V117, P5059, DOI 10.1242/jcs.01350; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fukuda M, 1996, CANCER RES, V56, P2237; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guo HB, 2005, J BIOL CHEM, V280, P8332, DOI 10.1074/jbc.M413532200; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hatakeyama S, 2009, P NATL ACAD SCI USA, V106, P3095, DOI 10.1073/pnas.0810110106; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; HUBBARD SC, 1987, J BIOL CHEM, V262, P16403; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inaba Y, 2003, INT J CANCER, V107, P949, DOI 10.1002/ijc.11513; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Iwai T, 2005, P NATL ACAD SCI USA, V102, P4572, DOI 10.1073/pnas.0407983102; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; LOTAN R, 1975, J BIOL CHEM, V250, P8518; Lyer P N, 1976, Arch Biochem Biophys, V177, P330; Machida E, 2001, CANCER RES, V61, P2226; MEROMSKY L, 1986, CANCER RES, V46, P5270; Mitoma J, 2003, J BIOL CHEM, V278, P9953, DOI 10.1074/jbc.M212756200; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; NAKAMORI S, 1993, CANCER RES, V53, P3632; OLSSON L, 1984, P NATL ACAD SCI-BIOL, V81, P3389, DOI 10.1073/pnas.81.11.3389; PIERCE M, 1986, J BIOL CHEM, V261, P772; PILLER F, 1988, J BIOL CHEM, V263, P15146; SCHACHTER H, 1992, BIOSYNTHESIS SERINE, P263; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; Schwientek T, 1999, J BIOL CHEM, V274, P4504, DOI 10.1074/jbc.274.8.4504; Sugihara K, 2007, P NATL ACAD SCI USA, V104, P3799, DOI 10.1073/pnas.0611516104; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; VAVASSEUR F, 1995, GLYCOBIOLOGY, V5, P351, DOI 10.1093/glycob/5.3.351; VAVASSEUR F, 1994, EUR J BIOCHEM, V222, P415, DOI 10.1111/j.1432-1033.1994.tb18880.x; YAMASHITA K, 1984, J BIOL CHEM, V259, P834; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Yu SY, 2006, GLYCOCONJUGATE J, V23, P355, DOI 10.1007/s10719-006-8492-3; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	48	53	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17157	17169		10.1074/jbc.M109.010934	http://dx.doi.org/10.1074/jbc.M109.010934			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19395705	Green Published, hybrid			2022-12-27	WOS:000266962400054
J	Ala-Laurila, P; Cornwall, MC; Crouch, RK; Kono, M				Ala-Laurila, Petri; Cornwall, M. Carter; Crouch, Rosalie K.; Kono, Masahiro			The Action of 11-cis-Retinol on Cone Opsins and Intact Cone Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL-PIGMENT; ROD PHOTORECEPTORS; DARK-ADAPTATION; 9-METHYL GROUP; SALAMANDER; ACTIVATION; RETINA; CYCLE; REGENERATION; PHOTOTRANSDUCTION	11-cis-Retinol has previously been shown in physiological experiments to promote dark adaptation and recovery of photo-responsiveness of bleached salamander red cones but not of bleached salamander red rods. The purpose of this study was to evaluate the direct interaction of 11-cis-retinol with expressed human and salamander cone opsins, and to determine by microspectrophotometry pigment formation in isolated salamander photoreceptors. We show here in a cell-free system using incorporation of radioactive guanosine 5'-3-O-( thio) triphosphate into transducin as an index of activity, that 11-cis-retinol inactivates expressed salamander cone opsins, acting an inverse agonist. Similar results were obtained with expressed human red and green opsins. 11-cis-Retinol had no significant effect on the activity of human blue cone opsin. In contrast, 11-cis-retinol activates the expressed salamander and human red rod opsins, acting as an agonist. Using microspectrophotometry of salamander cone photoreceptors before and after bleaching and following subsequent treatment with 11-cis-retinol, we show that 11-cis-retinol promotes pigment formation. Pigment was not formed in salamander red rods or green rods ( containing the same opsin as blue cones) treated under the same conditions. These results demonstrate that 11-cis-retinol is not a useful substrate for rod photoreceptors although it is for cone photoreceptors. These data support the premise that rods and cones have mechanisms for handling retinoids and regenerating visual pigment that are specific to photoreceptor type. These mechanisms are critical to providing regenerated pigments in a time scale required for the function of these two types of photoreceptors.	[Crouch, Rosalie K.; Kono, Masahiro] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Ala-Laurila, Petri; Cornwall, M. Carter] Boston Univ, Dept Physiol & Biophys, Sch Med, Boston, MA 02118 USA; [Ala-Laurila, Petri] Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland	Medical University of South Carolina; Boston University; University of Helsinki	Kono, M (corresponding author), Med Univ S Carolina, Dept Ophthalmol, Box 250676,167 Ashley Ave, Charleston, SC 29425 USA.	konom@musc.edu	Ala-Laurila, Petri/AAE-1203-2019; Kono, Masahiro/AAT-2265-2021	Ala-Laurila, Petri/0000-0002-6139-6825; Kono, Masahiro/0000-0001-7377-1664; Cornwall, M./0000-0002-0847-939X	National Institutes of Health [EY01157, EY04939, EY14793]; Academy of Finland [123231]; Foundation Fighting Blindness, Inc.; Owings Mills, MD; Research to Prevent Blindness, New York; NATIONAL EYE INSTITUTE [R01EY001157, R01EY004939, R24EY014793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Foundation Fighting Blindness, Inc.; Owings Mills, MD; Research to Prevent Blindness, New York(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY01157 (to M. C. C.), EY04939 (to R. K. C.), and EY14793 (vision core at the Medical University of South Carolina). This work was also supported by Academy of Finland Grant 123231 (to P. A.- L.), a grant from the Foundation Fighting Blindness, Inc., Owings Mills, MD (to R. K. C.), and an unrestricted grant to the Department of Ophthalmology at the Medical University of South Carolina from Research to Prevent Blindness, New York.	Ala-Laurila P, 2007, J PHYSIOL-LONDON, V585, P57, DOI 10.1113/jphysiol.2007.142935; Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; CORNWALL MC, 1984, VISION RES, V24, P1651, DOI 10.1016/0042-6989(84)90323-7; Cornwall MC, 2000, METHOD ENZYMOL, V316, P224; Crouch RK, 2002, METHOD ENZYMOL, V343, P29; DAEMEN FJM, 1978, NATURE, V276, P847, DOI 10.1038/276847a0; Das J, 2004, BIOCHEMISTRY-US, V43, P5532, DOI 10.1021/bi036097u; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Estevez ME, 2006, J GEN PHYSIOL, V128, P671, DOI 10.1085/jgp.200609630; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Isayama T, 2006, VISUAL NEUROSCI, V23, P899, DOI 10.1017/S0952523806230256; JIN J, 1994, VISUAL NEUROSCI, V11, P389, DOI 10.1017/S0952523800001735; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; JONES GJ, 1993, J GEN PHYSIOL, V102, P483, DOI 10.1085/jgp.102.3.483; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kono M, 2006, FEBS LETT, V580, P229, DOI 10.1016/j.febslet.2005.12.002; Kono M, 2008, BIOCHEMISTRY-US, V47, P7567, DOI 10.1021/bi800357b; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; MacNichol E. F.  Jr., 1978, Frontiers in Visual Science, P194; Makino CL, 1999, BIOPHYS J, V77, P1024, DOI 10.1016/S0006-3495(99)76953-5; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Muniz A, 2007, EXP EYE RES, V85, P175, DOI 10.1016/j.exer.2007.05.003; OPRIAN DD, 1993, METH NEUROSCI, V15, P301; Robinson PR, 2000, METHOD ENZYMOL, V315, P207; RUSHTON WAH, 1968, J PHYSIOL-LONDON, V198, P219, DOI 10.1113/jphysiol.1968.sp008603; RUSHTON WAH, 1968, VISION RES, V8, P617, DOI 10.1016/0042-6989(68)90040-0; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; YU HB, 1995, BIOCHEMISTRY-US, V34, P14963, DOI 10.1021/bi00046a002; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008	42	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16492	16500		10.1074/jbc.M109.004697	http://dx.doi.org/10.1074/jbc.M109.004697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386593	Green Published, hybrid			2022-12-27	WOS:000266730900046
J	Benakanakere, MR; Li, QY; Eskan, MA; Singh, AV; Zhao, JW; Galicia, JC; Stathopoulou, P; Knudsen, TB; Kinane, DF				Benakanakere, Manjunatha R.; Li, Qiyan; Eskan, Mehmet A.; Singh, Amar V.; Zhao, Jiawei; Galicia, Johnah C.; Stathopoulou, Panagiota; Knudsen, Thomas B.; Kinane, Denis F.			Modulation of TLR2 Protein Expression by miR-105 in Human Oral Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GINGIVAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; PORPHYROMONAS-GINGIVALIS; CYTOKINE PRODUCTION; MICRORNA GENES; UP-REGULATION; TOLL-LIKE-RECEPTOR-4; DIFFERENTIATION; RECEPTORS; RNA	Mammalian biological processes such as inflammation, involve regulation of hundreds of genes controlling onset and termination. MicroRNAs (miRNAs) can translationally repress target mRNAs and regulate innate immune responses. Our model system comprised primary human keratinocytes, which exhibited robust differences in inflammatory cytokine production (interleukin-6 and tumor necrosis factor-alpha) following specific Toll-like receptor 2 and 4 (TLR-2/TLR-4) agonist challenge. We challenged these primary cells with Porphyromonas gingivalis (a Gram-negative bacterium that triggers TLR-2 and TLR-4) and performed miRNA expression profiling. We identified miRNA (miR)-105 as a modulator of TLR-2 protein translation in human gingival keratinocytes. There was a strong inverse correlation between cells that had high cytokine responses following TLR-2 agonist challenge and miR-105 levels. Knock-in and knock-down of miR-105 confirmed this inverse relationship. In silico analysis predicted that miR-105 had complementarity for TLR-2 mRNA, and the luciferase reporter assay verified this. Further understanding of the role of miRNA in host responses may elucidate disease susceptibility and suggest new anti-inflammatory therapeutics.	[Benakanakere, Manjunatha R.; Li, Qiyan; Eskan, Mehmet A.; Zhao, Jiawei; Galicia, Johnah C.; Stathopoulou, Panagiota; Kinane, Denis F.] Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40202 USA; [Singh, Amar V.; Knudsen, Thomas B.] Univ Louisville, Sch Dent, Dept Mol Cellular & Craniofacial Biol, Louisville, KY 40202 USA; [Knudsen, Thomas B.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA; [Singh, Amar V.] Lockheed Martin, Res Triangle Pk, NC 27711 USA	University of Louisville; University of Louisville; United States Environmental Protection Agency; Lockheed Martin	Kinane, DF (corresponding author), Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, 501 S Preston St,Rm 204, Louisville, KY 40202 USA.	dfkina01@louisville.edu	Singh, Amar/K-4400-2013; Eskan, Mehmet A/AAP-5940-2021	Singh, Amar/0000-0003-3780-8233; Galicia, Johnah/0000-0003-1908-5801; Stathopoulou, Panagiota/0000-0001-8405-4679; MEHMET AKIF, ESKAN/0000-0002-5440-0291	National Institutes of Health [DE017384]; United States Public Health Service, NIDCR; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)United States Public Health Service); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE017384 (to D. F. K.) from the United States Public Health Service, NIDCR.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELL MV, 1989, AM J HUM GENET, V45, P883; Brozovic S, 2006, MICROBIOL-SGM, V152, P797, DOI 10.1099/mic.0.28472-0; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Eskan MA, 2008, EUR J IMMUNOL, V38, P1138, DOI 10.1002/eji.200737898; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; Eskan MA, 2007, INFECT IMMUN, V75, P892, DOI 10.1128/IAI.01604-06; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fritz Jorg H, 2006, Sci STKE, V2006, ppe27; Gantier MP, 2007, IMMUNOL CELL BIOL, V85, P458, DOI 10.1038/sj.icb.7100091; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Kinane D F, 2000, Ann R Australas Coll Dent Surg, V15, P42; Kinane DF, 2008, FRONT BIOSCI-LANDMRK, V13, P966, DOI 10.2741/2736; Kinane DF, 2006, GENES IMMUN, V7, P190, DOI 10.1038/sj.gene.6364282; Kinane DF, 2003, CRIT REV ORAL BIOL M, V14, P430, DOI 10.1177/154411130301400605; KRUEGER J, 1991, J CELL BIOCHEM, V45, P327, DOI 10.1002/jcb.240450404; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rowe Michael K., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008385; Sandros J, 2000, J DENT RES, V79, P1808, DOI 10.1177/00220345000790101301; Shiba H, 2005, J PERIODONTAL RES, V40, P153, DOI 10.1111/j.1600-0765.2005.00781.x; SINGH AV, 2007, BIRTH DEFECTS RES A, V79, P319; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; SPRATT D, 2003, MED BIOFILMS DETECTI, P175; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tian J, 1999, J NEUROIMMUNOL, V96, P21, DOI 10.1016/S0165-5728(98)00264-1; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	55	120	131	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23107	23115		10.1074/jbc.M109.013862	http://dx.doi.org/10.1074/jbc.M109.013862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19509287	Green Published, hybrid			2022-12-27	WOS:000268963100062
J	Wang, H; Chumnarnsilpa, S; Loonchanta, A; Li, Q; Kuan, YM; Robine, S; Larsson, M; Mihalek, I; Burtnick, LD; Robinson, RC				Wang, Hui; Chumnarnsilpa, Sakesit; Loonchanta, Anantasak; Li, Qiang; Kuan, Yang-Mei; Robine, Sylvie; Larsson, Marten; Mihalek, Ivana; Burtnick, Leslie D.; Robinson, Robert C.			Helix Straightening as an Activation Mechanism in the Gelsolin Superfamily of Actin Regulatory Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; BINDING PROTEINS; TERMINAL HALF; CALCIUM; VILLIN; HEADPIECE; SITES; DOMAINS	Villin and gelsolin consist of six homologous domains of the gelsolin/cofilin fold (V1-V6 and G1-G6, respectively). Villin differs from gelsolin in possessing at its C terminus an unrelated seventh domain, the villin headpiece. Here, we present the crystal structure of villin domain V6 in an environment in which intact villin would be inactive, in the absence of bound Ca2+ or phosphorylation. The structure of V6 more closely resembles that of the activated form of G6, which contains one bound Ca2+, rather than that of the calcium ion-free form of G6 within intact inactive gelsolin. Strikingly apparent is that the long helix in V6 is straight, as found in the activated form of G6, as opposed to the kinked version in inactive gelsolin. Molecular dynamics calculations suggest that the preferable conformation for this helix in the isolated G6 domain is also straight in the absence of Ca2+ and other gelsolin domains. However, the G6 helix bends in intact calcium ion-free gelsolin to allow interaction with G2 and G4. We suggest that a similar situation exists in villin. Within the intact protein, a bent V6 helix, when triggered by Ca2+, straightens and helps push apart adjacent domains to expose actin-binding sites within the protein. The sixth domain in this superfamily of proteins serves as a keystone that locks together a compact ensemble of domains in an inactive state. Perturbing the keystone initiates reorganization of the structure to reveal previously buried actin-binding sites.	[Burtnick, Leslie D.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Burtnick, Leslie D.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z1, Canada; [Chumnarnsilpa, Sakesit; Kuan, Yang-Mei; Larsson, Marten; Robinson, Robert C.] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Chumnarnsilpa, Sakesit] Uppsala Univ, Inst Med Biokemioch Mikrobiol, S-75123 Uppsala, Sweden; [Li, Qiang; Mihalek, Ivana] ASTAR, Bioinformat Inst, Singapore 138671, Singapore; [Robine, Sylvie] Inst Curie, UMR 144, F-75248 Paris 05, France	University of British Columbia; University of British Columbia; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Uppsala University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Burtnick, LD (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	burtnick@chem.ubc.ca	Larsson, Marten/A-5992-2012; Wang, Hui/C-4051-2012; Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903; Loonchanta, Tackey A./0000-0001-7098-5376; Larsson, Marten/0000-0002-7855-9539	Heart and Stroke Foundation of British Columbia and Yukon; Biomedical Research Council; University of British Columbia Centre for Blood Research X-ray Crystallography; Canada Foundation for Innovation; Michael Smith Foundation for Health Research; Howard Hughes Medical Institute; Canadian Institutes of Health Research; National Synchrotron Radiation Research Center, Taiwan, China; National Science Council of Taiwan; Taiwan National Research Program for Genomic Medicine	Heart and Stroke Foundation of British Columbia and Yukon; Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); University of British Columbia Centre for Blood Research X-ray Crystallography; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Synchrotron Radiation Research Center, Taiwan, China; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This work was supported in part by a grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon (to L. D. B.) and the Biomedical Research Council of A*STAR (to R. C. R. and I. M.). Funding for the University of British Columbia Centre for Blood Research X-ray Crystallography Hub is provided in part by grants from the Canada Foundation for Innovation, the Michael Smith Foundation for Health Research, the Howard Hughes Medical Institute, and the Canadian Institutes of Health Research. Portions of this research were carried out at the National Synchrotron Radiation Research Center, Taiwan, China, supported by the National Science Council of Taiwan. The Synchrotron Radiation Protein Crystallography Facility is supported by the Taiwan National Research Program for Genomic Medicine.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; FINIDORI J, 1992, J CELL BIOL, V116, P1145, DOI 10.1083/jcb.116.5.1145; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; HESTERBERG LK, 1983, J BIOL CHEM, V258, P365; JANMEY PA, 1988, J BIOL CHEM, V263, P16738; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Kolappan SL, 2003, J MOL BIOL, V329, P85, DOI 10.1016/S0022-2836(03)00383-8; Kumar N, 2004, J BIOL CHEM, V279, P45036, DOI 10.1074/jbc.M405424200; Kumar N, 2004, J BIOL CHEM, V279, P24915, DOI 10.1074/jbc.C400110200; Markus MA, 1997, PROTEIN SCI, V6, P1197; McGough AM, 2003, FEBS LETT, V552, P75, DOI 10.1016/S0014-5793(03)00932-3; Meng JM, 2005, BIOCHEMISTRY-US, V44, P11963, DOI 10.1021/bi050850x; Narayan K, 2003, FEBS LETT, V552, P82, DOI 10.1016/S0014-5793(03)00933-5; NORTHROP J, 1986, J BIOL CHEM, V261, P9274; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Smirnov SL, 2007, BIOCHEMISTRY-US, V46, P7488, DOI 10.1021/bi700110v; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vardar D, 1999, J MOL BIOL, V294, P1299, DOI 10.1006/jmbi.1999.3321	23	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21265	21269		10.1074/jbc.M109.019760	http://dx.doi.org/10.1074/jbc.M109.019760			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19491107	hybrid, Green Published			2022-12-27	WOS:000268564400020
J	Chan-Schaminet, KY; Baniwal, SK; Bublak, D; Nover, L; Scharf, KD				Chan-Schaminet, Kwan Yu; Baniwal, Sanjeev K.; Bublak, Daniela; Nover, Lutz; Scharf, Klaus-Dieter			Specific Interaction between Tomato HsfA1 and HsfA2 Creates Hetero-oligomeric Superactivator Complexes for Synergistic Activation of Heat Stress Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK TRANSCRIPTION FACTORS; DNA-BINDING DOMAIN; INTRACELLULAR-DISTRIBUTION; MOLECULAR CHAPERONES; NUCLEAR IMPORT; ARABIDOPSIS; THERMOTOLERANCE; IDENTIFICATION; TRIMERIZATION; ACCLIMATION	In plants, a family of more than 20 heat stress transcription factors (Hsf) controls the expression of heat stress (hs) genes. There is increasing evidence for the functional diversification between individual members of the Hsf family fulfilling distinct roles in response to various environmental stress conditions and developmental signals. In response to hs, accumulation of both heat stress proteins (Hsp) and Hsfs is induced. In tomato, the physical interaction between the constitutively expressed HsfA1 and the hs-inducible HsfA2 results in synergistic transcriptional activation (superactivation) of hs gene expression. Here, we show that the interaction is strikingly specific and not observed with other class A Hsfs. Hetero-oligomerization of the two-component Hsfs is preferred to homo-oligomerization, and each Hsf in the HsfA1/HsfA2 hetero-oligomeric complex has its characteristic contribution to its function as superactivator. Distinct regions of the oligomerization domain are responsible for specific homo-and hetero-oligomeric interactions leading to the formation of hexameric complexes. The results are summarized in a model of assembly and function of HsfA1/A2 superactivator complexes in hs gene regulation.	[Chan-Schaminet, Kwan Yu; Baniwal, Sanjeev K.; Bublak, Daniela; Nover, Lutz; Scharf, Klaus-Dieter] Goethe Univ Frankfurt, Dept Mol Cell Biol, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Scharf, KD (corresponding author), Goethe Univ Frankfurt, Dept Mol Cell Biol, Max von Laue Str 9-N200-R3-05, D-60438 Frankfurt, Germany.	scharf@bio.uni-frankfurt.de			Deutsche Forschungsgemeinschaft [249/4, Scha 577/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (to L.N. (No 249/4) and K. D. S. (Scha 577/6)).	Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Baniwal SK, 2007, J BIOL CHEM, V282, P3605, DOI 10.1074/jbc.M609545200; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; Bharti K, 2000, PLANT J, V22, P355, DOI 10.1046/j.1365-313x.2000.00746.x; Bharti K, 2004, PLANT CELL, V16, P1521, DOI 10.1105/tpc.019927; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Chen TX, 2002, P NATL ACAD SCI USA, V99, P1200, DOI 10.1073/pnas.032681299; DAMBERGER FF, 1995, J MOL BIOL, V254, P704, DOI 10.1006/jmbi.1995.0649; Doring P, 2000, PLANT CELL, V12, P265, DOI 10.1105/tpc.12.2.265; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Heerklotz D, 2001, MOL CELL BIOL, V21, P1759, DOI 10.1128/MCB.21.5.1759-1768.2001; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Kim BH, 2002, J EXP BOT, V53, P371, DOI 10.1093/jexbot/53.367.371; Kotak S, 2004, PLANT J, V39, P98, DOI 10.1111/j.1365-313X.2004.02111.x; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Liu PCC, 1999, J BIOL CHEM, V274, P17219, DOI 10.1074/jbc.274.24.17219; Lohmann C, 2004, MOL GENET GENOMICS, V271, P11, DOI 10.1007/s00438-003-0954-8; Lyck R, 1997, PLANTA, V202, P117, DOI 10.1007/s004250050110; Millar AH, 2006, CURR OPIN PLANT BIOL, V9, P610, DOI 10.1016/j.pbi.2006.09.002; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nakai A, 1999, CELL STRESS CHAPERON, V4, P86, DOI 10.1054/csac.1998.0002; NAKAI A, 1993, MOL CELL BIOL, V13, P1983, DOI 10.1128/MCB.13.4.1983; NIETOSOTELO J, 1990, CELL, V62, P807, DOI 10.1016/0092-8674(90)90124-W; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; NOVER L., 1991, HEAT SHOCK RESPONSE; Oreb M, 2008, TRENDS CELL BIOL, V18, P19, DOI 10.1016/j.tcb.2007.10.002; PELHAM HRB, 1982, EMBO J, V1, P1473, DOI 10.1002/j.1460-2075.1982.tb01340.x; Peteranderl R, 1999, BIOCHEMISTRY-US, V38, P3559, DOI 10.1021/bi981774j; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Port M, 2004, PLANT PHYSIOL, V135, P1457, DOI 10.1104/pp.104.042820; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Reichel C, 1996, P NATL ACAD SCI USA, V93, P5888, DOI 10.1073/pnas.93.12.5888; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; SCHARF KD, 1990, EMBO J, V9, P4495, DOI 10.1002/j.1460-2075.1990.tb07900.x; Scharf KD, 1998, MOL CELL BIOL, V18, P2240, DOI 10.1128/MCB.18.4.2240; Schoffl F, 1998, PLANT PHYSIOL, V117, P1135, DOI 10.1104/pp.117.4.1135; Schramm F, 2006, PLANT MOL BIOL, V60, P759, DOI 10.1007/s11103-005-5750-x; TOPFER R, 1988, NUCLEIC ACIDS RES, V16, P8725, DOI 10.1093/nar/16.17.8725; TREUTER E, 1993, MOL GEN GENET, V240, P113, DOI 10.1007/BF00276890; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Yamada K, 2007, J BIOL CHEM, V282, P37794, DOI 10.1074/jbc.M707168200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557	53	82	99	2	35	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20848	20857		10.1074/jbc.M109.007336	http://dx.doi.org/10.1074/jbc.M109.007336			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19491106	Green Published, hybrid			2022-12-27	WOS:000268316100048
J	Karamitri, A; Shore, AM; Docherty, K; Speakman, JR; Lomax, MA				Karamitri, Angeliki; Shore, Andrew M.; Docherty, Kevin; Speakman, John R.; Lomax, Michael A.			Combinatorial Transcription Factor Regulation of the Cyclic AMP-response Element on the Pgc-1 alpha Promoter in White 3T3-L1 and Brown HIB-1B Preadipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT/ENHANCER-BINDING-PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; STRESS-INDUCED PHOSPHORYLATION; CONVERTIBLE ADIPOSE-TISSUE; C/EBP-BETA; ADIPOCYTE DIFFERENTIATION; MESSENGER-RNA; HEPATIC GLUCONEOGENESIS; VENTRICULAR MYOCYTES; GENE-TRANSCRIPTION	Cold stress in rodents increases the expression of UCP1 and PGC-1 alpha in brown and white adipose tissue. We have previously reported that C/EBP beta specifically binds to the CRE on the proximal Pgc-1 alpha promoter and increases forskolin-sensitive Pgc-1 alpha and Ucp1 expression in white 3T3-L1 preadipocytes. Here we show that in mice exposed to a cold environment for 24 h, Pgc-1 alpha, Ucp1, and C/ebp beta but not C/ebp alpha or C/ebp delta expression were increased in BAT. Conversely, expression of the C/EBP dominant negative Chop10 was increased in WAT but not BAT during cold exposure. Reacclimatization of cold-exposed mice to a warm environment for 24 h completely reversed these changes in gene expression. In HIB-1B, brown preadipocytes, forskolin increased expression of Pgc-1 alpha, Ucp1, and C/ebp beta early in differentiation and inhibited Chop10 expression. Employing chromatin immunoprecipitation, we demonstrate that C/EBP beta, CREB, ATF-2, and CHOP10 are bound to the Pgc-1 alpha proximal CRE, but CHOP10 does not bind in HIB-1B cell lysates. Forskolin stimulation and C/EBP beta overexpression in 3T3-L1 cells increased C/EBP beta and CREB but displaced ATF-2 and CHOP10 binding to the Pgc-1 alpha proximal CRE. Overexpression of ATF-2 and CHOP10 in 3T3-L1 cells decreased Pgc-1 alpha transcription. Knockdown of Chop10 in 3T3-L1 cells using siRNA increased Pgc-1 alpha transcription, whereas siRNA against C/ebp beta in HIB-1B cells decreased Pgc-1 alpha and Ucp1 expression. We conclude that the increased cAMP stimulation of Pgc-1 alpha expression is regulated by the combinatorial effect of transcription factors acting at the CRE on the proximal Pgc-1 alpha promoter.	[Karamitri, Angeliki; Lomax, Michael A.] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England; [Shore, Andrew M.] Bournemouth Univ, Kingston Maurward Coll, Dorchester DT2 8PY, Dorset, England; [Docherty, Kevin] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Speakman, John R.] Univ Aberdeen, Sch Biol Sci, Aberdeen AB25 2ZD, Scotland	University of Nottingham; Bournemouth University; University of Aberdeen; University of Aberdeen	Lomax, MA (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.	michael.lomax@nottingham.ac.uk	Speakman, John R./A-9494-2008	Speakman, John R./0000-0002-2457-1823; Karamitri, Angeliki/0000-0002-8397-5529; Docherty, Kevin/0000-0001-6765-2060	Biotechnology and Biological Sciences Research Council; Greek State Scholarship's Foundation	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Greek State Scholarship's Foundation(Greek Ministry of Development-GSRT)	This work was supported by the Biotechnology and Biological Sciences Research Council and the Greek State Scholarship's Foundation.	ASHWELL M, 1987, INT J OBESITY, V11, P357; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; BAKKER O, 1991, NUCLEIC ACIDS RES, V19, P1213, DOI 10.1093/nar/19.6.1213; Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Cancello R, 1998, ENDOCRINOLOGY, V139, P4747, DOI 10.1210/en.139.11.4747; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CASTEILLA L, 1989, BIOCHEM J, V257, P665, DOI 10.1042/bj2570665; CHAMPIGNY O, 1991, P NATL ACAD SCI USA, V88, P10774, DOI 10.1073/pnas.88.23.10774; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; Cinti S, 2006, NUTR METAB CARDIOVAS, V16, P569, DOI 10.1016/j.numecd.2006.07.009; Clerk A, 1997, BIOCHEM J, V325, P801, DOI 10.1042/bj3250801; COUSIN B, 1992, J CELL SCI, V103, P931; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; GARRUTI G, 1992, INT J OBESITY, V16, P383; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LEAN MEJ, 1986, CLIN SCI, V71, P291, DOI 10.1042/cs0710291; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lomax MA, 2007, ENDOCRINOLOGY, V148, P461, DOI 10.1210/en.2006-0918; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; LONCAR D, 1989, J ULTRA MOL STRUCT R, V102, P9; LUETHY JD, 1990, J BIOL CHEM, V265, P16521; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MANCHADO C, 1994, BIOCHEM J, V302, P695, DOI 10.1042/bj3020695; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Oberkofler H, 1997, J LIPID RES, V38, P2125; PARK EA, 1993, J BIOL CHEM, V268, P613; Puigserver P, 1998, EUR J CELL BIOL, V77, P117, DOI 10.1016/S0171-9335(98)80079-4; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; REHNMARK S, 1993, FEBS LETT, V318, P235, DOI 10.1016/0014-5793(93)80519-Z; Rim JS, 2004, J BIOL CHEM, V279, P25916, DOI 10.1074/jbc.M402102200; ROESLER WJ, 1995, J BIOL CHEM, V270, P8225, DOI 10.1074/jbc.270.14.8225; Roesler WJ, 2000, MOL CELL ENDOCRINOL, V162, P1, DOI 10.1016/S0303-7207(00)00198-2; Roesler WJ, 1998, J BIOL CHEM, V273, P14950, DOI 10.1074/jbc.273.24.14950; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Ross HL, 2001, J VIROL, V75, P1842, DOI 10.1128/JVI.75.4.1842-1856.2001; ROSS SR, 1992, P NATL ACAD SCI USA, V89, P7561, DOI 10.1073/pnas.89.16.7561; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SOPPELA P, 1991, AM J PHYSIOL, V260, pR1229, DOI 10.1152/ajpregu.1991.260.6.R1229; Sugden PH, 1997, BIOCHEM SOC T, V25, pS221, DOI 10.1042/bst025221s; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Wang H, 2008, MOL ENDOCRINOL, V22, P1596, DOI 10.1210/me.2007-0388; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	70	44	48	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20738	20752		10.1074/jbc.M109.021766	http://dx.doi.org/10.1074/jbc.M109.021766			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19491401	hybrid, Green Published			2022-12-27	WOS:000268316100036
J	Kiely, PA; Baillie, GS; Barrett, R; Buckley, DA; Adams, DR; Houslay, MD; O'Connor, R				Kiely, Patrick A.; Baillie, George S.; Barrett, Robert; Buckley, Deirdre A.; Adams, David R.; Houslay, Miles D.; O'Connor, Rosemary			Phosphorylation of RACK1 on Tyrosine 52 by c-Abl Is Required for Insulin-like Growth Factor I-mediated Regulation of Focal Adhesion Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; ANCHORAGE-INDEPENDENT GROWTH; RECEPTOR-INTERACTING PROTEIN; PROMOTE CELL-MIGRATION; BREAST-CANCER CELLS; EXTRACELLULAR-MATRIX; MEMBRANE SUPPORTS; MAPK ACTIVATION; AKT ACTIVATION; PEPTIDE ARRAYS	Focal Adhesion Kinase (FAK) activity is controlled by growth factors and adhesion signals in tumor cells. The scaffolding protein RACK1 (receptor for activated C kinases) integrates insulin-like growth factor I (IGF-I) and integrin signaling, but whether RACK1 is required for FAK function is unknown. Here we show that association of FAK with RACK1 is required for both FAK phosphorylation and dephosphorylation in response to IGF-I. Suppression of RACK1 by small interfering RNA ablates FAK phosphorylation and reduces cell adhesion, cell spreading, and clonogenic growth. Peptide array and mutagenesis studies localize the FAK binding interface to blades I-III of the RACK1 beta-propeller and specifically identify a set of basic and hydrophobic amino acids (Arg-47, Tyr-52, Arg-57, Arg-60, Phe-65, Lys-127, and Lys-130) as key determinants for association with FAK. Mutation of tyrosine 52 alone is sufficient to disrupt interaction of RACK1 with FAK in cells where endogenous RACK1 is suppressed by small interfering RNA. Cells expressing a Y52F mutant RACK1 are impaired in adhesion, growth, and foci formation. Comparative analyses of homology models and crystal structures for RACK1 orthologues suggest a role for Tyr-52 as a site for phosphorylation that induces conformational change in RACK1, switching the protein into a FAK binding state. Tyrosine 52 is further shown to be phosphorylated by c-Abl kinase, and the c-Abl inhibitor STI571 disrupts FAK interaction with RACK1. We conclude that FAK association with RACK1 is regulated by phosphorylation of Tyr-52. Our data reveal a novel mechanism whereby IGF-I and c-Abl control RACK1 association with FAK to facilitate adhesion signaling.	[Kiely, Patrick A.; Barrett, Robert; Buckley, Deirdre A.; O'Connor, Rosemary] Natl Univ Ireland Univ Coll Cork, Dept Biochem, BioSci Inst, Cell Biol Lab, Cork, Ireland; [Baillie, George S.; Houslay, Miles D.] Univ Glasgow, Mol Pharmacol Grp, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Adams, David R.] Heriot Watt Univ, Dept Chem, Edinburgh EH1 4AS, Midlothian, Scotland	University College Cork; University of Glasgow; Heriot Watt University	O'Connor, R (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, BioSci Inst, Cell Biol Lab, Cork, Ireland.	r.oconnor@ucc.ie	Houslay, Miles/AAM-5281-2020; O'Connor, Rosemary/B-7902-2014; Houslay, Miles D/A-6825-2011; Adams, David R/E-3916-2010	O'Connor, Rosemary/0000-0002-0687-3422; Adams, David R/0000-0002-7154-7332; Houslay, Miles/0000-0002-3826-8091	Health Research Board of Ireland; Cancer Research Ireland; Science Foundation Ireland; Medical Research Council (UK) [G0600765, G0400053]; European Union [037189]; Fondation Leducq (Paris) [06VD02]; Medical Research Council [G0400053, G0600765] Funding Source: researchfish; MRC [G0600765, G0400053] Funding Source: UKRI	Health Research Board of Ireland; Cancer Research Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq (Paris)(Leducq Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Health Research Board of Ireland, Cancer Research Ireland, and Science Foundation Ireland as well as Medical Research Council (UK) Grants G0600765 and G0400053, European Union Grant 037189, and Fondation Leducq (Paris) Grant 06VD02 (to M. D. H. and G. S. B.).	Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Frank R, 1996, Methods Mol Biol, V66, P149; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Goel HL, 2005, CANCER RES, V65, P6692, DOI 10.1158/0008-5472.CAN-04-4315; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Guvakova MA, 1999, EXP CELL RES, V251, P244, DOI 10.1006/excr.1999.4566; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huang CC, 2008, INT J BIOCHEM CELL B, V40, P423, DOI 10.1016/j.biocel.2007.08.002; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2008, J BIOL CHEM, V283, P22952, DOI 10.1074/jbc.M800802200; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kramer A, 1998, METH MOL B, V87, P25; Kraus S, 2006, CANCER RES, V66, P11047, DOI 10.1158/0008-5472.CAN-06-0596; Leahy M, 2004, J BIOL CHEM, V279, P18306, DOI 10.1074/jbc.M309234200; Li W, 2001, AM J PHYSIOL-GASTR L, V280, pG75, DOI 10.1152/ajpgi.2001.280.1.G75; Lynch L, 2005, MOL BIOL CELL, V16, P51, DOI 10.1091/mbc.E04-05-0399; Mamidipudi V, 2007, ONCOGENE, V26, P2914, DOI 10.1038/sj.onc.1210091; Mamidipudi V, 2004, FEBS LETT, V567, P321, DOI 10.1016/j.febslet.2004.03.125; Manes S, 1999, MOL CELL BIOL, V19, P3125; Mauro L, 1999, EXP CELL RES, V252, P439, DOI 10.1006/excr.1999.4639; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitsushima M, 2006, FEBS LETT, V580, P4288, DOI 10.1016/j.febslet.2006.06.072; Mon NN, 2006, ANN NY ACAD SCI, V1086, P199, DOI 10.1196/annals.1377.019; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; Onishi I, 2007, CELL SIGNAL, V19, P194, DOI 10.1016/j.cellsig.2006.06.011; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Renshaw MW, 2000, ONCOGENE, V19, P3216, DOI 10.1038/sj.onc.1203667; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; Schlaepfer DD, 2007, J BIOL CHEM, V282, P17450, DOI 10.1074/jbc.M610672200; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Sechler JL, 1998, ANN NY ACAD SCI, V857, P143, DOI 10.1111/j.1749-6632.1998.tb10114.x; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Sottile J, 1998, J CELL SCI, V111, P2933; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Steele MR, 2001, CELL SIGNAL, V13, P507, DOI 10.1016/S0898-6568(01)00167-X; Ullah H, 2008, PROTEIN SCI, V17, P1771, DOI 10.1110/ps.035121.108; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Wang JG, 2005, LIFE SCI, V76, P2817, DOI 10.1016/j.lfs.2004.10.050; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006; Zvara A, 2001, ONCOGENE, V20, P951, DOI 10.1038/sj.onc.1204173	57	76	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20263	20274		10.1074/jbc.M109.017640	http://dx.doi.org/10.1074/jbc.M109.017640			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19423701	Green Published, hybrid			2022-12-27	WOS:000268097400053
J	Zhang, T; Berrocal, JG; Frizzell, KM; Gamble, MJ; DuMond, ME; Krishnakumar, R; Yang, TL; Sauve, AA; Kraus, WL				Zhang, Tong; Berrocal, Jhoanna G.; Frizzell, Kristine M.; Gamble, Matthew J.; DuMond, Michelle E.; Krishnakumar, Raga; Yang, Tianle; Sauve, Anthony A.; Kraus, W. Lee			Enzymes in the NAD(+) Salvage Pathway Regulate SIRT1 Activity at Target Gene Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-ENHANCING FACTOR; NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; WALLERIAN DEGENERATION; HISTONE ACETYLATION; BIOSYNTHETIC ENZYME; AXON DEGENERATION; MAMMALIAN-CELLS; EXPRESSION; PROTEIN; PHOSPHORIBOSYLTRANSFERASE	In mammals, nicotinamide phosphoribosyltransferase (NAMPT) and nicotinamide mononucleotide adenylyltransferase 1 (NMNAT-1) constitute a nuclear NAD(+) salvage pathway which regulates the functions of NAD(+)-dependent enzymes such as the protein deacetylase SIRT1. One of the major functions of SIRT1 is to regulate target gene transcription through modification of chromatin-associated proteins. However, little is known about the molecular mechanisms by which NAD(+) biosynthetic enzymes regulate SIRT1 activity to control gene transcription in the nucleus. In this study we show that stable short hairpin RNA-mediated knockdown of NAMPT or NMNAT-1 in MCF-7 breast cancer cells reduces total cellular NAD(+) levels and alters global patterns of gene expression. Furthermore, we show that SIRT1 plays a key role in mediating the gene regulatory effects of NAMPT and NMNAT-1. Specifically, we found that SIRT1 binds to the promoters of genes commonly regulated by NAMPT, NMNAT-1, and SIRT1 and that SIRT1 histone deacetylase activity is regulated by NAMPT and NMNAT-1 at these promoters. Most significantly, NMNAT-1 interacts with, and is recruited to target gene promoters by SIRT1. Collectively, our results reveal a mechanism for the direct control of SIRT1 deacetylase activity at a set of target gene promoters by NMNAT-1. This mechanism, in collaboration with NAMPT-dependent regulation of nuclear NAD(+) production, establishes an important pathway for transcription regulation by NAD(+).	[Krishnakumar, Raga; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Berrocal, Jhoanna G.; Frizzell, Kristine M.; Krishnakumar, Raga; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Yang, Tianle; Sauve, Anthony A.; Kraus, W. Lee] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 465 Biotechnol Bldg, Ithaca, NY 14853 USA.	wlk5@cornell.edu		Krishnakumar, Raga/0000-0002-2479-754X	National Institutes of Health [R01 DK069710, R01 DK73466]; Endocrine Society; Ellison Medical Foundation; New York State Health Research Science Board; American Heart Association; Alfred P. Sloan Foundation; AHA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073466, R01DK069710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society; Ellison Medical Foundation(Lawrence Ellison Foundation); New York State Health Research Science Board; American Heart Association(American Heart Association); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); AHA(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK069710 (NIDDK, to W. L. K.) and R01 DK73466 (NIDDK, to A. A. S.). This work was also supported by grants from the Endocrine Society (to W. L. K.) and the Ellison Medical Foundation (to A. A. S.), postdoctoral fellowships from the New York State Health Research Science Board (to T. Z.) and the American Heart Association (AHA; to M. J. G.), and predoctoral fellowships from the Alfred P. Sloan Foundation (to J. G. B.) and the AHA (to K. M. F.).	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Asaumi M, 2005, J BIOCHEM, V137, P147, DOI 10.1093/jb/mvi014; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Billington RA, 2008, J BIOL CHEM, V283, P6367, DOI 10.1074/jbc.M706204200; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Crawley JTB, 2008, ARTERIOSCL THROM VAS, V28, P233, DOI 10.1161/ATVBAHA.107.141606; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Fainzilber M, 2006, NEURON, V50, P819, DOI 10.1016/j.neuron.2006.05.023; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gillingwater TH, 2006, HUM MOL GENET, V15, P625, DOI 10.1093/hmg/ddi478; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Guarente L, 2000, GENE DEV, V14, P1021; Hollister RD, 1996, BRAIN RES, V728, P13; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Lin X, 2005, CEREBELLUM, V4, P37, DOI 10.1080/14734220510007897; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ohkawa N, 2008, GENES CELLS, V13, P1171, DOI 10.1111/j.1365-2443.2008.01235.x; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Turnley Ann M, 2005, Pediatr Endocrinol Rev, V2, P366; van der Veer E, 2005, CIRC RES, V97, P25, DOI 10.1161/01.RES.0000173298.38808.27; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yalowitz JA, 2004, BIOCHEM J, V377, P317, DOI 10.1042/BJ20030518; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Yang TL, 2006, TRENDS ENDOCRIN MET, V17, P186, DOI 10.1016/j.tem.2006.04.002; Yokoyama M, 1996, DNA Res, V3, P311, DOI 10.1093/dnares/3.5.311; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416	69	174	183	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20408	20417		10.1074/jbc.M109.016469	http://dx.doi.org/10.1074/jbc.M109.016469			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19478080	hybrid, Green Published			2022-12-27	WOS:000268097400066
J	Hislop, JN; Henry, AG; Marchese, A; von Zastrow, M				Hislop, James N.; Henry, Anastasia G.; Marchese, Adriano; von Zastrow, Mark			Ubiquitination Regulates Proteolytic Processing of G Protein-coupled Receptors after Their Sorting to Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-OPIOID RECEPTOR; ENDOCYTIC MEMBRANE TRAFFICKING; MULTIVESICULAR BODY PATHWAY; INDUCED DOWN-REGULATION; BETA(2)-ADRENERGIC RECEPTOR; MEDIATES UBIQUITINATION; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; PROTEASOME; CXCR4	Ubiquitination is essential for the endocytic sorting of various G protein-coupled receptors to lysosomes. Here we identify a distinct function of this covalent modification in controlling the later proteolytic processing of receptors. Mutation of all cytoplasmic lysine residues in the murine delta-opioid receptor blocked receptor ubiquitination without preventing ligand-induced endocytosis of receptors or their subsequent delivery to lysosomes, as verified by proteolysis of extramembrane epitope tags and down-regulation of radioligand binding to the transmembrane helices. Surprisingly, a functional screen revealed that the E3 ubiquitin ligase AIP4 specifically controls down-regulation of wild type receptors measured by radioligand binding without detectably affecting receptor delivery to lysosomes defined both immunochemically and biochemically. This specific AIP4-dependent regulation required direct ubiquitination of receptors and was also regulated by two deubiquitinating enzymes, AMSH and UBPY, which localized to late endosome/lysosome membranes containing internalized delta-opioid receptor. These results identify a distinct function of AIP4-dependent ubiquitination in controlling the later proteolytic processing of G protein-coupled receptors, without detectably affecting their endocytic sorting to lysosomes. We propose that ubiquitination or ubiquitination/deubiquitination cycling specifically regulates later proteolytic processing events required for destruction of the receptor's hydrophobic core.	[Hislop, James N.; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Hislop, James N.; von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Henry, Anastasia G.; von Zastrow, Mark] Univ Calif San Francisco, Cell Biol Program, San Francisco, CA 94158 USA; [Marchese, Adriano] Loyola Univ Chicago, Dept Pharmacol & Expt Therapeut, Stritch Sch Med, Maywood, IL 60153 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Loyola University Chicago	Hislop, JN (corresponding author), MC 2140,Rm GH N216P,600 16th St, San Francisco, CA 94158 USA.	james.hislop@ucsf.edu			National Institutes of Health, NIDA [DA012864, DA010711]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040, R29DA010711, R01DA010711, R01DA012864, R37DA010711] Funding Source: NIH RePORTER	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health, NIDA, Grants DA012864 and DA010711 ( to M. Z.).	Befort K, 1996, J BIOL CHEM, V271, P10161, DOI 10.1074/jbc.271.17.10161; Befort K, 1996, MOL PHARMACOL, V49, P216; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Chen LY, 2002, TRAFFIC, V3, P110, DOI 10.1034/j.1600-0854.2002.030204.x; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; LAW PY, 1984, J BIOL CHEM, V259, P4096; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Medina G, 2008, VIROLOGY, V377, P30, DOI 10.1016/j.virol.2008.04.024; Mosberg HI, 2002, J PEPT RES, V60, P329, DOI 10.1034/j.1399-3011.2002.21061.x; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsao PI, 2001, PHARMACOL THERAPEUT, V89, P139, DOI 10.1016/S0163-7258(00)00107-8; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Yadav PN, 2007, J PHARMACOL EXP THER, V320, P1186, DOI 10.1124/jpet.106.113621	50	68	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19361	19370		10.1074/jbc.M109.001644	http://dx.doi.org/10.1074/jbc.M109.001644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19433584	Green Published, hybrid			2022-12-27	WOS:000267908300027
J	Corre, S; Primot, A; Baron, Y; Le Seyec, J; Goding, C; Galibert, MD				Corre, Sebastien; Primot, Aline; Baron, Yorann; Le Seyec, Jacques; Goding, Colin; Galibert, Marie-Dominique			Target Gene Specificity of USF-1 Is Directed via p38-mediated Phosphorylation-dependent Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UPSTREAM STIMULATORY FACTOR; TRANSCRIPTION FACTOR USF; HELIX-LOOP-HELIX; ACTIVATES TRANSCRIPTION; HUMAN MELANOCYTES; IN-VIVO; C-MYC; EXPRESSION; PROMOTER; PROTEINS	How transcription factors interpret the output from signal transduction pathways to drive distinct programs of gene expression is a key issue that underpins development and disease. The ubiquitously expressed basic-helix-loop-helix leucine zipper upstream stimulating factor-1 binds E-box regulatory elements (CANNTG) to regulate a wide number of gene networks. In particular, USF-1 is a key component of the tanning process. Following UV irradiation, USF-1 is phosphorylated by the p38 stress-activated kinase on threonine 153 and directly up-regulates expression of the POMC, MC1R, TYR, TYRP-1 and DCT genes. However, how phosphorylation on Thr-153 might affect the activity of USF-1 is unclear. Here we show that, in response to DNA damage, oxidative stress and cellular infection USF-1 is acetylated in a phospho-Thr-153-dependent fashion. Phospho-acetylated USF-1 is nuclear and interacts with DNA but displays altered gene regulatory properties. Phospho-acetylated USF-1 is thus proposed to be associated with loss of transcriptional activation properties toward several target genes implicated in pigmentation process and cell cycle regulation. The identification of this critical stress-dependent USF-1 modification gives new insights into understanding USF-1 gene expression modulation associated with cancer development.	[Corre, Sebastien; Primot, Aline; Baron, Yorann; Galibert, Marie-Dominique] Univ Rennes 1, CNRS, Inst Genet & Dev Rennes,Regulat Transcript & Onco, Fac Med,UMR 6061,CS 34317,IFR GFAS 140, F-35043 Rennes, France; [Corre, Sebastien; Goding, Colin] Marie Curie Res Inst, Signaling & Dev Lab, Oxted RH8 0TL, England; [Le Seyec, Jacques] Hop Pontchaillou, INSERM, U522, IFR GFAS 140, F-35033 Rennes, France; [Goding, Colin] Univ Oxford, Ludwig Inst Canc Res, Oxford OX3 7DQ, England	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Ludwig Institute for Cancer Research; University of Oxford	Galibert, MD (corresponding author), Univ Rennes 1, CNRS, Inst Genet & Dev Rennes,Regulat Transcript & Onco, Fac Med,UMR 6061,CS 34317,IFR GFAS 140, 2 Av Pr Leon Bernard, F-35043 Rennes, France.	mgaliber@univ-rennes1.fr	CORRE, Sebastien/B-7069-2018; Le Seyec, Jacques/GLU-3933-2022; Le Seyec, Jacques/J-5680-2015	CORRE, Sebastien/0000-0003-1532-5660; Le Seyec, Jacques/0000-0002-1118-3311; Goding, Colin/0000-0002-1614-3909	Ligue National contre le Cancer-Comites Departementaux du Grand Ouest; Marie Curie Cancer Care,; Association pour la Recherche contre le Cancer Foundations.; Rennes University and the Intra-European Fellowship	Ligue National contre le Cancer-Comites Departementaux du Grand Ouest; Marie Curie Cancer Care,; Association pour la Recherche contre le Cancer Foundations.; Rennes University and the Intra-European Fellowship	This work was supported in part by the Ligue National contre le Cancer-Comites Departementaux du Grand Ouest, the Marie Curie Cancer Care, and the Association pour la Recherche contre le Cancer Foundations.; Supported by the Rennes University and the Intra-European Fellowship (6 Framework Programme).	Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; BAXEVANIS AD, 1993, CURR OPIN GENET DEV, V3, P278, DOI 10.1016/0959-437X(93)90035-N; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; Cheung E, 1999, BIOCHEM J, V344, P145, DOI 10.1042/0264-6021:3440145; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Davis PL, 1999, ONCOGENE, V18, P6000, DOI 10.1038/sj.onc.1202990; Deininger MH, 2000, BRAIN RES, V882, P1, DOI 10.1016/S0006-8993(00)02594-4; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Galibert MD, 1997, J IMMUNOL, V159, P6176; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Hock TD, 2004, BIOCHEM J, V383, P209, DOI 10.1042/BJ20040794; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; Ismail PM, 1999, ONCOGENE, V18, P5582, DOI 10.1038/sj.onc.1202932; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Kingsley-Kallesen ML, 1999, J BIOL CHEM, V274, P34020, DOI 10.1074/jbc.274.48.34020; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liu MJ, 2004, BIOCHEM J, V383, P249, DOI 10.1042/BJ20040414; MAEKAWA T, 1991, NUCLEIC ACIDS RES, V19, P4689, DOI 10.1093/nar/19.17.4689; Meyskens FL, 2001, PIGM CELL RES, V14, P148, DOI 10.1034/j.1600-0749.2001.140303.x; North S, 1999, ONCOGENE, V18, P1945, DOI 10.1038/sj.onc.1202506; Nowak M, 2005, MOL CELL BIOL, V25, P1537, DOI 10.1128/MCB.25.4.1537-1548.2005; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Pawar SA, 2004, ONCOGENE, V23, P6125, DOI 10.1038/sj.onc.1207806; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; Rahaus M, 2003, J GEN VIROL, V84, P2957, DOI 10.1099/vir.0.19335-0; REISMAN D, 1993, NUCLEIC ACIDS RES, V21, P345, DOI 10.1093/nar/21.2.345; Roth U, 2004, BIOL CHEM, V385, P239, DOI 10.1515/BC.2004.018; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Schwahn DJ, 2001, PIGM CELL RES, V14, P32, DOI 10.1034/j.1600-0749.2001.140106.x; Sirito M, 1998, P NATL ACAD SCI USA, V95, P3758, DOI 10.1073/pnas.95.7.3758; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; Sirito Mario, 1992, Gene Expression, V2, P231; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Takahashi K, 1999, J NEUROCHEM, V72, P2356, DOI 10.1046/j.1471-4159.1999.0722356.x; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Wu YL, 2002, BIOL REPROD, V66, P1505, DOI 10.1095/biolreprod66.5.1505; Xiao QX, 2002, AM J PHYSIOL-HEART C, V283, pH213, DOI 10.1152/ajpheart.01085.2001; Zachos G, 1999, J BIOL CHEM, V274, P5097, DOI 10.1074/jbc.274.8.5097	48	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18851	18862		10.1074/jbc.M808605200	http://dx.doi.org/10.1074/jbc.M808605200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19389701	Green Published, hybrid			2022-12-27	WOS:000267711500035
J	Modder, UI; Monroe, DG; Fraser, DG; Spelsberg, TC; Rosen, CJ; Gehin, M; Chambon, P; O'Malley, BW; Khosla, S				Modder, Ulrike I.; Monroe, David G.; Fraser, Daniel G.; Spelsberg, Thomas C.; Rosen, Clifford J.; Gehin, Martine; Chambon, Pierre; O'Malley, Bert W.; Khosla, Sundeep			Skeletal Consequences of Deletion of Steroid Receptor Coactivator-2/Transcription Intermediary Factor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; POSTMENOPAUSAL WOMEN; TISSUE-SPECIFICITY; GENE-EXPRESSION; DRUG-THERAPY; STEM-CELLS; BONE; ESTROGEN; MARROW; MICE	Both estrogen receptor (ER) and peroxisome proliferator-activated receptor gamma (PPAR gamma) regulate bone metabolism, and because steroid receptor coactivator (SRC)-2 (TIF-2) enhances ER and PPAR gamma activity, we examined the consequences of deletion of SRC-2 on bone using SRC-2 knock out (KO) mice. Loss of SRC-2 resulted in increased bone mass, with SRC-2 KO mice having 80% higher trabecular bone volume as compared with wild type mice. SRC-2 KO mice also had a marked decrease (by 50%) in bone marrow adipocytes. These data suggested that marrow precursor cells in the SRC-2 KO mice may be resistant to the inhibitory effects of endogenous PPAR gamma ligands on bone formation. Consistent with this, compared with cultures from wild type mice, marrow stromal cultures from SRC-2 KO mice formed significantly more mineralized nodules (by 3-fold) in the presence of the PPAR gamma agonist, rosiglitazone. Using chromatin immunoprecipitation analysis, we demonstrated that in bone marrow stromal cells, loss of SRC-2 leads to destabilization of the transcription complex at the peroxisome proliferator response elements of a number of PPAR gamma target genes, resulting in an overall decrease in the expression of adipocyte-related genes and a marked decrease in adipocyte development. Using ovariectomy with or without estrogen replacement, we also demonstrated that SRC-2 KO mice were partially resistant to the skeletal actions of estrogen. Collectively, these findings indicate that loss of SRC-2 leads to partial skeletal resistance to the ER and PPAR gamma, but resistance to PPAR gamma is dominant, leading to increased bone mass. Modulating SRC-2 action may, thus, represent a novel therapeutic target for osteoporosis.	[Modder, Ulrike I.; Monroe, David G.; Fraser, Daniel G.; Khosla, Sundeep] Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA; [Spelsberg, Thomas C.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA; [Gehin, Martine; Chambon, Pierre] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [O'Malley, Bert W.] Baylor Coll Med, Houston, TX 77030 USA	Mayo Clinic; Mayo Clinic; Maine Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Baylor College of Medicine	Khosla, S (corresponding author), Mayo Clin, Coll Med, Endocrine Res Unit, 200 1st St SW,Guggenheim 7, Rochester, MN 55905 USA.	khosla.sundeep@mayo.edu	Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372	National Institutes of Health [AG004875, AG028936, HD07857, DK59820]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD007857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028936, P01AG004875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG004875 and AG028936 (to S. K.) and HD07857 and DK59820 (to B. W. O.).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Aubin Jane E., 1996, P51; BENNETT JH, 1991, J CELL SCI, V99, P131; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; DUNNILL MS, 1967, J PATHOL BACTERIOL, V94, P275, DOI 10.1002/path.1700940205; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fu MG, 2001, J BIOL CHEM, V276, P45888, DOI 10.1074/jbc.M105490200; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gimble JM, 1996, MOL PHARMACOL, V50, P1087; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; Khastgir G, 2001, J CLIN ENDOCR METAB, V86, P289, DOI 10.1210/jc.86.1.289; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Modder UIL, 2004, EUR J ENDOCRINOL, V151, P503, DOI 10.1530/eje.0.1510503; Modder UIL, 2004, ENDOCRINOLOGY, V145, P913, DOI 10.1210/en.2003-1089; Modder UI, 2008, BONE, V42, P414, DOI 10.1016/j.bone.2007.10.017; Monroe DG, 2003, J ENDOCRINOL, V176, P349, DOI 10.1677/joe.0.1760349; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oda Y, 2003, MOL ENDOCRINOL, V17, P2329, DOI 10.1210/me.2003-0063; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Syed FA, 2008, OSTEOPOROSIS INT, V19, P1323, DOI 10.1007/s00198-008-0574-6; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Yamada T, 2004, J BONE MINER RES, V19, P1452, DOI 10.1359/JBMR.040515; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	42	19	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18767	18777		10.1074/jbc.M109.000836	http://dx.doi.org/10.1074/jbc.M109.000836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19423703	hybrid, Green Published			2022-12-27	WOS:000267711500026
J	Pinto, JR; Parvatiyar, MS; Jones, MA; Liang, JS; Ackerman, MJ; Potter, JD				Pinto, Jose Renato; Parvatiyar, Michelle S.; Jones, Michelle A.; Liang, Jingsheng; Ackerman, Michael J.; Potter, James D.			A Functional and Structural Study of Troponin C Mutations Related to Hypertrophic Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARDIAC TROPONIN; MUSCLE-CONTRACTION; CALCIUM-BINDING; CA2+ BINDING; STRIATED-MUSCLE; FORCE DEVELOPMENT; THIN-FILAMENTS; GENETIC-BASIS; N-DOMAIN; SITES	Recently four new hypertrophic cardiomyopathy mutations in cardiac troponin C (cTnC) (A8V, C84Y, E134D, and D145E) were reported, and their effects on the Ca2+ sensitivity of force development were evaluated (Landstrom, A. P., Parvatiyar, M. S., Pinto, J. R., Marquardt, M. L., Bos, J. M., Tester, D. J., Ommen, S. R., Potter, J. D., and Ackerman, M. J. (2008) J. Mol. Cell. Cardiol. 45, 281-288). We performed actomyosin ATPase and spectroscopic solution studies to investigate the molecular properties of these mutations. Actomyosin ATPase activity was measured as a function of [Ca2+] utilizing reconstituted thin filaments (TFs) with 50% mutant and 50% wild type (WT) and 100% mutant cardiac troponin (cTn) complexes: A8V, C84Y, and D145E increased the Ca2+ sensitivity with only A8V demonstrating lowered Ca2+ sensitization at the 50% ratio when compared with 100%; E134D was the same as WT at both ratios. Of these four mutants, only D145E showed increased ATPase activation in the presence of Ca2+. None of the mutants affected ATPase inhibition or the binding of cTn to the TF measured by co-sedimentation. Only D145E increased the Ca2+ affinity of site II measured by 2-(4'-(2 ''-iodoacetamido) phenyl) aminonaphthalene-6-sulfonic acid fluorescence in isolated cTnC or the cTn complex. In the presence of the TF, only A8V was further sensitized to Ca2+. Circular dichroism measurements in different metal-bound states of the isolated cTnCs showed changes in the secondary structure of A8V, C84Y, and D145E, whereas E134D was the same as WT. PyMol modeling of each cTnC mutant within the cTn complex revealed potential for local changes in the tertiary structure of A8V, C84Y, and D145E. Our results indicate that 1) three of the hypertrophic cardiomyopathy cTnC mutants increased the Ca2+ sensitivity of the myofilament; 2) the effects of the mutations on the Ca2+ affinity of isolated cTnC, cTn, and TF are not sufficient to explain the large Ca2+ sensitivity changes seen in reconstituted and fiber assays; and 3) changes in the secondary structure of the cTnC mutants may contribute to modified protein protein interactions along the sarcomere lattice disrupting the coupling between the cross-bridge and Ca2+ binding to cTnC.	[Pinto, Jose Renato; Parvatiyar, Michelle S.; Jones, Michelle A.; Liang, Jingsheng; Potter, James D.] Univ Miami, Dept Mol & Cellular Pharmacol, Miller Sch Med, Miami, FL 33136 USA; [Ackerman, Michael J.] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA	University of Miami; Mayo Clinic	Potter, JD (corresponding author), Univ Miami, Dept Mol & Cellular Pharmacol, Miller Sch Med, 1600 NW 10th Ave R-189, Miami, FL 33136 USA.	jdpotter@miami.edu	Pinto, Jose Renato/H-2631-2017; parvatiyar, michelle/ABH-7542-2020	Pinto, Jose Renato/0000-0001-9092-4976; Parvatiyar, Michelle/0000-0002-9416-0069	National Institutes of Health [HL-67415, HL-42325]; Windland Smith Rice Comprehensive Sudden Cardiac Death Program; American Heart Association Postdoctoral Fellowship [AHA 0825368E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R01HL067415, R37HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Windland Smith Rice Comprehensive Sudden Cardiac Death Program; American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-67415 and HL-42325 (to J. D. P.). This work was also supported by the Windland Smith Rice Comprehensive Sudden Cardiac Death Program (to M. A. J.) and American Heart Association Postdoctoral Fellowship AHA 0825368E (to J. R.P)	Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Bers D.M., 2001, EXCITATION CONTRACTI, P39, DOI [10.1007/978-94-010-0658-3_3, DOI 10.1007/978-94-010-0658-3_3]; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Blumenschein TMA, 2001, J BIOL CHEM, V276, P36606, DOI 10.1074/jbc.M105130200; BRITO RMM, 1993, J BIOL CHEM, V268, P20966; BRITO RMM, 1991, BIOCHEMISTRY-US, V30, P10236, DOI 10.1021/bi00106a023; CHANDRA M, 1994, J BIOL CHEM, V269, P14988; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; ELSALEH SC, 1987, J BIOL CHEM, V262, P17240; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Finley NL, 2004, J BIOL CHEM, V279, P54833, DOI 10.1074/jbc.M408304200; Finley NL, 2004, BIOCHEMISTRY-US, V43, P11371, DOI 10.1021/bi049672i; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fredricksen RS, 1996, BIOCHEMISTRY-US, V35, P14012, DOI 10.1021/bi961270q; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P99, DOI 10.1023/B:MCBI.0000041852.42291.aa; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Gordon AM, 2001, NEWS PHYSIOL SCI, V16, P49; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GUTH K, 1987, J BIOL CHEM, V262, P13627; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; JOHNSON JD, 1978, J BIOL CHEM, V253, P3775; KRUDY GA, 1992, BIOCHEMISTRY-US, V31, P1595, DOI 10.1021/bi00121a003; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; LEAVIS PC, 1978, ARCH BIOCHEM BIOPHYS, V186, P411, DOI 10.1016/0003-9861(78)90453-8; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Lindhout DA, 2005, BIOCHEMISTRY-US, V44, P14750, DOI 10.1021/bi051580l; Marian AJ, 1998, J CARDIOVASC ELECTR, V9, P88, DOI 10.1111/j.1540-8167.1998.tb00871.x; Maron Barry J, 2002, Card Electrophysiol Rev, V6, P100, DOI 10.1023/A:1017903709361; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MOEWS PC, 1975, J MOL BIOL, V91, P201, DOI 10.1016/0022-2836(75)90160-6; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; NEGELE JC, 1992, J BIOL CHEM, V267, P825; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Pinto JR, 2008, PFLUG ARCH EUR J PHY, V456, P1177, DOI 10.1007/s00424-008-0480-y; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; SATYSHUR KA, 1988, J BIOL CHEM, V263, P1628; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Smith L, 1999, BIOPHYS J, V76, P400, DOI 10.1016/S0006-3495(99)77206-1; SMITH L, 1994, J BIOL CHEM, V269, P9857; SOLARO RJ, 1986, J PHARMACOL EXP THER, V238, P502; Strynadka NCJ, 1997, J MOL BIOL, V273, P238, DOI 10.1006/jmbi.1997.1257; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031; ZOT HG, 1982, J BIOL CHEM, V257, P7678	65	70	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19090	19100		10.1074/jbc.M109.007021	http://dx.doi.org/10.1074/jbc.M109.007021			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19439414	Green Published, hybrid			2022-12-27	WOS:000267711500057
J	Scarpellini, A; Germack, R; Lortat-Jacob, H; Muramatsu, T; Billett, E; Johnson, T; Verderio, EAM				Scarpellini, Alessandra; Germack, Renee; Lortat-Jacob, Hugues; Muramatsu, Takashi; Billett, Ellen; Johnson, Timothy; Verderio, Elisabetta A. M.			Heparan Sulfate Proteoglycans Are Receptors for the Cell-surface Trafficking and Biological Activity of Transglutaminase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	19th International Symposium on Glycoconjugates	JUL 15-20, 2007	Cairns, AUSTRALIA				HUMAN-ERYTHROCYTE TRANSGLUTAMINASE; UNCONVENTIONAL EXPORT MACHINERY; SWISS 3T3 FIBROBLASTS; TISSUE TRANSGLUTAMINASE; CROSS-LINKING; EXTRACELLULAR-MATRIX; ESSENTIAL COMPONENTS; BINDING SITE; FIBRONECTIN; ADHESION	Transglutaminase type 2 (TG2) is both a protein cross-linking enzyme and a cell adhesion molecule with an elusive unconventional secretion pathway. In normal conditions, TG2-mediated modification of the extracellular matrix modulates cell motility, proliferation and tissue repair, but under continuous cell insult, higher expression and elevated extracellular trafficking of TG2 contribute to the pathogenesis of tissue scarring. In search of TG2 ligands that could contribute to its regulation, we characterized the affinity of TG2 for heparan sulfate (HS) and heparin, an analogue of the chains of HS proteoglycans (HSPGs). By using heparin/HS solid-binding assays and surface plasmon resonance we showed that purified TG2 has high affinity for heparin/HS, comparable to that for fibronectin, and that cell-surface TG2 interacts with heparin/HS. We demonstrated that cell-surface TG2 directly associates with the HS chains of syndecan-4 without the mediation of fibronectin, which has affinity for both syndecan-4 and TG2. Functional inhibition of the cell-surface HS chains of wild-type and syndecan-4-null fibroblasts revealed that the extracellular cross-linking activity of TG2 depends on the HS of HSPG and that syndecan-4 plays a major but not exclusive role. We found that heparin binding did not alter TG2 activity per se. Conversely, fibroblasts deprived of syndecan-4 were unable to effectively externalize TG2, resulting in its cytosolic accumulation. We propose that the membrane trafficking of TG2, and hence its extracellular activity, is linked to TG2 binding to cell-surface HSPG.	[Scarpellini, Alessandra; Germack, Renee; Billett, Ellen; Verderio, Elisabetta A. M.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England; [Lortat-Jacob, Hugues] UJF, CEA, CNRS, Inst Biol Struct, F-380272 Grenoble, France; [Muramatsu, Takashi] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Dept Hlth Sci, Aichi 47001953, Japan; [Johnson, Timothy] Univ Sheffield, Sch Med, Acad Nephrol Unit, Sheffield S10 2RZ, S Yorkshire, England	Nottingham Trent University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Aichi Gakuin University; University of Sheffield	Verderio, EAM (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England.	elisabetta.verderio-edwards@ntu.ac.uk	Verderio, Elisabetta/H-2789-2016	Verderio, Elisabetta/0000-0001-9153-8997; Billett, Ellen/0000-0001-8245-6519				Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Echtermeyer F, 1999, J CELL SCI, V112, P3433; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Feng JF, 1996, J BIOL CHEM, V271, P16451, DOI 10.1074/jbc.271.28.16451; Gambetti S, 2005, BIOCHIMIE, V87, P551, DOI 10.1016/j.biochi.2005.01.012; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; Germack R, 2006, J PHARMACOL EXP THER, V316, P392, DOI 10.1124/jpet.105.090597; Greene DK, 2003, J BIOL CHEM, V278, P7617, DOI 10.1074/jbc.M207123200; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; GRIFFIN M, 1979, BRIT J EXP PATHOL, V60, P653; Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Heath DJ, 2001, J BONE MINER RES, V16, P1477, DOI 10.1359/jbmr.2001.16.8.1477; IKURA K, 1989, BIOCHEMISTRY-US, V28, P2344, DOI 10.1021/bi00431a054; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; Johnson TS, 1999, J AM SOC NEPHROL, V10, P2146; Jones RA, 1997, J CELL SCI, V110, P2461; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Longley RL, 1999, J CELL SCI, V112, P3421; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Mahley RW, 1999, J LIPID RES, V40, P1; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; MARTINEZ J, 1994, BIOCHEMISTRY-US, V33, P2538, DOI 10.1021/bi00175a024; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nicholas B, 2003, BIOCHEM J, V371, P413, DOI 10.1042/BJ20021949; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; RICHARDS RJ, 1991, TOXICOL PATHOL, V19, P526; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Rudd TR, 2007, GLYCOBIOLOGY, V17, P983, DOI 10.1093/glycob/cwm062; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; SIGNORINI M, 1988, BIOL CHEM H-S, V369, P275, DOI 10.1515/bchm3.1988.369.1.275; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; Stephens P, 2004, J CELL SCI, V117, P3389, DOI 10.1242/jcs.01188; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; THOMAZY V, 1989, CELL TISSUE RES, V255, P215; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio E, 2001, J BIOMED MATER RES, V54, P294, DOI 10.1002/1097-4636(200102)54:2<294::AID-JBM17>3.0.CO;2-Q; Verderio EAM, 2009, AMINO ACIDS, V36, P671, DOI 10.1007/s00726-008-0134-6; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Zamir E, 2001, J CELL SCI, V114, P3577; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397	61	72	73	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18411	18423		10.1074/jbc.M109.012948	http://dx.doi.org/10.1074/jbc.M109.012948			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	467BW	19398782	Green Published, hybrid			2022-12-27	WOS:000267712400053
J	Hobeika, M; Brockmann, C; Gruessing, F; Neuhaus, D; Divita, G; Stewart, M; Dargemont, C				Hobeika, Maria; Brockmann, Christoph; Gruessing, Florian; Neuhaus, David; Divita, Gilles; Stewart, Murray; Dargemont, Catherine			Structural Requirements for the Ubiquitin-associated Domain of the mRNA Export Factor Mex67 to Bind Its Specific Targets, the Transcription Elongation THO Complex Component Hpr1 and Nucleoporin FXFG Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS48-LINKED POLYUBIQUITIN CHAIN; PROTEIN-PROTEIN INTERACTIONS; UBA DOMAIN; NUCLEAR EXPORT; DNA-REPAIR; QUALITY-CONTROL; LIGASE RSP5P; HIV-1 VPR; RECOGNITION; INTERACTS	The ubiquitin-associated (UBA) domain of the principal Saccharomyces cerevisiae mRNA nuclear export factor, Mex67, can bind both nuclear pore protein (nucleoporin) FG repeats and Hpr1, a component of the TREX center dot THO complex that functions to link transcription and export. Using fluorescence resonance energy transfer-based assays, we show here that Hpr1 and the FG repeats interact with overlapping binding sites on the Mex67 UBA domain. We present the solution structure of the Mex67 UBA domain (UBA-Mex67) complexed with a FXFG nucleoporin peptide and define residues engaged in the interaction and those involved in the FXFG-induced conformational change. We show by NMR titration that the binding of Hpr1 produces analogous changes in chemical shifts in similar regions of the UBA domain. Together the data presented here indicate that both Hpr1 and FXFG nucleoporins may bind in a similar way to the UBA-Mex67 domain. However, whereas binding of Hpr1 allows UBA-Mex67 to interact with tetra-ubiquitin, the complex between UBA-Mex67 and FXFG is unable to bind mono- or tetra-ubiquitin, suggesting that both substrate binding and also the nature of the substrate may influence the affinity of the UBA-Mex67 domain for ubiquitin.	[Hobeika, Maria; Dargemont, Catherine] Univ Paris 07, Inst Jacques Monod, CNRS, F-75251 Paris 05, France; [Brockmann, Christoph; Gruessing, Florian; Neuhaus, David; Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Divita, Gilles] Univ Montpellier 1, CNRS, CRBM, UMR 2593, F-34293 Montpellier 5, France; [Divita, Gilles] Univ Montpellier 2, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; MRC Laboratory Molecular Biology; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Dargemont, C (corresponding author), Univ Paris 07, Inst Jacques Monod, CNRS, 2 Pl Jussieu,Tour 43, F-75251 Paris 05, France.	dargemont@ijm.jussieu.fr	DIVITA, GILLES/AAV-9214-2021		Wellcome Trust; Agence Nationale pour la Recherche [BLAN06-1_134099]; Ligue contre le Cancer; Medical Research Council [MC_U105178934, MC_U105178939] Funding Source: researchfish; MRC [MC_U105178934, MC_U105178939] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue contre le Cancer(Ligue nationale contre le cancer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by a Program Grant from the Wellcome Trust (to M. S.), by Agence Nationale pour la Recherche Grant BLAN06-1_134099 (to C. D. and G. D.), and the Ligue contre le Cancer.	Agopian A, 2009, J BIOL CHEM, V284, P254, DOI 10.1074/jbc.M802199200; Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; CLORE GM, 1992, J MOL BIOL, V223, P853, DOI 10.1016/0022-2836(92)90247-H; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Duncan K, 2000, CURR BIOL, V10, P687, DOI 10.1016/S0960-9822(00)00527-3; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Grant RP, 2003, J MOL BIOL, V326, P849, DOI 10.1016/S0022-2836(02)01474-2; Grant RP, 2002, NAT STRUCT BIOL, V9, P247, DOI 10.1038/nsb773; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V115, P11620; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Heitz F, 1997, BIOCHEMISTRY-US, V36, P4995, DOI 10.1021/bi962349y; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hobeika M, 2007, MOL BIOL CELL, V18, P2561, DOI 10.1091/mbc.E07-02-0153; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Iglesias N, 2008, FEBS LETT, V582, P1987, DOI 10.1016/j.febslet.2008.03.038; KAY LE, 1990, J AM CHEM SOC, V112, P888, DOI 10.1021/ja00158a070; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Miao F, 2000, J BIOL CHEM, V275, P28433, DOI 10.1074/jbc.M001064200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Neumann S, 2003, EMBO REP, V4, P1156, DOI 10.1038/sj.embor.7400026; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Rodriguez MS, 2003, TRAFFIC, V4, P566, DOI 10.1034/j.1600-0854.2003.00115.x; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang QH, 2003, BIOCHEMISTRY-US, V42, P13529, DOI 10.1021/bi035391j; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; WithersWard ES, 1997, J VIROL, V71, P9732, DOI 10.1128/JVI.71.12.9732-9742.1997; Zenklusen D, 2001, FEBS LETT, V498, P150, DOI 10.1016/S0014-5793(01)02482-6; Zhu QZ, 2001, CANCER RES, V61, P64	53	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17575	17583		10.1074/jbc.M109.004374	http://dx.doi.org/10.1074/jbc.M109.004374			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19401465	Green Published, hybrid			2022-12-27	WOS:000267202500023
J	Price, PA; Toroian, D; Lim, JE				Price, Paul A.; Toroian, Damon; Lim, Joo Eun			Mineralization by Inhibitor Exclusion THE CALCIFICATION OF COLLAGEN WITH FETUIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-MICROSCOPIC TOMOGRAPHY; ACID-CONTAINING PROTEIN; DEMINERALIZED BONE; ORGANIC MATRIX; CORTICAL BONE; SERUM FACTOR; GLYCOPROTEIN; PARTICLES; CRYSTALS; TENDON	One of our goals is to understand the mechanisms that deposit mineral within collagen fibrils, and as a first step we recently determined the size exclusion characteristics of the fibril. This study revealed that apatite crystals up to 12 unit cells in size can access the water within the fibril, whereas molecules larger than a 40-kDa protein are excluded. Based on these observations, we proposed a novel mechanism for fibril mineralization: that macromolecular inhibitors of apatite growth favor fibril mineralization by selectively inhibiting crystal growth in the solution outside of the fibril. To test this mechanism, we developed a system in which crystal formation is driven by homogeneous nucleation at high calcium phosphate concentration and the only macromolecule in solution is fetuin, a 48-kDa inhibitor of apatite growth. Our experiments with this system demonstrated that fetuin determines the location of mineral growth; in the presence of fetuin mineral grows exclusively within the fibril, whereas in its absence mineral grows in solution outside the fibril. Additional experiments showed that fetuin is also able to localize calcification to the interior of synthetic matrices that have size exclusion characteristics similar to those of collagen and that it does so by selectively inhibiting mineral growth outside of these matrices. We termed this new calcification mechanism "mineralization by inhibitor exclusion," the selective mineralization of a matrix using a macromolecular inhibitor of mineral growth that is excluded from that matrix. Future studies will be needed to evaluate the possible role of this mechanism in bone mineralization.	[Price, Paul A.; Toroian, Damon; Lim, Joo Eun] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Price, PA (corresponding author), Univ Calif San Diego, Div Biol Sci, Mail Code 0368, La Jolla, CA 92093 USA.	pprice@ucsd.edu						ASHTON BA, 1976, CALC TISS RES, V22, P27; ASHTON BA, 1974, EUR J BIOCHEM, V45, P525, DOI 10.1111/j.1432-1033.1974.tb03577.x; Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; CHEN PS, 1956, ANAL CHEM, V28, P1758; DICKSON IR, 1975, NATURE, V256, P430, DOI 10.1038/256430a0; Fuchs RK, 2008, MATRIX BIOL, V27, P34, DOI 10.1016/j.matbio.2007.07.006; HALE JE, 1991, J BIOL CHEM, V266, P21145; Hamlin NJ, 2006, CALCIFIED TISSUE INT, V78, P326, DOI 10.1007/s00223-005-0205-6; Hamlin NJ, 2004, CALCIFIED TISSUE INT, V75, P231, DOI 10.1007/s00223-004-0190-1; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Ix JH, 2009, J BONE MINER RES, V24, P514, DOI 10.1359/JBMR.081017; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496; KATZ EP, 1973, J MOL BIOL, P1; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; MAROTTI G, 1972, CALC TISS RES, V10, P67, DOI 10.1007/BF02012537; MIZUNO M, 1991, BONE MINER, V13, P1, DOI 10.1016/0169-6009(91)90046-3; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nikolov S, 2008, BIOPHYS J, V94, P4220, DOI 10.1529/biophysj.107.125567; OHNISHI T, 1991, J BIOL CHEM, V266, P14636; Olivier E, 2000, BIOCHEM J, V350, P589, DOI 10.1042/0264-6021:3500589; Pedersen KO, 1944, NATURE, V154, P575, DOI 10.1038/154575a0; Price PA, 2006, KIDNEY INT, V70, P1577, DOI 10.1038/sj.ki.5001841; Price PA, 2004, J BIOL CHEM, V279, P19169, DOI 10.1074/jbc.M307880200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; QUELCH KJ, 1984, CALCIFIED TISSUE INT, V36, P545, DOI 10.1007/BF02405363; ROBINSON RA, 1957, J BONE JOINT SURG AM, V39, P167, DOI 10.2106/00004623-195739010-00015; Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7; Sasaki N, 1997, CALCIFIED TISSUE INT, V60, P361, DOI 10.1007/s002239900244; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Siperko LM, 2001, J STRUCT BIOL, V135, P313, DOI 10.1006/jsbi.2001.4414; Tong W, 2003, CALCIFIED TISSUE INT, V72, P592, DOI 10.1007/s00223-002-1077-7; Toroian D, 2008, CALCIFIED TISSUE INT, V82, P116, DOI 10.1007/s00223-007-9085-2; Toroian D, 2007, J BIOL CHEM, V282, P22437, DOI 10.1074/jbc.M700591200; WENDEL M, 1993, MATRIX, V13, P331, DOI 10.1016/S0934-8832(11)80029-6	38	122	128	3	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17092	17101		10.1074/jbc.M109.007013	http://dx.doi.org/10.1074/jbc.M109.007013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19414589	hybrid, Green Published			2022-12-27	WOS:000266962400047
J	Okumura, N; Koh, T; Hasebe, Y; Seki, T; Ariga, T				Okumura, Nobuaki; Koh, Tomohiko; Hasebe, Yuichi; Seki, Taiichiro; Ariga, Toyohiko			A Novel Function of Thrombin-activatable Fibrinolysis Inhibitor during Rat Liver Regeneration and in Growth-promoted Hepatocytes in Primary Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA PROCARBOXYPEPTIDASE-B; EXTRACELLULAR-MATRIX; PLASMINOGEN ACTIVATORS; PARTIAL-HEPATECTOMY; CARBOXYPEPTIDASE-N; SIGNALING PATHWAY; GENE-EXPRESSION; TOXIC INJURY; CLOT LYSIS; TAFI	Thrombin-activatable fibrinolysis inhibitor (TAFI) exhibits anti-fibrinolytic activity by removing C-terminal lysine residues from fibrin or plasminogen receptor proteins on the cellular surface, and plays an important role in the regulation of fibrinolysis. In this study, we examined the regulation of TAFI in hepatocytes during liver regeneration, and revealed its pivotal role in hepatocyte proliferation. In rat models, partial hepatectomy or carbon tetrachloride (CCl4)-induced acute liver injury suppressed the levels of plasma TAFI activity and hepatic TAFI mRNA, whereas this operation markedly increased both the hepatic plasmin activity and the level of proliferating cell nuclear antigen. In primary cultures of rat hepatocytes, the TAFI mRNA level was decreased under growth-promoting culture conditions. Treatment of the hepatocytes with TAFI siRNA increased the amount of plasmin on the hepatocytes and promoted hepatocyte proliferation. We concluded that TAFI regulates plasmin activity through its enzymatic activity whereby it reduces the plasminogen-binding capacity of the hepatocytes. The TAFI gene expression is down-regulated in hepatocyte proliferation for producing a fibrinolytic microenvironment suitable for cell growth. This is the first report on the role of TAFI in the pericellular fibrinolysis necessary for cellular proliferation.	[Seki, Taiichiro] Nihon Univ, Coll Bioresource Sci, Dept Chem & Life Sci, Kanagawa 2528510, Japan; Nihon Univ, Grad Sch Bioresource Sci, Dept Appl Life Sci, Kanagawa 2528510, Japan	Nihon University; Nihon University	Seki, T (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Chem & Life Sci, Kanagawa 2528510, Japan.	tseki@brs.nihon-u.ac.jp	Hasebe, Yuichi/C-5350-2016	Okumura, Nobuaki/0000-0002-2997-7291	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science (JSPS); Nihon University; COE Program	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nihon University; COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Academic Frontier Project (to T. S.), the Japan Society for the Promotion of Science (JSPS), grant-in aid for scientific research (C) (to T. S.), and a Nihon University individual research grant (to T. S.).; Supported by a Fellowship from the Academic Frontier Project from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and from the COE Program in the 21st Century in Japan.	Akao M, 2002, THROMB RES, V107, P169, DOI 10.1016/S0049-3848(02)00258-X; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Bajzar L, 2000, ARTERIOSCL THROM VAS, V20, P2511, DOI 10.1161/01.ATV.20.12.2511; BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161; Bezerra JA, 1999, P NATL ACAD SCI USA, V96, P15143, DOI 10.1073/pnas.96.26.15143; Bezerra JA, 2001, AM J PATHOL, V158, P921, DOI 10.1016/S0002-9440(10)64039-4; Boffa MB, 2003, J BIOL CHEM, V278, P9250, DOI 10.1074/jbc.M209588200; Bouma BN, 2003, J THROMB HAEMOST, V1, P1566, DOI 10.1046/j.1538-7836.2003.00329.x; Campbell WD, 2002, MICROBIOL IMMUNOL, V46, P131, DOI 10.1111/j.1348-0421.2002.tb02669.x; Colucci M, 2003, HEPATOLOGY, V38, P230, DOI 10.1053/jhep.2003.50277; Daveau M, 2004, J IMMUNOL, V173, P3418, DOI 10.4049/jimmunol.173.5.3418; Drixler TA, 2003, BRIT J SURG, V90, P1384, DOI 10.1002/bjs.4275; Grunnet N, 1999, J HEPATOL, V31, P117, DOI 10.1016/S0168-8278(99)80171-8; HAJJAR KA, 1995, THROMB HAEMOSTASIS, V74, P294; Hasebe Y, 2003, BIOCHEM BIOPH RES CO, V308, P852, DOI 10.1016/S0006-291X(03)01468-2; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hosaka Y, 1998, THROMB HAEMOSTASIS, V79, P371, DOI 10.1055/s-0037-1614994; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; Ichihara A, 1980, Ann N Y Acad Sci, V349, P77, DOI 10.1111/j.1749-6632.1980.tb29517.x; Kawao N, 2007, BBA-MOL CELL RES, V1773, P718, DOI 10.1016/j.bbamcr.2007.03.019; Kim TH, 1997, HEPATOLOGY, V26, P896, DOI 10.1002/hep.510260415; Mandal SK, 2005, J THROMB HAEMOST, V3, P163, DOI 10.1111/j.1538-7836.2004.01054.x; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Markiewski MM, 2004, J IMMUNOL, V173, P747, DOI 10.4049/jimmunol.173.2.747; MARTINEZHERNANDEZ A, 1991, LAB INVEST, V64, P157; MIZUNO K, 1993, J BIOCHEM-TOKYO, V114, P96, DOI 10.1093/oxfordjournals.jbchem.a124147; MOROI M, 1976, J BIOL CHEM, V251, P5956; Mosnier LO, 1998, THROMB HAEMOSTASIS, V80, P829; Nagaki M, 2000, J HEPATOL, V32, P488, DOI 10.1016/S0168-8278(00)80401-8; Nagashima M, 2002, J CLIN INVEST, V109, P101, DOI 10.1172/JCI12119; NAKAMURA T, 1983, J BIOCHEM-TOKYO, V94, P1029, DOI 10.1093/oxfordjournals.jbchem.a134444; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Nicholl SM, 2005, J SURG RES, V127, P39, DOI 10.1016/j.jss.2005.03.004; Noguchi T, 2001, THROMB RES, V104, P283, DOI 10.1016/S0049-3848(01)00370-X; ODA H, 1995, BIOCHEM BIOPH RES CO, V212, P800, DOI 10.1006/bbrc.1995.2039; Okada K, 2004, J HEPATOL, V40, P110, DOI 10.1016/j.jhep.2003.09.016; Okumura N, 2007, BIOSCI BIOTECH BIOCH, V71, P1542, DOI 10.1271/bbb.70126; Olaso E, 1998, J HEPATOL, V29, P836, DOI 10.1016/S0168-8278(98)80269-9; REDLITZ A, 1995, J CLIN INVEST, V96, P2534, DOI 10.1172/JCI118315; Renckens R, 2005, J IMMUNOL, V175, P6764, DOI 10.4049/jimmunol.175.10.6764; Sato T, 2000, J IMMUNOL, V165, P1053, DOI 10.4049/jimmunol.165.2.1053; Sun ZY, 2002, BBA-PROTEIN STRUCT M, V1596, P182, DOI 10.1016/S0167-4838(02)00233-9; Swaisgood CM, 2002, J CLIN INVEST, V110, P1275, DOI 10.1172/JCI200215082; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; Tanaka M, 2001, FIBRINOLYSIS PROTEOL, V15, P2, DOI 10.1054/fipr.2001.0097; Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200; Van Thiel DH, 2001, THROMB HAEMOSTASIS, V85, P667; Velde EAT, 2003, J THROMB HAEMOST, V1, P2087, DOI 10.1046/j.1538-7836.2003.00404.x	49	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16553	16561		10.1074/jbc.M109.011452	http://dx.doi.org/10.1074/jbc.M109.011452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386599	hybrid, Green Published			2022-12-27	WOS:000266730900052
J	Fink, GR				Fink, Gerald R.			Getting Along with a Little Help from My Friends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HISTIDINE REGULATORY MUTANTS; AMINO-ACID CONTROL; SACCHAROMYCES-CEREVISIAE; SALMONELLA TYPHIMURIUM; NUCLEOTIDE-SEQUENCE; TY ELEMENTS; YEAST; HIS4; BIOSYNTHESIS; OPERON		MIT, Whitehead Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Fink, GR (corresponding author), MIT, Whitehead Inst, Cambridge, MA 02142 USA.	gfink@wi.mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035010] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM035010] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES BN, 1963, COLD SPRING HARB SYM, V28, P349, DOI 10.1101/SQB.1963.028.01.049; ARNDT K, 1986, P NATL ACAD SCI USA, V83, P8516, DOI 10.1073/pnas.83.22.8516; BIGELIS R, 1981, J BIOL CHEM, V256, P5144; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Botstein David, 1993, P361; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; DONAHUE TF, 1982, GENE, V18, P47, DOI 10.1016/0378-1119(82)90055-5; DONAHUE TF, 1983, CELL, V32, P89, DOI 10.1016/0092-8674(83)90499-3; Fink Gerald R., 1993, P435; FINK GR, 1964, SCIENCE, V146, P525, DOI 10.1126/science.146.3643.525; FINK GR, 1966, GENETICS, V53, P445; FINK GR, 1968, J MOL BIOL, V33, P547, DOI 10.1016/0022-2836(68)90305-7; FINK GR, 1967, J MOL BIOL, V30, P81, DOI 10.1016/0022-2836(67)90245-8; FINK GR, 1967, J MOL BIOL, V30, P97, DOI 10.1016/0022-2836(67)90246-X; FINK GR, 1992, DYNAMIC GENOME BARBA, P281; FINK GR, 1902, NATURE, V359, P272; GARFINKEL DJ, 1985, CELL, V42, P507, DOI 10.1016/0092-8674(85)90108-4; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1985, P NATL ACAD SCI USA, V82, P498, DOI 10.1073/pnas.82.2.498; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; ROTH JR, 1966, COLD SPRING HARB SYM, V31, P383, DOI 10.1101/SQB.1966.031.01.050; SILBERT DF, 1966, J MOL BIOL, V22, P335, DOI 10.1016/0022-2836(66)90136-7; WINSTON F, 1984, CELL, V39, P675, DOI 10.1016/0092-8674(84)90474-4; WOLFNER M, 1975, J MOL BIOL, V96, P273, DOI 10.1016/0022-2836(75)90348-4	24	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23885	23890		10.1074/jbc.X109.029389	http://dx.doi.org/10.1074/jbc.X109.029389			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19515841	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000269380200002
J	Blaho, VA; Buczynski, MW; Brown, CR; Dennis, EA				Blaho, Victoria A.; Buczynski, Matthew W.; Brown, Charles R.; Dennis, Edward A.			Lipidomic Analysis of Dynamic Eicosanoid Responses during the Induction and Resolution of Lyme Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE EPOXIDE HYDROLASE; EPOXYEICOSATRIENOIC ACIDS; FATTY-ACIDS; PPAR-GAMMA; INFLAMMATION-RESOLUTION; LIQUID-CHROMATOGRAPHY; BORRELIA-BURGDORFERI; MASS-SPECTROMETRY; LEUKOTRIENE B-4; LIPOXIN A(4)	Eicosanoids and other bioactive lipid mediators are indispensable regulators of biological processes, as demonstrated by the numerous inflammatory diseases resulting from their dysregulation, including cancer, hyperalgesia, atherosclerosis, and arthritis. Despite their importance, a robust strategy comparable with gene or protein array technology for comprehensively analyzing the eicosanoid metabolome has not been forthcoming. We have developed liquid chromatography-tandem mass spectrometry methodology that quantitatively and comprehensively analyzes the eicosanoid metabolome and utilized this approach to characterize eicosanoid production during experimental Lyme arthritis in mice infected with the bacterium Borrelia burgdorferi. Eicosanoids were extracted throughout infection from the joints of Lyme arthritis-resistant and -susceptible mice and subjected to lipidomic profiling. We identified temporal and quantitative differences between these mouse strains in the production of eicosanoids, which correlated with differences in arthritis development. The eicosanoid biosynthetic enzyme cyclooxygenase (COX)-2 has been implicated in the regulation of Lyme arthritis pathology, and subsequent lipidomic profiling of B. burgdorferi-infected COX-2(-/-) mice identified reductions not only in COX-2 products but, surprisingly, also significant off-target reductions in 5-lipoxygenase metabolites. Our results demonstrate the utility of a comprehensive lipidomic approach for identifying potential contributors to disease pathology and may facilitate the development of more precisely targeted treatment strategies.	[Brown, Charles R.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Buczynski, Matthew W.; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Buczynski, Matthew W.; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Missouri System; University of Missouri Columbia; University of California System; University of California San Diego; University of California System; University of California San Diego	Brown, CR (corresponding author), Univ Missouri, Dept Vet Pathobiol, 315 Connaway Hall, Columbia, MO 65211 USA.	BrownChar@missouri.edu; edennis@ucsd.edu	Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140; Brown, Charles/0000-0002-1914-9601; Blaho, Victoria/0000-0001-8499-2278	NIGMS [GM069338]; National Institutes of Health [R01-AR052748]; NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health LIPID MAPS Large Scale Collaborative Grant GM069338 from NIGMS (to E. A. D.) and National Institutes of Health Grant R01-AR052748 from NIAMS (to C. R. B.).	Aliberti J, 2002, J EXP MED, V196, P1253, DOI 10.1084/jem.20021183; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Barthold SW, 1997, CLIN INFECT DIS, V25, pS9, DOI 10.1086/516166; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Blaho VA, 2008, ARTHRITIS RHEUM-US, V58, P1485, DOI 10.1002/art.23371; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Brown CR, 2000, J IMMUNOL, V165, P1446, DOI 10.4049/jimmunol.165.3.1446; Brown CR, 2003, J IMMUNOL, V171, P893, DOI 10.4049/jimmunol.171.2.893; Buczynski MW, 2007, J BIOL CHEM, V282, P22834, DOI 10.1074/jbc.M701831200; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chen M, 2008, ARTHRITIS RHEUM, V58, P1354, DOI 10.1002/art.23453; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; Deems R, 2007, METHOD ENZYMOL, V432, P59, DOI 10.1016/S0076-6879(07)32003-X; Dennis EA, 2009, P NATL ACAD SCI USA, V106, P2089, DOI 10.1073/pnas.0812636106; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Harkewicz R, 2007, J BIOL CHEM, V282, P2899, DOI 10.1074/jbc.M610067200; HAYAKAWA M, 1986, BIOCHEM BIOPH RES CO, V137, P424, DOI 10.1016/0006-291X(86)91227-1; Hong S, 2008, J IMMUNOL, V180, P3512, DOI 10.4049/jimmunol.180.5.3512; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jankov RP, 2002, J PHARMACOL EXP THER, V301, P435, DOI 10.1124/jpet.301.2.435; Kiss L, 2008, ANAL BIOANAL CHEM, V390, P697, DOI 10.1007/s00216-007-1718-9; Krause P, 2009, BLOOD, V113, P2451, DOI 10.1182/blood-2008-05-157123; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Ma Y, 1998, INFECT IMMUN, V66, P161, DOI 10.1128/IAI.66.1.161-168.1998; Mao JT, 2004, CLIN CANCER RES, V10, P6872, DOI 10.1158/1078-0432.CCR-04-0945; Marcouiller P, 2005, J RHEUMATOL, V32, P704; Masoodi M, 2008, RAPID COMMUN MASS SP, V22, P75, DOI 10.1002/rcm.3331; McCormick BA, 1998, J IMMUNOL, V160, P455; McCormick BA, 2007, FEBS J, V274, P3513, DOI 10.1111/j.1742-4658.2007.05911.x; Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003; Moghaddam MF, 1997, NAT MED, V3, P562, DOI 10.1038/nm0597-562; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Myers LK, 2000, ARTHRITIS RHEUM-US, V43, P2687, DOI 10.1002/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; OHTA A, 1990, LIPIDS, V25, P742, DOI 10.1007/BF02544044; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Powell WS, 2005, PROG LIPID RES, V44, P154, DOI 10.1016/j.plipres.2005.04.002; Powell WS, 2003, J CLIN INVEST, V112, P828, DOI 10.1172/JCI200319796; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Schmelzer K, 2007, METHOD ENZYMOL, V432, P171, DOI 10.1016/S0076-6879(07)32007-7; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Steere AC, 2004, NAT REV IMMUNOL, V4, P143, DOI 10.1038/nri1267; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wen YH, 2008, AM J PHYSIOL-HEART C, V294, pH1933, DOI 10.1152/ajpheart.00260.2007; Wen YS, 2007, ENDOCRINOLOGY, V148, P1313, DOI 10.1210/en.2006-0665; WERTHEIM WA, 1993, J IMMUNOL, V151, P2166; Wilson KR, 2007, MICROBIOL-SGM, V153, P968, DOI 10.1099/mic.0.2006/002261-0; Woods JM, 2003, EXP MOL PATHOL, V74, P282, DOI 10.1016/S0014-4800(03)00019-4; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V316, P443, DOI 10.1006/abbi.1995.1059	66	86	88	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21599	21612		10.1074/jbc.M109.003822	http://dx.doi.org/10.1074/jbc.M109.003822			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19487688	Green Published, hybrid			2022-12-27	WOS:000268564400054
J	Kawanami, D; Mahabeleshwar, GH; Lin, ZY; Atkins, GB; Hamik, A; Haldar, SM; Maemura, K; LaManna, JC; Jain, MK				Kawanami, Daiji; Mahabeleshwar, Ganapati H.; Lin, Zhiyong; Atkins, G. Brandon; Hamik, Anne; Haldar, Saptarsi M.; Maemura, Koji; LaManna, Joseph C.; Jain, Mukesh K.			Kruppel-like Factor 2 Inhibits Hypoxia-inducible Factor 1 alpha Expression and Function in the Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLF2 TRANSCRIPTION FACTOR; GROWTH-FACTOR; PROINFLAMMATORY ACTIVATION; ERYTHROPOIETIN GENE; CELLS; DEGRADATION; CANCER; STABILIZATION; ANGIOGENESIS; HIF-1-ALPHA	Hypoxia-inducible factor 1 (HIF-1) is a central regulator of the hypoxic response in many cell types. In endothelial cells, HIF-1 induces the expression of key proangiogenic factors to promote angiogenesis. Recent studies have identified Kruppel-like factor 2 (KLF2) as a potent inhibitor of angiogenesis. However, the role of KLF2 in regulating HIF-1 expression and function has not been evaluated. KLF2 expression was induced acutely by hypoxia in endothelial cells. Adenoviral overexpression of KLF2 inhibited hypoxia-induced expression of HIF-1 alpha and its target genes such as interleukin 8, angiopoietin-2, and vascular endothelial growth factor in endothelial cells. Conversely, knockdown of KLF2 increased expression of HIF-1 alpha and its targets. Furthermore, KLF2 inhibited hypoxia-induced endothelial tube formation, whereas endothelial cells from mice with haploinsufficiency of KLF2 showed increased tube formation in response to hypoxia. Consistent with this ex vivo observation, KLF2 heterozygous mice showed increased microvessel density in the brain. Mechanistically, KLF2 promoted HIF-1 alpha degradation in a von Hippel-Lindau protein-independent but proteasome-dependent manner. Finally, KLF2 disrupted the interaction between HIF-1 alpha and its chaperone Hsp90, suggesting that KLF2 promotes degradation of HIF-1 alpha by affecting its folding and maturation. These observations identify KLF2 as a novel inhibitor of HIF-1 alpha expression and function. Therefore, KLF2 may be a target for modulating the angiogenic response in disease states.	[Kawanami, Daiji; Mahabeleshwar, Ganapati H.; Lin, Zhiyong; Atkins, G. Brandon; Hamik, Anne; Haldar, Saptarsi M.; Jain, Mukesh K.] Case Western Reserve Univ, Univ Hosp Harrington, McLaughlin Heart & Vasc Inst, Sch Med, Cleveland, OH 44106 USA; [Kawanami, Daiji; Mahabeleshwar, Ganapati H.; Lin, Zhiyong; Atkins, G. Brandon; Hamik, Anne; Haldar, Saptarsi M.; Jain, Mukesh K.] Case Western Reserve Univ, Case Cardiovasc Res Inst, Sch Med, Cleveland, OH 44106 USA; [Maemura, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, Nagasaki 852, Japan; [LaManna, Joseph C.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Nagasaki University; Case Western Reserve University	Jain, MK (corresponding author), 2103 Cornell Rd,Rm 4-522, Cleveland, OH 44106 USA.	mukesh.jain2@case.edu	LaManna, Joseph/D-3860-2013; LaManna, Joseph C/C-3347-2012	LaManna, Joseph/0000-0002-0159-4512; LaManna, Joseph C/0000-0002-0159-4512	National Institutes of Health [HL72952, HL75427, HL76754, HL086548, HL084154, P01 HL048743, HL087595, HL088740, HL083090, HL086614, NS38632]; Alliance for Cancer Gene Therapy; Robert Wood Johnson/Harold Amos Medical Faculty Development; Dominic Visconsi Scholar Award; American Heart Association [0635579T, 0725297B]; Kanae Foundation for the Promotion of Medical Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084154, R01HL086548, K99HL087595, R01HL076754, R01HL072952, K08HL086614, R00HL087595, K08HL083090, R01HL075427, K01HL088740, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Cancer Gene Therapy; Robert Wood Johnson/Harold Amos Medical Faculty Development(Robert Wood Johnson Foundation (RWJF)); Dominic Visconsi Scholar Award; American Heart Association(American Heart Association); Kanae Foundation for the Promotion of Medical Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL72952, HL75427, HL76754, HL086548, HL084154, and P01 HL048743 ( to M. K. J.); HL087595 ( to Z. L.); HL088740 ( to G. B. A.); HL083090 ( to A. H.); HL086614 ( to S. H.); and NS38632 ( to J. C. L.). This work was also supported by an Alliance for Cancer Gene Therapy grant ( to M. K. J.), a Robert Wood Johnson/Harold Amos Medical Faculty Development grant ( to G. B. A.), a Dominic Visconsi Scholar Award ( to G. B. A., A. H., and S. H.), American Heart Association Grants 0635579T ( to Z. L.) and 0725297B ( to D. K.), and a Kanae Foundation for the Promotion of Medical Science grant ( to D. K.).	ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Atkins GB, 2008, CIRC RES, V103, P690, DOI 10.1161/CIRCRESAHA.108.184663; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Isaacs JS, 2004, J BIOL CHEM, V279, P16128, DOI 10.1074/jbc.M313342200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kong XG, 2006, FEBS LETT, V580, P6182, DOI 10.1016/j.febslet.2006.10.019; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lin ZY, 2006, ARTERIOSCL THROM VAS, V26, P1185, DOI 10.1161/01.ATV.0000215638.53414.99; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahabeleshwar Ganapati H., 2006, V129, P197; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; Ndubuizu O, 2007, ANTIOXID REDOX SIGN, V9, P1207, DOI 10.1089/ars.2007.1634; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Ravi R, 2000, GENE DEV, V14, P34; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Simon MP, 2008, J CELL PHYSIOL, V217, P809, DOI 10.1002/jcp.21558; Srinivas V, 1999, BIOCHEM BIOPH RES CO, V260, P557, DOI 10.1006/bbrc.1999.0878; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu JH, 2005, BIOCHEMISTRY-US, V44, P11098, DOI 10.1021/bi050166i; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Zhang WQ, 1998, J BIOL CHEM, V273, P17917, DOI 10.1074/jbc.273.28.17917	54	68	76	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20522	20530		10.1074/jbc.M109.025346	http://dx.doi.org/10.1074/jbc.M109.025346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19491109	hybrid, Green Published			2022-12-27	WOS:000268316100013
J	Fu, HL; Meng, YL; Ordonez, E; Villadangos, AF; Bhattacharjee, H; Gil, JA; Mateos, LM; Rosen, BP				Fu, Hseuh-Liang; Meng, Yuling; Ordonez, Efren; Villadangos, Almudena F.; Bhattacharjee, Hiranmoy; Gil, Jose A.; Mateos, Luis M.; Rosen, Barry P.			Properties of Arsenite Efflux Permeases (Acr3) from Alkaliphilus metalliredigens and Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; ARS OPERON; TRANSLOCATING ATPASE; BACILLUS-SUBTILIS; BINDING-SITE; ANION PUMP; RESISTANCE; TRANSPORTER	Members of the Acr3 family of arsenite permeases confer resistance to trivalent arsenic by extrusion from cells, with members in every phylogenetic domain. In this study bacterial Acr3 homologues from Alkaliphilus metalliredigens and Corynebacterium glutamicum were cloned and expressed in Escherichia coli. Modification of a single cysteine residue that is conserved in all analyzed Acr3 homologues resulted in loss of transport activity, indicating that it plays a role in Acr3 function. The results of treatment with thiol reagents suggested that the conserved cysteine is located in a hydrophobic region of the permease. A scanning cysteine accessibility method was used to show that Acr3 has 10 transmembrane segments, and the conserved cysteine would be predicted to be in the fourth transmembrane segment.	[Bhattacharjee, Hiranmoy; Rosen, Barry P.] Florida Int Univ, Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA; [Rosen, Barry P.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Ordonez, Efren; Villadangos, Almudena F.; Gil, Jose A.; Mateos, Luis M.] Univ Leon, Dept Biol Mol, Area Microbiol, Fac Biol Ambientales, E-24071 Leon, Spain	State University System of Florida; Florida International University; Wayne State University; Universidad de Leon	Rosen, BP (corresponding author), Florida Int Univ, Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA.	brosen@fiu.edu	MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Gil, José A./L-1800-2019; Gil, Jose A./C-3902-2009	MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Gil, José A./0000-0002-5069-2637; Gil, Jose A./0000-0002-5069-2637; Rosen, Barry P./0000-0002-5230-4271	National Institutes of Health [R37 GM55425]; Spanish Government [LE040A07, BIO2005-02723, BIO2008-00519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Government(Spanish GovernmentEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM55425 (to B. P. R.). This work was also supported by Grants LE040A07, BIO2005-02723, and BIO2008-00519 (to L. M. M. and J.A.G.) from the Spanish Government.	Aaltonen EKJ, 2008, BBA-BIOMEMBRANES, V1778, P963, DOI 10.1016/j.bbamem.2007.11.011; BHATTACHARJEE H, 2007, MOL MICROBIOLOGY HEA, P205; Bobrowicz P, 1997, YEAST, V13, P819, DOI 10.1002/(SICI)1097-0061(199707)13:9<819::AID-YEA142>3.0.CO;2-Y; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; CHEN CM, 1986, J BIOL CHEM, V261, P5030; Chen YX, 1996, J BACTERIOL, V178, P911, DOI 10.1128/jb.178.3.911-913.1996; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DEY S, 1994, ARCH BIOCHEM BIOPHYS, V311, P418, DOI 10.1006/abbi.1994.1256; DEY S, 1994, J BIOL CHEM, V269, P25442; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Lin YF, 2007, J BIOL CHEM, V282, P16783, DOI 10.1074/jbc.M700886200; Lin YF, 2006, P NATL ACAD SCI USA, V103, P15617, DOI 10.1073/pnas.0603974103; Mansour NM, 2007, FEBS J, V274, P612, DOI 10.1111/j.1742-4658.2006.05627.x; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Olsowski A, 1998, BIOCHEMISTRY-US, V37, P10738, DOI 10.1021/bi980440r; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Qin J, 2007, J BIOL CHEM, V282, P34346, DOI 10.1074/jbc.M706565200; Ruan X, 2006, J BIOL CHEM, V281, P9925, DOI 10.1074/jbc.M600125200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Shi WP, 1996, J BIOL CHEM, V271, P9291, DOI 10.1074/jbc.271.16.9291; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; TISA LS, 1990, J BIOL CHEM, V265, P190; WU JH, 1992, J BIOL CHEM, V267, P12570; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Xia XB, 2008, MOL MEMBR BIOL, V25, P691, DOI 10.1080/09687680802535930; Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004; Zoccarato F, 1999, NEUROSCI LETT, V274, P107, DOI 10.1016/S0304-3940(99)00680-1	34	68	71	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19887	19895		10.1074/jbc.M109.011882	http://dx.doi.org/10.1074/jbc.M109.011882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494117	hybrid, Green Published			2022-12-27	WOS:000268097400015
J	Schade, B; Rao, T; Dourdin, N; Lesurf, R; Hallett, M; Cardiff, RD; Muller, WJ				Schade, Babette; Rao, Trisha; Dourdin, Nathalie; Lesurf, Robert; Hallett, Michael; Cardiff, Robert D.; Muller, William J.			PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; TUMOR-SUPPRESSOR GENE; DIFFERENTIAL EXPRESSION; TRASTUZUMAB RESISTANCE; SIGNALING NETWORK; MICE; ACTIVATION; SURVIVAL; AMPLIFICATION; PHOSPHATASE	Overexpression and/or amplification of the ErbB-2 oncogene as well as inactivation of the PTEN tumor suppressor are two important genetic events in human breast carcinogenesis. To address the biological impact of conditional inactivation of PTEN on ErbB-2-induced mammary tumorigenesis, we generated a novel transgenic mouse model that utilizes the murine mammary tumor virus (MMTV) promoter to directly couple expression of activated ErbB-2 and Cre recombinase to the same mammary epithelial cell (MMTV-NIC). Disruption of PTEN in the mammary epithelium of the MMTV-NIC model system dramatically accelerated the formation of multifocal and highly metastatic mammary tumors, which exhibited homogenous pathology. PTEN-deficient/NIC-induced tumorigenesis was associated with an increase in angiogenesis. Moreover, inactivation of PTEN in the MMTV-NIC mouse model resulted in hyperactivation of the phosphatidylinositol 3'-kinase/Akt signaling pathway. However, like the parental strain, tumors obtained from PTEN-deficient/NIC mice displayed histopathological and molecular features of the luminal subtype of primary human breast cancer. Taken together, our findings provide important implications in understanding the molecular determinants of mammary tumorigenesis driven by PTEN deficiency and ErbB-2 activation and could provide a valuable tool for testing the efficacy of therapeutic strategies that target these critical signaling pathways.	[Schade, Babette; Rao, Trisha; Dourdin, Nathalie; Lesurf, Robert; Hallett, Michael; Muller, William J.] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3G 0B1, Canada; [Lesurf, Robert; Hallett, Michael] McGill Ctr Bioinformat, Montreal, PQ H3G 0B1, Canada; [Cardiff, Robert D.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Cardiff, Robert D.] Univ Calif Davis, Sch Med, Ctr Comparat Med, Davis, CA 95616 USA	McGill University; McGill University; University of California System; University of California Davis; University of California System; University of California Davis	Muller, WJ (corresponding author), 1160 Pine Ave W, Montreal, PQ H3G 0B1, Canada.	william.muller@mcgill.ca		Hallett, Michael/0000-0001-6738-6786	Terry Fox Foundation New Frontiers Program [NCIC 017003]; Cancer Research Society/Quebec Breast Cancer Foundation; Canadian Institutes of Health Research Team [79857]; Natural Science and Engineering Research Council Postgraduate Scholarship	Terry Fox Foundation New Frontiers Program; Cancer Research Society/Quebec Breast Cancer Foundation; Canadian Institutes of Health Research Team(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council Postgraduate Scholarship	This work was supported by a Terry Fox Foundation New Frontiers Program Project Grant NCIC 017003, a Cancer Research Society/Quebec Breast Cancer Foundation grant, and Canadian Institutes of Health Research Team Grant 79857. Supported by a Natural Science and Engineering Research Council Postgraduate Scholarship.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Andrulis IL, 1998, J CLIN ONCOL, V16, P1340, DOI 10.1200/JCO.1998.16.4.1340; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Da Silva L, 2007, J CLIN PATHOL, V60, P1328, DOI 10.1136/jcp.2006.041731; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Dourdin N, 2008, CANCER RES, V68, P2122, DOI 10.1158/0008-5472.CAN-07-5727; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Garcia JM, 1999, BREAST CANCER RES TR, V57, P237, DOI 10.1023/A:1006273516976; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; LAZARD D, 1993, P NATL ACAD SCI USA, V90, P999, DOI 10.1073/pnas.90.3.999; Li G, 2002, DEVELOPMENT, V129, P4159; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maglione JE, 2001, CANCER RES, V61, P8298; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sano T, 1999, CANCER RES, V59, P1820; Schade B, 2007, CANCER RES, V67, P7579, DOI 10.1158/0008-5472.CAN-06-4724; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2000, CANCER RES, V60, P3605; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Takei Y, 2008, MOL CANCER THER, V7, P704, DOI 10.1158/1535-7163.MCT-06-0724; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025	54	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19018	19026		10.1074/jbc.M109.018937	http://dx.doi.org/10.1074/jbc.M109.018937			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19435886	hybrid, Green Published			2022-12-27	WOS:000267711500051
J	Stamatovic, SM; Keep, RF; Wang, MM; Jankovic, I; Andjelkovic, AV				Stamatovic, Svetlana M.; Keep, Richard F.; Wang, Michael M.; Jankovic, Ivana; Andjelkovic, Anuska V.			Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; DEPENDENT ENDOCYTOSIS; BARRIER FUNCTION; KNOCKOUT MICE; VE-CADHERIN; RHO-KINASE; IN-VITRO; PERMEABILITY; PROTEINS; EXPRESSION	Disturbance of the tight junction (TJ) complexes between brain endothelial cells leads to increased paracellular permeability, allowing leukocyte entry into inflamed brain tissue and also contributing to edema formation. The current study dissects the mechanisms by which a chemokine, CCL2, induces TJ disassembly. It investigates the potential role of selective internalization of TJ transmembrane proteins (occludin and claudin-5) in increased permeability of the brain endothelial barrier in vitro. To map the internalization and intracellular fate of occludin and claudin-5, green fluorescent protein fusion proteins of these TJ proteins were generated and imaged by fluorescent microscopy with simultaneous measurement of transendothelial electrical resistance. During CCL2-induced reductions in transendothelial electrical resistance, claudin-5 and occludin became internalized via caveolae and further processed to early (EEA1+) and recycling (Rab4+) endosomes but not to late endosomes. Western blot analysis of fractions collected from a sucrose gradient showed the presence of claudin-5 and occludin in the same fractions that contained caveolin-1. For the first time, these results suggest an underlying molecular mechanism by which the pro-inflammatory chemokine CCL2 mediates brain endothelial barrier disruption during CNS inflammation.	[Stamatovic, Svetlana M.; Jankovic, Ivana; Andjelkovic, Anuska V.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Keep, Richard F.; Andjelkovic, Anuska V.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Keep, Richard F.; Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Andjelkovic, AV (corresponding author), Univ Michigan, Dept Pathol, 7520A MSRB I,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	anuskaa@umich.edu		Keep, Richard/0000-0001-6441-5334	National Institutes of Health [NS 044907]; Office of the Vice President for Research Faculty Grants and Awards Program, University of Michigan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Vice President for Research Faculty Grants and Awards Program, University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant (AVA) NS 044907. This work was also supported by the Office of the Vice President for Research Faculty Grants and Awards Program, University of Michigan.	Abedinpour P, 2003, ANAL BIOCHEM, V313, P1, DOI 10.1016/S0003-2697(02)00561-4; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Bamforth SD, 1999, J CELL SCI, V112, P1879; Bazzoni G, 2006, THROMB HAEMOSTASIS, V95, P36, DOI 10.1160/TH05-07-0488; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Chen JJ, 2007, ARTERIOSCL THROM VAS, V27, P2005, DOI 10.1161/ATVBAHA.107.145961; D'Alessio A, 2005, AM J PATHOL, V166, P1273, DOI 10.1016/S0002-9440(10)62346-2; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; DeMaio L, 2006, AM J PHYSIOL-HEART C, V290, pH674, DOI 10.1152/ajpheart.00554.2005; Diacovo TG, 1996, BLOOD, V88, P146; Echarri A, 2007, SEMIN CELL DEV BIOL, V18, P627, DOI 10.1016/j.semcdb.2007.08.004; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Farshori P, 1999, J MEMBRANE BIOL, V170, P147, DOI 10.1007/s002329900544; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; GARCIA JGN, 1995, J INVEST MED, V43, P117; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hartmann C, 2007, EXP CELL RES, V313, P1318, DOI 10.1016/j.yexcr.2007.01.024; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Lee HS, 2004, MICROVASC RES, V68, P231, DOI 10.1016/j.mvr.2004.07.005; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lin MI, 2007, CANCER RES, V67, P2849, DOI 10.1158/0008-5472.CAN-06-4082; Liu LB, 2008, J NEUROSCI RES, V86, P1153, DOI 10.1002/jnr.21558; Martineau M, 2008, GLIA, V56, P1271, DOI 10.1002/glia.20696; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Medina R, 2000, J MEMBRANE BIOL, V178, P235, DOI 10.1007/s002320010031; Miakotina OL, 2002, AM J PHYSIOL-LUNG C, V283, pL418, DOI 10.1152/ajplung.00470.2001; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Mul FPJ, 2000, J LEUKOCYTE BIOL, V68, P529; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; NAKAJIMA S, 1994, AM J PHYSIOL-LUNG C, V267, pL422, DOI 10.1152/ajplung.1994.267.4.L422; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nusrat A, 2000, J CELL SCI, V113, P1771; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Persidsky Y, 2006, BLOOD, V107, P4770, DOI 10.1182/blood-2005-11-4721; Poritz LS, 2004, J SURG RES, V116, P14, DOI 10.1016/S0022-4804(03)00311-1; Ruffer C, 2004, EUR J CELL BIOL, V83, P135, DOI 10.1078/0171-9335-00366; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shakirova Y, 2006, AM J PHYSIOL-CELL PH, V291, pC1326, DOI 10.1152/ajpcell.00046.2006; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Wilhelm I, 2007, PHYS MED BIOL, V52, P6261, DOI 10.1088/0031-9155/52/20/012; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Yamamoto M, 2008, AM J PATHOL, V172, P521, DOI 10.2353/ajpath.2008.070076; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	66	141	151	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19053	19066		10.1074/jbc.M109.000521	http://dx.doi.org/10.1074/jbc.M109.000521			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19423710	Green Published, hybrid			2022-12-27	WOS:000267711500054
J	Antonyak, MA; Li, B; Regan, AD; Feng, QY; Dusaban, SS; Cerione, RA				Antonyak, Marc A.; Li, Bo; Regan, Andrew D.; Feng, Qiyu; Dusaban, Stephanie S.; Cerione, Richard A.			Tissue Transglutaminase Is an Essential Participant in the Epidermal Growth Factor-stimulated Signaling Pathway Leading to Cancer Cell Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; DRUG-RESISTANCE; CARCINOMA-CELLS; FACTOR RECEPTOR; HUMAN BREAST; EXPRESSION; ACTIVATION; TARGET; TUMORS; RAS	Epidermal growth factor (EGF) exerts pleiotropic effects during oncogenesis, including the stimulation of cell migration and invasiveness. Although a number of traditional signaling proteins (e. g. Ras and Rho GTPases) have been implicated in EGF-stimulated cancer cell migration, less is known about the identity of those proteins functioning further downstream in this growth factor pathway. Here we have used HeLa carcinoma cells as a model system for investigating the role of tissue transglutaminase (TGase), a protein that has been linked to oncogenesis, in EGF-stimulated cancer cell migration and invasion. Treatment of HeLa cells with EGF resulted in TGase activation and its accumulation at their leading edges, whereas knocking down TGase expression, or treating cells with a TGase inhibitor, blocked EGF-stimulated cell migration and invasion. We show that EGF signaling through Ras and c-Jun N-terminal kinase is responsible for targeting TGase to the leading edges of cells and activating it. The requirement for EGF to properly localize and activate TGase can be circumvented by the expression of oncogenic Ras (G12V), whose ability to stimulate migration is also dependent on TGase. We further show that, in the highly aggressive breast cancer cell line MDAMB231, where EGF stimulation is unnecessary for migration and invasive activity, TGase is already at the leading edge and activated. These findings demonstrate that TGase plays a key role in cancer cell motility and invasiveness and represents a previously unappreciated participant in the EGF pathway that stimulates these processes in cancer cells.	[Antonyak, Marc A.; Regan, Andrew D.; Feng, Qiyu; Dusaban, Stephanie S.; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Li, Bo; Cerione, Richard A.] Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Li, Bo/O-7127-2019; Li, Bo/M-2192-2013; Li, Bo/M-2192-2013	Li, Bo/0000-0002-7979-8339; Li, Bo/0000-0001-8256-5045				Antonyak MA, 2004, J BIOL CHEM, V279, P41461, DOI 10.1074/jbc.M404976200; Antonyak MA, 2003, J BIOL CHEM, V278, P15859, DOI 10.1074/jbc.M300037200; Antonyak MA, 2002, J BIOL CHEM, V277, P14712, DOI 10.1074/jbc.M112259200; Antonyak MA, 2002, ONCOGENE, V21, P5038, DOI 10.1038/sj.onc.1205593; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; CHIOCCA EA, 1988, J BIOL CHEM, V263, P11584; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cui XJ, 2006, CANCER RES, V66, P5304, DOI 10.1158/0008-5472.CAN-05-2858; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; Hauck CR, 2001, CANCER RES, V61, P7079; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Hill K, 2000, J BIOL CHEM, V275, P3741, DOI 10.1074/jbc.275.6.3741; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang C, 2004, CELL CYCLE, V3, P4, DOI 10.4161/cc.3.1.601; Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Laskin JJ, 2004, CANCER TREAT REV, V30, P1, DOI 10.1016/j.ctrv.2003.10.002; Li G, 2008, EXPERT REV VACCINES, V7, P977, DOI 10.1586/14760584.7.7.977; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Moscatello DK, 1997, CANCER RES, V57, P1419; PIACENTINI M, 1988, BIOCHEM J, V253, P33, DOI 10.1042/bj2530033; Piccolo E, 2002, ONCOGENE, V21, P6520, DOI 10.1038/sj.onc.1205821; Pouliot N, 2001, EXP CELL RES, V266, P1, DOI 10.1006/excr.2001.5197; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Singer CF, 2006, CLIN EXP METASTAS, V23, P33, DOI 10.1007/s10585-006-9015-0; SPORN MB, 1983, CANCER RES, V43, P3034; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Yip SC, 2007, J CELL SCI, V120, P3138, DOI 10.1242/jcs.005298; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505	38	59	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17914	17925		10.1074/jbc.M109.013037	http://dx.doi.org/10.1074/jbc.M109.013037			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19403524	Green Published, hybrid			2022-12-27	WOS:000267712400003
J	Chiang, MH; Liang, FY; Chen, CP; Chang, CW; Cheong, ML; Wang, LJ; Liang, CY; Lin, FY; Chou, CC; Chen, HW				Chiang, Meng-Hsiu; Liang, Feng-Yu; Chen, Chie-Pein; Chang, Ching-Wen; Cheong, Mei-Leng; Wang, Liang-Jie; Liang, Ching-Yeu; Lin, Fang-Yu; Chou, Chih-Chine; Chen, Hungwen			Mechanism of Hypoxia-induced GCM1 Degradation IMPLICATIONS FOR THE PATHOGENESIS OF PREECLAMPSIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL GROWTH-FACTOR; BREAST-CANCER CELLS; INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTIONAL ACTIVITY; 3-KINASE/AKT PATHWAY; ESTROGEN-RECEPTOR; SOLUBLE ENDOGLIN; TROPHOBLAST; SYNCYTIN; PROTEIN	Preeclampsia is a major pregnancy-specific disorder affecting 5-7% of pregnancies worldwide. Although hypoxia caused by incomplete trophoblast invasion and impaired spiral arterial remodeling is thought to be a major cause of preeclampsia, how hypoxia affects placental development remains uncertain. GCM1 (glial cells missing homolog 1) is a transcription factor critical for placental development. In preeclampsia, GCM1 and its target genes syncytin 1 and placental growth factor, important for syncytiotrophoblast formation and placental vasculogenesis, are all decreased. Here we present evidence that GCM1 is a major target of hypoxia associated with preeclampsia. We show that hypoxia triggers GCM1 degradation by suppressing the phosphatidylinositol 3-kinase-Akt signaling pathway, leading to GSK-3 beta activation. Activated GSK-3 beta phosphorylates GCM1 on Ser(322), which in turn recruits the F-box protein FBW2, leading to GCM1 ubiquitination and degradation. Importantly, the GSK-3 beta inhibitor LiCl prevented hypoxia-induced GCM1 degradation. Our study identifies a molecular basis for the disrupted GCM1 transcription network in preeclampsia and provides a potential avenue for therapeutic intervention.	[Liang, Ching-Yeu; Chou, Chih-Chine; Chen, Hungwen] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Chiang, Meng-Hsiu; Liang, Feng-Yu; Chang, Ching-Wen; Wang, Liang-Jie; Lin, Fang-Yu; Chen, Hungwen] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei 106, Taiwan; [Chen, Chie-Pein] Mackay Mem Hosp, Div High Risk Pregnancy, Taipei 104, Taiwan; [Cheong, Mei-Leng] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei 106, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Mackay Memorial Hospital; Cathay General Hospital	Chen, HW (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.	hwchen@gate.sinica.edu.tw	Chang, Ching-Wen/N-7867-2018; CHEN, CHEN/HDM-6657-2022	Chang, Ching-Wen/0000-0002-5693-3809; 	National Science Council [96-2311-B-001-034]; Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant 96-2311-B-001-034 (to H. C.) and a grant from Academia Sinica, Taiwan (to H. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Alvarez-Tejado M, 2002, J BIOL CHEM, V277, P13508, DOI 10.1074/jbc.M200017200; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Beitner-Johnson D, 2001, CELL SIGNAL, V13, P23, DOI 10.1016/S0898-6568(00)00128-5; BENIRSCHKE K, 2001, PATHOLOGY HUMAN PLAC, P134; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Chang M, 2008, BIOL REPROD, V78, P841, DOI 10.1095/biolreprod.107.065599; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Chen CP, 2006, BJOG-INT J OBSTET GY, V113, P152, DOI 10.1111/j.1471-0528.2005.00843.x; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Chen EY, 2001, CANCER RES, V61, P2429; Chiang MH, 2008, BIOL REPROD, V79, P914, DOI 10.1095/biolreprod.108.071407; Cho JY, 2005, MOL ENDOCRINOL, V19, P1191, DOI 10.1210/me.2004-0162; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Ilekis JV, 2007, REPROD SCI, V14, P508, DOI 10.1177/1933719107306232; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li H, 2005, PLACENTA, V26, P210, DOI 10.1016/j.placenta.2004.05.004; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; MOORE STA, 2007, AM J OBSTET GYNECOL, V197; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Munaut C, 2008, HUM REPROD, V23, P1407, DOI 10.1093/humrep/den114; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Stoner M, 2002, MOL ENDOCRINOL, V16, P2231, DOI 10.1210/me.2001-0347; Torry DS, 1998, AM J OBSTET GYNECOL, V179, P1539, DOI 10.1016/S0002-9378(98)70021-3; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1; Wulff C, 2003, REPRODUCTION, V126, P569, DOI 10.1530/rep.0.1260569; Yamada K, 1999, J BIOL CHEM, V274, P32279, DOI 10.1074/jbc.274.45.32279; Yang CS, 2005, J BIOL CHEM, V280, P10083, DOI 10.1074/jbc.M413986200; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Zhou Y, 2003, DEV BIOL, V263, P114, DOI 10.1016/S0012-1606(03)00449-4; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	43	49	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17411	17419		10.1074/jbc.M109.016170	http://dx.doi.org/10.1074/jbc.M109.016170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19416964	Green Published, hybrid			2022-12-27	WOS:000267202500007
J	Iino, R; Hasegawa, R; Tabata, KV; Noji, H				Iino, Ryota; Hasegawa, Rie; Tabata, Kazuhito V.; Noji, Hiroyuki			Mechanism of Inhibition by C-terminal alpha-Helices of the epsilon Subunit of Escherichia coli FoF1-ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ATP SYNTHESIS; ROTARY MOTOR; THERMOPHILIC F-1-ATPASE; CONFORMATIONAL-CHANGES; ENDOGENOUS INHIBITOR; CATALYTIC SUBUNITS; MOLECULAR MACHINE; F1F0-ATP SYNTHASE; CRYSTAL-STRUCTURE; H+/ATP RATIO	The epsilon subunit of bacterial FoF1-ATP synthase (FoF1), a rotary motor protein, is known to inhibit the ATP hydrolysis reaction of this enzyme. The inhibitory effect is modulated by the conformation of the C-terminal alpha-helices of epsilon, and the "extended" but not "hairpin-folded" state is responsible for inhibition. Although the inhibition of ATP hydrolysis by the C-terminal domain of epsilon has been extensively studied, the effect on ATP synthesis is not fully understood. In this study, we generated an Escherichia coli FoF1 (EFoF1) mutant in which the epsilon subunit lacked the C-terminal domain (FoF1 epsilon Delta C), and ATP synthesis driven by acid-base transition (Delta pH) and the K+-valinomycin diffusion potential (Delta Psi) was compared in detail with that of the wild-type enzyme (FoF1 epsilon WT). The turnover numbers (k(cat)) of FoF1 epsilon WT were severalfold lower than those of FoF1 epsilon Delta C.FoF1 epsilon WT showed higher Michaelis constants (K-m). The dependence of the activities of FoF1 epsilon WT and FoF1 epsilon Delta C on various combinations of Delta pH and Delta Psi was similar, suggesting that the rate-limiting step in ATP synthesis was unaltered by the C-terminal domain of epsilon. Solubilized FoF1 epsilon WT also showed lower k(cat) and higher K-m values for ATP hydrolysis than the corresponding values of FoF1 epsilon Delta C. These results suggest that the C-terminal domain of the epsilon subunit of EFoF1 slows multiple elementary steps in both the ATP synthesis/hydrolysis reactions by restricting the rotation of the gamma subunit.	[Iino, Ryota; Hasegawa, Rie; Tabata, Kazuhito V.; Noji, Hiroyuki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Osaka University	Iino, R (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.	iino@sanken.osaka-u.ac.jp; hnoji@sanken.osaka-u.ac.jp	Iino, Ryota/B-7746-2011; 田端, 和仁/GON-3471-2022	Iino, Ryota/0000-0003-0110-5704; 田端, 和仁/0000-0002-0463-1374	Ministry of Education, Culture, Sports, Science and Technology, Japan [18770134, 18074005]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 18770134 and 18074005 (to R. I. and H. N., respectively) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Aggeler R, 1997, J BIOL CHEM, V272, P19621, DOI 10.1074/jbc.272.31.19621; AGGELER R, 1992, BIOCHEMISTRY-US, V31, P2956, DOI 10.1021/bi00126a016; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bulygin VV, 2004, J BIOL CHEM, V279, P35616, DOI 10.1074/jbc.M405012200; Capaldi RA, 2000, BBA-BIOENERGETICS, V1458, P263, DOI 10.1016/S0005-2728(00)00078-5; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; DUNN SD, 1987, BIOCHEMISTRY-US, V26, P4488, DOI 10.1021/bi00388a047; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; FISCHER S, 1994, EUR J BIOCHEM, V225, P167, DOI 10.1111/j.1432-1033.1994.00167.x; Ganti S, 2007, J BIOENERG BIOMEMBR, V39, P99, DOI 10.1007/s10863-006-9066-6; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hausrath AC, 2001, J BIOL CHEM, V276, P47227, DOI 10.1074/jbc.M107536200; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Iino R, 2005, J BIOENERG BIOMEMBR, V37, P451, DOI 10.1007/s10863-005-9489-5; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Kaim G, 1998, FEBS LETT, V434, P57, DOI 10.1016/S0014-5793(98)00969-7; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P10987, DOI 10.1021/bi00109a025; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Schulenberg B, 1999, J BIOL CHEM, V274, P28351, DOI 10.1074/jbc.274.40.28351; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; STERNWEIS PC, 1980, BIOCHEMISTRY-US, V19, P526, DOI 10.1021/bi00544a021; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; Vik SB, 2000, J BIOENERG BIOMEMBR, V32, P485, DOI 10.1023/A:1005664908066; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Xiong H, 1998, BIOCHEMISTRY-US, V37, P16423, DOI 10.1021/bi981522i; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	55	65	65	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17457	17464		10.1074/jbc.M109.003798	http://dx.doi.org/10.1074/jbc.M109.003798			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19411254	Green Published, hybrid			2022-12-27	WOS:000267202500012
J	Mole, DR; Blancher, C; Copley, RR; Pollard, PJ; Gleadle, JM; Ragoussis, J; Ratcliffe, PJ				Mole, David R.; Blancher, Christine; Copley, Richard R.; Pollard, Patrick J.; Gleadle, Jonathan M.; Ragoussis, Jiannis; Ratcliffe, Peter J.			Genome-wide Association of Hypoxia-inducible Factor (HIF)-1 alpha and HIF-2 alpha DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TARGET GENE; FACTOR-I; C-MYC; CELLULAR ADAPTATION; PROMOTER REGION; UP-REGULATION; STEM-CELLS; HIF-1-ALPHA; CANCER	Hypoxia-inducible factor (HIF) controls an extensive range of adaptive responses to hypoxia. To better understand this transcriptional cascade we performed genome-wide chromatin immuno-precipitation using antibodies to two major HIF-alpha subunits, and correlated the results with genome-wide transcript profiling. Within a tiled promoter array we identified 546 and 143 sequences that bound, respectively, to HIF-1 alpha or HIF-2 alpha at high stringency. Analysis of these sequences confirmed an identical core binding motif for HIF-1 alpha and HIF-2 alpha (RCGTG) but demonstrated that binding to this motif was highly selective, with binding enriched at distinct regions both upstream and downstream of the transcriptional start. Comparison of HIF-promoter binding data with bidirectional HIF-dependent changes in transcript expression indicated that whereas a substantial proportion of positive responses (> 20% across all significantly regulated genes) are direct, HIF-dependent gene suppression is almost entirely indirect. Comparison of HIF-1 alpha- versus HIF-2 alpha-binding sites revealed that whereas some loci bound HIF-1 alpha in isolation, many bound both isoforms with similar affinity. Despite high-affinity binding to multiple promoters, HIF-2 alpha contributed to few, if any, of the transcriptional responses to acute hypoxia at these loci. Given emerging evidence for biologically distinct functions of HIF-1 alpha versus HIF-2 alpha understanding the mechanisms restricting HIF-2 alpha activity will be of interest.	[Mole, David R.; Pollard, Patrick J.; Ratcliffe, Peter J.] Univ Oxford, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England; [Blancher, Christine; Copley, Richard R.; Ragoussis, Jiannis] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Gleadle, Jonathan M.] Flinders Med Ctr, Renal Unit, Bedford Pk, SA 5042, Australia	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Flinders Medical Centre	Mole, DR (corresponding author), Univ Oxford, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England.	drmole@well.ox.ac.uk	Ragoussis, Ioannis/AAD-9790-2022; Gleadle, Jonathan M/K-4188-2012; Pollard, Patrick/F-7516-2012	Gleadle, Jonathan M/0000-0002-5215-7208; Pollard, Patrick/0000-0002-4459-4993; Mole, David/0000-0002-0984-300X; Ratcliffe, Peter/0000-0002-2853-806X	The Wellcome Trust; Cancer Research UK	The Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was supported by The Wellcome Trust and Cancer Research UK.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chen KF, 2005, NUCLEIC ACIDS RES, V33, P5190, DOI 10.1093/nar/gki839; Choi SM, 2008, FEBS J, V275, P5618, DOI 10.1111/j.1742-4658.2008.06686.x; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Imamura T, 2009, INT J CANCER, V124, P763, DOI 10.1002/ijc.24032; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Ji HK, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl803; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Koudritsky M, 2008, NUCLEIC ACIDS RES, V36, P6795, DOI 10.1093/nar/gkn752; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Laderoute KR, 2002, MOL CELL BIOL, V22, P2515, DOI 10.1128/MCB.22.8.2515-2523.2002; Lando D, 2003, EUR J BIOCHEM, V270, P781, DOI 10.1046/j.1432-1033.2003.03445.x; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mazure NM, 2002, CANCER RES, V62, P1158; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Oikawa M, 2001, BIOCHEM BIOPH RES CO, V289, P39, DOI 10.1006/bbrc.2001.5927; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Ragel BT, 2007, NEUROSURG REV, V30, P181, DOI 10.1007/s10143-007-0070-z; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; REINHOLD W, 1995, MOL CELL BIOL, V15, P3041; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Sowter HM, 2003, CANCER RES, V63, P6130; Sung FL, 2007, CANCER LETT, V253, P74, DOI 10.1016/j.canlet.2007.01.012; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	62	408	417	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16767	16775		10.1074/jbc.M901790200	http://dx.doi.org/10.1074/jbc.M901790200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386601	Green Published, hybrid			2022-12-27	WOS:000266962400012
J	Li, HZ; Liu, GD; Yu, JK; Cao, WG; Lobo, VG; Xie, JY				Li, Hongzhao; Liu, Guodong; Yu, Jiankun; Cao, Wenguang; Lobo, Vincent G.; Xie, Jiuyong			In Vivo Selection of Kinase-responsive RNA Elements Controlling Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TRACT-BINDING PROTEIN; CATALYTIC SUBUNIT; SEQUENCE MOTIFS; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; ENHANCERS; CASCADE; EXON	Alternative pre-mRNA splicing is often controlled by cell signals, for example, those activating the cAMP-dependent protein kinase (PKA) or the Ca2+/calmodulin-dependent protein kinase IV (CaMKIV). We have shown that CaMKIV regulates alternative splicing through short CA repeats and hnRNP L. Here we use a splicing reporter that shows PKA/CaMKIV promotion of exon inclusion to select from exons containing random 13-nt sequences for RNA elements responsive to the kinases in cultured cells. This selection not only identified both PKA- and CaMKIV-responsive elements that are similar to the CaMKIV-responsive RNA element 1 (CaRRE1) or CA repeats, but also A-rich elements not previously known to respond to these kinases. Consistently, hnRNP L is identified as a factor binding the CA-rich elements. Analyses of the motifs in the highly responsive elements indicate that they are indeed critical for the kinase effect and are enriched in alternative exons. Interestingly, a CAAAAAA motif is sufficient for the PKA/CaMKIV-regulated splicing of the exon 16 of the CaMK kinase beta 1 (CaMKK2) transcripts, implying a role of this motif in signaling cross-talk or feedback regulation between these kinases through alternative splicing. Therefore, these experiments identified a group of RNA elements responsive to PKA and CaMKIV from in vivo selection. This also provides an approach for selecting RNA elements similarly responsive to other cell signals controlling alternative splicing.	[Li, Hongzhao; Liu, Guodong; Yu, Jiankun; Cao, Wenguang; Lobo, Vincent G.; Xie, Jiuyong] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB R3E 0J9, Canada	University of Manitoba	Xie, JY (corresponding author), 439 BMSB,745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	xiej@cc.umanitoba.ca	Xie, Jiuyong/D-2899-2013	Xie, Jiuyong/0000-0003-2909-1033; Yu, Jiankun/0000-0001-9916-1012	Canadian Institutes of Health Research (CIHR) [MOP 68919]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR, MOP 68919) (to J. X.).	An P, 2007, PLOS BIOL, V5, P263, DOI 10.1371/journal.pbio.0050036; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berke JD, 2001, NEURON, V32, P277, DOI 10.1016/S0896-6273(01)00465-2; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BORTFELDT R, 2007, MATH MODELING BIOL S, V1, P337; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Dunster K, 2005, CLIN EXP IMMUNOL, V140, P556, DOI 10.1111/j.1365-2249.2005.02774.x; Feng Y, 2008, NAT STRUCT MOL BIOL, V15, P1040, DOI 10.1038/nsmb.1485; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Hai Y, 2008, NUCLEIC ACIDS RES, V36, P3320, DOI 10.1093/nar/gkn207; Holste D, 2006, NUCLEIC ACIDS RES, V34, pD56, DOI 10.1093/nar/gkj048; Hsu LS, 2001, J BIOL CHEM, V276, P31113, DOI 10.1074/jbc.M011720200; Kataoka Naoyuki, 2008, V488, P357, DOI 10.1007/978-1-60327-475-3_23; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kitani T, 2001, J BIOCHEM, V130, P515, DOI 10.1093/oxfordjournals.jbchem.a003014; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Kuppers E, 2000, MOL BRAIN RES, V81, P19, DOI 10.1016/S0169-328X(00)00156-X; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mckee AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r159; Modafferi EF, 1997, MOL CELL BIOL, V17, P6537, DOI 10.1128/MCB.17.11.6537; Okuno S, 2001, J BIOCHEM, V130, P503, DOI 10.1093/oxfordjournals.jbchem.a003013; PINOLROMA S, 1989, J CELL BIOL, V109, P2575, DOI 10.1083/jcb.109.6.2575; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Sgambato V, 2003, J NEUROCHEM, V86, P153, DOI 10.1046/j.1471-4159.2003.01816.x; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Yu JK, 2009, J BIOL CHEM, V284, P1505, DOI 10.1074/jbc.M805113200; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	50	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16191	16201		10.1074/jbc.M900393200	http://dx.doi.org/10.1074/jbc.M900393200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386606	Green Published, hybrid			2022-12-27	WOS:000266730900016
J	Deng, XX; Wang, YJ; Zhou, YD; Soboloff, J; Gill, DL				Deng, Xiaoxiang; Wang, Youjun; Zhou, Yandong; Soboloff, Jonathan; Gill, Donald L.			STIM and Orai: Dynamic Intermembrane Coupling to Control Cellular Calcium Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							STROMAL INTERACTION MOLECULE-1; OPERATED CA2+ ENTRY; STORE-INDEPENDENT MODES; ACTIVATES CRAC CHANNELS; OLIGOMERIZATION; DEPLETION; PROTEIN; DOMAIN; IDENTIFICATION; BORATE	Ca2+ signals controlling a vast array of cell functions involve both Ca2+ store release and external Ca2+ entry. These two events are coordinated through a dynamic intermembrane coupling between two distinct membrane proteins, STIM and Orai. STIM proteins are endoplasmic reticulum (ER) luminal Ca2+ sensors that undergo a profound redistribution into discrete junctional ER domains closely juxtaposed with the plasma membrane (PM). Orai proteins are PM Ca2+ channels that migrate and become tethered by STIM within the ER-PM junctions, where they mediate exceedingly selective Ca2+ entry. We describe a new understanding of the nature of the proteins and how they function to mediate this remarkable intermembrane signaling process controlling Ca2+ signals.	[Deng, Xiaoxiang; Wang, Youjun; Zhou, Yandong; Soboloff, Jonathan; Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Soboloff, J (corresponding author), Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA.	soboloff@temple.edu; dgill@temple.edu	Soboloff, Jonathan/I-6995-2012; Wang, Youjun/H-4016-2013	Soboloff, Jonathan/0000-0001-5192-1297; Wang, Youjun/0000-0003-0961-1716				Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Demaurex N, 2003, CELL CALCIUM, V34, P109, DOI 10.1016/S0143-4160(03)00081-2; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gill DL, 2006, SCIENCE, V313, P183, DOI 10.1126/science.1130811; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hauser CT, 2007, P NATL ACAD SCI USA, V104, P3693, DOI 10.1073/pnas.0611713104; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oritani K, 1996, J CELL BIOL, V134, P771, DOI 10.1083/jcb.134.3.771; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Strange K, 2007, CELL CALCIUM, V42, P193, DOI 10.1016/j.ceca.2007.02.007; Tian G, 2009, J BIOL CHEM, V284, P18980, DOI 10.1074/jbc.M109.003160; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129	67	103	105	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22501	22505		10.1074/jbc.R109.018655	http://dx.doi.org/10.1074/jbc.R109.018655			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19473984	Green Published, hybrid			2022-12-27	WOS:000268963100001
J	Faye, C; Moreau, C; Chautard, E; Jetne, R; Fukai, N; Ruggiero, F; Humphries, MJ; Olsen, BR; Ricard-Blum, S				Faye, Clement; Moreau, Christophe; Chautard, Emilie; Jetne, Reidunn; Fukai, Naomi; Ruggiero, Florence; Humphries, Martin J.; Olsen, Bjorn R.; Ricard-Blum, Sylvie			Molecular Interplay between Endostatin, Integrins, and Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; ANGIOGENESIS INHIBITOR; ACTIN CYTOSKELETON; DOWN-REGULATION; BREAST-CANCER; CELL-ADHESION; COLLAGEN-I; BINDING; PROTEIN; POLYMORPHISM	Endostatin is an endogenous inhibitor of angiogenesis. Although several endothelial cell surface molecules have been reported to interact with endostatin, its molecular mechanism of action is not fully elucidated. We used surface plasmon resonance assays to characterize interactions between endostatin, integrins, and heparin/heparan sulfate. alpha 5 beta 1 and alpha v beta 3 integrins form stable complexes with immobilized endostatin (K-D = similar to 1.8 x 10(-8) M, two-state model). Two arginine residues (Arg(27) and Arg(139)) are crucial for the binding of endostatin to integrins and to heparin/heparan sulfate, suggesting that endostatin would not bind simultaneously to integrins and to heparan sulfate. Experimental data and molecular modeling support endostatin binding to the headpiece of the alpha v beta 3 integrin at the interface between the beta-propeller domain of the alpha v subunit and the beta A domain of the beta 3 subunit. In addition, we report that alpha 5 beta 1 and alpha v beta 3 integrins bind to heparin/heparan sulfate. The ectodomain of the alpha 5 beta 1 integrin binds to haparin with high affinity (K-D = 15.5 nM). The direct binding between integrins and heparin/heparan sulfate might explain why both heparan sulfate and alpha 5 beta 1 integrin are required for the localization of endostatin in endothelial cell lipid rafts.	[Faye, Clement; Moreau, Christophe; Chautard, Emilie; Ruggiero, Florence; Ricard-Blum, Sylvie] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR Biosci Gerland Lyon Sud, F-69367 Lyon 07, France; [Jetne, Reidunn; Fukai, Naomi; Olsen, Bjorn R.] Harvard Univ, Sch Med, Harvard Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Jetne, Reidunn; Fukai, Naomi; Olsen, Bjorn R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Harvard University; Harvard Medical School; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; University of Manchester	Ricard-Blum, S (corresponding author), Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR Biosci Gerland Lyon Sud, 7 Passage Vercors, F-69367 Lyon 07, France.	s.ricard-blum@ibcp.fr	MOREAU, Christophe J/D-3736-2009; MOREAU, Christophe/AAC-7912-2020; Chautard, Emilie/C-7836-2011	MOREAU, Christophe J/0000-0002-5463-9593; MOREAU, Christophe/0000-0002-5463-9593; Chautard, Emilie/0000-0003-1456-5347; Humphries, Martin/0000-0002-4331-6967; RUGGIERO, Florence/0000-0003-2915-5359; RICARD-BLUM, Sylvie/0000-0001-9263-1851	National Institutes of Health [36820]; Association pour la Recherche contre le Cancer [3652]; INSERM [A04115SP]; Region Rhone-Alpes; University Lyon-1	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); University Lyon-1	This work was supported, in whole or in part, by National Institutes of Health Grant 36820 (to B.R.O.). This work was also supported by Association pour la Recherche contre le Cancer Grant 3652 (to F. R. and S.R.-B.), Groupement d'Interet Scientifique Maladies Rares INSERM Grant A04115SP (to F. R. and S.R.-B.), Contrat Plan Etat Region Rhone-Alpes (to C. F., E. C., F. R., and S.R.-B.), funds from the Emergence Research Program, Region Rhone-Alpes (to F. R. and S.R.-B.), and a Bonus Qualite Recherche grant from University Lyon-1 (to S.R.-B.).	Balasubramanian SP, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-107; Cao Y, 2008, ADV CANCER RES, V100, P113, DOI 10.1016/S0065-230X(08)00004-3; Celik I, 2005, CANCER RES, V65, P11044, DOI 10.1158/0008-5472.CAN-05-2617; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Digtyar AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P235, DOI 10.1134/S0006297907030017; Elamaa H, 2005, AM J PATHOL, V166, P221, DOI 10.1016/S0002-9440(10)62246-8; Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Gestwicki JE, 2002, ANAL BIOCHEM, V305, P149, DOI 10.1006/abio.2002.5652; Hoffmann J, 1999, J HISTOCHEM CYTOCHEM, V47, P373, DOI 10.1177/002215549904700311; KAESBERG PR, 1989, J CLIN INVEST, V83, P994, DOI 10.1172/JCI113986; Karumanchi SA, 2001, MOL CELL, V7, P811, DOI 10.1016/S1097-2765(01)00225-8; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Lang K, 2003, SCAND J IMMUNOL, V57, P350, DOI 10.1046/j.1365-3083.2003.01247.x; Li CY, 2005, BIOCHEM BIOPH RES CO, V329, P873, DOI 10.1016/j.bbrc.2005.02.055; Lourenco GJ, 2006, BREAST CANCER RES TR, V100, P335, DOI 10.1007/s10549-006-9259-z; Macpherson GR, 2004, CANCER BIOL THER, V3, P1298, DOI 10.4161/cbt.3.12.1453; Nascimento H, 2007, LEUKEMIA RES, V31, P1158, DOI 10.1016/j.leukres.2006.09.019; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Sasaki T, 1999, EMBO J, V18, P6240, DOI 10.1093/emboj/18.22.6240; Schmidt A, 2004, CANCER BIOL THER, V3, P1162, DOI 10.4161/cbt.3.11.1219; Schmidt A, 2004, DEV DYNAM, V230, P468, DOI 10.1002/dvdy.20072; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; SIJN RMT, 2006, CANCER GENE THER, V13, P619; Stahl S, 2005, GENES CELLS, V10, P929, DOI 10.1111/j.1365-2443.2005.00890.x; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Vorup-Jensen T, 2007, J BIOL CHEM, V282, P30869, DOI 10.1074/jbc.M706114200; Wickstrom SA, 2004, J BIOL CHEM, V279, P20178, DOI 10.1074/jbc.M312921200; Wickstrom SA, 2003, J BIOL CHEM, V278, P37895, DOI 10.1074/jbc.M303569200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414; Zambon L, 2008, LUNG CANCER, V59, P276, DOI 10.1016/j.lungcan.2007.10.018	42	79	82	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22029	22040		10.1074/jbc.M109.002840	http://dx.doi.org/10.1074/jbc.M109.002840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19502598	Green Published, hybrid			2022-12-27	WOS:000268783700027
J	Umar, S; Sarkar, S; Wang, Y; Singh, P				Umar, Shahid; Sarkar, Shubhashish; Wang, Yu; Singh, Pomila			Functional Cross-talk between beta-Catenin and NF kappa B Signaling Pathways in Colonic Crypts of Mice in Response to Progastrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; GLYCOGEN-SYNTHASE KINASE-3-BETA; COLORECTAL-CANCER CELLS; IN-VIVO; SUBSTRATE-SPECIFICITY; PROGENITOR PHENOTYPE; GENE-EXPRESSION; TRANSGENIC MICE; STEM-CELLS; ACTIVATION	We recently reported a critical role of NF kappa B in mediating hyperproliferative and anti-apoptotic effects of progastrin on proximal colonic crypts of transgenic mice overexpressing progastrin (Fabp-PG mice). We now report activation of beta-catenin in colonic crypts of mice in response to chronic (Fabp-PG mice) and acute (wild type FVB/N mice) progastrin stimulation. Significant increases were measured in relative levels of cellular and nuclear beta-catenin and p beta-cat(45) in proximal colonic crypts of Fabp-PG mice compared with that in wild type littermates. Distal colonic crypts were less responsive. Interestingly, beta-catenin activation was downstream of IKK alpha,beta/NF kappa B, because treatment of Fabp-PG mice with the NF kappa B essential modulator (NEMO) peptide (inhibitor of IKK alpha,beta/NF kappa B activation) significantly blocked increases in cellular/nuclear levels of total beta-catenin/p beta-cat(45)/and p beta-cat(552) in proximal colons. Cellular levels of p beta-cat(33,37,41), however, increased in proximal colons in response to NEMO, probably because of a significant increase in pGSK-3 beta(Tyr216), facilitating degradation of beta-catenin. NEMO peptide significantly blocked increases in cyclin D1 expression, thereby, abrogating hyperplasia of proximal crypts. Goblet cell hyperplasia in colonic crypts of Fabp-PG mice was abrogated by NEMO treatment, suggesting a cross-talk between the NF kappa B/beta-catenin and Notch pathways. Cellular proliferation and crypt lengths increased significantly in proximal but not distal crypts of FVB/N mice injected with 1 nM progastrin associated with a significant increase in cellular/nuclear levels of total beta-catenin and cyclin D1. Thus, intracellular signals, activated in response to acute and chronic stimulation with progastrin, were similar and specific to proximal colons. Our studies suggest a novel possibility that activation of beta-catenin, downstream to the IKK alpha,beta/NF kappa B pathway, may be integral to the hyperproliferative effects of progastrin on proximal colonic crypts.	[Sarkar, Shubhashish; Wang, Yu; Singh, Pomila] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Umar, Shahid] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Umar, Shahid] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK 73104 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Oklahoma System; University of Oklahoma Health Sciences Center	Singh, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, 10-104 Med Res Bldg,Route 1043, Galveston, TX 77555 USA.	posingh@utmb.edu			NCI [R01 CA97959, CA114264, R01 CA131413]; NATIONAL CANCER INSTITUTE [R01CA097959, R01CA114264, R01CA131413] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA97959 and CA114264 (to P. S.) and R01 CA131413 (to S. U.) from the NCI.	Albanese C, 2003, MOL BIOL CELL, V14, P585, DOI 10.1091/mbc.02-06-0101; Aly A, 2001, INT J CANCER, V94, P307, DOI 10.1002/ijc.1483; Baldwin GS, 2001, J BIOL CHEM, V276, P7791, DOI 10.1074/jbc.M009985200; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Carayol N, 2006, CELL SIGNAL, V18, P1941, DOI 10.1016/j.cellsig.2006.02.014; Cho HH, 2008, FEBS LETT, V582, P616, DOI 10.1016/j.febslet.2008.01.029; Cho HH, 2008, BBA-MOL CELL RES, V1783, P419, DOI 10.1016/j.bbamcr.2007.08.005; Cho M, 2005, FEBS LETT, V579, P4213, DOI 10.1016/j.febslet.2005.06.049; Cobb S, 2004, CANCER-AM CANCER SOC, V100, P1311, DOI 10.1002/cncr.20094; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dockray GJ, 1996, PHYSIOL REV, V76, P767, DOI 10.1152/physrev.1996.76.3.767; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Flandez M, 2008, EXP CELL RES, V314, P3712, DOI 10.1016/j.yexcr.2008.10.004; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Grabowska AM, 2007, CANCER LETT, V257, P1, DOI 10.1016/j.canlet.2007.06.017; He H, 2008, BBA-MOL CELL RES, V1783, P1943, DOI 10.1016/j.bbamcr.2008.04.016; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hollande F, 2003, J CELL SCI, V116, P1187, DOI 10.1242/jcs.00321; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; KOCHMAN ML, 1992, BIOCHEM BIOPH RES CO, V189, P1165, DOI 10.1016/0006-291X(92)92326-S; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; NEMETH J, 1993, GUT, V34, P90, DOI 10.1136/gut.34.1.90; Ottewell PD, 2005, AM J PHYSIOL-GASTR L, V288, pG541, DOI 10.1152/ajpgi.00268.2004; Pannequin J, 2007, GASTROENTEROLOGY, V133, P1554, DOI 10.1053/j.gastro.2007.08.023; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Rengifo-Cam W, 2004, CURR PHARM DESIGN, V10, P2345, DOI 10.2174/1381612043383999; Rengifo-Cam W, 2007, CANCER RES, V67, P7266, DOI 10.1158/0008-5472.CAN-07-1206; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; SARKAR S, 2009, 100 AACR ANN M APR 1; Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019; SEVA C, 1994, SCIENCE, V265, P410, DOI 10.1126/science.8023165; Singh P, 2007, ONCOGENE, V26, P425, DOI 10.1038/sj.onc.1209798; Singh P, 2000, GASTROENTEROLOGY, V119, P162, DOI 10.1053/gast.2000.8527; Singh P, 2000, AM J PHYSIOL-GASTR L, V278, pG390, DOI 10.1152/ajpgi.2000.278.3.G390; Singh P, 2003, AM J PHYSIOL-GASTR L, V284, pG328, DOI 10.1152/ajpgi.00351.2002; Song DH, 2005, BRIT J CANCER, V92, P1581, DOI 10.1038/sj.bjc.6602509; Sun J, 2005, AM J PHYSIOL-GASTR L, V289, pG129, DOI 10.1152/ajpgi.00515.2004; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Umar S, 2008, ONCOGENE, V27, P5599, DOI 10.1038/onc.2008.169; Umar S, 2003, CELL PROLIFERAT, V36, P361, DOI 10.1046/j.1365-2184.2003.00291.x; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VANSOLINGE WW, 1993, GASTROENTEROLOGY, V104, P1099, DOI 10.1016/0016-5085(93)90279-L; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; Wu H, 2003, AM J PHYSIOL-GASTR L, V285, pG1097, DOI 10.1152/ajpgi.00216.2003; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008	54	41	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22274	22284		10.1074/jbc.M109.020941	http://dx.doi.org/10.1074/jbc.M109.020941			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19497850	hybrid, Green Published			2022-12-27	WOS:000268783700051
J	Weaver, TM; Hocking, JM; Bailey, LJ; Wawrzyn, GT; Howard, DR; Sikkink, LA; Ramirez-Alvarado, M; Thompson, JR				Weaver, Todd M.; Hocking, Jason M.; Bailey, Lucas J.; Wawrzyn, Grayson T.; Howard, David R.; Sikkink, Laura A.; Ramirez-Alvarado, Marina; Thompson, James R.			Structural and Functional Studies of Truncated Hemolysin A from Proteus mirabilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERRATIA-MARCESCENS HEMOLYSIN; GRAM-NEGATIVE BACTERIA; 2-PARTNER SECRETION; ERYTHROCYTE-MEMBRANES; CONFORMATIONAL-CHANGE; ACTIVATION; MODEL; SHLA; AUTOTRANSPORTER; PATHWAY	In this study we analyzed the structure and function of a truncated form of hemolysin A (HpmA265) from Proteus mirabilis using a series of functional and structural studies. Hemolysin A belongs to the two-partner secretion pathway. The two-partner secretion pathway has been identified as the most common protein secretion pathway among Gram-negative bacteria. Currently, the mechanism of action for the two-partner hemolysin members is not fully understood. In this study, hemolysis experiments revealed a unidirectional, cooperative, biphasic activity profile after full-length, inactive hemolysin A was seeded with truncated hemolysin A. We also solved the first x-ray structure of a TpsA hemolysin. The truncated hemolysin A formed a right-handed parallel beta-helix with three adjoining segments of anti-parallel beta-sheet. A CXXC disulfide bond, four buried solvent molecules, and a carboxyamide ladder were all located at the third complete beta-helix coil. Replacement of the CXXC motif led to decreased activity and stability according to hemolysis and CD studies. Furthermore, the crystal structure revealed a sterically compatible, dry dimeric interface formed via anti-parallel beta-sheet interactions between neighboring beta-helix monomers. Laser scanning confocal microscopy further supported the unidirectional interconversion of full-length hemolysin A. From these results, a model has been proposed, where cooperative, beta-strand interactions between HpmA265 and neighboring full-length hemolysin A molecules, facilitated in part by the highly conserved CXXC pattern, account for the template-assisted hemolysis.	[Weaver, Todd M.; Hocking, Jason M.; Bailey, Lucas J.; Wawrzyn, Grayson T.] Univ Wisconsin, Dept Chem, La Crosse, WI 54601 USA; [Howard, David R.] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA; [Sikkink, Laura A.; Ramirez-Alvarado, Marina] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Coll Med, Dept Physiol & Biomed Imaging, Rochester, MN 55905 USA	University of Wisconsin System; University of Wisconsin System; Mayo Clinic; Mayo Clinic	Weaver, TM (corresponding author), Univ Wisconsin, Dept Chem, 1725 State St,4020 Cowley Hall, La Crosse, WI 54601 USA.	weaver.todd@uwlax.edu		Ramirez-Alvarado, Marina/0000-0003-2325-6773; Weaver, Todd/0000-0002-7749-5094	National Institutes of Health [AI057437]; National Science Foundation [MCB0744754, DBI619289]; University of Wisconsin; UW-La Crosse, College of Science and Health Dean's Summer Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI057437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Wisconsin; UW-La Crosse, College of Science and Health Dean's Summer Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI057437 (to T. W.). This work was also supported by National Science Foundation Grant MCB0744754 (to T. W.), by the University of Wisconsin (UW)-La Crosse Faculty Research Program (to T. W.), and by a UW-La Crosse, College of Science and Health Dean's Summer Fellowship (to G. W.) supported the work. A National Science Foundation Grant DBI619289 (to Jennifer Miskowski, UW-La Crosse, Dept. of Biology) supported the laser scanning confocal microscopy studies.	BERNHEIMER AW, 1988, METHOD ENZYMOL, V165, P213; BRAUN V, 1993, ZBL BAKT-INT J MED M, V278, P306, DOI 10.1016/S0934-8840(11)80847-9; Cellmer T, 2007, BIOPHYS CHEM, V125, P350, DOI 10.1016/j.bpc.2006.09.010; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hennetin J, 2006, J MOL BIOL, V358, P1094, DOI 10.1016/j.jmb.2006.02.039; Hertle R, 1997, MOL MICROBIOL, V26, P853, DOI 10.1046/j.1365-2958.1997.6031978.x; Hertle R, 2005, CURR PROTEIN PEPT SC, V6, P313, DOI 10.2174/1389203054546370; Hertle R, 1999, INFECT IMMUN, V67, P817, DOI 10.1128/IAI.67.2.817-825.1999; Hertle R, 2002, J MEMBRANE BIOL, V189, P1, DOI 10.1007/s00232-001-0191-1; Hertle R, 2000, J CHROMATOGR B, V737, P13, DOI 10.1016/S0378-4347(99)00381-3; Hertle R, 2000, CURR PROTEIN PEPT SC, V1, P75, DOI 10.2174/1389203003381423; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHIEBEL E, 1989, MOL MICROBIOL, V3, P445, DOI 10.1111/j.1365-2958.1989.tb00190.x; SCHONHERR R, 1993, MOL MICROBIOL, V9, P1229, DOI 10.1111/j.1365-2958.1993.tb01252.x; SCHONHERR R, 1994, EUR J BIOCHEM, V223, P655, DOI 10.1111/j.1432-1033.1994.tb19038.x; Siepen JA, 2003, PROTEIN SCI, V12, P2348, DOI 10.1110/ps.03234503; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; SWIHART KG, 1990, INFECT IMMUN, V58, P1853, DOI 10.1128/IAI.58.6.1853-1860.1990; Thanassi DG, 2005, MOL MEMBR BIOL, V22, P63, DOI 10.1080/09687860500063290; Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607; UPHOFF TS, 1990, J BACTERIOL, V172, P1206, DOI 10.1128/jb.172.3.1206-1216.1990; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Walker G, 2004, INFECT IMMUN, V72, P611, DOI 10.1128/IAI.72.1.611-614.2004; Wilson DR, 1997, PROTEIN ENG, V10, P519, DOI 10.1093/protein/10.5.519; Wouters MA, 2007, CURR PROTEIN PEPT SC, V8, P484, DOI 10.2174/138920307782411464; Yang FL, 2000, INT J MED MICROBIOL, V290, P529; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Yeo HJ, 2007, J BIOL CHEM, V282, P31076, DOI 10.1074/jbc.M705750200; YOUNG JDE, 1986, ANAL BIOCHEM, V154, P649, DOI 10.1016/0003-2697(86)90042-4	42	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22297	22309		10.1074/jbc.M109.014431	http://dx.doi.org/10.1074/jbc.M109.014431			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19494116	Green Published, hybrid			2022-12-27	WOS:000268783700053
J	Zhang, Y; Kang, YH; Chang, N; Lam, PPL; Liu, YF; Olkkonen, VM; Gaisano, HY				Zhang, Yi; Kang, You-hou; Chang, Nathan; Lam, Patrick P. L.; Liu, Yunfeng; Olkkonen, Vesa M.; Gaisano, Herbert Y.			Cab45b, a Munc18b-interacting Partner, Regulates Exocytosis in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; CA2+-BINDING PROTEIN; SECRETORY GRANULES; INSULIN EXOCYTOSIS; VESICLE EXOCYTOSIS; SYNTAXIN 3; B-CELLS; MEMBRANE; INTERACTS; TRAFFICKING	Cab45b is a cytosolic Ca2+-binding protein reported to regulate zymogen secretion in pancreatic acini. We now show that Cab45b is also expressed in pancreatic islet beta-cells and interacts there with the Sec1-Munc18 protein Munc18b. We employed patch clamp cell capacitance measurements to show that antibodies against Cab45b inhibited depolarization-evoked membrane capacitance increments, suggesting an impact on beta-cell granule exocytosis, both the readily releasable granule pool and refilling of this pool. Site-specific mutants in the Cab45b EF-hands were used to dissect the molecular interactions involved in Cab45b function. Mutants in EF-hands 2 and 3 had no detectable effects on interaction of Cab45b with Munc18b and did not affect the depolarization-evoked calcium currents, but remarkably, they facilitated the complex formation of Munc18b with syntaxin-2 and -3. As a result, these two EF-hand mutants inhibited beta-cell membrane capacitance increments. This inhibition is mediated via Munc18b because Munc18b silencing with small interfering RNA abolished the effects of these two mutants. The results suggest a mechanism for Cab45b action that involves regulating the dynamic association of Munc18b with SNAREs to impact beta-cell granule exocytosis.	[Zhang, Yi; Kang, You-hou; Chang, Nathan; Lam, Patrick P. L.; Liu, Yunfeng; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Zhang, Yi; Kang, You-hou; Chang, Nathan; Lam, Patrick P. L.; Liu, Yunfeng; Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Olkkonen, Vesa M.] Univ Helsinki, Biomedicum, Natl Inst Hlth & Welf, FI-00251 Helsinki, Finland; [Olkkonen, Vesa M.] Univ Helsinki, Biomedicum, Inst Mol Med Finland FIMM, FI-00251 Helsinki, Finland	University of Toronto; University of Toronto; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki	Gaisano, HY (corresponding author), Univ Toronto, Dept Med, Rm 7226 Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca		Olkkonen, Vesa/0000-0001-5553-7997; Liu, Yunfeng/0000-0003-2826-5804	Canadian Institutes for Health [MOP 89889]	Canadian Institutes for Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grant MOP 89889.	Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; Gromada J, 1999, J PHYSIOL-LONDON, V518, P745, DOI 10.1111/j.1469-7793.1999.0745p.x; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Koivu T, 1997, DNA SEQUENCE, V7, P217, DOI 10.3109/10425179709034038; Kwan EP, 2007, DIABETES, V56, P2579, DOI 10.2337/db06-1207; Kwan EP, 2005, DIABETES, V54, P2734, DOI 10.2337/diabetes.54.9.2734; Lam PPL, 2007, MOL BIOL CELL, V18, P2473, DOI 10.1091/mbc.E06-10-0950; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Nicoletta JA, 2004, AM J PHYSIOL-CELL PH, V287, pC1366, DOI 10.1152/ajpcell.00588.2003; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2007, J BIOL CHEM, V282, P32613, DOI 10.1074/jbc.M706591200; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Pickett JA, 2005, J BIOL CHEM, V280, P1506, DOI 10.1074/jbc.M411967200; Riento K, 1996, EUR J BIOCHEM, V239, P638, DOI 10.1111/j.1432-1033.1996.0638u.x; Riento K, 2000, J BIOL CHEM, V275, P13476, DOI 10.1074/jbc.275.18.13476; Riento K, 1998, J CELL SCI, V111, P2681; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Takahashi N, 2004, J CELL BIOL, V165, P255, DOI 10.1083/jcb.200312033; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Tomas A, 2008, TRAFFIC, V9, P813, DOI 10.1111/j.1600-0854.2008.00709.x; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Tsuboi T, 2006, MOL BIOL CELL, V17, P2101, DOI 10.1091/mbc.E05-11-1047; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	37	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20840	20847		10.1074/jbc.M109.017467	http://dx.doi.org/10.1074/jbc.M109.017467			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19487699	Green Published, hybrid			2022-12-27	WOS:000268316100047
J	Bah, A; Carrell, CJ; Chen, ZW; Gandhi, PS; Di Cera, E				Bah, Alaji; Carrell, Christopher J.; Chen, Zhiwei; Gandhi, Prafull S.; Di Cera, Enrico			Stabilization of the E* Form Turns Thrombin into an Anticoagulant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTORS; CRYSTAL-STRUCTURE; MUTANT W215A/E217A; BOVINE TRYPSINOGEN; NA+ BINDING; POTENT ANTICOAGULANT; ALPHA-CHYMOTRYPSIN; THROMBOMODULIN; SPECIFICITY; COMPLEX	Previous studies have shown that deletion of nine residues in the autolysis loop of thrombin produces a mutant with an anticoagulant propensity of potential clinical relevance, but the molecular origin of the effect has remained unresolved. The x-ray crystal structure of this mutant solved in the free form at 1.55 angstrom resolution reveals an inactive conformation that is practically identical (root mean square deviation of 0.154 angstrom) to the recently identified E* form. The side chain of Trp(215) collapses into the active site by shifting > 10 angstrom from its position in the active E form, and the oxyanion hole is disrupted by a flip of the Glu(192)-Gly(193) peptide bond. This finding confirms the existence of the inactive form E* in essentially the same incarnation as first identified in the structure of the thrombin mutant D102N. In addition, it demonstrates that the anticoagulant profile often caused by a mutation of the thrombin scaffold finds its likely molecular origin in the stabilization of the inactive E* form that is selectively shifted to the active E form upon thrombomodulin and protein C binding.	[Bah, Alaji; Carrell, Christopher J.; Chen, Zhiwei; Gandhi, Prafull S.; Di Cera, Enrico] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231, St Louis, MO 63110 USA.	enrico@wustl.edu			National Institutes of Health [HL49413, HL58141, HL73813]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073813, R01HL049413, R29HL049413, R01HL058141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL58141, and HL73813 (to E. D. C.).	Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrette-Ng IH, 2002, J BIOL CHEM, V277, P39960, DOI 10.1074/jbc.M206978200; Berny MA, 2008, ARTERIOSCL THROM VAS, V28, P329, DOI 10.1161/ATVBAHA.107.156273; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; Cantwell AM, 2000, J BIOL CHEM, V275, P39827, DOI 10.1074/jbc.C000751200; Carrell CJ, 2006, BIOPHYS CHEM, V121, P177, DOI 10.1016/j.bpc.2005.12.008; Carter WJ, 2004, J BIOL CHEM, V279, P26387, DOI 10.1074/jbc.M402364200; Carvalho AL, 2002, J MOL BIOL, V322, P325, DOI 10.1016/S0022-2836(02)00705-2; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dang QD, 1997, J BIOL CHEM, V272, P19649, DOI 10.1074/jbc.272.32.19649; DANG QD, 1995, P NATL ACAD SCI USA, V92, P5977, DOI 10.1073/pnas.92.13.5977; Dang QD, 1997, NAT BIOTECHNOL, V15, P146, DOI 10.1038/nbt0297-146; Di Cera E., 1995, THERMODYNAMIC THEORY; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; DiBella EE, 1996, BIOCHEMISTRY-US, V35, P4427, DOI 10.1021/bi952617c; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; FERSHT AR, 1972, J MOL BIOL, V64, P497, DOI 10.1016/0022-2836(72)90513-X; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gianni S, 2007, BIOPHYS CHEM, V131, P111, DOI 10.1016/j.bpc.2007.09.009; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; GRIFFIN JH, 1995, NATURE, V378, P337, DOI 10.1038/378337a0; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Gruber A, 2002, J BIOL CHEM, V277, P27581, DOI 10.1074/jbc.C200237200; Gruber A, 2007, BLOOD, V109, P3733, DOI 10.1182/blood-2006-07-035147; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hink-Schauer C, 2002, J BIOL CHEM, V277, P50923, DOI 10.1074/jbc.M207962200; Jing H, 1998, J MOL BIOL, V282, P1061, DOI 10.1006/jmbi.1998.2089; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P19341; Levi M, 2008, CURR OPIN HEMATOL, V15, P481, DOI 10.1097/MOH.0b013e328304b3e3; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P1943, DOI 10.1007/s00018-008-8179-y; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2002, J BIOL CHEM, V277, P32015, DOI 10.1074/jbc.M205009200; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; Prasad S, 2003, P NATL ACAD SCI USA, V100, P13785, DOI 10.1073/pnas.2333109100; Reiling KK, 2003, BIOCHEMISTRY-US, V42, P2616, DOI 10.1021/bi020594d; Rickert KW, 2008, J BIOL CHEM, V283, P34864, DOI 10.1074/jbc.M805262200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Rohr KB, 2006, J MOL BIOL, V357, P195, DOI 10.1016/j.jmb.2005.12.037; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; Tanaka KA, 2008, BLOOD COAGUL FIBRIN, V19, P465, DOI 10.1097/MBC.0b013e328304e044; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; Vindigni A, 1996, BIOCHEMISTRY-US, V35, P4417, DOI 10.1021/bi952834d; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WU QY, 1991, P NATL ACAD SCI USA, V88, P6775, DOI 10.1073/pnas.88.15.6775; Wyman J., 1990, BINDING LINKAGE; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	71	19	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20034	20040		10.1074/jbc.M109.012344	http://dx.doi.org/10.1074/jbc.M109.012344			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19473969	hybrid, Green Published			2022-12-27	WOS:000268097400030
J	Fan, CG; Fromm, HJ; Bobik, TA				Fan, Chenguang; Fromm, Herbert J.; Bobik, Thomas A.			Kinetic and Functional Analysis of L-Threonine Kinase, the PduX Enzyme of Salmonella enterica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; MEVALONATE DIPHOSPHATE DECARBOXYLASE; SEROVAR TYPHIMURIUM LT2; HUMAN INHERITED DISEASE; COENZYME B-12 SYNTHESIS; HOMOSERINE KINASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; MOLECULAR-STRUCTURE	The PduX enzyme of Salmonella enterica is an L-threonine kinase used for the de novo synthesis of coenzyme B-12 and the assimilation of cobyric acid. PduX with an N-terminal histidine tag (His(8)-PduX) was produced in Escherichia coli and purified. The recombinant enzyme was soluble and active. Kinetic analysis indicated a steady-state Ordered Bi Bi complex mechanism in which ATP is the first substrate to bind. Based on a multiple sequence alignment of PduX homologues and other GHMP (galactokinase, homoserine kinase, mevalonate kinase, and phosphomevalonate kinase) family members, 14 PduX variants having changes at 10 conserved serine/threonine and aspartate/glutamate sites were constructed by site-directed mutagenesis. Each variant was produced in E. coli and purified. Comparison of the circular dichroism spectra and kinetic properties of the PduX variants with those of the wild-type enzyme indicated that Glu-24 and Asp-135 are needed for proper folding, Ser-99 and Glu-132 are used for ATP binding, and Ser-253 and Ser-255 are critical to L-threonine binding whereas Ser-100 is essential to catalysis, but its precise role is uncertain. The studies reported here are the first to investigate the kinetic and catalytic mechanisms of L-threonine kinase from any organism.	[Fan, Chenguang; Fromm, Herbert J.; Bobik, Thomas A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Bobik, TA (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	bobik@iastate.edu	Fan, Cheguang/O-9709-2016	Fan, Cheguang/0000-0003-0662-1185	National Science Foundation [0616008]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 0616008.	ALBERTY RA, 1958, J AM CHEM SOC, V80, P1777, DOI 10.1021/ja01541a001; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; Andreassi JL, 2007, PROTEIN SCI, V16, P983, DOI 10.1110/ps.072755707; BALLARD FJ, 1966, BIOCHEM J, V101, P70, DOI 10.1042/bj1010070; Banerjee R., 1999, CHEM BIOCH B 12; Bates PA, 2001, PROTEINS, P39; Bates PA, 1999, PROTEINS, P47; BEYTIA E, 1970, J BIOL CHEM, V245, P5450; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bonanno JB, 2001, P NATL ACAD SCI USA, V98, P12896, DOI 10.1073/pnas.181466998; BORK P, 1993, PROTEIN SCI, V2, P31; BOYER PD, 1959, ARCH BIOCHEM BIOPHYS, V82, P387, DOI 10.1016/0003-9861(59)90136-5; Cho YK, 2001, J BIOL CHEM, V276, P12573, DOI 10.1074/jbc.M011478200; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; DEY PM, 1983, EUR J BIOCHEM, V136, P155, DOI 10.1111/j.1432-1033.1983.tb07720.x; EFTINK MR, 1991, BIOCHEMISTRY-US, V30, P1193, DOI 10.1021/bi00219a005; Escalante-Semerena JC, 2007, J BACTERIOL, V189, P4555, DOI 10.1128/JB.00503-07; Fan CG, 2008, J BIOL CHEM, V283, P11322, DOI 10.1074/jbc.M800287200; Fromm H. G., 1975, INITIAL RATE ENZYME, P121; Fromm H J, 1979, Methods Enzymol, V63, P467; FROMM HJ, 1962, J BIOL CHEM, V237, P3027; FROMM HJ, 1962, J BIOL CHEM, V237, P215; Fu ZJ, 2002, J BIOL CHEM, V277, P18134, DOI 10.1074/jbc.M200912200; GULBINSKY JS, 1968, BIOCHEMISTRY-US, V7, P566, DOI 10.1021/bi00842a009; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; Huo XW, 1996, ARCH BIOCHEM BIOPHYS, V330, P373, DOI 10.1006/abbi.1996.0264; Huo XW, 1996, BIOCHEMISTRY-US, V35, P16180, DOI 10.1021/bi962203z; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; Krepkiy DV, 2005, BIOCHEMISTRY-US, V44, P2671, DOI 10.1021/bi0484217; Krishna SS, 2001, BIOCHEMISTRY-US, V40, P10810, DOI 10.1021/bi010851z; Leskovac V., 2003, COMPREHENSIVE ENZYME, P117; Liu Y, 2007, J BACTERIOL, V189, P1589, DOI 10.1128/JB.01151-06; Miallau L, 2003, P NATL ACAD SCI USA, V100, P9173, DOI 10.1073/pnas.1533425100; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; Potter D, 1997, J BIOL CHEM, V272, P5741, DOI 10.1074/jbc.272.9.5741; Potter D, 1997, J BIOL CHEM, V272, P25449, DOI 10.1074/jbc.272.41.25449; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Romanowski MJ, 2002, PROTEINS, V47, P568, DOI 10.1002/prot.10118; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Schneider Z., 1987, COMPREHENSIVE B12 CH; Sgraja T, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-20; SHAMES SL, 1984, ARCH BIOCHEM BIOPHYS, V235, P359, DOI 10.1016/0003-9861(84)90209-1; TAYLOR KB, 2002, ENZYME KINETICS MECH, P66; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Thoden JB, 2005, J BIOL CHEM, V280, P32784, DOI 10.1074/jbc.M505730200; Thoden JB, 2005, J BIOL CHEM, V280, P9662, DOI 10.1074/jbc.M412916200; Thoden JB, 2003, J BIOL CHEM, V278, P33305, DOI 10.1074/jbc.M304789200; Timson DJ, 2003, EUR J BIOCHEM, V270, P1767, DOI 10.1046/j.1432-1033.2003.03538.x; Timson DJ, 2002, BIOCHIMIE, V84, P265, DOI 10.1016/S0300-9084(02)01399-8; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wada T, 2003, J BIOL CHEM, V278, P30022, DOI 10.1074/jbc.M304339200; Yang D, 2002, J BIOL CHEM, V277, P9462, DOI 10.1074/jbc.M110787200; Zhou T, 2000, STRUCTURE, V8, P1247, DOI 10.1016/S0969-2126(00)00533-5	55	20	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20240	20248		10.1074/jbc.M109.027425	http://dx.doi.org/10.1074/jbc.M109.027425			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19509296	Green Published, hybrid			2022-12-27	WOS:000268097400051
J	Mercier, A; Labbe, S				Mercier, Alexandre; Labbe, Simon			Both Php4 Function and Subcellular Localization Are Regulated by Iron via a Multistep Mechanism Involving the Glutaredoxin Grx4 and the Exportin Crm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FEP1; YEAST SCHIZOSACCHAROMYCES-POMBE; CCAAT-BINDING FACTOR; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; NUCLEAR EXPORT; GENE-EXPRESSION; OXIDATIVE STRESS; DNA-BINDING; FLUORESCENCE COMPLEMENTATION	In Schizosaccharomyces pombe, the CCAAT-binding factor is a multisubunit complex that contains the proteins Php2, Php3, Php4, and Php5. Under low iron conditions, Php4 acts as a negative regulatory subunit of the CCAAT-binding factor and fosters repression of genes encoding iron-using proteins. Under conditions of iron excess, Php4 expression is turned off by the iron-dependent transcriptional repressor Fep1. In this study, we developed a biological system that allows us to unlink iron-dependent behavior of Php4 protein from its transcriptional regulation by Fep1. Microscopic analyses revealed that a functional GFP-Php4 protein accumulates in the nucleus under conditions of iron starvation. Conversely, in cells undergoing a transition from low to high iron, GFP-Php4 is exported from the nucleus to the cytoplasm. We mapped a leucine-rich nuclear export signal that is necessary for nuclear exclusion of Php4. This latter process was blocked by leptomycin B. By using coimmunoprecipitation analysis, we showed that Php4 and Crm1 physically interact with each other. Although we determined that nuclear retention of Php4 per se is not sufficient to cause a constitutive repression of iron-using genes, we found that deletion of the grx4(+)-encoded glutaredoxin-4 renders Php4 constitutively active and invariably localized in the nucleus. Further analysis by bimolecular fluorescence complementation assay and by two-hybrid assays showed that Php4 and Grx4 are physically associated in vivo. Taken together, our findings indicate that Grx4 and Crm1 are novel components involved in the mechanism by which Php4 is inactivated by iron in a Fep1-independent manner.	[Mercier, Alexandre; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Labbe, S (corresponding author), 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X	Natural Sciences and Engineering Research Council of Canada [MOP-238238-01]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada Grant MOP-238238-01 ( to S. L.).	An ZQ, 1997, P NATL ACAD SCI USA, V94, P5882, DOI 10.1073/pnas.94.11.5882; An ZQ, 1997, EMBO J, V16, P1742, DOI 10.1093/emboj/16.7.1742; APOLINARIO E, 1993, CURR GENET, V24, P491, DOI 10.1007/BF00351711; Beaudoin J, 2006, EUKARYOT CELL, V5, P277, DOI 10.1128/EC.5.2.277-292.2006; Beaudoin J, 2007, EUKARYOT CELL, V6, P764, DOI 10.1128/EC.00002-07; Bellemare DR, 2001, GENE, V273, P191, DOI 10.1016/S0378-1119(01)00591-1; Bird AJ, 2008, ADV MICROB PHYSIOL, V53, P231, DOI 10.1016/SO065-2911(07)53004-3; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chao LY, 2008, BIOCHEMISTRY-US, V47, P7274, DOI 10.1021/bi800066s; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chung WH, 2005, BIOCHEM BIOPH RES CO, V330, P604, DOI 10.1016/j.bbrc.2005.02.183; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; KEENEY JB, 1994, GENETICS, V136, P849; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim J, 1998, GENETICS, V149, P795; Kudo N, 1999, J BIOL CHEM, V274, P15151, DOI 10.1074/jbc.274.21.15151; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Labbe S, 2007, BIOMETALS, V20, P523, DOI 10.1007/s10534-006-9056-5; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McNabb DS, 1997, MOL CELL BIOL, V17, P7008, DOI 10.1128/MCB.17.12.7008; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Miller J. H, 1972, EXPT MOL GENETICS; Moreno MB, 2000, YEAST, V16, P861; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Pelleber B, 2007, YEAST, V24, P883, DOI 10.1002/yea.1539; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Ueta R, 2003, J BIOL CHEM, V278, P50120, DOI 10.1074/jbc.M305046200; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; VOJTEK AB, 1997, YEAST 2 HYBRID SYSTE, P29; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Zhou LW, 1998, MOL GEN GENET, V259, P532, DOI 10.1007/s004380050845; Znaidi S, 2004, J BIOL CHEM, V279, P9462, DOI 10.1074/jbc.M312787200	69	58	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20249	20262		10.1074/jbc.M109.009563	http://dx.doi.org/10.1074/jbc.M109.009563			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19502236	hybrid, Green Published			2022-12-27	WOS:000268097400052
J	Singh, AK; Singh, N; Sinha, M; Bhushan, A; Kaur, P; Srinivasan, A; Sharma, S; Singh, TP				Singh, Amit K.; Singh, Nagendra; Sinha, Mau; Bhushan, Asha; Kaur, Punit; Srinivasan, Alagiri; Sharma, Sujata; Singh, Tej P.			Binding Modes of Aromatic Ligands to Mammalian Heme Peroxidases with Associated Functional Implications CRYSTAL STRUCTURES OF LACTOPEROXIDASE COMPLEXES WITH ACETYLSALICYLIC ACID, SALICYLHYDROXAMIC ACID, AND BENZYLHYDROXAMIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTHROMYCES-RAMOSUS PEROXIDASE; RAY CRYSTALLOGRAPHIC ANALYSIS; HORSERADISH-PEROXIDASE; BOVINE LACTOPEROXIDASE; HUMAN MYELOPEROXIDASE; ASCORBATE PEROXIDASE; INTESTINAL PEROXIDASE; BENZHYDROXAMIC ACID; ANGSTROM RESOLUTION; OXIDATIVE STRESS	The binding and structural studies of bovine lactoperoxidase with three aromatic ligands, acetylsalicylic acid (ASA), salicylhydoxamic acid (SHA), and benzylhydroxamic acid (BHA) show that all the three compounds bind to lactoperoxidase at the substrate binding site on the distal heme side. The binding of ASA occurs without perturbing the position of conserved heme water molecule W-1, whereas both SHA and BHA displace it by the hydroxyl group of their hydroxamic acid moieties. The acetyl group carbonyl oxygen atom of ASA forms a hydrogen bond with W-1, which in turn makes three other hydrogen-bonds, one each with heme iron, His-109N(epsilon 2), and Gln-105 N-epsilon 2. In contrast, in the complexes of SHA and BHA, the OH group of hydroxamic acid moiety in both complexes interacts with heme iron directly with Fe-OH distances of 3.0 and 3.2 angstrom respectively. The OH is also hydrogen bonded to His-109N(epsilon 2) and Gln-105N(epsilon 2). The plane of benzene ring of ASA is inclined at 70.7 degrees from the plane of heme moiety, whereas the aromatic planes of SHA and BHA are nearly parallel to the heme plane with inclinations of 15.7 and 6.2, respectively. The mode of ASA binding provides the information about the mechanism of action of aromatic substrates, whereas the binding characteristics of SHA and BHA indicate the mode of inhibitor binding.	[Singh, Amit K.; Singh, Nagendra; Sinha, Mau; Bhushan, Asha; Kaur, Punit; Srinivasan, Alagiri; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, Ansari Nagar, New Delhi 110029, India.	tpsingh.aiims@gmail.com		SINHA, MAU/0000-0003-3011-9160; Singh, Nagendra/0000-0003-0419-0684	Council of Scientific and Industrial Research, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Supported by a Council of Scientific and Industrial Research, New Delhi fellowship.	Agner K., 1941, ACTA PHYSIOL SCAND, V2, P1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; CALS MM, 1991, EUR J BIOCHEM, V198, P733, DOI 10.1111/j.1432-1033.1991.tb16073.x; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; CHATTERJEE R, 1993, BIOCHIM BIOPHYS ACTA, V1161, P168, DOI 10.1016/0167-4838(93)90210-I; Davey CA, 1996, BIOCHEMISTRY-US, V35, P10967, DOI 10.1021/bi960577m; DAVIES B, 1989, BIOCHEM J, V258, P801, DOI 10.1042/bj2580801; DeLano W.L, PYMOL MOL GRAPHICS S; DOERGE DR, 1994, CHEM RES TOXICOL, V7, P164, DOI 10.1021/tx00038a008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; FENNA R, 1995, ARCH BIOCHEM BIOPHYS, V316, P653, DOI 10.1006/abbi.1995.1086; FERRARI RP, 1993, SPECTROCHIM ACTA A, V49, P1261, DOI 10.1016/0584-8539(93)80034-8; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Gajhede M, 2001, BIOCHEM SOC T, V29, P91, DOI 10.1042/0300-5127:0290091; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Ghibaudi EM, 2000, REDOX REP, V5, P229, DOI 10.1179/135100000101535672; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Henriksen A, 1998, BIOCHEMISTRY-US, V37, P8054, DOI 10.1021/bi980234j; HORI H, 1994, J BIOL CHEM, V269, P8388; IKEDASAITO M, 1991, J BIOL CHEM, V266, P3611; Itakura H, 1997, FEBS LETT, V412, P107, DOI 10.1016/S0014-5793(97)00751-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIMURA S, 1979, ARCH BIOCHEM BIOPHYS, V198, P580, DOI 10.1016/0003-9861(79)90534-4; KITAGAWA T, 1983, BIOCHEMISTRY-US, V22, P2788, DOI 10.1021/bi00281a003; Kooter IM, 1999, J BIOL CHEM, V274, P26794, DOI 10.1074/jbc.274.38.26794; KUMAR R, 1995, ACTA CRYSTALLOGR D, V51, P1094, DOI 10.1107/S0907444995004422; KUNISHIMA N, 1994, J MOL BIOL, V235, P331, DOI 10.1016/S0022-2836(05)80037-3; LIPMANN F, 1945, J BIOL CHEM, V159, P21; METODIEWA D, 1989, BIOCHEM BIOPH RES CO, V160, P1183, DOI 10.1016/S0006-291X(89)80128-7; METODIEWA D, 1989, ARCH BIOCHEM BIOPHYS, V274, P601, DOI 10.1016/0003-9861(89)90475-X; Monzani E, 1997, BIOCHEMISTRY-US, V36, P1918, DOI 10.1021/bi961868y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oakley GG, 1996, CHEM RES TOXICOL, V9, P1285, DOI 10.1021/tx960103o; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oxvig C, 1999, J BIOL CHEM, V274, P16953, DOI 10.1074/jbc.274.24.16953; Poulos TL, 2007, NAT PROD REP, V24, P504, DOI 10.1039/b604195g; POULOS TL, 1980, J BIOL CHEM, V255, P575; POULOS TL, 1993, J BIOL CHEM, V268, P4429; RAMAKRISHNA NVS, 1993, CHEM RES TOXICOL, V6, P837, DOI 10.1021/tx00036a013; Schuller DJ, 1996, STRUCTURE, V4, P311, DOI 10.1016/S0969-2126(96)00035-4; Sharp KH, 2004, BIOCHEMISTRY-US, V43, P8644, DOI 10.1021/bi049343q; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Sheikh IA, 2009, J BIOL CHEM, V284, P14849, DOI 10.1074/jbc.M807644200; SIEVERS G, 1981, FEBS LETT, V127, P253; Singh AK, 2009, BIOPHYS J, V96, P646, DOI 10.1016/j.bpj.2008.09.019; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; SIPE HJ, 1994, CARCINOGENESIS, V15, P2637, DOI 10.1093/carcin/15.11.2637; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Tsukamoto K, 1999, BIOCHEMISTRY-US, V38, P12558, DOI 10.1021/bi982925l; Wada K, 2003, J BIOCHEM, V134, P239, DOI 10.1093/jb/mvg136; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5; ZHANG HC, 1993, CAN J CHEM, V71, P1990, DOI 10.1139/v93-248	55	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20311	20318		10.1074/jbc.M109.010280	http://dx.doi.org/10.1074/jbc.M109.010280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19465478	Green Published, hybrid			2022-12-27	WOS:000268097400057
J	Tashiro, K; Tsunematsu, T; Okubo, H; Ohta, T; Sano, E; Yamauchi, E; Taniguchi, H; Konishi, H				Tashiro, Kyoko; Tsunematsu, Takumi; Okubo, Hiroko; Ohta, Takeshi; Sano, Etsuko; Yamauchi, Emiko; Taniguchi, Hisaaki; Konishi, Hiroaki			GAREM, a Novel Adaptor Protein for Growth Factor Receptor-bound Protein 2, Contributes to Cellular Transformation through the Activation of Extracellular Signal-regulated Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CANCER-CELLS; EGF-RECEPTOR; DOMAIN; PHOSPHATASE; NETWORKS; SITES; TRANSDUCTION; SPECIFICITY; COMPLEXITY	Adaptor proteins for the various growth factor receptors play a crucial role in signal transduction through tyrosine phosphorylation. Several candidates for adaptor proteins with potential effects on the epidermal growth factor (EGF) receptor-mediated signaling pathway have been identified by recent phosphoproteomic studies. Here, we focus on a novel protein, GAREM (Grb2-associated and regulator of Erk/MAPK) as a downstream molecule of the EGF receptor. GAREM is phosphorylated at tyrosine 105 and 453 after EGF stimulation. Grb2 was identified as its binding partner, and the proline-rich motifs of GAREM are recognized by the Nand C-terminal SH3 domains of Grb2. In addition, the tyrosine phosphorylations of GAREM are necessary for its binding to Grb2. Because the amino acid sequence surrounding tyrosine 453 is similar to the immunoreceptor tyrosine-based inhibitory motif, Shp2, a positive regulator of Erk, binds to GAREM in this phosphorylation-dependent manner. Consequently, Erk activation in response to EGF stimulation is regulated by the expression of GAREM in COS-7 and HeLa cells, which occurs independent of the presence of other binding proteins, such as Gab1 and SOS, to the activated EGF receptor. Furthermore, the expression of GAREM has an effect on the transformation activity of cultured cells. Together, these findings suggest that GAREM plays a key role in the ligand-mediated signaling pathway of the EGF receptor and the tumorigenesis of cells.	[Tsunematsu, Takumi; Okubo, Hiroko; Ohta, Takeshi; Konishi, Hiroaki] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara, Hiroshima 7270023, Japan; [Tashiro, Kyoko; Sano, Etsuko; Yamauchi, Emiko; Taniguchi, Hisaaki; Konishi, Hiroaki] Univ Tokushima, Inst Enzyme Res, Div Dis Prote, Tokushima 7708503, Japan	Tokushima University	Konishi, H (corresponding author), Prefectural Univ Hiroshima, Fac Life & Environm Sci, 562 Nanatsuka, Shobara, Hiroshima 7270023, Japan.	hkonishi@pu-hiroshima.ac.jp	Taniguchi, Hisaaki/I-9171-2012		Ministry of Education, Culture, Sports, Science and Technology, Japan; Prefectural University of Hiroshima	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Prefectural University of Hiroshima	This work was supported in part by Grants-in-Aid for Scientific Research and by the Knowledge Cluster Initiative from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by basic research grants from the Prefectural University of Hiroshima.	Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; CASE RD, 1994, J BIOL CHEM, V269, P10467; Chang YZ, 2002, CIRC RES, V91, P390, DOI 10.1161/01.RES.0000033524.92083.64; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Claudio JO, 2002, BLOOD, V100, P2175, DOI 10.1182/blood-2002-01-0008; da Silva FP, 2008, TRENDS IMMUNOL, V29, P366, DOI 10.1016/j.it.2008.05.001; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Frigola J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e28; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; HONEGGER A, 1988, EMBO J, V7, P3045, DOI 10.1002/j.1460-2075.1988.tb03169.x; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Konishi H, 2006, J BIOL CHEM, V281, P28919, DOI 10.1074/jbc.M605693200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lewitzky M, 2001, ONCOGENE, V20, P1052, DOI 10.1038/sj.onc.1204202; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Maroun CR, 1999, J BIOL CHEM, V274, P31719, DOI 10.1074/jbc.274.44.31719; Mayer BJ, 2001, J CELL SCI, V114, P1253; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; NISHIDA K, 2003, CANCER SCI, V27, P4; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sano E, 2008, BBA-MOL CELL RES, V1783, P1036, DOI 10.1016/j.bbamcr.2007.12.009; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Tashiro K, 2006, J BIOL CHEM, V281, P24612, DOI 10.1074/jbc.M604184200; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; WHITE MF, 2002, ENDOCRINOL METAB, V283, pE413; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	36	34	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20206	20214		10.1074/jbc.M109.021139	http://dx.doi.org/10.1074/jbc.M109.021139			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19509291	hybrid, Green Published			2022-12-27	WOS:000268097400048
J	van der Veen, JN; van Dijk, TH; Vrins, CLJ; van Meer, H; Havinga, R; Bijsterveld, K; Tietge, UJF; Groen, AK; Kuipers, F				van der Veen, Jelske N.; van Dijk, Theo H.; Vrins, Carlos L. J.; van Meer, Hester; Havinga, Rick; Bijsterveld, Klaas; Tietge, Uwe J. F.; Groen, Albert K.; Kuipers, Folkert			Activation of the Liver X Receptor Stimulates Trans-intestinal Excretion of Plasma Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTOPOMER DISTRIBUTION ANALYSIS; HIGH-DENSITY-LIPOPROTEIN; NEUTRAL STEROL LOSS; SCAVENGER RECEPTOR; MICE LACKING; RATIO METHOD; ABSORPTION; SECRETION; METABOLISM; SITOSTEROLEMIA	Recent studies have indicated that direct intestinal secretion of plasma cholesterol significantly contributes to fecal neutral sterol loss in mice. The physiological relevance of this novel route, which represents a part of the reverse cholesterol transport pathway, has not been directly established in vivo as yet. We have developed a method to quantify the fractional and absolute contributions of several cholesterol fluxes to total fecal neutral sterol loss in vivo in mice, by assessing the kinetics of orally and intravenously administered stable isotopically labeled cholesterol combined with an isotopic approach to assess the fate of de novo synthesized cholesterol. Our results show that trans-intestinal cholesterol excretion significantly contributes to removal of blood-derived free cholesterol in C57B16/J mice (33% of 231 mu mol/kg/day) and that pharmacological activation of LXR with T0901317 strongly stimulates this pathway (63% of 706 mu mol/kg/day). Trans-intestinal cholesterol excretion is impaired in mice lacking Abcg5 (-4%), suggesting that the cholesterol transporting Abcg5/Abcg8 heterodimer is involved in this pathway. Our data demonstrate that intestinal excretion represents a quantitatively important route for fecal removal of neutral sterols independent of biliary secretion in mice. This pathway is sensitive to pharmacological activation of the LXR system. These data support the concept that the intestine substantially contributes to reverse cholesterol transport.	[Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9713 GZ Groningen, Netherlands; [Vrins, Carlos L. J.] Univ Amsterdam, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; University of Amsterdam	Kuipers, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, Dept Pediat, Rm Y2145,CMC 4,Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	f.kuipers@med.umcg.nl		Kuipers, Folkert/0000-0003-2518-737X	Netherlands Organization for Scientific Research [912-02-063]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Grant 912-02-063 from the Netherlands Organization for Scientific Research.	ARCA M, 1983, J LIPID RES, V24, P332; Bandsma RHJ, 1998, BIOCHEM J, V329, P699, DOI 10.1042/bj3290699; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORGSTROM B, 1968, J LIPID RES, V9, P473; Bosner MS, 1999, J LIPID RES, V40, P302; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Cai SF, 2001, J LIPID RES, V42, P902; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; FEREZOU J, 1981, DIGESTION, V21, P232, DOI 10.1159/000198568; FIELDING CJ, 1995, J LIPID RES, V36, P211; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Groen AK, 2001, J CLIN INVEST, V108, P843, DOI 10.1172/JCI12473; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; HERZ J, 1995, P NATL ACAD SCI USA, V92, P4611, DOI 10.1073/pnas.92.10.4611; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jolley CD, 1998, J LIPID RES, V39, P2143; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; KUKSIS A, 1986, J CHROMATOGR, V381, P1, DOI 10.1016/S0378-4347(00)83559-8; Narita K, 2005, FASEB J, V19, P1558, DOI 10.1096/fj.04-2714fje; NEESE RA, 1993, AM J PHYSIOL, V264, pE136, DOI 10.1152/ajpendo.1993.264.1.E136; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Plosch T, 2004, GASTROENTEROLOGY, V126, P290, DOI 10.1053/j.gastro.2003.10.074; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; REDGRAVE TG, 1987, BIOCHIM BIOPHYS ACTA, V921, P154, DOI 10.1016/0005-2760(87)90182-2; REDGRAVE TG, 1985, BIOCHIM BIOPHYS ACTA, V835, P104, DOI 10.1016/0005-2760(85)90036-0; RENSEN PCN, 1995, NAT MED, V1, P221, DOI 10.1038/nm0395-221; Rensen PCN, 1997, J LIPID RES, V38, P1070; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; TURLEY SD, 1994, J LIPID RES, V35, P328; van der Velde AE, 2008, AM J PHYSIOL-GASTR L, V295, pG203, DOI 10.1152/ajpgi.90231.2008; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; ZILVERSMIT DB, 1974, J LIPID RES, V15, P465	41	162	164	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19211	19219		10.1074/jbc.M109.014860	http://dx.doi.org/10.1074/jbc.M109.014860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19416968	hybrid, Green Published			2022-12-27	WOS:000267908300011
J	Cha-Molstad, H; Saxena, G; Chen, JQ; Shalev, A				Cha-Molstad, Hyunjoo; Saxena, Geetu; Chen, Junqin; Shalev, Anath			Glucose-stimulated Expression of Txnip Is Mediated by Carbohydrate Response Element-binding Protein, p300, and Histone H4 Acetylation in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-INTERACTING PROTEIN; TRANSCRIPTION FACTOR; ORDERED RECRUITMENT; MICROARRAY ANALYSIS; GENE-TRANSCRIPTION; APOPTOSIS; MLX; CHREBP; MONDOA; COACTIVATOR	Recently, we identified Txnip (thioredoxin-interacting protein) as a mediator of glucotoxic beta cell death and discovered that lack of Txnip protects against streptozotocin- and obesity-induced diabetes by preventing beta cell apoptosis and preserving endogenous beta cell mass. Txnip has therefore become an attractive target for diabetes therapy, but although we have found that txnip transcription is highly induced by glucose through a unique carbohydrate response element, the factors controlling this effect have remained unknown. Using transient transfection experiments, we now show that overexpression of the carbohydrate response element-binding protein (ChREBP) transactivates the txnip promoter, whereas ChREBP knockdown by small interfering RNA completely blunts glucose-induced txnip transcription. Moreover, chromatin immunoprecipitation demonstrated that glucose leads to a dose- and time-dependent recruitment of ChREBP to the txnip promoter in vivo in INS-1 beta cells as well as human islets. Furthermore, we found that the co-activator and histone acetyltransferase p300 co-immunoprecipitates with ChREBP and also binds to the txnip promoter in response to glucose. Interestingly, this is associated with specific acetylation of histone H4 and recruitment of RNA polymerase II as measured by chromatin immunoprecipitation. Thus, with this study we have identified ChREBP as the transcription factor that mediates glucose-induced txnip expression in human islets and INS-1 beta cells and have characterized the chromatin modification associated with glucose-induced txnip transcription. In addition, the results reveal for the first time that ChREBP interacts with p300. This may explain how ChREBP induces H4 acetylation and sheds new light on glucose-mediated regulation of chromatin structure and transcription.	[Cha-Molstad, Hyunjoo; Saxena, Geetu; Chen, Junqin; Shalev, Anath] Univ Wisconsin, Dept Med, Madison, WI 53792 USA; [Cha-Molstad, Hyunjoo; Saxena, Geetu; Chen, Junqin; Shalev, Anath] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Shalev, A (corresponding author), Univ Wisconsin, Dept Med, H4-526 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.	as7@medicine.wisc.edu			National Institutes of Health [R01DK-078752, R21HL-089205]; American Diabetes Association [7-07-CD-22]; Juvenile Diabetes Research Foundation [1-2007-790]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant R01DK-078752 and National Institutes of Health, NHLBI, Grant R21HL-089205. This work was also supported by American Diabetes Association Grant 7-07-CD-22 and Juvenile Diabetes Research Foundation Grant 1-2007-790.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Breen GAM, 1999, BBA-GEN SUBJECTS, V1428, P169, DOI 10.1016/S0304-4165(99)00061-6; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Eckert DT, 2008, BIOCHEM BIOPH RES CO, V372, P131, DOI 10.1016/j.bbrc.2008.05.002; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Eizirik DL, 2003, ANN NY ACAD SCI, V1005, P55, DOI 10.1196/annals.1288.007; Espinoza CR, 2005, J IMMUNOL, V175, P6668, DOI 10.4049/jimmunol.175.10.6668; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kaur H, 2006, DIABETES, V55, P3104, DOI 10.2337/db06-0519; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kee BL, 1996, J BIOL CHEM, V271, P2373, DOI 10.1074/jbc.271.5.2373; Kim MY, 2001, EMBO J, V20, P6084, DOI 10.1093/emboj/20.21.6084; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lan H, 2003, DIABETES, V52, P688, DOI 10.2337/diabetes.52.3.688; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2007, NUCLEIC ACIDS RES, V35, P35, DOI 10.1093/nar/gkl987; Meroni G, 2000, ONCOGENE, V19, P3266, DOI 10.1038/sj.onc.1203634; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; Saitoh T, 2001, J NEUROCHEM, V78, P1267, DOI 10.1046/j.1471-4159.2001.00505.x; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	45	162	168	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16898	16905		10.1074/jbc.M109.010504	http://dx.doi.org/10.1074/jbc.M109.010504			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19411249	hybrid, Green Published			2022-12-27	WOS:000266962400026
J	Charbonneau, ME; Janvore, J; Mourez, M				Charbonneau, Marie-Eve; Janvore, Julie; Mourez, Michael			Autoprocessing of the Escherichia coli AIDA-I Autotransporter A NEW MECHANISM INVOLVING ACIDIC RESIDUES IN THE JUNCTION REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZAE HAP AUTOTRANSPORTER; DIFFUSE ADHERENCE; SERINE-PROTEASE; NEISSERIA-MENINGITIDIS; BACTERIAL AUTOTRANSPORTER; BARTONELLA-HENSELAE; CRYSTAL-STRUCTURE; PASSENGER DOMAIN; BETA-HELIX; ADHESIN	The cleavage of the autotransporter adhesin involved in diffuse adherence (AIDA-I) of Escherichia coli yields a membrane-embedded fragment, AIDAc, and an extracellular fragment, the mature AIDA-I adhesin. The latter remains noncovalently associated with AIDAc but can be released by heat treatment. In this study we determined the mechanism of AIDA-I cleavage. We showed that AIDA-I processing is an autocatalytic event by monitoring the in vitro cleavage of an uncleaved mutant protein isolated from inclusion bodies. Furthermore, by following changes in circular dichroism spectra and protease resistance of the renaturated protein, we showed that the cleavage of the protein is correlated with folding. With site-directed deletions, we showed that the catalytic activity of the protein lies in a region encompassing amino acids between Ala-667 and Thr-953, which includes the conserved junction domain of some auto-transporters. With site-directed point mutations, we also found that Asp-878 and Glu-897 are involved in the processing of AIDA-I and that a mutation preserving the acidic side chain of Asp-878 was tolerated, giving evidence that this carboxylic acid group is directly involved in catalysis. Last, we confirmed that cleavage of AIDA-I is intramolecular. Our results unveil a new mechanism of auto-processing in the autotransporter family.	[Charbonneau, Marie-Eve; Janvore, Julie; Mourez, Michael] Univ Montreal, Canada Res Chair Bacterial Anim Dis, Fac Med Vet, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal	Mourez, M (corresponding author), Univ Montreal, Canada Res Chair Bacterial Anim Dis, Fac Med Vet, 3200 Sicotte, St Hyacinthe, PQ J2S 7C6, Canada.	m.mourez@umontreal.ca			Groupe de Recherche et dEtudes sur les Maladies Infectieuses du Porc (GREMIP); Canadian Institutes of Health Research [84578]; Canada Research Chair program and the Canada Foundation for Innovation [201414]; Natural Sciences and and Engineering Research Council of Canada [85297596]	Groupe de Recherche et dEtudes sur les Maladies Infectieuses du Porc (GREMIP); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program and the Canada Foundation for Innovation; Natural Sciences and and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by financial contributions from the Groupe de Recherche et dEtudes sur les Maladies Infectieuses du Porc (GREMIP), Canadian Institutes of Health Research Grant 84578, Canada Research Chair program and the Canada Foundation for Innovation Grant 201414, and a graduate fellowship from the Natural Sciences and and Engineering Research Council of Canada (Grant 85297596, to M.-E.C.).	Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Benz I, 2001, MOL MICROBIOL, V40, P1403, DOI 10.1046/j.1365-2958.2001.02487.x; BENZ I, 1989, INFECT IMMUN, V57, P1506, DOI 10.1128/IAI.57.5.1506-1511.1989; BENZ I, 1992, MOL MICROBIOL, V6, P1539, DOI 10.1111/j.1365-2958.1992.tb00875.x; Chapman TA, 2006, APPL ENVIRON MICROB, V72, P4782, DOI 10.1128/AEM.02885-05; Charbonneau ME, 2008, RES MICROBIOL, V159, P537, DOI 10.1016/j.resmic.2008.06.009; Charbonneau ME, 2007, J BACTERIOL, V189, P9020, DOI 10.1128/JB.01238-07; Charbonneau ME, 2007, J BACTERIOL, V189, P8880, DOI 10.1128/JB.00969-07; Charbonneau ME, 2006, J BACTERIOL, V188, P8504, DOI 10.1128/JB.00864-06; Coutte L, 2003, MOL MICROBIOL, V49, P529, DOI 10.1046/j.1365-2958.2003.03573.x; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; dHauteville H, 1996, INFECT IMMUN, V64, P511, DOI 10.1128/IAI.64.2.511-517.1996; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Fink DL, 2003, J BACTERIOL, V185, P1608, DOI 10.1128/JB.185.5.1608-1615.2003; Fink DL, 2001, J BIOL CHEM, V276, P39492, DOI 10.1074/jbc.M106913200; Girard V, 2006, RES MICROBIOL, V157, P407, DOI 10.1016/j.resmic.2006.02.001; Henderson IR, 1999, J BACTERIOL, V181, P2132, DOI 10.1128/JB.181.7.2132-2141.1999; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Hritonenko V, 2007, MOL MEMBR BIOL, V24, P395, DOI 10.1080/09687680701443822; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Klemm P, 2004, MOL MICROBIOL, V51, P283, DOI 10.1046/j.1365-2958.2003.03833.x; Klemm P, 2006, INT J MED MICROBIOL, V296, P187, DOI 10.1016/j.ijmm.2005.10.002; Litwin CM, 2007, INFECT IMMUN, V75, P5255, DOI 10.1128/IAI.00533-07; Litwin CM, 2005, INFECT IMMUN, V73, P4205, DOI 10.1128/IAI.73.7.4205-4213.2005; Mogensen JE, 2005, BIOCHEMISTRY-US, V44, P4533, DOI 10.1021/bi0475121; Navarro-Garcia F, 2001, INFECT IMMUN, V69, P1053, DOI 10.1128/IAI.69.2.1053-1060.2001; Nguyen VQ, 2001, INFECT IMMUN, V69, P543, DOI 10.1128/IAI.69.1.543-546.2001; Niewerth U, 2001, CLIN DIAGN LAB IMMUN, V8, P143, DOI 10.1128/CDLI.8.1.143-149.2001; Ohnishi Y, 1997, J BIOCHEM, V121, P902; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Serruto D, 2003, MOL MICROBIOL, V48, P323, DOI 10.1046/j.1365-2958.2003.03420.x; Shere KD, 1997, MOL MICROBIOL, V25, P451, DOI 10.1046/j.1365-2958.1997.4681827.x; Sherlock O, 2004, J BACTERIOL, V186, P8058, DOI 10.1128/JB.186.23.8058-8065.2004; Suhr M, 1996, MOL MICROBIOL, V22, P31, DOI 10.1111/j.1365-2958.1996.tb02653.x; Turner DPJ, 2006, INFECT IMMUN, V74, P2957, DOI 10.1128/IAI.74.5.2957-2964.2006; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; van Ulsen P, 2006, MICROBES INFECT, V8, P2088, DOI 10.1016/j.micinf.2006.03.007; Vandahl BB, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-36; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018	48	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17340	17351		10.1074/jbc.M109.010108	http://dx.doi.org/10.1074/jbc.M109.010108			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19398552	hybrid, Green Published			2022-12-27	WOS:000266962400069
J	Lu, SP; Kato, M; Lin, SJ				Lu, Shu-Ping; Kato, Michiko; Lin, Su-Ju			Assimilation of Endogenous Nicotinamide Riboside Is Essential for Calorie Restriction-mediated Life Span Extension in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE; NMN ADENYLYLTRANSFERASE; INSULIN-SECRETION; NAD(+) METABOLISM; GENE DISRUPTION; LONGEVITY; MONONUCLEOTIDE; IDENTIFICATION; SALVAGE; SIR2	NAD(+) (nicotinamide adenine dinucleotide) is an essential cofactor involved in various biological processes including calorie restriction-mediated life span extension. Administration of nicotinamide riboside (NmR) has been shown to ameliorate deficiencies related to aberrant NAD(+) metabolism in both yeast and mammalian cells. However, the biological role of endogenous NmR remains unclear. Here we demonstrate that salvaging endogenous NmR is an integral part of NAD(+) metabolism. A balanced NmR salvage cycle is essential for calorie restriction-induced life span extension and stress resistance in yeast. Our results also suggest that partitioning of the pyridine nucleotide flux between the classical salvage cycle and the NmR salvage branch might be modulated by the NAD(+)-dependent Sir2 deacetylase. Furthermore, two novel deamidation steps leading to nicotinic acid mononucleotide and nicotinic acid riboside production are also uncovered that further underscore the complexity and flexibility of NAD(+) metabolism. In addition, utilization of extracellular nicotinamide mononucleotide requires prior conversion to NmR mediated by a periplasmic phosphatase Pho5. Conversion to NmR may thus represent a strategy for the transport and assimilation of large nonpermeable NAD(+) precursors. Together, our studies provide a molecular basis for how NAD(+) homeostasis factors confer metabolic flexibility.	[Lu, Shu-Ping; Kato, Michiko; Lin, Su-Ju] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA	University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Dept Microbiol, 323 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu			National Institute on Aging; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R01AG024351] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging and the Ellison Medical Foundation.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Brachmann CB, 1998, YEAST, V14, P115; Burke D., 2000, METHODS YEAST GENETI, P171; Chen P, 2007, ANAL BIOANAL CHEM, V387, P2441, DOI 10.1007/s00216-006-0615-y; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Dilova I, 2007, CELL MOL LIFE SCI, V64, P752, DOI 10.1007/s00018-007-6381-y; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; Emanuelli M, 2003, PROTEIN EXPRES PURIF, V27, P357, DOI 10.1016/S1046-5928(02)00645-9; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Grose JH, 2005, J BACTERIOL, V187, P4521, DOI 10.1128/JB.187.13.4521-4530.2005; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Kemmer G, 2001, J BACTERIOL, V183, P3974, DOI 10.1128/JB.183.13.3974-3981.2001; Kennedy EJ, 2005, EUKARYOT CELL, V4, P1892, DOI 10.1128/EC.4.11.1892-1901.2005; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Ma B, 2007, MOL MICROBIOL, V66, P14, DOI 10.1111/j.1365-2958.2007.05886.x; McClure JM, 2008, GENETICS, V180, P797, DOI 10.1534/genetics.108.091090; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Roth GS, 2001, ANN NY ACAD SCI, V928, P305; Sandmeier JJ, 2002, GENETICS, V160, P877; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schmidt-Brauns J, 2001, INT J MED MICROBIOL, V291, P219, DOI 10.1078/1438-4221-00122; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Spronck JC, 2007, NUTR CANCER, V57, P88, DOI 10.1080/01635580701268337; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; WEINDRUCH W, 1998, RETARDATION AGING DI; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c	50	52	60	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17110	17119		10.1074/jbc.M109.004010	http://dx.doi.org/10.1074/jbc.M109.004010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19416965	Green Published, hybrid			2022-12-27	WOS:000266962400049
J	Monastyrskaya, K; Babiychuk, EB; Hostettler, A; Wood, P; Grewal, T; Draeger, A				Monastyrskaya, Katia; Babiychuk, Eduard B.; Hostettler, Andrea; Wood, Peta; Grewal, Thomas; Draeger, Annette			Plasma Membrane-associated Annexin A6 Reduces Ca2+ Entry by Stabilizing the Cortical Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; LIPID RAFTS; H-RAS; STORE; VI; ACTIVATION; STIM1; INHIBITION; DYNAMICS; BINDING	The annexins are a family of Ca2+- and phospholipid-binding proteins, which interact with membranes upon increase of [Ca2+](i) or during cytoplasmic acidification. The transient nature of the membrane binding of annexins complicates the study of their influence on intracellular processes. To address the function of annexins at the plasma membrane ( PM), we fused fluorescent protein-tagged annexins A6, A1, and A2 with H- and K-Ras membrane anchors. Stable PM localization of membrane-anchored annexin A6 significantly decreased the store-operated Ca2+ entry (SOCE), but did not influence the rates of Ca2+ extrusion. This attenuation was specific for annexin A6 because PM-anchored annexins A1 and A2 did not alter SOCE. Membrane association of annexin A6 was necessary for a measurable decrease of SOCE, because cytoplasmic annexin A6 had no effect on Ca2+ entry as long as [Ca2+](i) was below the threshold of annexin A6-membrane translocation. However, when[Ca2+](i) reached the levels necessary for the Ca2+-dependent PM association of ectopically expressed wild-type annexin A6, SOCE was also inhibited. Conversely, knockdown of the endogenous annexin A6 in HEK293 cells resulted in an elevated Ca2+ entry. Constitutive PM localization of annexin A6 caused a rearrangement and accumulation of F-actin at the PM, indicating a stabilized cortical cytoskeleton. Consistent with these findings, disruption of the actin cytoskeleton using latrunculin A abolished the inhibitory effect of PM-anchored annexin A6 on SOCE. In agreement with the inhibitory effect of annexin A6 on SOCE, constitutive PM localization of annexin A6 inhibited cell proliferation. Taken together, our results implicate annexin A6 in the actin-dependent regulation of Ca2+ entry, with consequences for the rates of cell proliferation.	[Monastyrskaya, Katia; Draeger, Annette] Univ Bern, Inst Anat, Dept Cell Biol, CH-3000 Bern 9, Switzerland; [Wood, Peta; Grewal, Thomas] Univ Sydney, Dept Pharmaceut Chem, Fac Pharm, Sydney, NSW 2006, Australia	University of Bern; University of Sydney	Monastyrskaya, K (corresponding author), Univ Bern, Inst Anat, Dept Cell Biol, CH-3000 Bern 9, Switzerland.	monastyk@ana.unibe.ch	Babiychuk, Eduard/AAV-7223-2021	Grewal, Thomas/0000-0002-7937-8887; Monastyrskaya, Katia/0000-0003-2042-1139; Babiychuk, Eduard/0000-0003-1786-0085	Swiss National Science Foundation [320000-111778, 3100A0-121980/1]; National Research Programme NRP 53 [405340-104679/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Research Programme NRP 53	This work was supported in part by the Swiss National Science Foundation (SNF Grants 320000-111778 to K. M. and 3100A0-121980/1 to E. B.) and the National Research Programme NRP 53 "Musculoskeletal Health-Chronic Pain" (Grant 405340-104679/1 to A. D.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Babiychuk EB, 1999, J BIOL CHEM, V274, P35191, DOI 10.1074/jbc.274.49.35191; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Babiychuk EB, 2002, BBA-PROTEINS PROTEOM, V1600, P154, DOI 10.1016/S1570-9639(02)00456-9; Babiychuk EB, 2008, TRAFFIC, V9, P1757, DOI 10.1111/j.1600-0854.2008.00800.x; Babiychuk EB, 2006, BIOCHEM J, V397, P407, DOI 10.1042/BJ20060056; Camors E, 2006, J MOL CELL CARDIOL, V40, P47, DOI 10.1016/j.yjmcc.2005.08.009; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; DIAZMUNOZ M, 1990, J BIOL CHEM, V265, P15894; Draeger A, 2005, BIOCHEM J, V387, P309, DOI 10.1042/BJ20041363; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Fleet A, 1999, BIOCHEM BIOPH RES CO, V260, P540, DOI 10.1006/bbrc.1999.0915; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Golczak M, 2001, FEBS LETT, V496, P49, DOI 10.1016/S0014-5793(01)02402-4; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; HAMBLIN AMG, 1996, AM J PHYSIOL, V270, pH1091; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Hawkins TE, 2000, CELL BIOCHEM BIOPHYS, V33, P275, DOI 10.1385/CBB:33:3:275; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Jardin I, 2008, J BIOL CHEM, V283, P25296, DOI 10.1074/jbc.M802904200; Jardin I, 2008, CHANNELS, V2, P401, DOI 10.4161/chan.2.6.7055; KAETZEL MA, 1994, J BIOL CHEM, V269, P5297; Kim YE, 2005, J BIOL CHEM, V280, P32398, DOI 10.1074/jbc.M505017200; Kohler G, 1997, BIOCHEMISTRY-US, V36, P8189, DOI 10.1021/bi9703960; Locate S, 2008, CELL BIOL INT, V32, P1388, DOI 10.1016/j.cellbi.2008.08.009; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Monastyrskaya K, 2008, BIOCHEM J, V409, P65, DOI 10.1042/BJ20071116; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Morales S, 2005, CELL SIGNAL, V17, P635, DOI 10.1016/j.cellsig.2004.10.002; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Naciff JM, 1996, AM J PHYSIOL-CELL PH, V271, pC2004; Ong HL, 2007, J BIOL CHEM, V282, P12176, DOI 10.1074/jbc.M609435200; Parekh AB, 2006, PFLUG ARCH EUR J PHY, V453, P303, DOI 10.1007/s00424-006-0089-y; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Prior IA, 2001, J CELL SCI, V114, P1603; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Song GJ, 2002, FASEB J, V16, P622, DOI 10.1096/fj.01-0892fje; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; de Muga SV, 2009, ONCOGENE, V28, P363, DOI 10.1038/onc.2008.386; Zaidi A, 1998, NEUROBIOL AGING, V19, P487, DOI 10.1016/S0197-4580(98)00078-5; Zhu H, 2008, J PHARMACOL SCI, V106, P287, DOI 10.1254/jphs.FP0071192; Zylinska L, 2000, ACTA BIOCHIM POL, V47, P529	58	54	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17227	17242		10.1074/jbc.M109.004457	http://dx.doi.org/10.1074/jbc.M109.004457			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386597	Green Published, hybrid			2022-12-27	WOS:000266962400060
J	Yang, T; Bar-Peled, L; Gebhart, L; Lee, SG; Bar-Peled, M				Yang, Ting; Bar-Peled, Liron; Gebhart, Lindsay; Lee, Sung G.; Bar-Peled, Maor			Identification of Galacturonic Acid-1-phosphate Kinase, a New Member of the GHMP Kinase Superfamily in Plants, and Comparison with Galactose-1-phosphate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-SUGAR PYROPHOSPHORYLASE; D-GLUCURONATE 4-EPIMERASE; MOLECULAR-STRUCTURE; SUBSTRATE-SPECIFICITY; PYROCOCCUS-FURIOSUS; FUNCTIONAL CLONING; PHASEOLUS-AUREUS; GENE FAMILY; ARABIDOPSIS; GALACTOKINASE	The process of salvaging sugars released from extracellular matrix, during plant cell growth and development, is not well understood, and many molecular components remain to be identified. Here we identify and functionally characterize a unique Arabidopsis gene encoding an alpha-D-galacturonic acid-1-phosphate kinase (GalAK) and compare it with galactokinase. The GalAK gene appeared to be expressed in all tissues implicating that glycose salvage is a common catabolic pathway. GalAK catalyzes the ATP-dependent conversion of alpha-D-galacturonic acid (D-GalA) to alpha-D-galacturonic acid-1-phosphate (GalA-1-P). This sugar phosphate is then converted to UDP-GalA by a UDP-sugar pyrophosphorylase as determined by a real-time H-1 NMR-based assay. GalAK is a distinct member of the GHMP kinase family that includes galactokinase (G), homoserine kinase (H), mevalonate kinase (M), and phosphomevalonate kinase (P). Although these kinases have conserved motifs for sugar binding, nucleotide binding, and catalysis, they do have subtle difference. For example, GalAK has an additional domain near the sugar-binding motif. Using site-directed mutagenesis we established that mutation in A368S reduces phosphorylation activity by 40%; A41E mutation completely abolishes GalAK activity; Y250F alters sugar specificity and allows phosphorylation of D-glucuronic acid, the 4-epimer of GalA. Unlike many plant genes that undergo duplication, GalAK occurs as a single copy gene in vascular plants. We suggest that GalAK generates GalA-1-P from the salvaged GalA that is released during growth-dependent cell wall restructuring, or from storage tissue. The GalA-1-P itself is then available for use in the formation of UDP-GalA required for glycan synthesis.	Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), CCRC 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu			National Science Foundation [IOB-0453664]; U. S. Dept. of Agriculture [2002-3531812620]; BioEnergy Science Center; DOE Office of Science	National Science Foundation(National Science Foundation (NSF)); U. S. Dept. of Agriculture(United States Department of Agriculture (USDA)); BioEnergy Science Center; DOE Office of Science(United States Department of Energy (DOE))	This work was supported by National Science Foundation Grant IOB-0453664 (to M. B.-P.), by U. S. Dept. of Agriculture Grant 2002-3531812620 (to M. B.-P.), and by the BioEnergy Science Center, which is supported by the Office of Biological and Environmental Research in the DOE Office of Science.	ANGYAL SJ, 1988, CARBOHYD RES, V174, P121, DOI 10.1016/0008-6215(88)85086-9; Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; Bar-Peled C., 2008, BIOMASS RECALCITRANC, V94-187, P94, DOI DOI 10.1002/9781444305418.CH5; BARAKATE A, 1993, J MOL BIOL, V229, P797, DOI 10.1006/jmbi.1993.1084; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; DUBALD M, 1993, PLANT J, V4, P781, DOI 10.1046/j.1365-313X.1993.04050781.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gu XG, 2004, PLANT PHYSIOL, V136, P4256, DOI 10.1104/pp.104.052365; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; Hoffmeister D, 2004, CHEMBIOCHEM, V5, P989, DOI 10.1002/cbic.200400003; Holmes-Davis R, 2005, PROTEOMICS, V5, P4864, DOI 10.1002/pmic.200402011; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kaplan CP, 1997, PLANT MOL BIOL, V34, P497, DOI 10.1023/A:1005816104743; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; Kotake T, 2008, J BIOL CHEM, V283, P8125, DOI 10.1074/jbc.M710078200; Litterer LA, 2006, PLANT PHYSIOL BIOCH, V44, P171, DOI 10.1016/j.plaphy.2006.04.004; LOEWUS FA, 1961, ANN NY ACAD SCI, V92, P57, DOI 10.1111/j.1749-6632.1961.tb46106.x; Molhoj M, 2004, PLANT PHYSIOL, V135, P1221, DOI 10.1104/pp.104.043745; NEUFELD EF, 1961, J BIOL CHEM, V236, P3102; NEUFELD EF, 1959, ARCH BIOCHEM BIOPHYS, V83, P96, DOI 10.1016/0003-9861(59)90014-1; PRESSEY R, 1977, PLANT PHYSIOL, V60, P548, DOI 10.1104/pp.60.4.548; PRESSEY R, 1984, EUR J BIOCHEM, V144, P217, DOI 10.1111/j.1432-1033.1984.tb08452.x; Ren CW, 2000, PLANT PHYSIOL, V124, P231, DOI 10.1104/pp.124.1.231; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Sherson S, 1999, PLANT MOL BIOL, V39, P1003, DOI 10.1023/A:1006181908753; Sitrit Y, 1999, PLANT PHYSIOL, V121, P419, DOI 10.1104/pp.121.2.419; Sterling JD, 2001, PLANT PHYSIOL, V127, P360, DOI 10.1104/pp.127.1.360; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Thoden JB, 2005, J BIOL CHEM, V280, P9662, DOI 10.1074/jbc.M412916200; Thoden JB, 2003, J BIOL CHEM, V278, P33305, DOI 10.1074/jbc.M304789200; Timson David J, 2003, BMC Biochem, V4, P16, DOI 10.1186/1471-2091-4-16; Usadel B, 2004, FEBS LETT, V569, P327, DOI 10.1016/j.febslet.2004.06.005; Verhees CH, 2002, BIOCHEM J, V366, P121, DOI 10.1042/BJ20011597; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131; YOUNG LCT, 1966, NATURE, V209, P530, DOI 10.1038/209530a0; [No title captured]	40	43	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21526	21535		10.1074/jbc.M109.014761	http://dx.doi.org/10.1074/jbc.M109.014761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509290	hybrid, Green Published			2022-12-27	WOS:000268564400047
J	Ittner, LM; Ke, YD; Gotz, J				Ittner, Lars M.; Ke, Yazi D.; Goetz, Juergen			Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL-TRANSPORT; SCAFFOLD PROTEIN; NEUROFIBRILLARY TANGLES; KINESIN; JNK; BINDING; BRAIN; OVEREXPRESSION; MICROTUBULES; AXONOPATHY	In Alzheimer disease (AD) and frontotemporal dementia the microtubule-associated protein Tau becomes progressively hyperphosphorylated, eventually forming aggregates. However, how Tau dysfunction is associated with functional impairment is only partly understood, especially at early stages when Tau is mislocalized but has not yet formed aggregates. Impaired axonal transport has been proposed as a potential pathomechanism, based on cellular Tau models and Tau transgenic mice. We recently reported K369I mutant Tau transgenic K3 mice with axonal transport defects that suggested a cargo-selective impairment of kinesin-driven anterograde transport by Tau. Here, we show that kinesin motor complex formation is disturbed in the K3 mice. We show that under pathological conditions hyperphosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1), which is associated with the kinesin motor protein complex. As a result, transport of JIP1 into the axon is impaired, causing JIP1 to accumulate in the cell body. Because we found trapping of JIP1 and a pathological Tau/JIP1 interaction also in AD brain, this may have pathomechanistic implications in diseases with a Tau pathology. This is supported by JIP1 sequestration in the cell body of Tau-transfected primary neuronal cultures. The pathological Tau/JIP1 interaction requires phosphorylation of Tau, and Tau competes with the physiological binding of JIP1 to kinesin light chain. Because JIP1 is involved in regulating cargo binding to kinesin motors, our findings may, at least in part, explain how hyperphosphorylated Tau mediates impaired axonal transport in AD and frontotemporal dementia.	[Ittner, Lars M.; Ke, Yazi D.] Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Camperdown, NSW 2050, Australia	University of Sydney	Ittner, LM (corresponding author), Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, 100 Mallett St, Camperdown, NSW 2050, Australia.	littner@med.usyd.edu.au; jgoetz@med.usyd.edu.au	Ke, Yazi/ABC-3052-2020; Götz, Jürgen/C-2448-2014	Ke, Yazi/0000-0002-1423-0451; Götz, Jürgen/0000-0001-8501-7896; Ittner, Lars/0000-0001-6738-3825	University of Sydney; National Health and Medical Research Council (NHMRC); Judith Jane Mason and Harold Stannett Williams Memorial Foundation; Australian Research Council (ARC); New South Wales Government; Ministry for Science and Medical Research; ARC; Deutsche Forschungsgemeinschaft	University of Sydney(University of Sydney); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Judith Jane Mason and Harold Stannett Williams Memorial Foundation; Australian Research Council (ARC)(Australian Research Council); New South Wales Government; Ministry for Science and Medical Research; ARC(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by grants from the University of Sydney, The Medical Foundation (University of Sydney), the National Health and Medical Research Council (NHMRC), the Judith Jane Mason and Harold Stannett Williams Memorial Foundation, the Australian Research Council (ARC), and the New South Wales Government through the Ministry for Science and Medical Research (BioFirst grant) (to J.G.) and by the NHMRC, the ARC, the University of Sydney, and the Deutsche Forschungsgemeinschaft (to L. M. I.).	Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Baas PW, 2005, TRENDS CELL BIOL, V15, P183, DOI 10.1016/j.tcb.2005.02.001; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Chen F, 2004, CURR DRUG TARGETS, V5, P503, DOI 10.2174/1389450043345236; Cruts M, 2008, TRENDS GENET, V24, P186, DOI 10.1016/j.tig.2008.01.004; Cuchillo-Ibanez I, 2008, FASEB J, V22, P3186, DOI 10.1096/fj.08-109181; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; David DC, 2006, PROTEOMICS, V6, P6566, DOI 10.1002/pmic.200600634; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Gotz J, 2006, J NEUROCHEM, V98, P993, DOI 10.1111/j.1471-4159.2006.03955.x; Helbecque N, 2003, MOL PSYCHIATR, V8, P413, DOI 10.1038/sj.mp.4001344; HELBECQUE N, 2003, MOL PSYCHIATR, V8, P363, DOI DOI 10.1038/SJ.MP.4001342; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Ittner LM, 2005, BIOCHEMISTRY-US, V44, P5749, DOI 10.1021/bi048111o; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Merrick SE, 1997, J NEUROSCI, V17, P5726; Morfini G, 2007, J NEUROSCI RES, V85, P2620, DOI 10.1002/jnr.21154; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008	50	120	124	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20909	20916		10.1074/jbc.M109.014472	http://dx.doi.org/10.1074/jbc.M109.014472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19491104	hybrid, Green Published			2022-12-27	WOS:000268316100054
J	Arthur, PK; Claussen, M; Koch, S; Tarbashevich, K; Jahn, O; Pieler, T				Arthur, Patrick K.; Claussen, Maike; Koch, Susanne; Tarbashevich, Katsiaryna; Jahn, Olaf; Pieler, Tomas			Participation of Xenopus Elr-type Proteins in Vegetal mRNA Localization during Oogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; TRANSLATIONAL REPRESSION; VG1; CORTEX; IDENTIFICATION; TRANSPORT; COMPLEX; ELEMENT; ELAV; GENE	Directional transport of specific mRNAs is of primary biological relevance. In Xenopus oocytes, mRNA localization to the vegetal pole is important for germ layer formation and germ cell development. Using a biochemical approach, we identified Xenopus Elr-type proteins, homologs of the Hu/ELAV proteins, as novel components of the vegetal mRNA localization machinery. They bind specifically to the localization elements of several different vegetally localizing Xenopus mRNAs, and they are part of one RNP together with other localization proteins, such as Vg1RBP and XStaufen 1. Blocking Elr-type protein binding by either localization element mutagenesis or antisense morpholino oligonucleotide-mediated masking of their target RNA structures, as well as overexpression of wild type and mutant ElrB proteins, interferes with vegetal localization in Xenopus oocytes.	[Pieler, Tomas] Univ Gottingen, Dept Dev Biochem, Gottingen Ctr Mol Biosci, D-37077 Gottingen, Germany; [Jahn, Olaf] Max Planck Inst Expt Med, Prote Grp, D-37075 Gottingen, Germany	University of Gottingen; Max Planck Society	Pieler, T (corresponding author), Univ Gottingen, Dept Dev Biochem, Gottingen Ctr Mol Biosci, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	tpieler@gwdg.de	Arthur, Patrick Kobina/Y-6109-2018; Jahn, Olaf/AAD-8212-2020	Arthur, Patrick Kobina/0000-0002-5974-3955; Jahn, Olaf/0000-0002-3397-8924	Deutsche Forschungsgemeinschaft [SFB523]; Faculty of Medicine, Georg-August-University Gottingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Faculty of Medicine, Georg-August-University Gottingen	This work was supported by funds from the Deutsche Forschungsgemeinschaft Grant SFB523 (to T.P.) and by the research program of the Faculty of Medicine, Georg-August-University Gottingen (to M.C.).	ABE S, 1986, Memoirs of the College of Agriculture Ehime University, V31, P187; Alarcon VB, 2001, J CELL SCI, V114, P1731; Allen L, 2003, DIFFERENTIATION, V71, P311, DOI 10.1046/j.1432-0436.2003.7106003.x; Allison R, 2004, RNA, V10, P1751, DOI 10.1261/rna.7450204; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Atasoy U, 1998, J CELL SCI, V111, P3145; Atlas R, 2007, J NEUROSCI RES, V85, P173, DOI 10.1002/jnr.21099; Betley JN, 2004, CURR BIOL, V14, P219, DOI 10.1016/j.cub.2004.01.028; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chan AP, 1999, DEVELOPMENT, V126, P4943; Chang P, 2004, MOL BIOL CELL, V15, P4669, DOI 10.1091/mbc.E04-03-0265; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Chung SM, 1996, J BIOL CHEM, V271, P11518, DOI 10.1074/jbc.271.19.11518; Claussen M, 2004, DEVELOPMENT, V131, P4263, DOI 10.1242/dev.01283; Claussen M, 2004, DEV BIOL, V266, P270, DOI 10.1016/j.ydbio.2003.09.043; Colegrove-Otero LJ, 2005, MOL CELL BIOL, V25, P9028, DOI 10.1128/MCB.25.20.9028-9039.2005; Condeelis J, 2005, BIOL CELL, V97, P97; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; Czaplinski K, 2005, DEV CELL, V8, P505, DOI 10.1016/j.devcel.2005.01.012; Deshler JO, 1998, CURR BIOL, V8, P489, DOI 10.1016/S0960-9822(98)70200-3; Devaux A, 2006, FEBS LETT, V580, P4947, DOI 10.1016/j.febslet.2006.08.012; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; EVANS JP, 1991, METHOD CELL BIOL, V36, P133; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; FORRISTALL C, 1995, DEVELOPMENT, V121, P201; Git A, 2002, RNA, V8, P1319, DOI 10.1017/S135583820202705X; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Havin L, 1998, GENE DEV, V12, P1593, DOI 10.1101/gad.12.11.1593; Heasman J, 2001, DEV BIOL, V240, P377, DOI 10.1006/dbio.2001.0495; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hollemann T, 1999, ADV MOLEC BIOL, P279; Horvay K, 2006, DEV BIOL, V291, P1, DOI 10.1016/j.ydbio.2005.06.013; Hudson C, 1998, MECH DEVELOP, V73, P159, DOI 10.1016/S0925-4773(98)00047-1; Jahn O, 2006, ANAL BIOANAL CHEM, V386, P92, DOI 10.1007/s00216-006-0592-1; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; King ML, 2005, BIOL CELL, V97, P19; Kloc M, 1999, ADV MOLEC BIOL, P256; Kloc M, 2005, DEVELOPMENT, V132, P3445, DOI 10.1242/dev.01919; KLOC M, 1995, DEVELOPMENT, V121, P287; KLOC M, 1994, SCIENCE, V265, P1101, DOI 10.1126/science.7520603; Koebernick K, 2003, DEV BIOL, V260, P325, DOI 10.1016/S0012-1606(03)00242-2; Kolev NG, 2003, MOL CELL, V11, P745, DOI 10.1016/S1097-2765(03)00071-6; Kress TL, 2004, J CELL BIOL, V165, P203, DOI 10.1083/jcb.200309145; Kroll TT, 2002, DEVELOPMENT, V129, P5609, DOI 10.1242/dev.00160; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; Lewis RA, 2008, MOL CELL BIOL, V28, P678, DOI 10.1128/MCB.00999-07; Lisbin MJ, 2000, GENETICS, V155, P1789; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lustig KD, 1996, DEVELOPMENT, V122, P4001; Marnef A, 2009, INT J BIOCHEM CELL B, V41, P977, DOI 10.1016/j.biocel.2008.06.015; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Minshall N, 2004, NUCLEIC ACIDS RES, V32, P1325, DOI 10.1093/nar/gkh303; MOSQUERA L, 1993, DEVELOPMENT, V117, P377; Mowry KL, 1996, P NATL ACAD SCI USA, V93, P14608, DOI 10.1073/pnas.93.25.14608; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Pannese M, 2000, MECH DEVELOP, V90, P111, DOI 10.1016/S0925-4773(99)00228-2; REBAGLIATI MR, 1985, CELL, V42, P769, DOI 10.1016/0092-8674(85)90273-9; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Rudt F, 1996, EMBO J, V15, P1383, DOI 10.1002/j.1460-2075.1996.tb00480.x; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Stennard F, 1996, DEVELOPMENT, V122, P4179; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; White JA, 2008, J EXP ZOOL PART B, V310B, P73, DOI 10.1002/jez.b.21153; YISRAELI JK, 1988, NATURE, V336, P592, DOI 10.1038/336592a0; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; Yoon YJ, 2004, DEVELOPMENT, V131, P3035, DOI 10.1242/dev.01170; Zearfoss NR, 2004, DEV BIOL, V267, P60, DOI 10.1016/j.ydbio.2003.10.032; Zhang J, 1996, DEVELOPMENT, V122, P4119; Zhang QH, 1999, MECH DEVELOP, V88, P101, DOI 10.1016/S0925-4773(99)00162-8; Zhao WM, 2001, EMBO J, V20, P2315, DOI 10.1093/emboj/20.9.2315; Zhou Y, 2004, IUBMB LIFE, V56, P19, DOI 10.1080/15216540310001658886; Zhou Y, 1996, DEV BIOL, V179, P173, DOI 10.1006/dbio.1996.0249	79	24	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19982	19992		10.1074/jbc.M109.009928	http://dx.doi.org/10.1074/jbc.M109.009928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19458392	Green Published, hybrid			2022-12-27	WOS:000268097400025
J	Darlyuk, I; Goldman, A; Roberts, SC; Ullman, B; Rentsch, D; Zilberstein, D				Darlyuk, Ilona; Goldman, Adele; Roberts, Sigrid C.; Ullman, Buddy; Rentsch, Doris; Zilberstein, Dan			Arginine Homeostasis and Transport in the Human Pathogen Leishmania donovani	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE DELETION MUTANTS; AMINO-ACID PERMEASE; SACCHAROMYCES-CEREVISIAE; ENDOPROTEOLYTIC ACTIVATION; METABOLISM; YEAST; PROMASTIGOTES; EXPRESSION; CAT-1; AMASTIGOTES	Arginine is an essential amino acid for the human pathogen Leishmania but not to its host. Thus, the mechanism by which this protozoan parasite regulates cellular homeostasis of arginine is critical for its survival and virulence. In a previous study, we cloned and functionally characterized a high affinity arginine-specific transporter, LdAAP3, from Leishmania donovani. In this investigation, we have characterized the relationship between arginine transport via LdAAP3 and amino acid availability. Starving promastigotes for amino acids decreased the cellular level of most amino acids including arginine but also increased the abundance of both LdAAP3 mRNA and protein and up-regulated arginine transport activity. Genetic obliteration of the polyamine biosynthesis pathway for which arginine is the sole precursor caused a significant decrease in the rate of arginine transport. Cumulatively, we established that LdAAP3 expression and activity changed whenever the cellular level of arginine changed. Our findings have led to the hypothesis that L. donovani promastigotes have a signaling pathway that senses cellular concentrations of arginine and subsequently activates a mechanism that regulates LdAAP3 expression and activity. Interestingly, this response of LdAAP3 to amino acid availability in L. donovani is identical to that of the mammalian cation amino acid transporter 1. Thus, we conjecture that Leishmania mimics the host response to amino acid availability to improve virulence.	[Darlyuk, Ilona; Goldman, Adele; Zilberstein, Dan] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Roberts, Sigrid C.] Pacific Univ, Sch Pharm, Hillsboro, OR 97123 USA; [Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Rentsch, Doris] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland	Technion Israel Institute of Technology; Oregon Health & Science University; University of Bern	Zilberstein, D (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	danz@tx.technion.ac.il		Rentsch, Doris/0000-0003-4313-7683	NIAID [AI 41622]; The Academy of Sciences and Humanities [490/02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI041622, R01AI041622] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); The Academy of Sciences and Humanities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 41622 from NIAID. This work was also supported by Grant 490/02 from The Israel Science Foundation founded by The Academy of Sciences and Humanities.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Akerman M, 2004, BIOCHEM BIOPH RES CO, V325, P353, DOI 10.1016/j.bbrc.2004.09.212; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Aulak KS, 1999, J BIOL CHEM, V274, P30424, DOI 10.1074/jbc.274.43.30424; Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Chattopadhyay S, 2002, EUKARYOT CELL, V1, P606, DOI 10.1128/EC.1.4.606-612.2002; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; FEKKES D, 1995, J CHROMATOGR B, V669, P177, DOI 10.1016/0378-4347(95)00111-U; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Jiang YQ, 1999, J BIOL CHEM, V274, P3781, DOI 10.1074/jbc.274.6.3781; Klasson H, 1999, MOL CELL BIOL, V19, P5405; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Mazareb S, 1999, EXP PARASITOL, V91, P341, DOI 10.1006/expr.1998.4391; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; OSWALD IP, 1994, COMP BIOCHEM PHYS C, V108, P11, DOI 10.1016/1367-8280(94)90083-3; PIPER RC, 1995, J CELL BIOL, V128, P499, DOI 10.1083/jcb.128.4.499; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Roberts SC, 2001, MOL BIOCHEM PARASIT, V115, P217, DOI 10.1016/S0166-6851(01)00293-6; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; Shaked-Mishan P, 2006, MOL MICROBIOL, V60, P30, DOI 10.1111/j.1365-2958.2006.05060.x; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Vieira LL, 1995, MOL BIOCHEM PARASIT, V75, P15, DOI 10.1016/0166-6851(95)02505-7; ZILBERSTEIN D, 1984, MOL BIOCHEM PARASIT, V12, P327, DOI 10.1016/0166-6851(84)90089-6	35	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19800	19807		10.1074/jbc.M901066200	http://dx.doi.org/10.1074/jbc.M901066200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19439418	hybrid, Green Published			2022-12-27	WOS:000268097400006
J	Nerlich, A; Rohde, M; Talay, SR; Genth, H; Just, I; Chhatwal, GS				Nerlich, Andreas; Rohde, Manfred; Talay, Susanne R.; Genth, Harald; Just, Ingo; Chhatwal, Gursharan S.			Invasion of Endothelial Cells by Tissue-invasive M3 Type Group A Streptococci Requires Src Kinase and Activation of Rac1 by a Phosphatidylinositol 3-Kinase-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; RECEPTOR TYROSINE KINASE; INTEGRIN-LINKED KINASE; EXCHANGE FACTOR TIAM1; EPITHELIAL-CELLS; GROWTH-FACTOR; STAPHYLOCOCCUS-AUREUS; PYOGENES INFECTIONS; MEDIATED INVASION; BINDING PROTEIN	Streptococcus pyogenes can cause invasive diseases in humans, such as sepsis or necrotizing fasciitis. Among the various M serotypes of group A streptococci (GAS), M3 GAS lacks the major epithelial invasins SfbI/PrtF1 and M1 protein but has a high potential to cause invasive disease. We examined the uptake of M3 GAS into human endothelial cells and identified host signaling factors required to initiate streptococcal uptake. Bacterial uptake is accompanied by local F-actin accumulation and formation of membrane protrusions at the entry site. We found that Src kinases and Rac1 but not phosphatidylinositol 3-kinases (PI3Ks) are essential to mediate S. pyogenes internalization. Pharmacological inhibition of Src activity reduced bacterial uptake and abolished the formation of membrane protrusions and actin accumulation in the vicinity of adherent streptococci. We found that Src kinases are activated in a time-dependent manner in response to M3 GAS. We also demonstrated that PI3K is dispensable for internalization of M3 streptococci and the formation of F-actin accumulations at the entry site. Furthermore, Rac1 was activated in infected cells and accumulated with F-actin in a PI3K-independent manner at bacterial entry sites. Genetic interference with Rac1 function inhibited streptococcal internalization, demonstrating an essential role of Rac1 for the uptake process of streptococci into endothelial cells. In addition, we demonstrated for the first time accumulation of the actin nucleation complex Arp2/3 at the entry port of invading M3 streptococci.	[Nerlich, Andreas; Rohde, Manfred; Talay, Susanne R.; Chhatwal, Gursharan S.] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; [Genth, Harald; Just, Ingo] Hannover Med Sch, Inst Toxicol, D-30625 Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School	Rohde, M (corresponding author), Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Inhoffenstr 7, D-38124 Braunschweig, Germany.	manfred.rohde@helmholtz-hzi.de	Genth, Harald/HHS-0118-2022; Nerlich, Andreas/F-9336-2012	Nerlich, Andreas/0000-0001-8577-2744				Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200; Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bryant AE, 2003, INFECT IMMUN, V71, P1903, DOI 10.1128/IAI.71.4.1903-1910.2003; Buchanan FG, 2000, J BIOL CHEM, V275, P9742, DOI 10.1074/jbc.275.13.9742; Burns EH, 1998, MICROB PATHOGENESIS, V24, P333, DOI 10.1006/mpat.1998.0204; Carabeo RA, 2007, CELL MICROBIOL, V9, P2278, DOI 10.1111/j.1462-5822.2007.00958.x; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Dombek PE, 1999, MOL MICROBIOL, V31, P859, DOI 10.1046/j.1365-2958.1999.01223.x; Eitel J, 2005, CELL MICROBIOL, V7, P63, DOI 10.1111/j.1462-5822.2004.00434.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evans DJ, 2002, MICROB PATHOGENESIS, V33, P135, DOI 10.1006/mpat.2002.0521; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Forster B, 2004, MICROSC RES TECHNIQ, V65, P33, DOI 10.1002/jemt.20092; GRECO R, 1995, RES MICROBIOL, V146, P551, DOI 10.1016/0923-2508(96)80561-4; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Horn MP, 2008, J PHARMACOL EXP THER, V326, P135, DOI 10.1124/jpet.108.137927; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lambotin M, 2005, J CELL SCI, V118, P3805, DOI 10.1242/jcs.02514; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07; McLaughlin R E, 1995, Methods Mol Biol, V47, P185; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Munter S., 2006, SCI STKE, V2006, pre5, DOI DOI 10.1126/STKE.3352006RE5; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; NOBES CD, 1995, J CELL SCI, V108, P225; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Purushothaman SS, 2003, INFECT IMMUN, V71, P5823, DOI 10.1128/IAI.71.10.5823-5830.2003; Reddy MA, 2000, INFECT IMMUN, V68, P6423, DOI 10.1128/IAI.68.11.6423-6430.2000; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200; Shin S, 2006, MICROB PATHOGENESIS, V41, P168, DOI 10.1016/j.micpath.2006.07.003; STEVENS DL, 1992, CLIN INFECT DIS, V14, P2, DOI 10.1093/clinids/14.1.2; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Tran Van Nhieu G., 1997, EMBO J, V16, P2717; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Vlaminckx BJM, 2007, INFECT IMMUN, V75, P2603, DOI 10.1128/IAI.01291-06; Wahl RU, 2007, CLIN MICROBIOL INFEC, V13, P1173, DOI 10.1111/j.1469-0691.2007.01821.x; Wang BN, 2007, CELL MICROBIOL, V9, P1519, DOI 10.1111/j.1462-5822.2007.00889.x; Wang BN, 2006, CELL MICROBIOL, V8, P257, DOI 10.1111/j.1462-5822.2005.00618.x; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X	54	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20319	20328		10.1074/jbc.M109.016501	http://dx.doi.org/10.1074/jbc.M109.016501			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19473989	Green Published, hybrid			2022-12-27	WOS:000268097400058
J	Park, SY; Cho, JH; Oh, DY; Park, JW; Ahn, MJ; Han, JS; Oh, JW				Park, Shin-Young; Cho, Ju Hwan; Oh, Doo-Yi; Park, Jung-Won; Ahn, Myung-Ju; Han, Joong-Soo; Oh, Jae-Won			House Dust Mite Allergen Der f 2-induced Phospholipase D1 Activation Is Critical for the Production of Interleukin-13 through Activating Transcription Factor-2 Activation in Human Bronchial Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; 15-LIPOXYGENASE GENE-EXPRESSION; P38 MAP KINASE; DERMATOPHAGOIDES-FARINAE; SIGNAL-TRANSDUCTION; ATOPIC-DERMATITIS; DENDRITIC CELLS; HUMAN MONOCYTES; PKC; PATHWAY	The purpose of this study was to identify the role of phospholipase D1 (PLD1) in Der f 2-induced interleukin (IL)-13 production. The major house dust mite allergen, Der f 2, increased PLD activity in human bronchial epithelial cells (BEAS-2B), and dominant negative PLD1 or PLD1 siRNA decreased Der f 2-induced IL-13 expression and production. Treatment of Der f 2 activated the phospholipase C gamma (PLC gamma)/protein kinase C alpha (PKC alpha)/p38 MAPK pathway. Der f 2-induced PLD activation was attenuated by PLC gamma inhibitors (U73122 and PAO), PKC alpha inhibitors (RO320432 and GO6976), and p38 MAPK inhibitors (SB203580 and SB202190). These results indicate that PLC gamma, PKC alpha, and p38 MAPK act as upstream activators of PLD in Der f 2-treated BEAS-2B cells. Furthermore, expression and production of IL-13 increased by Der f 2 were also blocked by inhibition of PLC gamma, PKC alpha, or p38 MAPK, indicating that IL-13 expression and production are related to a PLC gamma/PKC alpha/p38 MAPK pathway. We found that activating transcription factor-2 (ATF-2) was activated by Der f 2 in BEAS-2B cells and activation of ATF-2 was controlled by PLD1. When ATF-2 activity was blocked with ATF-2 siRNA, Der f 2-induced IL-13 expression and production were decreased. Thus, ATF-2 might be one of the transcriptional factors for the expression of IL-13 inDer f 2-treated BEAS-2B cells. Taken together, PLD1 acts as an important regulator in Der f 2-induced expression and production of IL-13 through activation of ATF-2 in BEAS-2B cells.	[Park, Shin-Young; Cho, Ju Hwan; Oh, Doo-Yi; Han, Joong-Soo] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, Sungdong Gu, South Korea; [Oh, Jae-Won] Hanyang Univ, Coll Med, Dept Pediat, Seoul 133791, Sungdong Gu, South Korea; [Park, Jung-Won] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Park, Jung-Won] Yonsei Univ, Coll Med, Inst Allergy, Seoul 120749, South Korea; [Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul 135710, South Korea	Hanyang University; Hanyang University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center	Han, JS (corresponding author), Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, 17 Haengdang Dong, Seoul 133791, Sungdong Gu, South Korea.	jshan@hanyang.ac.kr; jaewonoh@hanyang.ac.kr	Han, Joong-Soo/P-2072-2015	Han, Joong-Soo/0000-0002-0875-6158	Korea Research Foundation [E00273]; Korea Science and Engineering Foundation, Ministry of Education, Science, and Technology (MEST) [RB-2008-026-01000-0]	Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation, Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grant E00273 (2007) from the Korea Research Foundation and by Grant RB-2008-026-01000-0 from the Korea Science and Engineering Foundation funded by the Ministry of Education, Science, and Technology (MEST).	Abebe W, 1998, AM J PHYSIOL-LUNG C, V275, pL990, DOI 10.1152/ajplung.1998.275.5.L990; Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Bandyopadhaya A, 2009, MOL IMMUNOL, V46, P1129, DOI 10.1016/j.molimm.2008.11.003; Banno Y, 2003, BIOCHEM BIOPH RES CO, V312, P1087, DOI 10.1016/j.bbrc.2003.11.036; Bussmann C, 2006, J ALLERGY CLIN IMMUN, V118, P1292, DOI 10.1016/j.jaci.2006.07.054; Carneiro-Santos P, 2002, PARASITE IMMUNOL, V24, P493, DOI 10.1046/j.1365-3024.2002.00487.x; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; CHUA KY, 1990, INT ARCH ALLER A IMM, V91, P118, DOI 10.1159/000235101; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cummings RJ, 2002, J BIOL CHEM, V277, P30227, DOI 10.1074/jbc.M111078200; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Fan HY, 2004, BIOL REPROD, V70, P1178, DOI 10.1095/biolreprod.103.024737; FREEMAN EJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P84, DOI 10.1006/abbi.1995.1269; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Gomez-Cambronero J, 1998, CELL SIGNAL, V10, P387, DOI 10.1016/S0898-6568(97)00197-6; Hagendorens MM, 2004, PEDIAT ALLERG IMM-UK, V15, P308, DOI 10.1111/j.1399-3038.2004.00169.x; Hodgkin MN, 1999, BIOCHEM J, V339, P87, DOI 10.1042/0264-6021:3390087; HOLCK A, 1986, ALLERGY, V41, P408, DOI 10.1111/j.1398-9995.1986.tb00320.x; Hsu HY, 2008, J CELL PHYSIOL, V215, P15, DOI 10.1002/jcp.21144; Humar M, 2007, INT J BIOCHEM CELL B, V39, P2278, DOI 10.1016/j.biocel.2007.06.013; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kanazawa H, 2002, J BIOL CHEM, V277, P20026, DOI 10.1074/jbc.M109218200; Kang HK, 2004, INT IMMUNOPHARMACOL, V4, P911, DOI 10.1016/j.intimp.2004.04.001; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Katan M, 1998, BBA-MOL CELL BIOL L, V1436, P5, DOI 10.1016/S0005-2760(98)00125-8; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; Kim SY, 2004, EUR J BIOCHEM, V271, P3470, DOI 10.1111/j.0014-2956.2004.04242.x; Kiss Z, 1996, ARCH BIOCHEM BIOPHYS, V335, P191, DOI 10.1006/abbi.1996.0497; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Lee BS, 2007, J DERMATOL SCI, V46, P31, DOI 10.1016/j.jdermsci.2007.01.001; Lee CH, 2008, MOL IMMUNOL, V45, P3693, DOI 10.1016/j.molimm.2008.06.007; Lim JY, 2005, J MOL CELL CARDIOL, V39, P627, DOI 10.1016/j.yjmcc.2005.06.016; Lin CI, 2008, CELL SIGNAL, V20, P1804, DOI 10.1016/j.cellsig.2008.06.008; Makino C, 2006, GENES CELLS, V11, P1239, DOI 10.1111/j.1365-2443.2006.01016.x; Mwanjewe J, 2001, BIOCHEM J, V359, P211, DOI 10.1042/0264-6021:3590211; Oh DY, 2007, J CELL BIOCHEM, V101, P221, DOI 10.1002/jcb.21166; Oh JW, 2000, EXP MOL MED, V32, P67, DOI 10.1038/emm.2000.12; Oh JW, 2004, EXP MOL MED, V36, P486, DOI 10.1038/emm.2004.61; Parmentier JH, 2003, HYPERTENSION, V41, P794, DOI 10.1161/01.HYP.0000047873.76255.0B; Prescott SL, 1998, J IMMUNOL, V160, P4730; Rajaiya J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-17; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rivedal E, 2001, CARCINOGENESIS, V22, P1543, DOI 10.1093/carcin/22.9.1543; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Shimizu Y, 1998, CLIN EXP ALLERGY, V28, P497, DOI 10.1046/j.1365-2222.1998.00267.x; Sohn MH, 2007, RESPIRATION, V74, P447, DOI 10.1159/000099264; THOMAS AE, 1989, J ALLERGY CLIN IMMUN, V83, P416; VANDERZEE JS, 1988, J ALLERGY CLIN IMMUN, V81, P884, DOI 10.1016/0091-6749(88)90946-3; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wong CK, 2006, INT IMMUNOL, V18, P1327, DOI 10.1093/intimm/dxl065; Xu B, 2004, J BIOL CHEM, V279, P15954, DOI 10.1074/jbc.M400413200; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; YASUEDA H, 1986, INT ARCH ALLER A IMM, V81, P214, DOI 10.1159/000234137; YASUEDA H, 1989, INT ARCH ALLER A IMM, V88, P402, DOI 10.1159/000234724; YUUKI T, 1991, AGR BIOL CHEM TOKYO, V55, P1233, DOI 10.1080/00021369.1991.10870757; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang SP, 2006, FEBS J, V273, P3779, DOI 10.1111/j.1742-4658.2006.05386.x; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	64	22	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20099	20110		10.1074/jbc.M109.010017	http://dx.doi.org/10.1074/jbc.M109.010017			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19487697	Green Published, hybrid			2022-12-27	WOS:000268097400037
J	Tilley, DG; Kim, IM; Patel, PA; Violin, JD; Rockman, HA				Tilley, Douglas G.; Kim, Il-Man; Patel, Priyesh A.; Violin, Jonathan D.; Rockman, Howard A.			beta-Arrestin Mediates beta 1-Adrenergic Receptor-Epidermal Growth Factor Receptor Interaction and Downstream Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II TYPE-1 RECEPTOR; PROTEIN-COUPLED RECEPTORS; GASTRIC EPITHELIAL-CELLS; EGF RECEPTOR; REGULATED KINASES; ERK ACTIVATION; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; TYROSINE KINASES; TRANSACTIVATION	beta 1-Adrenergic receptor (beta 1AR) stimulation confers cardioprotection via beta-arrestin-dependent transactivation of epidermal growth factor receptors (EGFRs), however, the precise mechanism for this salutary process is unknown. We tested the hypothesis that the beta 1AR and EGFR form a complex that differentially directs intracellular signaling pathways. beta 1AR stimulation and EGF ligand can each induce equivalent EGFR phosphorylation, internalization, and downstream activation of ERK1/2, but only EGF ligand causes translocation of activated ERK to the nucleus, whereas beta 1AR-stimulated/EGFR-transactivated ERK is restricted to the cytoplasm. beta 1AR and EGFR are shown to interact as a receptor complex both in cell culture and endogenously in human heart, an interaction that is selective and undergoes dynamic regulation by ligand stimulation. Although catecholamine stimulation mediates the retention of beta 1AR-EGFR interaction throughout receptor internalization, direct EGF ligand stimulation initiates the internalization of EGFR alone. Continued interaction of beta 1AR with EGFR following activation is dependent upon C-terminal tail GRK phosphorylation sites of the beta 1AR and recruitment of beta-arrestin. These data reveal a new signaling paradigm in which beta-arrestin is required for the maintenance of a beta 1AR-EGFR interaction that can direct cytosolic targeting of ERK in response to catecholamine stimulation.	[Tilley, Douglas G.; Kim, Il-Man; Patel, Priyesh A.; Violin, Jonathan D.; Rockman, Howard A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Rockman, Howard A.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Rockman, Howard A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Rockman, HA (corresponding author), 226 CARL Bldg,Res Dr,DUMC 3104, Durham, NC 27710 USA.	h.rockman@duke.edu		Tilley, Douglas/0000-0002-9681-3377; Kim, Il-man/0000-0002-9268-8337	National Institutes of Health [HL-56687]; Heart and Stroke Foundation of Canada Fellowship Award; American Heart Association Fellowship Award [0825499E]; Howard Hughes Medical Institute Medical Student Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada Fellowship Award(Heart & Stroke Foundation of Canada); American Heart Association Fellowship Award(American Heart Association); Howard Hughes Medical Institute Medical Student Research Training Fellowship(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-56687 (to H. A. R.). This work was also supported by a Heart and Stroke Foundation of Canada Fellowship Award (to D. G. T.), an American Heart Association Fellowship Award 0825499E (to I. M. K.), and a Howard Hughes Medical Institute Medical Student Research Training Fellowship (to P. A. P.).	Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ancha HR, 2007, INT J BIOCHEM CELL B, V39, P2143, DOI 10.1016/j.biocel.2007.06.003; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; Basu S, 2008, J BIOL CHEM, V283, P32369, DOI 10.1074/jbc.M805053200; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Buvinic S, 2007, J CELL SCI, V120, P4289, DOI 10.1242/jcs.03490; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Christenn M, 2007, FEBS LETT, V581, P5173, DOI 10.1016/j.febslet.2007.10.003; DAVIDSON AL, 1991, J BIOL CHEM, V266, P8946; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drube S, 2006, CELL SIGNAL, V18, P1633, DOI 10.1016/j.cellsig.2006.01.003; Fuentes LQ, 2008, CELL SIGNAL, V20, P1642, DOI 10.1016/j.cellsig.2008.05.009; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Guerrero J, 2004, EXP CELL RES, V292, P201, DOI 10.1016/j.yexcr.2003.08.011; Han C, 2006, J CELL PHYSIOL, V207, P261, DOI 10.1002/jcp.20560; Haugh Jason M, 2002, Mol Interv, V2, P292, DOI 10.1124/mi.2.5.292; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Kim J, 2002, J BIOL CHEM, V277, P32116, DOI 10.1074/jbc.M204895200; Kobayashi H, 2005, CELL SIGNAL, V17, P1248, DOI 10.1016/j.cellsig.2004.12.014; Kodali R, 2006, CARDIOVASC RES, V69, P706, DOI 10.1016/j.cardiores.2005.09.012; Kodama H, 2002, J MOL CELL CARDIOL, V34, P139, DOI 10.1006/jmcc.2001.1496; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; McCole DF, 2007, J BIOL CHEM, V282, P13303, DOI 10.1074/jbc.M700424200; Mendez M, 2005, AM J PHYSIOL-HEART C, V288, pH2111, DOI 10.1152/ajpheart.00838.2004; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; Mifune M, 2005, J BIOL CHEM, V280, P26592, DOI 10.1074/jbc.M502906200; Nelson CD, 2008, J BIOL CHEM, V283, P21093, DOI 10.1074/jbc.M800431200; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Seta K, 2003, J BIOL CHEM, V278, P9019, DOI 10.1074/jbc.M208017200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Voisin L, 2002, AM J PHYSIOL-CELL PH, V283, pC446, DOI 10.1152/ajpcell.00261.2001; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yano S, 2004, BONE, V35, P664, DOI 10.1016/j.bone.2004.04.014; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhai PY, 2006, CIRC RES, V99, P528, DOI 10.1161/01.RES.0000240147.49390.61; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842	50	78	84	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20375	20386		10.1074/jbc.M109.005793	http://dx.doi.org/10.1074/jbc.M109.005793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19509284	hybrid, Green Published			2022-12-27	WOS:000268097400063
J	Mancek-Keber, M; Gradisar, H; Pestana, MI; de Tejada, GM; Jerala, R				Mancek-Keber, Mateja; Gradisar, Helena; Inigo Pestana, Melania; Martinez de Tejada, Guillermo; Jerala, Roman			Free Thiol Group of MD-2 as the Target for Inhibition of the Lipopolysaccharide-induced Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LPS-INDUCED HOMODIMERIZATION; TRANSFER PROTEIN INHIBITOR; KAPPA-B KINASE; TLR4-MD-2 COMPLEX; LIPID-A; INFLAMMATORY RESPONSE; GOLD COMPOUND; RECEPTOR 4; TLR4; ENDOTOXIN	MD-2 is a part of the Toll-like 4 signaling complex with an indispensable role in activation of the lipopolysaccharide (LPS) signaling pathway and thus a suitable target for the therapeutic inhibition of TLR4 signaling. Elucidation of MD-2 structure provides a foundation for rational design of inhibitors that bind to MD-2 and inhibit LPS signaling. Since the hydrophobic binding pocket of MD-2 provides little specificity for inhibitors, we have investigated targeting the solvent-accessible cysteine residue within the hydrophobic binding pocket of MD-2. Compounds with affinity for the hydrophobic pocket that contain a thiol-reactive group, which mediates covalent bond formation with the free cysteine residue of MD-2, were tested. Fluorescent compounds 2-(4'-(iodoacetamido) anilino) naphthalene-6-sulfonic acid and N-pyrene maleimide formed a covalent bond with MD-2 through Cys(133) and inhibited LPS signaling. Cell activation was also inhibited by thiol-reactive compounds JTT-705 originally targeted against cholesterol ester transfer protein and antirheumatic compound auranofin. Oral intake of JTT-705 significantly inhibited endotoxin-triggered tumor necrosis factor alpha production in mice. The thiol group of MD-2 also represents the target of environmental or endogenous thiol-reactive compounds that are produced in inflammation.	[Mancek-Keber, Mateja; Gradisar, Helena; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana 1000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Inigo Pestana, Melania; Martinez de Tejada, Guillermo] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain	National Institute of Chemistry - Slovenia; University of Ljubljana; University of Navarra	Jerala, R (corresponding author), Natl Inst Chem, Dept Biotechnol, Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si	Martinez-de-Tejada, Guillermo/H-3849-2017; Martinez-de-Tejada, Guillermo/AAT-8535-2020; Jerala, Roman/H-9850-2015	Martinez-de-Tejada, Guillermo/0000-0003-3755-451X; Martinez-de-Tejada, Guillermo/0000-0003-3755-451X; Jerala, Roman/0000-0002-6337-5251; Lazaro-Anton, Leticia/0000-0001-7720-5627	Slovenian Research Agency [P4-176, J1-7206, J1-9793, Z4-9595]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the state budget of the Slovenian Research Agency ( Program P4-176, Projects J1-7206, J1-9793, and Z4-9595).	Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Andreakos E, 2005, FRONT BIOSCI-LANDMRK, V10, P2478, DOI 10.2741/1712; Aybay C, 1998, FEMS IMMUNOL MED MIC, V22, P263, DOI 10.1111/j.1574-695X.1998.tb01215.x; Barsness KA, 2004, AM J PHYSIOL-REG I, V287, pR592, DOI 10.1152/ajpregu.00412.2003; Bondeson J, 1995, BIOCHEM PHARMACOL, V50, P1753, DOI 10.1016/0006-2952(95)02030-6; de Grooth GJ, 2002, CIRCULATION, V105, P2159, DOI 10.1161/01.CIR.0000015857.31889.7B; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; FEIST W, 1992, FEMS MICROBIOL IMMUN, V89, P73, DOI 10.1016/0378-1097(92)90264-O; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gradisar H, 2007, J LEUKOCYTE BIOL, V82, P968, DOI 10.1189/jlb.1206727; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Gunatilleke SS, 2006, J MED CHEM, V49, P3933, DOI 10.1021/jm060158f; Hawkins LD, 2004, CURR TOP MED CHEM, V4, P1147, DOI 10.2174/1568026043388123; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Jeon KI, 2003, EXP MOL MED, V35, P61, DOI 10.1038/emm.2003.9; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Johnson DA, 2008, CURR TOP MED CHEM, V8, P64, DOI 10.2174/156802608783378882; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lee JS, 2008, MOL CELLS, V25, P253; LEONG D, 1970, Infection and Immunity, V1, P174; Li L, 1999, AM J PHYSIOL-LUNG C, V277, pL550, DOI 10.1152/ajplung.1999.277.3.L550; Lindvall MK, 2002, CURR PHARM DESIGN, V8, P1673, DOI 10.2174/1381612023394142; Mancek-Keber M, 2006, FASEB J, V20, P1836, DOI 10.1096/fj.06-5862com; Maresso AW, 2007, J BIOL CHEM, V282, P23129, DOI 10.1074/jbc.M701857200; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Mollnes TE, 2008, ADV EXP MED BIOL, V632, P253, DOI 10.1007/978-0-387-78952-1_18; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; Resman N, 2008, FEBS LETT, V582, P3929, DOI 10.1016/j.febslet.2008.10.037; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tobias P, 2005, J LIPID RES, V46, P404, DOI 10.1194/jlr.R400015-JLR200; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Viriyakosol S, 2006, HYBRIDOMA, V25, P349, DOI 10.1089/hyb.2006.25.349; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; YANG JP, 1995, FEBS LETT, V361, P89, DOI 10.1016/0014-5793(95)00157-5; Youn HS, 2008, BIOCHEM PHARMACOL, V75, P494, DOI 10.1016/j.bcp.2007.08.033; Youn HS, 2006, BIOCHEM BIOPH RES CO, V350, P866, DOI 10.1016/j.bbrc.2006.09.097	47	38	41	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19493	19500		10.1074/jbc.M109.003756	http://dx.doi.org/10.1074/jbc.M109.003756			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473973	Green Published, hybrid			2022-12-27	WOS:000267908300041
J	Yan, J; Menendez, D; Yang, XP; Resnick, MA; Jetten, AM				Yan, Jun; Menendez, Daniel; Yang, Xiao-Ping; Resnick, Michael A.; Jetten, Anton M.			A Regulatory Loop Composed of RAP80-HDM2-p53 Provides RAP80-enhanced p53 Degradation by HDM2 in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; DEPENDENT PHOSPHORYLATION; TRANSCRIPTION-FACTOR; BINDING-SITES; RAP80; REPAIR; BRCA1; RNF8; CHECKPOINTS; GENOME	The ubiquitin interaction motif-containing protein RAP80 plays a key role in DNA damage response signaling. Using genomic and functional analysis, we established that the expression of the RAP80 gene is regulated in a DNA damage-responsive manner by the master regulator p53. This regulation occurs at the transcriptional level through a noncanonical p53 response element in the RAP80 promoter. Although it is inducible by p53, RAP80 is also able to regulate p53 through an association with both p53 and the E3 ubiquitin ligase HDM2, providing HDM2-dependent enhancement of p53 poly-ubiquitination. Depletion of RAP80 by small interfering RNA stabilizes p53, which, following DNA damage, results in an increased transactivation of several p53 target genes as well as greater apoptosis. Consistent with these observations, exogenous expression of RAP80 selectively inhibits p53-dependent transactivation of target genes in an mdm2-dependent manner in MEF cells. Thus, we identify a new DNA damage-associated role for RAP80. It can function in an autoregulatory loop consisting of RAP80, HDM2, and the p53 master regulatory network, implying an important role for this loop in genome stability and oncogenesis.	[Menendez, Daniel; Resnick, Michael A.] NIEHS, Chromosome Stabil Grp, Mol Genet Lab, Div Intramural Res,NIH, Res Triangle Pk, NC 27709 USA; [Yan, Jun; Yang, Xiao-Ping; Jetten, Anton M.] NIEHS, Cell Biol Sect, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Chromosome Stabil Grp, Mol Genet Lab, Div Intramural Res,NIH, Res Triangle Pk, NC 27709 USA.	resnick@niehs.nih.gov; jetten@niehs.nih.gov	Jetten, Anton/C-3736-2019; resnick, Michael/F-1668-2019	Jetten, Anton/0000-0003-0954-4445; resnick, Michael/0000-0002-8473-7506	National Institutes of Health [Z01 ES101586, Z01 ES065079]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065079, ZIAES101586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01 ES101586 ( to A. M. J.) and Z01 ES065079 ( to M. A. R.).	Akbari MR, 2009, BREAST CANCER RES TR, V113, P377, DOI 10.1007/s10549-008-9938-z; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Menendez D, 2007, ONCOGENE, V26, P2191, DOI 10.1038/sj.onc.1210277; Menendez D, 2006, MOL CELL BIOL, V26, P2297, DOI 10.1128/MCB.26.6.2297-2308.2006; Menendez D, 2007, MOL CELL BIOL, V27, P2590, DOI 10.1128/MCB.01742-06; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Osorio A, 2009, BREAST CANCER RES TR, V113, P371, DOI 10.1007/s10549-008-9933-4; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Shebzukhov YV, 2007, CANCER LETT, V255, P255, DOI 10.1016/j.canlet.2007.04.013; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tomso DJ, 2005, P NATL ACAD SCI USA, V102, P6431, DOI 10.1073/pnas.0501721102; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yan J, 2007, NUCLEIC ACIDS RES, V35, P1673, DOI 10.1093/nar/gkl1112; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	49	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19280	19289		10.1074/jbc.M109.013102	http://dx.doi.org/10.1074/jbc.M109.013102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19433585	hybrid, Green Published			2022-12-27	WOS:000267908300019
J	Ren, G; Helwani, FM; Verma, S; McLachlan, RW; Weed, SA; Yap, AS				Ren, Gang; Helwani, Falak M.; Verma, Suzie; McLachlan, Robert W.; Weed, Scott A.; Yap, Alpha S.			Cortactin Is a Functional Target of E-cadherin-activated Src Family Kinases in MCF7 Epithelial Monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL-ADHESION; TYROSINE PHOSPHORYLATION; ARP2/3 COMPLEX; C-SRC; ACTIN; CONTACTS; DYNAMICS; POLARIZATION; CYTOSKELETON; FIBROBLASTS	Src family kinases (SFKs) signal in response to E-cadherin to support cadherin adhesion and the integrity of cell-cell contacts (McLachlan, R. W., Kraemer, A., Helwani, F. M., Kovacs, E. M., and Yap, A. S. ( 2007) Mol. Biol. Cell 18, 3214-3223). We now identify the actin-regulatory protein, cortactin, as a target of E-cadherin-activated SFK signaling. Tyr-phosphorylated cortactin was found at cell-cell contacts in established epithelial monolayers, and cortactin became acutely tyrosine-phosphorylated when E-cadherin adhesion was engaged. In all circumstances, cortactin tyrosine phosphorylation was blocked by inhibiting SFK signaling. Importantly, Tyr-phosphorylated cortactin was necessary to preserve the integrity of cadherin contacts and the perijunctional actin cytoskeleton. Moreover, expression of a phosphomimetic cortactin mutant could prevent SFK blockade from disrupting cadherin organization, thereby placing cortactin functionally downstream of SFK signaling at cadherin adhesions. We conclude that SFK and cortactin constitute an important signaling pathway that functionally links E-cadherin adhesion and the actin cytoskeleton.	[Ren, Gang; Helwani, Falak M.; Verma, Suzie; McLachlan, Robert W.; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia; [Weed, Scott A.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Program Canc Cell Biol, Dept Anat & Neurosci, Morgantown, WV 26506 USA	University of Queensland; West Virginia University	Yap, AS (corresponding author), Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Bldg 80,Serv Rd, Brisbane, Qld 4072, Australia.	a.yap@uq.edu.au	Yap, Alpha S./J-1554-2014	Yap, Alpha S./0000-0002-1038-8956; Weed, Scott/0000-0001-7033-9999	National Health and Medical Research Council of Australia; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014578] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the National Health and Medical Research Council of Australia.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; BARETTINO D, 1994, NUCLEIC ACIDS RES, V22, P541, DOI 10.1093/nar/22.3.541; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Bennett HL, 2008, ONCOGENE, V27, P2693, DOI 10.1038/sj.onc.1210928; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; El Sayegh TY, 2005, MOL BIOL CELL, V16, P5514, DOI 10.1091/mcbE05-05-0410; El Sayegh TY, 2004, J CELL SCI, V117, P5117, DOI 10.1242/jcs.01385; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kraemer A, 2007, AM J PHYSIOL-CELL PH, V292, pC1061, DOI 10.1152/ajpcell.00073.2006; Luxenburg C, 2006, J CELL SCI, V119, P4878, DOI 10.1242/jcs.03271; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; McLachlan RW, 2007, J MOL MED-JMM, V85, P545, DOI 10.1007/s00109-007-0198-x; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Pang JH, 2005, J BIOL CHEM, V280, P3043, DOI 10.1074/jbc.M412148200; Takahashi F, 1996, GENE DEV, V10, P1645, DOI 10.1101/gad.10.13.1645; Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; ZHAN X, 1993, J BIOL CHEM, V268, P24427	38	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18913	18922		10.1074/jbc.M109.000307	http://dx.doi.org/10.1074/jbc.M109.000307			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19457864	Green Published, hybrid			2022-12-27	WOS:000267711500041
J	Gangopadhyay, SS; Kengni, E; Appel, S; Gallant, C; Kim, HR; Leavis, P; DeGnore, J; Morgan, KG				Gangopadhyay, Samudra S.; Kengni, Edouard; Appel, Sarah; Gallant, Cynthia; Kim, Hak Rim; Leavis, Paul; DeGnore, Jon; Morgan, Kathleen G.			Smooth Muscle Archvillin Is an ERK Scaffolding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-II; ACTIVATION; CALPONIN; PEPTIDE	ERK influences a number of pathways in all cells, but how ERK activities are segregated between different pathways has not been entirely clear. Using immunoprecipitation and pulldown experiments with domain-specific recombinant fragments, we show that smooth muscle archvillin (SmAV) binds ERK and members of the ERK signaling cascade in a domain-specific, stimulus-dependent, and pathway-specific manner. MEK binds specifically to the first 445 residues of SmAV. B-Raf, an upstream regulator of MEK, constitutively interacts with residues 1-445 and 446-1250. Both ERK and 14-3-3 bind to both fragments, but in a stimulus-specific manner. Phosphorylated ERK is associated only with residues 1-445. An ERK phosphorylation site was determined by mass spectrometry to reside at Ser(132). Aphospho-antibody raised to this site shows that the site is phosphorylated during alpha-agonist-mediated ERK activation in smooth muscle tissue. Phosphorylation of SmAV by ERK decreases the association of phospho-ERK with SmAV. These results, combined with previous observations, indicate that SmAV serves as a new ERK scaffolding protein and provide a mechanism for regulation of ERK binding, activation, and release from the signaling complex.	[Gangopadhyay, Samudra S.; Kengni, Edouard; Appel, Sarah; Gallant, Cynthia; Kim, Hak Rim; Morgan, Kathleen G.] Boston Univ, Boston, MA 02215 USA; [Gangopadhyay, Samudra S.; Gallant, Cynthia; Leavis, Paul; Morgan, Kathleen G.] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Leavis, Paul; DeGnore, Jon] Tufts Univ, Sch Med, Boston, MA 02111 USA	Boston University; Boston Biomedical Research Institute; Tufts University	Morgan, KG (corresponding author), Boston Univ, 635 Commonwealth Ave, Boston, MA 02215 USA.	kmorgan@bu.edu		Morgan, Kathleen/0000-0003-3300-3630; Appel, Sarah/0000-0003-0315-6513	National Institutes of Health [HL31704, HL80003, HL86655, HD43054, HL074470]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043054] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL074470, P01HL086655, R01HL031704, R01HL080003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL31704, HL80003, HL86655, and HD43054 (to K. G. M.) and HL074470 (to S. S. G.).	Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; ADAM LP, 1995, CIRC RES, V76, P183, DOI 10.1161/01.RES.76.2.183; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Gangopadhyay SS, 2004, J CELL SCI, V117, P5043, DOI 10.1242/jcs.01378; Gerthoffer WT, 1996, J PHYSIOL-LONDON, V495, P597, DOI 10.1113/jphysiol.1996.sp021619; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; KHALIL RA, 1993, AM J PHYSIOL, V265, pC406, DOI 10.1152/ajpcell.1993.265.2.C406; KHALIL RA, 1995, CIRC RES, V76, P1101, DOI 10.1161/01.RES.76.6.1101; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Marganski WA, 2005, CIRC RES, V97, P541, DOI 10.1161/01.RES.0000182630.29093.0d; Menice CB, 1997, J BIOL CHEM, V272, P25157, DOI 10.1074/jbc.272.40.25157; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Taggart MJ, 2007, SEMIN CELL DEV BIOL, V18, P296, DOI 10.1016/j.semcdb.2007.05.006; Veprek P, 1999, J PEPT SCI, V5, P203, DOI 10.1002/(SICI)1099-1387(199905)5:5<203::AID-PSC181>3.0.CO;2-N; Wier WG, 2004, REV PHYSIOL BIOCH P, V150, P91, DOI 10.1007/s10254-003-0019-8; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	23	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17607	17615		10.1074/jbc.M109.002386	http://dx.doi.org/10.1074/jbc.M109.002386			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19406750	Green Published, hybrid			2022-12-27	WOS:000267202500026
J	Smith, NJ; Stoddart, LA; Devine, NM; Jenkins, L; Milligan, G				Smith, Nicola J.; Stoddart, Leigh A.; Devine, Nicola M.; Jenkins, Laura; Milligan, Graeme			The Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; STIMULATED INSULIN-SECRETION; BETA-CELLS; IN-VIVO; GPR40; ACTIVATION; AGONISTS; DISCOVERY; GENE; MICE	The endogenous ligands for free fatty acid receptor 1 (FFA1) are medium and longer chain free fatty acids. However, a range of selective, small molecule ligands have recently been developed as tool compounds to explore the therapeutic potential of this receptor, whereas clinically employed thiazolidinedione "glitazone" drugs are also agonists at FFA1. Each of these classes of agonist was able to promote phosphorylation of the ERK1/2 mitogen-activated protein (MAP) kinases in cells able to express human FFA1 on demand. However, although both lauric acid and the synthetic agonist GW9508X produced rapid and transient ERK1/2 MAP kinase phosphorylation, the thiazolidinedione rosiglitazone produced responses that were sustained for a substantially longer period. Despite this difference, the effects of each ligand required FFA1 and were transduced in each case predominantly via G proteins of the G alpha(q)/G alpha(11) family. Different glitazone drugs also displayed markedly different efficacy and kinetics of sustainability of ERK1/2 MAP kinase phosphorylation. A number of orthosteric binding site mutants of FFA1 were generated, and despite variations in the changes of potency and efficacy of the three ligand classes in different functional end point assays, these were consistent with rosiglitazone also binding at the orthosteric site. Four distinct polymorphic variants of human FFA1 have been described. Despite previous indications that these display differences in function and pharmacology, they all responded in entirely equivalent ways to lauric acid, rosiglitazone, and GW9508X in measures of ERK1/2 MAP kinase phosphorylation, enhancement of binding of [S-35]GTP gamma S (guanosine 5'-O-(3-[S-35] thio) triphosphate) to G alpha(q), and elevation of intracellular [Ca2+], suggesting that individuals expressing each variant are likely to respond equivalently to orthosteric agonists of FFA1.	[Smith, Nicola J.; Stoddart, Leigh A.; Devine, Nicola M.; Jenkins, Laura; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Mol Pharmacol Grp, Fac Biomed & Life Sci, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	g.milligan@bio.gla.ac.uk	Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519; Smith, Nicola J/0000-0002-7247-9562; Stoddart, Leigh/0000-0002-4469-0600	Biotechnology and Biosciences Research Council [BB/E019455/1]; Biotechnology and Biological Sciences Research Council [BB/E019455/1] Funding Source: researchfish; BBSRC [BB/E019455/1] Funding Source: UKRI	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biosciences Research Council Grant BB/E019455/1.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bharate SB, 2008, BIOORG MED CHEM LETT, V18, P6357, DOI 10.1016/j.bmcl.2008.10.085; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brownlie R, 2008, BIOCHEM SOC T, V36, P950, DOI 10.1042/BST0360950; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Costanzi S, 2008, J BIOL CHEM, V283, P16269, DOI 10.1074/jbc.R800014200; Crespo Piero, 2004, Methods Mol Biol, V250, P203; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Gardner OS, 2005, MOL PHARMACOL, V68, P933, DOI 10.1124/mol.105.012260; Garrido DM, 2006, BIOORG MED CHEM LETT, V16, P1840, DOI 10.1016/j.bmcl.2006.01.007; Hamid YH, 2005, DIABETIC MED, V22, P74, DOI 10.1111/j.1464-5491.2005.01505.x; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jha RJ, 1999, CLIN EXP HYPERTENS, V21, P157, DOI 10.3109/10641969909068658; Kazius J, 2008, HUM MUTAT, V29, P39, DOI 10.1002/humu.20638; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Milasta S, 2006, MOL PHARMACOL, V69, P479, DOI 10.1124/mol.105.018788; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Milligan G, 2006, CELL SIGNAL, V18, P1360, DOI 10.1016/j.cellsig.2006.03.011; MITCHELL FM, 1993, BIOCHEM J, V293, P495, DOI 10.1042/bj2930495; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Ogawa T, 2005, METABOLISM, V54, P296, DOI 10.1016/j.metabol.2004.09.008; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Smith NJ, 2006, HYPERTENSION, V48, P173, DOI 10.1161/01.HYP.0000232641.84521.92; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Sundriyal S, 2008, J PHYS ORG CHEM, V21, P30, DOI 10.1002/poc.1273; Swaminath G, 2008, ARCH PHARM, V341, P755, DOI 10.1002/ardp.200800096; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Telvekar VN, 2008, CURR DRUG TARGETS, V9, P899, DOI 10.2174/138945008785909301; Thompson Miles D., 2008, V448, P139, DOI 10.1007/978-1-59745-205-2_8; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680	56	70	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17527	17539		10.1074/jbc.M109.012849	http://dx.doi.org/10.1074/jbc.M109.012849			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19398560	hybrid, Green Published			2022-12-27	WOS:000267202500019
J	Thein, MC; Winter, AD; Stepek, G; McCormack, G; Stapleton, G; Johnstone, IL; Page, AP				Thein, Melanie C.; Winter, Alan D.; Stepek, Gillian; McCormack, Gillian; Stapleton, Genevieve; Johnstone, Iain L.; Page, Antony P.			Combined Extracellular Matrix Cross-linking Activity of the Peroxidase MLT-7 and the Dual Oxidase BLI-3 Is Critical for Post-embryonic Viability in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR EVOLUTION; DISULFIDE-ISOMERASE; CUTICLE COLLAGEN; BRUGIA-MALAYI; PROTEIN; NEMATODE; IDENTIFICATION; PROCOLLAGEN; TRANSGLUTAMINASE; BIOSYNTHESIS	The nematode cuticle is a protective collagenous extracellular matrix that is modified, cross-linked, and processed by a number of key enzymes. This Ecdysozoan-specific structure is synthesized repeatedly and allows growth and development in a linked degradative and biosynthetic process known as molting. A targeted RNA interference screen using a cuticle collagen marker has been employed to identify components of the cuticle biosynthetic pathway. We have characterized an essential peroxidase, MoLT-7 (MLT-7), that is responsible for proper cuticle molting and re-synthesis. MLT-7 is an active, inhibitable peroxidase that is expressed in the cuticle-synthesizing hypodermis coincident with each larval molt. mlt-7 mutants show a range of body morphology defects, most notably molt, dumpy, and early larval stage arrest phenotypes that can all be complemented with a wild type copy of mlt-7. The cuticles of these mutants lacks di-tyrosine cross-links, becomes permeable to dye and accessible to tyrosine iodination, and have aberrant collagen protein expression patterns. Overexpression of MLT-7 causes mutant phenotypes further supporting its proposed enzymatic role. In combination with BLI-3, an H2O2-generating NADPH dual oxidase, MLT-7 is essential for post-embryonic development. Disruption of mlt-7, and particularly bli-3, via RNA interference also causes dramatic changes to the in vivo cross-linking patterns of the cuticle collagens DPY-13 and COL-12. This points toward a functionally cooperative relationship for these two hypodermally expressed proteins that is essential for collagen cross-linking and proper extracellular matrix formation.	[Thein, Melanie C.; Winter, Alan D.; Stepek, Gillian; McCormack, Gillian; Page, Antony P.] Univ Glasgow, Fac Vet, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland; [Stapleton, Genevieve; Johnstone, Iain L.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G61 1QH, Lanark, Scotland	University of Glasgow; University of Glasgow	Page, AP (corresponding author), Univ Glasgow, Fac Vet, Inst Comparat Med, Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland.	a.page@vet.gla.ac.uk			Medical Research and the Biotechnology and Biological Sciences Research Councils of the United Kingdom; Biotechnology and Biological Sciences Research Council [BB/D000661/1] Funding Source: researchfish; Medical Research Council [G0401202, G117/476] Funding Source: researchfish; BBSRC [BB/D000661/1] Funding Source: UKRI; MRC [G117/476, G0401202] Funding Source: UKRI	Medical Research and the Biotechnology and Biological Sciences Research Councils of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research and the Biotechnology and Biological Sciences Research Councils of the United Kingdom.	Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Blaxter M, 1998, SCIENCE, V282, P2041, DOI 10.1126/science.282.5396.2041; COX GN, 1981, DEV BIOL, V86, P456, DOI 10.1016/0012-1606(81)90204-9; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Daiyasu H, 2000, J MOL EVOL, V51, P433, DOI 10.1007/s002390010106; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Eschenlauer SCP, 2003, J BIOL CHEM, V278, P4227, DOI 10.1074/jbc.M210510200; FETTERER RH, 1993, J PARASITOL, V79, P160, DOI 10.2307/3283502; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; FUJIMOTO D, 1981, BIOCHEM BIOPH RES CO, V99, P637, DOI 10.1016/0006-291X(81)91792-7; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; McMahon L, 2003, MOL BIOL CELL, V14, P1366, DOI 10.1091/mbc.E02-08-0479; MEHTA K, 1992, MOL BIOCHEM PARASIT, V53, P1, DOI 10.1016/0166-6851(92)90002-2; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; MORRISON M, 1976, ANNU REV BIOCHEM, V45, P861, DOI 10.1146/annurev.bi.45.070176.004241; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nomura K, 1999, ARCH BIOCHEM BIOPHYS, V367, P173, DOI 10.1006/abbi.1999.1219; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; Page AP, 2006, INT J PARASITOL, V36, P681, DOI 10.1016/j.ijpara.2006.01.004; Page AP, 2003, ADV PARASIT, V53, P85, DOI 10.1016/S0065-308X(03)53003-2; Page AP, 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.138.1; SAKURA S, 1984, PHOTOCHEM PHOTOBIOL, V40, P731, DOI 10.1111/j.1751-1097.1984.tb04644.x; SCHOFIELD JD, 1974, BIOCHEMISTRY-US, V13, P1801, DOI 10.1021/bi00706a004; SELKIRK ME, 1989, MOL BIOCHEM PARASIT, V32, P229, DOI 10.1016/0166-6851(89)90073-X; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Thein MC, 2003, DEV DYNAM, V226, P523, DOI 10.1002/dvdy.10259; Tsang SW, 2007, DEV BIOL, V312, P353, DOI 10.1016/j.ydbio.2007.09.037; Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000; Winter AD, 2007, DEV BIOL, V308, P449, DOI 10.1016/j.ydbio.2007.05.041	35	60	68	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17549	17563		10.1074/jbc.M900831200	http://dx.doi.org/10.1074/jbc.M900831200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19406744	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000267202500021
J	Amundsen, SK; Fero, J; Salama, NR; Smith, GR				Amundsen, Susan K.; Fero, Jutta; Salama, Nina R.; Smith, Gerald R.			Dual Nuclease and Helicase Activities of Helicobacter pylori AddAB Are Required for DNA Repair, Recombination, and Mouse Infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; COMPLETE NUCLEOTIDE-SEQUENCE; BINDING CONSENSUS SEQUENCE; COGNATE CHI SEQUENCE; ATP-DEPENDENT DNASE; RECBCD ENZYME; BACILLUS-SUBTILIS; RECD SUBUNIT; HOMOLOGOUS RECOMBINATION; DEFICIENT MUTANTS	Helicobacter pylori infection of the human stomach is associated with disease-causing inflammation that elicits DNA damage in both bacterial and host cells. Bacteria must repair their DNA to persist. The H. pylori AddAB helicase-exonuclease is required for DNA repair and efficient stomach colonization. To dissect the role of each activity in DNA repair and infectivity, we altered the AddA and AddB nuclease (NUC) domains and the AddA helicase (HEL) domain by site-directed mutagenesis. Extracts of Escherichia coli expressing H. pylori addA(NUC)B or addAB(NUC) mutants unwound DNA but had approximately half of the exonuclease activity of wild-type AddAB; the addA(NUC)B(NUC) double mutant lacked detectable nuclease activity but retained helicase activity. Extracts with AddA(HEL)B lacked detectable helicase and nuclease activity. H. pylori with the single nuclease domain mutations were somewhat less sensitive to the DNA-damaging agent ciprofloxacin than the corresponding deletion mutant, suggesting that residual nuclease activity promotes limited DNA repair. The addA(NUC) and addA(HEL) mutants colonized the stomach less efficiently than the wild type; addB(NUC) showed partial attenuation. E. coli Delta recBCD expressing H. pylori addAB was recombination-deficient unless H. pylori recA was also expressed, suggesting a species-specific interaction between AddAB and RecA and also that H. pylori AddAB participates in both DNA repair and recombination. These results support a role for both the AddAB nuclease and helicase in DNA repair and promoting infectivity.	[Amundsen, Susan K.; Smith, Gerald R.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Fero, Jutta; Salama, Nina R.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,A1-162, Seattle, WA 98109 USA.	gsmith@fhcrc.org	Salama, Nina Reda/AAG-2437-2019	Salama, Nina Reda/0000-0003-2762-1424; Smith, Gerald/0000-0002-8747-1352	National Institutes of Health [GM031693, AI054423]; Fred Hutchinson Cancer Research Center Synergy Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM031693, R01GM031693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Hutchinson Cancer Research Center Synergy Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by National Institutes of Health Grants GM031693 (to G. R. S.) and AI054423 (to N. R. S.). This work was also supported by the Fred Hutchinson Cancer Research Center Synergy Fund (to G. R. S. and N. R. S.).	Allen LAH, 2005, J IMMUNOL, V174, P3658, DOI 10.4049/jimmunol.174.6.3658; Amundsen SK, 2000, P NATL ACAD SCI USA, V97, P7399, DOI 10.1073/pnas.130192397; AMUNDSEN SK, 1990, GENETICS, V126, P25; Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Amundsen SK, 2002, GENETICS, V161, P483; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Amundsen SK, 2008, MOL MICROBIOL, V69, P994, DOI 10.1111/j.1365-2958.2008.06336.x; Amundsen SK, 2007, GENE DEV, V21, P3296, DOI 10.1101/gad.1605807; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; CHAUDHURY AM, 1985, MOL GEN GENET, V201, P525, DOI 10.1007/BF00331350; Chedin F, 2000, J MOL BIOL, V298, P7, DOI 10.1006/jmbi.2000.3556; Chedin F, 2006, J BIOL CHEM, V281, P18610, DOI 10.1074/jbc.M600882200; Chen HW, 1997, J BIOL CHEM, V272, P10072; Chen HW, 1998, J MOL BIOL, V278, P89, DOI 10.1006/jmbi.1998.1694; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; DEVRIES J, 1992, J GEN MICROBIOL, V138, P31, DOI 10.1099/00221287-138-1-31; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; EICHLER DC, 1977, J BIOL CHEM, V252, P499; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P8583, DOI 10.1093/nar/14.21.8583; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P4437, DOI 10.1093/nar/14.11.4437; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P8573, DOI 10.1093/nar/14.21.8573; Fischer W, 2004, J BACTERIOL, V186, P777, DOI 10.1128/JB.186.3.777-784.2004; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; GOLDMARK PJ, 1972, J BIOL CHEM, V247, P1849; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Haijema BJ, 1996, J BACTERIOL, V178, P5086, DOI 10.1128/jb.178.17.5086-5091.1996; Haijema BJ, 1996, J BACTERIOL, V178, P5130, DOI 10.1128/jb.178.17.5130-5137.1996; Haijema BJ, 1996, MOL MICROBIOL, V21, P989, DOI 10.1046/j.1365-2958.1996.601424.x; HOWARDFLANDERS P, 1966, GENETICS, V53, P1137; IYER VN, 1963, P NATL ACAD SCI USA, V50, P355, DOI 10.1073/pnas.50.2.355; KARU AE, 1973, J BIOL CHEM, V248, P4874; KARU AE, 1972, P NATL ACAD SCI USA, V69, P2855, DOI 10.1073/pnas.69.10.2855; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kooistra J, 1997, MOL MICROBIOL, V23, P137, DOI 10.1046/j.1365-2958.1997.1991570.x; KOOISTRA J, 1991, J BACTERIOL, V173, P3644, DOI 10.1128/JB.173.12.3644-3655.1991; KOOISTRA J, 1988, J BACTERIOL, V170, P4791, DOI 10.1128/jb.170.10.4791-4797.1988; KOOISTRA J, 1993, MOL MICROBIOL, V7, P915, DOI 10.1111/j.1365-2958.1993.tb01182.x; KORANGY F, 1992, J BIOL CHEM, V267, P3088; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KORANGY F, 1992, J BIOL CHEM, V267, P1733; KORANGY F, 1992, J BIOL CHEM, V267, P1727; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LIPINSKA B, 1989, J BACTERIOL, V171, P488, DOI 10.1128/jb.171.1.488-497.1989; MACKAY V, 1974, J BIOL CHEM, V249, P4286; Marsin S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000146; MASTERSON C, 1992, J BIOL CHEM, V267, P13564; MCPARTLAND A, 1980, CELL, V20, P731, DOI 10.1016/0092-8674(80)90319-0; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; O'Rourke EJ, 2003, P NATL ACAD SCI USA, V100, P2789, DOI 10.1073/pnas.0337641100; OLIVER DB, 1977, J MOL BIOL, V116, P877, DOI 10.1016/0022-2836(77)90276-5; PONTICELLI AS, 1985, CELL, V41, P145, DOI 10.1016/0092-8674(85)90069-8; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; SCHMITT W, 1995, MOL GEN GENET, V248, P563, DOI 10.1007/BF02423452; SCHULTZ DW, 1983, J BACTERIOL, V155, P664, DOI 10.1128/JB.155.2.664-680.1983; SIOUD M, 1989, BIOCHEMISTRY-US, V28, P3638, DOI 10.1021/bi00435a002; Smeets LC, 2000, J BACTERIOL, V182, P3948, DOI 10.1128/JB.182.14.3948-3954.2000; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Teshima S, 1999, FEBS LETT, V452, P243, DOI 10.1016/S0014-5793(99)00636-5; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang G, 2008, INFECT IMMUN, V76, P153, DOI 10.1128/IAI.00791-07; WANG Y, 1993, J GEN MICROBIOL, V139, P2485, DOI 10.1099/00221287-139-10-2485; WILLETTS NS, 1969, J BACTERIOL, V100, P923, DOI 10.1128/JB.100.2.923-934.1969; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; WILLETTS NS, 1969, J BACTERIOL, V100, P231, DOI 10.1128/JB.100.1.231-239.1969; WOLFSON JS, 1985, ANTIMICROB AGENTS CH, V28, P581, DOI 10.1128/AAC.28.4.581; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Yeeles JTP, 2007, J MOL BIOL, V371, P66, DOI 10.1016/j.jmb.2007.05.053; Yu M, 1998, J MOL BIOL, V283, P797, DOI 10.1006/jmbi.1998.2127; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	80	27	27	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16759	16766		10.1074/jbc.M109.005587	http://dx.doi.org/10.1074/jbc.M109.005587			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19395381	hybrid, Green Published			2022-12-27	WOS:000266962400011
J	Yotsumoto, K; Saito, T; Asada, A; Oikawa, T; Kimura, T; Uchida, C; Ishiguro, K; Uchida, T; Hasegawa, M; Hisanaga, S				Yotsumoto, Kensuke; Saito, Taro; Asada, Akiko; Oikawa, Takayuki; Kimura, Taeko; Uchida, Chiyoko; Ishiguro, Koichi; Uchida, Takafumi; Hasegawa, Masato; Hisanaga, Shin-ichi			Effect of Pin1 or Microtubule Binding on Dephosphorylation of FTDP-17 Mutant Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; ABNORMALLY PHOSPHORYLATED-TAU; FRONTOTEMPORAL DEMENTIA; WILD-TYPE; ALZHEIMER-DISEASE; PROLYL ISOMERASE; P301L TAU; MUTATIONS; BRAIN; SITE	Neurodegenerative tauopathies, including Alzheimer disease, are characterized by abnormal hyperphosphorylation of the microtubule-associated protein Tau. One group of tauopathies, known as frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), is directly associated with mutations of the gene tau. However, it is unknown why mutant Tau is highly phosphorylated in the patient brain. In contrast to in vivo high phosphorylation, FTDP-17 Tau is phosphorylated less than wild-type Tau in vitro. Because phosphorylation is a balance between kinase and phosphatase activities, we investigated dephosphorylation of mutant Tau proteins, P301L and R406W. Tau phosphorylated by Cdk5-p25 was dephosphorylated by protein phosphatases in rat brain extracts. Compared with wildtype Tau, R406W was dephosphorylated faster and P301L slower. The two-dimensional phosphopeptide map analysis suggested that faster dephosphorylation of R406W was due to a lack of phosphorylation at Ser-404, which is relatively resistant to dephosphorylation. We studied the effect of the peptidylprolyl isomerase Pin1 or microtubule binding on dephosphorylation of wild-type Tau, P301L, and R406W in vitro. Pin1 catalyzes the cis/trans isomerization of phospho-Ser/Thr-Pro sequences in a subset of proteins. Dephosphorylation of wildtype Tau was reduced in brain extracts of Pin1-knockout mice, and this reduction was not observed with P301L and R406W. On the other hand, binding to microtubules almost abolished dephosphorylation of wild-type and mutant Tau proteins. These results demonstrate that mutation of Tau and its association with microtubules may change the conformation of Tau, thereby suppressing dephosphorylation and potentially contributing to the etiology of tauopathies.	[Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Fac Sci & Engn, Dept Biol Sci, Tokyo 1920397, Japan; [Oikawa, Takayuki; Hasegawa, Masato] Tokyo Metropolitan Inst Psychiat, Mol Neurobiol Lab, Tokyo 1568585, Japan; [Uchida, Chiyoko] Ibaraki Univ, Univ Hlth Ctr, Ibaraki 3108512, Japan; [Ishiguro, Koichi] Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Tokyo Metropolitan University; Ibaraki University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Tohoku University	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Fac Sci & Engn, Dept Biol Sci, 1-1 Minami Osawa, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp		yotsumoto, Kensuke/0000-0003-2258-6324; Uchida, Takafumi/0000-0003-3665-4906	MEXT of Japan	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research on Priority Area from MEXT of Japan (to S. H.).	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Bird TD, 1999, BRAIN, V122, P741, DOI 10.1093/brain/122.4.741; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Cole AR, 2008, J BIOL CHEM, V283, P18227, DOI 10.1074/jbc.M801645200; Connell JW, 2001, FEBS LETT, V493, P40, DOI 10.1016/S0014-5793(01)02267-0; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; Fanghanel J, 2006, FEBS LETT, V580, P3237, DOI 10.1016/j.febslet.2006.04.087; Fischer D, 2007, BIOCHEMISTRY-US, V46, P2574, DOI 10.1021/bi061318s; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Han D, 2009, NEUROCHEM INT, V54, P14, DOI 10.1016/j.neuint.2008.09.014; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 2006, NEUROPATHOLOGY, V26, P484, DOI 10.1111/j.1440-1789.2006.00666.x; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Horowitz PM, 2006, BIOCHEMISTRY-US, V45, P12859, DOI 10.1021/bi061325g; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Imahori K, 1997, J BIOCHEM, V121, P179; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Kins S, 2001, J BIOL CHEM, V276, P38193; Krishnamurthy PK, 2004, J BIOL CHEM, V279, P7893, DOI 10.1074/jbc.M311203200; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; Mack TGA, 2001, NEUROSCIENCE, V108, P701, DOI 10.1016/S0306-4522(01)00434-1; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; Matsumura N, 1999, AM J PATHOL, V154, P1649, DOI 10.1016/S0002-9440(10)65420-X; Miyasaka T, 2001, AM J PATHOL, V158, P373, DOI 10.1016/S0002-9440(10)63979-X; Morfini G, 2007, J NEUROSCI RES, V85, P2620, DOI 10.1002/jnr.21154; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Rizzu P, 2000, HUM MOL GENET, V9, P3075, DOI 10.1093/hmg/9.20.3075; Sahara N, 2000, J NEUROSCI RES, V60, P380, DOI 10.1002/(SICI)1097-4547(20000501)60:3<380::AID-JNR13>3.0.CO;2-5; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Sakaue F, 2005, J BIOL CHEM, V280, P31522, DOI 10.1074/jbc.M504792200; Sasaki T, 2002, J BIOL CHEM, V277, P36032, DOI 10.1074/jbc.M206674200; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; Tatebayashi Y, 2006, FASEB J, V20, P762, DOI 10.1096/fj.05-4362fje; van Swieten JC, 1999, ANN NEUROL, V46, P617, DOI 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; YAMAMOTO H, 1995, J BIOCHEM-TOKYO, V118, P1224, DOI 10.1093/oxfordjournals.jbchem.a125011; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	63	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16840	16847		10.1074/jbc.M109.003277	http://dx.doi.org/10.1074/jbc.M109.003277			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19401603	hybrid, Green Published			2022-12-27	WOS:000266962400020
J	An, CJ; Ishibashi, J; Ragan, EJ; Jiang, HB; Kanost, MR				An, Chunju; Ishibashi, Jun; Ragan, Emily J.; Jiang, Haobo; Kanost, Michael R.			Functions of Manduca sexta Hemolymph Proteinases HP6 and HP8 in Two Innate Immune Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPHENOLOXIDASE-ACTIVATING PROTEINASE-2; SERINE PROTEASES; TOBACCO HORNWORM; DROSOPHILA TOLL; IN-VITRO; RECOGNITION; SYSTEM; INSECT; PEPTIDOGLYCAN; INFECTION	Serine proteinases in insect plasma have been implicated in two types of immune responses; that is, activation of prophenoloxidase (proPO) and activation of cytokine-like proteins. We have identified more than 20 serine proteinases in hemolymph of the tobacco hornworm, Manduca sexta, but functions are known for only a few of them. We report here functions of two additional M. sexta proteinases, hemolymph proteinases 6 and 8 (HP6 and HP8). HP6 and HP8 are each composed of an amino-terminal clip domain and a carboxyl-terminal proteinase domain. HP6 is an apparent ortholog of Drosophila Persephone, whereas HP8 is most similar to Drosophila and Tenebrio spatzle-activating enzymes, all of which activate the Toll pathway. proHP6 and proHP8 are expressed constitutively in fat body and hemocytes and secreted into plasma, where they are activated by proteolytic cleavage in response to infection. To investigate activation and biological activity of HP6 and HP8, we purified recombinant proHP8, proHP6, and mutants of proHP6 in which the catalytic serine was replaced with alanine, and/or the activation site was changed to permit activation by bovine factor Xa. HP6 was found to activate proPO-activating proteinase (proPAP1) in vitro and induce proPO activation in plasma. HP6 was also determined to activate proHP8. Active HP6 or HP8 injected into larvae induced expression of antimicrobial peptides and proteins, including attacin, cecropin, gloverin, moricin, and lysozyme. Our results suggest that proHP6 becomes activated in response to microbial infection and participates in two immune pathways; activation of PAP1, which leads to proPO activation and melanin synthesis, and activation of HP8, which stimulates a Toll-like pathway.	[An, Chunju; Ragan, Emily J.; Kanost, Michael R.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Ishibashi, Jun] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Jiang, Haobo] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	Kansas State University; National Institute of Agrobiological Sciences - Japan; Oklahoma State University System; Oklahoma State University - Stillwater	Kanost, MR (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	kanost@ksu.edu		Kanost, Michael/0000-0002-6827-0061; Jiang, Haobo/0000-0003-1357-1315	National Institutes of Health [GM41247, GM58643]; National Center for Research Resources, Department of Health and Human Services, National Institutes of Health [P20 RR-016464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041247, R37GM041247, R29GM041247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM41247 and GM58643. This is Contribution 07-125 from the Kansas Agricultural Experiment Station.; We thank Peter Dunn for antiserum to M. sexta lysozyme and Maureen Gorman for helpful comments on the manuscript. Protein digestion and mass spectrometry was performed by the Nevada Proteomics Center at the University of Nevada, which is supported by P20 RR-016464 from the IDeA Network of Biomedical Research Excellence Program of the National Center for Research Resources, Department of Health and Human Services, National Institutes of Health.	Ashida Masaaki, 1998, P135; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Coligan JE, 1995, CURRENT PROTOCOLS PR; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; DUNN PE, 1983, J INVERTEBR PATHOL, V41, P77, DOI 10.1016/0022-2011(83)90238-0; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Huang RD, 2007, BIOCHEMISTRY-US, V46, P11431, DOI 10.1021/bi7010724; HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kurata S, 2006, IMMUNOBIOLOGY, V211, P237, DOI 10.1016/j.imbio.2005.10.016; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Saux A, 2008, J MOL BIOL, V377, P902, DOI 10.1016/j.jmb.2008.01.045; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Levitin A, 2008, CELL MICROBIOL, V10, P1021, DOI 10.1111/j.1462-5822.2008.01120.x; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Osaki T, 2004, CELL MOL LIFE SCI, V61, P1257, DOI 10.1007/s00018-004-3396-5; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Sim RB, 2004, BIOCHEM SOC T, V32, P21, DOI 10.1042/BST0320021; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang Y, 2006, J BIOL CHEM, V281, P9271, DOI 10.1074/jbc.M513797200; Wang Y, 2008, INSECT BIOCHEM MOLEC, V38, P763, DOI 10.1016/j.ibmb.2008.04.008; Wang Y, 2007, INSECT BIOCHEM MOLEC, V37, P1015, DOI 10.1016/j.ibmb.2007.05.013; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	54	127	139	3	46	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19716	19726		10.1074/jbc.M109.007112	http://dx.doi.org/10.1074/jbc.M109.007112			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19487692	hybrid, Green Published			2022-12-27	WOS:000267908300062
J	Molle, D; Segura-Morales, C; Camus, G; Berlioz-Torrent, C; Kjems, J; Basyuk, E; Bertrand, E				Molle, Dorothee; Segura-Morales, Carolina; Camus, Gregory; Berlioz-Torrent, Clarisse; Kjems, Jorgen; Basyuk, Eugenia; Bertrand, Edouard			Endosomal Trafficking of HIV-1 Gag and Genomic RNAs Regulates Viral Egress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATE-BUDDING DOMAINS; VIRUS TYPE-1 GAG; PLASMA-MEMBRANE; LIVE CELLS; MULTIVESICULAR BODIES; PRIMARY MACROPHAGES; ENV INCORPORATION; INFECTIOUS HIV-1; MATRIX PROTEIN; IN-VITRO	HIV-1 Gag can assemble and generate virions at the plasma membrane, but it is also present in endosomes where its role remains incompletely characterized. Here, we show that HIV-1 RNAs and Gag are transported on endosomal vesicles positive for TiVamp, a v-SNARE involved in fusion events with the plasma membrane. Inhibition of endosomal traffic did not prevent viral release. However, inhibiting lysosomal degradation induced an accumulation of Gag in endosomes and increased viral production 7-fold, indicating that transport of Gag to lysosomes negatively regulates budding. This also suggested that endosomal Gag-RNA complexes could access retrograde pathways to the cell surface and indeed, depleting cells of TiVamp-reduced viral production. Moreover, inhibition of endosomal transport prevented the accumulation of Gag at sites of cellular contact. HIV-1 Gag could thus generate virions using two pathways, either directly from the plasma membrane or through an endosome-dependent route. Endosomal Gag-RNA complexes may be delivered at specific sites to facilitate cell-to-cell viral transmission.	[Molle, Dorothee; Segura-Morales, Carolina; Basyuk, Eugenia; Bertrand, Edouard] IGMM, CNRS, UMR5535, Inst Federatif Rech 3, F-34293 Montpellier 5, France; [Camus, Gregory; Berlioz-Torrent, Clarisse] Univ Paris 05, CNRS, UMR8104, Inst Cochin, Paris, France; [Camus, Gregory; Berlioz-Torrent, Clarisse] INSERM, U567, F-75014 Paris, France; [Kjems, Jorgen] Aarhus Univ, DK-8000 Aarhus C, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Aarhus University	Bertrand, E (corresponding author), IGMM, CNRS, UMR5535, Inst Federatif Rech 3, 1919 Route Mende, F-34293 Montpellier 5, France.	Edouard.Bertrand@igmm.cnrs.fr	Morales, Carolina Segura/AAL-1694-2021; Kjems, Jorgen/I-3490-2016; BERLIOZ-TORRENT, clarisse/F-2570-2013; Segura Morales, Carolina/H-7862-2015	Morales, Carolina Segura/0000-0002-1746-6865; Kjems, Jorgen/0000-0003-4128-9317; Segura Morales, Carolina/0000-0002-1746-6865; bertrand, edouard/0000-0002-9642-7994; Basyuk, Eugenia/0000-0001-9768-4557	EURASNET; ANRS; SIDACTION	EURASNET; ANRS(ANRSFrench National Research Agency (ANR)); SIDACTION	This work was supported in part by EURASNET, ANRS, and SIDACTION.	Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Basyuk E, 2003, DEV CELL, V5, P161, DOI 10.1016/S1534-5807(03)00188-6; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Blot G, 2003, J VIROL, V77, P6931, DOI 10.1128/JVI.77.12.6931-6945.2003; Boireau S, 2007, J CELL BIOL, V179, P291, DOI 10.1083/jcb.200706018; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goff A, 2003, J VIROL, V77, P9173, DOI 10.1128/JVI.77.17.9173-9182.2003; Gottlinger HG, 2001, AIDS, V15, pS13; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; Harila K, 2007, VIROLOGY, V369, P299, DOI 10.1016/j.virol.2007.08.009; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Ikeda Y, 2003, NAT BIOTECHNOL, V21, P569, DOI 10.1038/nbt815; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Muriaux D, 2001, P NATL ACAD SCI USA, V98, P5246, DOI 10.1073/pnas.091000398; Muzerelle A, 2003, NEUROSCIENCE, V122, P59, DOI 10.1016/S0306-4522(03)00567-0; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perez-Caballero D, 2004, J VIROL, V78, P9560, DOI 10.1128/JVI.78.17.9560-9563.2004; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Proux-Gillardeaux V, 2005, TRAFFIC, V6, P366, DOI 10.1111/j.1600-0854.2005.00288.x; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Sharova N, 2005, EMBO J, V24, P2481, DOI 10.1038/sj.emboj.7600707; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tritel M, 2000, J VIROL, V74, P5845, DOI 10.1128/JVI.74.13.5845-5855.2000; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	75	45	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19727	19743		10.1074/jbc.M109.019844	http://dx.doi.org/10.1074/jbc.M109.019844			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19451649	Green Published, hybrid			2022-12-27	WOS:000267908300063
J	Nagatoshi, Y; Nakamura, T				Nagatoshi, Yukari; Nakamura, Tatsuo			Arabidopsis HARMLESS TO OZONE LAYER Protein Methylates a Glucosinolate Breakdown Product and Functions in Resistance to Pseudomonas syringae pv. maculicola	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORINE EMISSIONS INVENTORY; BRASSICA-OLERACEA; BIOSYNTHESIS; METHYLTRANSFERASE; METHANETHIOL; TRANSFERASE; METABOLISM; INDOLE-3-ACETONITRILE; PURIFICATION; HALOMETHANES	Almost all of the chlorine-containing gas emitted from natural sources is methyl chloride (CH3Cl), which contributes to the destruction of the stratospheric ozone layer. Tropical and subtropical plants emit substantial amounts of CH3Cl. A gene involved in CH3Cl emission from Arabidopsis was previously identified and designated HARMLESS TO OZONE LAYER (hereafter AtHOL1) based on the mutant phenotype. Our previous studies demonstrated that AtHOL1 and its homologs, AtHOL2 and AtHOL3, have S-adenosyl-L-methionine-dependent methyltransferase activities. However, the physiological functions of AtHOLs have yet to be elucidated. In the present study, our comparative kinetic analyses with possible physiological substrates indicated that all of the AtHOLs have low activities toward chloride. AtHOL1 was highly reactive to thiocyanate (NCS-), a pseudohalide, synthesizing methylthiocyanate (CH3SCN) with a very high k(cat)/K-m value. We demonstrated in vivo that substantial amounts of NCS- were synthesized upon tissue damage in Arabidopsis and that NCS- was largely derived from myrosinase-mediated hydrolysis of glucosinolates. Analyses with the T-DNA insertion Arabidopsis mutants (hol1, hol2, and hol3) revealed that only hol1 showed increased sensitivity to NCS- in medium and a concomitant lack of CH3SCN synthesis upon tissue damage. Bacterial growth assays indicated that the conversion of NCS- into CH3SCN dramatically increased antibacterial activities against Arabidopsis pathogens that normally invade the wound site. Furthermore, hol1 seedlings showed an increased susceptibility toward an Arabidopsis pathogen, Pseudomonas syringae pv. maculicola. Here we propose that AtHOL1 is involved in glucosinolate metabolism and defense against phytopathogens. Moreover, CH3Cl synthesized by AtHOL1 could be considered a byproduct of NCS- metabolism.	[Nagatoshi, Yukari; Nakamura, Tatsuo] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Kanagawa 2408501, Japan	Yokohama National University	Nakamura, T (corresponding author), 79-7 Tokiwadai,Hodogaya Ku, Kanagawa 2408501, Japan.	t-nakamu@ynu.ac.jp	Nakamura, Tatsuo/AAI-9172-2020; Nakamura, Tatsuo/C-2826-2013	Nakamura, Tatsuo/0000-0002-8761-0498; Nakamura, Tatsuo/0000-0002-8761-0498; Nagatoshi, Yukari/0000-0002-9029-7826	Ministry of Education, Science, Sports, and Culture of Japan [19780249]; Sasagawa Scientific Research Grant from the Japan Science Society; ESPEC Foundation for Global Environmental Research and Technology	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sasagawa Scientific Research Grant from the Japan Science Society; ESPEC Foundation for Global Environmental Research and Technology	This work was supported by Grant-in-aid for Scientific Research 19780249 from the Ministry of Education, Science, Sports, and Culture of Japan ( to T. N.), a Sasagawa Scientific Research Grant from the Japan Science Society ( to Y. N.), and a research grant from the ESPEC Foundation for Global Environmental Research and Technology ( to T. N.).	Agerbirk N, 1998, J AGR FOOD CHEM, V46, P1563, DOI 10.1021/jf9708498; Agerbirk N, 2009, PHYTOCHEM REV, V8, P101, DOI 10.1007/s11101-008-9098-0; Attieh J, 2000, PLANT CELL ENVIRON, V23, P165, DOI 10.1046/j.1365-3040.2000.00541.x; Attieh J, 2002, PLANT MOL BIOL, V50, P511, DOI 10.1023/A:1019865829534; ATTIEH JM, 1995, J BIOL CHEM, V270, P9250, DOI 10.1074/jbc.270.16.9250; BATES TS, 1992, J ATMOS CHEM, V14, P315, DOI 10.1007/BF00115242; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Bones AM, 2006, PHYTOCHEMISTRY, V67, P1053, DOI 10.1016/j.phytochem.2006.02.024; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Brown J., 2005, GLUCOSINOLATE CONTAI; CAMMUE BPA, 1992, J BIOL CHEM, V267, P2228; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Vos M, 2008, PLANT PHYSIOL, V146, P916, DOI 10.1104/pp.107.112185; DOUGHTY KJ, 1991, ANN APPL BIOL, V118, P469, DOI 10.1111/j.1744-7348.1991.tb05648.x; Feder R, 2000, J BIOL CHEM, V275, P4230, DOI 10.1074/jbc.275.6.4230; Goyer A, 2007, PLANT CELL PHYSIOL, V48, P232, DOI 10.1093/pcp/pcl055; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Harper DB, 2003, CHEMOSPHERE, V52, P433, DOI 10.1016/S0045-6535(03)00206-6; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; JU HY, 1983, J CHEM ECOL, V9, P1255, DOI 10.1007/BF00982227; Kabisch U, 2005, MICROBIOL-SGM, V151, P269, DOI 10.1099/mic.0.27491-0; Khalil MAK, 1999, J GEOPHYS RES-ATMOS, V104, P8333, DOI 10.1029/1998JD100079; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Lobert JM, 1999, J GEOPHYS RES-ATMOS, V104, P8373, DOI 10.1029/1998JD100077; MASDUKI A, 1995, J BACTERIOL, V177, P948, DOI 10.1128/jb.177.4.948-952.1995; MIDORIKAWA K, 2009, PLANT BIOTE IN PRESS, V26; Nagatoshi Y, 2007, PLANT BIOTECHNOL-NAR, V24, P503, DOI 10.5511/plantbiotechnology.24.503; Ni XH, 1998, P NATL ACAD SCI USA, V95, P12866, DOI 10.1073/pnas.95.22.12866; Ni XH, 1999, P NATL ACAD SCI USA, V96, P3611, DOI 10.1073/pnas.96.7.3611; OHGA T, 1993, FEMS MICROBIOL LETT, V113, P63; Pedras MSC, 2002, PHYTOCHEMISTRY, V59, P611, DOI 10.1016/S0031-9422(02)00026-2; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Rhew RC, 2003, CURR BIOL, V13, P1809, DOI 10.1016/j.cub.2003.09.055; Rhew RC, 2002, BIOGEOCHEMISTRY, V60, P141, DOI 10.1023/A:1019812006560; Rostas M, 2002, J CHEM ECOL, V28, P2449, DOI 10.1023/A:1021427917603; SAINI HS, 1995, PLANT CELL ENVIRON, V18, P1027, DOI 10.1111/j.1365-3040.1995.tb00613.x; Saito T, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000127; SAITO T, 2008, GEOPHYS RES IN PRESS, V35; Saito T, 2006, ATMOS ENVIRON, V40, P2806, DOI 10.1016/j.atmosenv.2006.01.016; Sasaki-Sekimoto Y, 2005, PLANT J, V44, P653, DOI 10.1111/j.1365-313X.2005.02560.x; STIEHL B, 1989, HORTSCIENCE, V24, P99; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; *WORLD MET ORG, 2007, 50 WORLD MET ORG; WUOSMAA AM, 1990, SCIENCE, V249, P160, DOI 10.1126/science.2371563; Yokouchi Y, 2002, NATURE, V416, P163, DOI 10.1038/416163a	48	31	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19301	19309		10.1074/jbc.M109.001032	http://dx.doi.org/10.1074/jbc.M109.001032			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19419967	Green Published, hybrid			2022-12-27	WOS:000267908300021
J	Hayes, D; Napoli, V; Mazurkie, A; Stafford, WF; Graceffa, P				Hayes, David; Napoli, Vanessa; Mazurkie, Andrew; Stafford, Walter F.; Graceffa, Philip			Phosphorylation Dependence of Hsp27 Multimeric Size and Molecular Chaperone Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ALPHA-CRYSTALLIN DOMAIN; SELF-ASSOCIATION; SEDIMENTATION-VELOCITY; THERMAL-DENATURATION; SUBUNIT INTERACTIONS; PROTECTIVE ACTIVITY; NONNATIVE PROTEIN; STRESS-PROTEIN; MAPKAP KINASE	The molecular chaperone Hsp27 exists as a distribution of large oligomers that are disassembled by phosphorylation at Ser-15, -78, and -82. It is controversial whether the unphosphorylated Hsp27 or the widely used triple Ser-to-Asp phosphomimic mutant is the more active molecular chaperone in vitro. This question was investigated here by correlating chaperone activity, as measured by the aggregation of reduced insulin or alpha-lactalbumin, with Hsp27 self-association as monitored by analytical ultracentrifugation. Furthermore, because the phosphomimic is generally assumed to reproduce the phosphorylated molecule, the size and chaperone activity of phosphorylated Hsp27 were compared with that of the phospho-mimic. Hsp27 was triply phosphorylated by MAPKAP-2 kinase, and phosphorylation was tracked by urea-PAGE. An increasing degree of suppression of insulin or alpha-lactalbumin aggregation correlated with a decreasing Hsp27 self-association, which was the least for phosphorylated Hsp27 followed by the mimic followed by the unphosphorylated protein. It was also found that Hsp27 added to pre-aggregated insulin did not reverse aggregation but did inhibit these aggregates from assembling into even larger aggregates. This chaperone activity appears to be independent of Hsp27 phosphorylation. In conclusion, the most active chaperone of insulin and alpha-lactalbumin was the Hsp27 ( elongated) dimer, the smallest Hsp27 subunit observed under physiological conditions. Next, the Hsp27 phospho-mimic is only a partial mimic of phosphorylated Hsp27, both in self-association and in chaperone function. Finally, the efficient inhibition of insulin aggregation by Hsp27 dimer led to the proposal of two models for this chaperone activity.	[Hayes, David; Napoli, Vanessa; Mazurkie, Andrew; Stafford, Walter F.; Graceffa, Philip] Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Graceffa, P (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	Graceffa@bbri.org	Stafford, Walter/ABC-6553-2020; Hayes, David B/CAH-1880-2022	Hayes, David B/0000-0002-1133-3471	National Institutes of Health [HL66219, AR41637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR041637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL66219 and AR41637. This work was also supported by an American Heart Association post-doctoral fellowship (to A. M.) and a Boston Biomedical Research Institute pilot grant.	AGRAWAL HC, 1982, BIOCHEM J, V201, P39, DOI 10.1042/bj2010039; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Berengian AR, 1999, J BIOL CHEM, V274, P6305, DOI 10.1074/jbc.274.10.6305; Chernik IS, 2004, BIOCHEM BIOPH RES CO, V324, P1199, DOI 10.1016/j.bbrc.2004.09.176; Chiou YW, 2008, BBA-MOL BASIS DIS, V1782, P169, DOI 10.1016/j.bbadis.2007.12.010; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Diaz-Latoud C, 2005, ANTIOXID REDOX SIGN, V7, P436, DOI 10.1089/ars.2005.7.436; Dillmann WH, 1999, ANN NY ACAD SCI, V874, P66, DOI 10.1111/j.1749-6632.1999.tb09225.x; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; Geum D, 2002, J BIOL CHEM, V277, P19913, DOI 10.1074/jbc.M104396200; Gusev NB, 2002, BIOCHEMISTRY-MOSCOW+, V67, P511, DOI 10.1023/A:1015549725819; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; HARISANOVA NT, 1986, MOL BIOL REP, V11, P199, DOI 10.1007/BF00419597; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hayley M, 2008, J MUSCLE RES CELL M, V29, P101, DOI 10.1007/s10974-008-9143-z; KATO K, 1994, J BIOL CHEM, V269, P11274; KNAUF U, 1994, EMBO J, V13, P54, DOI 10.1002/j.1460-2075.1994.tb06234.x; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LANDRY J, 1992, J BIOL CHEM, V267, P794; Larsen JK, 1997, AM J PHYSIOL-LUNG C, V273, pL930, DOI 10.1152/ajplung.1997.273.5.L930; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Lelj-Garolla B, 2005, J MOL BIOL, V345, P631, DOI 10.1016/j.jmb.2004.10.056; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; Markov DI, 2008, FEBS LETT, V582, P1407, DOI 10.1016/j.febslet.2008.03.035; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P14627, DOI 10.1021/bi971700s; MIRON T, 1988, EUR J BIOCHEM, V178, P543, DOI 10.1111/j.1432-1033.1988.tb14481.x; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; PAL BK, 1975, J VIROL, V16, P123, DOI 10.1128/JVI.16.1.123-131.1975; Panasenko OO, 2002, BBA-PROTEINS PROTEOM, V1601, P64, DOI 10.1016/S1570-9639(02)00430-2; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; Pivovarova AV, 2005, BIOCHEM BIOPH RES CO, V331, P1548, DOI 10.1016/j.bbrc.2005.04.077; Roberts CJ, 2007, BIOTECHNOL BIOENG, V98, P927, DOI 10.1002/bit.21627; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; SANGER F, 1949, BIOCHEM J, V44, P126, DOI 10.1042/bj0440126; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Theriault JR, 2004, J BIOL CHEM, V279, P23463, DOI 10.1074/jbc.M402325200; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Van Montfort RLM, 2003, PROTEIN SCI, V12, P2606, DOI 10.1110/ps.03265903; Welsh MJ, 1998, ANN NY ACAD SCI, V851, P28, DOI 10.1111/j.1749-6632.1998.tb08973.x; Zavialov A, 1998, INT J BIOL MACROMOL, V22, P163, DOI 10.1016/S0141-8130(98)00014-2; Zavialov AV, 1998, BBA-PROTEIN STRUCT M, V1388, P123, DOI 10.1016/S0167-4838(98)00172-1	50	100	104	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18801	18807		10.1074/jbc.M109.011353	http://dx.doi.org/10.1074/jbc.M109.011353			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19411251	hybrid, Green Published			2022-12-27	WOS:000267711500029
J	Nguyen, T; Lindner, R; Tedeschi, A; Forsberg, K; Green, A; Wuttke, A; Gaub, P; Di Giovanni, S				Nguyen, Tuan; Lindner, Ricco; Tedeschi, Andrea; Forsberg, Kirsi; Green, Andrew; Wuttke, Anja; Gaub, Perrine; Di Giovanni, Simone			NFAT-3 Is a Transcriptional Repressor of the Growth-associated Protein 43 during Neuronal Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; GAP-43 PROMOTER; AXON GROWTH; MOUSE-BRAIN; CALCINEURIN; ACTIVATION; DIFFERENTIATION; REGENERATION	Transcription is essential for neurite and axon outgrowth during development. Recent work points to the involvement of nuclear factor of activated T cells ( NFAT) in the regulation of genes important for axon growth and guidance. However, NFAT has not been reported to directly control the transcription of axon outgrowth-related genes. To identify transcriptional targets, we performed an in silico promoter analysis and found a putative NFAT site within the GAP-43 promoter. Using in vitro and in vivo experiments, we demonstrated that NFAT-3 regulates GAP-43, but unexpectedly, does not promote but represses the expression of GAP-43 in neurons and in the developing brain. Specifically, in neuron-like PC-12 cells and in cultured cortical neurons, the overexpression of NFAT-3 represses GAP-43 activation mediated by neurotrophin signaling. Using chromatin immunoprecipitation assays, we also show that prior to neurotrophin activation, endogenous NFAT-3 occupies the GAP-43 promoter in PC-12 cells, in cultured neurons, and in the mouse brain. Finally, we observe that NFAT-3 is required to repress the physiological expression of GAP-43 and other proaxon outgrowth genes in specific developmental windows in the mouse brain. Taken together, our data reveal an unexpected role for NFAT-3 as a direct transcriptional repressor of GAP-43 expression and suggest a more general role for NFAT-3 in the control of the neuronal outgrowth program.	[Nguyen, Tuan; Lindner, Ricco; Tedeschi, Andrea; Forsberg, Kirsi; Green, Andrew; Wuttke, Anja; Gaub, Perrine; Di Giovanni, Simone] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol, Lab NeuroRegenerat & Repair, D-72076 Tubingen, Germany; [Lindner, Ricco; Tedeschi, Andrea; Forsberg, Kirsi; Gaub, Perrine] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Di Giovanni, S (corresponding author), Otfried Mueller Str 27, D-72076 Tubingen, Germany.	simone.digiovanni@medizin.uni-tuebingen.de		Green, Andrew/0000-0002-1077-7417	National Institutes of Health [R21 NS052640]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 NS052640 (to S. D. I.). This work was also supported by grants from the Hertie Foundation; the Fortune Grant, University of Tuebingen; and Deutsche Forschungsgemeinschaft Grant DI 1497/1-1 ( to S. D. I.).	AIGNER L, 1993, J CELL BIOL, V123, P417, DOI 10.1083/jcb.123.2.417; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BENOWITZ LI, 1990, PROG BRAIN RES, V86, P309; Bradley KC, 2005, J NEUROSCI RES, V82, P762, DOI 10.1002/jnr.20695; Chen Lin, 1999, Current Opinion in Structural Biology, V9, P48; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; DELAMONTE SM, 1989, DEV BRAIN RES, V46, P161, DOI 10.1016/0165-3806(89)90279-4; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Gianola S, 2004, EUR J NEUROSCI, V19, P819, DOI 10.1111/j.0953-816X.2004.03190.x; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Groth RD, 2008, EUR J NEUROSCI, V27, P31, DOI 10.1111/j.1460-9568.2007.05980.x; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Im SH, 2004, MOL CELLS, V18, P1; JACOBSON RD, 1986, J NEUROSCI, V6, P1843; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; MAHALIK TJ, 1992, DEV BRAIN RES, V67, P75, DOI 10.1016/0165-3806(92)90027-T; Namgung U, 2000, EUR J NEUROSCI, V12, P3124, DOI 10.1046/j.1460-9568.2000.00196.x; NEDIVI E, 1992, J NEUROSCI, V12, P691; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Ogata K, 2003, CURR OPIN STRUC BIOL, V13, P40, DOI 10.1016/S0959-440X(03)00012-5; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Ooi L, 2008, BIOCHEM J, V414, P327, DOI 10.1042/BJ20080963; Plyte S, 2001, J BIOL CHEM, V276, P14350, DOI 10.1074/jbc.M007854200; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; REINHARD E, 1994, DEVELOPMENT, V120, P1767; Reinhard E, 1992, Perspect Dev Neurobiol, V1, P29; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Seybold VS, 2006, J NEUROCHEM, V97, P397, DOI 10.1111/j.1471-4159.2006.03744.x; STARR RG, 1994, BRAIN RES, V638, P211, DOI 10.1016/0006-8993(94)90652-1; Tedeschi A, 2009, CELL DEATH DIFFER, V16, P543, DOI 10.1038/cdd.2008.175; VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505; Vihma H, 2008, GENOMICS, V92, P279, DOI 10.1016/j.ygeno.2008.06.011; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Yoshida T, 2005, J NEUROSCI, V25, P3067, DOI 10.1523/JNEUROSCI.3738-04.2005	51	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18816	18823		10.1074/jbc.M109.015719	http://dx.doi.org/10.1074/jbc.M109.015719			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19443652	Green Published, hybrid			2022-12-27	WOS:000267711500031
J	Zhou, JG; Feng, X; Ban, B; Liu, JX; Wang, Z; Xiao, WH				Zhou, Jiangang; Feng, Xi; Ban, Bin; Liu, Jingxia; Wang, Zhou; Xiao, Wuhan			Elongation Factor ELL (Eleven-Nineteen Lysine-rich Leukemia) Acts as a Transcription Factor for Direct Thrombospondin-1 Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED LINEAGE LEUKEMIA; ACUTE MYELOID-LEUKEMIA; MLL-ELL; TUMOR-GROWTH; STEM-CELLS; GENE; EXPRESSION; ANGIOGENESIS; P53; POLYMERASE	The eleven-nineteen lysine-rich leukemia (ELL) gene undergoes translocation and fuses in-frame to the multiple lineage leukemia gene in a substantial proportion of patients suffering from acute forms of leukemia. Studies show that ELL indirectly modulates transcription by serving as a regulator for transcriptional elongation as well as for p53, U19/Eaf2, and steroid receptor activities. Our in vitro and in vivo data demonstrate that ELL could also serve as a transcriptional factor to directly induce transcription of the thrombospondin-1 (TSP-1) gene. Experiments using ELL deletion mutants established that full-length ELL is required for the TSP-1 up-regulation and that the trans-activation domain likely resides in the carboxyl terminus. Moreover, the DNA binding domain may localize to the first 45 amino acids of ELL. Not surprisingly, multiple lineage leukemia-ELL, which lacks these amino acids, did not induce expression from the TSP-1 promoter. In addition, the ELL core-response element appears to localize in the -1426 to -1418 region of the TSP-1 promoter. Finally, studies using zebrafish confirmed that ELL regulates TSP-1 mRNA expression in vivo, and ELL could inhibit zebrafish vasculogenesis, at least in part, through up-regulating TSP-1. Given the importance of TSP-1 as an anti-angiogenic protein, our findings may have important ramifications for better understanding cancer.	[Zhou, Jiangang; Feng, Xi; Ban, Bin; Liu, Jingxia; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan 430072, Peoples R China; [Wang, Zhou] Univ Pittsburgh, Inst Canc, Dept Urol, Sch Med, Pittsburgh, PA 15232 USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Feng, Xi/N-7160-2016; Xiao, Wuhan/GLU-7352-2022	Feng, Xi/0000-0002-6920-1519; 	National Natural Science Foundation of China Grant (Youth Foundation) [30700440]	National Natural Science Foundation of China Grant (Youth Foundation)(National Natural Science Foundation of China (NSFC))	Supported by National Natural Science Foundation of China Grant (Youth Foundation) 30700440.	Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Cinatl J, 1999, AM J PATHOL, V155, P285, DOI 10.1016/S0002-9440(10)65122-X; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; DiMartino JF, 2000, BLOOD, V96, P3887, DOI 10.1182/blood.V96.12.3887.h8003887_3887_3893; Dou YL, 2008, INT J HEMATOL, V87, P10, DOI 10.1007/s12185-007-0009-8; Eguchi M, 2005, INT J HEMATOL, V82, P9, DOI 10.1532/IJH97.05042; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Hahn J, 2007, PROSTATE, V67, P146, DOI 10.1002/pros.20481; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Jiang F, 2007, CANCER LETT, V253, P265, DOI 10.1016/j.canlet.2007.02.003; Johnstone RW, 2001, MOL CELL BIOL, V21, P1672, DOI 10.1128/MCB.21.5.1672-1681.2001; Kong CT, 2006, LEUKEMIA, V20, P1829, DOI 10.1038/sj.leu.2404342; Kranenburg O, 2004, BBA-REV CANCER, V1654, P23, DOI 10.1016/j.bbcan.2003.09.004; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lavau C, 2000, P NATL ACAD SCI USA, V97, P10984, DOI 10.1073/pnas.190167297; Lawler J, 2001, AM J PATHOL, V159, P1949, DOI 10.1016/S0002-9440(10)63042-8; Liu H, 2008, CELL CYCLE, V7, P428, DOI 10.4161/cc.7.4.5426; Luo RT, 2001, MOL CELL BIOL, V21, P5678, DOI 10.1128/MCB.21.16.5678-5687.2001; Maki K, 1999, BLOOD, V93, P3216, DOI 10.1182/blood.V93.10.3216.410k45_3216_3224; Miller T, 2000, J BIOL CHEM, V275, P32052, DOI 10.1074/jbc.M005175200; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mitani K, 2000, BIOCHEM BIOPH RES CO, V279, P563, DOI 10.1006/bbrc.2000.3970; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P1158, DOI 10.1210/me.2004-0331; Reiher FK, 2001, J UROLOGY, V165, P2075, DOI 10.1016/S0022-5347(05)66297-0; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Sheibani N, 1996, CANCER LETT, V107, P45, DOI 10.1016/0304-3835(96)04341-8; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shilatifard A, 1997, J BIOL CHEM, V272, P22355, DOI 10.1074/jbc.272.35.22355; Shinobu N, 1999, J BIOL CHEM, V274, P17003, DOI 10.1074/jbc.274.24.17003; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Simone F, 2001, BLOOD, V98, P201, DOI 10.1182/blood.V98.1.201; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Wiederschain D, 2005, J BIOL CHEM, V280, P24315, DOI 10.1074/jbc.M412237200; Wiederschain D, 2003, MOL CELL BIOL, V23, P4230, DOI 10.1128/MCB.23.12.4230-4246.2003; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2006, PROSTATE, V66, P1, DOI 10.1002/pros.20309; Xiao WH, 2003, CANCER RES, V63, P4698; Yang ZG, 2001, DEV BIOL, V231, P138, DOI 10.1006/dbio.2000.0139; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; Zhong HB, 2006, P NATL ACAD SCI USA, V103, P16800, DOI 10.1073/pnas.0603959103	48	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19142	19152		10.1074/jbc.M109.010439	http://dx.doi.org/10.1074/jbc.M109.010439			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19447890	Green Published, hybrid			2022-12-27	WOS:000267711500062
J	Hoshino, T; Namba, T; Takehara, M; Nakaya, T; Sugimoto, Y; Araki, W; Narumiya, S; Suzuki, T; Mizushima, T				Hoshino, Tatsuya; Namba, Takushi; Takehara, Masaya; Nakaya, Tadashi; Sugimoto, Yukihiko; Araki, Wataru; Narumiya, Shuh; Suzuki, Toshiharu; Mizushima, Tohru			Prostaglandin E-2 Stimulates the Production of Amyloid-beta Peptides through Internalization of the EP4 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; AGONIST-INDUCED INTERNALIZATION; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; A-BETA; ENDOCYTIC PATHWAY; NEURODEGENERATIVE DISEASES; CARBOXYL-TERMINUS; TRANSGENIC MICE	Amyloid-beta (A beta) peptides, generated by the proteolysis of beta-amyloid precursor protein by beta- and gamma-secretases, play an important role in the pathogenesis of Alzheimer disease. Inflammation is also important. We recently reported that prostaglandin E-2 (PGE(2)), a strong inducer of inflammation, stimulates the production of A beta through EP2 and EP4 receptors, and here we have examined the molecular mechanism. Activation of EP2 and EP4 receptors is coupled to an increase in cellular cAMP levels and activation of protein kinase A (PKA). We found that inhibitors of adenylate cyclase and PKA suppress EP2, but not EP4, receptor-mediated stimulation of the A beta production. In contrast, inhibitors of endocytosis suppressed EP4, but not EP2, receptor-mediated stimulation. Activation of gamma-secretase was observed with the activation of EP4 receptors but not EP2 receptors. PGE(2)-dependent internalization of the EP4 receptor was observed, and cells expressing a mutant EP4 receptor lacking the internalization activity did not exhibit PGE(2)-stimulated production of A beta. A physical interaction between the EP4 receptor and PS-1, a catalytic subunit of gamma-secretases, was revealed by immunoprecipitation assays. PGE(2)-induced internalization of PS-1 and co-localization of EP4, PS-1, and Rab7 (a marker of late endosomes and lysosomes) was observed. Co-localization of PS-1 and Rab7 was also observed in the brain of wild-type mice but not of EP4 receptor null mice. These results suggest that PGE(2)-stimulated production of A beta involves EP4 receptor-mediated endocytosis of PS-1 followed by activation of the gamma-secretase, as well as EP2 receptor-dependent activation of adenylate cyclase and PKA, both of which are important in the inflammation-mediated progression of Alzheimer disease.	[Hoshino, Tatsuya; Namba, Takushi; Takehara, Masaya; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Nakaya, Tadashi; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Sugimoto, Yukihiko] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Araki, Wataru] Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Narumiya, Shuh] Kyoto Univ, Fac Med, Kyoto 6068501, Japan	Kumamoto University; Hokkaido University; Kyoto University; National Center for Neurology & Psychiatry - Japan; Kyoto University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp	Suzuki, Toshiharu/B-5342-2013; Araki, Wataru/G-7913-2014; Sugimoto, Yukihiko/AAV-6470-2021	Araki, Wataru/0000-0001-8467-6937; Sugimoto, Yukihiko/0000-0001-6973-932X	Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Science and Technology Agency	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid for scientific research from the Ministry of Health, Labor, and Welfare, Japan and the Ministry of Education, Culture, Sports, Science, and Technology, Japan and by the Japan Science and Technology Agency.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Andreasson KI, 2001, J NEUROSCI, V21, P8198; Bastepe M, 1997, MOL PHARMACOL, V51, P343, DOI 10.1124/mol.51.2.343; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; De Strooper B, 2000, J CELL SCI, V113, P1857; Desai S, 2000, MOL PHARMACOL, V58, P1279, DOI 10.1124/mol.58.6.1279; Desai S, 2001, FEBS LETT, V501, P156, DOI 10.1016/S0014-5793(01)02640-0; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gonzalez-Gaitan Marcos, 2003, Cell, V115, P513, DOI 10.1016/S0092-8674(03)00932-2; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Guo DF, 2001, CELL RES, V11, P165, DOI 10.1038/sj.cr.7290083; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Ho L, 2001, ARCH NEUROL-CHICAGO, V58, P487, DOI 10.1001/archneur.58.3.487; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Hoshino T, 2007, J BIOL CHEM, V282, P32676, DOI 10.1074/jbc.M703087200; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Kitamura Y, 1999, BIOCHEM BIOPH RES CO, V254, P582, DOI 10.1006/bbrc.1998.9981; KOO EH, 1994, J BIOL CHEM, V269, P17386; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Lee RKK, 1999, J NEUROSCI, V19, P940; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Montine TJ, 1999, NEUROLOGY, V53, P1495, DOI 10.1212/WNL.53.7.1495; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pooler AM, 2004, NEUROSCI LETT, V362, P127, DOI 10.1016/j.neulet.2004.03.013; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Qin WP, 2003, J BIOL CHEM, V278, P50970, DOI 10.1074/jbc.M307699200; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shie FS, 2005, AM J PATHOL, V166, P1163, DOI 10.1016/S0002-9440(10)62336-X; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Srinivasan B D, 1989, Prog Clin Biol Res, V312, P229; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; VANE J, 1994, NATURE, V367, P215, DOI 10.1038/367215a0; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X	60	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18493	18502		10.1074/jbc.M109.003269	http://dx.doi.org/10.1074/jbc.M109.003269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19407341	hybrid, Green Published			2022-12-27	WOS:000267712400060
J	Hsieh, JY; Chen, SH; Hung, HC				Hsieh, Ju-Yi; Chen, Shao-Hung; Hung, Hui-Chih			Functional Roles of the Tetramer Organization of Malic Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VELOCITY ANALYTICAL ULTRACENTRIFUGATION; SIZE-DISTRIBUTION ANALYSIS; OXIDATIVE DECARBOXYLASES; STRUCTURAL STABILITY; SUBUNIT INTERACTIONS; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; ADRENAL-CORTEX; CDNA CLONING; RAT-LIVER	Malic enzyme has a dimer of dimers quaternary structure in which the dimer interface associates more tightly than the tetramer interface. In addition, the enzyme has distinct active sites within each subunit. The mitochondrial NAD(P)(+)-dependent malic enzyme (m-NAD(P)-ME) isoform behaves cooperatively and allosterically and exhibits a quaternary structure in dimertetramer equilibrium. The cytosolic NADP(+)-dependent malic enzyme (c-NADP-ME) isoform is noncooperative and nonallosteric and exists as a stable tetramer. In this study, we analyze the essential factors governing the quaternary structure stability for human c-NADP-ME and m-NAD(P)-ME. Site-directed mutagenesis at the dimer and tetramer interfaces was employed to generate a series of dimers of c-NADP-ME and m-NAD(P)ME. Size distribution analysis demonstrated that human c-NADP-ME exists mainly as a tetramer, whereas human m-NAD(P)-ME exists as a mixture of dimers and tetramers. Kinetic data indicated that the enzyme activity of c-NADP-ME is not affected by disruption of the interface. There are no significant differences in the kinetic properties between AB and AD dimers, and the dimeric form of c-NADP-ME is as active as tetramers. In contrast, disrupting the interface of m-NAD(P)-ME causes the enzyme to be less active than wild type and to become less cooperative for malate binding; the k(cat) values of mutants decreased with increasing K-d,K-24 values, indicating that the dissociation of subunits at the dimer or tetramer interfaces significantly affects the enzyme activity. The above results suggest that the tetramer is required for a fully functional m-NAD(P)-ME. Taken together, the analytical ultracentrifugation data and the kinetic analysis of these interface mutants demonstrate the differential role of tetramer organization for the c-NADP-ME and m-NAD(P)-ME isoforms. The regulatory mechanism of m-NAD(P)-ME is closely related to the tetramer formation of this isoform.	[Hsieh, Ju-Yi; Chen, Shao-Hung; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Bioinformat, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University	Hung, HC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, 250 Kuo Kuang Rd, Taichung 40227, Taiwan.	hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/L-8061-2019; Hung, Hui-Chih/G-4485-2013	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council [NSC-96-2311B-005-005]; Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by National Science Council Grant NSC-96-2311B-005-005 (to H.-C. H.) and in part by the Ministry of Education, Taiwan, under the Aiming for Top University plan.	BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; CHANG GG, 1991, EUR J BIOCHEM, V202, P681, DOI 10.1111/j.1432-1033.1991.tb16423.x; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Chang HC, 2003, J BIOL CHEM, V278, P23996, DOI 10.1074/jbc.M213242200; Chang HC, 2002, J BIOL CHEM, V277, P4663, DOI 10.1074/jbc.M111156200; Chang HC, 2007, BIOPHYS J, V93, P3977, DOI 10.1529/biophysj.107.111385; Chou WY, 1996, BIOCHEMISTRY-US, V35, P9873, DOI 10.1021/bi960200g; Chou WY, 1997, PROTEIN ENG, V10, P1205, DOI 10.1093/protein/10.10.1205; Coleman DE, 2002, BIOCHEMISTRY-US, V41, P6928, DOI 10.1021/bi0255120; Edens WA, 1997, BIOCHEMISTRY-US, V36, P1141, DOI 10.1021/bi962128s; FAHIEN LA, 1992, J BIOL CHEM, V267, P10411; Frenkel R, 1975, Curr Top Cell Regul, V9, P157; Hsieh JY, 2008, FEBS J, V275, P5383, DOI 10.1111/j.1742-4658.2008.06668.x; Hsieh JY, 2006, J BIOL CHEM, V281, P23237, DOI 10.1074/jbc.M603451200; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; Hsu WC, 2004, BIOCHEMISTRY-US, V43, P7382, DOI 10.1021/bi049600r; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Hung HC, 2005, BIOCHEMISTRY-US, V44, P12737, DOI 10.1021/bi050510b; Karsten WE, 2003, BIOCHEMISTRY-US, V42, P9712, DOI 10.1021/bi034101w; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LOEBER G, 1994, BIOCHEM J, V304, P687, DOI 10.1042/bj3040687; LOEBER G, 1994, FEBS LETT, V344, P181, DOI 10.1016/0014-5793(94)00386-6; LOEBER G, 1991, J BIOL CHEM, V266, P3016; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MCKEEHAN WL, 1982, CELL BIOL INT REP, V6, P635, DOI 10.1016/0309-1651(82)90125-4; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Rao GSJ, 2003, J BIOL CHEM, V278, P38051, DOI 10.1074/jbc.M305145200; Sanz N, 1997, BRIT J CANCER, V75, P487, DOI 10.1038/bjc.1997.85; SAUER LA, 1973, BIOCHEM BIOPH RES CO, V50, P524, DOI 10.1016/0006-291X(73)90871-1; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Tao X, 2003, STRUCTURE, V11, P1141, DOI 10.1016/S0969-2126(03)00168-0; TELLER JK, 1992, J BIOL CHEM, V267, P10423; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, PROTEIN SCI, V11, P332, DOI 10.1110/ps.38002; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8; ZOLNIEROWICZ S, 1988, BIOCHEM MED METAB B, V39, P208, DOI 10.1016/0885-4505(88)90078-3	44	25	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18096	18105		10.1074/jbc.M109.005082	http://dx.doi.org/10.1074/jbc.M109.005082			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416979	Green Published, hybrid			2022-12-27	WOS:000267712400021
J	Zhou, JM; Zhong, Q; Li, GL; Greenberg, ML				Zhou, Jingming; Zhong, Quan; Li, Guiling; Greenberg, Miriam L.			Loss of Cardiolipin Leads to Longevity Defects That Are Alleviated by Alterations in Stress Response Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL INTEGRITY PATHWAY; LIFE-SPAN EXTENSION; SUPPRESSES TEMPERATURE SENSITIVITY; YEAST SACCHAROMYCES-CEREVISIAE; RAT-LIVER MITOCHONDRIA; HIGH-OSMOLARITY; CALORIE RESTRICTION; LIPID-COMPOSITION; OUTER-MEMBRANE	Perturbation of cardiolipin (CL) synthesis in yeast cells leads to defective respiratory chain function and mitochondrial DNA loss, both of which have been implicated in aging in mammals. The availability of yeast CL mutants enabled us to directly investigate the role of CL synthesis in aging. In this report, we show that the replicative life span of pgs1 Delta, which lacks both CL and the precursor phosphatidylglycerol (PG), was significantly decreased at 30 degrees C. The life span of crd1 Delta, which has PG but not CL, was unaffected at 30 degrees C but reduced at 37 degrees C. Life span extension induced by calorie restriction was not affected by the loss of CL. However, mild heat and osmotic stress, which extend life span in wild type cells, did not increase longevity in CL mutants, suggesting that the stress response is perturbed in these mutants. Consistent with this, longevity defects in pgs1 Delta were alleviated by down-regulation of the high osmolarity glycerol stress response pathway, as well as by promoting cell integrity with the osmotic stabilizer sorbitol or via genetic suppression with the kre5(W1166X) mutant. These findings show for the first time that perturbation of CL synthesis leads to decreased longevity in yeast, which is restored by altering signaling through stress response pathways.	[Zhou, Jingming; Zhong, Quan; Li, Guiling; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	MLGREEN@sun.science.wayne.edu	zhong, quan/AAE-8893-2021	Zhong, Quan/0000-0003-2910-5597; He, Quan/0000-0001-7706-9960	National Institutes of Health [HL62263]; Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL62263. This work was also supported by a grant from the Barth Syndrome Foundation.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bonawitz ND, 2007, CELL CYCLE, V6, P1574, DOI 10.4161/cc.6.13.4457; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Ferreira FM, 2003, BBA-MOL BASIS DIS, V1639, P113, DOI 10.1016/j.bbadis.2003.08.001; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garcia-Rodriguez LJ, 2005, FEBS LETT, V579, P6186, DOI 10.1016/j.febslet.2005.10.001; Grethe S, 2004, EXP CELL RES, V298, P632, DOI 10.1016/j.yexcr.2004.05.007; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Harris N, 2003, FREE RADICAL BIO MED, V34, P1599, DOI 10.1016/S0891-5849(03)00210-7; Hayashi M, 2006, J BIOCHEM, V139, P797, DOI 10.1093/jb/mvj089; Heinisch JJ, 2005, BBA-PROTEINS PROTEOM, V1754, P171, DOI 10.1016/j.bbapap.2005.07.032; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; JANITOR M, 1993, CURR GENET, V24, P307, DOI 10.1007/BF00336781; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 1999, MOL MICROBIOL, V31, P373, DOI 10.1046/j.1365-2958.1999.01181.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kaeberlein M, 2004, GENETICS, V166, P1661, DOI 10.1534/genetics.166.4.1661; Kaeberlein M, 2002, GENETICS, V160, P83; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kirchman PA, 1999, GENETICS, V152, P179; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Korolyev E, 2005, FEMS MICROBIOL LETT, V244, P379, DOI 10.1016/j.femsle.2005.02.009; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Krantz M, 2004, EUKARYOT CELL, V3, P1381, DOI 10.1128/EC.3.6.1381-1390.2004; Laun P, 2007, NUCLEIC ACIDS RES, V35, P7514, DOI 10.1093/nar/gkm919; Lee JR, 2002, BIOCHEM J, V362, P395, DOI 10.1042/bj3620395; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lussier M, 1997, GENETICS, V147, P435; MAFTAH A, 1994, MECH AGEING DEV, V77, P83, DOI 10.1016/0047-6374(94)90017-5; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; McVey M, 2001, GENETICS, V157, P1531; Ostrander DB, 2001, J BIOL CHEM, V276, P25262, DOI 10.1074/jbc.M103689200; PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H; Peter PS, 2007, J CLIN INVEST, V117, P1335, DOI 10.1172/JCI29576; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Popolo L, 2001, MED MYCOL, V39, P111, DOI 10.1080/744118881; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; Sato H, 2007, SHOCK, V28, P291, DOI 10.1097/SHK.0b013e3180326e3d; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 1999, J LIPID RES, V40, P1585; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Shama S, 1998, EXP CELL RES, V245, P379, DOI 10.1006/excr.1998.4279; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Struchkov VA, 2002, BIOELECTROCHEMISTRY, V56, P195, DOI 10.1016/S1567-5394(02)00052-X; Swiecilo A, 2000, ACTA BIOCHIM POL, V47, P355; Tamas MJ, 2000, FEBS LETT, V472, P159, DOI 10.1016/S0014-5793(00)01445-9; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yaakov G, 2003, MOL CELL BIOL, V23, P4826, DOI 10.1128/MCB.23.14.4826-4840.2003; Zhong Q, 2005, BIOCHEM SOC T, V33, P1158, DOI 10.1042/BST0331158; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200	72	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18106	18114		10.1074/jbc.M109.003236	http://dx.doi.org/10.1074/jbc.M109.003236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19401462	hybrid, Green Published			2022-12-27	WOS:000267712400022
J	Horie, Y; Ito, H; Kusaba, M; Tanaka, R; Tanaka, A				Horie, Yukiko; Ito, Hisashi; Kusaba, Makoto; Tanaka, Ryouichi; Tanaka, Ayumi			Participation of Chlorophyll b Reductase in the Initial Step of the Degradation of Light-harvesting Chlorophyll a/b-Protein Complexes in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; ACCLIMATIVE PROTEOLYSIS; THYLAKOID MEMBRANES; DUNALIELLA-SALINA; ANTENNA SYSTEMS; OXYGENASE CAO; CONVERSION; SENESCENCE; PHOTOSYNTHESIS; BIOSYNTHESIS	The light-harvesting chlorophyll a/b-protein complex of photosystem II (LHCII) is the most abundant membrane protein in green plants, and its degradation is a crucial process for the acclimation to high light conditions and for the recovery of nitrogen (N) and carbon (C) during senescence. However, the molecular mechanism of LHCII degradation is largely unknown. Here, we report that chlorophyll b reductase, which catalyzes the first step of chlorophyll b degradation, plays a central role in LHCII degradation. When the genes for chlorophyll b reductases NOL and NYC1 were disrupted in Arabidopsis thaliana, chlorophyll b and LHCII were not degraded during senescence, whereas other pigment complexes completely disappeared. When purified trimeric LHCII was incubated with recombinant chlorophyll b reductase (NOL), expressed in Escherichia coli, the chlorophyll b in LHCII was converted to 7-hydroxymethyl chlorophyll a. Accompanying this conversion, chlorophylls were released from LHCII apoproteins until all the chlorophyll molecules in LHCII dissociated from the complexes. Chlorophyll-depleted LHCII apoproteins did not dissociate into monomeric forms but remained in the trimeric form. Based on these results, we propose the novel hypothesis that chlorophyll b reductase catalyzes the initial step of LHCII degradation, and that trimeric LHCII is a substrate of LHCII degradation.	[Horie, Yukiko; Ito, Hisashi; Tanaka, Ryouichi; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Kusaba, Makoto] Hiroshima Univ, Grad Sch Sci, Higashihiroshima 7398526, Japan	Hokkaido University; Hiroshima University	Tanaka, A (corresponding author), N19 W8,Kita Ku, Sapporo, Hokkaido 0600819, Japan.	ayumi@lowtem.hokudai.ac.jp	Kusaba, Makoto/AAQ-4469-2021; Tanaka, Ryouichi/A-4030-2012; Ito, Hisashi/A-4211-2012; Tanaka, Ayumi/D-9003-2012	Tanaka, Ryouichi/0000-0002-5858-5326; Ito, Hisashi/0000-0002-2482-5870; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [17GS0314, 68700307]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for creative scientific research (17GS0314 to A. T.) and a Grant-in-aid for Scientific Research (68700307 to R. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ANDERSON JM, 1988, TRENDS BIOCHEM SCI, V13, P351, DOI 10.1016/0968-0004(88)90106-5; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Barber J, 2000, BBA-BIOENERGETICS, V1459, P239, DOI 10.1016/S0005-2728(00)00158-4; BENNETT J, 1981, EUR J BIOCHEM, V118, P61, DOI 10.1111/j.1432-1033.1981.tb05486.x; CHITNIS PR, 1988, PHOTOSYNTH RES, V16, P41, DOI 10.1007/BF00039485; Consoli E, 2005, EMBO REP, V6, P782, DOI 10.1038/sj.embor.7400464; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Folly P, 1999, J BIOL CHEM, V274, P21811, DOI 10.1074/jbc.274.31.21811; Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4; GandulRojas B, 1996, J SCI FOOD AGR, V72, P291, DOI 10.1002/(SICI)1097-0010(199611)72:3&lt;291::AID-JSFA654&gt;3.0.CO;2-O; Georgakopoulos JH, 2002, BBA-BIOENERGETICS, V1556, P53, DOI 10.1016/S0005-2728(02)00306-7; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hirashima M, 2006, J BIOL CHEM, V281, P15385, DOI 10.1074/jbc.M602903200; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; HONDA H, 1991, REGULATION CHLOROPLA, P329; Horn R, 2004, J BIOL CHEM, V279, P44400, DOI 10.1074/jbc.M407188200; Ito H, 1996, J BIOL CHEM, V271, P1475, DOI 10.1074/jbc.271.3.1475; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Lensch M, 2001, J BIOL CHEM, V276, P33645, DOI 10.1074/jbc.M100506200; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Masuda T, 2003, PLANT MOL BIOL, V51, P757, DOI 10.1023/A:1022545118212; Mimuro M, 2004, PHOTOSYNTH RES, V81, P129, DOI 10.1023/B:PRES.0000035047.50742.bf; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Nagata N, 2007, PLANT CELL PHYSIOL, V48, P1803, DOI 10.1093/pcp/pcm153; Ohtsuka T, 1997, PLANT PHYSIOL, V113, P137, DOI 10.1104/pp.113.1.137; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Reinsberg D, 2001, J MOL BIOL, V308, P59, DOI 10.1006/jmbi.2001.4573; Rudiger W, 2002, PHOTOSYNTH RES, V74, P187, DOI 10.1023/A:1020959610952; Sato Y, 2009, PLANT J, V57, P120, DOI 10.1111/j.1365-313X.2008.03670.x; Shioi Y, 1996, PLANT PHYSIOL BIOCH, V34, P41; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Tanaka A, 1997, PLANT CELL PHYSIOL, V38, P17, DOI 10.1093/oxfordjournals.pcp.a029080; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; TANAKA A, 1991, PLANT CELL PHYSIOL, V32, P195, DOI 10.1093/oxfordjournals.pcp.a078064; TANAKA A, 1987, PLANT CELL PHYSIOL, V28, P1537; Tanaka Ayumi, 1993, Planta (Heidelberg), V192, P92; Tanaka R, 2005, PHOTOSYNTH RES, V85, P327, DOI 10.1007/s11120-005-6807-z; Tsuchiya T, 1999, P NATL ACAD SCI USA, V96, P15362, DOI 10.1073/pnas.96.26.15362; Tziveleka LA, 1998, PLANT PHYSIOL, V117, P961, DOI 10.1104/pp.117.3.961; Yang CH, 2006, BBA-BIOENERGETICS, V1757, P1642, DOI 10.1016/j.bbabio.2006.08.010; Yang DH, 2000, FEBS LETT, V466, P385, DOI 10.1016/S0014-5793(00)01107-8; Yang DH, 1998, PLANT PHYSIOL, V118, P827, DOI 10.1104/pp.118.3.827; Yang DH, 2001, PHOTOSYNTH RES, V68, P163, DOI 10.1023/A:1011849919438; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102	48	171	184	4	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17449	17456		10.1074/jbc.M109.008912	http://dx.doi.org/10.1074/jbc.M109.008912			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19403948	Green Published, hybrid			2022-12-27	WOS:000267202500011
J	Song, P; Zhang, M; Wang, SX; Xu, J; Choi, HC; Zou, MH				Song, Ping; Zhang, Miao; Wang, Shuangxi; Xu, Jian; Choi, Hyoung Chul; Zou, Ming-Hui			Thromboxane A(2) Receptor Activates a Rho-associated Kinase/literKB1/PTEN Pathway to Attenuate Endothelium Insulin Signaling (Withdrawn Publication. See vol. 294, pg. 13830, 2019) (Publication with Expression of Concern. See vol. 294, pg. 10020, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE; HUMAN PLATELETS; INHIBITION; PTEN; AKT; PHOSPHORYLATION; ANTAGONIST; EXPRESSION; APOPTOSIS	This study was conducted to elucidate the molecular mechanisms of thromboxane A2 receptor (TP)-induced insulin resistance in endothelial cells. Exposure of human umbilical vein endothelial cells (HUVECs) or mouse aortic endothelial cells to either IBOP or U46619, two structurally related thromboxane A(2) mimetics, significantly reduced insulin-stimulated phosphorylation of endothelial nitric-oxide synthase (eNOS) at Ser(1177) and Akt at Ser(473). These effects were abolished by pharmacological or genetic inhibitors of TP. TP-induced suppression of both eNOS and Akt phosphorylation was accompanied by up-regulation of PTEN (phosphatase and tension homolog deleted on chromosome 10), Ser(380)/Thr(382/383) PTEN phosphorylation, and PTEN lipid phosphatase activity. PTEN-specific small interference RNA restored insulin signaling in the face of TP activation. The small GTPase, Rho, was also activated by TP stimulation, and pretreatment of HUVECs with Y27632, a Rho-associated kinase inhibitor, rescued TP-impaired insulin signaling. Consistent with this result, pertussis toxin abrogated IBOP-induced dephosphorylation of both Akt and eNOS, implicating the G(i) family of G proteins in the suppressive effects of TP. In mice, high fat diet-induced diabetes was associated with aortic PTEN up-regulation, PTEN-Ser(380)/Thr(382/383) phosphorylation, and dephosphorylation of both Akt (at Ser(473)) and eNOS (at Ser(1177)). Importantly, administration of TP antagonist blocked these changes. We conclude that TP stimulation impairs insulin signaling in vascular endothelial cells by selectively activating the Rho/Rho-associated kinase/literKB1/PTEN pathway.	[Song, Ping; Zhang, Miao; Wang, Shuangxi; Xu, Jian; Choi, Hyoung Chul; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabet, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabet, BSEB 306, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	Song, Ping/N-8456-2018; Song, Ping/D-6972-2011	Song, Ping/0000-0002-6143-4270; Song, Ping/0000-0002-2654-6162	National Institutes of Health [HL079584, HL074399, HL080499, HL089920, HL096032]; American Diabetes Association; Juvenile Diabetes Research Foundation; Oklahoma Center for Advancement of Science and Technology; Travis Endowed Chair in Endocrinology; University of Oklahoma Health Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089920, R01HL074399, R01HL080499, R01HL079584, R01HL096032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Oklahoma Center for Advancement of Science and Technology; Travis Endowed Chair in Endocrinology; University of Oklahoma Health Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL074399, HL080499, HL089920, and HL096032. This work was also supported by a research award from the American Diabetes Association, a research award from the Juvenile Diabetes Research Foundation, a grant from Oklahoma Center for Advancement of Science and Technology, and funds from the Travis Endowed Chair in Endocrinology, University of Oklahoma Health Sciences Center.	Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Ashton AW, 2007, J EXP MED, V204, P929, DOI 10.1084/jem.20062432; Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Ashton AW, 2004, CIRC RES, V95, P372, DOI 10.1161/01.RES.0000138300.41642.15; Ashton AW, 2003, J BIOL CHEM, V278, P11858, DOI 10.1074/jbc.M210766200; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Citro S, 2005, AM J RESP CELL MOL, V32, P326, DOI 10.1165/rcmb.2004-0356OC; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; COLEMAN RA, 1981, BRIT J PHARMACOL, V73, P773, DOI 10.1111/j.1476-5381.1981.tb16814.x; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fichtlscherer S, 2004, CIRCULATION, V110, P1926, DOI 10.1161/01.CIR.0000143378.58099.8C; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gao YL, 2000, CIRC RES, V87, P739, DOI 10.1161/01.RES.87.9.739; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; Hirata T, 1996, J CLIN INVEST, V97, P949, DOI 10.1172/JCI118518; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Jimenez AI, 2003, CANCER RES, V63, P1382; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Laroche G, 2005, J BIOL CHEM, V280, P23215, DOI 10.1074/jbc.M414071200; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; MAYEUX PR, 1991, J BIOL CHEM, V266, P13752; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Nie DT, 2008, CANCER RES, V68, P115, DOI 10.1158/0008-5472.CAN-07-1018; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nohria A, 2006, CIRC RES, V99, P1426, DOI 10.1161/01.RES.0000251668.39526.c7; OGLETREE ML, 1985, J PHARMACOL EXP THER, V234, P435; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; Sebekova K, 2007, DIABETES, V56, P968, DOI 10.2337/db06-1136; SHENKER A, 1991, J BIOL CHEM, V266, P9309; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Song P, 2007, CIRCULATION, V116, P1585, DOI 10.1161/CIRCULATIONAHA.107.716498; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Takayama K, 2005, NAT MED, V11, P562, DOI 10.1038/nm1231; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Xu SQ, 2006, DIABETES, V55, P110, DOI 10.2337/diabetes.55.1.110; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253; Zuccollo A, 2005, CIRCULATION, V112, P3001, DOI 10.1161/CIRCULATIONAHA.105.581892	52	42	43	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17120	17128		10.1074/jbc.M109.012583	http://dx.doi.org/10.1074/jbc.M109.012583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19403525	Green Published, hybrid			2022-12-27	WOS:000266962400050
J	Marques-Garcia, F; Ferrandiz, N; Fernandez-Alonso, R; Gonzalez-Cano, L; Herreros-Villanueva, M; Rosa-Garrido, M; Fernandez-Garcia, B; Vaque, JP; Marques, MM; Alonso, ME; Segovia, JC; Leon, J; Marin, MC				Marques-Garcia, Fernando; Ferrandiz, Nuria; Fernandez-Alonso, Rosalia; Gonzalez-Cano, Laura; Herreros-Villanueva, Marta; Rosa-Garrido, Manuel; Fernandez-Garcia, Belen; Vaque, Jose P.; Marques, Margarita M.; Eugenia Alonso, Maria; Carlos Segovia, Jose; Leon, Javier; Marin, Maria C.			p73 Plays a Role in Erythroid Differentiation through GATA1 Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; SPECTRIN GENE PROMOTER; DEVELOPMENT IN-VIVO; K562 CELLS; PRIMITIVE ERYTHROPOIESIS; TRANSCRIPTIONAL ACTIVITY; ERYTHROLEUKEMIA-CELLS; ISOFORM EXPRESSION; MYELOID-LEUKEMIA; HEME-SYNTHESIS	The TP73 gene gives rise to transactivation domain-p73 isoforms (TAp73) as well as Delta Np73 variants with a truncated N terminus. Although TAp73 alpha and -beta proteins are capable of inducing cell cycle arrest, apoptosis, and differentiation, Delta Np73 acts in many cell types as a dominant-negative repressor of p53 and TAp73. It has been proposed that p73 is involved in myeloid differentiation, and its altered expression is involved in leukemic degeneration. However, there is little evidence as to which p73 variants (TA or Delta N) are expressed during differentiation and whether specific p73 isoforms have the capacity to induce, or hinder, this differentiation in leukemia cells. In this study we identify GATA1 as a direct transcriptional target of TAp73 alpha. Furthermore, TAp73 alpha induces GATA1 activity, and it is required for erythroid differentiation. Additionally, we describe a functional cooperation between TAp73 and Delta Np73 in the context of erythroid differentiation in human myeloid cells, K562 and UT-7. Moreover, the impaired expression of GATA1 and other erythroid genes in the liver of p73KO embryos, together with the moderated anemia observed in p73KO young mice, suggests a physiological role for TP73 in erythropoiesis.	[Herreros-Villanueva, Marta; Fernandez-Garcia, Belen; Marin, Maria C.] Univ Leon, Inst Biomed, E-24071 Leon, Spain; [Marques, Margarita M.] Univ Leon, Inst Desarrollo Ganadero & Sanidad Anim, E-24071 Leon, Spain; [Eugenia Alonso, Maria; Carlos Segovia, Jose] Inst Salud Carlos III, CIBERER, CIEMAT,Haematopoiesis Div, CSIC,Dept Biol Mol,Grp Biol Mol Canc, Madrid 28040, Spain; [Ferrandiz, Nuria; Rosa-Garrido, Manuel; Vaque, Jose P.; Leon, Javier] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantanbria, Santander 39011, Spain	Universidad de Leon; Universidad de Leon; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Marin, MC (corresponding author), Univ Leon, Inst Biomed, Campus Vegazana, E-24071 Leon, Spain.	carmen.marin@unileon.es	Segovia, Jose Carlos/L-2922-2014; Vaqué, José P/H-8413-2015; Marqués-García, Fernando/AAU-3998-2020; Alonso, Rosalia Fernandez/AAQ-2276-2021; , Herreros-Villanueva/M-5702-2016; Ferrandiz-Diaz, Nuria/V-4071-2017; Marques, Margarita M/I-1260-2015; Marín Vieira, María del Carmen/B-8108-2015; Rosa-Garrido, Manuel/AAE-4188-2019; Marin, Maria C/G-1040-2010; Leon, Javier/K-4615-2014	Segovia, Jose Carlos/0000-0003-4101-6124; Vaqué, José P/0000-0002-3913-2495; Alonso, Rosalia Fernandez/0000-0002-6971-5130; , Herreros-Villanueva/0000-0002-6905-0693; Ferrandiz-Diaz, Nuria/0000-0002-7410-3470; Marques, Margarita M/0000-0003-2818-035X; Marín Vieira, María del Carmen/0000-0002-7149-287X; Rosa-Garrido, Manuel/0000-0002-2169-3972; Marin, Maria C/0000-0002-7149-287X; Marques Garcia, Fernando/0000-0002-2324-4003; Fernandez-Garcia, Belen/0000-0002-9950-2494; Leon, Javier/0000-0001-5803-0112	Spanish Ministerio de Educacio y Ciencia [SAF2006-10756, SAF2005-00461, SAF2008-1883, RETIC-RD06/0020]; Junta de Castilla y Leon [LE030A07]	Spanish Ministerio de Educacio y Ciencia(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Grants SAF2006-10756, SAF2005-00461, SAF2008-1883, and RETIC-RD06/0020 from Spanish Ministerio de Educacio y Ciencia (to M. C. M., J. L. S., and J. C. S.) and Grant LE030A07 from the Junta de Castilla y Leon (to M. M. M.).	Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Basu P, 2007, BLOOD, V110, P3417, DOI 10.1182/blood-2006-11-057307; Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; Boulanger L, 2002, J BIOL CHEM, V277, P41563, DOI 10.1074/jbc.M208184200; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11366, DOI 10.1073/pnas.90.23.11366; Chenais B, 1998, BIOCHEM BIOPH RES CO, V253, P883, DOI 10.1006/bbrc.1998.9869; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Daniels G, 2000, VOX SANG, V78, P149; de la Grange PB, 2006, BLOOD, V108, P2998, DOI 10.1182/blood-2006-05-022988; De Laurenzi V, 2000, BIOCHEM BIOPH RES CO, V273, P342, DOI 10.1006/bbrc.2000.2932; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Deguchi T, 1999, EXP HEMATOL, V27, P542, DOI 10.1016/S0301-472X(98)00047-2; Deguillien M, 2001, BLOOD, V98, P3809, DOI 10.1182/blood.V98.13.3809; DELGADO MD, 1995, ONCOGENE, V10, P1659; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Fang L, 1999, J CELL BIOL, V147, P823, DOI 10.1083/jcb.147.4.823; Fernandez-Garcia B, 2007, CELL DEATH DIFFER, V14, P254, DOI 10.1038/sj.cdd.4401945; FERRARI B, 1986, INT J PEPT PROT RES, V28, P456; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Fukuchi Y, 2001, ONCOGENE, V20, P704, DOI 10.1038/sj.onc.1204142; Furukawa Y, 2002, LEUKEMIA LYMPHOMA, V43, P225, DOI 10.1080/10428190290005973; Gallagher PG, 1999, J BIOL CHEM, V274, P6062, DOI 10.1074/jbc.274.10.6062; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; GHAFFARI S, 1995, BLOOD, V86, P2976; Goldschneider D, 2005, J CELL SCI, V118, P1245, DOI 10.1242/jcs.01704; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Hafid-Medheb K, 2003, BLOOD, V101, P2575, DOI 10.1182/blood-2002-02-0478; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Ishimoto O, 2002, CANCER RES, V62, P636; Jacobs-Helber SM, 2004, BLOOD, V104, P696, DOI 10.1182/blood-2003-05-1754; Jacobs-Helber SM, 2002, J BIOL CHEM, V277, P4859, DOI 10.1074/jbc.M107243200; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Jung MS, 2001, ONCOGENE, V20, P5818, DOI 10.1038/sj.onc.1204748; Kartasheva NN, 2003, ONCOGENE, V22, P8246, DOI 10.1038/sj.onc.1207138; Kawano T, 2004, LEUKEMIA RES, V28, P623, DOI 10.1016/j.leukres.2003.10.022; Kawasaki N, 1996, ARCH BIOCHEM BIOPHYS, V328, P289, DOI 10.1006/abbi.1996.0175; KUDO S, 1994, J BIOL CHEM, V269, P22969; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Li CY, 2004, CELL DEATH DIFFER, V11, P1299, DOI 10.1038/sj.cdd.4401490; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Mainardi S, 2007, CELL DEATH DIFFER, V14, P1968, DOI 10.1038/sj.cdd.4402210; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Meza NW, 2007, HUM GENE THER, V18, P502, DOI 10.1089/hum.2006.052; Moll UM, 2004, MOL CANCER RES, V2, P371; Morceau F, 1996, CELL GROWTH DIFFER, V7, P1023; Morena A, 2002, BLOOD, V100, P96, DOI 10.1182/blood.V100.1.96; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Neri LM, 2002, CELL SIGNAL, V14, P21, DOI 10.1016/S0898-6568(01)00224-8; Nishimura S, 2000, MOL CELL BIOL, V20, P713, DOI 10.1128/MCB.20.2.713-723.2000; ORKIN SH, 1992, BLOOD, V80, P575; Papoutsaki M, 2004, J INVEST DERMATOL, V123, P1162, DOI 10.1111/j.0022-202X.2004.23498.x; Peters UR, 1999, CANCER RES, V59, P4233; Petrenko O, 2003, MOL CELL BIOL, V23, P5540, DOI 10.1128/MCB.23.16.5540-5555.2003; RANA AP, 1993, P NATL ACAD SCI USA, V90, P6651, DOI 10.1073/pnas.90.14.6651; Sbisa E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S20; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shimizu R, 2007, J BIOL CHEM, V282, P15862, DOI 10.1074/jbc.M701936200; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Slade N, 2004, CELL DEATH DIFFER, V11, P357, DOI 10.1038/sj.cdd.4401335; Snow JW, 2002, BLOOD, V99, P95, DOI 10.1182/blood.V99.1.95; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Takahashi T, 2000, ONCOGENE, V19, P134, DOI 10.1038/sj.onc.1203228; Tanaka Y, 2006, EXP CELL RES, V312, P1254, DOI 10.1016/j.yexcr.2005.12.013; Tanaka Y, 2004, BIOCHEM BIOPH RES CO, V317, P865, DOI 10.1016/j.bbrc.2004.03.124; Tschan MP, 2000, BIOCHEM BIOPH RES CO, V277, P62, DOI 10.1006/bbrc.2000.3627; Tsiftsoglou AS, 2003, PHARMACOL THERAPEUT, V100, P257, DOI 10.1016/j.pharmthera.2003.09.002; Wang J, 2007, EXP CELL RES, V313, P4120, DOI 10.1016/j.yexcr.2007.09.008; WATANABE T, 1985, MOL PHARMACOL, V27, P683; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wickenhauser C, 2003, INT J ONCOL, V23, P437; Wiener E, 1998, BRIT J HAEMATOL, V103, P259, DOI 10.1046/j.1365-2141.1998.00936.x; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; YEN J, 1991, P NATL ACAD SCI USA, V88, P5077, DOI 10.1073/pnas.88.12.5077; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	86	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21139	21156		10.1074/jbc.M109.026849	http://dx.doi.org/10.1074/jbc.M109.026849			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509292	Green Published, hybrid			2022-12-27	WOS:000268564400007
J	Rangarajan, ES; Proteau, A; Cui, QZ; Logan, SM; Potetinova, Z; Whitfield, D; Purisima, EO; Cygler, M; Matte, A; Sulea, T; Schoenhofen, IC				Rangarajan, Erumbi S.; Proteau, Ariane; Cui, Qizhi; Logan, Susan M.; Potetinova, Zhanna; Whitfield, Dennis; Purisima, Enrico O.; Cygler, Miroslaw; Matte, Allan; Sulea, Traian; Schoenhofen, Ian C.			Structural and Functional Analysis of Campylobacter jejuni PseG A UDP-SUGAR HYDROLASE FROM THE PSEUDAMINIC ACID BIOSYNTHETIC PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE MANNOSYL HYDROLASE; N-ACETYLGLUCOSAMINE 2-EPIMERASE; SOLVATED INTERACTION ENERGY; ESCHERICHIA-COLI MURG; UNUSUAL NUDIX ENZYME; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; FLAGELLIN GLYCOSYLATION; PSEUDOMONAS-AERUGINOSA; MOLECULAR-DYNAMICS	Flagella of the bacteria Helicobacter pylori and Campylobacter jejuni are important virulence determinants, whose proper assembly and function are dependent upon glycosylation at multiple positions by sialic acid-like sugars, such as 5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-L-manno-nonulosonic acid (pseudaminic acid (Pse)). The fourth enzymatic step in the pseudaminic acid pathway, the hydrolysis of UDP-2,4-diacetamido2,4,6-trideoxy-beta-L-altropyranose to generate 2,4-diacetamido-2,4,6-trideoxy-L-altropyranose, is performed by the nucleotide sugar hydrolase PseG. To better understand the molecular basis of the PseG catalytic reaction, we have determined the crystal structures of C. jejuni PseG in apo-form and as a complex with its UDP product at 1.8 and 1.85 angstrom resolution, respectively. In addition, molecular modeling was utilized to provide insight into the structure of the PseG-substrate complex. This modeling identifies a His(17)-coordinated water molecule as the putative nucleophile and suggests the UDP-sugar substrate adopts a twist-boat conformation upon binding to PseG, enhancing the exposure of the anomeric bond cleaved and favoring inversion at C-1. Furthermore, based on these structures a series of amino acid substitution derivatives were constructed, altering residues within the active site, and each was kinetically characterized to examine its contribution to PseG catalysis. In conjunction with structural comparisons, the almost complete inactivation of the PseG H17F and H17L derivatives suggests that His(17) functions as an active site base, thereby activating the nucleophilic water molecule for attack of the anomeric C-O bond of the UDP-sugar. As the PseG structure reveals similarity to those of glycosyltransferase family-28 members, in particular that of Escherichia coli MurG, these findings may also be of relevance for the mechanistic understanding of this important enzyme family.	[Proteau, Ariane; Cui, Qizhi; Purisima, Enrico O.; Cygler, Miroslaw; Matte, Allan; Sulea, Traian] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Rangarajan, Erumbi S.; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 1V6, Canada; [Logan, Susan M.; Potetinova, Zhanna; Whitfield, Dennis; Schoenhofen, Ian C.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	National Research Council Canada; McGill University; National Research Council Canada	Sulea, T (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	traian.sulea@nrc-cnrc.gc.ca; ian.schoenhofen@nrc-cnrc.gc.ca			National Research Council Canada; Canadian Institutes of Health [GSP-48370]	National Research Council Canada; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by the National Research Council Canada (to S. M. L., E. O. P., and M. C.) and Canadian Institutes of Health Research Operating Grant GSP-48370 (to M. C.). This is publication number NRC49599 from the National Research Council Canada.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biarnes X, 2006, J BIOL CHEM, V281, P1432, DOI 10.1074/jbc.M507643200; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P14993, DOI 10.1021/bi001627x; Canals R, 2007, MICROBIOL-SGM, V153, P1165, DOI 10.1099/mic.0.2006/000687-0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200; Chen L, 2002, BIOCHEMISTRY-US, V41, P6824, DOI 10.1021/bi0256678; Chou WK, 2005, J BIOL CHEM, V280, P35922, DOI 10.1074/jbc.M507483200; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; Crouvoisier M, 2007, BIOCHIMIE, V89, P1498, DOI 10.1016/j.biochi.2007.06.011; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabelli SB, 2006, BIOCHEMISTRY-US, V45, P11290, DOI 10.1021/bi061239g; Geremia S, 2002, J MOL BIOL, V322, P413, DOI 10.1016/S0022-2836(02)00771-4; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Gryllos I, 2001, INFECT IMMUN, V69, P65, DOI 10.1128/IAI.69.1.65-74.2001; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; Kiss E, 2001, MOL PLANT MICROBE IN, V14, P1395, DOI 10.1094/MPMI.2001.14.12.1395; Knirel YA, 2003, ADV CARBOHYD CHEM BI, V58, P371, DOI 10.1016/S0065-2318(03)58007-6; KNIREL YA, 1984, CARBOHYD RES, V133, pC5, DOI 10.1016/0008-6215(84)85213-1; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lariviere L, 2003, J MOL BIOL, V330, P1077, DOI 10.1016/S0022-2836(03)00635-1; Le Quere AJL, 2006, J BIOL CHEM, V281, P28981, DOI 10.1074/jbc.M513639200; Legler PM, 2000, BIOCHEMISTRY-US, V39, P8603, DOI 10.1021/bi000537p; Legler PM, 2002, BIOCHEMISTRY-US, V41, P10834, DOI 10.1021/bi020362e; Legler PM, 2002, BIOCHEMISTRY-US, V41, P4655, DOI 10.1021/bi012118d; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Lin K, 1996, SCIENCE, V273, P1539, DOI 10.1126/science.273.5281.1539; Liu F, 2006, J BIOL CHEM, V281, P20902, DOI 10.1074/jbc.M602972200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McNally DJ, 2006, CHEMBIOCHEM, V7, P1865, DOI 10.1002/cbic.200600298; Megraud F, 2007, GUT, V56, P1502, DOI 10.1136/gut.2007.132514; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Murkin AS, 2004, BIOCHEMISTRY-US, V43, P14290, DOI 10.1021/bi048606d; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Rangarajan ES, 2008, BIOCHEMISTRY-US, V47, P1827, DOI 10.1021/bi702032r; Raymond CK, 2002, J BACTERIOL, V184, P3614, DOI 10.1128/JB.184.13.3614-3622.2002; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schirm M, 2005, ANAL CHEM, V77, P7774, DOI 10.1021/ac051316y; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Schoenhofen IC, 2006, J BIOL CHEM, V281, P8907, DOI 10.1074/jbc.M512987200; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Walker RC, 2008, J COMPUT CHEM, V29, P1019, DOI 10.1002/jcc.20857; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151	75	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20989	21000		10.1074/jbc.M109.012351	http://dx.doi.org/10.1074/jbc.M109.012351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19483088	hybrid, Green Published			2022-12-27	WOS:000268316100062
J	Halai, R; Clark, RJ; Nevin, ST; Jensen, JE; Adams, DJ; Craik, DJ				Halai, Reena; Clark, Richard J.; Nevin, Simon T.; Jensen, Jonas E.; Adams, David J.; Craik, David J.			Scanning Mutagenesis of alpha-Conotoxin Vc1.1 Reveals Residues Crucial for Activity at the alpha 9 alpha 10 Nicotinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR-CELLS; PHARMACOLOGICAL-PROPERTIES; CHOLINERGIC-RECEPTOR; CONUS PEPTIDES; SUBUNIT; NEURONS; BINDING; RGIA; PAIN; CONOPEPTIDES	Vc1.1 is a disulfide-rich peptide inhibitor of nicotinic acetylcholine receptors that has stimulated considerable interest in these receptors as potential therapeutic targets for the treatment of neuropathic pain. Here we present an extensive series of mutational studies in which all residues except the conserved cysteines were mutated separately to Ala, Asp, or Lys. The effect on acetylcholine (ACh)-evoked membrane currents at the alpha 9 alpha 10 nicotinic acetylcholine receptor (nAChR), which has been implicated as a target in the alleviation of neuropathic pain, was then observed. The analogs were characterized by NMR spectroscopy to determine the effects of mutations on structure. The structural fold was found to be preserved in all peptides except where Pro was substituted. Electrophysiological studies showed that the key residues for functional activity are Asp(5)-Arg(7) and Asp(11)-Ile(15), because changes at these positions resulted in the loss of activity at the alpha 9 alpha 10 nAChR. Interestingly, the S4K and N9A analogs were more potent than Vc1.1 itself. A second generation of mutants was synthesized, namely N9G, N9I, N9L, S4R, and S4K + N9A, all of which were more potent than Vc1.1 at both the rat alpha 9 alpha 10 and the human alpha 9/rat alpha 10 hybrid receptor, providing a mechanistic insight into the key residues involved in eliciting the biological function of Vc1.1. The most potent analogs were also tested at the alpha 3 beta 2, alpha 3 beta 4, and alpha 7 nAChR subtypes to determine their selectivity. All mutants tested were most selective for the alpha 9 alpha 10 nAChR. These findings provide valuable insight into the interaction of Vc1.1 with the alpha 9 alpha 10 nAChR subtype and will help in the further development of analogs of Vc1.1 as analgesic drugs.	[Halai, Reena; Clark, Richard J.; Jensen, Jonas E.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Nevin, Simon T.; Adams, David J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@uq.edu.au	Adams, David John/K-3578-2019; Craik, David/B-1695-2010; Adams, David/J-9125-2014; Clark, Richard J/G-8848-2012; Jensen, Jonas/A-6393-2010; Halai, Reena/C-3311-2014; Nevin, Simon/B-2663-2014	Adams, David John/0000-0002-7030-2288; Craik, David/0000-0003-0007-6796; Adams, David/0000-0002-7030-2288; Clark, Richard J/0000-0002-6807-5426; 	National Health and Medical Research Council (NHMRC); Australian Research Council (ARC)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	The work was supported in part by a grant from the National Health and Medical Research Council (NHMRC). Work in our laboratory on conotoxins is supported by a grant from the Australian Research Council (ARC).	Adams DJ, 1999, DRUG DEVELOP RES, V46, P219; Armishaw C, 2009, J BIOL CHEM, V284, P9498, DOI 10.1074/jbc.M806136200; Baker ER, 2004, MOL PHARMACOL, V65, P453, DOI 10.1124/mol.65.2.453; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Clark RJ, 2008, FEBS LETT, V582, P597, DOI 10.1016/j.febslet.2008.01.027; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Clark RJ, 2005, P NATL ACAD SCI USA, V102, P13767, DOI 10.1073/pnas.0504613102; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutton JL, 2001, CURR MED CHEM, V8, P327, DOI 10.2174/0929867013373453; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Ellison M, 2008, J MOL BIOL, V377, P1216, DOI 10.1016/j.jmb.2008.01.082; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Gomez-Casati ME, 2005, J PHYSIOL-LONDON, V566, P103, DOI 10.1113/jphysiol.2005.087155; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; Itier V, 2001, FEBS LETT, V504, P118, DOI 10.1016/S0014-5793(01)02702-8; Jakubowski JA, 2004, J MASS SPECTROM, V39, P548, DOI 10.1002/jms.624; Lips KS, 2002, NEUROSCIENCE, V115, P1, DOI 10.1016/S0306-4522(02)00274-9; Livett BG, 2004, CURR MED CHEM, V11, P1715, DOI 10.2174/0929867043364928; Livett BG, 2006, TOXICON, V48, P810, DOI 10.1016/j.toxicon.2006.07.023; Lovelace ES, 2006, J MED CHEM, V49, P6561, DOI 10.1021/jm060299h; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Olivera BM, 2008, CHANNELS, V2, P143, DOI 10.4161/chan.2.2.6276; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Olivera BM, 1997, MOL BIOL CELL, V8, P2101, DOI 10.1091/mbc.8.11.2101; Peng HS, 2004, LIFE SCI, V76, P263, DOI 10.1016/j.lfs.2004.05.031; Plazas PV, 2005, J NEUROSCI, V25, P10905, DOI 10.1523/JNEUROSCI.3805-05.2005; Quiram PA, 1998, J BIOL CHEM, V273, P11007, DOI 10.1074/jbc.273.18.11007; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Sgard F, 2002, MOL PHARMACOL, V61, P150, DOI 10.1124/mol.61.1.150; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	41	72	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20275	20284		10.1074/jbc.M109.015339	http://dx.doi.org/10.1074/jbc.M109.015339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19447885	hybrid, Green Published			2022-12-27	WOS:000268097400054
J	Rush, JS; Gao, NG; Lehrman, MA; Matveev, S; Waechter, CJ				Rush, Jeffrey S.; Gao, Ningguo; Lehrman, Mark A.; Matveev, Sergey; Waechter, Charles J.			Suppression of Rft1 Expression Does Not Impair the Transbilayer Movement of Man(5)GlcNAc(2)-P-P-Dolichol in Sealed Microsomes from Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; WATER-SOLUBLE ANALOG; GLC-P-DOLICHOL; ENDOPLASMIC-RETICULUM; PIG BRAIN; SACCHAROMYCES-CEREVISIAE; LINKED OLIGOSACCHARIDES; BIOLOGICAL FUNCTIONS; N-ACETYLGLUCOSAMINE; LIPID FLIPPASES	To further evaluate the role of Rft1 in the transbilayer movement of Man(5)GlcNAc(2)-P-P-dolichol (M5-DLO), a series of experiments was conducted with intact cells and sealed microsomal vesicles. First, an unexpectedly large accumulation (37-fold) of M5-DLO was observed in Rft1-depleted cells (YG1137) relative to Glc(3)Man(9)GlcNAc(2)-P-P-Dol in wild type (SS328) cells when glycolipid levels were compared by fluorophore-assisted carbohydrate electrophoresis analysis. When sealed microsomes from wild type cells and cells depleted of Rft1 were incubated with GDP-[H-3]mannose or UDP-[H-3]GlcNAc in the presence of unlabeled GDP-Man, no difference was observed in the rate of synthesis of [H-3]Man(9)GlcNAc(2)-P-P-dolichol or Man(9)[H-3]GlcNAc(2)-P-P-dolichol, respectively. In addition, no difference was seen in the level of M5-DLO flippase activity in sealed wild type and Rft1-depleted microsomal vesicles when the activity was assessed by the transport of GlcNAc(2)-P-P-Dol(15), a water-soluble analogue. The entry of the analogue into the lumenal compartment was confirmed by demonstrating that [H-3]chitobiosyl units were transferred to endogenous peptide acceptors via the yeast oligosaccharyltransferase when sealed vesicles were incubated with [H-3]GlcNAc(2)-P-P-Dol(15) in the presence of an exogenously supplied acceptor peptide. In addition, several enzymes involved in Dol-P and lipid intermediate biosynthesis were found to be up-regulated in Rft1-depleted cells. All of these results indicate that although Rft1 may play a critical role in vivo, depletion of this protein does not impair the transbilayer movement of M5-DLO in sealed microsomal fractions prepared from disrupted cells.	[Rush, Jeffrey S.; Matveev, Sergey; Waechter, Charles J.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Gao, Ningguo; Lehrman, Mark A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Kentucky; University of Texas System; University of Texas Southwestern Medical Center Dallas	Waechter, CJ (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, BBSRB,741 S Limestone St, Lexington, KY 40536 USA.	waechte@uky.edu			National Institutes of Health [GM36065, GM38545]; Welch Foundation [I-1168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038545, R01GM036065, R56GM038545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM36065 (to C.J.W.) and GM38545 (to M.A.L.). This work was also supported by Welch Foundation Grant I-1168 (to M.A.L.).	Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; CHEN WW, 1977, J BIOL CHEM, V252, P3473; Cho SK, 2005, GLYCOBIOLOGY, V15, P637, DOI 10.1093/glycob/cwi042; CRICK DC, 1994, J BIOL CHEM, V269, P10559; Cueva R, 1998, YEAST, V14, P773, DOI 10.1002/(SICI)1097-0061(19980615)14:8<773::AID-YEA284>3.3.CO;2-J; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Haeuptle MA, 2008, AM J HUM GENET, V82, P600, DOI 10.1016/j.ajhg.2007.12.021; HARFORD JB, 1979, ARCH BIOCHEM BIOPHYS, V197, P424, DOI 10.1016/0003-9861(79)90264-9; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; KOERTE A, 1995, J BIOL CHEM, V270, P22556, DOI 10.1074/jbc.270.38.22556; LEHLE L, 1978, EUR J BIOCHEM, V83, P563, DOI 10.1111/j.1432-1033.1978.tb12124.x; LEHLE L, 1980, EUR J BIOCHEM, V109, P589, DOI 10.1111/j.1432-1033.1980.tb04832.x; MENON A, 1995, TRENDS CELL BIOL, V5, P355, DOI 10.1016/S0962-8924(00)89069-8; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; REUVERS F, 1977, BIOCHIM BIOPHYS ACTA, V486, P541, DOI 10.1016/0005-2760(77)90104-7; Rick PD, 2003, J BIOL CHEM, V278, P16534, DOI 10.1074/jbc.M301750200; RUNGE KW, 1984, J BIOL CHEM, V259, P412; RUSH JS, 1993, J BIOL CHEM, V268, P13110; RUSH JS, 1995, ANAL BIOCHEM, V224, P494, DOI 10.1006/abio.1995.1078; RUSH JS, 1995, J CELL BIOL, V130, P529, DOI 10.1083/jcb.130.3.529; Rush JS, 2005, METHODS, V35, P316, DOI 10.1016/j.ymeth.2004.10.002; Rush JS, 1998, GLYCOBIOLOGY, V8, P1207, DOI 10.1093/glycob/8.12.1207; Rush JS, 1998, GLYCOBIOLOGY, V8, P1195, DOI 10.1093/glycob/8.12.1195; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Sanyal S, 2009, P NATL ACAD SCI USA, V106, P767, DOI 10.1073/pnas.0810225106; SCHENK B, 2001, GLYCOBIOLOGY, V11, P61; SNIDER MD, 1982, J BIOL CHEM, V257, P6796; STRUCK DK, 1978, J BIOL CHEM, V253, P5786; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71, DOI 10.1111/j.1432-1033.1994.tb19996.x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; WAECHTER CJ, 1981, RES METHODS NEUROCHE, V5, P201; ZHU XY, 1992, J BIOL CHEM, V267, P8895; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	40	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19835	19842		10.1074/jbc.M109.000893	http://dx.doi.org/10.1074/jbc.M109.000893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494107	Green Published, hybrid			2022-12-27	WOS:000268097400010
J	Cohen-Gonsaud, M; Barthe, P; Canova, MJ; Stagier-Simon, C; Kremer, L; Roumestand, C; Molle, V				Cohen-Gonsaud, Martin; Barthe, Philippe; Canova, Marc J.; Stagier-Simon, Charlotte; Kremer, Laurent; Roumestand, Christian; Molle, Virginie			The Mycobacterium tuberculosis Ser/Thr Kinase Substrate Rv2175c Is a DNA-binding Protein Regulated by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE KINASES; CHEMICAL-SHIFT; DOMAIN; EMBR; PKNB; IDENTIFICATION; PHOSPHATASES; RECOGNITION; RESTRAINTS; PHYLOGENY	Recent efforts have underlined the role of serine/threonine protein kinases in growth, pathogenesis, and cell wall metabolism in Mycobacterium tuberculosis. Although most kinases have been investigated for their physiological roles, little information is available regarding how serine/threonine protein kinase-dependent phosphorylation regulates the activity of kinase substrates. Herein, we focused on M. tuberculosis Rv2175c, a protein of unknown function, conserved in actinomycetes, and recently identified as a substrate of the PknL kinase. We solved the solution structure of Rv2175c by multidimensional NMR and demonstrated that it possesses an original winged helix-turn-helix motif, indicative of a DNA-binding protein. The DNA-binding activity of Rv2175c was subsequently confirmed by fluorescence anisotropy, as well as in electrophoretic mobility shift assays. Mass spectrometry analyses using a combination of MALDI-TOF and LC-ESI/MS/MS identified Thr(9) as the unique phosphoacceptor. This was further supported by complete loss of PknL-dependent phosphorylation of an Rv2175c_T9A mutant. Importantly, the DNA-binding activity was completely abrogated in a Rv2175c_T9D mutant, designed to mimic constitutive phosphorylation, but not in a mutant lacking the first 13 residues. This implies that the function of the N-terminal extension is to provide a phosphoacceptor (Thr(9)), which, following phosphorylation, negatively regulates the Rv2175c DNA-binding activity. Interestingly, the N-terminal disordered extension, which bears the phosphoacceptor, was found to be restricted to members of the M. tuberculosis complex, thus suggesting the existence of an original mechanism that appears to be unique to the M. tuberculosis complex.	[Cohen-Gonsaud, Martin; Barthe, Philippe; Stagier-Simon, Charlotte; Roumestand, Christian] CNRS, UMR 5048, Ctr Biochim Struct, F-34090 Montpellier, France; [Cohen-Gonsaud, Martin; Barthe, Philippe; Stagier-Simon, Charlotte; Roumestand, Christian] INSERM, U554, Montpellier, France; [Cohen-Gonsaud, Martin; Barthe, Philippe; Stagier-Simon, Charlotte; Roumestand, Christian] Univ Montpellier I, F-34090 Montpellier, France; [Canova, Marc J.; Molle, Virginie] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR128 BioSci, F-69367 Lyon, France; [Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Kremer, Laurent] CNRS, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, DIMNP, F-34095 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Cohen-Gonsaud, M (corresponding author), CNRS, UMR 5048, Ctr Biochim Struct, F-34090 Montpellier, France.	martin@cbs.cnrs.fr; vmolle@ibcp.fr	Kremer, Laurent/M-4935-2017; MOLLE, Virginie/D-4050-2019	Kremer, Laurent/0000-0002-6604-4458; MOLLE, Virginie/0000-0002-6573-3411; ROUMESTAND, Christian/0000-0002-4082-3293; Barthe, Philippe/0000-0003-4282-6604; Cohen-Gonsaud, Martin/0000-0002-0150-9912	Agence Nationale de la Recherche [JC07_203251, ANR-06-MIME-027-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grants JC07_203251 ( to M. C.- G.) and ANR-06-MIME-027-01 ( to V. M. and L. K.). NMR experiments were recorded and analyzed using the facilities of the Structural Biology platform RIO (CBS, Montpellier, France).	Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barthe P, 2009, STRUCTURE, V17, P568, DOI 10.1016/j.str.2009.02.012; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Canova MJ, 2008, PROTEOMICS, V8, P521, DOI 10.1002/pmic.200700442; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Cohen-Gonsaud M, 2004, J BIOMOL NMR, V30, P373, DOI 10.1007/s10858-004-3466-x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cottin V, 1999, J BIOL CHEM, V274, P32975, DOI 10.1074/jbc.274.46.32975; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; Sam MD, 2004, J MOL BIOL, V338, P229, DOI 10.1016/j.jmb.2004.02.053; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; [No title captured]	39	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19290	19300		10.1074/jbc.M109.019653	http://dx.doi.org/10.1074/jbc.M109.019653			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19457863	Green Published, hybrid			2022-12-27	WOS:000267908300020
J	Li, X; Molina, H; Huang, HY; Zhang, YY; Liu, M; Qian, SW; Slawson, C; Dias, WB; Pandey, A; Hart, GW; Lane, MD; Tang, QQ				Li, Xi; Molina, Henrik; Huang, Haiyan; Zhang, You-you; Liu, Mei; Qian, Shu-wen; Slawson, Chad; Dias, Wagner B.; Pandey, Akhilesh; Hart, Gerald W.; Lane, M. Daniel; Tang, Qi-Qun			O-Linked N-Acetylglucosamine Modification on CCAAT Enhancer-binding Protein beta ROLE DURING ADIPOCYTE DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; C/EBP-BETA; NUCLEOCYTOPLASMIC PROTEINS; MYELOMONOCYTIC CELLS; 3T3-L1 PREADIPOCYTES; TRANSCRIPTION FACTOR; CYTOSOLIC PROTEINS; GLCNAC TRANSFERASE; TERMINAL DOMAIN; FAMILY-MEMBERS	CCAAT enhancer-binding protein (C/EBP)beta is a basic leucine zipper transcription factor family member, and can be phosphorylated, acetylated, and sumoylated. C/EBP beta undergoes sequential phosphorylation during 3T3-L1 adipocyte differentiation. Phosphorylation on Thr(188) by MAPK or cyclin A/cdk2 primes the phosphorylations on Ser(184)/Thr(179) by GSK3 beta, and these phosphorylations are required for the acquisition of DNA binding activity of C/EBP beta. Here we show that C/EBP beta is modified by O-GlcNAc, a dynamic single sugar modification found on nucleocytoplasmic proteins. The GlcNAcylation sites are Ser(180) and Ser(181), which are in the regulation domain and are very close to the phosphorylation sites (Thr(188), Ser(184), and Thr(179)) required for the gain of DNA binding activity. Both in vitro and ex vivo experiments demonstrate that GlcNAcylation on Ser(180) and Ser(181) prevents phosphorylation on Thr(188), Ser(184), and Thr(179), as indicated by the decreased relative phosphorylation and DNA binding activity of C/EBP beta delayed the adipocyte differentiation program. Mutation of both Ser(180) and Ser(181) to Ala significantly increase the transcriptional activity of C/EBP beta. These data suggest that GlcNAcylation regulates both the phosphorylation and DNA binding activity of C/EBP beta.	[Li, Xi; Huang, Haiyan; Zhang, You-you; Liu, Mei; Qian, Shu-wen; Tang, Qi-Qun] Fudan Univ, Shanghai Med Coll, Key Lab Mol Med, Minist Educ, Shanghai 200032, Peoples R China; [Li, Xi; Huang, Haiyan; Zhang, You-you; Liu, Mei; Qian, Shu-wen; Tang, Qi-Qun] Fudan Univ, Shanghai Med Coll, Dept Biochem & Microbiol, Shanghai 200032, Peoples R China; [Li, Xi; Huang, Haiyan; Zhang, You-you; Qian, Shu-wen; Tang, Qi-Qun] Fudan Univ, Inst Biomed Sci, Inst Stem Cell & Regenerat Med, Shanghai 200032, Peoples R China; [Molina, Henrik; Slawson, Chad; Dias, Wagner B.; Pandey, Akhilesh; Hart, Gerald W.; Lane, M. Daniel] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21218 USA	Fudan University; Fudan University; Fudan University; Johns Hopkins University	Tang, QQ (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Mol Med, Minist Educ, 138 Yi Xue Yuan Rd,POB 238, Shanghai 200032, Peoples R China.	qqtang@shmu.edu.cn	Pandey, Akhilesh/B-4127-2009; Zhang, Youyou/H-9677-2017; Li, Xi/W-4034-2019; Dias, Wagner/B-1401-2016	Pandey, Akhilesh/0000-0001-9943-6127; Dias, Wagner/0000-0002-8378-8846; Hart, Gerald/0000-0001-7812-4351	National Key Basic Research [2006CB943704]; National Natural Science Foundation for Distinguished Scholars [30625015]; Program for Outstanding Medical Academic Leader [B-LJ06032]; Shanghai Key Science and Technology Research Project [08dj1400603]; National Natural Science Foundation [30700121]; Shanghai Rising Star Program [08QA14012]; National Institutes of Health [DK61671, HD13563]; Shanghai Leading Academic Discipline [B110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013563, R37HD013563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER	National Key Basic Research(National Basic Research Program of China); National Natural Science Foundation for Distinguished Scholars(National Natural Science Foundation of China (NSFC)); Program for Outstanding Medical Academic Leader; Shanghai Key Science and Technology Research Project; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Rising Star Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Key Basic Research Project Grant 2006CB943704, National Natural Science Foundation for Distinguished Scholars Grant 30625015, Program for Outstanding Medical Academic Leader Grant B-LJ06032, Shanghai Key Science and Technology Research Project 08dj1400603 ( to Q.- Q. T.); by National Natural Science Foundation Grant 30700121 and Shanghai Rising Star Program 08QA14012 ( to X. L.), and by National Institutes of Health Grants DK61671 and HD13563 ( to G. W. H.). This work was also supported in part by Shanghai Leading Academic Discipline Project B110.	CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; KATZ S, 1993, EMBO J, V12, P1321, DOI 10.1002/j.1460-2075.1993.tb05777.x; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Liu S, 1999, J CLIN INVEST, V103, P207, DOI 10.1172/JCI4243; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; RAY A, 1994, MOL CELL BIOL, V14, P4324, DOI 10.1128/MCB.14.6.4324; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; SCOTT LM, 1992, BLOOD, V80, P1725; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wang Z, 2009, DIABETES, V58, P309, DOI 10.2337/db08-0994; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	32	55	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19248	19254		10.1074/jbc.M109.005678	http://dx.doi.org/10.1074/jbc.M109.005678			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19478079	Green Published, hybrid			2022-12-27	WOS:000267908300015
J	Walmacq, C; Kireeva, ML; Irvin, J; Nedialkov, Y; Lubkowska, L; Malagon, F; Strathern, JN; Kashlev, M				Walmacq, Celine; Kireeva, Maria L.; Irvin, Jordan; Nedialkov, Yuri; Lubkowska, Lucyna; Malagon, Francisco; Strathern, Jeffrey N.; Kashlev, Mikhail			Rpb9 Subunit Controls Transcription Fidelity by Delaying NTP Sequestration in RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE KINETIC-ANALYSIS; STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; DRIVEN TRANSLOCATION; TRIGGER LOOP; IN-VIVO; DEPENDENT RNA-POLYMERASE-(3D(POL)); RIBONUCLEOTIDE INCORPORATION; SEQUENCE INSERTIONS; CLEAVAGE ACTIVITY	Rpb9 is a small non-essential subunit of yeast RNA polymerase II located on the surface on the enzyme. Deletion of the RPB9 gene shows synthetic lethality with the low fidelity rpb1-E1103G mutation localized in the trigger loop, a mobile element of the catalytic Rpb1 subunit, which has been shown to control transcription fidelity. Similar to the rpb1-E1103G mutation, the RPB9 deletion substantially enhances NTP misincorporation and increases the rate of mismatch extension with the next cognate NTP in vitro. Using pre-steady state kinetic analysis, we show that RPB9 deletion promotes sequestration of NTPs in the polymerase active center just prior to the phosphodiester bond formation. We propose a model in which the Rpb9 subunit controls transcription fidelity by delaying the closure of the trigger loop on the incoming NTP via interaction between the C-terminal domain of Rpb9 and the trigger loop. Our findings reveal a mechanism for regulation of transcription fidelity by protein factors located at a large distance from the active center of RNA polymerase II.	[Walmacq, Celine; Kireeva, Maria L.; Irvin, Jordan; Nedialkov, Yuri; Lubkowska, Lucyna; Malagon, Francisco; Strathern, Jeffrey N.; Kashlev, Mikhail] NCI, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Nedialkov, Yuri] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Malagon, Francisco] Aarhus Univ, Inst Mol Biol, DK-8000 Aarhus C, Denmark	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University; Aarhus University	Kashlev, M (corresponding author), NCI, Ctr Canc Res, NIH, Frederick, MD 21702 USA.	mkashlev@mail.ncifcrf.gov	Malagon, Francisco/A-7059-2013; Kireeva, Maria/B-4391-2018	Kireeva, Maria/0000-0003-0527-3182; Irvin, Jordan/0000-0001-8504-5985	National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010795, Z01BC010795, ZIABC011202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health through the NCI. The contents of this publication do not necessarily reveal the views of the policy of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement of the U. S. government.	Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Bischler N, 2002, EMBO J, V21, P4136, DOI 10.1093/emboj/cdf392; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Burton ZF, 2005, BIOCHEM CELL BIOL, V83, P486, DOI 10.1139/O05-059; Castro C, 2005, VIRUS RES, V107, P141, DOI 10.1016/j.virusres.2004.11.004; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Hemming SA, 2000, J BIOL CHEM, V275, P2288, DOI 10.1074/jbc.275.4.2288; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kashkina E, 2006, MOL CELL, V24, P257, DOI 10.1016/j.molcel.2006.10.001; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; KERPPOLA TK, 1990, BIOCHEMISTRY-US, V29, P269, DOI 10.1021/bi00453a037; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Koyama H, 2003, GENES CELLS, V8, P779, DOI 10.1046/j.1365-2443.2003.00677.x; Koyama H, 2007, GENES CELLS, V12, P547, DOI 10.1111/j.1365-2443.2007.01072.x; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; Lorenzen K, 2007, STRUCTURE, V15, P1237, DOI 10.1016/j.str.2007.07.016; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Shaw RJ, 2002, J BIOL CHEM, V277, P24420, DOI 10.1074/jbc.M202059200; TELESNITSKY A, 1989, BIOCHEMISTRY-US, V28, P5210, DOI 10.1021/bi00438a044; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Van Mullem V, 2002, MOL MICROBIOL, V43, P1105; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Xiong YL, 2007, J BIOL CHEM, V282, P36582, DOI 10.1074/jbc.M707014200; Zhang CF, 2005, MOL CELL BIOL, V25, P3583, DOI 10.1128/MCB.25.9.3583-3595.2005; Zhang CF, 2004, J MOL BIOL, V342, P1085, DOI 10.1016/j.jmb.2004.07.070	59	60	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19601	19612		10.1074/jbc.M109.006908	http://dx.doi.org/10.1074/jbc.M109.006908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19439405	Green Published, hybrid			2022-12-27	WOS:000267908300052
J	Weiss, MA				Weiss, Michael A.			Proinsulin and the Genetics of Diabetes Mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GROWTH-FACTOR-I; ENDOPLASMIC-RETICULUM; BIOLOGICAL-ACTIVITY; RECEPTOR-BINDING; DISULFIDE BOND; HUMAN INSULIN; B-CHAIN; FOLDING INTERMEDIATE; ACTIVE CONFORMATION; CONNECTING PEPTIDE	Insulin plays a central role in the regulation of vertebrate metabolism. The hormone, the post-translational product of a single-chain precursor, is a globular protein containing two chains, A (21 residues) and B (30 residues). Recent advances in human genetics have identified dominant mutations in the insulin gene causing permanent neonatal-onset DM2 (1-4). The mutations are predicted to block folding of the precursor in the ER of pancreatic beta-cells. Although expression of the wild-type allele would in other circumstances be sufficient to maintain homeostasis, studies of a corresponding mouse model (5-7) suggest that the misfolded variant perturbs wild-type biosynthesis (8, 9). Impaired beta-cell secretion is associated with ER stress, distorted organelle architecture, and cell death (10). These findings have renewed interest in insulin biosynthesis (11-13) and the structural basis of disulfide pairing (14-19). Protein evolution is constrained not only by structure and function but also by susceptibility to toxic misfolding.	Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu			National Institutes of Health [DK40949, DK0697674]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK069764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK40949 and DK0697674 ( to M. A. W.). This work was also supported by the American Diabetes Association. This minireview is a contribution from the Cleveland Center for Membrane and Structural Biology. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BALDWIN TO, 1993, J BIOL CHEM, V268, P10766; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1997, DIABETOLOGIA, V40, pS48, DOI 10.1007/s001250051400; BREMS DN, 1990, BIOCHEMISTRY-US, V29, P9289, DOI 10.1021/bi00491a026; CHU YC, 1987, BIOCHEMISTRY-US, V26, P6975, DOI 10.1021/bi00396a018; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Creighton TE, 1997, BIOL CHEM, V378, P731; Dai Y, 1996, BBA-PROTEIN STRUCT M, V1296, P63, DOI 10.1016/0167-4838(96)00054-4; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Feng YG, 2003, J MOL BIOL, V330, P821, DOI 10.1016/S0022-2836(03)00660-0; GALLOWAY JA, 1992, DIABETES CARE, V15, P666, DOI 10.2337/diacare.15.5.666; Guo ZY, 2008, ANTIOXID REDOX SIGN, V10, P127, DOI 10.1089/ars.2007.1860; Guo ZY, 2001, BIOL CHEM, V382, P443, DOI 10.1515/BC.2001.054; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; HOBER S, 1992, BIOCHEMISTRY-US, V31, P1749, DOI 10.1021/bi00121a024; Hober S, 1997, BIOCHEMISTRY-US, V36, P4616, DOI 10.1021/bi9611265; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; HUANG XF, 1994, J BIOL CHEM, V269, P20838; Huang YD, 2001, SCI CHINA SER C, V44, P593, DOI 10.1007/BF02879353; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jia XY, 2003, PROTEIN SCI, V12, P2412, DOI 10.1110/ps.0389303; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NARHI LO, 1993, BIOCHEMISTRY-US, V32, P5214, DOI 10.1021/bi00070a033; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; PTITSYN OB, 1991, FEBS LETT, V285, P176, DOI 10.1016/0014-5793(91)80799-9; Qiao ZS, 2006, PROTEIN PEPTIDE LETT, V13, P423, DOI 10.2174/092986606776819583; Qiao ZS, 2001, BIOCHEMISTRY-US, V40, P2662, DOI 10.1021/bi001613r; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; SIEBER P, 1978, H-S Z PHYSIOL CHEM, V359, P113; Slingerland AS, 2005, ANN MED, V37, P186, DOI 10.1080/07853890510007287; SNELL CR, 1975, J BIOL CHEM, V250, P6291; Steiner D F, 1969, Recent Prog Horm Res, V25, P207; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; WANG CC, 1991, TRENDS BIOCHEM SCI, V16, P279, DOI 10.1016/0968-0004(91)90114-B; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8389, DOI 10.1021/bi00488a028; Weiss MA, 2002, BIOCHEMISTRY-US, V41, P809, DOI 10.1021/bi011839+; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yan H, 2003, PROTEIN SCI, V12, P768, DOI 10.1110/ps.0237203; Yoshinaga T, 2005, BIOL CHEM, V386, P1077, DOI 10.1515/BC.2005.124; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang BY, 2003, J BIOL CHEM, V278, P3687, DOI 10.1074/jbc.M209474200; Zhu YL, 2004, ENDOCRINOLOGY, V145, P3840, DOI 10.1210/en.2003-1512	78	60	62	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19159	19163		10.1074/jbc.R109.009936	http://dx.doi.org/10.1074/jbc.R109.009936			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19395706	Green Published, hybrid			2022-12-27	WOS:000267908300002
J	Bansal, PK; Mishra, A; High, AA; Abdulle, R; Kitagawa, K				Bansal, Parmil K.; Mishra, Ashutosh; High, Anthony A.; Abdulle, Rashid; Kitagawa, Katsumi			Sgt1 Dimerization Is Negatively Regulated by Protein Kinase CK2-mediated Phosphorylation at Ser361	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE KINETOCHORE; CENTROMERE-BINDING PROTEIN; BUDDING YEAST KINETOCHORE; CHROMOSOME SEGREGATION; ESSENTIAL COMPONENT; CASEIN KINASE-2; IN-VIVO; HSP90; GENE; DNA	The kinetochore, which consists of centromere DNA and structural proteins, is essential for proper chromosome segregation in eukaryotes. In budding yeast, Sgt1 and Hsp90 are required for the binding of Skp1 to Ctf13 ( a component of the core kinetochore complex CBF3) and therefore for the assembly of CBF3. We have previously shown that Sgt1 dimerization is important for this kinetochore assembly mechanism. In this study, we report that protein kinase CK2 phosphorylates Ser(361) on Sgt1, and this phosphorylation inhibits Sgt1 dimerization.	[Bansal, Parmil K.; Abdulle, Rashid; Kitagawa, Katsumi] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; [Mishra, Ashutosh; High, Anthony A.] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kitagawa, K (corresponding author), St Jude Childrens Hosp, Dept Mol Pharmacol, MS 230,262 Danny Thomas Pl, Memphis, TN 38105 USA.	katsumi.kitagawa@stjude.org			National Institutes of Health [GM68418]; NCI; Cancer Center [CA21765]; American Lebanese Syrian Association Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center; American Lebanese Syrian Association Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Cancer Center Support Grant CA21765 and National Institutes of Health Grant GM68418. This work was also supported by the American Lebanese Syrian Association Charities.	Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; BAKER RE, 1990, MOL CELL BIOL, V10, P2458, DOI 10.1128/MCB.10.6.2458; Bansal PK, 2009, J BIOL CHEM, V284, P3586, DOI 10.1074/jbc.M806281200; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; CAI MJ, 1989, MOL CELL BIOL, V9, P2544, DOI 10.1128/MCB.9.6.2544; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; CARMICHAEL DF, 1982, J BIOL CHEM, V257, P440; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Domanska K, 2005, ACTA BIOCHIM POL, V52, P947; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; Fritz G, 1999, ONCOGENE, V18, P1033, DOI 10.1038/sj.onc.1202394; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; HEGEMANN JH, 1988, MOL CELL BIOL, V8, P2523, DOI 10.1128/MCB.8.6.2523; HIETER P, 1985, CELL, V42, P913, DOI 10.1016/0092-8674(85)90287-9; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JIANG WD, 1993, J CELL BIOL, V121, P513, DOI 10.1083/jcb.121.3.513; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Kitagawa K, 2003, MOL CELL, V11, P1201, DOI 10.1016/S1097-2765(03)00145-X; Kitagawa K, 2002, BIOTECHNIQUES, V33, P288, DOI 10.2144/02332bm07; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; LECHNER J, 1994, EMBO J, V13, P5203, DOI 10.1002/j.1460-2075.1994.tb06851.x; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mckenzie JA, 2003, ANAL BIOCHEM, V313, P9; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; Nowotny M, 2003, J BIOL CHEM, V278, P26923, DOI 10.1074/jbc.M211518200; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Rose MD., 1990, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Sorger PK, 1995, P NATL ACAD SCI USA, V92, P12026, DOI 10.1073/pnas.92.26.12026; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Stemmann O, 1996, EMBO J, V15, P3611, DOI 10.1002/j.1460-2075.1996.tb00730.x; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; STRUNNIKOV AV, 1995, J CELL BIOL, V128, P749, DOI 10.1083/jcb.128.5.749; Sudakin V, 2007, BIODRUGS, V21, P225, DOI 10.2165/00063030-200721040-00003; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	49	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18692	18698		10.1074/jbc.M109.012732	http://dx.doi.org/10.1074/jbc.M109.012732			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19398558	hybrid, Green Published			2022-12-27	WOS:000267711500018
J	Chen, SH; Zhou, HL				Chen, Sheng-hong; Zhou, Huilin			Reconstitution of Rad53 Activation by Mec1 through Adaptor Protein Mrc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; S-PHASE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; REPLICATION FORKS; FHA DOMAIN; IN-VITRO; FISSION YEAST; KINASE CDS1; DPB11; PHOSPHORYLATION	Upon DNA replication stress, stalled DNA replication forks serve as a platform to recruit many signaling proteins, leading to the activation of the DNA replication checkpoint. Activation of Rad53, a key effector kinase in the budding yeast Saccharomyces cerevisiae, is essential for stabilizing DNA replication forks during replication stress. Using an activity-based assay for Rad53, we found that Mrc1, a replication fork-associated protein, cooperates with Mec1 to activate Rad53 directly. Reconstitution of Rad53 activation using purified Mec1 and Mrc1 showed that the addition of Mrc1 stimulated a more than 70-fold increase in the ability of Mec1 to activate Rad53. Instead of increasing the catalytic activity of Mec1, Mrc1 was found to facilitate the phosphorylation of Rad53 by Mec1 via promotion of a stronger enzyme-substrate interaction between them. Further, the conserved C-terminal domain of Mrc1 was found to be required for Rad53 activation. These results thus provide insights into the role of the adaptor protein Mrc1 in activating Rad53 in the DNA replication checkpoint.	[Chen, Sheng-hong] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Chen, Sheng-hong; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), CMM E, Rm 3050,9500 Gilman Dr, La Jolla, CA 92093 USA.	huzhou@ucsd.edu	Chen, Sheng-hong/AAU-4018-2021	Chen, Sheng-hong/0000-0002-7722-2221; Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health [GM080469]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080469 ( to H. Z.).	Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Lee SJ, 2004, MOL BIOL CELL, V15, P5443, DOI 10.1091/mbc.E04-07-0608; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Nakada D, 2005, MOL BIOL CELL, V16, P5227, DOI 10.1091/mbc.E05-05-0405; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Pasero P, 1999, METHODS, V18, P368, DOI 10.1006/meth.1999.0794; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Usui T, 2007, P NATL ACAD SCI USA, V104, P2797, DOI 10.1073/pnas.0611259104; Wang H, 2002, GENETICS, V160, P1295; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Zhao H, 2004, J BIOL CHEM, V279, P53023, DOI 10.1074/jbc.M410449200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	44	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18593	18604		10.1074/jbc.M109.018242	http://dx.doi.org/10.1074/jbc.M109.018242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19457865	hybrid, Green Published			2022-12-27	WOS:000267711500008
J	Brooks, YS; Wang, G; Yang, Z; Smith, KK; Bieberich, E; Ko, L				Brooks, Yang S.; Wang, Guanghu; Yang, Zheqiong; Smith, Kimberly K.; Bieberich, Erhard; Ko, Lan			Functional Pre-mRNA trans-Splicing of Coactivator CoAA and Corepressor RBM4 during Stem/Progenitor Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICED LEADER SEQUENCE; BINDING PROTEIN; NONCODING RNA; STEM-CELLS; DROSOPHILA; TRANSCRIPTION; CEREBELLUM; EXPRESSION; MUTATIONS; DIVERSITY	Alternative splicing yields functionally distinctive gene products, and their balance plays critical roles in cell differentiation and development. We have previously shown that tumor-associated enhancer loss in coactivator gene CoAA leads to its altered alternative splicing. Here we identified two intergenic splicing variants, a zinc finger-containing coactivator CoAZ and a non-coding transcript ncCoAZ, between CoAA and its downstream corepressor gene RBM4. During stem/progenitor cell neural differentiation, we found that the switched alternative splicing and trans-splicing between CoAA and RBM4 transcripts result in lineage-specific expression of wild type CoAA, RBM4, and their variants. Stable expression of CoAA, RBM4, or their variants prevents the switch and disrupts the embryoid body formation. In addition, CoAA and RBM4 counter-regulate the target gene Tau at exon 10, and their splicing activities are subjected to the control by each splice variant. Further phylogenetic analysis showed that mammalian CoAA and RBM4 genes share common ancestry with the Drosophila melanogaster gene Lark, which is known to regulate early development and circadian rhythms. Thus, the trans-splicing between CoAA and RBM4 transcripts may represent a required regulation preserved during evolution. Our results demonstrate that a linked splicing control of transcriptional coactivator and corepressor is involved in stem/progenitor cell differentiation. The alternative splicing imbalance of CoAA and RBM4, because of loss of their common enhancer in cancer, may deregulate stem/progenitor cell differentiation.	[Brooks, Yang S.; Wang, Guanghu; Yang, Zheqiong; Bieberich, Erhard; Ko, Lan] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Smith, Kimberly K.; Ko, Lan] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Ko, L (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, 1120 15th St,CB2803, Augusta, GA 30912 USA.	lko@mcg.edu		Ko, Lan/0000-0002-0089-9090	Georgia Cancer Coalition Distinguished Cancer Scholar Award	Georgia Cancer Coalition Distinguished Cancer Scholar Award	This work was supported by a Georgia Cancer Coalition Distinguished Cancer Scholar Award (to L. K.).	Adamia S, 2005, BLOOD, V105, P4836, DOI 10.1182/blood-2004-10-3825; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Brose MS, 2004, GENET TEST, V8, P133, DOI 10.1089/1090657041797347; Cavaleri F, 2003, CELL, V113, P551, DOI 10.1016/S0092-8674(03)00394-5; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; Dehmelt L, 2005, GENOME BIOL, V6; Dorn R, 2001, P NATL ACAD SCI USA, V98, P9724, DOI 10.1073/pnas.151268698; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; EUL J, 1995, EMBO J, V14, P3226, DOI 10.1002/j.1460-2075.1995.tb07325.x; Finta C, 2002, J BIOL CHEM, V277, P5882, DOI 10.1074/jbc.M109175200; Goedert M, 2005, MOVEMENT DISORD, V20, pS45, DOI 10.1002/mds.20539; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; Jackson FB, 1997, GENOMICS, V41, P444, DOI 10.1006/geno.1997.4704; Kalnina Z, 2005, GENE CHROMOSOME CANC, V42, P342, DOI 10.1002/gcc.20156; Kang YK, 2008, CANCER RES, V68, P7887, DOI 10.1158/0008-5472.CAN-08-1734; Kar A, 2006, J BIOL CHEM, V281, P24479, DOI 10.1074/jbc.M603971200; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mayer MG, 2005, MEM I OSWALDO CRUZ, V100, P501, DOI 10.1590/S0074-02762005000500010; McNeil GP, 1998, NEURON, V20, P297, DOI 10.1016/S0896-6273(00)80457-2; McNeil GP, 2001, GENETICS, V159, P229; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Neklason Deborah W, 2004, Fam Cancer, V3, P35; Ozcelik H, 1999, HUM MUTAT, V14, P540, DOI 10.1002/(SICI)1098-1004(199912)14:6<540::AID-HUMU13>3.3.CO;2-3; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; PARSONS M, 1984, CELL, V38, P309, DOI 10.1016/0092-8674(84)90552-X; Pfuhl T, 2008, NEUROSCI LETT, V444, P11, DOI 10.1016/j.neulet.2008.08.017; Pittman AM, 2006, HUM MOL GENET, V15, pR188, DOI 10.1093/hmg/ddl190; RAJKOVIC A, 1990, P NATL ACAD SCI USA, V87, P8879, DOI 10.1073/pnas.87.22.8879; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Sui Y, 2007, ONCOGENE, V26, P822, DOI 10.1038/sj.onc.1209847; TESSIER LH, 1991, EMBO J, V10, P2621, DOI 10.1002/j.1460-2075.1991.tb07804.x; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yang ZQ, 2007, NUCLEIC ACIDS RES, V35, P1919, DOI 10.1093/nar/gkl1092; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196	52	28	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18033	18046		10.1074/jbc.M109.006999	http://dx.doi.org/10.1074/jbc.M109.006999			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416963	Green Published, hybrid			2022-12-27	WOS:000267712400015
J	Khozoie, C; Pleass, RJ; Avery, SV				Khozoie, Combiz; Pleass, Richard J.; Avery, Simon V.			The Antimalarial Drug Quinine Disrupts Tat2p-mediated Tryptophan Transport and Causes Tryptophan Starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-TRANSPORT; SACCHAROMYCES-CEREVISIAE; PLASMODIUM-FALCIPARUM; GENE-EXPRESSION; YEAST; TOXICITY; MALARIA; PERMEASES; PROTEINS; SYSTEM	Quinine is a major drug of choice for the treatment of malaria. However, the primary mode of quinine action is unclear, and its efficacy is marred by adverse reactions among patients. To help address these issues, a genome-wide screen for quinine sensitivity was carried out using the yeast deletion strain collection. Quinine-sensitive mutants identified in the screen included several that were defective for tryptophan biosynthesis (trp strains). This sensitivity was confirmed in independent assays and was suppressible with exogenous Trp, suggesting that quinine caused Trp starvation. Accordingly, quinine was found to inhibit [H-3] Trp uptake by cells, and the quinine sensitivity of a trp1 Delta mutant could be rescued by overexpression of Trp permeases, encoded by TAT1 and TAT2. The site of quinine action was identified specifically as the high affinity Trp/Tyr permease, Tat2p, with which quinine associated in a Trp-suppressible manner. A resultant action also on Tyr levels was reflected by the Tyr-suppressible quinine hypersensitivity of an aro7 Delta deletion strain, which is auxotrophic for Tyr (and Phe). The present genome-wide dataset provides an important resource for discovering modes of quinine toxicity. That potential was validated with our demonstration that Trp and Tyr uptake via Tat2p is a major target of cellular quinine toxicity. The results also suggest that dietary tryptophan supplements could help to avert the toxic effects of quinine.	[Khozoie, Combiz; Pleass, Richard J.; Avery, Simon V.] Univ Nottingham, Sch Biol, Inst Genet, Nottingham NG7 2RD, England	University of Nottingham	Pleass, RJ (corresponding author), Univ Nottingham, Sch Biol, Inst Genet, Univ Pk, Nottingham NG7 2RD, England.	Richard.Pleass@nottingham.ac.uk; Simon.Avery@nottingham.ac.uk	Avery, Simon/U-5816-2019; Pleass, Richard/N-7831-2019; Avery, Simon/AAS-5291-2021; Pleass, Richard J/L-4148-2015	Pleass, Richard/0000-0001-7438-8296; Avery, Simon/0000-0002-2102-2255; Pleass, Richard J/0000-0001-7438-8296	Sir Halley Stewart Trust	Sir Halley Stewart Trust	This work was supported by a grant from the Sir Halley Stewart Trust (to S.V.A. and R.J.P.).	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; ABE F, 2007, INT C TRYPT REL SUBS, P75; Alkadi HO, 2007, CHEMOTHERAPY, V53, P385, DOI 10.1159/000109767; ALVAN G, 1991, BRIT J CLIN PHARMACO, V31, P409, DOI 10.1111/j.1365-2125.1991.tb05554.x; AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Avery SV, 2000, J BACTERIOL, V182, P76, DOI 10.1128/JB.182.1.76-80.2000; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bell DJ, 2007, EXPERT REV ANTI-INFE, V5, P141, DOI 10.1586/14787210.5.1.141; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Bisswanger H., 2008, ENZYME KINETICS PRIN; Blackburn AS, 2003, ANTIMICROB AGENTS CH, V47, P676, DOI 10.1128/AAC.47.2.676-681.2003; Booij L, 2006, BIOL PSYCHIAT, V60, P507, DOI 10.1016/j.biopsych.2006.02.010; Craig CL, 1998, MOL BIOL EVOL, V15, P774, DOI 10.1093/oxfordjournals.molbev.a025981; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Dobson PD, 2009, CURR TOP MED CHEM, V9, P163, DOI 10.2174/156802609787521616; Ericson E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000151; Eriksson T, 1997, PSYCHOL MED, V27, P477, DOI 10.1017/S0033291796003935; Ferreira PE, 2008, PERS MED, V5, P627, DOI 10.2217/17410541.5.6.627; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GREASHAM RL, 1973, J BACTERIOL, V115, P975, DOI 10.1128/JB.115.3.975-981.1973; Hall AP, 1997, BRIT J OPHTHALMOL, V81, P1029, DOI 10.1136/bjo.81.12.1029; Holland S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r268; Huston M, 2006, J EMERG MED, V31, P395, DOI 10.1016/j.jemermed.2006.07.018; Kakkar T, 1999, DRUG METAB DISPOS, V27, P756; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; LEETE E, 1969, ACCOUNTS CHEM RES, V2, P59, DOI 10.1021/ar50014a005; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Lovegrove FE, 2008, TRENDS PARASITOL, V24, P288, DOI 10.1016/j.pt.2008.04.004; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Morales FJ, 2007, J AGR FOOD CHEM, V55, P6793, DOI 10.1021/jf071036e; Morton CO, 2007, ANTIMICROB AGENTS CH, V51, P3948, DOI 10.1128/AAC.01007-07; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; PEET M, 1976, BRIT J PSYCHIAT, V128, P255, DOI 10.1192/bjp.128.3.255; Porter RJ, 2008, J AFFECT DISORDERS, V109, P209, DOI 10.1016/j.jad.2007.11.010; Raiford DW, 2008, J MOL EVOL, V67, P621, DOI 10.1007/s00239-008-9162-9; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Rojas M, 2008, ANTIMICROB AGENTS CH, V52, P3844, DOI 10.1128/AAC.00532-08; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Seymour RL, 2006, J LEUKOCYTE BIOL, V80, P1320, DOI 10.1189/jlb.1205727; Simpson JJ, 2000, HEARING RES, V145, P1, DOI 10.1016/S0378-5955(00)00093-9; Smith MCA, 2007, MOL MICROBIOL, V66, P699, DOI 10.1111/j.1365-2958.2007.05951.x; Sullivan DJ, 2002, INT J PARASITOL, V32, P1645, DOI 10.1016/S0020-7519(02)00193-5; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003; Tetsutani K, 2007, PARASITOLOGY, V134, P923, DOI 10.1017/S0031182007002326; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Tucker CL, 2004, COMP FUNCT GENOM, V5, P216, DOI 10.1002/cfg.391; van der Veen FM, 2008, PSYCHOPHARMACOLOGY, V199, P255, DOI 10.1007/s00213-008-1176-x; Welsch CA, 2003, J BIOL CHEM, V278, P26976, DOI 10.1074/jbc.M213144200; WOLF L R, 1992, Journal of Emergency Medicine, V10, P295, DOI 10.1016/0736-4679(92)90336-R; Zhang NS, 2003, GENE, V303, P121, DOI 10.1016/S0378-1119(02)01142-3	57	34	35	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17968	17974		10.1074/jbc.M109.005843	http://dx.doi.org/10.1074/jbc.M109.005843			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416971	Green Published, hybrid			2022-12-27	WOS:000267712400008
J	Menon, BRK; Waltho, JP; Scrutton, NS; Heyes, DJ				Menon, Binuraj R. K.; Waltho, Jonathan P.; Scrutton, Nigel S.; Heyes, Derren J.			Cryogenic and Laser Photoexcitation Studies Identify Multiple Roles for Active Site Residues in the Light-driven Enzyme Protochlorophyllide Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRODUCT RELEASE STEPS; CATALYTIC CYCLE; DIRECTED MUTAGENESIS; REDUCTASE; NADPH; IDENTIFICATION; DEHYDROGENASE; ENZYMOLOGY; DYNAMICS; INSIGHTS	The light-activated enzyme NADPH-protochlorophyllide oxidoreductase (POR) catalyzes the trans addition of hydrogen across the C-17-C-18 double bond of protochlorophyllide ( Pchlide), a key step in chlorophyll biosynthesis. Similar to other members of the short chain alcohol dehydrogenase/reductase family of enzymes, POR contains a conserved Tyr and Lys residue in the enzyme active site, which are implicated in a proposed reaction mechanism involving proton transfer from the Tyr hydoxyl group to Pchlide. We have analyzed a number of POR variant enzymes altered in these conserved residues using a combination of steady-state turnover, laser photoexcitation studies, and low temperature fluorescence spectroscopy. None of the mutations completely abolished catalytic activity. We demonstrate their importance to catalysis by defining multiple roles in the overall reaction pathway. Mutation of either residue impairs formation of the ground state ternary enzyme-substrate complex, pointing to a key role in substrate binding. By analyzing the most active variant (Y193F), we show that Tyr-193 participates in proton transfer to Pchlide and stabilizes the Pchlide excited state, enabling hydride transfer from NADPH to Pchilde. Thus, in addition to confirming the probable identity of the proton donor in Pchlide reduction, our work defines additional roles for these residues in facilitating hydride transfer through stabilization of the ground and excited states of the ternary enzyme complex.	[Menon, Binuraj R. K.; Waltho, Jonathan P.; Scrutton, Nigel S.; Heyes, Derren J.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Manchester	Scrutton, NS (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk; derren.heyes@manchester.ac.uk	menon, binuraj/D-6731-2015; Menon, Binuraj/AAO-7752-2021	Menon, Binuraj/0000-0001-6852-8053; Heyes, Derren/0000-0002-7453-1571; Waltho, Jonathan/0000-0002-7402-5492	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; BBSRC [BB/D01963X/1, BB/D01798X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01798X/1, BB/D01963X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom.	BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; CHEN Z, 1993, BIOCHEMISTRY-US, V32, P3342, DOI 10.1021/bi00064a017; DEONARAIN MP, 1989, BIOCHEMISTRY-US, V28, P9602, DOI 10.1021/bi00451a008; Dietzek B, 2006, J PHYS CHEM B, V110, P4399, DOI 10.1021/jp0556456; Dietzek B, 2009, CHEMPHYSCHEM, V10, P144, DOI 10.1002/cphc.200800536; ENSOR CM, 1991, BIOCHEM BIOPH RES CO, V176, P840, DOI 10.1016/S0006-291X(05)80262-1; Hammes-Schiffer S, 2002, BIOCHEMISTRY-US, V41, P13335, DOI 10.1021/bi0267137; HENNEKE CM, 1975, ARCH BIOCHEM BIOPHYS, V168, P436, DOI 10.1016/0003-9861(75)90272-6; Heyes DJ, 2008, BIOCHEMISTRY-US, V47, P10991, DOI 10.1021/bi801521c; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2009, J BIOL CHEM, V284, P3762, DOI 10.1074/jbc.M808548200; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, BIOCHEM SOC T, V30, P601, DOI 10.1042/bst0300601; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Jimenez MC, 2005, CHEM SOC REV, V34, P783, DOI 10.1039/b416410p; Kohen A, 2000, J AM CHEM SOC, V122, P10738, DOI 10.1021/ja002229k; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Lebedev N, 2001, BIOCHEMISTRY-US, V40, P12562, DOI 10.1021/bi0105025; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; OBEID J, 1992, BIOCHEM BIOPH RES CO, V188, P222, DOI 10.1016/0006-291X(92)92373-6; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Sutcliffe MJ, 2000, TRENDS BIOCHEM SCI, V25, P405, DOI 10.1016/S0968-0004(00)01642-X; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; VALERA V, 1987, BIOCHEM BIOPH RES CO, V148, P515, DOI 10.1016/0006-291X(87)91141-7; VARUGHESE KI, 1994, P NATL ACAD SCI USA, V91, P5582, DOI 10.1073/pnas.91.12.5582; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; Zhao GJ, 2008, BIOPHYS J, V94, P38, DOI 10.1529/biophysj.107.113738; Zheng YJ, 1997, J AM CHEM SOC, V119, P1523, DOI 10.1021/ja961667h	39	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18160	18166		10.1074/jbc.M109.020719	http://dx.doi.org/10.1074/jbc.M109.020719			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19439417	Green Published, hybrid			2022-12-27	WOS:000267712400027
J	Sy, SMH; Huen, MSY; Zhu, YY; Chen, JJ				Sy, Shirley M. -H.; Huen, Michael S. Y.; Zhu, Yongyou; Chen, Junjie			PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; STRAND BREAK REPAIR; TUMOR-SUPPRESSOR GENES; S-PHASE CHECKPOINT; HOMOLOGOUS RECOMBINATION; GENOMIC STABILITY; FANCONI-ANEMIA; SACCHAROMYCES-CEREVISIAE; HUMAN CTIP; PROTEIN	Maintenance of genomic stability ensures faithful transmission of genetic information and helps suppress neoplastic transformation and tumorigenesis. Although recent progress has advanced our understanding of DNA damage checkpoint regulations, little is known as to how DNA repair, especially the RAD51-dependent homologous recombination repair pathway, is executed in vivo. Here, we reveal novel properties of the BRCA2-associated protein PALB2 in the assembly of the recombinational DNA repair machinery at DNA damage sites. Although the chromatin association of PALB2 is a prerequisite for subsequent BRCA2 and RAD51 loading, the focal accumulation of the PALB2.BRCA2.RAD51 complex at DSBs occurs independently of known DNA damage checkpoint and repair proteins. We provide evidence to support that PALB2 exists as homo-oligomers and that PALB2 oligomerization is essential for its focal accumulation at DNA breaks in vivo. We propose that both PALB2 chromatin association and its oligomerization serve to secure the BRCA2.RAD51 repair machinery at the sites of DNA damage. These attributes of PALB2 are likely instrumental for proficient homologous recombination DNA repair in the cell.	[Sy, Shirley M. -H.; Huen, Michael S. Y.; Zhu, Yongyou; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, Hunter Bldg Rm 213C,333 Cedar St,POB 208040, New Haven, CT 06520 USA.	Junjie.Chen@yale.edu	Zhu, Yongyou/H-3791-2013; Huen, Michael Shing Yan/E-9862-2010	Sy, Ming Hui/0000-0002-2731-6692	National Institutes of Health [CA089239]; NATIONAL CANCER INSTITUTE [R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA089239 ( to J. C.).	Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Lord CJ, 2007, NAT STRUCT MOL BIOL, V14, P461, DOI 10.1038/nsmb0607-461; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shin DS, 2004, DNA REPAIR, V3, P863, DOI 10.1016/j.dnarep.2004.03.022; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Usui T, 2009, MOL CELL, V33, P147, DOI 10.1016/j.molcel.2008.12.022; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhang HB, 1998, CELL, V92, P433, DOI 10.1016/S0092-8674(00)80936-8; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	44	75	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18302	18310		10.1074/jbc.M109.016717	http://dx.doi.org/10.1074/jbc.M109.016717			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19423707	hybrid, Green Published			2022-12-27	WOS:000267712400043
J	Qadri, YJ; Berdiev, BK; Song, YH; Lippton, HL; Fuller, CM; Benos, DJ				Qadri, Yawar J.; Berdiev, Bakhrom K.; Song, Yuhua; Lippton, Howard L.; Fuller, Catherine M.; Benos, Dale J.			Psalmotoxin-1 Docking to Human Acid-sensing Ion Channel-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARANTULA TOXIN PSALMOTOXIN-1; POISSON-BOLTZMANN EQUATION; PROTEIN-DOCKING; MOLECULAR-DYNAMICS; PEPTIDE INHIBITOR; PK(A) VALUES; NA+ CHANNEL; ASIC1A; PH; RATIONALIZATION	Acid- sensing ion channel-1 (ASIC-1) is a proton-gated ion channel implicated in nociception and neuronal death during ischemia. Recently the first crystal structure of a chicken ASIC was obtained. Expanding upon this work, homology models of the human ASICs were constructed and evaluated. Energy-minimized structures were tested for validity by in silico docking of the models to psalmotoxin-1, which potently inhibits ASIC-1 and not other members of the family. The data are consistent with prior radioligand binding and functional assays while also explaining the selectivity of PcTX-1 for homomeric hASIC-1a. Binding energy calculations suggest that the toxin and channel create a complex that is more stable than the channel alone. The binding is dominated by the coulombic contributions, which account for why the toxin-channel interaction is not observed at low pH. The computational data were experimentally verified with single channel and whole-cell electrophysiological studies. These validated models should allow for the rational design of specific and potent peptidomimetic compounds that may be useful for the treatment of pain or ischemic stroke.	[Benos, Dale J.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Berdiev, Bakhrom K.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Song, Yuhua] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Lippton, Howard L.] Pneumosite LLC, Shreveport, LA 71103 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA.	benos@uab.edu	Fuller, Cathy/B-4046-2011	Qadri, Yawar/0000-0003-2138-4018	National Institutes of Health [DK37206]; American Medical Association Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037206, R01DK037206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Medical Association Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK37206. This work was also supported by the American Medical Association Foundation.	Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Berdiev BK, 2002, J BIOL CHEM, V277, P45734, DOI 10.1074/jbc.M208995200; Berdiev BK, 2001, J BIOL CHEM, V276, P38755, DOI 10.1074/jbc.M107266200; Chagot B, 2005, PROTEIN SCI, V14, P2003, DOI 10.1110/ps.051378905; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; Holst M, 2001, ADV COMPUT MATH, V15, P139, DOI 10.1023/A:1014246117321; Holst M, 2001, J COMPUT CHEM, V22, P475, DOI 10.1002/1096-987X(200103)22:4<475::AID-JCC1018>3.0.CO;2-7; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Ismailov II, 1997, J PHYSIOL-LONDON, V504, P287, DOI 10.1111/j.1469-7793.1997.287be.x; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jensen JE, 2009, TOXICON, V54, P56, DOI 10.1016/j.toxicon.2009.03.014; Kedem K, 1999, PROTEINS, V37, P554, DOI 10.1002/(SICI)1097-0134(19991201)37:4<554::AID-PROT6>3.0.CO;2-1; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Reddy SLC, 2006, EUR J CARDIO-THORAC, V30, P126, DOI 10.1016/j.ejcts.2006.03.045; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Samways DSK, 2009, CELL CALCIUM, V45, P319, DOI 10.1016/j.ceca.2008.12.002; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2007, FRONT BIOSCI-LANDMRK, V12, P1376, DOI 10.2741/2154; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	49	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17625	17633		10.1074/jbc.M109.003913	http://dx.doi.org/10.1074/jbc.M109.003913			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19395383	hybrid, Green Published			2022-12-27	WOS:000267202500028
J	Datta, K; Johnson, NP; LiCata, VJ; von Hippel, PH				Datta, Kausiki; Johnson, Neil P.; LiCata, Vince J.; von Hippel, Peter H.			Local Conformations and Competitive Binding Affinities of Single- and Double-stranded Primer-Template DNA at the Polymerization and Editing Active Sites of DNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I KLENOW FRAGMENT; SEDIMENTATION-VELOCITY ANALYSIS; COEFFICIENT DISTRIBUTIONS C(S); PROTEIN-PROTEIN INTERACTIONS; NUCLEIC-ACID FRAMEWORK; LOW-ENERGY CD; ESCHERICHIA-COLI; THERMUS-AQUATICUS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	In addition to their capacity for template-directed 5' -> 3' DNA synthesis at the polymerase (pol) site, DNA polymerases have a separate 3' -> 5' exonuclease (exo) editing activity that is involved in assuring the fidelity of DNA replication. Upon mis-incorporation of an incorrect nucleotide residue, the 3' terminus of the primer strand at the primer-template (P/T) junction is preferentially transferred to the exo site, where the faulty residue is excised, allowing the shortened primer to rebind to the template strand at the pol site and incorporate the correct dNTP. Here we describe the conformational changes that occur in the primer strand as it shuttles between the pol and exo sites of replication-competent Klenow and Klentaq DNA polymerase complexes in solution and use these conformational changes to measure the equilibrium distribution of the primer between these sites for P/TDNA constructs carrying both matched and mismatched primer termini. To this end, we have measured the fluorescence and circular dichroism spectra at wavelengths of >300 nm for conformational probes comprising pairs of 2-aminopurine bases site-specifically replacing adenine bases at various positions in the primer strand of P/T DNA constructs bound to DNA polymerases. Control experiments that compare primer conformations with available x-ray structures confirm the validity of this approach. These distributions and the conformational changes in the P/T DNA that occur during template-directed DNA synthesis in solution illuminate some of the mechanisms used by DNA polymerases to assure the fidelity of DNA synthesis.	[Datta, Kausiki; von Hippel, Peter H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Datta, Kausiki; von Hippel, Peter H.] Univ Oregon, Dept Chem, Eugene, OR 97403 USA; [Johnson, Neil P.] CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France; [LiCata, Vince J.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	University of Oregon; University of Oregon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Louisiana State University System; Louisiana State University	von Hippel, PH (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	petevh@molbio.uoregon.edu		von Hippel, Peter H./0000-0003-2512-8097	National Institutes of Health [GM-15792]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015792, R37GM015792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-15792 ( to P. H. v. H.).	Allen WJ, 2008, PROTEIN SCI, V17, P401, DOI 10.1110/ps.073309208; ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945; Bailey MF, 2001, METHODS, V25, P62, DOI 10.1006/meth.2001.1216; Bailey MF, 2007, BIOCHEMISTRY-US, V46, P8085, DOI 10.1021/bi6024148; Beechem JM, 1998, BIOCHEMISTRY-US, V37, P10144, DOI 10.1021/bi980074b; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CARVER TE, 1994, P NATL ACAD SCI USA, V91, P10670, DOI 10.1073/pnas.91.22.10670; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Datta K, 2003, J BIOL CHEM, V278, P5694, DOI 10.1074/jbc.M208133200; Datta K, 2008, J BIOL CHEM, V283, P3537, DOI 10.1074/jbc.M707998200; Datta K, 2006, J MOL BIOL, V360, P800, DOI 10.1016/j.jmb.2006.05.053; DELUCIA P, 1969, NATURE, V224, P1164, DOI 10.1038/2241164a0; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Gangurde R, 2002, BIOCHEMISTRY-US, V41, P14552, DOI 10.1021/bi0264216; Hariharan C, 2005, BIOCHEMISTRY-US, V44, P15674, DOI 10.1021/bi051462y; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Johnson NP, 2005, J BIOL CHEM, V280, P32177, DOI 10.1074/jbc.M504619200; Johnson NP, 2004, P NATL ACAD SCI USA, V101, P3426, DOI 10.1073/pnas.0400591101; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Jose D, 2009, P NATL ACAD SCI USA, V106, P4231, DOI 10.1073/pnas.0900803106; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 1995, METHOD ENZYMOL, V262, P3; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KOROLEV S, 1995, P NATL ACAD SCI USA, V92, P9264, DOI 10.1073/pnas.92.20.9264; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Kukreti P, 2008, J BIOL CHEM, V283, P17979, DOI 10.1074/jbc.M801053200; KUNKEL TA, 1988, CELL, V53, P837, DOI 10.1016/S0092-8674(88)90189-4; Lam WC, 1998, BIOCHEMISTRY-US, V37, P1513, DOI 10.1021/bi9720181; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; MULLEN GP, 1990, J BIOL CHEM, V265, P14327; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; SETLOW P, 1972, J BIOL CHEM, V247, P224; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Thompson EHZ, 2002, BIOCHEMISTRY-US, V41, P713, DOI 10.1021/bi0114271; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Tleugabulova D, 2007, BIOCHEMISTRY-US, V46, P6559, DOI 10.1021/bi700380a; Turner RM, 2003, BIOCHEMISTRY-US, V42, P2373, DOI 10.1021/bi026566c	48	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17180	17193		10.1074/jbc.M109.007641	http://dx.doi.org/10.1074/jbc.M109.007641			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19411253	Green Published, hybrid			2022-12-27	WOS:000266962400056
J	Frey, T; De Maio, A				Frey, Tiffany; De Maio, Antonio			The Antifungal Agent Itraconazole Induces the Accumulation of High Mannose Glycoproteins in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED GLYCOSYLATION; SECRETORY PATHWAY; INHIBITION; CD14; LYMPHOCYTE; ACTIVATION; BACTERIA; CALCIUM; LPS	Bacterial lipopolysaccharide (LPS) is a key mediator in the development of Gram-negative septic shock, which is a major health problem. The effect of LPS on myeloid cells is mediated by a multicomplex receptor system in which CD14, a glycosylphosphatidylinositol-anchored glycoprotein, and Toll-like receptor 4 are the major players. We have found that incubation of macrophages with itraconazole (ICZ), an azole antifungal commonly used in humans, altered both the expression and glycosylation of CD14. This glycoprotein, which is endo H-resistant in untreated cells, becomes endo H-sensitive following ICZ treatment. The effect of ICZ on glycan processing was observed in all newly synthesized glycoproteins as indicated by incorporation of [2-H-3] mannose. In addition, cells treated with ICZ increased surface concanavalin A (ConA) binding, corroborating an increase in high mannose surface glycoproteins. Although the glycosylation pattern of CD14 was altered, this glycoprotein was delivered to the cell surface or was secreted. Moreover, it appeared functional as demonstrated by the release of LPS-induced tumor necrosis factor-alpha under conditions specific for a CD14-mediated activation process. The effect of ICZ on glycosylation was not dependent on inhibition of the cholesterol biosynthetic pathway and was specific for this drug because other azole antifungals, such as ketoconazole and econazole, did not alter glycan processing. These results suggest a possible secondary effect of ICZ that impacts the processing of glyconjugates and may alter cellular function and homeostasis.	[De Maio, Antonio] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [De Maio, Antonio] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [De Maio, Antonio] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins University	De Maio, A (corresponding author), 9500 Gilman Dr 0739, La Jolla, CA 92093 USA.	ademaio@ucsd.edu			National Institutes of Health Grant NIGMS [GM 073825, GM05078]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073825] Funding Source: NIH RePORTER	National Institutes of Health Grant NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant NIGMS Grants GM 073825 and GM05078.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; BRUMMER E, 1992, ANTIMICROB AGENTS CH, V36, P2487, DOI 10.1128/AAC.36.11.2487; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; DEMAIO A, 1986, CELL IMMUNOL, V99, P345, DOI 10.1016/0008-8749(86)90243-1; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Frey T, 2007, MOL MED, V13, P592, DOI 10.2119/2007-00054.Frey; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Kageyama S., 1999, J Infect Chemother, V5, P213, DOI 10.1007/s101560050038; KAUFMAN RJ, 1994, BIOCHEMISTRY-US, V33, P9813, DOI 10.1021/bi00199a001; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KUZNETSOV G, 1993, J BIOL CHEM, V268, P2001; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Marques SA, 2008, MED MYCOL, V46, P725, DOI 10.1080/13693780802247736; Meng J, 2008, J BIOL CHEM, V283, P3376, DOI 10.1074/jbc.M707640200; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Ochi H, 1998, FEMS IMMUNOL MED MIC, V20, P181, DOI 10.1111/j.1574-695X.1998.tb01126.x; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Steel HC, 2007, CLIN EXP IMMUNOL, V150, P144, DOI 10.1111/j.1365-2249.2007.03470.x; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; VARKI A, 1994, METHOD ENZYMOL, V230, P16; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zonios DI, 2008, SEMIN RESP CRIT CARE, V29, P198, DOI 10.1055/s-2008-1063858	30	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16882	16890		10.1074/jbc.M109.007609	http://dx.doi.org/10.1074/jbc.M109.007609			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19414590	Green Published, hybrid			2022-12-27	WOS:000266962400024
J	Quaye, O; Cowins, S; Gadda, G				Quaye, Osbourne; Cowins, Sharonda; Gadda, Giovanni			Contribution of Flavin Covalent Linkage with Histidine 99 to the Reaction Catalyzed by Choline Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN 7-HALOGENASE PRNA; ACCUMULATE GLYCINE BETAINE; HYDRIDE TRANSFER-REACTION; GLUCOSE-OXIDASE; DIHYDROOROTATE DEHYDROGENASE; CHOLESTEROL OXIDASE; LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURE; ABIOTIC-STRESS; GLUCOOLIGOSACCHARIDE OXIDASE	The FAD-dependent choline oxidase has a flavin cofactor covalently attached to the protein via histidine 99 through an 8 alpha-N(3)-histidyl linkage. The enzyme catalyzes the four-electron oxidation of choline to glycine betaine, forming betaine aldehyde as an enzyme-bound intermediate. The variant form of choline oxidase in which the histidine residue has been replaced with asparagine was used to investigate the contribution of the 8 alpha-N(3)-histidyl linkage of FAD to the protein toward the reaction catalyzed by the enzyme. Decreases of 10-fold and 30-fold in the k(cat)/K-m and k(cat) values were observed as compared with wild-type choline oxidase at pH 10 and 25 degrees C, with no significant effect on k(cat)/K-O using choline as substrate. Both the k(cat)/K-m and kcat values increased with increasing pH to limiting values at high pH consistent with the participation of an unprotonated group in the reductive half-reaction and the overall turnover of the enzyme. The pH independence of both (D)(k(cat)/K-m) and (D)k(cat), with average values of 9.2 +/- 3.3 and 7.4 +/- 0.5, respectively, is consistent with absence of external forward and reverse commitments to catalysis, and the chemical step of CH bond cleavage being rate-limiting for both the reductive half-reaction and the overall enzyme turnover. The temperature dependence of the (D)k(red) values suggests disruption of the preorganization in the asparagine variant enzyme. Altogether, the data presented in this study are consistent with the FAD-histidyl covalent linkage being important for the optimal positioning of the hydride ion donor and acceptor in the tunneling reaction catalyzed by choline oxidase.	[Gadda, Giovanni] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA; [Cowins, Sharonda] Albany State Univ, Dept Chem, Albany, GA 31705 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Albany State University	Gadda, G (corresponding author), Georgia State Univ, Dept Chem, POB 4098, Atlanta, GA 30302 USA.	ggadda@gsu.edu	Gadda, Giovanni/M-2354-2016	Gadda, Giovanni/0000-0002-7508-4195; Quaye, Osbourne/0000-0002-0621-876X	National Science Foundation [MCB-0545712]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by a National Science Foundation Career Award (Grant MCB-0545712 to G. G.).	Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Basran J, 2003, J BIOL CHEM, V278, P43973, DOI 10.1074/jbc.M305983200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200; Caldinelli L, 2008, PROTEIN SCI, V17, P409, DOI 10.1110/ps.073137708; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen XP, 2008, ACTA BIOCH BIOPH SIN, V40, P183, DOI 10.1111/j.1745-7270.2008.00390.x; CLELAND WW, 1982, METHOD ENZYMOL, V87, P390; COOK PF, 1980, BIOCHEMISTRY-US, V19, P4853, DOI 10.1021/bi00562a023; Cui Q, 2002, J AM CHEM SOC, V124, P3093, DOI 10.1021/ja0118439; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; EMANUELE JJ, 1995, BIOCHEMISTRY-US, V34, P3710, DOI 10.1021/bi00011a028; Fagan RL, 2006, BIOCHEMISTRY-US, V45, P14926, DOI 10.1021/bi060919g; Fan F, 2005, J AM CHEM SOC, V127, P17954, DOI 10.1021/ja0560377; Fan F, 2005, J AM CHEM SOC, V127, P2067, DOI 10.1021/ja044541q; Fan F, 2004, ARCH BIOCHEM BIOPHYS, V421, P149, DOI 10.1016/j.abb.2003.10.003; Fan F, 2006, BIOCHEMISTRY-US, V45, P1979, DOI 10.1021/bi0517537; Fan F, 2007, BIOCHEMISTRY-US, V46, P6402, DOI 10.1021/bi700255v; Finnegan S, 2008, BIOCHEMISTRY-US, V47, P13850, DOI 10.1021/bi801424p; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Gadda G, 2004, ARCH BIOCHEM BIOPHYS, V430, P264, DOI 10.1016/j.abb.2004.07.011; Gadda G, 2003, BBA-PROTEINS PROTEOM, V1650, P4, DOI 10.1016/S1570-9639(03)00188-2; Gadda G, 2008, BIOCHEMISTRY-US, V47, P13745, DOI 10.1021/bi801994c; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Ghanem M, 2006, BIOCHEMISTRY-US, V45, P3437, DOI 10.1021/bi052514m; Ghanem M, 2003, BIOCHEMISTRY-US, V42, P15179, DOI 10.1021/bi035435o; Hassan-Abdallah A, 2006, BIOCHEMISTRY-US, V45, P9454, DOI 10.1021/bi0607352; Heuts DPHM, 2008, BIOCHEM J, V413, P175, DOI 10.1042/BJ20071591; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; HUANG CH, 2008, J BIOL CHEM, V0283; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Kim J, 1995, J BIOL CHEM, V270, P31202, DOI 10.1074/jbc.270.52.31202; Kohen A, 1997, BIOCHEMISTRY-US, V36, P2603, DOI 10.1021/bi962492r; Lee MH, 2005, APPL ENVIRON MICROB, V71, P8881, DOI 10.1128/AEM.71.12.8881-8887.2005; Malmquist NA, 2008, BIOCHEMISTRY-US, V47, P2466, DOI 10.1021/bi702218c; Marcus RA, 2006, PHILOS T R SOC B, V361, P1445, DOI 10.1098/rstb.2006.1873; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Motteran L, 2001, J BIOL CHEM, V276, P18024, DOI 10.1074/jbc.M010953200; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; O'Callaghan J, 2000, INT J FOOD MICROBIOL, V55, P127, DOI 10.1016/S0168-1605(00)00168-9; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Pang JY, 2008, J AM CHEM SOC, V130, P7092, DOI 10.1021/ja800471f; Peddie BA, 1996, J LAB CLIN MED, V128, P417, DOI 10.1016/S0022-2143(96)80014-X; Quan RD, 2004, PLANT BIOTECHNOL J, V2, P477, DOI 10.1111/j.1467-7652.2004.00093.x; Quaye O, 2008, BIOCHEMISTRY-US, V47, P243, DOI 10.1021/bi7017943; Rand T, 2006, FEBS J, V273, P2693, DOI 10.1111/j.1742-4658.2006.05285.x; Rontein D, 2002, METAB ENG, V4, P49, DOI 10.1006/mben.2001.0208; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Rowland P, 1997, STRUCTURE, V5, P239, DOI 10.1016/S0969-2126(97)00182-2; Rowland P, 1998, PROTEIN SCI, V7, P1269, DOI 10.1002/pro.5560070601; Rungsrisuriyachai K, 2008, BIOCHEMISTRY-US, V47, P6762, DOI 10.1021/bi800650w; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Seymour SL, 2002, BIOCHEMISTRY-US, V41, P8747, DOI 10.1021/bi020054g; Sharma SC, 2008, J AM CHEM SOC, V130, P17632, DOI 10.1021/ja806354w; Shirasawa K, 2006, ANN BOT-LONDON, V98, P565, DOI 10.1093/aob/mcl126; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; Sygmund C, 2008, J BIOTECHNOL, V133, P334, DOI 10.1016/j.jbiotec.2007.10.013; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Pee KH, 2006, APPL MICROBIOL BIOT, V70, P631, DOI 10.1007/s00253-005-0232-2; Velasco-Garcia R, 2003, CHEM-BIOL INTERACT, V143, P149, DOI 10.1016/S0009-2797(02)00199-0; Waditee R, 2005, P NATL ACAD SCI USA, V102, P1318, DOI 10.1073/pnas.0409017102; Waditee R, 2007, J BIOL CHEM, V282, P34185, DOI 10.1074/jbc.M704939200; WINKKLER A, 2008, NAT CHEM BIOL; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Wong CM, 2008, APPL MICROBIOL BIOT, V78, P927, DOI 10.1007/s00253-008-1407-4; Zamocky M, 2006, CURR PROTEIN PEPT SC, V7, P255, DOI 10.2174/138920306777452367; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	69	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16990	16997		10.1074/jbc.M109.003715	http://dx.doi.org/10.1074/jbc.M109.003715			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19398559	Green Published, hybrid			2022-12-27	WOS:000266962400036
J	Revil, T; Pelletier, J; Toutant, J; Cloutier, A; Chabot, B				Revil, Timothee; Pelletier, Jordan; Toutant, Johanne; Cloutier, Alexandre; Chabot, Benoit			Heterogeneous Nuclear Ribonucleoprotein K Represses the Production of Pro-apoptotic Bcl-x(S) Splice Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; BCL-X; MESSENGER-RNA; HNRNP-K; 5'-SPLICE-SITE SELECTION; PROSTATE-CANCER; GENOME-WIDE; IN-VITRO; PROTEIN; OVEREXPRESSION	The Bcl-x pre-mRNA is alternatively spliced to produce the anti-apoptotic Bcl-x(L) and the pro-apoptotic Bcl-x(S) isoforms. By performing deletion mutagenesis on a human Bcl-x minigene, we have identified a novel exonic element that controls the use of the 5' splice site of Bcl-xS. The proximal portion of this element acts as a repressor and is located downstream of an enhancer. Further mutational analysis provided a detailed topological map of the regulatory activities revealing a sharp transition between enhancer and repressor sequences. Portions of the enhancer can function when transplanted in another alternative splicing unit. Chromatography and immunoprecipitation assays indicate that the silencer element interacts with heterogeneous ribonucleoprotein particle (hnRNP) K, consistent with the presence of putative high affinity sites for this protein. Finally, down-regulation of hnRNP K by RNA interference enhanced splicing to Bcl-x(S), an effect seen only when the sequences bound by hnRNP K are present. Our results therefore document a clear role for hnRNP K in preventing the production of the pro-apoptotic Bcl-x(S) splice isoform.	[Revil, Timothee; Pelletier, Jordan; Toutant, Johanne; Cloutier, Alexandre; Chabot, Benoit] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Chabot, B (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Benoit.Chabot@USherbrooke.ca		Chabot, Benoit/0000-0003-0994-0042				Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Boon-Unge K, 2007, CHEM BIOL, V14, P1386, DOI 10.1016/j.chembiol.2007.11.004; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Castilla C, 2006, ENDOCRINOLOGY, V147, P4960, DOI 10.1210/en.2006-0502; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Charlet-B N, 2002, MOL CELL, V9, P649, DOI 10.1016/S1097-2765(02)00479-3; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; Da Silva N, 2002, BLOOD, V100, P3536, DOI 10.1182/blood.V100.10.3536; DEJGAARD K, 1994, J MOL BIOL, V236, P33, DOI 10.1006/jmbi.1994.1116; Espana L, 2004, BREAST CANCER RES TR, V87, P33, DOI 10.1023/B:BREA.0000041579.51902.89; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Expert-Bezancon A, 2002, J BIOL CHEM, V277, P16614, DOI 10.1074/jbc.M201083200; Forch P, 2001, RNA, V7, P1185, DOI 10.1017/S1355838201010536; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Gorla L, 2006, CELL SIGNAL, V18, P2272, DOI 10.1016/j.cellsig.2006.05.016; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Griffith BN, 2006, BBA-GENE STRUCT EXPR, V1759, P552, DOI 10.1016/j.bbaexp.2006.10.001; Hatakeyama H, 2006, PROTEOMICS, V6, P6300, DOI 10.1002/pmic.200600488; Hipfner DR, 2004, NAT REV MOL CELL BIO, V5, P805, DOI 10.1038/nrm1491; Hossini AM, 2003, FEBS LETT, V553, P250, DOI 10.1016/S0014-5793(03)01017-2; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; Klimek-Tomczak K, 2004, J MOL BIOL, V342, P1131, DOI 10.1016/j.jmb.2004.07.099; Lebedeva I, 2000, CANCER RES, V60, P6052; Lee MH, 1996, J BIOL CHEM, V271, P3420; Li C, 2004, MOL CELL PROTEOMICS, V3, P399, DOI 10.1074/mcp.M300133-MCP200; Li CY, 2004, CELL RES, V14, P473, DOI 10.1038/sj.cr.7290250; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Linden M, 2004, BLOOD, V103, P2779, DOI 10.1182/blood-2003-10-3399; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Naarmann IS, 2008, J BIOL CHEM, V283, P18461, DOI 10.1074/jbc.M710328200; Nasim FUH, 2002, RNA, V8, P1078, DOI 10.1017/S1355838202024056; Ostrowski J, 2003, BRIT J CANCER, V89, P1493, DOI 10.1038/sj.bjc.6601250; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paradis C, 2007, RNA, V13, P1287, DOI 10.1261/rna.403607; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Roychoudhury P, 2007, BRIT J CANCER, V97, P574, DOI 10.1038/sj.bjc.6603911; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shkreta L, 2008, MOL CANCER THER, V7, P1398, DOI 10.1158/1535-7163.MCT-08-0192; Shukla S, 2005, RNA, V11, P1725, DOI 10.1261/rna.7176605; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; SUMANTRAN VN, 1995, CANCER RES, V55, P2507; Swanson AK, 1998, J BIOL CHEM, V273, P34551, DOI 10.1074/jbc.273.51.34551; Thisted T, 2001, J BIOL CHEM, V276, P17484, DOI 10.1074/jbc.M010594200; Tsuruo T, 2003, CANCER SCI, V94, P15, DOI 10.1111/j.1349-7006.2003.tb01345.x; Ule J, 2007, ADV EXP MED BIOL, V623, P148, DOI 10.1007/978-0-387-77374-2_9; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Venables JP, 2008, CANCER RES, V68, P9525, DOI 10.1158/0008-5472.CAN-08-1769; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Viktorsson K, 2005, ADV CANCER RES, V94, P143, DOI 10.1016/S0065-230X(05)94004-9; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang ZB, 2006, CELL BIOL INT, V30, P15, DOI 10.1016/j.cellbi.2005.08.006; Watanabe J, 2002, INT J ONCOL, V21, P515; Wilusz JE, 2005, NUCLEIC ACIDS RES, V33, P6547, DOI 10.1093/nar/gki960; Yang HP, 2002, ONCOGENE, V21, P7187, DOI 10.1038/sj.onc.1205759; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08	81	60	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21458	21467		10.1074/jbc.M109.019711	http://dx.doi.org/10.1074/jbc.M109.019711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520842	hybrid, Green Published			2022-12-27	WOS:000268564400040
J	Bertuccio, CA; Chapin, HC; Cai, YQ; Mistry, K; Chauvet, V; Somlo, S; Caplan, MJ				Bertuccio, Claudia A.; Chapin, Hannah C.; Cai, Yiqiang; Mistry, Kavita; Chauvet, Veronique; Somlo, Stefan; Caplan, Michael J.			Polycystin-1 C-terminal Cleavage Is Modulated by Polycystin-2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; KIDNEY-DISEASE; GENE-PRODUCT; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTOR; CALCIUM-RELEASE; CATION CHANNEL; PKD1; ACTIVATION; CELLS	Autosomal dominant polycystic kidney disease is caused by mutations in the genes encoding polycystin-1 (PC-1) and polycystin-2 (PC-2). PC-1 cleavage releases its cytoplasmic C-terminal tail (CTT), which enters the nucleus. To determine whether PC-1 CTT cleavage is influenced by PC-2, a quantitative cleavage assay was utilized, in which the DNA binding and activation domains of Gal4 and VP16, respectively, were appended to PC-1 downstream of its CTT domain (PKDgalvp). Cells cotransfected with the resultant PKDgalvp fusion protein and PC-2 showed an increase in luciferase activity and in CTT expression, indicating that the C- terminal tail of PC-1 is cleaved and enters the nucleus. To assess whether CTT cleavage depends upon Ca2+ signaling, cells transfected with PKDgalvp alone or together with PC-2 were incubated with several agents that alter intracellular Ca2+ concentrations. PC-2 enhancement of luciferase activity was not altered by any of these treatments. Using a series of PC-2 C-terminal truncated mutations, we identified a portion of the PC-2 protein that is required to stimulate PC-1 CTT accumulation. These data demonstrate that release of the CTT from PC-1 is influenced and stabilized by PC-2. This effect is independent of Ca2+ but is regulated by sequences contained within the PC-2 C-terminal tail, suggesting a mechanism through which PC-1 and PC-2 may modulate a novel signaling pathway.	[Bertuccio, Claudia A.; Chapin, Hannah C.; Mistry, Kavita; Chauvet, Veronique; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Cai, Yiqiang; Somlo, Stefan] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University; Yale University	Caplan, MJ (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, POB 208026, New Haven, CT 06520 USA.	michael.caplan@yale.edu		Caplan, Michael/0000-0001-5768-4405	National Institutes of Health [DK57328]; National Kidney Foundation; National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK57328 (to S. S. and M.J.C.). This work was also supported by fellowships from the National Kidney Foundation (to C. A. B.) and the National Science Foundation (to H. C. C.).	Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Arnould T, 1999, MOL CELL BIOL, V19, P3423; Arnould T, 1998, J BIOL CHEM, V273, P6013, DOI 10.1074/jbc.273.11.6013; Bandyopadhyay A, 2000, BIOCHEM J, V348, P173, DOI 10.1042/0264-6021:3480173; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; Hackmann K, 2005, HUM MOL GENET, V14, P3249, DOI 10.1093/hmg/ddi356; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hayashi T, 1997, GENOMICS, V44, P131, DOI 10.1006/geno.1997.4851; Hiesberger T, 2006, J BIOL CHEM, V281, P34357, DOI 10.1074/jbc.M606740200; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kim H, 2004, J AM SOC NEPHROL, V15, P2042, DOI 10.1097/01.ASN.0000133490.00348.59; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; LAN Z, 2004, J AM SOC NEPHROL, V15, pA218; Li Q, 2002, FEBS LETT, V516, P270, DOI 10.1016/S0014-5793(02)02513-9; Li XH, 2002, P NATL ACAD SCI USA, V99, P9260, DOI 10.1073/pnas.132051799; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Ong ACM, 2005, KIDNEY INT, V67, P1234, DOI 10.1111/j.1523-1755.2005.00201.x; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reynolds DM, 1999, J AM SOC NEPHROL, V10, P2342; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Vandorpe DH, 2001, J BIOL CHEM, V276, P4093, DOI 10.1074/jbc.M006252200	42	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21011	21026		10.1074/jbc.M109.017756	http://dx.doi.org/10.1074/jbc.M109.017756			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19491093	Green Published, hybrid			2022-12-27	WOS:000268316100064
J	Dennis, MD; Browning, KS				Dennis, Michael D.; Browning, Karen S.			Differential Phosphorylation of Plant Translation Initiation Factors by Arabidopsis thaliana CK2 Holoenzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; GUANINE-NUCLEOTIDE EXCHANGE; REGULATORY BETA-SUBUNIT; WHEAT-GERM; CELL-CYCLE; PURIFICATION; DEGRADATION; EXPRESSION; SITES; ACTIVATION	A previously described wheat germ protein kinase (Yan, T. F., and Tao, M. (1982) J. Biol. Chem. 257, 7037-7043) was identified unambiguously as CK2 using mass spectrometry. CK2 is a ubiquitous eukaryotic protein kinase that phosphorylates a wide range of substrates. In previous studies, this wheat germ kinase was shown to phosphorylate eIF2 alpha, eIF3c, and three large subunit (60 S) ribosomal proteins (Browning, K. S., Yan, T. F., Lauer, S. J., Aquino, L. A., Tao, M., and Ravel, J. M. (1985) Plant Physiol. 77, 370-373). To further characterize the role of CK2 in the regulation of translation initiation, Arabidopsis thaliana catalytic (alpha 1 and alpha 2) and regulatory (beta 1, beta 2, beta 3, and beta 4) subunits of CK2 were cloned and expressed in Escherichia coli. Recombinant A. thaliana CK2 beta subunits spontaneously dimerize and assemble into holoenzymes in the presence of either CK2 alpha 1 or CK2 alpha 2 and exhibit autophosphorylation. The purified CK2 subunits were used to characterize the properties of the individual subunits and their ability to phosphorylate various plant protein substrates. CK2 was shown to phosphorylate eIF2 alpha, eIF2 beta, eIF3c, eIF4B, eIF5, and histone deacetylase 2B but did not phosphorylate eIF1, eIF1A, eIF4A, eIF4E, eIF4G, eIFiso4E, or eIFiso4G. Differential phosphorylation was exhibited by CK2 in the presence of various regulatory beta-subunits. Analysis of A. thaliana mutants either lacking or overexpressing CK2 subunits showed that the amount of eIF2 beta protein present in extracts was affected, which suggests that CK2 phosphorylation may play a role in eIF2 beta stability. These results provide evidence for a potential mechanism through which the expression and/or subcellular distribution of CK2 beta-subunits could participate in the regulation of the initiation of translation and other physiological processes in plants.	[Browning, Karen S.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Browning, KS (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	kbrowning@mail.utexas.edu		Dennis, Michael/0000-0002-0645-6864	United States Department of Energy [DE-FG02-04ER15575]; National Science Foundation [MCB0214996]; Welch Foundation [F1339]	United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation)	This work was supported by Grant DE-FG02-04ER15575 from the United States Department of Energy, Grant MCB0214996 from the National Science Foundation, and Grant F1339 from The Welch Foundation ( to K. S. B.).	Abramczyk O, 2003, BIOCHEM BIOPH RES CO, V307, P31, DOI 10.1016/S0006-291X(03)01126-4; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; BOLDYREFF B, 1994, CELL MOL BIOL RES, V40, P391; Browning KS, 2004, BIOCHEM SOC T, V32, P589, DOI 10.1042/BST0320589; BROWNING KS, 1985, PLANT PHYSIOL, V77, P370, DOI 10.1104/pp.77.2.370; Chang LY, 1999, PLANT MOL BIOL, V41, P363, DOI 10.1023/A:1006379623534; De Marchis ML, 2005, RNA, V11, P495, DOI 10.1261/rna.7200205; Dennis MD, 2009, J BIOL CHEM, V284, P20615, DOI 10.1074/jbc.M109.007658; DHOLAKIA JN, 1988, P NATL ACAD SCI USA, V85, P51, DOI 10.1073/pnas.85.1.51; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Espunya MC, 2005, J EXP BOT, V56, P3183, DOI 10.1093/jxb/eri315; GALLIE DR, 2007, TRANSLATIONAL CONTRO, P747; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Homma MK, 2005, P NATL ACAD SCI USA, V102, P15688, DOI 10.1073/pnas.0506791102; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kubinski K, 2007, MOL CELL BIOCHEM, V295, P229, DOI 10.1007/s11010-006-9292-6; LAX SR, 1986, METHOD ENZYMOL, V118, P109; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Llorens F, 2006, BIOCHEM J, V394, P227, DOI 10.1042/BJ20050605; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; MAYBERRY LK, 2006, CURR PROTOC MICROBIO; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meggio F, 2000, BIOCHEM BIOPH RES CO, V267, P427, DOI 10.1006/bbrc.1999.1924; Metz AM, 1997, ARCH BIOCHEM BIOPHYS, V342, P187, DOI 10.1006/abbi.1997.0119; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; Olsten MEK, 2005, MOL CELL BIOCHEM, V274, P115, DOI 10.1007/s11010-005-3072-6; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Orru S, 2007, MOL CELL PROTEOMICS, V6, P382, DOI 10.1074/mcp.M600156-MCP200; Pagano MA, 2005, MOL CELL BIOCHEM, V274, P23, DOI 10.1007/s11010-005-3116-y; Park HJ, 2008, J BIOL CHEM, V283, P23264, DOI 10.1074/jbc.M801720200; Perales M, 2006, PLANT J, V46, P849, DOI 10.1111/j.1365-313X.2006.02744.x; Pinna LA, 2003, ACCOUNTS CHEM RES, V36, P378, DOI 10.1021/ar020164f; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; REED JC, 1994, J BIOL CHEM, V269, P18192; Riera M, 2003, PROTEIN EXPRES PURIF, V29, P24, DOI 10.1016/S1046-5928(03)00005-6; Riera M, 2001, MOL CELL BIOCHEM, V227, P119, DOI 10.1023/A:1013141713277; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Sarno S, 2002, J BIOL CHEM, V277, P22509, DOI 10.1074/jbc.M200486200; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Shen JJ, 2007, J PROTEOME RES, V6, P273, DOI 10.1021/pr060418h; SINGH LP, 1994, BIOCHEMISTRY-US, V33, P9152, DOI 10.1021/bi00197a018; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Szebeni A, 2003, J BIOL CHEM, V278, P9107, DOI 10.1074/jbc.M204411200; Wang XM, 2001, EMBO J, V20, P4349, DOI 10.1093/emboj/20.16.4349; YAN TFJ, 1982, J BIOL CHEM, V257, P7037; YAN TFJ, 1982, J BIOL CHEM, V257, P7044; Zhang CJ, 2002, ONCOGENE, V21, P3754, DOI 10.1038/sj.onc.1205467	47	39	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20602	20614		10.1074/jbc.M109.006692	http://dx.doi.org/10.1074/jbc.M109.006692			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509278	Green Published, hybrid			2022-12-27	WOS:000268316100022
J	Herr, AB; Farndale, RW				Herr, Andrew B.; Farndale, Richard W.			Structural Insights into the Interactions between Platelet Receptors and Fibrillar Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							VON-WILLEBRAND-FACTOR; HUMAN GLYCOPROTEIN-VI; FACTOR A1 DOMAIN; CRYSTAL-STRUCTURE; I COLLAGEN; MOLECULAR PACKING; OUTSIDE-IN; BINDING; INTEGRIN; IDENTIFICATION	Collagen peptides have been used to identify binding sites for several important collagen receptors, including integrin alpha(2)beta(1), glycoprotein VI, and von Willebrand factor. In parallel, the structures of these collagen receptors have been reported, and their interactions with collagen peptides have been studied. Recently, the three-dimensional structure of the intact type I collagen fiber from rat tail tendon has been resolved by fiber diffraction. It is now possible to map the binding sites of platelet collagen receptors onto the intact collagen fiber in three dimensions. This minireview will discuss these recent findings and their implications for platelet activation by collagen.	[Herr, Andrew B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Coll Med, Cincinnati, OH 45267 USA; [Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University System of Ohio; University of Cincinnati; University of Cambridge	Herr, AB (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Coll Med, Cincinnati, OH 45267 USA.	Andrew.Herr@UC.edu; rwf10@cam.ac.uk	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399	American Heart Association; Ohio Eminent Scholar Program; Wellcome Trust; British Heart Foundation; Medical Research Council; British Heart Foundation [RG/09/003/27122] Funding Source: researchfish; Medical Research Council [G0500707] Funding Source: researchfish; MRC [G0500707] Funding Source: UKRI	American Heart Association(American Heart Association); Ohio Eminent Scholar Program; Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the American Heart Association and the Ohio Eminent Scholar Program (to A. B. H.) and by the Wellcome Trust, the British Heart Foundation, and the Medical Research Council (to R. W. F.). This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Arthur JF, 2007, J BIOL CHEM, V282, P30434, DOI 10.1074/jbc.M701330200; Arthur JF, 2005, THROMB HAEMOSTASIS, V93, P716, DOI 10.1160/TH04-09-0584; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Berlanga O, 2007, J THROMB HAEMOST, V5, P1026, DOI 10.1111/j.1538-7836.2007.02449.x; Boylan B, 2008, BLOOD, V112, P2780, DOI 10.1182/blood-2008-02-142125; Chen H, 2003, MOL CELL BIOL, V23, P4764, DOI 10.1128/MCB.23.14.4764-4777.2003; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Farndale RW, 2007, J THROMB HAEMOST, V5, P220, DOI 10.1111/j.1538-7836.2007.02521.x; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Farndale RW, 2003, BIOCHEM SOC SYMP, V70, P81, DOI 10.1042/bss0700081; FOX JEB, 1988, J BIOL CHEM, V263, P4882; FRASER RDB, 1987, J MOL BIOL, V193, P115, DOI 10.1016/0022-2836(87)90631-0; FRASER RDB, 1983, J MOL BIOL, V167, P497, DOI 10.1016/S0022-2836(83)80347-7; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; Huizinga EG, 1997, STRUCTURE, V5, P1147, DOI 10.1016/S0969-2126(97)00266-9; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; HULMES DJS, 1979, NATURE, V282, P878, DOI 10.1038/282878a0; HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; Kasirer-Friede A, 2007, IMMUNOL REV, V218, P247, DOI 10.1111/j.1600-065X.2007.00532.x; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; Kunicki TJ, 2005, BLOOD, V106, P2744, DOI 10.1182/blood-2005-04-1454; Lecut C, 2004, J BIOL CHEM, V279, P52293, DOI 10.1074/jbc.M406342200; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; Nishida N, 2003, NAT STRUCT BIOL, V10, P53, DOI 10.1038/nsb876; O'Connor MN, 2006, J THROMB HAEMOST, V4, P869, DOI 10.1111/j.1538-7836.2005.01764.x; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Smethurst PA, 2004, BLOOD, V103, P903, DOI 10.1182/blood-2003-01-0308; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Terraube V, 2006, J THROMB HAEMOST, V4, P519, DOI 10.1111/j.1538-7836.2005.01770.x; Wess TJ, 1998, J MOL BIOL, V275, P255, DOI 10.1006/jmbi.1997.1449	47	81	83	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19781	19785		10.1074/jbc.R109.013219	http://dx.doi.org/10.1074/jbc.R109.013219			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19401461	hybrid, Green Published			2022-12-27	WOS:000268097400003
J	Melicoff, E; Sansores-Garcia, L; Gomez, A; Moreira, DC; Datta, P; Thakur, P; Petrova, Y; Siddiqi, T; Murthy, JN; Dickey, BF; Heidelberger, R; Adachi, R				Melicoff, Ernestina; Sansores-Garcia, Leticia; Gomez, Alejandra; Moreira, Daniel C.; Datta, Proleta; Thakur, Pratima; Petrova, Youlia; Siddiqi, Tanya; Murthy, Jayasimha N.; Dickey, Burton F.; Heidelberger, Ruth; Adachi, Roberto			Synaptotagmin-2 Controls Regulated Exocytosis but Not Other Secretory Responses of Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER RELEASE; CAPACITANCE MEASUREMENTS; INFLAMMATORY ARTHRITIS; CENTRAL SYNAPSE; MICE; CALCIUM; INFLUX; DEGRANULATION; MEDIATORS; VESICLES	Mast cell degranulation is a highly regulated, calcium-dependent process, which is important for the acute release of inflammatory mediators during the course of many pathological conditions. We previously found that Synaptotagmin-2, a calcium sensor in neuronal exocytosis, was expressed in a mast cell line. We postulated that this protein may be involved in the control of mast cell-regulated exocytosis, and we generated Synaptotagmin-2 knock-out mice to test our hypothesis. Mast cells from this mutant animal conferred an abnormally decreased passive cutaneous anaphylaxis reaction on mast cell-deficient mice that correlated with a specific defect in mast cell-regulated exocytosis, leaving constitutive exocytosis and nonexocytic mast cell effector responses intact. This defect was not secondary to abnormalities in the development, maturation, migration, morphology, synthesis, and storage of inflammatory mediators, or intracellular calcium transients of the mast cells. Unlike neurons, the lack of Synaptotagmin-2 in mast cells was not associated with increased spontaneous exocytosis.	[Melicoff, Ernestina; Sansores-Garcia, Leticia; Petrova, Youlia; Siddiqi, Tanya; Murthy, Jayasimha N.; Dickey, Burton F.; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Gomez, Alejandra; Moreira, Daniel C.] Tecnol Monterrey, Sch Med, Monterrey 64710, Nuevo Leon, Mexico; [Datta, Proleta; Thakur, Pratima; Heidelberger, Ruth] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; University of Texas System; University of Texas Health Science Center Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 Holcombe Blvd,703D,Box 1100, Houston, TX 77030 USA.	radachi@mdanderson.org	Datta, Proleta/AAK-2377-2021	Dickey, Burton/0000-0002-4780-1847; Moreira, Daniel/0000-0003-4082-156X; Melicoff, Ernestina/0000-0001-5696-7112; Datta, Proleta/0000-0002-1772-8845; Heidelberger, Ruth/0000-0002-8033-2050; Sansores-Garcia, Leticia/0000-0003-2510-225X; Adachi, Roberto/0000-0002-0146-0768	American Heart Association [0655003Y]; NATIONAL EYE INSTITUTE [R01EY012128] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grant 0655003Y from the American Heart Association ( to R. A.).	ADACHI R, 2003, MAST CELL EXOCYTOSIS, P327; Baram D, 1999, J EXP MED, V189, P1649, DOI 10.1084/jem.189.10.1649; Carr CM, 2007, EMBO REP, V8, P834, DOI 10.1038/sj.embor.7401051; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; INAGAKI N, 1986, INT ARCH ALLER A IMM, V81, P58, DOI 10.1159/000234108; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEVEQUE C, 1992, P NATL ACAD SCI USA, V89, P3625, DOI 10.1073/pnas.89.8.3625; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Peterson DA, 1999, METHODS, V18, P493, DOI 10.1006/meth.1999.0818; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Tuvim MJ, 2009, J BIOL CHEM, V284, P9781, DOI 10.1074/jbc.M807849200; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; Vig M, 2007, CELL CALCIUM, V42, P157, DOI 10.1016/j.ceca.2007.03.008; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; WONG A, 1991, BIOCHEMISTRY-US, V30, P9346, DOI 10.1021/bi00102a030; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Zhou ZY, 2006, J NEUROPHYSIOL, V96, P2539, DOI 10.1152/jn.00688.2006	37	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19445	19451		10.1074/jbc.M109.002550	http://dx.doi.org/10.1074/jbc.M109.002550			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473977	hybrid, Green Published			2022-12-27	WOS:000267908300036
J	Tharp, AC; Laha, M; Panizzi, P; Thompson, MW; Fuentes-Prior, P; Bock, PE				Tharp, Anthony C.; Laha, Malabika; Panizzi, Peter; Thompson, Michael W.; Fuentes-Prior, Pablo; Bock, Paul E.			Plasminogen Substrate Recognition by the Streptokinase-Plasminogen Catalytic Complex Is Facilitated by Arg(253), Lys(256), and Lys(257) in the Streptokinase beta-Domain and Kringle 5 of the Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE CHLOROMETHYL KETONES; BLOOD-COAGULATION PROTEINASES; STREPTOCOCCAL SURFACE PROTEIN; EPSILON-AMINOCAPROIC ACID; LYSINE-BINDING-SITE; ACTIVE-SITE; FLUORESCENCE PROBES; CRYSTAL-STRUCTURE; CONFORMATIONAL ACTIVATION; EQUIMOLAR COMPLEXES	Streptokinase (SK) conformationally activates the central zymogen of the fibrinolytic system, plasminogen (Pg). The SK.Pg* catalytic complex binds Pg as a specific substrate and cleaves it into plasmin (Pm), which binds SK to form the SK.Pm complex that propagates Pm generation. Catalytic complex formation is dependent on lysine-binding site (LBS) interactions between a Pg/Pm kringle and the SK COOH-terminal Lys(414). Pg substrate recognition is also LBS-dependent, but the kringle and SK structural element(s) responsible have not been identified. SK mutants lacking Lys(414) with Ala substitutions of charged residues in the SK beta-domain 250-loop were evaluated in kinetic studies that resolved conformational and proteolytic Pg activation. Activation of [Lys] Pg and mini-Pg (containing only kringle 5 of Pg) by SK with Ala substitutions of Arg(253), Lys(256), and Lys(257) showed decreases in the bimolecular rate constant for Pm generation, with nearly total inhibition for the SK Lys(256)/Lys(257) double mutant. Binding of bovine Pg (BPg) to the SK.Pm complex containing fluorescently labeled Pm demonstrated LBS-dependent assembly of a SK.labeled Pm.BPg ternary complex, whereas BPg did not bind to the complex containing the SK Lys(256)/Lys(257) mutant. BPg was activated by SK.Pm with a K-m indistinguishable from the K-D for BPg binding to form the ternary complex, whereas the SK Lys(256)/Lys(257) mutant did not support BPg activation. We conclude that SK residues Arg(253), Lys(256), and Lys(257) mediate Pg substrate recognition through kringle 5 of the [Lys] Pg and mini-Pg substrates. A molecular model of the SK.kringle 5 complex identifies the putative interactions involved in LBS-dependent Pg substrate recognition.	[Tharp, Anthony C.; Laha, Malabika; Panizzi, Peter; Thompson, Michael W.; Bock, Paul E.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA; [Fuentes-Prior, Pablo] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona 08025, Spain	Vanderbilt University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau	Bock, PE (corresponding author), C3321A Med Ctr N, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu	Panizzi, Peter/A-6072-2019	Panizzi, Peter/0000-0003-0141-8807; Fuentes-Prior, Pablo/0000-0002-6618-3204; Thompson, Michael/0000-0003-1850-5579	National Institutes of Health, NHLBI [RO1 HL056181]; Spanish Ministerio de Ciencia e Innovacion ( MICINN) [SAF2007-64140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751, R01HL056181, R00HL094533] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Spanish Ministerio de Ciencia e Innovacion ( MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant RO1 HL056181 ( to P. E. B.) and by Spanish Ministerio de Ciencia e Innovacion ( MICINN) Grant SAF2007-64140 ( to P. F.-P.).	BAJAJ SP, 1977, J BIOL CHEM, V252, P492; Bean RR, 2005, J BIOL CHEM, V280, P7504, DOI 10.1074/jbc.M411637200; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; BOCK PE, 1993, METHOD ENZYMOL, V222, P478; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Brown Philip J., 2003, Journal of Structural and Functional Genomics, V4, P227, DOI 10.1023/B:JSFG.0000016118.87333.03; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; CASTELLINO FJ, 1997, CIBA F SYMP, V212, P60; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; Chaudhary A, 1999, PROTEIN SCI, V8, P2791; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; CHRISTENSEN U, 1984, BIOCHEM J, V223, P413, DOI 10.1042/bj2230413; Cnudde SE, 2006, BIOCHEMISTRY-US, V45, P11052, DOI 10.1021/bi060914j; COLLEN D, 1991, BLOOD, V78, P3114; Conejero-Lara F, 1998, PROTEIN SCI, V7, P2190, DOI 10.1002/pro.5560071017; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; DAVIDSON DJ, 1990, BIOCHEMISTRY-US, V29, P3585, DOI 10.1021/bi00466a023; DeLano W.L, PYMOL MOL GRAPHICS S; Dhar J, 2002, J BIOL CHEM, V277, P13257, DOI 10.1074/jbc.M108422200; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Fu QH, 2008, J BIOL CHEM, V283, P1580, DOI 10.1074/jbc.M705063200; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Kim DM, 2000, THROMB RES, V99, P93, DOI 10.1016/S0049-3848(00)00225-5; Lin LF, 1996, BIOCHEMISTRY-US, V35, P16879, DOI 10.1021/bi961531w; Lin LF, 2000, BIOCHEMISTRY-US, V39, P4740, DOI 10.1021/bi992028x; Liu L, 2000, J BIOL CHEM, V275, P37686, DOI 10.1074/jbc.M003963200; Loy JA, 2001, BIOCHEMISTRY-US, V40, P14686, DOI 10.1021/bi011309d; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; Marti DN, 1999, BIOCHEMISTRY-US, V38, P15741, DOI 10.1021/bi9917378; Marti DN, 1997, BIOCHEMISTRY-US, V36, P11591, DOI 10.1021/bi971316v; Mathews II, 1996, BIOCHEMISTRY-US, V35, P2567, DOI 10.1021/bi9521351; NIEUWENHUIZEN W, 1989, THROMB HAEMOSTASIS, V61, P208; Nihalani D, 1997, PROTEIN SCI, V6, P1284, DOI 10.1002/pro.5560060616; Nihalani D, 1998, PROTEIN SCI, V7, P637, DOI 10.1002/pro.5560070313; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PADMANABHAN K, 1994, PROTEIN SCI, V3, P898; Panizzi P, 2006, J BIOL CHEM, V281, P26774, DOI 10.1074/jbc.C600171200; PONTING CP, 1992, BIOCHIM BIOPHYS ACTA, V1159, P155, DOI 10.1016/0167-4838(92)90020-E; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646; SCHALLER J, 1985, EUR J BIOCHEM, V149, P267, DOI 10.1111/j.1432-1033.1985.tb08921.x; SCHICK LA, 1974, BIOCHEM BIOPH RES CO, V57, P47, DOI 10.1016/S0006-291X(74)80355-4; SJOHOLM I, 1973, EUR J BIOCHEM, V39, P471, DOI 10.1111/j.1432-1033.1973.tb03146.x; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; THEWES T, 1990, J BIOL CHEM, V265, P3906; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Verhamme IM, 2008, J BIOL CHEM, V283, P26137, DOI 10.1074/jbc.M804038200; VIOLAND BN, 1976, J BIOL CHEM, V251, P3906; Wakeham N, 2002, PROTEIN ENG, V15, P753, DOI 10.1093/protein/15.9.753; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Wang XQ, 1999, FEBS LETT, V459, P85, DOI 10.1016/S0014-5793(99)01214-4; WOHL RC, 1983, BIOCHIM BIOPHYS ACTA, V745, P20, DOI 10.1016/0167-4838(83)90165-6; WOHL RC, 1978, J BIOL CHEM, V253, P1402; WU TP, 1991, BIOCHEMISTRY-US, V30, P10589, DOI 10.1021/bi00107a030; Yadav S, 2008, BBA-PROTEINS PROTEOM, V1784, P1310, DOI 10.1016/j.bbapap.2008.05.013; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110	68	23	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19511	19521		10.1074/jbc.M109.005512	http://dx.doi.org/10.1074/jbc.M109.005512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473980	hybrid, Green Published			2022-12-27	WOS:000267908300043
J	Faure, L; Coulon, D; Laroche-Traineau, J; Le Guedard, M; Schmitter, JM; Testet, E; Lessire, R; Bessoule, JJ				Faure, Lionel; Coulon, Denis; Laroche-Traineau, Jeanny; Le Guedard, Marina; Schmitter, Jean-Marie; Testet, Eric; Lessire, Rene; Bessoule, Jean-Jacques			Discovery and Characterization of an Arabidopsis thaliana N-Acylphosphatidylethanolamine Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; ACYLTRANSFERASE; ACYLETHANOLAMINES; EXPRESSION; ANANDAMIDE; RECEPTOR; PATHWAY; CELLS; LAUROYLETHANOLAMINE; ENDOCANNABINOIDS	N-Acylethanolamines (NAEs) are lipids involved in several physiological processes in animal and plant cells. In brain, NAEs are ligands of endocannabinoid receptors, which modulate various signaling pathways. In plant, NAEs regulate seed germination and root development, and they are involved in plant defense against pathogen attack. This signaling activity is started by an enzyme called N-acylphosphatidylethanolamine (NAPE) synthase. This catalyzes the N-acylation of phosphatidylethanolamine to form NAPE, which is most likely hydrolyzed by phospholipase D beta/gamma isoforms to generate NAE. This compound is further catabolized by fatty amide hydrolase. The genes encoding the enzymes involved in NAE metabolism are well characterized except for the NAPE synthase gene(s). By heterologous expression in Escherichia coli and overexpression in plants, we characterized an acyltransferase from Arabidopsis thaliana (At1g78690p) catalyzing the synthesis of lipids identified as NAPEs (two-dimensional TLC, phospholipase D hydrolysis assay, and electrospray ionization-tandem mass spectrometry analyses). The ability of free fatty acid and acyl-CoA to be used as acyl donor was compared in vitro with E. coli membranes and purified enzyme (obtained by immobilized metal ion affinity chromatography). In both cases, NAPE was synthesized only in the presence of acyl-CoA. beta-Glucuronidase promoter experiments revealed a strong expression in roots and young tissues of plants. Using yellow fluorescent protein fusion, we showed that the NAPE synthase is located in the plasmalemma of plant cells.	[Faure, Lionel; Coulon, Denis; Laroche-Traineau, Jeanny; Le Guedard, Marina; Testet, Eric; Lessire, Rene; Bessoule, Jean-Jacques] Univ Bordeaux 2, Lab Biogenese Membranaire, CNRS, UMR 5200, F-33076 Bordeaux, France; [Schmitter, Jean-Marie] Univ Bordeaux, UMR 5248, CNRS, ENITAB,IECB,UBX1, F-33607 Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Coulon, D (corresponding author), Univ Bordeaux 2, Lab Biogenese Membranaire, CNRS, UMR 5200, 146 Rue Leo Saignat,Case 92, F-33076 Bordeaux, France.	denis.coulon@estbb.u-bordeaux2.fr		Faure, Lionel/0000-0002-7022-3934; Le Guedard, Marina/0000-0002-9797-7584; COULON, Denis/0000-0002-3943-1970	Conseil Regional d'Aquitaine	Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This work was supported by the Conseil Regional d'Aquitaine.	Beeckman T., 1994, Plant Molecular Biology Reporter, V12, P37, DOI 10.1007/BF02668662; BESSOULE JJ, 1989, BIOCHIM BIOPHYS ACTA, V983, P35, DOI 10.1016/0005-2736(89)90377-5; Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Chapman KD, 1999, PLANT PHYSIOL, V120, P1157, DOI 10.1104/pp.120.4.1157; Chapman KD, 1997, PLANT CELL PHYSIOL, V38, P1359, DOI 10.1093/oxfordjournals.pcp.a029130; CHAPMAN KD, 1993, ARCH BIOCHEM BIOPHYS, V301, P21, DOI 10.1006/abbi.1993.1110; CHAPMAN KD, 1993, PLANT PHYSIOL, V102, P761, DOI 10.1104/pp.102.3.761; Chatre L, 2005, PLANT PHYSIOL, V139, P1244, DOI 10.1104/pp.105.067447; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Petrocellis L, 2000, CHEM PHYS LIPIDS, V108, P191, DOI 10.1016/S0009-3084(00)00196-1; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Hansen HH, 1999, J MASS SPECTROM, V34, P761, DOI 10.1002/(SICI)1096-9888(199907)34:7<761::AID-JMS832>3.0.CO;2-R; Hansen HS, 2002, PHARMACOL THERAPEUT, V95, P119, DOI 10.1016/S0163-7258(02)00251-6; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; Kim HU, 2005, PLANT CELL, V17, P1073, DOI 10.1105/tpc.104.030403; Kumar RN, 2001, ANAESTHESIA, V56, P1059, DOI 10.1046/j.1365-2044.2001.02269.x; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; McAndrew RS, 1998, BBA-LIPID LIPID MET, V1390, P21, DOI 10.1016/S0005-2760(97)00166-5; Nielsen MJ, 2004, J LIPID RES, V45, P1027, DOI 10.1194/jlr.C300008-JLR200; Paria BC, 2000, CHEM PHYS LIPIDS, V108, P211, DOI 10.1016/S0009-3084(00)00197-3; SANDOVAL JA, 1995, PLANT PHYSIOL, V109, P269, DOI 10.1104/pp.109.1.269; Sarker KP, 2000, FEBS LETT, V472, P39, DOI 10.1016/S0014-5793(00)01425-3; SCHMID HHO, 1990, PROG LIPID RES, V29, P1, DOI 10.1016/0163-7827(90)90004-5; Shiratsuchi A, 2009, J BIOCHEM, V145, P43, DOI 10.1093/jb/mvn139; SIMON GM, 2006, P NATL ACAD SCI USA, V281, P26465; Terrazzino S, 2004, FASEB J, V18, P1580, DOI 10.1096/fj.03-1080fje; Testet E, 2002, J LIPID RES, V43, P1150, DOI 10.1194/jlr.M200075-JLR200; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Tripathy S, 1999, PLANT PHYSIOL, V121, P1299, DOI 10.1104/pp.121.4.1299; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103; Zhang Y, 2007, J PLANT PHYSIOL, V164, P993, DOI 10.1016/j.jplph.2006.07.003	36	23	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18734	18741		10.1074/jbc.M109.005744	http://dx.doi.org/10.1074/jbc.M109.005744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19447891	Green Published, hybrid			2022-12-27	WOS:000267711500023
J	Gordon, JW; Pagiatakis, C; Salma, J; Du, M; Andreucci, JJ; Zhao, JZ; Hou, GP; Perry, RL; Dan, QH; Courtman, D; Bendeck, MP; McDermott, JC				Gordon, Joseph W.; Pagiatakis, Christina; Salma, Jahan; Du, Min; Andreucci, John J.; Zhao, Jianzhong; Hou, Guangpei; Perry, Robert L.; Dan, Qinghong; Courtman, David; Bendeck, Michelle P.; McDermott, John C.			Protein Kinase A-regulated Assembly of a MEF2.HDAC4 Repressor Complex Controls c-Jun Expression in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT TRANSCRIPTIONAL TARGET; SERUM RESPONSE FACTOR; GROWTH-FACTOR; GENE-EXPRESSION; NEOINTIMAL HYPERPLASIA; HISTONE DEACETYLASE-5; MOUSE EMBRYOGENESIS; CARDIAC-HYPERTROPHY; SIGNALING PATHWAYS; NUCLEAR EXPORT	Vascular smooth muscle cells (VSMCs) maintain the ability to modulate their phenotype in response to changing environmental stimuli. This phenotype modulation plays a critical role in the development of most vascular disease states. In these studies, stimulation of cultured vascular smooth muscle cells with platelet-derived growth factor resulted in marked induction of c-jun expression, which was attenuated by protein kinase C delta and calcium/calmodulin-dependent protein kinase inhibition. Given that these signaling pathways have been shown to relieve the repressive effects of class II histone deacetylases (HDACs) on myocyte enhancer factor (MEF) 2 proteins, we ectopically expressed HDAC4 and observed repression of c-jun expression. Congruently, suppression of HDAC4 by RNA interference resulted in enhanced c-jun expression. Consistent with these findings, mutation of the MEF2 cis-element in the c-jun promoter resulted in promoter activation during quiescent conditions, suggesting that the MEF2 cis-element functions as a repressor in this context. Furthermore, we demonstrate that protein kinase A attenuates c-Jun expression by promoting the formation of a MEF2.HDAC4 repressor complex by inhibiting salt-inducible kinase 1. Finally, we document a physical interaction between c-Jun and myocardin, and we document that forced expression of c-Jun represses the ability of myocardin to activate smooth muscle gene expression. Thus, MEF2 and HDAC4 act to repress c-Jun expression in quiescent VSMCs, protein kinase A enhances this repression, and platelet-derived growth factor derepresses c-Jun expression through calcium/calmodulin-dependent protein kinases and novel protein kinase Cs. Regulation of this molecular "switch" on the c-jun promoter may thus prove critical for toggling between the activated and quiescent VSMC phenotypes.	[Gordon, Joseph W.; Pagiatakis, Christina; Salma, Jahan; Du, Min; Andreucci, John J.; Zhao, Jianzhong; Perry, Robert L.; McDermott, John C.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Hou, Guangpei; Bendeck, Michelle P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Dan, Qinghong; Courtman, David] Univ Toronto, St Michaels Hosp, Terrence Donnelly Cardiovasc Labs, Toronto, ON M5S 1A8, Canada	York University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	McDermott, JC (corresponding author), 4700 Keele St, Toronto, ON MJ3 1P3, Canada.	jmcderm@yorku.ca	Pagiatakis, Christina/AAB-3844-2019	Pagiatakis, Christina/0000-0002-9315-9648; Gordon, Joseph/0000-0002-0061-2168	Muscular Dystrophy Association of Canada and Canadian Institute of Health Research; Canadian Institute of Health Research	Muscular Dystrophy Association of Canada and Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a postdoctoral fellowship from the Muscular Dystrophy Association of Canada and Canadian Institute of Health Research (to R. L. P.) and by a grant from the Canadian Institute of Health Research (to J. C. M.).	Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Anderson JP, 2004, MOL CELL BIOL, V24, P3757, DOI 10.1128/MCB.24.9.3757-3768.2004; Andreucci JJ, 2002, J BIOL CHEM, V277, P16426, DOI 10.1074/jbc.M110891200; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Assadnia S, 1999, CIRC RES, V84, P1252, DOI 10.1161/01.RES.84.11.1252; Bendeck MP, 2002, AM J PATHOL, V160, P1089, DOI 10.1016/S0002-9440(10)64929-2; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; BILATO C, 1995, J CLIN INVEST, V96, P1905, DOI 10.1172/JCI118236; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bornfeldt KE, 1999, CELL SIGNAL, V11, P465, DOI 10.1016/S0898-6568(99)00020-0; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Courtman DW, 2004, J VASC RES, V41, P157, DOI 10.1159/000077145; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Fetalvero KM, 2006, AM J PHYSIOL-HEART C, V290, pH1337, DOI 10.1152/ajpheart.00936.2005; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Firulli AB, 1996, CIRC RES, V78, P196, DOI 10.1161/01.RES.78.2.196; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Ho B, 2008, AM J PATHOL, V173, P278, DOI 10.2353/ajpath.2008.071046; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; Ioroi T, 2003, J PHARMACOL SCI, V91, P145; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kuhel DG, 2002, ARTERIOSCL THROM VAS, V22, P955, DOI 10.1161/01.ATV.0000017994.77066.75; Laaksamo E, 2008, STROKE, V39, P886, DOI 10.1161/STROKEAHA.107.497875; Lee JS, 1996, MOL CELL BIOL, V16, P4312; LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676; Lin Q, 1998, DEVELOPMENT, V125, P4565; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Markou T, 2006, J BIOL CHEM, V281, P8321, DOI 10.1074/jbc.M508398200; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Meier KE, 1998, CELL SIGNAL, V10, P415, DOI 10.1016/S0898-6568(97)00140-X; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Najwer I, 2005, AM J PHYSIOL-CELL PH, V289, pC785, DOI 10.1152/ajpcell.00098.2005; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Ornatsky OI, 1999, NUCLEIC ACIDS RES, V27, P2646, DOI 10.1093/nar/27.13.2646; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rao GN, 1996, J BIOL CHEM, V271, P20805, DOI 10.1074/jbc.271.34.20805; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; SCHUNKERT H, 1991, P NATL ACAD SCI USA, V88, P11480, DOI 10.1073/pnas.88.24.11480; Suzuki E, 2004, CIRC RES, V95, P42, DOI 10.1161/01.RES.0000134631.75684.4A; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P2355, DOI 10.1161/ATVBAHA.107.151704; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Zhan YM, 2002, ARTERIOSCL THROM VAS, V22, P82, DOI 10.1161/hq0102.101821; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	60	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19027	19042		10.1074/jbc.M109.000539	http://dx.doi.org/10.1074/jbc.M109.000539			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19389706	Green Published, hybrid			2022-12-27	WOS:000267711500052
J	Iwahori, S; Murata, T; Kudoh, A; Sato, Y; Nakayama, S; Isomura, H; Kanda, T; Tsurumi, T				Iwahori, Satoko; Murata, Takayuki; Kudoh, Ayumi; Sato, Yoshitaka; Nakayama, Sanae; Isomura, Hiroki; Kanda, Teru; Tsurumi, Tatsuya			Phosphorylation of p27(Kip1) by Epstein-Barr Virus Protein Kinase Induces Its Degradation through SCFSkp2 Ubiquitin Ligase Actions during Viral Lytic Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; CDK INHIBITOR P27; S-PHASE; NUCLEAR ANTIGEN; LINE AKATA; BGLF4; COMPLEX; CELLS; HERPESVIRUSES; BZLF1	Epstein-Barr virus (EBV) productive replication occurs in an S-phase-like cellular environment with high cyclin-dependent kinase (CDK) activity. The EBV protein kinase (PK), encoded by the viral BGLF4 gene, is a Ser/Thr protein kinase, which phosphorylates both viral and cellular proteins, modifying the cellular environment for efficient viral productive replication. We here provide evidence that the EBV PK phosphorylates the CDK inhibitor p27(Kip1), resulting in ubiquitination and degradation in a proteasome-dependent manner during EBV productive replication. Experiments with BGLF4 knockdown by small interfering RNA and BGLF4 knock-out viruses clarified that EBV PK is involved in p27(Kip1) degradation upon lytic replication. Transfection of the BGLF4 expression vector revealed that EBV PK alone could phosphorylate the Thr-187 residue of p27(Kip1) and that the ubiquitination and degradation of p27(Kip1) occurred in an SCFSkp2 ubiquitin ligase-dependent manner. In vitro, EBV PK proved capable of phosphorylating p27(Kip1) at Thr-187. Unlike cyclin E-CDK2 activity, the EBV PK activity was not inhibited by p27(Kip1). Overall, EBV PK enhances p27(Kip1) degradation effectively upon EBV productive replication, contributing to establishment of an S-phase-like cellular environment with high CDK activity.	[Iwahori, Satoko; Murata, Takayuki; Kudoh, Ayumi; Sato, Yoshitaka; Nakayama, Sanae; Isomura, Hiroki; Kanda, Teru; Tsurumi, Tatsuya] Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan	Aichi Cancer Center	Tsurumi, T (corresponding author), Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp	Kanda, Teru/J-7313-2019; Murata, Takayuki/I-2621-2013; Sato, Yoshitaka/P-9728-2015; Iwahori, Satoko/L-1948-2019	Murata, Takayuki/0000-0001-7228-0839; Sato, Yoshitaka/0000-0002-8541-6413; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Science, Sports, Culture, and Technology of Japan. [21022055, 20012056, 20390137]	Ministry of Education, Science, Sports, Culture, and Technology of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 21022055, 20012056, and 20390137 from the Ministry of Education, Science, Sports, Culture, and Technology of Japan.	Asai R, 2006, J VIROL, V80, P5125, DOI 10.1128/JVI.02674-05; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen MR, 2000, J VIROL, V74, P3093, DOI 10.1128/JVI.74.7.3093-3104.2000; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Ellis M, 1999, EMBO J, V18, P644, DOI 10.1093/emboj/18.3.644; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; Gershburg E, 2007, J VIROL, V81, P5407, DOI 10.1128/JVI.02398-06; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kato K, 2003, J GEN VIROL, V84, P3381, DOI 10.1099/vir.0.19454-0; Kato K, 2001, J GEN VIROL, V82, P1457, DOI 10.1099/0022-1317-82-6-1457; Kawaguchi Y, 2003, REV MED VIROL, V13, P331, DOI 10.1002/rmv.402; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; Knight JS, 2005, MOL CELL BIOL, V25, P1749, DOI 10.1128/MCB.25.5.1749-1763.2005; Knipe DM, 2007, FIELDS VIROLOGY; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Kudoh A, 2004, J VIROL, V78, P104, DOI 10.1128/JVI.78.1.104-115.2004; Kudoh A, 2003, J VIROL, V77, P851, DOI 10.1128/JVI.77.2.851-861.2003; Kudoh A, 2006, J VIROL, V80, P10064, DOI 10.1128/JVI.00678-06; Lee CP, 2007, J VIROL, V81, P5166, DOI 10.1128/JVI.00120-07; Lee CP, 2008, J VIROL, V82, P11913, DOI 10.1128/JVI.01100-08; LeRoux F, 1996, J GEN VIROL, V77, P501, DOI 10.1099/0022-1317-77-3-501; Mann DJ, 1999, EMBO J, V18, P654, DOI 10.1093/emboj/18.3.654; Murata T, 2006, J BIOL CHEM, V281, P20788, DOI 10.1074/jbc.M600563200; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parker GA, 2000, ONCOGENE, V19, P700, DOI 10.1038/sj.onc.1203327; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Sato Y, 2009, VIROLOGY, V388, P204, DOI 10.1016/j.virol.2009.03.017; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHIMIZU N, 1994, J VIROL, V68, P6069, DOI 10.1128/JVI.68.9.6069-6073.1994; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Yarmishyn A, 2008, EXP CELL RES, V314, P204, DOI 10.1016/j.yexcr.2007.09.016; Yue W, 2005, J VIROL, V79, P5880, DOI 10.1128/JVI.79.9.5880-5885.2005; Zhu J, 2009, J VIROL, V83, P5219, DOI 10.1128/JVI.02378-08	46	21	27	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18923	18931		10.1074/jbc.M109.015123	http://dx.doi.org/10.1074/jbc.M109.015123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19451650	Green Published, hybrid			2022-12-27	WOS:000267711500042
J	Kwak, SY; Wiedemann-Bidlack, FB; Beniash, E; Yamakoshi, Y; Simmer, JP; Litman, A; Margolis, HC				Kwak, Seo-Young; Wiedemann-Bidlack, Felicitas B.; Beniash, Elia; Yamakoshi, Yasuo; Simmer, James P.; Litman, Amy; Margolis, Henry C.			Role of 20-kDa Amelogenin (P148) Phosphorylation in Calcium Phosphate Formation in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY STAGE; ENAMEL; HYDROXYAPATITE; GROWTH; NUCLEATION; CARBONATE; PROTEINS; CRYSTALS; CLEAVAGE; TISSUES	The potential role of amelogenin phosphorylation in enamel formation is elucidated through in vitro mineralization studies. Studies focused on the native 20-kDa porcine amelogenin proteolytic cleavage product P148 that is prominent in developing enamel. Experimental conditions supported spontaneous calcium phosphate precipitation with the initial formation of amorphous calcium phosphate (ACP). In the absence of protein, ACP was found to undergo relatively rapid transformation to randomly oriented plate-like apatitic crystals. In the presence of non-phosphorylated recombinant full-length amelogenin, rP172, a longer induction period was observed during which relatively small ACP nanoparticles were transiently stabilized. In the presence of rP172, these nanoparticles were found to align to form linear needle-like particles that subsequently transformed and organized into parallel arrays of apatitic needle-like crystals. In sharp contrast to these findings, P148, with a single phosphate group on serine 16, was found to inhibit calcium phosphate precipitation and stabilize ACP formation for more than 1 day. Additional studies using non- phosphorylated recombinant (rP147) and partially dephosphorylated forms of P148 (dephoso-P148) showed that the single phosphate group in P148 was responsible for the profound effect on mineral formation in vitro. The present study has provided, for the first time, evidence suggesting that the native proteolytic cleavage product P148 may have an important functional role in regulating mineralization during enamel formation by preventing unwanted mineral formation within the enamel matrix during the secretory stage of amelogenesis. Results obtained have also provided new insights into the functional role of the highly conserved hydrophilic C terminus found in full-length amelogenin. found in full-length amelogenin.	[Kwak, Seo-Young; Wiedemann-Bidlack, Felicitas B.; Litman, Amy; Margolis, Henry C.] Forsyth Inst, Dept Biomineralizat, Boston, MA 02115 USA; [Beniash, Elia] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA 15261 USA; [Yamakoshi, Yasuo; Simmer, James P.] Univ Michigan, Dent Res Lab, Ann Arbor, MI 48109 USA	Harvard University; Forsyth Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan	Margolis, HC (corresponding author), 140 Fenway, Boston, MA 02115 USA.	hmargolis@forsyth.org		Simmer, James/0000-0002-7192-6105; Bidlack, Felicitas/0000-0001-8105-223X	National Institutes of Health [DE-016376, T32 DE-007327]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE016376, R01DE016376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE-016376 (to H.C.M.) from NIDCR.; The on-line version of this article (available at http://www.jbc.org) contains Supplemental material, a reference, and Figs. S1-S5.; Supported in part by National Institutes of Health Grant T32 DE-007327.	Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; AOBA T, 1987, CALCIFIED TISSUE INT, V41, P86, DOI 10.1007/BF02555250; AOBA T, 1989, J DENT RES, V68, P1331, DOI 10.1177/00220345890680090901; AOBA T, 1987, CALCIFIED TISSUE INT, V41, P281, DOI 10.1007/BF02555230; Aparicio S, 2002, CALCIFIED TISSUE INT, V70, P422, DOI 10.1007/s00223-001-1016-z; Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; Bodier-Houlle P, 2000, CELL TISSUE RES, V301, P389, DOI 10.1007/s004410000241; Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059; Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f; Diekwisch TGH, 1998, CONNECT TISSUE RES, V38, P101, DOI 10.3109/03008209809017026; Eanes E D, 2001, Monogr Oral Sci, V18, P130; Fan YW, 2007, BIOMATERIALS, V28, P3034, DOI 10.1016/j.biomaterials.2007.02.016; FUKAE M, 2002, P INT S OR SCI TSUR, P73; Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200; GEE A, 1953, ANAL CHEM, V25, P1320, DOI 10.1021/ac60081a006; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; Habelitz S, 2006, EUR J ORAL SCI, V114, P315, DOI 10.1111/j.1600-0722.2006.00312.x; Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022; Levi-Kalisman Y, 2000, J CHEM SOC DALTON, P3977, DOI 10.1039/b003242p; LOWENSTAM HA, 1985, SCIENCE, V227, P51, DOI 10.1126/science.227.4682.51; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Moradian-Oldak J, 2002, MATRIX BIOL, V21, P197, DOI 10.1016/S0945-053X(01)00190-1; Robinson C, 2007, J DENT RES, V86, P677, DOI 10.1177/154405910708600801; ROBINSON C, 1988, ARCH ORAL BIOL, V33, P159, DOI 10.1016/0003-9969(88)90040-4; Ryu OH, 1999, J DENT RES, V78, P743, DOI 10.1177/00220345990780030601; SCHWARTZ SS, 1992, CALCIFIED TISSUE INT, V50, P511, DOI 10.1007/BF00582164; Sikes C.S., 1991, SURFACE REACTIVE PEP; SIKES CS, 1988, CHEM ASPECTS REGULAT; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Suvorova EI, 2001, CRYSTALLOGR REP+, V46, P722, DOI 10.1134/1.1405856; TANABE T, 1992, CALCIFIED TISSUE INT, V51, P213, DOI 10.1007/BF00334549; Tao JH, 2007, J PHYS CHEM B, V111, P13410, DOI 10.1021/jp0732918; Tarasevich BJ, 2007, J CRYST GROWTH, V304, P407, DOI 10.1016/j.jcrysgro.2007.02.035; UCHIDA T, 1991, HISTOCHEMISTRY, V96, P129, DOI 10.1007/BF00315983; Wang LJ, 2008, J PHYS CHEM C, V112, P5892, DOI 10.1021/jp077105+; Wang LJ, 2007, J PHYS CHEM C, V111, P6398, DOI 10.1021/jp0675429; Weiner S, 2005, SCIENCE, V309, P1027, DOI 10.1126/science.1114920; Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007; Wu LNY, 1997, J BIOL CHEM, V272, P4404, DOI 10.1074/jbc.272.7.4404; YAMAKOSHI Y, 1994, CALCIFIED TISSUE INT, V54, P69, DOI 10.1007/BF00316293	43	84	87	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18972	18979		10.1074/jbc.M109.020370	http://dx.doi.org/10.1074/jbc.M109.020370			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19443653	hybrid, Green Published			2022-12-27	WOS:000267711500047
J	Jensen, JK; Dolmer, K; Gettins, PGW				Jensen, Jan K.; Dolmer, Klavs; Gettins, Peter G. W.			Specificity of Binding of the Low Density Lipoprotein Receptor-related Protein to Different Conformational States of the Clade E Serpins Plasminogen Activator Inhibitor-1 and Proteinase Nexin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR SOLUTION STRUCTURE; METHYL-D-ASPARTATE; LDL RECEPTOR; ALPHA(2)-MACROGLOBULIN RECEPTOR; ALPHA(1)-PROTEINASE INHIBITOR; COVALENT COMPLEXES; ENDOCYTIC RECEPTOR; RAP COMPLEX; SITE; LRP	The low density lipoprotein receptor-related protein (LRP) is the principal clearance receptor for serpins and serpin-proteinase complexes. The ligand binding regions of LRP consist of clusters of cysteine-rich similar to 40-residue complement-like repeats (CR), with cluster II being the principal ligand-binding region. To better understand the specificity of binding at different sites within the cluster and the ability of LRP to discriminate in vivo between uncomplexed and proteinase-complexed serpins, we have systematically examined the affinities of plasminogen activator inhibitor-1 (PAI-1) and proteinase nexin-1 (PN-1) in their native, cleaved, and proteinase-complexed states to (CR)(2) and (CR)(3) fragments of LRP cluster II. A consistent blue shift of the CR domain tryptophan fluorescence suggested a common mode of serpin binding, involving lysines on the serpin engaging the acidic region around the calcium binding site of the CR domain. High affinity binding of non-proteinase-complexed PAI-1 and PN-1 occurred to all fragments containing three CR domains (3 -59 nM) and most that contain only two CR domains, although binding energies to different (CR)(3) fragments differed by up to 18% for PAI-1 and 9% for PN-1. No detectable difference in affinity was seen between native and cleaved serpin. However, the presence of proteinase in complex with the serpin enhanced affinity modestly and presumably nonspecifically. This may be sufficient to give preferential binding of such complexes in vivo at the relevant physiological concentrations.	[Jensen, Jan K.; Dolmer, Klavs; Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland,M-C 669, Chicago, IL 60607 USA.	pgettins@uic.edu	Dolmer, Klavs/G-5512-2012	Dolmer, Klavs/0000-0001-7359-360X	National Institutes of Health [R01 GM54414, R01HL79430]; Danish Research Council; Carlsberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Council(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM54414 and R01HL79430. This work was also supported by fellowships from the Danish Research Council and the Carlsberg Foundation (to J. K. J.).	Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Backovic M, 2002, PROTEIN SCI, V11, P1182, DOI 10.1110/ps.4320102; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; CONARD J, 1983, HAEMOSTASIS, V13, P363; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; DESMET BJGL, 1993, BLOOD, V81, P56, DOI 10.1182/blood.V81.1.56.bloodjournal81156; Dobo J, 2004, J BIOL CHEM, V279, P9264, DOI 10.1074/jbc.M311731200; Dolmer K, 1998, BIOCHEMISTRY-US, V37, P17016, DOI 10.1021/bi982022s; Dolmer K, 2000, J BIOL CHEM, V275, P3264, DOI 10.1074/jbc.275.5.3264; Dolmer K, 2006, J BIOL CHEM, V281, P34189, DOI 10.1074/jbc.M604389200; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GUENTHER J, 1985, EMBO J, V4, P1963, DOI 10.1002/j.1460-2075.1985.tb03878.x; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Horn IR, 1998, THROMB HAEMOSTASIS, V80, P822; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2008, PROTEIN SCI, V17, P1844, DOI 10.1110/ps.036707.108; JOSLIN G, 1991, J BIOL CHEM, V266, P11282; Kasza A, 1997, EUR J BIOCHEM, V248, P270, DOI 10.1111/j.1432-1033.1997.00270.x; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; LAWRENCE DA, 1994, BIOCHEMISTRY-US, V33, P3643, DOI 10.1021/bi00178a022; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; LEIPER K, 1994, J CLIN PATHOL, V47, P214, DOI 10.1136/jcp.47.3.214; Li YH, 2002, BIOCHEMISTRY-US, V41, P4921, DOI 10.1021/bi011894i; Lutz C, 2002, J BIOL CHEM, V277, P43143, DOI 10.1074/jbc.M204426200; Malek R, 1996, CLIN EXP IMMUNOL, V105, P191, DOI 10.1046/j.1365-2249.1996.d01-714.x; MAST AE, 1991, BIOCHEMISTRY-US, V30, P1723, DOI 10.1021/bi00220a039; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; Panizzi P, 2006, J BIOL CHEM, V281, P26774, DOI 10.1074/jbc.C600171200; Picard V, 1999, J BIOL CHEM, V274, P4586, DOI 10.1074/jbc.274.8.4586; Qiu ZH, 2002, J BIOL CHEM, V277, P14458, DOI 10.1074/jbc.M112066200; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Skeldal S, 2006, FEBS J, V273, P5143, DOI 10.1111/j.1742-4658.2006.05511.x; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; Tesch LD, 2005, PROTEIN SCI, V14, P533, DOI 10.1110/ps.041104905; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753	43	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17989	17997		10.1074/jbc.M109.009530	http://dx.doi.org/10.1074/jbc.M109.009530			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19439404	hybrid, Green Published			2022-12-27	WOS:000267712400010
J	Guzman-Hernandez, ML; Vazquez-Macias, A; Carretero-Ortega, J; Hernandez-Garcia, R; Garcia-Regalado, A; Hernandez-Negrete, I; Reyes-Cruz, G; Gutkind, JS; Vazquez-Prado, J				Luisa Guzman-Hernandez, Maria; Vazquez-Macias, Aleida; Carretero-Ortega, Jorge; Hernandez-Garcia, Ricardo; Garcia-Regalado, Alejandro; Hernandez-Negrete, Ivette; Reyes-Cruz, Guadalupe; Silvio Gutkind, J.; Vazquez-Prado, Jose			Differential Inhibitor of G beta gamma Signaling to AKT and ERK Derived from Phosducin-like Protein EFFECT ON SPHINGOSINE 1-PHOSPHATE-INDUCED ENDOTHELIAL CELL MIGRATION AND IN VITRO ANGIOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ENDOTHELIAL-CELL CHEMOTAXIS; HEPATOCYTE GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; SPHINGOSINE 1-PHOSPHATE; DICTYOSTELIUM-DISCOIDEUM; COUPLED RECEPTORS; ACTIVATION; COMPLEX; TRANSDUCIN	Differential inhibitors of G beta gamma-effector regions are required to dissect the biological contribution of specific G beta gamma-initiated signaling pathways. Here, we characterize PhLP-M1-G149, a G beta gamma-interacting construct derived from phosducin-like protein 1 (PhLP) as a differential inhibitor of G beta gamma, which, in endothelial cells, prevented sphingosine 1-phosphate- induced phosphorylation of AKT, glycogen synthase kinase 3 beta, cell migration, and tubulogenesis, while having no effect on ERK phosphorylation or hepatocyte growth factor-dependent responses. This construct attenuated the recruitment of phosphoinositide 3-kinase gamma (PI3K gamma) to the plasma membrane and the signaling to AKT in response to G beta gamma overexpression. In coimmunoprecipitation experiments, PhLP-M1-G149 interfered with the interaction between PI3K gamma and G beta gamma. Other PhLP- derived constructs interacted with G beta gamma but were not effective inhibitors of G beta gamma signaling to AKT or ERK. Our results indicate that PhLP-M1-G149 is a suitable tool to differentially modulate the G beta gamma-initiated pathway linking this heterodimer to AKT, endothelial cell migration, and in vitro angiogenesis. It can be also useful to further characterize the molecular determinants of the G beta gamma-PI3K gamma interaction.	[Vazquez-Prado, Jose] Natl Polytech Inst, CINVESTAV IPN, Dept Pharmacol, Ctr Res & Adv Studies, Mexico City 14740, DF, Mexico; [Luisa Guzman-Hernandez, Maria; Vazquez-Macias, Aleida; Carretero-Ortega, Jorge; Hernandez-Garcia, Ricardo; Hernandez-Negrete, Ivette; Vazquez-Prado, Jose] Inst Politecn Nacl, Ctr Res & Adv Studies, Dept Pharmacol, Mexico City 07000, DF, Mexico; [Luisa Guzman-Hernandez, Maria; Vazquez-Macias, Aleida; Carretero-Ortega, Jorge; Hernandez-Garcia, Ricardo; Hernandez-Negrete, Ivette; Vazquez-Prado, Jose] Inst Politecn Nacl, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 07000, DF, Mexico; [Silvio Gutkind, J.] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Vazquez-Prado, J (corresponding author), Natl Polytech Inst, CINVESTAV IPN, Dept Pharmacol, Ctr Res & Adv Studies, Av Inst Politcn Nacl 2508,Col San Pedro Zacatenco, Mexico City 14740, DF, Mexico.	jvazquez@cinvestav.mx	Gutkind, J. Silvio/J-1201-2016; Guzman-Hernandez, Maria Luisa/AAN-2347-2021; VAZQUEZ-PRADO, JOSE/C-1630-2017; Garcia-Regalado, Alejandro/ABA-2604-2021; Gutkind, J. Silvio/A-1053-2009	Gutkind, J. Silvio/0000-0002-5150-4482; Guzman-Hernandez, Maria Luisa/0000-0003-3366-6813; VAZQUEZ-PRADO, JOSE/0000-0001-5797-6643; Hernandez Negrete, Ivette/0000-0003-1097-0038; Garcia-Regalado, Alejandro/0000-0002-4201-8423; Carretero-Ortega, Jorge/0000-0003-1295-9596	National Institutes of Health [R01TW006664]; Fogarty International Center; the Consejo Nacional de Ciencia y Tecnologia [61127, 45957]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); the Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01TW006664 ( to J. V. P.) from the Fogarty International Center. This work was also supported by the Consejo Nacional de Ciencia y Tecnologia ( CONACyT, Grant 61127 to J. V. P. and Grant 45957 to G. R. C.).	BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; Blaauw M, 2003, EMBO J, V22, P5047, DOI 10.1093/emboj/cdg508; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Chen SH, 2005, J BIOL CHEM, V280, P33445, DOI 10.1074/jbc.M505422200; Chen SH, 2004, J MOL CELL CARDIOL, V37, P399, DOI 10.1016/j.yjmcc.2004.04.019; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Craft CM, 1998, BIOCHEMISTRY-US, V37, P15758, DOI 10.1021/bi980921a; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; English D, 2002, BBA-MOL CELL BIOL L, V1582, P228, DOI 10.1016/S1388-1981(02)00176-2; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Igarashi J, 2001, J BIOL CHEM, V276, P36281, DOI 10.1074/jbc.M105628200; Kasahara S, 2000, P NATL ACAD SCI USA, V97, P412, DOI 10.1073/pnas.97.1.412; Kerchner KR, 2004, J BIOL CHEM, V279, P44554, DOI 10.1074/jbc.M406071200; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Knol JC, 2005, MOL CELL BIOL, V25, P8393, DOI 10.1128/MCB.25.18.8393-8400.2005; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KUO CH, 1989, BIOCHEM BIOPH RES CO, V162, P1063, DOI 10.1016/0006-291X(89)90781-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; LEE RH, 1987, BIOCHEMISTRY-US, V26, P3983, DOI 10.1021/bi00387a036; Li Z, 2005, PROSTAG OTH LIPID M, V76, P95, DOI 10.1016/j.prostaglandins.2005.02.002; Liu F, 2001, AM J RESP CELL MOL, V24, P711, DOI 10.1165/ajrcmb.24.6.4323; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; MILES MF, 1993, P NATL ACAD SCI USA, V90, P10831, DOI 10.1073/pnas.90.22.10831; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Nakagami H, 2001, HYPERTENSION, V37, P581, DOI 10.1161/01.HYP.37.2.581; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Schulz R, 2001, PHARMACOL RES, V43, P1, DOI 10.1006/phrs.2000.0757; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Watterson K, 2003, PROG LIPID RES, V42, P344, DOI 10.1016/S0163-7827(03)00015-8; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561; YOSHIDA T, 1994, J BIOL CHEM, V269, P24050	55	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18334	18346		10.1074/jbc.M109.008839	http://dx.doi.org/10.1074/jbc.M109.008839			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19403526	hybrid, Green Published			2022-12-27	WOS:000267712400046
J	Silverman, WR; Vaccari, JPDR; Locovei, S; Qiu, F; Carlsson, SK; Scemes, E; Keane, RW; Dahl, G				Silverman, William R.; Vaccari, Juan Pablo de Rivero; Locovei, Silviu; Qiu, Feng; Carlsson, Steven K.; Scemes, Eliana; Keane, Robert W.; Dahl, Gerhard			The Pannexin 1 Channel Activates the Inflammasome in Neurons and Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; P2X(7) RECEPTOR; CASPASE-1 ACTIVATION; MOLECULAR PLATFORM; ATP; RELEASE; CELL; GAP; INTERLEUKIN-1-BETA; INHIBITION	The inflammasome is a multiprotein complex involved in innate immunity. Activation of the inflammasome causes the processing and release of the cytokines interleukins 1 beta and 18. In primary macrophages, potassium ion flux and the membrane channel pannexin 1 have been suggested to play roles in inflammasome activation. However, the molecular mechanism(s) governing inflammasome signaling remains poorly defined, and it is undetermined whether these mechanisms apply to the central nervous system. Here we show that high extracellular potassium opens pannexin channels leading to caspase-1 activation in primary neurons and astrocytes. The effect of K+ on pannexin 1 channels was independent of membrane potential, suggesting that stimulation of inflammasome signaling was mediated by an allosteric effect. The activation of the inflammasome by K+ was inhibited by the pannexin 1 channel blocker probenecid, supporting a role of pannexin 1 in inflammasome activation. Co-immunoprecipitation of neuronal lysates indicates that pannexin 1 associates with components of the multiprotein inflammasome complex, including the P2X7 receptor and caspase-1. Moreover antibody neutralization of the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD) blocked ATP-induced cell death in oocytes co-expressing P2X7 receptor and pannexin 1. Thus, in contrast to macrophages and monocytes in which low intracellular K+ has been suggested to trigger inflammasome activation, in neural cells, high extracellular K+ activates caspase-1 probably through pannexin 1.	[Silverman, William R.; Locovei, Silviu; Qiu, Feng; Carlsson, Steven K.; Keane, Robert W.; Dahl, Gerhard] Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Vaccari, Juan Pablo de Rivero] Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Scemes, Eliana] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	University of Miami; University of Miami; Yeshiva University; Albert Einstein College of Medicine	Dahl, G (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, 1600 NW 10th Ave,RSMB 5135, Miami, FL 33136 USA.	gdahl@miami.edu	Silverman, William/AAE-4799-2019; Qiu, Feng/D-8223-2011; de Rivero Vaccari, Juan Pablo/ABE-3248-2020; de Rivero Vaccari, Juan Pablo/H-5718-2019; Scemes, Eliana/K-6257-2019	de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834; Scemes, Eliana/0000-0002-6650-3976	National Institutes of Health [GM48610, NS052245]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM48610 (to G. D.) and NS052245 (to E. S.) and a training grant (to W. S.).	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bodin P, 1996, J CARDIOVASC PHARM, V27, P872, DOI 10.1097/00005344-199606000-00015; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; DEUTICKE B, 1970, NATURWISSENSCHAFTEN, V57, P172, DOI 10.1007/BF00592968; DOUCET JP, 1992, J BIOL CHEM, V267, P16503; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; GUTMAN AB, 1951, B NEW YORK ACAD MED, V27, P144; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; KAWAMOTO JC, 1986, BRAIN RES, V384, P84, DOI 10.1016/0006-8993(86)91222-9; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; KEANE RW, 1992, TRANSPLANTATION, V54, P520, DOI 10.1097/00007890-199209000-00025; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; TEDESCHI B, 1986, J CELL BIOL, V102, P2244, DOI 10.1083/jcb.102.6.2244; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; [No title captured]	47	401	409	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18143	18151		10.1074/jbc.M109.004804	http://dx.doi.org/10.1074/jbc.M109.004804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416975	hybrid, Green Published			2022-12-27	WOS:000267712400025
J	Kaye, NM; Emmett, KJ; Merrick, WC; Jankowsky, E				Kaye, Nicholas M.; Emmett, Kelly J.; Merrick, William C.; Jankowsky, Eckhard			Intrinsic RNA Binding by the Eukaryotic Initiation Factor 4F Depends on a Minimal RNA Length but Not on the m(7)G Cap	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBIN MESSENGER-RNA; BOX PROTEIN EIF4A; FACTOR 4E; TRANSLATIONAL EFFICIENCY; DECAPPING ENZYME; PURIFICATION; RECOGNITION; COMPLEX; KINASE; NUCLEOTIDE	The eukaryotic initiation factor 4F (eIF4F) is thought to be the first factor to bind mRNA during 7-methylguanosine (m(7)G) cap-dependent translation initiation. The multipartite eIF4F contains the cap-binding protein eIF4E, and it is assumed that eIF4F binds mRNAs primarily at the 5' m(7)G cap structure. We have analyzed equilibrium binding of rabbit eIF4F to a series of diverse RNAs and found no impact of the 5'-cap on the stability of eIF4F-RNA complexes. However, eIF4F preferentially and cooperatively binds to RNAs with a minimum length of similar to 60 nucleotides in vitro. Furthermore, translation activity in rabbit reticulocyte lysate is strongly inhibited by RNAs exceeding this length, but not by shorter ones, consistent with the notion that eIF4F in its physiological environment preferentially binds longer RNAs, too. Collectively, our results indicate that intrinsic RNA binding by eIF4F depends on a minimal RNA length, rather than on cap recognition. The nonetheless essential m(7)G cap may either function at steps subsequent to eIF4F-RNA binding, or other factors facilitate preferential binding of eIF4F to the m(7)G cap.	Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Jankowsky, E (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	exj13@case.edu		Jankowsky, Eckhard/0000-0001-7677-7412	National Institutes of Health [GM067700, GM0026796]; Damon Runyon Cancer Research Foundation [DRS042]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R01GM026796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM067700 (to E. J.) and GM0026796 (to W. C. M.). This work was also supported by Damon Runyon Cancer Research Foundation Grant DRS042 (to E. J.).	ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; GODEFROYCOLBURN T, 1981, J BIOL CHEM, V256, P1762; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; GRIFO JA, 1982, J BIOL CHEM, V257, P5246; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Grudzien E, 2004, RNA, V10, P1479, DOI 10.1261/rna.7380904; Hagedorn CH, 1997, PROTEIN EXPRES PURIF, V9, P53, DOI 10.1006/prep.1996.0661; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HARTZ D, 1991, J MOL BIOL, V218, P99, DOI 10.1016/0022-2836(91)90876-8; Jankowsky Eckhard, 2008, V488, P343, DOI 10.1007/978-1-60327-475-3_22; JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992; Jemielity J, 2003, NUCLEOS NUCLEOT NUCL, V22, P691, DOI 10.1081/NCN-120022611; Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kaye NM, 2002, J MOL BIOL, V324, P429, DOI 10.1016/S0022-2836(02)01094-X; KELLY RC, 1976, J BIOL CHEM, V251, P7240; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; LAWSON TG, 1986, J BIOL CHEM, V261, P13979; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Pyle AM, 2000, METHOD ENZYMOL, V317, P140; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; SAFER B, 1976, P NATL ACAD SCI USA, V73, P2584, DOI 10.1073/pnas.73.8.2584; SHA M, 1995, J BIOL CHEM, V270, P29904; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Volpon L, 2006, EMBO J, V25, P5138, DOI 10.1038/sj.emboj.7601380; von der Haar T, 2000, J BIOL CHEM, V275, P30551, DOI 10.1074/jbc.M004565200; von der Haar T, 2006, J MOL BIOL, V356, P982, DOI 10.1016/j.jmb.2005.12.034; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946	46	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17742	17750		10.1074/jbc.M109.009001	http://dx.doi.org/10.1074/jbc.M109.009001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19414591	Green Published, hybrid			2022-12-27	WOS:000267202500040
J	Morley, TJ; Willis, LM; Whitfield, C; Wakarchuk, WW; Withers, SG				Morley, Thomas J.; Willis, Lisa M.; Whitfield, Chris; Wakarchuk, Warren W.; Withers, Stephen G.			A New Sialidase Mechanism BACTERIOPHAGE K1F ENDO-SIALIDASE IS AN INVERTING GLYCOSIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION-MOLECULE; COMPLETE NUCLEOTIDE-SEQUENCE; INVERTING MUTANT SIALIDASE; ENDO-N-ACETYLNEURAMINIDASE; POLYSIALIC ACID; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; GROUP-B; ACTIVE-SITE; POLYSACCHARIDE ANTIGENS	Bacteriophages specific for Escherichia coli K1 express a tailspike protein that degrades the polysialic acid coat of E. coli K1 that is essential for bacteriophage infection. This enzyme is specific for polysialic acid and is a member of a family of endo-sialidases. This family is unusual because all other previously reported sialidases outside of this family are exo- or trans-sialidases. The recently determined structure of an endo-sialidase derived from bacteriophage K1F (endoNF) revealed an active site that lacks a number of the residues that are conserved in other sialidases, implying a new, endo-sialidase-specific catalytic mechanism. Using synthetic trifluoromethylumbelliferyl oligosialoside substrates, kinetic parameters for hydrolysis at a single cleavage site were determined. Measurement of k(cat)/K-m at a series of pH values revealed a dependence on a single protonated group of pK(a) 5. Mutation of a putative active site acidic residue, E581A, resulted in complete loss of sialidase activity. Direct H-1 NMR analysis of the hydrolysis of trifluoromethylumbelliferyl sialotrioside revealed that endoNF is an inverting sialidase. All other wild type sialidases previously reported are retaining glycosidases, implying a new mechanism of sialidase action specific to this family of endo-sialidases.	[Morley, Thomas J.; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Willis, Lisa M.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of British Columbia; University of Guelph; National Research Council Canada	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Wakarchuk, Warren/Q-9514-2017; Morley, Thomas/A-5224-2013; Wakarchuk, Warren/AAO-2774-2020	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Willis, Lisa/0000-0001-6204-033X	Leverhulme Trust; Natural Sciences and Engineering Research Council; Canada Research Chairs; Canadian Institute of Health Research	Leverhulme Trust(Leverhulme Trust); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by the Leverhulme Trust. Supported by the Natural Sciences and Engineering Research Council. Recipients of Canada Research Chairs. Supported by the Canadian Institute of Health Research.	ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; ADLAM C, 1987, FEMS MICROBIOL LETT, V42, P23, DOI 10.1111/j.1574-6968.1987.tb02293.x; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; ASHWELL M, 1992, J AM CHEM SOC, V114, P10158, DOI 10.1021/ja00052a011; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Brayer GD, 2000, BIOCHEMISTRY-US, V39, P4778, DOI 10.1021/bi9921182; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; BRISSON JR, 1992, BIOCHEMISTRY-US, V31, P4996, DOI 10.1021/bi00136a012; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; CIPPOLA L, 2008, CURR MED CHEM ANTICA, V8, P92; Damager I, 2008, BIOCHEMISTRY-US, V47, P3507, DOI 10.1021/bi7024832; Damude HG, 1996, BIOCHEM J, V315, P467, DOI 10.1042/bj3150467; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DEVI SJN, 1991, INFECT IMMUN, V59, P732, DOI 10.1128/IAI.59.2.732-736.1991; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Engstler M, 1997, ANAL BIOCHEM, V250, P176, DOI 10.1006/abio.1997.2205; EVANS SV, 1995, BIOCHEMISTRY-US, V34, P6737, DOI 10.1021/bi00020a019; FIGARELLABRANGER DF, 1990, CANCER RES, V50, P6364; FINNE J, 1985, J BIOL CHEM, V260, P1265; FINNE J, 1982, J BIOL CHEM, V257, P1966; FINNE J, 1983, LANCET, V2, P355; Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; GOTSCHLICH EC, 1981, J BIOL CHEM, V256, P8915; GROSS RJ, 1977, J CLIN MICROBIOL, V6, P548; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Haselhorst T, 2006, CHEMBIOCHEM, V7, P1875, DOI 10.1002/cbic.200600252; HENKEL E, 1983, CLIN CHEM, V29, P1182; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; Jakobsson E, 2007, BIOCHEM J, V405, P465, DOI 10.1042/BJ20070177; JANN K, 1983, PROG ALLERGY, V33, P53; JENNINGS HJ, 1985, J IMMUNOL, V134, P2651; JENNINGS HJ, 1984, PURE APPL CHEM, V56, P893, DOI 10.1351/pac198456070893; JENNINGS HJ, 1993, GLYCOCONJUGATE J, V10, P328, DOI 10.1007/BF01210139; JOLLEY ME, 1974, CARBOHYD RES, V33, P377, DOI 10.1016/S0008-6215(00)82819-0; Joshi MD, 2000, J MOL BIOL, V299, P255, DOI 10.1006/jmbi.2000.3722; Kao YH, 1997, GLYCOBIOLOGY, V7, P559, DOI 10.1093/glycob/7.4.559; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kataoka Y, 2006, J BIOSCI BIOENG, V101, P198, DOI 10.1263/jbb.101.198; KEY B, 1990, J CELL BIOL, V110, P1729, DOI 10.1083/jcb.110.5.1729; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kobayashi T, 2000, J BIOCHEM-TOKYO, V127, P569, DOI 10.1093/oxfordjournals.jbchem.a022642; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; LONG GS, 1995, BIOCHEM J, V309, P543, DOI 10.1042/bj3090543; Machida Y, 2000, J BIOSCI BIOENG, V90, P62, DOI 10.1016/S1389-1723(00)80035-3; Machida Y, 2000, FEMS MICROBIOL LETT, V182, P333, DOI 10.1111/j.1574-6968.2000.tb08917.x; MANZI AE, 1994, J BIOL CHEM, V269, P23617; Manzoni M, 2007, BIOCHEM J, V408, P395, DOI 10.1042/BJ20070627; MICHON F, 1987, BIOCHEMISTRY-US, V26, P8399, DOI 10.1021/bi00399a055; Miyake K, 1997, J FERMENT BIOENG, V84, P90, DOI 10.1016/S0922-338X(97)82793-6; MOOLENAAR CECK, 1990, CANCER RES, V50, P1102; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Namchuk MN, 2000, J AM CHEM SOC, V122, P1270, DOI 10.1021/ja992044h; Newstead S, 2005, BIOCHEMISTRY-US, V44, P9117, DOI 10.1021/bi050517t; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; OGURA H, 1986, CARBOHYD RES, V158, P37, DOI 10.1016/0008-6215(86)84004-6; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; PELKONEN S, 1989, J VIROL, V63, P4409, DOI 10.1128/JVI.63.10.4409-4416.1989; PETTER JG, 1993, J BACTERIOL, V175, P4354, DOI 10.1128/JB.175.14.4354-4363.1993; Rockle I, 2008, DEV NEUROBIOL, V68, P1170, DOI 10.1002/dneu.20649; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; Rutishauser U, 1998, J CELL BIOCHEM, V70, P304, DOI 10.1002/(SICI)1097-4644(19980901)70:3<304::AID-JCB3>3.0.CO;2-R; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Schauer R, 2000, GLYCOCONJUGATE J, V17, P485, DOI 10.1023/A:1011062223612; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; SCHAUER R, 1997, GLYCOPROTEINS 2, V19, P243; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001; Schwarzer D, 2009, J BIOL CHEM, V284, P9465, DOI 10.1074/jbc.M808475200; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Seidenfaden R, 2003, EUR J CELL BIOL, V82, P48; Severi E, 2008, J BIOL CHEM, V283, P4841, DOI 10.1074/jbc.M707822200; SILVER RP, 1984, J BACTERIOL, V157, P568, DOI 10.1128/JB.157.2.568-575.1984; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; TROY FA, 1979, J BIOL CHEM, V254, P7377; TULL D, 1994, BIOCHEMISTRY-US, V33, P6363, DOI 10.1021/bi00186a041; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034; Watson JN, 2006, BIOCHEMISTRY-US, V45, P13264, DOI 10.1021/bi061489x; Watson JN, 2003, BIOCHEMISTRY-US, V42, P12682, DOI 10.1021/bi035396g; Willis LM, 2008, GLYCOBIOLOGY, V18, P177, DOI 10.1093/glycob/cwm126; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P851, DOI 10.1021/bi00217a039	88	31	32	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17404	17410		10.1074/jbc.M109.003970	http://dx.doi.org/10.1074/jbc.M109.003970			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19411257	Green Published, hybrid			2022-12-27	WOS:000267202500006
J	Anandatheerthavarada, HK; Sepuri, NBV; Avadhani, NG				Anandatheerthavarada, Hindupur K.; Sepuri, Naresh Babu V.; Avadhani, Narayan G.			Mitochondrial Targeting of Cytochrome P450 Proteins Containing NH2-terminal Chimeric Signals Involves an Unusual TOM20/TOM22 Bypass Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTORS TOM20; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES; OUTER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; TRANSLOCATION; BIOGENESIS; ACTIVATION; PATHWAY; PREPROTEINS	Previously we showed that xenobiotic inducible cytochrome P450 (CYP) proteins are bimodally targeted to the endoplasmic reticulum and mitochondria. In this study, we investigated the mechanism of delivery of chimeric signal containing CYP proteins to the peripheral and channel-forming mitochondrial outer membrane translocases (TOMs). CYP+33/1A1 and CYP2B1 did not require peripheral TOM70, TOM20, or TOM22 for translocation through the channel-forming TOM40 protein. In contrast, CYP+5/1A1 and CYP2E1 were able to bypass TOM20 and TOM22 but required TOM70. CYP27, which contains a canonical cleavable mitochondrial signal, required all of the peripheral TOMs for its mitochondrial translocation. We investigated the underlying mechanisms of bypass of peripheral TOMs by CYPs with chimeric signals. The results suggested that interaction of CYPs with Hsp70, a cytosolic chaperone involved in the mitochondrial import, alone was sufficient for the recognition of chimeric signals by peripheral TOMs. However, sequential interaction of chimeric signal containing CYPs with Hsp70 and Hsp90 resulted in the bypass of peripheral TOMs, whereas CYP27A1 interacted only with Hsp70 and was not able to bypass peripheral TOMs. Our results also show that delivery of a chimeric signal containing client protein by Hsp90 required the cytosol-exposed NH2-terminal 143 amino acids of TOM40. TOM40 devoid of this domain was unable to import CYP proteins. These results suggest that compared with the unimodal mitochondrial targeting signals, the chimeric mitochondrial targeting signals are highly evolved and dynamic in nature.	[Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Sepuri, Naresh/AAF-2704-2020		National Institutes of Health [GM-34883]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-34883.	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; BARNUN S, 1980, P NATL ACAD SCI-BIOL, V77, P965, DOI 10.1073/pnas.77.2.965; Beddoe T, 2002, BBA-MOL CELL RES, V1592, P35, DOI 10.1016/S0167-4889(02)00262-8; Bhagwat SV, 1999, J BIOL CHEM, V274, P24014, DOI 10.1074/jbc.274.34.24014; Boopathi E, 2008, MOL CELL, V32, P32, DOI 10.1016/j.molcel.2008.09.008; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Brunner M, 1995, COLD SPRING HARB SYM, V60, P619, DOI 10.1101/SQB.1995.060.01.066; Chacinska A, 2002, TRENDS CELL BIOL, V12, P299, DOI 10.1016/S0962-8924(02)02310-3; DESHAIES RJ, 1988, TRENDS BIOCHEM SCI, V13, P384, DOI 10.1016/0968-0004(88)90180-6; Diekert K, 2001, EMBO J, V20, P5626, DOI 10.1093/emboj/20.20.5626; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Ellis RJ, 2003, NATURE, V421, P801, DOI 10.1038/421801a; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; Gabaldon T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; JAUSSI R, 1995, EUR J BIOCHEM, V228, P551, DOI 10.1111/j.1432-1033.1995.tb20294.x; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Kurz M, 1999, MOL BIOL CELL, V10, P2461, DOI 10.1091/mbc.10.7.2461; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITHGOW T, 1994, J BIOL CHEM, V269, P15325; Ma YL, 2008, J BIOL CHEM, V283, P11743, DOI 10.1074/jbc.M710494200; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; NOTHWEHR SF, 1990, BIOESSAYS, V12, P479, DOI 10.1002/bies.950121005; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; PFALLER R, 1989, J BIOL CHEM, V264, P34; PFANNER N, 1994, TRENDS BIOCHEM SCI, V19, P368, DOI 10.1016/0968-0004(94)90113-9; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; ROSE MD, 1987, METHOD ENZYMOL, V152, P481; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; Stan T, 2003, MOL CELL BIOL, V23, P2239, DOI 10.1128/MCB.23.7.2239-2250.2003; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; SU P, 1990, DNA CELL BIOL, V9, P657, DOI 10.1089/dna.1990.9.657; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Suzuki H, 2004, J BIOL CHEM, V279, P50619, DOI 10.1074/jbc.M408604200; SZCZESNASKORUPA E, 1995, J BIOL CHEM, V270, P24327, DOI 10.1074/jbc.270.41.24327; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Van Ael E, 2006, BBA-MOL CELL RES, V1763, P1629, DOI 10.1016/j.bbamcr.2006.08.020; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; Wilkinson BM, 1997, J MEMBRANE BIOL, V155, P189, DOI 10.1007/s002329900171; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; ZALMAN LS, 1980, J BIOL CHEM, V255, P1771	68	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17352	17363		10.1074/jbc.M109.007492	http://dx.doi.org/10.1074/jbc.M109.007492			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19401463	hybrid, Green Published			2022-12-27	WOS:000266962400070
J	Shi, ZC; Cai, ZY; Wen, S; Chen, CY; Gendron, C; Sanchez, A; Patterson, K; Fu, SB; Yang, J; Wildman, D; Finnell, RH; Zhang, DK				Shi, Zhongcheng; Cai, Zhenyu; Wen, Shu; Chen, Caoyi; Gendron, Christi; Sanchez, Amir; Patterson, Kevin; Fu, Songbin; Yang, Jianhua; Wildman, Derek; Finnell, Richard H.; Zhang, Dekai			Transcriptional Regulation of the Novel Toll-like Receptor Tlr13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INNATE IMMUNITY; MACROPHAGE DIFFERENTIATION; GENE-EXPRESSION; ACTIVATION; PROMOTER; ETS; PU.1; RECOGNITION; MONOCYTES	Little has been known about Tlr13 (Toll-like receptor 13), a novel member of the Toll-like receptor family. To elucidate the molecular basis of murine Tlr13 gene expression, the activity of the Tlr13 gene promoter was characterized. Reporter gene analysis and electrophoretic mobility shift assays demonstrated that Tlr13 gene transcription was regulated through three cis-acting elements that interacted with the Ets2, Sp1, and PU.1 transcription factors. Furthermore, our work suggests that these transcription factors may cooperate, culminating in maximal transcription of the Tlr13 gene. In contrast, NF-kappa B appeared to act as an inhibitor of Tlr13 transcription. Overexpression of Ets2 caused a strong increase in the transcriptional activity of the Tlr13 promoter; however, overexpression of NF-kappa B p65 dramatically inhibited it. Additionally, interferon-beta is capable of acting Tlr13 transcription, but the activated signaling of lipopolysaccharide/TLR4 and peptidoglycan/TLR2 strongly inhibited the Tlr13 gene promoter. Thus, these findings reveal the mechanism of Tlr13 gene regulation, thereby providing insight into the function of Tlr13 in the immune response to pathogen.	[Shi, Zhongcheng; Cai, Zhenyu; Gendron, Christi; Sanchez, Amir; Patterson, Kevin; Zhang, Dekai] Texas A&M Univ, Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Wen, Shu; Finnell, Richard H.] Texas A&M Univ, Hlth Sci Ctr, Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX 77030 USA; [Chen, Caoyi; Wildman, Derek] Wayne State Univ, Dept Med & Mol Genet, Detroit, MI 48201 USA; [Shi, Zhongcheng; Fu, Songbin] Harbin Med Coll, Med Genet Lab, Harbin 150081, Peoples R China; [Yang, Jianhua] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Wayne State University; Harbin Medical University; Baylor College of Medicine	Zhang, DK (corresponding author), 2121 W Holcombe Blvd, Houston, TX 77030 USA.	dzhang@ibt.tamhsc.edu	Finnell, Richard/D-8174-2018	Finnell, Richard/0000-0002-5962-8754; Wildman, Derek/0000-0002-6374-5136	National Institutes of Health [AI072263]; Texas A&M University Health Science Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Health Science Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI072263. This work was also supported by the Texas A&M University Health Science Center.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anderson A F, 2000, Am J Knee Surg, V13, P19; Andreakos E, 2004, IMMUNOL REV, V202, P250, DOI 10.1111/j.0105-2896.2004.00202.x; Armstrong L, 2004, CLIN EXP IMMUNOL, V136, P312, DOI 10.1111/j.1365-2249.2004.02433.x; Beutler B, 2002, CURR OPIN HEMATOL, V9, P2, DOI 10.1097/00062752-200201000-00002; Blumenthal SG, 1999, J BIOL CHEM, V274, P12910, DOI 10.1074/jbc.274.18.12910; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bowie AG, 2008, NAT IMMUNOL, V9, P348, DOI 10.1038/ni0408-348; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Gri G, 1998, J BIOL CHEM, V273, P6431, DOI 10.1074/jbc.273.11.6431; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Janeway CA, 1999, CURR BIOL, V9, pR879, DOI 10.1016/S0960-9822(00)80073-1; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JIN DI, 1995, MOL CELL BIOL, V15, P693; Johnson CM, 2007, J BIOL CHEM, V282, P31197, DOI 10.1074/jbc.M705151200; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Ma XJ, 1996, ANN NY ACAD SCI, V795, P357, DOI 10.1111/j.1749-6632.1996.tb52692.x; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MEDZHITOV R, 1997, NATURE, V388, P397; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; Rees LEN, 2002, CELL MOL LIFE SCI, V59, P560, DOI 10.1007/s00018-002-8448-0; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sevilla L, 2001, J BIOL CHEM, V276, P17800, DOI 10.1074/jbc.M008270200; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeshita F, 2004, J IMMUNOL, V173, P2552, DOI 10.4049/jimmunol.173.4.2552; Totemeyer S, 2003, INFECT IMMUN, V71, P6653, DOI 10.1128/IAI.71.11.6653-6657.2003; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Wang TY, 2001, J IMMUNOL, V167, P6924, DOI 10.4049/jimmunol.167.12.6924; Wei G, 2004, J IMMUNOL, V173, P1374, DOI 10.4049/jimmunol.173.2.1374; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zaldumbide A, 2002, J IMMUNOL, V169, P4873, DOI 10.4049/jimmunol.169.9.4873; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhang DK, 2001, CANCER RES, V61, P6899	48	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20540	20547		10.1074/jbc.M109.022541	http://dx.doi.org/10.1074/jbc.M109.022541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19487701	Green Published, hybrid			2022-12-27	WOS:000268316100015
J	He, H; Li, W; Tseng, DY; Zhang, S; Chen, SY; Day, AJ; Tseng, SCG				He, Hua; Li, Wei; Tseng, David Y.; Zhang, Shan; Chen, Szu-Yu; Day, Anthony J.; Tseng, Scheffer C. G.			Biochemical Characterization and Function of Complexes Formed by Hyaluronan and the Heavy Chains of Inter-alpha-inhibitor (HC.HA) Purified from Extracts of Human Amniotic Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-STIMULATED GENE-6; TUBULAR EPITHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; TRYPSIN INHIBITOR; EXTRACELLULAR-MATRIX; LINK MODULE; MYOFIBROBLAST DIFFERENTIATION; CHROMOSOMAL LOCALIZATION; OOCYTE COMPLEXES; BINDING-PROTEINS	Clinically, amniotic membrane (AM) suppresses inflammation, scarring, and angiogenesis. AM contains abundant hyaluronan (HA) but its function in exerting these therapeutic actions remains unclear. Herein, AM was extracted sequentially with buffers A, B, and C, or separately by phosphate-buffered saline (PBS) alone. Agarose gel electrophoresis showed that high molecular weight (HMW) HA (an average of similar to 3000 kDa) was predominantly extracted in isotonic Extract A (70.1 +/- 6.0%) and PBS (37.7 +/- 3.2%). Western blot analysis of these extracts with hyaluronidase digestion or NaOH treatment revealed that HMW HA was covalently linked with the heavy chains (HCs) of inter-alpha-inhibitor (I alpha I) via a NaOH-sensitive bond, likely transferred by the tumor necrosis factor-alpha stimulated gene-6 protein (TSG-6). This HC.HA complex (nHC.HA) could be purified from Extract PBS by two rounds of CsCl/guanidine HCl ultracentrifugation as well as in vitro reconstituted (rcHC.HA) by mixing HMW HA, serum I alpha I, and recombinant TSG-6. Consistent with previous reports, Extract PBS suppressed transforming growth factor-beta 1 promoter activation in corneal fibroblasts and induced macrophage apoptosis. However, these effects were abolished by hyaluronidase digestion or heat treatment. More importantly, the effects were retained in the nHC.HA or rcHC.HA. These data collectively suggest that the HC.HA complex is the active component in AM responsible in part for clinically observed anti-inflammatory and anti-scarring actions.	[He, Hua; Li, Wei; Zhang, Shan; Chen, Szu-Yu; Tseng, Scheffer C. G.] TissueTech Inc, Miami, FL 33173 USA; [He, Hua; Li, Wei; Zhang, Shan; Chen, Szu-Yu; Tseng, Scheffer C. G.] Ocular Surface Ctr, Miami, FL 33173 USA; [Tseng, David Y.] Ocular Surface Res Educ Fdn, Miami, FL 33173 USA; [Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Day, AJ (corresponding author), Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk; stseng@ocularsurface.com	Day, Anthony/O-1658-2015; Li, Wei/P-8985-2015	Day, Anthony/0000-0002-1415-3134; Li, Wei/0000-0001-7458-2590	National Institutes of Health [R01 EY06819, EY15735]; NEI; TissueTech, Inc.; Ocular Surface Research & Education Foundation, Miami, FL; Medical Research Council [MC_U138274352] Funding Source: researchfish; MRC [MC_U138274352] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY006819, R01EY015735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); TissueTech, Inc.; Ocular Surface Research & Education Foundation, Miami, FL; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY06819 and EY15735 (to S. C. G. T.) from the NEI. This work was also supported by a research grant from TissueTech, Inc. and an unrestricted grant from Ocular Surface Research & Education Foundation, Miami, FL.	ADZICK NS, 1991, CLIN EXPT APPROACHES; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; Bouchard Charles S, 2004, Ocul Surf, V2, P201; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; Espana EM, 2004, INVEST OPHTH VIS SCI, V45, P2985, DOI 10.1167/iovs.04-0201; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Frost GI, 1997, ANAL BIOCHEM, V251, P263, DOI 10.1006/abio.1997.2262; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; GOETINCK PF, 1987, J CELL BIOL, V105, P2403, DOI 10.1083/jcb.105.5.2403; HARDINGHAM TE, 1972, BIOCHEM J, V126, P791, DOI 10.1042/bj1260791; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; He H, 2008, INVEST OPHTH VIS SCI, V49, P4468, DOI 10.1167/iovs.08-1781; Heng BC, 2008, J BIOL CHEM, V283, P32294, DOI 10.1074/jbc.M804155200; Higa K, 2005, CORNEA, V24, P206, DOI 10.1097/01.ico.0000133999.45262.83; HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435; HUANG L, 1993, J BIOL CHEM, V268, P26725; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; JESSEN TE, 1994, BIOL CHEM H-S, V375, P521, DOI 10.1515/bchm3.1994.375.8.521; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Kawakita T, 2005, J BIOL CHEM, V280, P27085, DOI 10.1074/jbc.M409567200; Kawakita T, 2006, INVEST OPHTH VIS SCI, V47, P1918, DOI 10.1167/iovs.05-1040; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lee SB, 2000, CURR EYE RES, V20, P325, DOI 10.1076/0271-3683(200004)20:4;1-5;FT325; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Li W, 2006, EXP EYE RES, V82, P282, DOI 10.1016/j.exer.2005.06.022; Li W, 2008, J CELL PHYSIOL, V215, P657, DOI 10.1002/jcp.21345; MAST BA, 1992, SURG GYNECOL OBSTET, V174, P441; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Meinert M, 2001, AM J OBSTET GYNECOL, V184, P679, DOI 10.1067/mob.2001.110294; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; ROONEY P, 1993, J CELL SCI, V105, P213; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sandson J, 1965, Trans Assoc Am Physicians, V78, P304; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.0.CO;2-X; Tseng Scheffer C G, 2004, Ocul Surf, V2, P177; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Wisniewski HG, 2005, J BIOL CHEM, V280, P14476, DOI 10.1074/jbc.M411734200; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; YONEDA M, 1990, J BIOL CHEM, V265, P5247; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	67	90	111	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20136	20146		10.1074/jbc.M109.021881	http://dx.doi.org/10.1074/jbc.M109.021881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19491101	Green Published, hybrid			2022-12-27	WOS:000268097400041
J	Masters, BSS				Masters, Bettle Sue Siler			A Professional and Personal Odyssey	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item									Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Masters, BSS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	masters@uthscsa.edu							0	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19765	19780		10.1074/jbc.X109.007518	http://dx.doi.org/10.1074/jbc.X109.007518			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19398561	Green Published, hybrid			2022-12-27	WOS:000268097400002
J	Fernandez-Sanchez, E; Martinez-Villarreal, J; Gimenez, C; Zafra, F				Fernandez-Sanchez, Enrique; Martinez-Villarreal, Jaime; Gimenez, Cecilio; Zafra, Francisco			Constitutive and Regulated Endocytosis of the Glycine Transporter GLYT1b Is Controlled by Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; DOPAMINE TRANSPORTER; NMDA RECEPTOR; GLUTAMATE TRANSPORTER; MEDIATED INTERNALIZATION; DEPENDENT ENDOCYTOSIS; IN-VIVO; GLYCINE-TRANSPORTER-1; DEGRADATION; MODULATION	The glycine transporter GLYT1 regulates both glycinergic and glutamatergic neurotransmission by controlling the reuptake of glycine at synapses. Trafficking of GLYT1 to and from the cell surface is critical for its function. Activation of PKC down-regulates the activity of GLYT1 through a mechanism that has so far remained uncharacterized. Here we show that GLYT1b undergoes fast constitutive endocytosis that is accelerated by phorbol esters. Both constitutive and regulated endocytosis occur through a dynamin 2- and clathrin-dependent pathway, accumulating in the transporter in transferrin-containing endosomes. A chimera with the extracellular and transmembrane domains of the nerve growth factor receptor and the COOH-terminal tail of GLYT1 was efficiently internalized through this clathrin pathway, suggesting the presence of molecular determinants for GLYT1b endocytosis in its COOH-terminal tail. Extensive site-directed mutagenesis in this region of the chimera highlighted the involvement of lysine residues in its internalization. In the context of the full-length transporter, lysine 619 played a prominent role in both the constitutive and phorbol 12-myristate 13-acetate-induced endocytosis of GLYT1b, suggesting the involvement of ubiquitin modification of GLYT1b during the internalization process. Indeed, we show that GLYT1b undergoes ubiquitination and that this process is stimulated by phorbol 12-myristate 13-acetate. In addition, this endocytosis is impaired in an ubiquitination-deficient cell line, further evidence that constitutive and regulated endocytosis of GLYT1b is ubiquitin-dependent. It remains to be determined whether GLYT1b recycling might be affected in pathologies involving alterations to the ubiquitin system, thereby interfering with its influence on inhibitory and excitatory neurotransmission.	[Fernandez-Sanchez, Enrique; Martinez-Villarreal, Jaime; Gimenez, Cecilio; Zafra, Francisco] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Fac Ciencias,Ctr Invest Red Enfermedades Raras, Consejo Super Invest Cient, E-28049 Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Zafra, F (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Fac Ciencias,Ctr Invest Red Enfermedades Raras, Consejo Super Invest Cient, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	fzafra@cbm.uam.es	Gimenez, Cecilio/K-8027-2014; Zafra, Francisco/A-6121-2008	Gimenez, Cecilio/0000-0001-6726-8405; Zafra, Francisco/0000-0003-3801-3109; Martinez Villarreal, Jaime/0000-0002-3003-7766	Spanish Direccion General de Investigacion Cientifica y Tecnica Grant [SAF2008-01059]; Fondo de Investigaciones Sanitarias (CIBERER); Comunidad Autonoma de Madrid; Fundacion Ramon Areces	Spanish Direccion General de Investigacion Cientifica y Tecnica Grant; Fondo de Investigaciones Sanitarias (CIBERER)(Instituto de Salud Carlos III); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	This work was supported by Spanish Direccion General de Investigacion Cientifica y Tecnica Grant SAF2008-01059, a grant from the Fondo de Investigaciones Sanitarias (CIBERER), a grant from the Comunidad Autonoma de Madrid, and an institutional grant from the Fundacion Ramon Areces.	BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Benmerah A, 1999, J CELL SCI, V112, P1303; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Betz H, 2006, BIOCHEM SOC T, V34, P55, DOI 10.1042/BST0340055; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Chen L, 2003, J NEUROPHYSIOL, V89, P691, DOI 10.1152/jn.00680.2002; Cubelos B, 2005, J NEUROCHEM, V95, P1047, DOI 10.1111/j.1471-4159.2005.03438.x; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; Deken SL, 2003, J NEUROSCI, V23, P1563; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Fournier KM, 2004, J BIOL CHEM, V279, P34505, DOI 10.1074/jbc.M404032200; Gabernet L, 2005, NEUROSCI LETT, V373, P79, DOI 10.1016/j.neulet.2004.09.064; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; GOMEZA J, 1995, BBA-BIOMEMBRANES, V1233, P41, DOI 10.1016/0005-2736(94)00249-O; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Heilker R, 1999, BIOESSAYS, V21, P558, DOI 10.1002/(SICI)1521-1878(199907)21:7<558::AID-BIES4>3.0.CO;2-R; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; Kinney GG, 2003, J NEUROSCI, V23, P7586; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Morioka N, 2008, NEUROCHEM INT, V53, P248, DOI 10.1016/j.neuint.2008.08.002; OLIVARES L, 1995, J BIOL CHEM, V270, P9437, DOI 10.1074/jbc.270.16.9437; POTAU N, 1984, ENDOCRINOLOGY, V115, P205, DOI 10.1210/endo-115-1-205; Poyatos I, 2000, MOL CELL NEUROSCI, V15, P99, DOI 10.1006/mcne.1999.0807; SATO K, 1995, J NEUROCHEM, V65, P1967; Sheldon AL, 2008, NEUROCHEM INT, V53, P296, DOI 10.1016/j.neuint.2008.07.010; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sur C, 2007, CURR DRUG TARGETS, V8, P643, DOI 10.2174/138945007780618535; Tsai G, 2004, P NATL ACAD SCI USA, V101, P8485, DOI 10.1073/pnas.0402662101; Yee BK, 2006, J NEUROSCI, V26, P3169, DOI 10.1523/JNEUROSCI.5120-05.2006; Zafra F, 2008, IUBMB LIFE, V60, P810, DOI 10.1002/iub.128	38	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19482	19492		10.1074/jbc.M109.005165	http://dx.doi.org/10.1074/jbc.M109.005165			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473961	hybrid, Green Published			2022-12-27	WOS:000267908300040
J	Lin, YP; Lee, DW; McDonough, SP; Nicholson, LK; Sharma, Y; Chang, YF				Lin, Yi-Pin; Lee, Dae-Won; McDonough, Sean P.; Nicholson, Linda K.; Sharma, Yogendra; Chang, Yung-Fu			Repeated Domains of Leptospira Immunoglobulin-like Proteins Interact with Elastin and Tropoelastin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; PULMONARY HEMORRHAGE; C-TERMINUS; INTERROGANS; BINDING; FIBRONECTIN; LIGB; MSCRAMM; GLYCOSAMINOGLYCANS; IDENTIFICATION	Leptospira spp., the causative agents of leptospirosis, adhere to components of the extracellular matrix, a pivotal role for colonization of host tissues during infection. Previously, we and others have shown that Leptospira immunoglobulin-like proteins (Lig) of Leptospira spp. bind to fibronectin, laminin, collagen, and fibrinogen. In this study, we report that Leptospira can be immobilized by human tropoelastin (HTE) or elastin from different tissues, including lung, skin, and blood vessels, and that Lig proteins can bind to HTE or elastin. Moreover, both elastin and HTE bind to the same LigB immunoglobulin-like domains, including LigBCon4, LigBCen7'-8, LigBCen9, and LigBCen12 as demonstrated by enzyme-linked immunosorbent assay (ELISA) and competition ELISAs. The LigB immunoglobulin-like domain binds to the 17th to 27th exons of HTE (17-27HTE) as determined by ELISA ( LigBCon4, K-D = 0.50 mu M; LigBCen7'-8, K-D = 0.82 mu M; LigBCen9, K-D = 1.54 mu M; and LigBCen12, K-D = 0.73 mu M). The interaction of LigBCon4 and 17-27HTE was further confirmed by steady state fluorescence spectroscopy (K-D = 0.49 mu M) and ITC (K-D = 0.54 mu M). Furthermore, the binding was enthalpy-driven and affected by environmental pH, indicating it is a charge-charge interaction. The binding affinity of LigBCon4D341N to 17-27HTE was 4.6-fold less than that of wild type LigBCon4. In summary, we show that Lig proteins of Leptospira spp. interact with elastin and HTE, and we conclude this interaction may contribute to Leptospira adhesion to host tissues during infection.	[Lin, Yi-Pin; Lee, Dae-Won; Chang, Yung-Fu] Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Dept Biomed Sci, Coll Vet Med, Ithaca, NY 14853 USA; [Nicholson, Linda K.] Cornell Univ, Dept Mol Biol & Genet, Coll Agr & Life Sci, Ithaca, NY 14853 USA; [Sharma, Yogendra] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Cornell University; Cornell University; Cornell University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chang, YF (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA.	yc42@cornell.edu	LEE, Daewon/GWZ-8418-2022		Harry M. Zweig Memorial Fund; New York State Science and Technology Foundation; Biotechnology Research and Development Corp.	Harry M. Zweig Memorial Fund; New York State Science and Technology Foundation; Biotechnology Research and Development Corp.	This work was supported in part by the Harry M. Zweig Memorial Fund for Equine Research, the New York State Science and Technology Foundation ( Center for Advanced Technology), and the Biotechnology Research and Development Corp.	Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; Dolhnikoff M, 2007, CURR OPIN PULM MED, V13, P230, DOI 10.1097/MCP.0b013e3280f9df74; Donahue JM, 2000, VET CLIN N AM-EQUINE, V16, P443, DOI 10.1016/S0749-0739(17)30088-3; FAINE S, 1999, LEPTOSPIRA LEPTOSPIR, P67; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089; Graf R, 1996, CELL TISSUE RES, V283, P133; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; HONG CB, 1993, J VET DIAGN INVEST, V5, P56, DOI 10.1177/104063879300500113; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Keane FM, 2007, BIOCHEMISTRY-US, V46, P7226, DOI 10.1021/bi700454x; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1111/j.1574-6968.2000.tb09034.x; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Murray GL, 2008, MICROBES INFECT, V10, P791, DOI 10.1016/j.micinf.2008.04.010; Murray GL, 2009, MICROBES INFECT, V11, P311, DOI 10.1016/j.micinf.2008.11.014; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Piontkivska H, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-31; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002; SANDELL LJ, 1990, EXTRACELLULAR MATRIX, P224; Sebastian M, 2005, VET PATHOL, V42, P659, DOI 10.1354/vp.42-5-659; Seijo A, 2002, EMERG INFECT DIS, V8, P1004, DOI 10.3201/eid0809.010499; SILVERTHORN DU, 2001, HUMAN PHYSL INTEGRAT, P590; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; STARCHER BC, 1986, THORAX, V41, P577, DOI 10.1136/thx.41.8.577; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Verma A, 2008, CLIN VACCINE IMMUNOL, V15, P1019, DOI 10.1128/CVI.00203-07; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; Wachi H, 2007, BIOCHEM J, V402, P63, DOI 10.1042/BJ20061145; Wagenaar JFP, 2004, J TRAVEL MED, V11, P379, DOI 10.2310/7060.2004.19208; Walsh EJ, 2008, MICROBIOL-SGM, V154, P550, DOI 10.1099/mic.0.2007/010868-0; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008	54	89	89	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19380	19391		10.1074/jbc.M109.004531	http://dx.doi.org/10.1074/jbc.M109.004531			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473986	Green Published, hybrid			2022-12-27	WOS:000267908300029
J	Suemasu, S; Tanaka, KI; Namba, T; Ishihara, T; Katsu, T; Fujimoto, M; Adachi, H; Sobue, G; Takeuchi, K; Nakai, A; Mizushima, T				Suemasu, Shintaro; Tanaka, Ken-Ichiro; Namba, Takushi; Ishihara, Tomoaki; Katsu, Takashi; Fujimoto, Mitsuaki; Adachi, Hiroaki; Sobue, Gen; Takeuchi, Koji; Nakai, Akira; Mizushima, Tohru			A Role for HSP70 in Protecting against Indomethacin-induced Gastric Lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HEAT-SHOCK PROTEINS; WATER-IMMERSION STRESS; MUCOSAL CELLS; INDUCED APOPTOSIS; GERANYLGERANYLACETONE PROTECTS; UP-REGULATION; APAF-1 APOPTOSOME; GENETIC-EVIDENCE; PRIMARY CULTURE	A major clinical problem encountered with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, is gastrointestinal complications. Both NSAID-dependent cyclooxygenase inhibition and gastric mucosal apoptosis are involved in NSAID-produced gastric lesions, and this apoptosis is mediated by the endoplasmic reticulum stress response and resulting activation of Bax. Heat shock proteins (HSPs) have been suggested to protect gastric mucosa from NSAID-induced lesions; here we have tested this idea genetically. The severity of gastric lesions produced by indomethacin was worse in mice lacking heat shock factor 1 (HSF1), a transcription factor for hsp genes, than in control mice. Indomethacin administration up-regulated the expression of gastric mucosal HSP70. Indomethacin-induced gastric lesions were ameliorated in transgenic mice expressing HSP70. After indomethacin administration, fewer apoptotic cells were observed in the gastric mucosa of transgenic mice expressing HSP70 than in wild-type mice, whereas the gastric levels of prostaglandin E-2 for the two were indistinguishable. This suggests that expression of HSP70 ameliorates indomethacin-induced gastric lesions by affecting mucosal apoptosis. Suppression of HSP70 expression in vitro stimulated indomethacin-induced apoptosis and activation of Bax but not the endoplasmic reticulum stress response. Geranylgeranylacetone induced HSP70 at gastric mucosa in an HSF1-dependent manner and suppressed the formation of indomethacin-induced gastric lesions in wild-type mice but not in HSF1-null mice. The results of this study provide direct genetic evidence that expression of HSP70 confers gastric protection against indomethacin-induced lesions by inhibiting the activation of Bax. The HSP inducing activity of geranylgeranylacetone seems to contribute to its gastro-protective activity against indomethacin.	[Suemasu, Shintaro; Tanaka, Ken-Ichiro; Namba, Takushi; Ishihara, Tomoaki; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Katsu, Takashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Fujimoto, Mitsuaki; Nakai, Akira] Yamaguchi Univ, Sch Med, Yamaguchi 7558505, Japan; [Adachi, Hiroaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Takeuchi, Koji] Kyoto Pharmaceut Univ, Kyoto 6078414, Japan	Kumamoto University; Okayama University; Yamaguchi University; Nagoya University; Kyoto Pharmaceutical University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp	Longo, Kenneth A/A-5631-2010; Tanaka, Ken-ichiro/J-8557-2013; Adachi, Hiroaki/AAM-7812-2020; KATSU, Takashi/B-1640-2011	Adachi, Hiroaki/0000-0002-9302-4663; 	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid of scientific research from the Ministry of Health, Labour, and Welfare of Japan, grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants-in-aid of the Japan Science and Technology Agency.	Aburaya M, 2006, J BIOL CHEM, V281, P33422, DOI 10.1074/jbc.M602074200; Appleton EL, 1996, DATAMATION, V42, P48; BARRIER CH, 1989, ARTHRITIS RHEUM, V32, P926; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ebert MPA, 2005, J PATHOL, V207, P177, DOI 10.1002/path.1815; FRIES JF, 1989, GASTROENTEROLOGY, V96, P647, DOI 10.1016/S0016-5085(89)80061-7; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gehrmann M, 2004, CLIN CANCER RES, V10, P3354, DOI 10.1158/1078-0432.CCR-03-0382; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Hawkey CJ, 2000, GASTROENTEROLOGY, V119, P521, DOI 10.1053/gast.2000.9561; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Ishihara T, 2007, BIOCHEM BIOPH RES CO, V356, P711, DOI 10.1016/j.bbrc.2007.03.034; Itoh YH, 2000, INT J HYPERTHER, V16, P183, DOI 10.1080/026567300285376; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; KUNISAKI C, 1992, DIGESTION, V53, P45, DOI 10.1159/000200970; Lichtenberger LM, 2001, BIOCHEM PHARMACOL, V61, P631, DOI 10.1016/S0006-2952(00)00576-1; Makin GWJ, 2001, EMBO J, V20, P6306, DOI 10.1093/emboj/20.22.6306; Mathew A, 1998, ANN NY ACAD SCI, V851, P99, DOI 10.1111/j.1749-6632.1998.tb08982.x; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mizushima T, 1999, DIGEST DIS SCI, V44, P510, DOI 10.1023/A:1026692920848; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; NAKAMURA K, 1991, GASTROENTEROLOGY, V101, P161, DOI 10.1016/0016-5085(91)90473-X; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Saika M, 2000, DIGEST DIS SCI, V45, P2455, DOI 10.1023/A:1005615714451; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; SANTUCCI L, 1995, GASTROENTEROLOGY, V108, P393, DOI 10.1016/0016-5085(95)90065-9; SMALLEY WE, 1995, AM J EPIDEMIOL, V141, P539, DOI 10.1093/oxfordjournals.aje.a117469; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Takano T, 2002, DIGEST DIS SCI, V47, P1546, DOI 10.1023/A:1015819203084; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; TERANO A, 1986, DIGESTION, V33, P206, DOI 10.1159/000199296; Tomisato W, 2004, BIOCHEM BIOPH RES CO, V323, P1032, DOI 10.1016/j.bbrc.2004.08.205; Tomisato W, 2004, BIOCHEM PHARMACOL, V67, P575, DOI 10.1016/j.bcp.2003.09.020; Tomisato W, 2001, BIOL PHARM BULL, V24, P887, DOI 10.1248/bpb.24.887; Tomisato W, 2001, AM J PHYSIOL-GASTR L, V281, pG1092, DOI 10.1152/ajpgi.2001.281.4.G1092; Tomisato W, 2000, DIGEST DIS SCI, V45, P1674, DOI 10.1023/A:1005597902470; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Tsutsumi S, 2002, BBA-MOL CELL RES, V1589, P168, DOI 10.1016/S0167-4889(02)00171-4; Ushijima H, 2005, MOL PHARMACOL, V68, P1156, DOI 10.1124/mol.105.015784; WALLACE JL, 1990, AM J PHYSIOL, V259, pG462, DOI 10.1152/ajpgi.1990.259.3.G462; Yanaka A, 2007, DIGESTION, V75, P148, DOI 10.1159/000106756; ZENIYA A, 1995, J GASTROENTEROL, V30, P572, DOI 10.1007/BF02367781	48	72	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19705	19715		10.1074/jbc.M109.006817	http://dx.doi.org/10.1074/jbc.M109.006817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19439408	Green Published, hybrid			2022-12-27	WOS:000267908300061
J	Wang, HS; Fukushima, H; Kida, S; Zhuo, M				Wang, Hansen; Fukushima, Hotaka; Kida, Satoshi; Zhuo, Min			Ca2+/Calmodulin-dependent Protein Kinase IV Links Group I Metabotropic Glutamate Receptors to Fragile X Mental Retardation Protein in Cingulate Cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; NEURONAL GENE-EXPRESSION; CONTEXTUAL FEAR MEMORY; SYNAPTIC PLASTICITY; MOUSE MODEL; MOLECULAR-MECHANISMS; CREB PHOSPHORYLATION; CULTURED NEURONS; BINDING PROTEIN; RNA-BINDING	Fragile X syndrome is caused by a lack of fragile X mental retardation protein (FMRP) due to silencing of the FMR1 gene. The metabotropic glutamate receptors (mGluRs) in the central nervous system contribute to higher brain functions including learning/memory, persistent pain, and mental disorders. Our recent study has shown that activation of Group I mGluR up-regulated FMRP in anterior cingulate cortex (ACC), a key region for brain cognitive and executive functions; Ca2+ signaling pathways could be involved in the regulation of FMRP by Group I mGluRs. In this study we demonstrate that stimulating Group I mGluRs activates Ca2+/calmodulin-dependent protein kinase IV (CaMKIV) in ACC neurons. In ACC neurons of adult mice overexpressing CaMKIV, the up-regulation of FMRP by stimulating Group I mGluR is enhanced. The enhancement occurs at the transcriptional level as the Fmr1 mRNA level was further elevated compared with wild-type mice. Using pharmacological approaches, we found that inhibition of CaMKIV could attenuate the up-regulation of FMRP by Group I mGluRs. CaMKIV contribute to the regulation of FMRP by Group I mGluRs probably through cyclic AMP-responsive element binding protein (CREB) activation, as manipulation of CaMKIV could simultaneously cause the change of CREB phosphorylation induced by Group I mGluR activation. Our study has provided strong evidence for CaMKIV as a molecular link between Group I mGluRs and FMRP in ACC neurons and may help us to elucidate the pathogenesis of fragile X syndrome.	[Wang, Hansen; Zhuo, Min] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Fukushima, Hotaka; Kida, Satoshi] Tokyo Univ Agr, Fac Appl Biosci, Dept Biosci, Tokyo 1568502, Japan	University of Toronto; Tokyo University of Agriculture	Zhuo, M (corresponding author), Univ Toronto, Fac Med, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	min.zhuo@utoronto.ca	wang, hansen/I-2510-2019; Zhuo, Min/A-2072-2008	wang, hansen/0000-0003-4414-3372; Zhuo, Min/0000-0001-9062-3241	EJLB-Canadian Institutes of Health Research (CIHR); CIHR [CIHR81086, CIHR84256]	EJLB-Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the EJLB-Canadian Institutes of Health Research (CIHR) Michael Smith Chair in Neurosciences and Mental Health, Canada Research Chair, NeuroCanada, and CIHR Operating Grants CIHR81086 and CIHR84256 (to M.Z.).	Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Bianchi R, 1999, J NEUROPHYSIOL, V81, P2903, DOI 10.1152/jn.1999.81.6.2903; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; CHAVIS P, 1995, NEUROPHARMACOLOGY, V34, P929, DOI 10.1016/0028-3908(95)00082-H; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Colomer J., 2007, V45, P169; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Coutinho V, 2002, NEUROSCIENTIST, V8, P551, DOI 10.1177/1073858402238514; Fahling M, 2009, J BIOL CHEM, V284, P4255, DOI 10.1074/jbc.M807354200; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Fitzjohn SM, 2001, J PHYSIOL-LONDON, V537, P421, DOI 10.1111/j.1469-7793.2001.00421.x; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Fukushima H, 2008, J NEUROSCI, V28, P9910, DOI 10.1523/JNEUROSCI.2625-08.2008; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Gong B, 2007, EUR J NEUROSCI, V26, P275, DOI 10.1111/j.1460-9568.2007.05669.x; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; He XP, 2000, J CELL BIOL, V149, P783, DOI 10.1083/jcb.149.4.783; Heinke B, 2005, PAIN, V118, P145, DOI 10.1016/j.pain.2005.08.004; Heinke B, 2007, NEUROPHARMACOLOGY, V52, P1015, DOI 10.1016/j.neuropharm.2006.10.020; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Hu HJ, 2002, J NEUROSCI, V22, P7444; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Hwu WL, 1997, DNA CELL BIOL, V16, P449, DOI 10.1089/dna.1997.16.449; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kushnareva YE, 2005, J BIOL CHEM, V280, P28894, DOI 10.1074/jbc.M503090200; Lu YF, 1999, J NEUROSCI, V19, P10250; Mao LM, 2003, EUR J NEUROSCI, V17, P741, DOI 10.1046/j.1460-9568.2003.02495.x; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Rae MG, 2004, NEUROPHARMACOLOGY, V46, P1057, DOI 10.1016/j.neuropharm.2004.02.002; Rae MG, 2000, J NEUROSCI, V20, P8628; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Sharma AK, 2004, J BIOL CHEM, V279, P35564, DOI 10.1074/jbc.M401037200; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smith KT, 2006, NUCLEIC ACIDS RES, V34, P1205, DOI 10.1093/nar/gkj521; Tamminga CA, 2007, AM J PSYCHIAT, V164, P556, DOI 10.1176/appi.ajp.164.4.556; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; Thuault SJ, 2002, NEUROPHARMACOLOGY, V43, P141, DOI 10.1016/S0028-3908(02)00095-3; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tremper-Wells B, 2005, J BIOL CHEM, V280, P2165, DOI 10.1074/jbc.M410591200; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Wang HS, 2008, J NEUROSCI, V28, P4385, DOI 10.1523/JNEUROSCI.0646-08.2008; Wang HS, 2007, J BIOL CHEM, V282, P1507, DOI 10.1074/jbc.M607291200; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wei F, 1999, J NEUROSCI, V19, P9346; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003; Zhuo M, 2006, J NEUROSCI RES, V84, P927, DOI 10.1002/jnr.21003	73	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18953	18962		10.1074/jbc.M109.019141	http://dx.doi.org/10.1074/jbc.M109.019141			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19436069	Green Published, hybrid			2022-12-27	WOS:000267711500045
J	Chen, WY; Marcellin, E; Hung, J; Nielsen, LK				Chen, Wendy Yiting; Marcellin, Esteban; Hung, Jacky; Nielsen, Lars Keld			Hyaluronan Molecular Weight Is Controlled by UDP-N-acetylglucosamine Concentration in Streptococcus zooepidemicus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; TYPE-3 CAPSULAR POLYSACCHARIDE; CONSERVED CYSTEINE RESIDUES; ACID PRODUCTION; LACTOCOCCUS-LACTIS; SODIUM HYALURONATE; SUGAR NUCLEOTIDES; SYNTHASE; BIOSYNTHESIS; PNEUMONIAE	The molecular weight of hyaluronan is important for its rheological and biological function. The molecular mechanisms underlying chain termination and hence molecular weight control remain poorly understood, not only for hyaluronan synthases but also for other beta-polysaccharide synthases, e. g. cellulose, chitin, and 1,3-betaglucan synthases. In this work, we manipulated metabolite concentrations in the hyaluronan pathway by overexpressing the five genes of the hyaluronan synthesis operon in Streptococcus equi subsp. zooepidemicus. Overexpression of genes involved in UDP-glucuronic acid biosynthesis decreased molecular weight, whereas overexpression of genes involved in UDP-N-acetylglucosamine biosynthesis increased molecular weight. The highest molecular mass observed was at 3.4 +/- 0.1 MDa twice that observed in the wild-type strain, 1.8 +/- 0.1 MDa. The data indicate that (a) high molecular weight is achieved when an appropriate balance of UDP-N-acetylglucosamine and UDP-glucuronic acid is achieved, (b) UDP-N-acetylglucosamine exerts the dominant effect on molecular weight, and (c) the wild-type strain has suboptimal levels of UDP-Nacetylglucosamine. Consistent herewith molecular weight correlated strongly (rho = 0.84, p = 3 x 10(-5)) with the concentration of UDP-N-acetylglucosamine. Data presented in this paper represent the first model for hyaluronan molecular weight control based on the concentration of activated sugar precursors. These results can be used to engineer strains producing high molecular weight hyaluronan and may provide insight into similar polymerization mechanisms in other polysaccharides.	[Chen, Wendy Yiting; Marcellin, Esteban; Hung, Jacky; Nielsen, Lars Keld] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia; [Chen, Wendy Yiting; Hung, Jacky; Nielsen, Lars Keld] Univ Queensland, Cooperat Res Ctr Sugar Ind Innovat Biotechnol, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Nielsen, LK (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.	lars.nielsen@uq.edu.au	Nielsen, Lars K/A-5519-2011	Nielsen, Lars K/0000-0001-8191-3511; Marcellin, Esteban/0000-0003-3173-7956	Australian Institute for Bioengineering and Nanotechnology; CRC Sugar Industry Innovation through Biotechnology; Mexican Council of Science and Technology	Australian Institute for Bioengineering and Nanotechnology; CRC Sugar Industry Innovation through Biotechnology(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Mexican Council of Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was financially supported by the Australian Institute for Bioengineering and Nanotechnology, the CRC Sugar Industry Innovation through Biotechnology, and the Mexican Council of Science and Technology. 1 Both authors contributed equally to this work.	Armstrong DC, 1997, APPL ENVIRON MICROB, V63, P2759, DOI 10.1128/AEM.63.7.2759-2764.1997; Blank LM, 2008, J MOL EVOL, V67, P13, DOI 10.1007/s00239-008-9117-1; Blank LM, 2005, BIOTECHNOL BIOENG, V90, P685, DOI 10.1002/bit.20466; Cartee RT, 2000, J BIOL CHEM, V275, P3907, DOI 10.1074/jbc.275.6.3907; Chien LJ, 2007, APPL MICROBIOL BIOT, V77, P339, DOI 10.1007/s00253-007-1153-z; Chong BF, 2003, BIOCHEM ENG J, V16, P153, DOI 10.1016/S1369-703X(03)00031-7; Chong BF, 2003, J BIOTECHNOL, V100, P33, DOI 10.1016/S0168-1656(02)00239-0; Chong BF, 2005, APPL MICROBIOL BIOT, V66, P341, DOI 10.1007/s00253-004-1774-4; CHONG BF, 2002, THESIS U QUEENSLAND; DEANGELIS PL, 1993, J BIOL CHEM, V268, P19181; DEANGELIS PL, 1993, J BIOL CHEM, V268, P14568; Degeest B, 2000, APPL ENVIRON MICROB, V66, P3519, DOI 10.1128/AEM.66.8.3519-3527.2000; DIFERRANTE N, 1956, J BIOL CHEM, V220, P303; DOUGHERTY BA, 1993, J BIOL CHEM, V268, P7118; Forsee WT, 2000, J BIOL CHEM, V275, P25972, DOI 10.1074/jbc.M002613200; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; FOUISSAC E, 1993, MACROMOLECULES, V26, P6945, DOI 10.1021/ma00077a036; GASSON MJ, 1983, J BACTERIOL, V154, P1; Goh L.T., 1998, THESIS U QUEENSLAND; Grobben GJ, 1996, APPL MICROBIOL BIOT, V46, P279, DOI 10.1007/s002530050817; Heldermon CD, 2001, GLYCOBIOLOGY, V11, P1017, DOI 10.1093/glycob/11.12.1017; Huang WC, 2006, BIOCHEM ENG J, V32, P239, DOI 10.1016/j.bej.2006.10.011; JANG PM, 1996, Patent No. 5496726; Jensen NBS, 1999, BIOTECHNOL BIOENG, V63, P356, DOI 10.1002/(SICI)1097-0290(19990505)63:3&lt;356::AID-BIT12&gt;3.0.CO;2-1; JOHNS MR, 1994, BIOTECHNOL LETT, V16, P507, DOI 10.1007/BF01023334; Kumari K, 2006, J BIOL CHEM, V281, P11755, DOI 10.1074/jbc.M600727200; Kumari K, 2002, J BIOL CHEM, V277, P13943, DOI 10.1074/jbc.M110638200; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Marcellin Esteban, 2009, Biotechnology Journal, V4, P58, DOI 10.1002/biot.200800197; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Pummill PE, 2003, J BIOL CHEM, V278, P19808, DOI 10.1074/jbc.M301097200; SAETTONE MF, 1991, INT J PHARMACEUT, V72, P131, DOI 10.1016/0378-5173(91)90051-O; Sambrook J., 2001, MOL CLONING LAB MANU; Saso L, 1999, RES COMMUN MOL PATH, V104, P277; SLOMA A, 2003, Patent No. 20030175902; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Spurlock SL, 1999, J EQUINE VET SCI, V19, P338, DOI 10.1016/S0737-0806(06)82052-6; SUZUKI Y, 1993, AGENTS ACTIONS, V38, P32, DOI 10.1007/BF02027210; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4246, DOI 10.1074/jbc.274.7.4246; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Ventura CL, 2006, MOL MICROBIOL, V61, P723, DOI 10.1111/j.1365-2958.2006.05259.x; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Weigel PH, 2002, IUBMB LIFE, V54, P201, DOI 10.1080/15216540214931; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005; Yu HM, 2008, METAB ENG, V10, P24, DOI 10.1016/j.ymben.2007.09.001	47	69	76	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18007	18014		10.1074/jbc.M109.011999	http://dx.doi.org/10.1074/jbc.M109.011999			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19451654	Green Published, hybrid			2022-12-27	WOS:000267712400012
J	Davies, MJ; Miranda, E; Roussel, BD; Kaufman, RJ; Marciniak, SJ; Lomas, DA				Davies, Mark J.; Miranda, Elena; Roussel, Benoit D.; Kaufman, Randal J.; Marciniak, Stefan J.; Lomas, David A.			Neuroserpin Polymers Activate NF-kappa B by a Calcium Signaling Pathway That Is Independent of the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-OVERLOAD RESPONSE; ENDOPLASMIC-RETICULUM; CONFORMATIONAL DISEASE; INCLUSION-BODIES; REACTIVE LOOP; DEMENTIA; PHOSPHORYLATION; ACCUMULATION; TRANSDUCTION; TRANSLATION	The autosomal dominant dementia familial encephalopathy with neuroserpin inclusion bodies is characterized by the accumulation of ordered polymers of mutant neuroserpin within the endoplasmic reticulum of neurones. We show here that intracellular neuroserpin polymers activate NF-kappa B by a pathway that is independent of the IRE1, ATF6, and PERK limbs of the canonical unfolded protein response but is dependent on intracellular calcium. This pathway provides a mechanism for cells to sense and react to the accumulation of folded structures of mutant serpins within the endoplasmic reticulum. Our results provide strong support for the endoplasmic reticulum overload response being independent of the unfolded protein response.	[Davies, Mark J.; Miranda, Elena; Roussel, Benoit D.; Marciniak, Stefan J.; Lomas, David A.] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Kaufman, Randal J.] Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Cambridge; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lomas, DA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med, Wellcome Trust Med Res Council Bldg,Hills Rd, Cambridge CB2 0XY, England.	dal16@cam.ac.uk	Roussel, Benoit/L-9520-2018; Marciniak, Stefan J/F-1855-2010; Roussel, Benoit/P-9309-2019; Miranda, Elena/J-4999-2012; Longo, Kenneth A/A-5631-2010	Roussel, Benoit/0000-0003-0575-8112; Miranda, Elena/0000-0002-0586-8795; Marciniak, Stefan/0000-0001-8472-7183	National Institutes of Health [RO1-DK042394, RO1-HL052173, PO1-HL057346]; Medical Research Council; Papworth National Health Service Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK042394] Funding Source: NIH RePORTER; Medical Research Council [G0500306, G0601840] Funding Source: researchfish; MRC [G0601840, G0500306] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Papworth National Health Service Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK042394, RO1-HL052173, and PO1-HL057346 ( to R. J. K.). This work was also supported by the Medical Research Council ( MRC, UK) and Papworth National Health Service Trust.	Bartz SR, 1997, METHODS, V12, P337, DOI 10.1006/meth.1997.0487; Belorgey D, 2002, J BIOL CHEM, V277, P17367, DOI 10.1074/jbc.M200680200; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Davis RL, 1999, AM J PATHOL, V155, P1901, DOI 10.1016/S0002-9440(10)65510-1; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Davis RL, 2002, LANCET, V359, P2242, DOI 10.1016/S0140-6736(02)09293-0; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Knorre A, 2002, BIOL CHEM, V383, P271, DOI 10.1515/BC.2002.029; Kuang E, 2005, J CELL PHYSIOL, V204, P549, DOI 10.1002/jcp.20340; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; LIBBY P, 1978, SCIENCE, V199, P534, DOI 10.1126/science.622552; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Pahl HL, 1996, J CELL BIOL, V132, P511, DOI 10.1083/jcb.132.4.511; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Palmer EA, 2003, J CELL SCI, V116, P2361, DOI 10.1242/jcs.00439; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Sivasothy P, 2000, J BIOL CHEM, V275, P33663, DOI 10.1074/jbc.M004054200; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923	46	61	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18202	18209		10.1074/jbc.M109.010744	http://dx.doi.org/10.1074/jbc.M109.010744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19423713	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000267712400032
J	Funabara, D; Osawa, R; Ueda, M; Kanoh, S; Hartshorne, DJ; Watabe, S				Funabara, Daisuke; Osawa, Rika; Ueda, Miki; Kanoh, Satoshi; Hartshorne, David J.; Watabe, Shugo			Myosin Loop 2 Is Involved in the Formation of a Trimeric Complex of Twitchin, Actin, and Myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLLUSCAN CATCH MUSCLE; HEAD DETACHMENT; PHOSPHORYLATION; PROTEIN; PHOSPHATASE; PARAMYOSIN; CALCIUM	Molluscan smooth muscles exhibit a low energy cost contraction called catch. Catch is regulated by twitchin phosphorylation and dephosphorylation. Recently, we found that the D2 fragment of twitchin containing the D2 site (Ser-4316) and flanking immunoglobulin motifs (TWD2-S) formed a heterotrimeric complex with myosin and with actin in the region that interacts with myosin loop 2 (Funabara, D., Hamamoto, C., Yamamoto, K., Inoue, A., Ueda, M., Osawa, R., Kanoh, S., Hartshorne, D. J., Suzuki, S., and Watabe, S. (2007) J. Exp. Biol. 210, 4399-4410). Here, we show that TWD2-S interacts directly with myosin loop 2 in a phosphorylation-sensitive manner. A synthesized peptide, CAQNKEAETTGTHKKRKSSA, based on the myosin loop 2 sequence (loop 2 peptide), competitively inhibited the formation of the trimeric complex. Isothermal titration calorimetry showed that TWD2-S binds to the loop 2 peptide with a K-a of (2.44 +/- 0.09) x 10(5) M-1 with two binding sites. The twitchin-binding peptide of actin, AGFAGDDAP, which also inhibited formation of the trimeric complex, bound to TWD2-S with a K-a of (5.83 +/- 0.05) x 10(4) M-1 with two binding sites. The affinity of TWD2-S to actin and myosin was slightly decreased with an increase of pH, but this effect could not account for the marked pH dependence of catch in permeabilized fibers. The complex formation also showed a moderate Ca2+ sensitivity in that in the presence of Ca2+ complex formation was reduced.	[Funabara, Daisuke; Osawa, Rika; Ueda, Miki; Kanoh, Satoshi] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Hartshorne, David J.] Univ Arizona, Muscle Biol Grp, Tucson, AZ 85721 USA; [Watabe, Shugo] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Mie University; University of Arizona; University of Tokyo	Watabe, S (corresponding author), Yayoi 1-1-1,Bunkyo Ku, Tokyo 1138657, Japan.	awatabe@ecc.mail.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and from the Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency (to D. F.).	Andruchova O, 2005, PFLUG ARCH EUR J PHY, V450, P326, DOI 10.1007/s00424-005-1447-x; Butler TM, 2006, BIOPHYS J, V90, P3193, DOI 10.1529/biophysj.105.077453; CASTELLANI L, 1992, FEBS LETT, V309, P321, DOI 10.1016/0014-5793(92)80798-L; Funabara D, 2003, J BIOL CHEM, V278, P29308, DOI 10.1074/jbc.M303272200; Funabara D, 2001, BIOCHEMISTRY-US, V40, P2087, DOI 10.1021/bi0022691; Funabara D, 2007, J EXP BIOL, V210, P4399, DOI 10.1242/jeb.008722; Hopflinger MC, 2006, J EXP BIOL, V209, P668, DOI 10.1242/jeb.02033; ISHII N, 1989, SCIENCE, V243, P1367, DOI 10.1126/science.2922614; JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127; LOWY J, 1964, PROC R SOC SER B-BIO, V160, P525, DOI 10.1098/rspb.1964.0068; MOMMAERTS WFHM, 1951, J BIOL CHEM, V188, P559; Shelud'ko NS, 2007, ARCH BIOCHEM BIOPHYS, V466, P125, DOI 10.1016/j.abb.2007.07.014; Siegman MJ, 1997, J MUSCLE RES CELL M, V18, P655, DOI 10.1023/A:1018683823020; Siegman MJ, 1998, P NATL ACAD SCI USA, V95, P5383, DOI 10.1073/pnas.95.9.5383; SZENTGYORGYI AG, 1994, MYOLOGY, P506; Takahashi I, 2003, COMP BIOCHEM PHYS A, V134, P117; TWAROG BM, 1976, PHYSIOL REV, V56, P829, DOI 10.1152/physrev.1976.56.4.829; Van Dijk J, 1998, BIOCHEMISTRY-US, V37, P8385, DOI 10.1021/bi980139a; WATABE S, 1990, COMP BIOCHEM PHYS B, V96, P639, DOI 10.1016/0305-0491(90)90207-A; Yamada A, 2004, J BIOL CHEM, V279, P40762, DOI 10.1074/jbc.M405191200; Yamada A, 2000, J MOL BIOL, V295, P169, DOI 10.1006/jmbi.1999.3349	21	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18015	18020		10.1074/jbc.M109.016485	http://dx.doi.org/10.1074/jbc.M109.016485			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19439402	Green Published, hybrid			2022-12-27	WOS:000267712400013
J	Chen, RQ; Yang, QK; Chen, YL; Oliveira, VA; Dalton, WS; Fearns, C; Lee, JD				Chen, Run-Qiang; Yang, Qing-Kai; Chen, Yan-Ling; Oliveira, Vasco A.; Dalton, William S.; Fearns, Colleen; Lee, Jiing-Dwan			Kinome Sirna Screen Identifies SMG-1 as a Negative Regulator of Hypoxia-inducible Factor-1 alpha in Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA SURVEILLANCE PROTEIN; OXIDATIVE STRESS; LIFE-SPAN; CANCER; KINASE; HIF-1; MTOR; PATHWAYS; COMPLEX; HSMG-1	Hypoxia-inducible factor-1 (HIF-1) plays a central role in tumor progression by regulating genes involved in proliferation, glycolysis, angiogenesis, and metastasis. To improve our understanding of HIF-1 regulation by kinome, we screened a kinase-specific small interference RNA library using a hypoxia-response element (HRE) luciferase reporter assay under hypoxic conditions. This screen determined that depletion of cellular SMG-1 kinase most significantly modified cellular HIF-1 activity in hypoxia. SMG-1 is the newest and least studied member of the phosphoinositide 3-kinase-related kinase family, which consists of ATM, ATR, DNA-PKcs, mTOR, and SMG-1. We individually depleted members of the phosphoinositide 3-kinase-related kinase family, and only SMG-1 deficiency significantly augmented HIF-1 activity in hypoxia. We subsequently discovered that SMG-1 kinase activity was activated by hypoxia, and depletion of SMG-1 up-regulated MAPK activity under low oxygen. Suppressing cellular MAPK by silencing ERK1/2 or by treatment with U0126, a MAPK inhibitor, partially blocked the escalation of HIF-1 activity resulting from SMG-1 deficiency in hypoxic cells. Increased expression of SMG-1 but not kinase-dead SMG-1 effectively inhibited the activity of HIF-1 alpha. In addition, cellular SMG-1 deficiency increased secretion of the HIF-1 alpha-regulated angiogenic factor, vascular epidermal growth factor, and survival factor, carbonic anhydrase IX (CA9), as well as promoted the hypoxic cell motility. Taken together, we discovered that SMG-1 negatively regulated HIF-1 alpha activity in hypoxia, in part through blocking MAPK activation.	[Lee, Jiing-Dwan] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Fearns, Colleen] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Oliveira, Vasco A.; Dalton, William S.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut & Interdisciplinary Oncol, Tampa, FL 33612 USA	Scripps Research Institute; Scripps Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Lee, JD (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, IMM 12,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jdlee@scripps.edu	chen, yanling/GRE-8287-2022; Yang, Qingkai/AAK-5111-2021	Yang, Qingkai/0000-0001-6628-5393	National Institutes of Health [CA079871, CA114059]; Tobacco-Related Disease, Research Program of the University of California [15RT-0104]; NATIONAL CANCER INSTITUTE [R01CA079871, R01CA114059] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease, Research Program of the University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA079871 and CA114059 (to J.-D.L.). This work was also supported by funds from the Tobacco-Related Disease, Research Program of the University of California (Grant 15RT-0104 to J.-D.L.).	Abraham RT, 2004, DNA REPAIR, V3, P919, DOI 10.1016/j.dnarep.2004.04.003; Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Gehen SC, 2008, ONCOGENE, V27, P4065, DOI 10.1038/onc.2008.48; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Liu CJ, 2005, EXP CELL RES, V309, P410, DOI 10.1016/j.yexcr.2005.06.022; Masse I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003354; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Morita T, 2007, J BIOL CHEM, V282, P7799, DOI 10.1074/jbc.M610159200; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Oliveira V, 2008, J BIOL CHEM, V283, P13174, DOI 10.1074/jbc.M708008200; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sodhi A, 2001, BIOCHEM BIOPH RES CO, V287, P292, DOI 10.1006/bbrc.2001.5532; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Sutton KM, 2007, ONCOGENE, V26, P3920, DOI 10.1038/sj.onc.1210168; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	38	20	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16752	16758		10.1074/jbc.M109.014316	http://dx.doi.org/10.1074/jbc.M109.014316			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19406746	hybrid, Green Published			2022-12-27	WOS:000266962400010
J	Wei, XL; Guo, W; Wu, SH; Wang, L; Lu, YL; Xu, B; Liu, JS; Fang, BL				Wei, Xiaoli; Guo, Wei; Wu, Shuhong; Wang, Li; Lu, Yiling; Xu, Bo; Liu, Jinsong; Fang, Bingliang			Inhibiting JNK Dephosphorylation and Induction of Apoptosis by Novel Anticancer Agent NSC-741909 in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; ALPHA-INDUCED APOPTOSIS; N-TERMINAL KINASE; PROTEIN-KINASE; SYNTHETIC LETHALITY; SIGNAL-TRANSDUCTION; ACTIVATION DOMAIN; MAP KINASES; HA-RAS; C-IOTA	NSC-741909 is a recently identified novel anticancer agent that suppresses the growth of several NCI-60 cancer cell lines with a unique anticancer spectrum. However, its molecular mechanisms remain unknown. To determine the molecular mechanisms of NSC-741909- induced antitumor activity, we analyzed the changes of 77 protein biomarkers in a sensitive lung cancer cell line after treatment with this compound by using reverse-phase protein microarray. The results showed that phosphorylation of mitogen-activated protein (MAP) kinases (P38 MAPK, ERK, and JNK) were persistently elevated by the treatment with NSC-741909. However, only the JNK-specific inhibitor SP600125 effectively blocked the apoptosis induced by NSC-741909. Moreover, NSC-741909-mediated apoptosis was also blocked by a dominant-negative JNK construct, suggesting that sustained activation of JNK is critical for the apoptosis induction. Further studies revealed that treatment with NSC-741909 suppressed dephosphorylation of JNK and the expression of MAPK phosphatase-1. Thus, NSC-741909 mediated inhibition of JNK dephosphorylation results in sustained JNK activation, which leads to apoptosis in cancer cells.	[Wei, Xiaoli; Guo, Wei; Wu, Shuhong; Wang, Li; Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Lu, Yiling] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Liu, Jinsong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Xu, Bo] Univ Texas Med Branch, Prot Biosynth & Biomarker Core Lab, Galveston, TX 77555 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Medical Branch Galveston	Fang, BL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	bfang@mdanderson.org			National Institutes of Health [R01 CA 092487]; Cancer Center [CA 3P30CA016672]; Lockton; NATIONAL CANCER INSTITUTE [R01CA131183, R01CA124951, P30CA016672, R01CA092487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; Lockton; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA 092487 (to B. F.) through the NCI. This work was also supported by Lockton Grant matching funds and by Cancer Center Support Grant CA 3P30CA016672 (J. Mendelsohn).	ADLER V, 1995, P NATL ACAD SCI USA, V92, P10585, DOI 10.1073/pnas.92.23.10585; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOBZHANSKY T, 1946, GENETICS, V31, P269; Guo W, 2008, CANCER RES, V68, P7403, DOI 10.1158/0008-5472.CAN-08-1449; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Joneson T, 1997, J MOL MED-JMM, V75, P587, DOI 10.1007/s001090050143; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang HJ, 2003, INT J CANCER, V103, P475, DOI 10.1002/ijc.10855; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Santibanez JF, 2005, FEBS LETT, V579, P6459, DOI 10.1016/j.febslet.2005.10.025; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wojtaszek PA, 1998, J BIOL CHEM, V273, P800, DOI 10.1074/jbc.273.2.800; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zhang L, 2002, GENE THER, V9, P1262, DOI 10.1038/sj.gt.3301797	32	20	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16948	16955		10.1074/jbc.M109.010256	http://dx.doi.org/10.1074/jbc.M109.010256			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19414586	hybrid, Green Published			2022-12-27	WOS:000266962400032
J	Charriere, F; O'Donoghue, P; Helgadottir, S; Marechal-Drouard, L; Cristodero, M; Horn, EK; Soll, D; Schneider, A				Charriere, Fabien; O'Donoghue, Patrick; Helgadottir, Sunna; Marechal-Drouard, Laurence; Cristodero, Marina; Horn, Elke K.; Soell, Dieter; Schneider, Andre			Dual Targeting of a tRNA(Asp) Requires Two Different Aspartyl-tRNA Synthetases in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; LEISHMANIA-TARENTOLAE; EVOLUTIONARY HISTORY; GENETIC-CODE; MITOCHONDRIAL; ANTICODON; IMPORT; SYSTEM; BIOGENESIS	The mitochondrion of the parasitic protozoon Trypanosoma brucei does not encode any tRNAs. This deficiency is compensated for by partial import of nearly all of its cytosolic tRNAs. Most trypanosomal aminoacyl-tRNA synthetases are encoded by single copy genes, suggesting the use of the same enzyme in the cytosol and in the mitochondrion. However, the T. brucei genome encodes two distinct genes for eukaryotic aspartyl-tRNA synthetase (AspRS), although the cell has a single tRNA(Asp) isoacceptor only. Phylogenetic analysis showed that the two T. brucei AspRSs evolved from a duplication early in kinetoplastid evolution and also revealed that eight other major duplications of AspRS occurred in the eukaryotic domain. RNA interference analysis established that both Tb-AspRS1 and Tb-AspRS2 are essential for growth and required for cytosolic and mitochondrial Asp-tRNA(Asp) formation, respectively. In vitro charging assays demonstrated that the mitochondrial Tb-AspRS2 aminoacylates both cytosolic and mitochondrial tRNA(Asp), whereas the cytosolic Tb-AspRS1 selectively recognizes cytosolic but not mitochondrial tRNA(Asp). This indicates that cytosolic and mitochondrial tRNA(Asp), although derived from the same nuclear gene, are physically different, most likely due to a mitochondria-specific nucleotide modification. Mitochondrial Tb-AspRS2 defines a novel group of eukaryotic AspRSs with an expanded substrate specificity that are restricted to trypanosomatids and therefore may be exploited as a novel drug target.	[Charriere, Fabien; Cristodero, Marina; Horn, Elke K.; Schneider, Andre] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [O'Donoghue, Patrick; Helgadottir, Sunna; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [O'Donoghue, Patrick; Helgadottir, Sunna; Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Marechal-Drouard, Laurence] Univ Strasbourg, Unite Propre Rech 2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Marechal-Drouard, Laurence] Univ Strasbourg, CNRS, F-67084 Strasbourg, France	University of Bern; Yale University; Yale University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schneider, A (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	andre.schneider@ibc.unibe.ch	Drouard, Laurence/D-2385-2010; Cristodero, Marina/AAK-5703-2021; Cristodero, Marina/AAC-8824-2022	Drouard, Laurence/0000-0001-6537-524X; O'Donoghue, Patrick/0000-0002-9500-8640	Swiss National Foundation [3100A0_121937]; VELUX Foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); VELUX Foundation(Velux Fonden)	This work was supported by Swiss National Foundation Grant 3100A0_121937 (to A. S.) and by a grant from the VELUX Foundation (to F.C.).	Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Bhattacharyya Suvendra Nath, 2004, RNA Biol, V1, P84, DOI 10.4161/rna.1.2.1180; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; CHATTON B, 1988, J BIOL CHEM, V263, P52; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; Dorner M, 2001, MOL BIOL CELL, V12, P2688, DOI 10.1091/mbc.12.9.2688; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; Dutta Shuchismita, 2008, V426, P81, DOI 10.1007/978-1-60327-058-8_5; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Feagin JE, 2000, INT J PARASITOL, V30, P371, DOI 10.1016/S0020-7519(99)00190-3; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Horvath A, 2002, J BIOL CHEM, V277, P7222, DOI 10.1074/jbc.M109715200; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; O'Donoghue P, 2005, P NATL ACAD SCI USA, V102, P19003, DOI 10.1073/pnas.0509617102; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Rinehart J, 2005, GENE DEV, V19, P583, DOI 10.1101/gad.1269305; Rinehart J, 2004, J BIOL CHEM, V279, P1161, DOI 10.1074/jbc.M310100200; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Sauter C, 2000, J MOL BIOL, V299, P1313, DOI 10.1006/jmbi.2000.3791; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; SCHNEIDER A, 1994, NUCLEIC ACIDS RES, V22, P3699, DOI 10.1093/nar/22.18.3699; Schneider A, 2001, TRENDS GENET, V17, P557, DOI 10.1016/S0168-9525(01)02439-8; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Schneider Andre, 2007, Methods Mol Biol, V372, P379, DOI 10.1007/978-1-59745-365-3_27; Shen N, 2006, NUCLEIC ACIDS RES, V34, P3246, DOI 10.1093/nar/gkl441; Sheppard K, 2008, J MOL BIOL, V377, P831, DOI 10.1016/j.jmb.2008.01.016; Small I, 1998, PLANT MOL BIOL, V38, P265, DOI 10.1023/A:1006081903354; van der Giezen M, 2005, INT REV CYTOL, V244, P175, DOI 10.1016/S0074-7696(05)44005-X; VASSELLA E, 1994, NUCLEIC ACIDS RES, V22, P1359, DOI 10.1093/nar/22.8.1359; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100	45	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16210	16217		10.1074/jbc.M109.005348	http://dx.doi.org/10.1074/jbc.M109.005348			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386587	hybrid, Green Published			2022-12-27	WOS:000266730900018
J	Yalcin, A; Clem, BF; Simmons, A; Lane, A; Nelson, K; Clem, AL; Brock, E; Siow, D; Wattenberg, B; Telang, S; Chesney, J				Yalcin, Abdullah; Clem, Brian F.; Simmons, Alan; Lane, Andrew; Nelson, Kristin; Clem, Amy L.; Brock, Erin; Siow, Deanna; Wattenberg, Binks; Telang, Sucheta; Chesney, Jason			Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; FRUCTOSE 2,6-BISPHOSPHATE; LIVER 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; CARBOHYDRATE-METABOLISM; BISPHOSPHATASE REACTION; INHIBITOR P27; P27(KIP1); CANCER; PHOSPHORYLATION; DEGRADATION	The regulation of metabolism and growth must be tightly coupled to guarantee the efficient use of energy and anabolic substrates throughout the cell cycle. Fructose 2,6-bisphosphate (Fru-2,6-BP) is an allosteric activator of 6-phosphofructo-1-kinase (PFK-1), a rate-limiting enzyme and essential control point in glycolysis. The concentration of Fru-2,6-BP in mammalian cells is set by four 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFKFB1-4), which interconvert fructose 6-phosphate and Fru-2,6-BP. The relative functions of the PFKFB3 and PFKFB4 enzymes are of particular interest because they are activated in human cancers and increased by mitogens and low oxygen. We examined the cellular localization of PFKFB3 and PFKFB4 and unexpectedly found that whereas PFKFB4 localized to the cytoplasm (i.e. the site of glycolysis), PFKFB3 localized to the nucleus. We then overexpressed PFKFB3 and observed no change in glucose metabolism but rather a marked increase in cell proliferation. These effects on proliferation were completely abrogated by mutating either the active site or nuclear localization residues of PFKFB3, demonstrating a requirement for nuclear delivery of Fru-2,6-BP. Using protein array analyses, we then found that ectopic expression of PFKFB3 increased the expression of several key cell cycle proteins, including cyclin-dependent kinase (Cdk)-1, Cdc25C, and cyclinD3 and decreased the expression of the cell cycle inhibitor p27, a universal inhibitor of Cdk-1 and the cell cycle. We also observed that the addition of Fru-2,6-BP to HeLa cell lysates increased the phosphorylation of the Cdk-specific Thr-187 site of p27. Taken together, these observations demonstrate an unexpected role for PFKFB3 in nuclear signaling and indicate that Fru-2,6-BP may couple the activation of glucose metabolism with cell proliferation.	[Yalcin, Abdullah; Clem, Brian F.; Simmons, Alan; Lane, Andrew; Nelson, Kristin; Clem, Amy L.; Brock, Erin; Siow, Deanna; Wattenberg, Binks; Telang, Sucheta; Chesney, Jason] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Grp, Div Med Oncol, Louisville, KY 40202 USA; [Yalcin, Abdullah] Uludag Univ, Sch Vet Med, Dept Biochem, TR-16059 Bursa, Turkey	University of Louisville; Uludag University	Chesney, J (corresponding author), 580 S Preston St,204E, Louisville, KY 40202 USA.	jason.chesney@louisville.edu	Yalcin, Abdullah/ABI-4164-2020; Yalcin, Abdullah/AAA-6938-2022	Yalcin, Abdullah/0000-0001-8519-8375; 	National Institutes of Health [1 R01 CA11642801]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R01 CA11642801 (to J. C.).	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; ARGAUD D, 1995, J BIOL CHEM, V270, P24229, DOI 10.1074/jbc.270.41.24229; Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Atsumi T, 2002, CANCER RES, V62, P5881; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; Bohnsack BL, 2004, ANNU REV NUTR, V24, P433, DOI 10.1146/annurev.nutr.23.011702.073203; Borriello A, 2007, CELL CYCLE, V6, P1053, DOI 10.4161/cc.6.9.4142; Bruni P, 1999, EUR J BIOCHEM, V259, P756, DOI 10.1046/j.1432-1327.1999.00104.x; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; CHIU RW, 1975, J BIOL CHEM, V250, P7951; DalSanto P, 1996, J CELL SCI, V109, P1919; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; EREMENKO T, 1975, EUR J BIOCHEM, V52, P203, DOI 10.1111/j.1432-1033.1975.tb03988.x; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Hamilton JA, 1997, MOL ENDOCRINOL, V11, P490, DOI 10.1210/me.11.4.490; Han HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1058, DOI 10.1152/ajpcell.00063.2004; HUE L, 1993, ADV ENZYME REGUL, V33, P97; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kessler R, 2001, MOL BRAIN RES, V87, P190, DOI 10.1016/S0169-328X(01)00014-6; Kim SG, 2006, J BIOL CHEM, V281, P2939, DOI 10.1074/jbc.M511019200; LANE A, 2007, BIOPHYSICAL TOOLS BI; Lane AN, 2008, METHOD CELL BIOL, V84, P541, DOI 10.1016/S0091-679X(07)84018-0; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; McAndrew CW, 2007, CELL CYCLE, V6, P1937, DOI 10.4161/cc.6.15.4520; Michels PAM, 2006, IUBMB LIFE, V58, P133, DOI 10.1080/15216540600688280; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakagawa Hiroshi, 2007, Methods Mol Biol, V371, P167; Newcomb LL, 2003, EUKARYOT CELL, V2, P143, DOI 10.1128/EC.2.1.143-149.2003; Nguyen H, 1999, MOL CELL BIOL, V19, P1190; Okar DA, 1999, BIOCHEMISTRY-US, V38, P4471, DOI 10.1021/bi9828728; Okar DA, 2000, BIOCHEMISTRY-US, V39, P9754, DOI 10.1021/bi000815k; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Ramaiah A, 1974, Curr Top Cell Regul, V8, P297; Riera L, 2003, FEBS LETT, V550, P23, DOI 10.1016/S0014-5793(03)00808-1; Riera L, 2002, BBA-MOL CELL RES, V1589, P89, DOI 10.1016/S0167-4889(02)00169-6; Sakakibara R, 1997, J BIOCHEM-TOKYO, V122, P122; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Smith WE, 2007, MOL ENDOCRINOL, V21, P1478, DOI 10.1210/me.2006-0356; STANISZ J, 1983, J CELL PHYSIOL, V115, P320, DOI 10.1002/jcp.1041150316; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P263, DOI 10.1042/bj1920263; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang Q, 2008, CELL DEATH DIFFER, V15, P908, DOI 10.1038/cdd.2008.2; Watanabe F, 1999, FEBS LETT, V458, P304, DOI 10.1016/S0014-5793(99)01174-6; Watanabe F, 1997, J NEUROCHEM, V69, P1; WAYBILL MM, 1991, AM J PHYSIOL, V261, pE49, DOI 10.1152/ajpendo.1991.261.1.E49; Wu CD, 2006, ADV ENZYME REGUL, V46, P72, DOI 10.1016/j.advenzreg.2006.01.010; WU R, 1959, J BIOL CHEM, V234, P1036; Zhu XH, 2004, MOL CELL BIOL, V24, P6058, DOI 10.1128/MCB.24.13.6058-6066.2004	70	148	158	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24223	24232		10.1074/jbc.M109.016816	http://dx.doi.org/10.1074/jbc.M109.016816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19473963	Green Published, hybrid			2022-12-27	WOS:000269380200036
J	Corcoran, CA; Montalbano, J; Sun, H; He, Q; Huang, Y; Sheikh, MS				Corcoran, Chad A.; Montalbano, JoAnne; Sun, Hong; He, Qin; Huang, Ying; Sheikh, M. Saeed			Identification and Characterization of Two Novel Isoforms of Pirh2 Ubiquitin Ligase That Negatively Regulate p53 Independent of RING Finger Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARF TUMOR-SUPPRESSOR; PROTEIN LIGASE; MDM2 GENE; P53-MEDIATED TRANSCRIPTION; HUMAN CANCER; E3; DEGRADATION; EXPRESSION; PROMOTER; PUMA	Pirh2 is a newly identified E3 ubiquitin ligase known to inhibit tumor suppressor p53 function via ubiquitination and proteasomal degradation. We have identified two novel Pirh2 splice variants that encode different Pirh2 isoforms and named these Pirh2B and Pirh2C. Accordingly, the full-length protein is now classified as isoform Pirh2A. The central region of Pirh2 harbors a RING finger domain that is critical for its ubiquitin ligase function. The Pirh2B isoform lacks amino acids 171-179, whereas Pirh2C is missing C-terminal amino acids 180-261, which for each isoform results in a RING domain deletion and the abrogation of ubiquitin ligase activity. Our findings further indicate that the Pirh2B isoform but not the Pirh2C isoform is capable of binding to Pirh2A, suggesting that the C-terminal region absent in Pirh2C is critical for Pirh2-Pirh2 interactions. Similar to Pirh2A, both Pirh2B and Pirh2C interact with p53; however, interactions between p53 and Pirh2B appear stronger than those between p53 and Pirh2C. Interestingly, although both Pirh2B and Pirh2C are not able to promote in vitro p53 ubiquitination, both are capable of negatively regulating p53 protein stability and promoting the intracellular ubiquitination of p53. Furthermore, like Pirh2A, both isoforms are able to inhibit p53 transcriptional activity. We have also for the first time demonstrated that Pirh2A as well as the novel isoforms also interact directly with MDM2 within a region encompassing MDM2 acidic and zinc finger domains. It is therefore possible that Pirh2A and the novel Pirh2 isoforms identified in this study may also modulate p53 function by engaging MDM2.	[Corcoran, Chad A.; Montalbano, JoAnne; Sun, Hong; He, Qin; Huang, Ying; Sheikh, M. Saeed] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Sheikh, MS (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.	sheikhm@upstate.edu			National Institutes of Health [ES014489, ES005633, CA113868]; NATIONAL CANCER INSTITUTE [R21CA113868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES005633, R21ES014489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES014489 and ES005633 (to M. S. S.) and CA113868 (to Y. H.).	BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Bartel F, 2002, CANCER CELL, V2, P9, DOI 10.1016/S1535-6108(02)00091-0; Bartel F, 2004, MOL CANCER RES, V2, P29; Beitel LK, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290041; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cheng TH, 2007, MOL CELL BIOL, V27, P111, DOI 10.1128/MCB.00235-06; Corcoran CA, 2005, ONCOGENE, V24, P1634, DOI 10.1038/sj.onc.1208353; Corcoran CA, 2004, CANCER BIOL THER, V3, P721, DOI 10.4161/cbt.3.8.1068; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Duan WR, 2004, JNCI-J NATL CANCER I, V96, P1718, DOI 10.1093/jnci/djh292; Erster S, 2005, BIOCHEM BIOPH RES CO, V331, P843, DOI 10.1016/j.bbrc.2005.03.187; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; JUVEN T, 1993, ONCOGENE, V8, P3411; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Logan IR, 2004, J BIOL CHEM, V279, P11696, DOI 10.1074/jbc.M312712200; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Montes de Oca LR, 1995, NATURE, V378, P203; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Perfettini JL, 2004, NAT CELL BIOL, V6, P386, DOI 10.1038/ncb0504-386; Pozzoli U, 2005, CELL MOL LIFE SCI, V62, P1579, DOI 10.1007/s00018-005-5030-6; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Schuster K, 2007, MOL CANCER RES, V5, P403, DOI 10.1158/1541-7786.MCR-06-0146; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Sigalas I, 1996, NAT MED, V2, P912, DOI 10.1038/nm0896-912; Singh RK, 2007, J BIOL CHEM, V282, P10901, DOI 10.1074/jbc.M610879200; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang WG, 2003, CANCER BIOL THER, V2, P196, DOI 10.4161/cbt.2.2.347; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yang W, 2007, CANCER BIOL THER, V6, P1676, DOI 10.4161/cbt.6.11.4939; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zheng G, 2007, BIOCHEM BIOPH RES CO, V364, P344, DOI 10.1016/j.bbrc.2007.10.003	57	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21955	21970		10.1074/jbc.M109.024232	http://dx.doi.org/10.1074/jbc.M109.024232			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19483087	Green Published, hybrid			2022-12-27	WOS:000268783700020
J	Turner, JD; Langley, RS; Johnston, KL; Gentil, K; Ford, L; Wu, B; Graham, M; Sharpley, F; Slatko, B; Pearlman, E; Taylor, MJ				Turner, Joseph D.; Langley, R. Stuart; Johnston, Kelly L.; Gentil, Katrin; Ford, Louise; Wu, Bo; Graham, Maia; Sharpley, Faye; Slatko, Barton; Pearlman, Eric; Taylor, Mark J.			Wolbachia Lipoprotein Stimulates Innate and Adaptive Immunity through Toll-like Receptors 2 and 6 to Induce Disease Manifestations of Filariasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN; WUCHERERIA-BANCROFTI INFECTION; ONCHOCERCIASIS RIVER-BLINDNESS; HUMAN ENDOTHELIAL-CELLS; DENDRITIC CELLS; LYMPHATIC FILARIASIS; BRUGIA-MALAYI; DIACYLATED LIPOPEPTIDES; BACTERIAL ENDOSYMBIONTS; INDUCED KERATITIS	Wolbachia endosymbiotic bacteria have been implicated in the inflammatory pathogenesis of filariasis. Inflammation induced by Brugia malayi female worm extract (BMFE) is dependent on Toll-like receptors 2 and 6 (TLR2/6) with only a partial requirement for TLR1. Removal of Wolbachia, lipids, or proteins eliminates all inflammatory activity. Wolbachia bacteria contain the lipoprotein biosynthesis genes Ltg and LspA but not Lnt, suggesting Wolbachia proteins cannot be triacylated, accounting for recognition by TLR2/6. Lipoprotein databases revealed 3-11 potential lipoproteins from Wolbachia. Peptidoglycan-associated lipoprotein (PAL) and Type IV secretion system-VirB6 were consistently predicted, and B. malayi Wolbachia PAL (wBmPAL) was selected for functional characterization. Diacylated 20-mer peptides of wBmPAL (Diacyl Wolbachia lipopeptide (Diacyl WoLP)) showed a near identical TLR2/6 and TLR2/1 usage compared with BMFE and bound directly to TLR2. Diacyl WoLP induced systemic tumor necrosis factor-alpha and neutrophil-mediated keratitis in mice. Diacyl WoLP activated monocytes induce up-regulation of gp38 on human lymphatic endothelial cells and induced dendritic cell maturation and activation. Dendritic cells primed with BMFE generated a non-polarized Th1/Th2 CD4(+) T cell profile, whereas priming with Wolbachia depleted extracts (following tetracycline treatment; BMFEtet) polarized to a Th2 profile that could be reversed by reconstitution with Diacyl WoLP. BMFE generated IgG1 and IgG2c antibody responses, whereas BMFEtet or inoculation of TLR2 or MyD88(-/-) mice produced defective IgG2c responses. Thus, in addition to innate inflammatory activation, Wolbachia lipoproteins drive interferon-gamma-dependent CD4(+) T cell polarization and antibody switching.	[Turner, Joseph D.; Langley, R. Stuart; Johnston, Kelly L.; Ford, Louise; Graham, Maia; Sharpley, Faye; Taylor, Mark J.] Univ Liverpool, Liverpool Sch Trop Med, Filariasis Res Lab, Liverpool L3 5QA, Merseyside, England; [Gentil, Katrin; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA; [Wu, Bo; Slatko, Barton] New England Biolabs Inc, Ipswich, MA 01938 USA	Liverpool School of Tropical Medicine; University of Liverpool; Case Western Reserve University; New England Biolabs	Taylor, MJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Filariasis Res Lab, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	mark.taylor@liverpool.ac.uk		Ford, Louise/0000-0001-7919-2866; Turner, Joseph/0000-0002-2185-5476; Taylor, Mark/0000-0003-3396-9275	Wellcome Trust; Bill and Melinda Gates Foundation; German Research Foundation [DA1024/1-1]; National Institutes of Health [EY10320, EY11373]; Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [P30EY011373, R01EY010320] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); German Research Foundation(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Wellcome Trust for Senior Fellowship support (to M. T., J. T., S. L., and K. J.), by the Bill and Melinda Gates Foundation for A-WOL consortium support (to M. T., K. J., L. F., B. W., and B. S.), and by Grant DA1024/1-1 from the German Research Foundation (to K. G.). This work was also supported, in whole or in part, by National Institutes of Health Grant EY10320 (to E. P.) and EY11373 (to E. P.) and by the Research to Prevent Blindness Foundation and the Ohio Lions Eye Research Foundation (to E. P.).	Al-Rawi MAA, 2005, INT J ONCOL, V27, P721; Babu S, 2005, J IMMUNOL, V175, P1170, DOI 10.4049/jimmunol.175.2.1170; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brattig NW, 2000, MICROBES INFECT, V2, P1147, DOI 10.1016/S1286-4579(00)01269-7; Brattig NW, 2004, J IMMUNOL, V173, P437, DOI 10.4049/jimmunol.173.1.437; Brattig NW, 2001, MICROBES INFECT, V3, P439, DOI 10.1016/S1286-4579(01)01399-5; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cross HF, 2001, LANCET, V358, P1873, DOI 10.1016/S0140-6736(01)06899-4; Daehnel K, 2007, PARASITE IMMUNOL, V29, P455, DOI 10.1111/j.1365-3024.2007.00962.x; Debrah AY, 2007, AM J TROP MED HYG, V77, P601, DOI 10.4269/ajtmh.2007.77.601; Debrah AY, 2006, PLOS PATHOG, V2, P829, DOI 10.1371/journal.ppat.0020092; Dreyer G, 2000, PARASITOL TODAY, V16, P544, DOI 10.1016/S0169-4758(00)01778-6; Esterre P, 2005, PARASITE IMMUNOL, V27, P9, DOI 10.1111/j.1365-3024.2005.00732.x; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Gillette-Ferguson I, 2006, INFECT IMMUN, V74, P2442, DOI 10.1128/IAI.74.4.2442-2445.2006; Gillette-Ferguson I, 2004, INFECT IMMUN, V72, P5687, DOI 10.1128/IAI.72.10.5687-5692.2004; Gillette-Ferguson I, 2007, INFECT IMMUN, V75, P5908, DOI 10.1128/IAI.00991-07; Groger M, 2004, J IMMUNOL, V173, P7161, DOI 10.4049/jimmunol.173.12.7161; Hellman J, 2002, J BIOL CHEM, V277, P14274, DOI 10.1074/jbc.M109696200; Hise AG, 2007, J IMMUNOL, V178, P1068, DOI 10.4049/jimmunol.178.2.1068; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hoerauf A, 2005, PARASITE IMMUNOL, V27, P417, DOI 10.1111/j.1365-3024.2005.00792.x; Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jenkins SJ, 2005, INFECT IMMUN, V73, P395, DOI 10.1128/IAI.73.1.395-402.2005; Jiang HR, 2006, J IMMUNOL, V177, P4288, DOI 10.4049/jimmunol.177.7.4288; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kaneko M, 2004, J BIOL CHEM, V279, P38838, DOI 10.1074/jbc.M407210200; Keiser PB, 2002, J INFECT DIS, V185, P805, DOI 10.1086/339344; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Korten S, 2008, MICROBES INFECT, V10, P313, DOI 10.1016/j.micinf.2007.12.004; Liang MD, 2005, J INFECT DIS, V191, P939, DOI 10.1086/427815; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Molyneux DH, 2003, TRENDS PARASITOL, V19, P516, DOI 10.1016/j.pt.2003.09.004; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Punkosdy GA, 2003, INFECT IMMUN, V71, P5104, DOI 10.1128/IAI.71.9.5104-5114.2003; Saint Andre AV, 2002, SCIENCE, V295, P1892, DOI 10.1126/science.1068732; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Semnani RT, 2006, INFECT IMMUN, V74, P4409, DOI 10.1128/IAI.01106-05; Sher A, 2003, CURR OPIN IMMUNOL, V15, P421, DOI 10.1016/S0952-7915(03)00072-4; Suba N, 2007, EXP PARASITOL, V116, P291, DOI 10.1016/j.exppara.2006.12.006; Supali T, 2008, CLIN INFECT DIS, V46, P1385, DOI 10.1086/586753; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Taylor MJ, 2000, J EXP MED, V191, P1429, DOI 10.1084/jem.191.8.1429; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Turner JD, 2006, CLIN INFECT DIS, V42, P1081, DOI 10.1086/501351; Turner JD, 2006, J IMMUNOL, V177, P1240, DOI 10.4049/jimmunol.177.2.1240; Vasselon T, 2004, J IMMUNOL, V173, P7401, DOI 10.4049/jimmunol.173.12.7401; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; Zhu XS, 2007, CRIT CARE MED, V35, P886, DOI 10.1097/01.CCM.0000256723.37586.A2	57	105	105	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22364	22378		10.1074/jbc.M901528200	http://dx.doi.org/10.1074/jbc.M901528200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19458089	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000268783700059
J	Bartos, M; Price, KL; Lummis, SCR; Bouzat, C				Bartos, Mariana; Price, Kerry L.; Lummis, Sarah C. R.; Bouzat, Cecilia			Glutamine 57 at the Complementary Binding Site Face Is a Key Determinant of Morantel Selectivity for alpha 7 Nicotinic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP RECEPTORS; ACETYLCHOLINE-RECEPTORS; LIGAND-BINDING; GATING KINETICS; CHANNEL; MUSCLE; DOMAIN; AGONIST; DESENSITIZATION; LEVAMISOLE	Nicotinic receptors (AChRs) play key roles in synaptic transmission. We explored activation of neuronal alpha 7 and mammalian muscle AChRs by morantel and oxantel. Our results revealed a novel action of morantel as a high efficacy and more potent agonist than ACh of alpha 7 receptors. The EC50 for activation by morantel of both alpha 7 and alpha 7-5HT(3A) receptors is 7-fold lower than that determined for ACh. The minimum morantel concentration required to activate alpha 7-5HT(3A) channels is 6-fold lower than that of ACh, and activation episodes are more prolonged than in the presence of ACh. By contrast, oxantel is a weak agonist of alpha 7 and alpha 7-5HT(3A), and both drugs are very low efficacy agonists of muscle AChRs. The replacement of Gln(57) in alpha 7 by glycine, which is found in the equivalent position of the muscle AChR, decreases the efficacy for activation and turns morantel into a partial agonist. The reverse mutation in the muscle AChR (epsilon G57Q) increases 7-fold the efficacy of morantel. The mutations do not affect activation by ACh or oxantel, indicating that this position is selective for morantel. In silico studies show that the tetrahydropyrimidinyl group, common to both drugs, is close to Trp(149) of the principal face of the binding site, whereas the other cyclic group is proximal to Gln(57) of the complementary face in morantel but not in oxantel. Thus, position 57 at the complementary face is a key determinant of the high selectivity of morantel for alpha 7. These results provide new information for further progress in drug design.	[Bartos, Mariana; Bouzat, Cecilia] UNS CONICET, Inst Invest Bioquim, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Price, Kerry L.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Cambridge	Bouzat, C (corresponding author), UNS CONICET, Inst Invest Bioquim, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	inbouzat@criba.edu.ar		Price, Kerry/0000-0002-5563-4567	Universidad Nacional del Sur; Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Loreal-United Nations Educational, Scientific, and Cultural Organization; Fundacion F. Fiorini; Wellcome Trust	Universidad Nacional del Sur; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Loreal-United Nations Educational, Scientific, and Cultural Organization; Fundacion F. Fiorini; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by grants from the Universidad Nacional del Sur, Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Loreal-United Nations Educational, Scientific, and Cultural Organization, Fundacion F. Fiorini (to C. B.), and the Wellcome Trust (to K. P. and S. C. R. L.).	Bartos M, 2006, MOL PHARMACOL, V70, P1307, DOI 10.1124/mol.106.026336; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2002, BIOPHYS J, V82, P1920, DOI 10.1016/S0006-3495(02)75541-0; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Changeux JP, 2008, TRENDS MOL MED, V14, P93, DOI 10.1016/j.molmed.2008.01.001; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Levandoski MM, 2003, EUR J PHARMACOL, V471, P9, DOI 10.1016/S0014-2999(03)01796-5; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martin RJ, 1997, VET J, V154, P11, DOI 10.1016/S1090-0233(05)80005-X; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; Rayes D, 2004, J BIOL CHEM, V279, P36372, DOI 10.1074/jbc.M403096200; Rayes D, 2001, NEUROPHARMACOLOGY, V41, P238, DOI 10.1016/S0028-3908(01)00057-0; Rayes D, 2007, MOL PHARMACOL, V71, P1407, DOI 10.1124/mol.106.033514; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shimomura M, 2002, BRIT J PHARMACOL, V137, P162, DOI 10.1038/sj.bjp.0704848; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Spitzmaul G, 2001, MOL PHARMACOL, V60, P235, DOI 10.1124/mol.60.2.235; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Wu TY, 2008, MOL PHARMACOL, V74, P466, DOI 10.1124/mol.107.044388; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	36	16	16	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21478	21487		10.1074/jbc.M109.013797	http://dx.doi.org/10.1074/jbc.M109.013797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506073	hybrid, Green Published			2022-12-27	WOS:000268564400042
J	Daddaoua, A; Krell, T; Ramos, JL				Daddaoua, Abdelali; Krell, Tino; Ramos, Juan-Luis			Regulation of Glucose Metabolism in Pseudomonas THE PHOSPHORYLATIVE BRANCH AND ENTNER-DOUDOROFF ENZYMES ARE REGULATED BY A REPRESSOR CONTAINING A SUGAR ISOMERASE DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; PV. TOMATO DC3000; CARBOHYDRATE CATABOLISM; PUTIDA; AERUGINOSA; PATHWAYS; PROTEIN; GENES; MULTIDRUG; CLONING	In Pseudomonas putida, genes for the glucose phosphorylative pathway and the Entner-Doudoroff pathway are organized in two operons; one made up of the zwf, pgl, and eda genes and another consisting of the edd, glk, gltR2, and gltS genes. Divergently with respect to the edd gene is the gap-1 gene. Expression from P-zwf, P-edd, and P-gap is modulated by HexR in response to the availability of glucose in the medium. To study the regulatory process in greater detail we purified HexR and showed that it is a monomer in solution. Electrophoretic mobility shift assays and isothermal titration calorimetry assays were done showing that HexR recognizes the P-edd, P-zwf, and Pgap-1 promoters with affinity in the nanomolar range. DNA footprinting assays identified the binding site between +30 and +1at P-zwf, between +16 and +41 at P-edd, and between -6 and +18 at Pgap-1. Based on DNA sequence alignment of the target sites and isothermal titration calorimetry data, two monomers of HexR bind to a pseudopalindrome with a consensus sequence of 5'-TTGTN(7-8)ACAA-3'. Binding of the Entner-Doudoroff pathway intermediate 2-keto-3-deoxy-6-phosphogluconate to HexR released the repressor from its target operators, whereas other chemicals such as glucose, glucose 6-phosphate, and 6-phosphogluconate did not induce complex dissociation. The phosphorylated effector is likely to be recognized by a sugar isomerase domain located at the C-terminal end of HexR, whereas the helix-turn-helix DNA binding domain of HexR exhibits high similarity to proteins of the RpiR family of regulators.	[Daddaoua, Abdelali; Krell, Tino; Ramos, Juan-Luis] Consejo Super Invest Cient, Environm Protect Dept, Estn Expt Zaidin, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Ramos, JL (corresponding author), Consejo Super Invest Cient, Environm Protect Dept, Estn Expt Zaidin, C Prof Albareda 1, E-18008 Granada, Spain.	juanluis.ramos@eez.csic.es	Daddaoua, Abdelali/D-6930-2014; Krell, Tino/G-7296-2015	Krell, Tino/0000-0002-9040-3166; Daddaoua, Abdelali/0000-0002-7348-6393; Ramos, Juan L./0000-0002-8731-7435	Ministerio de Investigacion y Ciencia of Spain [BIO-2006-05668]	Ministerio de Investigacion y Ciencia of Spain	This work was supported by Grant BIO-2006-05668 from the Ministerio de Investigacion y Ciencia of Spain.	ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Bateman A, 1999, TRENDS BIOCHEM SCI, V24, P94, DOI 10.1016/S0968-0004(99)01357-2; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Bucio MI, 1999, IMMUNOL INVEST, V28, P257, DOI 10.3109/08820139909060860; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; CUSKEY SM, 1985, J BACTERIOL, V162, P865, DOI 10.1128/JB.162.3.865-871.1985; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; del Castillo T, 2007, J BACTERIOL, V189, P6602, DOI 10.1128/JB.00679-07; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; DETHEUX M, 1993, FEBS LETT, V321, P111, DOI 10.1016/0014-5793(93)80089-D; Duque E, 2007, PSEUDOMONAS, VV, P227; ENTNER N, 1952, J BIOL CHEM, V196, P853; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Fillet S, 2009, J BACTERIOL, V191, P1901, DOI 10.1128/JB.01504-08; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Hager PW, 2000, J BACTERIOL, V182, P3934, DOI 10.1128/JB.182.14.3934-3941.2000; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; HOEY T, 2001, CURR PROTOC MOL BIOL, pCH16; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kim J, 2008, MICROBIOL-SGM, V154, P3905, DOI 10.1099/mic.0.2008/020362-0; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Llamas MA, 2003, J BACTERIOL, V185, P4707, DOI 10.1128/JB.185.16.4707-4716.2003; Ma JF, 1998, J BACTERIOL, V180, P1741, DOI 10.1128/JB.180.7.1741-1749.1998; MARQUES S, 1993, BIOCHIM BIOPHYS ACTA, V1216, P227, DOI 10.1016/0167-4781(93)90149-8; Mathew DC, 2008, J MOL EVOL, V66, P519, DOI 10.1007/s00239-008-9073-9; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Petruschka L, 2002, FEMS MICROBIOL LETT, V215, P89, DOI 10.1016/S0378-1097(02)00923-0; RALEIGH EA, 1989, GENETICS, V122, P279; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rojas A, 2003, J BACTERIOL, V185, P4755, DOI 10.1128/JB.185.16.4755-4763.2003; SARAVOLAC EG, 1991, J BACTERIOL, V173, P4970, DOI 10.1128/jb.173.16.4970-4976.1991; SASSE J, 2004, CURR PROTOC IMMUNOL, V8, P8; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Segura A, 2005, J BACTERIOL, V187, P5937, DOI 10.1128/JB.187.17.5937-5945.2005; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996; Stjepandic D, 2002, ENVIRON MICROBIOL, V4, P819, DOI 10.1046/j.1462-2920.2002.00313.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Taylor PL, 2008, J BIOL CHEM, V283, P2835, DOI 10.1074/jbc.M706163200; TEMPLE L, 1994, J BACTERIOL, V176, P4700, DOI 10.1128/JB.176.15.4700-4709.1994; Velazquez F, 2004, J BACTERIOL, V186, P8267, DOI 10.1128/JB.186.24.8267-8275.2004; Wheeler DL, 2004, NUCLEIC ACIDS RES, V32, pD35, DOI 10.1093/nar/gkh073; WHITING PH, 1976, J GEN MICROBIOL, V92, P304, DOI 10.1099/00221287-92-2-304; WYLIE JL, 1995, J BACTERIOL, V177, P3021, DOI 10.1128/jb.177.11.3021-3026.1995; Yamamoto H, 2001, J BACTERIOL, V183, P5110, DOI 10.1128/JB.183.17.5110-5121.2001	48	62	64	6	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21360	21368		10.1074/jbc.M109.014555	http://dx.doi.org/10.1074/jbc.M109.014555			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506074	hybrid, Green Published			2022-12-27	WOS:000268564400030
J	Dias, WB; Cheung, WD; Wang, ZH; Hart, GW				Dias, Wagner B.; Cheung, Win D.; Wang, Zihao; Hart, Gerald W.			Regulation of Calcium/Calmodulin-dependent Kinase IV by O-GlcNAc Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; PROTEIN-KINASE; NUCLEOCYTOPLASMIC PROTEINS; TETRATRICOPEPTIDE REPEATS; SIGNALING COMPLEX; POSTTRANSLATIONAL MODIFICATIONS; SUBSTRATE-SPECIFICITY; DYNAMIC GLYCOSYLATION; TRANSCRIPTION FACTOR; CYTOSOLIC PROTEINS	Similar to phosphorylation, GlcNAcylation (the addition of O-GlcNAc to Ser(Thr) residues on polypeptides) is an abundant, dynamic, and inducible post-translational modification. Glc-NAcylated proteins are crucial in regulating virtually all cellular processes, including signaling, cell cycle, and transcription. Here we show that calcium/calmodulin-dependent kinase IV (CaMKIV) is highly GlcNAcylated in vivo. In addition, we show that upon activation of HEK293 cells, hemagglutinin-tagged CaMKIV GlcNAcylation rapidly decreases, in a manner directly opposing its phosphorylation at Thr-200. Correspondingly, there is an increase in CaMKIV interaction with O-GlcNAcase during CaMKIV activation. Furthermore, we identify at least five sites of GlcNAcylation on CaMKIV. Using site-directed mutagenesis, we determine that the GlcNAcylation sites located in the active site of CaMKIV can modulate its phosphorylation at Thr-200 and its activity toward cAMP-response element-binding transcription factor. Our results strongly indicate that the O-GlcNAc modification participates in the regulation of CaMKIV activation and function, possibly coordinating nutritional signals with the immune and nervous systems. This is the first example of an O-GlcNAc/phosphate cycle involving O-GlcNAc transferase/kinase cross-talk.	[Dias, Wagner B.; Cheung, Win D.; Wang, Zihao; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Dias, Wagner/B-1401-2016	Hart, Gerald/0000-0001-7812-4351; Dias, Wagner/0000-0002-8378-8846	National Institutes of Health [CA42486, DK61671]; NHLBI [N01-HV-28180]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA42486 and DK61671 and Contract N01-HV-28180 from NHLBI. G. W. H. receives a share of royalty received by the University on sales of the CTD 110.6 antibody. Terms of this arrangement are managed by The Johns Hopkins University.	Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002; Anderson KA, 1998, BIOMETALS, V11, P331, DOI 10.1023/A:1009276932076; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Cohen PTW, 2002, J CELL SCI, V115, P241; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P17592; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; HANISSIAN SH, 1993, J BIOL CHEM, V268, P20055; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; Pan F, 2005, EMBO J, V24, P2104, DOI 10.1038/sj.emboj.7600685; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Raman V, 2001, J IMMUNOL, V167, P6270, DOI 10.4049/jimmunol.167.11.6270; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; REASON AJ, 1992, J BIOL CHEM, V267, P16911; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Tai HC, 2004, J AM CHEM SOC, V126, P10500, DOI 10.1021/ja047872b; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Wu LJ, 2008, EUR J NEUROSCI, V27, P1923, DOI 10.1111/j.1460-9568.2008.06183.x; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	68	104	111	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21327	21337		10.1074/jbc.M109.007310	http://dx.doi.org/10.1074/jbc.M109.007310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506079	Green Published, hybrid			2022-12-27	WOS:000268564400027
J	Genschel, J; Modrich, P				Genschel, Jochen; Modrich, Paul			Functions of MutL alpha, Replication Protein A (RPA), and HMGB1 in 5 '-Directed Mismatch Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMLH1 EXPRESSION; TUMOR-CELLS; EXCISION; SYSTEM; RECONSTITUTION; MECHANISMS; RESISTANCE; EXTRACTS; COMPLEX; INVITRO	A purified system comprised of MutS alpha, MutL alpha, exonuclease 1 (Exo1), and replication protein A(RPA)(in the absence or presence of HMGB1) supports 5'-directed mismatch-provoked excision that terminates after mismatch removal. MutL alpha is not essential for this reaction but enhances excision termination, although the basis of this effect has been uncertain. One model attributes the primary termination function in this system to RPA, with MutL alpha functioning in a secondary capacity by suppressing Exo1 hydrolysis of mismatch-free DNA (Genschel, J., and Modrich, P. (2003) Mol. Cell 12, 1077-1086). A second invokes MutL alpha as the primary effector of excision termination (Zhang, Y., Yuan, F., Presnell, S. R., Tian, K., Gao, Y., Tomkinson, A. E., Gu, L., and Li, G. M. (2005) Cell 122, 693-705). In the latter model, RPA provides a secondary termination function, but together with HMGB1, also participates in earlier steps of the reaction. To distinguish between these models, we have reanalyzed the functions of MutL alpha, RPA, and HMGB1 in 5'-directed mismatch-provoked excision using purified components as well as mammalian cell extracts. Analysis of extracts derived from A2780/AD cells, which are devoid of MutL alpha but nevertheless support 5'-directed mismatch repair, has demonstrated that 5'-directed excision terminates normally in the absence of MutL alpha. Experiments using purified components confirm a primary role for RPA in terminating excision by MutS alpha-activated Exo1 but are in consistent with direct participation of MutL alpha in this process. While HMGB1 attenuates excision by activated Exo1, this effect is distinct from that mediated by RPA. Assay of extracts derived from HMGB1(+/+) and HMGB1(-/) mouse embryo fibroblast cells indicates that HMGB1 is not essential for mismatch repair.	[Genschel, Jochen] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	modrich@biochem.duke.edu		Modrich, Paul/0000-0001-8708-9885	NIGMS [R01 GM45190]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant R01 GM45190 from the NIGMS.	Brown R, 1997, ONCOGENE, V15, P45, DOI 10.1038/sj.onc.1201167; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; CHALLBERG MD, 1979, P NATL ACAD SCI USA, V76, P655, DOI 10.1073/pnas.76.2.655; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; FANG WH, 1993, J BIOL CHEM, V268, P11838; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Genschel J, 2006, METHOD ENZYMOL, V408, P273, DOI 10.1016/S0076-6879(06)08017-7; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; McKinney K, 2002, MOL CELL BIOL, V22, P6797, DOI 10.1128/MCB.22.19.6797-6808.2002; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Pavlov YI, 2002, MOL CELL, V10, P207, DOI 10.1016/S1097-2765(02)00567-1; Strathdee G, 1999, ONCOGENE, V18, P2335, DOI 10.1038/sj.onc.1202540; SU SS, 1988, J BIOL CHEM, V263, P6829; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Tomer G, 2002, J BIOL CHEM, V277, P21801, DOI 10.1074/jbc.M111342200; Yuan FH, 2004, J BIOL CHEM, V279, P20935, DOI 10.1074/jbc.M401931200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	31	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21536	21544		10.1074/jbc.M109.021287	http://dx.doi.org/10.1074/jbc.M109.021287			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19515846	Green Published, hybrid			2022-12-27	WOS:000268564400048
J	Awai, T; Kimura, S; Tomikawa, C; Ochi, A; Ihsanawati; Bessho, Y; Yokoyama, S; Ohno, S; Nishikawa, K; Yokogawa, T; Suzuki, T; Hori, H				Awai, Takako; Kimura, Satoshi; Tomikawa, Chie; Ochi, Anna; Ihsanawati; Bessho, Yoshitaka; Yokoyama, Shigeyuki; Ohno, Satoshi; Nishikawa, Kazuya; Yokogawa, Takashi; Suzuki, Tsutomu; Hori, Hiroyuki			Aquifex aeolicus tRNA (N-2, N-2-Guanine)-dimethyltransferase (Trm1) Catalyzes Transfer of Methyl Groups Not Only to Guanine 26 but Also to Guanine 27 in tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; SACCHAROMYCES-CEREVISIAE; RECOGNITION MECHANISM; PYROCOCCUS-FURIOSUS; NUCLEOTIDE-SEQUENCE; ENZYMATIC FORMATION; IDENTITY ELEMENTS; CELL-GROWTH; METHYLTRANSFERASE; GENE	Transfer RNA (N-2, N-2-guanine)-dimethyltransferase (Trm1) catalyzes N-2, N-2-dimethylguanine formation at position 26 (m(2)(2)G26) in tRNA. In the reaction, N-2-guanine at position 26 (m(2)G26) is generated as an intermediate. The trm1 genes are found only in archaea and eukaryotes, although it has been reported that Aquifex aeolicus, a hyper-thermophilic eubacterium, has a putative trm1 gene. To confirm whether A. aeolicus Trm1 has tRNA methyltransferase activity, we purified recombinant Trm1 protein. In vitro methyl transfer assay revealed that the protein has a strong tRNA methyltransferase activity. We confirmed that this gene product is expressed in living A. aeolicus cells and that the enzymatic activity exists in cell extract. By preparing 22 tRNA transcripts and testing their methyl group acceptance activities, it was demonstrated that this Trm1 protein has a novel tRNA specificity. Mass spectrometry analysis revealed that it catalyzes methyl transfers not only to G26 but also to G27 in substrate tRNA. Furthermore, it was confirmed that native tRNA(Cys) has an m(2)(2)G26m(2)G27 or m(2)(2)G26m(2)(2)G27 sequence, demonstrating that these modifications occur in living cells. Kinetic studies reveal that the m(2)G26 formation is faster than the m(2)G27 formation and that disruption of the G27-C43 base pair accelerates velocity of the G27 modification. Moreover, we prepared an additional 22 mutant tRNA transcripts and clarified that the recognition sites exist in the T-arm structure. This long distance recognition results in multisite recognition by the enzyme.	[Awai, Takako; Tomikawa, Chie; Ochi, Anna; Hori, Hiroyuki] Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Matsuyama, Ehime 7908577, Japan; [Kimura, Satoshi; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Ihsanawati; Bessho, Yoshitaka; Yokoyama, Shigeyuki; Hori, Hiroyuki] RIKEN, Yokohama Inst, Syst & Struct Biol Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Bessho, Yoshitaka; Yokoyama, Shigeyuki] RIKEN, SPring Ctr 8, Harima Inst, Sayo, Hyogo 6795148, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Ohno, Satoshi; Nishikawa, Kazuya; Yokogawa, Takashi] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 5011193, Japan; [Hori, Hiroyuki] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan	Ehime University; University of Tokyo; RIKEN; RIKEN; University of Tokyo; Gifu University; Ehime University	Hori, H (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Hori, Hiroyuki/AAB-3911-2021; Bessho, Yoshitaka/K-7702-2012; Yokoyama, Shigeyuki/N-6911-2015; Suzuki, Tsutomu/J-1776-2015	Bessho, Yoshitaka/0000-0001-9297-7473; Yokoyama, Shigeyuki/0000-0003-3133-7338; Suzuki, Tsutomu/0000-0002-9731-1731; Kimura, Satoshi/0000-0003-3555-5877	Japan Society for the Promotion of Science Research Fellowship for Young Scientists [20-4827]; Ministry of Education, Science, Sports, and Culture of Japan [20034041, 19350087]	Japan Society for the Promotion of Science Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science Research Fellowship for Young Scientists 20-4827 ( to C. T.), Grant-in-aid for Science Research on Priority Areas 20034041 ( to H. H.), and Grant-in-aid for Science Research 19350087 ( to H. H.) from the Ministry of Education, Science, Sports, and Culture of Japan.	Armengaud J, 2004, J BIOL CHEM, V279, P37142, DOI 10.1074/jbc.M403845200; Auffinger P, 1998, MODIFICATION EDITING, P569; Auxilien S, 2007, J BIOL CHEM, V282, P18711, DOI 10.1074/jbc.M607459200; Bujnicki JM, 2002, J MOL MICROB BIOTECH, V4, P405; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Constantinesco F, 1999, NUCLEIC ACIDS RES, V27, P1308, DOI 10.1093/nar/27.5.1308; Constantinesco F, 1999, J MOL BIOL, V291, P375, DOI 10.1006/jmbi.1999.2976; Constantinesco F, 1998, NUCLEIC ACIDS RES, V26, P3753, DOI 10.1093/nar/26.16.3753; De Bie LGS, 2003, J BACTERIOL, V185, P3238, DOI 10.1128/JB.185.10.3238-3243.2003; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Droogmans L, 2003, NUCLEIC ACIDS RES, V31, P2148, DOI 10.1093/nar/gkg314; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; EDQVIST J, 1992, NUCLEIC ACIDS RES, V20, P6575, DOI 10.1093/nar/20.24.6575; EDQVIST J, 1994, BIOCHEMISTRY-US, V33, P9546, DOI 10.1021/bi00198a021; ELLIS SR, 1986, J BIOL CHEM, V261, P9703; Gabant G, 2006, NUCLEIC ACIDS RES, V34, P2483, DOI 10.1093/nar/gkl145; GARCIA GR, 1998, MODIFICATION EDITING, P555; GLICK JM, 1978, BIOCHIM BIOPHYS ACTA, V518, P158, DOI 10.1016/0005-2787(78)90125-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Griffiths E, 2006, INT J SYST EVOL MICR, V56, P99, DOI 10.1099/ijs.0.63927-0; Griffiths E, 2001, MICROBIOL-SGM, V147, P2611, DOI 10.1099/00221287-147-9-2611; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; Grosjean H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-470; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Hori H, 2003, J BIOL CHEM, V278, P25081, DOI 10.1074/jbc.M212577200; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; Ihsanawati, 2008, J MOL BIOL, V383, P871, DOI 10.1016/j.jmb.2008.08.068; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Ikeuchi Y, 2008, EMBO J, V27, P2194, DOI 10.1038/emboj.2008.154; JOHNSON GD, 1985, ARCH BIOCHEM BIOPHYS, V236, P448, DOI 10.1016/0003-9861(85)90647-2; KAMMEN HO, 1988, J BIOL CHEM, V263, P2255; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; KUCHINO Y, 1970, BIOCHEM BIOPH RES CO, V40, P306, DOI 10.1016/0006-291X(70)91010-7; Liu JM, 1999, GENE, V226, P73, DOI 10.1016/S0378-1119(98)00550-2; Liu JM, 2000, NUCLEIC ACIDS RES, V28, P3445, DOI 10.1093/nar/28.18.3445; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Niederberger C, 1999, FEBS LETT, V464, P67, DOI 10.1016/S0014-5793(99)01679-8; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Okamoto H, 2004, J BIOL CHEM, V279, P49151, DOI 10.1074/jbc.M408209200; PHILLIPS JH, 1967, J MOL BIOL, V26, P509, DOI 10.1016/0022-2836(67)90318-X; Pintard L, 2002, EMBO J, V21, P1811, DOI 10.1093/emboj/21.7.1811; Purushothaman SK, 2005, MOL CELL BIOL, V25, P4359, DOI 10.1128/MCB.25.11.4359-4370.2005; REINHART MP, 1986, NUCLEIC ACIDS RES, V14, P1131, DOI 10.1093/nar/14.3.1131; Roovers M, 2004, NUCLEIC ACIDS RES, V32, P465, DOI 10.1093/nar/gkh191; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Shigi N, 2006, J BIOL CHEM, V281, P14296, DOI 10.1074/jbc.M511675200; Shigi N, 2008, EMBO J, V27, P3267, DOI 10.1038/emboj.2008.246; STANGE N, 1987, EMBO J, V6, P2811, DOI 10.1002/j.1460-2075.1987.tb02577.x; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomikawa C, 2008, PROTEINS, V71, P1400, DOI 10.1002/prot.21827; Toyooka T, 2008, GENES CELLS, V13, P807, DOI 10.1111/j.1365-2443.2008.01207.x; TSURUI H, 1994, ANAL BIOCHEM, V221, P166, DOI 10.1006/abio.1994.1393; Urbonavicius J, 2006, J MOL BIOL, V357, P387, DOI 10.1016/j.jmb.2005.12.087; VANTOL H, 1987, EMBO J, V6, P35, DOI 10.1002/j.1460-2075.1987.tb04715.x; WATANABE K, 1976, BIOCHEM BIOPH RES CO, V72, P1137, DOI 10.1016/S0006-291X(76)80250-1	60	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20467	20478		10.1074/jbc.M109.020024	http://dx.doi.org/10.1074/jbc.M109.020024			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19491098	Green Published, hybrid			2022-12-27	WOS:000268316100008
J	Baumgartner, HK; Gerasimenko, JV; Thorne, C; Ferdek, P; Pozzan, T; Tepikin, AV; Petersen, OH; Sutton, R; Watson, AJM; Gerasimenko, OV				Baumgartner, Heidi K.; Gerasimenko, Julia V.; Thorne, Christopher; Ferdek, Pawel; Pozzan, Tullio; Tepikin, Alexei V.; Petersen, Ole H.; Sutton, Robert; Watson, Alastair J. M.; Gerasimenko, Oleg V.			Calcium Elevation in Mitochondria Is the Main Ca2+ Requirement for Mitochondrial Permeability Transition Pore (mPTP) Opening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; CYTOCHROME-C RELEASE; ENDOPLASMIC-RETICULUM; INOSITOL TRISPHOSPHATE; OXIDATIVE STRESS; INTRACELLULAR CA2+; INDUCED APOPTOSIS; AR42J CELLS; DEATH; INDUCTION	We have investigated in detail the role of intra-organelle Ca2+ content during induction of apoptosis by the oxidant menadione while changing and monitoring the Ca2+ load of endoplasmic reticulum (ER), mitochondria, and acidic organelles. Menadione causes production of reactive oxygen species, induction of oxidative stress, and subsequently apoptosis. In both pancreatic acinar and pancreatic tumor AR42J cells, menadione was found to induce repetitive cytosolic Ca2+ responses because of the release of Ca2+ from both ER and acidic stores. Ca2+ responses to menadione were accompanied by elevation of Ca2+ in mitochondria, mitochondrial depolarization, and mitochondrial permeability transition pore (mPTP) opening. Emptying of both the ER and acidic Ca2+ stores did not necessarily prevent menadione-induced apoptosis. High mitochondrial Ca2+ at the time of menadione application was the major factor determining cell fate. However, if mitochondria were prevented from loading with Ca2+ with 10 mu M RU360, then caspase-9 activation did not occur irrespective of the content of other Ca2+ stores. These results were confirmed by ratiometric measurements of intramitochondrial Ca2+ with pericam. We conclude that elevated Ca2+ in mitochondria is the crucial factor in determining whether cells undergo oxidative stress-induced apoptosis.	[Gerasimenko, Oleg V.] Univ Liverpool, Physiol Lab, MRC Secretory Control Res Grp, Sch Biomed Sci, Liverpool L69 3BX, Merseyside, England; [Baumgartner, Heidi K.; Watson, Alastair J. M.] Univ Liverpool, Sch Clin Sci, Div Gastroenterol, Liverpool L69 3BX, Merseyside, England; [Sutton, Robert] Univ Liverpool, Sch Canc Studies, Div Surg & Oncol, Liverpool L69 3BX, Merseyside, England; [Pozzan, Tullio] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Pozzan, Tullio] Univ Padua, CNR, Inst Neurosci, I-35121 Padua, Italy	University of Liverpool; University of Liverpool; University of Liverpool; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua	Gerasimenko, OV (corresponding author), Univ Liverpool, Physiol Lab, MRC Secretory Control Res Grp, Sch Biomed Sci, Crown St, Liverpool L69 3BX, Merseyside, England.	o.v.gerasimenko@liverpool.ac.uk	Gerasimenko, Julia/A-7688-2010; Gerasimenko, Oleg/A-6622-2010; Petersen, Ole H/E-8708-2010; Sutton, Robert/I-3587-2016	Gerasimenko, Oleg/0000-0003-2573-8258; Sutton, Robert/0000-0001-6600-562X; Petersen, Ole/0000-0002-6998-0380; Tepikin, Alexei/0000-0002-8172-7513; Gerasimenko, Julia/0000-0002-2262-2543	Medical Research Council (MRC) [G0300076, G8801575]; Wellcome Trust; MRC [G8801575, G9900432, G0700167, G0300076] Funding Source: UKRI; Medical Research Council [G0300076, G0700167, G9900432, G8801575] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council (MRC) Cooperative Grant G0300076 and MRC Programme Grant G8801575 and by a Wellcome Trust Prize Ph.D. studentship (to P. F.).	Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; BAUMGARTNER HK, 2007, AM J PHYSIOL-GASTR L, V307, pG296; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhatia M, 2000, J PATHOL, V190, P117; Bhatia M, 2004, AM J PHYSIOL-GASTR L, V286, pG189, DOI 10.1152/ajpgi.00304.2003; Bhatia M, 1998, BIOCHEM BIOPH RES CO, V246, P476, DOI 10.1006/bbrc.1998.8519; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Camello-Almaraz C, 2000, BIOCHEM BIOPH RES CO, V271, P311, DOI 10.1006/bbrc.2000.2633; Cao Y, 2007, AM J PATHOL, V170, P1521, DOI 10.2353/ajpath.2007.061149; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dolman NJ, 2005, J BIOL CHEM, V280, P15794, DOI 10.1074/jbc.M412694200; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Gerasimenko JV, 2006, J BIOL CHEM, V281, P40154, DOI 10.1074/jbc.M606402200; Gerasimenko JV, 2002, J CELL SCI, V115, P485; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Gerasimenko O, 2005, CELL CALCIUM, V38, P201, DOI 10.1016/j.ceca.2005.06.025; Gerasimenko OV, 2002, CELL CALCIUM, V32, P261, DOI 10.1016/S0143416002001938; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hahm KB, 1998, PANCREAS, V17, P153, DOI 10.1097/00006676-199808000-00007; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Huang Y, 1996, PEPTIDES, V17, P497, DOI 10.1016/0196-9781(96)00004-6; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Martinou JC, 2000, NAT CELL BIOL, V2, pE41, DOI 10.1038/35004069; MARUYAMA Y, 1994, CELL CALCIUM, V16, P419, DOI 10.1016/0143-4160(94)90035-3; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Parekh AB, 2000, P NATL ACAD SCI USA, V97, P12933, DOI 10.1073/pnas.97.24.12933; Petersen OH, 2001, TRENDS NEUROSCI, V24, P271, DOI 10.1016/S0166-2236(00)01787-2; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Putney JW, 2006, CURR BIOL, V16, pR812, DOI 10.1016/j.cub.2006.08.040; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Sata N, 1997, FREE RADICAL BIO MED, V23, P844, DOI 10.1016/S0891-5849(97)00064-6; SAXENA K, 1995, ARCH BIOCHEM BIOPHYS, V317, P79, DOI 10.1006/abbi.1995.1138; Schlattner U, 2001, J BIOL CHEM, V276, P48027, DOI 10.1074/jbc.M106524200; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Song JY, 2003, J BIOL CHEM, V278, P36676, DOI 10.1074/jbc.M303692200; Sweiry JH, 1996, SCAND J GASTROENTERO, V31, P10, DOI 10.3109/00365529609104992; Szabadkai G, 2004, FEBS LETT, V567, P111, DOI 10.1016/j.febslet.2004.04.059; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tian XM, 2005, MOL CELL BIOCHEM, V277, P33, DOI 10.1007/s11010-005-4818-x; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; WARD JB, 1995, LANCET, V346, P1016, DOI 10.1016/S0140-6736(95)91695-4	56	171	177	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20796	20803		10.1074/jbc.M109.025353	http://dx.doi.org/10.1074/jbc.M109.025353			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19515844	Green Published, hybrid			2022-12-27	WOS:000268316100042
J	Reininger, L; Tewari, R; Fennell, C; Holland, Z; Goldring, D; Ranford-Cartwright, L; Billker, O; Doerig, C				Reininger, Luc; Tewari, Rita; Fennell, Clare; Holland, Zoe; Goldring, Dean; Ranford-Cartwright, Lisa; Billker, Oliver; Doerig, Christian			An Essential Role for the Plasmodium Nek-2 Nima-related Protein Kinase in the Sexual Development of Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ASPERGILLUS-NIDULANS; OSMIOPHILIC BODIES; FALCIPARUM; EXPRESSION; GAMETOCYTE; MOSQUITO; GAMETE; SENSITIVITY; CENTRIOLES	The molecular control of cell division and development in malaria parasites is far from understood. We previously showed that a Plasmodium gametocyte-specific NIMA-related protein kinase, nek-4, is required for completion of meiosis in the ookinete, the motile form that develops from the zygote in the mosquito vector. Here, we show that another NIMA-related kinase, Pfnek-2, is also predominantly expressed in gametocytes, and that Pfnek-2 is an active enzyme displaying an in vitro substrate preference distinct from that of Pfnek-4. A functional nek-2 gene is required for transmission of both Plasmodium falciparum and the rodent malaria parasite Plasmodium berghei to the mosquito vector, which is explained by the observation that disruption of the nek-2 gene in P. berghei causes dysregulation of DNA replication during meiosis and blocks ookinete development. This has implications (i) in our understanding of sexual development of malaria parasites and (ii) in the context of control strategies aimed at interfering with malaria transmission.	[Tewari, Rita] Univ Nottingham, Sch Biol, Inst Genet, Nottingham NG7 2UH, England; [Reininger, Luc; Fennell, Clare; Holland, Zoe; Doerig, Christian] Univ Glasgow, Biomed Res Ctr, Wellcome Ctr Mol Parasitol, INSERM,U609, Glasgow G12 8TA, Lanark, Scotland; [Ranford-Cartwright, Lisa] Univ Glasgow, Fac Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8TA, Lanark, Scotland; [Goldring, Dean] Univ KwaZulu Natal, Sch Biochem Genet Microbiol & Plant Pathol, Dept Biochem, ZA-3209 Scottsville, South Africa; [Billker, Oliver] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Tewari, Rita; Billker, Oliver] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Doerig, Christian] Ecole Polytech Fed Lausanne EPFL, INSERM, Global Hlth Inst, U609, CH-1015 Lausanne, Switzerland	University of Nottingham; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Dundee; University of Glasgow; University of Glasgow; University of Kwazulu Natal; Wellcome Trust Sanger Institute; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Tewari, R (corresponding author), Univ Nottingham, Sch Biol, Inst Genet, Nottingham NG7 2UH, England.	rita.tewari@nottingham.ac.uk; christian.doerig@epfl.ch	Ranford-Cartwright, Lisa C/H-4701-2013; Doerig, Christian/Q-9900-2019; Reininger, Luc/O-5301-2015; Tewari, Rita/M-5698-2014	Ranford-Cartwright, Lisa C/0000-0003-1992-3940; Doerig, Christian/0000-0002-3188-094X; Goldring, James Philip Dean/0000-0001-6713-9515; Billker, Oliver/0000-0003-1716-168X; REININGER, LUC/0000-0002-7014-7783; Tewari, Rita/0000-0003-3943-1847	Burroughs Wellcome Fund; Wellcome Trust; National Institutes of Health (NIAID); U.S. Department of Defense; Military Infectious Diseases Research Program; French Institut National de la Sante et de la Recherche Medicale (Inserm); European Commission; Novartis Institute for Tropical Diseases (NITD, Singapore); Medical Research Council; MRC [G0501670] Funding Source: UKRI; Medical Research Council [G0501670] Funding Source: researchfish	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Wellcome Trust(Wellcome Trust); National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Defense(United States Department of Defense); Military Infectious Diseases Research Program; French Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Commission(European CommissionEuropean Commission Joint Research Centre); Novartis Institute for Tropical Diseases (NITD, Singapore); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work at the Plasmodium Genome Consortium was supported by the Burroughs Wellcome Fund, the Wellcome Trust, the National Institutes of Health (NIAID), and the U.S. Department of Defense, Military Infectious Diseases Research Program. Financial support for PlasmoDB was provided by the Burroughs Wellcome Fund. Work in the laboratory of C. D. was supported by the French Institut National de la Sante et de la Recherche Medicale (Inserm), FP6 (SIGMAL and ANTIMAL projects, BioMalPar Network of Excellence) and FP7 (MALSIG project) programs of the European Commission, and by a grant from the Novartis Institute for Tropical Diseases (NITD, Singapore). The work on P. berghei was supported by grants from the Wellcome Trust (to R. T. and O.B.) and the Medical Research Council (to O.B.).	Alano P, 1995, MOL BIOCHEM PARASIT, V74, P143, DOI 10.1016/0166-6851(95)02491-3; Arama E, 1998, ONCOGENE, V16, P1813, DOI 10.1038/sj.onc.1201710; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Carter R, 1993, Methods Mol Biol, V21, P67; Davies JR, 2004, EUKARYOT CELL, V3, P1433, DOI 10.1128/EC.3.6.1433-1444.2004; de Koning-Ward TF, 2008, MOL MICROBIOL, V67, P278, DOI 10.1111/j.1365-2958.2007.06039.x; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Dorin-Semblat D, 2007, MOL MICROBIOL, V65, P1170, DOI 10.1111/j.1365-2958.2007.05859.x; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Hayward DG, 2006, CANCER LETT, V237, P155, DOI 10.1016/j.canlet.2005.06.017; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Lye YM, 2006, FEBS LETT, V580, P6083, DOI 10.1016/j.febslet.2006.10.003; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Motose H, 2008, PLANT J, V54, P829, DOI 10.1111/j.1365-313X.2008.03445.x; Nagasato C, 2005, J PLANT RES, V118, P361, DOI 10.1007/s10265-005-0244-0; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; OAKLEY BR, 1983, J CELL BIOL, V96, P1155, DOI 10.1083/jcb.96.4.1155; PALERMO G, 1994, HUM REPROD, V9, P1220, DOI 10.1093/oxfordjournals.humrep.a138682; Reininger L, 2005, J BIOL CHEM, V280, P31957, DOI 10.1074/jbc.M504523200; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Rhee K, 1997, DEVELOPMENT, V124, P2167; Ringwald P, 1999, J CLIN MICROBIOL, V37, P700, DOI 10.1128/JCM.37.3.700-705.1999; SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; SCHULTZ SJ, 1994, CELL GROWTH DIFFER, V5, P625; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Silvestrini F, 2000, PARASITOLOGY, V121, P465, DOI 10.1017/S0031182099006691; SINDEN RE, 1978, PROC R SOC SER B-BIO, V201, P375, DOI 10.1098/rspb.1978.0051; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	36	68	69	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20858	20868		10.1074/jbc.M109.017988	http://dx.doi.org/10.1074/jbc.M109.017988			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19491095	Green Published, hybrid			2022-12-27	WOS:000268316100049
J	Shlyakhtenko, LS; Gilmore, J; Kriatchko, AN; Kumar, S; Swanson, PC; Lyubchenko, YL				Shlyakhtenko, Luda S.; Gilmore, Jamie; Kriatchko, Aleksei N.; Kumar, Sushil; Swanson, Patrick C.; Lyubchenko, Yuri L.			Molecular Mechanism Underlying RAG1/RAG2 Synaptic Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; RECOMBINATION SIGNAL COMPLEXES; PROTEIN-DNA COMPLEXES; V(D)J RECOMBINATION; IN-VITRO; B-CELLS; RAG; CLEAVAGE; BINDING; DYNAMICS	Two lymphoid cell-specific proteins, RAG1 and RAG2 (RAG), initiate V(D)J recombination by assembling a synaptic complex with recombination signal sequences (RSSs) abutting two different antigen receptor gene coding segments, and then introducing a DNA double strand break at the end of each RSS. Despite the biological importance of this system, the structure of the synaptic complex, and the RAG protein stoichiometry and arrangement of DNA within the synaptosome, remains poorly understood. Here we applied atomic force microscopy to directly visualize and characterize RAG synaptic complexes. We report that the pre-cleavage RAG synaptic complex contains about twice the protein content as a RAG complex bound to a single RSS, with a calculated mass consistent with a pair of RAG heterotetramers. In the synaptic complex, the RSSs are predominantly oriented in a side-by-side configuration with no DNA strand crossover. The mass of the synaptic complex, and the conditions under which it is formed in vitro, favors an association model of assembly in which isolated RAG-RSS complexes undergo synapsis mediated by RAG protein-protein interactions. The replacement of Mg2+ cations with Ca2+ leads to a dramatic change in protein stoichiometry for all RAG-RSS complexes, suggesting that the cation composition profoundly influences the type of complex assembled.	[Shlyakhtenko, Luda S.; Gilmore, Jamie; Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Kriatchko, Aleksei N.; Kumar, Sushil; Swanson, Patrick C.] Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Nebraska System; University of Nebraska Medical Center; Creighton University	Swanson, PC (corresponding author), 2500 Calif Plaza, Omaha, NE 68178 USA.	pswanson@creighton.edu; ylyubchenko@unmc.edu			National Institutes of Health [R01 AI055599, R01 GM0062235, S10 RR023400]; National Science Foundation [061590]; National Institutes of Health National Center for Research Resources [C06 RR17417-01]; Nebraska Research Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023400, C06RR017417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nebraska Research Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI055599 (to P.C.S.) and R01 GM0062235 and S10 RR023400 (to Y.L.L.). This work was also supported by National Science Foundation Grant 061590 (to Y.L.L.), Research Facilities Improvement Program of the National Institutes of Health National Center for Research Resources Grant C06 RR17417-01 (to P.C.S.), and the Nebraska Research Initiative (to Y.L.L.).	Aidinis V, 1999, MOL CELL BIOL, V19, P6532; Akamatsu Y, 1998, MOL CELL BIOL, V18, P4670, DOI 10.1128/MCB.18.8.4670; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bergeron S, 2005, J BIOL CHEM, V280, P31314, DOI 10.1074/jbc.M503063200; Bergeron S, 2006, METHOD ENZYMOL, V408, P511, DOI 10.1016/S0076-6879(06)08032-3; Cassell G, 1999, NUCLEIC ACIDS RES, V27, P1145, DOI 10.1093/nar/27.4.1145; Ciubotaru M, 2003, J BIOL CHEM, V278, P5584, DOI 10.1074/jbc.M209758200; Ciubotaru M, 2007, MOL CELL BIOL, V27, P4745, DOI 10.1128/MCB.00177-07; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; Henderson RM, 1996, P NATL ACAD SCI USA, V93, P8756, DOI 10.1073/pnas.93.16.8756; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Hesslein DGT, 2006, MOL IMMUNOL, V43, P326, DOI 10.1016/j.molimm.2005.02.010; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Huye LE, 2002, MOL CELL BIOL, V22, P3460, DOI 10.1128/MCB.22.10.3460-3473.2002; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Kriatchko AN, 2006, MOL CELL BIOL, V26, P4712, DOI 10.1128/MCB.02487-05; Kumar S, 2009, NUCLEIC ACIDS RES, V37, P2211, DOI 10.1093/nar/gkp047; Landree MA, 2001, MOL CELL BIOL, V21, P4256, DOI 10.1128/MCB.21.13.4256-4264.2001; Lieber MR, 2008, CELL RES, V18, P125, DOI 10.1038/cr.2007.108; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Lushnikov AY, 2006, BIOCHEMISTRY-US, V45, P152, DOI 10.1021/bi051767c; Lyubchenko YL, 2004, CELL BIOCHEM BIOPHYS, V41, P75, DOI 10.1385/CBB:41:1:075; Lyubchenko YL, 2009, METHODS, V47, P206, DOI 10.1016/j.ymeth.2008.09.002; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mundy CL, 2002, MOL CELL BIOL, V22, P69, DOI 10.1128/MCB.22.1.69-77.2002; Pavlicek JW, 2008, BIOCHEMISTRY-US, V47, P11204, DOI 10.1021/bi801426x; Santagata S, 1998, J BIOL CHEM, V273, P16325, DOI 10.1074/jbc.273.26.16325; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Shlyakhtenko LS, 2007, BIOCHEMISTRY-US, V46, P11128, DOI 10.1021/bi701123u; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Swanson PC, 2004, J BIOL CHEM, V279, P4034, DOI 10.1074/jbc.M311100200; Swanson PC, 2002, MOL CELL BIOL, V22, P7790, DOI 10.1128/MCB.22.22.7790-7801.2002; Swanson PC, 2002, MOL CELL BIOL, V22, P1340, DOI 10.1128/MCB.22.5.1340-1351.2002; Swanson PC, 1999, MOL CELL BIOL, V19, P3674; Tang M, 2005, GENE DEV, V19, P1422, DOI 10.1101/gad.1317605; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Vanamee ES, 2005, EMBO J, V24, P4198, DOI 10.1038/sj.emboj.7600880; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; Wang XM, 2008, NAT IMMUNOL, V9, P794, DOI 10.1038/ni.1614; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	43	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20956	20965		10.1074/jbc.M109.028977	http://dx.doi.org/10.1074/jbc.M109.028977			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19502597	hybrid, Green Published			2022-12-27	WOS:000268316100059
J	Deward, AD; Alberts, AS				Deward, Aaron D.; Alberts, Arthur S.			Ubiquitin-mediated Degradation of the Formin mDia2 upon Completion of Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; AUTOREGULATORY DOMAIN; ACTIN NUCLEATION; HOMOLOGY PROTEIN; CONTRACTILE RING; CENTRAL SPINDLE; CYTOKINESIS; MICROTUBULES; MECHANISM; PROFILIN	Formins assemble non-branched actin filaments and modulate microtubule dynamics during cell migration and cell division. At the end of mitosis formins contribute to the generation of actin filaments that form the contractile ring. Rho small GTP-binding proteins activate mammalian diaphanous-related (mDia) formins by directly binding and disrupting an intramolecular autoinhibitory mechanism. Although the Rho-regulated activation mechanism is well characterized, little is known about how formins are switched off. Here we reveal a novel mechanism of formin regulation during cytokinesis based on the following observations; 1) mDia2 is degraded at the end of mitosis, 2) mDia2 is targeted for disposal by post-translational ubiquitin modification, 3) forced expression of activated mDia2 yields binucleate cells due to failed cytokinesis, and 4) the cytokinesis block is dependent upon mDia2-mediated actin assembly as versions of mDia2 incapable of nucleating actin but that still stabilize microtubules have no effect on cytokinesis. We propose that the tight control of mDia2 expression and ubiquitin-mediated degradation is essential for the completion of cell division. Because of the many roles for formins in cell morphology, we discuss the relevance of mDia protein turnover in other processes where ubiquitin-mediated proteolysis is an essential component.	[Deward, Aaron D.; Alberts, Arthur S.] Van Andel Res Inst, Lab Cell Struct & Signal Integrat, Grand Rapids, MI 49503 USA; [Deward, Aaron D.] Michigan State Univ, Program Cell & Mol Biol, E Lansing, MI 48824 USA	Van Andel Institute; Michigan State University	Alberts, AS (corresponding author), 333 Bostwick Ave, Grand Rapids, MI 49503 USA.	art.alberts@vai.org			Van Andel Foundation	Van Andel Foundation	This work was supported by the Van Andel Foundation.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Albertson R, 2008, J CELL BIOL, V181, P777, DOI 10.1083/jcb.200803096; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Denis NJ, 2007, PROTEOMICS, V7, P868, DOI 10.1002/pmic.200600410; DeWard AD, 2008, CURR BIOL, V18, pR605, DOI 10.1016/j.cub.2008.06.001; Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Kamasani U, 2007, CANCER BIOL THER, V6, P1422; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kovar DR, 2006, CURR BIOL, V16, pR535, DOI 10.1016/j.cub.2006.06.039; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; Mukai A, 2008, J CELL SCI, V121, P1325, DOI 10.1242/jcs.027417; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pollard TD, 2008, BIOCHEM SOC T, V36, P425, DOI 10.1042/BST0360425; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Satoh S, 2001, J BIOL CHEM, V276, P39290, DOI 10.1074/jbc.M107026200; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Tully GH, 2009, MOL BIOL CELL, V20, P1201, DOI 10.1091/mbc.E08-08-0822; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Werner M, 2008, BIOCHEM SOC T, V36, P371, DOI 10.1042/BST0360371; Yonetani A, 2008, MOL BIOL CELL, V19, P2208, DOI 10.1091/mbc.E07-07-0731	47	43	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20061	20069		10.1074/jbc.M109.000885	http://dx.doi.org/10.1074/jbc.M109.000885			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19457867	Green Published, hybrid			2022-12-27	WOS:000268097400033
J	Groh, S; Zong, HH; Goddeeris, MM; Lebakken, CS; Venzke, D; Pessin, JE; Campbell, KP				Groh, Severine; Zong, Haihong; Goddeeris, Matthew M.; Lebakken, Connie S.; Venzke, David; Pessin, Jeffrey E.; Campbell, Kevin P.			Sarcoglycan Complex IMPLICATIONS FOR METABOLIC DEFECTS IN MUSCULAR DYSTROPHIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; GAMMA-SARCOGLYCAN; BETA-SARCOGLYCAN; MUSCLE; DYSTROGLYCAN; LIPODYSTROPHY; EXPRESSION; ADIPOGENESIS; DISRUPTION; SARCOSPAN	The sarcoglycans are known as an integral subcomplex of the dystrophin glycoprotein complex, the function of which is best characterized in skeletal muscle in relation to muscular dystrophies. Here we demonstrate that the white adipocytes, which share a common precursor with the myocytes, express a cell-specific sarcoglycan complex containing beta-, delta-, and epsilon-sarcoglycan. In addition, the adipose sarcoglycan complex associates with sarcospan and laminin binding dystroglycan. Using multiple sarcoglycan null mouse models, we show that loss of alpha-sarcoglycan has no consequence on the expression of the adipocyte sarcoglycan complex. However, loss of beta- or delta-sarcoglycan leads to a concomitant loss of the sarcoglycan complex as well as sarcospan and a dramatic reduction in dystroglycan in adipocytes. We further demonstrate that beta-sarcoglycan null mice, which lack the sarcoglycan complex in adipose tissue and skeletal muscle, are glucose-intolerant and exhibit whole body insulin resistance specifically due to impaired insulin-stimulated glucose uptake in skeletal muscles. Thus, our data demonstrate a novel function of the sarcoglycan complex in whole body glucose homeostasis and skeletal muscle metabolism, suggesting that the impairment of the skeletal muscle metabolism influences the pathogenesis of muscular dystrophy.	[Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Groh, Severine; Goddeeris, Matthew M.; Lebakken, Connie S.; Venzke, David; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Groh, Severine; Goddeeris, Matthew M.; Lebakken, Connie S.; Venzke, David; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Zong, Haihong; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Diabet Res Ctr, Bronx, NY 10461 USA; [Zong, Haihong; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Diabet Res Ctr, Bronx, NY 10461 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu		Campbell, Kevin/0000-0003-2066-5889; Venzke, David/0000-0001-8180-9562	National Institutes of Health [R01 AR051199-01]; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR051199-01 through the NIAMS. This work was also supported by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant and by a grant from the Muscular Dystrophy Association.	Abbatecola AM, 2008, CURR PHARM DESIGN, V14, P405; Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Asterholm Ingrid Wernstedt, 2007, Drug Discov Today Dis Models, V4, P17; Atanassova Pepa K, 2003, Folia Med (Plovdiv), V45, P31; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2000, J BIOL CHEM, V275, P38554, DOI 10.1074/jbc.M007799200; Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005; Bluher M, 2005, BEST PRACT RES CL EN, V19, P605, DOI 10.1016/j.beem.2005.07.006; Capeau J, 2005, BIOCHEM SOC T, V33, P1073, DOI 10.1042/BST0331073; Carpene C, 2000, METH MOL B, V155, P129; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Crosbie RH, 2000, HUM MOL GENET, V9, P2019, DOI 10.1093/hmg/9.13.2019; Davies KE, 2006, CELL, V127, P1304, DOI 10.1016/j.cell.2006.12.010; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Durbeej M, 1999, J BIOL CHEM, V274, P26609, DOI 10.1074/jbc.274.37.26609; Fischbach C, 2004, EXP CELL RES, V300, P54, DOI 10.1016/j.yexcr.2004.05.036; Garg A, 1999, J CLIN ENDOCR METAB, V84, P170, DOI 10.1210/jc.84.1.170; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hegele RA, 2007, J LIPID RES, V48, P1433, DOI 10.1194/jlr.R700004-JLR200; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hertzel AV, 2000, J LIPID RES, V41, P1082; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Lodi R, 1997, NEUROMUSCULAR DISORD, V7, P505, DOI 10.1016/S0960-8966(97)00108-9; McNally EM, 2007, ANNU REV PATHOL-MECH, V2, P87, DOI 10.1146/annurev.pathol.2.010506.091936; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Mojallal A, 2008, BIO-MED MATER ENG, V18, P187, DOI 10.3233/BME-2008-0523; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Piasecki Justin H, 2008, Aesthet Surg J, V28, P306, DOI 10.1016/j.asj.2008.02.005; Reue K, 2006, CURR OPIN CLIN NUTR, V9, P436, DOI 10.1097/01.mco.0000232904.82038.db; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shi WX, 2004, MUSCLE NERVE, V29, P409, DOI 10.1002/mus.10566; Shiga K, 2006, EXP CELL RES, V312, P2083, DOI 10.1016/j.yexcr.2006.03.011; Simha V, 2002, J CLIN ENDOCR METAB, V87, P776, DOI 10.1210/jc.87.2.776; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Tomas E, 2004, P NUTR SOC, V63, P381, DOI 10.1079/PNS2004356; Tyler KL, 2003, MUSCLE NERVE, V28, P402, DOI 10.1002/mus.10435; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732; Yamanouchi K, 2006, EXP CELL RES, V312, P2701, DOI 10.1016/j.yexcr.2006.04.014; Yang XL, 2004, BIOCHEM BIOPH RES CO, V317, P1045, DOI 10.1016/j.bbrc.2004.03.152	44	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19178	19182		10.1074/jbc.C109.010728	http://dx.doi.org/10.1074/jbc.C109.010728			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19494113	Green Published, hybrid			2022-12-27	WOS:000267908300006
J	Nembrini, C; Kisielow, J; Shamshiev, AT; Tortola, L; Coyle, AJ; Kopf, M; Marsland, BJ				Nembrini, Chiara; Kisielow, Jan; Shamshiev, Abdijapar T.; Tortola, Luigi; Coyle, Anthony J.; Kopf, Manfred; Marsland, Benjamin J.			The Kinase Activity of Rip2 Determines Its Stability and Consequently Nod1-and Nod2-mediated Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN-KINASE; INNATE; NOD2; RECEPTOR; PEPTIDOGLYCAN; CELLS; IDENTIFICATION; INFLAMMATION; RECOGNITION	Rip2 (RICK, CARD3) has been identified as a key effector molecule downstream of the pattern recognition receptors, Nod1 and Nod2; however, its mechanism of action remains to be elucidated. In particular, it is unclear whether its kinase activity is required for signaling or for maintaining protein stability. We have investigated the expression level of different retrovirally expressed kinase-dead Rip2 mutants and the role of Rip2 kinase activity in the signaling events that follow Nod1 and Nod2 stimulation. We show that in primary cells expressing kinase-inactive Rip2, protein levels were severely compromised, and stability could not be reconstituted by the addition of a phospho-mimetic mutation in its autophosphorylation site. Consequently, inflammatory cytokine production in response to Nod1 and Nod2 ligands was abrogated both in vitro and in vivo in the absence of Rip2 kinase activity. Our results highlight the central role that Rip2 kinase activity plays in conferring stability to the protein and thus in the preservation of Nod1- and Nod2-mediated innate immune responses.	[Marsland, Benjamin J.] Swiss Fed Inst Technol, Inst Integrat Biol, CH-8952 Zurich, Switzerland; [Coyle, Anthony J.] Millennium Pharmaceut Inc, Inflammat Div, Cambridge, MA 01239 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Marsland, BJ (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Wagistr 27, CH-8952 Zurich, Switzerland.	marsland@env.ethz.ch	Kopf, Manfred/B-6907-2009	Kopf, Manfred/0000-0002-0628-7140; Tortola, Luigi/0000-0002-8480-2080; Kisielow, Jan/0000-0002-4482-5202	Swiss National Science Foundation [310000-116675]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 310000-116675.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Crcareva A, 2005, EXP HEMATOL, V33, P1459, DOI 10.1016/j.exphem.2005.09.001; Dorsch M, 2006, CELL SIGNAL, V18, P2223, DOI 10.1016/j.cellsig.2006.05.005; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Lu CF, 2005, J BIOL CHEM, V280, P16278, DOI 10.1074/jbc.M410114200; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Navas TA, 1999, J BIOL CHEM, V274, P33684, DOI 10.1074/jbc.274.47.33684; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Park JH, 2007, J IMMUNOL, V179, P514, DOI 10.4049/jimmunol.179.1.514; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Ruefli-Brasse AA, 2004, J BIOL CHEM, V279, P1570, DOI 10.1074/jbc.C300460200; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Swift S., 2001, CURRENT PROTOCOLS IM; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704	36	68	70	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19183	19188		10.1074/jbc.M109.006353	http://dx.doi.org/10.1074/jbc.M109.006353			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473975	Green Published, hybrid			2022-12-27	WOS:000267908300007
J	Seibold, MA; Reese, TA; Choudhry, S; Salam, MT; Beckman, K; Eng, C; Atakilit, A; Meade, K; Lenoir, M; Watson, HG; Thyne, S; Kumar, R; Weiss, KB; Grammer, LC; Avila, P; Schleimer, RP; Fahy, JV; Rodriguez-Santana, J; Rodriguez-Cintron, W; Boot, RG; Sheppard, D; Gilliland, FD; Locksley, RM; Burchard, EG				Seibold, Max A.; Reese, Tiffany A.; Choudhry, Shweta; Salam, Muhammad T.; Beckman, Kenny; Eng, Celeste; Atakilit, Amha; Meade, Kelley; Lenoir, Michael; Watson, H. Geoffrey; Thyne, Shannon; Kumar, Rajesh; Weiss, Kevin B.; Grammer, Leslie C.; Avila, Pedro; Schleimer, Robert P.; Fahy, John V.; Rodriguez-Santana, Jose; Rodriguez-Cintron, William; Boot, Rolf G.; Sheppard, Dean; Gilliland, Frank D.; Locksley, Richard M.; Burchard, Esteban G.			Differential Enzymatic Activity of Common Haplotypic Versions of the Human Acidic Mammalian Chitinase Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOUTHERN CALIFORNIA COMMUNITIES; DIFFERING LEVELS; AIR-POLLUTION; ENVIRONMENT; RESIDUES; CELL	Mouse models have shown the importance of acidic mammalian chitinase activity in settings of chitin exposure and allergic inflammation. However, little is known regarding genetic regulation of AMCase enzymatic activity in human allergic diseases. Resequencing the AMCase gene exons we identified 8 non-synonymous single nucleotide polymorphisms including three novel variants (A290G, G296A, G339T) near the gene area coding for the enzyme active site, all in linkage disequilibrium. AMCase protein isoforms, encoded by two gene-wide haplotypes, and differentiated by these three single nucleotide polymorphisms, were recombinantly expressed and purified. Biochemical analysis revealed the isoform encoded by the variant haplotype displayed a distinct pH profile exhibiting greater retention of chitinase activity at acidic and basic pH values. Determination of absolute kinetic activity found the variant isoform encoded by the variant haplotype was 4-, 2.5-, and 10-fold more active than the wild type AMCase isoform at pH 2.2, 4.6, and 7.0, respectively. Modeling of the AMCase isoforms revealed positional changes in amino acids critical for both pH specificity and substrate binding. Genetic association analyses of AMCase haplotypes for asthma revealed significant protective associations between the variant haplotype in several asthma cohorts. The structural, kinetic, and genetic data regarding the AMCase isoforms are consistent with the Th2-priming effects of environmental chitin and a role for AMCase in negatively regulating this stimulus.	[Seibold, Max A.; Reese, Tiffany A.; Choudhry, Shweta; Eng, Celeste; Fahy, John V.; Sheppard, Dean; Locksley, Richard M.; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Seibold, Max A.; Burchard, Esteban G.] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; [Seibold, Max A.; Choudhry, Shweta; Eng, Celeste; Atakilit, Amha; Sheppard, Dean; Burchard, Esteban G.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Choudhry, Shweta; Burchard, Esteban G.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Thyne, Shannon] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Fahy, John V.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Salam, Muhammad T.; Gilliland, Frank D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Beckman, Kenny] CHORI, Oakland, CA 94609 USA; [Lenoir, Michael] Bay Area Pediat, Oakland, CA 94609 USA; [Watson, H. Geoffrey] James A Watson Wellness Ctr, Oakland, CA 94608 USA; [Kumar, Rajesh] Northwestern Univ, Childrens Mem Hosp, Chicago, IL 60611 USA; [Weiss, Kevin B.] Northwestern Univ, Inst Hlth Care Studies, Chicago, IL 60611 USA; [Grammer, Leslie C.; Avila, Pedro; Schleimer, Robert P.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Rodriguez-Santana, Jose] Profess Serv Corp, Ctr Neumol Pediat, San Juan, PR 00927 USA; [Rodriguez-Cintron, William] Vet Caribbean Hlth Care Syst, San Juan, PR 00927 USA; [Boot, Rolf G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Southern California; Children's Hospital Oakland Research Institute; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University; Northwestern University; University of Amsterdam; Academic Medical Center Amsterdam	Seibold, MA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	seiboldm@njc.org		Salam, Muhammad/0000-0002-3565-8916; Reese, Tiffany/0000-0003-2325-6546; Grammer, Leslie/0000-0001-6860-2014; Kumar, Rajesh/0000-0002-1962-7108; Boot, Rolf/0000-0002-7031-3390	National Institutes of Health [HL078885, HL088133, U19 AI077439, ES015794]; Flight Attendant Medical Research Institute (FAMRI),; R.W.J. Amos Medical Faculty Development Award; National Institutes of Health NHLBI [5U01 HL072478-05, 5R01HL61768, 5R01HL76647]; Sandler Asthma Basic Research Center (SABRE),; Sandler Program for Asthma Research (SPAR); Sandler Family Supporting Foundation; Southern California Environmental Health Sciences Center [5P30ES007048]; National Institute of Environmental Health Sciences, Children's Environmental Health [5P01ES009581, R826708-01, RD831861-01, 5P01ES011627]; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072478, R01HL088133, R01HL076647, R01HL061768, R01HL078885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011627, P30ES007048, R01ES015794, P01ES009581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI),; R.W.J. Amos Medical Faculty Development Award; National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Sandler Asthma Basic Research Center (SABRE),; Sandler Program for Asthma Research (SPAR); Sandler Family Supporting Foundation; Southern California Environmental Health Sciences Center; National Institute of Environmental Health Sciences, Children's Environmental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL078885, HL088133, U19 AI077439, and ES015794 (to E. G. B.), the Flight Attendant Medical Research Institute (FAMRI), and the R.W.J. Amos Medical Faculty Development Award (to E. G. B.).; The Chicago Initiative to Raise Asthma Health Equity (CHIRAH) and the Asthma Clinical Research Network are supported by National Institutes of Health NHLBI Grant 5U01 HL072478-05, Sandler Asthma Basic Research Center (SABRE), Sandler Program for Asthma Research (SPAR), and the Sandler Family Supporting Foundation. The Children's Health Study was supported by NHLBI Grants 5R01HL61768 and 5R01HL76647, Southern California Environmental Health Sciences Center Grant 5P30ES007048 supported by the National Institute of Environmental Health Sciences, Children's Environmental Health Center Grants 5P01ES009581, R826708-01, and RD831861-01 supported by the National Institute of Environmental Health Sciences and the Environmental Protection Agency, National Institute of Environmental Health Sciences Grant 5P01ES011627, and the Hastings Foundation.	Aguilera B, 2003, J BIOL CHEM, V278, P40911, DOI 10.1074/jbc.M301804200; ARAUJO ACG, 1993, J HISTOCHEM CYTOCHEM, V41, P571, DOI 10.1177/41.4.8450196; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bierbaum S, 2005, AM J RESP CRIT CARE, V172, P1505, DOI 10.1164/rccm.200506-890OC; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Bussink AP, 2006, INT REV CYTOL, V252, P71, DOI 10.1016/S0074-7696(06)52001-7; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; *CDCP, 1982, MMWR-MORBID MORTAL W, V31, P95; Chatterjee R, 2008, J ALLERGY CLIN IMMUN, V122, P202, DOI 10.1016/j.jaci.2008.04.030; Chen HC, 2002, FEMS MICROBIOL LETT, V209, P53, DOI 10.1111/j.1574-6968.2002.tb11108.x; Chou YT, 2006, BIOCHEMISTRY-US, V45, P4444, DOI 10.1021/bi0525977; DEBONO M, 1994, ANNU REV MICROBIOL, V48, P471, DOI 10.1146/annurev.mi.48.100194.002351; FUHRMAN JA, 1985, MOL BIOCHEM PARASIT, V17, P93, DOI 10.1016/0166-6851(85)90130-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Lin DY, 2005, GENET EPIDEMIOL, V29, P299, DOI 10.1002/gepi.20098; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; Miller BT, 2008, J CHEM INF MODEL, V48, P1920, DOI 10.1021/ci800133b; NACLERIO RM, 1999, LUNG BIOL HEALTH DIS, V123, P23; NEVILLE AC, 1976, J CELL SCI, V21, P73; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Olland AM, 2009, PROTEIN SCI, V18, P569, DOI 10.1002/pro.63; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Peters JM, 1999, AM J RESP CRIT CARE, V159, P768, DOI 10.1164/ajrccm.159.3.9804144; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; SHAHABUDDIN M, 1994, EXP PARASITOL, V79, P85, DOI 10.1006/expr.1994.1066; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	31	44	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19650	19658		10.1074/jbc.M109.012443	http://dx.doi.org/10.1074/jbc.M109.012443			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19435888	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000267908300056
J	Lenoir, G; Williamson, P; Puts, CF; Holthuis, JCM				Lenoir, Guillaume; Williamson, Patrick; Puts, Catheleyne F.; Holthuis, Joost C. M.			Cdc50p Plays a Vital Role in the ATPase Reaction Cycle of the Putative Aminophospholipid Transporter Drs2p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASES; NA,K-ATPASE BETA-SUBUNIT; PLASMA-MEMBRANE; PHOSPHOLIPID TRANSLOCATION; ADENOSINE-TRIPHOSPHATASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN; YEAST	Members of the P-4 subfamily of P-type ATPases are believed to catalyze transport of phospholipids across cellular bilayers. However, most P-type ATPases pump small cations or metal ions, and atomic structures revealed a transport mechanism that is conserved throughout the family. Hence, a challenging problem is to understand how this mechanism is adapted in P-4-ATPases to flip phospholipids. P-4-ATPases form heteromeric complexes with Cdc50 proteins. The primary role of these additional polypeptides is unknown. Here, we show that the affinity of yeast P-4-ATPase Drs2p for its Cdc50-binding partner fluctuates during the transport cycle, with the strongest interaction occurring at a point where the enzyme is loaded with phospholipid ligand. We also find that specific interactions with Cdc50p are required to render the ATPase competent for phosphorylation at the catalytically important aspartate residue. Our data indicate that Cdc50 proteins are integral components of the P-4-ATPase transport machinery. Thus, acquisition of these subunits may have been a crucial step in the evolution of flippases from a family of cation pumps.	[Lenoir, Guillaume; Puts, Catheleyne F.; Holthuis, Joost C. M.] Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, NL-3584 CH Utrecht, Netherlands; [Lenoir, Guillaume; Puts, Catheleyne F.; Holthuis, Joost C. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; [Williamson, Patrick] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Utrecht University; Utrecht University; Amherst College	Holthuis, JCM (corresponding author), Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	j.c.holthuis@uu.nl	Lenoir, Guillaume/I-4002-2019; Holthuis, Joost/AAL-9157-2020	Lenoir, Guillaume/0000-0002-8759-5179; Holthuis, Joost/0000-0001-8912-1586	Fondation Recherge Medicale; Dutch Organization of Sciences; National Science Foundation	Fondation Recherge Medicale; Dutch Organization of Sciences; National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the Fondation Recherge Medicale (to G. L.), the Dutch Organization of Sciences (NWO-CW), the Utrecht High Potential Program (to J. H.), and the National Science Foundation (to P. W.).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; ALLEN G, 1976, FEBS LETT, V63, P188, DOI 10.1016/0014-5793(76)80223-2; Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Dempski RE, 2005, J GEN PHYSIOL, V125, P505, DOI 10.1085/jgp.200409186; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; EBASHI F, 1962, NATURE, V194, P378, DOI 10.1038/194378a0; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GOTTARDI CJ, 1993, SCIENCE, V260, P552, DOI 10.1126/science.8386395; GREFEN C, 2007, CURRENT PROTOCOLS NE; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; KAWAMURA M, 1985, BIOCHIM BIOPHYS ACTA, V821, P115, DOI 10.1016/0005-2736(85)90161-0; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; LUTSENKO S, 1994, J BIOL CHEM, V269, P4555; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; ORRWEAVER TL, 1983, METHOD ENZYMOL, V101, P228; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; VILSEN B, 1986, BIOCHIM BIOPHYS ACTA, V855, P429, DOI 10.1016/0005-2736(86)90089-1; VILSEN B, 1989, J BIOL CHEM, V264, P21024; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004	53	95	100	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17956	17967		10.1074/jbc.M109.013722	http://dx.doi.org/10.1074/jbc.M109.013722			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19411703	Green Published, hybrid			2022-12-27	WOS:000267712400007
J	Goetz, R; Dover, K; Laezza, F; Shtraizent, N; Huang, X; Tchetchik, D; Eliseenkova, AV; Xu, CF; Neubert, TA; Ornitz, DM; Goldfarb, M; Mohammadi, M				Goetz, Regina; Dover, Katarzyna; Laezza, Fernanda; Shtraizent, Nataly; Huang, Xiao; Tchetchik, Dafna; Eliseenkova, Anna V.; Xu, Chong-Feng; Neubert, Thomas A.; Ornitz, David M.; Goldfarb, Mitchell; Mohammadi, Moosa			Crystal Structure of a Fibroblast Growth Factor Homologous Factor (FHF) Defines a Conserved Surface on FHFs for Binding and Modulation of Voltage-gated Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR-14 GENE; INACTIVATION GATE; NERVOUS-SYSTEM; MUTATION; FGF; EXPRESSION; EXCITABILITY; EVOLUTION; NA(V)1.6; MEMBERS	Voltage-gated sodium channels (Na-v) produce sodium currents that underlie the initiation and propagation of action potentials in nerve and muscle cells. Fibroblast growth factor homologous factors (FHFs) bind to the intracellular C-terminal region of the Na-v alpha subunit to modulate fast inactivation of the channel. In this study we solved the crystal structure of a 149-residue-long fragment of human FHF2A which unveils the structural features of the homology core domain of all 10 human FHF isoforms. Through analysis of crystal packing contacts and site-directed mutagenesis experiments we identified a conserved surface on the FHF core domain that mediates channel binding in vitro and in vivo. Mutations at this channel binding surface impaired the ability of FHFs to co-localize with Na(v)s at the axon initial segment of hippocampal neurons. The mutations also disabled FHF modulation of voltage-dependent fast inactivation of sodium channels in neuronal cells. Based on our data, we propose that FHFs constitute auxiliary subunits for Na(v)s.	[Dover, Katarzyna; Shtraizent, Nataly; Huang, Xiao; Tchetchik, Dafna; Goldfarb, Mitchell] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Goetz, Regina; Eliseenkova, Anna V.; Neubert, Thomas A.; Mohammadi, Moosa] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Xu, Chong-Feng; Neubert, Thomas A.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Dover, Katarzyna] CUNY, Grad Program Biol, New York, NY 10021 USA; [Huang, Xiao] CUNY, Grad Program Biochem, New York, NY 10021 USA; [Laezza, Fernanda; Ornitz, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	City University of New York (CUNY) System; Hunter College (CUNY); New York University; New York University; City University of New York (CUNY) System; City University of New York (CUNY) System; Washington University (WUSTL)	Goldfarb, M (corresponding author), 695 Pk Ave,Rm HN834, New York, NY 10021 USA.	goldfarb@genectr.hunter.cuny.edu; Moosa.Mohammadi@nyumc.org	Goetz, Regina/M-2411-2019; Laezza, Fernanda/L-6019-2016; Laezza, Fernanda/X-4076-2019; kasaei, fahime/T-7197-2018; Mohammadi, Moosa/ABA-6745-2020	Goetz, Regina/0000-0003-3681-4703; Laezza, Fernanda/0000-0003-1141-1852; Laezza, Fernanda/0000-0003-1141-1852; Mohammadi, Moosa/0000-0003-2434-9437; Ornitz, David/0000-0003-1592-7629	National Institutes of Health [DE13686, NS39906, R03 NS62431, S10 RR017990, P30 NS050276]; Washington University Hope Center for Neurological Disorders; National Ataxia Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039906, P30NS050276, R03NS062431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Hope Center for Neurological Disorders; National Ataxia Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE13686 (to M. M.), NS39906 (to M. G.), R03 NS62431 (to D. M. O.), and S10 RR017990 and P30 NS050276 (to T. A. N.). This work was also supported by the Washington University Hope Center for Neurological Disorders (to D. M. O.) and the National Ataxia Foundation (to D. M. O.).	Abriel H, 2005, TRENDS CARDIOVAS MED, V15, P35, DOI 10.1016/j.tcm.2005.01.001; Boehm MK, 2000, BIOCHEM J, V346, P519, DOI 10.1042/0264-6021:3460519; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Dalski A, 2005, EUR J HUM GENET, V13, P118, DOI 10.1038/sj.ejhg.5201286; DILL KA, 1985, BIOCHEMISTRY-US, V24, P1501, DOI 10.1021/bi00327a032; Ferrero GB, 1997, AM J HUM GENET, V61, P395, DOI 10.1086/514857; Gecz J, 1999, HUM GENET, V104, P56, DOI 10.1007/s004390050910; Gedeon AK, 1996, AM J MED GENET, V64, P121, DOI 10.1002/(SICI)1096-8628(19960712)64:1<121::AID-AJMG20>3.0.CO;2-O; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Loll PJ, 2008, ACTA CRYSTALLOGR F, V64, P243, DOI 10.1107/S1744309108007574; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; MALMGREN H, 1993, AM J HUM GENET, V52, P1046; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Munoz-Sanjuan I, 2000, MECH DEVELOP, V95, P101, DOI 10.1016/S0925-4773(00)00336-1; Munoz-Sanjuan I, 2000, J BIOL CHEM, V275, P2589, DOI 10.1074/jbc.275.4.2589; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Nishimoto S, 2007, J BIOL CHEM, V282, P24255, DOI 10.1074/jbc.M704277200; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Ornitz DM, 2001, GENOME BIOL, V2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PATTON DE, 1993, NEURON, V11, P967; Rush AM, 2006, EUR J NEUROSCI, V23, P2551, DOI 10.1111/j.1460-9568.2006.04789.x; Shakkottai VG, 2009, NEUROBIOL DIS, V33, P81, DOI 10.1016/j.nbd.2008.09.019; SHILOH Y, 1990, AM J HUM GENET, V47, P20; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020	45	95	100	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17883	17896		10.1074/jbc.M109.001842	http://dx.doi.org/10.1074/jbc.M109.001842			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19406745	Green Published, hybrid			2022-12-27	WOS:000267202500054
J	Liu, R; Zheng, HQ; Zhou, ZM; Dong, JT; Chen, CS				Liu, Rong; Zheng, Han-Qiu; Zhou, Zhongmei; Dong, Jin-Tang; Chen, Ceshi			KLF5 Promotes Breast Cell Survival Partially through Fibroblast Growth Factor-binding Protein 1-pERK-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-5; KINASE PHOSPHATASE-1; TRANSCRIPTION FACTOR; EXPRESSION; CANCER; ACTIVATION; APOPTOSIS; ERK; PROLIFERATION; DEGRADATION	Krupple-like transcription factor 5 (KLF5) is a zinc-finger transcription factor promoting cell survival and tumorigenesis in multiple cancers. A high expression level of KLF5 has been shown to be associated with shorter breast cancer patient survival. However, the role of KLF5 and mechanism of KLF5 actions in breast cancer remain unclear. In this study, we found that KLF5 knockdown by small interfering RNA in two breast cell lines, MCF10A and BT20, induces apoptosis. Interestingly, a pro-survival phosphatase, dual specificity mitogen-activated protein kinase phosphatase 1 (MKP-1), is down-regulated by KLF5 ablation. Consistently, KLF5 overexpression increases the MKP-1 protein expression in Hs578T and MCF7. We further found that MKP-1 is essential and sufficient for KLF5 to promote breast cell survival. However, MKP-1 is not a KLF5 direct transcription target because the MKP-1 mRNA level is not regulated by KLF5. By cycloheximide chase assays, we found that KLF5 decreases MKP-1 protein degradation via activating the ERK signaling. Inhibition of pERK by the pharmacological inhibitor U0126 specifically blocks KLF5-induced MKP-1 phosphorylation and stabilization. Additionally, constitutive activation of ERK by constitutively activated MEK1 rescues the KLF5 depletion-induced MKP-1 down-regulation. Consistently, the phosphorylation-deficient MKP-1 mutant cannot be stabilized by KLF5. Finally, the activation of ERK by KLF5 is very likely through the KLF5 direct target gene FGF-BP in breast cells. These findings suggest that KLF5 is a pro-survival factor that promotes breast cell survival partially through pERK-mediated MKP-1 phosphorylation and stabilization. The KLF5-FGF-BP-pERK-MKP-1 signaling axis may provide new therapeutic targets for invasive breast cancer.	[Liu, Rong; Zheng, Han-Qiu; Zhou, Zhongmei; Chen, Ceshi] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Dong, Jin-Tang] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Oncol, Atlanta, GA 30322 USA	Albany Medical College; Emory University; Emory University	Chen, CS (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	chenc@mail.amc.edu		Chen, Ceshi/0000-0001-6398-3516; Dong, Jin-Tang/0000-0003-2349-5782; Zheng, Hanqiu/0000-0002-8062-1215	Komen for the Cure [BCTR0503705]; American Cancer Society [RSG-08-199-01]; Department of Defense [W81XWH-07-1-0191]	Komen for the Cure(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense)	This work was supported by Grant BCTR0503705 from Komen for the Cure, Grant RSG-08-199-01 from the American Cancer Society, and Grant W81XWH-07-1-0191 from the Department of Defense.	Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Beckers J, 2005, INT J CANCER, V114, P590, DOI 10.1002/ijc.20798; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Goldstein BG, 2007, AM J PHYSIOL-GASTR L, V292, pG1784, DOI 10.1152/ajpgi.00541.2006; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Loda M, 1996, AM J PATHOL, V149, P1553; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Suzuki T, 2007, J BIOL CHEM, V282, P9895, DOI 10.1074/jbc.M608098200; Taneyhill Lisa, 2004, BMC Developmental Biology, V4; Tassi E, 2001, J BIOL CHEM, V276, P40247, DOI 10.1074/jbc.M104933200; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Yang YZ, 2008, J BIOL CHEM, V283, P18812, DOI 10.1074/jbc.M801384200; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Zhao Y, 2008, ONCOGENE, V27, P1, DOI 10.1038/sj.onc.1210625; Zhou JY, 2006, CANCER RES, V66, P4888, DOI 10.1158/0008-5472.CAN-05-4229; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200	35	68	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16791	16798		10.1074/jbc.M808919200	http://dx.doi.org/10.1074/jbc.M808919200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19411256	Green Published, hybrid			2022-12-27	WOS:000266962400015
J	Selevsek, N; Rival, S; Tholey, A; Heinzle, E; Heinz, U; Hemmingsen, L; Adolph, HW				Selevsek, Nathalie; Rival, Sandrine; Tholey, Andreas; Heinzle, Elmar; Heinz, Uwe; Hemmingsen, Lars; Adolph, Hans W.			Zinc Ion-induced Domain Organization in Metallo-beta-lactamases A FLEXIBLE "ZINC ARM" FOR RAPID METAL ION TRANSFER?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTURBED-ANGULAR-CORRELATION; IONIZATION MASS-SPECTROMETRY; BACILLUS-CEREUS; BINDING-SITES; CONFORMATIONAL-CHANGES; COORDINATION GEOMETRY; CATALYZED-HYDROLYSIS; INHIBITOR COMPLEXES; PAC SPECTROSCOPY; GLYOXALASE II	The reversible unfolding of metallo-beta-lactamase from Chryseobacterium meningosepticum (BlaB) by guanidinium hydrochloride is best described by a three-state model including folded, intermediate, and unfolded states. The transformation of the folded apoenzyme into the intermediate state requires only very low denaturant concentrations, in contrast to the Zn-2-enzyme. Similarly, circular dichroism spectra of both BlaB and metallo-beta-lactamase from Bacillus cereus 569/H/9 (BcII) display distinct differences between metal-free and Zn-2-enzymes, indicating that the zinc ions affect the folding of the proteins, giving a larger alpha-helix content. To identify the regions of the protein involved in this zinc ion-induced change, a hydrogen deuterium exchange study with matrix-assisted laser desorption ionization tandem time of flight mass spectrometry on metal-free and Zn-1- and Zn-2-BcII was carried out. The region spanning the metal binding metallo-beta-lactamases (MBL) superfamily consensus sequence His-X-His-X-Asp motif and the loop connecting the N- and C-terminal domains of the protein undergoes a zinc ion-dependent structural change between intrinsically disordered and ordered states. The inherent flexibility even appears to allow for the formation of metal ion-bridged protein-protein complexes which may account for both electrospray ionization-mass spectroscopy results obtained upon variation of the zinc/protein ratio and stoichiometry-dependent variations of Hg-199m-perturbed angular correlation of gamma-rays spectroscopic data. We suggest that this flexible "zinc arm" motif, present in all the MBL subclasses, is disordered in metal-free MBLs and may be involved in metal ion acquisition from zinc-carrying molecules different from MBL in an "activation on demand" regulation of enzyme activity.	[Heinz, Uwe; Hemmingsen, Lars; Adolph, Hans W.] Univ Copenhagen, Dept Basic Sci & Environm, Fac Life Sci, DK-1871 Frederiksberg C, Denmark; [Selevsek, Nathalie; Tholey, Andreas; Heinzle, Elmar] Univ Saarland, Dept Biochem & Engn, D-66041 Saarbrucken, Germany; [Rival, Sandrine] Univ Saarland, Dept Biochem, D-66041 Saarbrucken, Germany; [Tholey, Andreas] Univ Kiel, Inst Expt Med Syst Proteome Res & Bioanalyt, D-24105 Kiel, Germany	University of Copenhagen; Saarland University; Saarland University; University of Kiel	Adolph, HW (corresponding author), Univ Copenhagen, Dept Basic Sci & Environm, Fac Life Sci, DK-1871 Frederiksberg C, Denmark.	hwa@life.ku.dk	Hemmingsen, Lars/AAD-1318-2020; Hemmingsen, Lars/A-6780-2015; Tholey, Andreas/B-3407-2010	Hemmingsen, Lars/0000-0002-1823-3035; Hemmingsen, Lars/0000-0002-1823-3035; Tholey, Andreas/0000-0002-8687-6817	European Union [CT 98-0232, HPRN-CT-2002-00,264]; Villum Kann Rasmussen Foundation; Danish Instrument Centre for Cern; Danish Natural Science Research Council; European Union via EURONS	European Union(European Commission); Villum Kann Rasmussen Foundation(Villum Fonden); Danish Instrument Centre for Cern; Danish Natural Science Research Council(Danish Natural Science Research Council); European Union via EURONS	This work was supported by European Union Contracts CT 98-0232 and HPRN-CT-2002-00,264), the Villum Kann Rasmussen Foundation, the Danish Instrument Centre for Cern, The Danish Natural Science Research Council, and the European Union via EURONS.	Aravind L, 1999, In Silico Biol, V1, P69; Badarau A, 2008, J BIOL INORG CHEM, V13, P919, DOI 10.1007/s00775-008-0379-2; Badarau A, 2006, BIOCHEMISTRY-US, V45, P11012, DOI 10.1021/bi0610146; BUTZ T, 1991, CHEM PHYS, V149, P437, DOI 10.1016/0301-0104(91)90043-S; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P313, DOI 10.1107/S0907444997010627; Costello AL, 2006, BIOCHEMISTRY-US, V45, P13650, DOI 10.1021/bi061547e; de Peredo AG, 2001, J MOL BIOL, V310, P83, DOI 10.1006/jmbi.2001.4769; de Seny D, 2002, BIOCHEM J, V363, P687, DOI 10.1042/0264-6021:3630687; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Dragani B, 1999, J MOL BIOL, V291, P481, DOI 10.1006/jmbi.1999.2965; Faller P, 2000, J BIOL INORG CHEM, V5, P393, DOI 10.1007/PL00010668; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garcia-Saez I, 2003, J BIOL CHEM, V278, P23868, DOI 10.1074/jbc.M301062200; Heinz U, 2005, J BIOL CHEM, V280, P3197, DOI 10.1074/jbc.M409425200; Heinz U, 2004, CELL MOL LIFE SCI, V61, P2827, DOI 10.1007/s00018-004-4214-9; Heinz U, 2003, J BIOL CHEM, V278, P20659, DOI 10.1074/jbc.M212581200; Hemmingsen L, 2004, CHEM REV, V104, P4027, DOI 10.1021/cr030030v; Hemmingsen L, 1996, EUR J BIOCHEM, V241, P546, DOI 10.1111/j.1432-1033.1996.00546.x; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; Hu ZX, 2008, BIOCHEMISTRY-US, V47, P7947, DOI 10.1021/bi8004768; Iranzo O, 2007, CHEM-EUR J, V13, P9178, DOI 10.1002/chem.200701208; Krezel A, 2007, J AM CHEM SOC, V129, P10911; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r; Melino S, 1998, TRENDS BIOCHEM SCI, V23, P381, DOI 10.1016/S0968-0004(98)01264-X; NATH U, 1995, BIOCHEMISTRY-US, V34, P1702, DOI 10.1021/bi00005a027; Nemirovskiy O, 1999, J AM SOC MASS SPECTR, V10, P711, DOI 10.1016/S1044-0305(99)00036-7; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pace C N, 1986, Methods Enzymol, V131, P266; Paul-Soto R, 1999, BIOCHEMISTRY-US, V38, P16500, DOI 10.1021/bi9911381; Paul-Soto R, 1998, FEBS LETT, V438, P137, DOI 10.1016/S0014-5793(98)01289-7; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; PAYNE DJ, 1994, BIOL MASS SPECTROM, V23, P159, DOI 10.1002/bms.1200230307; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Periyannan G, 2004, PROTEIN SCI, V13, P2236, DOI 10.1110/ps.04742704; Rossolini GM, 1998, BIOCHEM J, V332, P145, DOI 10.1042/bj3320145; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515; Selevsek N, 2006, J AM SOC MASS SPECTR, V17, P1000, DOI 10.1016/j.jasms.2006.03.010; Siemann S, 2002, BBA-GEN SUBJECTS, V1571, P190, DOI 10.1016/S0304-4165(02)00258-1; Troger W, 2000, HYPERFINE INTERACT, V129, P511, DOI 10.1023/A:1012646808055; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; van den Bremer ETJ, 2002, PROTEIN SCI, V11, P1738, DOI 10.1110/ps.0200502; Vessillier S, 2002, ANTIMICROB AGENTS CH, V46, P1921, DOI 10.1128/AAC.46.6.1921-1927.2002; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang F, 1999, J AM SOC MASS SPECTR, V10, P703, DOI 10.1016/S1044-0305(99)00039-2; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	51	28	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16419	16431		10.1074/jbc.M109.001305	http://dx.doi.org/10.1074/jbc.M109.001305			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19395380	hybrid, Green Published			2022-12-27	WOS:000266730900039
J	Estabrook, RA; Nguyen, TT; Fera, N; Reich, NO				Estabrook, R. August; Nguyen, Trung T.; Fera, Nickolas; Reich, Norbert O.			Coupling Sequence-specific Recognition to DNA Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION-ENDONUCLEASE; HHAL METHYLTRANSFERASE; TARGET BASE; MECHANISM; METHYLATION; BINDING; CATALYSIS; M.HHAI	Enzymes that modify DNA are faced with significant challenges in specificity for both substrate binding and catalysis. We describe how single hydrogen bonds between M. HhaI, a DNA cytosine methyltransferase, and its DNA substrate regulate the positioning of a peptide loop which is similar to 28 angstrom away. Stopped-flow fluorescence measurements of a tryptophan inserted into the loop provide real-time observations of conformational rearrangements. These long-range interactions that correlate with substrate binding and critically, enzyme turnover, will have broad application to enzyme specificity and drug design for this medically relevant class of enzymes.	[Estabrook, R. August; Nguyen, Trung T.; Fera, Nickolas; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Reich, NO (corresponding author), PSBN 1148, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu			National Institutes of Health [GM053763]; National Science Foundation [MCB-9983125]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053763. This work was also supported by National Science Foundation Grant MCB-9983125.	Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Estabrook RA, 2006, J BIOL CHEM, V281, P37205, DOI 10.1074/jbc.M607538200; Estabrook RA, 2004, J BIOL CHEM, V279, P31419, DOI 10.1074/jbc.M402950200; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; LI Y, 1991, BIOCHEMISTRY-US, V30, P7566, DOI 10.1021/bi00244a028; Lindstrom WM, 2000, J BIOL CHEM, V275, P4912, DOI 10.1074/jbc.275.7.4912; Martin AM, 1999, NAT STRUCT BIOL, V6, P269; Merkiene E, 2005, NUCLEIC ACIDS RES, V33, P307, DOI 10.1093/nar/gki175; O'Gara M, 1999, J MOL BIOL, V287, P201, DOI 10.1006/jmbi.1999.2608; Parry D, 2003, J MOL BIOL, V331, P1005, DOI 10.1016/S0022-2836(03)00861-1; Russo VEA, 1996, EPIGENETIC MECH GENE; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Svedruzic ZM, 2004, BIOCHEMISTRY-US, V43, P11460, DOI 10.1021/bi0496743; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wahnon DC, 2001, J AM CHEM SOC, V123, P976, DOI 10.1021/ja003285o; Youngblood B, 2006, BIOCHEMISTRY-US, V45, P15563, DOI 10.1021/bi061414t; Youngblood B, 2006, J MOL BIOL, V362, P334, DOI 10.1016/j.jmb.2006.07.031	21	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22690	22696		10.1074/jbc.M109.015966	http://dx.doi.org/10.1074/jbc.M109.015966			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19497854	Green Published, hybrid			2022-12-27	WOS:000268963100023
J	Mukherjee, S; Thomas, M; Dadgar, N; Lieberman, AP; Iniguez-Lluhi, JA				Mukherjee, Sarmistha; Thomas, Monzy; Dadgar, Nahid; Lieberman, Andrew P.; Iniguez-Lluhi, Jorge A.			Small Ubiquitin-like Modifier (SUMO) Modification of the Androgen Receptor Attenuates Polyglutamine-mediated Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BULBAR MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; E3 LIGASE ACTIVITY; GLUCOCORTICOID-RECEPTOR; TRANSCRIPTIONAL ACTIVITY; CELL-DEATH; NEURODEGENERATIVE DISEASE; SUBNUCLEAR LOCALIZATION; NUCLEAR-LOCALIZATION; KENNEDYS-DISEASE	The neurodegenerative disorder spinal and bulbar muscular atrophy or Kennedy disease is caused by a CAG trinucleotide repeat expansion within the androgen receptor (AR) gene. The resulting expanded polyglutamine tract in the N-terminal region of the receptor renders AR prone to ligand-dependent misfolding and formation of oligomers and aggregates that are linked to neuronal toxicity. How AR misfolding is influenced by post-translational modifications, however, is poorly understood. AR is a target of SUMOylation, and this modification inhibits AR activity in a promoter context-dependent manner. SUMOylation is up-regulated in response to multiple forms of cellular stress and may therefore play an important cytoprotective role. Consistent with this view, we find that gratuitous enhancement of overall SUMOylation significantly reduced the formation of polyglutamine-expanded AR aggregates without affecting the levels of the receptor. Remarkably, this effect requires SUMOylation of AR itself because it depends on intact AR SUMOylation sites. Functional analyses, however, indicate that the protective effects of enhanced AR SUMOylation are not due to alterations in AR transcriptional activity because a branched protein structure in the appropriate context of the N-terminal region of AR is necessary to antagonize aggregation but not for inhibiting AR transactivation. Remarkably, small ubiquitin-like modifier (SUMO) attenuates AR aggregation through a unique mechanism that does not depend on critical features essential for its interaction with canonical SUMO binding motifs. Our findings therefore reveal a novel function of SUMOylation and suggest that approaches that enhance AR SUMOylation may be of clinical use in polyglutamine expansion diseases.	[Mukherjee, Sarmistha; Iniguez-Lluhi, Jorge A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Thomas, Monzy; Dadgar, Nahid; Lieberman, Andrew P.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Iniguez-Lluhi, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	iniguez@umich.edu		Iniguez-Lluhi, Jorge/0000-0001-7010-089X	National Institutes of Health [DK61656-01]; USPHS [NS055746]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061656, R56DK061656, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61656-01 (to J. A. I.) and NS055746 (to A. P. L.) from the USPHS.	Abdel-Hafiz H, 2002, J BIOL CHEM, V277, P33950, DOI 10.1074/jbc.M204573200; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Azuma Y, 2002, DEV CELL, V2, P130, DOI 10.1016/S1534-5807(02)00124-7; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Chun TH, 2003, CIRC RES, V92, P1201, DOI 10.1161/01.RES.0000076893.70898.36; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; Chupreta S, 2007, J BIOL CHEM, V282, P36155, DOI 10.1074/jbc.M708130200; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Fischbeck KH, 2001, BRAIN RES BULL, V56, P161, DOI 10.1016/S0361-9230(01)00577-9; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kotaja N, 2002, J BIOL CHEM, V277, P17781, DOI 10.1074/jbc.M106354200; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lafevre-Bernt MA, 2003, J BIOL CHEM, V278, P34918, DOI 10.1074/jbc.M302841200; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Lieberman AP, 1999, ANN NEUROL, V46, P271, DOI 10.1002/1531-8249(199908)46:2<271::AID-ANA21>3.0.CO;2-M; Lieberman AP, 2004, EXP NEUROL, V185, P204, DOI 10.1016/j.expneurol.2003.10.009; Lieberman AP, 2000, MUSCLE NERVE, V23, P843, DOI 10.1002/(SICI)1097-4598(200006)23:6<843::AID-MUS2>3.0.CO;2-8; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; Mullen JR, 2008, J BIOL CHEM, V283, P19912, DOI 10.1074/jbc.M802690200; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Palacios S, 2005, MOL BIOL CELL, V16, P2822, DOI 10.1091/mbc.E04-11-1005; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Riley BE, 2005, J BIOL CHEM, V280, P21942, DOI 10.1074/jbc.M501677200; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Sharma D, 2005, PROTEINS, V61, P398, DOI 10.1002/prot.20602; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Tanaka M, 2001, J BIOL CHEM, V276, P45470, DOI 10.1074/jbc.M107502200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Terashima T, 2002, NEUROREPORT, V13, P2359, DOI 10.1097/00001756-200212030-00038; Thomas M, 2005, J BIOL CHEM, V280, P21264, DOI 10.1074/jbc.M500144200; Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; YANG W, 2007, J CEREB BLOOD FLOW M; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zheng G, 2004, J BIOL CHEM, V279, P42410, DOI 10.1074/jbc.M407287200; Zheng Z, 2006, J BIOL CHEM, V281, P4002, DOI 10.1074/jbc.M509260200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	84	67	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21296	21306		10.1074/jbc.M109.011494	http://dx.doi.org/10.1074/jbc.M109.011494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19497852	Green Published, hybrid			2022-12-27	WOS:000268564400024
J	Tchesnokov, EP; Obikhod, A; Massud, I; Lisco, A; Vanpouille, C; Brichacek, B; Balzarini, J; McGuigan, C; Derudas, M; Margolis, L; Schinazi, RF; Gotte, M				Tchesnokov, Egor P.; Obikhod, Aleksandr; Massud, Ivana; Lisco, Andrea; Vanpouille, Christophe; Brichacek, Beda; Balzarini, Jan; McGuigan, Christopher; Derudas, Marco; Margolis, Leonid; Schinazi, Raymond F.; Goette, Matthias			Mechanisms Associated with HIV-1 Resistance to Acyclovir by the V75I Mutation in Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; MOLECULAR-MECHANISMS; DRUG-RESISTANCE; DOUBLE-BLIND; POLYMERASE TRANSLOCATION; MULTIDRUG-RESISTANCE; CONFERS RESISTANCE; NUCLEOTIDE ANALOGS; PRIMER UNBLOCKING; INHIBITORS NRTIS	It has recently been demonstrated that the anti-herpetic drug acyclovir (ACV) also displays antiviral activity against the human immunodeficiency virus type 1 (HIV-1). The triphosphate form of ACV is accepted by HIV-1 reverse transcriptase (RT), and subsequent incorporation leads to classical chain termination. Like all approved nucleoside analogue RT inhibitors (NRTIs), the selective pressure of ACV is associated with the emergence of resistance. The V75I mutation in HIV-1 RT appears to be dominant in this regard. By itself, this mutation is usually not associated with resistance to currently approved NRTIs. Here we studied the underlying biochemical mechanism. We demonstrate that V75I is also selected under the selective pressure of a monophosphorylated prodrug that was designed to bypass the bottleneck in drug activation to the triphosphate form (ACV-TP). Pre-steady-state kinetics reveal that V75I discriminates against the inhibitor at the level of catalysis, whereas binding of the inhibitor remains largely unaffected. The incorporated ACV-monophosphate (ACV-MP) is vulnerable to excision in the presence of the pyrophosphate donor ATP. V75I compromises binding of the next nucleotide that can otherwise provide a certain degree of protection from excision. Collectively, the results of this study suggest that ACV is sensitive to two different resistance pathways, which warrants further investigation regarding the detailed resistance profile of ACV. Such studies will be crucial in assessing the potential clinical utility of ACV and its derivatives in combination with established NRTIs.	[Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Obikhod, Aleksandr; Massud, Ivana; Schinazi, Raymond F.] Emory Univ, Sch Med & Vet Affairs Med Res, Dept Pediat, Ctr AIDS Res, Atlanta, GA 30322 USA; [Lisco, Andrea; Vanpouille, Christophe; Brichacek, Beda; Margolis, Leonid] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [McGuigan, Christopher; Derudas, Marco] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3NB, S Glam, Wales	McGill University; Emory University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); KU Leuven; Cardiff University	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca	; McGuigan, Chris/P-1580-2014	Lisco, Andrea/0000-0002-1475-356X; Derudas, Marco/0000-0003-1731-2855; McGuigan, Chris/0000-0001-8409-710X	National Institutes of Health [5R37-AI-041980, 4R37-AI-025899, 5P30-AI-50409]; NICHD; Canadian Institutes for Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R37AI041980, R37AI025899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R37-AI-041980, 4R37-AI-025899, and 5P30-AI-50409 (Centers for AIDS Research; to R. F. S.) and by the NICHD Intramural Program (to A. L., C. V., B. B., and L. M.). This study was also supported by the Canadian Institutes for Health Research.	Bacon TH, 2003, CLIN MICROBIOL REV, V16, P114, DOI 10.1128/CMR.16.1.114-128.2003; Basavapathruni A, 2007, FASEB J, V21, P3795, DOI 10.1096/fj.07-8697rev; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Burgess K, 2000, CHEM REV, V100, P2047, DOI 10.1021/cr990045m; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Conant MA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/0956462021924550; COOPER DA, 1993, AIDS, V7, P197, DOI 10.1097/00002030-199302000-00007; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; DERSE D, 1981, J BIOL CHEM, V256, P1447; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Dharmasena S, 2007, BIOCHEMISTRY-US, V46, P828, DOI 10.1021/bi061364s; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; FURMAN PA, 1981, ANTIMICROB AGENTS CH, V20, P518, DOI 10.1128/AAC.20.4.518; FURMAN PA, 1979, J VIROL, V32, P72, DOI 10.1128/JVI.32.1.72-77.1979; FURMAN PA, 1984, J BIOL CHEM, V259, P9575; FYFE JA, 1978, J BIOL CHEM, V253, P8721; Gilbert C, 2002, DRUG RESIST UPDATE, V5, P88, DOI 10.1016/S1368-7646(02)00021-3; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Gotte Matthias, 2004, Expert Rev Anti Infect Ther, V2, P707, DOI 10.1586/14789072.2.5.707; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; KATI WM, 1992, J BIOL CHEM, V267, P25988; KELLER PM, 1985, J BIOL CHEM, V260, P8664; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; LACEY SF, 1994, ANTIMICROB AGENTS CH, V38, P1428, DOI 10.1128/AAC.38.6.1428; LACEY SF, 1992, J BIOL CHEM, V267, P15789; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; Lisco A, 2008, CELL HOST MICROBE, V4, P260, DOI 10.1016/j.chom.2008.07.008; Marchand B, 2004, INT J BIOCHEM CELL B, V36, P1823, DOI 10.1016/j.biocel.2004.02.029; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Matamoros T, 2008, J MOL BIOL, V375, P1234, DOI 10.1016/j.jmb.2007.11.021; McGuigan C, 2008, BIOORG MED CHEM LETT, V18, P4364, DOI 10.1016/j.bmcl.2008.06.069; McMahon MA, 2008, J BIOL CHEM, V283, P31289, DOI 10.1074/jbc.C800188200; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 2004, J BIOL CHEM, V279, P45389, DOI 10.1074/jbc.M405072200; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Miller MD, 2001, NUCLEOS NUCLEOT NUCL, V20, P1025, DOI 10.1081/NCN-100002483; MILLER WH, 1982, BIOCHEM PHARMACOL, V31, P3879, DOI 10.1016/0006-2952(82)90305-7; MILLER WH, 1980, J BIOL CHEM, V255, P7204; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Ray AS, 2003, BIOCHEMISTRY-US, V42, P8831, DOI 10.1021/bi034435l; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; SARAFIANOS SG, 1995, BIOCHEMISTRY-US, V34, P7207, DOI 10.1021/bi00021a036; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Selmi B, 2001, J BIOL CHEM, V276, P13965, DOI 10.1074/jbc.M009837200; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Sluis-Cremer N, 2005, J BIOL CHEM, V280, P29047, DOI 10.1074/jbc.M503166200; Sluis-Cremer N, 2000, CELL MOL LIFE SCI, V57, P1408, DOI 10.1007/PL00000626; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Snoeck J, 2005, J VIROL METHODS, V128, P47, DOI 10.1016/j.jviromet.2005.04.001; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; UENO T, 1995, J BIOL CHEM, V270, P23605, DOI 10.1074/jbc.270.40.23605; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	62	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21496	21504		10.1074/jbc.M109.024026	http://dx.doi.org/10.1074/jbc.M109.024026			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509419	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000268564400044
J	Congdon, EE; Figueroa, YH; Wang, LL; Toneva, G; Chang, E; Kuret, J; Conrad, C; Duff, KE				Congdon, Erin E.; Figueroa, Yvette H.; Wang, Lili; Toneva, Galina; Chang, Edward; Kuret, Jeff; Conrad, Christopher; Duff, Karen E.			Inhibition of Tau Polymerization with a Cyanine Dye in Two Distinct Model Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; ALZHEIMER-DISEASE; CELL MODELS; PHOTOPHYSICAL PROPERTIES; TRANSGENIC MICE; NEURONAL LOSS; IN-VITRO; AGGREGATION; TAUOPATHY	In a host of neurodegenerative diseases Tau, a microtubule-associated protein, aggregates into insoluble lesions within neurons. Previous studies have utilized cyanine dyes as Tau aggregation inhibitors in vitro. Herein we utilize cyanine dye 3,3'-diethyl-9-methyl-thiacarbocyanine iodide (C11) to modulate Tau polymerization in two model systems, an organotypic slice culture model derived from Tau transgenic mice and a split green fluorescent protein complementation assay in Tau-expressing cells. In slice cultures, submicromolar concentrations (0.001 mu M) of C11 produced a significant reduction of aggregated Tau and a corresponding increase in unpolymerized Tau. In contrast, treatment with a 1 mu M dose promoted aggregation of Tau. These results were recapitulated in the complementation assay where administration of 1 mu M C11 produced a significant increase in polymerized Tau relative to control, whereas treatment of cells with 0.01 mu M C11 resulted in a marked reduction of aggregated Tau. In the organotypic slice cultures, modulation of Tau aggregation was independent of changes in phosphorylation at disease and microtubule binding relevant epitopes for both dosing regimes. Furthermore, treatment with 0.001 mu M C11 resulted in a decrease in both total filament mass and number. There was no evidence of apoptosis or loss of synaptic integrity at either dose, however, whereas submicromolar concentrations of C11 did not interfere with microtubule binding, higher doses resulted in a decrease in the levels of microtubule-bound Tau. Overall, a cyanine dye can dissociate aggregated Tau in an ex vivo model of tauopathy with little toxicity and exploration of the use of these type of dyes as therapeutic agents is warranted.	[Duff, Karen E.] Columbia Univ, Med Ctr, Taub Inst, Dept Pathol, New York, NY 10032 USA; [Congdon, Erin E.; Figueroa, Yvette H.; Wang, Lili; Toneva, Galina; Conrad, Christopher; Duff, Karen E.] New York State Psychiat Inst & Hosp, Dept Integrat Neurosci, New York, NY 10032 USA; [Chang, Edward] Ohio State Univ, Integrated Biomed Sci Program, Columbus, OH 43210 USA; [Kuret, Jeff] Ohio State Univ, Dept Cellular & Mol Biol, Columbus, OH 43210 USA	Columbia University; New York State Psychiatry Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Duff, KE (corresponding author), Columbia Univ, Med Ctr, Taub Inst, Dept Pathol, P&S 12th Floor,Rm 12-461, New York, NY 10032 USA.	ked2115@columbia.edu	Duff, Karen EK/C-2510-2009	Duff, Karen/0000-0002-6177-868X; Congdon, Erin/0000-0001-8322-6176	National Institutes of Health [NS047447, AG14452]; NINDS; Alzheimer Drug Discovery Foundation/Institute for the Study of Aging; Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research New Investigator Award in Alzheimer Disease; American Health Assistance Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer Drug Discovery Foundation/Institute for the Study of Aging; Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research New Investigator Award in Alzheimer Disease; American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047447 (to K. D.) and AG14452 (to J.K.) from the NINDS. This work was also supported by the Alzheimer Drug Discovery Foundation/Institute for the Study of Aging, a Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research New Investigator Award in Alzheimer Disease, and the American Health Assistance Foundation.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; CALLAHAN LM, 1995, NEUROBIOL AGING, V16, P311, DOI 10.1016/0197-4580(95)00035-D; Callahan LM, 2002, J NEUROPATH EXP NEUR, V61, P384, DOI 10.1093/jnen/61.5.384; Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P158, DOI 10.1097/nen.0b013e3180303b93; CHANG E, 2009, J MED CHEM IN PRESS; Chirita C, 2004, BIOCHEMISTRY-US, V43, P2879, DOI 10.1021/bi036094h; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chun WJ, 2007, J NEUROCHEM, V103, P2529, DOI 10.1111/j.1471-4159.2007.04941.x; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Congdon EE, 2007, ARCH BIOCHEM BIOPHYS, V465, P127, DOI 10.1016/j.abb.2007.05.004; CRAS P, 1995, ACTA NEUROPATHOL, V89, P291; Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Duff K, 2002, J MOL NEUROSCI, V19, P317, DOI 10.1385/JMN:19:3:317; Eckermann K, 2007, J BIOL CHEM, V282, P31755, DOI 10.1074/jbc.M705282200; Farah CA, 2006, CELL MOTIL CYTOSKEL, V63, P710, DOI 10.1002/cm.20157; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Khlistunova I, 2007, CURR ALZHEIMER RES, V4, P544, DOI 10.2174/156720507783018307; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Licha K, 2000, PHOTOCHEM PHOTOBIOL, V72, P392, DOI 10.1562/0031-8655(2000)072<0392:HCDACA>2.0.CO;2; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Necula M, 2005, BIOCHEMISTRY-US, V44, P10227, DOI 10.1021/bi050387o; Necula M, 2004, ANAL BIOCHEM, V329, P238, DOI 10.1016/j.ab.2004.02.023; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Perez M, 2003, J ALZHEIMERS DIS, V5, P301, DOI 10.3233/JAD-2003-5405; Petrov NK, 2003, J PHYS CHEM A, V107, P6341, DOI 10.1021/jp0345654; Pickhardt A, 2007, CURR ALZHEIMER RES, V4, P397, DOI 10.2174/156720507781788765; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Pickhardt M, 2007, BIOCHEMISTRY-US, V46, P10016, DOI 10.1021/bi700878g; Rankin CA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-12; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Smith DL, 2001, NEUROBIOL DIS, V8, P1017, DOI 10.1006/nbdi.2001.0438; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tsai CC, 2006, SHOCK, V26, P601, DOI 10.1097/01.shk.0000230298.01387.d8; Tseng HY, 2005, BIOORG MED CHEM LETT, V15, P2027, DOI 10.1016/j.bmcl.2005.02.063; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Volkova KD, 2007, J BIOCHEM BIOPH METH, V70, P727, DOI 10.1016/j.jbbm.2007.03.008; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213	53	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20830	20839		10.1074/jbc.M109.016089	http://dx.doi.org/10.1074/jbc.M109.016089			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19478088	Green Published, hybrid			2022-12-27	WOS:000268316100046
J	Kang, HJ; Baker, EN				Kang, Hae Joo; Baker, Edward N.			Intramolecular Isopeptide Bonds Give Thermodynamic and Proteolytic Stability to the Major Pilin Protein of Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN; CROSS-LINKING; COLLAGEN; BINDING; DOMAIN; MODEL; REFINEMENT; LYSOZYME; CAPSIDS	The pili expressed by Streptococcus pyogenes and certain other Gram-positive bacterial pathogens are based on a polymeric backbone in which individual pilin subunits are joined end-to-end by covalent isopeptide bonds through the action of sortase enzymes. The crystal structure of the major pilin of S. pyogenes, Spy0128, revealed that each domain of the two domain protein contained an intramolecular isopeptide bond cross-link joining a Lys side chain to an Asn side chain. In the present work, mutagenesis was used to create mutant proteins that lacked either one isopeptide bond (E117A, N168A, and E258A mutants) or both isopeptide bonds (E117A/E258A). Both the thermal stability and proteolytic stability of Spy0128 were severely compromised by loss of the isopeptide bonds. Unfolding experiments, monitored by circular dichroism, revealed a transition temperature T-m of 85 degrees C for the wild type protein. In contrast, mutants with only one isopeptide bond showed biphasic unfolding, with the domain lacking an isopeptide bond having a T-m that was similar to 30 degrees C lower than the unaltered domain. High resolution crystal structures of the E117A and N168A mutants showed that the loss of an isopeptide bond did not change the overall pilin structure but caused local disturbance of the protein core that was greater for E117A than for N168A. These effects on stability appear also to be important for pilus assembly.	[Kang, Hae Joo; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Baker, Edward N.] Univ Auckland, Dept Chem, Auckland 1142, New Zealand	University of Auckland; University of Auckland	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz	Kang, H J/D-4845-2009	Baker, Edward/0000-0003-2456-7661	Health Research Council of New Zealand; Centres of Research Excellence	Health Research Council of New Zealand(Health Research Council of New Zealand); Centres of Research Excellence	This work was supported by the Health Research Council of New Zealand and Centres of Research Excellence funding to the Maurice Wilkins Centre of Molecular Biodiscovery.	Brockwell DJ, 2005, BIOPHYS J, V89, P506, DOI 10.1529/biophysj.105.061465; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dierkes LE, 2009, J VIROL, V83, P2088, DOI 10.1128/JVI.02000-08; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman JR, 2007, CURR OPIN STRUC BIOL, V17, P58, DOI 10.1016/j.sbi.2007.01.006; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; LANCEFIELD RC, 1946, J EXP MED, V84, P449, DOI 10.1084/jem.84.5.449; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng SP, 2005, J MOL BIOL, V350, P776, DOI 10.1016/j.jmb.2005.04.070; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; SCHNEEWIND O, 1990, J BACTERIOL, V172, P3310, DOI 10.1128/jb.172.6.3310-3317.1990; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Trevino SR, 2005, J MOL BIOL, V354, P967, DOI 10.1016/j.jmb.2005.09.091; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	32	85	87	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20729	20737		10.1074/jbc.M109.014514	http://dx.doi.org/10.1074/jbc.M109.014514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497855	Green Published, hybrid			2022-12-27	WOS:000268316100035
J	Kleyman, TR; Carattino, MD; Hughey, RP				Kleyman, Thomas R.; Carattino, Marcelo D.; Hughey, Rebecca P.			ENaC at the Cutting Edge: Regulation of Epithelial Sodium Channels by Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SURFACE LIQUID VOLUME; GAMMA-SUBUNIT; NA+ CHANNEL; CYSTIC-FIBROSIS; XENOPUS-OOCYTES; ALPHA-SUBUNIT; RAT-KIDNEY; PROTEOLYTIC ACTIVATION; ELASTASE ACTIVATION; SERINE PROTEASES	Epithelial Na+ channels facilitate the transport of Na+ across high resistance epithelia. Proteolytic cleavage has an important role in regulating the activity of these channels by increasing their open probability. Specific proteases have been shown to activate epithelial Na+ channels by cleaving channel subunits at defined sites within their extracellular domains. This minireview addresses the mechanisms by which proteases activate this channel and the question of why proteolysis has evolved as a mechanism of channel activation.	[Kleyman, Thomas R.; Carattino, Marcelo D.; Hughey, Rebecca P.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.; Hughey, Rebecca P.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, 930 Scaife Hall, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu			National Institutes of Health [R56 DK065161]; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R56 DK065161. This work was also supported by a Carl W. Gottschalk award from the American Society of Nephrology (to M. D. C.).	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bengrine A, 2007, J BIOL CHEM, V282, P26884, DOI 10.1074/jbc.M611829200; Blazer-Yost BL, 2004, ADV EXP MED BIOL, V559, P359; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Frindt G, 2008, J GEN PHYSIOL, V131, P617, DOI 10.1085/jgp.200809989; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Narikiyo T, 2002, J CLIN INVEST, V109, P401, DOI 10.1172/JCI13229; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; ORCE GG, 1980, AM J PHYSIOL, V239, pF459, DOI 10.1152/ajprenal.1980.239.5.F459; PACHA J, 1993, J GEN PHYSIOL, V102, P25, DOI 10.1085/jgp.102.1.25; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Picard N, 2008, J BIOL CHEM, V283, P4602, DOI 10.1074/jbc.M705664200; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787	47	227	230	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20447	20451		10.1074/jbc.R800083200	http://dx.doi.org/10.1074/jbc.R800083200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19401469	hybrid, Green Published			2022-12-27	WOS:000268316100004
J	Murakami, T; Felinski, EA; Antonetti, DA				Murakami, Tomoaki; Felinski, Edward A.; Antonetti, David A.			Occludin Phosphorylation and Ubiquitination Regulate Tight Junction Trafficking and Vascular Endothelial Growth Factor-induced Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; DIABETIC-RETINOPATHY; EPITHELIAL-CELLS; PARACELLULAR PERMEABILITY; MEMBRANE-PROTEIN; LIGASE ITCH; MECHANISMS; MICE; INTERNALIZATION; ENDOCYTOSIS	Vascular endothelial growth factor (VEGF) alters tight junctions (TJs) and promotes vascular permeability in many retinal and brain diseases. However, the molecular mechanisms of barrier regulation are poorly understood. Here we demonstrate that occludin phosphorylation and ubiquitination regulate VEGF-induced TJ protein trafficking and concomitant vascular permeability. VEGF treatment induced TJ fragmentation and occludin trafficking from the cell border to early and late endosomes, concomitant with increased occludin phosphorylation on Ser-490 and ubiquitination. Furthermore, both co-immunoprecipitation and immunocytochemistry demonstrated that VEGF treatment increased the interaction between occludin and modulators of intracellular trafficking that contain the ubiquitin interacting motif, including Epsin-1, epidermal growth factor receptor pathway substrate 15 (Eps15), and hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs). Inhibiting occludin phosphorylation by mutating Ser-490 to Ala suppressed VEGF-induced ubiquitination, inhibited trafficking of TJ proteins, and prevented the increase in endothelial permeability. In addition, an occludin-ubiquitin chimera disrupted TJs and increased permeability without VEGF. These data demonstrate a novel mechanism of VEGF- induced occludin phosphorylation and ubiquitination that contributes to TJ trafficking and subsequent vascular permeability.	[Murakami, Tomoaki; Felinski, Edward A.; Antonetti, David A.] Penn State Coll Med, Dept Cellular & Mol Physiol & Ophthalmol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Antonetti, DA (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol & Ophthalmol, Hershey, PA 17033 USA.	dantonetti@psu.edu		antonetti, david/0000-0003-1130-6577	National Institutes of Health [EY 016413, EY 012021]; Juvenile Diabetes Research Foundation International; NATIONAL EYE INSTITUTE [R01EY012021, R01EY016413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY 016413 and EY 012021 (to D. A. A.). This work was also supported by the Juvenile Diabetes Research Foundation International (to D. A. A.).	Aiello LP, 1997, INVEST OPHTH VIS SCI, V38, P1647; Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Antonetti David A, 2003, Methods Mol Med, V89, P365; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Bojarski C, 2004, J CELL SCI, V117, P2097, DOI 10.1242/jcs.01071; Chang YS, 2000, MICROVASC RES, V59, P265, DOI 10.1006/mvre.1999.2225; Dallasta LM, 1999, AM J PATHOL, V155, P1915, DOI 10.1016/S0002-9440(10)65511-3; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Dorrell M, 2007, SURV OPHTHALMOL, V52, pS3, DOI 10.1016/j.survophthal.2006.10.017; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Dvorak AM, 1996, J LEUKOCYTE BIOL, V59, P100, DOI 10.1002/jlb.59.1.100; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gardner TW, 2008, CURR DIABETES REP, V8, P263, DOI 10.1007/s11892-008-0047-5; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Harhaj NS, 2006, INVEST OPHTH VIS SCI, V47, P5106, DOI 10.1167/iovs.06-0322; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hirase T, 1997, J CELL SCI, V110, P1603; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Lui WY, 2005, J CELL PHYSIOL, V203, P564, DOI 10.1002/jcp.20254; Machein MR, 2000, J NEURO-ONCOL, V50, P109, DOI 10.1023/A:1006416003964; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Phillips BE, 2008, INVEST OPHTH VIS SCI, V49, P2568, DOI 10.1167/iovs.07-1204; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Sundstrom JM, 2009, J PROTEOME RES, V8, P808, DOI 10.1021/pr7007913; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Yamamura R, 2008, MOL BIOL CELL, V19, P971, DOI 10.1091/mbc.E07-06-0551	51	258	265	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21036	21046		10.1074/jbc.M109.016766	http://dx.doi.org/10.1074/jbc.M109.016766			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19478092	Green Published, hybrid			2022-12-27	WOS:000268316100066
J	Poeckel, D; Berry, KAZ; Murphy, RC; Funk, CD				Poeckel, Daniel; Berry, Karin A. Zemski; Murphy, Robert C.; Funk, Colin D.			Dual 12/15-and 5-Lipoxygenase Deficiency in Macrophages Alters Arachidonic Acid Metabolism and Attenuates Peritonitis and Atherosclerosis in ApoE Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRORESOLVING LIPID MEDIATORS; LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-E; IN-VIVO; 12/15-LIPOXYGENASE EXPRESSION; LEUKOTRIENE BIOSYNTHESIS; CYSTEINYL LEUKOTRIENES; TARGETED DISRUPTION; HUMAN NEUTROPHILS; INFLAMMATION	Lipoxygenase (LO) enzymes catalyze the conversion of arachidonic acid (AA) into biologically active lipid mediators. Two members, 12/15-LO and 5-LO, regulate inflammatory responses and have been studied for their roles in atherogenesis. Both 12/15-LO and 5- LO inhibitors have been suggested as potential therapy to limit the development of atherosclerotic lesions. Here we used a genetic strategy to disrupt both 12/15-LO and 5-LO on an apolipoprotein E (apoE) atherosclerosis-susceptible background to study the impact of dual LO blockade in atherosclerosis and inflammation. Resident peritoneal macrophages are the major cell type that expresses both LO enzymes, and we verified their absence in dual LO-deficient mice. Examination of AA conversion by phorbol myristate acetate-primed and A23187-challenged macrophages from dual LO-deficient mice revealed extensive accumulation of AA with virtually no diversion into the most common cyclooxygenase (COX) products measured (prostaglandin E-2 and thromboxane B-2). Instead the COX-1 by-products 11-hydroxy-eicosatetraenoic acid ( HETE) and 15-HETE were elevated. The interrelationship between the two LO pathways in combination with COX-1 inhibition (SC-560) also revealed striking patterns of unique substrate utilization. 5-LO- and dual LO-deficient mice exhibited an attenuated response to zymosan-induced peritoneal inflammation, emphasizing roles for 5- LO in regulating vascular permeability. We observed gender-specific attenuation of atheroma formation at 6 months of age at both the aortic root and throughout the entire aorta in chow-fed female dual LO-deficient mice. We propose that some of the inconsistent data obtained with single LO-deficient mice could be attributable to macrophage-specific patterns of altered AA metabolism.	[Poeckel, Daniel; Funk, Colin D.] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada; [Berry, Karin A. Zemski; Murphy, Robert C.] Univ Colorado Denver, Div Cell Biol, Aurora, CO 80045 USA; [Berry, Karin A. Zemski; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	Queens University - Canada; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Funk, CD (corresponding author), Queens Univ, Dept Physiol, Botterell Hall, Kingston, ON K7L 3N6, Canada.	funkc@queensu.ca	Murphy, Robert/AAO-5349-2020; Funk, Colin D/A-9518-2010	Murphy, Robert/0000-0002-9430-6515; Funk, Colin/0000-0001-7029-4233	NIGMS, LipidMaps [GM069338]; German Research Foundation (Deutsche Forschungsgemeinschaft) [PO 1308/1]; Canadian Institutes of Health Research [MOP-67146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NIGMS, LipidMaps(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069338 from the NIGMS, LipidMaps. This work was also supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Postdoctoral Fellowship PO 1308/1 (to D. P.) and Canadian Institutes of Health Research Grant MOP-67146 (to C. D. F.).	BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Byrum RS, 1999, J IMMUNOL, V163, P6810; Cao RY, 2009, ATHEROSCLEROSIS, V203, P395, DOI 10.1016/j.atherosclerosis.2008.07.045; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Conrad DJ, 1999, CLIN REV ALLERG IMMU, V17, P71, DOI 10.1007/BF02737598; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; DOHERTY NS, 1985, PROSTAGLANDINS, V30, P769, DOI 10.1016/0090-6980(85)90006-1; Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Funk CD, 2001, TRENDS CARDIOVAS MED, V11, P116; FUNK CD, 1995, ADV PROSTAG THROMB L, V23, P145; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; GOWN AM, 1986, AM J PATHOL, V125, P191; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; HARRISON KA, 1995, J BIOL CHEM, V270, P17273, DOI 10.1074/jbc.270.29.17273; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Heydeck D, 1998, BLOOD, V92, P2503, DOI 10.1182/blood.V92.7.2503.2503_2503_2510; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Luo M, 2006, BBA-MOL CELL BIOL L, V1761, P618, DOI 10.1016/j.bbalip.2006.02.018; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Moghadasian MH, 2001, FASEB J, V15, P2623, DOI 10.1096/fj.01-0463com; Moos MPW, 2008, TRENDS CARDIOVAS MED, V18, P268, DOI 10.1016/j.tcm.2008.11.009; Murphy RC, 2005, ANAL BIOCHEM, V346, P1, DOI 10.1016/j.ab.2005.04.042; NEUFELD EJ, 1985, J CELL BIOL, V101, P573, DOI 10.1083/jcb.101.2.573; Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105; Radmark O, 2002, PROSTAG OTH LIPID M, V68-9, P211, DOI 10.1016/S0090-6980(02)00032-1; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; RANDALL RW, 1994, AGENTS ACTIONS, V43, P176, DOI 10.1007/BF01986685; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sendobry SM, 1998, J IMMUNOL, V161, P1477; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; Turchyn LR, 2007, COMPARATIVE MED, V57, P574; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; VANREE JH, 1994, ATHEROSCLEROSIS, V111, P25, DOI 10.1016/0021-9150(94)90188-0; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412; Zarini S, 2006, J BIOL CHEM, V281, P10134, DOI 10.1074/jbc.M510783200; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	60	67	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21077	21089		10.1074/jbc.M109.000901	http://dx.doi.org/10.1074/jbc.M109.000901			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509298	hybrid, Green Published			2022-12-27	WOS:000268316100070
J	Wang, Q; Rajshankar, D; Branch, DR; Siminovitch, KA; Abreu, MTH; Downey, GP; McCulloch, CA				Wang, Qin; Rajshankar, Dhaarmini; Branch, Donald R.; Siminovitch, Katherine A.; Abreu, Maria Teresa Herrera; Downey, Gregory P.; McCulloch, Christopher A.			Protein-tyrosine Phosphatase-alpha and Src Functionally Link Focal Adhesions to the Endoplasmic Reticulum to Mediate Interleukin-1-induced Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; GENE-EXPRESSION; PTP-ALPHA; PLASMA-MEMBRANE; FAMILY KINASES; GROWTH-FACTOR; IP3 RECEPTOR; RPTP-ALPHA; C-SRC; PHOSPHORYLATION	Calcium (Ca2+) signaling by the pro-inflammatory cytokine interleukin-1 (IL-1) is dependent on focal adhesions, which contain diverse structural and signaling proteins including protein phosphatases. We examined here the role of protein-tyrosine phosphatase (PTP) alpha in regulating IL-1-induced Ca2+ signaling in fibroblasts. IL-1 promoted recruitment of PTP alpha to focal adhesions and endoplasmic reticulum (ER) fractions, as well as tyrosine phosphorylation of the ER Ca2+ release channel IP3R. In response to IL-1, catalytically active PTP alpha was required for Ca2+ release from the ER, Src-dependent phosphorylation of IP(3)R1 and accumulation of IP(3)R1 in focal adhesions. In pull-down assays and immunoprecipitations PTP alpha was required for the association of PTP alpha with IP(3)R1 and c-Src, and this association was increased by IL-1. Collectively, these data indicate that PTP alpha acts as an adaptor to mediate functional links between focal adhesions and the ER that enable IL-1-induced Ca2+ signaling.	[Wang, Qin; Rajshankar, Dhaarmini; Abreu, Maria Teresa Herrera; McCulloch, Christopher A.] Univ Toronto, Fac Dent, Canadian Inst Hlth Res Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada; [Branch, Donald R.] Canadian Blood Serv, Toronto, ON M5G 2M1, Canada; [Siminovitch, Katherine A.] Samuel Lunenfeld Inst, Toronto, ON M5G 1X5, Canada; [Downey, Gregory P.] Univ Toronto, Dept Med, Div Respirol, Toronto, ON M5G 1L7, Canada; [Downey, Gregory P.] Univ Colorado, Denver Hlth Sci Ctr, Div Pulm & Crit Care Med, Natl Jewish Hlth, Denver, CO 80206 USA	University of Toronto; Canadian Blood Services; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	McCulloch, CA (corresponding author), Univ Toronto, Fac Dent, Canadian Inst Hlth Res Grp Matrix Dynam, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca	Siminovitch, Katherine/K-1475-2013	Downey, Gregory P/0000-0003-3253-5862	Canadian Institutes of Health Research; Canada Research Chairs Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054899, F32GM019739] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Canadian Institutes of Health Research Operating grant (to G. P. D. and C. A. M.).; Supported by the Canada Research Chairs Program.	Abreu MTH, 2008, AM J PHYSIOL-CELL PH, V294, pC931, DOI 10.1152/ajpcell.00359.2007; Aplin AE, 1999, J CELL SCI, V112, P695; ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Boyle DL, 1997, ARTHRITIS RHEUM, V40, P1772, DOI 10.1002/art.1780401008; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Caron JP, 1996, AM J VET RES, V57, P1631; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Cui J, 2004, J BIOL CHEM, V279, P16311, DOI 10.1074/jbc.M400206200; Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Edwards A, 2007, AM J PHYSIOL-RENAL, V293, pF1518, DOI 10.1152/ajprenal.00251.2007; FAGARASAN MO, 1990, P NATL ACAD SCI USA, V87, P7871, DOI 10.1073/pnas.87.20.7871; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Hamid QA, 2000, CYTOKINE, V12, P1609, DOI 10.1006/cyto.2000.0676; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; ILLC D, 1995, NATURE, V377, P539; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; KHAN AA, 1992, P NATL ACAD SCI USA, V89, P2849, DOI 10.1073/pnas.89.7.2849; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KUMKUMIAN GK, 1989, J IMMUNOL, V143, P833; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; Li LW, 2000, SEMIN IMMUNOL, V12, P75, DOI 10.1006/smim.2000.0209; Lim KL, 1997, EUR J BIOCHEM, V245, P693, DOI 10.1111/j.1432-1033.1997.00693.x; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; Mak DOD, 2001, J GEN PHYSIOL, V117, P435, DOI 10.1085/jgp.117.5.435; McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109; Miyakawa T, 2001, EMBO J, V20, P1674, DOI 10.1093/emboj/20.7.1674; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pieper AA, 2001, NEUROSCIENCE, V102, P433, DOI 10.1016/S0306-4522(00)00470-X; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Sugiyama T, 2000, FEBS LETT, V466, P29, DOI 10.1016/S0014-5793(99)01732-9; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Tanimura A, 2000, J BIOL CHEM, V275, P27488; Vacaresse N, 2008, J BIOL CHEM, V283, P35815, DOI 10.1074/jbc.M807964200; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang Q, 2005, FASEB J, V19, P837, DOI 10.1096/fj.04-2657fje; Wang Q, 2005, J BIOL CHEM, V280, P8397, DOI 10.1074/jbc.M410462200; Wang Q, 2003, FASEB J, V17, pA1072; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; WANG Y, 1991, EMBO J, V10, P3231, DOI 10.1002/j.1460-2075.1991.tb04886.x; Weng LP, 1999, GENES CELLS, V4, P185, DOI 10.1046/j.1365-2443.1999.00251.x; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	72	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20763	20772		10.1074/jbc.M808828200	http://dx.doi.org/10.1074/jbc.M808828200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497848	hybrid, Green Published			2022-12-27	WOS:000268316100038
J	Bains, M; Florez-McClure, ML; Heidenreich, KA				Bains, Mona; Florez-McClure, Maria L.; Heidenreich, Kim A.			Insulin-like Growth Factor-I Prevents the Accumulation of Autophagic Vesicles and Cell Death in Purkinje Neurons by Increasing the Rate of Autophagosome-to-lysosome Fusion and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; CEREBELLAR GRANULE NEURONS; PROTEIN-KINASE; ALZHEIMERS-DISEASE; SIGNALING PATHWAYS; GLUTAMATE-RECEPTOR; TRANSGENIC MICE; LURCHER MICE; APOPTOSIS; MACROAUTOPHAGY	Continuous macroautophagic activity is critical for the maintenance of neuronal homeostasis; however, unchecked or dysregulated autophagy can lead to cell death. Cultured Purkinje neurons die by an autophagy-associated cell death mechanism when deprived of trophic support. Here, we report that insulin-like growth factor-I ( IGF-I) completely blocked the autophagy-associated cell death of Purkinje neurons. To examine the mechanism by which IGF-I influences autophagy, neurons were infected with adeno-RFP-LC3 and subjected to trophic factor withdrawal, and the size and number of autophagosomes were analyzed by live-cell fluorescence imaging. In control neurons, autophagy occurred at a constitutive low level with most autophagosomes measuring less than 0.75 mu m. Trophic factor withdrawal increased the number and size of autophagosomes with most autophagosomes ranging between 0.75 and 1.5 mu m and some reaching 1.5-2.25 mu m. IGF-I added at the time of trophic factor withdrawal prevented the accumulation of the larger autophagosomes; however, it had no effect on the conversion of LC3, an indicator of autophagy induction. Instead, the rate of autophagosome-to-lysosome fusion measured by colocalization of RFP-LC3 and LysoSensor Green was accelerated by IGF-I. Treating the neurons with bafilomycin A(1) in the presence of IGF-I led to the accumulation of autophagosomes even larger than those induced by trophic factor withdrawal alone, indicating that IGF-I regulates autophagic vesicle turnover. Finally, the effect of IGF-I on autophagy was mediated by an Akt/mTOR-dependent and an ERK-independent pathway. These data suggest a novel role for IGF-I in protecting Purkinje neurons from autophagy-associated cell death by increasing autophagy efficiency downstream of autophagy induction.	[Bains, Mona; Heidenreich, Kim A.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Florez-McClure, Maria L.] Discovery Martek Biosci Corp, Neurosci Res, Boulder, CO 80301 USA; [Heidenreich, Kim A.] Denver Vet Affairs Med Ctr, Denver, CO 80262 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Heidenreich, KA (corresponding author), Univ Colorado Denver, Dept Pharmacol, MS 8303,POB 6511, Aurora, CO 80045 USA.	Kim.Heidenreich@ucdenver.edu			National Institutes of Health [NS045560, 1F32NS062534-01A1]; Department of Veterans Affairs merit awards; Department of Defense [03281009]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS062534, F31NS045560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs merit awards(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS045560 and 1F32NS062534-01A1 (NINDS). This work was also supported by a Department of Veterans Affairs merit awards and Department of Defense Grant 03281009 (United States Army Medical Research and Material Command).	Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Bains M, 2009, METHOD ENZYMOL, V453, P145, DOI 10.1016/S0076-6879(08)04007-X; Barenberg P, 2001, NEUROSCI RES, V40, P245, DOI 10.1016/S0168-0102(01)00234-6; BOELLAARD JW, 1991, ACTA NEUROPATHOL, V82, P225, DOI 10.1007/BF00294449; Cataldo AM, 1996, J NEUROSCI, V16, P186; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195, DOI 10.1152/ajprenal.1999.277.2.F195; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; FESSATIDIS IT, 1993, EUR J CARDIO-THORAC, V7, P465, DOI 10.1016/1010-7940(93)90275-G; Florez-McClure ML, 2004, J NEUROSCI, V24, P4498, DOI 10.1523/JNEUROSCI.5744-03.2004; GALLI C, 1995, J NEUROSCI, V15, P1172; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; JEFFREY M, 1992, ACTA NEUROPATHOL, V84, P559, DOI 10.1007/BF00304476; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2007, AUTOPHAGY, V3, P413, DOI 10.4161/auto.4377; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin WL, 2003, J NEUROCYTOL, V32, P1091, DOI 10.1023/B:NEUR.0000021904.61387.95; Linseman DA, 2002, J BIOL CHEM, V277, P24546, DOI 10.1074/jbc.M201098200; Linseman DA, 2002, J NEUROSCI, V22, P9287; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Precht TA, 2005, CELL DEATH DIFFER, V12, P255, DOI 10.1038/sj.cdd.4401552; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Remacle-Bonnet MM, 2000, CANCER RES, V60, P2007; Saeki K, 2003, J LEUKOCYTE BIOL, V74, P1108, DOI 10.1189/jlb.0503211; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Selimi F, 2003, NEURON, V37, P813, DOI 10.1016/S0896-6273(03)00093-X; Sikorska B, 2004, INT J BIOCHEM CELL B, V36, P2563, DOI 10.1016/j.biocel.2004.04.014; Skinner PJ, 2001, AM J PATHOL, V159, P905, DOI 10.1016/S0002-9440(10)61766-X; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Zhu JH, 2003, BRAIN PATHOL, V13, P473; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	55	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20398	20407		10.1074/jbc.M109.011791	http://dx.doi.org/10.1074/jbc.M109.011791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19509289	Green Published, hybrid			2022-12-27	WOS:000268097400065
J	Korkmaz, B; Jaillet, J; Jourdan, ML; Gauthier, A; Gauthier, F; Attucci, S				Korkmaz, Brice; Jaillet, Jerome; Jourdan, Marie-Lise; Gauthier, Alexandre; Gauthier, Francis; Attucci, Sylvie			Catalytic Activity and Inhibition of Wegener Antigen Proteinase 3 on the Cell Surface of Human Polymorphonuclear Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEINASE-3; PR3-ANCA-ASSOCIATED VASCULITIS; ALPHA-1-PROTEASE INHIBITOR; RHEUMATOID-ARTHRITIS; PLASMA-MEMBRANE; CATHEPSIN-G; EXPRESSION; ELASTASE; PR3; GRANULOMATOSIS	Proteinase 3 (Pr3), the main target of anti-neutrophil cytoplasmic antibodies, is a neutrophil serine protease that may be constitutively expressed at the surface of quiescent circulating neutrophils. This raises the question of the simultaneous presence in the circulation of constitutive membrane-bound Pr3 (mPr3) and its plasma inhibitor alpha 1-protease inhibitor (alpha 1-Pi). We have looked at the fate of constitutive mPr3 at the surface of circulating blood neutrophils and of induced mPr3 on triggered neutrophils. We found significant Pr3 activity at the surface of activated neutrophils but not at the surface of quiescent neutrophils whatever the constitutive expression. This suggests that constitutive mPr3 is enzymatically inactive or its active site is not accessible to the substrate. Supporting this conclusion, we have not been able to demonstrate any interaction between constitutive mPr3 and alpha 1-Pi, whereas induced mPr3 is cleared from the cell surface when activated cells are incubated with this inhibitor. But, unlike membrane-bound elastase that is also cleared from the surface of activated cells, mPr3 remained bound to the membrane when inhibited by elafin or by a low molecular weight chloromethyl ketone inhibitor, which shows that it binds more tightly to the neutrophil membrane. mPr3 may thus be present at the surface of circulating neutrophils in an environment replete with alpha 1-Pi. The permanent presence of inactive Pr3 at the surface of quiescent neutrophils may explain why Pr3 is a major target of anti-neutrophil cytoplasmic antibodies, whose binding activates neutrophils and triggers inflammation, as in Wegener granulomatosis.	[Korkmaz, Brice; Jaillet, Jerome; Gauthier, Alexandre; Gauthier, Francis; Attucci, Sylvie] INSERM, U618, Fac Med, F-37032 Tours, France; [Korkmaz, Brice; Jaillet, Jerome; Gauthier, Alexandre; Gauthier, Francis; Attucci, Sylvie] Univ Tours, F-37041 Tours, France; [Jourdan, Marie-Lise] Ctr Hosp Reg Univ, F-37042 Tours, France; [Jourdan, Marie-Lise] INSERM Nutr, U921, Fac Med, F-37032 Tours, France; [Jourdan, Marie-Lise; Gauthier, Francis; Attucci, Sylvie] Inst Federatif Rech 135, F-37044 Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gauthier, F (corresponding author), INSERM, U618, Fac Med, 10 Bd Tonnelle, F-37032 Tours, France.	francis.gauthier@univ-tours.fr		KORKMAZ, BRICE/0000-0002-5159-8706				Abdel-Salam B, 2004, KIDNEY INT, V66, P1009, DOI 10.1111/j.1523-1755.2004.00849.x; Attucci S, 2006, J PHARMACOL EXP THER, V318, P803, DOI 10.1124/jpet.106.103440; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CALAFAT J, 1990, BLOOD, V75, P242; Campbell EJ, 2000, J IMMUNOL, V165, P3366, DOI 10.4049/jimmunol.165.6.3366; CSERNOK E, 1990, AM J PATHOL, V137, P1113; David A, 2005, EXP CELL RES, V308, P156, DOI 10.1016/j.yexcr.2005.03.034; David A, 2003, J LEUKOCYTE BIOL, V74, P551, DOI 10.1189/jlb.1202624; Fridlich R, 2006, J CELL BIOCHEM, V99, P117, DOI 10.1002/jcb.20901; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Goldmann WH, 1999, EUR J BIOCHEM, V261, P155, DOI 10.1046/j.1432-1327.1999.00259.x; Hajjar E, 2008, PROTEINS, V71, P1655, DOI 10.1002/prot.21853; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Hu N, 2009, AUTOIMMUN REV, V8, P510, DOI 10.1016/j.autrev.2008.01.003; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Korkmaz B, 2002, J BIOL CHEM, V277, P39074, DOI 10.1074/jbc.M202918200; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Korkmaz B, 2005, AM J RESP CELL MOL, V32, P553, DOI 10.1165/rcmb.2004-0374OC; Korkmaz B, 2004, AM J RESP CELL MOL, V30, P801, DOI 10.1165/rcmb.2003-0139OC; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; Korkmaz B, 2008, J BIOL CHEM, V283, P35976, DOI 10.1074/jbc.M806754200; Matsumoto T, 2008, CLIN APPL THROMB-HEM, V14, P186, DOI 10.1177/1076029607303961; Owen CA, 2008, INT J BIOCHEM CELL B, V40, P1246, DOI 10.1016/j.biocel.2008.01.020; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rarok AA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028642.26222.00; Rooney CP, 2001, AM J RESP CELL MOL, V24, P747, DOI 10.1165/ajrcmb.24.6.4147; Schreiber A, 2004, KIDNEY INT, V65, P2172, DOI 10.1111/j.1523-1755.2004.00640.x; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; SERVEAU C, 1992, FEBS LETT, V309, P405, DOI 10.1016/0014-5793(92)80817-Z; Skold S, 1999, BLOOD, V93, P849, DOI 10.1182/blood.V93.3.849.403k07_849_856; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Van der Geld YM, 2002, CLIN EXP IMMUNOL, V129, P562; Van Rossum AP, 2005, KIDNEY INT, V68, P537, DOI 10.1111/j.1523-1755.2005.00431.x; van Rossum AP, 2004, J LEUKOCYTE BIOL, V76, P1162, DOI 10.1189/jlb.0604319; van Rossum AP, 2003, CLIN EXP RHEUMATOL, V21, pS64; von Vietinghoff S, 2008, CLIN EXP IMMUNOL, V152, P508, DOI 10.1111/j.1365-2249.2008.03663.x; von Vietinghoff S, 2005, CLIN NEPHROL, V64, P453; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224	43	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19896	19902		10.1074/jbc.M901471200	http://dx.doi.org/10.1074/jbc.M901471200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19447886	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000268097400016
J	Guy, JE; Stahl, U; Lindqvist, Y				Guy, Jodie E.; Stahl, Ulf; Lindqvist, Ylva			Crystal Structure of a Class XIB Phospholipase A(2) (PLA(2)) RICE (ORYZA SATIVA) ISOFORM-2 PLA(2) AND AN OCTANOATE COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COBRA-VENOM PHOSPHOLIPASE-A2; ARABIDOPSIS-THALIANA; BACTERIAL EXPRESSION; ESCHERICHIA-COLI; SYNTHETIC GENE; ACTIVE-SITE; PURIFICATION; SUPERFAMILY; SPECIFICITY; FACE	Phospholipase A(2) catalyzes the specific hydrolysis of the sn-2 acyl bond of various glycerophospholipids, producing fatty acids and lysophospholipids. Phospholipase A(2)s (PLA(2)s) constitute a large superfamily of enzymes whose products are important for a multitude of signal transduction processes, lipid mediator release, lipid metabolism, development, plant stress responses, and host defense. The crystal structure of rice (Oryza sativa) isoform 2 phospholipase A(2) has been determined to 2.0 angstrom resolution using sulfur SAD phasing, and shows that the class XIb phospholipases have a unique structure compared with other secreted PLA(2)s. The N-terminal half of the chain contains mainly loop structure, including the conserved Ca2+-binding loop, but starts with a short 3(10)-helix and also includes two short anti-parallel beta-strands. The C-terminal half is folded into three anti-parallel alpha-helices, of which the two first are also present in other secreted PLA(2)s and contain the conserved catalytic histidine and calcium liganding aspartate residues. The structure is stabilized by six disulfide bonds. The water structure around the calcium ion binding site suggests the involvement of a second water molecule in the mechanism for hydrolysis, the water-assisted calcium-coordinate oxyanion mechanism. The octanoate molecule in the complex structure is bound in a hydrophobic pocket, which extends to the likely membrane interface and is proposed to model the binding of the product fatty acid. Due to the differences in structure, the suggested surface for binding to the membrane has a different morphology in the rice PLA(2) compared with other phospholipases.	[Guy, Jodie E.; Lindqvist, Ylva] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Stahl, Ulf] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, S-75007 Uppsala, Sweden	Karolinska Institutet; Swedish University of Agricultural Sciences	Lindqvist, Y (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	Ylva.Lindqvist@ki.se	Lindqvist, Ylva/F-9009-2010	Lindqvist, Ylva/0000-0003-3162-8661; Guy, Jodie/0000-0003-0331-0699	Swedish Research Council; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Swedish Research Council ( to Y. L.).	Bahn SC, 2003, FEBS LETT, V553, P113, DOI 10.1016/S0014-5793(03)00982-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNIE S, 1985, J BIOL CHEM, V260, P9742; Chapman KD, 1998, TRENDS PLANT SCI, V3, P419, DOI 10.1016/S1360-1385(98)01326-0; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4; DUDLER T, 1992, BIOCHIM BIOPHYS ACTA, V1165, P201, DOI 10.1016/0005-2760(92)90188-2; Edwards SH, 2002, BIOCHEMISTRY-US, V41, P15468, DOI 10.1021/bi020485z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein TM, 2001, BIOCHEMISTRY-US, V40, P11411, DOI 10.1021/bi011228h; Han SK, 1998, BIOCHEM J, V331, P353, DOI 10.1042/bj3310353; Han SK, 1997, BBA-LIPID LIPID MET, V1346, P185, DOI 10.1016/S0005-2760(97)00034-9; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jain MK, 2006, CURR OPIN CHEM BIOL, V10, P473, DOI 10.1016/j.cbpa.2006.08.015; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KELLEY MJ, 1992, BIOCHIM BIOPHYS ACTA, V1118, P107, DOI 10.1016/0167-4838(92)90136-2; Kim JY, 1999, BBA-GENE STRUCT EXPR, V1489, P389, DOI 10.1016/S0167-4781(99)00193-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HY, 2005, PROG LIPID RES, V44, P52, DOI 10.1016/j.plipres.2004.10.002; Lee HY, 2003, PLANT CELL, V15, P1990, DOI 10.1105/tpc.014423; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Mansfeld J, 2006, BIOCHEMISTRY-US, V45, P5687, DOI 10.1021/bi052563z; Mansfeld J, 2007, CHEM PHYS LIPIDS, V150, P156, DOI 10.1016/j.chemphyslip.2007.07.001; Matoba Y, 2002, J BIOL CHEM, V277, P20059, DOI 10.1074/jbc.M200263200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Othman R, 1996, BBA-LIPID LIPID MET, V1303, P92, DOI 10.1016/0005-2760(96)00083-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan YH, 2002, J BIOL CHEM, V277, P29086, DOI 10.1074/jbc.M202531200; Pan YH, 2001, BIOCHEMISTRY-US, V40, P609, DOI 10.1021/bi002514g; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rogers J, 1996, BIOCHEMISTRY-US, V35, P9375, DOI 10.1021/bi960526p; Ryu SB, 2004, TRENDS PLANT SCI, V9, P229, DOI 10.1016/j.tplants.2004.03.004; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Scherer GFE, 2002, PLANT MOL BIOL, V49, P357, DOI 10.1023/A:1015290510483; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; Sekar K, 1998, ACTA CRYSTALLOGR D, V54, P334, DOI 10.1107/S090744499701247X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Stahl U, 1998, PLANT PHYSIOL, V117, P197, DOI 10.1104/pp.117.1.197; Stahl U, 1999, PLANT MOL BIOL, V41, P481, DOI 10.1023/A:1006323405788; THANNHAUSER TW, 1984, ANAL BIOCHEM, V138, P181, DOI 10.1016/0003-2697(84)90786-3; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Valentin E, 2000, BIOCHEM BIOPH RES CO, V279, P223, DOI 10.1006/bbrc.2000.3908; VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91; Wang XM, 2004, CURR OPIN PLANT BIOL, V7, P329, DOI 10.1016/j.pbi.2004.03.012; WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu S, 2003, ACTA CRYSTALLOGR D, V59, P1574, DOI 10.1107/S0907444903014598; Yu BZ, 1998, BIOCHEMISTRY-US, V37, P12576, DOI 10.1021/bi9728607	58	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19371	19379		10.1074/jbc.M109.008466	http://dx.doi.org/10.1074/jbc.M109.008466			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19457861	Green Published, hybrid			2022-12-27	WOS:000267908300028
J	Pan, YJ; Cho, CC; Kao, YY; Sun, CH				Pan, Yu-Jiao; Cho, Chao-Cheng; Kao, Yu-Yun; Sun, Chin-Hung			A Novel WRKY-like Protein Involved in Transcriptional Activation of Cyst Wall Protein Genes in Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-DIVERGING EUKARYOTE; DNA-BINDING PROTEINS; PRIMITIVE EUKARYOTE; ARABIDOPSIS; PROMOTER; IDENTIFICATION; ENCYSTATION; PATHOGEN; EXPRESSION; ELEMENTS	Synthesis of a protective cyst wall is required for survival outside of the host and for infection of Giardia lamblia. Little is known of gene regulation of the cyst wall proteins (CWPs) during differentiation into dormant cysts. WRKY homologues constitute a large family of DNA-binding proteins in plants that are involved in several key cellular functions, including disease resistance, stress response, dormancy, and development. A putative wrky gene has been identified in the G. lamblia genome. We found that wrky expression levels increased significantly during encystation. The epitope-tagged WRKY was translocated into the nuclei during encystation. Recombinant WRKY specifically bound to its own promoter and the encystation-induced cwp1 and cwp2 promoters. WRKY contains several key residues for DNA binding, and mutation analysis revealed that its binding sequences are similar to those of the known plant WRKY proteins and that two of them are positive cis-acting elements of the wrky and cwp2 promoters. Overexpression of WRKY increased the cwp1-2 and myb2 mRNA levels, and these gene promoters were bound by WRKY in vivo. Interestingly, the wrky and cwp1-2 genes were up-regulated by ERK1 (extracellular signal-related kinase 1) overexpression, suggesting that WRKY may be a downstream component of the ERK1 pathway. In addition, a WRKY mutant that cannot enter nuclei and an ERK1 mutant lacking the predicted kinase domain showed decreased cwp1-2 gene expression. Our results suggest that the WRKY family has been conserved during evolution and that WRKY is an important transactivator of the cwp1-2 genes during G. lamblia differentiation into dormant cysts.	[Pan, Yu-Jiao; Cho, Chao-Cheng; Kao, Yu-Yun; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan	National Taiwan University	Sun, CH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council [NSC 94-2320B-002-093, NSC 96-2320-B-002-040-MY3]; National Health Research Institutes [NHRI-EX96-9510NC, \NHRI-EX97-9510NC, NHRI-EX989510NC]; Department of Medical Research of National Taiwan University Hospital	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Department of Medical Research of National Taiwan University Hospital	This work was supported by National Science Council Grants NSC 94-2320B- 002-093 and NSC 96-2320-B-002-040-MY3 and National Health Research Institutes Grants NHRI-EX96-9510NC, NHRI-EX97-9510NC, and NHRI-EX989510NC in Taiwan and was also supported in part by the Department of Medical Research of National Taiwan University Hospital.	Abel ES, 2001, J BIOL CHEM, V276, P10320, DOI 10.1074/jbc.M006589200; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Celiksoz A, 2005, PEDIATR INT, V47, P567, DOI 10.1111/j.1442-200x.2005.02110.x; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COLL M, 1987, P NATL ACAD SCI USA, V84, P8385, DOI 10.1073/pnas.84.23.8385; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Ellis JG, 2003, J BIOL CHEM, V278, P1936, DOI 10.1074/jbc.M209274200; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Maeo K, 2001, BIOSCI BIOTECH BIOCH, V65, P2428, DOI 10.1271/bbb.65.2428; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Pnueli L, 2002, PLANT J, V31, P319, DOI 10.1046/j.1365-313X.2002.01364.x; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Svard SG, 1999, MOL BIOCHEM PARASIT, V98, P253, DOI 10.1016/S0166-6851(98)00174-1; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Van Keulen H, 1998, J EUKARYOT MICROBIOL, V45, P637, DOI 10.1111/j.1550-7408.1998.tb04560.x; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992; Worgall TS, 2004, J LIPID RES, V45, P981, DOI 10.1194/jlr.M400024-JLR200; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Yoda H, 2002, MOL GENET GENOMICS, V267, P154, DOI 10.1007/s00438-002-0651-z; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1	59	52	61	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17975	17988		10.1074/jbc.M109.012047	http://dx.doi.org/10.1074/jbc.M109.012047			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19423705	Green Published, hybrid			2022-12-27	WOS:000267712400009
J	Agranoff, BW				Agranoff, Bernard W.			Turtles All the Way: Reflections on myo-Inositol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL DIHYDROXYACETONE PHOSPHATE; INOSITOL HEXAKISPHOSPHATE; MYO-INOSITOL; PYROPHOSPHATE ISOMERASE; ENZYMATIC SYNTHESIS; GLUCURONIC ACID; BRAIN; BIOSYNTHESIS; EVOLUTION; TURNOVER		[Agranoff, Bernard W.] Univ Michigan, Mol & Behav Res Inst, Ann Arbor, MI 48109 USA; [Agranoff, Bernard W.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Agranoff, BW (corresponding author), Univ Michigan, Mol & Behav Res Inst, Ann Arbor, MI 48109 USA.	agranoff@umich.edu						ABDELLATIF AA, 1977, BIOCHEM J, V162, P61, DOI 10.1042/bj1620061; Agranoff B W, 2001, Psychopharmacol Bull, V35, P5; AGRANOFF BW, 1958, J BIOL CHEM, V233, P1077; AGRANOFF BW, 1991, ACS SYM SER, V463, P20; AGRANOFF BW, 1978, TRENDS BIOCHEM SCI, V3, pN283; AGRANOFF BW, 1960, J BIOL CHEM, V235, P326; AGRANOFF BW, 1959, NATURE, V183, P1259, DOI 10.1038/1831259a0; AGRANOFF BW, 1983, J BIOL CHEM, V258, P2076; AGRANOFF BW, 1959, J AM CHEM SOC, V81, P1254, DOI 10.1021/ja01514a059; AGRANOFF BW, 1974, PREP BIOCHEM, V4, P359, DOI 10.1080/00327487408068211; AGRANOFF BW, 1971, P NATL ACAD SCI USA, V68, P411, DOI 10.1073/pnas.68.2.411; AGRANOFF BW, 1963, BIOCHEM PREP, V10, P47; AGRANOFF BW, 2008, HIST NEUROSCIENCE AU, V6, P1; Atack JR, 1996, BRAIN RES REV, V22, P183; BENJAMINS JA, 1969, J NEUROCHEM, V16, P513, DOI 10.1111/j.1471-4159.1969.tb06850.x; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; BURNS JJ, 1959, BIOCHIM BIOPHYS ACTA, V33, P215, DOI 10.1016/0006-3002(59)90516-5; Butlerow A, 1861, CR HEBD ACAD SCI, V53, P145; Cantley L, 2007, SCIENTIST, V21, P44; CHARALAMPOUS FC, 1957, J BIOL CHEM, V228, P1; Cooper G, 2001, NATURE, V414, P879, DOI 10.1038/414879a; COSGROVE DJ, 1980, INOSITOL PHOSPHATES, P15; DAVIS PA, 1979, J BIOL CHEM, V254, P4760; DITTMER JC, 1961, BIOCHEM J, V81, P535, DOI 10.1042/bj0810535; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; DUREL J, 1969, SCIENCE, V165, P862, DOI 10.1126/science.165.3896.862; EAGLE H, 1960, J BIOL CHEM, V235, P1891; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; FISHER SK, 1981, J NEUROCHEM, V37, P968; FISHER SK, 1983, J BIOL CHEM, V258, P7358; FISHER SK, 1981, J NEUROSCI, V1, P1407; FOLCH J, 1949, J BIOL CHEM, V177, P505; GRADO C, 1961, J BIOL CHEM, V236, P54; HAJRA AK, 1968, J BIOL CHEM, V243, P1617; HAWKING SW, 1988, BRIEF HIST TIME; Heacock AM, 1996, J NEUROCHEM, V67, P2200; HOKIN LE, 1955, BIOCHIM BIOPHYS ACTA, V18, P102, DOI 10.1016/0006-3002(55)90013-5; *INT UN BIOCH NOM, 1989, BIOCHEM J, V258, P1; Irvine RF, 2005, J PHYSIOL-LONDON, V566, P295, DOI 10.1113/jphysiol.2005.087387; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; KORNBERG A, 1953, J BIOL CHEM, V204, P345; KORNBERG A, 1994, PHOSPHATE MICROORGAN; LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158; Majumder AL, 2003, FEBS LETT, V553, P3, DOI 10.1016/S0014-5793(03)00974-8; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Mizuno T., 1974, Advances in Carbohydrate Chemistry and Biochemistry, V29, P173; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; PAULUS H, 1960, J BIOL CHEM, V235, P1303; PETZOLD GL, 1967, J BIOL CHEM, V242, P1187; POSTERNAK T, 1965, CYCLITOLS; SEIFFERT UB, 1965, BIOCHIM BIOPHYS ACTA, V98, P574, DOI 10.1016/0005-2760(65)90154-2; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Springsteen G, 2004, J AM CHEM SOC, V126, P9578, DOI 10.1021/ja0483692; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; WONG YHH, 1987, J NEUROCHEM, V48, P1434, DOI 10.1111/j.1471-4159.1987.tb05682.x	59	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21121	21126		10.1074/jbc.X109.004747	http://dx.doi.org/10.1074/jbc.X109.004747			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19447884	hybrid, Green Published			2022-12-27	WOS:000268564400004
J	Barbas, A; Matos, RG; Amblar, M; Lopez-Vinas, E; Gomez-Puertas, P; Arraiano, CM				Barbas, Ana; Matos, Rute G.; Amblar, Monica; Lopez-Vinas, Eduardo; Gomez-Puertas, Paulino; Arraiano, Cecilia M.			Determination of Key Residues for Catalysis and RNA Cleavage Specificity ONE MUTATION TURNS RNase II INTO A "SUPER-ENZYME"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RIBONUCLEASE-II; YEAST EXOSOME CORE; ESCHERICHIA-COLI; MESSENGER-RNA; STRUCTURAL-ANALYSIS; DEGRADATION; EXPRESSION; COMPLEX; DECAY; EXORIBONUCLEASES	RNase II is the prototype of a ubiquitous family of enzymes that are crucial for RNA metabolism. In Escherichia coli this protein is a single-stranded-specific 3'-exoribonuclease with a modular organization of four functional domains. In eukaryotes, the RNase II homologue Rrp44 (also known as Dis3) is the catalytic subunit of the exosome, an exoribonuclease complex essential for RNA processing and decay. In this work we have performed a functional characterization of several highly conserved residues located in the RNase II catalytic domain to address their precise role in the RNase II activity. We have constructed a number of RNase II mutants and compared their activity and RNA binding to the wild type using different single- or double-stranded substrates. The results presented in this study substantially improve the RNase II model for RNA degradation. We have identified the residues that are responsible for the discrimination of cleavage of RNA versus DNA. We also show that the Arg-500 residue present in the RNase II active site is crucial for activity but not for RNA binding. The most prominent finding presented is the extraordinary catalysis observed in the E542A mutant that turns RNase II into a "super-enzyme."	[Barbas, Ana; Matos, Rute G.; Arraiano, Cecilia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Amblar, Monica] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid 28029, Spain; [Lopez-Vinas, Eduardo] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Madrid 28029, Spain; [Lopez-Vinas, Eduardo; Gomez-Puertas, Paulino] Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	Universidade Nova de Lisboa; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Arraiano, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Apartado 127, P-2781901 Oeiras, Portugal.	cecilia@itqb.unl.pt	Gomez-Puertas, Paulino/G-8821-2014; Amblar, Monica/E-2366-2016; López-Viñas, Eduardo/AAT-1124-2021; Matos, Rute/J-4983-2013; Amblar, 2405/C-3941-2011	Gomez-Puertas, Paulino/0000-0003-3131-729X; Amblar, Monica/0000-0003-3530-615X; Arraiano, Cecilia/0000-0003-1934-9301; Matos Luis, Rute/0000-0002-9788-7562; Barbas, Ana/0000-0002-6245-8549	Ministerio de Educacion y Ciencia, Spain [SAF2007-61926]; Fundacion Ramon Arecesm; Fundacao para a Ciencia e a Tecnologia, Portugal	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Fundacion Ramon Arecesm; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The work was supported by Ministerio de Educacion y Ciencia, Spain, Grant SAF2007-61926, an institutional grant from the "Fundacion Ramon Arecesm," and by Fundacao para a Ciencia e a Tecnologia, Portugal.	Amblar M, 2005, FEBS J, V272, P363, DOI 10.1111/j.1742-4658.2004.04477.x; Amblar M, 2007, RNA, V13, P317, DOI 10.1261/rna.220407; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Andrade JM, 2006, MOL MICROBIOL, V60, P219, DOI 10.1111/j.1365-2958.2006.05092.x; Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Arraiano CM, 2008, METHOD ENZYMOL, V447, P131, DOI 10.1016/S0076-6879(08)02208-8; Barbas A, 2008, J BIOL CHEM, V283, P13070, DOI 10.1074/jbc.M709989200; Cairrao F, 2006, BIOCHEM BIOPH RES CO, V343, P731, DOI 10.1016/j.bbrc.2006.03.040; Cairrao F, 2003, MOL MICROBIOL, V50, P1349, DOI 10.1046/j.1365-2958.2003.03766.x; Cairrao F, 2001, MOL MICROBIOL, V276, P19172; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Cannistraro VJ, 2001, METHOD ENZYMOL, V342, P309, DOI 10.1016/S0076-6879(01)42555-9; Case D, 2006, AMBER 9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 2004, AMBER 8; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Coburn GA, 1996, J BIOL CHEM, V271, P1048, DOI 10.1074/jbc.271.2.1048; DEUTSCHER MP, 1991, P NATL ACAD SCI USA, V88, P3277, DOI 10.1073/pnas.88.8.3277; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Grossman D, 2006, NAT STRUCT MOL BIOL, V13, P760, DOI 10.1038/nsmb0906-760; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUPTA RS, 1977, J BIOL CHEM, V252, P8945; Higuchi R., 1990, PCR PROTOCOLS GUIDE; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Marujo PE, 2000, RNA, V6, P1185, DOI 10.1017/S135583820000073X; MCLAREN RS, 1991, J MOL BIOL, V221, P81, DOI 10.1016/0022-2836(91)90806-H; McVey CE, 2006, ACTA CRYSTALLOGR F, V62, P684, DOI 10.1107/S1744309106021506; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Park SM, 2000, MOL CELL BIOL, V20, P4765, DOI 10.1128/MCB.20.13.4765-4772.2000; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; ZILHAO R, 1993, MOL MICROBIOL, V8, P43, DOI 10.1111/j.1365-2958.1993.tb01201.x; Zilhao R, 1996, MOL MICROBIOL, V20, P1033, DOI 10.1111/j.1365-2958.1996.tb02544.x; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	45	33	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20486	20498		10.1074/jbc.M109.020693	http://dx.doi.org/10.1074/jbc.M109.020693			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19458082	hybrid, Green Published			2022-12-27	WOS:000268316100010
J	Jang, SW; Svaren, J				Jang, Sung-Wook; Svaren, John			Induction of Myelin Protein Zero by Early Growth Response 2 through Upstream and Intragenic Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE MYELINATION; SCHWANN-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR SOX10; REPORTER GENE-EXPRESSION; HUMAN GENOME; TRANSGENIC MICE; LIVING MICE; EGR2; BINDING; KROX-20	The Mpz (myelin protein zero) gene codes for the principal component of myelin in the peripheral nervous system, and mutations in this gene cause human peripheral myelinopathies. Expression of the Mpz gene is controlled by two major transactivators that coordinate Schwann cell development: Egr2/Krox20 and Sox10. Our in vivo ChIP-chip analysis in myelinating peripheral nerve identified major sites of Egr2 interaction within the first intron of the Mpz gene and similar to 5 kb upstream of the transcription start site. In addition, the sites of Egr2 binding display many of the hallmarks associated with enhancer elements. Interestingly, the upstream Egr2 binding sites lie proximal to the divergently transcribed succinate dehydrogenase C gene, but Sdhc expression was not affected by the massive induction of Mpz mediated by Egr2. Mpz induction was greatly enhanced in the presence of the Egr2 binding sites, and removal of them markedly diminished transgenic expression of a construct derived from the Mpz locus. Sox10 was also found to be associated with the upstream region, and its binding was required for Egr2-mediated activation in this distal regulatory region. Our findings highlight that peripheral nerve-specific expression of Mpz is primarily regulated by both upstream and intron-associated regulatory elements. Overall, these results provide a locus-wide analysis of the role and activity of Egr2 in regulation of the Mpz gene within its native chromosomal context.	[Svaren, John] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Jang, Sung-Wook; Svaren, John] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53705 USA; [Svaren, John] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Svaren, J (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Dr, Madison, WI 53705 USA.	jpsvaren@wisc.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921	National Institutes of Health, NICHD [HD41590]; Core [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041590] Funding Source: NIH RePORTER	National Institutes of Health, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Core(Luxembourg National Research Fund); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health, NICHD, Grant HD41590 (to J. S.) and Core Grant P30 HD03352 (to the Waisman Center).	Arthur-Farraj P, 2006, NEUROBIOL DIS, V24, P159, DOI 10.1016/j.nbd.2006.06.006; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BHATTACHARYYA A, 1991, NEURON, V7, P831, DOI 10.1016/0896-6273(91)90285-8; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Brown AM, 1997, J BIOL CHEM, V272, P28939, DOI 10.1074/jbc.272.46.28939; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Feltri ML, 1999, EUR J NEUROSCI, V11, P1577, DOI 10.1046/j.1460-9568.1999.00568.x; Fraser P, 2006, CURR OPIN GENET DEV, V16, P490, DOI 10.1016/j.gde.2006.08.002; GREENFIELD S, 1973, J NEUROCHEM, V20, P1207, DOI 10.1111/j.1471-4159.1973.tb00089.x; Hai M, 2002, J NEUROSCI RES, V69, P497, DOI 10.1002/jnr.10327; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Jones EA, 2007, NEURON GLIA BIOL, V3, P377, DOI 10.1017/S1740925X08000173; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; LeBlanc SE, 2005, J NEUROCHEM, V93, P737, DOI 10.1111/j.1471-4159.2005.03056.x; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Lee MJ, 1997, MOL CELL NEUROSCI, V8, P336, DOI 10.1006/mcne.1996.0589; LEMKE G, 1988, DEVELOPMENT, V102, P499; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; MESSING A, 1992, NEURON, V8, P507, DOI 10.1016/0896-6273(92)90279-M; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Previtali SC, 2000, J CELL BIOL, V151, P1035, DOI 10.1083/jcb.151.5.1035; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schreiner S, 2007, DEVELOPMENT, V134, P3271, DOI 10.1242/dev.003350; Slutsky SG, 2003, J BIOL CHEM, V278, P8960, DOI 10.1074/jbc.M210569200; STAHL N, 1990, MOL BRAIN RES, V8, P209, DOI 10.1016/0169-328X(90)90018-9; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; WRABETZ L, 2004, MYELIN BIOL DISORDER, P905; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Zorick TS, 1999, DEVELOPMENT, V126, P1397; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	48	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20111	20120		10.1074/jbc.M109.022426	http://dx.doi.org/10.1074/jbc.M109.022426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19487693	hybrid, Green Published			2022-12-27	WOS:000268097400038
J	Wildey, GM; Howe, PH				Wildey, Gary M.; Howe, Philip H.			Runx1 Is a Co-activator with FOXO3 to Mediate Transforming Growth Factor beta (TGF beta)-induced Bim Transcription in Hepatic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; WEHI-231 B-LYMPHOCYTES; BCL-2 RELATIVE BIM; TGF-BETA; INDUCED APOPTOSIS; BH3-ONLY PROTEINS; DEPENDENT EXPRESSION; SIGNAL-TRANSDUCTION; DOWN-REGULATION; JNK ACTIVATION	Transforming growth factor beta (TGF beta) regulates essential cellular functions such as cellular proliferation, differentiation, and apoptosis. The Bcl-2 family of proteins has been implicated as mediators of TGF beta-induced apoptosis. We demonstrated previously that TGF beta induces the expression of Bim (Bcl-2-interacting mediator of cell death), a member of the BH3-only family of proapoptotic Bcl-2 proteins, to induce cell death in B-lymphocytes. Here, we investigated the mechanism of TGF beta-mediated Bim expression in two hepatocyte cell lines that undergo apoptosis with TGF beta, AML-12 and Hep3B. We show that TGF beta induces Bimprotein and mRNA levels, and its expression is sufficient to induce cell death. Gene array results revealed that Runx1, a member of the Runx family of transcription factors, was induced by TGF beta, and this induction was confirmed at the mRNA and protein levels. Interestingly, TGF beta specifically induced the expression of Runx1 protein from an internal ribosome entry site (IRES)-dependent, cap-independent, mRNA transcript, and its overexpression was sufficient to induce hepatocyte apoptosis. Deletion and mutation analyses of the murine Bim promoter identified a putative forkhead binding element, at position -174 to -168 from the transcription start site, as the mediator of Runx1 induction. Co-immunoprecipitation, electrophoretic mobility shift assays, and chromatin immunoprecipitation assays demonstrated that Runx1 does not bind directly to the identified forkhead binding element but rather binds the transcriptional regulator FOXO3, which occupies this site. Finally, small interfering RNA knockdown of Runx1 or FOXO3 decreased TGF beta-induced Bim expression. Our results support a mechanism in which TGF beta stimulates Bim transcription by up-regulating Runx1 expression, which binds FOXO3, and the two cooperate in the transcriptional induction of Bim.	[Wildey, Gary M.; Howe, Philip H.] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Howe, PH (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, NB4, Cleveland, OH 44195 USA.	howep@ccf.org		Wildey, Gary/0000-0001-7105-1313	National Institutes of Health, NCI [CA80095 and CA55536]; NATIONAL CANCER INSTITUTE [R01CA055536, R01CA080095, R29CA055536] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA80095 and CA55536 from NCI (to P. H. H.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cai BB, 2008, APOPTOSIS, V13, P803, DOI 10.1007/s10495-008-0218-5; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Eliseev RA, 2008, ONCOGENE, V27, P3605, DOI 10.1038/sj.onc.1211020; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hasegawa K, 2007, CANCER SCI, V98, P838, DOI 10.1111/j.1349-7006.2007.00460.x; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Herzer K, 2008, MOL CANCER RES, V6, P1169, DOI 10.1158/1541-7786.MCR-08-0073; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kim BC, 2002, MOL CELL BIOL, V22, P1369, DOI 10.1128/MCB.22.5.1369-1378.2002; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Levanon D, 2001, GENE, V262, P23, DOI 10.1016/S0378-1119(00)00532-1; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Lewis Susan E., 1996, Methods (Orlando), V10, P301, DOI 10.1006/meth.1996.0107; Miyagawa K, 2006, ANTICANCER RES, V26, P3633; MIYOSHI H, 1995, NUCLEIC ACIDS RES, V23, P2762, DOI 10.1093/nar/23.14.2762; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Patil S, 2000, J BIOL CHEM, V275, P38363, DOI 10.1074/jbc.M004861200; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Pozner A, 2000, MOL CELL BIOL, V20, P2297, DOI 10.1128/MCB.20.7.2297-2307.2000; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Roset R, 2007, FRONT BIOSCI-LANDMRK, V12, P4722, DOI 10.2741/2421; Sakakura C, 2005, INT J CANCER, V113, P221, DOI 10.1002/ijc.20551; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi MJ, 1998, J IMMUNOL, V161, P6751; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Yu J, 2008, J CELL PHYSIOL, V215, P422, DOI 10.1002/jcp.21325	65	38	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20227	20239		10.1074/jbc.M109.027201	http://dx.doi.org/10.1074/jbc.M109.027201			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494111	Green Published, hybrid			2022-12-27	WOS:000268097400050
J	Rottenberg, H; Covian, R; Trumpower, BL				Rottenberg, Hagai; Covian, Raul; Trumpower, Bernard L.			Membrane Potential Greatly Enhances Superoxide Generation by the Cytochrome bc(1) Complex Reconstituted into Phospholipid Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							Q-CYCLE; C REDUCTASE; Q(O) SITE; OXIDOREDUCTASE COMPLEX; UBIQUINOL OXIDATION; MITOCHONDRIA; ELECTRON; MECHANISM; TRANSPORT; TISSUE	The mitochondrial cytochrome bc(1) complex (ubiquinol/cytochrome c oxidoreductase) is generally thought to generate superoxide anion that participates in cell signaling and contributes to cellular damage in aging and degenerative disease. However, the isolated, detergent-solubilized bc(1) complex does not generate measurable amounts of superoxide except when inhibited by antimycin. In addition, indirect measurements of superoxide production by cells and isolated mitochondria have not clearly resolved the contribution of the bc(1) complex to the generation of superoxide by mitochondria in vivo, nor did they establish the effect, if any, of membrane potential on superoxide formation by this enzyme complex. In this study we show that the yeast cytochrome bc(1) complex does generate significant amounts of superoxide when reconstituted into phospholipid vesicles. The rate of superoxide generation by the reconstituted bc(1) complex increased exponentially with increased magnitude of the membrane potential, a finding that is compatible with the suggestion that membrane potential inhibits electron transfer from the cytochrome b(L) to b(H) hemes, thereby promoting the formation of a ubisemiquinone radical that interacts with oxygen to generate superoxide. When the membrane potential was further increased, by the addition of nigericin or by the imposition of a diffusion potential, the rate of generation of superoxide was further accelerated and approached the rate obtained with antimycin. These findings suggest that the bc(1) complex may contribute significantly to superoxide generation by mitochondria in vivo, and that the rate of superoxide generation can be controlled by modulation of the mitochondrial membrane potential.	[Rottenberg, Hagai; Covian, Raul; Trumpower, Bernard L.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Trumpower, BL (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail, Hanover, NH 03755 USA.	rotteh@hotmail.com; Trumpower@Dartmouth.edu			National Institutes of Health [20379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020379, R01GM020379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 20379.	Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Banfi C, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2008.03204.x; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Guzy RD, 2007, ANTIOXID REDOX SIGN, V9, P1317, DOI 10.1089/ars.2007.1708; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; KATZ Y, 1974, J MEMBRANE BIOL, V17, P87, DOI 10.1007/BF01870174; Kawamata H, 2008, HUM MOL GENET, V17, P3303, DOI 10.1093/hmg/ddn226; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; LEUNG KH, 1975, J BIOL CHEM, V250, P8467; Lin X, 2008, P NATL ACAD SCI USA, V105, P174, DOI 10.1073/pnas.0706585104; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; LJUNGDAHL O, 1987, BIOCHIM BIOPHYS ACTA, V891, P227; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; ROTTENBERG H, 1979, BIOCHIM BIOPHYS ACTA, V549, P225, DOI 10.1016/0304-4173(79)90001-6; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; YANG XH, 1988, J BIOL CHEM, V263, P11962; YU CA, 1972, J BIOL CHEM, V247, P1012; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; ZOCCARATO F, 1988, BIOCHEM BIOPH RES CO, V154, P727, DOI 10.1016/0006-291X(88)90200-8	41	77	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19203	19210		10.1074/jbc.M109.017376	http://dx.doi.org/10.1074/jbc.M109.017376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19478336	Green Published, hybrid			2022-12-27	WOS:000267908300010
J	Zhou, YD; Mancarella, S; Wang, YJ; Yue, CY; Ritchie, M; Gill, DL; Soboloff, J				Zhou, Yandong; Mancarella, Salvatore; Wang, Youjun; Yue, Chanyu; Ritchie, Michael; Gill, Donald L.; Soboloff, Jonathan			The Short N-terminal Domains of STIM1 and STIM2 Control the Activation Kinetics of Orai1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STORE-INDEPENDENT MODES; OPERATED CA2+ ENTRY; I-CRAC; OLIGOMERIZATION; INITIATION; PROTEINS; REGION; INFLUX	STIM1 and STIM2 are dynamic transmembrane endoplasmic reticulum Ca2+ sensors, coupling directly to activate plasma membrane Orai Ca2+ entry channels. Despite extensive sequence homology, the STIM proteins are functionally distinct. We reveal that the short variable N-terminal random coil sequences of STIM1 and STIM2 confer profoundly different activation properties. Using Orai1-expressing HEK293 cells, chimeric replacement of the 43-amino-acid STIM1 N terminus with that of STIM2 attenuates Orai1-mediated Ca2+ entry and drastically slows store-induced Orai1 channel activation. Conversely, the 55-amino-acid STIM2 terminus substituted within STIM1 strikingly enhances both Orai1-mediated Ca2+ entry and constitutive coupling to activate Orai1 channels. Hence, STIM N termini are powerful coupling modifiers, functioning in STIM2 to "brake" the otherwise constitutive activation of Orai1 channels afforded by its high sensitivity to luminal Ca2+.	[Zhou, Yandong; Mancarella, Salvatore; Wang, Youjun; Yue, Chanyu; Ritchie, Michael; Gill, Donald L.; Soboloff, Jonathan] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gill, DL (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3400 N Broad St, Philadelphia, PA 19140 USA.	dgill@temple.edu; soboloff@temple.edu	Yue, Chanyu/H-1792-2015; Wang, Youjun/H-4016-2013; Soboloff, Jonathan/I-6995-2012	Wang, Youjun/0000-0003-0961-1716; Soboloff, Jonathan/0000-0001-5192-1297	Pennsylvania Department of Health; American Heart Association [0730184N]; National Institutes of Health [AI058173]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER	Pennsylvania Department of Health; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Pennsylvania Department of Health ( to J. S.), American Heart Association Grant 0730184N ( to J. S.), and National Institutes of Health Grant AI058173 ( to D. L. G.).	Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129	29	87	90	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19164	19168		10.1074/jbc.C109.010900	http://dx.doi.org/10.1074/jbc.C109.010900			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19487696	Green Published, hybrid			2022-12-27	WOS:000267908300003
J	Meitzler, JL; de Montellano, PRO				Meitzler, Jennifer L.; de Montellano, Paul R. Ortiz			Caenorhabditis elegans and Human Dual Oxidase 1 (DUOX1) "Peroxidase" Domains INSIGHTS INTO HEME BINDING AND CATALYTIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN COVALENT BONDS; RESPIRATORY-TRACT EPITHELIUM; CYTOCHROME-C PEROXIDASE; FAMILY NADPH OXIDASES; HORSERADISH-PEROXIDASE; MAMMALIAN PEROXIDASES; THYROID PEROXIDASE; HOST-DEFENSE; CONGENITAL HYPOTHYROIDISM; ANGSTROM RESOLUTION	The seven members of the NOX/DUOX family are responsible for generation of the superoxide and H2O2 required for a variety of host defense and cell signaling functions in nonphagocytic cells. Two members, the dual oxidase isozymes DUOX1 and DUOX2, share a structurally unique feature: an N-terminal peroxidase-like domain. Despite sequence similarity to the mammalian peroxidases, the absence of key active site residues makes their binding of heme and their catalytic function uncertain. To explore this domain we have expressed in a baculovirus system and purified the Caenorhabditis elegans CeDUOX1(1-589)) and human hDUOX1(1-593)) DUOX1 "peroxidase" domains. Evaluation of these proteins demonstrated that the isolated hDUOX1(1-593) does not bind heme and has no intrinsic peroxidase activity. In contrast, CeDUOX1(1-589) binds heme covalently, exhibits a modest peroxidase activity, but does not oxidize bromide ion. Surprisingly, the heme appears to have two covalent links to the protein despite the absence of a second conserved carboxyl group in the active site. Although the N-terminal dual oxidase motif has been proposed to directly convert superoxide to H2O2, neither DUOX1 domain demonstrated significant superoxide dismutase activity. These results strengthen the in vivo conclusion that the CeDUOX1 protein supports controlled peroxidative polymerization of tyrosine residues and indicate that the hDUOX1 protein either has a unique function or must interact with other protein factors to express its catalytic activity.	[Meitzler, Jennifer L.; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu		Meitzler, Jennifer/0000-0001-9798-2124	National Institutes of Health [GM32488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32488.	Andersson LA, 1996, J BIOL CHEM, V271, P3406, DOI 10.1074/jbc.271.7.3406; Babior B M, 1995, Curr Opin Hematol, V2, P55; BANGA JP, 1990, FEBS LETT, V266, P133, DOI 10.1016/0014-5793(90)81524-R; BASILE G, 1980, J BIOL CHEM, V255, P7181; Boscolo B, 2007, BBA-PROTEINS PROTEOM, V1774, P1164, DOI 10.1016/j.bbapap.2007.07.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caillou B, 2001, J CLIN ENDOCR METAB, V86, P3351, DOI 10.1210/jc.86.7.3351; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Colas C, 2004, J BIOL CHEM, V279, P24131, DOI 10.1074/jbc.M401687200; DE D, 2002, EXP CELL RES, V273, P187; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; DePillis GD, 1997, J BIOL CHEM, V272, P8857; DOLMAN D, 1968, BIOCHEMISTRY-US, V7, P3991, DOI 10.1021/bi00851a028; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; FOLZ RJ, 1994, GENOMICS, V22, P162, DOI 10.1006/geno.1994.1357; Franzen S, 2006, BIOCHEMISTRY-US, V45, P9085, DOI 10.1021/bi060020z; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Grandvaux N, 2007, BIOCHIMIE, V89, P1113, DOI 10.1016/j.biochi.2007.04.008; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Harper RW, 2006, FEBS LETT, V580, P5150, DOI 10.1016/j.febslet.2006.08.048; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Hildebrandt A G, 1978, Methods Enzymol, V52, P342; Howes BD, 1997, BIOCHEMISTRY-US, V36, P1532, DOI 10.1021/bi962502o; Huang LS, 2006, J BIOL CHEM, V281, P18983, DOI 10.1074/jbc.M602307200; Huang LS, 2006, ARCH BIOCHEM BIOPHYS, V446, P77, DOI 10.1016/j.abb.2005.11.011; Johnson KR, 2007, MOL ENDOCRINOL, V21, P1593, DOI 10.1210/me.2007-0085; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Lockney D, 2006, J PHYS CHEM B, V110, P24165, DOI 10.1021/jp0641233; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Newmyer SL, 1996, J BIOL CHEM, V271, P14891, DOI 10.1074/jbc.271.25.14891; OHTAKI S, 1985, J BIOL CHEM, V260, P441; Ohye H, 2008, THYROID, V18, P561, DOI 10.1089/thy.2007.0258; Pacquelet S, 2008, J BIOL CHEM, V283, P24649, DOI 10.1074/jbc.M709108200; Palamakumbura AH, 1999, BIOCHEMISTRY-US, V38, P15653, DOI 10.1021/bi991498o; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; POCIOT F, 1993, DIS MARKERS, V11, P267, DOI 10.1155/1993/678310; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Rokutan K, 2008, SEMIN IMMUNOPATHOL, V30, P315, DOI 10.1007/s00281-008-0124-5; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Shin K, 2001, BIOCHEM BIOPH RES CO, V281, P1024, DOI 10.1006/bbrc.2001.4448; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; STUGARD CE, 1989, INFECT IMMUN, V57, P3534, DOI 10.1128/IAI.57.11.3534-3539.1989; Tanaka T, 2003, BIOSCI BIOTECH BIOCH, V67, P2254, DOI 10.1271/bbb.67.2254; TAUROG A, 1991, ARCH BIOCHEM BIOPHYS, V287, P288, DOI 10.1016/0003-9861(91)90481-W; THONYMEYER L, 1994, BBA-BIOENERGETICS, V1187, P260, DOI 10.1016/0005-2728(94)90123-6; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; VITELLO LB, 1993, BIOCHEMISTRY-US, V32, P9807, DOI 10.1021/bi00088a036; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Xie ZY, 1996, J BIOL CHEM, V271, P4632; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhou JY, 2006, J PHARMACEUT BIOMED, V40, P1143, DOI 10.1016/j.jpba.2005.09.022	62	65	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18634	18643		10.1074/jbc.M109.013581	http://dx.doi.org/10.1074/jbc.M109.013581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19460756	Green Published, hybrid			2022-12-27	WOS:000267711500012
J	Quintanilla, RA; Matthews-Roberson, TA; Dolan, PJ; Johnson, GVW				Quintanilla, Rodrigo A.; Matthews-Roberson, Tori A.; Dolan, Philip J.; Johnson, Gail V. W.			Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION; PROTEIN-TAU; HIPPOCAMPAL-NEURONS; OXIDATIVE STRESS; MOUSE MODEL; CELL-DEATH; IN-VITRO; APOPTOSIS; MORPHOLOGY; ABNORMALITIES	In Alzheimer disease (AD) mitochondrial abnormalities occur early in the pathogenic process and likely play a significant role in disease progression. Tau is a microtubule-associated protein that is abnormally processed in AD, and a connection between tau pathology and mitochondrial impairment has been proposed. However, few studies have examined the relationship between pathological forms of tau and mitochondrial dysfunction. We recently demonstrated that inducible expression of tau truncated at Asp-421 to mimic caspase cleavage (T4C3) was toxic to immortalized cortical neurons compared with a full-length tau isoform (T4). In this study we investigated the effects of T4C3 on mitochondrial function. Expression of T4C3 induced mitochondrial fragmentation and elevated oxidative stress levels in comparison with T4-expressing cells. Thapsigargin treatment of T4 or T4C3 cells, which causes an increase in intracellular calcium levels, resulted in a significant decrease in mitochondrial potential and loss of mitochondrial membrane integrity in T4C3 cells when compared with cells expressing T4. The mitochondrial fragmentation and mitochondrial membrane damage were ameliorated in T4C3 cells by pretreatment with cyclosporine A or FK506, implicating the calcium-dependent phosphatase calcineurin in these pathogenic events. Increased calcineurin activity has been reported in AD brain, and thus, inhibition of this phosphatase may provide a therapeutic target for the treatment of AD.	[Johnson, Gail V. W.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Matthews-Roberson, Tori A.; Dolan, Philip J.; Johnson, Gail V. W.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Matthews-Roberson, Tori A.; Dolan, Philip J.; Johnson, Gail V. W.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Alabama System; University of Alabama Birmingham; University of Rochester	Johnson, GVW (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, 601 Elmwood Ave,Box 604,Rm 4-6314, Rochester, NY 14642 USA.	gail_johnsonvoll@urmc.rochester.edu	Johnson, Gail V.W./K-4723-2012; QUINTANILLA, RODRIGO/ABG-8829-2021; Zhu, Longjun/C-2938-2012	Johnson, Gail V.W./0000-0003-3464-0404; 	National Institutes of Health [NS051279]; Alzheimer Disease Association; Merck Graduate Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Disease Association; Merck Graduate Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS051279 ( to G. V. W. J.). This work also supported by a grant from the Alzheimer Disease Association ( to G. V. W. J.) and a Merck Graduate Dissertation Fellowship ( to T. M.- R.).	AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Blass JP, 2002, J ALZHEIMERS DIS, V4, P225, DOI 10.3233/JAD-2002-4312; Bongarzone ER, 1998, J NEUROSCI RES, V54, P309, DOI 10.1002/(SICI)1097-4547(19981101)54:3<309::AID-JNR2>3.0.CO;2-5; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Ding HP, 2008, J ALZHEIMERS DIS, V14, P441; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Dubinsky JM, 1998, J NEUROSCI RES, V53, P728, DOI 10.1002/(SICI)1097-4547(19980915)53:6<728::AID-JNR10>3.0.CO;2-U; Fasulo L, 2005, J ALZHEIMERS DIS, V7, P3; Fasulo L, 2000, J NEUROCHEM, V75, P624, DOI 10.1046/j.1471-4159.2000.0750624.x; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Garcia-Sierra F, 2008, J ALZHEIMERS DIS, V14, P401; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Han XJ, 2008, NEUROSCI RES, V60, P114, DOI 10.1016/j.neures.2007.09.012; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; HAUPTMANN S, 2008, NEUROBIOL A IN PRESS; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Krishnamurthy PK, 2004, J BIOL CHEM, V279, P7893, DOI 10.1074/jbc.M311203200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Matthews-Roberson TA, 2008, BRAIN RES, V1234, P206, DOI 10.1016/j.brainres.2008.07.111; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shelton SB, 2004, J NEUROSCI RES, V76, P110, DOI 10.1002/jnr.20051; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Szydlowska K, 2006, J NEUROCHEM, V99, P965, DOI 10.1111/j.1471-4159.2006.04136.x; Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; WERTH JL, 1994, J NEUROSCI, V14, P348; Yu DY, 2008, BBA-MOL CELL RES, V1783, P2255, DOI 10.1016/j.bbamcr.2008.06.015; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhu LP, 2000, CELL CALCIUM, V28, P107, DOI 10.1054/ceca.2000.0138	50	121	127	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18754	18766		10.1074/jbc.M808908200	http://dx.doi.org/10.1074/jbc.M808908200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19389700	hybrid, Green Published			2022-12-27	WOS:000267711500025
J	Vollmar, M; Schlieper, D; Winn, M; Buchner, C; Groth, G				Vollmar, Melanie; Schlieper, Daniel; Winn, Martyn; Buechner, Claudia; Groth, Georg			Structure of the c(14) Rotor Ring of the Proton Translocating Chloroplast ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SUBUNIT OLIGOMER; F-ATPASE; BOVINE F-1-ATPASE; AQUEOUS ACCESS; CROSS-LINKING; ROTARY MOTOR; NA+-ATPASE; ROTATION; MODEL; RESOLUTION	The structure of the membrane integral rotor ring of the proton translocating F1F0 ATP synthase from spinach chloroplasts was determined to 3.8 angstrom resolution by x-ray crystallography. The rotor ring consists of 14 identical protomers that are symmetrically arranged around a central pore. Comparisons with the c(11) rotor ring of the sodium translocating ATPase from Ilyobacter tartaricus show that the conserved carboxylates involved in proton or sodium transport, respectively, are 10.6-10.8 angstrom apart in both c ring rotors. This finding suggests that both ATPases have the same gear distance despite their different stoichiometries. The putative proton-binding site at the conserved carboxylate Glu(61) in the chloroplast ATP synthase differs from the sodium-binding site in Ilyobacter. Residues adjacent to the conserved carboxylate show increased hydrophobicity and reduced hydrogen bonding. The crystal structure reflects the protonated form of the chloroplast c ring rotor. We propose that upon deprotonation, the conformation of Glu(61) is changed to another rotamer and becomes fully exposed to the periphery of the ring. Reprotonation of Glu(61) by a conserved arginine in the adjacent a subunit returns the carboxylate to its initial conformation.	[Vollmar, Melanie; Schlieper, Daniel; Buechner, Claudia; Groth, Georg] Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany; [Winn, Martyn] SERC, Daresbury Lab, Sci & Technol Facil Council, Computat Sci & Engn Dept, Warrington WA4 4AD, Cheshire, England	Heinrich Heine University Dusseldorf; STFC Daresbury Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC)	Groth, G (corresponding author), Univ Dusseldorf, Inst Biochem Pflanzen, Univ Str 1, D-40225 Dusseldorf, Germany.	georg.groth@uni-duesseldorf.de		Vollmar, Melanie/0000-0002-9162-9159	German Research Foundation [GR1616/5-3]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grant GR1616/5-3 ( to G. G.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abrahams JP, 1996, P NATL ACAD SCI USA, V93, P9420, DOI 10.1073/pnas.93.18.9420; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BIRKENHAGER R, 1995, EUR J BIOCHEM, V230, P58, DOI 10.1111/j.1432-1033.1995.tb20534.x; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; BUCHNER C, 2004, THESIS U DUSSELDORF; DeLano W.L, PYMOL MOL GRAPHICS S; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dmitriev OY, 2004, FEBS LETT, V556, P35, DOI 10.1016/S0014-5793(03)01360-7; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Groth G, 2002, P NATL ACAD SCI USA, V99, P3464, DOI 10.1073/pnas.052546099; Groth G, 1999, EUR J BIOCHEM, V260, P15, DOI 10.1046/j.1432-1327.1999.00101.x; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; HOPPE J, 1984, BIOCHIM BIOPHYS ACTA, V768, P1, DOI 10.1016/0304-4173(84)90005-3; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 2000, J BIOL CHEM, V275, P31340, DOI 10.1074/jbc.M003687200; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Junge W, 1996, BER BUNSEN PHYS CHEM, V100, P2014, DOI 10.1002/bbpc.19961001215; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Luo PZ, 1999, P NATL ACAD SCI USA, V96, P4930, DOI 10.1073/pnas.96.9.4930; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Meier T, 2006, J BACTERIOL, V188, P7759, DOI 10.1128/JB.00934-06; Meiss E, 2008, J BIOL CHEM, V283, P24594, DOI 10.1074/jbc.M802574200; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; PALLSDOTTIR H, 2004, BIOCHIM BIOPHYS ACTA, V1666, P2; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Singh S, 1996, FEBS LETT, V397, P30, DOI 10.1016/S0014-5793(96)01127-1; Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; STROTMANN H, 1973, BIOCHIM BIOPHYS ACTA, V314, P202, DOI 10.1016/0005-2728(73)90135-7; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Varco-Merth B, 2008, BBA-BIOENERGETICS, V1777, P605, DOI 10.1016/j.bbabio.2008.05.009; von Ballmoos C, 2007, BIOCHEMISTRY-US, V46, P11800, DOI 10.1021/bi701083v; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Watts SD, 1996, J BIOL CHEM, V271, P28341, DOI 10.1074/jbc.271.45.28341	71	99	102	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18228	18235		10.1074/jbc.M109.006916	http://dx.doi.org/10.1074/jbc.M109.006916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19423706	hybrid, Green Published			2022-12-27	WOS:000267712400035
J	Walcott, S; Fagnant, PM; Trybus, KM; Warshaw, DM				Walcott, Sam; Fagnant, Patricia M.; Trybus, Kathleen M.; Warshaw, David M.			Smooth Muscle Heavy Meromyosin Phosphorylated on One of Its Two Heads Supports Force and Motion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHORYLATION; MYOSIN MOLECULES; LASER TRAP; IN-VITRO; DEPENDENT REGULATION; IONIC-STRENGTH; BINDING LOOP; SINGLE HEAD; STEP-SIZE; ACTIN	Smooth muscle myosin is activated by regulatory light chain (RLC) phosphorylation. In the unphosphorylated state the activity of both heads is suppressed due to an asymmetric, intramolecular interaction between the heads. The properties of myosin with only one of its two RLCs phosphorylated, a state likely to be present both during the activation and the relaxation phase of smooth muscle, is less certain despite much investigation. Here we further characterize the mechanical properties of an expressed heavy meromyosin (HMM) construct with only one of its RLCs phosphorylated (HMM-1P). This construct was previously shown to have more than 50% of the ATPase activity of fully phosphorylated myosin (HMM-2P) and to move actin at the same speed in a motility assay as HMM-2P (Rovner, A. S., Fagnant, P. M., and Trybus, K. M. (2006) Biochemistry 45, 5280-5289). Here we show that the unitary step size and attachment time to actin of HMM-1P is indistinguishable from that of HMM-2P. Force-velocity measurements on small ensembles show that HMM-1P can generate approximately half the force of HMM-2P, which may relate to the observed duty ratio of HMM-1P being approximately half that of HMM-2P. Therefore, single-phosphorylated smooth muscle HMM molecules are active species, and the head associated with the unphosphorylated RLC is mechanically competent, allowing it to make a substantial contribution to both motion and force generation during smooth muscle contraction.	[Walcott, Sam; Fagnant, Patricia M.; Trybus, Kathleen M.; Warshaw, David M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Vermont	Warshaw, DM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	david.warshaw@uvm.edu		Walcott, Sam/0000-0002-8871-6964	National Institutes of Health [HL085489, HL38113, HL007944]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038113, R01HL085489, T32HL007944, R29HL038113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085489 ( to D. W.), HL38113 ( to K. T.), and HL007944 ( to S. W.).	Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Berger CEM, 2001, J BIOL CHEM, V276, P23240, DOI 10.1074/jbc.M100524200; Burgess SA, 2007, J MOL BIOL, V372, P1165, DOI 10.1016/j.jmb.2007.07.014; CHACKO S, 1982, P NATL ACAD SCI-BIOL, V79, P292, DOI 10.1073/pnas.79.2.292; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; CREMO CR, 1995, J BIOL CHEM, V270, P2171, DOI 10.1074/jbc.270.5.2171; Debold EP, 2005, BIOPHYS J, V89, pL34, DOI 10.1529/biophysj.105.072967; DILLON PF, 1981, SCIENCE, V211, P495, DOI 10.1126/science.6893872; Ellison PA, 2000, J BIOL CHEM, V275, P15142, DOI 10.1074/jbc.275.20.15142; FUGLSANG A, 1993, J MUSCLE RES CELL M, V14, P666, DOI 10.1007/BF00141563; Gollub J, 1999, BIOCHEMISTRY-US, V38, P10107, DOI 10.1021/bi990267e; Guilford WH, 1997, BIOPHYS J, V72, P1006, DOI 10.1016/S0006-3495(97)78753-8; HARRIS DE, 1995, AM J PHYSIOL-CELL PH, V269, pC1160, DOI 10.1152/ajpcell.1995.269.5.C1160; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; IKEBE M, 1982, J BIOCHEM-TOKYO, V91, P1809, DOI 10.1093/oxfordjournals.jbchem.a133874; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Kad NM, 2003, J CELL BIOL, V162, P481, DOI 10.1083/jcb.200304023; Konishi K, 2001, J BIOCHEM-TOKYO, V129, P365, DOI 10.1093/oxfordjournals.jbchem.a002866; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; Li XD, 2000, BIOCHEMISTRY-US, V39, P2254, DOI 10.1021/bi9924617; ONISHI H, 1982, J BIOCHEM-TOKYO, V92, P871, DOI 10.1093/oxfordjournals.jbchem.a134001; PATLAK JB, 1993, BIOPHYS J, V65, P29, DOI 10.1016/S0006-3495(93)81041-5; PERSECHINI A, 1981, SCIENCE, V213, P1383, DOI 10.1126/science.6455737; PERSECHINI A, 1986, J BIOL CHEM, V261, P6293; Rovner AS, 2006, BIOCHEMISTRY-US, V45, P5280, DOI 10.1021/bi060154c; Rovner AS, 1998, J BIOL CHEM, V273, P27939, DOI 10.1074/jbc.273.43.27939; Sellers JR, 2007, J MUSCLE RES CELL M, V28, P363, DOI 10.1007/s10974-008-9134-0; SELLERS JR, 1982, J BIOL CHEM, V257, P3880; SELLERS JR, 1983, J BIOL CHEM, V258, P4181; Sherwood JJ, 2004, P NATL ACAD SCI USA, V101, P10973, DOI 10.1073/pnas.0401699101; Sweeney HL, 2000, J BIOL CHEM, V275, P41273, DOI 10.1074/jbc.M008310200; Tanaka H, 2008, J BIOL CHEM, V283, P15611, DOI 10.1074/jbc.M710597200; TRYBUS KM, 1984, J BIOL CHEM, V259, P8564; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; TRYBUS KM, 1985, J BIOL CHEM, V260, P5988; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; VYAS TB, 1992, AM J PHYSIOL, V263, pC210, DOI 10.1152/ajpcell.1992.263.1.C210; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Wu XD, 1999, J BIOL CHEM, V274, P20328, DOI 10.1074/jbc.274.29.20328	44	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18244	18251		10.1074/jbc.M109.003293	http://dx.doi.org/10.1074/jbc.M109.003293			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419961	Green Published, hybrid			2022-12-27	WOS:000267712400037
J	Grote, M; Polyhach, Y; Jeschke, G; Steinhoff, HJ; Schneider, E; Bordignon, E				Grote, Mathias; Polyhach, Yevhen; Jeschke, Gunnar; Steinhoff, Heinz-Juergen; Schneider, Erwin; Bordignon, Enrica			Transmembrane Signaling in the Maltose ABC Transporter MalFGK(2)-E PERIPLASMIC MalF-P2 LOOP COMMUNICATES SUBSTRATE AVAILABILITY TO THE ATP-BOUND MalK DIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; ELECTRON-PARAMAGNETIC-RESONANCE; ESCHERICHIA-COLI; PROTEIN MALE; CATALYTIC CYCLE; SALMONELLA; P2; TYPHIMURIUM; INTERACTS; COMPLEX	ABC transporters are ubiquitous membrane proteins that translocate solutes across biological membranes at the expense of ATP. In prokaryotic ABC importers, the extracytoplasmic anchoring of the substrate-binding protein (receptor) is emerging as a key determinant for the structural rearrangements in the cytoplasmically exposed ATP-binding cassette domains and in the transmembrane gates during the nucleotide cycle. Here the molecular mechanism of such signaling events was addressed by electron paramagnetic resonance spectroscopy of spin-labeled ATP-binding cassette maltose transporter variants (MalFGK(2)-E). A series of doubly spin-labeled mutants in the MalF-P2 domain involving positions 92, 205, 239, 252, and 273 and one triple mutant labeled at positions 205/252 in P2 and 83 in the Q-loop of MalK were assayed. The EPR data revealed that the substrate-binding protein MalE is bound to the transporter throughout the transport cycle. Concomitantly with the three conformations of the ATP-binding cassette MalK(2), three functionally relevant conformations are found also in the periplasmic MalF-P2 loop, strictly dependent on cytoplasmic nucleotide binding and periplasmic docking of liganded MalE to MalFG. The reciprocal communication across the membrane unveiled here gives first insights into the stimulatory effect of MalE on the ATPase activity, and it is suggested to be an important mechanistic feature of receptor-coupled ABC transporters.	[Grote, Mathias; Schneider, Erwin] Humboldt Univ, Inst Biol Bakterienphysiol, D-10115 Berlin, Germany; [Polyhach, Yevhen; Jeschke, Gunnar; Bordignon, Enrica] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Steinhoff, Heinz-Juergen] Univ Osnabruck, Fachbereich Phys, D-49076 Osnabruck, Germany	Humboldt University of Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; University Osnabruck	Schneider, E (corresponding author), Humboldt Univ, Inst Biol Bakterienphysiol, Chausseestr 117, D-10115 Berlin, Germany.	erwin.schneider@rz.hu-berlin.de; enrica.bordignon@phys.chem.ethz.ch	Steinhoff, Heinz-Juergen/H-3791-2014	Steinhoff, Heinz-Juergen/0000-0002-5888-0157; Bordignon, Enrica/0000-0003-2450-5161; Jeschke, Gunnar/0000-0001-6853-8585	Deutsche Forschungsgemeinschaft [SCHN 274/9-3, STE 640/7]; German National Academic Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German National Academic Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants SCHN 274/9-3 (to E. S.) and STE 640/7 (to H.- J. S.) and by a fellowship from the German National Academic Foundation (to M. G.).	Beier C, 2006, BIOPHYS J, V91, P2647, DOI 10.1529/biophysj.105.080051; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Crosa JH., 2004, IRON TRANSPORT BACTE; Daus ML, 2007, MOL MICROBIOL, V66, P1107, DOI 10.1111/j.1365-2958.2007.05982.x; Daus ML, 2009, J BACTERIOL, V191, P754, DOI 10.1128/JB.01439-08; Daus ML, 2006, J BIOL CHEM, V281, P3856, DOI 10.1074/jbc.M511953200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; Holland I. B., 2003, ABC PROTEINS BACTERI; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jacso T, 2009, BIOCHEMISTRY-US, V48, P2216, DOI 10.1021/bi801376m; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tapia MI, 1999, J BACTERIOL, V181, P2267, DOI 10.1128/JB.181.7.2267-2272.1999; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001	24	62	62	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17521	17526		10.1074/jbc.M109.006270	http://dx.doi.org/10.1074/jbc.M109.006270			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19395376	Green Published, hybrid			2022-12-27	WOS:000267202500018
J	Ishikawa, Y; Wirz, J; Vranka, JA; Nagata, K; Bachinger, HP				Ishikawa, Yoshihiro; Wirz, Jackie; Vranka, Janice A.; Nagata, Kazuhiro; Baechinger, Hans Peter			Biochemical Characterization of the Prolyl 3-Hydroxylase 1(.)Cartilage-associated Protein(.)Cyclophilin B Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; PROTEIN DISULFIDE-ISOMERASE; FK506-BINDING PROTEIN; MOLECULAR CHAPERONE; IN-VITRO; MUTATIONS; COLLAGEN; ENZYME; DEFICIENCY; CATALYSIS	The rough endoplasmic reticulum-resident protein complex consisting of prolyl 3-hydroxylase 1 (P3H1), cartilage-associated protein (CRTAP), and cyclophilin B (CypB) can be isolated from chick embryos on a gelatin-Sepharose column, indicating some involvement in the biosynthesis of procollagens. Prolyl 3-hydroxylase 1 modifies a single proline residue in the alpha chains of type I, II, and III collagens to (3S)-hydroxyproline. The peptidyl-prolyl cis-trans isomerase activity of cyclophilin B was shown previously to catalyze the rate of triple helix formation. Here we show that cyclophilin B in the complex shows peptidyl-prolyl cis-trans isomerase activity and that the P3H1(.)CRTAP(.)CypB complex has another important function: it acts as a chaperone molecule when tested with two classical chaperone assays. The P3H1(.)CRTAP(.)CypB complex inhibited the thermal aggregation of citrate synthase and was active in the denatured rhodanese refolding and aggregation assay. The chaperone activity of the complex was higher than that of protein-disulfide isomerase, a well characterized chaperone. The P3H1(.)CRTAP(.)CypB complex also delayed the in vitro fibril formation of type I collagen, indicating that this complex is also able to interact with triple helical collagen and acts as a collagen chaperone.	[Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Wirz, Jackie; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan	Oregon Health & Science University; Kyoto University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Wirz, Jacqueline/0000-0003-2046-610X; Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospitals for Children; Osteogenesis Imperfecta Foundation	Shriners Hospitals for Children; Osteogenesis Imperfecta Foundation	This work was supported by a grant from the Shriners Hospitals for Children (to H. P. B.) and in part by a Michael Geisman Research Fellowship from the Osteogenesis Imperfecta Foundation (to J.A.V.).	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Horibe T, 2002, J BIOCHEM, V132, P401, DOI 10.1093/oxfordjournals.jbchem.a003236; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Knappe TA, 2007, J MOL BIOL, V368, P1458, DOI 10.1016/j.jmb.2007.02.097; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NATSUME T, 1994, J BIOL CHEM, V269, P31224; OGLE JD, 1962, J BIOL CHEM, V237, P3667; RISTELI J, 1978, ANAL BIOCHEM, V84, P423, DOI 10.1016/0003-2697(78)90060-X; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	27	87	89	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17641	17647		10.1074/jbc.M109.007070	http://dx.doi.org/10.1074/jbc.M109.007070			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19419969	Green Published, hybrid			2022-12-27	WOS:000267202500030
J	Zhang, F; Tsai, S; Kato, K; Yamanouchi, D; Wang, CJ; Rafii, S; Liu, B; Kent, KC				Zhang, Fan; Tsai, Shirling; Kato, Kaori; Yamanouchi, Dai; Wang, Chunjie; Rafii, Shahin; Liu, Bo; Kent, K. Craig			Transforming Growth Factor-beta Promotes Recruitment of Bone Marrow Cells and Bone Marrow-derived Mesenchymal Stem Cells through Stimulation of MCP-1 Production in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INTIMAL HYPERPLASIA; PROGENITOR CELLS; NEOINTIMAL HYPERPLASIA; ARTERIAL INJURY; PKC-DELTA; IN-VIVO; MIGRATION; EXPRESSION; MECHANISMS	Bone marrow-derived progenitor cells have recently been shown to be involved in the development of intimal hyperplasia after vascular injury. Transforming growth factor-beta (TGF-beta) has profound stimulatory effects on intimal hyperplasia, but it is unknown whether these effects involve progenitor cell recruitment. In this study we found that although TGF-beta had no direct effect on progenitor cell recruitment, conditioned media derived from vascular smooth muscle cells (VSMC) stimulated with TGF-beta induced migration of both total bone marrow (BM) cells and BM-mesenchymal stem cells (MSC) and also induced MSC differentiation into smooth muscle like cells. Furthermore, overexpression of the signaling molecule Smad3 in VSMC via adenovirus-mediated gene transfer (AdSmad3) enhanced the TGF-beta's chemotactic effect. Microarray analysis of VSMC stimulated by TGF-beta/AdSmad3 revealed monocyte chemoattractant protein-1 (MCP-1) as a likely factor responsible for progenitor cell recruitment. We then demonstrated that TGF-beta through Smad3 phosphorylation induced a robust expression of MCP-1 in VSMC. Recombinant MCP-1 mimicked the stimulatory effect of conditioned media on BM and MSC migration. In the rat carotid injury model, Smad3 overexpression significantly increased MCP-1 expression after vascular injury, consistent with our in vitro results. Interestingly, TGF-beta/Smad3-induced MCP-1 was completely blocked by both Ro-32-0432 and rotterlin, suggesting protein kinase C-delta (PKC delta) may play a role in TGF-beta/Smad3-induced MCP-1 expression. In summary, our data demonstrate that TGF-beta, through Smad3 and PKC delta, stimulates VSMC production of MCP-1, which is a chemoattractant for bone marrow-derived cells, specifically MSC. Manipulation of this signaling system may provide a novel approach to inhibition of intimal hyperplasia.	[Zhang, Fan; Kato, Kaori; Yamanouchi, Dai; Liu, Bo; Kent, K. Craig] Univ Wisconsin, Dept Surg, Sch Med, Madison, WI 53705 USA; [Tsai, Shirling; Wang, Chunjie] Cornell Univ, Weill Med Coll, Div Vasc Surg, Dept Surg, New York, NY 10065 USA; [Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA	University of Wisconsin System; University of Wisconsin Madison; Cornell University; Cornell University; Howard Hughes Medical Institute	Liu, B (corresponding author), Univ Wisconsin, Dept Surg, Sch Med, WIMR 5137,1111 Highland Ave, Madison, WI 53705 USA.	liub@surgery.wisc.edu			National Institutes of Health [F32 HL088818-01]; Public Health Service [R01 HL-68673]; American Heart Association [0455859T]; Society of University Surgeons-Ethicon Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL088818, R01HL068673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association(American Heart Association); Society of University Surgeons-Ethicon Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant F32 HL088818-01 (to S. T.) and Public Health Service Grant R01 HL-68673 (NHLBI, to K. K. and B. L.). The work was also supported by American Heart Association Grant-in-aid 0455859T (to B. L.) and a Society of University Surgeons-Ethicon Scholarship Grant Award (to S. T.).	Abedin M, 2004, CIRC RES, V95, P671, DOI 10.1161/01.RES.0000143421.27684.12; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; CLOWES AW, 1989, J CARDIOVASC PHARM, V14, pS12, DOI 10.1097/00005344-198906146-00005; CLOWES AW, 1983, LAB INVEST, V49, P208; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; COMBADIERE C, 1995, J BIOL CHEM, V270, P29671; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Devine SM, 2001, EXP HEMATOL, V29, P244, DOI 10.1016/S0301-472X(00)00635-4; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hollenbeck ST, 2004, J SURG RES, V120, P288, DOI 10.1016/j.jss.2004.01.005; Iwata H, 2007, FRONT BIOSCI, V12, P4157, DOI 10.2741/2377; Kamiya K, 2007, J SURG RES, V141, P91, DOI 10.1016/j.jss.2007.02.025; KANZAKI T, 1995, ARTERIOSCL THROM VAS, V15, P1951, DOI 10.1161/01.ATV.15.11.1951; Kashiwakura Y, 2003, CIRCULATION, V107, P2078, DOI 10.1161/01.CIR.0000070082.64414.B5; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; NIKOL S, 1992, J CLIN INVEST, V90, P1582, DOI 10.1172/JCI116027; REIDY MA, 1992, CIRCULATION, V86, P43; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Roque M, 2002, ARTERIOSCL THROM VAS, V22, P554, DOI 10.1161/hq0402.105720; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Ryan ST, 2003, J VASC RES, V40, P37, DOI 10.1159/000068937; Ryer EJ, 2006, ARTERIOSCL THROM VAS, V26, P780, DOI 10.1161/01.ATV.0000209517.00220.cd; Ryer EJ, 2005, J BIOL CHEM, V280, P35310, DOI 10.1074/jbc.M507187200; Sahara M, 2005, STEM CELLS, V23, P874, DOI 10.1634/stemcells.2005-0012; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Tsai S, 2009, J VASC SURG, V49, P502, DOI 10.1016/j.jvs.2008.07.060; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang CH, 2008, ARTERIOSCL THROM VAS, V28, P54, DOI 10.1161/ATVBAHA.107.147256; Wang CH, 2006, CIRC RES, V99, P617, DOI 10.1161/01.RES.0000243210.79654.fd; Wang L, 2002, EXP HEMATOL, V30, P831, DOI 10.1016/S0301-472X(02)00829-9; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; WOLF YG, 1994, J CLIN INVEST, V93, P1172, DOI 10.1172/JCI117070; Yakmovych I, 2001, FASEB J, V15, P553; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zhang L, 2004, J BIOL CHEM, V279, P28315, DOI 10.1074/jbc.C400115200; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100	48	101	109	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17564	17574		10.1074/jbc.M109.013987	http://dx.doi.org/10.1074/jbc.M109.013987			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19406748	Green Published, hybrid			2022-12-27	WOS:000267202500022
J	Lamkanfi, M; Malireddi, RKS; Kanneganti, TD				Lamkanfi, Mohamed; Malireddi, R. K. Subbarao; Kanneganti, Thirumala-Devi			Fungal Zymosan and Mannan Activate the Cryopyrin Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALP3 INFLAMMASOME; HOST-DEFENSE; INTERLEUKIN-1-BETA RELEASE; CASPASE-1 ACTIVATION; MICE DEFICIENT; RECEPTOR; RECOGNITION; DECTIN-1; INNATE; IPAF	Some fungal species are opportunistic pathogens that can cause infection in people with compromised immune systems. Activation of caspase-1 and the subsequent secretion of mature interleukin (IL)-1 beta is a major signaling pathway of the innate immune system, but how yeasts induce caspase-1 activation is unknown. We show here that stimulation of macrophages and dendritic cells with heat-killed Saccharomyces cerevisiae or the purified cell wall components zymosan and mannan induced caspase-1 activation and IL-1 beta secretion when combined with ATP. Macrophages deficient for the inflammasome adaptor ASC were defective in caspase-1 activation and IL-1 beta secretion, suggesting involvement of an ASC-dependent inflammasome. Indeed, caspase-1 activation was abrogated in macrophages lacking the NOD-like (NLR) protein Cryopyrin/Nalp3 and in wild type macrophages pre-treated with the pannexin-1 inhibitor probenecid. IL-1 beta secretion further required the Toll-like receptor (TLR) adaptors MyD88 and TRIF, and partially relied on TLR2. We previously showed that bacterial molecules such as lipopolysaccharide (LPS) and peptidoglycan induce activation of caspase-7 through the Cryopyrin inflammasome. Similarly, Cryopyrin and ASC were required for activation of caspase-7 in macrophages stimulated with zymosan or mannan and ATP. These results demonstrate that the conserved fungal components zymosan and mannan require ASC and Cryopyrin for caspase-1 activation and IL-1 beta secretion and suggest an important role for the Cryopyrin inflammasome during fungal infections.	[Lamkanfi, Mohamed; Malireddi, R. K. Subbarao; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, MS 351,570,St Jude Pl,Ste E7004, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018; Malireddi, RKSubbarao/C-5804-2013	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malireddi, RKSubbarao/0000-0001-8855-9447	National Institutes of Health [AR056296]; American Lebanese Syrian Association Charities; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Association Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR056296. This work was also supported by the American Lebanese Syrian Association Charities ( to T.- D. K.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2009, BLOOD, V113, P2742, DOI 10.1182/blood-2008-09-178038; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605	37	106	113	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20574	20581		10.1074/jbc.M109.023689	http://dx.doi.org/10.1074/jbc.M109.023689			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509280	hybrid, Green Published			2022-12-27	WOS:000268316100019
J	Yoshizawa-Sugata, N; Masai, H				Yoshizawa-Sugata, Naoko; Masai, Hisao			Roles of Human AND-1 in Chromosome Transactions in S Phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; DNA-POLYMERASE-ALPHA; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION REPAIR; STALLED REPLICATION FORKS; SACCHAROMYCES-CEREVISIAE; IONIZING-RADIATION; CDC7 KINASE; EFFICIENT PROGRESSION; CHECKPOINT RESPONSE	Coordinated execution of DNA replication, checkpoint activation, and postreplicative chromatid cohesion is intimately related to the replication fork machinery. Human AND-1/chromosome transmission fidelity 4 is localized adjacent to replication foci and is required for efficient DNA synthesis. In S phase, AND-1 is phosphorylated in response to replication arrest in a manner dependent on checkpoint kinase, ataxia telangiectasia-mutated, ataxia telangiectasia-mutated and Rad3-related protein, and Cdc7 kinase but not on Chk1. Depletion of AND-1 increases DNA damage, delays progression of S phase, leads to accumulation of late S and/or G(2) phase cells, and induces cell death in cancer cells. It also elevated UV-radioresistant DNA synthesis and caused premature recovery of replication after hydroxyurea arrest, indicating that lack of AND-1 compromises checkpoint activation. This may be partly due to the decreased levels of Chk1 protein in AND-1-depleted cells. Furthermore, AND-1 interacts with cohesin proteins Smc1, Smc3, and Rad21/Scc1, consistent with proposed roles of yeast counterparts of AND-1 in sister chromatid cohesion. Depletion of AND-1 leads to significant inhibition of homologous recombination repair of an I-SceI-driven double strand break. Based on these data, we propose that AND-1 coordinates multiple cellular events in S phase and G(2) phase, such as DNA replication, checkpoint activation, sister chromatid cohesion, and DNA damage repair, thus playing a pivotal role in maintenance of genome integrity.	[Yoshizawa-Sugata, Naoko; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	masai-hs@igakuken.or.jp		Yoshizawa-Sugata, Naoko/0000-0001-8792-8669	Ministry of Education, Science, Sports and Culture; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders	This work was supported by grants-in-aid for scientific research "A" and scientific research on priority areas "Chromosome Cycle" (to H. M.), by scientific research "C" (to N.Y.) from the Ministry of Education, Science, Sports and Culture, and by Astellas Foundation for Research on Metabolic Disorders (to H. M.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Cortes-Ledesma F, 2006, EMBO REP, V7, P919, DOI 10.1038/sj.embor.7400774; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; DESJARDINS LM, 1995, EXP CELL RES, V216, P380, DOI 10.1006/excr.1995.1048; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Formosa T, 1999, GENETICS, V151, P1459; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Jessberger R, 1996, EMBO J, V15, P4061, DOI 10.1002/j.1460-2075.1996.tb00779.x; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kohler A, 1997, J CELL SCI, V110, P1051; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Li J, 2005, J BIOL CHEM, V280, P37948, DOI 10.1074/jbc.M509299200; Liu QH, 2000, GENE DEV, V14, P1448; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; Montagnoli A, 2004, CANCER RES, V64, P7110, DOI 10.1158/0008-5472.CAN-04-1547; Naiki T, 2001, MOL CELL BIOL, V21, P5838, DOI 10.1128/MCB.21.17.5838-5845.2001; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Nomura M, 2005, BIOCHEM BIOPH RES CO, V335, P900, DOI 10.1016/j.bbrc.2005.07.160; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ogiwara H, 2007, BIOCHEM BIOPH RES CO, V354, P222, DOI 10.1016/j.bbrc.2006.12.185; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schar P, 2004, NUCLEIC ACIDS RES, V32, P3921, DOI 10.1093/nar/gkh716; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Strom L, 2007, CURR OPIN CELL BIOL, V19, P344, DOI 10.1016/j.ceb.2007.04.003; Sugata N, 2000, HUM MOL GENET, V9, P2919, DOI 10.1093/hmg/9.19.2919; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Takeda T, 2001, MOL BIOL CELL, V12, P1257, DOI 10.1091/mbc.12.5.1257; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou YJ, 2004, MOL CELL BIOL, V24, P9568, DOI 10.1128/MCB.24.21.9568-9579.2004; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	90	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20718	20728		10.1074/jbc.M806711200	http://dx.doi.org/10.1074/jbc.M806711200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19439411	Green Published, hybrid			2022-12-27	WOS:000268316100034
J	Kelly, TJ; Lerin, C; Haas, W; Gygi, SP; Puigserver, P				Kelly, Timothy J.; Lerin, Carles; Haas, Wilhelm; Gygi, Steven P.; Puigserver, Pere			GCN5-mediated Transcriptional Control of the Metabolic Coactivator PGC-1 beta through Lysine Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA COACTIVATOR-1; FATTY-ACID OXIDATION; MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; RECEPTOR-ALPHA; ERR-ALPHA; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; PGC-1-ALPHA; ACTIVATION	Changes in expression levels of genes encoding for proteins that control metabolic pathways are essential to maintain nutrient and energy homeostasis in individual cells as well as in organisms. An important regulated step in this process is accomplished through covalent chemical modifications of proteins that form complexes with the chromatin of gene promoters. The peroxisome proliferators gamma co-activator 1 (PGC-1) family of transcriptional co-activators comprises important components of a number of these complexes and participates in a large array of glucose and lipid metabolic adaptations. Here, we show that PGC-1 beta is acetylated on at least 10 lysine residues distributed along the length of the protein by the acetyl transferase general control of amino-acid synthesis (GCN5) and that this acetylation reaction is reversed by the deacetylase sirtuin 1 (SIRT1). GCN5 strongly interacts with PGC-1 beta and represses its transcriptional activity associated with transcription factors such as ERR alpha, NRF-1, and HNF4 alpha, however acetylation and transcriptional repression do not occur when a catalytically inactive GCN5 is co-expressed. Transcriptional repression coincides with PGC-1 beta redistribution to nuclear foci where it co-localizes with GCN5. Furthermore, knockdown of GCN5 ablates PGC-1 beta acetylation and increases transcriptional activity. In primary skeletal muscle cells, PGC-1 beta induction of endogenous target genes, including MCAD and GLUT4, is largely repressed by GCN5. Functionally, this translates to a blunted response to PGC-1 beta-induced insulin-mediated glucose transport. These results suggest that PGC-1 beta acetylation by GCN5 might be an important step in the control of glucose and lipid pathways and its dysregulation could contribute to metabolic diseases.	[Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Kelly, Timothy J.; Lerin, Carles; Haas, Wilhelm; Gygi, Steven P.; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kelly, Timothy J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Johns Hopkins University	Puigserver, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 1 Jimmy Fund Way,Smith 932C, Boston, MA 02115 USA.	pere_puigserver@dfci.harvard.edu	Lerin, Carles/AAP-9916-2020	Lerin, Carles/0000-0003-0950-4363	National Institutes of Health [RO1 DK069966]; Ellison Medical Foundation New Scholar Award; American Diabetes Association; U.S. Dept. of Defense; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation New Scholar Award(Lawrence Ellison Foundation); American Diabetes Association(American Diabetes Association); U.S. Dept. of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK069966 (to P. P.). This work was also supported by an Ellison Medical Foundation New Scholar Award, by the American Diabetes Association, and by the U.S. Dept. of Defense.	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Imoberdorf RM, 2006, MOL CELL BIOL, V26, P1610, DOI 10.1128/MCB.26.5.1610-1616.2006; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Ling C, 2007, DIABETOLOGIA, V50, P1615, DOI 10.1007/s00125-007-0729-6; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Stafford JM, 2001, J BIOL CHEM, V276, P39885, DOI 10.1074/jbc.M105370200; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	46	94	97	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19945	19952		10.1074/jbc.M109.015164	http://dx.doi.org/10.1074/jbc.M109.015164			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19491097	Green Published, hybrid			2022-12-27	WOS:000268097400021
J	Aberg, E; Torgersen, KM; Johansen, B; Keyse, SM; Perander, M; Seternes, OM				Aberg, Espen; Torgersen, Knut Martin; Johansen, Bjarne; Keyse, Stephen M.; Perander, Maria; Seternes, Ole-Morten			Docking of PRAK/MK5 to the Atypical MAPKs ERK3 and ERK4 Defines a Novel MAPK Interaction Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; PATHWAY; BINDING; SPECIFICITY; SUBSTRATE; PROTEIN-KINASE-5; PHOSPHORYLATION; IDENTIFICATION; MECHANISM; MUTANTS	ERK3 and ERK4 are atypical MAPKs in which the canonical TXY motif within the activation loop of the classical MAPKs is replaced by SEG. Both ERK3 and ERK4 bind, translocate, and activate the MAPK-activated protein kinase (MK) 5. The classical MAPKs ERK1/2 and p38 interact with downstream MKs (RSK1-3 and MK2-3, respectively) through conserved clusters of acidic amino acids, which constitute the common docking (CD) domain. In contrast to the classical MAPKs, the interaction between ERK3/4 and MK5 is strictly dependent on phosphorylation of the SEG motif of these kinases. Here we report that the conserved CD domain is dispensable for the interaction of ERK3 and ERK4 with MK5. Using peptide overlay assays, we have defined a novel MK5 interaction motif (FRIEDE) within both ERK4 and ERK3 that is essential for binding to the C-terminal region of MK5. This motif is located within the L16 extension lying C-terminal to the CD domain in ERK3 and ERK4 and a single isoleucine to lysine substitution in FRIEDE totally abrogates binding, activation, and translocation of MK5 by both ERK3 and ERK4. These findings are the first to demonstrate binding of a physiological substrate via this region of the L16 loop in a MAPK. Furthermore, the link between activation loop phosphorylation and accessibility of the FRIEDE interaction motif suggests a switch mechanism for these atypical MAPKs in which the phosphorylation status of the activation loop regulates the ability of both ERK3 and ERK4 to bind to a downstream effector.	[Aberg, Espen; Seternes, Ole-Morten] Univ Tromso, Inst Pharm, N-9037 Tromso, Norway; [Johansen, Bjarne; Perander, Maria] Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway; [Torgersen, Knut Martin] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Keyse, Stephen M.] Ninewells Hosp & Med Sch, Canc Res UK Stress Response Lab, Biomed Res Inst, Dundee DD1 9SY, Scotland	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of Oslo; University of Dundee	Seternes, OM (corresponding author), Univ Tromso, Inst Pharm, N-9037 Tromso, Norway.	ole-morten.seternes@uit.no	Seternes, Ole Morten/M-9520-2019; Keyse, Stephen M./B-9575-2009	Seternes, Ole Morten/0000-0001-8537-3612; Keyse, Stephen M./0000-0002-5150-8221; Perander, Maria/0000-0002-1177-2407	National Programme for Research in Functional Genomics in Norway of the Research Council of Norway; Norwegian Cancer Society; Blix Family Foundation; Cancer Research UK Programme grant	National Programme for Research in Functional Genomics in Norway of the Research Council of Norway; Norwegian Cancer Society(Norwegian Cancer Society); Blix Family Foundation; Cancer Research UK Programme grant(Cancer Research UK)	This work was supported by the National Programme for Research in Functional Genomics in Norway of the Research Council of Norway, the Norwegian Cancer Society, the Blix Family Foundation, and a Cancer Research UK Programme grant ( to S. M. K.).	Aberg E, 2006, J BIOL CHEM, V281, P35499, DOI 10.1074/jbc.M606225200; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bogoyevitch MA, 2004, CELL SIGNAL, V16, P1345, DOI 10.1016/j.cellsig.2004.05.004; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kostich M, 2002, GENOME BIOL, V3; Kramer A, 1998, METH MOL B, V87, P25; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Mooney LM, 2004, J BIOL CHEM, V279, P11843, DOI 10.1074/jbc.M311841200; Perander M, 2008, BIOCHEM J, V411, P613, DOI 10.1042/BJ20071369; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Seternes OM, 2002, MOL CELL BIOL, V22, P6931, DOI 10.1128/MCB.22.20.6931-6945.2002; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Smith JK, 2000, J BIOL CHEM, V275, P31588, DOI 10.1074/jbc.M005892200; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Wilsbacher JL, 2006, BIOCHEMISTRY-US, V45, P13175, DOI 10.1021/bi061041w; Xu BE, 2001, J BIOL CHEM, V276, P26509, DOI 10.1074/jbc.M102769200; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200	41	28	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19392	19401		10.1074/jbc.M109.023283	http://dx.doi.org/10.1074/jbc.M109.023283			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473979	hybrid, Green Published			2022-12-27	WOS:000267908300030
J	Haque, MM; Fadlalla, M; Wang, ZQ; Ray, SS; Panda, K; Stuehr, DJ				Haque, Mohammad Mahfuzul; Fadlalla, Mohammed; Wang, Zhi-Qiang; Ray, Sougata Sinha; Panda, Koustubh; Stuehr, Dennis J.			Neutralizing a Surface Charge on the FMN Subdomain Increases the Activity of Neuronal Nitric-oxide Synthase by Enhancing the Oxygen Reactivity of the Enzyme Heme-Nitric Oxide Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAPROTEIN ELECTRON-TRANSFER; C-TERMINAL TAIL; CONFORMATIONAL EQUILIBRIUM; CATALYTIC PROFILES; OUTPUT STATE; NO SYNTHASE; DOMAIN; REDUCTION; CALMODULIN; FLAVIN	Nitric-oxide synthases (NOSs) are calmodulin-dependent flavoheme enzymes that oxidize L-Arg to nitric oxide ( NO) and L-citrulline. Their catalytic behaviors are complex and are determined by their rates of heme reduction (k(r)), ferric heme-NO dissociation (k(d)), and ferrous heme-NO oxidation (k(ox)). We found that point mutation (E762N) of a conserved residue on the enzyme's FMN subdomain caused the NO synthesis activity to double compared with wild type nNOS. However, in the absence of L-Arg, NADPH oxidation rates suggested that electron flux through the heme was slower in E762N nNOS, and this correlated with the mutant having a 60% slower k(r). During NO synthesis, little heme-NO complex accumulated in the mutant, compared with similar to 50-70% of the wild-type nNOS accumulating as this complex. This suggested that the E762N nNOS is hyperactive because it minimizes buildup of an inactive ferrous heme-NO complex during NO synthesis. Indeed, we found that k(ox) was 2 times faster in the E762N mutant than in wild-type nNOS. The mutational effect on k(ox) was independent of calmodulin. Computer simulation and experimental measures both indicated that the slower k(r) and faster k(ox) of E762N nNOS combine to lower its apparent K-m,K-O2 for NO synthesis by at least 5-fold, which in turn increases its V/K-m value and enables it to be hyperactive in steady-state NO synthesis. Our work underscores how sensitive nNOS activity is to changes in the k(ox) and reveals a novel means for the FMN module or protein-protein interactions to alter nNOS activity.	[Haque, Mohammad Mahfuzul; Fadlalla, Mohammed; Wang, Zhi-Qiang; Ray, Sougata Sinha; Stuehr, Dennis J.] Cleveland Clin, Dept Pathol, Lerner Res Inst, Cleveland, OH 44195 USA; [Wang, Zhi-Qiang] Kent State Univ Tuscarawas, Dept Chem, New Philadelphia, OH 44663 USA; [Panda, Koustubh] Univ Calcutta, Ctr Genet Engn & Biotechnol, Kolkata 700019, India	Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Tuscarawas; University of Calcutta	Stuehr, DJ (corresponding author), Cleveland Clin, Dept Pathol NC22, 9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Panda, Koustubh/E-5273-2017	Panda, Koustubh/0000-0002-4783-2221; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [GM51491, CA53914, HL58883]; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51491,CA53914,and HL58883 ( to D. J. S.).	ABU SH, 1993, P NATL ACAD SCI USA, V90, P10769; ABUSOUD HM, 1995, J BIOL CHEM, V270, P22997, DOI 10.1074/jbc.270.39.22997; AbuSoud HM, 1996, J BIOL CHEM, V271, P32515, DOI 10.1074/jbc.271.51.32515; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Couture M, 2001, J BIOL CHEM, V276, P38280; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; Feng CJ, 2007, J AM CHEM SOC, V129, P5621, DOI 10.1021/ja068685b; Feng CJ, 2006, BIOCHEMISTRY-US, V45, P6354, DOI 10.1021/bi060223n; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2006, J BIOL CHEM, V281, P14173, DOI 10.1074/jbc.M509937200; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Golser R, 2000, J BIOL CHEM, V275, P5291, DOI 10.1074/jbc.275.8.5291; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Kone BC, 2000, ACTA PHYSIOL SCAND, V168, P27; Li HY, 2008, J BIOL CHEM, V283, P34762, DOI 10.1074/jbc.M806949200; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Nishida CR, 1998, J BIOL CHEM, V273, P5566, DOI 10.1074/jbc.273.10.5566; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Ost TWB, 2005, J BIOL CHEM, V280, P965, DOI 10.1074/jbc.M411191200; Panda K, 2004, J BIOL CHEM, V279, P18323, DOI 10.1074/jbc.M310391200; Panda K, 2003, J BIOL CHEM, V278, P37122, DOI 10.1074/jbc.M304456200; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Sagami I, 2001, J BIOL CHEM, V276, P30036, DOI 10.1074/jbc.M104123200; Salerno JC, 2008, FEBS LETT, V582, P1395, DOI 10.1016/j.febslet.2008.03.051; Sam KA, 2008, J BIOL CHEM, V283, P12555, DOI 10.1074/jbc.M800954200; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Sato Y, 2004, J BIOL CHEM, V279, P8827, DOI 10.1074/jbc.M310327200; Sempombe J, 2009, J AM CHEM SOC, V131, P6940, DOI 10.1021/ja902141v; Shimanuki T, 1999, J BIOL CHEM, V274, P26956, DOI 10.1074/jbc.274.38.26956; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Song Y, 2001, AM J PHYSIOL-CELL PH, V281, pC1819, DOI 10.1152/ajpcell.2001.281.6.C1819; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; Wang ZQ, 2005, BIOCHEMISTRY-US, V44, P4676, DOI 10.1021/bi047508p; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350	59	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19237	19247		10.1074/jbc.M109.013144	http://dx.doi.org/10.1074/jbc.M109.013144			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473991	Green Published, hybrid			2022-12-27	WOS:000267908300014
J	Xu, DM; Sillaots, S; Davison, J; Hu, WQ; Jiang, B; Kauffman, S; Martel, N; Ocampo, P; Oh, C; Trosok, S; Veillette, K; Wang, H; Yang, MH; Zhang, L; Becker, J; Martin, CE; Roemer, T				Xu, Deming; Sillaots, Susan; Davison, John; Hu, Wenqi; Jiang, Bo; Kauffman, Sarah; Martel, Nick; Ocampo, Pam; Oh, Chanseok; Trosok, Steve; Veillette, Karynn; Wang, Hao; Yang, Minghui; Zhang, Li; Becker, Jeffrey; Martin, Charles E.; Roemer, Terry			Chemical Genetic Profiling and Characterization of Small-molecule Compounds That Affect the Biosynthesis of Unsaturated Fatty Acids in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FUNGAL PATHOGEN; SACCHAROMYCES-CEREVISIAE; BIOLOGICAL-ACTIVITY; LARGE-SCALE; YEAST; DESATURASE; GENOME; EXPRESSION; OLE1; INHERITANCE	The balance between saturated and unsaturated fatty acids plays a crucial role in determining the membrane fluidity. In the diploid fungal pathogen Candida albicans, the gene for fatty acid Delta 9 desaturase, OLE1, is essential for viability. Using a reverse genetic approach, termed the fitness test, we identified a group of structurally related synthetic compounds that induce specific hypersensitivity of the OLE1(+/-) strain. Genetic repression of OLE1 and chemical inhibition by two selected compounds, ECC145 and ECC188, resulted in a marked decrease in the total unsaturated fatty acids and impaired hyphal development. The resulting auxotroph of both was suppressed by the exogenous monounsaturated fatty acids (16:1 Delta 9 and 18:1 Delta 9). These correlations suggest that both compounds affect the level of unsaturated fatty acids, likely by impairing Ole1p directly or indirectly. However, the residual levels of monounsaturated fatty acids (MUFAs) resulted from chemical inhibition were significantly higher than OLE1 repression, indicating even partial inhibition of MUFAs is sufficient to stop cellular proliferation. Although the essentiality of OLE1 was suppressed by MUFAs in vitro, we demonstrated that it was required for virulence in a murine model of systemic candidiasis even when the animals were supplemented with a high fat diet. Thus, the fungal fatty acid desaturase is an attractive antifungal drug target. Taking advantage of the inhibitors and the relevant conditional shut-off strains, we validated several chemical genetic interactions observed in the fitness test profiles that reveal novel genetic interactions between OLE1/unsaturated fatty acids and other cellular processes.	[Xu, Deming; Sillaots, Susan; Davison, John; Hu, Wenqi; Jiang, Bo; Martel, Nick; Ocampo, Pam; Trosok, Steve; Veillette, Karynn; Wang, Hao; Yang, Minghui; Zhang, Li; Roemer, Terry] Merck Frosst Canada Ltd, Ctr Fungal Genet, Montreal, PQ H9H 3L1, Canada; [Kauffman, Sarah; Becker, Jeffrey] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Oh, Chanseok; Martin, Charles E.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Roemer, Terry] Merck & Co Inc, Dept Infect Dis, Rahway, NJ 07065 USA	Merck & Company; University of Tennessee System; University of Tennessee Knoxville; Rutgers State University New Brunswick; Merck & Company	Xu, DM (corresponding author), Merck Frosst Canada Ltd, Ctr Fungal Genet, Montreal, PQ H9H 3L1, Canada.	xu_deming@hotmail.com	Hu, wenqi/GSI-7291-2022; Martel, Nick/ABD-3138-2020	Hu, wenqi/0000-0003-0813-6001; Martel, Nick/0000-0003-2003-4147	Genome Canada; Genome Quebec	Genome Canada(Genome Canada); Genome Quebec	This work was supported in part by Genome Canada and Genome Quebec.	Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; BOSSIE MA, 1989, J BACTERIOL, V171, P6409, DOI 10.1128/jb.171.12.6409-6413.1989; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Cassola A, 2004, EUKARYOT CELL, V3, P190, DOI 10.1128/EC.3.1.190-199.2004; CHIRALA SS, 1992, P NATL ACAD SCI USA, V89, P10232, DOI 10.1073/pnas.89.21.10232; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erb-Downward JR, 2007, INFECT IMMUN, V75, P3498, DOI 10.1128/IAI.00232-07; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; Herath K, 2009, BIOORGAN MED CHEM, V17, P1361, DOI 10.1016/j.bmc.2008.12.009; Jiang B, 2008, CHEM BIOL, V15, P363, DOI 10.1016/j.chembiol.2008.02.016; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Krishnamurthy S, 2004, MICROBIOL-SGM, V150, P1991, DOI 10.1099/mic.0.27029-0; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; MISHRA P, 1992, BIOCHIM BIOPHYS ACTA, V1127, P1, DOI 10.1016/0005-2760(92)90194-Z; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Murayama SY, 2006, MICROBIOL-SGM, V152, P1551, DOI 10.1099/mic.0.28751-0; Noble SM, 2007, ANNU REV GENET, V41, P193, DOI 10.1146/annurev.genet.41.042007.170146; Oh CS, 2006, J BIOL CHEM, V281, P7030, DOI 10.1074/jbc.M510746200; Ondeyka J, 2009, J NAT PROD, V72, P136, DOI 10.1021/np800511r; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rodriguez-Suarez R, 2007, CHEM BIOL, V14, P1163, DOI 10.1016/j.chembiol.2007.09.009; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Schneiter R, 1997, CELL, V88, P431, DOI 10.1016/S0092-8674(00)81882-6; Sherman D, 2004, NUCLEIC ACIDS RES, V32, pD315, DOI 10.1093/nar/gkh091; STEWART LC, 1991, J CELL BIOL, V115, P1249, DOI 10.1083/jcb.115.5.1249; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Wenz P, 2001, NUCLEIC ACIDS RES, V29, P4625, DOI 10.1093/nar/29.22.4625; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092	33	54	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19754	19764		10.1074/jbc.M109.019877	http://dx.doi.org/10.1074/jbc.M109.019877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19487691	Green Published, hybrid			2022-12-27	WOS:000267908300065
J	Fu, QS; Zhou, CJ; Gao, HC; Jiang, YJ; Zhou, ZR; Hong, J; Yao, WM; Song, AX; Lin, DH; Hu, HY				Fu, Qing-Shan; Zhou, Chen-Jie; Gao, Hong-Chang; Jiang, Ya-Jun; Zhou, Zi-Ren; Hong, Jing; Yao, Wen-Ming; Song, Ai-Xin; Lin, Dong-Hai; Hu, Hong-Yu			Structural Basis for Ubiquitin Recognition by a Novel Domain from Human Phospholipase A(2)-activating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING MOTIF; CHEMICAL-SHIFT; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; BINDING DOMAINS; COMPLEX REVEALS; PROTEASOME; ERAD; NMR; S5A	Ubiquitin (Ub) is an essential modifier conserved in all eukaryotes from yeast to human. Phospholipase A(2)-activating protein (PLAA), a mammalian homolog of yeast DOA1/UFD3, has been proposed to be able to bind with Ub, which plays important roles in endoplasmic reticulum-associated degradation, vesicle formation, and DNA damage response. We have identified a core domain from the PLAA family ubiquitin-binding region of human PLAA (residues 386-465, namely PFUC) that can bind Ub and elucidated its solution structure and Ub-binding mode by NMR approaches. The PFUC domain possesses equal population of two conformers in solution by cis/trans-isomerization, whereas the two isomers exhibit almost equivalent Ub binding abilities. This domain structure takes a novel fold consisting of four beta-strands and two alpha-helices, and the Ub-binding site on PFUC locates in the surface of alpha 2-helix, which is to some extent analogous to those of UBA, CUE, and UIM domains. This study provides structural basis and biochemical information for Ub recognition of the novel PFU domain from a PLAA family protein that may connect ubiquitination and degradation in endoplasmic reticulum-associated degradation.	[Gao, Hong-Chang; Hong, Jing; Yao, Wen-Ming; Lin, Dong-Hai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China; [Fu, Qing-Shan; Zhou, Chen-Jie; Jiang, Ya-Jun; Zhou, Zi-Ren; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Fu, Qing-Shan; Jiang, Ya-Jun; Zhou, Zi-Ren] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lin, DH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China.	dhlin@mail.shcnc.ac.cn; hyhu@sibs.ac.cn	Jiang, Yajun/AAE-7853-2020; Chou, Steven Ziren/M-1995-2014; Fu, Qingshan/E-8083-2015; Hu, Hong-Yu/AAQ-2633-2020; Fu, Qingshan/E-1405-2015	Fu, Qingshan/0000-0002-7445-2355; Jiang, Yajun/0000-0002-0886-292X	National Basic Research Program of China [2006CB910305, 2006CB806508, 2007CB914304]; National Natural Science Foundation of China [30600103, 30670431]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2006CB910305, 2006CB806508, and 2007CB914304 and National Natural Science Foundation of China Grants 30600103 and 30670431.	Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hu HY, 2004, J BIOL CHEM, V279, P39736, DOI 10.1074/jbc.M402842200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Lord JM, 2005, CURR BIOL, V15, pR963, DOI 10.1016/j.cub.2005.11.013; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Osipiuk J, 2001, ACTA CRYSTALLOGR D, V57, P1747, DOI 10.1107/S0907444901014019; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Ren JH, 2008, J BIOL CHEM, V283, P21599, DOI 10.1074/jbc.M802982200; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Romisch K, 2005, TRAFFIC, V6, P706, DOI 10.1111/j.1600-0854.2005.00310.x; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Russell NS, 2004, BIOCHEMISTRY-US, V43, P4844, DOI 10.1021/bi035626r; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Souphron J, 2008, BIOCHEMISTRY-US, V47, P8961, DOI 10.1021/bi800604c; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983	41	17	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19043	19052		10.1074/jbc.M109.009126	http://dx.doi.org/10.1074/jbc.M109.009126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19423704	Green Published, hybrid			2022-12-27	WOS:000267711500053
J	Johnsen, IB; Nguyen, TT; Bergstroem, B; Fitzgerald, KA; Anthonsen, MW				Johnsen, Ingvild B.; Nguyen, Thuy Thanh; Bergstroem, Bjarte; Fitzgerald, Katherine A.; Anthonsen, Marit W.			The Tyrosine Kinase c-Src Enhances RIG-I (Retinoic Acid-inducible Gene I)-elicited Antiviral Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FAMILY KINASES; RECEPTOR; PHOSPHORYLATION; TRAF3; RESPONSES; PROTEIN; VIRUS; DNA; UBIQUITINATION	Antiviral immune responses are initiated through Toll-like receptors (TLRs) and RIG-I (retinoic acid-inducible gene-I)-like RNA helicases that recognize nucleic acids from distinct viruses. In this study, we show that the tyrosine kinase c-Src participates in antiviral responses induced by the cytoplasmic RNA helicase RIG-I. Sendai virus (SV), which is recognized by RIG-I, induced c-Src phosphorylation. Functional impairment of c-Src through chemical inhibition or transient expression of a c-Src kinase-inactive mutant attenuated production of endogenous antiviral proteins after SV infection or after expression of RIG-I or its adapter protein MAVS. Importantly, SV-stimulated synthesis of antiviral proteins was significantly impaired in cells treated with c-Src small interfering RNA and in cells from c-Src-deficient mice. In addition, we found that c-Src interacted with components of the RIG-I pathway: RIG-I, MAVS, and TRAF3 (tumor necrosis factor receptor-associated factor-3). The interaction between c-Src and TRAF3 was found to occur within the RING domain of TRAF3. Taken together, our results suggest that c-Src enhances RIG-I-mediated signaling, acting at the level of TRAF3.	[Johnsen, Ingvild B.; Nguyen, Thuy Thanh; Bergstroem, Bjarte; Anthonsen, Marit W.] Norwegian Univ Sci & Technol, Fac Med, Childrens & Womens Hlth, Dept Lab Med, N-7006 Trondheim, Norway; [Bergstroem, Bjarte] Sor Trondelag Univ Coll, Fac Med Technol & Food Sci, N-7004 Trondheim, Norway; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester	Anthonsen, MW (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Childrens & Womens Hlth, Dept Lab Med, N-7006 Trondheim, Norway.	Marit.W.Anthonsen@ntnu.no	Bergstrøm, Bjarte/H-8159-2016; Fitzgerald, Katherine/ABE-6317-2020	Bergstrøm, Bjarte/0000-0002-5042-6697; Fitzgerald, Kate/0000-0003-3175-609X; Bjellmo Johnsen, Ingvild/0000-0002-3520-6776	National Programme for Research in Functional Genomics in Norway (FUGE); FUGE Mid-Norway; Research Council of Norway; Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067497] Funding Source: NIH RePORTER	National Programme for Research in Functional Genomics in Norway (FUGE)(Research Council of Norway); FUGE Mid-Norway; Research Council of Norway(Research Council of Norway); Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Programme for Research in Functional Genomics in Norway (FUGE) (to M. W. A.), FUGE Mid-Norway (to M. W. A.), the Research Council of Norway (to M. W. A.), the Faculty of Medicine, Norwegian University of Science and Technology (to I. B. J. and M. W. A.), and the Cancer Fund at St. Olavs Hospital (to M. W. A.). at ISI, Thomson Scientific on July 7, 2009 www. jbc. org Downloaded from	Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Schneider K, 2006, NAT IMMUNOL, V7, P15, DOI 10.1038/ni0106-15; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wagner AM, 2003, COMPARATIVE MED, V53, P173; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	36	27	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19122	19131		10.1074/jbc.M808233200	http://dx.doi.org/10.1074/jbc.M808233200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19419966	hybrid, Green Published			2022-12-27	WOS:000267711500060
J	Wong, J; Weickert, CS				Wong, Jenny; Weickert, Cynthia Shannon			Transcriptional Interaction of an Estrogen Receptor Splice Variant and ErbB4 Suggests Convergence in Gene Susceptibility Pathways in Schizophrenia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; PREFRONTAL CORTEX; BREAST-CANCER; WILD-TYPE; PREOPTIC AREA; IN-VITRO; ER-ALPHA; EXPRESSION; NEUREGULIN-1; ESTRADIOL	Mounting evidence from clinical and basic research suggests that estrogen signaling may be altered in the brains of people with schizophrenia. Previously, we found that DNA sequence variation in the estrogen receptor (ER) alpha gene, lower ER alpha mRNA levels, and/or blunted ER alpha signaling is associated with schizophrenia. In this study, we asked whether the naturally occurring truncated ER alpha isoform, Delta 7, which acts as a dominant negative, can attenuate gene expression induced by the wildtype (WT) receptor in an estrogen-dependent manner in neuronal (SHSY5Y) and non-neuronal (CHOK1 and HeLa) cells. In addition, we determined the extent to which ER alpha interacts with NRG1-ErbB4, a leading schizophrenia susceptibility pathway. Reductions in the transcriptionally active form of ErbB4 comprising the intracytoplasmic domain (ErbB4-ICD) have been found in schizophrenia, and we hypothesized that ER alpha and ErbB4 may converge to control gene expression. In the present study, we show that truncated Delta 7-ER alpha attenuates WT-ER alpha-driven gene expression across a wide range of estrogen concentrations in cells that express functional ER alpha at base line or upon co-transfection of full-length ER alpha. Furthermore, we find that ErbB4-ICD can potentiate the transcriptional activity of WT-ER alpha at EREs in two cell lines and that this potentiation effect is abolished by the presence of Delta 7-ER alpha. Immunofluorescence microscopy revealed nuclear co-localization of WT-ER alpha, Delta 7-ER alpha, and ErbB4-ICD, whereas immunoprecipitation assays showed direct interaction. Our findings demonstrate convergence between ER alpha and ErbB4-ICD in the transcriptional control of ER alpha-target gene expression and suggest that this may represent a convergent pathway that may be disrupted in schizophrenia.	[Wong, Jenny; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Sydney, NSW 2052, Australia; [Wong, Jenny; Weickert, Cynthia Shannon] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW 2052, Australia; Univ New S Wales, Fac Med, Sch Psychiat, Sydney, NSW 2052, Australia; [Wong, Jenny; Weickert, Cynthia Shannon] Prince Wales Med Res Inst, Schizophrenia Res Lab, Randwick, NSW 2031, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Prince Wales Medical Research Institute	Weickert, CS (corresponding author), Univ New S Wales, Dept Psychiat, Prince Wales Med Res Inst, Schizophrenia Res Lab, Corner Barker & Easy St, Sydney, NSW 2031, Australia.	c.weickert@powmri.edu.au	Weickert, Cynthia Shannon/G-3171-2011	Shannon Weickert, Cynthia/0000-0002-4560-0259	Schizophrenia Research Institute, New South Wales Health, Macquarie Group Foundation; Prince of Wales Medical Research Institute; University of New South Wales	Schizophrenia Research Institute, New South Wales Health, Macquarie Group Foundation; Prince of Wales Medical Research Institute; University of New South Wales	This work was supported by the Schizophrenia Research Institute, New South Wales Health, Macquarie Group Foundation, Prince of Wales Medical Research Institute, and the University of New South Wales.	Arai Y, 1996, NEUROSCI RES, V25, P403; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; Beyer C, 2000, J NEUROSCI RES, V59, P107, DOI 10.1002/(SICI)1097-4547(20000101)59:1<107::AID-JNR13>3.0.CO;2-W; Bollig A, 2000, MOL ENDOCRINOL, V14, P634, DOI 10.1210/me.14.5.634; Cheng CM, 2001, FASEB J, V15, P907, DOI 10.1096/fj.00-0398com; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; Di Paolo T, 1994, Rev Neurosci, V5, P27; DODSON RE, 1988, J COMP NEUROL, V275, P623, DOI 10.1002/cne.902750410; Dominguez R, 2004, J NEUROSCI, V24, P982, DOI 10.1523/JNEUROSCI.2586-03.2004; Erenburg I, 1997, MOL ENDOCRINOL, V11, P2004, DOI 10.1210/me.11.13.2004; Ferro P, 2003, INT J MOL MED, V12, P355; Fleming JGW, 2006, ENDOCRINOLOGY, V147, P899, DOI 10.1210/en.2005-1120; FUQUA SAW, 1992, CANCER RES, V52, P483; Gorski R A, 1985, J Anim Sci, V61 Suppl 3, P38; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Grigoriadis S, 2002, CAN J PSYCHIAT, V47, P437, DOI 10.1177/070674370204700504; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Hao JD, 2006, J NEUROSCI, V26, P2571, DOI 10.1523/JNEUROSCI.3440-05.2006; HARLAN RE, 1988, MOL NEUROBIOL, V2, P183, DOI 10.1007/BF02935345; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Horvath G, 2000, INT J GYNECOL CANCER, V10, P128, DOI 10.1046/j.1525-1438.2000.00009.x; Horvath G, 2002, GYNECOL ONCOL, V84, P271, DOI 10.1006/gyno.2001.6509; Ishunina TA, 2005, J CLIN ENDOCR METAB, V90, P3757, DOI 10.1210/jc.2004-1858; KOEHORST SGA, 1993, J STEROID BIOCHEM, V45, P227, DOI 10.1016/0960-0760(93)90336-U; Kulkarni J, 2002, Arch Womens Ment Health, V5, P99, DOI 10.1007/s00737-002-0001-5; Kulkarni J, 1996, SCHIZOPHR RES, V20, P247, DOI 10.1016/0920-9964(96)82949-5; Kulkarni J, 2001, SCHIZOPHR RES, V48, P137, DOI 10.1016/S0920-9964(00)00088-8; Kulkarni J, 2008, ARCH GEN PSYCHIAT, V65, P955, DOI 10.1001/archpsyc.65.8.955; KUMAR V, 1986, EMBO J, V5, P2231, DOI 10.1002/j.1460-2075.1986.tb04489.x; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; LIAW JJ, 1992, MOL BRAIN RES, V13, P231, DOI 10.1016/0169-328X(92)90031-6; Liu CM, 2005, AM J MED GENET B, V134B, P79, DOI 10.1002/ajmg.b.20161; LUSTIG RH, 1994, HORM BEHAV, V28, P383, DOI 10.1006/hbeh.1994.1035; MATSUMOTO A, 1976, CELL TISSUE RES, V169, P143; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; MCEWEN BS, 1994, EXP GERONTOL, V29, P431, DOI 10.1016/0531-5565(94)90022-1; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; MIKSICEK RJ, 1993, BREAST CANCER RES TR, V26, P163, DOI 10.1007/BF00689689; MIRANDA RC, 1994, HORM BEHAV, V28, P367, DOI 10.1006/hbeh.1994.1033; Montague D, 2008, J NEUROENDOCRINOL, V20, P893, DOI 10.1111/j.1365-2826.2008.01743.x; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Osterlund MK, 2000, SYNAPSE, V35, P39; Pedrero JMG, 2003, ENDOCRINOLOGY, V144, P2967, DOI 10.1210/en.2002-0027; Perlman WR, 2005, BIOL PSYCHIAT, V58, P812, DOI 10.1016/j.biopsych.2005.04.047; Perlman WR, 2005, NEUROSCIENCE, V134, P81, DOI 10.1016/j.neuroscience.2005.03.055; Poola I, 2001, J STEROID BIOCHEM, V78, P459, DOI 10.1016/S0960-0760(01)00118-2; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; Riecher-Rossler A, 2002, Arch Womens Ment Health, V5, P91, DOI 10.1007/s007370200026; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; SEEMAN MV, 1986, ACTA PSYCHIAT SCAND, V73, P609, DOI 10.1111/j.1600-0447.1986.tb02732.x; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Singer CA, 1998, BRAIN RES, V789, P343, DOI 10.1016/S0006-8993(98)00142-5; SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TORANALLERAND CD, 1976, BRAIN RES, V106, P407; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Wang H, 1999, MOL CELL ENDOCRINOL, V156, P159, DOI 10.1016/S0303-7207(99)00125-2; WANG L, 2002, SCI STKE, pPE29; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Woolley CS, 1997, J NEUROSCI, V17, P1848; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	70	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18824	18832		10.1074/jbc.M109.013243	http://dx.doi.org/10.1074/jbc.M109.013243			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19439407	Green Published, hybrid			2022-12-27	WOS:000267711500032
J	Bryan, KE; Rubenstein, PA				Bryan, Keith E.; Rubenstein, Peter A.			Allele-specific Effects of Human Deafness gamma-Actin Mutations (DFNA20/26) on the Actin/Cofilin Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUDITORY HAIR-CELLS; F-ACTIN; YEAST ACTIN; FILAMENT DYNAMICS; BINDING PROTEINS; LATERAL CONTACTS; CUTICULAR PLATE; RATE CONSTANTS; ADP-ACTIN; COFILIN	Auditory hair cell function requires proper assembly and regulation of the nonmuscle gamma isoactin-rich cytoskeleton, and six point mutations in this isoactin cause a type of delayed onset autosomal dominant nonsyndromic progressive hearing loss, DFNA20/26. The molecular basis underlying this actin-dependent hearing loss is unknown. To address this problem, the mutations have been introduced into yeast actin, and their effects on actin function were assessed in vivo and in vitro. Because we previously showed that polymerization was unaffected in five of the six mutants, we have focused on proteins that regulate actin, in particular cofilin, which severs F-actin and sequesters actin monomers. The mutations do not affect the interaction of cofilin with G-actin. However, T89I and V370A mutant F-actins are much more susceptible to cofilin disassembly than WT filaments in vitro. Conversely, P332A filaments demonstrate enhanced resistance. Wild type actin solutions containing T89I, K118M, or P332A mutant actins at mole fractions similar to those found in the hair cell respond in vitro toward cofilin in a manner proportional to the level of the mutant present. Finally, depression of cofilin action in vivo by elimination of the cofilin-activating protein, Aip1p, rescues the inability to grow on glycerol caused by K118M, T278I, P332A, and V370A. These results suggest that a filament instability caused by these mutations can be balanced by decreasing a system in vivo that promotes increased filament turnover. Such mutant-dependent filament destabilization could easily result in hair cell malfunction leading to the late-onset hearing loss observed in these patients.	[Bryan, Keith E.; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [DC008803]; National Research Service Award Predoctoral Fellowship [F31DC008913]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC008803, R01DC008803, F31DC008913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC008803 ( from the NIDCD; to P. A. R.) and National Research Service Award Predoctoral Fellowship F31DC008913 ( from the NIDCD; to K. E. B.).	ADAMS SB, 1994, BIOCHEMISTRY-US, V33, P14426, DOI 10.1021/bi00252a008; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Bobkov AA, 2004, J MOL BIOL, V337, P93, DOI 10.1016/j.jmb.2004.01.014; Bryan KE, 2005, J BIOL CHEM, V280, P1696, DOI 10.1074/jbc.M410180200; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; COOK RK, 1992, PRACTICAL APPROACHES, P99; Costa CF, 2004, J CELL SCI, V117, P3367, DOI 10.1242/jcs.01172; DalleDonne I, 1998, BIOCHEM CELL BIOL, V76, P583, DOI 10.1139/bcb-76-4-583; DEROSIER DJ, 1989, J CELL BIOL, V109, P2853, DOI 10.1083/jcb.109.6.2853; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Furness DN, 2005, HEARING RES, V207, P22, DOI 10.1016/j.heares.2005.05.006; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; Hofer D, 1997, J CELL SCI, V110, P765; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Iida K, 1999, GENES CELLS, V4, P21, DOI 10.1046/j.1365-2443.1999.00235.x; KAISER C, 1994, METHODS YEAST GENETI, P133; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; Kudryashov DS, 2006, J MOL BIOL, V358, P785, DOI 10.1016/j.jmb.2006.02.029; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; MACIVER SK, 1994, FEBS LETT, V347, P251, DOI 10.1016/0014-5793(94)00552-4; McGough A, 1999, J MOL BIOL, V291, P513, DOI 10.1006/jmbi.1999.2968; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; MOORE PB, 1970, J MOL BIOL, V50, P279, DOI 10.1016/0022-2836(70)90192-0; Muller U, 2001, TRENDS CELL BIOL, V11, P334, DOI 10.1016/S0962-8924(01)02046-3; Okada K, 1999, J CELL SCI, V112, P1553; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pavlov D, 2006, CELL MOTIL CYTOSKEL, V63, P533, DOI 10.1002/cm.20142; POLLARD TD, 1981, J CELL BIOL, V88, P654, DOI 10.1083/jcb.88.3.654; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Rendtorff ND, 2006, EUR J HUM GENET, V14, P1097, DOI 10.1038/sj.ejhg.5201670; Renoult C, 1999, J BIOL CHEM, V274, P28893, DOI 10.1074/jbc.274.41.28893; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Stokasimov E, 2008, J BIOL CHEM, V283, P34844, DOI 10.1074/jbc.M804419200; STRZELECKAGOLASZEWSKA H, 1995, BIOCHEM J, V307, P527, DOI 10.1042/bj3070527; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; TILNEY LG, 1983, J CELL BIOL, V96, P822, DOI 10.1083/jcb.96.3.822; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	63	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18260	18269		10.1074/jbc.M109.015818	http://dx.doi.org/10.1074/jbc.M109.015818			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419963	Green Published, hybrid			2022-12-27	WOS:000267712400039
J	Voehler, MW; Eoff, RL; McDonald, WH; Guengerich, FP; Stone, MP				Voehler, Markus W.; Eoff, Robert L.; McDonald, W. Hayes; Guengerich, F. Peter; Stone, Michael P.			Modulation of the Structure, Catalytic Activity, and Fidelity of African Swine Fever Virus DNA Polymerase X by a Reversible Disulfide Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE NMR; BASE-EXCISION-REPAIR; VIRAL-DNA; QUANTITATIVE-ANALYSIS; SUBSTRATE-SPECIFICITY; IMPROVED SENSITIVITY; FUNCTIONAL STRUCTURE; CHEMICAL-SHIFTS; CELL-CULTURES; ERROR-PRONE	African swine fever virus polymerase X (pol X) is the smallest DNA polymerase known (174 amino acids), and its tertiary structure resembles the C-terminal half of prototypical X-family pol beta, which includes a catalytic dNTP-binding site (palm domain) and a finger domain. This structural similarity and the presence of viral genes coding for other base excision repair proteins suggest that pol X functions in a manner similar to pol beta, but inconsistencies concerning pol X catalysis have been reported. We examined the structural and functional properties of two forms of pol X using spectroscopic and kinetic analysis. Using H-1-N-15 correlated NMR, we unambiguously demonstrated the slow interconversion of pol X between a reduced (pol X-red) and an oxidized form (pol X-ox), confirmed by mass spectrometry. Steady-state kinetic analysis revealed that pol X-ox, with a disulfide bond between Cys-81 and Cys-86, has similar to 10-fold lower fidelity than pol X-red during dNTP insertion opposite a template G. The disulfide linkage is located between two beta-strands in the palm domain, near the putative dNTP-binding site. Structural alignment of pol X with a pol beta ternary structure suggests that the disulfide switch may modulate fidelity by altering the ability of the palm domain to align and stabilize the primer terminus and catalytic metal ion for deprotonation of the 3'-OH group and subsequent phosphoryl transfer. Thus, DNA polymerase fidelity is altered by the redox state of the enzyme and its related conformational changes.	[Eoff, Robert L.; Guengerich, F. Peter; Stone, Michael P.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Eoff, Robert L.; Guengerich, F. Peter; Stone, Michael P.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Voehler, Markus W.; Stone, Michael P.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Voehler, Markus W.; Stone, Michael P.] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37235 USA; [McDonald, W. Hayes] Vanderbilt Univ, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X; Stone, Michael/0000-0002-0922-0216	National Institutes of Health [R01 CA055678, R01 ES010375, F32 CA119776, P30 ES000267]; USPHS; Vanderbilt Centers for Structural Biology and Mass Spectrometry; NATIONAL CANCER INSTITUTE [F32CA119776, R01CA055678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, R01ES010375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Vanderbilt Centers for Structural Biology and Mass Spectrometry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA055678 (to M. P. S.), R01 ES010375 (to F. P. G.), F32 CA119776 (to R. L. E.), and P30 ES000267 (to M. W. V., F. P. G., and M. P. S.) from the USPHS. This work was also supported by Vanderbilt Centers for Structural Biology and Mass Spectrometry.	ALCAMI A, 1989, VIROLOGY, V171, P68, DOI 10.1016/0042-6822(89)90511-4; Andres G, 2002, J VIROL, V76, P2654, DOI 10.1128/JVI.76.6.2654-2666.2002; Andres G, 1997, J VIROL, V71, P2331; Andres G, 2001, J BIOL CHEM, V276, P780, DOI 10.1074/jbc.M006844200; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Bernardes C, 1995, BIOCHEM MOL BIOL INT, V37, P481; BLASCO R, 1989, VIROLOGY, V173, P251, DOI 10.1016/0042-6822(89)90241-9; BREESE SS, 1978, J GEN VIROL, V40, P499, DOI 10.1099/0022-1317-40-2-499; Brookes SM, 1998, VIROLOGY, V249, P175, DOI 10.1006/viro.1998.9308; Brookes SM, 1996, VIROLOGY, V224, P84, DOI 10.1006/viro.1996.0509; CARRASCOSA AL, 1985, J VIROL, V54, P337, DOI 10.1128/JVI.54.2.337-344.1985; CARRASCOSA JL, 1986, J VIROL, V58, P377, DOI 10.1128/JVI.58.2.377-384.1986; CHANG HW, 1980, ANAL BIOCHEM, V104, P112, DOI 10.1016/0003-2697(80)90283-3; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Cobbold C, 2007, J GEN VIROL, V88, P77, DOI 10.1099/vir.0.82257-0; CORTES HJ, 1987, J HIGH RES CHROMATOG, V10, P446, DOI 10.1002/jhrc.1240100805; DATE T, 1990, BIOCHEMISTRY-US, V29, P5027, DOI 10.1021/bi00473a005; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427; Dixon L.K., 2000, VIRUS TAXONOMY; Dixon LK, 2004, VET IMMUNOL IMMUNOP, V100, P117, DOI 10.1016/j.vetimm.2004.04.002; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ENJUANES L, 1977, J GEN VIROL, V34, P455, DOI 10.1099/0022-1317-34-3-455; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Garcia-Escudero R, 2003, J MOL BIOL, V326, P1403, DOI 10.1016/S0022-2836(03)00019-6; GARCIABEATO R, 1992, VIROLOGY, V188, P637, DOI 10.1016/0042-6822(92)90518-T; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hajduk PJ, 1997, J MED CHEM, V40, P3144, DOI 10.1021/jm9703404; Hernaez B, 2006, VIROLOGY, V350, P1, DOI 10.1016/j.virol.2006.01.021; Jezewska MJ, 2007, BIOCHEMISTRY-US, V46, P12909, DOI 10.1021/bi700677j; Jezewska MJ, 2007, J MOL BIOL, V373, P75, DOI 10.1016/j.jmb.2007.06.054; Jezewska MJ, 2006, J MOL BIOL, V356, P121, DOI 10.1016/j.jmb.2005.10.061; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P13895, DOI 10.1021/bi961186a; Jouvenet N, 2006, CELL MICROBIOL, V8, P1803, DOI 10.1111/j.1462-5822.2006.00750.x; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kraynov VS, 2000, BIOCHEMISTRY-US, V39, P16008, DOI 10.1021/bi0008480; Kumar S, 2008, BIOCHEMISTRY-US, V47, P7875, DOI 10.1021/bi800731m; Lamarche BJ, 2005, BIOCHEMISTRY-US, V44, P8408, DOI 10.1021/bi047706g; Lamarche BJ, 2006, BIOCHEMISTRY-US, V45, P14826, DOI 10.1021/bi0613325; Maciejewski MW, 2001, NAT STRUCT BIOL, V8, P936, DOI 10.1038/nsb1101-936; Maciejewski MW, 2001, J BIOMOL NMR, V21, P177, DOI 10.1023/A:1012426928104; MARION D, 1989, J MAGN RESON, V84, P425, DOI 10.1016/0022-2364(89)90391-0; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MONTGOMERY R. Eustace, 1921, Journal of Comparative Pathology and Therapeutics, V34, P243; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; MOULTON J, 1968, AM J VET RES, V29, P219; MOURANUNES JF, 1975, ARCH VIROL, V49, P59, DOI 10.1007/BF02175596; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NEWTON AC, 2003, PROTEIN KINASE C PRO; Oliveros M, 1997, J BIOL CHEM, V272, P30899, DOI 10.1074/jbc.272.49.30899; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PAN IC, 1980, AM J VET RES, V41, P1357; Peng C, 2004, J BIOMOL NMR, V29, P491, DOI 10.1023/B:JNMR.0000034351.37982.9e; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Rojo G, 1999, VIROLOGY, V257, P524, DOI 10.1006/viro.1999.9704; Ross A, 2000, J BIOMOL NMR, V16, P139, DOI 10.1023/A:1008394910612; Rouiller I, 1998, J VIROL, V72, P2373, DOI 10.1128/JVI.72.3.2373-2387.1998; Salas M.L., 1999, ENCY VIROLOGY, P30; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Showalter AK, 2001, NAT STRUCT BIOL, V8, P942, DOI 10.1038/nsb1101-942; Showalter AK, 2001, J AM CHEM SOC, V123, P1776, DOI 10.1021/ja005758x; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vallee I, 2001, J VIROL, V75, P10372, DOI 10.1128/JVI.75.21.10372-10382.2001; Voehler MW, 2006, J MAGN RESON, V183, P102, DOI 10.1016/j.jmr.2006.08.002; Walowsky C, 1999, J BIOL CHEM, V274, P7302, DOI 10.1074/jbc.274.11.7302; Wang ZH, 2002, GENETICS, V160, P381; WEBER DJ, 1992, PROTEINS, V13, P275, DOI 10.1002/prot.340130402; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; YANEZ RJ, 1995, VIROLOGY, V208, P249, DOI 10.1006/viro.1995.1149	86	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18434	18444		10.1074/jbc.M109.012542	http://dx.doi.org/10.1074/jbc.M109.012542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419958	hybrid, Green Published			2022-12-27	WOS:000267712400055
J	Choi, K; Ahn, YH; Gibbons, DL; Tran, HT; Creighton, CJ; Girard, L; Minna, JD; Qin, FXF; Kurie, JM				Choi, Kuicheon; Ahn, Young-Ho; Gibbons, Don L.; Tran, Hai T.; Creighton, Chad J.; Girard, Luc; Minna, John D.; Qin, F. Xiao-Feng; Kurie, Jonathan M.			Distinct Biological Roles for the Notch Ligands Jagged-1 and Jagged-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN LUNG CANCERS; NUCLEAR TRANSLOCATION; MICROARRAY DATA; CELL; PROTEIN; ACTIVATION; GENE; IDENTIFICATION; INHIBITOR	Notch signaling is activated in a subset of non-small cell lung cancer cells because of overexpression of Notch3, but the role of Notch ligands has not been fully defined. On the basis of gene expression profiling of a panel of non-small cell lung cancer cell lines, we found that the predominant Notch ligands were JAG1, JAG2, DLL1, and DLL3. Given that Notch ligands reportedly have overlapping receptor binding specificities, we postulated that they have redundant biological roles. Arguing against this hypothesis, we found that JAG1 and JAG2 were differentially regulated; JAG1 expression was dependent upon epidermal growth factor receptor (EGFR) activation in HCC827 cells, which require EGFR for survival, whereas JAG2 expression was EGFR-independent in these cells. Furthermore, HCC827 cells underwent apoptosis following depletion of JAG1 but not JAG2, whereas co-culture experiments revealed that depletion of JAG2, but not JAG1, enhanced the ability of HCC827 cells to chemoattract THP-1 human monocytes. JAG2-depleted HCC827 cells expressed high levels of inflammation-related genes, including interleukin 1 (IL1) and a broad range of IL1-regulated cytokines, which was attenuated by inhibition of IL1 receptor (IL1R). Our findings suggest that JAG1 and JAG2 have distinct biological roles including a previously undiscovered role for JAG2 in regulating the expression of cytokines that can promote antitumor immunity.	[Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Girard, Luc; Minna, John D.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Qin, F. Xiao-Feng] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Kurie, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jkurie@mdanderson.org		QIN, FRANK XIAOFENG/0000-0002-5395-0304; Tran, Hai/0000-0003-4065-9355	National Institutes of Health [P50 CA70907, CA117965]; NATIONAL CANCER INSTITUTE [R01CA117965, P50CA070907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA70907 and CA117965 (to J. M. K.).	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gray GE, 1999, AM J PATHOL, V154, P785, DOI 10.1016/S0002-9440(10)65325-4; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Lee JH, 2005, J ENDOCRINOL, V187, P283, DOI 10.1677/joe.1.06305; LIAO Z, 1984, J EXP MED, V159, P126, DOI 10.1084/jem.159.1.126; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Nakata A, 2004, GENES CELLS, V9, P1125, DOI 10.1111/j.1365-2443.2004.00795.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pfister S, 2003, J MOL BIOL, V333, P229, DOI 10.1016/j.jmb.2003.08.043; Pintar A, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-19; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rohn JL, 1996, J VIROL, V70, P8071, DOI 10.1128/JVI.70.11.8071-8080.1996; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Shoji H, 2000, J BIOL CHEM, V275, P5485, DOI 10.1074/jbc.275.8.5485; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Wislez M, 2007, CLIN CANCER RES, V13, P3518, DOI 10.1158/1078-0432.CCR-06-2558; Wright GJ, 2004, DEVELOPMENT, V131, P5659, DOI 10.1242/dev.01417; Zayzafoon M, 2004, J BIOL CHEM, V279, P3662, DOI 10.1074/jbc.M308158200	41	43	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17766	17774		10.1074/jbc.M109.003111	http://dx.doi.org/10.1074/jbc.M109.003111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19398556	hybrid, Green Published			2022-12-27	WOS:000267202500042
J	Ehira, S; Ogino, H; Teramoto, H; Inui, M; Yukawa, H				Ehira, Shigeki; Ogino, Hidetaka; Teramoto, Haruhiko; Inui, Masayuki; Yukawa, Hideaki			Regulation of Quinone Oxidoreductase by the Redox-sensing Transcriptional Regulator QorR in Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; DNA-BINDING; ESCHERICHIA-COLI; DEHALORESPIRATION; IDENTIFICATION; ACTIVATION; REPRESSOR; PEROXIDE; PROTEIN; OHRR	Corynebacterium glutamicum cgR_1435 (cg1552) encodes a protein of the DUF24 protein family, which is a novel family of transcriptional regulators. CgR1435 (QorR) is a negative regulator of cgR 1436 (qor2), which is located upstream of cgR 1435 (qorR) in the opposite orientation, and its structural gene. QorR binds to the intergenic region between qor2 and qorR to repress their expression, which is induced by the thiol-specific oxidant diamide. The DNA-binding activity of QorR is impaired by oxidants such as diamide, H2O2, and cumene hydroperoxide in vitro, and its lone cysteine residue (Cys-17) is essential for redox-responsive regulation of QorR activity both in vivo and in vitro. Moreover, a disruptant of qor2, which is a homologue of the ytfG gene of Escherichia coli encoding quinone oxidoreductase, shows increased sensitivity to diamide. It is concluded that the redox-sensing transcriptional regulator QorR is involved in disulfide stress response of C. glutamicum by regulating qor2 expression.	[Ehira, Shigeki; Ogino, Hidetaka; Teramoto, Haruhiko; Inui, Masayuki; Yukawa, Hideaki] Res Inst Innovat Technol Earth, Kyoto 6190292, Japan	Research Institute of Innovative Technology for the Earth	Yukawa, H (corresponding author), Res Inst Innovat Technol Earth, 9-2 Kizugawadai, Kyoto 6190292, Japan.	mmg-lab@rite.or.jp	Ehira, Shigeki/D-6081-2013	Ehira, Shigeki/0000-0002-4121-7367; Inui, Masayuki/0000-0001-5953-7740	New Energy and Industrial Technology Development Organization	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This study was partially supported by a grant from the New Energy and Industrial Technology Development Organization.	BABIYCHUK E, 1995, J BIOL CHEM, V270, P26224, DOI 10.1074/jbc.270.44.26224; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Brune I, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-86; Ehira S, 2008, APPL ENVIRON MICROB, V74, P5146, DOI 10.1128/AEM.00944-08; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Gupta N, 2008, J BIOL CHEM, V283, P28721, DOI 10.1074/jbc.M800630200; Hermann T, 2003, J BIOTECHNOL, V104, P155, DOI 10.1016/S0168-1656(03)00149-4; Kim IK, 2008, J MOL BIOL, V379, P372, DOI 10.1016/j.jmb.2008.04.003; Kim TH, 2005, BIOCHEM BIOPH RES CO, V331, P1542, DOI 10.1016/j.bbrc.2005.04.073; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Leelakriangsak M, 2008, MOL MICROBIOL, V67, P1108, DOI 10.1111/j.1365-2958.2008.06110.x; Leelakriangsak M, 2007, J BACTERIOL, V189, P1736, DOI 10.1128/JB.01520-06; Liu X, 2001, Pac Symp Biocomput, P127; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Nakunst D, 2007, J BACTERIOL, V189, P4696, DOI 10.1128/JB.00382-07; Ogino H, 2008, MOL MICROBIOL, V67, P597, DOI 10.1111/j.1365-2958.2007.06069.x; Pop SM, 2004, J BIOL CHEM, V279, P49910, DOI 10.1074/jbc.M409435200; Pop SM, 2006, J BIOL CHEM, V281, P26382, DOI 10.1074/jbc.M602158200; Suzuki N, 2006, APPL ENVIRON MICROB, V72, P3750, DOI 10.1128/AEM.72.5.3750-3755.2006; Terasawa M, 1993, Bioprocess Technol, V16, P37; Wang G, 2004, INFECT IMMUN, V72, P1391, DOI 10.1128/IAI.72.3.1391-1396.2004; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0; Yurimoto H, 2005, MOL MICROBIOL, V57, P511, DOI 10.1111/j.1365-2958.2005.04702.x; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	27	32	33	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16736	16742		10.1074/jbc.M109.009027	http://dx.doi.org/10.1074/jbc.M109.009027			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19403527	Green Published, hybrid			2022-12-27	WOS:000266962400008
J	Kelly, E; Greene, CM; Carroll, TP; McElvaney, NG; O'Neill, SJ				Kelly, Emer; Greene, Catherine M.; Carroll, Tomas P.; McElvaney, Noel G.; O'Neill, Shane J.			Selenoprotein S/SEPS1 Modifies Endoplasmic Reticulum Stress in Z Variant alpha(1)-Antitrypsin Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; ER STRESS; ALPHA-1-ANTITRYPSIN DEFICIENCY; LIVER-DISEASE; SELENIUM; MECHANISM; ACTIVATION; PATHWAY; CELLS; GENE	Z alpha(1)-antitrypsin (ZAAT) deficiency is a disease associated with emphysematous lung disease and also with liver disease. The liver disease of AAT deficiency is associated with endoplasmic reticulum (ER) stress. SEPS1 is a selenoprotein that, through a chaperone activity, decreases ER stress. To determine the effect of SEPS1 on ER stress in ZAAT deficiency, we measured activity of the grp78 promoter and levels of active ATF6 as markers of the unfolded protein response in HepG2 cells transfected with the mutant form of AAT, a ZAAT transgene. We evaluated levels of NF kappa B activity as a marker of the ER overload response. To determine the effect of selenium supplementation on the function of SEPS1, we investigated glutathione peroxidase activity, grp78 promoter activity, and NF kappa B activity in the presence or absence of selenium. SEPS1 reduced levels of active ATF6. Overexpression of SEPS1 also inhibited grp78 promoter and NF kappa B activity, and this effect was enhanced in the presence of selenium supplementation. This finding demonstrates a role for SEPS1 in ZAAT deficiency and suggests a possible therapeutic potential for selenium supplementation.	[Kelly, Emer; Greene, Catherine M.; Carroll, Tomas P.; McElvaney, Noel G.; O'Neill, Shane J.] Royal Coll Surgeons Ireland, Dept Med, Resp Res Div, Beaumont Hosp,Educ & Res Ctr, Dublin 9, Ireland	Royal College of Surgeons - Ireland	Greene, CM (corresponding author), Royal Coll Surgeons Ireland, Dept Med, Resp Res Div, Beaumont Hosp,Educ & Res Ctr, Dublin 9, Ireland.	cmgreene@rcsi.ie	McElvaney, Noel/A-6809-2010; Greene, Catherine M/D-3513-2012	Greene, Catherine M/0000-0003-2549-2569; mcelvaney, Noel/0000-0002-0152-4370; Carroll, Tomas/0000-0002-0418-1641	Alpha One Foundation	Alpha One Foundation	This work was supported by a Pilot and Feasibility grant from the Alpha One Foundation.	Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BRANTLY M, 1988, AM J MED, V84, P13; Castellano S, 2005, P NATL ACAD SCI USA, V102, P16188, DOI 10.1073/pnas.0505146102; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; Gao Y, 2006, CYTOKINE, V33, P246, DOI 10.1016/j.cyto.2006.02.005; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Greene CM, 2008, J INHERIT METAB DIS, V31, P21, DOI 10.1007/s10545-007-0748-y; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Kim KH, 2007, BIOCHEM BIOPH RES CO, V354, P127, DOI 10.1016/j.bbrc.2006.12.183; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; LE A, 1990, J BIOL CHEM, V265, P14001; LE AQ, 1992, J BIOL CHEM, V267, P1072; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; MULLINS C, 2005, BIOGENESIS CELLULAR, P63; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SUNDE RA, 2008, BIOSCI REP IN PRESS; SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404; SVEGER T, 1988, ACTA PAEDIATR SCAND, V77, P847, DOI 10.1111/j.1651-2227.1988.tb10767.x; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Venkateswaran V, 2002, CANCER RES, V62, P2540; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	33	47	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16891	16897		10.1074/jbc.M109.006288	http://dx.doi.org/10.1074/jbc.M109.006288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19398551	Green Published, hybrid			2022-12-27	WOS:000266962400025
J	Santi, CM; Butler, A; Kuhn, J; Wei, A; Salkoff, L				Santi, Celia M.; Butler, Alice; Kuhn, Julia; Wei, Aguan; Salkoff, Lawrence			Bovine and Mouse SLO3 K+ Channels EVOLUTIONARY DIVERGENCE POINTS TO AN RCK1 REGION OF CRITICAL FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; REPRODUCTIVE-TRACT PROTEINS; RAPID EVOLUTION; DROSOPHILA-MELANOGASTER; DEPENDENT ACTIVATION; CALCIUM SENSITIVITY; POSITIVE SELECTION; SIGNALING PATHWAYS; SPERM; PH	The slo3 gene encodes a K+ channel found only in mammalian testis. This is in contrast to slo1, which is expressed in many tissues. Genes pertaining to male reproduction, especially those involved in sperm production, evolve morphologically and functionally much faster than their nonsexual counterparts. A comparison of SLO3 channel amino acid sequences from several species revealed a high degree of structural divergence relative to their SLO1 channel paralogues. To reveal any biophysical differences accompanying this rapid structural divergence, we analyzed the functional properties of SLO3 channels from two species, bovine and mouse. We observed several functional differences including voltage range of activation, kinetics, and pH sensitivity. Although SLO3 channel proteins from these two species lack conservation in many structural regions, we found that the first two of these three functional differences map to the same loop structure in their RCK1 (regulator of K+ conductance 1) domain, which links the intermediate RCK1 subdomain to the C-terminal subdomain. We found that small structural changes in this region produce major changes in the voltage range of activation and kinetics. This rapidly evolving loop peptide shows the greatest length and sequence polymorphisms within RCK1 domains from many different species. In SLO3 channels this region may permit evolutionary changes that tune the gating properties in different species.	[Santi, Celia M.; Butler, Alice; Kuhn, Julia; Wei, Aguan; Salkoff, Lawrence] WA Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Santi, CM (corresponding author), WA Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid,Campus Box 8108, St Louis, MO 63110 USA.	santic@pcg.wustl.edu			National Institutes of Health [R21 HD056444, R24 RR017342, R01 GM067154]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056444] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HD056444 (to C. S.) and R24 RR017342 and R01 GM067154 (to L. S.).	Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Breitbart H, 2003, CELL MOL BIOL, V49, P321; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cai XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003569; Civetta A, 1995, J MOL EVOL, V41, P1085, DOI 10.1007/BF00173190; COULTHART MB, 1988, MOL BIOL EVOL, V5, P182; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Fay JC, 2001, GENETICS, V158, P1227; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kim HJ, 2006, J BIOL CHEM, V281, P38573, DOI 10.1074/jbc.M604769200; Martinez-Lopez P, 2009, BIOCHEM BIOPH RES CO, V381, P204, DOI 10.1016/j.bbrc.2009.02.008; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Podlaha O, 2005, MOL BIOL EVOL, V22, P1845, DOI 10.1093/molbev/msi178; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Singh RS, 2000, GENES GENET SYST, V75, P119, DOI 10.1266/ggs.75.119; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Zhang X, 2006, J GEN PHYSIOL, V128, P301, DOI 10.1085/jgp.200609551	30	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21589	21598		10.1074/jbc.M109.015040	http://dx.doi.org/10.1074/jbc.M109.015040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19473978	Green Published, hybrid			2022-12-27	WOS:000268564400053
J	Durr, KL; Abe, K; Tavraz, NN; Friedrich, T				Duerr, Katharina L.; Abe, Kazuhiro; Tavraz, Neslihan N.; Friedrich, Thomas			E2P State Stabilization by the N-terminal Tail of the H,K-ATPase beta-Subunit Is Critical for Efficient Proton Pumping under in Vivo Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-CLAMP FLUOROMETRY; SITE-DIRECTED MUTAGENESIS; P-TYPE ATPASES; ALPHA-SUBUNIT; NA+/K+-ATPASE; FUNCTIONAL-SIGNIFICANCE; CRYSTAL-STRUCTURE; DISULFIDE BONDS; CALCIUM-PUMP; NA,K-ATPASE	The catalytic alpha-subunits of Na,K-and H, K-ATPase require an accessory beta-subunit for proper folding, maturation, and plasma membrane delivery but also for cation transport. To investigate the functional significance of the beta-N terminus of the gastric H, K-ATPase in vivo, several N-terminally truncated beta-variants were expressed in Xenopus oocytes, together with the S806C alpha-subunit variant. Upon labeling with the reporter fluorophore tetramethylrhodamine-6-maleimide, this construct can be used to determine the voltage-dependent distribution between E1P/E2P states. Whereas the E1P/E2P conformational equilibrium was unaffected for the shorter N-terminal deletions beta Delta 4 and beta Delta 8, we observed significant shifts toward E1P for the two larger deletions beta Delta 13 and beta Delta 29. Moreover, the reduced Delta F/F ratios of beta Delta 13 and beta Delta 29 indicated an increased reverse reaction via E2P -> E1P + ADP -> E-1 + ATP, because cell surface expression was completely unaffected. This interpretation is supported by the reduced sensitivity of the mutants toward the E2P-specific inhibitor SCH28080, which becomes especially apparent at high concentrations (100 mu M). Despite unaltered apparent Rb+ affinities, the maximal Rb+ uptake of these mutants was also significantly lowered. Considering the two putative interaction sites between the beta-N terminus and alpha-subunit revealed by the recent cryo-EM structure, the N-terminal tail of the H, K-ATPase beta-subunit may stabilize the pump in the E2P conformation, thereby increasing the efficiency of proton release against the million-fold proton gradient of the stomach lumen. Finally, we demonstrate that a similar truncation of the beta-N terminus of the closely related Na, K-ATPase does not affect the E1P/E2P distribution or pump activity, indicating that the E2P-stabilizing effect by the beta-N terminus is apparently a unique property of the H, K-ATPase.	[Duerr, Katharina L.; Tavraz, Neslihan N.; Friedrich, Thomas] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Abe, Kazuhiro] Kyoto Univ, Dept Biophys, Fac Sci, Sakyo Ku, Kyoto 6068502, Japan	Technical University of Berlin; Kyoto University	Durr, KL (corresponding author), Tech Univ Berlin, Inst Chem, Secr PC 14,Str 17 Juni 135, D-10623 Berlin, Germany.	katharina.duerr@TU-berlin.de	Abe, Kazuhiro/D-7662-2013; Friedrich, Thomas/AAA-3418-2022; Duerr, Katharina/A-6975-2015	Abe, Kazuhiro/0000-0003-2681-5921; Duerr, Katharina/0000-0002-3245-4088	Deutsche Forschungsgemeinschaft [SFB 740]; Japan New Energy and Industrial Technology Development Organization	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 740 and Cluster of Excellence "UNICAT" and Grants-in aid for Specially Promoted Research and by the Japan New Energy and Industrial Technology Development Organization.	Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; Abriel H, 1999, BBA-BIOMEMBRANES, V1418, P85, DOI 10.1016/S0005-2736(99)00025-5; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; CHOW DC, 1995, J EXP BIOL, V198, P1; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; DEMAREST JR, 1985, AM J PHYSIOL, V249, pC535, DOI 10.1152/ajpcell.1985.249.5.C535; Dempski RE, 2005, J GEN PHYSIOL, V125, P505, DOI 10.1085/jgp.200409186; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; Durr KL, 2008, BIOCHEMISTRY-US, V47, P4288, DOI 10.1021/bi800092k; EAKLE KA, 1994, J BIOL CHEM, V269, P6550; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Geibel S, 2003, ANN NY ACAD SCI, V986, P31, DOI 10.1111/j.1749-6632.2003.tb07136.x; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; Hu YK, 2000, J BIOL CHEM, V275, P30734, DOI 10.1074/jbc.M003737200; JAISSER F, 1994, J GEN PHYSIOL, V103, P605, DOI 10.1085/jgp.103.4.605; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; KAWAMURA M, 1985, BIOCHIM BIOPHYS ACTA, V821, P115, DOI 10.1016/0005-2736(85)90161-0; KEELING DJ, 1989, J BIOL CHEM, V264, P5545; KIRLEY TL, 1990, J BIOL CHEM, V265, P4227; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; LUTSENKO S, 1994, J BIOL CHEM, V269, P4555; MATHEWS PM, 1995, AM J PHYSIOL-CELL PH, V268, pC1207, DOI 10.1152/ajpcell.1995.268.5.C1207; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; MENDLEIN J, 1990, J BIOL CHEM, V265, P5030; MORI Y, 1989, GASTROENTEROLOGY, V97, P364, DOI 10.1016/0016-5085(89)90072-3; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; NOGUCHI S, 1994, FEBS LETT, V341, P233, DOI 10.1016/0014-5793(94)80463-X; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; SACHS G, 1976, J BIOL CHEM, V251, P7690; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; Shainskaya A, 1996, J BIOL CHEM, V271, P10309, DOI 10.1074/jbc.271.17.10309; Shainskaya A, 2000, J BIOL CHEM, V275, P2019, DOI 10.1074/jbc.275.3.2019; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; WALLMARK B, 1983, BIOCHIM BIOPHYS ACTA, V728, P31, DOI 10.1016/0005-2736(83)90433-9; WALLMARK B, 1990, J INTERN MED, V228, P3, DOI 10.1111/j.1365-2796.1990.tb01465.x	41	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20147	20154		10.1074/jbc.M109.005769	http://dx.doi.org/10.1074/jbc.M109.005769			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19491099	Green Published, hybrid			2022-12-27	WOS:000268097400042
J	Ding, B; Kirkiles-Smith, NC; Pober, JS				Ding, Bo; Kirkiles-Smith, Nancy C.; Pober, Jordan S.			FOXO3a Regulates Oxygen-responsive Expression of Tumor Necrosis Factor Receptor 2 in Human Dermal Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ISCHEMIA-MEDIATED ARTERIOGENESIS; TRANSCRIPTION FACTOR FOXO3A; SIGNALING PATHWAYS; TERMINAL KINASE; UP-REGULATION; HUMAN KIDNEY; FACTOR-ALPHA; APOPTOSIS; ACTIVATION	Microvascular endothelial cell (EC) expression of tumor necrosis factor receptor (TNFR) 2 is induced in situ by ischemia/reperfusion injury. To assess effects of molecular oxygen on TNFR2 expression, we subjected cultured human dermal microvascular ECs (HDMECs) to hypoxic conditions (1% O-2) or to hypoxic conditions followed by return to normoxic conditions. TNFR2 mRNA and protein are expressed under normoxic conditions but are rapidly reduced by hypoxia; they fall even further upon reoxygenation but rebound by 6-9 h. TNFR1 expression is unaffected by hypoxia or reoxygenation in these same cells. We identified a potential FOXO3a binding site in the 5' enhancer region of the TNFR2 gene. FOXO3a from normoxic but not hypoxic HDMECs binds an oligonucleotide sequence matching this site, and the endogenous enhancer binds FOXO3a at this site in HDMECs under normoxic but not hypoxic conditions. Unphosphorylated FOXO3a is present in the nucleus of HDMECs under normoxic conditions. Hypoxia leads to FOXO3a phosphorylation at an Akt/protein kinase B target site and subsequent nuclear export; these processes are reversed by reoxygenation and blocked by LY294002, a phosphatidylinositol 3-kinase inhibitor that blocks Akt activation. LY294002 also prevents the hypoxia-mediated decrease in TNFR2 expression. Transiently transfected FOXO3a activates a TNFR2 promoter/reporter construct in HDMECs, whereas small interference RNA knockdown of FOXO3a reduces TNFR2 but not TNFR1 expression under normoxic conditions. Reduction in TNFR2 by small interference RNA sensitizes HDMECs to TNFR1-mediated apoptosis. We conclude that FOXO3a regulates oxygen-dependent changes in expression of TNFR2 in HDMECs, controlling sensitivity to TNF-mediated apoptosis.	[Ding, Bo; Kirkiles-Smith, Nancy C.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Pober, JS (corresponding author), POB 208089, New Haven, CT 06520 USA.	jordan.pober@yale.edu			National Institutes of Health [HL36003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036003, R37HL036003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL36003.	Al-Lamki RS, 2008, J AM SOC NEPHROL, V19, P953, DOI 10.1681/ASN.2007060706; Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com; Al-Lamki RS, 2003, AM J PATHOL, V163, P401, DOI 10.1016/S0002-9440(10)63670-X; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; De Palma C, 2006, ARTERIOSCL THROM VAS, V26, P99, DOI 10.1161/01.ATV.0000194074.59584.42; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Grethe S, 2006, BIOCHEM BIOPH RES CO, V347, P781, DOI 10.1016/j.bbrc.2006.06.159; Haridas V, 1998, J IMMUNOL, V160, P3152; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Hehlgans T, 2001, J INTERF CYTOK RES, V21, P757, DOI 10.1089/107999001753124480; Hoffmann G, 2004, EXP DERMATOL, V13, P113, DOI 10.1111/j.0906-6705.2004.00142.x; Kluger MS, 2002, J IMMUNOL, V168, P2091, DOI 10.4049/jimmunol.168.5.2091; Krol J, 2007, MOL CANCER THER, V6, P3169, DOI 10.1158/1535-7163.MCT-07-0507; Lee HY, 2008, ARTERIOSCL THROM VAS, V28, P112, DOI 10.1161/ATVBAHA.107.153304; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; Qin ZH, 2001, J BIOL CHEM, V276, P8079, DOI 10.1074/jbc.M007028200; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Santee SM, 1996, J BIOL CHEM, V271, P21151, DOI 10.1074/jbc.271.35.21151; Schattenberg JM, 2006, LIVER INT, V26, P904, DOI 10.1111/j.1478-3231.2006.01324.x; Seitz C, 2001, J BIOL CHEM, V276, P19390, DOI 10.1074/jbc.M101336200; Seitz C, 1998, GENOMICS, V48, P111, DOI 10.1006/geno.1997.5161; Takada Y, 2004, J IMMUNOL, V173, P1066, DOI 10.4049/jimmunol.173.2.1066; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Yamanaka Y, 2006, J ORTHOP RES, V24, P1349, DOI 10.1002/jor.20199	32	11	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19331	19339		10.1074/jbc.M109.006536	http://dx.doi.org/10.1074/jbc.M109.006536			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473970	Green Published, hybrid			2022-12-27	WOS:000267908300024
J	Lund, C; Olsen, CM; Skogtvedt, S; Tveit, H; Prydz, K; Tranulis, MA				Lund, Christoffer; Olsen, Christel M.; Skogtvedt, Susan; Tveit, Heidi; Prydz, Kristian; Tranulis, Michael A.			Alternative Translation Initiation Generates Cytoplasmic Sheep Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; ENDOPLASMIC-RETICULUM; TRANSGENIC MICE; PRIMARY NEURONS; PRP; SCRAPIE; LOCALIZATION; EXPRESSION; TRANSMEMBRANE; DISEASE	Cytoplasmic localization of the prion protein (PrP) has been observed in different species and cell types. We have investigated this poorly understood phenomenon by expressing fusion proteins of sheep prion protein and green fluorescent protein ((PrP)-Pr-GFP) in N2a cells, with variable sequence context surrounding the start codon Met(1). (PrP)-Pr-GFP expressed with the wild-type sequence was transported normally through the secretory pathway to the cell surface with acquisition of N-glycan groups, but two N-terminal fragments of (PrP)-Pr-GFP were detected intracellularly, starting in frame from Met(17). When (PrP)-Pr-GFP was expressed with a compromised Kozak sequence ((PrP)-Pr-GFP*), dispersed intracellular fluorescence was observed. A similar switch from pericellular to intracellular PrP localization was seen when analogous constructs of sheep PrP, without inserted GFP, were expressed, showing that this phenomenon is not caused by the GFP tag. Western blotting revealed a reduction in glycosylated forms of (PrP)-Pr-GFP*, whereas the N-terminal fragments starting from Met(17) were still present. Formation of these N-terminal fragments was completely abolished when Met(17) was replaced by Thr, indicating that leaky ribosomal scanning occurs for normal sheep PrP and that translation from Met(17) is the cause of the aberrant cytoplasmic localization observed for a fraction of the protein. In contrast, the same phenomenon was not detected upon expression of similar constructs for mouse PrP. Analysis of samples from sheep brain allowed immunological detection of N-terminal PrP fragments, indicating that sheep PrP is subject to similar processing mechanisms in vivo.	[Lund, Christoffer; Olsen, Christel M.; Skogtvedt, Susan; Tranulis, Michael A.] Norwegian Sch Vet Sci, Dept Biochem & Physiol, Inst Basic Sci & Aquat Med, N-0033 Oslo, Norway; [Tveit, Heidi; Prydz, Kristian] Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway	Norwegian University of Life Sciences; University of Oslo	Tranulis, MA (corresponding author), Norwegian Sch Vet Sci, Dept Biochem & Physiol, Inst Basic Sci & Aquat Med, Box 8146, N-0033 Oslo, Norway.	Michael.Tranulis@veths.no			Norwegian Research Council; Torsted's Fund for Animal Welfare	Norwegian Research Council(Research Council of NorwayEuropean Commission); Torsted's Fund for Animal Welfare	This work was supported by the Norwegian Research Council and the Torsted's Fund for Animal Welfare.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Bailly Y, 2004, J COMP NEUROL, V473, P244, DOI 10.1002/cne.20117; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; Fournier JG, 2008, CELL TISSUE RES, V332, P1, DOI 10.1007/s00441-007-0565-5; Gonzalez L, 2005, J COMP PATHOL, V132, P273, DOI 10.1016/j.jcpa.2004.10.004; Hegde RS, 2003, TRENDS NEUROSCI, V26, P337, DOI 10.1016/S0166-2236(03)00143-7; Heggebo R, 2000, J GEN VIROL, V81, P2327, DOI 10.1099/0022-1317-81-9-2327; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Heller U, 2003, J BIOL CHEM, V278, P36139, DOI 10.1074/jbc.M304002200; Juanes ME, 2009, J BIOL CHEM, V284, P2787, DOI 10.1074/jbc.M804051200; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kozak M, 2003, GENE, V318, P1, DOI 10.1016/S0378-1119(03)00774-1; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; Laine J, 2001, EUR J NEUROSCI, V14, P47, DOI 10.1046/j.0953-816x.2001.01621.x; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Norstrom EM, 2007, J VIROL, V81, P2831, DOI 10.1128/JVI.02157-06; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Park KW, 2008, BIOCHEM BIOPH RES CO, V372, P697, DOI 10.1016/j.bbrc.2008.05.132; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Pergami P, 1996, ANAL BIOCHEM, V236, P63, DOI 10.1006/abio.1996.0132; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Smith E, 2005, NUCLEIC ACIDS RES, V33, P1298, DOI 10.1093/nar/gki248; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Strom A, 2007, LAB INVEST, V87, P139, DOI 10.1038/labinvest.3700500; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Thuring CMA, 2005, J COMP PATHOL, V132, P59, DOI 10.1016/j.jcpa.2004.06.004; Tveit H, 2005, BIOCHEM BIOPH RES CO, V337, P232, DOI 10.1016/j.bbrc.2005.09.031; VANKEULEN LJM, 1995, VET PATHOL, V32, P299, DOI 10.1177/030098589503200312; Wang XH, 2006, J BIOL CHEM, V281, P13559, DOI 10.1074/jbc.M512306200; Weissmann C, 1996, INT J EXP PATHOL, V77, P283; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Zhao HX, 2006, VIRUS RES, V115, P43, DOI 10.1016/j.virusres.2005.07.004; Zou WQ, 2005, CELL, V121, P155, DOI 10.1016/j.cell.2005.04.002	50	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19668	19678		10.1074/jbc.M109.003566	http://dx.doi.org/10.1074/jbc.M109.003566			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19451655	Green Published, hybrid			2022-12-27	WOS:000267908300058
J	Reitinger, S; Mullegger, J; Greiderer, B; Nielsen, JE; Lepperdinger, G				Reitinger, Stephan; Muellegger, Johannes; Greiderer, Brigitte; Nielsen, Jens Erik; Lepperdinger, Guenter			Designed Human Serum Hyaluronidase 1 Variant, HYAL1(Delta L), Exhibits Activity up to pH 5.9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POISSON-BOLTZMANN EQUATION; TESTICULAR HYALURONIDASE; PK(A) CALCULATIONS; SWISS-MODEL; PROTEIN; ENZYME; PH-20; PURIFICATION; ENVIRONMENT; EXPRESSION	Hyaluronidases from diverse species and sources have different pH optima. Distinct mechanisms with regard to dynamic structural changes, which control hyaluronidase activity at varying pH, are unknown. Human serum hyaluronidase 1 (HYAL1) is active solely below pH 5.1. Here we report the design of a HYAL1 variant that degrades hyaluronan up to pH 5.9. Besides highly conserved residues in close proximity of the active site of most hyaluronidases, we identified a bulky loop formation located at the end of the substrate binding crevice of HYAL1 to be crucial for substrate hydrolysis. The stretch between cysteine residues 207 and 221, which normally contains 13 amino acids, could be replaced by a tetrapeptide sequence of alternating glycine serine residues, thereby yielding an active enzyme with an extended binding cleft. This variant exhibited hyaluronan degradation at elevated pH. This is indicative for appropriate substrate binding and proper positioning being decisively affected by sites far off from the active center.	[Reitinger, Stephan; Greiderer, Brigitte; Lepperdinger, Guenter] Austrian Acad Sci, Inst Biomed Aging Res, Extracellular Matrix Res Grp, A-6020 Innsbruck, Austria; [Muellegger, Johannes] Zymeworks Inc, Vancouver, BC V6H 3V9, Canada; [Nielsen, Jens Erik] Univ Coll Dublin, Conway Inst, Ctr Synth & Chem Biol, Sch Biomol & Biomed Sci, Dublin 4, Ireland	Austrian Academy of Sciences; University College Dublin	Lepperdinger, G (corresponding author), Austrian Acad Sci, Inst Biomed Aging Res, Extracellular Matrix Res Grp, Rennweg 10, A-6020 Innsbruck, Austria.	Guenter.Lepperdinger@oeaw.ac.at		Nielsen, Jens Erik/0000-0002-2831-7718; Lepperdinger, Gunter/0000-0002-4265-4489				Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; Cherr GN, 1996, DEV BIOL, V175, P142, DOI 10.1006/dbio.1996.0102; Csoka TB, 1997, FEBS LETT, V417, P307, DOI 10.1016/S0014-5793(97)01309-4; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; GMACHL M, 1993, FEBS LETT, V336, P545, DOI 10.1016/0014-5793(93)80873-S; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Joshi MD, 2001, BIOCHEMISTRY-US, V40, P10115, DOI 10.1021/bi0105429; KREIL G, 1995, PROTEIN SCI, V4, P1666, DOI 10.1002/pro.5560040902; Lepperdinger G, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P585; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; Lepperdinger G, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P71; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5; Meyer MF, 1997, FEBS LETT, V413, P385, DOI 10.1016/S0014-5793(97)00936-8; Mullegger J, 2002, MECH DEVELOP, V111, P25, DOI 10.1016/S0925-4773(01)00593-7; Mullegger J, 2001, ANAL BIOCHEM, V293, P291, DOI 10.1006/abio.2001.5125; Natowicz MR, 1996, CLIN CHIM ACTA, V245, P1, DOI 10.1016/0009-8981(95)06182-7; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nielsen JE, 2001, PROTEINS, V43, P403, DOI 10.1002/prot.1053; Nielsen JE, 1999, PROTEIN ENG, V12, P657, DOI 10.1093/protein/12.8.657; Nielsen JE, 2003, PROTEIN SCI, V12, P313, DOI 10.1110/ps.0229903; Nielsen JE, 2007, J MOL GRAPH MODEL, V25, P691, DOI 10.1016/j.jmgm.2006.05.007; Oettl M, 2003, EUR J PHARM SCI, V18, P267, DOI 10.1016/S0928-0987(03)00022-8; Podyma KA, 1997, BIOCHEM BIOPH RES CO, V241, P446, DOI 10.1006/bbrc.1997.7829; Reitinger S, 2001, FEBS LETT, V505, P213, DOI 10.1016/S0014-5793(01)02813-7; Reitinger S, 2008, PROTEIN EXPRES PURIF, V57, P226, DOI 10.1016/j.pep.2007.10.001; Reitinger S, 2007, BIOCHEM J, V401, P79, DOI 10.1042/BJ20060598; Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687; Sondergaard CR, 2008, J MOL BIOL, V376, P269, DOI 10.1016/j.jmb.2007.09.070; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; W DeLano, 2002, PYMOL RELEASE 0 99	35	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19173	19177		10.1074/jbc.C109.004358	http://dx.doi.org/10.1074/jbc.C109.004358			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19478093	Green Published, hybrid			2022-12-27	WOS:000267908300005
J	Boland, C; Hayes, P; Santa-Maria, I; Nishimura, S; Kelly, VP				Boland, Coilin; Hayes, Patti; Santa-Maria, Ismael; Nishimura, Susumu; Kelly, Vincent P.			Queuosine Formation in Eukaryotic tRNA Occurs via a Mitochondria-localized Heteromeric Transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER RIBONUCLEIC-ACID; NUCLEAR-EXPORT SIGNALS; GUANINE TRANSGLYCOSYLASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; ERYTHROLEUKEMIA-CELLS; QUEUINE; BASE; PURIFICATION	tRNA guanine transglycosylase (TGT) enzymes are responsible for the formation of queuosine in the anticodon loop ( position 34) of tRNAAsp, tRNAAsn, tRNAHis, and tRNATyr; an almost universal event in eubacterial and eukaryotic species. Despite extensive characterization of the eubacterial TGT the eukaryotic activity has remained undefined. Our search of mouse EST and cDNA data bases identified a homologue of the Escherichia coli TGT and three spliced variants of the queuine tRNA guanine transglycosylase domain containing 1 (QTRTD1) gene. QTRTD1 variant_1 (Qv1) was found to be the predominant adult form. Functional cooperativity of TGT and Qv1 was suggested by their coordinate mRNA expression in Northern blots and from their association in vivo by immunoprecipitation. Neither TGT nor Qv1 alone could complement a tgt mutation in E. coli. However, transglycosylase activity could be obtained when the proteins were combined in vitro. Confocal and immunoblot analysis suggest that TGT weakly interacts with the outer mitochondrial membrane possibly through association with Qv1, which was found to be stably associated with the organelle.	[Boland, Coilin; Hayes, Patti; Kelly, Vincent P.] Trinity Coll Dublin, Coll Green, Sch Biochem & Immunol, Dublin 2, Ireland; [Santa-Maria, Ismael] Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa CSIC UAM, E-28049 Madrid, Spain; [Nishimura, Susumu] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan	Trinity College Dublin; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Tsukuba	Kelly, VP (corresponding author), Trinity Coll Dublin, Coll Green, Sch Biochem & Immunol, Dublin 2, Ireland.	kellyvp@tcd.ie	Kelly, Vincent P/I-2151-2017; Santa-Maria, Ismael/AAI-7630-2020	Kelly, Vincent P/0000-0001-7067-5407; Boland, Coilin/0000-0001-6763-3767; Santa-Maria Perez, Ismael/0000-0003-2801-5020	Science Foundation Ireland [05-IN3-I761, BIMF318]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Programme Grant 05-IN3-I761 and Research Frontiers Grant BIMF318 from the Science Foundation Ireland.	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; BARANOWSKI W, 1994, CANCER RES, V54, P4468; CARBON P, 1982, NUCLEIC ACIDS RES, V10, P3715, DOI 10.1093/nar/10.12.3715; CHEN YL, 1994, CANCER RES, V54, P2192; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Deshpande KL, 1996, ARCH BIOCHEM BIOPHYS, V326, P1, DOI 10.1006/abbi.1996.0039; Deshpande KL, 2001, GENE, V265, P205, DOI 10.1016/S0378-1119(01)00368-7; Dineshkumar TK, 2002, MICROBIOL-SGM, V148, P3779, DOI 10.1099/00221287-148-12-3779; DIRHEIMER G, 1995, BIOCHIMIE, V77, P99, DOI 10.1016/0300-9084(96)88111-9; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Garcia GA, 2005, BIOORG CHEM, V33, P229, DOI 10.1016/j.bioorg.2005.01.001; GARCIA GA, 1993, J MOL BIOL, V231, P489, DOI 10.1006/jmbi.1993.1296; GREGSON JM, 1993, J BIOL CHEM, V268, P10076; GUNDUZ U, 1984, J BIOL CHEM, V259, P1110; GUNDUZ U, 1992, BIOCHIM BIOPHYS ACTA, V1139, P229, DOI 10.1016/0925-4439(92)90139-E; HAUMONT E, 1987, EUR J BIOCHEM, V168, P219, DOI 10.1111/j.1432-1033.1987.tb13408.x; HOOPS GC, 1995, BIOCHEMISTRY-US, V34, P15381, DOI 10.1021/bi00046a047; HOWES NK, 1978, J BIOL CHEM, V253, P9082; Ishitani R, 2002, J MOL BIOL, V318, P665, DOI 10.1016/S0022-2836(02)00090-6; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; KASAI H, 1975, BIOCHEMISTRY-US, V14, P4198, DOI 10.1021/bi00690a008; KATZE JR, 1982, SCIENCE, V216, P55; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Marks T, 1997, BIOCHEM BIOPH RES CO, V230, P233, DOI 10.1006/bbrc.1996.5768; MORL M, 1995, NUCLEIC ACIDS RES, V23, P3380, DOI 10.1093/nar/23.17.3380; MORRIS RC, 1995, NUCLEIC ACIDS RES, V23, P2492, DOI 10.1093/nar/23.13.2492; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; NISHIMURA S, 1983, PROG NUCLEIC ACID RE, V28, P49, DOI 10.1016/S0079-6603(08)60082-3; OKADA N, 1979, J BIOL CHEM, V254, P3061; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; RANDERATH E, 1984, CANCER RES, V44, P1167; REUTER K, 1995, J BACTERIOL, V177, P5284, DOI 10.1128/jb.177.18.5284-5288.1995; Romier C, 1996, EMBO J, V15, P2850, DOI 10.1002/j.1460-2075.1996.tb00646.x; SHINDOOKADA N, 1980, BIOCHEMISTRY-US, V19, P395, DOI 10.1021/bi00543a023; SHINDOOKADA N, 1981, EUR J BIOCHEM, V115, P423, DOI 10.1111/j.1432-1033.1981.tb05254.x; SINGHAL RP, 1981, BIOCHEM BIOPH RES CO, V99, P120, DOI 10.1016/0006-291X(81)91721-6; SLANY RK, 1995, EUR J BIOCHEM, V230, P221, DOI 10.1111/j.1432-1033.1995.0221i.x; Stengl B, 2005, CHEMBIOCHEM, V6, P1926, DOI 10.1002/cbic.200500063; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030; WALDEN TL, 1982, J BIOL CHEM, V257, P13218; Xie W, 2003, NAT STRUCT BIOL, V10, P781, DOI 10.1038/nsb976; Yang W. K., 1971, METHOD ENZYMOL, V20, P44	44	47	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18218	18227		10.1074/jbc.M109.002477	http://dx.doi.org/10.1074/jbc.M109.002477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19414587	Green Published, hybrid			2022-12-27	WOS:000267712400034
J	Carnemolla, A; Fossale, E; Agostoni, E; Michelazzi, S; Calligaris, R; De Maso, L; Del Sal, G; MacDonald, ME; Persichetti, F				Carnemolla, Alisia; Fossale, Elisa; Agostoni, Elena; Michelazzi, Silvia; Calligaris, Raffaella; De Maso, Luca; Del Sal, Giannino; MacDonald, Marcy E.; Persichetti, Francesca			Rrs1 Is Involved in Endoplasmic Reticulum Stress Response in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KNOCK-IN MICE; PROTEIN L11-BINDING PROTEIN; CAG REPEAT INSTABILITY; 5S RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; CELL-DEATH; NEURODEGENERATIVE DISEASE; NUCLEAR-ENVELOPE; GENE-EXPRESSION; ER STRESS	The induction of Rrs1 expression is one of the earliest events detected in a presymptomatic knock-in mouse model of Huntington disease (HD). Rrs1 up-regulation fulfills the HD criteria of dominance, striatal specificity, and polyglutamine dependence. Here we show that mammalian Rrs1 is localized both in the nucleolus as well as in the endoplasmic reticulum ( ER) of neurons. This dual localization is shared with its newly identified molecular partner 3D3/lyric. We then show that both genes are induced by ER stress in neurons. Interestingly, we demonstrate that ER stress is an early event in a presymptomatic HD mouse model that persists throughout the life span of the rodent. We further show that ER stress also occurs in postmortem brains of HD patients.	[Carnemolla, Alisia; Agostoni, Elena; Michelazzi, Silvia; Calligaris, Raffaella; De Maso, Luca; Persichetti, Francesca] Scuola Int Super Studi Avanzati, Sector Neurobiol, I-34151 Trieste, Italy; [Fossale, Elisa; MacDonald, Marcy E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Del Sal, Giannino] Area Sci Pk Padriciano, Lab Nazl CIB, I-34149 Trieste, Italy; [Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy	International School for Advanced Studies (SISSA); Harvard University; Massachusetts General Hospital; University of Trieste	Persichetti, F (corresponding author), Univ Piemonte Orientale, Dipartimento Sci Ambiente & Vita, Alessandria, Italy.	persiche@sissa.it		Persichetti, Francesca/0000-0002-9804-644X; DEL SAL, GIANNINO/0000-0003-2185-6003	Telethon Foundation of Italy [GGP06264]; Italian Government; Comitato Interministerale per la Programmazione Economica/Friuli Venezia Giulia, Italy	Telethon Foundation of Italy(Fondazione Telethon); Italian Government; Comitato Interministerale per la Programmazione Economica/Friuli Venezia Giulia, Italy	This work was supported by Telethon Foundation of Italy Grant GGP06264, by the Italian Government ( Brain Gain Program, Ministero dell'Istruzione, dell'Universita e della Ricerca), and by Comitato Interministerale per la Programmazione Economica/Friuli Venezia Giulia, Italy Grant GRAND.	Atwal RS, 2008, AUTOPHAGY, V4, P91, DOI 10.4161/auto.5201; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Fossale E, 2002, HUM MOL GENET, V11, P2233, DOI 10.1093/hmg/11.19.2233; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Isaac C, 2001, J CELL SCI, V114, P4253; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Miyoshi K, 2004, FEBS LETT, V565, P106, DOI 10.1016/j.febslet.2004.03.087; Miyoshi K, 2002, J BIOL CHEM, V277, P18334, DOI 10.1074/jbc.M201667200; MIZUTA K, 1994, MOL CELL BIOL, V14, P2493, DOI 10.1128/MCB.14.4.2493; Nariai M, 2005, NUCLEIC ACIDS RES, V33, P4553, DOI 10.1093/nar/gki772; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Reijonen S, 2008, EXP CELL RES, V314, P950, DOI 10.1016/j.yexcr.2007.12.025; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wade C, 2001, MOL CELL BIOL, V21, P8638, DOI 10.1128/MCB.21.24.8638-8650.2001; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	32	115	120	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18167	18173		10.1074/jbc.M109.018325	http://dx.doi.org/10.1074/jbc.M109.018325			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433866	Green Published, hybrid			2022-12-27	WOS:000267712400028
J	Maruyama, Y; Nakamichi, Y; Itoh, T; Mikami, B; Hashimoto, W; Murata, K				Maruyama, Yukie; Nakamichi, Yusuke; Itoh, Takafumi; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Substrate Specificity of Streptococcal Unsaturated Glucuronyl Hydrolases for Sulfated Glycosaminoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SP GL1; CRYSTAL-STRUCTURE; HYALURONIDASE GENE; ESCHERICHIA-COLI; GENOME SEQUENCE; DEGRADATION; PNEUMONIAE; AGALACTIAE; ENZYME; PURIFICATION	Unsaturated glucuronyl hydrolase (UGL) categorized into the glycoside hydrolase family 88 catalyzes the hydrolytic release of an unsaturated glucuronic acid from glycosaminoglycan disaccharides, which are produced from mammalian extracellular matrices through the beta-elimination reaction of polysaccharide lyases. Here, we show enzyme characteristics of pathogenic streptococcal UGLs and structural determinants for the enzyme substrate specificity. The putative genes for UGL and phosphotransferase system for amino sugar, a component of glycosaminoglycans, are assembled into a cluster in the genome of pyogenic and hemolytic streptococci such as Streptococcus agalactiae, Streptococcus pneumoniae, and Streptococcus pyogenes, which produce extracellular hyaluronate lyase as a virulent factor. The UGLs of these three streptococci were overexpressed in Escherichia coli cells, purified, and characterized. Streptococcal UGLs degraded unsaturated hyaluronate and chondroitin disaccharides most efficiently at approximately pH 5.5 and 37 degrees C. Distinct from Bacillus sp. GL1 UGL, streptococcal UGLs preferred sulfated substrates. DNA microarray and Western blotting indicated that the enzyme was constitutively expressed in S. agalactiae cells, although the expression level increased in the presence of glycosaminoglycan. The crystal structure of S. agalactiae UGL (SagUGL) was determined at 1.75 A resolution by x-ray crystallography. SagUGL adopts alpha(6)/alpha(6)-barrel structure as a basic scaffold similar to Bacillus UGL, but the arrangement of amino acid residues in the active site differs between the two. SagUGL Arg-236 was found to be one of the residues involved in its activity for the sulfated substrate through structural comparison and site-directed mutagenesis. This is the first report on the structure and function of streptococcal UGLs.	[Maruyama, Yukie; Nakamichi, Yusuke; Itoh, Takafumi; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Lab Appl Struct Biol, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp	Nakamichi, Yusuke/Y-2830-2019; Nakamichi, Yusuke/H-1221-2018	Nakamichi, Yusuke/0000-0001-7089-663X; Nakamichi, Yusuke/0000-0001-7089-663X	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (to K. M. and W. H.) and by Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported in part by Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (to Y. M.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERRY AM, 1994, INFECT IMMUN, V62, P1101, DOI 10.1128/IAI.62.3.1101-1108.1994; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gase K, 1998, BBA-GENE STRUCT EXPR, V1398, P86, DOI 10.1016/S0167-4781(98)00045-1; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gunther E, 1996, ZBL BAKT-INT J MED M, V285, P64; Hashimoto W, 1997, ARCH BIOCHEM BIOPHYS, V339, P17, DOI 10.1006/abbi.1996.9851; HASHIMOTO W, 1995, J BIOCHEM-TOKYO, V118, P75, DOI 10.1093/oxfordjournals.jbchem.a124894; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Hashimoto W, 2007, INT MICROBIOL, V10, P233, DOI 10.2436/20.1501.01.32; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hynes WL, 2000, FEMS MICROBIOL LETT, V184, P109, DOI 10.1016/S0378-1097(00)00029-X; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh T, 2000, J MOL BIOL, V303, P733, DOI 10.1006/jmbi.2000.4188; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Itoh T, 2006, J BIOL CHEM, V281, P29807, DOI 10.1074/jbc.M604975200; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; JUY M, 1992, NATURE, V357, P89, DOI 10.1038/357089a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; LINKER A, 1955, J BIOL CHEM, V213, P237; Mello LV, 2002, J BIOL CHEM, V277, P36678, DOI 10.1074/jbc.M205140200; Mori S, 2003, PROTEIN EXPRES PURIF, V29, P77, DOI 10.1016/S1046-5928(03)00019-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATON JC, 1993, ANNU REV MICROBIOL, V47, P89, DOI 10.1146/annurev.mi.47.100193.000513; PRITCHARD DG, 1994, ARCH BIOCHEM BIOPHYS, V315, P431, DOI 10.1006/abbi.1994.1521; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yoshinari S, 2006, BIOCHEM BIOPH RES CO, V346, P1024, DOI 10.1016/j.bbrc.2006.06.011; Yum DY, 1999, APPL ENVIRON MICROB, V65, P3341	50	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18059	18069		10.1074/jbc.M109.005660	http://dx.doi.org/10.1074/jbc.M109.005660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416976	Green Published, hybrid			2022-12-27	WOS:000267712400017
J	Wu, JX; Prindle, MJ; Dressler, GR; Yu, XC				Wu, Jiaxue; Prindle, Marc J.; Dressler, Gregory R.; Yu, Xiaochun			PTIP Regulates 53BP1 and SMC1 at the DNA Damage Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2AX PHOSPHORYLATION; DOUBLE-STRAND BREAKS; BRCT-DOMAIN; ATM ACTIVATION; CELLULAR-RESPONSES; GENOMIC STABILITY; PROTEIN PTIP; MDC1; REPAIR; BINDING	Although PTIP is implicated in the DNA damage response, through interactions with 53BP1, the function of PTIP in the DNA damage response remain elusive. Here, we show that RNF8 controls DNA damage-induced nuclear foci formation of PTIP, which in turn regulates 53BP1 localization to the DNA damage sites. In addition, SMC1, a substrate of ATM, could not be phosphorylated at the DNA damage sites in the absence of PTIP. The PTIP-dependent pathway is important for DNA double strand breaks repair and DNA damage-induced intra-S phase checkpoint activation. Taken together, these results suggest that the role of PTIP in the DNA damage response is downstream of RNF8 and upstream of 53BP1. Thus, PTIP regulates 53BP1-dependent signaling pathway following DNA damage.	[Prindle, Marc J.; Dressler, Gregory R.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Wu, Jiaxue; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dressler, GR (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	dressler@umich.edu; xiayu@umich.edu			National Institutes of Health [CA132755, CA130899, DK054740]; University of Michigan Cancer Center; GI Peptide Research Center of the University of Michigan; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); GI Peptide Research Center of the University of Michigan(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132755 and CA130899 (to X. Y.) and DK054740 (to G. R. D.). This work was also supported by the University of Michigan Cancer Center and the GI Peptide Research Center of the University of Michigan.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Caldecott KW, 2003, SCIENCE, V302, P579, DOI 10.1126/science.1091463; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Mochan TA, 2003, CANCER RES, V63, P8586; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schar P, 2004, NUCLEIC ACIDS RES, V32, P3921, DOI 10.1093/nar/gkh716; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stracker TH, 2007, NATURE, V447, P218, DOI 10.1038/nature05740; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	66	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18078	18084		10.1074/jbc.M109.002527	http://dx.doi.org/10.1074/jbc.M109.002527			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19414588	hybrid, Green Published			2022-12-27	WOS:000267712400019
J	Adair, JE; Stober, V; Sobhany, M; Zhuo, LS; Roberts, JD; Negishi, M; Kimata, K; Garantziotis, S				Adair, Jennifer E.; Stober, Vandy; Sobhany, Mack; Zhuo, Lisheng; Roberts, John D.; Negishi, Masahiko; Kimata, Koji; Garantziotis, Stavros			Inter-alpha-trypsin Inhibitor Promotes Bronchial Epithelial Repair after Injury through Vitronectin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; SHAP-HYALURONAN COMPLEX; LUNG INJURY; CELLS; MIGRATION; INTEGRIN; PROVIDES; CD44; GENE; KEY	Pulmonary epithelial injury is central to the pathogenesis of many lung diseases, such as asthma, pulmonary fibrosis, and the acute respiratory distress syndrome. Regulated epithelial repair is crucial for lung homeostasis and prevents scar formation and inflammation that accompany dysregulated healing. The extracellular matrix (ECM) plays an important role in epithelial repair after injury. Vitronectin is a major ECM component that promotes epithelial repair. However, the factors that modify cell-vitronectin interactions after injury and help promote epithelial repair are not well studied. Inter-alpha-trypsin inhibitor (IaI) is an abundant serum protein. IaI heavy chains contain von Willebrand A domains that can bind the arginine-glycine-aspartate domain of vitronectin. We therefore hypothesized that IaI can bind vitronectin and promote vitronectin-induced epithelial repair after injury. We show that IaI binds vitronectin at the arginine-glycine-aspartate site, thereby promoting epithelial adhesion and migration in vitro. Furthermore, we show that IaI-deficient mice have a dysregulated response to epithelial injury in vivo, consisting of decreased proliferation and epithelial metaplasia. We conclude that IaI interacts not only with hyaluronan, as previously reported, but also other ECM components like vitronectin and is an important regulator of cellular repair after injury.	[Garantziotis, Stavros] NIEHS, Res Triangle Pk, NC 27709 USA; [Zhuo, Lisheng; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Aichi Medical University	Garantziotis, S (corresponding author), NIEHS, Res Triangle Pk, NC 27709 USA.	garantziotis@niehs.nih.gov	Garantziotis, Stavros/A-6903-2009; Negishi, Masahiko/F-7805-2019	Garantziotis, Stavros/0000-0003-4007-375X; Negishi, Masahiko/0000-0002-2076-8928; Adair, Jennifer/0000-0003-4599-016X	National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, ZIAES102605, Z01ES023018, Z01ES080040, Z01ES102605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program.	Bayram H, 2002, CLIN EXP ALLERGY, V32, P1285, DOI 10.1046/j.1365-2745.2002.01435.x; Bloemendal HJ, 2004, CANCER IMMUNOL IMMUN, V53, P799, DOI 10.1007/s00262-004-0506-z; Casey RC, 2000, CLIN EXP METASTAS, V18, P67, DOI 10.1023/A:1026519016213; Craig D, 2004, STRUCTURE, V12, P2049, DOI 10.1016/j.str.2004.09.009; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Forrest IA, 2005, EUR RESPIR J, V26, P1080, DOI 10.1183/09031936.05.00141404; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Garantziotis S, 2008, AM J RESP CRIT CARE, V178, P939, DOI 10.1164/rccm.200803-386OC; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Lazar MH, 2004, AM J RESP CELL MOL, V31, P672, DOI 10.1165/rcmb.2004-0025OC; Lechner J F, 1985, J TISSUE CULT METHOD, V9, P43; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Minor KH, 2005, J BIOL CHEM, V280, P28711, DOI 10.1074/jbc.M500478200; Miyazaki T, 2004, J BIOL CHEM, V279, P44667, DOI 10.1074/jbc.M408101200; PREISSNER KT, 1990, BIOCHEM BIOPH RES CO, V168, P966, DOI 10.1016/0006-291X(90)91123-A; PRESS WH, 1989, NUMERICAL RECIPES FO; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; SEIFFERT D, 1991, BIOCHIM BIOPHYS ACTA, V1078, P23, DOI 10.1016/0167-4838(91)90087-G; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Stripp BR, 1995, AM J PHYSIOL-LUNG C, V269, pL791, DOI 10.1152/ajplung.1995.269.6.L791; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Wadsworth SJ, 2004, AM J PHYSIOL-LUNG C, V286, pL596, DOI 10.1152/ajplung.00217.2003; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	29	27	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16922	16930		10.1074/jbc.M808560200	http://dx.doi.org/10.1074/jbc.M808560200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19395377	Green Published, hybrid			2022-12-27	WOS:000266962400029
J	Zhang, WJ; Chan, RJ; Chen, HY; Yang, ZY; He, YT; Zhang, X; Luo, Y; Yin, FQ; Moh, A; Miller, LC; Payne, RM; Zhang, ZY; Fu, XY; Shou, WN				Zhang, Wenjun; Chan, Rebecca J.; Chen, Hanying; Yang, Zhenyun; He, Yantao; Zhang, Xian; Luo, Yong; Yin, Fuqing; Moh, Akira; Miller, Lucy C.; Payne, R. Mark; Zhang, Zhong-Yin; Fu, Xin-Yuan; Shou, Weinian			Negative Regulation of Stat3 by Activating PTPN11 Mutants Contributes to the Pathogenesis of Noonan Syndrome and Juvenile Myelomonocytic Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHP-2 TYROSINE PHOSPHATASE; COLONY-STIMULATING FACTOR; EPIDERMAL-GROWTH-FACTOR; MUTATIONS CAUSE NOONAN; OF-FUNCTION MUTATIONS; CELL-DIFFERENTIATION; MYELOID-LEUKEMIA; MOUSE MODEL; GERMLINE; SPECTRUM	Noonan syndrome (NS) is an autosomal dominant congenital disorder characterized by multiple birth defects including heart defects and myeloproliferative disease (MPD). Approximately 50% of NS patients have germline gain-of-function mutations in PTPN11, which encodes the protein-tyrosine phosphatase, Shp2. We provide evidence that conditional ablation of Stat3 in hematopoietic cells and cardiac valvular tissues leads to myeloid progenitor hyperplasia and pulmonary stenosis due to the leaflet thickening, respectively. Consistently, STAT3 activation is significantly compromised in peripheral blood cells from NS patients bearing Shp2-activating mutations. Biochemical and functional analyses demonstrate that activated Shp2 is able to down-regulate Tyr(P)-Stat3 and that constitutively active Stat3 rescues activating mutant Shp2-induced granulocyte-macrophage colony-stimulating factor hypersensitivity in bone marrow cells. Collectively, our work demonstrates that Stat3 is an essential signaling component potentially contributing to the pathogenesis of NS and juvenile myelomonocytic leukemia caused by PTPN11 gain-of-function mutations.	[Zhang, Wenjun; Moh, Akira; Fu, Xin-Yuan] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [He, Yantao; Zhang, Xian; Luo, Yong; Zhang, Zhong-Yin; Shou, Weinian] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chan, Rebecca J.; Yang, Zhenyun; Yin, Fuqing; Miller, Lucy C.] Indiana Univ, Sch Med, Dept Pediat, Sect Neonatol, Indianapolis, IN 46202 USA; [Zhang, Wenjun; Chan, Rebecca J.; Chen, Hanying; Payne, R. Mark; Shou, Weinian] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Zhang, Wenjun; Payne, R. Mark; Shou, Weinian] Indiana Univ, Sch Med, Riley Heart Res Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Fu, XY (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	xfu@iupui.edu; wshou@iupui.edu			National Institutes of Health [HL81092, HL70259, HL85098, HL82981, CA69202]; Indiana University Department of Pediatrics, Protocol Development Team; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082981, R01HL081092, P01HL085098, R01HL070259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Department of Pediatrics, Protocol Development Team; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81092 (to W. S.), HL70259 (to W. S.), HL85098 (to W. S. and M. P.), HL82981 (to R. J. C.), and CA69202 (to Z. Y. Z.). This work was also supported in part by the Indiana University Department of Pediatrics, Protocol Development Team.	Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Asao H, 2000, J BIOL CHEM, V275, P867, DOI 10.1074/jbc.275.2.867; BaderMeunier B, 1997, J PEDIATR-US, V130, P885, DOI 10.1016/S0022-3476(97)70273-7; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chan RJ, 2003, BLOOD, V102, P2074, DOI 10.1182/blood-2003-04-1171; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Choong K, 1999, J PEDIAT HEMATOL ONC, V21, P523, DOI 10.1097/00043426-199911000-00014; EMANUEL PD, 1991, BLOOD, V77, P925; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gamero AM, 2006, J BIOL CHEM, V281, P16238, DOI 10.1074/jbc.M509516200; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; Kamezaki K, 2005, STEM CELLS, V23, P252, DOI 10.1634/stemcells.2004-0173a; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kratz CP, 2007, J MOL MED-JMM, V85, P223, DOI 10.1007/s00109-006-0135-4; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Qu CK, 1999, P NATL ACAD SCI USA, V96, P8528, DOI 10.1073/pnas.96.15.8528; Rajan P, 1998, J NEUROSCI, V18, P3620; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Sarkozy A, 2009, HUM MUTAT, V30, P695, DOI 10.1002/humu.20955; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M., 2009, V17, P20; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	50	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22353	22363		10.1074/jbc.M109.020495	http://dx.doi.org/10.1074/jbc.M109.020495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19509418	Green Published, hybrid			2022-12-27	WOS:000268783700058
J	Zheng, XD; Wang, YY; Wei, HM; Sun, R; Tian, ZG				Zheng, Xiaodong; Wang, Yanyan; Wei, Haiming; Sun, Rui; Tian, Zhigang			LFA-1 and CD2 Synergize for the Erk1/2 Activation in the Natural Killer (NK) Cell Immunological Synapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ORGANIZING CENTER; GRANULE POLARIZATION; CYTOTOXICITY; RECEPTORS; ADHESION; LINE; PATHWAYS; ERK2; PHOSPHORYLATION; IDENTIFICATION	Natural killer (NK) cell recognition and formation of a conjugate with target cells, followed by intracellular signal pathway activation and degradation of cytolytic granules, are essential for NK cell cytotoxicity. In this study, NK92 cells were used to investigate synapse formation and subsequent signaling after binding to the target cell. The binding rate of the NK92-target cell was associated with NK92 cell cytotoxicity. Confocal results showed that adhesion molecules, LFA-1 (CD11a) and CD2, accumulated at the interface of the NK92-K562 contact. Ligation with K562 cells activated the Erk1/2 signal pathway of NK92 cells. The blocking of the NK-target conjugate by EDTA or anti-CD11a or/and anti-CD2 antibody decreased the phosphorylation of Erk1/2 and NK cell cytotoxicity. Inhibition of Erk1/2 phosphorylation by the chemical inhibitor U0126 suppressed the cytolytic activity of NK92 cells, but had no effect on NK-target conjugate formation. Thus, conjugate formation of the NK92-target cell was prerequisite to NK cell activation, and subsequent signal transduction was also required for NK cell cytotoxicity.	Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Inst Immunol, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tian, ZG (corresponding author), 443 Huangshan Rd, Hefei 230027, Anhui, Peoples R China.	tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Zheng, Xiaodong/N-2830-2013		Natural Science Foundation of China [30630059, 30721002, 30801007]; Ministry of Science & Technology of China [2007CB512405, 2006CB806504]; China Postdoctoral Science Foundation [200801237]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science & Technology of China(Ministry of Science and Technology, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by the Natural Science Foundation of China (Grants 30630059, 30721002, and 30801007), Ministry of Science & Technology of China (973 Basic Science Projects 2007CB512405 and 2006CB806504), and the China Postdoctoral Science Foundation (Grant 200801237).	Banham AH, 1999, J LEUKOCYTE BIOL, V65, P841, DOI 10.1002/jlb.65.6.841; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Bottino C, 2005, TRENDS IMMUNOL, V26, P221, DOI 10.1016/j.it.2005.02.007; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Burshtyn DN, 2000, CURR BIOL, V10, P777, DOI 10.1016/S0960-9822(00)00568-6; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; CHONG ASF, 1994, CELL IMMUNOL, V157, P92, DOI 10.1006/cimm.1994.1208; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Djeu JY, 2002, CLIN CANCER RES, V8, P636; Dustin ML, 2007, J BIOL CHEM, V282, P34748, DOI 10.1074/jbc.M705616200; Friberg Diana D., 1996, Methods (Orlando), V9, P316, DOI 10.1006/meth.1996.0037; GONG JH, 1994, LEUKEMIA, V8, P652; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Helander TS, 1998, CURR TOP MICROBIOL, V230, P89; Inoue H, 2002, EUR J IMMUNOL, V32, P2188, DOI 10.1002/1521-4141(200208)32:8<2188::AID-IMMU2188>3.0.CO;2-T; Kirwan SE, 2005, J IMMUNOL, V175, P5006, DOI 10.4049/jimmunol.175.8.5006; Lanier LL, 1998, ADV EXP MED BIOL, V452, P13; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; Maki G, 2001, J HEMATOTH STEM CELL, V10, P369, DOI 10.1089/152581601750288975; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; MORETTA L, 1994, ADV IMMUNOL, V55, P341; Orange JS, 2007, ADV EXP MED BIOL, V601, P225; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Perez OD, 2004, BLOOD, V104, P1083, DOI 10.1182/blood-2003-08-2652; RAULET DH, 1995, CELL, V82, P697, DOI 10.1016/0092-8674(95)90466-2; Rezzonico R, 2000, BLOOD, V95, P3868; RODER JC, 1982, J CLIN IMMUNOL, V2, P249, DOI 10.1007/BF00915064; SELVARAJ P, 1987, NATURE, V326, P400, DOI 10.1038/326400a0; Tonn T, 2001, J HEMATOTH STEM CELL, V10, P535, DOI 10.1089/15258160152509145; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Trotta R, 1998, J IMMUNOL, V161, P6648; Visse E, 2003, BIOL RES, V36, P263, DOI 10.4067/S0716-97602003000200016; Vyas YM, 2002, IMMUNOL REV, V189, P161, DOI 10.1034/j.1600-065X.2002.18914.x; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753	36	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21280	21287		10.1074/jbc.M807053200	http://dx.doi.org/10.1074/jbc.M807053200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19502238	hybrid, Green Published			2022-12-27	WOS:000268564400022
J	McDonough, H; Charles, PC; Hilliard, EG; Qian, SB; Min, JN; Portbury, A; Cyr, DM; Patterson, C				McDonough, Holly; Charles, Peter C.; Hilliard, Eleanor G.; Qian, Shu-Bing; Min, Jin-Na; Portbury, Andrea; Cyr, Douglas M.; Patterson, Cam			Stress-dependent Daxx-CHIP Interaction Suppresses the p53 Apoptotic Program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; UBIQUITIN LIGASE; TRANSCRIPTIONAL ACTIVITY; C-TERMINUS; CELL-DEATH; ACTIVATION; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; INDUCTION	Our previous studies have implicated CHIP (carboxyl terminus of Hsp70-interacting protein) as a co-chaperone/ubiquitin ligase whose activities yield protection against stress-induced apoptotic events. In this report, we demonstrate a stress-dependent interaction between CHIP and Daxx (death domain-associated protein). This interaction interferes with the stress-dependent association of HIPK2 with Daxx, blocking phosphorylation of serine 46 in p53 and inhibiting the p53-dependent apoptotic program. Microarray analysis confirmed suppression of the p53-dependent transcriptional portrait in CHIP+/+ but not in CHIP-/- heat shocked mouse embryonic fibroblasts. The interaction between CHIP and Daxx results in ubiquitination of Daxx, which is then partitioned to an insoluble compartment of the cell. In vitro ubiquitination of Daxx by CHIP revealed that ubiquitin chain formation utilizes non-canonical lysine linkages associated with resistance to proteasomal degradation. The ubiquitination of Daxx by CHIP utilizes lysines 630 and 631 and competes with the sumoylation machinery of the cell at these residues. These studies implicate CHIP as a stress-dependent regulator of Daxx that counters the pro-apoptotic influence of Daxx in the cell. By abrogating p53-dependent apoptotic pathways and by ubiquitination competitive with Daxx sumoylation, CHIP integrates the proteotoxic stress response of the cell with cell cycle pathways that influence cell survival.	[Patterson, Cam] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Cyr, Douglas M.; Patterson, Cam] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Patterson, Cam] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [McDonough, Holly; Charles, Peter C.; Hilliard, Eleanor G.; Qian, Shu-Bing; Min, Jin-Na; Portbury, Andrea; Patterson, Cam] Univ N Carolina, Crolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA; [Patterson, Cam] Univ N Carolina, Div Cardiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Patterson, C (corresponding author), Univ N Carolina, Div Cardiol, 8200 Med Biomol Res Bldg, Chapel Hill, NC 27599 USA.	cpatters@med.unc.edu		Cyr, Douglas/0000-0002-4928-3414	National Institutes of Health [AG024282, GM61728]; American Heart Association Scientist Development [0635100N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG024282 and GM61728.; Supported in part by American Heart Association Scientist Development Grant 0635100N.	Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Copanaki E, 2007, BBA-MOL CELL RES, V1773, P157, DOI 10.1016/j.bbamcr.2006.10.002; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; He XR, 2004, BIOTECHNIQUES, V37, P464, DOI 10.2144/04373RT02; Hwang JR, 2005, CELL STRESS CHAPERON, V10, P147, DOI 10.1379/CSC-90R.1; Ishov AM, 2004, J CELL SCI, V117, P3807, DOI 10.1242/jcs.01230; Jang MS, 2002, BIOCHEM BIOPH RES CO, V295, P495, DOI 10.1016/S0006-291X(02)00699-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Matsumoto K, 2007, J BIOL CHEM, V282, P17053, DOI 10.1074/jbc.M701956200; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mohammed KA, 2007, LUNG, V185, P355, DOI 10.1007/s00408-007-9046-6; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Muromoto R, 2006, J IMMUNOL, V177, P1160, DOI 10.4049/jimmunol.177.2.1160; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; Nakamura Y, 2006, CANCER SCI, V97, P633, DOI 10.1111/j.1349-7006.2006.00214.x; Nefkens I, 2003, J CELL SCI, V116, P513, DOI 10.1242/jcs.00253; Nesbit CE, 1998, BLOOD, V92, P1003; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Riva A, 2005, COMPUT BIOL CHEM, V29, P319, DOI 10.1016/j.compbiolchem.2005.08.006; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Schmitz C, 2005, MOL BIOL CELL, V16, P1319, DOI 10.1091/mbc.E04-05-0425; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Sugimoto M, 2006, MOL CELL BIOL, V26, P502, DOI 10.1128/MCB.26.2.502-512.2006; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu SY, 2002, NEOPLASIA, V4, P486, DOI 10.1038/sj.neo.7900264; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Yu H, 2005, GENE, V352, P75, DOI 10.1016/j.gene.2005.03.033; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004	58	25	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20649	20659		10.1074/jbc.M109.011767	http://dx.doi.org/10.1074/jbc.M109.011767			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19465479	Green Published, hybrid			2022-12-27	WOS:000268316100026
J	Kim, H; Heo, K; Kim, JH; Kim, K; Choi, J; An, WJ				Kim, Hyunjung; Heo, Kyu; Kim, Jeong Hoon; Kim, Kyunghwan; Choi, Jongkyu; An, Woojin			Requirement of Histone Methyltransferase SMYD3 for Estrogen Receptor-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER-CELLS; NUCLEAR RECEPTORS; HETEROCHROMATIN FORMATION; DEPENDENT TRANSCRIPTION; METHYLATION; COACTIVATORS; ACETYLATION; ALPHA; P300; H3K4	SMYD3 is a SET domain-containing protein with histone methyltransferase activity on histone H3-K4. Recent studies showed that SMYD3 is frequently overexpressed in different types of cancer cells, but how SMYD3 regulates the development and progression of these malignancies remains unknown. Here, we report the previously unrecognized role of SMYD3 in estrogen receptor (ER)-mediated transcription via its histone methyltransferase activity. We demonstrate that SMYD3 functions as a coactivator of ER alpha and potentiates ER alpha activity in response to ligand. SMYD3 directly interacts with the ligand binding domain of ER and is recruited to the proximal promoter regions of ER target genes upon gene induction. Importantly, our chromatin immunoprecipitation analyses provide compelling evidence that SMYD3 is responsible for the accumulation of di- and trimethylation of H3-K4 at the induced ER target genes. Furthermore, RNA interference-directed down-regulation of SMYD3 reveals that SMYD3 is required for ER-regulated gene transcription in estrogen signaling pathway. Thus, our results identify SMYD3 as a new coactivator for ER-mediated transcription, providing a possible link between SMYD3 overexpression and breast cancer.	[Kim, Hyunjung; Heo, Kyu; Kim, Jeong Hoon; Kim, Kyunghwan; Choi, Jongkyu; An, Woojin] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	An, WJ (corresponding author), 1450 Biggy St,NRT 6517, Los Angeles, CA 90033 USA.	woojinan@usc.edu		Heo, Kyu/0000-0001-8833-4731	National Institutes of Health [R01GM84209]; Margaret E. Early Medical Research Grant; Donald E. & Delia B. Baxter Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Margaret E. Early Medical Research Grant; Donald E. & Delia B. Baxter Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM84209. This work was also supported by a Margaret E. Early Medical Research Grant and a Donald E. & Delia B. Baxter Foundation Award.	Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Carling T, 2004, MOL CELL BIOL, V24, P7032, DOI 10.1128/MCB.24.16.7032-7042.2004; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; DUBIK D, 1987, CANCER RES, V47, P6517; Enmark E, 1999, J INTERN MED, V246, P133, DOI 10.1046/j.1365-2796.1999.00545.x; FOSTER JS, 1996, J MOL ENDOCRINOL, V10, P488; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; JAKOWLEW SB, 1984, NUCLEIC ACIDS RES, V12, P2861, DOI 10.1093/nar/12.6.2861; Kim MY, 2001, EMBO J, V20, P6084, DOI 10.1093/emboj/20.21.6084; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Kraus WL, 2002, EUR J BIOCHEM, V269, P2275, DOI 10.1046/j.1432-1033.2002.02889.x; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rochefort H, 1986, Prog Clin Biol Res, V204, P125; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; YAMAMOTO KR, 1988, COLD SPRING HARB SYM, V53, P803, DOI 10.1101/SQB.1988.053.01.091; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703	39	70	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19867	19877		10.1074/jbc.M109.021485	http://dx.doi.org/10.1074/jbc.M109.021485			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19509295	Green Published, hybrid			2022-12-27	WOS:000268097400013
J	Sampath, H; Flowers, MT; Liu, XQ; Paton, CM; Sullivan, R; Chu, KK; Zhao, MH; Ntambi, JM				Sampath, Harini; Flowers, Matthew T.; Liu, Xueqing; Paton, Chad M.; Sullivan, Ruth; Chu, Kiki; Zhao, Minghui; Ntambi, James M.			Skin-specific Deletion of Stearoyl-CoA Desaturase-1 Alters Skin Lipid Composition and Protects Mice from High Fat Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; SKELETAL-MUSCLE; INSULIN-RESISTANCE; THYROID-HORMONE; UNCOUPLING PROTEIN-3; SEBACEOUS GLAND; MITOCHONDRIAL BIOGENESIS; ENERGY-EXPENDITURE; LIPOPROTEIN-LIPASE; METABOLIC SYNDROME	Stearoyl-CoA desaturase-1 (SCD1) catalyzes the synthesis of monounsaturated fatty acids and is an important regulator of whole body energy homeostasis. Severe cutaneous changes in mice globally deficient in SCD1 also indicate a role for SCD1 in maintaining skin lipids. We have generated mice with a skin-specific deletion of SCD1 (SKO) and report here that SKO mice display marked sebaceous gland hypoplasia and depletion of sebaceous lipids. In addition, SKO mice have significantly increased energy expenditure and are protected from high fat diet-induced obesity, thereby recapitulating the hypermetabolic phenotype of global SCD1 deficiency. Genes of fat oxidation, lipolysis, and thermogenesis, including uncoupling proteins and peroxisome proliferator-activated receptor-gamma co-activator-1 alpha, are up-regulated in peripheral tissues of SKO mice. However, unlike mice globally deficient in SCD1, SKO mice have an intact hepatic lipogenic response to acute high carbohydrate feeding. Despite increased basal thermogenesis, SKO mice display severe cold intolerance because of rapid depletion of fuel substrates, including hepatic glycogen, to maintain core body temperature. These data collectively indicate that SKO mice have increased cold perception because of loss of insulating factors in the skin. This results in up-regulation of thermogenic processes for temperature maintenance at the expense of fuel economy, illustrating cross-talk between the skin and peripheral tissues in maintaining energy homeostasis.	[Sampath, Harini; Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Flowers, Matthew T.; Liu, Xueqing; Paton, Chad M.; Chu, Kiki; Zhao, Minghui; Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Sullivan, Ruth] Univ Wisconsin, Res Anim Resources Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ntambi, JM (corresponding author), Univ Wisconsin, Dept Nutr Sci, 433 Babcock Dr, Madison, WI 53706 USA.	ntambi@biochem.wisc.edu			National Institutes of Health [RO1DK-62388]; Wisconsin Distinguished Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Distinguished Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK-62388 (to J.M.N.). This work was also supported by a Wisconsin Distinguished Graduate Fellowship (to H. S.).	Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Crooke S.T, 2008, ANTISENSE DRUG TECHN, V2nd, P183; Dassule HR, 2000, DEVELOPMENT, V127, P4775; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; ELIAS PM, 1992, SEMIN DERMATOL, V11, P176; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Grundy SM, 2007, J CLIN ENDOCR METAB, V92, P399, DOI 10.1210/jc.2006-0513; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Hillenius WJ, 2007, ANN ANAT, V189, P423, DOI 10.1016/j.aanat.2006.10.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jensen DR, 2008, J LIPID RES, V49, P870, DOI 10.1194/jlr.M700519-JLR200; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Jong MC, 2001, DIABETES, V50, P2779, DOI 10.2337/diabetes.50.12.2779; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651; Lodhi IJ, 2009, CELL METAB, V9, P111, DOI 10.1016/j.cmet.2009.01.004; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lu Y, 2004, MOL GENET GENOMICS, V272, P129, DOI 10.1007/s00438-004-1043-3; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Mensah GA, 2004, CARDIOL CLIN, V22, P485, DOI 10.1016/j.ccl.2004.06.005; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Mirza R, 2006, J INVEST DERMATOL, V126, P638, DOI 10.1038/sj.jid.5700111; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Miyazaki M, 2003, J BIOL CHEM, V278, P33904, DOI 10.1074/jbc.M304724200; Miyazaki M, 2001, J BIOL CHEM, V276, P39455, DOI 10.1074/jbc.M106442200; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Miyazaki M, 2001, J LIPID RES, V42, P1018; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; PAYNE AP, 1994, J ANAT, V185, P1; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rahman SM, 2005, AM J PHYSIOL-ENDOC M, V288, pE381, DOI 10.1152/ajpendo.00314.2004; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shih MYS, 2009, J BIOL CHEM, V284, P4292, DOI 10.1074/jbc.M807503200; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Son C, 2004, DIABETOLOGIA, V47, P47, DOI 10.1007/s00125-003-1272-8; Strom K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001793; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wondisford FE, 2006, CELL METAB, V3, P81, DOI 10.1016/j.cmet.2006.01.008; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xie ZJ, 2002, J INVEST DERMATOL, V118, P11, DOI 10.1046/j.1523-1747.2002.01644.x; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Zheng Y, 2001, GENOMICS, V71, P182, DOI 10.1006/geno.2000.6429	81	111	115	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19961	19973		10.1074/jbc.M109.014225	http://dx.doi.org/10.1074/jbc.M109.014225			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19429677	Green Published, hybrid			2022-12-27	WOS:000268097400023
J	Sun, L; Haun, S; Jones, RC; Edmondson, RD; Machaca, K				Sun, Lu; Haun, Shirley; Jones, Richard C.; Edmondson, Ricky D.; Machaca, Khaled			Kinase-dependent Regulation of Inositol 1,4,5-Trisphosphate-dependent Ca2+ Release during Oocyte Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING DIFFERENTIATION; CALCIUM-RELEASE; PROTEIN-KINASE; XENOPUS-LAEVIS; ENDOPLASMIC-RETICULUM; STATISTICAL-MODEL; EGG ACTIVATION; CELL-CYCLE; RECEPTOR; PHOSPHORYLATION	Fertilization induces a species-specific Ca2+ transient with specialized spatial and temporal dynamics, which are essential to temporally encode egg activation events such as the block to polyspermy and resumption of meiosis. Eggs acquire the competence to produce the fertilization-specific Ca2+ transient during oocyte maturation, which encompasses dramatic potentiation of inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ release. Here we show that increased IP3 receptor (IP3R) sensitivity is initiated at the germinal vesicle breakdown stage of maturation, which correlates with maturation promoting factor (MPF) activation. Extensive phosphopeptide mapping of the IP3R resulted in similar to 70% coverage and identified three residues, Thr-931, Thr-1136, and Ser-114, which are specifically phosphorylated during maturation. Phospho-specific antibody analyses show that Thr-1136 phosphorylation requires MPF activation. Activation of either MPF or the mitogen-activated protein kinase cascade independently, functionally sensitizes IP3-dependent Ca2+ release. Collectively, these data argue that the kinase cascades driving meiotic maturation potentiates IP3-dependent Ca2+ release, possibly trough direct phosphorylation of the IP3R.	[Sun, Lu; Haun, Shirley; Machaca, Khaled] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Jones, Richard C.; Edmondson, Ricky D.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Machaca, Khaled] Qatar Fdn, Weill Cornell Med Coll, Doha, Qatar	University of Arkansas System; University of Arkansas Medical Sciences; US Food & Drug Administration (FDA); Qatar Foundation (QF); Weill Cornell Medical College Qatar	Machaca, K (corresponding author), POB 24144, Doha, Qatar.	khm2002@qatar-med.cornell.edu	Machaca, Khaled/AAF-3579-2019	Machaca, Khaled/0000-0001-6215-2411	National Institutes of Health, NIGMS [GM61829]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061829] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61829 from NIGMS.	Ben-Yehoshua LJ, 2007, MOL ENDOCRINOL, V21, P664, DOI 10.1210/me.2006-0256; CHARBONNEAU M, 1984, DEV BIOL, V102, P90, DOI 10.1016/0012-1606(84)90177-5; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200; El-Jouni W, 2005, DEV BIOL, V288, P514, DOI 10.1016/j.ydbio.2005.10.034; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; FUJIWARA T, 1993, DEV BIOL, V156, P69, DOI 10.1006/dbio.1993.1059; Jellerette T, 2004, DEV BIOL, V274, P94, DOI 10.1016/j.ydbio.2004.06.020; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LARABELL C, 1992, DEV BIOL, V153, P347, DOI 10.1016/0012-1606(92)90119-2; Lee B, 2006, DEVELOPMENT, V133, P4355, DOI 10.1242/dev.02624; Li XG, 2005, J IMMUNOL, V175, P6205, DOI 10.4049/jimmunol.175.9.6205; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Machaca K, 2004, DEV BIOL, V275, P170, DOI 10.1016/j.ydbio.2004.08.004; Machaca K, 2000, J BIOL CHEM, V275, P38710, DOI 10.1074/jbc.M007887200; Machaca K., 2001, CALCIUM ACTIVATES CH, P3; Machaca K, 2007, J CELL PHYSIOL, V213, P331, DOI 10.1002/jcp.21194; Malathi K, 2003, J CELL BIOCHEM, V90, P1186, DOI 10.1002/jcb.10720; MALLER JL, 1979, J BIOL CHEM, V254, P579; MEHLMANN LM, 1994, BIOL REPROD, V51, P1088, DOI 10.1095/biolreprod51.6.1088; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NUCCITELLI R, 1993, DEV BIOL, V158, P200, DOI 10.1006/dbio.1993.1179; Ozil JP, 2005, DEV BIOL, V282, P39, DOI 10.1016/j.ydbio.2005.02.035; PARYS JB, 1994, DEV BIOL, V161, P466, DOI 10.1006/dbio.1994.1045; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Perdiguero E, 2004, CELL CYCLE, V3, P733; Santella L, 2003, BIOCHEM SOC T, V31, P79, DOI 10.1042/bst0310079; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Sun L, 2004, J CELL BIOL, V165, P63, DOI 10.1083/jcb.200309138; Terasaki M, 2001, MOL BIOL CELL, V12, P1103, DOI 10.1091/mbc.12.4.1103; Ullah G, 2007, CELL CALCIUM, V42, P556, DOI 10.1016/j.ceca.2007.01.010; Villmann C, 1997, J NEUROSCI, V17, P7634, DOI 10.1523/jneurosci.17-20-07634.1997; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200	42	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20184	20196		10.1074/jbc.M109.004515	http://dx.doi.org/10.1074/jbc.M109.004515			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19473987	Green Published, hybrid			2022-12-27	WOS:000268097400046
J	Wilson, MC; Meredith, D; Bunnun, C; Sessions, RB; Halestrap, AP				Wilson, Marieangela C.; Meredith, David; Bunnun, Chotirote; Sessions, Richard B.; Halestrap, Andrew P.			Studies on the DIDS-binding Site of Monocarboxylate Transporter 1 Suggest a Homology Model of the Open Conformation and a Plausible Translocation Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE LACTATE TRANSPORTER; XENOPUS-LAEVIS OOCYTES; LACTOSE PERMEASE; IMMUNOGLOBULIN SUPERFAMILY; ANCILLARY PROTEIN; PLASMA-MEMBRANES; BASIGIN CD147; MCT1; INHIBITION; EXPRESSION	Site-directed mutagenesis of MCT1 was performed on exofacial lysines Lys(38), Lys(45), Lys(282), and Lys(413). K38Q-MCT1 and K38R-MCT1 were inactive when expressed at the plasma membrane of Xenopus laevis oocytes, whereas K45R/K282R/K413R-MCT1 and K45Q/K282Q/K413Q-MCT1 were active. The former exhibited normal reversible and irreversible inhibition by DIDS, whereas the latter showed less reversible and no irreversible inhibition. K45Q/K413Q-MCT1 retained some irreversible inhibition, whereas K45Q/K282Q-MCT1 and K282Q/K413Q-MCT1 did not. These data suggest that the twoDIDSSO(3)(-) groups interact with positively charged Lys(282) together with Lys(45) and/or Lys(413). This positions one DIDS isothiocyanate group close to Lys(38), leading to its covalent modification and irreversible inhibition. Additional mutagenesis revealed that DIDS cross-links MCT1 to its ancillary protein embigin using either Lys(38) or Lys(290) of MCT1 and Lys(160) or Lys(164) of embigin. We have modeled a possible structure for the outward facing (open) conformation of MCT1 by employing modest rotations of the C-terminal domain of the inner facing conformation modeled previously. The resulting model structure has a DIDS-binding site consistent with experimental data and locates Lys(38) in a hydrophobic environment at the bottom of a substrate-binding channel. Our model suggests a translocation cycle in which Lys(38) accepts a proton before binding lactate. Both the lactate and proton are then passed through the channel via Asp(302-) and Asp(306-), an ion pair already identified as important for transport and located adjacent to Phe(360), which controls channel selectivity. The cross-linking data have also been used to model a structure of MCT1 bound to embigin that is consistent with published data.	[Wilson, Marieangela C.; Meredith, David; Bunnun, Chotirote; Sessions, Richard B.; Halestrap, Andrew P.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Halestrap, AP (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	a.halestrap@bristol.ac.uk	Halestrap, Andrew P/G-7275-2011; Meredith, David/F-3664-2010	Sessions, Richard/0000-0003-0320-0895; Halestrap, Andrew/0000-0001-5374-2778; Wilson, Marieangela/0000-0001-6218-3533	Wellcome Trust [079792/z/06]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Project Grant 079792/z/06 from the Wellcome Trust.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; CARPENTER L, 1994, BIOCHEM J, V304, P751, DOI 10.1042/bj3040751; DEUTICKE B, 1982, J MEMBRANE BIOL, V70, P89, DOI 10.1007/BF01870219; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Galic S, 2003, BIOCHEM J, V376, P413, DOI 10.1042/BJ20030799; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; Grollman EF, 2000, BIOCHEMISTRY-US, V39, P9351, DOI 10.1021/bi000464+; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guenette RS, 1997, DEV GENET, V21, P268, DOI 10.1002/(SICI)1520-6408(1997)21:4<268::AID-DVG4>3.0.CO;2-5; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Kim DK, 2001, J BIOL CHEM, V276, P17221, DOI 10.1074/jbc.M009462200; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Manoharan C, 2006, MOL MEMBR BIOL, V23, P486, DOI 10.1080/09687860600841967; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; POOLE RC, 1990, BIOCHEM SOC T, V18, P1245, DOI 10.1042/bst0181245; POOLE RC, 1991, BIOCHEM J, V275, P307, DOI 10.1042/bj2750307; POOLE RC, 1992, BIOCHEM J, V283, P855, DOI 10.1042/bj2830855; POOLE RC, 1988, BIOCHEM J, V254, P385, DOI 10.1042/bj2540385; POOLE RC, 1991, BIOCHIM BIOPHYS ACTA, V1070, P69, DOI 10.1016/0005-2736(91)90147-Z; Poole RC, 1996, BIOCHEM J, V320, P817, DOI 10.1042/bj3200817; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; Poole RC, 1997, J BIOL CHEM, V272, P14624, DOI 10.1074/jbc.272.23.14624; Rahman B, 1999, BIOCHEMISTRY-US, V38, P11577, DOI 10.1021/bi990973f; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Wilson MC, 2002, J BIOL CHEM, V277, P3666, DOI 10.1074/jbc.M109658200; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105	33	68	73	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20011	20021		10.1074/jbc.M109.014217	http://dx.doi.org/10.1074/jbc.M109.014217			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19473976	Green Published, hybrid			2022-12-27	WOS:000268097400028
J	Danos, AM; Osmanovic, S; Brady, MJ				Danos, Arpad M.; Osmanovic, Senad; Brady, Matthew J.			Differential Regulation of Glycogenolysis by Mutant Protein Phosphatase-1 Glycogen-targeting Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DIABETIC-RATS; AMINO-ACID-SEQUENCE; 3T3-L1 ADIPOCYTES; BINDING-PROTEIN; STARVED RATS; PHOSPHORYLASE; INSULIN; LIVER; HEPATOCYTES; METABOLISM	PTG and G(L) are hepatic protein phosphatase-1 (PP1) glycogen-targeting subunits, which direct PP1 activity against glycogen synthase (GS) and/or phosphorylase (GP). The C-terminal 16 amino residues of G(L) comprise a high affinity binding site for GP that regulates bound PP1 activity against GS. In this study, a truncated G(L) construct lacking the GP-binding site (G(L)tr) and a chimeric PTG molecule containing the C-terminal site (PTG-G(L)) were generated. As expected, GP binding to glutathione S-transferase (GST)-G(L)tr was reduced, whereas GP binding to GST-PTG-G(L) was increased 2- to 3-fold versus GST-PTG. In contrast, PP1 binding to all proteins was equivalent. Primary mouse hepatocytes were infected with adenoviral constructs for each subunit, and their effects on glycogen metabolism were investigated. G(L)tr expression was more effective at promoting GP inactivation, GS activation, and glycogen accumulation than G(L). Removal of the regulatory GP-binding site from G(L)tr completely blocked the inactivation of GS seen in G(L)-expressing cells following a drop in extracellular glucose. As a result, G(L)tr expression prevented glycogen mobilization under 5 mM glucose conditions. In contrast, equivalent overexpression of PTG or PTG-G(L) caused a similar increase in glycogen-targeted PP1 levels and GS dephosphorylation. Surprisingly, GP dephosphorylation was significantly reduced in PTG-G(L)-overexpressing cells. As a result, PTG-G(L) expression permitted glycogenolysis under 5 mM glucose conditions that was prevented in PTG-expressing cells. Thus, expression of constructs that contained the high affinity GP-binding site (G(L) and PTG-G(L)) displayed reduced glycogen accumulation and enhanced glycogenolysis compared with their respective controls, albeit via different mechanisms.	Univ Chicago, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA; Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Brady, MJ (corresponding author), MC1027,5841 S Maryland Ave, Chicago, IL 60637 USA.	mbrady@medicine.bsd.uchicago.edu			National Institutes of Health Grant [R01 DK064772]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064772] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK064772. This work was also supported by a Career Development Award from the American Diabetes Association.	Aiston S, 2004, BIOCHEM J, V377, P195, DOI 10.1042/BJ20031191; Aiston S, 2003, EUR J BIOCHEM, V270, P2773, DOI 10.1046/j.1432-1033.2003.03648.x; ALEMANY S, 1986, FEBS LETT, V198, P194, DOI 10.1016/0014-5793(86)80404-5; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Armstrong CG, 1998, BIOCHEM J, V336, P699, DOI 10.1042/bj3360699; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Brady MJ, 1997, J BIOL CHEM, V272, P20198, DOI 10.1074/jbc.272.32.20198; Browne GJ, 2001, BIOCHEM J, V360, P449, DOI 10.1042/0264-6021:3600449; Ceulemans H, 2002, BIOESSAYS, V24, P371, DOI 10.1002/bies.10069; COATS WS, 1991, J BIOL CHEM, V266, P16113; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; Doherty MJ, 1998, BIOCHEM J, V333, P253, DOI 10.1042/bj3330253; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Doherty MJ, 1996, FEBS LETT, V399, P339, DOI 10.1016/S0014-5793(96)01357-9; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; Green AR, 2004, J BIOL CHEM, V279, P46474, DOI 10.1074/jbc.M405660200; Greenberg CC, 2006, MOL CELL BIOL, V26, P334, DOI 10.1128/MCB.26.1.334-342.2006; Greenberg CC, 2003, J BIOL CHEM, V278, P30835, DOI 10.1074/jbc.M303846200; HERS HG, 1976, ANNU REV BIOCHEM, V45, P167, DOI 10.1146/annurev.bi.45.070176.001123; Kelsall IR, 2007, FEBS LETT, V581, P4749, DOI 10.1016/j.febslet.2007.08.073; Kelsall IR, 2009, CELL SIGNAL, V21, P1123, DOI 10.1016/j.cellsig.2009.03.001; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; MOORHEAD G, 1995, FEBS LETT, V362, P101, DOI 10.1016/0014-5793(95)00197-H; Munro S, 2005, FEBS J, V272, P1478, DOI 10.1111/j.1742-4658.2005.04585.x; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; Pautsch A, 2008, J BIOL CHEM, V283, P8913, DOI 10.1074/jbc.M706612200; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; PRINTEN JA, 1994, GENETICS, V138, P609; Ros S, 2009, J BIOL CHEM, V284, P6370, DOI 10.1074/jbc.M808576200; STALMANS W, 1971, EUR J BIOCHEM, V18, P582, DOI 10.1111/j.1432-1033.1971.tb01279.x; TANG PM, 1991, J BIOL CHEM, V266, P15782; Yang RJ, 2003, J BIOL CHEM, V278, P23418, DOI 10.1074/jbc.M213112200; Yang RJ, 2002, J BIOL CHEM, V277, P1514, DOI 10.1074/jbc.M107001200; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050; Zibrova D, 2008, BIOCHEM J, V412, P359, DOI 10.1042/BJ20071483	37	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19544	19553		10.1074/jbc.M109.015073	http://dx.doi.org/10.1074/jbc.M109.015073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19487702	Green Published, hybrid			2022-12-27	WOS:000267908300046
J	Noel, G; Tham, DKL; Moukhles, H				Noel, Geoffroy; Tham, Daniel Kai Long; Moukhles, Hakima			Interdependence of Laminin-mediated Clustering of Lipid Rafts and the Dystrophin Complex in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; NEUROMUSCULAR-JUNCTION; WATER CHANNEL; CULTURED ASTROCYTES; NULL MICE; MDX-MICE; DYSTROGLYCAN; AQUAPORIN-4; MEMBRANE; AGRIN	Astrocyte endfeet surrounding blood vessels are active domains involved in water and potassium ion transport crucial to the maintenance of water and potassium ion homeostasis in brain. A growing body of evidence points to a role for dystroglycan and its interaction with perivascular laminin in the targeting of the dystrophin complex and the water-permeable channel, aquaporin 4 (AQP4), at astrocyte endfeet. However, the mechanisms underlying such compartmentalization remain poorly understood. In the present study we found that AQP4 resided in Triton X-100-insoluble fraction, whereas dystroglycan was recovered in the soluble fraction in astrocytes. Cholesterol depletion resulted in the translocation of a pool of AQP4 to the soluble fraction indicating that its distribution is indeed associated with cholesterol-rich membrane domains. Upon laminin treatment AQP4 and the dystrophin complex, including dystroglycan, reorganized into laminin-associated clusters enriched for the lipid raft markers GM1 and flotillin-1 but not caveolin-1. Reduced diffusion rates of GM1 in the laminin-induced clusters were indicative of the reorganization of raft components in these domains. In addition, both cholesterol depletion and dystroglycan silencing reduced the number and area of laminin-induced clusters of GM1, AQP4, and dystroglycan. These findings demonstrate the interdependence between laminin binding to dystroglycan and GM1-containing lipid raft reorganization and provide novel insight into the dystrophin complex regulation of AQP4 polarization in astrocytes.	[Moukhles, Hakima] Univ British Columbia, Dept Cellular & Physiol Sci, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Moukhles, H (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	moukhles@interchange.ubc.ca		Noel, Geoffroy/0000-0003-2192-7756	Canadian Institutes of Health Research; University Graduate Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University Graduate Fellowship	This work was supported by grants from the Canadian Institutes of Health Research, Muscular Dystrophy Canada, and Amyotrophic Lateral Sclerosis Society of Canada (to H.M.) and by a University Graduate Fellowship (to G.N.).	Amiry-Moghaddam M, 2004, FASEB J, V18, P542, DOI 10.1096/fj.03-0869fje; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Arikawa-Hirasawa E, 2002, NAT NEUROSCI, V5, P119, DOI 10.1038/nn801; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; BARRANTES FJ, 1993, BRAZ J MED BIOL RES, V26, P553; Benfenati V, 2007, J NEUROCHEM, V100, P87, DOI 10.1111/j.1471-4159.2006.04164.x; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Campagna JA, 2006, NEUROSCIENCE, V138, P123, DOI 10.1016/j.neuroscience.2005.11.019; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Frigeri A, 2001, FASEB J, V15, P90, DOI 10.1096/fj.00-0260com; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Hering H, 2003, J NEUROSCI, V23, P3262; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; Huk KH, 2002, MOL NEUROBIOL, V25, P79; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; Ishikawa Y, 2006, BBA-BIOMEMBRANES, V1758, P1053, DOI 10.1016/j.bbamem.2006.03.026; Kenworthy Anne K., 2007, V398, P179, DOI 10.1007/978-1-59745-513-8_13; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Marangi PA, 2002, J CELL BIOL, V157, P883, DOI 10.1083/jcb.200202110; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moukhles H, 2001, J NEUROCHEM, V78, P824, DOI 10.1046/j.1471-4159.2001.00466.x; Nicchia GP, 2003, FASEB J, V17, P1508, DOI 10.1096/fj.02-1183fje; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; Nishimune H, 2008, J CELL BIOL, V182, P1201, DOI 10.1083/jcb.200805095; Noel G, 2005, J NEUROCHEM, V94, P691, DOI 10.1111/j.1471-4159.2005.03191.x; Noell S, 2007, EUR J NEUROSCI, V26, P2109, DOI 10.1111/j.1460-9568.2007.05850.x; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Ramseger R, 2009, J BIOL CHEM, V284, P7697, DOI 10.1074/jbc.M806719200; Rash JE, 2004, NEUROSCIENCE, V129, P915, DOI 10.1016/j.neuroscience.2004.06.076; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; Rurak J, 2007, J NEUROCHEM, V103, P1940, DOI 10.1111/j.1471-4159.2007.04886.x; Sasaki H, 1996, CELL STRUCT FUNCT, V21, P133, DOI 10.1247/csf.21.133; Shah WA, 2006, J GEN VIROL, V87, P673, DOI 10.1099/vir.0.81444-0; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Stetzkowski-Marden F, 2006, J MOL NEUROSCI, V30, P37, DOI 10.1385/JMN:30:1:37; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; Susuki K, 2007, GLIA, V55, P746, DOI 10.1002/glia.20503; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Zaccaria ML, 2001, NEUROSCIENCE, V104, P311, DOI 10.1016/S0306-4522(01)00092-6	48	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19694	19704		10.1074/jbc.M109.010090	http://dx.doi.org/10.1074/jbc.M109.010090			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19451651	hybrid, Green Published			2022-12-27	WOS:000267908300060
J	Yeung, ML; Houzet, L; Yedavalli, VSRK; Jeang, KT				Yeung, Man Lung; Houzet, Laurent; Yedavalli, Venkat S. R. K.; Jeang, Kuan-Teh			A Genome-wide Short Hairpin RNA Screening of Jurkat T-cells for Human Proteins Contributing to Productive HIV-1 Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTION; GENE; ACTIVATION; ESCAPE; PPAR	Short interfering RNAs (siRNAs) have been used to inhibit HIV-1 replication. The durable inhibition of HIV-1 replication by RNA interference has been impeded, however, by a high mutation rate when viral sequences are targeted and by cytotoxicity when cellular genes are knocked down. To identify cellular proteins that contribute to HIV-1 replication that can be chronically silenced without significant cytotoxicity, we employed a shRNA library that targets 54,509 human transcripts. We used this library to select a comprehensive population of Jurkat T-cell clones, each expressing a single discrete shRNA. The Jurkat clones were then infected with HIV-1. Clones that survived viral infection represent moieties silenced for a human mRNA needed for virus replication, but whose chronic knockdown did not cause cytotoxicity. Overall, 252 individual Jurkat mRNAs were identified. Twenty-two of these mRNAs were secondarily verified for their contributions to HIV-1 replication. Five mRNAs, NRF1, STXBP2, NCOA3, PRDM2, and EXOSC5, were studied for their effect on steps of the HIV-1 life cycle. We discuss the similarities and differences between our shRNA findings for HIV-1 using a spreading infection assay in human Jurkat T-cells and results from other investigators who used siRNA-based screenings in HeLa or 293T cells.	[Yeung, Man Lung; Houzet, Laurent; Yedavalli, Venkat S. R. K.; Jeang, Kuan-Teh] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jeang, KT (corresponding author), Bldg 4,Rm 306,9000 Rockville Pike, Bethesda, MD 20892 USA.	kj7e@nih.gov	Jeang, Kuan-Teh/A-2424-2008; Yeung, Man Lung/E-9903-2010	Yeung, Man Lung/0000-0002-6117-7884	NIAID; Office of the Director, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547, Z01AI000547] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of the Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health intramural research funds from NIAID. This work was also supported by the IATAP program from the Office of the Director, NIH.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Arimura A, 2004, J BIOL CHEM, V279, P31105, DOI 10.1074/jbc.M404428200; Bennasser Y, 2007, BIODRUGS, V21, P17, DOI 10.2165/00063030-200721010-00003; Berkhout B, 2007, J BIOL CHEM, V282, P26641, DOI 10.1074/jbc.R700023200; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brouwer R, 2001, J BIOL CHEM, V276, P6177, DOI 10.1074/jbc.M007603200; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Green S, 1995, MUTAT RES-FUND MOL M, V333, P101, DOI 10.1016/0027-5107(95)00136-0; Huang W, 2008, J NEUROCHEM, V107, P497, DOI 10.1111/j.1471-4159.2008.05626.x; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kumar A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-26; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Luciano-Montalvo C, 2008, PLACENTA, V29, P1016, DOI 10.1016/j.placenta.2008.09.005; Mahalingam S, 1995, VIROLOGY, V214, P647, DOI 10.1006/viro.1995.0079; Michienzi A, 2003, ANN NY ACAD SCI, V1002, P63, DOI 10.1196/annals.1281.008; Moriuchi M, 1999, AIDS RES HUM RETROV, V15, P821, DOI 10.1089/088922299310728; Munier S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-73; Naito Y, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-80; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Riento K, 2000, J BIOL CHEM, V275, P13476, DOI 10.1074/jbc.275.18.13476; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Stavru F, 2006, J CELL BIOL, V173, P477, DOI 10.1083/jcb.200601002; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	35	194	196	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19463	19473		10.1074/jbc.M109.010033	http://dx.doi.org/10.1074/jbc.M109.010033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19460752	Green Published, hybrid			2022-12-27	WOS:000267908300038
J	Mathew, S; Fu, LZ; Fiorentino, M; Matsuda, H; Das, B; Shi, YB				Mathew, Smita; Fu, Liezhen; Fiorentino, Maria; Matsuda, Hiroki; Das, Biswajit; Shi, Yun-Bo			Differential Regulation of Cell Type-specific Apoptosis by Stromelysin-3 A POTENTIAL MECHANISM VIA THE CLEAVAGE OF THE LAMININ RECEPTOR DURING TAIL RESORPTION IN XENOPUS LAEVIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE STROMELYSIN-3; HORMONE RESPONSE GENES; THYROID-HORMONE; MOUSE STROMELYSIN-3; EXPRESSION PATTERN; BREAST-CANCER; GELATINASE-A; TADPOLE TAIL; METAMORPHOSIS; GROWTH	Matrix metalloproteinases (MMPs) have been extensively studied because of their functional attributes in development and diseases. However, relatively few in vivo functional studies have been reported on the roles of MMPs in postembryonic organ development. Amphibian metamorphosis is a unique model for studying MMP function during vertebrate development because of its dependence on thyroid hormone (T3) and the ability to easily manipulate this process with exogenous T3. The MMP stromelysin-3 (ST3) is induced by T3, and its expression correlates with cell death during metamorphosis. We have previously shown that ST3 is both necessary and sufficient for larval epithelial cell death in the remodeling intestine. To investigate the roles of ST3 in other organs and especially on different cell types, we have analyzed the effect of transgenic overexpression of ST3 in the tail of premetamorphic tadpoles. We report for the first time that ST3 expression, in the absence of T3, caused significant muscle cell death in the tail of premetamorphic transgenic tadpoles. On the other hand, only relatively low levels of epidermal cell death were induced by precocious ST3 expression in the tail, contrasting what takes place during natural and T3-induced metamorphosis when ST3 expression is high. This cell type-specific apoptotic response to ST3 in the tail suggests distinct mechanisms regulating cell death in different tissues. Furthermore, our analyses of laminin receptor, an in vivo substrate of ST3 in the intestine, suggest that laminin receptor cleavage may be an underlying mechanism for the cell type-specific effects of ST3.	[Mathew, Smita; Fu, Liezhen; Fiorentino, Maria; Matsuda, Hiroki; Das, Biswajit; Shi, Yun-Bo] NICHD, Sect Mol Morphogenesis, LGRD, PCRM,NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fu, LZ (corresponding author), NICHD, Sect Mol Morphogenesis, LGRD, PCRM,NIH, Bldg 18T,Rm 106, Rockville, MD 20852 USA.	fuliez@helix.nih.gov; shi@helix.nih.gov	Matsuda, Hiroki/K-5055-2019; Fiorentino, Maria/AAV-9514-2020	Shi, Yun-Bo/0000-0002-6330-0639; Fiorentino, Maria R/0000-0001-5318-7313	National Institutes of Health NICHD Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008859, ZIAHD008859] Funding Source: NIH RePORTER	National Institutes of Health NICHD Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health NICHD Intramural Research Program.	Ahmad A, 1998, AM J PATHOL, V152, P721; Alexander CM, 1991, CELL BIOL EXTRACELLU, P255; Amano T, 2005, DEV DYNAM, V234, P190, DOI 10.1002/dvdy.20511; Amano T, 2005, CELL RES, V15, P150, DOI 10.1038/sj.cr.7290280; ANDERSON IC, 1995, CANCER RES, V55, P4120; Basset P, 1997, CRIT REV ONCOL HEMAT, V26, P43, DOI 10.1016/S1040-8428(97)00010-3; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Berry DL, 1998, DEV BIOL, V203, P12, DOI 10.1006/dbio.1998.8974; Berry DL, 1998, DEV BIOL, V203, P24, DOI 10.1006/dbio.1998.8975; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; CASTRONOVO V, 1991, J BIOL CHEM, V266, P20440; Chenard MP, 1996, INT J CANCER, V69, P448, DOI 10.1002/(SICI)1097-0215(19961220)69:6<448::AID-IJC5>3.3.CO;2-4; Chin JR, 1997, DEVELOPMENT, V124, P1519; Damjanovski S, 1999, CELL RES, V9, P91, DOI 10.1038/sj.cr.7290009; Das B, 2002, P NATL ACAD SCI USA, V99, P12230, DOI 10.1073/pnas.182430599; Fingleton BM, 1999, APMIS, V107, P102, DOI 10.1111/j.1699-0463.1999.tb01532.x; Fiorentino M, 2009, INT J MOL MED, V23, P389, DOI 10.3892/ijmm_00000143; FOX H, 1972, Archives de Biologie, V83, P395; Fu LZ, 2006, J BIOL CHEM, V281, P16870, DOI 10.1074/jbc.M603041200; Fu LZ, 2005, J BIOL CHEM, V280, P27856, DOI 10.1074/jbc.M413275200; Fu LZ, 2002, MOL REPROD DEV, V62, P470, DOI 10.1002/mrd.10137; Fujimoto K, 2006, DEV GROWTH DIFFER, V48, P223, DOI 10.1111/j.1440-169x.2006.00859.x; Fujimoto K, 2007, DEV GROWTH DIFFER, V49, P131, DOI 10.1111/j.1440-169x.2007.00916.x; Gilbert L.I., 1996, METAMORPHOSIS POSTEM; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; IshizuyaOka A, 1996, CELL TISSUE RES, V283, P325, DOI 10.1007/s004410050542; KERR JFR, 1974, J CELL SCI, V14, P571; KIKUYAMA S, 1993, INT REV CYTOL, V145, P105, DOI 10.1016/S0074-7696(08)60426-X; Lee MH, 2004, J CELL SCI, V117, P4015, DOI 10.1242/jcs.01223; LEFEBVRE O, 1992, J CELL BIOL, V119, P997, DOI 10.1083/jcb.119.4.997; LEFEBVRE O, 1995, DEVELOPMENT, V121, P947; Lochter A, 1999, APMIS, V107, P128, DOI 10.1111/j.1699-0463.1999.tb01535.x; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; Manes S, 1997, J BIOL CHEM, V272, P25706, DOI 10.1074/jbc.272.41.25706; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Masson R, 1998, J CELL BIOL, V140, P1535, DOI 10.1083/jcb.140.6.1535; Matsuda H, 2001, DEV BIOL, V229, P351, DOI 10.1006/dbio.2000.9973; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; MURPHY G, 1993, J BIOL CHEM, V268, P15435; Nagase H, 1998, Cell Res, V8, P179; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Parks WC, 1998, BIOL EXTRAC, P263; PATTERTON D, 1995, DEV BIOL, V167, P252, DOI 10.1006/dbio.1995.1021; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; PEI DQ, 1994, J BIOL CHEM, V269, P25849; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 2001, PROG NUCLEIC ACID RE, V65, P53; SHI YB, 1993, J BIOL CHEM, V268, P20312; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; Starkey JR, 1999, CYTOMETRY, V35, P37, DOI 10.1002/(SICI)1097-0320(19990101)35:1<37::AID-CYTO6>3.0.CO;2-C; Stolow MA, 1996, MOL BIOL CELL, V7, P1471, DOI 10.1091/mbc.7.10.1471; Tetu B, 1998, HUM PATHOL, V29, P979, DOI 10.1016/S0046-8177(98)90204-0; Uria J A, 1998, Cell Res, V8, P187; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; WANG Z, 1993, J BIOL CHEM, V268, P16270; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; YOSHIZATO K, 1989, INT REV CYTOL, V119, P97	65	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18545	18556		10.1074/jbc.M109.017723	http://dx.doi.org/10.1074/jbc.M109.017723			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19429683	Green Published, hybrid			2022-12-27	WOS:000267712400065
J	Kochaniak, AB; Habuchi, S; Loparo, JJ; Chang, DJ; Cimprich, KA; Walter, JC; van Oijen, AM				Kochaniak, Anna B.; Habuchi, Satoshi; Loparo, Joseph J.; Chang, Debbie J.; Cimprich, Karlene A.; Walter, Johannes C.; van Oijen, Antoine M.			Proliferating Cell Nuclear Antigen Uses Two Distinct Modes to Move along DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FACTOR-C; DOUBLE-STRANDED DNA; ONE-DIMENSIONAL DIFFUSION; PROCESSIVITY FACTOR; POLYMERASE-DELTA; RNA-POLYMERASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATP UTILIZATION; PROTEINS	Proliferating cell nuclear antigen (PCNA) plays an important role in eukaryotic genomic maintenance by topologically binding DNA and recruiting replication and repair proteins. The ring-shaped protein forms a closed circle around double-stranded DNA and is able to move along the DNA in a random walk. The molecular nature of this diffusion process is poorly understood. We use single-molecule imaging to visualize the movement of individual, fluorescently labeled PCNA molecules along stretched DNA. Measurements of diffusional properties as a function of viscosity and protein size suggest that PCNA moves along DNA using two different sliding modes. Most of the time, the clamp moves while rotationally tracking the helical pitch of the DNA duplex. In a less frequently used second mode of diffusion, the movement of the protein is uncoupled from the helical pitch, and the clamp diffuses at much higher rates.	Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Kochaniak, Anna B.; Loparo, Joseph J.; Walter, Johannes C.; van Oijen, Antoine M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Habuchi, Satoshi] Tokyo Inst Technol, Grad Sch Sci & Engn, Tokyo 1528552, Japan; [Chang, Debbie J.; Cimprich, Karlene A.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Harvard University; Harvard University; Harvard Medical School; Tokyo Institute of Technology; Stanford University	van Oijen, AM (corresponding author), 250 Longwood Ave,SGM Bldg,Rm 204A, Boston, MA 02115 USA.	antoine_van_oijen@hms.harvard.edu	van Oijen, Antoine/I-3167-2014; Habuchi, Satoshi/N-6037-2018	van Oijen, Antoine/0000-0002-1794-5161; Habuchi, Satoshi/0000-0002-6663-2807; Walter, Johannes/0000-0002-4186-7570; Loveland, Anna B./0000-0001-9172-7747	National Institutes of Health [ES016486, GM62267]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267, R01GM077248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES016486 (to K.A.C.) and GM62267 ( to J.C.W.).	Bagchi B, 2008, J PHYS CHEM B, V112, P6282, DOI 10.1021/jp077568f; BERG HC, 1993, RANDOM WALKS BIOL, P9; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Cai JS, 1996, P NATL ACAD SCI USA, V93, P12896, DOI 10.1073/pnas.93.23.12896; Chang DJ, 2006, J BIOL CHEM, V281, P32081, DOI 10.1074/jbc.M606799200; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; Ivanov I, 2006, NUCLEIC ACIDS RES, V34, P6023, DOI 10.1093/nar/gkl744; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kim JH, 2007, NUCLEIC ACIDS RES, V35, P3848, DOI 10.1093/nar/gkm332; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Laurence TA, 2008, J BIOL CHEM, V283, P22895, DOI 10.1074/jbc.M800174200; Lavalette D, 1999, BIOPHYS J, V76, P2744, DOI 10.1016/S0006-3495(99)77427-8; Lavalette D, 2006, EUR BIOPHYS J BIOPHY, V35, P517, DOI 10.1007/s00249-006-0060-z; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; MEI LH, 1995, J CHEM ENG DATA, V40, P1168, DOI 10.1021/je00022a002; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; NG L, 1993, J BIOL CHEM, V268, P13571; PODUST LM, 1995, MOL CELL BIOL, V15, P3072; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P5003, DOI 10.1021/bi00015a011; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Randell JCW, 2004, J MOL BIOL, V335, P409, DOI 10.1016/j.jmb.2003.10.064; SCHURR JM, 1979, BIOPHYS CHEM, V9, P413, DOI 10.1016/0301-4622(75)80057-3; Schurtenberger P, 1998, J MOL BIOL, V275, P123, DOI 10.1006/jmbi.1997.1435; Sheely ML, 1932, IND ENG CHEM, V24, P1060, DOI 10.1021/ie50273a022; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; TINKER RL, 1994, EMBO J, V13, P5330, DOI 10.1002/j.1460-2075.1994.tb06867.x; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	49	96	96	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17700	17710		10.1074/jbc.M109.008706	http://dx.doi.org/10.1074/jbc.M109.008706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19411704	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000267202500036
J	Larder, R; Mellon, PL				Larder, Rachel; Mellon, Pamela L.			Otx2 Induction of the Gonadotropin-releasing Hormone Promoter Is Modulated by Direct Interactions with Grg Co-repressors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUCHO-RELATED GENE; NEURON-SPECIFIC ENHANCER; HOMEODOMAIN PROTEIN; GNRH RECEPTOR; ANTERIOR NEUROECTODERM; TRANSCRIPTION FACTORS; REGULATES EXPRESSION; DROSOPHILA-ENHANCER; TRANSGENIC MICE; NERVOUS-SYSTEM	Hormonal communication between the hypothalamus, pituitary, and gonads orchestrates the development and regulation of mammalian reproductive function. In mice, gonadotropin-releasing hormone (GnRH) expression is limited to similar to 1000 neurons that originate in the olfactory placode then migrate to specific positions scattered throughout the hypothalamus. Coordination of the hypothalamic-pituitary-gonadal axis is dependent upon correct migration of GnRH neurons into the hypothalamus followed by the appropriate synthesis and pulsatile secretion of GnRH. Defects in any one of these processes can cause infertility. Recently, substantial progress has been made in identifying transcription factors, and their cofactors, that regulate not only adult expression of GnRH, but also the maturation of GnRH neurons. Here, we show that expression of Otx2, a homeodomain protein required for the formation of the forebrain, is dramatically up-regulated during GnRH neuronal maturation and that overexpression of Otx2 increases GnRH promoter activity in GnRH neuronal cell lines. Furthermore, Otx2 transcriptional activity is modulated by Grg4, a member of the Groucho-related-gene (Grg) family. Using mutational analysis, we show that a WRPW peptide motif within the Otx2 protein is required for physical interaction between Otx2 and Grg4. Without this physical interaction, Grg4 cannot repress Otx2-dependent activation of GnRH gene transcription. Taken together, these data show that Otx2 is important for GnRH expression and that direct interaction between Otx2 and Grg co-repressors regulates GnRH gene expression in hypothalamic neurons.	Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Mellon, PL (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	pmellon@ucsd.edu		Larder, Rachel/0000-0003-1697-9455	National Institutes of Health [R01 DK044838, HD020377]; NICHD/NIH [U54 HD012303]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303, R01HD072754] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020377, R01HD020377] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK044838 and HD020377 (to P. L. M.). This work was also supported by NICHD/NIH through a cooperative agreement (U54 HD012303) as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (to P. L. M.).	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Ang SL, 1996, DEVELOPMENT, V122, P243; Briata P, 1999, FEBS LETT, V445, P160, DOI 10.1016/S0014-5793(99)00113-1; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Chatelain G, 2006, J MOL MED, V84, P604, DOI 10.1007/s00109-006-0048-2; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cherrington BD, 2008, MOL CELL ENDOCRINOL, V295, P106, DOI 10.1016/j.mce.2008.07.017; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Diaczok D, 2008, J CLIN ENDOCR METAB, V93, P4351, DOI 10.1210/jc.2008-1189; ERALY SA, 1995, MOL ENDOCRINOL, V9, P848, DOI 10.1210/me.9.7.848; Fossat N, 2005, DEV DYNAM, V233, P154, DOI 10.1002/dvdy.20287; Fossat N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-122; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Givens ML, 2005, J BIOL CHEM, V280, P19156, DOI 10.1074/jbc.M502004200; Givens ML, 2004, MOL ENDOCRINOL, V18, P2950, DOI 10.1210/me.2003-0437; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Heimbucher T, 2007, MOL CELL BIOL, V27, P340, DOI 10.1128/MCB.00811-06; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; Kepa JK, 1996, NUCLEIC ACIDS RES, V24, P3614, DOI 10.1093/nar/24.18.3614; Kim HH, 2007, MOL ENDOCRINOL, V21, P457, DOI 10.1210/me.2005-0216; Koop KE, 1996, MECH DEVELOP, V59, P73, DOI 10.1016/0925-4773(96)00582-5; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Larder R, 2004, BIOL REPROD, V71, P828, DOI 10.1095/biolreprod.104.030569; Larder R, 2006, ENDOCRINOLOGY, V147, P5676, DOI 10.1210/en.2006-0383; Lawson MA, 1996, MOL CELL BIOL, V16, P3596; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; Lepourcelet M, 2002, J BIOL CHEM, V277, P47732, DOI 10.1074/jbc.M208154200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Malin S, 2005, NUCLEIC ACIDS RES, V33, P4618, DOI 10.1093/nar/gki744; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; McGillivray SM, 2005, ENDOCRINOLOGY, V146, P2180, DOI 10.1210/en.2004-1566; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MIYASAKA H, 1993, EUR J BIOCHEM, V216, P343, DOI 10.1111/j.1432-1033.1993.tb18151.x; Mochizuki T, 2000, DEV BIOL, V224, P470, DOI 10.1006/dbio.2000.9778; Nakano T, 2000, BIOCHEM BIOPH RES CO, V267, P64, DOI 10.1006/bbrc.1999.1872; Nelson SB, 1998, MOL CELL ENDOCRINOL, V140, P151, DOI 10.1016/S0303-7207(98)00043-4; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; On ZS, 2008, AM J MED GENET A, V146A, P2480, DOI 10.1002/ajmg.a.32398; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles E, 2006, J NEUROSCI, V26, P5955, DOI 10.1523/JNEUROSCI.1097-06.2006; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Rave-Harel N, 2005, J BIOL CHEM, V280, P30975, DOI 10.1074/jbc.M502315200; Rave-Harel N, 2004, J BIOL CHEM, V279, P30287, DOI 10.1074/jbc.M402960200; Rhinn M, 1998, DEVELOPMENT, V125, P845; SCHWANZELFUKUDA M, 1992, ENDOCR REV, V13, P623, DOI 10.1210/er.13.4.623; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; Wang WF, 2004, DEV BIOL, V270, P364, DOI 10.1016/j.ydbio.2004.03.003; WETSEL WC, 1991, ENDOCRINOLOGY, V129, P1584, DOI 10.1210/endo-129-3-1584; WETSEL WC, 1992, P NATL ACAD SCI USA, V89, P4149, DOI 10.1073/pnas.89.9.4149; WHYTE DB, 1995, MOL ENDOCRINOL, V9, P467, DOI 10.1210/me.9.4.467; Wyatt A, 2008, HUM MUTAT, V29, pE278, DOI 10.1002/humu.20869; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	72	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16966	16978		10.1074/jbc.M109.002485	http://dx.doi.org/10.1074/jbc.M109.002485			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19401468	Green Published, hybrid			2022-12-27	WOS:000266962400034
J	Cohen, P				Cohen, Philip			Keep Nibbling at the Edges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RABBIT-SKELETAL-MUSCLE; GLYCOGEN-SYNTHASE KINASE-3; ACTIVATED PROTEIN-KINASE; P70 S6 KINASE; CELLULAR-REGULATION; PHOSPHORYLASE-KINASE; MAP KINASE; CATALYTIC SUBUNIT; GLUCOSE-6-PHOSPHATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3-KINASE		Univ Dundee, MRC, Prot Phosphorylat Unit, Sir James Black Ctr, Dundee DD1 5EH, Scotland	University of Dundee	Cohen, P (corresponding author), Univ Dundee, MRC, Prot Phosphorylat Unit, Sir James Black Ctr, Dow St, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk			MRC [MC_U127084348] Funding Source: UKRI; Medical Research Council [MC_U127084348] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; ANTONIW JF, 1977, BIOCHEM J, V162, P423, DOI 10.1042/bj1620423; ANTONIW JF, 1976, EUR J BIOCHEM, V68, P45, DOI 10.1111/j.1432-1033.1976.tb10763.x; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; CHISHOLM AAK, 1988, BIOCHIM BIOPHYS ACTA, V971, P163, DOI 10.1016/0167-4889(88)90188-7; COHEN P, 1977, BIOCHEM J, V162, P435, DOI 10.1042/bj1620435; COHEN P, 1973, FEBS LETT, V34, P43, DOI 10.1016/0014-5793(73)80699-4; Cohen P, 2004, SCIENTIST, V18, P28; Cohen P, 1978, Curr Top Cell Regul, V14, P117; COHEN P, 1973, EUR J BIOCHEM, V34, P1, DOI 10.1111/j.1432-1033.1973.tb02721.x; COHEN P, 1994, BIOESSAYS, V16, P583, DOI 10.1002/bies.950160812; COHEN P, 1969, EUR J BIOCHEM, V8, P1, DOI 10.1111/j.1432-1033.1969.tb00487.x; COHEN P, 1971, BIOCHEMISTRY-US, V10, P2683, DOI 10.1021/bi00790a005; COHEN P, 1969, EUR J BIOCHEM, V8, P8, DOI 10.1111/j.1432-1033.1969.tb00488.x; COHEN P, 1978, FEBS LETT, V92, P287, DOI 10.1016/0014-5793(78)80772-8; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Fersht A, 2009, P NATL ACAD SCI USA, V106, P6883, DOI 10.1073/pnas.0903307106; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Hershko A, 2009, J BIOL CHEM, V284, P10291, DOI 10.1074/jbc.X800016200; HIRAGA A, 1986, EUR J BIOCHEM, V161, P763, DOI 10.1111/j.1432-1033.1986.tb10505.x; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P711, DOI 10.1111/j.1432-1033.1989.tb15264.x; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P701, DOI 10.1111/j.1432-1033.1989.tb15263.x; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; HUGHES K, 1992, BIOCHEM J, V288, P309, DOI 10.1042/bj2880309; INGEBRITSEN TS, 1983, SCIENCE, V221, P331, DOI 10.1126/science.6306765; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P275, DOI 10.1111/j.1432-1033.1983.tb07359.x; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P263, DOI 10.1111/j.1432-1033.1983.tb07358.x; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P255, DOI 10.1111/j.1432-1033.1983.tb07357.x; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; Lin Tai-An, 1994, Journal of Biological Chemistry, V269, P21255; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; NIMMO GA, 1978, EUR J BIOCHEM, V87, P353, DOI 10.1111/j.1432-1033.1978.tb12384.x; NIMMO HG, 1974, FEBS LETT, V47, P162, DOI 10.1016/0014-5793(74)80450-3; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; PATO MD, 1983, EUR J BIOCHEM, V132, P283, DOI 10.1111/j.1432-1033.1983.tb07360.x; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; RYLATT DB, 1980, EUR J BIOCHEM, V107, P529; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; STEWART AA, 1983, EUR J BIOCHEM, V132, P289, DOI 10.1111/j.1432-1033.1983.tb07361.x; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; STRALFORS P, 1985, EUR J BIOCHEM, V149, P295, DOI 10.1111/j.1432-1033.1985.tb08926.x; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; TONKS NK, 1988, J BIOL CHEM, V263, P6722; TRAYNORKAPLAN AE, 1989, J BIOL CHEM, V264, P15668; TUNG HYL, 1984, EUR J BIOCHEM, V145, P57, DOI 10.1111/j.1432-1033.1984.tb08521.x; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06	74	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23891	23901		10.1074/jbc.X109.029835	http://dx.doi.org/10.1074/jbc.X109.029835			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19515842	Green Published, hybrid			2022-12-27	WOS:000269380200003
J	Neels, JG; Badeanlou, L; Hester, KD; Samad, F				Neels, Jaap G.; Badeanlou, Leylla; Hester, Kelly D.; Samad, Fahumiya			Keratinocyte-derived Chemokine in Obesity EXPRESSION, REGULATION, AND ROLE IN ADIPOSE MACROPHAGE INFILTRATION AND GLUCOSE HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; ADIPOCYTE DIFFERENTIATION; ATHEROSCLEROTIC LESIONS; CIRCULATING LEVELS; 3T3-L1 CELLS; FATTY-ACIDS; PPAR-GAMMA; TISSUE	Obese adipose tissue (AT) is associated with chronic inflammation, and we hypothesized that the keratinocyte-derived chemokine (KC), the mouse ortholog of human interleukin-8, plays a role in obesity-mediated AT inflammation and the subsequent manifestation of insulin resistance. KC expression is increased in the AT and plasma of genetically (ob/ob) and high fat diet-induced obese mouse models, and this increase may be mediated by the elevated leptin and tumor necrosis factor-alpha levels associated with obesity. Obesity-induced KC expression occurs primarily in stromal vascular cells and not in adipocytes, and it is high in preadipocytes and decreases during adipogenesis. Although KC has no effect on adipogenesis, it induces adipocyte expression of inflammatory factors and the insulin resistance mediator, suppressor of cytokine signaling 3. Using chimeric mice deficient in the KC receptor CXCR2 in their bone marrow, we show that the lack of CXCR2 in hematopoietic cells is sufficient to protect from adipose and skeletal muscle macrophage recruitment and development of insulin resistance in diet-induced obese mice. These studies suggest that KC and its receptor CXCR2 are potential targets for the development of new therapeutic approaches for treatment of obesity-related insulin resistance, type II diabetes, and related cardiovascular diseases.	[Badeanlou, Leylla; Hester, Kelly D.; Samad, Fahumiya] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Neels, Jaap G.; Samad, Fahumiya] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Neels, Jaap G.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA	Torrey Pines Institute for Molecular Studies, California; Scripps Research Institute; University of California System; University of California San Diego	Samad, F (corresponding author), Torrey Pines Inst Mol Studies, 3550 Gen Atom Court, San Diego, CA 92121 USA.	fsamad@tpims.org	Neels, Jaap G/F-5534-2010	Neels, Jaap G/0000-0002-5900-8395	National Institutes of Health [R01HL071146, HL075736]; American Heart Association [0635408N]; INSERM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075736, R01HL071146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL071146 (to F. S.). This work was also supported by Scientist Development Grant 0635408N from the American Heart Association and an INSERM junior researchers temporary contract (to J.G.N.).; Work performed in the laboratory of Dr. D. J. Loskutoff was supported by National Institutes of Health Grant HL075736.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Boisvert WA, 2000, IMMUNOL RES, V21, P129, DOI 10.1385/IR:21:2-3:129; Bruun JM, 2003, EUR J ENDOCRINOL, V148, P535, DOI 10.1530/eje.0.1480535; Bruun JM, 2004, AM J PHYSIOL-ENDOC M, V286, pE8, DOI 10.1152/ajpendo.00269.2003; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Ding ST, 2002, IN VITRO CELL DEV-AN, V38, P352; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Herder C, 2005, DIABETES, V54, pS11, DOI 10.2337/diabetes.54.suppl_2.S11; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI12877; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Modi WS, 1999, MOL BIOL EVOL, V16, P180, DOI 10.1093/oxfordjournals.molbev.a026101; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; OHSUMI J, 1994, ENDOCRINOLOGY, V135, P2279, DOI 10.1210/en.135.5.2279; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pradhan A, 2007, NUTR REV, V65, pS152, DOI [10.1111/j.1753-4887.2007.tb00354.x, 10.1301/nr.2007.dec.S152-S156]; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Straczkowski M, 2002, J CLIN ENDOCR METAB, V87, P4602, DOI 10.1210/jc.2002-020135; Straczkowski M, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-5; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; WATANABE K, 1993, EUR J BIOCHEM, V214, P267, DOI 10.1111/j.1432-1033.1993.tb17920.x; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776	43	57	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20692	20698		10.1074/jbc.M109.018556	http://dx.doi.org/10.1074/jbc.M109.018556			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19494115	Green Published, hybrid			2022-12-27	WOS:000268316100031
J	Wang, DDH; Shu, Z; Lieser, SA; Chen, PL; Lee, WH				Wang, Dennis Ding-Hwa; Shu, Zhanyong; Lieser, Scot A.; Chen, Phang-Lang; Lee, Wen-Hwa			Human Mitochondrial SUV3 and Polynucleotide Phosphorylase Form a 330-kDa Heteropentamer to Cooperatively Degrade Double-stranded RNA with a 3 '-to-5 ' Directionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; POLY(A) POLYMERASE; QUALITY-CONTROL; IN-VITRO; DNA NUCLEOIDS; HUMAN-CELLS; HELA CELLS; EXOSOME; HELICASE	Efficient turnover of unnecessary and misfolded RNAs is critical for maintaining the integrity and function of the mitochondria. The mitochondrial RNA degradosome of budding yeast (mtEXO) has been recently studied and characterized; yet no RNA degradation machinery has been identified in the mammalian mitochondria. In this communication, we demonstrated that purified human SUV3 (suppressor of Var1 3) dimer and polynucleotide phosphorylase (PNPase) trimer form a 330-kDa heteropentamer that is capable of efficiently degrading double-stranded RNA( dsRNA) substrates in the presence of ATP, a task the individual components cannot perform separately. The configuration of this complex is similar to that of the core complex of the E. coli RNA degradosome lacking RNase E but very different from that of the yeast mtEXO. The hSUV3-hPNPase complex prefers substrates containing a 3' overhang and degrades the RNA in a 3'-to-5' directionality. Deleting a short stretch of amino acids (positions 510-514) compromises the ability of hSUV3 to form a stable complex with hPNPase to degrade dsRNA substrates but does not affect its helicase activity. Furthermore, two additional hSUV3 mutants with abolished helicase activity because of disrupted ATPase or RNA binding activities were able to bind hPNPase. However, the resulting complexes failed to degrade dsRNA, suggesting that an intact helicase activity is essential for the complex to serve as an effective RNA degradosome. Taken together, these results strongly suggest that the complex of hSUV3-hPNPase is an integral entity for efficient degradation of structured RNA and may be the long sought RNA-degrading complex in the mammalian mitochondria.	[Wang, Dennis Ding-Hwa; Shu, Zhanyong; Lieser, Scot A.; Chen, Phang-Lang; Lee, Wen-Hwa] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, 124 Sprague Hall, Irvine, CA 92697 USA.	whlee@uci.edu	Chen, Phang-Lang/J-5031-2013; Lee, Wen-Hwa/C-2519-2014	Chen, Phang-Lang/0000-0002-0357-9017	National Institutes of Health [AG027877, CA-113265]; University of California; Irvine Medical Scientist Training Program; National Science Foundation Lifechips Program, Integrated Graduate Education and Research Traineeship [0549479]; NATIONAL CANCER INSTITUTE [T32CA113265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); Irvine Medical Scientist Training Program; National Science Foundation Lifechips Program, Integrated Graduate Education and Research Traineeship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027877 (to W. H. L.). Supported by the University of California, Irvine Medical Scientist Training Program and the National Science Foundation Lifechips Program, Integrated Graduate Education and Research Traineeship (0549479). Supported by National Institutes of Health Grant NCI T32 (CA-113265).	Abo T, 2000, EMBO J, V19, P3762, DOI 10.1093/emboj/19.14.3762; Akimitsu N, 2008, J BIOCHEM, V143, P1, DOI 10.1093/jb/mvm204; ALONI Y, 1971, P NATL ACAD SCI USA, V68, P1757, DOI 10.1073/pnas.68.8.1757; ALONI Y, 1971, J MOL BIOL, V55, P251, DOI 10.1016/0022-2836(71)90195-1; Blum E, 1999, J BIOL CHEM, V274, P4009, DOI 10.1074/jbc.274.7.4009; Blum E, 1997, MOL MICROBIOL, V26, P387, DOI 10.1046/j.1365-2958.1997.5901947.x; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Coligan JE, 1995, CURRENT PROTOCOLS PR; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Grunberg-Manago M, 1999, ANNU REV GENET, V33, P193, DOI 10.1146/annurev.genet.33.1.193; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Malecki M, 2007, J MOL BIOL, V372, P23, DOI 10.1016/j.jmb.2007.06.074; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Muto A, 1998, TRENDS BIOCHEM SCI, V23, P25, DOI 10.1016/S0968-0004(97)01159-6; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OJALA DK, 1980, NATURE, V287, P79, DOI 10.1038/287079a0; Piwowarski J, 2003, J MOL BIOL, V329, P853, DOI 10.1016/S0022-2836(03)00528-X; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; PY B, 1994, MOL MICROBIOL, V14, P717, DOI 10.1111/j.1365-2958.1994.tb01309.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Sarkar D, 2006, PHARMACOL THERAPEUT, V112, P243, DOI 10.1016/j.pharmthera.2006.04.003; Shu ZY, 2004, BIOCHEMISTRY-US, V43, P4781, DOI 10.1021/bi0356449; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Slornovic S, 2008, BBA-GENE REGUL MECH, V1779, P247, DOI 10.1016/j.bbagrm.2007.12.004; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Wagner E, 2002, J CELL SCI, V115, P3033; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; Yehudai-Resheff S, 2003, PLANT CELL, V15, P2003, DOI 10.1105/tpc.013326; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	52	70	73	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20812	20821		10.1074/jbc.M109.009605	http://dx.doi.org/10.1074/jbc.M109.009605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509288	Green Published, hybrid			2022-12-27	WOS:000268316100044
J	Wenzl, MV; Beretta, M; Gorren, ACF; Zeller, A; Baral, PK; Gruber, K; Russwurm, M; Koesling, D; Schmidt, K; Mayer, B				Wenzl, M. Verena; Beretta, Matteo; Gorren, Antonius C. F.; Zeller, Andreas; Baral, Pravas K.; Gruber, Karl; Russwurm, Michael; Koesling, Doris; Schmidt, Kurt; Mayer, Bernd			Role of the General Base Glu-268 in Nitroglycerin Bioactivation and Superoxide Formation by Aldehyde Dehydrogenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; VITAMIN-C; MITOCHONDRIAL; TOLERANCE; MECHANISM; HYDRALAZINE; DEFICIENCY; ACTIVATION; EXPRESSION; SITE	Mitochondrial aldehyde dehydrogenase-2 (ALDH2) plays an essential role in nitroglycerin (GTN) bioactivation, resulting in formation of NO or a related activator of soluble guanylate cyclase. ALDH2 denitrates GTN to 1,2-glyceryl dinitrate and nitrite but also catalyzes reduction of GTN to NO. To elucidate the relationship between ALDH2-catalyzed GTN bioconversion and established ALDH2 activities (dehydrogenase, esterase), we compared the function of the wild type (WT) enzyme with mutants lacking either the reactive Cys-302 (C302S) or the general base Glu-268 (E268Q). Although the C302S mutation led to >90% loss of all enzyme activities, the E268Q mutant exhibited virtually unaffected rates of GTN denitration despite low dehydrogenase and esterase activities. The nucleotide co-factor NAD caused a pronounced increase in the rates of 1,2-glyceryl dinitrate formation by WT-ALDH2 but inhibited the reaction catalyzed by the E268Q mutant. GTN bioactivation measured as activation of purified soluble guanylate cyclase or release of NO in the presence of WT- or E268Q-ALDH2 was markedly potentiated by superoxide dismutase, suggesting that bioavailability of GTN-derived NO is limited by co-generation of superoxide. Formation of superoxide was confirmed by determination of hydroethidine oxidation that was inhibited by superoxide dismutase and the ALDH2 inhibitor chloral hydrate. E268Q-ALDH2 exhibited similar to 50% lower rates of superoxide formation than the WT enzyme. Our results suggest that Glu-268 is involved in the structural organization of the NAD-binding pocket but is not required for GTN denitration. ALDH2-catalyzed superoxide formation may essentially contribute to oxidative stress in GTN-exposed blood vessels.	[Wenzl, M. Verena; Beretta, Matteo; Gorren, Antonius C. F.; Zeller, Andreas; Schmidt, Kurt; Mayer, Bernd] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Baral, Pravas K.; Gruber, Karl] Karl Franzens Univ Graz, Dept Mol Biosci, A-8010 Graz, Austria; [Russwurm, Michael; Koesling, Doris] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44780 Bochum, Germany	University of Graz; University of Graz; Ruhr University Bochum	Mayer, B (corresponding author), Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, Univ Pl 2, A-8010 Graz, Austria.	mayer@uni-graz.at	Mayer, Bernd/B-9391-2008; Gruber, Karl/GPP-6706-2022; Beretta, Matteo/D-8573-2012	Gruber, Karl/0000-0002-3485-9740; Gorren, Antonius Cornelis Franciscus/0000-0003-3476-6162; Beretta, Matteo/0000-0001-5564-4282; Mayer, Bernd/0000-0002-2921-3494	Fonds zur Forderung der Wissenschaftlichen Forschung [W901, P20669]; Deutsche Forschungsgemeinschaft [KO1157/4-1]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by Fonds zur Forderung der Wissenschaftlichen Forschung in Austria Grants W901 (DK Molecular Enzymology) and P20669 and Deutsche Forschungsgemeinschaft Grant KO1157/4-1.	Bassenge E, 1998, J CLIN INVEST, V102, P67, DOI 10.1172/JCI977; Beretta M, 2008, J BIOL CHEM, V283, P17873, DOI [10.1074/jbc.M801182200, 10.1074/jbc.M804001200]; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Chen ZQ, 2006, TRENDS CARDIOVAS MED, V16, P259, DOI 10.1016/j.tcm.2006.05.001; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; Daiber A, 2005, BIOCHEM BIOPH RES CO, V338, P1865, DOI 10.1016/j.bbrc.2005.10.106; Daiber A, 2005, MOL PHARMACOL, V68, P579, DOI 10.1124/mol.105.011585; Difabio J, 2003, MOL PHARMACOL, V64, P1109, DOI 10.1124/mol.64.5.1109; Esplugues JV, 2006, CIRC RES, V99, P1067, DOI 10.1161/01.RES.0000250430.62775.99; Fung HL, 2004, ANNU REV PHARMACOL, V44, P67, DOI 10.1146/annurev.pharmtox.44.101802.121646; Hurley TD, 2001, CHEM-BIOL INTERACT, V130, P3, DOI 10.1016/S0009-2797(00)00217-9; Kaesemeyer WH, 2000, BRIT J PHARMACOL, V131, P1019, DOI 10.1038/sj.bjp.0703665; Kleschyov AL, 2003, CIRC RES, V93, pE104, DOI 10.1161/01.RES.0000100067.62876.50; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4445, DOI 10.1021/bi9521093; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; Larson HN, 2007, J BIOL CHEM, V282, P12940, DOI 10.1074/jbc.M607959200; Mann CJ, 1999, PROTEIN SCI, V8, P1922, DOI 10.1110/ps.8.10.1922; Mayer B, 2008, BRIT J PHARMACOL, V155, P170, DOI 10.1038/bjp.2008.263; MAYER B, 1995, J BIOL CHEM, V270, P655, DOI 10.1074/jbc.270.2.655; Miller MR, 2008, J VASC RES, V45, P375, DOI 10.1159/000121407; Munzel T, 1996, J CLIN INVEST, V98, P1465, DOI 10.1172/JCI118935; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Munzel T, 2000, CIRC RES, V86, pE7, DOI 10.1161/01.RES.86.1.e7; Nunez C, 2005, CIRC RES, V97, P1063, DOI 10.1161/01.RES.0000190588.84680.34; Parker JO, 2002, J AM COLL CARDIOL, V39, P1199, DOI 10.1016/S0735-1097(02)01729-1; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; RACKER E, 1949, J BIOL CHEM, V177, P883; Russwurm M, 2005, METHOD ENZYMOL, V396, P492, DOI 10.1016/S0076-6879(05)96041-2; SACHS L, 1974, APPL STAT HDB TECHNI; Schultz G., 1984, METHOD ENZYMAT AN, P379; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Watanabe H, 1998, J AM COLL CARDIOL, V31, P1323, DOI 10.1016/S0735-1097(98)00085-0; WINTERBOURN CC, 1994, ARCH BIOCHEM BIOPHYS, V314, P284, DOI 10.1006/abbi.1994.1444; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; ZHENG CF, 1993, ALCOHOL CLIN EXP RES, V17, P828, DOI 10.1111/j.1530-0277.1993.tb00849.x	36	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19878	19886		10.1074/jbc.M109.005652	http://dx.doi.org/10.1074/jbc.M109.005652			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19506075	Green Published, hybrid			2022-12-27	WOS:000268097400014
J	Yabu, T; Shimuzu, A; Yamashita, M				Yabu, Takeshi; Shimuzu, Akio; Yamashita, Michiaki			A Novel Mitochondrial Sphingomyelinase in Zebrafish Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+-DEPENDENT NEUTRAL SPHINGOMYELINASE; SUBCELLULAR-LOCALIZATION; SPHINGOLIPID METABOLISM; PARTIAL-PURIFICATION; CERAMIDE GENERATION; INDUCED APOPTOSIS; BACILLUS-CEREUS; PHOSPHOLIPASE-C; HL-60 CELLS; ACTIVATION	Sphingolipids are important signaling molecules in many biological processes, but little is known regarding their physiological roles in the mitochondrion. We focused on the biochemical characters of a novel sphingomyelinase (SMase) and its function in mitochondrial ceramide generation in zebrafish embryonic cells. The cloned SMase cDNA encoded a polypeptide of 545 amino acid residues (putative molecular weight, 61,300) containing a mitochondrial localization signal (MLS) and a predicted transmembrane domain. The mature endogenous enzyme was predicted to have a molecular weight of 57,000, and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis indicated that the N-terminal amino acid residue of the mature enzyme was Ala-36. The purified enzyme optimally hydrolyzed [C-14] sphingomyelin in the presence of 10 mM Mg2+ at pH 7.5. In HEK293 cells that overexpressed SMase cDNA, the enzyme was localized to the mitochondrial fraction, whereas mutant proteins lacking MLS or both the MLS and the transmembrane domain were absent from the mitochondrial fraction. Endogenous SMase protein co-localized with a mitochondrial cytostaining marker. Using a protease protection assay, we found that SMase was distributed throughout the intermembrane space and/or the inner membrane of the mitochondrion. Furthermore, the overexpression of SMase in HEK293 cells induced ceramide generation and sphingomyelin hydrolysis in the mitochondrial fraction. Antisense phosphorothioate oligonucleotide-induced knockdown repressed ceramide generation and sphingomyelin hydrolysis in the mitochondrial fraction in zebrafish embryonic cells. These observations indicate that SMase catalyzes the hydrolysis of sphingomyelin and generates ceramide in mitochondria in fish cells.	[Yabu, Takeshi; Shimuzu, Akio; Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Kanagawa 2368648, Japan	Japan Fisheries Research & Education Agency (FRA)	Yamashita, M (corresponding author), Natl Res Inst Fisheries Sci, Kanagawa 2368648, Japan.	mic@affrc.go.jp			Japan Science and Technology Corporation; Japan Society for Promotion of Science; Ministry of Agriculture, Forestry, and Fisheries of Japan	Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported in part by grants from the Japan Science and Technology Corporation, the Japan Society for Promotion of Science, and the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bernardo K, 2000, J BIOL CHEM, V275, P7641, DOI 10.1074/jbc.275.11.7641; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Fujii S, 1998, J BIOCHEM-TOKYO, V124, P1178, DOI 10.1093/oxfordjournals.jbchem.a022236; Fujii S, 1999, J BIOCHEM-TOKYO, V126, P90, DOI 10.1093/oxfordjournals.jbchem.a022441; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hayashi Y, 1997, J BIOL CHEM, V272, P18082, DOI 10.1074/jbc.272.29.18082; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Jana A, 2004, J BIOL CHEM, V279, P51451, DOI 10.1074/jbc.M404635200; KALRA J, 1974, J BIOL CHEM, V249, P3255; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levade T, 2002, NEUROCHEM RES, V27, P601, DOI 10.1023/A:1020215815013; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Liu B, 1998, J BIOL CHEM, V273, P34472, DOI 10.1074/jbc.273.51.34472; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Matsuo Y, 1996, PROTEIN SCI, V5, P2459, DOI 10.1002/pro.5560051208; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Okamoto Y, 2003, BIOCHEMISTRY-US, V42, P7855, DOI 10.1021/bi0341354; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Sawai H, 1999, J BIOL CHEM, V274, P38131, DOI 10.1074/jbc.274.53.38131; SAWAI H, 1995, J BIOL CHEM, V270, P27326, DOI 10.1074/jbc.270.45.27326; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; SUGIURA Y, 1981, J BIOL CHEM, V256, P664; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Thongboonkerd V, 2002, J BIOL CHEM, V277, P16599, DOI 10.1074/jbc.M200746200; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Yabu T, 2001, BIOCHEM J, V360, P39, DOI 10.1042/0264-6021:3600039; Yabu T, 2008, J BIOL CHEM, V283, P29971, DOI 10.1074/jbc.M805402200; YAMASHITA M, 1991, J AGR FOOD CHEM, V39, P1402, DOI 10.1021/jf00008a009; Zumbansen M, 2002, MOL CELL BIOL, V22, P3633, DOI 10.1128/MCB.22.11.3633-3638.2002	59	26	27	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20349	20363		10.1074/jbc.M109.004580	http://dx.doi.org/10.1074/jbc.M109.004580			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19429680	Green Published, hybrid			2022-12-27	WOS:000268097400061
J	Bally, I; Rossi, V; Lunardi, T; Thielens, NM; Gaboriaud, C; Arlaud, GJ				Bally, Isabelle; Rossi, Veronique; Lunardi, Thomas; Thielens, Nicole M.; Gaboriaud, Christine; Arlaud, Gerard J.			Identification of the C1q-binding Sites of Human C1r and C1s A REFINED THREE-DIMENSIONAL MODEL OF THE C1 COMPLEX OF COMPLEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN-BINDING LECTIN; COMPLEMENT PROTEASE C1R; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; SERINE PROTEASES; STRUCTURAL BIOLOGY; 1ST COMPONENT; CUB DOMAIN; L-FICOLIN; ACTIVATION	The C1 complex of complement is assembled from a recognition protein C1q and C1s-C1r-C1r-C1s, a Ca2+-dependent tetramer of two modular proteases C1r and C1s. Resolution of the x-ray structure of the N-terminal CUB1-epidermal growth factor (EGF) C1s segment has led to a model of the C1q/C1s-C1r-C1r-C1s interaction where the C1q collagen stem binds at the C1r/C1s interface through ionic bonds involving acidic residues contributed by the C1r EGF module (Gregory, L. A., Thielens, N. M., Arlaud, G. J., Fontecilla-Camps, J. C., and Gaboriaud, C. (2003) J. Biol. Chem. 278, 32157-32164). To identify the C1q-binding sites of C1s-C1r-C1r-C1s, a series of C1r and C1s mutants was expressed, and the C1q binding ability of the resulting tetramer variants was assessed by surface plasmon resonance. Mutations targeting the Glu137-Glu-Asp139 stretch in the C1r EGF module had no effect on C1 assembly, ruling out our previous interaction model. Additional mutations targeting residues expected to participate in the Ca2+-binding sites of the C1r and C1s CUB modules provided evidence for high affinity C1q-binding sites contributed by the C1r CUB1 and CUB2 modules and lower affinity sites contributed by C1s CUB1. All of the sites implicate acidic residues also contributing Ca2+ ligands. C1s-C1r-C1r-C1s thus contributes six C1q-binding sites, one per C1q stem. Based on the location of these sites and available structural information, we propose a refined model of C1 assembly where the CUB1-EGF-CUB2 interaction domains of C1r and C1s are entirely clustered inside C1q and interact through six binding sites with reactive lysines of the C1q stems. This mechanism is similar to that demonstrated for mannan-binding lectin (MBL)-MBL-associated serine protease and ficolin-MBL-associated serine protease complexes.	[Bally, Isabelle; Rossi, Veronique; Lunardi, Thomas; Thielens, Nicole M.; Arlaud, Gerard J.] Univ Grenoble 1, CEA, CNRS,UMR 5075, Lab Enzymol Mol,Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble 1, France; [Gaboriaud, Christine] Univ Grenoble 1, CEA, CNRS,UMR 5075, Lab Cristallog & Cristallogenese Prot,Inst Biol S, F-38027 Grenoble 1, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Arlaud, GJ (corresponding author), Univ Grenoble 1, CEA, CNRS,UMR 5075, Lab Enzymol Mol,Inst Biol Struct Jean Pierre Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	gerard.arlaud@ibs.fr	Thielens, Nicole M/F-2512-2013; Rossi, Véronique/AAF-3412-2021	Thielens, Nicole M/0000-0002-7354-0302; Rossi, Véronique/0000-0002-6700-3578	Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique; Universite Joseph Fourier, Grenoble	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier, Grenoble	This work was supported by the Commissariat a l'Energie Atomique, the Centre National de la Recherche Scientifique, and the Universite Joseph Fourier, Grenoble.	ARLAUD GJ, 1987, IMMUNOL TODAY, V8, P106, DOI 10.1016/0167-5699(87)90860-7; Arlaud GJ, 2002, MOL IMMUNOL, V39, P383, DOI 10.1016/S0161-5890(02)00143-8; Arlaud GJ, 2001, IMMUNOL REV, V180, P136, DOI 10.1034/j.1600-065X.2001.1800112.x; ARLAUD GJ, 1979, MOL IMMUNOL, V16, P445, DOI 10.1016/0161-5890(79)90069-5; Bally I, 2005, J IMMUNOL, V175, P4536, DOI 10.4049/jimmunol.175.7.4536; Bersch B, 1998, BIOCHEMISTRY-US, V37, P1204, DOI 10.1021/bi971851v; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; BUSBY TF, 1990, BIOCHEMISTRY-US, V29, P4613, DOI 10.1021/bi00471a016; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; Cseh S, 2002, J IMMUNOL, V169, P5735, DOI 10.4049/jimmunol.169.10.5735; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; GAL P, 1989, COMPLEMENT INFLAMMAT, V6, P433; Gregory LA, 2004, J BIOL CHEM, V279, P29391, DOI 10.1074/jbc.M402687200; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOURNET A, 1986, BIOCHEM J, V240, P783, DOI 10.1042/bj2400783; KING LA, 1992, BACULOVIRUS EXPRESSI, P111; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Lacroix M, 1997, BIOCHEMISTRY-US, V36, P6270, DOI 10.1021/bi962719i; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUO C, 1992, BIOCHEMISTRY-US, V31, P4254, DOI 10.1021/bi00132a015; PERKINS SJ, 1984, J MOL BIOL, V179, P547, DOI 10.1016/0022-2836(84)90079-2; REID KBM, 1986, IMMUNOL TODAY, V7, P230, DOI 10.1016/0167-5699(86)90110-6; Romero A, 1997, NAT STRUCT BIOL, V4, P783, DOI 10.1038/nsb1097-783; STRANG CJ, 1982, P NATL ACAD SCI-BIOL, V79, P586, DOI 10.1073/pnas.79.2.586; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Thielens NM, 1999, J BIOL CHEM, V274, P9149, DOI 10.1074/jbc.274.14.9149; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; THIELENS NM, 1990, J BIOL CHEM, V265, P14469; THIELENS NM, 1994, BIOCHEM J, V301, P378; Tsai SW, 1997, MOL IMMUNOL, V34, P1273, DOI 10.1016/S0161-5890(97)00149-1; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	39	65	69	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19340	19348		10.1074/jbc.M109.004473	http://dx.doi.org/10.1074/jbc.M109.004473			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473974	Green Published, hybrid			2022-12-27	WOS:000267908300025
J	Cho, G; Lim, Y; Golden, JA				Cho, Ginam; Lim, Youngshin; Golden, Jeffrey A.			SUMO Interaction Motifs in Sizn1 Are Required for Promyelocytic Leukemia Protein Nuclear Body Localization and for Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; PML; BODIES; BAX; IDENTIFICATION; DOMAINS; SITES; CELLS; MAP-1; DAXX	Mutations in Sizn1 (Zcchc12), a novel transcriptional co-activator in the BMP signaling pathway, are associated with X-linked mental retardation. Previously, we demonstrated that Sizn1 positively modulates the BMP signal by interacting with Smad family members and cAMP-responsive element-binding protein-binding protein. To further define the molecular basis of Sizn1 function, we have explored its subcellular localization and generated various deletion mutants to carry out domain analyses. Here, we report that Sizn1 localizes to promyelocytic leukemia protein nuclear bodies (PML-NBs). Sizn1 deletion mutants that disrupt the MA homologous domain or the middle region fail to target to the PML-NB. We show that two SUMO interaction motifs (SIMs) in Sizn1 can bind to SUMO and govern SUMO conjugation to Sizn1 in the absence of the consensus motif for SUMO attachment. Interestingly, the SIM mutant Sizn1 localizes to nuclear bodies, but not to PML-NBs. Thus, SIMs mediate the localization of Sizn1 to PML-NB. Interestingly, mutations in SIM sequences and deletion of the MA homologous domain also affected the transcriptional co-activation function of a Sizn1. Taken together, our data indicate that the SIMs in Sizn1 are required for its PML-NB localization and for the full transcriptional co-activation function in BMP signaling.	[Cho, Ginam; Lim, Youngshin; Golden, Jeffrey A.] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19072 USA; [Golden, Jeffrey A.] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Golden, JA (corresponding author), Childrens Hosp Philadelphia, Dept Pathol, ARC 516G,34th Civ Ctr Blvd, Philadelphia, PA 19072 USA.	youngshl@mail.med.upenn.edu; goldenj@mail.med.upenn.edu	Lim, Youngshin/HGV-0369-2022	Lim, Youngshin/0000-0002-7842-3244; Golden, Jeffrey/0000-0001-9933-5502	National Institutes of Health [NS45034]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045034, R56NS045034, R01NS046616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS45034.	ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Boisvert FM, 2000, J CELL BIOL, V148, P283, DOI 10.1083/jcb.148.2.283; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Cho G, 2008, AM J MED GENET A, V146A, P2644, DOI 10.1002/ajmg.a.32472; Cho G, 2008, MOL CELL BIOL, V28, P1565, DOI 10.1128/MCB.01038-07; Dalmau J, 1999, BRAIN, V122, P27, DOI 10.1093/brain/122.1.27; Dalmau J, 2004, BRAIN, V127, P1831, DOI 10.1093/brain/awh203; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Eskiw CH, 2004, J BIOL CHEM, V279, P9577, DOI 10.1074/jbc.M312580200; Gambacorta M, 1996, AM J PATHOL, V149, P2023; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Kiesslich A, 2002, J STRUCT BIOL, V140, P167, DOI 10.1016/S1047-8477(02)00571-3; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Maul GG, 1995, J CELL BIOCHEM, V59, P498, DOI 10.1002/jcb.240590410; Mauri F, 2008, J BIOL CHEM, V283, P20848, DOI 10.1074/jbc.M710186200; Navascues J, 2007, CHROMOSOMA, V116, P441, DOI 10.1007/s00412-007-0107-7; Negorev D, 2001, J CELL SCI, V114, P59; Rosenfeld MR, 2001, ANN NEUROL, V50, P339, DOI 10.1002/ana.1288; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Spector DL, 2001, J CELL SCI, V114, P2891; Suzuki H, 2001, BIOCHEM BIOPH RES CO, V286, P322, DOI 10.1006/bbrc.2001.5387; Tan KO, 2005, P NATL ACAD SCI USA, V102, P14623, DOI 10.1073/pnas.0503524102; Tan KO, 2001, J BIOL CHEM, V276, P2802, DOI 10.1074/jbc.M008955200; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Vos MD, 2006, J BIOL CHEM, V281, P4557, DOI 10.1074/jbc.M512128200; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	37	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19592	19600		10.1074/jbc.M109.010181	http://dx.doi.org/10.1074/jbc.M109.010181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19416967	Green Published, hybrid			2022-12-27	WOS:000267908300051
J	Kim, BY; Olzmann, JA; Choi, SI; Ahn, SY; Kim, TI; Cho, HS; Suh, H; Kim, EK				Kim, Bong-Yoon; Olzmann, James A.; Choi, Seung-il; Ahn, So Yeon; Kim, Tae-im; Cho, Hyun-Soo; Suh, Hwal; Kim, Eung Kweon			Corneal Dystrophy-associated R124H Mutation Disrupts TGFBI Interaction with Periostin and Causes Mislocalization to the Lysosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MATRIX PROTEIN BETA-IG-H3; KERATO-EPITHELIN MUTATIONS; FASCICLIN-I; COLON-CANCER; COLLAGEN-VI; CELL-LINE; GENE; INTEGRIN; EXPRESSION	The 5q31-linked corneal dystrophies are heterogeneous autosomal-dominant eye disorders pathologically characterized by the progressive accumulation of aggregated proteinaceous deposits in the cornea, which manifests clinically as severe vision impairment. The 5q31-linked corneal dystrophies are commonly caused by mutations in the TGFBI (transforming growth (f) under bar actor-(beta) under bar-(i) under bar nduced) gene. However, despite the identification of the culprit gene, the cellular roles of TGFBI and the molecular mechanisms underlying the pathogenesis of corneal dystrophy remain poorly understood. Here we report the identification of periostin, a molecule that is highly related to TGFBI, as a specific TGFBI-binding partner. The association of TGFBI and periostin is mediated by the amino-terminal cysteine-rich EMI domains of TGFBI and periostin. Our results indicate that the endogenous TGFBI and periostin colocalize within the trans-Golgi network and associate prior to secretion. The corneal dystrophy-associated R124H mutation in TGFBI severely impairs interaction with periostin in vivo. In addition, the R124H mutation causes aberrant redistribution of the mutant TGFBI into lysosomes. We also find that the periostin-TGFBI interaction is disrupted in corneal fibroblasts cultured from granular corneal dystrophy type II patients and that periostin accumulates in TGFBI-positive corneal deposits in granular corneal dystrophy type II (also known as Avellino corneal dystrophy). Together, our findings suggest that TGFBI and periostin may play cooperative cellular roles and that periostin may be involved in the pathogenesis of 5q31-linked corneal dystrophies.	[Kim, Bong-Yoon; Choi, Seung-il; Ahn, So Yeon; Kim, Tae-im; Kim, Eung Kweon] Yonsei Univ, Dept Ophthalmol, Coll Med, Seoul 120752, South Korea; [Kim, Bong-Yoon; Choi, Seung-il; Ahn, So Yeon; Kim, Tae-im; Kim, Eung Kweon] Yonsei Univ, Corneal Dystrophy Res Inst, Coll Med, Seoul 120752, South Korea; [Kim, Bong-Yoon; Suh, Hwal] Yonsei Univ, Dept Med Engn, Coll Med, Seoul 120752, South Korea; [Kim, Bong-Yoon; Kim, Tae-im; Suh, Hwal; Kim, Eung Kweon] Yonsei Univ, Brain Korean Project 21, Coll Med, Team Nanobiomat Cell Based Implants, Seoul 120752, South Korea; [Cho, Hyun-Soo] Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Olzmann, James A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Stanford University	Kim, EK (corresponding author), Yonsei Univ, Dept Ophthalmol, Coll Med, 134 Shinchon Dong, Seoul 120752, South Korea.	eungkkim@yuhs.ac		Kim, Eung Kweon/0000-0002-1453-8042; Kim, Tae-im/0000-0001-6414-3842; Olzmann, James/0000-0001-7751-8316; choi, seung-il/0000-0001-7168-8795	Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A080320]	Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea, Grant A080320.	ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; Billings PC, 2002, J BIOL CHEM, V277, P28003, DOI 10.1074/jbc.M106837200; Brodsky JL, 2007, AUTOPHAGY, V3, P623, DOI 10.4161/auto.4906; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Clout N, 2003, MOL VIS, V9, P440; Clout NJ, 2003, STRUCTURE, V11, P197, DOI 10.1016/S0969-2126(03)00002-9; Dighiero P, 2001, OPHTHALMOLOGY, V108, P818, DOI 10.1016/S0161-6420(00)00662-X; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; El Kochairi I, 2006, MOL VIS, V12, P461; El-Ashry MF, 2003, BRIT J OPHTHALMOL, V87, P839, DOI 10.1136/bjo.87.7.839; GILLAN L, 2002, CANCER RES, V62, P5385; Hanssen E, 2003, J BIOL CHEM, V278, P24334, DOI 10.1074/jbc.M303455200; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jester JV, 2003, INVEST OPHTH VIS SCI, V44, P1850, DOI 10.1167/iovs.02-0973; Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334; Kern CB, 2005, ANAT REC PART A, V284A, P415, DOI 10.1002/ar.a.20193; Kim BY, 2001, J BIOL CHEM, V276, P29393, DOI 10.1074/jbc.M101778200; Kim HJ, 2008, INT J BIOCHEM CELL B, V40, P991, DOI 10.1016/j.biocel.2007.11.001; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; Kim JE, 2002, INVEST OPHTH VIS SCI, V43, P656; Korvatska E, 1999, INVEST OPHTH VIS SCI, V40, P2213; Korvatska E, 1998, AM J HUM GENET, V62, P320, DOI 10.1086/301720; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Lee SH, 2003, KIDNEY INT, V64, P1012, DOI 10.1046/j.1523-1755.2003.00158.x; Lindsley A, 2005, GENE EXPR PATTERNS, V5, P593, DOI 10.1016/j.modgep.2005.03.005; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Mashima Y, 1999, ARCH OPHTHALMOL-CHIC, V117, P90; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Nam EJ, 2006, ARTHRITIS RHEUM-US, V54, P2734, DOI 10.1002/art.22076; Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200; Okada M, 1998, AM J OPHTHALMOL, V126, P535, DOI 10.1016/S0002-9394(98)00135-4; Park SJ, 2004, PEPTIDES, V25, P199, DOI 10.1016/j.peptides.2003.12.002; Pieramici SF, 2006, CURR OPIN OPHTHALMOL, V17, P361, DOI 10.1097/01.icu.0000233955.94347.84; Poulaki Vasilliki, 2008, Semin Ophthalmol, V23, P9, DOI 10.1080/08820530701745173; Rawe IM, 1997, INVEST OPHTH VIS SCI, V38, P893; Reinboth B, 2006, J BIOL CHEM, V281, P7816, DOI 10.1074/jbc.M511316200; Runager K, 2008, EXP EYE RES, V87, P298, DOI 10.1016/j.exer.2007.12.001; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; STONE EM, 1994, NAT GENET, V6, P47, DOI 10.1038/ng0194-47; Streeten BW, 1999, ARCH OPHTHALMOL-CHIC, V117, P67; Takacs L, 1998, EXP EYE RES, V66, P739, DOI 10.1006/exer.1998.0471; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; Yoshioka N, 2002, EXP CELL RES, V279, P91, DOI 10.1006/excr.2002.5590	51	49	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19580	19591		10.1074/jbc.M109.013607	http://dx.doi.org/10.1074/jbc.M109.013607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19478074	hybrid, Green Published			2022-12-27	WOS:000267908300050
J	Bippes, CA; Zeltina, A; Casagrande, F; Ratera, M; Palacin, M; Muller, DJ; Fotiadis, D				Bippes, Christian A.; Zeltina, Antra; Casagrande, Fabio; Ratera, Merce; Palacin, Manuel; Muller, Daniel J.; Fotiadis, Dimitrios			Substrate Binding Tunes Conformational Flexibility and Kinetic Stability of an Amino Acid Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ATOMIC-FORCE MICROSCOPY; DETECTING MOLECULAR-INTERACTIONS; LYSINURIC PROTEIN INTOLERANCE; NATIVE MEMBRANE-PROTEINS; DYNAMIC ENERGY LANDSCAPE; UNFOLDING PATHWAYS; SINGLE PROTEIN; TRANSPORTER SUPERFAMILY; TRANSMEMBRANE HELICES; MECHANICAL-PROPERTIES	We used single molecule dynamic force spectroscopy to unfold individual serine/threonine antiporters SteT from Bacillus subtilis. The unfolding force patterns revealed interactions and energy barriers that stabilized structural segments of SteT. Substrate binding did not establish strong localized interactions but appeared to be facilitated by the formation of weak interactions with several structural segments. Upon substrate binding, all energy barriers of the antiporter changed thereby describing the transition from brittle mechanical properties of SteT in the unbound state to structurally flexible conformations in the substrate-bound state. The lifetime of the unbound state was much shorter than that of the substrate-bound state. This leads to the conclusion that the unbound state of SteT shows a reduced conformational flexibility to facilitate specific substrate binding and a reduced kinetic stability to enable rapid switching to the bound state. In contrast, the bound state of SteT showed an increased conformational flexibility and kinetic stability such as required to enable transport of substrate across the cell membrane. This result supports the working model of antiporters in which alternate substrate access from one to the other membrane surface occurs in the substrate-bound state.	[Bippes, Christian A.; Zeltina, Antra; Muller, Daniel J.] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Casagrande, Fabio] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ratera, Merce; Palacin, Manuel] Univ Barcelona, Inst Res Biomed, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland	Technische Universitat Dresden; University of California System; University of California San Diego; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Bern	Muller, DJ (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-51, D-01307 Dresden, Germany.	mueller@biotec.tu-dresden.de	Müller, Daniel J./A-5967-2010; Palacín, Manuel/G-9786-2015	Müller, Daniel J./0000-0003-3075-0665; Zeltina, Antra/0000-0002-5485-5480; Palacin, Manuel/0000-0002-8670-293X; Ratera, Merce/0000-0001-5224-9172	European Union; Deutsche Forschungsgemeinschaft; Berne University Research Foundation; Swiss National Foundation for Scientific Research; Spanish Ministry of Science and Education	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Berne University Research Foundation; Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Spanish Ministry of Science and Education(Spanish Government)	This work was supported by the European Union, the Deutsche Forschungsgemeinschaft, the Berne University Research Foundation, the Swiss National Foundation for Scientific Research, and the Spanish Ministry of Science and Education.	Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Aranda-Espinoza H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208301; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; Bosshart PD, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384014; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Cisneros DA, 2005, STRUCTURE, V13, P235, DOI 10.1016/j.str.2004.12.005; Cisneros DA, 2008, STRUCTURE, V16, P1206, DOI 10.1016/j.str.2008.04.014; Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103; DILL KA, 1995, PROTEIN SCI, V4, P561; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2000, J PHYS-CONDENS MAT, V12, pA315, DOI 10.1088/0953-8984/12/8A/341; Evans E, 1998, FARADAY DISCUSS, V111, P1; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200; Grater F, 2007, J STRUCT BIOL, V157, P557, DOI 10.1016/j.jsb.2006.11.005; GRUSZECKI WI, 1990, BIOCHIM BIOPHYS ACTA, V1023, P405, DOI 10.1016/0005-2736(90)90133-9; HAMMOND GS, 1955, J AM CHEM SOC, V77, P338, DOI 10.1021/ja01607a028; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; HOWARD J, 2001, MARXIST SHAKESPEARES, P9; Hu YL, 2008, J MOL BIOL, V382, P99, DOI 10.1016/j.jmb.2008.06.091; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Janovjak H, 2005, EUR BIOPHYS J BIOPHY, V34, P91, DOI 10.1007/s00249-004-0430-3; Janovjak H, 2004, STRUCTURE, V12, P871, DOI 10.1016/j.str.2004.03.016; Janovjak H, 2007, J AM CHEM SOC, V129, P246, DOI 10.1021/ja065684a; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455; Kedrov A, 2004, J MOL BIOL, V340, P1143, DOI 10.1016/j.jmb.2004.05.026; Kedrov A, 2008, J MOL BIOL, V375, P1258, DOI 10.1016/j.jmb.2007.11.032; Kedrov A, 2007, J STRUCT BIOL, V159, P290, DOI 10.1016/j.jsb.2007.02.010; Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640; Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023; Klyszejko AL, 2008, J MOL BIOL, V376, P35, DOI 10.1016/j.jmb.2007.11.030; Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1; Kumar S, 2000, PROTEIN SCI, V9, P10; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Ludwig T, 2008, PFLUG ARCH EUR J PHY, V456, P29, DOI 10.1007/s00424-007-0398-9; MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; Muller DJ, 2008, BIOCHEMISTRY-US, V47, P7986, DOI 10.1021/bi800753x; Muller DJ, 2002, BIOPHYS J, V83, P3578, DOI 10.1016/S0006-3495(02)75358-7; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Palacin M, 2005, PHYSIOLOGY, V20, P112, DOI 10.1152/physiol.00051.2004; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Prajapati RS, 2007, BIOCHEMISTRY-US, V46, P10339, DOI 10.1021/bi700577m; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; Sanders CR, 2000, CURR OPIN STRUC BIOL, V10, P438, DOI 10.1016/S0959-440X(00)00112-3; Sapra KT, 2008, BIOPHYS J, V95, P3407, DOI 10.1529/biophysj.108.131904; Sapra KT, 2008, J MOL BIOL, V376, P1076, DOI 10.1016/j.jmb.2007.12.027; Sapra KT, 2008, LANGMUIR, V24, P1330, DOI 10.1021/la702299z; Sapra KT, 2006, J MOL BIOL, V358, P255, DOI 10.1016/j.jmb.2006.02.008; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Schlierf M, 2005, J MOL BIOL, V354, P497, DOI 10.1016/j.jmb.2005.09.070; Sobczak I, 2004, J BIOL CHEM, V279, P31113, DOI 10.1074/jbc.M404283200; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Verrey F, 1999, J MEMBRANE BIOL, V172, P181, DOI 10.1007/s002329900595; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; West IC, 1997, BBA-REV BIOMEMBRANES, V1331, P213, DOI 10.1016/S0304-4157(97)00007-5; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Yu JS, 2007, J BIOL CHEM, V282, P8895, DOI 10.1074/jbc.M609317200	102	28	28	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18651	18663		10.1074/jbc.M109.004267	http://dx.doi.org/10.1074/jbc.M109.004267			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19419962	Green Published, hybrid			2022-12-27	WOS:000267711500014
J	Martens, EC; Roth, R; Heuser, JE; Gordon, JI				Martens, Eric C.; Roth, Robyn; Heuser, John E.; Gordon, Jeffrey I.			Coordinate Regulation of Glycan Degradation and Polysaccharide Capsule Biosynthesis by a Prominent Human Gut Symbiont	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTEROIDES-THETAIOTAOMICRON; BACTERIA; EVOLUTION; MUCIN	Bacteria in the distal human gut have evolved diverse abilities to metabolize complex glycans, including the capacity to degrade these compounds as nutrients and to assemble their component sugars into new polymers such as extracellular capsules. The human gut bacterium Bacteroides thetaiotaomicron is well endowed with the ability to metabolize both host-and diet-derived glycans. Its genome contains 88 different polysaccharide utilization loci (PULs) for complex glycan catabolism and eight different gene clusters for capsular polysaccharide biosynthesis. Here, we investigate one of the prominent mechanisms by which this gut symbiont regulates many PULs involved in host mucin O-glycan degradation; namely, transcriptional regulation via the concerted interactions of cell-envelope-localized TonB-dependent transporters, extra-cytoplasmic function sigma factors and anti-sigma factors, which participate together in a regulatory pathway termed trans-envelope signaling. Unexpectedly, we found that several different trans-envelope signaling switches involved in PUL-mediated O-glycan degradation also modulate capsular polysaccharide synthesis. A novel regulatory pathway, which is dependent on expression of O-glycan-targeting outer membrane proteins, governs this coordinated regulation of glycan catabolism and capsule synthesis. This latter finding provides a new link in the dynamic interplay between complex glycan metabolism, microbial physiology, and host responses that occurs during colonization of the gut.	[Martens, Eric C.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; [Roth, Robyn; Heuser, John E.] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, Campus Box 8510,4444 Forest Pk Ave, St Louis, MO 63108 USA.	jgordon@wustl.edu	Heuser, John/H-5940-2012		National Institutes of Health [DK30292]; Missouri Life Sciences Trust Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI073060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Missouri Life Sciences Trust Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK30292. This work is also supported by the Missouri Life Sciences Trust Fund.	Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; BOOTH SJ, 1979, REV INFECT DIS, V1, P325; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Clements A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003817; Coyne MJ, 2008, P NATL ACAD SCI USA, V105, P13099, DOI 10.1073/pnas.0804220105; Coyne MJ, 2008, J BACTERIOL, V190, P736, DOI 10.1128/JB.01559-07; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Della JN, 1996, J BACTERIOL, V178, P7180; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; HEUSER J, 1981, TRENDS BIOCHEM SCI, V6, P64, DOI 10.1016/0968-0004(81)90024-4; Heuser J E, 1989, Prog Clin Biol Res, V295, P71; HEUSER JE, 1979, J CELL BIOL, V82, P150, DOI 10.1083/jcb.82.1.150; Holdeman L.V., 1975, ANAEROBE LAB MANUAL; Karlsson NG, 1997, BIOCHEM J, V326, P911, DOI 10.1042/bj3260911; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vingadassalom D, 2005, MOL MICROBIOL, V56, P888, DOI 10.1111/j.1365-2958.2005.04590.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	33	119	121	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18445	18457		10.1074/jbc.M109.008094	http://dx.doi.org/10.1074/jbc.M109.008094			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19403529	Green Published, hybrid			2022-12-27	WOS:000267712400056
J	Wang, HY; Zhang, XS; Geng, LY; Teng, LS; Legerski, RJ				Wang, Haiyong; Zhang, Xiaoshan; Geng, Liyi; Teng, Lisong; Legerski, Randy J.			Artemis Regulates Cell Cycle Recovery from the S Phase Checkpoint by Promoting Degradation of Cyclin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; STRAND BREAK REPAIR; POLO-LIKE KINASE-1; F-BOX PROTEIN; GENOTOXIC STRESS; PROTEASOME PATHWAY; MAMMALIAN-CELLS; PHOSPHORYLATION; ATM; ACTIVATION	Artemis, a member of the SNM1 gene family, is a known phosphorylation target of ATM, ATR, and DNA-PKcs. We have previously identified two serine residues in Artemis (Ser(516) and Ser(645)) that are subject to phosphorylation by ATM and are involved in mediating recovery from the G(2)/M checkpoint in response to ionizing radiation. Here we show that these same sites are also phosphorylated by ATR in response to various types of replication stress including UVC, aphidicolin, and hydroxyurea. We also show that mutation of the Ser(516) and Ser(645) residues causes a prolonged S phase checkpoint recovery after treatment with UV or aphidicolin, and that this delayed recovery process coincides with a prolonged stabilization of cyclin E and down-regulation of Cdk2 kinase activity. Furthermore, we show that Artemis interacts with the F-box protein Fbw7, and that this interaction regulates cyclin E degradation through the SCFFbw7 E3 ubiquitin ligase complex. The interaction between Artemis and Fbw7 is regulated by phosphorylation of Ser(516) and Ser(645) sites that occur in response to replication stress. Thus, our findings suggest a novel pathway of recovery from the S phase checkpoint in that in response to replication stress phosphorylation of Artemis by ATR enhances its interaction with Fbw7, which in turn promotes ubiquitylation and the ultimate degradation of cyclin E.	[Wang, Haiyong; Geng, Liyi; Legerski, Randy J.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Wang, Haiyong; Teng, Lisong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Zhejiang University	Legerski, RJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	rlegersk@mdanderson.org		Wang, Haiyong/0000-0003-0124-5301	National Institutes of Health NCI [CA096574, CA097175]; Cancer Center Support [CA16672]; NATIONAL CANCER INSTITUTE [R01CA096574, P01CA097175, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NCI Grants CA096574 and CA097175 ( to R. J. L.). This work was also supported by DNA sequencing resources from Cancer Center Support Grant CA16672.	Bansal P, 2007, CANCER RES, V67, P3356, DOI 10.1158/0008-5472.CAN-06-3685; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Chen L, 2005, CANCER SCI, V96, P134, DOI 10.1111/j.1349-7006.2005.00019.x; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dahm K, 2007, J CELL BIOCHEM, V100, P1346, DOI 10.1002/jcb.21226; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Freire R, 2006, CELL CYCLE, V5, P2831, DOI 10.4161/cc.5.24.3559; Geng LY, 2007, MOL CELL BIOL, V27, P2625, DOI 10.1128/MCB.02072-06; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Poinsignon C, 2004, EUR J IMMUNOL, V34, P3146, DOI 10.1002/eji.200425455; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Soubeyrand S, 2006, J MOL BIOL, V358, P1200, DOI 10.1016/j.jmb.2006.02.061; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wang JH, 2005, DNA REPAIR, V4, P556, DOI 10.1016/j.dnarep.2005.02.001; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; WIMMEL A, 1994, ONCOGENE, V9, P995; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Yin MB, 1999, EXP CELL RES, V247, P189, DOI 10.1006/excr.1998.4346; Zhang XS, 2004, MOL CELL BIOL, V24, P9207, DOI 10.1128/MCB.24.20.9207-9220.2004; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	47	23	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18236	18243		10.1074/jbc.M109.002584	http://dx.doi.org/10.1074/jbc.M109.002584			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19423708	hybrid, Green Published			2022-12-27	WOS:000267712400036
J	Wang, Q; Liu-Chen, LY; Traynor, JR				Wang, Qin; Liu-Chen, Lee-Yuan; Traynor, John R.			Differential Modulation of mu- and delta-Opioid Receptor Agonists by Endogenous RGS4 Protein in SH-SY5Y Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; INTRACELLULAR CALCIUM; SIGNALING PROTEINS; MESSENGER-RNA; DRUG TARGETS; RAT-BRAIN; EXPRESSION; BINDING; REGULATOR; TOLERANCE	Regulator of G-protein signaling (RGS) proteins are a family of molecules that control the duration of G protein signaling. A variety of RGS proteins have been reported to modulate opioid receptor signaling. Here we show that RGS4 is abundantly expressed in human neuroblastoma SH-SY5Y cells that endogenously express mu- and delta-opioid receptors and test the hypothesis that the activity of opioids in these cells is modulated by RGS4. Endogenous RGS4 protein was reduced by similar to 90% in SH-SY5Y cells stably expressing short hairpin RNA specifically targeted to RGS4. In these cells, the potency and maximal effect of delta-opioid receptor agonist (SNC80)-mediated inhibition of forskolin-stimulated cAMP accumulation was increased compared with control cells. This effect was reversed by transient transfection of a stable RGS4 mutant (HA-RGS4C2S). Furthermore, MAPK activation by SNC80 was increased in cells with knockdown of RGS4. In contrast, there was no change in the mu-opioid ( morphine) response at adenylyl cyclase or MAPK. FLAG-tagged opioid receptors and HA-RGS4C2S were transiently expressed in HEK293T cells, and co-immunoprecipitation experiments showed that the delta-opioid receptor but not the mu-opioid receptor could be precipitated together with the stable RGS4. Using chimeras of the delta- and mu-opioid receptors, the C-tail and third intracellular domain of the delta-opioid receptor were suggested to be the sites of interaction with RGS4. The findings demonstrate a role for endogenous RGS4 protein in modulating delta-opioid receptor signaling in SH-SY5Y cells and provide evidence for a receptor-specific effect of RGS4.	[Wang, Qin; Traynor, John R.] Univ Michigan, Dept Pharmacol, Sch Med, Ann Arbor, MI 48109 USA; [Traynor, John R.] Univ Michigan, Subst Abuse Res Ctr, Sch Med, Ann Arbor, MI 48109 USA; [Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Traynor, JR (corresponding author), Univ Michigan, Dept Pharmacol, Sch Med, 1303 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	jtraynor@umich.edu			National Institutes of Health [DA04087, DA17302]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017302, R01DA004087, P30DA013429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA04087 ( to J. R. T.) and DA17302 ( to L. Y.- L. C.).	Alt A, 2002, BRIT J PHARMACOL, V135, P217, DOI 10.1038/sj.bjp.0704430; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Clark MJ, 2003, J BIOL CHEM, V278, P9418, DOI 10.1074/jbc.M208885200; Clark MJ, 2004, METHOD ENZYMOL, V389, P155; Connor M, 1996, BRIT J PHARMACOL, V117, P333, DOI 10.1111/j.1476-5381.1996.tb15195.x; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Dhawan BN, 1996, PHARMACOL REV, V48, P567; Elenko E, 2003, MOL PHARMACOL, V64, P11, DOI 10.1124/mol.64.1.11; Garnier M, 2003, J PHARMACOL EXP THER, V304, P1299, DOI 10.1124/jpet.102.043471; Garzon J, 2005, NEUROPSYCHOPHARMACOL, V30, P1632, DOI 10.1038/sj.npp.1300726; Garzon J, 2004, NEUROPSYCHOPHARMACOL, V29, P1091, DOI 10.1038/sj.npp.1300408; Georgoussi Z, 2006, CELL SIGNAL, V18, P771, DOI 10.1016/j.cellsig.2005.07.003; Gold SJ, 1997, J COMP NEUROL, V385, P491, DOI 10.1002/(SICI)1096-9861(19970908)385:4<491::AID-CNE1>3.0.CO;2-Z; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Huang P, 2007, BRAIN RES, V1184, P46, DOI 10.1016/j.brainres.2007.09.096; Ippolito DL, 2002, J BIOL CHEM, V277, P32692, DOI 10.1074/jbc.M204407200; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; LAW PY, 1991, J PHARMACOL EXP THER, V256, P710; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Neill JD, 1997, ENDOCRINOLOGY, V138, P843, DOI 10.1210/en.138.2.843; Neitzel KL, 2006, SEMIN CELL DEV BIOL, V17, P383, DOI 10.1016/j.semcdb.2006.03.002; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Psifogeorgou K, 2007, J NEUROCHEM, V103, P617, DOI 10.1111/j.1471-4159.2007.04812.x; SADEE W, 1987, CANCER RES, V47, P5207; Schwendt M, 2006, J NEUROCHEM, V96, P1606, DOI 10.1111/j.1471-4159.2006.03669.x; Siderovski DP, 1999, CRIT REV BIOCHEM MOL, V34, P215, DOI 10.1080/10409239991209273; Snow BE, 2002, METHOD ENZYMOL, V344, P740; Szekeres PG, 1997, J PHARMACOL EXP THER, V283, P1276; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; UHL GR, 1994, TRENDS NEUROSCI, V17, P89, DOI 10.1016/0166-2236(94)90110-4; Ulens C, 2000, LIFE SCI, V67, P2305, DOI 10.1016/S0024-3205(00)00820-1; Wang Q, 2004, METHOD ENZYMOL, V389, P244; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xie GX, 2005, ANESTH ANALG, V100, P1034, DOI 10.1213/01.ANE.0000147711.51122.4B; Xie ZH, 2007, EUR J PHARMACOL, V565, P45, DOI 10.1016/j.ejphar.2007.03.005; Xu W, 2000, BIOCHEMISTRY-US, V39, P13904, DOI 10.1021/bi001099p; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; YU VC, 1988, J PHARMACOL EXP THER, V245, P350; YU VC, 1990, J NEUROCHEM, V55, P1390, DOI 10.1111/j.1471-4159.1990.tb03151.x; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zheng B, 1999, TRENDS BIOCHEM SCI, V24, P411, DOI 10.1016/S0968-0004(99)01474-7; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837	49	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18357	18367		10.1074/jbc.M109.015453	http://dx.doi.org/10.1074/jbc.M109.015453			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416973	Green Published, hybrid			2022-12-27	WOS:000267712400048
J	Haid, S; Pietschmann, T; Pecheur, EI				Haid, Sibylle; Pietschmann, Thomas; Pecheur, Eve-Isabelle			Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	15th International Symposium on Hepatitis C Virus and Related Viruses	OCT 05-09, 2008	San Antonio, TX				HUMAN MONOCLONAL-ANTIBODIES; B TYPE-I; SEMLIKI-FOREST-VIRUS; SCAVENGER-RECEPTOR; CELL-CULTURE; NEUTRALIZING ANTIBODIES; CONFORMATIONAL EPITOPES; HYPERVARIABLE REGION-1; LIPOPROTEIN RECEPTOR; ENVELOPE PROTEIN	Hepatitis C virus (HCV) is an enveloped, positive strand RNA virus of about 9.6 kb. Like all enveloped viruses, the HCV membrane fuses with the host cell membrane during the entry process and thereby releases the genome into the cytoplasm, initiating the viral replication cycle. To investigate the features of HCV membrane fusion, we developed an in vitro fusion assay using cell culture-produced HCV and fluorescently labeled liposomes. With this model we could show that HCV-mediated fusion can be triggered in a receptor-independent but pH-dependent manner and that fusion of the HCV particles with liposomes is dependent on the viral dose and on the lipid composition of the target membranes. In addition CBH-5, an HCV E2-specific antibody, inhibited fusion in a dose-dependent manner. Interestingly, point mutations in E2, known to abrogate HCV glycoprotein-mediated fusion in a cell-based assay, altered or even abolished fusion in the liposome-based assay. When assaying the fusion properties of HCV particles with different buoyant density, we noted higher fusogenicity of particles with lower density. This could be attributable to inherently different properties of low density particles, to association of these particles with factors stimulating fusion, or to co-floatation of factors enhancing fusion activity in trans. Taken together, these data show the important role of lipids of both the viral and target membranes in HCV-mediated fusion, point to a crucial role played by the E2 glycoprotein in the process of HCV fusion, and reveal an important behavior of HCV of different densities with regard to fusion.	[Haid, Sibylle; Pietschmann, Thomas] Hannover Med Sch & Helmholtz Ctr Infect Res, Ctr Expt & Clin Infect Res, TWINCORE, Dept Expt Virol, D-30625 Hannover, Germany; [Pecheur, Eve-Isabelle] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, IFR Lyon Biosci Gerland 182,UMR 5086, F-69367 Lyon, France	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Pietschmann, T (corresponding author), Hannover Med Sch & Helmholtz Ctr Infect Res, Ctr Expt & Clin Infect Res, TWINCORE, Dept Expt Virol, D-30625 Hannover, Germany.	thomas.pietschmann@twincore.de; e.pecheur@ibcp.fr	Pietschmann, Thomas/E-9241-2015	Pietschmann, Thomas/0000-0001-5138-6239; Pecheur, Eve/0000-0002-8613-862X				Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658; Boriskin YS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-56; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Brooks MJ, 2004, CURR OPIN PULM MED, V10, P197, DOI 10.1097/00063198-200405000-00009; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Drummer HE, 2007, J GEN VIROL, V88, P1144, DOI 10.1099/vir.0.82567-0; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Helle F, 2008, CELL MOL LIFE SCI, V65, P100, DOI 10.1007/s00018-007-7291-8; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; KARBER G, 1951, N-S ARCH EX PATH PH, V212, P509; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2007, J VIROL, V81, P1043, DOI 10.1128/JVI.01710-06; Keck ZY, 2005, J VIROL, V79, P13199, DOI 10.1128/JVI.79.21.13199-13208.2005; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kobayashi M, 2006, J VIROL, V80, P1817, DOI 10.1128/JVI.80.4.1817-1825.2006; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LINDENBACH BD, 2001, FIELDS VIROLOGY, V1, P991; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; MOESBY L, 1995, BIOCHEMISTRY-US, V34, P10319, DOI 10.1021/bi00033a001; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murphy D, 2007, HEPATOLOGY, V46, p623A; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Pecheur EI, 2007, BIOCHEMISTRY-US, V46, P6050, DOI 10.1021/bi700181j; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; SHIMIZU YK, 1994, J VIROL, V68, P1494, DOI 10.1128/JVI.68.3.1494-1500.1994; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; SMITH LC, 1978, ANNU REV BIOCHEM, V47, P751, DOI 10.1146/annurev.bi.47.070178.003535; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; Stamataki Z, 2008, CLIN LIVER DIS, V12, P693, DOI 10.1016/j.cld.2008.03.008; STEGMANN T, 1986, J BIOL CHEM, V261, P966; Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Umashankar M, 2008, J VIROL, V82, P9245, DOI 10.1128/JVI.00975-08; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Voisset C, 2008, CELL MICROBIOL, V10, P606, DOI 10.1111/j.1462-5822.2007.01070.x; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	83	72	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17657	17667		10.1074/jbc.M109.014647	http://dx.doi.org/10.1074/jbc.M109.014647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	460QP	19411248	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000267202500032
J	Lu, BB; Benning, C				Lu, Binbin; Benning, Christoph			A 25-Amino Acid Sequence of the Arabidopsis TGD2 Protein Is Sufficient for Specific Binding of Phosphatidic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID TRAFFICKING; RAF-1 KINASE; METABOLISM; CELLS; IDENTIFICATION; TRANSLOCATION; MEMBRANE; DOMAINS; PLANTS	Genetic analysis suggests that the TGD2 protein of Arabidopsis is required for the biosynthesis of endoplasmic reticulum derived thylakoid lipids. TGD2 is proposed to be the substrate-binding protein of a presumed lipid transporter consisting of the TGD1 (permease) and TGD3 (ATPase) proteins. The TGD1, -2, and -3 proteins are localized in the inner chloroplast envelope membrane. TGD2 appears to be anchored with an N-terminal membrane-spanning domain into the inner envelope membrane, whereas the C-terminal domain faces the intermembrane space. It was previously shown that the C-terminal domain of TGD2 binds phosphatidic acid (PtdOH). To investigate the PtdOH binding site of TGD2 in detail, the C-terminal domain of the TGD2 sequence lacking the transit peptide and transmembrane sequences was fused to the C terminus of the Discosoma sp. red fluorescent protein (DR). This greatly improved the solubility of the resulting DR-TGD2C fusion protein following production in Escherichia coli. The DR-TGD2C protein bound PtdOH with high specificity, as demonstrated by membrane lipid-protein overlay and liposome association assays. Internal deletion and truncation mutagenesis identified a previously undescribed minimal 25-amino acid fragment in the C-terminal domain of TGD2 that is sufficient for PtdOH binding. Binding characteristics of this 25-mer were distinctly different from those of TGD2C, suggesting that additional sequences of TGD2 providing the proper context for this 25-mer are needed for wild type-like PtdOH binding.	[Lu, Binbin; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Lu, Binbin] Michigan State Univ, Dept Energy Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Benning, C (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Biochem 215, E Lansing, MI 48824 USA.	benning@msu.edu	Benning, Christoph/Y-2528-2019	Benning, Christoph/0000-0001-8585-3667	National Science Foundation [MCB-0741395]; Michigan Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); Michigan Agricultural Experiment Station	This work was supported in part by a grant from the National Science Foundation (MCB-0741395) and the Michigan Agricultural Experiment Station.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Benning C, 2008, PROG LIPID RES, V47, P381, DOI 10.1016/j.plipres.2008.04.001; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; Chitale S, 2001, CELL MICROBIOL, V3, P247, DOI 10.1046/j.1462-5822.2001.00110.x; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Jones JA, 2002, J BIOL CHEM, V277, P15530, DOI 10.1074/jbc.M111555200; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lopez-Andreo MJ, 2003, MOL BIOL CELL, V14, P4885, DOI 10.1091/mbc.E03-05-0295; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Mamedov TG, 2005, PLANT J, V42, P832, DOI 10.1111/j.1365-313X.2005.02416.x; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4661, DOI 10.1021/bi00134a018; ROUGHAN PG, 1980, BIOCHEM J, V188, P17, DOI 10.1042/bj1880017; ROUGHAN PG, 1982, ANNU REV PLANT PHYS, V33, P97, DOI 10.1146/annurev.pp.33.060182.000525; Sano H, 1998, J BIOL CHEM, V273, P4783, DOI 10.1074/jbc.273.8.4783; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Xu CC, 2008, PLANT CELL, V20, P2190, DOI 10.1105/tpc.108.061176; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101	31	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17420	17427		10.1074/jbc.M109.016014	http://dx.doi.org/10.1074/jbc.M109.016014			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19416982	hybrid, Green Published			2022-12-27	WOS:000267202500008
J	Odawara, H; Iwasaki, T; Horiguchi, J; Rokutanda, N; Hirooka, K; Miyazaki, W; Koibuchi, Y; Shimokawa, N; Iino, Y; Takeyoshi, I; Koibuchi, N				Odawara, Hiroki; Iwasaki, Toshiharu; Horiguchi, Jun; Rokutanda, Nana; Hirooka, Kazumi; Miyazaki, Wataru; Koibuchi, Yukio; Shimokawa, Noriaki; Iino, Yuichi; Takeyoshi, Izumi; Koibuchi, Noriyuki			Activation of Aromatase Expression by Retinoic Acid Receptor-related Orphan Receptor (ROR) alpha in Breast Cancer Cells IDENTIFICATION OF A NOVEL ROR RESPONSE ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-CHAIN-REACTION; AMINO-TERMINAL DOMAINS; ESTROGEN BIOSYNTHESIS; REVERSE TRANSCRIPTION; CYP19 EXPRESSION; MESSENGER-RNA; STROMAL CELLS; GENE; TISSUE; CYTOCHROME-P-450	Estrogen is a key regulator of the proliferation and differentiation of breast cancer cells. In addition to the estrogen supply from the ovary, estrogen is produced locally from androgen by aromatase. However, the regulation of aromatase gene expression in breast cancer has not yet been fully clarified. Retinoic acid receptor-related orphan receptor (ROR) alpha plays an important role in the differentiation of many organs by regulating the transcription of target genes. Because aromatase and ROR alpha are expressed in breast cancer, the effect of ROR alpha on aromatase gene expression was studied. ROR alpha significantly augmented the expression of aromatase mRNA, particularly those containing exon I.4, in MCF7 cells, and aromatase activities in T47D and MCF7 cells. ROR alpha also stimulated the proliferation of these cells. Transient transfection-based reporter gene assays using the promoter at exon I. 4 showed that ROR alpha augmented the transcription. A series of truncated mutation studies revealed that ROR alpha activated the transcription through -147 to +14 bp of the promoter I.4. Furthermore, ROR alpha bound to the fragment containing -119 to -107 bp of the promoter in vitro, indicating that this region may contain a novel ROR response element. Chromatin immunoprecipitation assay showed that ROR alpha bound to the region containing this site of the promoter I. 4 in MCF7 cells. Moreover, we examined clinical samples and found a correlation between ROR alpha and aromatase expression. These results suggest that ROR alpha directly activates the aromatase expression to accelerate the local production of estrogen, which results in the proliferation of breast cancer cells.	[Iwasaki, Toshiharu; Hirooka, Kazumi; Miyazaki, Wataru; Shimokawa, Noriaki; Koibuchi, Noriyuki] Gunma Univ, Grad Sch Med, Dept Integrat Physiol, Gunma 3718511, Japan; [Koibuchi, Yukio; Takeyoshi, Izumi] Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Gunma 3718511, Japan; [Iino, Yuichi] Gunma Univ, Grad Sch Med, Dept Emergency Med, Gunma 3718511, Japan	Gunma University; Gunma University; Gunma University	Iwasaki, T (corresponding author), Gunma Univ, Grad Sch Med, Dept Integrat Physiol, 3-39-22 Showa Machi, Gunma 3718511, Japan.	tiwasaki@med.gunma-u.ac.jp		Koibuchi, Noriyuki/0000-0002-2247-9740	Ministry of Education, Culture, Sports, Science and Technology of Japan [17591319, 16591247, 18790928]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research 17591319 (to J.H. and T.I.), 16591247 (to Y.K. and N.K.), and 18790928 (to H.O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ACKERMAN GE, 1981, J CLIN ENDOCR METAB, V53, P412, DOI 10.1210/jcem-53-2-412; Atkins GB, 1999, MOL ENDOCRINOL, V13, P1550, DOI 10.1210/me.13.9.1550; BOLUFER P, 1992, J CLIN ONCOL, V10, P438, DOI 10.1200/JCO.1992.10.3.438; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; Bulun SE, 2003, J STEROID BIOCHEM, V86, P219, DOI 10.1016/S0960-0760(03)00359-5; CALBERG C, 1994, MOL ENDOCRINOL, V8, P757; Chen SU, 2001, J STEROID BIOCHEM, V79, P35, DOI 10.1016/S0960-0760(01)00132-7; Chetrite GS, 2000, J STEROID BIOCHEM, V72, P23, DOI 10.1016/S0960-0760(00)00040-6; Dal J, 2001, MOL CELL ENDOCRINOL, V176, P111, DOI 10.1016/S0303-7207(01)00449-X; EVANS CT, 1986, P NATL ACAD SCI USA, V83, P6387, DOI 10.1073/pnas.83.17.6387; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FISHMAN J, 1981, J BIOL CHEM, V256, P4466; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; HARADA N, 1993, P NATL ACAD SCI USA, V90, P11312, DOI 10.1073/pnas.90.23.11312; HARADA N, 1990, BIOCHEM BIOPH RES CO, V166, P365, DOI 10.1016/0006-291X(90)91954-Q; Harris JM, 2002, MOL ENDOCRINOL, V16, P998, DOI 10.1210/me.16.5.998; JAMES V H T, 1987, Steroids, V50, P269, DOI 10.1016/0039-128X(83)90077-6; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kinoshita Y, 2003, CANCER RES, V63, P3546; Koibuchi N, 1999, ENDOCRINOLOGY, V140, P1356, DOI 10.1210/en.140.3.1356; Lau P, 1999, NUCLEIC ACIDS RES, V27, P411, DOI 10.1093/nar/27.2.411; MCBROOM LDB, 1995, MOL CELL BIOL, V15, P796; MEANS GD, 1989, J BIOL CHEM, V264, P19385; Miki Y, 2007, CANCER RES, V67, P3945, DOI 10.1158/0008-5472.CAN-06-3105; MILLER W R, 1987, Steroids, V50, P537, DOI 10.1016/0039-128X(87)90037-7; MILLER WR, 1990, J STEROID BIOCHEM, V37, P1055, DOI 10.1016/0960-0760(90)90465-W; MILLER WR, 1991, J STEROID BIOCHEM, V39, P783, DOI 10.1016/0960-0760(91)90026-2; Miyazaki W, 2004, J BIOL CHEM, V279, P18195, DOI 10.1074/jbc.M310531200; Miyoshi Y, 2001, INT J CANCER, V94, P685, DOI 10.1002/ijc.1525; NAKAJIN S, 1986, BIOCHEM BIOPH RES CO, V134, P704, DOI 10.1016/S0006-291X(86)80477-6; Plant N, 2007, BBA-GEN SUBJECTS, V1770, P478, DOI 10.1016/j.bbagen.2006.09.024; Sasano H, 1998, ENDOCR REV, V19, P593, DOI 10.1210/er.19.5.593; Sebastian S, 2001, J CLIN ENDOCR METAB, V86, P4600, DOI 10.1210/jc.86.10.4600; Shao WL, 2004, BREAST CANCER RES, V6, P39, DOI 10.1186/bcr742; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Suzuki T, 2005, ENDOCR-RELAT CANCER, V12, P701, DOI 10.1677/erc.1.00834; THOMPSON EA, 1974, J BIOL CHEM, V249, P5373; Utsumi T, 1996, J CLIN ENDOCR METAB, V81, P2344, DOI 10.1210/jc.81.6.2344; VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900; Watanabe M, 2005, EUR J ENDOCRINOL, V152, P619, DOI 10.1530/eje.1.01882; ZHAO Y, 1995, MOL ENDOCRINOL, V9, P340, DOI 10.1210/me.9.3.340; Zhou CB, 1996, J STEROID BIOCHEM, V59, P163, DOI 10.1016/S0960-0760(96)00100-8	44	36	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17711	17719		10.1074/jbc.M109.009241	http://dx.doi.org/10.1074/jbc.M109.009241			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19439415	Green Published, hybrid			2022-12-27	WOS:000267202500037
J	Yanagida, K; Masago, K; Nakanishi, H; Kihara, Y; Hamano, F; Tajima, Y; Taguchi, R; Shimizu, T; Ishii, S				Yanagida, Keisuke; Masago, Kayo; Nakanishi, Hiroki; Kihara, Yasuyuki; Hamano, Fumie; Tajima, Yoko; Taguchi, Ryo; Shimizu, Takao; Ishii, Satoshi			Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA(6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; AUTOSOMAL RECESSIVE HYPOTRICHOSIS; HUMAN HAIR-GROWTH; ENDOTHELIAL-CELLS; EDG-FAMILY; SPHINGOSINE 1-PHOSPHATE; MORPHOLOGICAL-CHANGES; MOLECULAR-CLONING; WOOLLY HAIR; ROCK-I	p2y5 is an orphan G protein-coupled receptor that is closely related to the fourth lysophosphatidic acid (LPA) receptor, LPA(4). Here we report that p2y5 is a novel LPA receptor coupling to the G(13)-Rho signaling pathway. "LPA receptor-null" RH7777 and B103 cells exogenously expressing p2y5 showed [H-3] LPA binding, LPA-induced [S-35] guanosine 5'-3-O-(thio) triphosphate binding, Rho-dependent alternation of cellular morphology, and G(s/13) chimeric protein-mediated cAMP accumulation. LPA-induced contraction of human umbilical vein endothelial cells was suppressed by small interfering RNA knockdown of endogenously expressed p2y5. We also found that 2-acyl-LPA had higher activity to p2y5 than 1-acyl-LPA. A recent study has suggested that p2y5 is an LPA receptor essential for human hair growth. We confirmed that p2y5 is a functional LPA receptor and propose to designate this receptor LPA(6).	[Shimizu, Takao; Ishii, Satoshi] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Nakanishi, Hiroki; Tajima, Yoko; Taguchi, Ryo] Univ Tokyo, Fac Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; [Taguchi, Ryo] CREST, Kawaguchi, Saitama 3328613, Japan; [Ishii, Satoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3328613, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Ishii, S (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mame@m.u-tokyo.ac.jp	Kihara, Yasuyuki/C-8801-2011; Shimizu, Takao/AAV-7052-2021	Kihara, Yasuyuki/0000-0001-7462-3006; Nakanishi, Hiroki/0000-0002-5108-1598	Ministry of Education, Science, Sports, Culture, and Technology of Japan; Ministry of Health, Labor, and Welfare, Japan; Global Centers of Excellence Program; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, Culture, and Technology of Japan (to S. I. and T. S.); a grant to the Respiratory Failure Research Group from the Ministry of Health, Labor, and Welfare, Japan (to S. I.); grants-in-aid for comprehensive research on aging and health from the Ministry of Health, Labor, and Welfare, Japan (to S. I.) and the Global Centers of Excellence Program (to T. S.); and research fellowships of the Japan Society for the Promotion of Science (to K. Y. and Y. K.).	Ali G, 2007, HUM GENET, V121, P319, DOI 10.1007/s00439-007-0344-0; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Azeem Z, 2008, HUM GENET, V123, P515, DOI 10.1007/s00439-008-0507-7; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cooper MA, 2004, J MOL RECOGNIT, V17, P286, DOI 10.1002/jmr.675; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Hara T, 2009, MOL PHARMACOL, V75, P85, DOI 10.1124/mol.108.052225; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Herr DR, 2007, CURR DRUG TARGETS, V8, P155, DOI 10.2174/138945007779315669; Hirakawa M, 2004, J PHYSIOL-LONDON, V558, P479, DOI 10.1113/jphysiol.2004.065334; Hsu SH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1021, DOI 10.1152/ajpendo.00003.2007; Im DS, 2004, J LIPID RES, V45, P410, DOI 10.1194/jlr.R300006-JLR200; Im DS, 2000, MOL PHARMACOL, V57, P753, DOI 10.1124/mol.57.4.753; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jelani M, 2008, CLIN GENET, V74, P184, DOI 10.1111/j.1399-0004.2008.01011.x; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Murph M, 2006, CLIN CANCER RES, V12, P6598, DOI 10.1158/1078-0432.CCR-06-1721; NAHUM S, 2009, ARCH DERMAT IN PRESS; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Panetti TS, 2002, BBA-MOL CELL BIOL L, V1582, P190, DOI 10.1016/S1388-1981(02)00155-5; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Petukhova L, 2008, GENOMICS, V92, P273, DOI 10.1016/j.ygeno.2008.06.009; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; Qian L, 2006, CHEMMEDCHEM, V1, P376, DOI 10.1002/cmdc.200500042; ROGALSKA E, 1993, J BIOL CHEM, V268, P792; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Shimomura Y, 2009, EXP DERMATOL, V18, P218, DOI 10.1111/j.1600-0625.2008.00788.x; Shimomura Y, 2009, J INVEST DERMATOL, V129, P622, DOI 10.1038/jid.2008.290; Smyth SS, 2008, BBA-MOL CELL BIOL L, V1781, P563, DOI 10.1016/j.bbalip.2008.05.008; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, BIOCHEM J, V365, P617, DOI 10.1042/BJ20020348; TOKUMURA A, 1995, PROG LIPID RES, V34, P151, DOI 10.1016/0163-7827(95)00001-G; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Xu Y, 2005, J MED CHEM, V48, P3319, DOI 10.1021/jm049186t; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Ye XQ, 2008, HUM REPROD UPDATE, V14, P519, DOI 10.1093/humupd/dmn023; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v	60	189	198	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17731	17741		10.1074/jbc.M808506200	http://dx.doi.org/10.1074/jbc.M808506200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19386608	hybrid, Green Published			2022-12-27	WOS:000267202500039
J	Bogani, F; Chua, CN; Boehmer, PE				Bogani, Federica; Chua, Chian New; Boehmer, Paul E.			Reconstitution of Uracil DNA Glycosylase-initiated Base Excision Repair in Herpes Simplex Virus-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN ICP8; VIRAL REPLICATION; STRAND EXCHANGE; HUMAN-CELLS; POLYMERASE; TYPE-1; IDENTIFICATION; PURIFICATION; GENES; PROCESSIVITY	Herpes simplex virus-1 is a large double-stranded DNA virus that is self-sufficient in a number of genome transactions. Hence, the virus encodes its own DNA replication apparatus and is capable of mediating recombination reactions. We recently reported that the catalytic subunit of the HSV-1 DNA polymerase (UL30) exhibits apurinic/apyrimidinic and 5'-deoxyribose phosphate lyase activities that are integral to base excision repair. Base excision repair is required to maintain genome stability as a means to counter the accumulation of unusual bases and to protect from the loss of DNA bases. Here we have reconstituted a system with purified HSV-1 and human proteins that perform all the steps of uracil DNA glycosylase-initiated base excision repair. In this system nucleotide incorporation is dependent on the HSV-1 uracil DNA glycosylase (UL2), human AP endonuclease, and the HSV-1 DNA polymerase. Completion of base excision repair can be mediated by T4 DNA ligase as well as human DNA ligase I or ligase III alpha-XRCC1 complex. Of these, ligase III alpha-XRCC1 is the most efficient. Moreover, ligase III alpha-XRCC1 confers specificity onto the reaction in as much as it allows ligation to occur in the presence of the HSV-1 DNA polymerase processivity factor (UL42) and prevents base excision repair from occurring with heterologous DNA polymerases. Completion of base excision repair in this system is also dependent on the incorporation of the correct nucleotide. These findings demonstrate that the HSV-1 proteins in combination with cellular factors that are not encoded by the virus are capable of performing base excision repair. These results have implications on the role of base excision repair in viral genome maintenance during lytic replication and reactivation from latency.	[Bogani, Federica; Chua, Chian New; Boehmer, Paul E.] Arizona State Univ, Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85004 USA	Arizona State University; Arizona State University-Downtown Phoenix; University of Arizona	Boehmer, PE (corresponding author), 425 N 5th St, Phoenix, AZ USA.	boehmer@email.arizona.edu		Boehmer, Paul/0000-0003-4479-0529	National Institutes of Health [GM62643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62643.	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Boehmer PE, 2003, PROG NUCLEIC ACID RE, V75, P139, DOI 10.1016/S0079-6603(03)75005-3; Boehmer PE, 2003, IUBMB LIFE, V55, P13, DOI 10.1080/1521654031000070645; Boehmer PE, 1996, METHOD ENZYMOL, V275, P16; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Bogani F, 2008, P NATL ACAD SCI USA, V105, P11709, DOI 10.1073/pnas.0806375105; Courcelle CT, 2001, J VIROL, V75, P7592, DOI 10.1128/JVI.75.16.7592-7601.2001; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; FOCHER F, 1992, CHROMOSOMA, V102, pS67, DOI 10.1007/BF02451788; GALLO ML, 1988, J VIROL, V62, P2874, DOI 10.1128/JVI.62.8.2874-2883.1988; GALLO ML, 1989, J VIROL, V63, P5023, DOI 10.1128/JVI.63.12.5023-5029.1989; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; KNOPF KW, 1979, EUR J BIOCHEM, V98, P231, DOI 10.1111/j.1432-1033.1979.tb13181.x; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; MCGEOCH DJ, 1988, J VIROL, V62, P444, DOI 10.1128/JVI.62.2.444-453.1988; MULLANEY J, 1989, J GEN VIROL, V70, P449, DOI 10.1099/0022-1317-70-2-449; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Nimonkar AV, 2003, NUCLEIC ACIDS RES, V31, P5275, DOI 10.1093/nar/gkg740; Nimonkar AV, 2002, J BIOL CHEM, V277, P15182, DOI 10.1074/jbc.M109988200; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; PURIFOY DJM, 1977, NATURE, V269, P621, DOI 10.1038/269621a0; PYLES RB, 1994, J VIROL, V68, P4963, DOI 10.1128/JVI.68.8.4963-4972.1994; Qi JY, 2005, NUCLEIC ACIDS RES, V33, P3185, DOI 10.1093/nar/gki632; QUINN JP, 1985, NUCLEIC ACIDS RES, V13, P8143, DOI 10.1093/nar/13.22.8143; Reuven NB, 2004, J MOL BIOL, V342, P57, DOI 10.1016/j.jmb.2004.07.012; Severini A, 1996, J VIROL, V70, P3169, DOI 10.1128/JVI.70.5.3169-3175.1996; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; STOW ND, 1992, J GEN VIROL, V73, P313, DOI 10.1099/0022-1317-73-2-313; Tomkinson AE, 2001, PROG NUCLEIC ACID RE, V68, P151; VAUGHAN PJ, 1985, J VIROL, V53, P501, DOI 10.1128/JVI.53.2.501-508.1985; Wang YF, 2008, BIOORG MED CHEM LETT, V18, P3597, DOI 10.1016/j.bmcl.2008.04.076; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; WILLIAMS MV, 1984, J BIOL CHEM, V259, P80; WOLTERS M, 1989, NUCLEIC ACIDS RES, V17, P5163, DOI 10.1093/nar/17.13.5163; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988; Zhu Y, 2008, DNA REPAIR, V7, P95, DOI 10.1016/j.dnarep.2007.08.001	40	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16784	16790		10.1074/jbc.M109.010413	http://dx.doi.org/10.1074/jbc.M109.010413			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19411250	Green Published, hybrid			2022-12-27	WOS:000266962400014
J	D'mello, V; Singh, S; Wu, Y; Birge, RB				D'mello, Veera; Singh, Sukhwinder; Wu, Yi; Birge, Raymond B.			The Urokinase Plasminogen Activator Receptor Promotes Efferocytosis of Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ALPHA-V-BETA-5 INTEGRIN; SURFACE CALRETICULIN; PROSTATIC CARCINOMAS; RAC1 ACTIVATION; VITRONECTIN; ADHESION; PHAGOCYTOSIS; MIGRATION; BINDING	The urokinase receptor (uPAR), expressed on the surface of many cell types, coordinates plasmin-mediated cell surface proteolysis for matrix remodeling and promotes cell adhesion by acting as a binding protein for vitronectin. There is great clinical interest in uPAR in the cancer field as numerous reports have demonstrated that up-regulation of the uPA system is correlated with malignancy of various carcinomas. Using both stable cell lines overexpressing uPAR and transient gene transfer, here we provide evidence for a non-reported role of uPAR in the phagocytosis of apoptotic cells, a process that has recently been termed efferocytosis. When uPAR was expressed in human embryonic kidney cells, hamster melanoma cells, or breast cancer cells (BCCs), there was a robust enhancement in the efferocytosis of apoptotic cells. uPAR-expressing cells failed to stimulate engulfment of viable cells, suggesting that uPAR enhances recognition of one or more determinant on the surface of the apoptotic cell. uPAR-mediated engulfment was not inhibited by expression of mutant beta 5 integrin, nor was alpha v beta 5 integrin-mediated engulfment modulated by cleavage of uPAR by phosphatidylinositol-specific phospholipase C. Further, we found that the more aggressive BCCs had a higher phagocytic capacity that correlated with uPAR expression and cleavage of membrane-associated uPAR in MDA-MB231 BCCs significantly impaired phagocytic activity. Because efferocytosis is critical for the resolution of inflammation and production of anti-inflammatory cytokines, overexpression of uPAR in tumor cells may promote a tolerogenic microenvironment that favors tumor progression.	[Birge, Raymond B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Singh, Sukhwinder] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Birge, RB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.	birgera@umdnj.edu	D'Mello, Veera/GNM-5247-2022	Singh, Sukhwinder/0000-0002-7061-0096				Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Alfano M, 2003, J LEUKOCYTE BIOL, V74, P750, DOI 10.1189/jlb.0403176; BLASI F, 1993, BIOESSAYS, V15, P105, DOI 10.1002/bies.950150206; Carriero MV, 1999, CANCER RES, V59, P5307; Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Croucher DR, 2007, BIOCHEM J, V408, P203, DOI 10.1042/BJ20070767; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Franco P, 2006, J CELL SCI, V119, P3424, DOI 10.1242/jcs.03067; Furlan F, 2004, J CELL SCI, V117, P2909, DOI 10.1242/jcs.01149; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; GYETKO MR, 1995, J LEUKOCYTE BIOL, V58, P533, DOI 10.1002/jlb.58.5.533; HIENERT G, 1988, J UROLOGY, V140, P1466, DOI 10.1016/S0022-5347(17)42074-X; HOYERHANSEN G, 1992, J BIOL CHEM, V267, P18224; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; KIRCHHEIMER JC, 1985, INVAS METAST, V5, P344; Kjoller L, 2002, BIOL CHEM, V383, P5, DOI 10.1515/BC.2002.002; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Miyake H, 1999, PROSTATE, V39, P123, DOI 10.1002/(SICI)1097-0045(19990501)39:2<123::AID-PROS7>3.0.CO;2-2; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Park YJ, 2008, P NATL ACAD SCI USA, V105, P11784, DOI 10.1073/pnas.0801394105; Patel VA, 2007, AUTOIMMUNITY, V40, P274, DOI 10.1080/08916930701357463; Petzinger J, 2007, CELL COMMUN ADHES, V14, P137, DOI 10.1080/15419060701557487; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Pollanen J, 1988, Adv Exp Med Biol, V233, P187; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Reuning U, 1998, INT J ONCOL, V13, P893; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; Romer J, 1996, NAT MED, V2, P725, DOI 10.1038/nm0796-725a; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Schmitt M, 1995, J Obstet Gynaecol (Tokyo 1995), V21, P151; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Singh S, 2007, BIOCHEM BIOPH RES CO, V364, P540, DOI 10.1016/j.bbrc.2007.10.049; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Tang H, 1998, J BIOL CHEM, V273, P18268, DOI 10.1074/jbc.273.29.18268; VAHERI A, 1990, CELL DIFFER DEV, V32, P255, DOI 10.1016/0922-3371(90)90038-X; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; WUN TC, 1987, J BIOL CHEM, V262, P3646; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393	56	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17030	17038		10.1074/jbc.M109.010066	http://dx.doi.org/10.1074/jbc.M109.010066			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19383607	Green Published, hybrid			2022-12-27	WOS:000266962400041
J	Betzenhauser, MJ; Wagner, LE; Park, HS; Yule, DI				Betzenhauser, Matthew J.; Wagner, Larry E., II; Park, Hyung Seo; Yule, David I.			ATP Regulation of Type-1 Inositol 1,4,5-Trisphosphate Receptor Activity Does Not Require Walker A-type ATP-binding Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNELS; RYANODINE RECEPTOR; FUNCTIONAL-CHARACTERIZATION; TRISPHOSPHATE RECEPTORS; SIGNAL-TRANSDUCTION; SKELETAL-MUSCLE; CALCIUM; EXPRESSION; SENSITIVITY; CEREBELLUM	ATP is known to increase the activity of the type-1 inositol 1,4,5-trisphosphate receptor (InsP(3)R1). This effect is attributed to the binding of ATP to glycine rich Walker A-type motifs present in the regulatory domain of the receptor. Only two such motifs are present in neuronal S2+ splice variant of InsP(3)R1 and are designated the ATPA and ATPB sites. The ATPA site is unique to InsP(3)R1, and the ATPB site is conserved among all three InsP(3)R isoforms. Despite the fact that both the ATPA and ATPB sites are known to bind ATP, the relative contribution of these two sites to the enhancing effects of ATP on InsP(3)R1 function is not known. We report here a mutational analysis of the ATPA and ATPB sites and conclude neither of these sites is required for ATP modulation of InsP(3)R1. ATP augmented InsP(3)-induced Ca2+ release from permeabilized cells expressing wild type and ATP-binding site-deficient InsP(3)R1. Similarly, ATP increased the single channel open probability of the mutated InsP(3)R1 to the same extent as wild type. ATP likely exerts its effects on InsP(3)R1 channel function via a novel and as yet unidentified mechanism.	[Betzenhauser, Matthew J.; Wagner, Larry E., II; Park, Hyung Seo; Yule, David I.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol,Med Ctr, Rochester, NY 14642 USA; [Park, Hyung Seo] Konyang Univ, Coll Med, Dept Physiol, Taejon 302718, South Korea	University of Rochester; Konyang University; Konyang University Hospital	Yule, DI (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	David_Yule@urmc.rochester.edu			National Institutes of Health [R01-DK054568, R01-DE016999]; National Institutes of Health, NIDCR [T32-DE07202]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202, R01DE016999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK054568 and R01-DE016999 (to D. I. Y.). 1; Supported by National Institutes of Health, NIDCR Training Grant T32-DE07202.	ABE K, 1987, J NEUROCHEM, V48, P503, DOI 10.1111/j.1471-4159.1987.tb04121.x; Anyatonwu G, 2009, J BIOL CHEM, V284, P8093, DOI 10.1074/jbc.M806932200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Dias JM, 2006, BIOCHEMISTRY-US, V45, P9408, DOI 10.1021/bi060623a; Du GG, 2001, BIOCHEM J, V360, P97, DOI 10.1042/0264-6021:3600097; ERECINSKA M, 1994, PROG NEUROBIOL, V43, P37, DOI 10.1016/0301-0082(94)90015-9; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Foskett JK, 2004, BIOL RES, V37, P513, DOI 10.4067/s0716-97602004000400004; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; Kaplin AI, 1996, J NEUROSCI, V16, P2002; MAEDA N, 1991, J BIOL CHEM, V266, P1109; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Maes K, 2000, CELL CALCIUM, V27, P257, DOI 10.1054/ceca.2000.0121; MAK DOD, 1994, J BIOL CHEM, V269, P29375; Mak DOD, 1999, J BIOL CHEM, V274, P22231, DOI 10.1074/jbc.274.32.22231; Mak DOD, 2001, J GEN PHYSIOL, V117, P447, DOI 10.1085/jgp.117.5.447; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Park HS, 2008, J BIOL CHEM, V283, P26081, DOI 10.1074/jbc.M804184200; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Street VA, 1997, J NEUROSCI, V17, P635; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Tu HP, 2002, BIOPHYS J, V82, P1995, DOI 10.1016/S0006-3495(02)75548-3; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; ZARKA A, 1993, EUR J BIOCHEM, V213, P147, DOI 10.1111/j.1432-1033.1993.tb17744.x	40	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16156	16163		10.1074/jbc.M109.006452	http://dx.doi.org/10.1074/jbc.M109.006452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386591	Green Published, hybrid			2022-12-27	WOS:000266730900012
J	Kuhn, U; Gundel, M; Knoth, A; Kerwitz, Y; Rudel, S; Wahle, E				Kuehn, Uwe; Guendel, Miriam; Knoth, Anne; Kerwitz, Yvonne; Ruedel, Sabine; Wahle, Elmar			Poly(A) Tail Length Is Controlled by the Nuclear Poly(A)-binding Protein Regulating the Interaction between Poly(A) Polymerase and the Cleavage and Polyadenylation Specificity Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; HELA-CELL NUCLEAR; BINDING-PROTEIN; SUBUNIT; SEQUENCE; EUKARYOTES; EXPRESSION; MECHANISM; CLONING; REGION	Poly(A) tails of mRNAs are synthesized in the cell nucleus with a defined length, similar to 250 nucleotides in mammalian cells. The same type of length control is seen in an in vitro polyadenylation system reconstituted from three proteins: poly(A) polymerase, cleavage and polyadenylation specificity factor (CPSF), and the nuclear poly(A)-binding protein (PABPN1). CPSF, binding the polyadenylation signal AAUAAA, and PABPN1, binding the growing poly(A) tail, cooperatively stimulate poly(A) polymerase such that a complete poly(A) tail is synthesized in one processive event, which terminates at a length of similar to 250 nucleotides. We report that PABPN1 is required to restrict CPSF binding to the AAUAAA sequence and to permit the stimulation of poly(A) polymerase by AAUAAA-bound CPSF to be maintained throughout the elongation reaction. The stimulation by CPSF is disrupted when the poly(A) tail has reached a length of similar to 250 nucleotides, and this terminates processive elongation. PABPN1 measures the length of the tail and is responsible for disrupting the CPSF-poly(A) polymerase interaction.	[Kuehn, Uwe; Guendel, Miriam; Knoth, Anne; Kerwitz, Yvonne; Ruedel, Sabine; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Wahle, E (corresponding author), Kurt Mothes Str 3, D-06120 Halle, Germany.	ewahle@biochemtech.uni-halle.de		Wahle, Elmar/0000-0003-2504-0677	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft.	Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; BRAWERMAN G, 1981, CRC CR REV BIOCH MOL, V10, P1, DOI 10.3109/10409238109114634; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; CHRISTOFORI G, 1989, MOL CELL BIOL, V9, P193, DOI 10.1128/MCB.9.1.193; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; GRONER B, 1974, BIOCHEMISTRY-US, V13, P5378, DOI 10.1021/bi00723a020; Gu HD, 1999, P NATL ACAD SCI USA, V96, P8943, DOI 10.1073/pnas.96.16.8943; Hentze MW, 2007, TRANSLATIONAL CONTRO, P269; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; JENNY A, 1995, NUCLEIC ACIDS RES, V23, P2629, DOI 10.1093/nar/23.14.2629; Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; KLANN E, 2007, TRANSLATIONAL CONTRO, P485; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Kwak JE, 2008, P NATL ACAD SCI USA, V105, P14644, DOI 10.1073/pnas.0803185105; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Matzura O, 1996, COMPUT APPL BIOSCI, V12, P247; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; MURTHY KGK, 1992, J BIOL CHEM, V267, P14804; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0; Rao MN, 1996, NUCLEIC ACIDS RES, V24, P4078, DOI 10.1093/nar/24.20.4078; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; SAWICKI SG, 1977, J MOL BIOL, V113, P219, DOI 10.1016/0022-2836(77)90051-1; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; STREISIN.G, 1967, P NATL ACAD SCI USA, V57, P292, DOI 10.1073/pnas.57.2.292; TAKAGAKI Y, 1988, CELL, V52, P731, DOI 10.1016/0092-8674(88)90411-4; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Thompson B, 2007, TRANSLATIONAL CONTRO, V48, P507; WAHLE E, 1991, J BIOL CHEM, V266, P3131; WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; Winstall E, 2000, J BIOL CHEM, V275, P21817, DOI 10.1074/jbc.M002412200; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	54	112	116	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22803	22814		10.1074/jbc.M109.018226	http://dx.doi.org/10.1074/jbc.M109.018226			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19509282	Green Published, hybrid			2022-12-27	WOS:000268963100034
J	Wegiel, B; Baty, CJ; Gallo, D; Csizmadia, E; Scott, JR; Akhavan, A; Chin, BY; Kaczmarek, E; Alam, J; Bach, FH; Zuckerbraun, BS; Otterbein, LE				Wegiel, Barbara; Baty, Catherine J.; Gallo, David; Csizmadia, Eva; Scott, Jeffrey R.; Akhavan, Ardavan; Chin, Beek Y.; Kaczmarek, Elzbieta; Alam, Jawed; Bach, Fritz H.; Zuckerbraun, Brian S.; Otterbein, Leo E.			Cell Surface Biliverdin Reductase Mediates Biliverdin-induced Anti-inflammatory Effects via Phosphatidylinositol 3-Kinase and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTS RAT LIVERS; CARBON-MONOXIDE; HEME OXYGENASE-1; BILIRUBIN; ACTIVATION; MEMBRANE	Biliverdin reductase A (BVR) catalyzes the reduction of biliverdin (BV) to bilirubin (BR) in all cells. Others and we have shown that biliverdin is a potent anti-inflammatory molecule, however, the mechanism by which BV exerts its protective effects is unclear. We describe and elucidate a novel finding demonstrating that BVR is expressed on the external plasma membrane of macrophages (and other cells) where it quickly converts BV to BR. The enzymatic conversion of BV to BR on the surface by BVR initiates a signaling cascade through tyrosine phosphorylation of BVR on the cytoplasmic tail. Phosphorylated BVR in turn binds to the p85 alpha subunit of phosphatidylinositol 3-kinase and activates downstream signaling to Akt. Using bacterial endotoxin (lipopolysaccharide) to initiate an inflammatory response in macrophages, we find a rapid increase in BVR surface expression. One of the mechanisms by which BV mediates its protective effects in response to lipopolysaccharide is through enhanced production of interleukin-10 (IL-10) the prototypical anti-inflammatory cytokine. IL-10 regulation is dependent in part on the activation of Akt. The effects of BV on IL-10 expression are lost with blockade of Akt. Inhibition of surface BVR with RNA interference attenuates BV-induced Akt signaling and IL-10 expression and in vivo negates the cytoprotective effects of BV in models of shock and acute hepatitis. Collectively, our findings elucidate a potentially important new molecular mechanism by which BV, through the enzymatic activity and phosphorylation of surface BVR (BVR) surf modulates the inflammatory response.	[Wegiel, Barbara; Gallo, David; Csizmadia, Eva; Scott, Jeffrey R.; Chin, Beek Y.; Kaczmarek, Elzbieta; Bach, Fritz H.; Otterbein, Leo E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Transplant Inst, Boston, MA 02215 USA; [Baty, Catherine J.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15213 USA; [Akhavan, Ardavan; Zuckerbraun, Brian S.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA; [Alam, Jawed] Louisiana State Univ, Dept Mol Genet, Alton Ochsner Fdn, New Orleans, LA 70112 USA; [Alam, Jawed] Louisiana State Univ, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Louisiana State University System; Ochsner Health System; Louisiana State University System	Otterbein, LE (corresponding author), 3 Blackfan Circle,Rm 624, Boston, MA 02215 USA.	lotterbe@bidmc.harvard.edu	Alam, Jawed/F-2596-2010	Alam, Jawed/0000-0001-6520-482X	National Institutes of Health [HL-071797, HL-076167]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076167, R01HL071797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-071797 and HL-076167 ( to L. E. O.).	Ahmad Z, 2002, J BIOL CHEM, V277, P9226, DOI 10.1074/jbc.M108239200; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Berberat PO, 2005, INFLAMM BOWEL DIS, V11, P350, DOI 10.1097/01.MIB.0000164017.06538.8a; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Fondevila C, 2004, HEPATOLOGY, V40, P1333, DOI 10.1002/hep.20480; Fondevila C, 2003, TRANSPLANT P, V35, P1798, DOI 10.1016/S0041-1345(03)00720-6; GARCIASANCHO J, 1977, P NATL ACAD SCI USA, V74, P1488, DOI 10.1073/pnas.74.4.1488; Kikuchi A, 2001, NAT STRUCT BIOL, V8, P221, DOI 10.1038/84955; Kim HP, 2004, FASEB J, V18, P1080, DOI 10.1096/fj.03-1391com; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Maines MD, 2001, J PHARMACOL EXP THER, V296, P1091; McDonagh AF, 2001, NAT STRUCT BIOL, V8, P198, DOI 10.1038/84915; Nakao A, 2004, GASTROENTEROLOGY, V127, P595, DOI 10.1053/j.gastro.2004.05.059; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Persson B, 1996, PROTEIN SCI, V5, P363; Salim M, 2001, J BIOL CHEM, V276, P10929, DOI 10.1074/jbc.M010753200; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; Sass G, 2004, HEPATOLOGY, V40, P1128, DOI 10.1002/hep.20450; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; SUN IL, 1987, BIOCHEM INT, V14, P119; Wang WZW, 2004, HEPATOLOGY, V40, P424, DOI 10.1002/hep.20334; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003	27	84	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21369	21378		10.1074/jbc.M109.027433	http://dx.doi.org/10.1074/jbc.M109.027433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509285	Green Published, hybrid			2022-12-27	WOS:000268564400031
J	Li, YJ; Brodsky, B; Baum, J				Li, Yingjie; Brodsky, Barbara; Baum, Jean			NMR Conformational and Dynamic Consequences of a Gly to Ser Substitution in an Osteogenesis Imperfecta Collagen Model Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; MOLECULAR-STRUCTURE; I COLLAGEN; C-13/N-15-ENRICHED PROTEINS; CRYSTAL-STRUCTURE; BINDING SITES; NATURAL BREAK; MUTATIONS; SPECTROSCOPY; GLYCINE	Close packing of three chains in a standard collagen triple helix requires Gly as every third residue. Missense mutations replacing one Gly by a larger residue in the tripeptide repeating sequence in type I collagen are common molecular causes of osteogenesis imperfecta. The structural and dynamic consequences of such mutations are addressed here by NMR studies on a peptide with a Gly-to-Ser substitution within an alpha 1(I) sequence. Distances derived from nuclear Overhauser effects indicate that the three Ser residues are still packed in the center of the triple helix and that the standard 1-residue stagger is maintained. NMR dynamics using H-exchange and temperature-dependent amide chemical shifts indicate a greater disruption of hydrogen bonding and/or increased conformational flexibility C-terminal to the Ser site when compared with N terminal. This is consistent with recent suggestions relating clinical severity with an asymmetric effect of residues N-versus C-terminal to a mutation site. Dynamic studies also indicate that the relative position between a Gly in one chain and the mutation site in a neighboring staggered chain influences the disruption of the standard hydrogen-bonding pattern. The structural and dynamic alterations reported here may play a role in the etiology of osteogenesis imperfecta by affecting collagen secretion or interactions with other matrix molecules.	[Li, Yingjie; Baum, Jean] Rutgers State Univ, BIOMAPS Inst, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Brodsky, Barbara] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Baum, J (corresponding author), Rutgers State Univ, BIOMAPS Inst, Dept Chem & Chem Biol, 610 Taylor Rd, Piscataway, NJ 08854 USA.	jean.baum@rutgers.edu			National Institutes of Health [GM45302, GM60048]; National Science Foundation [DBI-0320746, DBI-0403062]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045302, R29GM045302, R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM45302 (to J.B.) and GM60048 (to B. B.). This work was also supported by National Science Foundation Grants DBI-0320746 (to J.B.) and DBI-0403062 (to J.B.).	Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602; Bodian DL, 2008, BIOCHEMISTRY-US, V47, P5424, DOI 10.1021/bi800026k; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Buevich A, 2001, PHILOS T R SOC B, V356, P159, DOI 10.1098/rstb.2000.0761; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Hyde TJ, 2006, J BIOL CHEM, V281, P36937, DOI 10.1074/jbc.M605135200; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; LIU X, 1997, THESIS STATE U NEW J, P101; Madhan B, 2008, J AM CHEM SOC, V130, P13520, DOI 10.1021/ja805496v; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; Mohs A, 2005, BIOCHEMISTRY-US, V44, P1793, DOI 10.1021/bi0482708; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; Mooney SD, 2002, MOL CELL PROTEOMICS, V1, P868, DOI 10.1074/mcp.M200064-MCP200; Mooney SD, 2001, BIOPOLYMERS, V58, P347, DOI 10.1002/1097-0282(200103)58:3<347::AID-BIP1011>3.0.CO;2-M; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; POWERS R, 1991, J MAGN RESON, V94, P209, DOI 10.1016/0022-2364(91)90312-H; RAMACHANDRAN GN, 1967, TREATISE COLLAGEN, P103; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Xu K, 2008, J BIOL CHEM, V283, P34337, DOI 10.1074/jbc.M805485200; ZHU GA, 1992, J MAGN RESON, V98, P192, DOI 10.1016/0022-2364(92)90124-P	37	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20660	20667		10.1074/jbc.M109.018077	http://dx.doi.org/10.1074/jbc.M109.018077			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19451653	Green Published, hybrid			2022-12-27	WOS:000268316100027
J	Kyle, JW; Berthoud, VM; Kurutz, J; Minogue, PJ; Greenspan, M; Hanck, DA; Beyer, EC				Kyle, John W.; Berthoud, Viviana M.; Kurutz, Josh; Minogue, Peter J.; Greenspan, Michael; Hanck, Dorothy A.; Beyer, Eric C.			The N Terminus of Connexin37 Contains an alpha-Helix That Is Required for Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; GAP-JUNCTION CHANNEL; MARIE-TOOTH-DISEASE; AMINO-ACID-RESIDUES; 3-DIMENSIONAL STRUCTURE; ALTERED TRAFFICKING; GATING POLARITY; RAT CONNEXIN40; MUTATIONS; CHARGE	The cytoplasmic N-terminal domain of connexins has been implicated in multiple aspects of gap junction function, including connexin trafficking/assembly and channel gating. A synthetic peptide corresponding to the first 23 amino acids of human connexin37 was prepared, and circular dichroism and nuclear magnetic resonance studies showed that this N-terminal peptide was predominantly alpha-helical between glycine 5 and glutamate 16. The importance of this structure for localization of the protein at appositional membranes and channel function was tested by expression of site-directed mutants of connexin37 in which amino acids leucine 10 and glutamine 15 were replaced with prolines or alanines. Wild type connexin37 and both substitution mutants localized to appositional membranes between transfected HeLa cells. The proline mutant did not allow intercellular transfer of microinjected neurobiotin; the alanine mutant allowed transfer, but less extensively than wild type connexin37. When expressed alone in Xenopus oocytes, wild type connexin37 produced hemichannel currents, but neither of the double substitution mutants produced detectable currents. The proline mutant ( but not the alanine mutant) inhibited co-expressed wild type connexin37. Taken together, our data suggest that the alpha-helical structure of the connexin37 N terminus may be dispensable for protein localization, but it is required for channel and hemichannel function.	[Berthoud, Viviana M.; Minogue, Peter J.; Greenspan, Michael; Beyer, Eric C.] Univ Chicago, Dept Pediat, Hematol Oncol Sect, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [Kurutz, Josh] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Beyer, EC (corresponding author), Univ Chicago, Dept Pediat, Hematol Oncol Sect, MC4060,5841 S Maryland Ave, Chicago, IL 60637 USA.	ebeyer@peds.bsd.uchicago.edu	Beyer, Eric/V-1317-2019; Greenspan, Michael/I-2466-2019; Kurutz, Josh/AAE-4641-2022	Beyer, Eric/0000-0001-8044-1356; Kurutz, Josh/0000-0002-3566-0514	National Institutes of Health [HL59199, EY08368]; Bernice Meltzer Fund for Pediatric Cancer Research; NATIONAL EYE INSTITUTE [R01EY008368, R29EY008368] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bernice Meltzer Fund for Pediatric Cancer Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL59199 and EY08368 (to E. C. B.). This work was also supported by the Bernice Meltzer Fund for Pediatric Cancer Research.	Arita K, 2006, AM J PATHOL, V169, P416, DOI 10.2353/ajpath.2006.051242; Beahm DL, 2002, BIOPHYS J, V82, P2016, DOI 10.1016/S0006-3495(02)75550-1; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Common JEA, 2003, CELL COMMUN ADHES, V10, P347, DOI 10.1080/15419060390263128; D'Andrea P, 2002, BIOCHEM BIOPH RES CO, V296, P685, DOI 10.1016/S0006-291X(02)00891-4; DAVIS DG, 1985, J AM CHEM SOC, V107, P2820, DOI 10.1021/ja00295a052; Deschenes SM, 1997, J NEUROSCI, V17, P9077; Dong LX, 2006, J PHYSIOL-LONDON, V576, P787, DOI 10.1113/jphysiol.2006.113837; Ebihara L, 2003, BIOPHYS J, V84, P277, DOI 10.1016/S0006-3495(03)74848-6; Essenfelder GM, 2004, HUM MOL GENET, V13, P1703, DOI 10.1093/hmg/ddh191; Falk MM, 2001, MICROSC RES TECHNIQ, V52, P251, DOI 10.1002/1097-0029(20010201)52:3<251::AID-JEMT1011>3.0.CO;2-#; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GIMLICH RL, 1990, J CELL BIOL, V110, P597, DOI 10.1083/jcb.110.3.597; GIRVIN ME, 1994, J MAGN RESON SER A, V108, P99, DOI 10.1006/jmra.1994.1095; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Kumar N M, 1992, Semin Cell Biol, V3, P3; Kyle JW, 2008, J CELL SCI, V121, P2744, DOI 10.1242/jcs.032482; Kyle JW, 2009, BIOPHYS J, V96, p287A, DOI 10.1016/j.bpj.2008.12.1422; Lagree V, 2003, J CELL SCI, V116, P3189, DOI 10.1242/jcs.00604; Laird DW, 2001, MICROSC RES TECHNIQ, V52, P263, DOI 10.1002/1097-0029(20010201)52:3<263::AID-JEMT1012>3.0.CO;2-Q; Larson D. M., 2000, Molecular Cell Biology Research Communications, V3, P115, DOI 10.1006/mcbr.2000.0200; Lin XM, 2006, J PHYSIOL-LONDON, V570, P251, DOI 10.1113/jphysiol.2005.097188; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Matsuyama W, 2001, J HUM GENET, V46, P307, DOI 10.1007/s100380170064; Minogue PJ, 2005, J BIOL CHEM, V280, P40788, DOI 10.1074/jbc.M504765200; Musa H, 2004, J PHYSIOL-LONDON, V557, P863, DOI 10.1113/jphysiol.2003.059386; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Oh S, 2000, J GEN PHYSIOL, V116, P13, DOI 10.1085/jgp.116.1.13; Oh S, 2008, J PHYSIOL-LONDON, V586, P2445, DOI 10.1113/jphysiol.2008.150805; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Puljung MC, 2004, J GEN PHYSIOL, V124, P587, DOI 10.1085/jgp.200409023; Purnick PEM, 2000, ARCH BIOCHEM BIOPHYS, V381, P181, DOI 10.1006/abbi.2000.1989; Purnick PEM, 2000, BIOPHYS J, V79, P2403, DOI 10.1016/S0006-3495(00)76485-X; REED KE, 1993, J CLIN INVEST, V91, P997, DOI 10.1172/JCI116321; Ressot C, 1998, J NEUROSCI, V18, P4063; Richard G, 2003, J INVEST DERMATOL, V120, P601, DOI 10.1046/j.1523-1747.2003.12080.x; Rouan F, 2003, EXP DERMATOL, V12, P191, DOI 10.1034/j.1600-0625.2003.120210.x; Shibayama J, 2005, CIRC RES, V96, pE83, DOI 10.1161/01.RES.0000168369.79972.d2; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sultana N, 2008, P NATL ACAD SCI USA, V105, P4763, DOI 10.1073/pnas.0708451105; Thomas BC, 2008, INVEST OPHTH VIS SCI, V49, P2549, DOI 10.1167/iovs.07-1658; Tong JJ, 2004, BIOPHYS J, V87, P2397, DOI 10.1529/biophysj.104.039594; Tong JJ, 2006, BIOPHYS J, V91, P2142, DOI 10.1529/biophysj.106.082859; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; VEENSTRA RD, 1994, BIOPHYS J, V66, P1915, DOI 10.1016/S0006-3495(94)80985-3; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441	55	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20418	20427		10.1074/jbc.M109.016907	http://dx.doi.org/10.1074/jbc.M109.016907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19478091	Green Published, hybrid			2022-12-27	WOS:000268097400067
J	Lin, WB; Ye, WD; Cai, LL; Meng, XY; Ke, GF; Huang, CX; Peng, Z; Yu, YH; Golden, JA; Tartakoff, AM; Tao, T				Lin, Wenbo; Ye, Wenduo; Cai, Lanlan; Meng, Xinyi; Ke, Guifen; Huang, Caoxin; Peng, Zi; Yu, Yinhua; Golden, Jeffrey A.; Tartakoff, Alan M.; Tao, Tao			The Roles of Multiple Importins for Nuclear Import of Murine Aristaless-related Homeobox Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; NUCLEOCYTOPLASMIC TRANSPORT; GLUCOCORTICOID-RECEPTOR; TRANSCRIPTION FACTOR; LOCALIZATION SIGNALS; ENDOCRINE PANCREAS; HOMEODOMAIN PROTEIN; MAMMALIAN-CELLS; FETAL LUNG; ALPHA-CELL	Nuclear import of proteins with nuclear localization signals (NLSs) is mediated by shuttling carriers, the importins. Some cargoes display more than a single NLS, and among these are homeodomain proteins such as Arx, which is critical for development of multiple tissues. Arx has two functional NLSs. The present studies show that several pathways can import Arx via its NLS2, which is within its DNA binding homeodomain. Using an in vitro nuclear import assay, we show that import of Arx via NLS2 can be mediated by importin beta 1, importin 9, or importin 13, with binding being strongest to importin beta 1. All binding is sensitive to RanGTP. Experiments based on precise domain deletions indicate that NLS2 binds imp beta 1, imp9, and imp13 and includes both an importin binding subdomain and a regulatory subdomain with arginine residues being important for function. Moreover, Arx can be co-precipitated with these importins when NLS2 is present. Although nuclear import of Arx can be mediated by these three importin beta s, importin beta 1 seems to play the major role judging from in vivo small interfering RNA ablations and the in vitro import assay. This is the first evidence to show the role of importin beta 1 in nuclear import of paired-type homeodomain proteins. We propose a novel and possibly quite general mechanism for nuclear import of paired-type homeodomain proteins which is critical for development.	[Tao, Tao] Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Yu, Yinhua] Univ Houston, Dept Expt Therapeut, Houston, TX 77030 USA; [Yu, Yinhua] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Golden, Jeffrey A.] Univ Penn, Dept Pathol, Sch Med, Philadelphia, PA 19104 USA; [Golden, Jeffrey A.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Tartakoff, Alan M.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Tartakoff, Alan M.] Case Western Reserve Univ, Sch Med, Cell Biol Program, Cleveland, OH 44106 USA	Xiamen University; University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Case Western Reserve University; Case Western Reserve University	Tao, T (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	taotao@xmu.edu.cn	Tao, T/G-3477-2010	Golden, Jeffrey/0000-0001-9933-5502	National Natural Science Foundation of China [3047085, 90608007]; Ministry of Science and Technology of China [2006AA02A310]; National Institutes of Health [NS46616]; NINDS [NS46616]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046616] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Natural Science Foundation of China Grants 3047085 and 90608007 and Ministry of Science and Technology of China Grant 2006AA02A310 (to T. T.). This work was also supported by National Institutes of Health Grant NS46616 through the NINDS NS46616 (to J. A. G.).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Affolter M, 1999, GENE DEV, V13, P913, DOI 10.1101/gad.13.8.913; Baranek C, 2005, NUCLEIC ACIDS RES, V33, P6277, DOI 10.1093/nar/gki947; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Bi XL, 2003, MOL CELL BIOL, V23, P1014, DOI 10.1128/MCB.23.3.1014-1024.2003; CADEPOND F, 1992, EXP CELL RES, V201, P99, DOI 10.1016/0014-4827(92)90352-9; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; Demidenko Z, 2001, DEVELOPMENT, V128, P1359; Do HJ, 2006, FEBS LETT, V580, P1865, DOI 10.1016/j.febslet.2006.02.049; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guillemain G, 2004, BIOCHEM J, V378, P219, DOI 10.1042/BJ20031549; Han SH, 2004, INSECT MOL BIOL, V13, P323, DOI 10.1111/j.0962-1075.2004.00491.x; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; Hood JK, 1999, CURR OPIN CELL BIOL, V11, P241, DOI 10.1016/S0955-0674(99)80032-5; Hussain S, 2008, J VIROL, V82, P7212, DOI 10.1128/JVI.02406-07; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kitamura K, 1997, MECH DEVELOP, V67, P83, DOI 10.1016/S0925-4773(97)00110-X; Knauer SK, 2005, MOL CELL BIOL, V25, P2573, DOI 10.1128/MCB.25.7.2573-2582.2005; Kovac CR, 2000, J BIOL CHEM, V275, P16752, DOI 10.1074/jbc.M001551200; Liang J, 2008, MOL CELL BIOCHEM, V307, P93, DOI 10.1007/s11010-007-9588-1; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Macara LG, 1999, CURR BIOL, V9, pR436, DOI 10.1016/S0960-9822(99)80275-9; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Miyauchi Y, 2005, J BIOL CHEM, V280, P40901, DOI 10.1074/jbc.M509347200; Nasrallah IM, 2004, J CELL BIOL, V167, P411, DOI 10.1083/jcb.200408091; Nawara M, 2006, AM J MED GENET A, V140A, P727, DOI 10.1002/ajmg.a.31151; Ohira R, 2002, MOL GENET METAB, V77, P179, DOI 10.1016/S1096-7192(02)00126-9; Orr HT, 2000, CELL, V101, P1, DOI 10.1016/S0092-8674(00)80617-0; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Ploski JE, 2004, MOL CELL BIOL, V24, P4824, DOI 10.1128/MCB.24.11.4824-4834.2004; Poirier K, 2004, MOL BRAIN RES, V122, P35, DOI 10.1016/j.molbrainres.2003.11.021; Quan Y, 2008, MOL CELL PROTEOMICS, V7, P1254, DOI 10.1074/mcp.M700511-MCP200; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saijou E, 2007, J BIOL CHEM, V282, P32327, DOI 10.1074/jbc.M706793200; Saleh M, 2000, EXP CELL RES, V260, P105, DOI 10.1006/excr.2000.5010; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Shoubridge C, 2007, GENOMICS, V90, P59, DOI 10.1016/j.ygeno.2007.03.005; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tao T, 2004, AM J RESP CELL MOL, V30, P350, DOI 10.1165/rcmb.2003-0126OC; Tao T, 2001, TRAFFIC, V2, P385, DOI 10.1034/j.1600-0854.2001.002006385.x; Tao T, 2006, AM J RESP CELL MOL, V35, P668, DOI 10.1165/rcmb.2006-0073OC; Tartakoff AM, 2000, J STRUCT BIOL, V129, P144, DOI 10.1006/jsbi.2000.4225; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Villanyi Z, 2008, MECH DEVELOP, V125, P196, DOI 10.1016/j.mod.2007.12.001; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yamaguchi YL, 2006, DEV BIOL, V297, P350, DOI 10.1016/j.ydbio.2006.04.465; Yasuhara N, 2004, EXP CELL RES, V297, P285, DOI 10.1016/j.yexcr.2004.03.010; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; Zhang CD, 2000, AM J RESP CELL MOL, V22, P451, DOI 10.1165/ajrcmb.22.4.3929; Zhang YA, 2002, MOL CELL NEUROSCI, V19, P430, DOI 10.1006/mcne.2001.1076	76	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20428	20439		10.1074/jbc.M109.004242	http://dx.doi.org/10.1074/jbc.M109.004242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494118	Green Published, hybrid			2022-12-27	WOS:000268097400068
J	Swietach, P; Patiar, S; Supuran, CT; Harris, AL; Vaughan-Jones, RD				Swietach, Pawel; Patiar, Shalini; Supuran, Claudiu T.; Harris, Adrian L.; Vaughan-Jones, Richard D.			The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell Growths	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA; RAT; TRANSPORT; PROTEIN; IX; CARBONIC-ANHYDRASE-9; MICROENVIRONMENT; CONSEQUENCES; FIBROBLASTS; GLYCOLYSIS	We have studied the role of carbonic anhydrase 9 (CA9), a cancer-associated extracellular isoform of the enzyme carbonic anhydrase in multicellular spheroid growths (radius of similar to 300 mu m) of human colon carcinoma HCT116 cells. Spheroids were transfected with CA9 (or empty vector) and imaged confocally (using fluorescent dyes) for both intracellular pH (pH(i)) and pH in the restricted extracellular spaces (pH(e)). With no CA9 expression, spheroids developed very low pHi (similar to 6.3) and reduced pH(e) (similar to 6.9) at their core, associated with a diminishing gradient of acidity extending out to the periphery. With CA9 expression, core intracellular acidity was less prominent (pH(i) = similar to 6.6), whereas extracellular acidity was enhanced (pH(e) = similar to 6.6), so that radial pHi gradients were smaller and radial pHe gradients were larger. These effects were reversed by eliminating CA9 activity with membrane-impermeant CA inhibitors. The observation that CA9 activity reversibly reduces pHe indicates the enzyme is facilitating CO2 excretion from cells (by converting vented CO2 to extracellular H+), rather than facilitating membrane H+ transport (such as H+ associated with metabolically generated lactic acid). This latter process requires titration of exported H+ ions with extracellular HCO3-, which would reduce rather than increase extracellular acidity. In a multicellular structure, the net effect of CA9 on pHe will depend on the cellular CO2/lactic acid emission ratio (set by local oxygenation and membrane HCO3- uptake). Our results suggest that CO2-producing tumors may express CA9 to facilitate CO2 excretion, thus raising pHi and reducing pHe, which promotes tumor proliferation and survival. The results suggest a possible basis for attenuating tumor development through inhibiting CA9 activity.	[Swietach, Pawel; Vaughan-Jones, Richard D.] Burdon Sanderson Cardiac Sci Ctr, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Patiar, Shalini; Harris, Adrian L.] Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Supuran, Claudiu T.] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy	University of Oxford; University of Oxford; University of Florence	Vaughan-Jones, RD (corresponding author), Burdon Sanderson Cardiac Sci Ctr, Dept Physiol Anat & Genet, Oxford OX1 3PT, England.	richard.vaughan-jones@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020; Harris, Adrian L/ABA-3343-2020; Supuran, Claudiu T/A-5151-2008	Swietach, Pawel/0000-0002-9945-9473; Harris, Adrian L/0000-0003-1376-8409; Supuran, Claudiu/0000-0003-4262-0323	Royal Society and Medical Research Council; British Heart Foundation; Wellcome Trust; EUROXY; Cancer Research UK; British Heart Foundation [RG/08/016/26423] Funding Source: researchfish; Medical Research Council [G0700698] Funding Source: researchfish; MRC [G0700698] Funding Source: UKRI	Royal Society and Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); EUROXY; Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funds from the Royal Society and Medical Research Council (to P. S.), the British Heart Foundation and Wellcome Trust (to R. D. V.-J.), EUROXY, and Cancer Research UK (to A. L. H.).	Airley RE, 2003, INT J CANCER, V104, P85, DOI 10.1002/ijc.10904; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; CARLSSON J, 1988, INT J CANCER, V42, P715, DOI 10.1002/ijc.2910420515; CHAMBARD JC, 1986, EXP CELL RES, V164, P282, DOI 10.1016/0014-4827(86)90029-7; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Griffiths J R, 2001, Novartis Found Symp, V240, P46; GRIFFITHS JR, 1981, BIOSCIENCE REP, V1, P319, DOI 10.1007/BF01114871; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; HOLM E, 1995, CANCER RES, V55, P1373; Huang WC, 2008, CURR BIOL, V18, P781, DOI 10.1016/j.cub.2008.04.049; JEAN T, 1985, J BIOL CHEM, V260, P9678; KATO Y, 1992, J BIOL CHEM, V267, P11424; Kunz-Schughart L, 2000, AM J PHYSIOL-CELL PH, V278, pC765, DOI 10.1152/ajpcell.2000.278.4.C765; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Morgan PE, 2007, AM J PHYSIOL-CELL PH, V293, pC738, DOI 10.1152/ajpcell.00157.2007; PASTOREK J, 1994, ONCOGENE, V9, P2877; Pastorekova S, 1997, GASTROENTEROLOGY, V112, P398, DOI 10.1053/gast.1997.v112.pm9024293; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stewart AK, 2009, J BIOL CHEM, V284, P6126, DOI 10.1074/jbc.M802051200; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2005, J PHYSIOL-LONDON, V566, P793, DOI 10.1113/jphysiol.2005.086165; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; VAUPEL P, 1989, CANCER RES, V49, P6449; Villafuerte FC, 2007, FASEB J, V21, pA1284; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353; Wykoff CC, 2000, CANCER RES, V60, P7075	42	213	216	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20299	20310		10.1074/jbc.M109.006478	http://dx.doi.org/10.1074/jbc.M109.006478			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19458084	Green Published, hybrid			2022-12-27	WOS:000268097400056
J	Wang, JH; Lee, B; Cai, S; Fukui, L; Hu, WD; Chen, Y				Wang, Jianghai; Lee, Brian; Cai, Sheng; Fukui, Lisa; Hu, Weidong; Chen, Yuan			Conformational Transition Associated with E1-E2 Interaction in Small Ubiquitin-like Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKBONE DYNAMICS; ACTIVATING ENZYME; NMR RELAXATION; CHEMICAL-SHIFT; PROTEIN; DOMAIN; SYSTEM; SUMO; E2; INSIGHTS	Ubiquitin-like modifications regulate nearly every aspect of cellular functions. A key step in these modifications is the recognition of the carrier enzyme (E2) by the activating enzyme (E1). In this study, we have found that a critical E2-binding surface on the E1 of the small ubiquitin-like modifier has unusually high populations in both ordered and disordered states. Upon binding the E2, the disordered state is converted to the ordered state, which resembles the structure of the bound conformation, providing a mechanism to resolve the "Levinthal Paradox" search problem in a folding-upon-binding process. The significance of the folding-unfolding equilibrium is shown by the loss of functions of the mutations that shift the equilibrium to the folded state. This study highlights the importance of conformational flexibility in the molecular recognition event.	[Wang, Jianghai; Lee, Brian; Cai, Sheng; Fukui, Lisa; Hu, Weidong; Chen, Yuan] Beckman Res Inst City Hope, Div Immunol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Chen, Y (corresponding author), Beckman Res Inst City Hope, Div Immunol, Duarte, CA 91010 USA.	ychen@coh.org	Moore, Lisa/A-3640-2013	Moore, Lisa/0000-0003-4345-6318	National Institutes of Health [R01GM074748, R01GM086171]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074748, R01GM086171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074748 and R01GM086171.	CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Ebert MO, 2008, BIOCHEMISTRY-US, V47, P1299, DOI 10.1021/bi701767j; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Farrow NA, 1997, BIOCHEMISTRY-US, V36, P2390, DOI 10.1021/bi962548h; Guo B, 2007, BIOCHEM SOC T, V35, P1414, DOI 10.1042/BST0351414; HAAS AL, 1982, J BIOL CHEM, V257, P329; Haas AL, 1997, FASEB J, V11, P1257; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Karplus M, 1997, FOLD DES, V2, pS69, DOI 10.1016/S1359-0278(97)00067-9; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Peng T, 2007, NAT STRUCT MOL BIOL, V14, P325, DOI 10.1038/nsmb1207; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777	33	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20340	20348		10.1074/jbc.M109.000257	http://dx.doi.org/10.1074/jbc.M109.000257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19443651	hybrid, Green Published			2022-12-27	WOS:000268097400060
J	Bellapadrona, G; Stefanini, S; Zamparelli, C; Theil, EC; Chiancone, E				Bellapadrona, Giuliano; Stefanini, Simonetta; Zamparelli, Carlotta; Theil, Elizabeth C.; Chiancone, Emilia			Iron Translocation into and out of Listeria innocua Dps and Size Distribution of the Protein-enclosed Nanomineral Are Modulated by the Electrostatic Gradient at the 3-fold "Ferritin-like" Pores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE DETOXIFICATION; BINDING PROTEIN; H-CHAIN; DODECAMERIC FERRITIN; ESCHERICHIA-COLI; CORE FORMATION; HUMAN-LIVER; SITE; APOFERRITIN; MECHANISM	Elucidating pore function at the 3-fold channels of 12-subunit, microbial Dps proteins is important in understanding their role in the management of iron/hydrogen peroxide. The Dps pores are called "ferritin-like" because of the structural resemblance to the 3-fold channels of 24-subunit ferritins used for iron entry and exit to and from the protein cage. In ferritins, negatively charged residues lining the pores generate a negative electrostatic gradient that guides iron ions toward the ferroxidase centers for catalysis with oxidant and destined for the mineralization cavity. To establish whether the set of three aspartate residues that line the pores in Listeria innocua Dps act in a similar fashion, D121N, D126N, D130N, and D121N/D126N/D130N proteins were produced; kinetics of iron uptake/release and the size distribution of the iron mineral in the protein cavity were compared. The results, discussed in the framework of crystal growth in a confined space, indicate that iron uses the hydrophilic 3-fold pores to traverse the protein shell. For the first time, the strength of the electrostatic potential is observed to modulate kinetic cooperativity in the iron uptake/release processes and accordingly the size distribution of the microcrystalline iron minerals in the Dps protein population.	[Bellapadrona, Giuliano; Stefanini, Simonetta; Zamparelli, Carlotta; Chiancone, Emilia] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Inst Mol Biol & Pathol, CNR, I-00185 Rome, Italy; [Theil, Elizabeth C.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Chiancone, E (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Inst Mol Biol & Pathol, CNR, Pl Moro 5, I-00185 Rome, Italy.	emilia.chiancone@uniroma1.it	Stefanini, Simonetta/D-5083-2009		National Institutes of Health [DK 20251]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK020251, R56DK020251, R01DK020251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 20251 (to G. B. and E. C. T.).	Bozzi M, 1997, J BIOL CHEM, V272, P3259, DOI 10.1074/jbc.272.6.3259; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; Chiaraluce R, 2000, EUR J BIOCHEM, V267, P5733, DOI 10.1046/j.1432-1327.2000.01639.x; Courteix A, 1996, AICHE J, V42, P829, DOI 10.1002/aic.690420321; DELANO W, 2006, PYMOL VERSION 0 99; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; Franceschini S, 2006, FEBS J, V273, P4913, DOI 10.1111/j.1742-4658.2006.05490.x; HILTY S, 1994, J INORG BIOCHEM, V56, P173, DOI 10.1016/0162-0134(94)85004-6; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Ilari A, 2005, BIOCHEMISTRY-US, V44, P5579, DOI 10.1021/bi050005e; Ilari A, 2002, J BIOL CHEM, V277, P37619, DOI 10.1074/jbc.M206186200; Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; LEVI S, 1988, J BIOL CHEM, V263, P18086; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Liu XS, 2007, J BIOL CHEM, V282, P31821, DOI 10.1074/jbc.C700153200; MACARA IG, 1972, BIOCHEM J, V126, P151, DOI 10.1042/bj1260151; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; RICARD J, 1989, BIOPHYS J, V56, P477, DOI 10.1016/S0006-3495(89)82695-5; STEFANINI S, 1989, BIOCHEMISTRY-US, V28, P378, DOI 10.1021/bi00427a052; STEFANINI S, 1976, MOL CELL BIOCHEM, V13, P55, DOI 10.1007/BF01732396; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; SUN SJ, 1993, BIOCHEMISTRY-US, V32, P9362, DOI 10.1021/bi00087a015; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	34	50	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19101	19109		10.1074/jbc.M109.014670	http://dx.doi.org/10.1074/jbc.M109.014670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19457858	Green Published, hybrid			2022-12-27	WOS:000267711500058
J	Bajpai, S; Feng, YF; Krishnamurthy, R; Longmore, GD; Wirtz, D				Bajpai, Saumendra; Feng, Yunfeng; Krishnamurthy, Ranjini; Longmore, Gregory D.; Wirtz, Denis			Loss of alpha-Catenin Decreases the Strength of Single E-cadherin Bonds between Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; RECEPTOR-LIGAND BINDING; TUMOR PROGRESSION; EXPRESSION; ADHESION; CARCINOMA; JUNCTIONS; COMPLEX	The progression of several human cancers correlates with the loss of cytoplasmic protein alpha-catenin from E-cadherin-rich intercellular junctions and loss of adhesion. However, the potential role of alpha-catenin in directly modulating the adhesive function of individual E-cadherin molecules in human cancer is unknown. Here we use single-molecule force spectroscopy to probe the tensile strength, unstressed bond lifetime, and interaction energy between E-cadherins expressed on the surface of live human parental breast cancer cells lacking alpha-catenin and these cells where alpha-catenin is re-expressed. We find that the tensile strength and the lifetime of single E-cadherin/E-cadherin bonds between parental cells are significantly lower over a wide range of loading rates. Statistical analysis of the force displacement spectra reveals that single cadherin bonds between cancer cells feature an exceedingly low energy barrier against tensile forces and low molecular stiffness. Disassembly of filamentous actin using latrunculin B has no significant effect on the strength of single intercellular E-cadherin bonds. The absence of alpha-catenin causes a dominant negative effect on both global cell-cell adhesion and single E-cadherin bond strength. These results suggest that the loss of alpha-catenin alone drastically reduces the adhesive force between individual cadherin pairs on adjoining cells, explain the global loss of cell adhesion in human breast cancer cells, and show that the forced expression of alpha-catenin in cancer cells can restore both higher intercellular avidity and intercellular E-cadherin bond strength.	[Bajpai, Saumendra; Krishnamurthy, Ranjini; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Feng, Yunfeng; Longmore, Gregory D.] Washington Univ, Sch Med, Dept Physiol, St Louis, MO 63110 USA; [Feng, Yunfeng; Longmore, Gregory D.] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; [Wirtz, Denis] Johns Hopkins Univ, Sch Med, Johns Hopkins Kimmel Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA	Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Medicine	Wirtz, D (corresponding author), Johns Hopkins Univ, Dept Chem, 3400 N Charles St, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Ladoux, Benoit/A-9879-2013; Wirtz, Denis/A-3257-2010; Bajpai, Saumendra/B-8120-2014	Bajpai, Saumendra/0000-0002-9397-2102; Feng, Yunfeng/0000-0001-9150-7795	National Institutes of Health [GM080673, CA137891]; American Heart Association [0855319E]; NATIONAL CANCER INSTITUTE [R21CA137891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080673 ( to G. D. L.) and CA137891 ( to D. W.). This work was also supported by Grant-in-aid 0855319E from the American Heart Association ( to D. W.).	Bajpai S, 2008, P NATL ACAD SCI USA, V105, P18331, DOI 10.1073/pnas.0806783105; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Carico E, 2001, GYNECOL ONCOL, V80, P156, DOI 10.1006/gyno.2000.6035; CAVELLERO U, 2004, NAT REV CELL MOL BIO, V4, P118; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Dobrowsky TM, 2008, METHOD CELL BIOL, V89, P411, DOI 10.1016/S0091-679X(08)00615-8; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; KADOWAKI T, 1994, CANCER RES, V54, P291; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Konstantopoulos K, 2003, CURR BIOL, V13, pR611, DOI 10.1016/S0960-9822(03)00529-3; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567; Nakopoulou L, 2002, HISTOPATHOLOGY, V40, P536, DOI 10.1046/j.1365-2559.2002.01392.x; Panorchan P, 2006, J MOL BIOL, V358, P665, DOI 10.1016/j.jmb.2006.02.021; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Ray C, 2007, LANGMUIR, V23, P6076, DOI 10.1021/la070131e; Ropponen KM, 1999, J CLIN PATHOL, V52, P10, DOI 10.1136/jcp.52.1.10; SHIOZAKI H, 1994, AM J PATHOL, V144, P667; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yu J, 2000, GUT, V46, P639, DOI 10.1136/gut.46.5.639	32	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18252	18259		10.1074/jbc.M109.000661	http://dx.doi.org/10.1074/jbc.M109.000661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19458087	hybrid, Green Published			2022-12-27	WOS:000267712400038
J	Bezaire, V; Mairal, A; Ribet, C; Lefort, C; Girousse, A; Jocken, J; Laurencikiene, J; Anesia, R; Rodriguez, AM; Ryden, M; Stenson, BM; Dani, C; Ailhaud, G; Arner, P; Langin, D				Bezaire, Veronic; Mairal, Aline; Ribet, Carole; Lefort, Corinne; Girousse, Amandine; Jocken, Johan; Laurencikiene, Jurga; Anesia, Rodica; Rodriguez, Anne-Marie; Ryden, Mikael; Stenson, Britta M.; Dani, Christian; Ailhaud, Gerard; Arner, Peter; Langin, Dominique			Contribution of Adipose Triglyceride Lipase and Hormone-sensitive Lipase to Lipolysis in hMADS Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN WHITE ADIPOCYTES; STIMULATED LIPOLYSIS; PROTEIN TRAFFICKING; TISSUE LIPOLYSIS; LIPID DROPLETS; FATTY-ACIDS; EXPRESSION; OBESITY; TRIACYLGLYCEROL; VITRO	Lipolysis is the catabolic pathway by which triglycerides are hydrolyzed into fatty acids. Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) have the capacity to hydrolyze in vitro the first ester bond of triglycerides, but their respective contributions to whole cell lipolysis in human adipocytes is unclear. Here, we have investigated the roles of HSL, ATGL, and its coactivator CGI-58 in basal and forskolin-stimulated lipolysis in a human white adipocyte model, the hMADS cells. The hMADS adipocytes express the various components of fatty acid metabolism and show lipolytic capacity similar to primary cultured adipocytes. We show that lipolysis and fatty acid esterification are tightly coupled except in conditions of stimulated lipolysis. Immunocytochemistry experiments revealed that acute forskolin treatment promotes HSL translocation from the cytosol to small lipid droplets and redistribution of ATGL from the cytosol and large lipid droplets to small lipid droplets, resulting in enriched colocalization of the two lipases. HSL or ATGL overexpression resulted in increased triglyceride-specific hydrolase capacity, but only ATGL overexpression increased whole cell lipolysis. HSL silencing had no effect on basal lipolysis and only partially reduced forskolin-stimulated lipolysis. Conversely, silencing of ATGL or CGI-58 significantly reduced basal lipolysis and essentially abolished forskolin-stimulated lipolysis. Altogether, these results suggest that ATGL/CGI-58 acts independently of HSL and precedes its action in the sequential hydrolysis of triglycerides in human hMADS adipocytes.	[Bezaire, Veronic; Mairal, Aline; Ribet, Carole; Lefort, Corinne; Girousse, Amandine; Anesia, Rodica; Langin, Dominique] Equipe 4, U858, INSERM, Lab Rech Obesites,I2MR, F-31432 Toulouse 4, France; [Bezaire, Veronic; Mairal, Aline; Ribet, Carole; Lefort, Corinne; Girousse, Amandine; Anesia, Rodica; Langin, Dominique] Univ Toulouse, UPS, Inst Med Mol Rangueil, IFR150, F-31432 Toulouse, France; [Jocken, Johan; Laurencikiene, Jurga; Ryden, Mikael; Stenson, Britta M.; Arner, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Med, S-14186 Huddinge, Sweden; [Rodriguez, Anne-Marie] Fac Med, INSERM, U955, F-94010 Creteil, France; [Dani, Christian; Ailhaud, Gerard] Univ Nice Sophia Antipolis, Inst Signalisat Biol Dev & Canc, F-06100 Nice, France; [Langin, Dominique] CHU Toulouse, Inst Federatif Biol Purpan, Biochim Lab, F-31059 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Cote d'Azur; CHU de Toulouse	Langin, D (corresponding author), Equipe 4, U858, INSERM, Lab Rech Obesites,I2MR, 1 Ave Jean Poulhes,BP 84225, F-31432 Toulouse 4, France.	dominique.langin@inserm.fr	girousse, amandine/GYD-3740-2022; Rodriguez, Anne-Marie/M-1190-2018; DANI, Christian/G-3639-2014	girousse, amandine/0000-0001-6142-4710; Rodriguez, Anne-Marie/0000-0001-5557-8975; DANI, Christian/0000-0003-3228-0230; Langin, Dominique/0000-0002-2669-7825; Ailhaud, Gerard/0000-0003-0596-2906; Arner, Peter/0000-0002-6208-6220; , Jurga/0000-0002-7032-2924	INSERM; YSL BEAUTE/BRI; Swedish Research Council; Commission of the European Communities Integrated Project HEPADIP [LSHM-CT-2005-018734]; ADAPT Contract [HEALTH-F2-2008-201100]; Natural Sciences and Engineering Research Council of Canada; Netherlands Organization for Scientific Research Grant NWO Rubicon [820.07.025]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); YSL BEAUTE/BRI; Swedish Research Council(Swedish Research CouncilEuropean Commission); Commission of the European Communities Integrated Project HEPADIP; ADAPT Contract; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Netherlands Organization for Scientific Research Grant NWO Rubicon(Netherlands Organization for Scientific Research (NWO))	This work was supported by INSERM, YSL BEAUTE/BRI, the Swedish Research Council, and the Commission of the European Communities Integrated Project HEPADIP Contract LSHM-CT-2005-018734 and Collaborative Project ADAPT Contract HEALTH-F2-2008-201100. This work was also supported by funds from the Natural Sciences and Engineering Research Council of Canada ( to V. B.) and The Netherlands Organization for Scientific Research Grant NWO Rubicon 820.07.025 ( to J. J.).	Belfrage P, 1978, Adv Exp Med Biol, V101, P113; Berndt J, 2008, EXP CLIN ENDOCR DIAB, V116, P203, DOI 10.1055/s-2007-993148; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bougneres P, 1997, J CLIN INVEST, V99, P2568, DOI 10.1172/JCI119444; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; EDENS NK, 1990, J LIPID RES, V31, P1351; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hellstrom L, 1996, DIABETOLOGIA, V39, P921; Holm C, 2001, ADIPOSE TISSUE PROTO, P97; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997; Jocken JWE, 2008, DIABETOLOGIA, V51, P320, DOI 10.1007/s00125-007-0866-y; Jocken JWE, 2007, J CLIN ENDOCR METAB, V92, P2292, DOI 10.1210/jc.2006-1318; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; KHOO JC, 1974, J CLIN INVEST, V53, P1124, DOI 10.1172/JCI107650; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Large V, 1999, J LIPID RES, V40, P2059; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Lowe DB, 2004, BIOORG MED CHEM LETT, V14, P3155, DOI 10.1016/j.bmcl.2004.04.015; Lucas S, 2003, J LIPID RES, V44, P154, DOI 10.1194/jlr.M200250-JLR200; Mairal A, 2006, DIABETOLOGIA, V49, P1629, DOI 10.1007/s00125-006-0272-x; Mazzucotelli A, 2007, DIABETES, V56, P2467, DOI 10.2337/db06-1465; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Raclot T, 2001, BBA-MOL CELL BIOL L, V1532, P88, DOI 10.1016/S1388-1981(01)00119-6; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; STRALFORS P, 1985, FEBS LETT, V180, P280, DOI 10.1016/0014-5793(85)81086-3; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; VAUGHAN M, 1962, J BIOL CHEM, V237, P3354; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang MH, 2006, CHEM BIOL, V13, P1019, DOI 10.1016/j.chembiol.2006.09.010; Wang T, 2003, OBES RES, V11, P880, DOI 10.1038/oby.2003.121; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	50	155	158	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18282	18291		10.1074/jbc.M109.008631	http://dx.doi.org/10.1074/jbc.M109.008631			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433586	Green Published, hybrid			2022-12-27	WOS:000267712400041
J	Mueller, S; Kleinau, G; Szkudlinski, MW; Jaeschke, H; Krause, G; Paschke, R				Mueller, Sandra; Kleinau, Gunnar; Szkudlinski, Mariusz W.; Jaeschke, Holger; Krause, Gerd; Paschke, Ralf			The Superagonistic Activity of Bovine Thyroid-stimulating Hormone (TSH) and the Human TR1401 TSH Analog Is Determined by Specific Amino Acids in the Hinge Region of the Human TSH Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYROTROPIN RECEPTOR; SITE-DIRECTED MUTAGENESIS; HIGH-AFFINITY BINDING; EXTRACELLULAR DOMAIN; ALPHA-SUBUNIT; METABOLIC-CLEARANCE; LIGAND-BINDING; RESIDUES; ACTIVATION; ECTODOMAIN	Bovine TSH (bTSH) has a higher affinity to the human TSHR (hTSHR) and a higher signaling activity than human TSH (hTSH). The molecular reasons for these phenomena are unknown. Distinct negatively charged residues (Glu(297), Glu(303), and Asp(382)) in the hinge region of the hTSHR are known to be important for bTSH binding and signaling. To investigate the potential relevance of these positions for differences between bTSH and hTSH in the interaction to the hTSHR, we determined bTSH-and hTSH-mediated cAMP production of several substitutions at these three hinge residues. To examine specific variations of hTSH, we also investigated the superagonistic hTSH analog TR1401 (TR1401), whose sequence differs from hTSH by four additional positively charged amino acids that are also present in bTSH. To characterize possible interactions between the acidic hTSHR positions Glu297, Glu303, or Asp382 and the additional basic residues of TR1401, we investigated TR1401 binding and signaling properties. Our data reveal increased cAMP signaling of the hTSHR using TR1401 and bTSH compared with hTSH. Whereas Asp382 seems to be important for bTSH-and TR1401-mediated but not for hTSH-mediated signaling, the substitution E297K exhibits a decreased signaling for all three TSH variants. Interestingly, bTSH and TR1401 showed only a slightly different binding pattern. These observations imply that specific residues of the hinge region are mediators of the superagonistic activity of bTSH and TR1401 in contrast to hTSH. Moreover, the simultaneous localization of binding components in the glycoprotein hormone molecule and the receptor hinge region permits important reevaluation of interacting hormone receptor domains.	[Mueller, Sandra; Jaeschke, Holger; Paschke, Ralf] Univ Leipzig, Dept Med 3, D-04103 Leipzig, Germany; [Kleinau, Gunnar; Krause, Gerd] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Szkudlinski, Mariusz W.] Trophogen Inc, Rockville, MD 20850 USA	Leipzig University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Paschke, R (corresponding author), Univ Leipzig, Dept Med, Philipp Rosenthal Str 27, D-04103 Leipzig, Germany.	pasr@medizin.uni-leipzig.de	Kleinau, Gunnar/GPX-6330-2022		Deutsche Forschungsgemeinschaft [KR 1223/1-2, PA 423 12-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KR 1223/1-2 and PA 423 12-2.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; AKAMIZU T, 1993, ENDOCR J, V40, P363, DOI 10.1507/endocrj.40.363; Alberti L, 2001, EUR J ENDOCRINOL, V145, P249, DOI 10.1530/eje.0.1450249; Angelova K, 2004, ENDOCRINE, V24, P25, DOI 10.1385/ENDO:24:1:025; Bhowmick N, 1996, MOL ENDOCRINOL, V10, P1147, DOI 10.1210/me.10.9.1147; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Chen CR, 2001, J BIOL CHEM, V276, P14767, DOI 10.1074/jbc.M008001200; Chistiakov DA, 2003, MOL GENET METAB, V80, P377, DOI 10.1016/j.ymgme.2003.09.001; COSTAGLIOLA S, 1992, J CLIN ENDOCR METAB, V75, P1540, DOI 10.1210/jc.75.6.1540; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; DALLAS JS, 1994, ENDOCRINOLOGY, V134, P1437, DOI 10.1210/en.134.3.1437; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; EASTPALMER J, 1995, THYROID, V5, P55, DOI 10.1089/thy.1995.5.55; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Grossmann M, 1998, NAT BIOTECHNOL, V16, P871, DOI 10.1038/nbt0998-871; Hong SH, 1999, ENDOCRINOLOGY, V140, P2486, DOI 10.1210/en.140.6.2486; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jeffreys J, 2002, THYROID, V12, P1051, DOI 10.1089/105072502321085144; Johnstone AP, 2003, CLIN ENDOCRINOL, V59, P437, DOI 10.1046/j.1365-2265.2003.01864.x; KERMODE JC, 1981, J ENDOCRINOL, V88, P205, DOI 10.1677/joe.0.0880205; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; KOSUGI S, 1991, BIOCHEM BIOPH RES CO, V180, P1118, DOI 10.1016/S0006-291X(05)81182-9; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; MORRIS JC, 1993, J BIOL CHEM, V268, P10900; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2006, J BIOL CHEM, V281, P31638, DOI 10.1074/jbc.M604770200; NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7; NAGAYAMA Y, 1994, THYROID, V4, P155, DOI 10.1089/thy.1994.4.155; NAGAYAMA Y, 1992, J CLIN ENDOCR METAB, V75, P1425, DOI 10.1210/jc.75.6.1425; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Neumann S, 2005, EUR J ENDOCRINOL, V152, P625, DOI 10.1530/eje.1.01891; Nishi S, 2002, J BIOL CHEM, V277, P3958, DOI 10.1074/jbc.M109617200; Nwosu BU, 2006, THYROID, V16, P505, DOI 10.1089/thy.2006.16.505; Puett D, 2007, MOL CELL ENDOCRINOL, V260, P126, DOI 10.1016/j.mce.2006.05.009; RAPOPORT B, 1982, J CLIN ENDOCR METAB, V54, P1059, DOI 10.1210/jcem-54-5-1059; Shepherd PS, 1999, MOL CELL ENDOCRINOL, V149, P197, DOI 10.1016/S0303-7207(98)00207-X; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Szkudlinski MW, 1996, NAT BIOTECHNOL, V14, P1257, DOI 10.1038/nbt1096-1257; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; SZKUDLINSKI MW, 1995, P NATL ACAD SCI USA, V92, P9062, DOI 10.1073/pnas.92.20.9062; THOTAKURA NR, 1991, ENDOCRINOLOGY, V128, P341, DOI 10.1210/endo-128-1-341; Vischer HF, 2006, MOL ENDOCRINOL, V20, P1880, DOI 10.1210/me.2005-0202; Willey KP, 1999, HUM REPROD UPDATE, V5, P330, DOI 10.1093/humupd/5.4.330; Wonerow P, 1998, J BIOL CHEM, V273, P7900, DOI 10.1074/jbc.273.14.7900; Wonerow P, 2001, J MOL MED, V79, P707, DOI 10.1007/s001090100279; YAMAZAKI K, 1995, J CLIN ENDOCR METAB, V80, P473, DOI 10.1210/jc.80.2.473; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200	51	29	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16317	16324		10.1074/jbc.M109.005710	http://dx.doi.org/10.1074/jbc.M109.005710			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386596	hybrid, Green Published			2022-12-27	WOS:000266730900029
J	Stanisic, V; Malovannaya, A; Qin, J; Lonard, DM; O'Malley, BW				Stanisic, Vladimir; Malovannaya, Anna; Qin, Jun; Lonard, David M.; O'Malley, Bert W.			OTU Domain-containing Ubiquitin Aldehyde-binding Protein 1 (OTUB1) Deubiquitinates Estrogen Receptor (ER) alpha and Affects ER alpha Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME; DEGRADATION; COACTIVATOR; TURNOVER; COREGULATORS; MECHANISMS; PATHWAYS; ENZYMES; H2A	Estrogen receptor (ER)alpha is an essential component in human physiology and is a key factor involved in the development of breast and endometrial cancers. ER alpha protein levels and transcriptional activity are tightly controlled by the ubiquitin proteasome system. Deubiquitinating enzymes, a class of proteases capable of removing ubiquitin from proteins, are increasingly being seen as key modulators of the ubiquitin proteasome system, regulating protein stability and other functions by countering the actions of ubiquitin ligases. Using mass spectrometry analysis of an ER alpha protein complex, we identified OTU domain containing ubiquitin aldehyde-binding protein 1 (OTUB1) as a novel ER alpha-interacting protein capable of deubiquitinating ER alpha in cells and in vitro. We show that OTUB1 negatively regulates transcription mediated by ER alpha in transient reporter gene assays and transcription mediated by endogenous ER alpha in Ishikawa endometrial cancer cells. We also show that OTUB1 regulates the availability and functional activity of ER alpha in Ishikawa cells by affecting the transcription of the ER alpha gene and by stabilizing the ER alpha protein in the chromatin.	[Stanisic, Vladimir; Malovannaya, Anna; Qin, Jun; Lonard, David M.; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	O'Malley, BW (corresponding author), 1 Baylor Plaza,BCM502, Houston, TX 77030 USA.	berto@bcm.tmc.edu			National Institutes of Health [HD08818, HD07857]; Welch Foundation [FY09-Q1521]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD007857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grants HD08818 and HD07857 and Welch Foundation Grant FY09-Q1521.	Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Berry NB, 2008, MOL ENDOCRINOL, V22, P1535, DOI 10.1210/me.2007-0449; Callige Mathilde, 2006, Nucl Recept Signal, V4, pe004; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Dhananjayan SC, 2005, ESSAYS BIOCHEM, V41, P69, DOI 10.1042/EB0410069; Eakin CM, 2007, P NATL ACAD SCI USA, V104, P5794, DOI 10.1073/pnas.0610887104; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Glass CK, 2000, GENE DEV, V14, P121; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Herynk MH, 2004, ENDOCR REV, V25, P869, DOI 10.1210/er.2003-0010; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Laios I, 2005, J STEROID BIOCHEM, V94, P347, DOI 10.1016/j.jsbmb.2005.02.005; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Lonard DM, 2008, NATURE, V452, P946, DOI 10.1038/452946a; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe16; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; McKenna NJ, 1999, J STEROID BIOCHEM, V69, P3, DOI 10.1016/S0960-0760(98)00144-7; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nakajima A, 2007, BIOCHEM BIOPH RES CO, V357, P245, DOI 10.1016/j.bbrc.2007.03.134; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Pinzone JJ, 2004, MOL CELL BIOL, V24, P4605, DOI 10.1128/MCB.24.11.4605-4612.2004; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Saji S, 2001, BIOCHEM BIOPH RES CO, V281, P259, DOI 10.1006/bbrc.2001.4339; SHAN TL, 2008, MOL BIOL RE IN PRESS; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	51	65	69	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16135	16145		10.1074/jbc.M109.007484	http://dx.doi.org/10.1074/jbc.M109.007484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19383985	hybrid, Green Published			2022-12-27	WOS:000266730900010
J	Sekiya, M; Nakamoto, RK; Al-Shawi, MK; Nakanishi-Matsui, M; Futai, M				Sekiya, Mizuki; Nakamoto, Robert K.; Al-Shawi, Marwan K.; Nakanishi-Matsui, Mayumi; Futai, Masamitsu			Temperature Dependence of Single Molecule Rotation of the Escherichia coli ATP Synthase F-1 Sector Reveals the Importance of gamma-beta Subunit Interactions in the Catalytic Dwell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSILON-SUBUNIT; UNCOUPLING MUTATION; TORQUE GENERATION; ROTARY MECHANISM; C-RING; ENERGY; F-1-ATPASE; F0F1; MUTANT; MOTOR	The temperature-dependent rotation of F-1-ATPase gamma subunit was observed in V-max conditions at low viscous drag using a 60-nm gold bead (Nakanishi-Matsui, M., Kashiwagi, S., Hosokawa, H., Cipriano, D. J., Dunn, S. D., Wada, Y., and Futai, M. (2006) J. Biol. Chem. 281, 4126-4131). The Arrhenius slopes of the speed of the individual 120 degrees steps and reciprocal of the pause length between rotation steps were very similar, indicating a flat energy pathway followed by the rotationally coupled catalytic cycle. In contrast, the Arrhenius slope of the reciprocal pause length of the gamma M23K mutant F-1 was significantly increased, whereas that of the rotation rate was similar to wild type. The effects of the rotor gamma M23K substitution and the counteracting effects of beta E381D mutation in the interacting stator subunits demonstrate that the rotor-stator interactions play critical roles in the utilization of stored elastic energy. The gamma M23K enzyme must overcome an abrupt activation energy barrier, forcing it onto a less favored pathway that results in uncoupling catalysis from rotation.	[Sekiya, Mizuki; Nakanishi-Matsui, Mayumi; Futai, Masamitsu] Iwate Med Univ, Fac Pharmaceut Sci, Dept Biochem, Yahaba, Iwate 0283694, Japan; [Sekiya, Mizuki; Nakanishi-Matsui, Mayumi; Futai, Masamitsu] Iwate Med Univ, Futai Special Lab, Yahaba, Iwate 0283694, Japan; [Nakamoto, Robert K.; Al-Shawi, Marwan K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	Iwate Medical University; Iwate Medical University; University of Virginia	Futai, M (corresponding author), Iwate Med Univ, Fac Pharmaceut Sci, Dept Biochem, Yahaba, Iwate 0283694, Japan.	futaim@iwate-med.ac.jp			National Institutes of Health [RO1 GM50957, RO1 GM52502]; Core Research for Evolutional Science and Technology, (CREST); Japan Science and Technology Agency; Japanese Ministry of Education, Culture, and Science; Daiichi Pharmaceutical Co., Ltd; Eisai Co., Ltd; Terumo Life Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052502, R01GM050957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Research for Evolutional Science and Technology, (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiichi Pharmaceutical Co., Ltd(Daiichi Sankyo Company Limited); Eisai Co., Ltd(Eisai Co Ltd); Terumo Life Science Foundation(Terumo Life Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM50957 (to R. K. N.) and RO1 GM52502 (to M. K. S.). This work was also supported by Core Research for Evolutional Science and Technology, (CREST) the Japan Science and Technology Agency, the Japanese Ministry of Education, Culture, and Science, funds from Daiichi Pharmaceutical Co., Ltd. and Eisai Co., Ltd., and funds from the Terumo Life Science Foundation (to M. N.-M.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AlShawi MK, 1997, J BIOL CHEM, V272, P2300; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12954, DOI 10.1021/bi971477z; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; ALSHAWI MK, 1990, J BIOL CHEM, V265, P4402; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Boyer P. D., 1979, MEMBRANE BIOENERGETI, P461; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; Futai M., 2004, HDB ATPASES BIOCH CE, P237; Iko Y, 2001, J BIOL CHEM, V276, P47508, DOI 10.1074/jbc.M108803200; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; JEANTEURDEBEUKELAER C, 1995, J BIOL CHEM, V270, P22850; KANAZAWA H, 1980, J BIOCHEM-TOKYO, V88, P695, DOI 10.1093/oxfordjournals.jbchem.a133022; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; NAKAMOTO RK, 1993, J BIOL CHEM, V268, P867; NAKAMOTO RK, 1995, J BIOL CHEM, V270, P14042, DOI 10.1074/jbc.270.23.14042; Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Peskova YB, 2000, BIOCHEMISTRY-US, V39, P11830, DOI 10.1021/bi0013694; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; Shimabukuro K, 2006, BIOPHYS J, V90, P1028, DOI 10.1529/biophysj.105.067298; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; SHIN K, 1992, J BIOL CHEM, V267, P20835; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Tanabe M, 2001, J BIOL CHEM, V276, P15269, DOI 10.1074/jbc.M100289200; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	47	25	26	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22401	22410		10.1074/jbc.M109.009019	http://dx.doi.org/10.1074/jbc.M109.009019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19502237	hybrid, Green Published			2022-12-27	WOS:000268783700062
J	Turk, B; Turk, V				Turk, Boris; Turk, Vito			Lysosomes as "Suicide Bags" in Cell Death: Myth or Reality?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TUMOR-NECROSIS-FACTOR; ALPHA-INDUCED APOPTOSIS; CYSTEINE CATHEPSINS; MEMBRANE PERMEABILIZATION; CYTOCHROME-C; AUTOPHAGY; DISEASE; PROTEASES; CLEAVAGE; PROTEINS		[Turk, Boris; Turk, Vito] Univ Ljubljana, Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Ljubljana	Turk, B (corresponding author), Univ Ljubljana, Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SI-1000 Ljubljana, Slovenia.	boris.turk@ijs.si		Turk, Boris/0000-0002-9007-5764	Human Frontier Science Program [RGP0024/2006-]; Ministry of Higher Education, Science, and Technology of the Republic of Slovenia [P-0140]	Human Frontier Science Program(Human Frontier Science Program); Ministry of Higher Education, Science, and Technology of the Republic of Slovenia	The work was supported by Human Frontier Science Program Grant RGP0024/2006-C (to B. T.) and by Grant P-0140 from the Ministry of Higher Education, Science, and Technology of the Republic of Slovenia (to V. T. and B. T.). This is part of the Thematic Minireview Series on Proteolytic Enzymes. The first article was published in the November 7, 2008 issue; the second and third articles were published in the May 22, 2009 issue; the fourth and fifth articles were published in the July 31, 2009 issue; and the sixth and seventh articles are published in this issue. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Bojic L, 2007, FEBS LETT, V581, P5185, DOI 10.1016/j.febslet.2007.10.005; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Caruso JA, 2006, J BIOL CHEM, V281, P10954, DOI 10.1074/jbc.M508383200; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Cuervo AM, 1998, J MOL MED-JMM, V76, P6, DOI 10.1007/s109-1998-8099-y; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DEDUVE C, 1959, SUBCELLULAR PARTICLE, P128; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Giusti C, 2009, EXP CELL RES, V315, P26, DOI 10.1016/j.yexcr.2008.09.028; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Houseweart MK, 2003, CELL DEATH DIFFER, V10, P1329, DOI 10.1038/sj.cdd.4401309; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nagaraj NS, 2006, J CANCER RES CLIN, V132, P171, DOI 10.1007/s00432-005-0053-9; Nilsson C, 2006, APOPTOSIS, V11, P1149, DOI 10.1007/s10495-006-7108-5; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Tang CH, 2006, MOL CELL BIOL, V26, P2309, DOI 10.1128/MCB.26.6.2309-2316.2006; Tardy C, 2003, CELL DEATH DIFFER, V10, P1090, DOI 10.1038/sj.cdd.4401272; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; TURK B, 1995, BIOL CHEM H-S, V376, P225, DOI 10.1515/bchm3.1995.376.4.225; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wattiaux R, 2007, BIOCHEM J, V403, P89, DOI 10.1042/BJ20061738; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	54	209	213	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21783	21787		10.1074/jbc.R109.023820	http://dx.doi.org/10.1074/jbc.R109.023820			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19473965	hybrid, Green Published			2022-12-27	WOS:000268783700002
J	Leow, CC; Wang, BE; Ross, J; Chan, SM; Zha, JP; Carano, RAD; Frantz, G; Shen, MM; de Sauvage, FJ; Gao, WQ				Leow, Ching Ching; Wang, Bu-er; Ross, Jed; Chan, Sara M.; Zha, Jiping; Carano, Richard A. D.; Frantz, Gretchen; Shen, Michael M.; de Sauvage, Frederic J.; Gao, Wei-Qiang			Prostate-specific Klf6 Inactivation Impairs Anterior Prostate Branching Morphogenesis through Increased Activation of the Shh Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; KRUPPEL-LIKE FACTOR-6; MESENCHYMAL-EPITHELIAL INTERACTIONS; TRANSCRIPTION FACTOR; SONIC-HEDGEHOG; ABNORMAL-DEVELOPMENT; COLORECTAL-CANCER; MICE; GROWTH; EXPRESSION	Kruppel-like factor 6 (Klf6) belongs to a family of zinc finger transcription factors known to play a role in development and tumor suppression. Although Klf6 is highly mutated in prostate cancer, its function in prostate development is unknown. We have generated a prostate-specific Klf6-deficient mouse model and report here a novel role for Klf6 in the regulation of prostate branching morphogenesis. Importantly, our study reveals a novel relationship between Klf6 and the Shh pathway. Klf6-deficiency leads to elevated levels of hedgehog pathway components (Shh, Ptc, and Gli) and loss of their localized expression, which in turn causes impaired lateral branching.	[Leow, Ching Ching; Wang, Bu-er; de Sauvage, Frederic J.; Gao, Wei-Qiang] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Ross, Jed; Carano, Richard A. D.] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Chan, Sara M.; Zha, Jiping; Frantz, Gretchen] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Shen, Michael M.] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Columbia University	de Sauvage, FJ (corresponding author), MS 37,1DNAWay, San Francisco, CA 94080 USA.	sauvage@gene.com; gao@gene.com	Gao, Wei/GXH-0380-2022; de Sauvage, Frederic/ABE-8400-2020; Shen, Michael M/C-7546-2009	de Sauvage, Frederic/0000-0002-5275-2584; Shen, Michael M/0000-0002-4042-1657	National Institutes of Health [CA115985]; NATIONAL CANCER INSTITUTE [R01CA115985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by National Institutes of Health Grant CA115985 (to M. M. S.).	Berman DM, 2004, DEV BIOL, V267, P387, DOI 10.1016/j.ydbio.2003.11.018; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Cunha G R, 1987, Prog Clin Biol Res, V239, P273; CUNHA GR, 1992, J ANDROL, V13, P465; CUNHA GR, 1994, CANCER, V74, P1030, DOI 10.1002/1097-0142(19940801)74:3+<1030::AID-CNCR2820741510>3.0.CO;2-Q; CUNHA GR, 1979, ACCESSORY GLANDS MAL, V6, P1; DONJACOUR AA, 1993, ENDOCRINOLOGY, V132, P2342, DOI 10.1210/en.132.6.2342; Fischer EA, 2001, J AM SOC NEPHROL, V12, P726, DOI 10.1681/ASN.V124726; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Hayward SW, 1996, ACTA ANAT, V155, P94; Hertveldt V, 2008, DEV DYNAM, V237, P883, DOI 10.1002/dvdy.21355; Huber TL, 2001, CURR BIOL, V11, P1456, DOI 10.1016/S0960-9822(01)00427-4; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Jubb Adrian M, 2006, Methods Mol Biol, V326, P255; Kimmelman AC, 2004, ONCOGENE, V23, P5077, DOI 10.1038/sj.onc.1207662; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lamm MLG, 2002, DEV BIOL, V249, P349, DOI 10.1006/dbio.2002.0774; Lamm MLG, 2001, DEV BIOL, V232, P301, DOI 10.1006/dbio.2001.0187; Laub F, 2001, DEV BIOL, V233, P305, DOI 10.1006/dbio.2001.0243; LUNG B, 1981, ANAT REC, V199, P73, DOI 10.1002/ar.1091990108; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Narla G, 2003, AM J PATHOL, V162, P1047, DOI 10.1016/S0002-9440(10)63901-6; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Nemeth JA, 1996, PROSTATE, V28, P124; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Oates AC, 2001, BLOOD, V98, P1792, DOI 10.1182/blood.V98.6.1792; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Pu YB, 2004, DEV BIOL, V273, P257, DOI 10.1016/j.ydbio.2004.06.002; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Reeves HL, 2004, GASTROENTEROLOGY, V126, P1090, DOI 10.1053/j.gastro.2004.01.005; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Thomson AA, 1999, DEVELOPMENT, V126, P3693; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Wang BE, 2003, J BIOL CHEM, V278, P18506, DOI 10.1074/jbc.M300968200; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	46	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21057	21065		10.1074/jbc.M109.001776	http://dx.doi.org/10.1074/jbc.M109.001776			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19494112	Green Published, hybrid			2022-12-27	WOS:000268316100068
J	Lanaspa, MA; Andres-Hernando, A; Rivard, CJ; Dai, Y; Li, NX; Berl, T				Lanaspa, Miguel A.; Andres-Hernando, Ana; Rivard, Christopher J.; Dai, Yue; Li, Nanxing; Berl, Tomas			ZAC1 Is Up-regulated by Hypertonicity and Decreases Sorbitol Dehydrogenase Expression, Allowing Accumulation of Sorbitol in Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; ALDOSE REDUCTASE; OSMOTIC-STRESS; CELLULAR-RESPONSE; DIABETIC-RATS; RENAL-CELLS; GENE; TONICITY; ADAPTATION; MEDULLA	Affymetrix GeneChip technology was employed to detect differentially expressed genes in inner medullary collecting duct (IMCD3) cells grown under isotonic and hypertonic conditions. A marked up-regulation was found for the zinc-finger protein ZAC1 under hypertonic stress (219-fold, p < 0.001). Changes in expression for ZAC1 were verified by quantitative PCR for message and Western blotting for protein. In mouse and human kidney tissues, ZAC1 expression was substantial in the papilla and was absent in the cortex. Furthermore, ZAC1 expression significantly increased in the papilla of mice following 36 h of fluid restriction and decreased in polyuric mice consuming sucrose in water. Because ZAC1 has been described to be a potential negative regulator of sorbitol dehydrogenase (SDH) in hippocampal cells, we examined whether this relationship also occurs in kidney cells under hypertonic stress. We found that stable IMCD3 clones silenced for ZAC1 to varying levels demonstrated an inverse effect on SDH expression. ZAC1 binds to a consensus repression site within the promoter of SDH, pointing to a mechanism whereby ZAC1 acts by repressing SDH transcriptional activity during hypertonic conditions. Taken together, these data strongly suggest that ZAC1 is up-regulated under hypertonic stress and negatively regulates expression of SDH, allowing for accumulation of sorbitol as a compatible organic osmolyte.	[Lanaspa, Miguel A.; Andres-Hernando, Ana; Rivard, Christopher J.; Dai, Yue; Li, Nanxing; Berl, Tomas] Univ Colorado, Dept Renal Dis & Hypertens, Hlth Sci Ctr, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Berl, T (corresponding author), Univ Colorado, Dept Renal Dis & Hypertens, Hlth Sci Ctr, 12700 E 19th Ave,C281, Aurora, CO 80045 USA.	tomas.berl@ucdenver.edu	Lanaspa, Miguel/AAO-4971-2020	Andres-Hernando, Ana/0000-0002-0676-0188	National Institutes of Health [DK-19928, DK-66544]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK019928, R01DK066544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-19928 and DK-66544 (to T.B.).	Abdollahi A, 1997, CANCER RES, V57, P2029; Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Andres-Hernando A, 2008, J BIOL CHEM, V283, P25082, DOI 10.1074/jbc.M802381200; Barz T, 2006, CANCER RES, V66, P11975, DOI 10.1158/0008-5472.CAN-06-1529; Beck FX, 1998, PFLUG ARCH EUR J PHY, V436, P814, DOI 10.1007/s004240050710; Berl T, 2000, AM J KIDNEY DIS, V35, pXLVII, DOI 10.1016/S0272-6386(00)70035-7; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Burger-Kentischer A, 1999, KIDNEY INT, V55, P1417, DOI 10.1046/j.1523-1755.1999.00382.x; Capasso JM, 2003, ANN NY ACAD SCI, V986, P410, DOI 10.1111/j.1749-6632.2003.tb07222.x; Capasso JM, 2001, AM J PHYSIOL-RENAL, V280, pF768, DOI 10.1152/ajprenal.2001.280.5.F768; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; Flogel U, 1996, DEV NEUROSCI-BASEL, V18, P449, DOI 10.1159/000111440; Grunewald RW, 1998, CELL PHYSIOL BIOCHEM, V8, P293, DOI 10.1159/000016291; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Handler JS, 2001, NEPHRON, V87, P106, DOI 10.1159/000045897; Handler JS, 1996, KIDNEY INT, V49, P1682, DOI 10.1038/ki.1996.246; Hoffmann A, 2003, MOL CELL BIOL, V23, P988, DOI 10.1128/MCB.23.3.988-1003.2003; Hoffmann A, 1998, ANN NY ACAD SCI, V865, P49, DOI 10.1111/j.1749-6632.1998.tb11162.x; Huang SM, 2001, ONCOGENE, V20, P2134, DOI 10.1038/sj.onc.1204298; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Kador PF, 1998, EXP EYE RES, V67, P203, DOI 10.1006/exer.1998.0502; Klawitter J, 2008, NEPHRON PHYSIOL, V109, pP1, DOI 10.1159/000129074; Lanaspa MA, 2007, P NATL ACAD SCI USA, V104, P13672, DOI 10.1073/pnas.0702752104; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; MORIYAMA T, 1989, J BIOL CHEM, V264, P16810; Pagotto U, 1999, ENDOCRINOLOGY, V140, P987, DOI 10.1210/en.140.2.987; Petrash JM, 2004, CELL MOL LIFE SCI, V61, P737, DOI 10.1007/s00018-003-3402-3; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Raccah D, 1998, J DIABETES COMPLICAT, V12, P154, DOI 10.1016/S1056-8727(97)00093-7; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Rivard CJ, 2007, J BIOL CHEM, V282, P6644, DOI 10.1074/jbc.M609432200; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Woo SK, 2002, INT REV CYTOL, V215, P189	36	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19974	19981		10.1074/jbc.M109.001792	http://dx.doi.org/10.1074/jbc.M109.001792			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19423711	Green Published, hybrid			2022-12-27	WOS:000268097400024
J	Millet, C; Yamashita, M; Heller, M; Yu, LR; Veenstra, TD; Zhang, YE				Millet, Caroline; Yamashita, Motozo; Heller, Mary; Yu, Li-Rong; Veenstra, Timothy D.; Zhang, Ying E.			A Negative Feedback Control of Transforming Growth Factor-beta Signaling by Glycogen Synthase Kinase 3-mediated Smad3 Linker Phosphorylation at Ser-204	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; CRYSTAL-STRUCTURE; BMP; PATHWAYS; DOMAIN; IDENTIFICATION; DEGRADATION; SPECIFICITY; ACTIVATION; MECHANISM	Through the action of its membrane-bound type I receptor, transforming growth factor-beta (TGF-beta) elicits a wide range of cellular responses that regulate cell proliferation, differentiation, and apoptosis. Many of these signaling responses are mediated by Smad proteins. As such, controlling Smad activity is crucial for proper signaling by TGF-beta and its related factors. Here, we show that TGF-beta induces phosphorylation at three sites in the Smad3 linker region in addition to the two C-terminal residues, and glycogen synthase kinase 3 is responsible for phosphorylation at one of these sites, namely Ser-204. Alanine substitution at Ser-204 and/or the neighboring Ser-208, the priming site for glycogen synthase kinase 3 in vivo activity, strengthened the affinity of Smad3 to CREB-binding protein, suggesting that linker phosphorylation may be part of a negative feedback loop that modulates Smad3 transcriptional activity. Thus, our findings reveal a novel aspect of the Smad3 signaling mechanism that controls the final amplitude of cellular responses to TGF-beta.	[Millet, Caroline; Yamashita, Motozo; Heller, Mary; Zhang, Ying E.] NCI, Ctr Canc Res, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Yu, Li-Rong] US FDA, Natl Ctr Toxicol Res, Ctr Prote, Div Syst Toxicol, Jefferson, AR 72079 USA; [Veenstra, Timothy D.] SAIC Frederick Inc, Lab Prote & Analyt Technol, Adv Technol Program, Frederick, MD 21702 USA; [Veenstra, Timothy D.] NCI, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhang, YE (corresponding author), NCI, Ctr Canc Res, Cellular & Mol Biol Lab, NIH, 37 Convent Dr,Bldg 37,Rm 2056B, Bethesda, MD 20892 USA.	yingz@helix.nih.gov	Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601; Yu, Li-Rong/0000-0001-6084-991X	National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program; NCI [N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC010419] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program and is funded in part by National Institutes of Health Contract N01-CO-12400 from NCI.	Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck Rik, 2008, P29; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Prokova V, 2005, NUCLEIC ACIDS RES, V33, P3708, DOI 10.1093/nar/gki679; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Wang GN, 2005, BIOCHEM J, V386, P29, DOI 10.1042/BJ20041820; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Ying SX, 2003, J BIOL CHEM, V278, P39029, DOI 10.1074/jbc.M301193200; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yu LR, 2004, MOL CELL PROTEOMICS, V3, P896, DOI 10.1074/mcp.M400034-MCP200; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	39	60	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19808	19816		10.1074/jbc.M109.016667	http://dx.doi.org/10.1074/jbc.M109.016667			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19458083	hybrid, Green Published			2022-12-27	WOS:000268097400007
J	Brent, MM; Iwata, A; Carten, J; Zhao, KH; Marmorstein, R				Brent, Michael M.; Iwata, Ayaka; Carten, Juliana; Zhao, Kehao; Marmorstein, Ronen			Structure and Biochemical Characterization of Protein Acetyltransferase from Sulfolobus solfataricus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEAL CHROMATIN PROTEIN; HISTONE ACETYLTRANSFERASE; CATALYTIC MECHANISM; TRANSCRIPTIONAL COACTIVATOR; MOLECULAR-GRAPHICS; ACETYLATION; RTT109; SIR2; P300/CBP; ENZYME	The Sulfolobus solfataricus protein acetyltransferase (PAT) acetylates ALBA, an abundant nonspecific DNA-binding protein, on Lys(16) to reduce its DNA affinity, and the Sir2 deacetylase reverses the modification to cause transcriptional repression. This represents a "primitive" model for chromatin regulation analogous to histone modification in eukaryotes. We report the 1.84-angstrom crystal structure of PAT in complex with coenzyme A. The structure reveals homology to both prokaryotic GNAT acetyltransferases and eukaryotic histone acetyltransferases (HATs), with an additional "bent helix" proximal to the substrate binding site that might play an autoregulatory function. Investigation of active site mutants suggests that PAT does not use a single general base or acid residue for substrate deprotonation and product reprotonation, respectively, and that a diffusional step, such as substrate binding, may be rate-limiting. The catalytic efficiency of PAT toward ALBA is low relative to other acetyltransferases, suggesting that there may be better, unidentified substrates for PAT. The structural similarity of PAT to eukaryotic HATs combined with its conserved role in chromatin regulation suggests that PAT is evolutionarily related to the eukaryotic HATs.	[Brent, Michael M.; Iwata, Ayaka; Carten, Juliana; Zhao, Kehao; Marmorstein, Ronen] Univ Penn, Wistar Inst, Philadelphia, PA 19104 USA; [Brent, Michael M.; Iwata, Ayaka; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Marmorstein, R (corresponding author), 3601 Spruce St, Philadelphia, PA 19104 USA.	marmor@wistar.org			National Institutes of Health Grant [GM060293]; NATIONAL CANCER INSTITUTE [T32CA009171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060293 ( to R. M.).	Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Braman J, 1996, Methods Mol Biol, V57, P31; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Edmondson SP, 2001, METHOD ENZYMOL, V334, P129; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Scheibner KA, 2002, J BIOL CHEM, V277, P18118, DOI 10.1074/jbc.M200595200; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Vetting MW, 2004, CHEM BIOL, V11, P565, DOI 10.1016/j.chembiol.2004.03.017; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; Wardleworth BN, 2001, ACTA CRYSTALLOGR D, V57, P1893, DOI 10.1107/S0907444901015517; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849	33	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19412	19419		10.1074/jbc.M109.014951	http://dx.doi.org/10.1074/jbc.M109.014951			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19473964	Green Published, hybrid			2022-12-27	WOS:000267908300032
J	Kasiviswanathan, R; Longley, MJ; Chan, SSL; Copeland, WC				Kasiviswanathan, Rajesh; Longley, Matthew J.; Chan, Sherine S. L.; Copeland, William C.			Disease Mutations in the Human Mitochondrial DNA Polymerase Thumb Subdomain Impart Severe Defects in Mitochondrial DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; TYPE-1 REVERSE-TRANSCRIPTASE; P55 ACCESSORY SUBUNIT; I KLENOW FRAGMENT; ALPERS-SYNDROME; POLG MUTATIONS; FRAMESHIFT FIDELITY; ANGSTROM RESOLUTION; AUTOSOMAL-DOMINANT; NUCLEOSIDE ANALOGS	Forty-five different point mutations in POLG, the gene encoding the catalytic subunit of the human mitochondrial DNA polymerase (pol gamma), cause the early onset mitochondrial DNA depletion disorder, Alpers syndrome. Sequence analysis of the C-terminal polymerase region of pol gamma revealed a cluster of four Alpers mutations at highly conserved residues in the thumb subdomain (G848S, c.2542g -> a; T851A, c.2551a -> g; R852C, c.2554c -> t; R853Q, c.2558g -> a) and two Alpers mutations at less conserved positions in the adjacent palm subdomain (Q879H, c.2637g -> t and T885S, c.2653a -> t). Biochemical characterization of purified, recombinant forms of pol gamma revealed that Alpers mutations in the thumb subdomain reduced polymerase activity more than 99% relative to the wild-type enzyme, whereas the palm subdomain mutations retained 50-70% wildtype polymerase activity. All six mutant enzymes retained physical and functional interaction with the pol gamma accessory subunit (p55), and none of the six mutants exhibited defects in misinsertion fidelity in vitro. However, differential DNA binding by these mutants suggests a possible orientation of the DNA with respect to the polymerase during catalysis. To our knowledge this study represents the first structure-function analysis of the thumb subdomain in pol gamma and examines the consequences of mitochondrial disease mutations in this region.	[Kasiviswanathan, Rajesh; Longley, Matthew J.; Chan, Sherine S. L.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Kasiviswanathan, Rajesh/D-2744-2012; Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953	National Institutes of Health Grant [ES 065078]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES015555, Z01ES065078, ZIAES065078] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES 065078 ( Intramural Research Program of the NIEHS).	Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002; Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150; Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002; BEARD WA, 1994, J BIOL CHEM, V269, P28091; BEBENEK K, 1995, J BIOL CHEM, V270, P19516, DOI 10.1074/jbc.270.33.19516; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424; Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007; Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010; Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498; de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9; Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Gonzalez-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320; Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088; Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341; Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200; Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196; McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911; Minnick DT, 1996, J BIOL CHEM, V271, P24954, DOI 10.1074/jbc.271.40.24954; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B; Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026; Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; OLLIS DL, 1985, NATURE, V313, P818, DOI 10.1038/313818a0; REARDON JE, 1990, J BIOL CHEM, V265, P20302; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180; Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852; Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200	54	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19501	19510		10.1074/jbc.M109.011940	http://dx.doi.org/10.1074/jbc.M109.011940			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19478085	Green Published, hybrid			2022-12-27	WOS:000267908300042
J	Martinelli, DC; Fan, CM				Martinelli, David C.; Fan, Chen-Ming			A Sonic Hedgehog Missense Mutation Associated with Holoprosencephaly Causes Defective Binding to GAS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE LIMB; GENE; PATHWAY; MICE; IDENTIFICATION; EXPRESSION; INDUCTION; PROTEIN; GLI3; CDO	Holoprosencephaly (HPE) is a common birth defect predominantly affecting the forebrain and face and has been linked to mutations in the sonic hedgehog (SHH) gene. HPE is genetically heterogeneous, and clinical presentation represents a spectrum of phenotypes. We have previously shown that Gas1 encodes a cell-autonomous Hedgehog signaling enhancer. Combining cell surface binding, in vitro activity, and explant culture assays, we provide evidence that SHH contains a previously unknown unique binding surface for its interaction with GAS1 and that this surface is also important for maximal signaling activity. Within this surface, the Asn-115 residue of human SHH has been documented to associate with HPE when mutated to lysine (N115K). We provide evidence that HPE associated with this mutation can be mechanistically explained by a severely reduced binding of SHH to GAS1, and we predict a similar result if a mutation were to occur at Tyr-80. Our data should encourage future searches for mutations in GAS1 as possible modifiers contributing to the wide spectrum of HPE.	[Martinelli, David C.; Fan, Chen-Ming] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Martinelli, David C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Johns Hopkins University	Fan, CM (corresponding author), Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	fan@ciwemb.edu		Martinelli, David/0000-0002-8318-3986	NIDDK NIH HHS [R01 DK084963, R01 DK084963-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084963] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Lee CS, 2001, MECH DEVELOP, V101, P293, DOI 10.1016/S0925-4773(01)00283-0; Lee CS, 2001, P NATL ACAD SCI USA, V98, P11347, DOI 10.1073/pnas.201418298; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; Martinelli DC, 2007, CELL CYCLE, V6, P2650, DOI 10.4161/cc.6.21.4877; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; MATSUNAGA E, 1977, TERATOLOGY, V16, P261, DOI 10.1002/tera.1420160304; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Schachter KA, 2008, CURR TOP DEV BIOL, V84, P139, DOI 10.1016/S0070-2153(08)00603-0; Seppala M, 2007, J CLIN INVEST, V117, P1575, DOI 10.1172/JCI32032; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Tsujita Y, 2006, P NATL ACAD SCI USA, V103, P11946, DOI 10.1073/pnas.0510138103; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	26	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19169	19172		10.1074/jbc.C109.011957	http://dx.doi.org/10.1074/jbc.C109.011957			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19478089	Green Published, hybrid			2022-12-27	WOS:000267908300004
J	Nakajima, M; Nishimoto, M; Kitaoka, M				Nakajima, Masahiro; Nishimoto, Mamoru; Kitaoka, Motomitsu			Characterization of Three beta-Galactoside Phosphorylases from Clostridium phytofermentans DISCOVERY OF D-GALACTOSYL-beta 1 -> 4-L-RHAMNOSE PHOSPHORYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-BIOSE PHOSPHORYLASE; GLYCOSIDE HYDROLASE FAMILY; CELLOBIOSE PHOSPHORYLASE; BIFIDOBACTERIUM-LONGUM; REACTION-MECHANISM; METABOLIC PATHWAY; MOLECULAR-CLONING; SIGNAL PEPTIDES; BINDING PROTEIN; IDENTIFICATION	We characterized three D-galactosyl-beta 1 -> 3-N-acetyl-D-hexosamine phosphorylase (EC 2.4.1.211) homologs from Clostridium phytofermentans (Cphy0577, Cphy1920, and Cphy3030 proteins). Cphy0577 and Cphy3030 proteins exhibited similar activity on galacto-N-biose (GNB; D-Gal-beta 1 -> 3-D-GalNAc) and lacto-N-biose I (LNB; D-Gal-beta 1 -> 3-D-GlcNAc), thus indicating that they are D-galactosyl-beta 1 -> 3-N-acetyl-D-hexosamine phosphorylases, subclassified as GNB/LNB phosphorylase. In contrast, Cphy1920 protein phosphorolyzed neither GNB nor LNB. It showed the highest activity with L-rhamnose as the acceptor in the reverse reaction using alpha-D-galactose 1-phosphate as the donor. The reaction product was D-galactosyl-beta 1 -> 4-L-rhamnose. The enzyme also showed activity on L-mannose, L-lyxose, D-glucose, 2-deoxy-D-glucose, and D-galactose in this order. When D-glucose derivatives were used as acceptors, reaction products were beta-1,3-galactosides. Kinetic parameters of phosphorolytic activity on D-galactosyl-beta 1 -> 4-L-rhamnose were k(cat) = 45 s(-1) and K-m = 7.9 mM, thus indicating that these values are common among other phosphorylases. We propose D-galactosyl-beta 1 -> 4-L-rhamnose phosphorylase as the name for Cphy1920 protein.	[Nakajima, Masahiro; Nishimoto, Mamoru; Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Kitaoka, M (corresponding author), Natl Agr & Food Res Org, Natl Food Res Inst, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	mkitaoka@affrc.go.jp	Nakajima, Masahiro/J-3566-2019; Kitaoka, Motomitsu/R-1536-2019	Nakajima, Masahiro/0000-0002-3182-0859; Kitaoka, Motomitsu/0000-0002-0083-1838				Andersson U, 2001, J BIOL CHEM, V276, P42707, DOI 10.1074/jbc.M108279200; Ashida H, 2008, GLYCOBIOLOGY, V18, P727, DOI 10.1093/glycob/cwn053; ASPINALL GO, 1978, CAN J CHEM, V56, P685, DOI 10.1139/v78-112; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bubb WA, 1997, CARBOHYD RES, V301, P41, DOI 10.1016/S0008-6215(97)00083-9; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Coutinho PM, 1999, ROY SOC CH, P3; DEBRUYN A, 1976, CARBOHYD RES, V47, P158, DOI 10.1016/S0008-6215(00)83559-4; Derensy-Dron D, 1999, BIOTECHNOL APPL BIOC, V29, P3; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Hidaka M, 2009, J BIOL CHEM, V284, P7273, DOI 10.1074/jbc.M808525200; Honda Y, 2004, BIOCHEM J, V377, P225, DOI 10.1042/BJ20031171; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kim YK, 2002, J BIOCHEM, V132, P197, DOI 10.1093/oxfordjournals.jbchem.a003210; KITAOKA M, 1992, BIOSCI BIOTECH BIOCH, V56, P652, DOI 10.1271/bbb.56.652; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; KITAOKA M, 1993, ARCH BIOCHEM BIOPHYS, V304, P508, DOI 10.1006/abbi.1993.1383; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Mega T, 2007, BIOSCI BIOTECH BIOCH, V71, P2893, DOI 10.1271/bbb.70240; MURAO S, 1985, AGR BIOL CHEM TOKYO, V49, P2113, DOI 10.1080/00021369.1985.10867024; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nakajima M, 2008, APPL ENVIRON MICROB, V74, P6333, DOI 10.1128/AEM.02846-07; Nakajima M, 2008, APPL MICROBIOL BIOT, V78, P465, DOI 10.1007/s00253-007-1319-8; Nakajima M, 2009, APPL MICROBIOL BIOT, V83, P109, DOI 10.1007/s00253-008-1838-y; Nidetzky B, 2000, BIOCHEM J, V351, P649, DOI 10.1042/0264-6021:3510649; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nihira T, 2007, ANAL BIOCHEM, V371, P259, DOI 10.1016/j.ab.2007.07.012; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1587, DOI 10.1271/bbb.70064; Polle AY, 2002, CARBOHYD POLYM, V49, P337, DOI 10.1016/S0144-8617(01)00346-0; Rajashekhara E, 2002, BIOSCI BIOTECH BIOCH, V66, P2578, DOI 10.1271/bbb.66.2578; SILVERSTEIN R, 1967, J BIOL CHEM, V242, P1338; STORVICK WO, 1960, J BIOL CHEM, V235, P303; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; SWISHER EJ, 1964, J BACTERIOL, V88, P817, DOI 10.1128/JB.88.4.817-820.1964; TSUMURAYA Y, 1990, ARCH BIOCHEM BIOPHYS, V281, P58, DOI 10.1016/0003-9861(90)90412-R; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Wada J, 2007, ACTA CRYSTALLOGR F, V63, P751, DOI 10.1107/S1744309107036263; Warnick TA, 2002, INT J SYST EVOL MICR, V52, P1155, DOI [10.1099/ijs.0.02125-0, 10.1099/00207713-52-4-1155]	45	32	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19220	19227		10.1074/jbc.M109.007666	http://dx.doi.org/10.1074/jbc.M109.007666			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19491100	Green Published, hybrid			2022-12-27	WOS:000267908300012
J	Diouf, B; Collazos, A; Labesse, G; Macari, F; Choquet, A; Clair, P; Gauthier-Rouviere, C; Guerineau, NC; Jay, P; Hollande, F; Joubert, D				Diouf, Barthelemy; Collazos, Alejandra; Labesse, Gilles; Macari, Francoise; Choquet, Armelle; Clair, Philippe; Gauthier-Rouviere, Cecile; Guerineau, Nathalie C.; Jay, Philippe; Hollande, Frederic; Joubert, Dominique			A 20-Amino Acid Module of Protein Kinase C epsilon Involved in Translocation and Selective Targeting at Cell-Cell Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-EPSILON; 14-3-3 BINDING; V3 REGION; T-CELLS; DOMAIN; ALPHA; ACTIVATION; PITUITARY; IDENTIFICATION; GOLGI	In the pituitary gland, activated protein kinase C (PKC) isoforms accumulate either selectively at the cell-cell contact (alpha and epsilon) or at the entire plasma membrane (beta 1 and delta). The molecular mechanisms underlying these various subcellular locations are not known. Here, we demonstrate the existence within PKC epsilon of a cell-cell contact targeting sequence (3CTS) that, upon stimulation, is capable of targeting PKC delta, chimerin-alpha 1, and the PKC epsilon C1 domain to the cell-cell contact. We show that this selective targeting of PKC epsilon is lost upon overexpression of 3CTS fused to a (R-Ahx-R)(4) (where Ahx is 6-aminohexanoic acid) vectorization peptide, reflecting a dominant-negative effect of the overexpressed 3CTS on targeting selectivity. 3CTS contains a putative amphipathic alpha-helix, a 14-3-3-binding site, and the Glu-374 amino acid, involved in targeting selectivity. We show that the integrity of the alpha-helix is important for translocation but that 14-3-3 is not involved in targeting selectivity. However, PKC epsilon translocation is increased when PKC epsilon/14-3-3 interaction is abolished, suggesting that phorbol 12-myristate 13-acetate activation may initiate two sets of PKC epsilon functions, those depending on 14-3-3 and those depending on translocation to cell-cell contacts. Thus, 3CTS is involved in the modulation of translocation via its 14-3-3-binding site, in cytoplasmic desequestration via the alpha-helix, and in selective PKC epsilon targeting at the cell-cell contact via Glu-374.	[Diouf, Barthelemy; Collazos, Alejandra; Macari, Francoise; Choquet, Armelle; Jay, Philippe; Hollande, Frederic; Joubert, Dominique] Univ Montpellier 1, INSERM, CNRS, UMR5203,U661, F-34094 Montpellier 5, France; [Diouf, Barthelemy; Collazos, Alejandra; Macari, Francoise; Choquet, Armelle; Jay, Philippe; Hollande, Frederic; Joubert, Dominique] Univ Montpellier 2, INSERM, CNRS, UMR5203,U661, F-34094 Montpellier 5, France; [Diouf, Barthelemy; Collazos, Alejandra; Macari, Francoise; Choquet, Armelle; Jay, Philippe; Hollande, Frederic; Joubert, Dominique] Inst Genom Fonct, Dept Cellular & Mol Oncol, F-34094 Montpellier 5, France; [Guerineau, Nathalie C.] Inst Genom Fonct, Dept Endocrinol, F-34094 Montpellier 5, France; [Labesse, Gilles] Univ Montpellier 1, INSERM, CNRS, Struct Biol Ctr,UMR5048,U554, F-34094 Montpellier 5, France; [Clair, Philippe] Univ Montpellier 2, Plateforme qPCR Haut Debit, F-34095 Montpellier, France; [Gauthier-Rouviere, Cecile] CNRS Format Rech, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Hollande, F (corresponding author), Univ Montpellier 1, INSERM, CNRS, UMR5203,U661, 141 Rue Cardonille, F-34094 Montpellier 5, France.	frederic.hollande@univ-montpl.fr; dominique.joubert@igf.cnrs.fr	macari, francoise/E-9941-2014; Hollande, Frederic/GLS-4120-2022; Jay, Philippe/I-7116-2016; Wegglin, Reto/AAV-4341-2021; Hollande, Frederic/E-3133-2013; Jay, Philippe/ABD-9223-2020	macari, francoise/0000-0001-8942-1845; Hollande, Frederic/0000-0002-7046-8392; Jay, Philippe/0000-0003-0156-5700; Jay, Philippe/0000-0003-0156-5700; Labesse, Gilles/0000-0002-6861-3300; Choquet, armelle/0000-0002-6959-9387; GAUTHIER-ROUVIERE, Cecile/0000-0002-8364-3882; Guerineau, Nathalie/0000-0003-2517-4210	Ministere de la Recherche et de la pour la Recherche contre le Cancer [5695]	Ministere de la Recherche et de la pour la Recherche contre le Cancer	This work was supported by the Ministere de la Recherche et de la pour la Recherche contre le Cancer Grant 5695.	Abes S, 2006, J CONTROL RELEASE, V116, P304, DOI 10.1016/j.jconrel.2006.09.011; ALVARO V, 1993, J CLIN ENDOCR METAB, V77, P1125, DOI 10.1210/jc.77.5.1125; Aschrafi A, 2003, BBA-MOL CELL BIOL L, V1634, P30, DOI 10.1016/j.bbalip.2003.08.004; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Collazos A, 2006, MOL CELL BIOL, V26, P2247, DOI 10.1128/MCB.26.6.2247-2261.2006; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Douguet D, 2001, BIOINFORMATICS, V17, P752, DOI 10.1093/bioinformatics/17.8.752; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Guerineau NC, 1998, J BIOL CHEM, V273, P10389, DOI 10.1074/jbc.273.17.10389; HOCEVAR BA, 1991, J BIOL CHEM, V266, P28; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; LEHEL C, 1995, P NATL ACAD SCI USA, V92, P1406, DOI 10.1073/pnas.92.5.1406; Louis K, 2005, J BIOL CHEM, V280, P1272, DOI 10.1074/jbc.M405482200; MattoYelin M, 1997, MOL BIOL CELL, V8, P1889, DOI 10.1091/mbc.8.10.1889; Meller N, 1996, MOL CELL BIOL, V16, P5782; Mochly-Rosen D, 1998, FASEB J, V12, P35; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; Nishizuka Y, 2003, J BIOCHEM, V133, P155, DOI 10.1093/jb/mvg035; O'Keefe JP, 2004, P NATL ACAD SCI USA, V101, P9351, DOI 10.1073/pnas.0305965101; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Pauken CM, 1999, MOL REPROD DEV, V54, P135, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;135::AID-MRD5&gt;3.0.CO;2-A; PREVOSTEL C, 1995, ONCOGENE, V11, P669; Quittau-Prevostel C, 2004, J CELL SCI, V117, P63, DOI 10.1242/jcs.00832; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schmalz D, 1998, J CELL SCI, V111, P1823; Schultz A, 2004, J BIOL CHEM, V279, P31750, DOI 10.1074/jbc.M313017200; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Vallentin A, 2001, MOL CELL BIOL, V21, P3351, DOI 10.1128/MCB.21.10.3351-3363.2001; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Zhu YM, 2005, CANCER RES, V65, P4520, DOI 10.1158/0008-5472.CAN-04-4506	39	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18808	18815		10.1074/jbc.M109.004614	http://dx.doi.org/10.1074/jbc.M109.004614			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19429675	Green Published, hybrid			2022-12-27	WOS:000267711500030
J	Hurley, JM; Woychik, NA				Hurley, Jennifer M.; Woychik, Nancy A.			Bacterial Toxin HigB Associates with Ribosomes and Mediates Translation-dependent mRNA Cleavage at A-rich Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; MULTIDRUG TOLERANCE; PROTEUS-MIRABILIS; ANTITOXIN MODULE; VIBRIO-CHOLERAE; PLASMID RTS1; IN-VIVO; LOCI	Most pathogenic Proteus species are primarily associated with urinary tract infections, especially in persons with indwelling catheters or functional/anatomic abnormalities of the urinary tract. Urinary tract infections caused by Proteus vulgaris typically form biofilms and are resistant to commonly used antibiotics. The Rts1 conjugative plasmid from a clinical isolate of P. vulgaris carries over 300 predicted open reading frames, including antibiotic resistance genes. The maintenance of the Rts1 plasmid is ensured in part by the HigBA toxin-antitoxin system. We determined the precise mechanism of action of the HigB toxin in vivo, which is distinct from other known toxins. We demonstrate that HigB is an endoribonuclease whose enzymatic activity is dependent on association with ribosomes through the 50 S subunit. Using primer extension analysis of several test mRNAs, we showed that HigB cleaved extensively across the entire length of coding regions only at specific recognition sequences. HigB mediated cleavage of 100% of both in-frame and out-of-frame AAA sequences. In addition, HigB cleaved similar to 20% of AA sequences in coding regions and occasionally cut single As. Remarkably, the cleavage specificity of HigB coincided with one of the most frequently used codons in the AT-rich Proteus spp., AAA (lysine). Therefore, the HigB-mediated plasmid maintenance system for the Rts1 plasmid highlights the intimate relationship between host cells and extrachromosomal DNA that enables the dynamic acquisition of genes that impart a spectrum of survival advantages, including those encoding multidrug resistance and virulence factors.	[Hurley, Jennifer M.; Woychik, Nancy A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Woychik, NA (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes La, Piscataway, NJ 08854 USA.	nancy.woychik@umdnj.edu		Hurley, Jennifer/0000-0002-1085-9391	National Institutes of Health [GM74097, U54, GM74958]; Takara Bio, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958, R01GM074097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara Bio, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM74097 and U54 Grant GM74958 (NE Structural Genomics Consortium). This work was also supported by Takara Bio, Inc.	Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brock JE, 2007, J BACTERIOL, V189, P501, DOI 10.1128/JB.01356-06; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; FALKOW S, 1962, J BACTERIOL, V83, P1318, DOI 10.1128/JB.83.6.1318-1321.1962; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; HIRASHIMA A, 1973, NATURE, V242, P405, DOI 10.1038/242405a0; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Redko Y, 2003, J BIOL CHEM, V278, P44001, DOI 10.1074/jbc.M306760200; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; TERAWAKI Y, 1972, J BACTERIOL, V109, P492, DOI 10.1128/JB.109.2.492-498.1972; TERAWAKI Y, 1967, J BACTERIOL, V94, P687, DOI 10.1128/JB.94.3.687-690.1967; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Tian QB, 1996, BIOCHEM BIOPH RES CO, V225, P679, DOI 10.1006/bbrc.1996.1229; Wang HC, 2002, NUCLEIC ACIDS RES, V30, P2501, DOI 10.1093/nar/30.11.2501; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	40	95	101	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18605	18613		10.1074/jbc.M109.008763	http://dx.doi.org/10.1074/jbc.M109.008763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19423702	Green Published, hybrid			2022-12-27	WOS:000267711500009
J	Winkler, L; Gehring, C; Wenzel, A; Muller, SL; Piehl, C; Krause, G; Blasig, IE; Piontek, J				Winkler, Lars; Gehring, Claudia; Wenzel, Ariane; Mueller, Sebastian L.; Piehl, Christian; Krause, Gerd; Blasig, Ingolf E.; Piontek, Joerg			Molecular Determinants of the Interaction between Clostridium perfringens Enterotoxin Fragments and Claudin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENT; TIGHT JUNCTION REGULATION; DRUG DISCOVERY; AMINO-ACIDS; ABSORPTION; PROTEINS; MODULATOR; MEMBRANE; OCCLUDIN; BARRIER	Clostridium perfringens enterotoxin (CPE) binds to the extracellular loop 2 of a subset of claudins, e. g. claudin-3. Here, the molecular mechanism of the CPE-claudin interaction was analyzed. Using peptide arrays, recombinant CPE-(116-319) bound to loop 2 peptides of mouse claudin-3, -6, -7, -9, and -14 but not of 1, 2, 4, 5, 8, 10-13, 15, 16, 18-20, and 22. Substitution peptide mapping identified the central motif (NPLVP)-N-148-V-150, supposed to represent a turn region in the loop 2, as essential for the interaction between CPE and murine claudin-3 peptides. CPE-binding assays with claudin-3 mutant- transfected HEK293 cells or lysates thereof demonstrated the involvement of Asn(148) and Leu(150) of full-length claudin-3 in the binding. CPE-(116-319) and CPE-(194-319) bound to HEK293 cells expressing claudin-3, whereas CPE-(116-319) bound to claudin-5-expressing HEK293 cells, also. This binding was inhibited by substitutions T151A and Q156E in claudin-5. In contrast, removal of the aromatic side chains in the loop 2 of claudin-3 and -5, involved in trans-interaction between claudins, increased the amount of CPE-(116-319) bound. These findings and molecular modeling indicate different molecular mechanisms of claudin-claudin trans-interaction and claudin-CPE interaction. Confocal microscopy showed that CPE-(116-319) and CPE-(194-319) bind to claudin-3 at the plasma membrane, outside cell-cell contacts. Together, these findings demonstrate that CPE binds to the hydrophobic turn and flanking polar residues in the loop 2 of claudin-3 outside tight junctions. The data can be used for the specific design of CPE- based modulators of tight junctions, to improve drug delivery, and as chemotherapeutics for tumors overexpressing claudins.	[Winkler, Lars; Gehring, Claudia; Wenzel, Ariane; Mueller, Sebastian L.; Piehl, Christian; Krause, Gerd; Blasig, Ingolf E.; Piontek, Joerg] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Blasig, IE (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	iblasig@fmp-berlin.de; piontek@fmp-berlin.de	Winkler, Lars/M-6134-2014; Piontek, Joerg/K-6305-2013; Piontek, Joerg/F-8549-2011; Winkler, Lars/D-1949-2012	Winkler, Lars/0000-0003-3350-1189; Piontek, Joerg/0000-0002-0880-8915; Piehl, Christian/0000-0002-1054-0081				Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Aungst BJ, 2000, J PHARM SCI, V89, P429, DOI 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Ebihara C, 2006, J PHARMACOL EXP THER, V316, P255, DOI 10.1124/jpet.105.093351; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; HANNA PC, 1991, J BIOL CHEM, V266, P11037; Harada M, 2007, BIOCHEM PHARMACOL, V73, P206, DOI 10.1016/j.bcp.2006.10.002; HOCHMAN J, 1994, J CONTROL RELEASE, V29, P253, DOI 10.1016/0168-3659(94)90072-8; Kokai-Kun JF, 1999, INFECT IMMUN, V67, P5634, DOI 10.1128/IAI.67.11.5634-5641.1999; Kominsky SL, 2007, CANCER RES, V67, P7977, DOI 10.1158/0008-5472.CAN-07-1314; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; Kondoh M, 2006, BIOL PHARM BULL, V29, P1783, DOI 10.1248/bpb.29.1783; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; Masuyama A, 2005, J PHARMACOL EXP THER, V314, P789, DOI 10.1124/jpet.105.085399; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Mizuno N, 2003, PHARMACOL REV, V55, P425, DOI 10.1124/pr.55.3.1; Morin PJ, 2007, DIS MARKERS, V23, P453, DOI 10.1155/2007/674058; Nishikawa K, 2006, FASEB J, V20, P2597, DOI 10.1096/fj.06-6572fje; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Robertson SL, 2007, CELL MICROBIOL, V9, P2734, DOI 10.1111/j.1462-5822.2007.00994.x; Salama NN, 2006, ADV DRUG DELIVER REV, V58, P15, DOI 10.1016/j.addr.2006.01.003; Santin AD, 2007, CANCER, V109, P1312, DOI 10.1002/cncr.22536; Schmidt A, 2004, CELL MOL LIFE SCI, V61, P1354, DOI 10.1007/s00018-004-4010-6; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; White RE, 2000, ANNU REV PHARMACOL, V40, P133, DOI 10.1146/annurev.pharmtox.40.1.133; Yamamoto A, 1996, J PHARM PHARMACOL, V48, P1285, DOI 10.1111/j.2042-7158.1996.tb03937.x	38	91	93	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18863	18872		10.1074/jbc.M109.008623	http://dx.doi.org/10.1074/jbc.M109.008623			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19429681	Green Published, hybrid			2022-12-27	WOS:000267711500036
J	D'Souza, DR; Salib, MM; Bennett, J; Mochin-Peters, M; Asrani, K; Goldblum, SE; Renoud, KJ; Shapiro, P; Passaniti, A				D'Souza, David R.; Salib, Maryann M.; Bennett, Jessica; Mochin-Peters, Maria; Asrani, Kaushal; Goldblum, Simeon E.; Renoud, Keli J.; Shapiro, Paul; Passaniti, Antonino			Hyperglycemia Regulates RUNX2 Activation and Cellular Wound Healing through the Aldose Reductase Polyol Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; TRANSCRIPTION FACTOR; GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; DIABETIC COMPLICATIONS; GLUCOSE-HOMEOSTASIS; ANGIOGENIC ACTIVITY; OXIDATIVE DAMAGE; PROTEIN-KINASE; EXPRESSION	Diabetes mellitus accelerates cardiovascular microangiopathies and atherosclerosis, which are a consequence of hyperglycemia. The aldose reductase (AR) polyol pathway contributes to these microvascular complications, but how it mediates vascular damage in response to hyperglycemia is less understood. The RUNX2 transcription factor, which is repressed in diabetic animals, promotes vascular endothelial cell (EC) migration, proliferation, and angiogenesis. Here we show that physiological levels of glucose (euglycemia) increase RUNX2 DNA binding and transcriptional activity, whereas hyperglycemia does not. However, inhibition of AR reverses hyperglycemic suppression of RUNX2. IGF-1 secretion and IGF receptor phosphorylation by autocrine IGF-1 occur equally in euglycemic or hyperglycemic conditions, suggesting that reduced RUNX2 activity in response to hyperglycemia is not because of altered IGF-1/IGF receptor activation. AR also negatively regulates RUNX2-dependent vascular remodeling in an EC wounded monolayer assay, which is reversed by specific AR inhibition in hyperglycemia. Thus, euglycemia supports RUNX2 activity and promotes normal microvascular EC migration and wound healing, which are repressed under hyperglycemic conditions through the AR polyol pathway.	[D'Souza, David R.; Salib, Maryann M.; Bennett, Jessica; Mochin-Peters, Maria; Asrani, Kaushal; Renoud, Keli J.; Passaniti, Antonino] Univ Maryland, Sch Med, Dept Pathol,Marlene & Stewart Greenebaum Canc Ctr, Grad Program Life Sci, Baltimore, MD 21201 USA; [D'Souza, David R.; Salib, Maryann M.; Bennett, Jessica; Mochin-Peters, Maria; Asrani, Kaushal; Renoud, Keli J.; Passaniti, Antonino] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Dept Biochem & Mol Biol,Grad Program Life Sci, Baltimore, MD 21201 USA; [Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Goldblum, Simeon E.; Passaniti, Antonino] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Shapiro, Paul] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Passaniti, A (corresponding author), Univ Maryland, Sch Med, Greenebaum Canc Ctr, 655 W Baltimore St, Baltimore, MD 21201 USA.	apass001@umaryland.edu			National Institutes of Health [RO1CA108846, RO1CA120215, RO1HL084223]; University of Maryland Greenebaum Cancer; Cigarette Restitution Fund of the State of Maryland; NATIONAL CANCER INSTITUTE [R01CA108846, R01CA120215] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Greenebaum Cancer; Cigarette Restitution Fund of the State of Maryland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA108846 (to A. P.), RO1CA120215 (to P. S.), and RO1HL084223 (to S. E. G.). This work was also supported by a University of Maryland Greenebaum Cancer Center pilot grant from the Cigarette Restitution Fund of the State of Maryland (to A. P.).	Abu-Abid Subhi, 2002, Journal of Medicine (Westbury), V33, P73; Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Campbell M, 2005, CIRC RES, V96, P197, DOI 10.1161/01.RES.0000152966.88353.9d; Chen FM, 2008, J CELL COMMUN SIGNAL, V2, P81, DOI 10.1007/s12079-008-0034-2; Cumbie BC, 2007, VASC HEALTH RISK MAN, V3, P823; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Facchiano F, 2002, AM J PATHOL, V161, P531, DOI 10.1016/S0002-9440(10)64209-5; Fowlkes JL, 2008, ENDOCRINOLOGY, V149, P1697, DOI 10.1210/en.2007-1408; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Hamuro M, 2002, ATHEROSCLEROSIS, V162, P277, DOI 10.1016/S0021-9150(01)00719-5; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Jain RK, 2008, SCI AM, V298, P56, DOI 10.1038/scientificamerican0108-56; Juttner KV, 2007, BONE, V41, P25, DOI 10.1016/j.bone.2007.03.012; Kang ES, 2007, FREE RADICAL BIO MED, V43, P535, DOI 10.1016/j.freeradbiomed.2007.05.006; Kuki S, 2006, CIRC J, V70, P1076, DOI 10.1253/circj.70.1076; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Li JH, 2003, KIDNEY INT, V63, P2010, DOI 10.1046/j.1523-1755.2003.00016.x; Lorenzi M, 2007, EXP DIABETES RES, DOI 10.1155/2007/61038; Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; Meugnier E, 2007, CURR OPIN CLIN NUTR, V10, P518, DOI 10.1097/MCO.0b013e3281298fef; Namba K, 2000, ONCOGENE, V19, P106, DOI 10.1038/sj.onc.1203257; Obrosova IG, 2003, DIABETES, V52, P864, DOI 10.2337/diabetes.52.3.864; Oyama T, 2006, DIABETES RES CLIN PR, V73, P227, DOI 10.1016/j.diabres.2006.02.010; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pladzyk A, 2006, INVEST OPHTH VIS SCI, V47, P5395, DOI 10.1167/iovs.06-0469; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Ramana KV, 2004, FEBS LETT, V570, P189, DOI 10.1016/j.febslet.2004.06.046; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P608, DOI 10.1161/ATVBAHA.108.162057; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruef J, 2000, ARTERIOSCL THROM VAS, V20, P1745, DOI 10.1161/01.ATV.20.7.1745; Spalding AC, 2008, TRANSL ONCOL, V1, P195, DOI 10.1593/tlo.08151; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Sun LX, 2004, ONCOGENE, V23, P4722, DOI 10.1038/sj.onc.1207589; Sun LX, 2001, CANCER RES, V61, P4994; Teixeira AS, 1999, LIFE SCI, V64, P655, DOI 10.1016/S0024-3205(98)00607-9; Tsuji K, 2004, J BONE MINER RES, V19, P1481, DOI 10.1359/JBMR.040601; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; Wilkinson-Berka JL, 2006, CURR MED CHEM, V13, P3307, DOI 10.2174/092986706778773086; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2	46	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17947	17955		10.1074/jbc.M109.002378	http://dx.doi.org/10.1074/jbc.M109.002378			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19383984	hybrid, Green Published			2022-12-27	WOS:000267712400006
J	Qamar, I; Park, E; Gong, EY; Lee, HJ; Lee, K				Qamar, Imteyaz; Park, Eunsook; Gong, Eun-Yeung; Lee, Hyun Joo; Lee, Keesook			ARR19 (Androgen Receptor Corepressor of 19 kDa), an Antisteroidogenic Factor, Is Regulated by GATA-1 in Testicular Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; CREB-BINDING PROTEIN; DNA-BINDING; LUTEINIZING-HORMONE; MOUSE TESTIS; HISTONE ACETYLTRANSFERASE; FUNCTIONAL-ANALYSIS; GENE-TRANSCRIPTION; SIGNALING PATHWAY; MOLECULAR-CLONING	ARR19 (androgen receptor corepressor of 19 kDa), which encodes for a leucine-rich protein, is expressed abundantly in the testis. Further analyses revealed that ARR19 was expressed in Leydig cells, and its expression was differentially regulated during Leydig cell development. Adenovirus-mediated overexpression of ARR19 in Leydig cells inhibited testicular steroidogenesis, down-regulating the expression of steroidogenic enzymes, which suggests that ARR19 is an antisteroidogenic factor. Interestingly, cAMP/luteinizing hormone attenuated ARR19 expression in a fashion similar to that of GATA-1, which was previously reported to be down-regulated by cAMP. Sequence analysis of the Arr19 promoter revealed the presence of two putative GATA-1 binding motifs. Further analyses with 5' deletion and point mutants of putative GATA-1 binding motifs showed that these GATA-1 binding sites were critical for high promoter activity. CREB-binding protein coactivated GATA-1 and markedly increased the activity of the Arr19 promoter. Both GATA-1 and CREB-binding proteins occupied the GATA-1 motifs within the Arr19 promoter, which was repressed by cAMP treatment. Altogether, these findings demonstrate that ARR19 is the target gene of GATA-1 and suggest that ARR19 gene expression in testicular Leydig cells is regulated by luteinizing hormone/cAMP signaling via the control of GATA-1 expression, resulting in the control of testicular steroidogenesis.	[Qamar, Imteyaz; Park, Eunsook; Gong, Eun-Yeung; Lee, Hyun Joo; Lee, Keesook] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea	Chonnam National University	Lee, K (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	klee@chonnam.ac.kr		Qamar, Imteyaz/0000-0003-2390-1808	Chonnam National University; Korea Research Foundation, Korean Government [KRF-2006005-J03002]	Chonnam National University; Korea Research Foundation, Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by Chonnam National University and by a Korea Research Foundation grant funded by the Korean Government (KRF-2006005-J03002).	Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barrett DM, 2004, MOL CELL BIOL, V24, P6194, DOI 10.1128/MCB.24.14.6194-6204.2004; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Campbell SE, 2002, GENE, V286, P233, DOI 10.1016/S0378-1119(02)00436-5; Carninci P, 1997, DNA Res, V4, P61, DOI 10.1093/dnares/4.1.61; CHEN CLC, 1996, 78 ANN M END SOC SAN, P564; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COOKE BA, 1996, LEYDIG CELL, P352; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Feng ZM, 2000, MOL ENDOCRINOL, V14, P1820, DOI 10.1210/me.14.11.1820; Feng ZM, 1998, MOL ENDOCRINOL, V12, P378, DOI 10.1210/me.12.3.378; Fox AH, 1998, J BIOL CHEM, V273, P33595, DOI 10.1074/jbc.273.50.33595; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; GE R, 1996, LEYDIG CELL, V1, P159; Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; HAIDER S, 1986, GEN COMP ENDOCR, V64, P321, DOI 10.1016/0016-6480(86)90065-1; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Han WL, 2003, GENOMICS, V81, P609, DOI 10.1016/S0888-7543(03)00095-8; Han WL, 2001, BIOCHEM J, V357, P127, DOI 10.1042/0264-6021:3570127; Hernandez-Hernandez A, 2006, EMBO J, V25, P3264, DOI 10.1038/sj.emboj.7601228; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Hung HL, 1999, MOL CELL BIOL, V19, P3496; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Jeong BC, 2004, MOL ENDOCRINOL, V18, P13, DOI 10.1210/me.2003-0065; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Ketola I, 1999, ENDOCRINOLOGY, V140, P1470, DOI 10.1210/en.140.3.1470; Ketola I, 2002, EUR J ENDOCRINOL, V147, P397, DOI 10.1530/eje.0.1470397; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Li T, 2006, INT J BIOCHEM CELL B, V38, P420, DOI 10.1016/j.biocel.2005.10.003; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Lo KC, 2004, ENDOCRINOLOGY, V145, P4011, DOI 10.1210/en.2003-1729; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Moraga PF, 1997, J ENDOCRINOL, V154, P201, DOI 10.1677/joe.0.1540201; Nishikawa K, 2003, MOL CELL BIOL, V23, P8295, DOI 10.1128/MCB.23.22.8295-8305.2003; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Onodera K, 1997, J BIOCHEM, V121, P251; Shi SR, 2002, APPL IMMUNOHISTO M M, V10, P368, DOI 10.1097/00022744-200212000-00014; Song F, 2002, GENE, V290, P115, DOI 10.1016/S0378-1119(02)00584-X; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Tremblay JJ, 2003, J BIOL CHEM, V278, P22128, DOI 10.1074/jbc.M213149200; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Viger RS, 1998, DEVELOPMENT, V125, P2665; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; WHYATT DJ, 1993, EMBO J, V12, P4993, DOI 10.1002/j.1460-2075.1993.tb06193.x; WING TY, 1985, ENDOCRINOLOGY, V117, P1779, DOI 10.1210/endo-117-5-1779; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Zhang ZF, 2002, ENDOCRINOLOGY, V143, P829, DOI 10.1210/en.143.3.829; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	65	20	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18021	18032		10.1074/jbc.M900896200	http://dx.doi.org/10.1074/jbc.M900896200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19398553	Green Published, hybrid			2022-12-27	WOS:000267712400014
J	Suhasini, AN; Sommers, JA; Mason, AC; Voloshin, ON; Camerini-Otero, RD; Wold, MS; Brosh, RM				Suhasini, Avvaru N.; Sommers, Joshua A.; Mason, Aaron C.; Voloshin, Oleg N.; Camerini-Otero, R. Daniel; Wold, Marc S.; Brosh, Robert M., Jr.			FANCJ Helicase Uniquely Senses Oxidative Base Damage in Either Strand of Duplex DNA and Is Stimulated by Replication Protein A to Unwind the Damaged DNA Substrate in a Strand-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; ESCHERICHIA-COLI; ANEMIA PATHWAY; GENOMIC STABILITY; MAMMALIAN-CELLS; BINDING PROTEIN; THYMINE GLYCOL; WRN HELICASE; HUMAN RECQ1; REPAIR	FANCJ mutations are genetically linked to the Fanconi anemia complementation group J and predispose individuals to breast cancer. Understanding the role of FANCJ in DNA metabolism and how FANCJ dysfunction leads to tumorigenesis requires mechanistic studies of FANCJ helicase and its protein partners. In this work, we have examined the ability of FANCJ to unwind DNA molecules with specific base damage that can be mutagenic or lethal. FANCJ was inhibited by a single thymine glycol, but not 8-oxoguanine, in either the translocating or nontranslocating strands of the helicase substrate. In contrast, the human RecQ helicases (BLM, RECQ1, and WRN) display strand-specific inhibition of unwinding by the thymine glycol damage, whereas other DNA helicases (DinG, DnaB, and UvrD) are not significantly inhibited by thymine glycol in either strand. In the presence of replication protein A (RPA), but not Escherichia coli single-stranded DNA-binding protein, FANCJ efficiently unwound the DNA substrate harboring the thymine glycol damage in the nontranslocating strand; however, inhibition of FANCJ helicase activity by the translocating strand thymine glycol was not relieved. Strand-specific stimulation of human RECQ1 helicase activity was also observed, and RPA bound with high affinity to single-stranded DNA containing a single thymine glycol. Based on the biochemical studies, we propose a model for the specific functional interaction between RPA and FANCJ on the thymine glycol substrates. These studies are relevant to the roles of RPA, FANCJ, and other DNA helicases in the metabolism of damaged DNA that can interfere with basic cellular processes of DNA metabolism.	[Suhasini, Avvaru N.; Sommers, Joshua A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Mason, Aaron C.; Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Voloshin, Oleg N.; Camerini-Otero, R. Daniel] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, 251 Bayview Blvd,Ste 100,Rm 06B125, Baltimore, MD 21224 USA.	BroshR@mail.nih.gov	Wold, Marc/F-5806-2010; Brosh, Robert/AAR-6124-2020	Wold, Marc/0000-0002-4580-1624	National Institutes of Health Research [GM44721]; NIA; NIDDK National Institutes of Health Intramural Research Program; Fanconi Anemia Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000741, ZIAAG000753] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fanconi Anemia Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM44721 (to M. S. W.) and the NIA and NIDDK National Institutes of Health Intramural Research Program. This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.).	Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; De Nicolo A, 2008, CLIN CANCER RES, V14, P4672, DOI 10.1158/1078-0432.CCR-08-0087; Du W, 2008, ANTIOXID REDOX SIGN, V10, P1909, DOI 10.1089/ars.2008.2129; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Gupta R, 2006, NUCLEIC ACIDS RES, V34, P6673, DOI 10.1093/nar/gkl964; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Kung HC, 1997, J BIOL CHEM, V272, P9227; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levitus M, 2006, CELL ONCOL, V28, P3; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sharma S, 2008, CELL CYCLE, V7, P989, DOI 10.4161/cc.7.8.5707; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Thompson LH, 2005, ENVIRON MOL MUTAGEN, V45, P128, DOI 10.1002/em.20109; Tornaletti S, 2001, J BIOL CHEM, V276, P45367, DOI 10.1074/jbc.M105282200; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07	48	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18458	18470		10.1074/jbc.M109.012229	http://dx.doi.org/10.1074/jbc.M109.012229			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419957	Green Published, hybrid			2022-12-27	WOS:000267712400057
J	Johnson, RP; El-Yazbi, AF; Hughes, MF; Schriemer, DC; Walsh, EJ; Walsh, MP; Cole, WC				Johnson, Rosalyn P.; El-Yazbi, Ahmed F.; Hughes, Morgan F.; Schriemer, David C.; Walsh, Emma J.; Walsh, Michael P.; Cole, William C.			Identification and Functional Characterization of Protein Kinase A-catalyzed Phosphorylation of Potassium Channel Kv1.2 at Serine 449	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; RECTIFIER K+ CHANNELS; CYCLIC-AMP; CORONARY ARTERIOLES; CEREBRAL-ARTERIES; ACTIVATION; CELLS; RELAXATION; ROLES; 4-AMINOPYRIDINE	Vascular smooth muscle Kv1 delayed rectifier K+ channels (K-DR) containing Kv1.2 control membrane potential and thereby regulate contractility. Vasodilatory agonists acting via protein kinase A (PKA) enhance vascule smooth muscle Kv1 activity, but the molecular basis of this regulation is uncertain. We characterized the role of a C-terminal phosphorylation site, Ser-449, in Kv1.2 expressed in HEK 293 cells by biochemical and electrophysiological methods. We found that 1) in vitro phosphorylation of Kv1.2 occurred exclusively at serine residues, 2) one major phosphopeptide that co-migrated with (449)pSASTISK was generated by proteolysis of in vitro phosphorylated Kv1.2, 3) the peptide (445)KKSRSASTISK exhibited stoichiometric phosphorylation by PKA in vitro, 4) matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectroscopy (MS) and MS/MS confirmed in vitro Ser-449 phosphorylation by PKA, 5) in situ phosphorylation at Ser-449 was detected in HEK 293 cells by MALDI-TOF MS followed by MS/MS. MIDAS (multiple reaction monitoring-initiated detection and sequencing) analysis revealed additional phosphorylated residues, Ser-440 and Ser-441, 6) in vitro P-32 incorporation was significantly reduced in Kv1.2-S449A, Kv1.2-S449D, and Kv1.2-S440A/S441A/S449A mutant channels, but Kv1.2-S440A/S441A was identical to wild-type Kv1.2 (Kv1.2-WT), and 7) bath applied 8-Br-cAMP or dialysis with PKA catalytic subunit (cPKA) increased Kv1.2-WT but not Kv1.2-S449A current amplitude. cPKA increased Kv1.2-WT current in inside-out patches. Rp-CPT-cAMPS reduced Kv1.2-WT current, blocked the increase due to 8-Br-cAMP, but had no effect on Kv1.2-S449A. cPKA increased current due to double mutant Kv1.2-S440A/S441A but had no effect on Kv1.2-S449D or Kv1.2-S440A/S441A/S449A. We conclude that Ser-449 in Kv1.2 is a site of PKA phosphorylation and a potential molecular mechanism for Kv1-containing K-DR channel modulation by agonists via PKA activation.	[Johnson, Rosalyn P.; El-Yazbi, Ahmed F.; Walsh, Emma J.; Walsh, Michael P.; Cole, William C.] Univ Calgary, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada; [Hughes, Morgan F.; Schriemer, David C.] Univ Calgary, So Alberta Mass Spectrometry Ctr, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Cole, WC (corresponding author), Univ Calgary, Smooth Muscle Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	wcole@ucalgary.ca	El-Yazbi, Ahmed/AAT-6837-2021	El-Yazbi, Ahmed/0000-0003-3432-3038	Canadian Institutes of Health Research [MOP-10569]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-10569 (to W.C.C. and M.P.W.).	Aiello EA, 1996, AM J PHYSIOL-HEART C, V271, pH109, DOI 10.1152/ajpheart.1996.271.1.H109; AIELLO EA, 1995, AM J PHYSIOL-HEART C, V268, pH926, DOI 10.1152/ajpheart.1995.268.2.H926; Aiello EA, 1998, AM J PHYSIOL-HEART C, V275, pH448, DOI 10.1152/ajpheart.1998.275.2.H448; Albarwani S, 2003, J PHYSIOL-LONDON, V551, P751, DOI 10.1113/jphysiol.2003.040014; ALLEN BG, 1994, J BIOL CHEM, V269, P29288; Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Berg T, 2003, EUR J PHARMACOL, V466, P301, DOI 10.1016/S0014-2999(03)01555-3; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chen TT, 2006, CIRC RES, V99, P53, DOI 10.1161/01.RES.0000229654.45090.57; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; Cole WC, 1996, BIOCHEM CELL BIOL, V74, P439, DOI 10.1139/o96-048; Connors EC, 2008, J BIOL CHEM, V283, P3445, DOI 10.1074/jbc.M708875200; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; DEMAILLE JG, 1978, FEBS LETT, V86, P113, DOI 10.1016/0014-5793(78)80110-0; Dong H, 1998, BRIT J PHARMACOL, V123, P821, DOI 10.1038/sj.bjp.0701680; DU C, 1994, J PHARMACOL EXP THER, V268, P208; ERICKSON AC, 1993, J NEUROSCI METH, V46, P245, DOI 10.1016/0165-0270(93)90073-Z; Hayabuchi Y, 2001, AM J PHYSIOL-HEART C, V281, pH2480, DOI 10.1152/ajpheart.2001.281.6.H2480; Heaps CL, 2005, AM J PHYSIOL-HEART C, V288, pH568, DOI 10.1152/ajpheart.00157.2004; Heaps CL, 2002, J APPL PHYSIOL, V92, P550, DOI 10.1152/japplphysiol.00566.2001; HUANG XY, 1994, P NATL ACAD SCI USA, V91, P624, DOI 10.1073/pnas.91.2.624; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kerr PM, 2001, CIRC RES, V89, P1038, DOI 10.1161/hh2301.100803; KNOT HJ, 1995, AM J PHYSIOL-HEART C, V269, pH348, DOI 10.1152/ajpheart.1995.269.1.H348; Koh SD, 1996, PFLUG ARCH EUR J PHY, V432, P401, DOI 10.1007/s004240050151; Li HW, 2003, AM J PHYSIOL-HEART C, V285, pH1213, DOI 10.1152/ajpheart.00226.2003; Luykenaar KD, 2004, AM J PHYSIOL-HEART C, V286, pH1088, DOI 10.1152/ajpheart.00903.2003; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Plane F, 2005, CIRC RES, V96, P216, DOI 10.1161/01.RES.0000154070.06421.25; Satake N, 1996, BRIT J PHARMACOL, V119, P505, DOI 10.1111/j.1476-5381.1996.tb15700.x; Shuttleworth CWR, 1996, J PHYSIOL-LONDON, V493, P651, DOI 10.1113/jphysiol.1996.sp021412; Thorneloe KS, 2001, CIRC RES, V89, P1030, DOI 10.1161/hh2301.100817; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Zhao LL, 2009, MOL MEMBR BIOL, V26, P186, DOI 10.1080/09687680802714741	39	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16562	16574		10.1074/jbc.M109.010918	http://dx.doi.org/10.1074/jbc.M109.010918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19389710	Green Published, hybrid			2022-12-27	WOS:000266730900053
J	Zemskov, EA; Loukinova, E; Mikhailenko, I; Coleman, RA; Strickland, DK; Belkin, AM				Zemskov, Evgeny A.; Loukinova, Elena; Mikhailenko, Irina; Coleman, Richard A.; Strickland, Dudley K.; Belkin, Alexey M.			Regulation of Platelet-derived Growth Factor Receptor Function by Integrin-associated Cell Surface Transglutaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; STIMULATORY AUTOANTIBODIES; EXTRACELLULAR-MATRIX; PDGF RECEPTOR; CROSS-LINKING; PHOSPHORYLATION; ACTIVATION; ADHESION; SHP-2; EXPRESSION	A functional collaboration between growth factor receptors such as platelet derived growth factor receptor (PDGFR) and integrins is required for effective signal transduction in response to soluble growth factors. However, the mechanisms of synergistic PDGFR/integrin signaling remain poorly understood. Our previous work showed that cell surface tissue transglutaminase (tTG) induces clustering of integrins and amplifies integrin signaling by acting as an integrin binding adhesion coreceptor for fibronectin. Here we report that in fibroblasts tTG enhances PDGFR-integrin association by interacting with PDGFR and bridging the two receptors on the cell surface. The interaction between tTG and PDGFR reduces cellular levels of the receptor by accelerating its turnover. Moreover, the association of PDGFR with tTG causes receptor clustering, increases PDGF binding, promotes adhesion-mediated and growth factor-induced PDGFR activation, and up-regulates downstream signaling. Importantly, tTG is required for efficient PDGF-dependent proliferation and migration of fibroblasts. These results reveal a previously unrecognized role for cell surface tTG in the regulation of the joint PDGFR/integrin signaling and PDGFR-dependent cell responses.	[Zemskov, Evgeny A.; Belkin, Alexey M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Zemskov, Evgeny A.; Loukinova, Elena; Mikhailenko, Irina; Strickland, Dudley K.; Belkin, Alexey M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Loukinova, Elena; Mikhailenko, Irina; Coleman, Richard A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Belkin, Alexey M.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Belkin, AM (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	abelkin@som.umaryland.edu			National Institutes of Health [GM62895, HL50784, HL54710]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050784, P01HL054710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62895 (to A.M.B.) and HL50784 and HL54710 (to D.K.S.).	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Bakker ENTP, 2008, J VASC RES, V45, P271, DOI 10.1159/000113599; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Barillari G, 2001, ATHEROSCLEROSIS, V154, P377, DOI 10.1016/S0021-9150(00)00506-2; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Ekman S, 2002, ONCOGENE, V21, P1870, DOI 10.1038/sj.onc.1205210; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Haroon ZA, 2001, LAB INVEST, V81, P83, DOI 10.1038/labinvest.3780214; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Molberg O, 2006, TRENDS IMMUNOL, V27, P188, DOI 10.1016/j.it.2006.02.006; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Raines EW, 2000, ANN NY ACAD SCI, V902, P39; Ronnstrand L, 1999, ONCOGENE, V18, P3696, DOI 10.1038/sj.onc.1202705; Sheppard D, 2000, MATRIX BIOL, V19, P203, DOI 10.1016/S0945-053X(00)00065-2; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Svegliati S, 2007, BLOOD, V110, P237, DOI 10.1182/blood-2007-01-071043; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Verderio EAM, 2005, PROG EXP TUMOR RES, V38, P89; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397	36	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16693	16703		10.1074/jbc.M109.010769	http://dx.doi.org/10.1074/jbc.M109.010769			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19386600	Green Published, hybrid			2022-12-27	WOS:000266730900064
J	Haurigot, V; Villacampa, P; Ribera, A; Llombart, C; Bosch, A; Nacher, V; Ramos, D; Ayuso, E; Segovia, JC; Bueren, JA; Ruberte, J; Bosch, F				Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Llombart, Cristina; Bosch, Assumpcio; Nacher, Victor; Ramos, David; Ayuso, Eduard; Segovia, Jose C.; Bueren, Juan A.; Ruberte, Jesus; Bosch, Fatima			Increased Intraocular Insulin-like Growth Factor-I Triggers Blood-Retinal Barrier Breakdown	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETIC-RETINOPATHY; BINDING-PROTEINS; ADHESION MOLECULE-1; TRANSGENIC MICE; TIGHT JUNCTIONS; MACULAR EDEMA; IGF-I; EXPRESSION; OCCLUDIN; LOCALIZATION	Blood-retinal barrier (BRB) breakdown is a key event in diabetic retinopathy and other ocular disorders that leads to increased retinal vascular permeability. This causes edema and tissue damage resulting in visual impairment. Insulin-like growth factor-I (IGF-I) is involved in these processes, although the relative contribution of increased systemic versus intraocular IGF-I remains controversial. Here, to elucidate the role of this factor in BRB breakdown, transgenic mice with either local or systemic elevations of IGF-I have been examined. High intraocular IGF-I, resulting from overexpression of IGF-I in the retina, increased IGF-I receptor content and signaling and led to accumulation of vascular endothelial growth factor. This was parallel to up-regulation of vascular Intercellular adhesion molecule I and retinal infiltration by bone marrow-derived microglial cells. These alterations resulted in increased vessel paracellular permeability to both low and high molecular weight compounds in IGF-I-overexpressing retinas and agreed with the loss of vascular tight junction integrity observed by electron microscopy and the altered junctional protein content. In contrast, mice with chronically elevated serum IGF-I did not show alterations in the retinal vasculature structure and permeability, indicating that circulating IGF-I cannot initiate BRB breakdown. Consistent with a key role of IGF-I signaling in retinal diseases, a strong up-regulation of the IGF-I receptor in human retinas with marked gliosis was also observed. Thus, this study demonstrates that intraocular IGF-I, but not systemic IGF-I, is sufficient to trigger processes leading to BRB breakdown and increased retinal vascular permeability. Therefore, therapeutic interventions designed to counteract local IGF-I effects may prove successful to prevent BRB disruption.	[Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Llombart, Cristina; Bosch, Assumpcio; Nacher, Victor; Ramos, David; Ayuso, Eduard; Ruberte, Jesus; Bosch, Fatima] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, E-08193 Barcelona, Spain; [Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Bosch, Assumpcio; Ayuso, Eduard; Bosch, Fatima] Univ Autonoma Barcelona, Sch Vet Med, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Llombart, Cristina; Nacher, Victor; Ramos, David; Ruberte, Jesus] Univ Autonoma Barcelona, Sch Vet Med, Dept Anim Hlth & Anat, E-08193 Barcelona, Spain; [Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Nacher, Victor; Ayuso, Eduard; Ruberte, Jesus; Bosch, Fatima] CIBER Diabet & Associated Metab Disorders CIBERDE, Barcelona 08036, Spain; [Segovia, Jose C.; Bueren, Juan A.] CIEMAT, Hematopoiesis & Gene Therapy Div, E-28040 Madrid, Spain; [Segovia, Jose C.; Bueren, Juan A.] Biomed Ctr Rare Dis CIBERER, Valencia 46010, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Bosch, F (corresponding author), Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Edifici H, E-08193 Barcelona, Spain.	fatima.bosch@uab.es	Segovia, Jose Carlos/L-2922-2014; Ribera, Albert/K-9744-2014; AYUSO LOPEZ, Eduardo/I-7686-2017; Ruberte, Jesus/AAS-9240-2021; Bosch, Assumpcio/C-7593-2015; Villacampa, Pilar/B-1801-2019; Bueren, Juan/L-6112-2014	Segovia, Jose Carlos/0000-0003-4101-6124; Ribera, Albert/0000-0002-7120-4276; Bosch, Assumpcio/0000-0002-7205-2796; Villacampa, Pilar/0000-0002-2860-7475; Bueren, Juan/0000-0002-3228-7013; Ayuso, Eduard/0000-0003-0811-2229; Haurigot, Virginia A./0000-0002-9772-2565; Nacher, Victor/0000-0002-1340-4675; RUBERTE, JESUS/0000-0003-1540-1432; BOSCH, FATIMA/0000-0002-7705-5515	Instituto de Salud Carlos III [PI 061417]; CIBER de Diabetes y Enfermedades Metabolicas Asociadas), Spain; European Community FP6 EUGENE2 [LSHM-CT-2004-512013]; European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBER de Diabetes y Enfermedades Metabolicas Asociadas), Spain; European Community FP6 EUGENE2(European Commission); European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk(Novo NordiskJuvenile Diabetes Research Foundation)	This study was supported by grants from Instituto de Salud Carlos III (PI 061417 and CIBER de Diabetes y Enfermedades Metabolicas Asociadas), Spain, and the European Community FP6 EUGENE2 (Grant LSHM-CT-2004-512013) and European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk.	Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; BALLINTINE EJ, 1981, ARCH INTERN MED, V141, P1625, DOI 10.1001/archinte.141.12.1625; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Blank D, 2000, J CLIN ENDOCR METAB, V85, P634, DOI 10.1210/jc.85.2.634; Burren CP, 1996, INVEST OPHTH VIS SCI, V37, P1459; Dal Monte M, 2007, INVEST OPHTH VIS SCI, V48, P3480; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Derevjanik NL, 2002, INVEST OPHTH VIS SCI, V43, P2462; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Frystyk J, 2005, HORM METAB RES, V37, pS44, DOI 10.1055/s-2005-861362; Funatsu H, 2006, OPHTHALMOLOGY, V113, P294, DOI 10.1016/j.ophtha.2005.10.030; Funatsu H, 2002, AM J OPHTHALMOL, V133, P70, DOI 10.1016/S0002-9394(01)01269-7; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Gerhardinger C, 2001, DIABETES, V50, P175, DOI 10.2337/diabetes.50.1.175; GRANT M, 1986, DIABETES, V35, P416, DOI 10.2337/diabetes.35.4.416; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Joussen AM, 2002, AM J PATHOL, V160, P501, DOI 10.1016/S0002-9440(10)64869-9; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Kent D, 2000, BRIT J OPHTHALMOL, V84, P542, DOI 10.1136/bjo.84.5.542; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; MCLEOD DS, 1995, AM J PATHOL, V147, P642; MERIMEE TJ, 1983, NEW ENGL J MED, V309, P527, DOI 10.1056/NEJM198309013090904; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Morcos Y, 2001, J NEUROCYTOL, V30, P107, DOI 10.1023/A:1011982906125; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Patel JI, 2006, EXP EYE RES, V82, P798, DOI 10.1016/j.exer.2005.10.002; Poulaki V, 2004, AM J PATHOL, V165, P457, DOI 10.1016/S0002-9440(10)63311-1; Prahalada S, 1999, HORM METAB RES, V31, P133, DOI 10.1055/s-2007-978710; Punglia RS, 1997, DIABETES, V46, P1619, DOI 10.2337/diabetes.46.10.1619; Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408; Ruberte J, 2004, J CLIN INVEST, V113, P1149, DOI 10.1172/JCI200419478; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Shaw LC, 2004, REV ENDOCR METAB DIS, V5, P199, DOI 10.1023/B:REMD.0000032408.18015.b1; Spoerri PE, 1998, GROWTH HORM IGF RES, V8, P125, DOI 10.1016/S1096-6374(98)80102-0; VALERA A, 1993, FASEB J, V7, P791, DOI 10.1096/fasebj.7.9.8330686; VORBRODT AW, 1986, J HISTOCHEM CYTOCHEM, V34, P251, DOI 10.1177/34.2.3753715; Xu HP, 2005, INVEST OPHTH VIS SCI, V46, P2487, DOI 10.1167/iovs.04-1333	41	46	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22961	22969		10.1074/jbc.M109.014787	http://dx.doi.org/10.1074/jbc.M109.014787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19473988	Green Published, hybrid			2022-12-27	WOS:000268963100049
J	Li, HQ; Gakh, O; Smith, DY; Isaya, G				Li, Hongqiao; Gakh, Oleksandr; Smith, Douglas Y., IV; Isaya, Grazia			Oligomeric Yeast Frataxin Drives Assembly of Core Machinery for Mitochondrial Iron-Sulfur Cluster Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; SACCHAROMYCES-CEREVISIAE; FRIEDREICH ATAXIA; SCAFFOLD PROTEIN; BINDING PROTEIN; ISCU; BIOSYNTHESIS; BIOGENESIS; MATURATION; DAMAGE	Mitochondrial biosynthesis of iron-sulfur clusters (ISCs) is a vital process involving the delivery of elemental iron and sulfur to a scaffold protein via molecular interactions that are still poorly defined. Analysis of highly conserved components of the yeast ISC assembly machinery shows that the iron-chaperone, Yfh1, and the sulfur-donor complex, Nfs1-Isd11, directly bind to each other. This interaction is mediated by direct Yfh1-Isd11 contacts. Moreover, both Yfh1 and Nfs1-Isd11 can directly bind to the scaffold, Isu1. Binding of Yfh1 to Nfs1-Isd11 or Isu1 requires oligomerization of Yfh1 and can occur in an iron-independent manner. However, more stable contacts are formed when Yfh1 oligomerization is normally coupled with the binding and oxidation of Fe2+. Our observations challenge the view that iron delivery for ISC synthesis is mediated by Fe2+-loaded monomeric Yfh1. Rather, we find that the iron oxidation-driven oligomerization of Yfh1 promotes the assembly of stable multicomponent complexes in which the iron donor and the sulfur donor simultaneously interact with each other as well as with the scaffold. Moreover, the ability to store ferric iron enables oligomeric Yfh1 to adjust iron release depending on the presence of Isu1 and the availability of elemental sulfur and reducing equivalents. In contrast, the use of anaerobic conditions that prevent Yfh1 oligomerization results in inhibition of ISC assembly on Isu1. These findings suggest that iron-dependent oligomerization is a mechanism by which the iron donor promotes assembly of the core machinery for mitochondrial ISC synthesis.	[Isaya, Grazia] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health [AG15709]; Friedreich Ataxia Research Alliance and the Muscular Dystrophy Association; Mayo Clinic Department of Pediatric & Adolescent Medicine; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich Ataxia Research Alliance and the Muscular Dystrophy Association; Mayo Clinic Department of Pediatric & Adolescent Medicine; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant AG15709. This work was also supported by the Friedreich Ataxia Research Alliance and the Muscular Dystrophy Association and by a fellowship from the Mayo Clinic Department of Pediatric & Adolescent Medicine (to H. L.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vivas E, 2006, J BACTERIOL, V188, P1175, DOI 10.1128/JB.188.3.1175-1179.2006; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200	35	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21971	21980		10.1074/jbc.M109.011197	http://dx.doi.org/10.1074/jbc.M109.011197			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19491103	hybrid, Green Published			2022-12-27	WOS:000268783700021
J	Liang, GQ; Bansal, G; Xie, ZH; Druey, KM				Liang, Genqing; Bansal, Geetanjali; Xie, Zhihui; Druey, Kirk M.			RGS16 Inhibits Breast Cancer Cell Growth by Mitigating Phosphatidylinositol 3-Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE; ACTIVATION; AKT; MUTATIONS; THERAPY; PATHWAY; P110-ALPHA/P85-ALPHA; PROLIFERATION; ASSOCIATION	Aberrant activity of the phosphatidylinositol 3-kinase (PI3K) pathway supports growth of many tumors including those of breast, lung, and prostate. Resistance of breast cancer cells to targeted chemotherapies including tyrosine kinase inhibitors (TKI) has been linked to persistent PI3K activity, which may in part be due to increased membrane expression of epidermal growth factor (EGF) receptors (HER2 and HER3). Recently we found that proteins of the RGS (regulator of (G) under bar protein signaling) family suppress PI3K activity downstream of the receptor by sequestering its p85 alpha subunit from signaling complexes. Because a substantial percentage of breast tumors have RGS16 mutations and reduced RGS16 protein expression, we investigated the link between regulation of PI3K activity by RGS16 and breast cancer cell growth. RGS16 overexpression in MCF7 breast cancer cells inhibited EGF-induced proliferation and Akt phosphorylation, whereas shRNA-mediated extinction of RGS16 augmented cell growth and resistance to TKI treatment. Exposure to TKI also reduced RGS16 expression in MCF7 and BT474 cell lines. RGS16 bound the amino-terminal SH2 and inter-SH2 domains of p85 alpha and inhibited its interaction with the EGF receptor-associated adapter protein Gab1. These results suggest that the loss of RGS16 in some breast tumors enhances PI3K signaling elicited by growth factors and thereby promotes proliferation and TKI evasion downstream of HER activation.	[Liang, Genqing; Bansal, Geetanjali; Xie, Zhihui; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Druey, KM (corresponding author), NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, 10 Ctr Dr,Rm 11N242, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	Bansal, Geetanjali/C-3854-2009; Liang, Genqing/B-7180-2011		Intramural Research funding from NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000746, Z01AI000746] Funding Source: NIH RePORTER	Intramural Research funding from NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Intramural Research funding from NIAID, National Institutes of Health.	Bahlis NJ, 2007, BLOOD, V109, P5002, DOI 10.1182/blood-2006-03-012542; Bansal G, 2008, NAT IMMUNOL, V9, P73, DOI 10.1038/ni1533; Buckbinder L, 1997, P NATL ACAD SCI USA, V94, P7868, DOI 10.1073/pnas.94.15.7868; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Clark MA, 2007, FEBS LETT, V581, P764, DOI 10.1016/j.febslet.2007.01.045; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Derrien A, 2001, J BIOL CHEM, V276, P48532, DOI 10.1074/jbc.M108862200; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Harvey R Donald, 2007, Future Oncol, V3, P639, DOI 10.2217/14796694.3.6.639; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; Huang CH, 2008, CELL CYCLE, V7, P1151, DOI 10.4161/cc.7.9.5817; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Johnson EN, 2003, NAT CELL BIOL, V5, P1095, DOI 10.1038/ncb1065; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Liang GQ, 2008, HUM MOL GENET, V17, P3254, DOI 10.1093/hmg/ddn221; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tazzari PL, 2007, LEUKEMIA, V21, P427, DOI 10.1038/sj.leu.2404523; Tokunaga Eriko, 2006, Breast Cancer, V13, P137, DOI 10.2325/jbcs.13.137; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Wiechec E, 2008, GENE CHROMOSOME CANC, V47, P766, DOI 10.1002/gcc.20578; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118	35	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21719	21727		10.1074/jbc.M109.028407	http://dx.doi.org/10.1074/jbc.M109.028407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509421	hybrid, Green Published			2022-12-27	WOS:000268564400064
J	Ruiz, CA; Rotundo, RL				Ruiz, Carlos A.; Rotundo, Richard L.			Dissociation of Transcription, Translation, and Assembly of Collagen-tailed Acetylcholinesterase in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT MUSCLE; NEUROMUSCULAR-JUNCTION; CULTURED MYOTUBES; MOLECULAR-FORMS; MESSENGER-RNA; FAST-TWITCH; EXPRESSION; FIBERS; CELLS; COLQ	The synaptic form of acetylcholinesterase (AChE) in skeletal muscle ColQ-AChE derives from two separate genes encoding the catalytic and the non-catalytic collagenic tail (ColQ) subunits, respectively. ColQ-AChE expression is regulated by muscle activity; however, how this regulation takes place in skeletal muscle remains poorly understood. In this study, we overexpressed or knocked down ColQ expression in skeletal muscle and found that the level of this non-catalytic component by itself was sufficient to change the levels of total AChE activity by promoting assembly of higher order oligomeric forms including the collagen-tailed forms. These results initially suggested that ColQ could be limiting in the assembly of synaptic ColQ-AChE during development and differentiation. We then determined the levels of ColQ protein and ColQ mRNA during primary quail muscle cell development and differentiation in culture (QMCs) and as a function of muscle activity. Surprisingly, we found dissociation between transcription and translation of the non-catalytic subunit from its assembly into ColQ-AChE. Furthermore, we found that the vast majority of the steady state ColQ molecules in mature quail muscle cultures are not assembled into ColQ-AChE, suggesting that they are either rapidly degraded or have alternative function(s).	[Ruiz, Carlos A.; Rotundo, Richard L.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA	University of Miami	Rotundo, RL (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol & Anat R124, 1600 NW 10th Ave, Miami, FL 33136 USA.	rrotundo@miami.edu			National Institutes of Health [AG005917, NS057994]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG005917 and NS057994 ( to R. L. R.).	BROCKMAN SK, 1984, J NEUROSCI, V4, P131; BUCKINGHAM ME, 1984, MOL BIOL DEV; Choi RCY, 2007, J NEUROCHEM, V102, P1316, DOI 10.1111/j.1471-4159.2007.04630.x; Couteaux R, 1938, NATURE, V142, P481, DOI 10.1038/142481a0; DELAPORTE S, 1984, DEV BIOL, V106, P450, DOI 10.1016/0012-1606(84)90244-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; EMERSON CP, 1975, J MOL BIOL, V93, P431, DOI 10.1016/0022-2836(75)90238-7; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; FERNANDEZVALLE C, 1989, J BIOL CHEM, V264, P14043; Hubatsch DA, 1997, AM J PHYSIOL-CELL PH, V273, pC2002, DOI 10.1152/ajpcell.1997.273.6.C2002; KOENIG J, 1978, NATURE, V271, P75, DOI 10.1038/271075a0; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; Krejci E, 1999, J NEUROSCI, V19, P10672, DOI 10.1523/JNEUROSCI.19-24-10672.1999; Lau FTC, 2008, MOL CELL NEUROSCI, V39, P429, DOI 10.1016/j.mcn.2008.07.018; Lee HHC, 2004, J BIOL CHEM, V279, P27098, DOI 10.1074/jbc.M402596200; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; LINKHART TA, 1975, J EXP ZOOL, V193, P191, DOI 10.1002/jez.1401930208; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; OLSON EN, 1984, J BIOL CHEM, V259, P3330; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; RIEGER F, 1984, DEV BIOL, V101, P181, DOI 10.1016/0012-1606(84)90128-3; RIEGER F, 1980, DEV BIOL, V76, P358, DOI 10.1016/0012-1606(80)90385-1; Rimer M, 1999, BIOCHEM BIOPH RES CO, V260, P251, DOI 10.1006/bbrc.1999.0893; Rossi SG, 2000, J NEUROSCI, V20, P919, DOI 10.1523/JNEUROSCI.20-03-00919.2000; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; ROTUNDO RL, 1980, CELL, V22, P583, DOI 10.1016/0092-8674(80)90368-2; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; Sambrook J., 2001, MOL CLONING LAB MANU; Ting AKL, 2005, CHEM-BIOL INTERACT, V157, P63, DOI 10.1016/j.cbi.2005.10.009; Trinkaus M, 2008, J NEUROCHEM, V105, P2535, DOI 10.1111/j.1471-4159.2008.05328.x; VIGNY M, 1976, FEBS LETT, V69, P277, DOI 10.1016/0014-5793(76)80703-X; VIGNY M, 1976, J NEUROCHEM, V27, P1347, DOI 10.1111/j.1471-4159.1976.tb02614.x; WEINBERG CB, 1979, DEV BIOL, V68, P631, DOI 10.1016/0012-1606(79)90233-1; WHALEN RG, 1981, NATURE, V292, P805, DOI 10.1038/292805a0	36	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21488	21495		10.1074/jbc.M109.030049	http://dx.doi.org/10.1074/jbc.M109.030049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509281	Green Published, hybrid			2022-12-27	WOS:000268564400043
J	Dennis, MD; Person, MD; Browning, KS				Dennis, Michael D.; Person, Maria D.; Browning, Karen S.			Phosphorylation of Plant Translation Initiation Factors by CK2 Enhances the in Vitro Interaction of Multifactor Complex Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; CARBOXYL-TERMINAL DOMAIN; BETA-SUBUNIT; WHEAT-GERM; ARABIDOPSIS-THALIANA; ELONGATION-FACTORS; EIF2-BETA SUBUNIT; EIF3; SITES; YEAST	CK2 phosphorylates a wide variety of substrates, including translation initiation factors. A mass spectrometric approach was used to identify residues phosphorylated by CK2, which may regulate the activity of initiation factors during the translation initiation process in plants. CK2 in vitro phosphorylation sites were identified in wheat and Arabidopsis thaliana eIF2 alpha, eIF2 beta, eIF5, and wheat eIF3c. Native wheat eIF5 and eIF2 alpha were found to have phosphorylation sites that corresponded to some of the in vitro CK2 phosphorylation sites. A large number of the CK2 sites identified in this study are in conserved binding domains that have been implicated in the yeast multifactor complex ( eIF1-eIF3-eIF5-eIF2-GTP-Met-tRNA(i)(Met)). This is the first study to demonstrate that plant initiation factors are capable of forming a multifactor complex in vitro. In addition, the interaction of factors within these complexes was enhanced both in vitro and in native extracts by phosphorylation of one or more initiation factors by CK2. The importance of CK2 phosphorylation of eIF5 was evaluated by site-directed mutagenesis of eIF5 to remove CK2 phosphorylation sites. Removal of CK2 phosphorylation sites from eIF5 inhibits the CK2-mediated increase in eIF5 interaction with eIF1 and eIF3c in pulldown assays and reduces the eIF5-mediated stimulation of translation initiation in vitro. These results suggest a functional role for CK2 phosphorylation in the initiation of plant translation.	[Dennis, Michael D.; Browning, Karen S.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Person, Maria D.] Univ Texas Austin, Div Pharmacol & Toxicol, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Browning, KS (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	kbrowning@mail.utexas.edu		Dennis, Michael/0000-0002-0645-6864	United States Department of Energy [DE-FG02-04ER15575]; National Science Foundation [MCB0214996]; Welch Foundation [F1339]	United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation)	This work was supported by Grant DE-FG02-04ER15575 from the United States Department of Energy, Grant MCB0214996 from the National Science Foundation, and Grant F1339 from The Welch Foundation ( to K. S. B.).	Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Bonnet H, 1996, J BIOL CHEM, V271, P24781, DOI 10.1074/jbc.271.40.24781; BROWNING KS, 1990, J BIOL CHEM, V265, P17967; BROWNING KS, 1985, PLANT PHYSIOL, V77, P370, DOI 10.1104/pp.77.2.370; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; Das S, 2000, MOL CELL BIOL, V20, P3942, DOI 10.1128/MCB.20.11.3942-3950.2000; Dennis MD, 2009, J BIOL CHEM, V284, P20602, DOI 10.1074/jbc.M109.006692; FENG L, 1994, MOL CELL BIOL, V14, P5139, DOI 10.1128/MCB.14.8.5139; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Homma MK, 2005, MOL CELL BIOCHEM, V274, P47, DOI 10.1007/s11010-005-3111-3; Homma MK, 2005, P NATL ACAD SCI USA, V102, P15688, DOI 10.1073/pnas.0506791102; Jiang XZ, 2004, BIOCHEMISTRY-US, V43, P15567, DOI 10.1021/bi0483965; LAX SR, 1982, J BIOL CHEM, V257, P8233; LAX SR, 1986, METHOD ENZYMOL, V118, P109; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Llorens F, 2006, BIOCHEM J, V394, P227, DOI 10.1042/BJ20050605; Llorens F, 2005, MOL CELL BIOCHEM, V274, P53, DOI 10.1007/s11010-005-3081-5; Maiti T, 2003, YEAST, V20, P97, DOI 10.1002/yea.937; Majumdar R, 2002, NUCLEIC ACIDS RES, V30, P1154, DOI 10.1093/nar/30.5.1154; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; MAYBERRY LK, 2006, CURR PROTOCOLS MICRO; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Metz AM, 1997, ARCH BIOCHEM BIOPHYS, V342, P187, DOI 10.1006/abbi.1997.0119; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Olsten MEK, 2005, MOL CELL BIOCHEM, V274, P115, DOI 10.1007/s11010-005-3072-6; OSTERHOUT JJ, 1983, J BIOL CHEM, V258, P8285; Person MD, 2003, CHEM RES TOXICOL, V16, P598, DOI 10.1021/tx020109f; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Singh CR, 2004, J BIOL CHEM, V279, P49644, DOI 10.1074/jbc.M409609200; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Valasek L, 2002, EMBO J, V21, P5886, DOI 10.1093/emboj/cdf563; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102	41	44	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20615	20628		10.1074/jbc.M109.007658	http://dx.doi.org/10.1074/jbc.M109.007658			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509420	hybrid, Green Published			2022-12-27	WOS:000268316100023
J	Guth, E; Farris, M; Bovee, M; Francklyn, CS				Guth, Ethan; Farris, Mindy; Bovee, Michael; Francklyn, Christopher S.			Asymmetric Amino Acid Activation by Class II Histidyl-tRNA Synthetase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-SITES REACTIVITY; RATE-LIMITING STEP; KINETIC MECHANISM; CRYSTAL-STRUCTURE; LIGAND-BINDING; BEEF PANCREAS; AMINOACYLATION; ADENYLATE; CATALYSIS; ENZYME	Aminoacyl-tRNA synthetases (ARSs) join amino acids to their cognate tRNAs to initiate protein synthesis. Class II ARS possess a unique catalytic domain fold, possess active site signature sequences, and are dimers or tetramers. The dimeric class I enzymes, notably TyrRS, exhibit half-of-sites reactivity, but its mechanistic basis is unclear. In class II histidyl-tRNA synthetase (HisRS), amino acid activation occurs at different rates in the two active sites when tRNA is absent, but half-of-sites reactivity has not been observed. To investigate the mechanistic basis of the asymmetry, and explore the relationship between adenylate formation and conformational events in HisRS, a fluorescently labeled version of the enzyme was developed by conjugating 7-diethylamino-3-((((2-maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC) to a cysteine introduced at residue 212, located in the insertion domain. The binding of the substrates histidine, ATP, and 5'-O-[N-(L-histidyl)sulfamoyl] adenosine to MDCC-HisRS produced fluorescence quenches on the order of 6-15%, allowing equilibrium dissociation constants to be measured. The rates of adenylate formation measured by rapid quench and domain closure as measured by stopped-flow fluorescence were similar and asymmetric with respect to the two active sites of the dimer, indicating that conformational change may be rate-limiting for product formation. Fluorescence resonance energy transfer experiments employing differential labeling of the two monomers in the dimer suggested that rigid body rotation of the insertion domain accompanies adenylate formation. The results support an alternating site model for catalysis in HisRS that may prove to be common to other class II aminoacyl-tRNA synthetases.	[Guth, Ethan; Farris, Mindy; Bovee, Michael; Francklyn, Christopher S.] Univ Vermont, Dept Biochem, Coll Med, Burlington, VT 05405 USA	University of Vermont	Francklyn, CS (corresponding author), Univ Vermont, Dept Biochem, Coll Med, Hlth Sci Complex,89 Beaumont Ave, Burlington, VT 05405 USA.	Christopher.Francklyn@uvm.edu			National Institutes of Health [RO1 GM54899, F32 GM19739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019739, R01GM054899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM54899 (to C.S.F.) and F32 GM19739 (to M. L. B.).	Aberg A, 1997, BIOCHEMISTRY-US, V36, P3084, DOI 10.1021/bi9618373; Arnez JG, 1997, P NATL ACAD SCI USA, V94, P7144, DOI 10.1073/pnas.94.14.7144; ARNEZ JG, 1995, EMBO J, V14, P4143, DOI 10.1002/j.1460-2075.1995.tb00088.x; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; BEDOUELLE H, 2005, AMINOACYL TRANS SYNT, P111; BLANQUET S, 1972, EUR J BIOCHEM, V24, P461, DOI 10.1111/j.1432-1033.1972.tb19707.x; Bovee ML, 2003, BIOCHEMISTRY-US, V42, P15102, DOI 10.1021/bi0355701; CARTER CW, 2005, AMINOACYL TRNA SYNTH, P99; COMMANS S, 1995, BIOCHEMISTRY-US, V34, P8180, DOI 10.1021/bi00025a025; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; DIBBELT L, 1980, NUCLEIC ACIDS RES, V8, P4021, DOI 10.1093/nar/8.17.4021; DIBBELT L, 1981, FEBS LETT, V129, P173, DOI 10.1016/0014-5793(81)80783-1; DINATALE P, 1976, EUR J BIOCHEM, V62, P293; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FASIOLO F, 1977, EUR J BIOCHEM, V73, P7, DOI 10.1111/j.1432-1033.1977.tb11286.x; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P5, DOI 10.1021/bi00672a002; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P13, DOI 10.1021/bi00672a003; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; First E.A., 2005, AMINOACYL TRNA SYNTH, P328; FRANCKLYN C, 1994, J MOL BIOL, V241, P275, DOI 10.1006/jmbi.1994.1498; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; FREEDMAN R, 1985, J BIOL CHEM, V260, P10063; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; Hauenstein SI, 2008, J BIOL CHEM, V283, P21997, DOI 10.1074/jbc.M801838200; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKES R, 1975, BIOCHEMISTRY-US, V14, P3344, DOI 10.1021/bi00686a009; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P369, DOI DOI 10.1007/978-1-4757-3061-6; LAZDUNSKI M, 1971, EUR J BIOCHEM, V20, P124, DOI 10.1111/j.1432-1033.1971.tb01370.x; MAZAT JP, 1982, EUR J BIOCHEM, V128, P389; Minajigi A, 2008, P NATL ACAD SCI USA, V105, P17748, DOI 10.1073/pnas.0804247105; Pope AJ, 1998, J BIOL CHEM, V273, P31680, DOI 10.1074/jbc.273.48.31680; Qiu XY, 1999, BIOCHEMISTRY-US, V38, P12296, DOI 10.1021/bi990482v; Takita T, 1998, J BIOCHEM-TOKYO, V124, P45, DOI 10.1093/oxfordjournals.jbchem.a022095; TREZEGUET V, 1986, BIOCHEMISTRY-US, V25, P7125, DOI 10.1021/bi00370a055; WARD WHJ, 1988, BIOCHEMISTRY-US, V27, P1041, DOI 10.1021/bi00403a029; WARD WHJ, 1988, BIOCHEMISTRY-US, V27, P5525, DOI 10.1021/bi00415a021; Yan W, 1996, BIOCHEMISTRY-US, V35, P6559, DOI 10.1021/bi952889f; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	40	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20753	20762		10.1074/jbc.M109.021311	http://dx.doi.org/10.1074/jbc.M109.021311			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19487703	Green Published, hybrid			2022-12-27	WOS:000268316100037
J	Korzeniowski, MK; Popovic, MA; Szentpetery, Z; Varnai, P; Stojilkovic, SS; Balla, T				Korzeniowski, Marek K.; Popovic, Marko A.; Szentpetery, Zsofia; Varnai, Peter; Stojilkovic, Stanko S.; Balla, Tamas			Dependence of STIM1/Orai1-mediated Calcium Entry on Plasma Membrane Phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; PHOSPHATIDYLINOSITOL 4-KINASE; CHANNEL ACTIVATION; ENDOTHELIAL-CELLS; HUMAN PLATELETS; CRAC CHANNELS; CA2+ CHANNELS; LIVING CELLS; STIM1; ORAI1	Recent studies identified two main components of store-operated calcium entry (SOCE): the endoplasmic reticulum-localized Ca2+ sensor protein, STIM1, and the plasma membrane (PM)-localized Ca2+ channel, Orai1/CRACM1. In the present study, we investigated the phosphoinositide dependence of Orai1 channel activation in the PM and of STIM1 movements from the tubular to PM-adjacent endoplasmic reticulum regions during Ca2+ store depletion. Phosphatidylinositol 4,5-bisphosphate ( PtdIns( 4,5)P-2) levels were changed either with agonist stimulation or by chemically induced recruitment of a phosphoinositide 5-phosphatase domain to the PM, whereas PtdIns4P levels were decreased by inhibition or down-regulation of phosphatidylinositol 4-kinases (PI4Ks). Agonist-induced phospholipase C activation and PI4K inhibition, but not isolated PtdIns(4,5)P-2 depletion, substantially reduced endogenous or STIM1/Orai1-mediated SOCE without preventing STIM1 movements toward the PM upon Ca2+ store depletion. Patch clamp analysis of cells overexpressing STIM1 and Orai1 proteins confirmed that phospholipase C activation or PI4K inhibition greatly reduced I-CRAC currents. These results suggest an inositide requirement of Orai1 activation but not STIM1 movements and indicate that PtdIns4P rather than PtdIns(4,5)P-2 is a likely determinant of Orai1 channel activity.	[Korzeniowski, Marek K.; Szentpetery, Zsofia; Balla, Tamas] NICHD, NIH, Sect Mol Signal Transduct, Program Dev Neurosci, Bethesda, MD 20892 USA; [Popovic, Marko A.; Stojilkovic, Stanko S.] NICHD, NIH, Sect Cellular Signaling, Program Dev Neurosci, Bethesda, MD 20892 USA; [Varnai, Peter] Semmelweis Univ, Fac Med, Dept Physiol, H-1094 Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Semmelweis University	Balla, T (corresponding author), NICHD, NIH, Sect Mol Signal Transduct, Program Dev Neurosci, Bldg 49,Rm 6A35,49 Convent Dr, Bethesda, MD 20892 USA.	ballat@mail.nih.gov	Korzeniowski, Marek/G-7214-2011	Balla, Tamas/0000-0002-9077-3335; Korzeniowski, Marek/0000-0002-5264-7303	NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196, ZIAHD000195] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000195, Z01HD000196] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by a National Institutes of Health grant from the Intramural Research Program of the NICHD.	Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Balla T, 2007, J PHYSIOL-LONDON, V582, P927, DOI 10.1113/jphysiol.2007.132795; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P17078; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; NAKANISHI S, 1994, J BIOL CHEM, V269, P6528; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2000, J BIOL CHEM, V275, P9110, DOI 10.1074/jbc.275.13.9110; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; SARKADI B, 1990, BIOCHIM BIOPHYS ACTA, V1027, P130, DOI 10.1016/0005-2736(90)90076-Z; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Takahashi R, 1997, BIOCHEM BIOPH RES CO, V235, P657, DOI 10.1006/bbrc.1997.6856; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Warashina A, 1999, ARCH BIOCHEM BIOPHYS, V367, P303, DOI 10.1006/abbi.1999.1273; Watanabe H, 1996, BIOCHEM BIOPH RES CO, V225, P777, DOI 10.1006/bbrc.1996.1250; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	42	112	114	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21027	21035		10.1074/jbc.M109.012252	http://dx.doi.org/10.1074/jbc.M109.012252			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19483082	hybrid, Green Published			2022-12-27	WOS:000268316100065
J	Fan, Y; Menon, RK; Cohen, P; Hwang, D; Clemens, T; DiGirolamo, DJ; Kopchick, JJ; Le Roith, D; Trucco, M; Sperling, MA				Fan, Yong; Menon, Ram K.; Cohen, Pinchas; Hwang, David; Clemens, Thomas; DiGirolamo, Douglas J.; Kopchick, John J.; Le Roith, Derek; Trucco, Massimo; Sperling, Mark A.			Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I IGF-I; INSULIN-RESISTANCE; BONE-GROWTH; MICE; INSULIN-LIKE-GROWTH-FACTOR-1; EXPRESSION; MOUSE; GENE; TISSUE; PLATE	Growth hormone (GH) plays a pivotal role in growth and metabolism, with growth promotion mostly attributed to generation of insulin-like growth factor I (IGF-I) in liver or at local sites of GH action, whereas the metabolic effects of GH are considered to be intrinsic to GH itself. To distinguish the effects of GH from those of IGF-I, we developed a Cre-lox-mediated model of tissue-specific deletion of the growth hormone receptor (GHR). Near total deletion of the GHR in liver (GHRLD) had no effect on total body or bone linear growth despite a >90% suppression of circulating IGF-I; however, total bone density was significantly reduced. Circulating GH was increased 4-fold, and GHRLD displayed insulin resistance, glucose intolerance, and increased circulating free fatty acids. Livers displayed marked steatosis, the result of increased triglyceride synthesis and decreased efflux; reconstitution of hepatic GHR signaling via adenoviral expression of GHR restored triglyceride output to normal, whereas IGF-I infusion did not correct steatosis despite restoration of circulating GH to normal. Thus, with near total absence of circulating IGF-I, GH action at the growth plate, directly and via locally generated IGF-I, can regulate bone growth, but at the expense of diabetogenic, lipolytic, and hepatosteatotic consequences. Our results indicate that IGF-I is essential for bone mineral density, whereas hepatic GH signaling is essential to regulate intrahepatic lipid metabolism. We propose that circulating IGF-I serves to amplify the growth-promoting effects of GH, while simultaneously dampening the catabolic effects of GH.	[Fan, Yong; Trucco, Massimo; Sperling, Mark A.] Univ Pittsburgh, Dept Pediat, Sch Med, Pittsburgh, PA 15260 USA; [Menon, Ram K.] Univ Michigan, Dept Pediat, Sch Med, Ann Arbor, MI 48109 USA; [Cohen, Pinchas; Hwang, David] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA; [Clemens, Thomas; DiGirolamo, Douglas J.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Kopchick, John J.] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA; [Le Roith, Derek] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio University; Icahn School of Medicine at Mount Sinai	Sperling, MA (corresponding author), Childrens Hosp Pittsburgh, 530 45th St, Pittsburgh, PA 15201 USA.	masp@pitt.edu			National Institutes of Health [RO1-AR052746-01, RO1-DK049845-11A2]; Henry Hillman Endowment Chair; Department of Defense [W81XWH-06-1-0317]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry Hillman Endowment Chair; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-AR052746-01 (to T. C. and M. A. S.) and RO1-DK049845-11A2 (to R. K. M. and M. A. S.). This work was also supported in part by a grant from the Henry Hillman Endowment Chair in Pediatric Immunology and by Department of Defense Grant W81XWH-06-1-0317 (to M. T.).	Clemmons David Robert, 2002, Pituitary, V5, P181, DOI 10.1023/A:1023321421760; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; del Rincon JP, 2007, DIABETES, V56, P1638, DOI 10.2337/db06-0299; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Fan Y, 1999, DEV BIOL, V210, P481, DOI 10.1006/dbio.1999.9279; Goldenberg N, 2007, ENDOCRIN METAB CLIN, V36, P37, DOI 10.1016/j.ecl.2006.11.003; Hwang DL, 2008, GROWTH HORM IGF RES, V18, P65, DOI 10.1016/j.ghir.2007.07.007; Imberti B, 2007, J AM SOC NEPHROL, V18, P2921, DOI 10.1681/ASN.2006121318; Johannsson G., 1999, Journal of Endocrinological Investigation, V22, P41; Kaplan SA, 2007, J CLIN ENDOCR METAB, V92, P4529, DOI 10.1210/jc.2007-0526; KOSTYO JL, 1959, SCIENCE, V130, P1653, DOI 10.1126/science.130.3389.1653; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; LeRoith Derek, 2008, Pediatr Endocrinol Rev, V5 Suppl 2, P739; Liu JL, 2000, P SOC EXP BIOL MED, V223, P344, DOI 10.1046/j.1525-1373.2000.22349.x; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; NILSSON A, 1986, SCIENCE, V233, P571, DOI 10.1126/science.3523759; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Rosenfeld RG, 2007, TRENDS ENDOCRIN MET, V18, P134, DOI 10.1016/j.tem.2007.03.004; SHERWIN RS, 1983, DIABETOLOGIA, V24, P155; Shimano H, 2007, J MOL MED, V85, P437, DOI 10.1007/s00109-007-0158-5; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Sjogren M, 2002, ENDOCRINE, V19, P249, DOI 10.1385/ENDO:19:3:249; Svensson J, 2007, J ENDOCRINOL, V193, P359, DOI 10.1677/JOE-07-0024; Wang J, 2004, J ENDOCRINOL, V180, P247, DOI 10.1677/joe.0.1800247; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	30	188	190	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19937	19944		10.1074/jbc.M109.014308	http://dx.doi.org/10.1074/jbc.M109.014308			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19460757	hybrid, Green Published			2022-12-27	WOS:000268097400020
J	Lin, IJ; Zhou, Z; Crusselle-Davis, VJ; Moghimi, B; Gandhi, K; Anantharaman, A; Pantic, D; Huang, S; Jayandharan, G; Zhong, L; Srivastava, A; Bungert, J				Lin, I-Ju; Zhou, Zhuo; Crusselle-Davis, Valerie J.; Moghimi, Babak; Gandhi, Kunjal; Anantharaman, Archana; Pantic, Dorjan; Huang, Suming; Jayandharan, Giridhararao; Zhong, Li; Srivastava, Arun; Bungert, Joerg			Calpeptin Increases the Activity of Upstream Stimulatory Factor and Induces High Level Globin Gene Expression in Erythroid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; MURINE ERYTHROLEUKEMIA-CELLS; LOOP-HELIX PROTEINS; TFII-I; TRANSCRIPTION FACTORS; STEM-CELLS; DIFFERENTIATION; CALPAIN; COMMITMENT; PROMOTER	Differentiation of erythroid cells is regulated by cell signaling pathways including those that change the intracellular concentration of calcium. Calcium-dependent proteases have been shown previously to process and regulate the activity of specific transcription factors. We show here that the protein levels of upstream stimulatory factor (USF) increase during differentiation of murine erythroleukemia (MEL) cells. USF was subject to degradation by the Ca2+-dependent protease m-calpain in undifferentiated but not in differentiated MEL cells. Treatment of MEL cells with the specific calpain inhibitor calpeptin increased the levels of USF and strongly induced expression of the adult alpha- and beta-globin genes. The induction of globin gene expression was associated with an increase in the association of USF and RNA polymerase II with regulatory elements of the beta-globin gene locus. Calpeptin also induced high level alpha- and beta-globin gene expression in primary CD71-positive erythroid progenitor cells. The combined data suggest that inhibition of calpain activity is required for erythroid differentiation-associated increase in globin gene expression.	[Lin, I-Ju; Zhou, Zhuo; Crusselle-Davis, Valerie J.; Moghimi, Babak; Gandhi, Kunjal; Anantharaman, Archana; Pantic, Dorjan; Huang, Suming; Bungert, Joerg] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Jayandharan, Giridhararao; Zhong, Li; Srivastava, Arun] Univ Florida, Coll Med, Div Cellular & Mol Therapy, Dept Pediat, Gainesville, FL 32610 USA; [Srivastava, Arun] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Bungert, Joerg] Univ Florida, Coll Med, Ctr Epigenet, Gainesville, FL 32610 USA; [Srivastava, Arun] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA; [Srivastava, Arun; Bungert, Joerg] Univ Florida, Coll Med, Genet Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bungert, J (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, 1600 Archer Rd,POB 100245, Gainesville, FL 32610 USA.	jbungert@ufl.edu	Zhong, Li/GZM-4358-2022	Zhong, Li/0000-0003-1611-5171	National Institutes of Health [DK052356, HL090589]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052356 (to J. B.) and HL090589 (to S. H.).	BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BRESNICK EH, 1993, J BIOL CHEM, V268, P18824; BRIDGES K, 1981, J CELL BIOL, V90, P542, DOI 10.1083/jcb.90.2.542; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Choe C, 2005, EXP CELL RES, V302, P1, DOI 10.1016/j.yexcr.2004.08.013; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Crusselle-Davis VJ, 2007, FEBS J, V274, P6065, DOI 10.1111/j.1742-4658.2007.06128.x; Crusselle-Davis VJ, 2006, MOL CELL BIOL, V26, P6832, DOI 10.1128/MCB.01770-05; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Elnitski L, 1997, J BIOL CHEM, V272, P369; FALETTO DL, 1985, J BIOL CHEM, V260, P4884; Giannola DM, 2000, J EXP MED, V192, P1479, DOI 10.1084/jem.192.10.1479; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GUSELLA J, 1976, CELL, V9, P221, DOI 10.1016/0092-8674(76)90113-6; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HENSOLD JO, 1991, BLOOD, V77, P1362; INOMATA M, 1993, BIOCHIM BIOPHYS ACTA, V1178, P207, DOI 10.1016/0167-4889(93)90011-D; Kim DW, 2000, MOL CELL BIOL, V20, P1140, DOI 10.1128/MCB.20.4.1140-1148.2000; Leach KM, 2003, NUCLEIC ACIDS RES, V31, P1292, DOI 10.1093/nar/gkg209; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; ROY AL, 1993, NATURE, V365, P355, DOI 10.1038/365355a0; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Vieira KF, 2004, J BIOL CHEM, V279, P50350, DOI 10.1074/jbc.M408883200; Wang JH, 2006, CELL BIOCHEM BIOPHYS, V45, P147, DOI 10.1385/CBB:45:2:147; WATT F, 1993, NUCLEIC ACIDS RES, V21, P5092, DOI 10.1093/nar/21.22.5092; Wood MA, 2009, BIOL REPROD, V80, P24, DOI 10.1095/biolreprod.108.070037; Yajima Y, 2002, BIOL CHEM, V383, P757, DOI 10.1515/BC.2002.079	32	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20130	20135		10.1074/jbc.M109.001461	http://dx.doi.org/10.1074/jbc.M109.001461			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19491096	Green Published, hybrid			2022-12-27	WOS:000268097400040
J	Nock, A; Ascano, JM; Jones, T; Barrero, MJ; Sugiyama, N; Tomita, M; Ishihama, Y; Malik, S				Nock, Adam; Ascano, Janice M.; Jones, Tara; Barrero, Maria J.; Sugiyama, Naoyuki; Tomita, Masaru; Ishihama, Yasushi; Malik, Sohail			Identification of DNA-dependent Protein Kinase as a Cofactor for the Forkhead Transcription Factor FoxA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN AI GENE; RNA-POLYMERASE-II; BINDING PROTEIN; HISTONE H1; IN-VIVO; PHOSPHORYLATION; EXPRESSION; ACTIVATION; CHROMATIN; COMPLEX	Forkhead factors are important regulators of animal development and homeostasis. They are among the earliest to bind quiescent genes, which they activate in conjunction with other transcription factors. Many liver-specific genes are under the control of FoxA2, a liver-enriched forkhead protein. Here we confirmed by chromatin immunoprecipitation that FoxA2 is one of the factors bound to the promoter-proximal enhancer of the gene encoding apolipoprotein AI (a component of high density lipoprotein) and that it functions in synergy with the nuclear receptor hepatocyte nuclear factor-4 alpha. Furthermore, toward identifying additional cofactors that could potentially regulate FoxA2 activity, we identified DNA-dependent protein kinase (DNA-PK) as a FoxA2-associated factor upon affinity purification of epitope-tagged FoxA2. We show that FoxA2, found to be a phosphoprotein in vivo, is also an efficient substrate for DNA-PK, which targets serine 283. This residue is contained within a conserved serine-glutamine phosphorylation signal for DNA-PK, located within the C-terminal third of the polypeptide, just distal to its winged-helix DNA binding domain. We establish that this residue is critical for FoxA2 function because FoxA2 bearing a mutation at this site is severely compromised in its ability to activate a reporter gene under the control of its cognate DNA-binding site (apoAI site B). Complementary experiments rule out that this mutation compromises the ability of FoxA2 to either translocate to the nucleus or to bind site B. We therefore conclude that DNA-PK-dependent phosphorylation of FoxA2 plays a critical role in its transcriptional activation function per se.	[Malik, Sohail] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Sugiyama, Naoyuki; Tomita, Masaru; Ishihama, Yasushi] Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan; [Ishihama, Yasushi] Japan Sci & Technol Agcy, PRESTO, Tokyo 1020075, Japan	Rockefeller University; Keio University; Japan Science & Technology Agency (JST)	Malik, S (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10065 USA.	maliks@rockefeller.edu	Nock, Adam/C-5287-2011; Barrero, Maria J./Q-1785-2017; Ishihama, Yasushi/B-3101-2016	Nock, Adam/0000-0003-2142-5334; Barrero, Maria J./0000-0002-5990-7040; Ishihama, Yasushi/0000-0001-7714-203X; Sugiyama, Naoyuki/0000-0001-7633-8495	National Institutes of Health [RO1 DK060764]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK060764 (to S.M.).	Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; ANDERSON CW, 1993, TRENDS BIOCHEM SCI, V18, P433, DOI 10.1016/0968-0004(93)90144-C; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chibazakura T, 1997, EUR J BIOCHEM, V247, P1166, DOI 10.1111/j.1432-1033.1997.01166.x; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dou YL, 2005, MOL CELL BIOL, V25, P3914, DOI 10.1128/MCB.25.10.3914-3922.2005; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; DVIR A, 1993, J BIOL CHEM, V268, P10440; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Glass CK, 2000, GENE DEV, V14, P121; Harnish DC, 1996, J BIOL CHEM, V271, P13621, DOI 10.1074/jbc.271.23.13621; HARNISH DC, 1994, J BIOL CHEM, V269, P28220; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Ko L, 2003, J BIOL CHEM, V278, P11471, DOI 10.1074/jbc.M209723200; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Kyono Y, 2008, J PROTEOME RES, V7, P4585, DOI 10.1021/pr800305y; Kysela B, 2005, P NATL ACAD SCI USA, V102, P1877, DOI 10.1073/pnas.0401179102; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2003, METHOD ENZYMOL, V364, P257; Malik S, 2003, FRONT BIOSCI, V8, pD360, DOI 10.2741/1005; MALIK S, 2003, HDB CELL SIGNALING, V3, P11; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; SASTRY KN, 1988, MOL CELL BIOL, V8, P605, DOI 10.1128/MCB.8.2.605; SLADEK FM, 1993, RECEPTOR, V3, P223; Tuteja G, 2007, CELL, V130, DOI 10.1016/j.cell.2007.09.005; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Woodard RL, 1999, J BIOL CHEM, V274, P478, DOI 10.1074/jbc.274.1.478; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Zannis VI, 2001, FRONT BIOSCI-LANDMRK, V6, pD456, DOI 10.2741/Zannis	50	6	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19915	19926		10.1074/jbc.M109.016295	http://dx.doi.org/10.1074/jbc.M109.016295			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19478084	hybrid, Green Published			2022-12-27	WOS:000268097400018
J	Sykes, SM; Stanek, TJ; Frank, A; Murphy, ME; McMahon, SB				Sykes, Stephen M.; Stanek, Timothy J.; Frank, Amanda; Murphy, Maureen E.; McMahon, Steven B.			Acetylation of the DNA Binding Domain Regulates Transcription-independent Apoptosis by p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED P53; P53-DEPENDENT APOPTOSIS; CELL-DEATH; MITOCHONDRIA; PHOSPHORYLATION; ACTIVATION; MUTATIONS; TRANSLOCATION; COMPLEX; BAX	The tumor suppressor p53 induces apoptosis by altering the transcription of pro-apoptotic targets in the nucleus and by a direct, nontranscriptional role at the mitochondria. Although the post-translational modifications regulating nuclear apoptotic functions of p53 have been thoroughly characterized, little is known of how transcription-independent functions are controlled. We and others identified acetylation of the p53 DNA binding domain at lysine 120 as a critical event in apoptosis induction. Although initial studies showed that Lys-120 acetylation plays a role in p53 function in the nucleus, we report here a role for Lys-120 acetylation in transcription-independent apoptosis. We demonstrate that the Lys-120-acetylated isoform of p53 is enriched at mitochondria. The acetylation of Lys-120 does not appear to regulate the ability of p53 to interact with the pro-apoptotic proteins BCL-XL and BAK. However, displacement of the inhibitory MCL-1 protein from BAK is compromised when Lys-120 acetylation is blocked. Functional studies show that mutation of Lys-120 to a nonacetylated residue, as occurs in human cancer, inhibits transcription-independent apoptosis, and enforced acetylation of Lys-120 enhances transcription-independent apoptosis. These data support a model whereby Lys-120 acetylation contributes to both the transcription-dependent and -independent apoptotic pathways induced by p53.	[Stanek, Timothy J.; McMahon, Steven B.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Sykes, Stephen M.] Univ Penn, Philadelphia, PA 19104 USA; [Frank, Amanda; Murphy, Maureen E.] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA	Jefferson University; University of Pennsylvania; Fox Chase Cancer Center	McMahon, SB (corresponding author), 609 BLSB,233 S 10th St, Philadelphia, PA 19107 USA.	Steven.McMahon@jci.tju.edu		McMahon, Steven/0000-0002-3405-1768; Murphy, Maureen/0000-0001-7644-7296; Stanek, Timothy/0000-0001-9192-4978	National Institutes of Health [CA090465, CA098172, R01 CA102184]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA090465, R01CA102184, R01CA098172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA090465 and CA098172 (to S. B. M.) and R01 CA102184 (to M. E. M.). This work was also supported by the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health.	Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Chan WM, 2006, MOL CANCER RES, V4, P15, DOI 10.1158/1541-7786.MCR-05-0097; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; EL DW, 1993, CELL, V75, P817; Erster S, 2005, BIOCHEM BIOPH RES CO, V331, P843, DOI 10.1016/j.bbrc.2005.03.187; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Galluzzi L, 2008, CELL CYCLE, V7, P1949, DOI 10.4161/cc.7.13.6222; Hashimoto T, 1999, CANCER RES, V59, P5572; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kuribayashi K, 2008, ADV EXP MED BIOL, V615, P201, DOI 10.1007/978-1-4020-6554-5_10; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; MEYERS FJ, 1993, J NATL CANCER I, V85, P1856, DOI 10.1093/jnci/85.22.1856; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Nemajerova A, 2005, CELL DEATH DIFFER, V12, P197, DOI 10.1038/sj.cdd.4401526; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864	28	57	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20197	20205		10.1074/jbc.M109.026096	http://dx.doi.org/10.1074/jbc.M109.026096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494119	Green Published, hybrid			2022-12-27	WOS:000268097400047
J	Itoh, T; Nozawa, Y; Akao, Y				Itoh, Tomohiro; Nozawa, Yoshinori; Akao, Yukihiro			MicroRNA-141 and-200a Are Involved in Bone Morphogenetic Protein-2-induced Mouse Pre-osteoblast Differentiation by Targeting Distal-less Homeobox 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; SKELETAL DEVELOPMENT; OSTERIX EXPRESSION; UP-REGULATION; SMALL RNAS; DLX5; RUNX2; PATHWAYS; PROTEINS; ELEGANS	MicroRNAs (miRs) are endogenously expressed 18-25-nucleotide RNAs that regulate gene expression through translational repression by binding to a target mRNA. Recently, it was indicated that miRs act as key regulators in cell differentiation, cell growth, and cell death. In osteogenesis, several miRs ( for example miR-26a, -125b, -133, and -135) regulate osteoblast cell growth or differentiation in human adipose tissue-derived stem cells, mouse mesenchymal ST2 stem cells, and mouse premyogenic C2C12 cells. Additionally, Smad proteins control Drosha-mediated miR maturation. Therefore, miRs are closely related to osteogenesis. Here we investigated miR expression profile by an miR array and identified the candidate miRs, miR-141 and -200a, as pre-osteoblast differentiation-related miRs. The effects of miR-141 and -200a on pre-osteoblast differentiation were examined by using transfection of murine pre-osteoblastic MC3T3-E1 cells with mature miR-141 or -200a and antisense inhibitor for miR-141 or -200a. It was shown that miR-141 and -200a remarkably modulated the BMP-2-induced pre-osteoblast differentiation through the translational repression of Dlx5, which is a bone-generating transcription factor expressed in pre-osteoblast differentiation. Furthermore, it was indicated that Dlx5 is a common target of miR-141 and -200a by using a luciferase reporter assay. Thus, we have observed for the first time that miR-141 and -200a are involved in pre-osteoblast differentiation in part by regulating the expression of Dlx5.	[Itoh, Tomohiro; Nozawa, Yoshinori; Akao, Yukihiro] Gifu Int Inst Biotechnol, Gifu 5040838, Japan		Itoh, T (corresponding author), Gifu Int Inst Biotechnol, 1-1 Naka Fudogaoka, Gifu 5040838, Japan.	titoh@giib.or.jp	ITOH, Tomohiro/ABG-7076-2020					Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Naguibneva Irina, 2007, Journal de la Societe de Biologie, V201, P367, DOI 10.1051/jbio:2007902; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	30	163	188	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19272	19279		10.1074/jbc.M109.014001	http://dx.doi.org/10.1074/jbc.M109.014001			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19454767	Green Published, hybrid			2022-12-27	WOS:000267908300018
J	Lamprecht, G; Hsieh, CJ; Lissner, S; Nold, L; Heil, A; Gaco, V; Schafer, J; Turner, JR; Gregor, M				Lamprecht, Georg; Hsieh, Chih-Jen; Lissner, Simone; Nold, Lilia; Heil, Andreas; Gaco, Veronika; Schaefer, Julia; Turner, Jerrold R.; Gregor, Michael			Intestinal Anion Exchanger Down-regulated in Adenoma (DRA) Is Inhibited by Intracellular Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER NA+/H+ EXCHANGER; PROTEIN-KINASE-C; CONGENITAL CHLORIDE DIARRHEA; BRUSH-BORDER; CL-/HCO3-EXCHANGER; PDZ-DOMAIN; CA2+-DEPENDENT INHIBITION; EPITHELIAL TRANSPORT; RECEPTOR SUBTYPES; NHE3 INHIBITION	The Na/H exchanger 3 (NHE3) and the Cl/HCO3 exchanger down-regulated in adenoma (DRA) together facilitate intestinal electroneutral NaCl absorption. Elevated Ca-i(2+) inhibits NHE3 through mechanisms involving the PDZ domain proteins NHE3 kinase A regulatory protein (E3KARP) or PDZ kidney 1 (PDZK1). DRA also possesses a PDZ-binding motif, but the roles of interactions with E3KARP or PDZK1 and Ca-i(2+) in DRA regulation are unknown. Wild type DRA and a mutant lacking the PDZ interaction motif (DRA-ETKFminus) were expressed constitutively in human embryonic kidney (HEK) and inducibly in Caco-2/BBE cells. DRA-mediated Cl/HCO3 exchange was measured as intracellular pH changes. Ca-i(2+) was assessed fluorometrically. DRA was induced 8 - 16-fold and was delivered to the apical surface of polarized Caco-2 cells. Putative anion transporter 1 and cystic fibrosis transmembrane regulator did not contribute to Cl/HCO3 exchange in transfected Caco-2 cells. The calcium ionophore 4Br-A23187 inhibited DRA and DRA-ETKFminus in HEK cells, but only full-length DRA was inhibited in Caco-2 cells. In contrast, 100 mu M UTP, which increased Ca-i(2+), inhibited full-length DRA but not DRA-ETKFminus in Caco-2 and HEK cells. In HEK cells, which express little PDZK1, additional transfection of PDZK1 was required for UTP to inhibit DRA. As HEK cells do not express cystic fibrosis transmembrane regulator or NHE3, the data indicate that Ca-i(2+)-dependent DRA inhibition is not because of modulation of other transport activities. In polarized epithelium, this inhibition requires interaction of DRA with PDZK1. Together with data from PDZK1(-/-) mice, these data underscore the prominent role of PDZK1 in Ca-i(2+)-mediated inhibition of colonic NaCl absorption.	[Lamprecht, Georg; Hsieh, Chih-Jen; Lissner, Simone; Nold, Lilia; Heil, Andreas; Gaco, Veronika; Schaefer, Julia; Gregor, Michael] Univ Tubingen, Dept Med 1, D-72076 Tubingen, Germany; [Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Eberhard Karls University of Tubingen; University of Chicago	Lamprecht, G (corresponding author), Univ Tubingen, Dept Med 1, D-72076 Tubingen, Germany.	hans-georg.lamprecht@uni-tuebingen.de	Turner, Jerrold/H-1502-2019; Turner, Jerrold R/A-6895-2009	Turner, Jerrold R/0000-0003-0627-9455	Deutsche Forschungsgemeinschaft [La 1066/3-2, La 1066/3-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants La 1066/3-2 and La 1066/3-3.	Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Bucheimer RE, 2004, J PHYSIOL-LONDON, V555, P311, DOI 10.1113/jphysiol.2003.056697; Chapman JM, 2002, CANCER RES, V62, P5083; Chernova MN, 2003, J PHYSIOL-LONDON, V549, P3, DOI 10.1113/jphysiol.2003.039818; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; Clayburgh DR, 2006, J CLIN INVEST, V116, P2682, DOI 10.1172/JCI29218; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P1, DOI 10.1113/jphysiol.2005.089698; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Fischer W, 2005, N-S ARCH PHARMACOL, V371, P466, DOI 10.1007/s00210-005-1070-6; Hayashi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1279, DOI 10.1152/ajpcell.00638.2008; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Inoue CN, 1997, AM J PHYSIOL-CELL PH, V272, pC1862, DOI 10.1152/ajpcell.1997.272.6.C1862; Jacob P, 2002, GASTROENTEROLOGY, V122, P709, DOI 10.1053/gast.2002.31875; Janecki AJ, 1998, J BIOL CHEM, V273, P8790, DOI 10.1074/jbc.273.15.8790; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Lamprecht G, 2005, PFLUG ARCH EUR J PHY, V449, P479, DOI 10.1007/s00424-004-1342-x; Lamprecht G, 2002, BIOCHEMISTRY-US, V41, P12336, DOI 10.1021/bi0259103; Lamprecht G, 2006, PFLUG ARCH EUR J PHY, V452, P307, DOI 10.1007/s00424-006-0049-6; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; McAlroy HL, 2000, BRIT J PHARMACOL, V131, P1651, DOI 10.1038/sj.bjp.0703743; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Musch MW, 2009, AM J PHYSIOL-GASTR L, V296, pG202, DOI 10.1152/ajpgi.90350.2008; Rossmann H, 2005, BIOCHEMISTRY-US, V44, P4477, DOI 10.1021/bi048828b; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; Shcheynikov N, 2006, J GEN PHYSIOL, V127, P511, DOI 10.1085/jgp.200509392; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Thomson RB, 2005, P NATL ACAD SCI USA, V102, P13331, DOI 10.1073/pnas.0506578102; Walker NM, 2009, GASTROENTEROLOGY, V136, P893, DOI 10.1053/j.gastro.2008.11.016; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zachos NC, 2006, GASTROENTEROLOGY, V130, pA51	45	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19744	19753		10.1074/jbc.M109.004127	http://dx.doi.org/10.1074/jbc.M109.004127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19447883	Green Published, hybrid			2022-12-27	WOS:000267908300064
J	Thomas, SR; McTamney, PM; Adler, JM; LaRonde-LeBlanc, N; Rokita, SE				Thomas, Seth R.; McTamney, Patrick M.; Adler, Jennifer M.; LaRonde-LeBlanc, Nicole; Rokita, Steven E.			Crystal Structure of Iodotyrosine Deiodinase, a Novel Flavoprotein Responsible for Iodide Salvage in Thyroid Glands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE STABILIZATION; ACYL-COA DEHYDROGENASES; ESCHERICHIA-COLI; NUCLEOTIDE BINDING; REDOX PROPERTIES; REDUCTASE P; FLAVIN; NITROREDUCTASE; DEHALOGENASE; RESOLUTION	The flavoprotein iodotyrosine deiodinase (IYD) salvages iodide from mono- and diiodotyrosine formed during the biosynthesis of the thyroid hormone thyroxine. Expression of a soluble domain of this membrane-bound enzyme provided sufficient material for crystallization and characterization by x-ray diffraction. The structures of IYD and two co-crystals containing substrates, mono- and diiodotyrosine, alternatively, were solved at resolutions of 2.0, 2.45, and 2.6 A, respectively. The structure of IYD is homologous to others in the NADH oxidase/flavin reductase superfamily, but the position of the active site lid in IYD defines a new subfamily within this group that includes BluB, an enzyme associated with vitamin B-12 biosynthesis. IYD and BluB also share key interactions involving their bound flavin mononucleotide that suggest a unique catalytic behavior within the superfamily. Substrate coordination to IYD induces formation of an additional helix and coil that act as an active site lid to shield the resulting substrate center dot flavin complex from solvent. This complex is stabilized by aromatic stacking and extensive hydrogen bonding between the substrate and flavin. The carbon-iodine bond of the substrate is positioned directly over the C-4a/N-5 region of the flavin to promote electron transfer. These structures now also provide a molecular basis for understanding thyroid disease based on mutations of IYD.	[Thomas, Seth R.; McTamney, Patrick M.; Adler, Jennifer M.; LaRonde-LeBlanc, Nicole; Rokita, Steven E.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Thomas, Seth R.; LaRonde-LeBlanc, Nicole] Univ Maryland, Ctr Biomol Struct & Org, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	LaRonde-LeBlanc, N (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	nlaronde@umd.edu; rokita@umd.edu	Rokita, Steven E/C-4793-2009; LaRonde-LeBlanc, Nicole A/C-3399-2009	LaRonde-LeBlanc, Nicole A/0000-0002-2778-8358	Herman Kraybill Biochemistry fellowship; National Center for Research Resources at the National Institutes of Health [RR-15301]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	Herman Kraybill Biochemistry fellowship; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Herman Kraybill Biochemistry fellowship (to P.M.).; We thank Chiwei Hung and Prof. Bentley for help with protein expression in Sf9 cells. This work is based upon research conducted in part at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. We are grateful to the excellent staff at the Northeastern Collaborative Access Team for assistance with data collection and analysis.	Afink G, 2008, J CLIN ENDOCR METAB, V93, P4894, DOI 10.1210/jc.2008-0865; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; CODY V, 1984, J MOL STRUCT, V112, P189, DOI 10.1016/0022-2860(84)85061-9; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; De Colibus L, 2006, CURR OPIN STRUC BIOL, V16, P722, DOI 10.1016/j.sbi.2006.10.003; DeLano W, 2002, PYMOL 0 99; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Friedman JE, 2006, J BIOL CHEM, V281, P2812, DOI 10.1074/jbc.M510365200; Gales L, 2005, BIOCHEM J, V388, P615, DOI 10.1042/BJ20042035; Gnidehou S, 2004, FASEB J, V18, P1574, DOI 10.1096/fj.04-2023fje; GOSWAMI A, 1977, ENDOCRINOLOGY, V101, P331, DOI 10.1210/endo-101-2-331; GOSWAMI A, 1979, J BIOL CHEM, V254, P2326; Haynes CA, 2002, J BIOL CHEM, V277, P11513, DOI 10.1074/jbc.M111334200; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Johansson E, 2003, J MED CHEM, V46, P4009, DOI 10.1021/jm030843b; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Kobori T, 2001, J BIOL CHEM, V276, P2816, DOI 10.1074/jbc.M002617200; Koike H, 1998, J MOL BIOL, V280, P259, DOI 10.1006/jmbi.1998.1871; Kunishima M, 1999, J AM CHEM SOC, V121, P4722, DOI 10.1021/ja990693n; Legrand YM, 2003, J AM CHEM SOC, V125, P15789, DOI 10.1021/ja036940b; Lovering AL, 2001, J MOL BIOL, V309, P203, DOI 10.1006/jmbi.2001.4653; Lyubimov AY, 2006, NAT CHEM BIOL, V2, P259, DOI 10.1038/nchembio784; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; Matter H, 2009, ANGEW CHEM INT EDIT, V48, P2911, DOI 10.1002/anie.200806219; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; Moreno JC, 2008, NEW ENGL J MED, V358, P1811, DOI 10.1056/NEJMoa0706819; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Reilly D., 1994, BACULOVIRUS EXPRESSI, P130; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parkinson GN, 2000, J MED CHEM, V43, P3624, DOI 10.1021/jm000159m; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Solis-S JC, 2004, J ENDOCRINOL, V181, P385, DOI 10.1677/joe.0.1810385; Suzuki T, 2003, TRENDS GLYCOSCI GLYC, V15, P329, DOI 10.4052/tigg.15.329; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P13531, DOI 10.1021/bi961400v; Tanner JJ, 1999, PROTEIN SCI, V8, P1725, DOI 10.1110/ps.8.9.1725; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; van Pee KH, 2006, APPL MICROBIOL BIOT, V70, P631, DOI 10.1007/s00253-005-0232-2; Vock P, 1998, BIOCHEMISTRY-US, V37, P1848, DOI 10.1021/bi971827h; Watson JA, 2008, CHEMBIOCHEM, V9, P504, DOI 10.1002/cbic.200700562; Yang KY, 2007, BIOCHEMISTRY-US, V46, P2289, DOI 10.1021/bi0616293	48	58	60	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19659	19667		10.1074/jbc.M109.013458	http://dx.doi.org/10.1074/jbc.M109.013458			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19436071	Green Published, hybrid			2022-12-27	WOS:000267908300057
J	Tian, G; Zhou, Y; Hajkova, D; Miyagi, M; Dinculescu, A; Hauswirth, WW; Palczewski, K; Geng, R; Alagramam, KN; Isosomppi, J; Sankila, EM; Flannery, JG; Imanishi, Y				Tian, Guilian; Zhou, Yun; Hajkova, Dagmar; Miyagi, Masaru; Dinculescu, Astra; Hauswirth, William W.; Palczewski, Krzysztof; Geng, Ruishuang; Alagramam, Kumar N.; Isosomppi, Juha; Sankila, Eeva-Marja; Flannery, John G.; Imanishi, Yoshikazu			Clarin-1, Encoded by the Usher Syndrome III Causative Gene, Forms a Membranous Microdomain POSSIBLE ROLE OF CLARIN-1 IN ORGANIZING THE ACTIN CYTOSKELETON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR CELL-DEVELOPMENT; ANKLE-LINK COMPLEX; AMES WALTZER MICE; LIPID RAFTS; MYOSIN VIIA; QUANTITATIVE PROTEOMICS; TETRASPANIN PROTEINS; PLASMA-MEMBRANE; E-CADHERIN; INNER-EAR	Clarin-1 is the protein product encoded by the gene mutated in Usher syndrome III. Although the molecular function of clarin-1 is unknown, its primary structure predicts four transmembrane domains similar to a large family of membrane proteins that include tetraspanins. Here we investigated the role of clarin-1 by using heterologous expression and in vivo model systems. When expressed in HEK293 cells, clarin-1 localized to the plasma membrane and concentrated in low density compartments distinct from lipid rafts. Clarin-1 reorganized actin filament structures and induced lamellipodia. This actin-reorganizing function was absent in the modified protein encoded by the most prevalent North American Usher syndrome III mutation, the N48K form of clarin-1 deficient in N-linked glycosylation. Proteomics analyses revealed a number of clarin-1-interacting proteins involved in cell-cell adhesion, focal adhesions, cell migration, tight junctions, and regulation of the actin cytoskeleton. Consistent with the hypothesized role of clarin-1 in actin organization, F-actin-enriched stereocilia of auditory hair cells evidenced structural disorganization in Clrn1(-/-) mice. These observations suggest a possible role for clarin-1 in the regulation and homeostasis of actin filaments, and link clarin-1 to the interactive network of Usher syndrome gene products.	[Imanishi, Yoshikazu] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Hajkova, Dagmar; Miyagi, Masaru] Case Western Reserve Univ, Case Ctr Prote, Cleveland, OH 44106 USA; [Dinculescu, Astra; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Geng, Ruishuang; Alagramam, Kumar N.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Isosomppi, Juha; Sankila, Eeva-Marja] Univ Helsinki, Folkhalsan Inst Genet, Dept Mol Genet, FIN-00014 Helsinki, Finland; [Isosomppi, Juha] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Sankila, Eeva-Marja] Univ Helsinki, Dept Ophthalmol, FIN-00014 Helsinki, Finland; [Flannery, John G.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Case Western Reserve University; Case Western Reserve University; State University System of Florida; University of Florida; Case Western Reserve University; Case Western Reserve University Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of California System; University of California Berkeley	Imanishi, Y (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Wood Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.	yxi19@case.edu	Imanishi, Yoshikazu/E-8178-2010; Geng, Ruishuang/F-8255-2013	Imanishi, Yoshikazu/0000-0003-4696-4836; hauswirth, william/0000-0002-3244-4947; Flannery, John/0000-0002-0720-8897	Hope for Vision Foundation; Elden Foundation	Hope for Vision Foundation; Elden Foundation	This work was supported by the Hope for Vision Foundation and the Elden Foundation.	Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Adato A, 1999, AM J HUM GENET, V65, P261, DOI 10.1086/302438; Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Blonder J, 2004, ELECTROPHORESIS, V25, P1307, DOI 10.1002/elps.200405891; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Charrin S, 2002, FEBS LETT, V516, P139, DOI 10.1016/S0014-5793(02)02522-X; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; DUKSIN D, 1977, J BIOL CHEM, V252, P955; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Fields RR, 2002, AM J HUM GENET, V71, P607, DOI 10.1086/342098; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Herrera W, 2008, INVEST OPHTH VIS SCI, V49, P2651, DOI 10.1167/iovs.07-1505; Inoue A, 2003, J BIOL CHEM, V278, P5478, DOI 10.1074/jbc.M210489200; Israels SJ, 2007, THROMB HAEMOSTASIS, V98, P1081, DOI 10.1160/TH06-08-0455; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Johnson E, 2004, J BIOL CHEM, V279, P31041, DOI 10.1074/jbc.M400024200; Kikkawa YS, 2008, ANAT REC, V291, P224, DOI 10.1002/ar.20632; Kiser JZ, 2009, J PROTEOME RES, V8, P1810, DOI 10.1021/pr8004919; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Lazo PA, 2007, CANCER SCI, V98, P1666, DOI 10.1111/j.1349-7006.2007.00584.x; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Maeda M, 2006, ONCOGENE, V25, P4595, DOI 10.1038/sj.onc.1209396; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; McMahon KA, 2006, PROTEOMICS, V6, P143, DOI 10.1002/pmic.200500208; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Miyagi M, 2007, MASS SPECTROM REV, V26, P121, DOI 10.1002/mas.20116; Mogensen MM, 2007, CELL MOTIL CYTOSKEL, V64, P496, DOI 10.1002/cm.20199; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pawlowski KS, 2006, JARO-J ASSOC RES OTO, V7, P83, DOI 10.1007/s10162-005-0024-5; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; RIZZOLO LJ, 1995, J CELL SCI, V108, P3623; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; TAKATSUKI A, 1971, J ANTIBIOT, V24, P785, DOI 10.7164/antibiotics.24.785; Tian GL, 2007, J BIOL CHEM, V282, P1727, DOI 10.1074/jbc.M609822200; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Udovichenko IP, 2002, J CELL SCI, V115, P445; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16	56	60	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18980	18993		10.1074/jbc.M109.003160	http://dx.doi.org/10.1074/jbc.M109.003160			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19423712	hybrid, Green Published			2022-12-27	WOS:000267711500048
J	Gupta, R; Srivastava, OP				Gupta, Ratna; Srivastava, Om P.			Identification of Interaction Sites between Human beta A3-and alpha A/alpha B-crystallins by Mammalian Two-hybrid and Fluorescence Resonance Energy Transfer Acceptor Photobleaching Methods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; WATER-INSOLUBLE FRACTION; CATARACTOUS HUMAN LENSES; CONGENITAL CATARACT; INHIBITOR ACTIVITY; BETA-CRYSTALLINS; A-CRYSTALLIN; LIVING CELLS; BOVINE LENS; IN-VITRO	Our recent study has shown that beta A3-crystallin along with beta B1- and beta B2-crystallins were part of high molecular weight complex obtained from young, old, and cataractous lenses suggesting potential interactions between alpha- and beta-crystallins (Srivastava, O. P., Srivastava, K., and Chaves, J. M. (2008) Mol. Vis. 14, 1872-1885). To investigate this further, this study was carried out to determine the interaction sites of beta A3-crystallin with alpha A- and alpha B-crystallins. The study employed a mammalian two-hybrid method, an in vivo assay to determine the regions of beta A3-crystallin that interact with alpha A- and alpha B-crystallins. Five regional truncated mutants of beta A3-crystallin were generated using specific primers with deletions of N-terminal extension (NT) (named beta A3-NT), N-terminal extension plus motif I (named beta A3-NT + I), N-terminal extension plus motifs I and II (named beta A3-NT + I + II), motif III plus IV (named beta A3-III + IV), and motif IV (named beta A3-IV). The mammalian two-hybrid studies were complemented with fluorescence resonance energy transfer acceptor photobleaching studies using the above described mutant proteins, fused with DsRed (Red) and AcGFP fluorescent proteins. The results showed that the motifs III and IV of beta A3-crystallin were interactive with alpha A-crystallin, and motifs II and III of beta A3-crystallin primarily interacted with alpha B-crystallin.	[Gupta, Ratna; Srivastava, Om P.] Univ Alabama, Dept Vis Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Srivastava, OP (corresponding author), Univ Alabama, Dept Vis Sci, Worrell Bldg,924 S 18th St, Birmingham, AL 35294 USA.	srivasta@uab.edu			National Institutes of Health [EY06400, P30 EY0303, P50 AT00477]; University of Alabama at Birmingham; EyeSight Foundation of Alabama; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham; EyeSight Foundation of Alabama; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in whole, or in part, by National Institutes of Health Grants EY06400, P30 EY0303, and P50 AT00477 (to C. Weaver). This work was also supported by a faculty development grant from the University of Alabama at Birmingham and the EyeSight Foundation of Alabama.	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; Bhat SP, 2004, EXP EYE RES, V79, P809, DOI 10.1016/j.exer.2004.08.020; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Feil IK, 2001, J BIOL CHEM, V276, P12024, DOI 10.1074/jbc.M010856200; Ferrini W, 2004, INVEST OPHTH VIS SCI, V45, P1436, DOI 10.1167/iovs.03-0760; Fu L, 2003, INVEST OPHTH VIS SCI, V44, P1155, DOI 10.1167/iovs.02-0950; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Gupta R, 2006, BIOCHEMISTRY-US, V45, P9964, DOI 10.1021/bi060499v; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Harrington V, 2007, MOL VIS, V13, P1680; Harrington V, 2004, MOL VIS, V10, P476; Kamei A, 2002, BIOL PHARM BULL, V25, P611, DOI 10.1248/bpb.25.611; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Krivandin A V, 2004, Dokl Biochem Biophys, V394, P1, DOI 10.1023/B:DOBI.0000017141.52122.57; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Liang JJ, 2006, PROTEIN SCI, V15, P1619, DOI 10.1110/ps.062216006; Liu BF, 2006, J BIOL CHEM, V281, P2624, DOI 10.1074/jbc.M509017200; Liu BF, 2005, MOL VIS, V11, P321; Liu BF, 2008, J CELL BIOCHEM, V104, P51, DOI 10.1002/jcb.21598; Liu BF, 2007, FEBS LETT, V581, P3936, DOI 10.1016/j.febslet.2007.07.022; Liu BF, 2007, MOL VIS, V13, P854; Lu SS, 2007, MOL VIS, V13, P1154; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; Marin-Vinader L, 2006, FEBS J, V273, P3172, DOI 10.1111/j.1742-4658.2006.05326.x; ORTWERTH BJ, 1992, EXP EYE RES, V54, P103, DOI 10.1016/0014-4835(92)90074-3; ORTWERTH BJ, 1992, EXP EYE RES, V54, P573, DOI 10.1016/0014-4835(92)90136-G; Ponce A, 2005, MOL VIS, V11, P752; Ponce A, 2006, MOL VIS, V12, P879; Rajan S, 2006, BIOCHEMISTRY-US, V45, P15684, DOI 10.1021/bi060705z; Robertson LJG, 2008, INVEST OPHTH VIS SCI, V49, P1016, DOI 10.1167/iovs.07-0792; SHARMA KK, 1987, BIOCHIM BIOPHYS ACTA, V915, P284; Song SH, 2008, MOL VIS, V14, P1282; Sreelakshmi Y, 2006, MOL VIS, V12, P581; Srivastava OP, 2008, MOL VIS, V14, P1872; SRIVASTAVA OP, 1989, EXP EYE RES, V48, P25, DOI 10.1016/0014-4835(89)90015-8; Srivastava OP, 2004, J BIOL CHEM, V279, P10901, DOI 10.1074/jbc.M308884200; Srivastava OP, 2003, MOL VIS, V9, P644; SRIVASTAVA OP, 1983, EXP EYE RES, V36, P363, DOI 10.1016/0014-4835(83)90118-5; Srivastava OP, 1999, BIOCHEM BIOPH RES CO, V258, P632, DOI 10.1006/bbrc.1999.0506; Srivastava OP, 1999, BBA-PROTEIN STRUCT M, V1434, P331, DOI 10.1016/S0167-4838(99)00183-1; Takemoto L, 2008, EXP EYE RES, V87, P496, DOI 10.1016/j.exer.2008.08.018; Weinreb O, 2000, INVEST OPHTH VIS SCI, V41, P3893; Xia JZ, 1996, BIOPHYS J, V71, P2815, DOI 10.1016/S0006-3495(96)79477-8; Zhang ZL, 2003, EXP EYE RES, V77, P259, DOI 10.1016/S0014-4835(03)00159-3	50	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18481	18492		10.1074/jbc.M109.013789	http://dx.doi.org/10.1074/jbc.M109.013789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19401464	Green Published, hybrid			2022-12-27	WOS:000267712400059
J	Han, YH; Zhou, H; Kim, JH; Yan, TD; Lee, KH; Wu, H; Lin, F; Lu, N; Liu, J; Zeng, JZ; Zhang, XK				Han, Young-Hoon; Zhou, Hu; Kim, Jin-Hee; Yan, Ting-dong; Lee, Kee-Ho; Wu, Hua; Lin, Feng; Lu, Na; Liu, Jie; Zeng, Jin-zhang; Zhang, Xiao-kun			A Unique Cytoplasmic Localization of Retinoic Acid Receptor-gamma and Its Regulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-TYPE PROTEASE; X-RECEPTOR; NUCLEAR EXPORT; RAR-GAMMA; THYROID-HORMONE; CELL-DENSITY; INTRACELLULAR-LOCALIZATION; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAY; LIVING CELLS	Recent evidence suggests that extranuclear action of retinoid receptors is involved in mediating the pleiotropic effects of retinoids. However, whether they reside in the cytoplasm remains elusive. Here, we showed that retinoic acid receptor-gamma (RAR gamma) was cytoplasmic in confluent cells, or when cells were released from serum depletion or treated with growth factors. In studying the regulation of RAR gamma subcellular localization, we observed that ectopically overexpressed RAR gamma was mainly cytoplasmic irrespective of serum concentration and cell density. The cytoplasmic retention of RAR gamma was inhibited by ligand retinoic acid (RA). In addition, coexpression of retinoid X receptor-alpha (RXR alpha) resulted in nuclear localization of RAR gamma through their heterodimerization. Mutagenesis studies revealed that a C-terminal fragment of RXR alpha potently prevents RA-induced RAR gamma nuclear localization and transcriptional function. Furthermore, our results showed that the cytoplasmic retention of RAR gamma was due to the presence of its unique N-terminal A/B domain, which was subject to regulation by p38 MAPK-mediated phosphorylation. Deletion or mutation of the N-terminal A/B domain largely impaired its cytoplasmic localization. Together, our data demonstrate that the subcellular localization of RAR gamma is regulated by complex interactions among ligand binding, receptor phosphorylation, and receptor dimerizations.	[Han, Young-Hoon; Kim, Jin-Hee; Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Han, Young-Hoon; Zhou, Hu; Lin, Feng; Liu, Jie; Zhang, Xiao-kun] Burnham Inst Med Res, Ctr Canc, La Jolla, CA 92037 USA; [Yan, Ting-dong; Wu, Hua; Lu, Na; Liu, Jie; Zeng, Jin-zhang; Zhang, Xiao-kun] Xiamen Univ, Inst Biomed Res, Xiamen 361005, Peoples R China	Korea Institute of Radiological & Medical Sciences; Sanford Burnham Prebys Medical Discovery Institute; Xiamen University	Han, YH (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Gon Gneung Dong 215-4, Seoul 139706, South Korea.	yhhan@kcch.re.kr; xzhang@burnham.org	Wu, Hua/W-4204-2019; Zeng, JZ/G-3377-2010		National Institutes of Health [CA87000, CA107039, GM60544, CA109345]; Korean Ministry of Sciences and Technology; Susan G. Komen Breast Cancer Foundation; U.S. Army Medical Research and Material Command; California Tobacco-Related Diseases Research Program; California Breast Cancer Research Program; Xiamen University [2007AA09Z404]; NATIONAL CANCER INSTITUTE [R01CA107039, R01CA109345, R01CA087000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Sciences and Technology; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); California Tobacco-Related Diseases Research Program; California Breast Cancer Research Program; Xiamen University(Xiamen University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA87000, CA107039, GM60544, and CA109345 (to X.-k. Z.). This work was also supported by a grant from the national nuclear R & D program funded by the Korean Ministry of Sciences and Technology, the Susan G. Komen Breast Cancer Foundation, the U.S. Army Medical Research and Material Command, the California Tobacco-Related Diseases Research Program, the California Breast Cancer Research Program, and the 985 Project and 863 Program (No. 2007AA09Z404) from Xiamen University.	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Aschrafi A, 2006, BBA-MOL CELL RES, V1763, P805, DOI 10.1016/j.bbamcr.2006.05.006; Bastien J, 2000, J BIOL CHEM, V275, P21896, DOI 10.1074/jbc.M001985200; Batchelor CL, 2004, EXP CELL RES, V296, P208, DOI 10.1016/j.yexcr.2004.02.010; Baumann CT, 2001, J BIOL CHEM, V276, P11237, DOI 10.1074/jbc.M011112200; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Chakravarti N, 2007, CLIN CANCER RES, V13, P4817, DOI 10.1158/1078-0432.CCR-06-3026; Chen CF, 2004, ONCOGENE, V23, P5350, DOI 10.1038/sj.onc.1207682; Dey N, 2007, MOL CELL BIOL, V27, P4179, DOI 10.1128/MCB.01352-06; Dufour JM, 1999, BIOL REPROD, V61, P1300, DOI 10.1095/biolreprod61.5.1300; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukunaka K, 2001, MOL HUM REPROD, V7, P437, DOI 10.1093/molehr/7.5.437; Georget V, 1997, MOL CELL ENDOCRINOL, V129, P17, DOI 10.1016/S0303-7207(97)04034-3; Ghose Romi, 2004, Nucl Recept, V2, P4, DOI 10.1186/1478-1336-2-4; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Glass CK, 2000, GENE DEV, V14, P121; Hager GL, 2000, J STEROID BIOCHEM, V74, P249, DOI 10.1016/S0960-0760(00)00100-X; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; HUSMANN M, 1991, MOL CELL BIOL, V11, P4097, DOI 10.1128/MCB.11.8.4097; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu JM, 2000, MOL ENDOCRINOL, V14, P40, DOI 10.1210/me.14.1.40; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; MatsushimaNishiwaki R, 1996, BIOCHEM BIOPH RES CO, V225, P946, DOI 10.1006/bbrc.1996.1276; Mey J, 2007, GLIA, V55, P152, DOI 10.1002/glia.20444; Mohan S, 2003, ONCOGENE, V22, P5270, DOI 10.1038/sj.onc.1206592; Moraes LA, 2007, BLOOD, V109, P3741, DOI 10.1182/blood-2006-05-022566; Nagaya T, 1998, J BIOL CHEM, V273, P33166, DOI 10.1074/jbc.273.50.33166; Nomura Y, 1999, BIOCHEM BIOPH RES CO, V254, P388, DOI 10.1006/bbrc.1998.9941; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Prufer K, 2000, J BIOL CHEM, V275, P41114, DOI 10.1074/jbc.M003791200; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; Rochette-Egly C, 2000, MOL ENDOCRINOL, V14, P1398, DOI 10.1210/me.14.9.1398; Sommer KM, 1999, P NATL ACAD SCI USA, V96, P8651, DOI 10.1073/pnas.96.15.8651; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; Takiyama Y, 2004, J CLIN ENDOCR METAB, V89, P5851, DOI 10.1210/jc.2003-032036; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; Taneja R, 1997, EMBO J, V16, P6452, DOI 10.1093/emboj/16.21.6452; Tyagi RK, 1998, MOL ENDOCRINOL, V12, P1684, DOI 10.1210/me.12.11.1684; Wang JG, 2006, FASEB J, V20, P2142, DOI 10.1096/fj.06-5900fje; Yen A, 1998, CANCER RES, V58, P3163; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001; ZHANG XK, 1994, MOL CELL BIOL, V14, P4311, DOI 10.1128/MCB.14.6.4311; ZHANG XK, 1993, RECEPTOR, V3, P183; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	62	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18503	18514		10.1074/jbc.M109.007708	http://dx.doi.org/10.1074/jbc.M109.007708			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19416983	Green Published, hybrid			2022-12-27	WOS:000267712400061
J	Lobo, S; Wiczer, BM; Bernlohr, DA				Lobo, Sandra; Wiczer, Brian M.; Bernlohr, David A.			Functional Analysis of Long-chain Acyl-CoA Synthetase 1 in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID TRANSPORT; ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; VECTORIAL ACYLATION; PLASMA-MEMBRANE; MICE; METABOLISM; OBESITY; SENSITIVITY; LIPOGENESIS	ACSL1 (acyl-CoA synthetase 1), the major acyl-CoA synthetase of adipocytes, has been proposed to function in adipocytes as mediating free fatty acid influx, esterification, and storage as triglyceride. To test this hypothesis, ACSL1 was stably silenced (knockdown (kd)) in 3T3-L1 cells, differentiated into adipocytes, and evaluated for changes in lipid metabolism. Surprisingly, ACSL1-silenced adipocytes exhibited no significant changes in basal or insulin-stimulated long-chain fatty acid uptake, lipid droplet size, or tri-, di-, or monoacylglycerol levels when compared with a control adipocyte line. However, ACSL1 kd adipocytes displayed a 7-fold increase in basal and a similar to 15% increase in forskolin-stimulated fatty acid efflux without any change in glycerol release, indicating a role for the protein in fatty acid reesterification following lipolysis. Consistent with this proposition, ACSL1 kd cells exhibited a decrease in activation and phosphorylation of AMP-activated protein kinase and its primary substrate acetyl-CoA carboxylase. Moreover, ACSL1 kd adipocytes displayed an increase in phosphorylated protein kinase C theta and phosphorylated JNK, attenuated insulin signaling, and a decrease in insulin-stimulated glucose uptake. These findings identify a primary role of ACSL1 in adipocytes not in control of lipid influx, as previously considered, but in lipid efflux and fatty acid-induced insulin resistance.	[Lobo, Sandra; Wiczer, Brian M.; Bernlohr, David A.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Bernlohr, DA (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	bernl001@umn.edu			American Diabetes Association [7-06RA-12]; Minnesota Obesity Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049807] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Minnesota Obesity Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by American Diabetes Association Grant 7-06RA-12 ( to D. A. B.) and the Minnesota Obesity Center.	Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chabowski A, 2007, PROSTAG LEUKOTR ESS, V77, P345, DOI 10.1016/j.plefa.2007.10.017; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gargiulo CE, 1999, J LIPID RES, V40, P881; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hertzel AV, 2006, AM J PHYSIOL-ENDOC M, V290, pE814, DOI 10.1152/ajpendo.00465.2005; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KALUZNY MA, 1985, J LIPID RES, V26, P135; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; Mater MK, 1998, J LIPID RES, V39, P1327; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; NAGAMATSU K, 1985, BIOCHIM BIOPHYS ACTA, V836, P80, DOI 10.1016/0005-2760(85)90223-1; Pinent M, 2008, GENOMICS, V92, P26, DOI 10.1016/j.ygeno.2008.03.010; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Shim J, 2009, J LIPID RES, V50, P491, DOI 10.1194/jlr.M800400-JLR200; Sleeman MW, 1998, J BIOL CHEM, V273, P3132, DOI 10.1074/jbc.273.6.3132; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wei EH, 2007, J BIOL CHEM, V282, P8027, DOI 10.1074/jbc.M605789200; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200	36	52	54	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18347	18356		10.1074/jbc.M109.017244	http://dx.doi.org/10.1074/jbc.M109.017244			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19429676	Green Published, hybrid			2022-12-27	WOS:000267712400047
J	Abeyweera, TP; Chen, XY; Rotenberg, SA				Abeyweera, Thushara P.; Chen, Xiangyu; Rotenberg, Susan A.			Phosphorylation of alpha 6-Tubulin by Protein Kinase C alpha Activates Motility of Human Breast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNNATURAL NUCLEOTIDE SPECIFICITY; MASS-SPECTROMETRY; BETA-TUBULIN; CANCER CELLS; MICROTUBULE DYNAMICS; TYROSINE KINASES; PKC-ALPHA; IDENTIFICATION; MIGRATION; GROWTH	Engineered overexpression of protein kinase C alpha (PKC alpha) was previously shown to endow nonmotile MCF-10A human breast cells with aggressive motility. A traceable mutant of PKC alpha (Abeyweera, T. P., and Rotenberg, S. A. (2007) Biochemistry 46, 2364-2370) revealed that alpha 6-tubulin is phosphorylated in cells expressing traceable PKC alpha and in vitro by wild type PKC alpha. Gain-of-function, single site mutations (Ser -> Asp) were constructed at each PKC consensus site in alpha 6-tubulin (Ser(158), Ser(165), Ser(241), and Thr(337)) to simulate phosphorylation. Following expression of each construct in MCF-10A cells, motility assays identified Ser(165) as the only site in alpha 6-tubulin whose pseudophosphorylation reproduced the motile behavior engendered by PKC alpha. Expression of a phosphorylation-resistant mutant (S165N-alpha 6-tubulin) resulted in suppression of MCF-10A cell motility stimulated either by expression of PKC alpha or by treatment with PKC alpha-selective activator diacylglycerol-lactone. MCF-10A cells treated with diacylglycerol-lactone showed strong phosphorylation of endogenous alpha-tubulin that could be blocked when S165N-alpha 6-tubulin was expressed. The S165N mutant also inhibited intrinsically motile human breast tumor cells that express high endogenous PKC alpha levels (MDA-MB-231 cells) or lack PKC alpha and other conventional isoforms (MDA-MB-468 cells). Comparison of Myc-tagged wild type alpha 6-tubulin and S165N-alpha 6-tubulin expressed in MDA-MB-468 cells demonstrated that Ser(165) is also a major site of phosphorylation for endogenously active, nonconventional PKC isoforms. PKC-stimulated motility of MCF-10A cells was nocodazole-sensitive, thereby implicating microtubule elongation in the mechanism. These findings support a model in which PKC phosphorylates alpha-tubulin at Ser(165), leading to microtubule elongation and motility.	[Rotenberg, Susan A.] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA; [Abeyweera, Thushara P.; Chen, Xiangyu] CUNY, Grad Ctr, Flushing, NY 11367 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System	Rotenberg, SA (corresponding author), CUNY Queens Coll, Dept Chem & Biochem, 65-30 Kissena Blvd, Flushing, NY 11367 USA.	Susan.Rotenberg@qc.cuny.edu		Rotenberg, Susan/0000-0002-6618-686X	National Institutes of Health [CA125632]; Breast Cancer Alliance (Greenwich, CT); Professional Staff Congress of The City University of New York; NATIONAL CANCER INSTITUTE [R15CA125632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Alliance (Greenwich, CT); Professional Staff Congress of The City University of New York; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA125632 (to S. A. R.) from NCI. This work was also supported by The Breast Cancer Alliance ( Greenwich, CT) (to S.A.R.) and the Professional Staff Congress of The City University of New York. This work was carried out by T. P. A. and X. C. in partial fulfillment of the requirements for the Ph.D. degree in Biochemistry administered by The City University of New York.	Abeyweera TP, 2007, BIOCHEMISTRY-US, V46, P2364, DOI 10.1021/bi0622017; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Banan A, 2004, AM J PHYSIOL-CELL PH, V287, pC218, DOI 10.1152/ajpcell.00575.2003; Banan A, 1998, AM J PHYSIOL-GASTR L, V274, pG111, DOI 10.1152/ajpgi.1998.274.1.G111; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; Duan D, 2008, J MED CHEM, V51, P5198, DOI 10.1021/jm8001907; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Garcia-Bermejo ML, 2004, J BIOL CHEM, V279, P23846; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Gauthier ML, 2003, BIOCHEM BIOPH RES CO, V307, P839, DOI 10.1016/S0006-291X(03)01273-7; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Hindley AD, 2004, FEBS LETT, V556, P26, DOI 10.1016/S0014-5793(03)01352-8; Hu YL, 2002, J VASC RES, V39, P465, DOI 10.1159/000067202; Hudder A, 2003, MOL CELL BIOL, V23, P9318, DOI 10.1128/MCB.23.24.9318-9326.2003; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kuntziger T, 2001, MOL BIOL CELL, V12, P437, DOI 10.1091/mbc.12.2.437; LAMB NJC, 1990, CELL, V60, P151, DOI 10.1016/0092-8674(90)90725-T; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mao ML, 2000, BIOCHEM J, V352, P475, DOI 10.1042/0264-6021:3520475; McKean PG, 2001, J CELL SCI, V114, P2723; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rao S, 2001, BIOCHEMISTRY-US, V40, P2096, DOI 10.1021/bi002323d; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; SOULE HD, 1990, CANCER RES, V50, P6075; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sun XG, 1999, CELL GROWTH DIFFER, V10, P343; Takano T, 2001, CANCER LETT, V168, P51, DOI 10.1016/S0304-3835(01)00509-2; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Ting AY, 2001, BIOPOLYMERS, V60, P220, DOI 10.1002/1097-0282(2001)60:3<220::AID-BIP10035>3.0.CO;2-C; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Verdier-Pinard P, 2003, BIOCHEMISTRY-US, V42, P12019, DOI 10.1021/bi0350147; Verdier-Pinard P, 2003, BIOCHEMISTRY-US, V42, P5349, DOI 10.1021/bi027293o; WANDOSELL F, 1987, J BIOL CHEM, V262, P8268; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2001, J CELL SCI, V114, P3795; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Witucki LA, 2002, CHEM BIOL, V9, P25, DOI 10.1016/S1074-5521(02)00091-1; Yoshida N, 2003, EUR J BIOCHEM, V270, P1154, DOI 10.1046/j.1432-1033.2003.03465.x; Yu BW, 2002, BREAST CANCER RES TR, V76, P181, DOI 10.1023/A:1020895504260	56	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17648	17656		10.1074/jbc.M902005200	http://dx.doi.org/10.1074/jbc.M902005200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19406749	Green Published, hybrid			2022-12-27	WOS:000267202500031
J	Boots, AW; Hristova, M; Kasahara, DI; Haenen, GRMM; Bast, A; van der Vliet, A				Boots, Agnes W.; Hristova, Milena; Kasahara, David I.; Haenen, Guido R. M. M.; Bast, Aalt; van der Vliet, Albert			ATP-mediated Activation of the NADPH Oxidase DUOX1 Mediates Airway Epithelial Responses to Bacterial Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; PSEUDOMONAS-AERUGINOSA; HYDROGEN-PEROXIDE; SIGNALING CASCADE; GENE-EXPRESSION; HOST-DEFENSE; MUCIN EXPRESSION; OXIDATIVE STRESS	Activation of the NADPH oxidase homolog dual oxidase 1 (DUOX1) within the airway epithelium represents a key mechanism of innate airway host defense, through enhanced production of H2O2, which mediates cellular signaling pathways that regulate the production of various inflammatory mediators. Production of the CXC chemokine interleukin (IL)-8/CXCL8 forms a common epithelial response to many diverse stimuli, including bacterial and viral triggers, environmental oxidants, and other biological mediators, suggesting the potential involvement of a common signaling pathway that may involve DUOX1-dependent H2O2 production. Following previous reports showing that DUOX1 is activated by extracellular ATP and purinergic receptor stimulation, this study demonstrates that airway epithelial IL-8 production in response to several bacterial stimuli involves ATP release and DUOX1 activation. ATP-mediated DUOX1 activation resulted in the activation of ERK1/2 and NF-kappa B pathways, which was associated with epidermal growth factor receptor (EGFR) ligand shedding by ADAM17 (a disintegrin and metalloproteinase-17). Although ATP-mediated ADAM17 activation and IL-8 release were not prevented by extracellular H2O2 scavenging by catalase, these responses were attenuated by intracellular scavengers of H2O2 or related oxidants, suggesting an intracellular redox signaling mechanism. Both ADAM17 activation and IL-8 release were suppressed by inhibitors of EGFR/ERK1/2 signaling, which can regulate ADAM17 activity by serine/threonine phosphorylation. Collectively, our results indicate that ATP-mediated DUOX1 activation represents a common response mechanism to several environmental stimuli, involving H2O2-dependent EGFR/ERK activation, ADAM17 activation, and EGFR ligand shedding, leading to amplified epithelial EGFR activation and IL-8 production.	[van der Vliet, Albert] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Boots, Agnes W.; Haenen, Guido R. M. M.; Bast, Aalt] Maastricht Univ, Fac Med, Dept Pharmacol & Toxicol, NL-6200 Maastricht, Netherlands	University of Vermont; Maastricht University	van der Vliet, A (corresponding author), Univ Vermont, Dept Pathol, D205 Given Bldg,89 Beaumont Ave, Burlington, VT 05405 USA.	Albert.van-der-Vliet@uvm.edu	Haenen, Guido/H-9209-2013; Bast, Aalt/I-7809-2013	Haenen, Guido/0000-0001-6986-290X; Bast, Aalt/0000-0002-5383-2789	National Institutes of Health [HL068865, HL074295, HL089646]; Kootstra fellowship; Niels Stensen Stipendium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085646, R01HL068865, R01HL074295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kootstra fellowship; Niels Stensen Stipendium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068865, HL074295, and HL089646 (to A. v. d. V.). This work was also supported by a Kootstra fellowship and a Niels Stensen Stipendium (to A. W. B.).	Ahmad S, 2006, FREE RADICAL BIO MED, V41, P29, DOI 10.1016/j.freeradbiomed.2006.03.004; Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Bevelander M, 2007, J IMMUNOL, V179, P3680, DOI 10.4049/jimmunol.179.6.3680; Biagioli MC, 1999, FREE RADICAL BIO MED, V26, P454, DOI 10.1016/S0891-5849(98)00233-0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Booth BW, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-51; Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009; Buvinic S, 2007, J CELL SCI, V120, P4289, DOI 10.1242/jcs.03490; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Communi D, 1999, BRIT J PHARMACOL, V127, P562, DOI 10.1038/sj.bjp.0702560; Coraux C, 2005, J PATHOL, V206, P160, DOI 10.1002/path.1757; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Fischer H, 2007, AM J PHYSIOL-LUNG C, V292, pL1506, DOI 10.1152/ajplung.00029.2007; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Geary C, 2005, AM J PHYSIOL-LUNG C, V289, pL890, DOI 10.1152/ajplung.00428.2004; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Gomez MI, 2008, PEDIATR PULM, V43, P11, DOI 10.1002/ppul.20735; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Hamilton LM, 2005, EUR RESPIR J, V25, P978, DOI 10.1183/09031936.05.00098604; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Kim HJ, 2008, AM J RESP CELL MOL, V39, P598, DOI 10.1165/rcmb.2007-0262OC; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Kuwahara I, 2007, AM J RESP CELL MOL, V37, P691, DOI 10.1165/rcmb.2007-0072OC; Kuwahara I, 2006, AM J PHYSIOL-LUNG C, V291, pL407, DOI 10.1152/ajplung.00471.2005; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Li J, 2003, AM J PHYSIOL-LUNG C, V284, pL307, DOI 10.1152/ajplung.00086.2002; Li J, 2002, AM J PHYSIOL-LUNG C, V283, pL690, DOI 10.1152/ajplung.00060.2002; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2008, BIOCHEM J, V411, P531, DOI 10.1042/BJ20071534; Lin CH, 2006, J IMMUNOL, V177, P3427, DOI 10.4049/jimmunol.177.5.3427; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Liu K, 2008, AM J RESP CELL MOL, V39, P305, DOI 10.1165/rcmb.2007-0458OC; Look DC, 2005, J IMMUNOL, V175, P4017, DOI 10.4049/jimmunol.175.6.4017; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; McNamara N, 2006, AM J RESP CELL MOL, V34, P653, DOI 10.1165/rcmb.2005-0441OC; McNamara N, 2001, P NATL ACAD SCI USA, V98, P9086, DOI 10.1073/pnas.161290898; Milla ME, 2006, CELL BIOCHEM BIOPHYS, V44, P342, DOI 10.1385/CBB:44:3:342; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nagai K, 2008, ANTIOXID REDOX SIGN, V10, P705, DOI 10.1089/ars.2007.1941; Nakanaga T, 2007, AM J PHYSIOL-LUNG C, V292, pL1289, DOI 10.1152/ajplung.00356.2006; Pacquelet S, 2008, J BIOL CHEM, V283, P24649, DOI 10.1074/jbc.M709108200; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Pelaia G, 2004, J CELL BIOCHEM, V93, P142, DOI 10.1002/jcb.20124; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Roger T, 1998, BIOCHEM J, V330, P429, DOI 10.1042/bj3300429; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; Song Y, 2007, J CLIN ENDOCR METAB, V92, P3764, DOI 10.1210/jc.2007-0660; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Strieter RM, 2002, AM J PHYSIOL-LUNG C, V283, pL688, DOI 10.1152/ajplung.00146.2002; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	72	83	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17858	17867		10.1074/jbc.M809761200	http://dx.doi.org/10.1074/jbc.M809761200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19386603	hybrid, Green Published			2022-12-27	WOS:000267202500051
J	Ji, BA; Gaiser, S; Chen, XQ; Ernst, SA; Logsdon, CD				Ji, Baoan; Gaiser, Sebastian; Chen, Xueqing; Ernst, Stephen A.; Logsdon, Craig D.			Intracellular Trypsin Induces Pancreatic Acinar Cell Death but Not NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT; CHOLECYSTOKININ; EXPRESSION; PROTEASES; ETHIONINE; RESPONSES; CLONING; SITES; FURIN	Premature intracellular activation of the digestive enzyme trypsinogen is considered to be the initiating event in pancreatitis. However, the direct consequences of intracellular trypsin activity have not previously been examined. In the current study, a mutant trypsinogen (paired basic amino acid cleaving enzyme (PACE)-trypsinogen), which is activated intracellularly by the endogenous protease PACE, was developed. This new construct allowed for the first time direct examination of the effects of intracellular trypsin on pancreatic acinar cells. We found that PACE-trypsinogen was expressed in the secretory pathway and was activated within acinar cells. Expression of PACE-trypsinogen induced apoptosis of HEK293 cells and pancreatic acinar cells, as indicated by histology, DNA laddering, PARP cleavage, and caspase-3 activation. Cell death was blocked by the trypsin inhibitor Pefabloc but not by the pan-caspase inhibitor benzyloxycarbonyl-VAD, indicating that caspase-independent pathways were also involved. However, intracellular trypsin had no significant effect on the activity of the proinflammatory transcription factor NF-kappa B. In contrast, extracellular trypsin caused cell damage and dramatically increased NF-kappa B activity. These data indicate that localization of active trypsin determines its effects on pancreatic acinar cells. This new model will greatly improve our understanding of the role of active trypsin in pancreatitis and its associated inflammatory response.	[Logsdon, Craig D.] Univ Texas MD Anderson Canc Ctr, Unit 953, Dept Canc Biol, Houston, TX 77030 USA; [Logsdon, Craig D.] Univ Texas MD Anderson Canc Ctr, Dept Med Oncol, Houston, TX 77030 USA; [Chen, Xueqing] Affiliated Hosp 1, Guangzhou Med Coll, Dept Gastroenterol, Guangzhou 510120, Peoples R China; [Ernst, Stephen A.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Guangzhou Medical University; University of Michigan System; University of Michigan	Logsdon, CD (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 953, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	clogsdon@mdanderson.org			National Institutes of Health [DK52067-05, R21 DK068414-02, 2P30 DK034933-20, P30 DK-34933, P60 DK-20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK068414, P60DK020572, R01DK052067, P30DK034933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52067-05 (to C. D. L.), R21 DK068414-02 (to B. J.), and 2P30 DK034933-20 (to B. J.). Resources from the combined Morphology and Image Analysis Core of the Michigan Gastrointestinal Peptide Center (National Institutes of Health Grant P30 DK-34933) and the Michigan Diabetes and Research Training Center (National Institutes of Health Grant P60 DK-20572) further contributed to this research.	BANERJEE AK, 1994, BRIT J SURG, V81, P1096, DOI 10.1002/bjs.1800810805; Baumann B, 2007, J CLIN INVEST, V117, P1502, DOI 10.1172/JCI30876; Berndt W, 1970, Pol Arch Med Wewn, V4, P535; BIALEK R, 1991, SCAND J GASTROENTERO, V26, P190, DOI 10.3109/00365529109025030; Bohm SK, 1996, BIOCHEM J, V314, P1009; Cavallini G, 1996, NEW ENGL J MED, V335, P919, DOI 10.1056/NEJM199609263351302; Chen XQ, 2002, GASTROENTEROLOGY, V122, P448, DOI 10.1053/gast.2002.31060; Chiari H., 1896, ZEITSCHRIFTFURHEILKU, V17, P69; GEOKAS MC, 1974, AM J DIG DIS, V19, P591, DOI 10.1007/BF01073012; GILLILAND L, 1980, AM J PHYSIOL, V239, pG418, DOI 10.1152/ajpgi.1980.239.5.G418; Grady T, 1997, GASTROENTEROLOGY, V113, P1966, DOI 10.1016/S0016-5085(97)70017-9; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; GRAF L, 1988, INT J PEPT PROT RES, V32, P512; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P974, DOI 10.1053/gast.2002.32409; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Han B, 2001, AM J PHYSIOL-CELL PH, V280, pC465, DOI 10.1152/ajpcell.2001.280.3.C465; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hietaranta AJ, 2001, BIOCHEM BIOPH RES CO, V280, P388, DOI 10.1006/bbrc.2000.4120; Ji B, 2001, GASTROENTEROLOGY, V121, P1380, DOI 10.1053/gast.2001.29557; Ji BA, 2000, J BIOL CHEM, V275, P19115, DOI 10.1074/jbc.M001685200; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Kawabata A, 2000, BRIT J PHARMACOL, V129, P1808, DOI 10.1038/sj.bjp.0703274; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; KOIKE H, 1982, AM J PHYSIOL, V242, pG297, DOI 10.1152/ajpgi.1982.242.4.G297; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; LEACH SD, 1991, J CLIN INVEST, V87, P362, DOI 10.1172/JCI114995; Lerch MM, 2000, ADV EXP MED BIOL, V477, P403; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; Nguyen TD, 1999, J CLIN INVEST, V103, P261, DOI 10.1172/JCI2539; NIEDERAU C, 1988, J CLIN INVEST, V81, P229, DOI 10.1172/JCI113300; Pandol SJ, 2005, CURR OPIN GASTROEN, V21, P538, DOI 10.1097/01.mog.0000174221.92708.50; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; STEER ML, 1988, ANNU REV MED, V39, P95, DOI 10.1146/annurev.me.39.020188.000523; Steinle AU, 1999, GASTROENTEROLOGY, V116, P420, DOI 10.1016/S0016-5085(99)70140-X; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; YANAGITA M, 1993, ENDOCRINOLOGY, V133, P639, DOI 10.1210/en.133.2.639	41	59	61	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17488	17498		10.1074/jbc.M109.005520	http://dx.doi.org/10.1074/jbc.M109.005520			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19383608	hybrid, Green Published			2022-12-27	WOS:000267202500015
J	McBryant, SJ; Klonoski, J; Sorensen, TC; Norskog, SS; Williams, S; Resch, MG; Toombs, JA; Hobdey, SE; Hansen, JC				McBryant, Steven J.; Klonoski, Joshua; Sorensen, Troy C.; Norskog, Sarah S.; Williams, Sere; Resch, Michael G.; Toombs, James A., III; Hobdey, Sarah E.; Hansen, Jeffrey C.			Determinants of Histone H4 N-terminal Domain Function during Nucleosomal Array Oligomerization ROLES OF AMINO ACID SEQUENCE, DOMAIN LENGTH, AND CHARGE DENSITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; SEDIMENTATION-VELOCITY ANALYSIS; REGULATES CHROMATIN COMPACTION; TAIL DOMAINS; H4-K16 ACETYLATION; SELF-ASSOCIATION; RECOMBINANT HISTONES; DIVALENT-CATIONS; CORE PARTICLE; IN-VITRO	Mg2+-dependent oligomerization of nucleosomal arrays is correlated with higher order folding transitions that stabilize chromosome structure beyond the 30-nm diameter fiber. In the present studies, we have employed a novel mutagenesis-based approach to identify the macromolecular determinants that control H4 N-terminal domain (NTD) function during oligomerization. Core histones were engineered in which 1) the H2A, H2B, and H3 NTDs were swapped onto the H4 histone fold; 2) the length of the H4 NTD and the H2A NTD on the H4 histone fold, were increased; 3) the charge density of the NTDs on the H4 histone fold was increased or decreased; and 4) the H4 NTD was placed on the H2B histone fold. Model nucleosomal arrays were assembled from wild type and mutant core histone octamers, and Mg2+-dependent oligomerization was characterized. The results demonstrated that the H2B and H3 NTDs could replace the H4NTD, as could the H2A NTD if it was duplicated to the length of the native H4NTD. Arrays oligomerized at lower salt concentrations as the length of the NTD on the H4 histone fold was increased. Mutations that decreased the NTD charge density required more Mg2+ to oligomerize, whereas mutants that increased the charge density required less salt. Finally, the H4 NTD functioned differently when attached to the H2B histone fold than the H4 histone fold. These studies have revealed new insights into the biochemical basis for H4 NTD effects on genome architecture as well as the protein chemistry that underlies the function of the intrinsically disordered H4 NTD.	[McBryant, Steven J.; Klonoski, Joshua; Sorensen, Troy C.; Norskog, Sarah S.; Williams, Sere; Resch, Michael G.; Toombs, James A., III; Hobdey, Sarah E.; Hansen, Jeffrey C.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Hansen, JC (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, 381 MRB, Ft Collins, CO 80523 USA.	jeffrey.c.hansen@colostate.edu		Toombs, James/0000-0002-1601-5675	National Institutes of Health [GM45916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045916, R29GM045916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45916 (to J.C.H.).	AARONSON RP, 1981, J CELL BIOL, V90, P181, DOI 10.1083/jcb.90.1.181; Arya G, 2006, BIOPHYS J, V91, P133, DOI 10.1529/biophysj.106.083006; Bartova E, 2008, J HISTOCHEM CYTOCHEM, V56, P711, DOI 10.1369/jhc.2008.951251; Baxevanis AD, 1996, NUCLEIC ACIDS RES, V24, P245, DOI 10.1093/nar/24.1.245; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; Carruthers LM, 2000, J BIOL CHEM, V275, P37285, DOI 10.1074/jbc.M006801200; Carruthers LM, 2000, METHOD ENZYMOL, V321, P66; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; DIXON DK, 1985, EUR J CELL BIOL, V36, P315; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; Fletcher TM, 1996, CRIT REV EUKAR GENE, V6, P149, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.40; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hansen JC, 2006, ACS CHEM BIOL, V1, P69, DOI 10.1021/cb6000894; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Krebs JE, 2007, MOL BIOSYST, V3, P590, DOI 10.1039/b703923a; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Lu X, 2006, BIOCHEM CELL BIOL, V84, P411, DOI 10.1139/O06-068; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Moore SC, 1997, BIOCHEM BIOPH RES CO, V230, P136, DOI 10.1006/bbrc.1996.5903; OLINS DE, 1972, J CELL BIOL, V53, P715, DOI 10.1083/jcb.53.3.715; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pollard KJ, 1999, EMBO J, V18, P5622, DOI 10.1093/emboj/18.20.5622; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Sharma S, 2007, BIOPHYS J, V92, P1457, DOI 10.1529/biophysj.106.094805; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Villar-Garea A, 2006, BBA-PROTEINS PROTEOM, V1764, P1932, DOI 10.1016/j.bbapap.2006.08.009; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; WEITH A, 1983, EXP CELL RES, V146, P199, DOI 10.1016/0014-4827(83)90338-5; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	70	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16716	16722		10.1074/jbc.M109.011288	http://dx.doi.org/10.1074/jbc.M109.011288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19395382	Green Published, hybrid			2022-12-27	WOS:000266962400006
J	Crispin, M; Chang, VT; Harvey, DJ; Dwek, RA; Evans, EJ; Stuart, DI; Jones, EY; Lord, JM; Spooner, RA; Davis, SJ				Crispin, Max; Chang, Veronica T.; Harvey, David J.; Dwek, Raymond A.; Evans, Edward J.; Stuart, David I.; Jones, E. Yvonne; Lord, J. Michael; Spooner, Robert A.; Davis, Simon J.			A Human Embryonic Kidney 293T Cell Line Mutated at the Golgi alpha-Mannosidase II Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCANS; HAMSTER OVARY CELLS; ELECTROPHORESIS-ELECTROSPRAY-TIME; LASER-DESORPTION IONIZATION; FLIGHT-MASS-SPECTROMETRY; RICIN-RESISTANT MUTANT; HIGH-LEVEL EXPRESSION; ENDOPLASMIC-RETICULUM; CONGENITAL DISORDER; NEGATIVE-IONS	Disruption of Golgi alpha-mannosidase II activity can result in type II congenital dyserythropoietic anemia and induce lupus-like autoimmunity in mice. Here, we isolated a mutant human embryonic kidney (HEK) 293T cell line called Lec36, which displays sensitivity to ricin that lies between the parental HEK 293T cells, in which the secreted and membrane-expressed proteins are dominated by complex-type glycosylation, and 293S Lec1 cells, which produce only oligomannose-type N-linked glycans. Stem cell marker 19A was transiently expressed in the HEK 293T Lec36 cells and in parental HEK 293T cells with and without the potent Golgi alpha-mannosidase II inhibitor, swainsonine. Negative ion nano-electrospray ionization mass spectra of the 19A N-linked glycans from HEK 293T Lec36 and swainsonine-treated HEK 293T cells were qualitatively indistinguishable and, as shown by collision-induced dissociation spectra, were dominated by hybrid-type glycosylation. Nucleotide sequencing revealed mutations in each allele of MAN2A1, the gene encoding Golgi alpha-mannosidase II: a point mutation that mapped to the active site was found in one allele, and an in-frame deletion of 12 nucleotides was found in the other allele. Expression of the wild type but not the mutant MAN2A1 alleles in Lec36 cells restored processing of the 19A reporter glycoprotein to complex-type glycosylation. The Lec36 cell line will be useful for expressing therapeutic glycoproteins with hybrid-type glycans and as a sensitive host for detecting mutations in human MAN2A1 causing type II congenital dyserythropoietic anemia.	[Lord, J. Michael; Spooner, Robert A.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Crispin, Max; Harvey, David J.; Dwek, Raymond A.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Chang, Veronica T.; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England	University of Warwick; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Spooner, RA (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	r.a.spooner@warwick.ac.uk; simon.davis@ndm.ox.ac.uk	Harvey, David/A-5579-2013; Spooner, Robert/A-9870-2010; Jones, Yvonne/N-8111-2019; Jones, Yvonne/J-2293-2016; Crispin, Max/AAG-4098-2020	Spooner, Robert/0000-0001-9593-0195; Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Crispin, Max/0000-0002-1072-2694; Stuart, David/0000-0002-3426-4210; Harvey, David/0000-0003-0544-771X	National Institutes of Health [5 U01AI 65869]; Wellcome Trust; Cancer Research UK; United Kingdom Medical Research Council; European Commission [QLG2-CT-2002-00988]; MRC [G0500365, G9900061] Funding Source: UKRI; Medical Research Council [G9900061, G0500365] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part, by National Institutes of Health Grant 5 U01AI 65869 (to J. M. L. and R. A. S.). This work was also supported by the Wellcome Trust, Cancer Research UK, the United Kingdom Medical Research Council, and the Oxford Glycobiology Institute Endowment and by Structural Proteomics in Europe (SPINE) Contract QLG2-CT-2002-00988 from the European Commission under the Integrated Programme "Quality of Life and Management of Living Resources."	Aghi M, 1998, J NATL CANCER I, V90, P370, DOI 10.1093/jnci/90.5.370; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Balaguer E, 2006, ELECTROPHORESIS, V27, P2638, DOI 10.1002/elps.200600075; BEBBINGTON C, 1987, DNA CLONING, V3, P168; BORNSEN KO, 1995, RAPID COMMUN MASS SP, V9, P1031, DOI 10.1002/rcm.1290091112; Butler M, 2003, GLYCOBIOLOGY, V13, P601, DOI 10.1093/glycob/cwg079; Butters TD, 1999, PROTEIN SCI, V8, P1696, DOI 10.1110/ps.8.8.1696; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Crispin M, 2006, GLYCOBIOLOGY, V16, P748, DOI 10.1093/glycob/cwj119; Crispin M, 2007, FEBS LETT, V581, P1963, DOI 10.1016/j.febslet.2007.04.020; DAVIS SJ, 1993, PROTEIN ENG, V6, P229, DOI 10.1093/protein/6.2.229; DAVIS SJ, 1995, J BIOL CHEM, V270, P369, DOI 10.1074/jbc.270.1.369; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Dwek RA, 1998, DEV BIOL STAND, V96, P43; FODDY L, 1986, BIOCHEM J, V233, P697, DOI 10.1042/bj2330697; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; FUKUDA MN, 1992, BRIT J HAEMATOL, V82, P745, DOI 10.1111/j.1365-2141.1992.tb06953.x; FUKUDA MN, 1990, P NATL ACAD SCI USA, V87, P7443, DOI 10.1073/pnas.87.19.7443; GLEESON PA, 1985, BIOCHEMISTRY-US, V24, P493, DOI 10.1021/bi00323a037; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Harvey DJ, 2008, RAPID COMMUN MASS SP, V22, P1047, DOI 10.1002/rcm.3470; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P622, DOI 10.1016/j.jasms.2005.01.004; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P647, DOI 10.1016/j.jasms.2005.01.006; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P631, DOI 10.1016/j.jasms.2005.01.005; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hong Y, 2004, J BIOL CHEM, V279, P49894, DOI 10.1074/jbc.M410121200; Hoppe H, 2000, J BIOTECHNOL, V76, P259, DOI 10.1016/S0168-1656(99)00165-0; HUGHES RC, 1983, CARBOHYD RES, V120, P215; HUGHES RC, 1986, EUR J BIOCHEM, V158, P227, DOI 10.1111/j.1432-1033.1986.tb09742.x; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lal A, 1998, GLYCOBIOLOGY, V8, P981, DOI 10.1093/glycob/8.10.981; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Martinez-Duncker I, 2005, BLOOD, V105, P2671, DOI 10.1182/blood-2004-09-3509; Moremen KW, 2002, BBA-GEN SUBJECTS, V1573, P225, DOI 10.1016/S0304-4165(02)00388-4; Neususs C, 2005, ELECTROPHORESIS, V26, P1442, DOI 10.1002/elps.200410269; Oh-eda M, 2001, EUR J BIOCHEM, V268, P1280, DOI 10.1046/j.1432-1327.2001.01992.x; Olsnes S., 1982, MOL ACTION TOXINS VI, P51; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Paschinger K, 2006, J BIOL CHEM, V281, P28265, DOI 10.1074/jbc.M602878200; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Paulson JC, 2007, CELL, V130, P589, DOI 10.1016/j.cell.2007.08.009; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; Sethuraman N, 2006, CURR OPIN BIOTECH, V17, P341, DOI 10.1016/j.copbio.2006.06.010; Shah N, 2008, P NATL ACAD SCI USA, V105, P9570, DOI 10.1073/pnas.0802206105; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; STANLEY P, 1992, GLYCOBIOLOGY, V2, P99, DOI 10.1093/glycob/2.2.99; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Watson P, 2006, ADV DRUG DELIVER REV, V58, P1581, DOI 10.1016/j.addr.2006.09.016; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041	61	31	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21684	21695		10.1074/jbc.M109.006254	http://dx.doi.org/10.1074/jbc.M109.006254			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19465480	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000268564400061
J	Das, S; Cano, J; Kalpana, GV				Das, Supratik; Cano, Jennifer; Kalpana, Ganjam V.			Multimerization and DNA Binding Properties of INI1/hSNF5 and Its Functional Significance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REPLICATION; SWI/SNF COMPLEX; NUCLEAR EXPORT; MINOR-GROOVE; MUTATIONS; HSNF5/INI1; INTEGRASE; PROTEINS; GENE; INHIBITION	INI1/hSNF5/BAF47/SMARCB1 is an HIV-1 integrase (IN)binding protein that modulates viral replication in multiple ways. A minimal IN-binding domain of INI1, S6 (amino acids 183-294), transdominantly inhibits late events, and down-modulation of INI1 stimulates early events of HIV-1 replication. INI1 both stimulates and inhibits in vitro integration depending on IN concentration. To gain further insight into its role in HIV-1 replication, we purified and biochemically characterized INI1. We found that INI1 forms multimeric structures. Deletion analysis indicated that the Rpt1 and Rpt2 motifs form the minimal multimerization domain. We isolated mutants of INI1 that are defective for multimerization using a reverse yeast two-hybrid system. Our results revealed that INI1 residues involved in multimerization overlap with IN-binding and nuclear export domains and are required for nuclear retention and co-localization with IN. Multimerization-defective mutants are also defective for mediating the transdominant effect of INI1-S6-(183-294). Furthermore, we found that INI1 is a minor groove DNA-binding protein. Although IN binding and multimerization are required for INI1-mediated inhibition, the acceptor DNA binding property of INI1 may be required for stimulation of in vitro strand transfer activities of IN. Binding of INI1 to IN results in the formation of presumably inactive high molecular weight IN-INI1 complexes, and the multimerization-defective mutant was unable to form these complexes. These results indicate that the multimerization and IN binding properties of INI1 are necessary for its ability to both inhibit integration and influence assembly and particle production, providing insights into the mechanism of INI1-mediated effects in HIV-1 replication.	Albert Einstein Coll Med, Dept Mol Genet, New York, NY 10461 USA; [Kalpana, Ganjam V.] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA	Yeshiva University; Yeshiva University	Kalpana, GV (corresponding author), 1300 Morris Pk Ave,Ullman 821, Bronx, NY 10461 USA.	kalpana@aecom.yu.edu		Kalpana, Ganjam/0000-0003-4111-0604	National Institutes of Health [R01 AI039951-11]; Irma T. Hirchl/Monique Weill-Caulier scholar award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007501, R01AI039951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirchl/Monique Weill-Caulier scholar award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI039951-11. This work was also supported by an Irma T. Hirchl/Monique Weill-Caulier scholar award (to G. V. K.).	Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee D, 1999, NATURE, V399, P487, DOI 10.1038/20966; Maroun M, 2006, J BIOL CHEM, V281, P22736, DOI 10.1074/jbc.M604849200; MCHUGH MM, 1989, BIOCHEM PHARMACOL, V38, P2323, DOI 10.1016/0006-2952(89)90472-3; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Sorin M, 2006, CURR HIV RES, V4, P117, DOI 10.2174/157016206776055048; Sorin M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-56; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600; Wu DY, 1996, J VIROL, V70, P6020, DOI 10.1128/JVI.70.9.6020-6028.1996; Yuge M, 2000, CANCER GENET CYTOGEN, V122, P37, DOI 10.1016/S0165-4608(00)00274-0; Yung E, 2004, J VIROL, V78, P2222, DOI 10.1128/JVI.78.5.2222-2231.2004; Yung E, 2001, NAT MED, V7, P920, DOI 10.1038/90959	27	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19903	19914		10.1074/jbc.M808141200	http://dx.doi.org/10.1074/jbc.M808141200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19398554	Green Published, hybrid			2022-12-27	WOS:000268097400017
J	Lapointe, J; Stepanyan, Z; Bigras, E; Hekimi, S				Lapointe, Jerome; Stepanyan, Zaruhi; Bigras, Eve; Hekimi, Siegfried			Reversal of the Mitochondrial Phenotype and Slow Development of Oxidative Biomarkers of Aging in Long-lived Mclk1(+/-) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE RELEASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; CALORIC RESTRICTION; STRESS HYPOTHESIS; OXIDANT STRESS; COENZYME-Q; DAMAGE; CLK-1; MOUSE	Although there is a consensus that mitochondrial function is somehow linked to the aging process, the exact role played by mitochondria in this process remains unresolved. The discovery that reduced activity of the mitochondrial enzyme CLK-1/MCLK1 (also known as COQ7) extends lifespan in both Caenorhabditis elegans and mice has provided a genetic model to test mitochondrial theories of aging. We have recently shown that the mitochondria of young, long-lived, Mclk(+/-) mice are dysfunctional, exhibiting reduced energy metabolism and a substantial increase in oxidative stress. Here we demonstrate that this altered mitochondrial condition in young animals paradoxically results in an almost complete protection from the age-dependent loss of mitochondrial function as well as in a significant attenuation of the rate of development of oxidative biomarkers of aging. Moreover, we show that reduction in MCLK1 levels can also gradually prevent the deterioration of mitochondrial function and associated increase of global oxidative stress that is normally observed in Sod2(+/-) mutants. We hypothesize that the mitochondrial dysfunction observed in young Mclk1(+/-) mutants induces a physiological state that ultimately allows for their slow rate of aging. Thus, our study provides for a unique vertebrate model in which an initial alteration in a specific mitochondrial function is linked to long term beneficial effects on biomarkers of aging and, furthermore, provides for new evidence which indicates that mitochondrial oxidative stress is not causal to aging.	[Lapointe, Jerome; Stepanyan, Zaruhi; Bigras, Eve; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	Siegfried.Hekimi@McGill.ca			National Science and Engineering Research Council of Canada; Canadian Institutes of Health Research	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded in part by grants from the National Science and Engineering Research Council of Canada and the Canadian Institutes of Health Research ( to S. H.).	Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; [Anonymous], 1922, BIOL DEATH; Arguelles S, 2004, BBA-GEN SUBJECTS, V1674, P251, DOI 10.1016/j.bbagen.2004.06.023; Asimakis GK, 2002, CIRCULATION, V105, P981, DOI 10.1161/hc0802.104502; Austad S, 2008, AGING CELL, V7, P119, DOI 10.1111/j.1474-9726.2008.00374.x; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Branicky R, 2006, MOL CELL BIOL, V26, P3976, DOI 10.1128/MCB.26.10.3976-3985.2006; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Chiou CC, 2003, CLIN CHIM ACTA, V334, P87, DOI 10.1016/S0009-8981(03)00191-8; Choksi KB, 2007, BIOCHEM BIOPH RES CO, V364, P761, DOI 10.1016/j.bbrc.2007.10.100; Davies SMK, 2001, FREE RADICAL BIO MED, V31, P181, DOI 10.1016/S0891-5849(01)00576-7; de Magalhaes JP, 2005, GENETICS, V169, P265, DOI 10.1534/genetics.104.032292; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Gonzales S, 2005, WORLD J GASTROENTERO, V11, P3533, DOI 10.3748/wjg.v11.i23.3533; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Hekimi S, 2006, NAT GENET, V38, P985, DOI 10.1038/ng1881; Hihi AK, 2003, J BIOL CHEM, V278, P41013, DOI 10.1074/jbc.M305034200; Huang TTK, 2001, OBES RES, V9, P283, DOI 10.1038/oby.2001.35; Jiang N, 2001, J BIOL CHEM, V276, P29218, DOI 10.1074/jbc.M103686200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lambert AJ, 2007, AGING CELL, V6, P417, DOI 10.1111/j.1474-9726.2007.00316.x; Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Morrow JD, 2000, DRUG METAB REV, V32, P377, DOI 10.1081/DMR-100102340; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Park KS, 2001, DIABETES, V50, P2837, DOI 10.2337/diabetes.50.12.2837; Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; RIGGS JE, 1992, MECH AGEING DEV, V62, P191, DOI 10.1016/0047-6374(92)90055-I; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SHIGENAGA MK, 1994, METHOD ENZYMOL, V234, P16; SOHAL RS, 1993, FREE RADICAL BIO MED, V14, P583, DOI 10.1016/0891-5849(93)90139-L; SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P573, DOI 10.1016/S0891-5849(02)00885-7; SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Stepanyan Z, 2006, EXP GERONTOL, V41, P940, DOI 10.1016/j.exger.2006.06.041; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788	56	72	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20364	20374		10.1074/jbc.M109.006569	http://dx.doi.org/10.1074/jbc.M109.006569			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19478076	Green Published, hybrid			2022-12-27	WOS:000268097400062
J	Simic, M; De Jonge, N; Loris, R; Vesnaver, G; Lah, J				Simic, Mario; De Jonge, Natalie; Loris, Remy; Vesnaver, Gorazd; Lah, Jurij			Driving Forces of Gyrase Recognition by the Addiction Toxin CcdB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA GYRASE; BREAKAGE-REUNION DOMAIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRUCTURAL FEATURES; PROTEIN-STRUCTURE; MOLECULAR-BASIS; ANTIDOTE MAZE; A-PROTEIN; BINDING	Gyrase, an essential bacterial topoisomerase, is the target of several antibiotics (e. g. quinolones) as well as of bacterial toxin CcdB. This toxin, encoded by Escherichia coli toxinantitoxin module ccd, poisons gyrase by causing inhibition of both transcription and replication. Because the molecular driving forces of gyrase unfolding and CcdB-gyrase binding were unknown, the nature of the CcdB-gyrase recognition remained elusive. Therefore, we performed a detailed thermodynamic analysis of CcdB binding to several fragments of gyrase A subunit (GyrA) that contain the CcdB-binding site. Binding of CcdB to the shorter fragments was studied directly by isothermal titration calorimetry. Its binding to the longer GyrA59 fragment in solution is kinetically limited and was therefore investigated via urea induced unfolding of the GyrA59-CcdB complex and unbound GyrA59 and CcdB, monitored by circular dichroism spectroscopy. Model analysis of experimental data, in combination with the relevant structural information, indicates that CcdB binding to gyrase is an enthalpic process driven mainly by specific interactions between CcdB and the highly stable dimerization domain of the GyrA. The dissection of binding energetics indicates that CcdB-gyrase recognition is accompanied by opening of the tower and catalytic domain of GyrA. Such extensive structural rearrangements appear to be crucial driving forces for the functioning of the ccd toxin-antitoxin module.	[Simic, Mario; Vesnaver, Gorazd; Lah, Jurij] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [De Jonge, Natalie; Loris, Remy] Vrije Univ Brussels, Inst Mol Biol, Lab Ultrastrutuur, B-1050 Brussels, Belgium; [De Jonge, Natalie; Loris, Remy] Vrije Univ Brussel VIB, B-1050 Brussels, Belgium	University of Ljubljana; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Lah, J (corresponding author), Univ Ljubljana, Fac Chem & Chem Technol, Askerceva 5, Ljubljana 1000, Slovenia.	jurij.lah@fkkt.uni-lj.si	Loris, Remy/GPG-0894-2022	Loris, Remy/0000-0002-8862-3338	Ministry of Higher Education, Science and Technology [P1-0201, J1-6653]; Fonds Wetenschappelijk Onderzoek-Vlaanderen; Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT); Vrije Universiteit Brussel in Belgium	Ministry of Higher Education, Science and Technology; Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO); Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Vrije Universiteit Brussel in Belgium	This work was supported by the Ministry of Higher Education, Science and Technology, by Republic of Slovenia Agency for Research Grants P1-0201 and J1-6653, and by Fonds Wetenschappelijk Onderzoek-Vlaanderen, Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT), and the Onzerzoeksraad of the Vrije Universiteit Brussel in Belgium.	Bahassi EM, 1999, J BIOL CHEM, V274, P10936, DOI 10.1074/jbc.274.16.10936; Bajaj K, 2004, BIOCHEM J, V380, P409, DOI 10.1042/BJ20031528; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P15400, DOI 10.1021/bi9814991; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Buts L, 2005, ACTA CRYSTALLOGR F, V61, P949, DOI [10.1107/S1744309105029258, 10.1107/s1744309105029258]; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Chaires JB, 1997, BIOPOLYMERS, V44, P201, DOI 10.1002/(SICI)1097-0282(1997)44:3<201::AID-BIP2>3.0.CO;2-Z; Dao-Thi MH, 2000, J MOL BIOL, V299, P1373, DOI 10.1006/jmbi.2000.3815; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dao-Thi MH, 2004, ACTA CRYSTALLOGR D, V60, P1132, DOI 10.1107/S0907444904007814; Dao-Thi MH, 2002, J BIOL CHEM, V277, P3733, DOI 10.1074/jbc.M105505200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hubbard S. J., 1993, NACCESS; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; Ladbury J.E., 1998, BIOCALORIMETRY APPL; Lah J, 2005, BIOCHEMISTRY-US, V44, P13883, DOI 10.1021/bi0512952; Lah J, 2005, J BIOL CHEM, V280, P17397, DOI 10.1074/jbc.M501128200; Lah J, 2004, J MOL BIOL, V342, P73, DOI 10.1016/j.jmb.2004.07.005; Lah J, 2003, J BIOL CHEM, V278, P14101, DOI 10.1074/jbc.M209855200; Lah J, 2008, NUCLEIC ACIDS RES, V36, P897, DOI 10.1093/nar/gkm1110; Lah J, 2006, J PHYS CHEM B, V110, P23279, DOI 10.1021/jp062796f; Lah N, 2003, J BIOL CHEM, V278, P24673, DOI 10.1074/jbc.M303194200; LEE KH, 1994, PROTEINS, V20, P68, DOI 10.1002/prot.340200108; Lopez Maria M, 2002, Methods Mol Biol, V173, P121; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; MIKI T, 1992, J MOL BIOL, V225, P39, DOI 10.1016/0022-2836(92)91024-J; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; Press W.H., 1992, NUMERICAL RECIPES, V2, P650; REECE RJ, 1989, J BIOL CHEM, V264, P19648; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; REECE RJ, 1991, J BIOL CHEM, V266, P3540; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; XIE D, 1994, PROTEINS, V19, P291, DOI 10.1002/prot.340190404	44	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20002	20010		10.1074/jbc.M109.014035	http://dx.doi.org/10.1074/jbc.M109.014035			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19465484	Green Published, hybrid			2022-12-27	WOS:000268097400027
J	Winkler, A; Motz, K; Riedl, S; Puhl, M; Macheroux, P; Gruber, K				Winkler, Andreas; Motz, Kerstin; Riedl, Sabrina; Puhl, Martin; Macheroux, Peter; Gruber, Karl			Structural and Mechanistic Studies Reveal the Functional Role of Bicovalent Flavinylation in Berberine Bridge Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENTLY ATTACHED FAD; TRIMETHYLAMINE DEHYDROGENASE; CHOLESTEROL OXIDASE; PICHIA-PASTORIS; C30A MUTANT; REDOX; OVEREXPRESSION; SECRETION; BINDING	Berberine bridge enzyme (BBE) is a member of the recently discovered family of bicovalently flavinylated proteins. In this group of enzymes, the FAD cofactor is linked via its 8 alpha-methyl group and the C-6 atom to conserved histidine and cysteine residues, His-104 and Cys-166 for BBE, respectively. 6-S-Cysteinylation has recently been shown to have a significant influence on the redox potential of the flavin cofactor; however, 8 alpha-histidylation evaded a closer characterization due to extremely low expression levels upon substitution. Co-overexpression of protein disulfide isomerase improved expression levels and allowed isolation and purification of the H104A protein variant. To gain more insight into the functional role of the unusual dual mode of cofactor attachment, we solved the x-ray crystal structures of two mutant proteins, H104A and C166A BBE, each lacking one of the covalent linkages. Information from a structure of wild type enzyme in complex with the product of the catalyzed reaction is combined with the kinetic and structural characterization of the protein variants to demonstrate the importance of the bicovalent linkage for substrate binding and efficient oxidation. In addition, the redox potential of the flavin cofactor is enhanced additively by the dual mode of cofactor attachment. The reduced level of expression for the H104A mutant protein and the difficulty of isolating even small amounts of the protein variant with both linkages removed (H104A-C166A) also points toward a possible role of covalent flavinylation during protein folding.	[Winkler, Andreas; Motz, Kerstin; Riedl, Sabrina; Puhl, Martin; Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Gruber, Karl] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	Graz University of Technology; University of Graz	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	peter.macheroux@tugraz.at; karl.gruber@uni-graz.at	Gruber, Karl/GPP-6706-2022; Macheroux, Peter/AAB-5157-2019	Gruber, Karl/0000-0002-3485-9740; Macheroux, Peter/0000-0002-0242-454X; Winkler, Andreas/0000-0001-6221-9671	Austrian Science Fund, Doktoratskolleg "Molecular Enzymology" [W901-B05]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund, Doktoratskolleg "Molecular Enzymology"(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung (FWF)) through the Doktoratskolleg "Molecular Enzymology" Grant W901-B05 (to K.G. and P.M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200; DITTRICH H, 1991, P NATL ACAD SCI USA, V88, P9969, DOI 10.1073/pnas.88.22.9969; Edmondson DE, 2001, ANTIOXID REDOX SIGN, V3, P789, DOI 10.1089/15230860152664984; Efimov I, 2001, BIOCHEMISTRY-US, V40, P2155, DOI 10.1021/bi001644m; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Hassan-Abdallah A, 2006, BIOCHEMISTRY-US, V45, P9454, DOI 10.1021/bi0607352; Heuts DPHM, 2008, BIOCHEM J, V413, P175, DOI 10.1042/BJ20071591; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Huang LX, 1996, J BIOL CHEM, V271, P13401, DOI 10.1074/jbc.271.23.13401; Inan M, 2006, BIOTECHNOL BIOENG, V93, P771, DOI 10.1002/bit.20762; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kim J, 1995, J BIOL CHEM, V270, P31202, DOI 10.1074/jbc.270.52.31202; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; Li YS, 2007, J AM CHEM SOC, V129, P13384, DOI 10.1021/ja075748x; Lim L, 2006, BIOCHEM J, V400, P13, DOI 10.1042/BJ20060664; Lin-Cereghino J, 2005, BIOTECHNIQUES, V38, P44, DOI 10.2144/05381BM04; Massey V, 1990, FLAVINS FLAVOPROTEIN, P59; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; MINNAERT K, 1965, BIOCHIM BIOPHYS ACTA, V110, P42, DOI 10.1016/S0926-6593(65)80093-5; Motteran L, 2001, J BIOL CHEM, V276, P18024, DOI 10.1074/jbc.M010953200; Rand T, 2006, FEBS J, V273, P2693, DOI 10.1111/j.1742-4658.2006.05285.x; ROBINSON AS, 1994, BIO-TECHNOL, V12, P381, DOI 10.1038/nbt0494-381; SINGER TP, 1956, ARCH BIOCHEM BIOPHYS, V60, P255, DOI 10.1016/0003-9861(56)90415-5; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P2818; Trickey P, 2000, BIOCHEMISTRY-US, V39, P7678, DOI 10.1021/bi9927181; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200	34	34	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19993	20001		10.1074/jbc.M109.015727	http://dx.doi.org/10.1074/jbc.M109.015727			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19457868	Green Published, hybrid			2022-12-27	WOS:000268097400026
J	Paiva, S; Vieira, N; Nondier, I; Haguenauer-Tsapis, R; Casal, M; Urban-Grimal, D				Paiva, Sandra; Vieira, Neide; Nondier, Isabelle; Haguenauer-Tsapis, Rosine; Casal, Margarida; Urban-Grimal, Daniele			Glucose-induced Ubiquitylation and Endocytosis of the Yeast Jen1 Transporter ROLE OF LYSINE 63-LINKED UBIQUITIN CHAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RSP5 UBIQUITIN LIGASE; CASEIN KINASE-I; AMINO-ACID PERMEASE; SACCHAROMYCES-CEREVISIAE; URACIL PERMEASE; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; DOWN-REGULATION; DEUBIQUITINATING ENZYME; DEPENDENT TRAFFICKING	Protein ubiquitylation is essential for many events linked to intracellular protein trafficking. Despite the significance of this process, the molecular mechanisms that govern the regulation of ubiquitylation remain largely unknown. Plasma membrane transporters are subjected to tightly regulated endocytosis, and ubiquitylation is a key signal at several stages of the endocytic pathway. The yeast monocarboxylate transporter Jen1 displays glucose-regulated endocytosis. We show here that casein kinase 1-dependent phosphorylation and HECT-ubiquitin ligase Rsp5-dependent ubiquitylation are required for Jen1 endocytosis. Ubiquitylation and endocytosis of Jen1 are induced within minutes in response to glucose addition. Jen1 is modified at the cell surface by oligo-ubiquitylation with ubiquitin-Lys(63) linked chain(s), and Jen1-Lys(338) is one of the target residues. Ubiquitin-Lys(63)-linked chain( s) are also required directly or indirectly to sort Jen1 into multivesicular bodies. Jen1 is one of the few examples for which ubiquitin-Lys(63)-linked chain(s) was shown to be required for correct trafficking at two stages of endocytosis: endocytic internalization and sorting at multivesicular bodies.	[Paiva, Sandra; Vieira, Neide; Casal, Margarida] Univ Minho, Mol & Environm Biol Ctr, Dept Biol, P-4710057 Braga, Portugal; [Nondier, Isabelle; Haguenauer-Tsapis, Rosine; Urban-Grimal, Daniele] Univ Paris 07, CNRS, Inst Jacques Monod, F-75013 Paris, France	Universidade do Minho; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Paiva, S (corresponding author), Univ Minho, Mol & Environm Biol Ctr, Dept Biol, Campus Gualtar, P-4710057 Braga, Portugal.	spaiva@bio.uminho.pt; haguenauer.rosine@ijm.univ-paris-diderot.fr	CASAL, MARGARIDA/B-6386-2009; Paiva, Sandra Cristina Almeida/H-8864-2013; Vieira, Neide/K-7702-2015; Haguenauer-Tsapis, Rosine/C-5446-2012	CASAL, MARGARIDA/0000-0002-0143-9758; Paiva, Sandra Cristina Almeida/0000-0003-2270-4546; Vieira, Neide/0000-0002-7166-4336; 	CNRS; Association pour la Recherche sur le Cancer [3298]; Ministere de l'Enseignement et de la Recherche and the Action Concertee Incitative [183]; European Network VI Framework [018683]; Portuguese Grant QCAIII-FEDER [POCI/BIA-BCM/57812/2004]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministere de l'Enseignement et de la Recherche and the Action Concertee Incitative; European Network VI Framework; Portuguese Grant QCAIII-FEDER	Experiments performed in the laboratory of R. H.-T. were supported by CNRS-University Paris Diderot Paris 7, by Association pour la Recherche sur le Cancer Grant 3298, a grant from the Ministere de l'Enseignement et de la Recherche and the Action Concertee Incitative (BCMS; contrat 183), and a grant from the European Network VI Framework (RUBICON; contract 018683). Experiments performed in the laboratory of M. C. were supported by Portuguese Grant POCI/BIA-BCM/57812/2004 (Eixo 2, Medida 2.3, QCAIII-FEDER).	Andrade RP, 2005, BIOCHEM BIOPH RES CO, V332, P254, DOI 10.1016/j.bbrc.2005.04.119; Andrade RP, 2001, FUNGAL GENET BIOL, V32, P105, DOI 10.1006/fgbi.2001.1254; Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Bugnicourt A, 2004, MOL BIOL CELL, V15, P4203, DOI 10.1091/mbc.E04-05-0420; Casal M, 1996, MICROBIOL-UK, V142, P1385, DOI 10.1099/13500872-142-6-1385; Casal M, 1999, J BACTERIOL, V181, P2620, DOI 10.1128/JB.181.8.2620-2623.1999; Casal M, 2008, FEMS MICROBIOL REV, V32, P974, DOI 10.1111/j.1574-6976.2008.00128.x; CASSIO F, 1987, APPL ENVIRON MICROB, V53, P509; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Haguenauer-Tsapis R, 2004, TOP CURR GENET, V9, P273; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Kim Y, 2007, MOL BIOL CELL, V18, P1790, DOI 10.1091/mbc.E06-09-0861; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Paiva S, 2004, YEAST, V21, P201, DOI 10.1002/yea.1056; Paiva S, 2002, BIOCHEM J, V363, P737, DOI 10.1042/0264-6021:3630737; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Soares-Silva I, 2003, BIOCHEM J, V376, P781, DOI 10.1042/BJ20031180; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Springael JY, 1999, J CELL SCI, V112, P1375; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; THOMAS BJ, 1989, GENETICS, V123, P725; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; VANCURA A, 1994, J BIOL CHEM, V269, P19271; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; WACH A, 1994, YEAST, V10, P1808; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	58	62	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19228	19236		10.1074/jbc.M109.008318	http://dx.doi.org/10.1074/jbc.M109.008318			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19433580	Green Published, hybrid			2022-12-27	WOS:000267908300013
J	Torii, S; Kobayashi, K; Takahashi, M; Katahira, K; Goryo, K; Matsushita, N; Yasumoto, KI; Fujii-Kuriyama, Y; Sogawa, K				Torii, Satoru; Kobayashi, Kentaro; Takahashi, Masayuki; Katahira, Kasumi; Goryo, Kenji; Matsushita, Natsuki; Yasumoto, Ken-ichi; Fujii-Kuriyama, Yoshiaki; Sogawa, Kazuhiro			Magnesium Deficiency Causes Loss of Response to Intermittent Hypoxia in Paraganglion Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-ISCHEMIA-REPERFUSION; CALCIUM-CHANNEL GENE; KAPPA-B ACTIVATION; PAS DOMAIN PROTEIN; INDUCIBLE FACTOR; SLEEP-APNEA; CAROTID-BODY; NEUROENDOCRINE CELLS; OXIDATIVE STRESS; EXPRESSION	Magnesium deficiency is suggested to contribute to many age-related diseases. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) is known to be a master regulator of hypoxic response. Here we show that hypomagnesemia suppresses reactive oxygen species (ROS)-induced HIF-1 alpha activity in paraganglion cells of the adrenal medulla and carotid body. In PC12 cells cultured in the low magnesium medium and treated with cobalt chloride (CoCl2) or exposed to intermittent hypoxia, ROS-mediated HIF-1 alpha activity was suppressed. This suppression was due to up-regulation of inhibitory PAS (Per/Arnt/Sim) domain protein (IPAS) that was caused by NF-kappa B activation, which resulted from ROS and calcium influx mainly through the T-type calcium channels. Induction of tyrosine hydroxylase, a target of HIF-1, by CoCl2 injection was suppressed in the adrenal medulla of magnesium-deficient mice because of up-regulation of IPAS. Also in the carotid body of magnesium-deficient mice, CoCl2 and chronic intermittent hypoxia failed to enhance the tyrosine hydroxylase expression. These results demonstrate that serum magnesium levels are a key determinant for ROS-induced hypoxic responses.	[Torii, Satoru; Kobayashi, Kentaro; Takahashi, Masayuki; Katahira, Kasumi; Goryo, Kenji; Yasumoto, Ken-ichi; Sogawa, Kazuhiro] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Matsushita, Natsuki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Matsuyama, Ehime 7910295, Japan; [Fujii-Kuriyama, Yoshiaki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Fujii-Kuriyama, Yoshiaki] Univ Tsukuba, SORST Project, Japan Sci & Technol Agcy, Tsukuba, Ibaraki 3058577, Japan	Tohoku University; Ehime University; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba	Sogawa, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	sogawa@mail.tains.tohoku.ac.jp	Takahashi, Masayuki/AAM-7033-2021	Torii, Satoru/0000-0003-4841-7131; Yasumoto, Ken-ichi/0000-0002-8090-1161	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ALTURA BM, 1984, SCIENCE, V223, P1315, DOI 10.1126/science.6701524; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; CACERES AI, 2007, ACTA PHYSIOL SCAND, V190, P655; Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC; Chen L, 2005, AM J RESP CRIT CARE, V172, P915, DOI 10.1164/rccm.200504-560OC; Del Toro R, 2003, J BIOL CHEM, V278, P22316, DOI 10.1074/jbc.M212576200; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Hui AS, 2003, HYPERTENSION, V42, P1130, DOI 10.1161/01.HYP.0000101691.12358.26; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parati G, 2007, AM J PHYSIOL-REG I, V293, pR1671, DOI 10.1152/ajpregu.00400.2007; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Parry RV, 2007, TRENDS IMMUNOL, V28, P161, DOI 10.1016/j.it.2007.02.004; Paulding WR, 2002, MICROSC RES TECHNIQ, V59, P178, DOI 10.1002/jemt.10192; PEERS C, 1995, J MEMBRANE BIOL, V144, P1; Peng YJ, 2006, J PHYSIOL-LONDON, V577, P705, DOI 10.1113/jphysiol.2006.114033; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Rude RK, 1998, J BONE MINER RES, V13, P749, DOI 10.1359/jbmr.1998.13.4.749; Schmitz ML, 2003, FASEB J, V17, P2187, DOI 10.1096/fj.02-1100rev; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Shin HS, 2008, CURR OPIN PHARMACOL, V8, P33, DOI 10.1016/j.coph.2007.12.003; Sogawa K, 1998, P NATL ACAD SCI USA, V95, P7368, DOI 10.1073/pnas.95.13.7368; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Springael C, 2007, BIOCHEM PHARMACOL, V73, P515, DOI 10.1016/j.bcp.2006.10.034; Tong Garrison M, 2005, J Intensive Care Med, V20, P3, DOI 10.1177/0885066604271539; TURLAPATY PDMV, 1980, SCIENCE, V208, P198, DOI 10.1126/science.7361117; Vinet R, 1999, AM J PHYSIOL-HEART C, V276, pH1313, DOI 10.1152/ajpheart.1999.276.4.H1313; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; Yunker AMR, 2003, J BIOENERG BIOMEMBR, V35, P533, DOI 10.1023/B:JOBB.0000008024.77488.48	41	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19077	19089		10.1074/jbc.M109.004424	http://dx.doi.org/10.1074/jbc.M109.004424			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19433582	hybrid, Green Published			2022-12-27	WOS:000267711500056
J	Yang, XM; Li, HC; Zhou, ZN; Wang, WH; Deng, AP; Andrisani, O; Liu, XQ				Yang, Xiaoming; Li, Hongchang; Zhou, Zinan; Wang, Wen-Horng; Deng, Anping; Andrisani, Ourania; Liu, Xiaoqi			Plk1-mediated Phosphorylation of Topors Regulates p53 Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-I-BINDING; POLO-LIKE KINASES; PLK1 PHOSPHORYLATION; TUMOR-SUPPRESSOR; CANCER-CELLS; PROTEIN; IDENTIFICATION; UBIQUITIN; LIGASE; VITRO	Polo-like kinase 1 (Plk1) overexpression is associated with tumorigenesis by an unknown mechanism. Likewise, Plk1 was suggested to act as a negative regulator of tumor suppressor p53, but the mechanism remains to be determined. Herein, we have identified topoisomerase I-binding protein (Topors), a p53-binding protein, as a Plk1 target. We show that Plk1 phosphorylates Topors on Ser(718) in vivo. Significantly, expression of a Plk1-unphosphorylatable Topors mutant (S718A) leads to a dramatic accumulation of p53 through inhibition of p53 degradation. Topors is an ubiquitin and small ubiquitin-like modifier ubiquitin-protein isopeptide ligase (SUMO E3) ligase. Plk1-mediated phosphorylation of Topors inhibits Topors-mediated sumoylation of p53, whereas p53 ubiquitination is enhanced, leading to p53 degradation. These results demonstrate that Plk1 modulates Topors activity in suppressing p53 function and identify a likely mechanism for the tumorigenic potential of Plk1.	[Yang, Xiaoming; Li, Hongchang; Zhou, Zinan; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Yang, Xiaoming; Deng, Anping] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China; [Wang, Wen-Horng; Andrisani, Ourania] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Sichuan University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	Li, Hongchang/GQO-9662-2022	Andrisani, Ourania/0000-0002-6230-0303	National Institutes of Health [K01 CA114401]; NATIONAL CANCER INSTITUTE [K01CA114401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Howard Temin Award K01 CA114401 through the NCI.	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Andrisani OM, 1999, INT J ONCOL, V15, P373; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Guan B, 2008, J BIOL CHEM, V283, P4834, DOI 10.1074/jbc.M708630200; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; Hammer E, 2007, FEBS LETT, V581, P5418, DOI 10.1016/j.febslet.2007.10.040; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Mauri F, 2008, J BIOL CHEM, V283, P20848, DOI 10.1074/jbc.M710186200; Mok TSK, 2002, CANCER, V95, P1511, DOI 10.1002/cncr.10836; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Park HJ, 2008, BIOCHEMISTRY-US, V47, P13887, DOI 10.1021/bi801904q; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rasheed ZA, 2002, EXP CELL RES, V277, P152, DOI 10.1006/excr.2002.5550; Saleem A, 2004, ONCOGENE, V23, P5293, DOI 10.1038/sj.onc.1207700; STUDACH LL, 2009, HEPATOLOGY IN PRESS; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; TAKANO YS, 1991, J PATHOL, V163, P329, DOI 10.1002/path.1711630410; Watson IR, 2006, NEOPLASIA, V8, P655, DOI 10.1593/neo.06439; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Wu ZQ, 2008, J BIOL CHEM, V283, P25503, DOI 10.1074/jbc.M803304200; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Zhou R, 1999, GENE, V235, P93, DOI 10.1016/S0378-1119(99)00203-6; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	28	78	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18588	18592		10.1074/jbc.C109.001560	http://dx.doi.org/10.1074/jbc.C109.001560			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19473992	hybrid, Green Published			2022-12-27	WOS:000267711500007
J	Zhao, WQ; Lacor, PN; Chen, H; Lambert, MP; Quon, MJ; Krafft, GA; Klein, WL				Zhao, Wei-Qin; Lacor, Pascale N.; Chen, Hui; Lambert, Mary P.; Quon, Michael J.; Krafft, Grant A.; Klein, William L.			Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric A beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; HIPPOCAMPAL SYNAPTIC PLASTICITY; AMYLOID PRECURSOR PROTEIN; TYROSINE KINASE-ACTIVITY; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; DEGRADING ENZYME; SIGNAL-TRANSDUCTION; APOLIPOPROTEIN-E	Accumulation of amyloid beta (A beta) oligomers in the brain is toxic to synapses and may play an important role in memory loss in Alzheimer disease. However, how these toxins are built up in the brain is not understood. In this study we investigate whether impairments of insulin and insulin-like growth factor-1 (IGF-1) receptors play a role in aggregation of A beta. Using primary neuronal culture and immortal cell line models, we show that expression of normal insulin or IGF-1 receptors confers cells with abilities to reduce exogenously applied A beta oligomers (also known as ADDLs) to monomers. In contrast, transfection of malfunctioning human insulin receptor mutants, identified originally from patient with insulin resistance syndrome, or inhibition of insulin and IGF-1 receptors via pharmacological reagents increases ADDL levels by exacerbating their aggregation. In healthy cells, activation of insulin and IGF-1 receptor reduces the extracellular ADDLs applied to cells via seemingly the insulin-degrading enzyme activity. Although insulin triggers ADDL internalization, IGF-1 appears to keep ADDLs on the cell surface. Nevertheless, both insulin and IGF-1 reduce ADDL binding, protect synapses from ADDL synaptotoxic effects, and prevent the ADDL-induced surface insulin receptor loss. Our results suggest that dysfunctions of brain insulin and IGF-1 receptors contribute to A beta aggregation and subsequent synaptic loss.	[Zhao, Wei-Qin; Lacor, Pascale N.; Lambert, Mary P.; Klein, William L.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Zhao, Wei-Qin] Blanchette Rockefeller Neurosci Inst, Rockville, MD 20680 USA; [Krafft, Grant A.] Acumen Pharmaceut Inc, Livermore, CA 94080 USA; [Chen, Hui; Quon, Michael J.] NIH, NCCAM, Bethesda, MD 20892 USA	Northwestern University; National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Zhao, WQ (corresponding author), Merck & Co Inc, Alzheimers Res, Merck Res Labs, West Point, PA 19486 USA.	wei-qin_zhao@merck.com		QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915	National Institutes of Health [RO1-AG022547]; NIA; Intramural funding at Blanchette Rockefeller Neurosciences Institute, Rockville, MD; American Health Assistance Foundation; Alzheimer's Association; Acumen Pharmaceuticals, Inc., South; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [ZIAAT000002, ZIAAT000001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural funding at Blanchette Rockefeller Neurosciences Institute, Rockville, MD; American Health Assistance Foundation; Alzheimer's Association(Alzheimer's Association); Acumen Pharmaceuticals, Inc., South; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-AG022547 from NIA. This work was also supported by Intramural funding at Blanchette Rockefeller Neurosciences Institute, Rockville, MD, the American Health Assistance Foundation, the Alzheimer's Association, Acumen Pharmaceuticals, Inc., South	Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; CAMA A, 1992, J BIOL CHEM, V267, P8383; CAMA A, 1991, J CLIN ENDOCR METAB, V73, P894, DOI 10.1210/jcem-73-4-894; Carro E, 2006, NEUROBIOL AGING, V27, P1618, DOI 10.1016/j.neurobiolaging.2005.09.039; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Del Rio MJ, 2006, GROWTH FACTORS, V24, P67, DOI 10.1080/08977190500361788; Donahue JE, 2008, J NEUROPATH EXP NEUR, V67, P261, DOI 10.1097/NEN.0b013e31816a0dc8; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; FOSTER NL, 1984, ANN NEUROL, V16, P649, DOI 10.1002/ana.410160605; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; HARADA S, 1993, ENDOCRINOLOGY, V132, P2293, DOI 10.1210/en.132.6.2293; Harris-White M. E., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P469, DOI 10.2174/156800705774322102; Hersh LB, 2008, CURR ALZHEIMER RES, V5, P225, DOI 10.2174/156720508783954703; Hoyer S, 2002, J NEURAL TRANSM, V109, P341, DOI 10.1007/s007020200028; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Klein William L., 2008, P103, DOI 10.1007/978-3-540-76330-7_9; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; Lacor PN, 2007, CURR GENOMICS, V8, P486, DOI 10.2174/138920207783769530; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Mattson MP, 1997, BRAIN RES REV, V23, P47, DOI 10.1016/S0165-0173(96)00014-8; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Messier C, 2003, EXP GERONTOL, V38, P941, DOI 10.1016/S0531-5565(03)00153-0; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Moir Robert D., 2005, Current Alzheimer Research, V2, P269, DOI 10.2174/1567205053585918; MOLONEY AM, 2008, NEUROBIOL A IN PRESS; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1427, DOI 10.1210/en.138.4.1427; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Ram TG, 1996, MOL CARCINOGEN, V15, P227, DOI 10.1002/(SICI)1098-2744(199603)15:3<227::AID-MC8>3.0.CO;2-E; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; RELKIN NR, 2008, NEUROBIOL A IN PRESS; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Watson GS, 2006, NEUROBIOL AGING, V27, P38, DOI 10.1016/j.neurobiolaging.2004.11.011; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Xing CH, 2005, NEUROSCI LETT, V384, P93, DOI 10.1016/j.neulet.2005.04.063; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 2009, BBA-MOL BASIS DIS, V1792, P482, DOI 10.1016/j.bbadis.2008.10.014; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045	86	119	122	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18742	18753		10.1074/jbc.M109.011015	http://dx.doi.org/10.1074/jbc.M109.011015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19406747	hybrid, Green Published			2022-12-27	WOS:000267711500024
J	Paxman, JJ; Borg, NA; Horne, J; Thompson, PE; Chin, Y; Sharma, P; Simpson, JS; Wielens, J; Piek, S; Kahler, CM; Sakellaris, H; Pearce, M; Bottomley, SP; Rossjohn, J; Scanlon, MJ				Paxman, Jason J.; Borg, Natalie A.; Horne, James; Thompson, Philip E.; Chin, Yanni; Sharma, Pooja; Simpson, Jamie S.; Wielens, Jerome; Piek, Susannah; Kahler, Charlene M.; Sakellaris, Harry; Pearce, Mary; Bottomley, Stephen P.; Rossjohn, Jamie; Scanlon, Martin J.			The Structure of the Bacterial Oxidoreductase Enzyme DsbA in Complex with a Peptide Reveals a Basis for Substrate Specificity in the Catalytic Cycle of DsbA Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS DSBA; DISULFIDE BOND; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; HUMAN THIOREDOXIN; ACTIVE-SITE; PROTEINS; MECHANISM; TARGET	Oxidative protein folding in Gram-negative bacteria results in the formation of disulfide bonds between pairs of cysteine residues. This is a multistep process in which the dithiol-disulfide oxidoreductase enzyme, DsbA, plays a central role. The structure of DsbA comprises an all helical domain of unknown function and a thioredoxin domain, where active site cysteines shuttle between an oxidized, substrate-bound, reduced form and a DsbB-bound form, where DsbB is a membrane protein that reoxidizes DsbA. Most DsbA enzymes interact with a wide variety of reduced substrates and show little specificity. However, a number of DsbA enzymes have now been identified that have narrow substrate repertoires and appear to interact specifically with a smaller number of substrates. The transient nature of the DsbA-substrate complex has hampered our understanding of the factors that govern the interaction of DsbA enzymes with their substrates. Here we report the crystal structure of a complex between Escherichia coli DsbA and a peptide with a sequence derived from a substrate. The binding site identified in the DsbA-peptide complex was distinct from that observed for DsbB in the DsbA-DsbB complex. The structure revealed details of the DsbA-peptide interaction and suggested a mechanism by which DsbA can simultaneously show broad specificity for substrates yet exhibit specificity for DsbB. This mode of binding was supported by solution nuclear magnetic resonance data as well as functional data, which demonstrated that the substrate specificity of DsbA could be modified via changes at the binding interface identified in the structure of the complex.	[Borg, Natalie A.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol,Prot Crystallog Unit, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia; [Paxman, Jason J.; Horne, James; Thompson, Philip E.; Chin, Yanni; Sharma, Pooja; Simpson, Jamie S.; Wielens, Jerome; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Piek, Susannah; Kahler, Charlene M.; Sakellaris, Harry] Univ Western Australia, QEII Med Ctr, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia	Monash University; Monash University; University of Western Australia	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol,Prot Crystallog Unit, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia.	jamie.rossjohn@med.monash.edu.au; martin.scanlon@pharm.monash.edu.au	sharma, pooja/AAQ-6387-2020; Rossjohn, Jamie/F-9032-2013; Chin, Yanni/D-2139-2017; Simpson, Jamie/ABC-7083-2020; Paxman, Jason/T-6932-2019; Simpson, Jamie S/A-1700-2012; Kahler, Charlene M/H-5159-2014	Rossjohn, Jamie/0000-0002-2020-7522; Chin, Yanni/0000-0002-3367-6897; Simpson, Jamie/0000-0002-8894-422X; Paxman, Jason/0000-0002-1418-5910; Simpson, Jamie S/0000-0002-8894-422X; Kahler, Charlene M/0000-0003-4322-3055; Scanlon, Martin/0000-0002-9230-7506; Thompson, Philip/0000-0002-5910-7625; Wielens, Jerome/0000-0003-3406-4136; Borg, Natalie/0000-0002-8677-9056; Horne, James/0000-0002-1935-2378	Australian Research Council (ARC) [LP0455508]; National Health and Medical Research Council (NHMRC) [455860]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian Research Council (ARC) Grant LP0455508 and National Health and Medical Research Council (NHMRC) Grant 455860.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; CHUNG CT, 1988, NUCLEIC ACIDS RES, V16, P3580, DOI 10.1093/nar/16.8.3580; Colbert CL, 2006, P NATL ACAD SCI USA, V103, P4410, DOI 10.1073/PNAS.0600552103; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Couprie J, 2000, BIOCHEMISTRY-US, V39, P6732, DOI 10.1021/bi992873f; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P3576, DOI 10.1021/bi00011a012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dumoulin A, 2005, ARCH MICROBIOL, V184, P117, DOI 10.1007/s00203-005-0024-1; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Grimshaw JPA, 2008, J MOL BIOL, V380, P667, DOI 10.1016/j.jmb.2008.05.031; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Guddat LW, 1997, PROTEIN SCI, V6, P1148, DOI 10.1002/pro.5560060603; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; Hizukuri Y, 2006, J BACTERIOL, V188, P4190, DOI 10.1128/JB.01896-05; Horne J, 2007, J MOL BIOL, V371, P703, DOI 10.1016/j.jmb.2007.05.067; Hu SH, 1997, J MOL BIOL, V268, P137, DOI 10.1006/jmbi.1997.0940; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jackson MW, 1999, J BACTERIOL, V181, P5126, DOI 10.1128/JB.181.16.5126-5130.1999; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Ladner JE, 2004, BIOCHEMISTRY-US, V43, P352, DOI 10.1021/bi035832z; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; MACNAB RM, 1986, METHOD ENZYMOL, V125, P563; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; Sardesai AA, 2003, EMBO J, V22, P1461, DOI 10.1093/emboj/cdg152; Schirra HJ, 1998, BIOCHEMISTRY-US, V37, P6263, DOI 10.1021/bi980136y; Sinha S, 2004, MICROBIOL-SGM, V150, P2993, DOI 10.1099/mic.0.27216-0; Skorko-Glonek J, 2006, ACTA BIOCHIM POL, V53, P585; Stafford SJ, 1999, FEMS MICROBIOL LETT, V174, P179, DOI 10.1111/j.1574-6968.1999.tb13566.x; Tinsley CR, 2004, J BIOL CHEM, V279, P27078, DOI 10.1074/jbc.M313404200; Vivian JP, 2008, J BIOL CHEM, V283, P32452, DOI 10.1074/jbc.M803990200; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; WATARAI M, 1995, P NATL ACAD SCI USA, V92, P4927, DOI 10.1073/pnas.92.11.4927; Wielens J, 2005, J COMPUT AID MOL DES, V19, P301, DOI 10.1007/s10822-005-5256-2; Yu J, 1998, INFECT IMMUN, V66, P3909, DOI 10.1128/IAI.66.8.3909-3917.1998	58	55	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17835	17845		10.1074/jbc.M109.011502	http://dx.doi.org/10.1074/jbc.M109.011502			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19389711	Green Published, hybrid			2022-12-27	WOS:000267202500049
J	Sandoval-Calderon, M; Geiger, O; Guan, ZQ; Barona-Gomez, F; Sohlenkamp, C				Sandoval-Calderon, Mario; Geiger, Otto; Guan, Ziqiang; Barona-Gomez, Francisco; Sohlenkamp, Christian			A Eukaryote-like Cardiolipin Synthase Is Present in Streptomyces coelicolor and in Most Actinobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RAT-LIVER MITOCHONDRIA; FATTY-ACID-COMPOSITION; SACCHAROMYCES-CEREVISIAE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; PHOSPHATIDYLCHOLINE SYNTHASE; RHIZOBIUM-LEGUMINOSARUM; PHOSPHOLIPASE-D; GENE	Cardiolipin (CL) is an anionic membrane lipid present in bacteria, plants, and animals, but absent from archaea. It is generally thought that bacteria use an enzyme belonging to the phospholipase D superfamily as cardiolipin synthase (Cls) catalyzing a reversible phosphatidyl group transfer from one phosphatidylglycerol (PG) molecule to another PG to form CL and glycerol. In contrast, in eukaryotes a Cls of the CDP-alcohol phosphatidyltransferase superfamily uses cytidine diphosphate-diacylglycerol (CDP-DAG) as the donor of the phosphatidyl group, which is transferred to a molecule of PG to form CL. Searching the genome of the actinomycete Streptomyces coelicolor A3(2) we identified a gene coding for a putative Cls of the CDP-alcohol phosphatidyltransferase superfamily (Sco1389). Here we show that expression of Sco1389 in a CL-deficient Rhizobium etli mutant restores CL formation. In an in vitro assay Sco1389 condenses CDP-DAG with PG to form CL and therefore catalyzes the same reaction as eukaryotic cardiolipin synthases. This is the first time that a CDP-alcohol phosphatidyltransferase from bacteria is shown to be responsible for CL formation. The broad occurrence of putative orthologues of Sco1389 among the actinobacteria suggests that CL synthesis involving a eukaryotic type Cls is common in actinobacteria.	[Sandoval-Calderon, Mario; Barona-Gomez, Francisco] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Evolut Metab Divers Lab, Lab Nacl Genom Biodiversidad, Guanajuato 36821, Mexico; [Sandoval-Calderon, Mario; Geiger, Otto; Sohlenkamp, Christian] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62210, Morelos, Mexico; [Guan, Ziqiang] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Duke University	Barona-Gomez, F (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Evolut Metab Divers Lab, Lab Nacl Genom Biodiversidad, Km 9-6 Libramiento Norte,Carretera Irapuato Leon, Guanajuato 36821, Mexico.	fbarona@ira.cinvestav.mx; chsohlen@ccg.unam.mx	Geiger, Otto/F-6356-2019; Sohlenkamp, Christian/C-6219-2018; Guan, Ziqiang/AAE-5110-2019	Geiger, Otto/0000-0002-7794-1568; Sohlenkamp, Christian/0000-0002-9962-2859; Sandoval-Calderon, Mario/0000-0001-7888-4334; Barona Gomez, Francisco/0000-0003-1492-9497	National Institutes of Health [GM-069338]; Consejo Nacional de Ciencia y Tecnologia, Mexico [46020-N, 82614, 82319]; Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico [IN217907]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-069338 (a LIPID MAPS glue grant to Z. G. and the mass spectrometry facility in the Department of Biochemistry, Duke University Medical Center). This work was also supported by the Consejo Nacional de Ciencia y Tecnologia, Mexico (Grants 46020-N, 82614, and 82319) and Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (Grant IN217907).	Barona-Gomez F, 2003, EMBO REP, V4, P296, DOI 10.1038/sj.embor.embor771; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705; BROM S, 1992, J BACTERIOL, V174, P5183, DOI 10.1128/JB.174.16.5183-5189.1992; Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758; DArrigo P, 1996, J CHEM SOC PERK T 1, P2657, DOI 10.1039/p19960002657; de Rudder KEE, 1999, J BIOL CHEM, V274, P20011, DOI 10.1074/jbc.274.28.20011; Demain AL, 2008, MOL BIOTECHNOL, V38, P41, DOI 10.1007/s12033-007-0035-z; deRudder KEE, 1997, J BACTERIOL, V179, P6921, DOI 10.1128/jb.179.22.6921-6928.1997; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; GOPALAKRISHNAN AS, 1986, J BIOL CHEM, V261, P1329; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haiens TH, 2002, FEBS LETT, V528, P35, DOI 10.1016/S0014-5793(02)03292-1; HJELMSTAD RH, 1991, J BIOL CHEM, V266, P5094; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Hoischen C, 1997, J BACTERIOL, V179, P3430, DOI 10.1128/jb.179.11.3430-3436.1997; HOSTETLER KY, 1975, BIOCHIM BIOPHYS ACTA, V380, P382, DOI 10.1016/0005-2760(75)90106-X; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; KATES M, 1993, LIPIDS, V28, P877, DOI 10.1007/BF02537494; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Kieser T., 2000, PRACTICAL STREPTOMYC, P412; MATHUR AK, 1976, CAN J MICROBIOL, V22, P354, DOI 10.1139/m76-054; Nampoothiri KM, 2002, APPL MICROBIOL BIOT, V58, P89, DOI 10.1007/s00253-001-0861-z; NIKAWA J, 1987, J BIOL CHEM, V262, P4876; NISHIJIMA S, 1988, J BACTERIOL, V170, P775, DOI 10.1128/jb.170.2.775-780.1988; NOEL KD, 1984, J BACTERIOL, V158, P148, DOI 10.1128/JB.158.1.148-155.1984; Nowicki M, 2005, FEBS LETT, V579, P2161, DOI 10.1016/j.febslet.2005.03.007; OKADA M, 1994, J BACTERIOL, V176, P7456, DOI 10.1128/JB.176.24.7456-7461.1994; Pangborn MC, 1942, J BIOL CHEM, V143, P247; Piazza GJ, 2007, J AM OIL CHEM SOC, V84, P645, DOI 10.1007/s11746-007-1081-1; Ponting CP, 1996, PROTEIN SCI, V5, P914; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; ROSS ID, 2006, EUKARYOT CELL, V5, P784; RUVKUN GB, 1981, NATURE, V289, P85, DOI 10.1038/289085a0; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SCHLAME M, 1991, J BIOL CHEM, V266, P22398; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Sohlenkamp C, 2000, J BIOL CHEM, V275, P18919, DOI 10.1074/jbc.M000844200; Sohlenkamp C, 2004, J BACTERIOL, V186, P1667, DOI 10.1128/JB.186.6.1667-1677.2004; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z; VASILENKO I, 1982, BIOCHIM BIOPHYS ACTA, V684, P282, DOI 10.1016/0005-2736(82)90018-9; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	52	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17383	17390		10.1074/jbc.M109.006072	http://dx.doi.org/10.1074/jbc.M109.006072			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19439403	Green Published, hybrid			2022-12-27	WOS:000267202500004
J	Wen, KK; Rubenstein, PA				Wen, Kuo-Kuang; Rubenstein, Peter A.			Differential Regulation of Actin Polymerization and Structure by Yeast Formin Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; CRYSTAL-STRUCTURES; CAPPING PROTEIN; MOUSE FORMIN; MECHANISM; PROFILIN; CYTOKINESIS; BNI1; DESTABILIZATION; ELONGATION	The budding yeast formins, Bnr1 and Bni1, behave very differently with respect to their interactions with muscle actin. However, the mechanisms underlying these differences are unclear, and these formins do not interact with muscle actin in vivo. We use yeast wild type and mutant actins to further assess these differences between Bnr1 and Bni1. Low ionic strength G-buffer does not promote actin polymerization. However, Bnr1, but not Bni1, causes the polymerization of pyrene-labeled Mg-G-actin in G-buffer into single filaments based on fluorometric and EM observations. Polymerization by Bnr1 does not occur with Ca-G-actin. By cosedimentation, maximum filament formation occurs at a Bnr1: actin ratio of 1:2. The interaction of Bnr1 with pyrene-labeled S265C Mg-actin yields a pyrene excimer peak, from the cross-strand interaction of pyrene probes, which only occurs in the context of F-actin. In F-buffer, Bnr1 promotes much faster yeast actin polymerization than Bni1. It also bundles the F-actin in contrast to the low ionic strength situation where only single filaments form. Thus, the differences previously observed with muscle actin are not actin isoform-specific. The binding of both formins to F-actin saturate at an equimolar ratio, but only about 30% of each formin cosediments with F-actin. Finally, addition of Bnr1 but not Bni1 to pyrene-labeled wild type and S265C Mg-F actins enhanced the pyrene- and pyrene- excimer fluorescence, respectively, suggesting Bnr1 also alters F-actin structure. These differences may facilitate the ability of Bnr1 to form the actin cables needed for polarized delivery of nutrients and organelles to the growing yeast bud.	[Wen, Kuo-Kuang; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Roy A & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Dept Biochem, Roy A & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM211105]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM211105 (to P. A. R.).	Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Conchaudron AP, 2006, J BIOL CHEM, V281, P24036, DOI 10.1074/jbc.M602747200; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Ezezika OC, 2009, J BIOL CHEM, V284, P2088, DOI 10.1074/jbc.M807073200; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; GERSHMAN LC, 1994, ADV EXP MED BIOL, V358, P35; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Hosek M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051907; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuang B, 1997, J BIOL CHEM, V272, P1237, DOI 10.1074/jbc.272.2.1237; Kudryashov DS, 2004, BIOPHYS J, V87, P1136, DOI 10.1529/biophysj.104.042242; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wen KK, 2000, BIOCHEMISTRY-US, V39, P8638, DOI 10.1021/bi000241j; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	42	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16776	16783		10.1074/jbc.M109.006981	http://dx.doi.org/10.1074/jbc.M109.006981			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386598	hybrid, Green Published			2022-12-27	WOS:000266962400013
J	Frischauf, I; Muik, M; Derler, I; Bergsmann, J; Fahrner, M; Schindl, R; Groschner, K; Romanin, C				Frischauf, Irene; Muik, Martin; Derler, Isabella; Bergsmann, Judith; Fahrner, Marc; Schindl, Rainer; Groschner, Klaus; Romanin, Christoph			Molecular Determinants of the Coupling between STIM1 and Orai Channels DIFFERENTIAL ACTIVATION OF Orai1-3 CHANNELS BY A STIM1 COILED-COIL MUTANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; CRAC CHANNELS; ENDOPLASMIC-RETICULUM; CALCIUM-CHANNELS; DEPLETION; ACTIVATION; DOMAINS; PROTEIN; BORATE	STIM1 and Orai1 have been reported to interact upon store depletion culminating in Ca2+ release-activated Ca2+ current activation. Recently, the essential region has been identified within the STIM1 C terminus that includes the second coiled-coil domain C-terminally extended by similar to 50 amino acids and exhibits a strong binding to the Orai1 C terminus. Based on the homology within the Orai family, an analogous scenario might be assumed for Orai2 as well as Orai3 channels as both are activated in a similar STIM1-dependent manner. A combined approach of electrophysiology and Foerster resonance energy transfer microscopy uncovered a general mechanism in the communication of STIM1 with Orai proteins that involved the conserved putative coiled-coil domains in the respective Orai C terminus and the second coiled-coil motif in the STIM1 C terminus. A coiled-coil single mutation in the Orai1 C terminus abrogated communication with the STIM1 C terminus, whereas an analogous mutation in Orai2 and Orai3 still allowed for their moderate activation. However, increasing coiled-coil probability by a gain of function deletion in Orai1 or by generating an Orai1-Orai3 chimera containing the Orai3 C terminus recovered stimulation to a similar extent as with Orai2/3. At the level of STIM1, decreasing probability of the second coiled-coil domain by a single mutation within the STIM1 C terminus abolished activation of Orai1 but still enabled partial stimulation of Orai2/3 channels. A double mutation within the second coiled-coil motif of the STIM1 C terminus fully disrupted communication with all three Orai channels. In aggregate, the impairment in the overall communication between STIM1 and Orai channels upon decreasing probabilities of either one of the putative coiled-coil domains in the C termini might be compatible with the concept of their functional, heteromeric interaction.	[Frischauf, Irene; Muik, Martin; Derler, Isabella; Bergsmann, Judith; Fahrner, Marc; Schindl, Rainer; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharm, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Romanin, C (corresponding author), Univ Linz, Inst Biophys, A-4040 Linz, Austria.	christoph.romanin@jku.at	Schindl, Rainer/E-3959-2013; Frischauf, Irene/AAG-2007-2019; Romanin, Christoph/D-5399-2009; Derler, Isabella/B-7871-2019; Fahrner, Marc/AAI-7927-2021; Schindl, Rainer/V-4205-2019; Groschner, Klaus/A-2550-2010	Schindl, Rainer/0000-0003-0896-8887; Frischauf, Irene/0000-0003-0661-2932; Romanin, Christoph/0000-0003-3756-4136; Derler, Isabella/0000-0002-4768-146X; Groschner, Klaus/0000-0002-8659-377X	Austrian Science Foundation Project [P19820, P18169, P21118]	Austrian Science Foundation Project(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation Project P19820 (to K. G.) and Projects P18169, P21118, and Subproject 11 of the Ph.D. Programme "Molecular Bioanalytics" (to C. R.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Csutora P, 2008, J BIOL CHEM, V283, P14524, DOI 10.1074/jbc.M709575200; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Fairman R, 1996, BIOCHEMISTRY-US, V35, P2824, DOI 10.1021/bi952784c; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; LEWIS RS, 1990, ANNU REV PHYSIOL, V52, P415; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2007, BIOCHEM SOC T, V35, P84, DOI 10.1042/BST0350084; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Spassova MA, 2008, J BIOL CHEM, V283, P14938, DOI 10.1074/jbc.M702208200; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Taylor CW, 2006, TRENDS BIOCHEM SCI, V31, P597, DOI 10.1016/j.tibs.2006.09.007; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	51	128	131	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21696	21706		10.1074/jbc.M109.018408	http://dx.doi.org/10.1074/jbc.M109.018408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506081	hybrid, Green Published			2022-12-27	WOS:000268564400062
J	Legleiter, J; Lotz, GP; Miller, J; Ko, J; Ng, C; Williams, GL; Finkbeiner, S; Patterson, PH; Muchowski, PJ				Legleiter, Justin; Lotz, Gregor P.; Miller, Jason; Ko, Jan; Ng, Cheping; Williams, Geneva L.; Finkbeiner, Steve; Patterson, Paul H.; Muchowski, Paul J.			Monoclonal Antibodies Recognize Distinct Conformational Epitopes Formed by Polyglutamine in a Mutant Huntingtin Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY FORMATION; AMYLOID-LIKE FIBRILS; IN-VITRO; PROTEIN; DISEASE; AGGREGATION; MODEL; TOXICITY; OLIGOMERS; BINDING	Huntington disease (HD) is a neurodegenerative disorder caused by an expansion of a polyglutamine (polyQ) domain in the N-terminal region of huntingtin (htt). PolyQ expansion above 35-40 results in disease associated with htt aggregation into inclusion bodies. It has been hypothesized that expanded polyQ domains adopt multiple potentially toxic conformations that belong to different aggregation pathways. Here, we used atomic force microscopy to analyze the effect of a panel of anti-htt antibodies (MW1-MW5, MW7, MW8, and 3B5H10) on aggregate formation and the stability of a mutant htt-exon1 fragment. Two antibodies, MW7 (polyproline-specific) and 3B5H10 (polyQ-specific), completely inhibited fibril formation and disaggregated preformed fibrils, whereas other polyQ-specific antibodies had widely varying effects on aggregation. These results suggest that expanded polyQ domains adopt multiple conformations in solution that can be readily distinguished by monoclonal antibodies, which has important implications for understanding the structural basis for polyQ toxicity and the development of intrabody-based therapeutics for HD.	[Legleiter, Justin; Lotz, Gregor P.; Miller, Jason; Ng, Cheping; Williams, Geneva L.; Finkbeiner, Steve; Muchowski, Paul J.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Legleiter, Justin; Lotz, Gregor P.; Finkbeiner, Steve; Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Miller, Jason] Univ Calif San Francisco, Dept Chem & Chem Biol, Grad Program, San Francisco, CA 94158 USA; [Miller, Jason; Finkbeiner, Steve] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94158 USA; [Finkbeiner, Steve] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Finkbeiner, Steve; Muchowski, Paul J.] CALTECH, Taube Koret Ctr Huntingtons Dis Res, Pasadena, CA 91125 USA; [Ko, Jan; Patterson, Paul H.] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Institute of Technology; California Institute of Technology	Muchowski, PJ (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	pmuchowski@gladstone.ucsf.edu		Lotz, Gregor/0000-0002-0231-5503; Legleiter, Justin/0000-0002-5262-1867; Miller, Jason/0000-0002-2784-9560	National Institutes of Health [R01NS047237, R01NS054753, P01AG022074, R01NS039074, R01NS045091, R01NS055298]; Hereditary Disease Foundation; Cure Huntington's Disease Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047237, R01NS055298, R01NS045091, R01NS054753, R01NS039074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; Cure Huntington's Disease Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS047237 and R01NS054753 (to P. J. M.), P01AG022074 (to S. F.), R01NS039074 (to S. F.), and R01NS045091 and R01NS055298 (to P. H. P.). This work was also supported by the Hereditary Disease Foundation and the Cure Huntington's Disease Initiative.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Brooks Elizabeth, 2004, V277, P103; Buxbaum JN, 2003, TRENDS BIOCHEM SCI, V28, P585, DOI 10.1016/j.tibs.2003.09.009; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Dahlgren PR, 2005, NANOMED-NANOTECHNOL, V1, P52, DOI 10.1016/j.nano.2004.11.004; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diaz-Hernandez M, 2004, J NEUROSCI, V24, P9361, DOI 10.1523/JNEUROSCI.2365-04.2004; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; FRANKLIN EC, 1972, P SOC EXP BIOL MED, V140, P565; Ghoshal N, 2001, J NEUROCHEM, V77, P1372, DOI 10.1046/j.1471-4159.2001.00346.x; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; JACKSON GR, 2004, SOC NEUR ABSTR, V30; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Li PW, 2007, NAT STRUCT MOL BIOL, V14, P381, DOI 10.1038/nsmb1234; LINKE RP, 1973, J IMMUNOL, V111, P10; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; McLear JA, 2008, FASEB J, V22, P2003, DOI 10.1096/fj.07-099689; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Peters-Libeu C, 2005, ACTA CRYSTALLOGR F, V61, P1065, DOI 10.1107/S1744309105036547; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Soreghan B, 2002, NEUROMOL MED, V1, P81; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Tanaka M, 2001, J BIOL CHEM, V276, P45470, DOI 10.1074/jbc.M107502200; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Vitalis A, 2008, J MOL BIOL, V384, P279, DOI 10.1016/j.jmb.2008.09.026; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang CE, 2008, J CELL BIOL, V181, P803, DOI 10.1083/jcb.200710158; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	63	73	76	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21647	21658		10.1074/jbc.M109.016923	http://dx.doi.org/10.1074/jbc.M109.016923			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19491400	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000268564400058
J	Li, F; Xie, P; Fan, YN; Zhang, H; Zheng, LF; Gu, DF; Patterson, C; Li, HH				Li, Fang; Xie, Ping; Fan, Yongna; Zhang, Hua; Zheng, Lianfang; Gu, Dongfeng; Patterson, Cam; Li, Huihua			C Terminus of Hsc70-interacting Protein Promotes Smooth Muscle Cell Proliferation and Survival through Ubiquitin-mediated Degradation of FoxO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; DEPENDENT CARDIAC-HYPERTROPHY; HEAT-SHOCK PROTEINS; NF-KAPPA-B; PROTEASOMAL DEGRADATION; NEOINTIMAL HYPERPLASIA; PHOSPHORYLATED TAU; INHIBITS APOPTOSIS; HUMAN HEPATOCYTES; CHIP	Forkhead transcription factors (FoxOs) play a pivotal role in controlling cellular proliferation and survival. The cellular level of these factors is tightly regulated through the phosphoinositide 3-kinase/Akt and ubiquitin-mediated degradation. However, the ubiquitin ligases responsible for the degradation of FoxO1 and the relevance of this regulation to smooth muscle cell (SMC) proliferation and survival have not been fully identified. Here we showed that overexpression of C terminus of Hsc70-interacting protein (CHIP) promoted ubiquitination and degradation of FoxO1 in SMCs in response to tumor necrosis factor-alpha. Both the U-box (containing ubiquitin ligase activity) and the charged (essential for FoxO1 binding) domains within CHIP were required for CHIP-mediated FoxO1 down-regulation. Moreover, interaction and ubiquitination of FoxO1 by CHIP depended on phosphorylation of FoxO1 at Ser-256. Furthermore, overexpression of CHIP repressed FoxO1-mediated transactivation and its proapoptotic function following tumor necrosis factor-alpha treatment. In contrast, knockdown of CHIP by small interfering RNA enhanced FoxO1-mediated transactivation and its effect on SMC proliferation and survival. Taken together, our data indicate that CHIP is a negative regulator of FoxO1 activity through ubiquitin-mediated degradation, and inhibition of CHIP may serve as a potential therapeutic target for reducing proliferative arterial diseases.	[Xie, Ping; Fan, Yongna; Zhang, Hua] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, Beijing 100005, Peoples R China; [Xie, Ping; Fan, Yongna; Zhang, Hua] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Xie, Ping; Fan, Yongna; Zhang, Hua] Peking Union Med Coll, Beijing 100005, Peoples R China; [Li, Fang; Zheng, Lianfang; Li, Huihua] Peking Union Med Hosp, Dept Nucl Med, Beijing 100730, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100037, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Peoples R China; [Gu, Dongfeng] Cardiovasc Inst, Div Populat Genet & Prevent, Beijing 100037, Peoples R China; [Patterson, Cam] Univ N Carolina, Div Cardiol & Carolina Cardiovasc Biol, Chapel Hill, NC 27599 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of North Carolina; University of North Carolina Chapel Hill	Li, HH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hhli1935@yahoo.cn			China Natural Science Foundation [2006CB910306, 2006CB503805, 30670860]; Ministry of Education of China [20060023051]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the China Natural Science Foundation (Grants 2006CB910306, 2006CB503805, and 30670860 to H. L.) and by The Ph. D. Programs Foundation of Ministry of Education of China (Grant 20060023051 to H. L.).	Abid MR, 2006, J BIOL CHEM, V281, P35544, DOI 10.1074/jbc.M608620200; Abid MR, 2005, J BIOL CHEM, V280, P29864, DOI 10.1074/jbc.M502149200; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Brenkman AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002819; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Choi JY, 2007, MOL CELL NEUROSCI, V34, P69, DOI 10.1016/j.mcn.2006.10.002; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Galigniana MD, 2004, MOL BRAIN RES, V123, P27, DOI 10.1016/j.molbrainres.2003.12.015; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hwang JR, 2005, CELL STRESS CHAPERON, V10, P147, DOI 10.1379/CSC-90R.1; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kosik KS, 2005, BBA-MOL BASIS DIS, V1739, P298, DOI 10.1016/j.bbadis.2004.10.011; Kumar A, 1997, CIRCULATION, V96, P4333; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Osawa Y, 2002, INFECT IMMUN, V70, P6294, DOI 10.1128/IAI.70.11.6294-6301.2002; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Owens G, 2007, DIS MANAGE, V10, P74, DOI 10.1089/dis.2006.638; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ozes ON, 1999, NATURE, V401, P82; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Park KW, 2005, ARTERIOSCL THROM VAS, V25, P742, DOI 10.1161/01.ATV.0000156288.70849.26; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004	43	58	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20090	20098		10.1074/jbc.M109.017046	http://dx.doi.org/10.1074/jbc.M109.017046			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19483080	hybrid, Green Published			2022-12-27	WOS:000268097400036
J	Sengupta, S; George, M; Miller, KK; Naik, K; Chou, J; Cheatham, MA; Dallos, P; Naramura, M; Band, H; Zheng, J				Sengupta, Soma; George, Manju; Miller, Katharine K.; Naik, Khurram; Chou, Jonathan; Cheatham, Mary Ann; Dallos, Peter; Naramura, Mayumi; Band, Hamid; Zheng, Jing			EHD4 and CDH23 Are Interacting Partners in Cochlear Hair Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; EARLY ENDOSOMAL TRANSPORT; TIP-LINK; MAMMALIAN-CELLS; PLASMA-MEMBRANE; FAMILY PROTEINS; SENSORY CELLS; WALTZER MICE; CADHERIN-23; ENDOCYTOSIS	Cadherin 23 (CDH23), a transmembrane protein localized near the tips of hair cell stereocilia in the mammalian inner ear, is important for delivering mechanical signals to the mechanoelectric transducer channels. To identify CDH23-interacting proteins, a membrane-based yeast two-hybrid screen of an outer hair cell (OHC) cDNA library was performed. EHD4, a member of the C-terminal EH domain containing a protein family involved in endocytic recycling, was identified as a potential interactor. To confirm the interaction, we first demonstrated the EHD4 mRNA expression in hair cells using in situ hybridization. Next, we showed that EHD4 co-localizes and co-immunoprecipitates with CDH23 in mammalian cells. Interestingly, the co-immunoprecipitation was found to be calcium-sensitive. To investigate the role of EHD4 in hearing, compound action potentials were measured in EHD4 knockout (KO) mice. Although EHD4 KO mice have normal hearing sensitivity, analysis of mouse cochlear lysates revealed a 2-fold increase in EHD1, but no increase in EHD2 or EHD3, in EHD4 KO cochleae compared with wild type, suggesting that a compensatory increase in EHD1 levels may account for the absence of a hearing defect in EHD4 KO mice. Taken together, these data indicate that EHD4 is a novel CDH23-interacting protein that could regulate CDH23 trafficking/localization in a calcium-sensitive manner.	[Sengupta, Soma; Miller, Katharine K.; Naik, Khurram; Chou, Jonathan; Cheatham, Mary Ann; Dallos, Peter; Zheng, Jing] Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL 60208 USA; [George, Manju; Naramura, Mayumi; Band, Hamid] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Coll Med, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Coll Med, Omaha, NE 68198 USA	Northwestern University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Zheng, J (corresponding author), Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, 2240 Campus Dr, Evanston, IL 60208 USA.	jzh215@northwestern.edu	Dallos, Peter/Q-9360-2019; Miller, Katharine K/O-6804-2015; Zheng, Jing/F-5273-2017	Dallos, Peter/0000-0002-9731-6591; Miller, Katharine K/0000-0002-0690-7426; Zheng, Jing/0000-0003-2790-1143; Naramura, Mayumi/0000-0003-3658-0767	National Institutes of Health [DC00089, DC006412, CA87986, CA105489, CA99900, CA116552, CA99163]; The Hugh Knowles Center Leadership Fund; NATIONAL CANCER INSTITUTE [R01CA116552, R01CA087986, R01CA099900, R01CA105489, R01CA099163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000089, R01DC006412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hugh Knowles Center Leadership Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC00089 (to P. D.), DC006412 (to J. Z.), CA87986, CA105489, CA99900, CA116552, and CA99163 (to H. B.) and The Hugh Knowles Center Leadership Fund (to J. Z.).	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; Judice TN, 2002, BRAIN RES PROTOC, V9, P65, DOI 10.1016/S1385-299X(01)00138-6; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kuo HJ, 2001, J BIOL CHEM, V276, P43103, DOI 10.1074/jbc.M106128200; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Naslavsky N, 2007, BIOCHEM BIOPH RES CO, V357, P792, DOI 10.1016/j.bbrc.2007.04.022; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Petit C, 2006, TRENDS MOL MED, V12, P57, DOI 10.1016/j.molmed.2005.12.006; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Wilson SM, 2001, GENOMICS, V74, P228, DOI 10.1006/geno.2001.6554; Xu ZG, 2008, J NEUROSCI, V28, P11269, DOI 10.1523/JNEUROSCI.3833-08.2008; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032; Zheng J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-127	48	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20121	20129		10.1074/jbc.M109.025668	http://dx.doi.org/10.1074/jbc.M109.025668			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19487694	Green Published, hybrid			2022-12-27	WOS:000268097400039
J	Tanaka, R; Owaki, T; Kamiya, S; Matsunaga, T; Shimoda, K; Kodama, H; Hayashi, R; Abe, T; Harada, YP; Shimonaka, M; Yajima, H; Terada, H; Fukai, F				Tanaka, Rika; Owaki, Toshiyuki; Kamiya, Sadahiro; Matsunaga, Takuya; Shimoda, Kazuya; Kodama, Hiroaki; Hayashi, Ryo; Abe, Takashi; Harada, Yosei P.; Shimonaka, Motoyuki; Yajima, Hirofumi; Terada, Hiroshi; Fukai, Fumio			VLA-5-mediated Adhesion to Fibronectin Accelerates Hemin-stimulated Erythroid Differentiation of K562 Cells through Induction of VLA-4 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; TENASCIN-C; EXTRACELLULAR-MATRIX; MEGAKARYOCYTIC DIFFERENTIATION; HEMATOPOIETIC MICROENVIRONMENT; DEPENDENT ERYTHROPOIESIS; ERYTHROLEUKEMIA-CELLS; ANTIADHESIVE SITE; BINDING-SITE	Fibronectin plays important roles in erythropoiesis through the fibronectin receptors VLA-4 and VLA-5. However, the substantial role of these fibronectin receptors and their functional assignment in erythroid differentiation are not yet fully understood. Here, we investigated the effects of cell adhesion to fibronectin on erythroid differentiation using K562 human erythroid progenitor cells. Erythroid differentiation could be induced in K562 cells in suspension by stimulating with hemin. This hemin-stimulated erythroid differentiation was highly accelerated when cells were induced to adhere to fibronectin by treatment with TNIIIA2, a peptide derived from tenascin-C, which has recently been found to induce beta 1-integrin activation. Another integrin activator, Mn2+, also accelerated hemin-stimulated erythroid differentiation. Adhesive interaction with fibronectin via VLA-4 as well as VLA-5 was responsible for acceleration of the hemin-stimulated erythroid differentiation in response to TNIIIA2, although K562 cells should have been lacking in VLA-4. Adhesion to fibronectin forced by TNIIIA2 causally induced VLA-4 expression in K562 cells, and this was blocked by the RGD peptide, an antagonist for VLA-5. The resulting adhesive interaction with fibronectin via VLA-4 strongly enhanced the hemin-stimulated activation of p38 mitogen-activated protein kinase, which was shown to serve as a signaling molecule crucial for erythroid differentiation. Suppression of VLA-4 expression by RNA interference abrogated acceleration of hemin-stimulated erythroid differentiation in response to TNIIIA2. Thus, VLA-4 and VLA-5 may contribute to erythropoiesis at different stages of erythroid differentiation.	[Fukai, Fumio] Tokyo Univ Sci, Dept Mol Pathophysiol, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Owaki, Toshiyuki; Terada, Hiroshi; Fukai, Fumio] Tokyo Univ Sci, Ctr Drug Delivery Res, Noda, Chiba 2788510, Japan; [Abe, Takashi; Shimonaka, Motoyuki; Yajima, Hirofumi] Tokyo Univ Sci, Dept Appl Chem, Noda, Chiba 2788510, Japan; [Kamiya, Sadahiro] Josai Int Univ, Dept Clin Sci, Fac Pharmaceut Sci, Chiba 2838555, Japan; [Matsunaga, Takuya; Shimoda, Kazuya] Miyazaki Univ, Dept Gastroenterol & Hematol, Fac Med, Miyazaki 8891692, Japan; [Kodama, Hiroaki; Hayashi, Ryo] Saga Univ, Dept Biochem, Fac Sci & Engn, Saga 8490922, Japan	Tokyo University of Science; Tokyo University of Science; Tokyo University of Science; University of Miyazaki; Saga University	Fukai, F (corresponding author), Tokyo Univ Sci, Dept Mol Pathophysiol, Fac Pharmaceut Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	fukai@rs.noda.tus.ac.jp			MEXT (Ministry for Education, Culture, Sports, Science and Technology) of Japan; Vehicle Racing Commemorative Foundation	MEXT (Ministry for Education, Culture, Sports, Science and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation	This work was supported, in part, by the "High-Tech Research Center" Project for Private Universities with a matching fund subsidy from MEXT (Ministry for Education, Culture, Sports, Science and Technology) of Japan, 2004-2008, and by the Vehicle Racing Commemorative Foundation.	CHILOSI M, 1993, AM J PATHOL, V143, P1348; CLARK BR, 1992, BAILLIERE CLIN HAEM, V5, P619, DOI 10.1016/S0950-3536(11)80010-7; COULOMBEL L, 1988, BLOOD, V71, P329; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; DAVIS GE, 1993, J IMMUNOL, V151, P7138; Di Pietro R, 2007, J CELL BIOCHEM, V100, P1070, DOI 10.1002/jcb.21106; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Fischer D, 1997, J CELL SCI, V110, P1513; Fukai F, 1996, BIOCHEM BIOPH RES CO, V220, P394, DOI 10.1006/bbrc.1996.0416; Fukai F, 1997, J BIOCHEM-TOKYO, V121, P189; Hamamura K, 1996, BLOOD, V87, P2513, DOI 10.1182/blood.V87.6.2513.bloodjournal8762513; Janowska-Wieczorek A, 1999, BLOOD, V93, P3379, DOI 10.1182/blood.V93.10.3379.410k09_3379_3390; Kamiya SL, 2002, BIOCHEMISTRY-US, V41, P3270, DOI 10.1021/bi015660a; Kapur R, 2001, BLOOD, V97, P1975, DOI 10.1182/blood.V97.7.1975; KLEIN G, 1993, J CELL BIOL, V123, P1027, DOI 10.1083/jcb.123.4.1027; MINEGISHI N, 1994, J BIOL CHEM, V269, P27700; Murti KG, 1996, EXP CELL RES, V226, P47, DOI 10.1006/excr.1996.0201; Nagata Y, 1998, BLOOD, V92, P1859, DOI 10.1182/blood.V92.6.1859.418k37_1859_1869; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; OCKLIND G, 1993, J HISTOCHEM CYTOCHEM, V41, P1163, DOI 10.1177/41.8.7687262; Ohta M, 1998, BLOOD, V91, P4074; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; Park JI, 2001, CELL GROWTH DIFFER, V12, P481; PATEL VP, 1987, J CELL BIOL, V105, P3105, DOI 10.1083/jcb.105.6.3105; Sage EH, 1997, TRENDS CELL BIOL, V7, P182; Saito Y, 2008, BIOL PHARM BULL, V31, P1003, DOI 10.1248/bpb.31.1003; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Seki M, 2006, EXP HEMATOL, V34, P519, DOI 10.1016/j.exphem.2006.01.001; StetlerStevenson WG, 1996, AM J PATHOL, V148, P1345; Tada T, 2006, ANAT HISTOL EMBRYOL, V35, P235, DOI 10.1111/j.1439-0264.2005.00671.x; Takagi J, 1997, J BIOCHEM, V121, P914; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; VU TH, 1998, GELATINASE B, P115; VUILLETGAUGLER MH, 1990, BLOOD, V75, P865; Watanabe K, 2000, BIOCHEMISTRY-US, V39, P7138, DOI 10.1021/bi992670r; WEINSTEIN R, 1989, BLOOD, V73, P111; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; WILLIAMS DA, 1994, PEDIATR RES, V36, P557, DOI 10.1203/00006450-199411000-00001; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; YANAI N, 1994, BLOOD, V83, P2844, DOI 10.1182/blood.V83.10.2844.2844; ZUTTER MM, 1992, J BIOL CHEM, V267, P20233; Zutter MM, 1999, BLOOD, V93, P1600, DOI 10.1182/blood.V93.5.1600.405k04_1600_1611	46	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19817	19825		10.1074/jbc.M109.009860	http://dx.doi.org/10.1074/jbc.M109.009860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19460753	Green Published, hybrid			2022-12-27	WOS:000268097400008
J	Volpato, JP; Yachnin, BJ; Blanchet, J; Guerrero, V; Poulin, L; Fossati, E; Berghuis, AM; Pelletier, JN				Volpato, Jordan P.; Yachnin, Brahm J.; Blanchet, Jonathan; Guerrero, Vanessa; Poulin, Lucie; Fossati, Elena; Berghuis, Albert M.; Pelletier, Joelle N.			Multiple Conformers in Active Site of Human Dihydrofolate Reductase F31R/Q35E Double Mutant Suggest Structural Basis for Methotrexate Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY CRYSTAL COMPLEXES; PNEUMOCYSTIS-CARINII; INHIBITOR BINDING; VARIANTS; ENZYME; NADPH; SUBSTITUTIONS; MUTATIONS; SELECTION; FOLATE	Methotrexate is a slow, tight-binding, competitive inhibitor of human dihydrofolate reductase (hDHFR), an enzyme that provides key metabolites for nucleotide biosynthesis. In an effort to better characterize ligand binding in drug resistance, we have previously engineered hDHFR variant F31R/Q35E. This variant displays a > 650-fold decrease in methotrexate affinity, while maintaining catalytic activity comparable to the native enzyme. To elucidate the molecular basis of decreased methotrexate affinity in the doubly substituted variant, we determined kinetic and inhibitory parameters for the simple variants F31R and Q35E. This demonstrated that the important decrease of methotrexate affinity in variant F31R/Q35E is a result of synergistic effects of the combined substitutions. To better understand the structural cause of this synergy, we obtained the crystal structure of hDHFR variant F31R/Q35E complexed with methotrexate at 1.7-angstrom resolution. The mutated residue Arg-31 was observed in multiple conformers. In addition, seven native active-site residues were observed in more than one conformation, which is not characteristic of the wild-type enzyme. This suggests that increased residue disorder underlies the observed methotrexate resistance. We observe a considerable loss of van der Waals and polar contacts with the p-aminobenzoic acid and glutamate moieties. The multiple conformers of Arg-31 further suggest that the amino acid substitutions may decrease the isomerization step required for tight binding of methotrexate. Molecular docking with folate corroborates this hypothesis.	[Blanchet, Jonathan; Guerrero, Vanessa; Poulin, Lucie; Pelletier, Joelle N.] Univ Montreal, Dept Chim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Volpato, Jordan P.; Fossati, Elena; Pelletier, Joelle N.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Yachnin, Brahm J.; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Berghuis, Albert M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 0B1, Canada	Universite de Montreal; Universite de Montreal; McGill University; McGill University	Pelletier, JN (corresponding author), Univ Montreal, Dept Chim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	joelle.pelletier@umontreal.ca	Yachnin, Brahm/AAP-3910-2021; Berghuis, Albert M/A-6495-2008	Yachnin, Brahm/0000-0001-6812-6329; Berghuis, Albert/0000-0002-2663-025X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada (NSERC).	Allay JA, 1998, NAT MED, V4, P1136, DOI 10.1038/2632; APPLEMAN JR, 1988, J BIOL CHEM, V263, P10304; Blakley RL, 1998, HUM MUTAT, V11, P259, DOI 10.1002/(SICI)1098-1004(1998)11:4<259::AID-HUMU1>3.3.CO;2-N; CHUNDURU SK, 1994, J BIOL CHEM, V269, P9547; Cody V, 2005, ACTA CRYSTALLOGR D, V61, P147, DOI 10.1107/S0907444904030422; Cody V, 2004, ACTA CRYSTALLOGR D, V60, P646, DOI 10.1107/S0907444904002094; Cody V, 2003, ACTA CRYSTALLOGR D, V59, P654, DOI 10.1107/S0907444903001951; Cody V, 2003, ACTA CRYSTALLOGR D, V59, P1603, DOI 10.1107/S0907444903014963; Cody V, 1998, ANTI-CANCER DRUG DES, V13, P307; Cody V, 1997, BIOCHEMISTRY-US, V36, P13897, DOI 10.1021/bi971711l; Cody V, 2006, PROTEINS, V65, P959, DOI 10.1002/prot.21131; DAVIES JF, 1990, BIOCHEMISTRY-US, V29, P9467, DOI 10.1021/bi00492a021; Daw NC, 2006, CANCER-AM CANCER SOC, V106, P403, DOI 10.1002/cncr.21626; DOUCET N, 2009, PROTEIN ENG HDB, P187; Doucet N, 2007, J BIOL CHEM, V282, P21448, DOI 10.1074/jbc.M609777200; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ErcikanAbali EA, 1996, CANCER RES, V56, P4142; ErcikanAbali EA, 1996, MOL PHARMACOL, V49, P430; FERNANDEZPATRON C, 1992, BIOTECHNIQUES, V12, P564; FLASSHOVE M, 1995, BLOOD, V85, P566; Flintoff WF, 2004, BBA-MOL BASIS DIS, V1690, P110, DOI 10.1016/j.bbadis.2004.05.008; Fossati E, 2008, J BIOMOL SCREEN, V13, P504, DOI 10.1177/1087057108318783; Gangjee A, 1998, J MED CHEM, V41, P3426, DOI 10.1021/jm980081y; Klon AE, 2002, J MOL BIOL, V320, P677, DOI 10.1016/S0022-2836(02)00469-2; LEWIS WS, 1995, J BIOL CHEM, V270, P5057, DOI 10.1074/jbc.270.10.5057; MCTIGUE MA, 1992, BIOCHEMISTRY-US, V31, P7264, DOI 10.1021/bi00147a009; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKANO T, 1994, BIOCHEMISTRY-US, V33, P9945, DOI 10.1021/bi00199a017; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; OEFNER C, 1988, EUR J BIOCHEM, V174, P377, DOI 10.1111/j.1432-1033.1988.tb14108.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel M, 1997, HUM GENE THER, V8, P2069, DOI 10.1089/hum.1997.8.17-2069; Ramanan AV, 2003, ARCH DIS CHILD, V88, P197, DOI 10.1136/adc.88.3.197; Segel I. H., 1993, ENZYME KINETICS BEHA, P100; SLAMON DJ, 2006, CLIN ADV HEMATOL S1, V4, P4; Spencer HT, 1996, LEUKEMIA, V10, P439; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strojan P, 2005, J SURG ONCOL, V92, P278, DOI 10.1002/jso.20422; Takemura Y, 1999, ANTI-CANCER DRUG, V10, P677, DOI 10.1097/00001813-199908000-00008; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; THOMPSON PD, 1991, BIOCHEMISTRY-US, V30, P8124, DOI 10.1021/bi00247a005; Volpato JP, 2007, J MOL BIOL, V373, P599, DOI 10.1016/j.jmb.2007.07.076; Volpato JP, 2009, DRUG RESIST UPDATE, V12, P28, DOI 10.1016/j.drup.2009.02.001; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104	45	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20079	20089		10.1074/jbc.M109.018010	http://dx.doi.org/10.1074/jbc.M109.018010			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19478082	Green Published, hybrid			2022-12-27	WOS:000268097400035
J	Wu, Y; Fishkin, NE; Pande, A; Pande, J; Sparrow, JR				Wu, Yalin; Fishkin, Nathan E.; Pande, Ajay; Pande, Jayanti; Sparrow, Janet R.			Novel Lipofuscin Bisretinoids Prominent in Human Retina and in a Model of Recessive Stargardt Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE PIGMENT A2-E; MACULAR DEGENERATION; MOUSE MODEL; EPITHELIAL-CELLS; RPE LIPOFUSCIN; OUTER SEGMENTS; VISUAL CYCLE; A2E; FLUOROPHORE; ABCR	Bisretinoid adducts accumulate as lipofuscin in retinal pigment epithelial (RPE) cells of the eye and are implicated in the pathology of inherited and age-related macular degeneration. Characterization of the bisretinoids A2E and the all-trans-retinal dimer series has shown that these pigments form from reactions in photoreceptor cell outer segments that involve all-trans-retinal, the product of photoisomerization of the visual chromophore 11-cis-retinal. Here we have identified two related but previously unknown RPE lipofuscin compounds. By high performance liquid chromatography-electrospray ionization-tandem mass spectrometry, we determined that the first of these compounds is a phosphatidyl-dihydropyridine bisretinoid; to indicate this structure and its formation from two vitamin A-aldehyde (A2), we will refer to it as A2-dihydropyridine-phosphatidylethanolamine (A2-DHP-PE). The second pigment, A2-dihydropyridine-ethanolamine, forms from phosphate hydrolysis of A2-DHP-PE. The structure of A2-DHP-PE was corroborated by Fourier transform infrared spectroscopy, and density functional theory confirmed the presence of a dihydropyridine ring. This lipofuscin pigment is a fluorescent compound with absorbance maxima at similar to 490 and 330 nm, and it was identified in human, mouse, and bovine eyes. We found that A2-DHP-PE forms in reaction mixtures of all-trans-retinal and phosphatidylethanolamine, and in mouse eyecups we observed an age-related accumulation. As compared with wild-type mice, A2-DHP-PE is more abundant in mice with a null mutation in Abca4 (ATP-binding cassette transporter 4), the gene causative for recessive Stargardt macular degeneration. Efforts to clarify the composition of RPE lipofuscin are important because these compounds are targets of gene-based and drug therapies that aim to alleviate ABCA4-related retinal disease.	[Wu, Yalin; Sparrow, Janet R.] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; [Sparrow, Janet R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Fishkin, Nathan E.] ImmunoGen Inc, Waltham, MA 02451 USA; [Pande, Ajay; Pande, Jayanti] SUNY Albany, Dept Chem, Albany, NY 12222 USA	Columbia University; Columbia University; ImmunoGen, Inc.; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Sparrow, JR (corresponding author), 630 W 168th St, New York, NY 10032 USA.	jrs88@columbia.edu			National Institutes of Health [EY 12951, EY 10535]; Kaplen Foundation; Department of Ophthalmology, Columbia University; NATIONAL EYE INSTITUTE [R01EY010535, R01EY012951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaplen Foundation; Department of Ophthalmology, Columbia University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY 12951 (to J. R. S.) and EY 10535 (to J. P.). This work was also supported by funds from the Kaplen Foundation (to J. R. S.) and unrestricted funds from Research to Prevent Blindness (to the Department of Ophthalmology, Columbia University).	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Bravaya K, 2007, J AM CHEM SOC, V129, P13035, DOI 10.1021/ja0732126; BUNTMILAM AH, 1983, INVEST OPHTH VIS SCI, V24, P458; Chalupa L.M., 2008, EYE RETINA VISUAL SY, P539; DALVIE D, 1992, J ORG CHEM, V57, P7321, DOI 10.1021/jo00052a056; Dillon J, 2004, EXP EYE RES, V79, P537, DOI 10.1016/j.exer.2004.06.024; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Fishkin N, 2004, CHIRALITY, V16, P637, DOI 10.1002/chir.20084; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Jang YP, 2005, J BIOL CHEM, V280, P39732, DOI 10.1074/jbc.M504933200; KATZ ML, 1986, MECH AGEING DEV, V35, P291, DOI 10.1016/0047-6374(86)90131-4; Katz ML, 2001, INVEST OPHTH VIS SCI, V42, P3023; KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2007, BIOCHEMISTRY-US, V46, P10122, DOI 10.1021/bi7009635; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kong J, 2008, GENE THER, V15, P1311, DOI 10.1038/gt.2008.78; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; ONERUS TA, 1978, CAN J CHEM, V56, P1026; Pang JJ, 2005, MOL VIS, V11, P152; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Ren RXF, 1997, J AM CHEM SOC, V119, P3619, DOI 10.1021/ja9700414; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Schroer J, 1997, J ORG CHEM, V62, P3220, DOI 10.1021/jo962179v; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; Sparrow J., 2007, ATLAS AUTOFLUORESCEN, P1; Sparrow JR, 2008, ADV EXP MED BIOL, V613, P393, DOI 10.1007/978-0-387-74904-4_46; Sparrow JR, 2006, ADV EXP MED BIOL, V572, P63; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; SZAMIER RB, 1977, INVEST OPHTH VIS SCI, V16, P947; TAYLOR KE, 1976, J AM CHEM SOC, V98, P5689, DOI 10.1021/ja00434a047; Tombran-Tink J, 2007, RETINAL DEGENERATION, P213; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9	46	82	92	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20155	20166		10.1074/jbc.M109.021345	http://dx.doi.org/10.1074/jbc.M109.021345			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19478335	hybrid, Green Published			2022-12-27	WOS:000268097400043
J	Cheli, Y; Luciani, F; Khaled, M; Beuret, L; Bille, K; Gounon, P; Ortonne, JP; Bertolotto, C; Ballotti, R				Cheli, Yann; Luciani, Flavie; Khaled, Mehdi; Beuret, Laurent; Bille, Karine; Gounon, Pierre; Ortonne, Jean-Paul; Bertolotto, Corine; Ballotti, Robert			alpha MSH and Cyclic AMP Elevating Agents Control Melanosome pH through a Protein Kinase A-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PINK-EYED DILUTION; OCULOCUTANEOUS ALBINISM; H+-ATPASE; INHIBITION; TYROSINASE; GENE; MELANOGENESIS; MELANOCYTES; ACTIVATION; MITF	Melanins are synthesized in melanocytes within specialized organelles called melanosomes. Numerous studies have shown that the pH of melanosome plays a key role in the regulation of melanin synthesis. However, until now, acute regulation of melanosome pH by a physiological stimulus has never been demonstrated. In the present study, we show that the activation of the cAMP pathway by alpha MSH or forskolin leads to an alkalinization of melanosomes and a concomitant regulation of vacuolar ATPases and ion transporters of the solute carrier family. The solute carrier family members include SLC45A2, which is mutated in oculocutaneous albinism type IV, SLC24A4 and SLC24A5, proteins implicated in the control of eye, hair, and skin pigmentation, and the P protein, encoded by the oculocutaneous albinism type II locus. Interestingly, H89, a pharmacological inhibitor of protein kinase A (PKA), prevents the cAMP-induced pigmentation and induces acidification of melanosomes. The drastic depigmenting effect of H89 is not due to an inhibition of tyrosinase expression. Indeed, H89 blocks the induction of melanogenesis induced by LY294002, a potent inhibitor of the PI 3-kinase pathway, without any effect on tyrosinase expression. Furthermore, PKA is not involved in the inhibition of pigmentation promoted by H89 because LY294002 induces pigmentation independently of PKA. Also, other PKA inhibitors do not affect pigmentation. Taken together, our results strengthen the support for a key role of melanosome pH in the regulation of melanin synthesis and, for the first time, demonstrate that melanosome pH is regulated by cAMP and alpha MSH. Notably, these are both mediators of the response to solar UV radiation, the main physiological stimulus of skin pigmentation.	[Cheli, Yann; Luciani, Flavie; Khaled, Mehdi; Beuret, Laurent; Bille, Karine; Ortonne, Jean-Paul; Bertolotto, Corine; Ballotti, Robert] C3M, INSERM, U895, Equipe 1, F-06204 Nice 3, France; [Ortonne, Jean-Paul; Bertolotto, Corine; Ballotti, Robert] CHU Nice, Dept Dermatol, F-06202 Nice 3, France; [Cheli, Yann; Luciani, Flavie; Khaled, Mehdi; Beuret, Laurent; Bille, Karine; Bertolotto, Corine; Ballotti, Robert] Univ Nice Sophia Antipolis, UFR Med, F-06107 Nice 2, France; [Gounon, Pierre] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Appl, F-06108 Nice 2, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Ballotti, R (corresponding author), INSERM, Equipe 1, U895, 28 Ave Valombrose, F-06107 Nice 2, France.	ballotti@unice.fr	Bertolotto, Corine/AAF-6634-2021; khaled, mehdi/C-4854-2012; Cheli, Yann/O-5783-2016; Bertolotto-Ballotti, Corine/O-2155-2016; BALLOTTI, Robert/F-8825-2013	Bertolotto, Corine/0000-0001-6971-7753; khaled, mehdi/0000-0002-9880-858X; Cheli, Yann/0000-0001-9839-4332; Luciani, Flavie/0000-0002-6130-0889; BALLOTTI, Robert/0000-0002-7322-4908				Ancans J, 2000, FEBS LETT, V478, P57, DOI 10.1016/S0014-5793(00)01795-6; Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251; ASANO T, 1989, BRIT J PHARMACOL, V98, P1091, DOI 10.1111/j.1476-5381.1989.tb12652.x; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; BHATNAGAR V, 1993, ARCH BIOCHEM BIOPHYS, V307, P183, DOI 10.1006/abbi.1993.1577; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Busca R, 1998, MOL BIOL CELL, V9, P1367, DOI 10.1091/mbc.9.6.1367; Busca R, 1996, J BIOL CHEM, V271, P31824, DOI 10.1074/jbc.271.50.31824; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fuller BB, 2001, EXP CELL RES, V262, P197, DOI 10.1006/excr.2000.5092; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Hearing VJ, 1999, J INVEST DERM SYMP P, V4, P24, DOI 10.1038/sj.jidsp.5640176; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; HIDAKA H, 1984, ADV CYCLIC NUCL PROT, V16, P245; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Ortonne JP, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.146.s61.3.x; Passeron T, 2004, FASEB J, V18, P989, DOI 10.1096/fj.03-1240fje; Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x; SAEKI H, 1985, J INVEST DERMATOL, V85, P423, DOI 10.1111/1523-1747.ep12277091; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Tabata H, 2008, CELL TISSUE RES, V332, P447, DOI 10.1007/s00441-008-0597-5; Toyofuku K, 2002, PIGM CELL RES, V15, P217, DOI 10.1034/j.1600-0749.2002.02007.x; Vetrini F, 2004, MOL CELL BIOL, V24, P6550, DOI 10.1128/mcb.24.15.6550-6559.2004; Wu M, 2000, GENE DEV, V14, P301; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803	40	54	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18699	18706		10.1074/jbc.M109.005819	http://dx.doi.org/10.1074/jbc.M109.005819			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19389708	hybrid, Green Published			2022-12-27	WOS:000267711500019
J	Ghosh, A; Kuppusamy, H; Pilarski, LM				Ghosh, Anirban; Kuppusamy, Hemalatha; Pilarski, Linda M.			Aberrant Splice Variants of HAS1 (Hyaluronan Synthase 1) Multimerize with and Modulate Normally Spliced HAS1 Protein A POTENTIAL MECHANISM PROMOTING HUMAN CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1; STREPTOCOCCUS-PYOGENES; MUTATIONAL SPECTRUM; MULTIPLE-MYELOMA; MATRIX RETENTION; CARCINOMA-CELLS; MSH2 MISSENSE; EXPRESSION; GENE; BREAST	Most human genes undergo alternative splicing, but aberrant splice forms are hallmarks of many cancers, usually resulting from mutations initiating abnormal exon skipping, intron retention, or the introduction of a new splice sites. We have identified a family of aberrant splice variants of HAS1 (the hyaluronan synthase 1 gene) in some B lineage cancers, characterized by exon skipping and/or partial intron retention events that occur either together or independently in different variants, apparently due to accumulation of inherited and acquired mutations. Cellular, biochemical, and oncogenic properties of full-length HAS1 (HAS1-FL) and HAS1 splice variants Va, Vb, and Vc (HAS1-Vs) are compared and characterized. When co-expressed, the properties of HAS1-Vs are dominant over those of HAS1-FL. HAS1-FL appears to be diffusely expressed in the cell, but HAS1-Vs are concentrated in the cytoplasm and/or Golgi apparatus. HAS1-Vs synthesize detectable de novo HA intracellularly. Each of the HAS1-Vs is able to relocalize HAS1-FL protein from diffuse cytoskeleton-anchored locations to deeper cytoplasmic spaces. This HAS1-Vs-mediated relocalization occurs through strong molecular interactions, which also serve to protect HAS1-FL from its otherwise high turnover kinetics. In co-transfected cells, HAS1-FL and HAS1-Vs interact with themselves and with each other to form heteromeric multiprotein assemblies. HAS1-Vc was found to be transforming in vitro and tumorigenic in vivo when introduced as a single oncogene to untransformed cells. The altered distribution and half-life of HAS1-FL, coupled with the characteristics of the HAS1-Vs suggest possible mechanisms whereby the aberrant splicing observed in human cancer may contribute to oncogenesis and disease progression.	[Pilarski, Linda M.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta	Pilarski, LM (corresponding author), Cross Canc Inst, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	lpilarsk@ualberta.ca			Alberta Cancer Research Institute and the Canadian Institutes of Health Research	Alberta Cancer Research Institute and the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Alberta Cancer Research Institute and the Canadian Institutes of Health Research.	Adamia S, 2007, HAEMATOL-HEMATOL J, V92, P104; Adamia S, 2004, BLOOD, V104, p383A; Adamia S, 2005, BLOOD, V105, P4836, DOI 10.1182/blood-2004-10-3825; Adamia S, 2003, SEMIN ONCOL, V30, P165, DOI 10.1053/sonc.2003.50042; Adamia Sophia, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P3, DOI 10.2174/1568006053005056; Adamia S, 2008, BLOOD, V112, P5111, DOI 10.1182/blood-2008-02-141770; Agrawal S, 2005, HUM MOL GENET, V14, P2459, DOI 10.1093/hmg/ddi246; Anttila MA, 2000, CANCER RES, V60, P150; Auclair J, 2006, HUM MUTAT, V27, P145, DOI 10.1002/humu.20280; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Auvinen PK, 1997, INT J CANCER, V74, P477, DOI 10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.3.CO;2-X; BANSAL MK, 1986, BIOCHEM J, V236, P515, DOI 10.1042/bj2360515; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Bullard KM, 2003, INT J CANCER, V107, P739, DOI 10.1002/ijc.11475; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Colgin L M, 1999, Hum Mutat, V14, P92, DOI 10.1002/(SICI)1098-1004(1999)14:1<92::AID-HUMU24>3.0.CO;2-#; Durocher F, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-230; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Golshani R, 2007, INT J CANCER, V120, P1712, DOI 10.1002/ijc.22222; Gordon LB, 2003, HUM GENET, V113, P178, DOI 10.1007/s00439-003-0958-9; Heldermon CD, 2001, GLYCOBIOLOGY, V11, P1017, DOI 10.1093/glycob/11.12.1017; Ichikawa T, 1999, J INVEST DERMATOL, V113, P935, DOI 10.1046/j.1523-1747.1999.00804.x; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Itano N, 1999, CANCER RES, V59, P2499; Kalnina Z, 2005, GENE CHROMOSOME CANC, V42, P342, DOI 10.1002/gcc.20156; Kanomata N, 2005, VIRCHOWS ARCH, V446, P246, DOI 10.1007/s00428-004-1197-8; Knudsen KE, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-15; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kosaki R, 1999, CANCER RES, V59, P1141; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Kyossev Z, 2007, ANAL BIOCHEM, V371, P62, DOI 10.1016/j.ab.2007.08.025; Lastella P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-243; LAURENT UBG, 1991, EXP PHYSIOL, V76, P695, DOI 10.1113/expphysiol.1991.sp003536; Lee JW, 2006, APMIS, V114, P646, DOI 10.1111/j.1600-0463.2006.apm_417.x; Liu NF, 2001, CANCER RES, V61, P5207; Lu FM, 2003, CANCER RES, V63, P7056; Ludes-Meyers JH, 2003, CYTOGENET GENOME RES, V100, P101, DOI 10.1159/000072844; Maxwell CA, 2004, BLOOD, V104, P1151, DOI 10.1182/blood-2003-11-4079; Maxwell CA, 2005, CANCER RES, V65, P850; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; MIAN N, 1986, BIOCHEM J, V237, P333, DOI 10.1042/bj2370333; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Moon SD, 2005, J CLIN ENDOCR METAB, V90, P878, DOI 10.1210/jc.2004-0991; Nascimento M, 2006, J BIOL CHEM, V281, P36257, DOI 10.1074/jbc.M606256200; NG CK, 1989, BIOCHEM J, V263, P761, DOI 10.1042/bj2630761; Nichols KE, 2005, HUM MUTAT, V25, P566, DOI 10.1002/humu.20184; Pagenstecher C, 2006, HUM GENET, V119, P9, DOI 10.1007/s00439-005-0107-8; Pilarski LM, 1999, BLOOD, V93, P2918; PILARSKI LM, 2005, HYALURONAN STRUCTURE, P329; Pros E, 2006, HUM MUTAT, V27, P1104, DOI 10.1002/humu.20396; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; Serra E, 2001, HUM GENET, V108, P416; Setala LP, 1999, BRIT J CANCER, V79, P1133, DOI 10.1038/sj.bjc.6690180; Sharp Andrew, 2004, Hum Mutat, V24, P272, DOI 10.1002/humu.9267; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Simpson MA, 2001, J BIOL CHEM, V276, P17949, DOI 10.1074/jbc.M010064200; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Spicer AP, 1997, GENOMICS, V41, P493, DOI 10.1006/geno.1997.4696; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Staalesen V, 2004, ONCOGENE, V23, P8535, DOI 10.1038/sj.onc.1207928; Stewart D, 2005, J VIROL, V79, P8773, DOI 10.1128/JVI.79.14.8773-8783.2005; TAKAHASHI T, 1990, J CLIN INVEST, V86, P363, DOI 10.1172/JCI114710; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Upadhyaya M, 2004, HUM MUTAT, V23, P134, DOI 10.1002/humu.10305; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Yabushita H, 2005, ONCOL REP, V13, P1101; Yabushita H, 2004, ONCOL REP, V12, P739; Yamada Y, 2004, CLIN EXP METASTAS, V21, P57, DOI 10.1023/B:CLIN.0000017203.71293.e0	79	20	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18840	18850		10.1074/jbc.M109.013813	http://dx.doi.org/10.1074/jbc.M109.013813			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19451652	Green Published, hybrid			2022-12-27	WOS:000267711500034
J	Handa, N; Amitani, I; Gumlaw, N; Sandler, SJ; Kowalczykowski, SC				Handa, Naofumi; Amitani, Ichiro; Gumlaw, Nathan; Sandler, Steven J.; Kowalczykowski, Stephen C.			Single Molecule Analysis of a Red Fluorescent RecA Protein Reveals a Defect in Nucleoprotein Filament Nucleation That Relates to Its Reduced Biological Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; DEPENDENT ATPASE ACTIVITY; ESCHERICHIA-COLI RECF; GENETIC-RECOMBINATION; SSB PROTEIN; BINDING-PROTEIN; CHI-RECOGNITION; MUTANT; MUTATIONS; RECBCD	Fluorescent fusion proteins are exceedingly useful for monitoring protein localization in situ or visualizing protein behavior at the single molecule level. Unfortunately, some proteins are rendered inactive by the fusion. To circumvent this problem, we fused a hyperactive RecA protein (RecA803 protein) to monomeric red fluorescent protein (mRFP1) to produce a functional protein (RecA-RFP) that is suitable for in vivo and in vitro analysis. In vivo, the RecA-RFP partially restores UV resistance, conjugational recombination, and SOS induction to recA(-) cells. In vitro, the purified RecA-RFP protein forms a nucleoprotein filament whose k(cat) for single-stranded DNA-dependent ATPase activity is reduced similar to 3-fold relative to wild-type protein, and which is largely inhibited by single-stranded DNA-binding protein. However, RecA protein is also a dATPase; dATP supports RecA-RFP nucleoprotein filament formation in the presence of single-stranded DNA-binding protein. Furthermore, as for the wild-type protein, the activities of RecA-RFP are further enhanced by shifting the pH to 6.2. As a consequence, RecA-RFP is proficient for DNA strand exchange with dATP or at lower pH. Finally, using single molecule visualization, RecA-RFP was seen to assemble into a continuous filament on duplex DNA, and to extend the DNA similar to 1.7-fold. Consistent with its attenuated activities, RecA-RFP nucleates onto double-stranded DNA similar to 3-fold more slowly than the wild-type protein, but still requires similar to 3 monomers to form the rate-limited nucleus needed for filament assembly. Thus, RecA-RFP reveals that its attenuated biological functions correlate with a reduced frequency of nucleoprotein filament nucleation at the single molecule level.	[Handa, Naofumi; Amitani, Ichiro; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Handa, Naofumi; Amitani, Ichiro; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Handa, Naofumi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 1088639, Japan; [Gumlaw, Nathan; Sandler, Steven J.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Tokyo; University of Massachusetts System; University of Massachusetts Amherst	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, 1 Shields Ave,Briggs Hall,Rm 310, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu	Handa, Naofumi/H-6640-2017	Handa, Naofumi/0000-0003-3695-1871	National Institutes of Health [GM-62653]; Japan Society for the Promotion of Science (JSPS) [1770001, 19790316]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [17049008, 19037006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062653, R01GM062653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-62653 (to S. C. K.). This work was also supported by " Grants-inaid for Scientific Research" from the Japan Society for the Promotion of Science (JSPS) (1770001 and 19790316) and Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants 17049008 and 19037006 to N.H.).	Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bianco P R, 1998, Front Biosci, V3, pD570; BRENNER SL, 1990, J MOL BIOL, V216, P949, DOI 10.1016/S0022-2836(99)80013-8; BRYANT FR, 1988, J BIOL CHEM, V263, P8716; Campbell MJ, 1999, J MOL BIOL, V286, P437, DOI 10.1006/jmbi.1998.2457; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; CLARK AJ, 1973, ANNU REV GENET, V7, P67, DOI 10.1146/annurev.ge.07.120173.000435; DUTREIX M, 1985, J BACTERIOL, V161, P1080, DOI 10.1128/JB.161.3.1080-1085.1985; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; KARASAKI Y, 1987, SANGYO IKA DAIGAKU Z, V9, P141; Katz FS, 2001, BIOCHEMISTRY-US, V40, P11082, DOI 10.1021/bi011030x; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P5872, DOI 10.1021/bi00368a006; KOWALCZYKOWSKI SC, 1989, J MOL BIOL, V207, P719, DOI 10.1016/0022-2836(89)90239-8; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LAVERY PE, 1992, J BIOL CHEM, V267, P20648; LAVERY PE, 1992, J BIOL CHEM, V267, P9307; LAVERY PE, 1990, J BIOL CHEM, V265, P4004; LEBOWITZ J, 1985, BIOCH MECH STRAND IN; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; MADIRAJU MVVS, 1988, P NATL ACAD SCI USA, V85, P6592, DOI 10.1073/pnas.85.18.6592; McCool JD, 2001, P NATL ACAD SCI USA, V98, P8203, DOI 10.1073/pnas.121007698; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; MEAH YS, 1993, J BIOL CHEM, V268, P23991; MENETSKI JP, 1989, BIOCHEMISTRY-US, V28, P5871, DOI 10.1021/bi00440a025; MENETSKI JP, 1990, J MOL BIOL, V211, P845, DOI 10.1016/0022-2836(90)90078-Z; MIKAWA T, 1995, J MOL BIOL, V250, P471, DOI 10.1006/jmbi.1995.0391; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5945, DOI 10.1021/bi027233i; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MUENCH KA, 1991, J BIOL CHEM, V266, P844; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; PINSINCE JM, 1993, J MOL BIOL, V233, P59, DOI 10.1006/jmbi.1993.1484; PUGH BF, 1987, J BIOL CHEM, V262, P1337; Renzette N, 2005, MOL MICROBIOL, V57, P1074, DOI 10.1111/j.1365-2958.2005.04755.x; Sandler SJ, 1996, GENETICS, V143, P5; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; SKIBA MC, 1994, J BIOL CHEM, V269, P3823; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Spies Maria, 2005, P389; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; VOLKERT MR, 1984, J BACTERIOL, V157, P498, DOI 10.1128/JB.157.2.498-506.1984; West SC, 1996, J BACTERIOL, V178, P1237, DOI 10.1128/jb.178.5.1237-1241.1996; Zaitsev EN, 1999, MOL MICROBIOL, V34, P1, DOI 10.1046/j.1365-2958.1999.01552.x; Zaitsev EN, 1998, NUCLEIC ACIDS RES, V26, P650, DOI 10.1093/nar/26.2.650	65	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18664	18673		10.1074/jbc.M109.004895	http://dx.doi.org/10.1074/jbc.M109.004895			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19419960	Green Published, hybrid			2022-12-27	WOS:000267711500015
J	Thomas, JT; Canelos, P; Luyten, FP; Moos, M				Thomas, J. Terrig; Canelos, Paola; Luyten, Frank P.; Moos, Malcolm, Jr.			Xenopus SMOC-1 Inhibits Bone Morphogenetic Protein Signaling Downstream of Receptor Binding and Is Essential for Postgastrulation Development in Xenopus.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; SPEMANN ORGANIZER; NEURAL INDUCTION; EXPRESSION; BMP; FAMILY; LAEVIS; NOGGIN	The bone morphogenetic protein (BMP) family of signaling molecules and their antagonists are involved in patterning of the body axis and numerous aspects of organogenesis. Classical biochemical purification and protein sequencing of highly purified fractions containing potent bone forming activity from bovine cartilage identified several BMPs together with a number of other proteins. One such protein was SMOC-2 (secreted modular calcium-binding protein-2), classified as belonging to the BM-40 family of modular extracellular proteins. Data regarding the biological function of SMOC-2 and closely related SMOC-1 remain limited, and their expression or function during embryological development is unknown. We therefore isolated the Xenopus ortholog of human SMOC-1 (XSMOC-1) and explored its function in Xenopus embryos. In gain-of-function assays, XSMOC-1 acted similarly to a BMP antagonist. However, in contrast to known extracellular ligand-binding BMP antagonists, such as noggin, SMOC antagonizes BMP activity in the presence of a constitutively active BMP receptor, indicating a mechanism of action downstream of the receptor. We provide several lines of evidence to suggest that SMOC acts downstream of the BMP receptor via MAPK-mediated phosphorylation of the Smad linker region. Loss-of-function studies, using antisense morpholino oligonucleotides, revealed XSMOC-1 to be essential for postgastrulation development. The catastrophic developmental failure observed following XSMOC knockdown resembles that observed following simultaneous depletion of three ligand-binding BMP antagonists described in prior studies. These findings provide a direct link between the extracellular matrix-associated protein SMOC and a signaling pathway of general importance in anatomic patterning and cell or tissue fate specification.	[Thomas, J. Terrig; Canelos, Paola; Moos, Malcolm, Jr.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Luyten, Frank P.] Katholieke Univ Leuven, Dept Musculoskeletal Sci, Div Rheumatol, Lab Skeletal Dev & Joint Disorders, B-3000 Louvain, Belgium	US Food & Drug Administration (FDA); KU Leuven	Thomas, JT (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	john.thomas@fda.hhs.gov; malcolm.moos@fda.hhs.gov	Luyten, Frank/GPS-7793-2022; Moos, Malcolm C/F-3673-2011	Moos, Malcolm C/0000-0002-9575-9938				Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Chang CB, 1999, DEVELOPMENT, V126, P3347; CHANG SC, 1994, J BIOL CHEM, V269, P28227; CLEMENT JH, 1995, MECH DEVELOP, V52, P357, DOI 10.1016/0925-4773(95)00413-U; COOKE J, 1979, J EMBRYOL EXP MORPH, V51, P165; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Gurdon J. B., 1967, METHODS DEV BIOL, P75; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; KELLER R, 1991, METHOD CELL BIOL, V36, P61; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Lallier TE, 2000, DEV BIOL, V225, P135, DOI 10.1006/dbio.2000.9833; Lallier TE, 1996, DEVELOPMENT, V122, P2539; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moos M, 1995, DEVELOPMENT, V121, P4293; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Vonica A, 2006, SEMIN CELL DEV BIOL, V17, P117, DOI 10.1016/j.semcdb.2005.11.013; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang Shouwen, 1997, Genes and Function, V1, P259; Weinstein DC, 1999, ANNU REV CELL DEV BI, V15, P411, DOI 10.1146/annurev.cellbio.15.1.411; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	48	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18994	19005		10.1074/jbc.M807759200	http://dx.doi.org/10.1074/jbc.M807759200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19414592	Green Published, hybrid			2022-12-27	WOS:000267711500049
J	Kostan, J; Gregor, M; Walko, G; Wiche, G				Kostan, Julius; Gregor, Martin; Walko, Gernot; Wiche, Gerhard			Plectin Isoform-dependent Regulation of Keratin-Integrin alpha 6 beta 4 Anchorage via Ca2+/Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING DOMAIN; F-ACTIN; EPIDERMOLYSIS-BULLOSA; BETA-4 INTEGRIN; CULTURED-CELLS; IN-VIVO; HEMIDESMOSOMES; MIGRATION; RECEPTOR; IDENTIFICATION	The detachment of epithelial cells from the basal matrix during wound healing and differentiation of keratinocytes requires the disassembly of the hemidesmosomal multiprotein adhesion complex. Integrin alpha 6 beta 4-plectin interaction plays a major role in the formation of hemidesmosomes, and thus the mechanisms regulating this interaction should be critical also for the disassembly process. Here we show that a particular plectin isoform (1a) interacts with the Ca2+-sensing protein calmodulin in a Ca2+-dependent manner. As a result of this interaction, binding of the hemidesmosome-associated plectin isoform 1a to integrin beta 4 is substantially diminished. Calmodulin-binding inhibits also the interaction of plectin with F-actin. Further, we found that, during Ca2+-induced keratinocyte differentiation, plectin 1a is first relocated within the cell and later down-regulated, suggesting that Ca2+ affects the fate of plectin 1a upon its release from hemidesmosomes. We propose a novel model for the disassembly of hemidesmosomes during keratinocyte differentiation, where both, binding of calmodulin to plectin 1a and phosphorylation of integrin beta 4 by protein kinases, are required for disruption of the integrin alpha 6 beta 4-plectin complex.	[Kostan, Julius; Gregor, Martin; Walko, Gernot; Wiche, Gerhard] Univ Vienna, Max F Perutz Labs, Dept Mol Cell Biol, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Wiche, G (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Mol Cell Biol, Waehringer Guertel 18, A-1030 Vienna, Austria.	gerhard.wiche@univie.ac.at	WICHE, Gerhard/AAA-3227-2021; Gregor, Martin/G-4411-2014	Gregor, Martin/0000-0001-6841-9527; Kostan, Julius/0000-0002-8347-111X; Wiche, Gerhard/0000-0001-9550-5463; Walko, Gernot/0000-0002-8504-1738	Austrian Science Research Fund [P20744-B11]; Dystrophic Epidermolysis Research Association, UK	Austrian Science Research Fund(Austrian Science Fund (FWF)); Dystrophic Epidermolysis Research Association, UK	This work was supported by the Austrian Science Research Fund (Grant P20744-B11) and from Dystrophic Epidermolysis Research Association, UK.	Ackerl R, 2007, J CELL SCI, V120, P2435, DOI 10.1242/jcs.004481; Andra K, 2003, J INVEST DERMATOL, V120, P189, DOI 10.1046/j.1523-1747.2003.12027.x; Andra K, 1998, GENE DEV, V12, P3442, DOI 10.1101/gad.12.21.3442; Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; BONETKERRACHE A, 1994, FEBS LETT, V355, P49, DOI 10.1016/0014-5793(94)01162-1; Eger A, 1997, J CELL SCI, V110, P1307; Elliott CE, 1997, GENOMICS, V42, P115, DOI 10.1006/geno.1997.4724; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; Garcia-Alvarez B, 2003, STRUCTURE, V11, P615, DOI 10.1016/S0969-2126(03)00090-X; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; GIPSON IK, 1993, EXP CELL RES, V207, P86, DOI 10.1006/excr.1993.1166; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; JARRETT HW, 1995, J BIOL CHEM, V270, P5578, DOI 10.1074/jbc.270.10.5578; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; KITAJIMA Y, 1992, EXP CELL RES, V203, P17, DOI 10.1016/0014-4827(92)90034-6; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Koss-Harnes D, 2002, J INVEST DERMATOL, V118, P87, DOI 10.1046/j.0022-202x.2001.01591.x; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Lee Karen Ying, 2004, J Med, V35, P141; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Litjens SHM, 2003, MOL BIOL CELL, V14, P4039, DOI 10.1091/mbc.E03-05-0268; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Nakamura F, 2005, J BIOL CHEM, V280, P32426, DOI 10.1074/jbc.M502203200; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; Osmanagic-Myers S, 2004, J BIOL CHEM, V279, P18701, DOI 10.1074/jbc.M312382200; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Pfendner E, 2005, EXP DERMATOL, V14, P241, DOI 10.1111/j.0906-6705.2005.00324.x; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rezniczek GA, 2004, METHOD CELL BIOL, V78, P721; Rezniczek GA, 2003, HUM MOL GENET, V12, P3181, DOI 10.1093/hmg/ddg345; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sevcik J, 2004, EUR J BIOCHEM, V271, P1873, DOI 10.1111/j.1432-1033.2004.04095.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Stepp MA, 1996, INVEST OPHTH VIS SCI, V37, P1593; Tennenbaum T, 1996, CELL GROWTH DIFFER, V7, P615; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; Wiche G, 1998, J CELL SCI, V111, P2477; WICHE G, 1984, EXP CELL RES, V155, P43, DOI 10.1016/0014-4827(84)90766-3; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; WINDER SJ, 1995, FEBS LETT, V357, P125, DOI 10.1016/0014-5793(94)01347-4; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151	47	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18525	18536		10.1074/jbc.M109.008474	http://dx.doi.org/10.1074/jbc.M109.008474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419971	Green Published, hybrid			2022-12-27	WOS:000267712400063
J	Zunino, R; Braschi, E; Xu, LQ; McBride, HM				Zunino, Rodolfo; Braschi, Emelie; Xu, Liqun; McBride, Heidi M.			Translocation of SenP5 from the Nucleoli to the Mitochondria Modulates DRP1-dependent Fission during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CELL-CYCLE PROGRESSION; SUMO-SPECIFIC PROTEASE; E3 UBIQUITIN LIGASE; IN-VIVO; TOPORS FUNCTIONS; DRP1; SUMOYLATION; PHOSPHORYLATION; MORPHOLOGY	The mechanisms that ensure an equal inheritance of cellular organelles during mitosis are an important area of study in cell biology. For the mitochondria fragment during mitosis, however, the cellular links that signal these changes are largely unknown. Werecently identified a SUMO protease, SenP5, that deSUMOylates a number of mitochondrial targets, including the dynamin-related fission GTPase, DRP1. In interphase, SenP5 resides primarily within the nucleoli, in addition to a cytosolic pool. Here we report the relocalization of SenP5 from the nucleoli to the mitochondrial surface at G(2)/M transition prior to nuclear envelope breakdown. The recruitment of SenP5 results in a significant loss in mitochondrial SUMOylation, and a concomitant increase in the labile pool of DRP1 that drives mitochondrial fragmentation. Importantly, silencing of SenP5 leads to an arrest in the cell cycle precisely at the time when the protease is translocated to the mitochondria. These data indicate that transition of SenP5 to the mitochondria plays an important role in mitochondrial fragmentation during mitosis. The altered intracellular localization of SenP5 represents the first example of the mitochondrial recruitment of a SUMO protease and provides new insights into the mechanisms of interorganellar communication during the cell cycle.	[Zunino, Rodolfo; Braschi, Emelie; Xu, Liqun; McBride, Heidi M.] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada	University of Ottawa; University of Ottawa Heart Institute	McBride, HM (corresponding author), Rm H445A,40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	hmcbride@ottawaheart.ca	McBride, Heidi M/C-1162-2008; McBride, Heidi M./ABD-5774-2021	McBride, Heidi M/0000-0003-4666-2280; McBride, Heidi M./0000-0003-4666-2280	Canadian Institutes of Health Research [68833]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant 68833.	Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Felberbaum R, 2008, CELL CYCLE, V7, P52, DOI 10.4161/cc.7.1.5218; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hammer E, 2007, FEBS LETT, V581, P5418, DOI 10.1016/j.febslet.2007.10.040; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Ihara M, 2007, J BIOL CHEM, V282, P16465, DOI 10.1074/jbc.M610723200; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Makhnevych T, 2007, J CELL BIOL, V177, P39, DOI 10.1083/jcb.200608066; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Matic I, 2008, J PROTEOME RES, V7, P4050, DOI 10.1021/pr800368m; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shin HW, 1999, J BIOL CHEM, V274, P2780, DOI 10.1074/jbc.274.5.2780; STEIN GS, 1972, J CELL BIOL, V52, P292, DOI 10.1083/jcb.52.2.292; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Taylor DL, 2002, J CELL SCI, V115, P1113; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Xu Z, 2006, BIOCHEM J, V398, P345, DOI 10.1042/BJ20060526; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	50	117	122	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17783	17795		10.1074/jbc.M901902200	http://dx.doi.org/10.1074/jbc.M901902200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19411255	hybrid, Green Published			2022-12-27	WOS:000267202500044
J	Kawada, J; Zou, P; Mazitschek, R; Bradner, JE; Cohen, JI				Kawada, Junichi; Zou, Ping; Mazitschek, Ralph; Bradner, James E.; Cohen, Jeffrey I.			Tubacin Kills Epstein-Barr Virus (EBV)-Burkitt Lymphoma Cells by Inducing Reactive Oxygen Species and EBV Lymphoblastoid Cells by Inducing Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; BURKITTS-LYMPHOMA; IN-VIVO; MULTIPLE-MYELOMA; PROTEASOME; BORTEZOMIB; LINE; EXPRESSION; INDUCTION; ESTABLISHMENT	Tubacin is a small molecule inhibitor of histone deacetylase 6 and blocks aggresome activity. We found that Epstein-Barr virus (EBV)-positive Burkitt lymphoma (BL) cells were generally killed by lower doses of tubacin than EBV-transformed lymphoblastoid cells (LCLs) or EBV-negative BL cells. Tubacin induced apoptosis of LCLs, which was inhibited by pretreatment with a pancaspase inhibitor but not by butylated hydroxyanisole, which inhibits reactive oxygen species. In contrast, tubacin killed EBV-positive BL cells in a caspase-3-independent pathway that involved reactive oxygen species and was blocked by butylated hydroxyanisole. Previously, we showed that bortezomib, a proteasome inhibitor, induces apoptosis of EBV LCLs and that LCLs are killed by lower doses of bortezomib than EBV-positive BL cells. Here we found that the combination of bortezomib and tubacin acted in synergy to kill EBV-positive BL cells and LCLs. Tubacin or the combination of bortezomib and tubacin did not induce EBV lytic replication. These findings suggest that the combination of a proteasome inhibitor and an HDAC6 inhibitor may represent a useful strategy for the treatment of certain EBV-associated B cell lymphomas.	[Kawada, Junichi; Zou, Ping; Cohen, Jeffrey I.] NIAID, Med Virol Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Mazitschek, Ralph; Bradner, James E.] Harvard Univ, Broad Inst, Chem Biol Program, Cambridge, MA 02142 USA; [Mazitschek, Ralph; Bradner, James E.] MIT, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Cohen, JI (corresponding author), NIAID, Med Virol Sect, Lab Clin Infect Dis, NIH, 10 Ctr Dr,Bldg 10,Rm 11N234, Bethesda, MD 20892 USA.	jcohen@niaid.nih.gov	Kawada, Jun-ichi/I-7322-2014; Kawada, Jun-ichi/AGA-5782-2022; Mazitschek, Ralph/E-3741-2013	Kawada, Jun-ichi/0000-0003-1553-2539; Kawada, Jun-ichi/0000-0003-1553-2539; Mazitschek, Ralph/0000-0002-1105-689X	National Institutes of Health [K08CA128972, P01CA078048]; NATIONAL CANCER INSTITUTE [P01CA078048, K08CA128972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NIAID and National Institutes of Health Grants K08CA128972 (to J. E. B.) and P01CA078048 (to R. M.).	Adams J, 2002, TRENDS MOL MED, V8, pS49, DOI 10.1016/S1471-4914(02)02315-8; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; DeBiasi RL, 2004, J VIROL, V78, P11040, DOI 10.1128/JVI.78.20.11040-11050.2004; Faller DV, 2001, CURR OPIN ONCOL, V13, P360, DOI 10.1097/00001622-200109000-00008; Feng WH, 2006, CANCER RES, V66, P8762, DOI 10.1158/0008-5472.CAN-06-1006; GREGORY CD, 1990, J GEN VIROL, V71, P1481, DOI 10.1099/0022-1317-71-7-1481; Haggarty SJ, 2003, CHEM BIOL, V10, P383, DOI 10.1016/S1074-5521(03)00095-4; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; MENEZES J, 1975, BIOMEDICINE, V22, P276; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Park JH, 2002, VIROLOGY, V303, P345, DOI 10.1006/viro.2002.1638; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; RICKINSON AB, 2007, FIELDS VIROLOGY, P2655; Roychowdhury S, 2004, JNCI-J NATL CANCER I, V96, P1447, DOI 10.1093/jnci/djh271; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Son YO, 2006, J CELL BIOCHEM, V99, P1420, DOI 10.1002/jcb.21022; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; Yu CR, 2003, BLOOD, V102, P3765, DOI 10.1182/blood-2003-03-0737; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zou P, 2007, J VIROL, V81, P10029, DOI 10.1128/JVI.02241-06	35	27	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17102	17109		10.1074/jbc.M809090200	http://dx.doi.org/10.1074/jbc.M809090200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19386607	hybrid, Green Published			2022-12-27	WOS:000266962400048
J	Peyot, ML; Guay, C; Latour, MG; Lamontagne, J; Lussier, R; Pineda, M; Ruderman, NB; Haemmerle, G; Zechner, R; Joly, E; Madiraju, SRM; Poitout, V; Prentki, M				Peyot, Marie-Line; Guay, Claudiane; Latour, Martin G.; Lamontagne, Julien; Lussier, Roxane; Pineda, Marco; Ruderman, Neil B.; Haemmerle, Guenter; Zechner, Rudolf; Joly, Erik; Madiraju, S. R. Murthy; Poitout, Vincent; Prentki, Marc			Adipose Triglyceride Lipase Is Implicated in Fuel- and Non-fuel-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; GLUCAGON-LIKE PEPTIDE-1; PANCREATIC BETA-CELLS; LIPID STORAGE DISEASE; FREE FATTY-ACIDS; RAT ISLETS; GLYCEROLIPID METABOLISM; SIGNALING PATHWAYS; GLUCOSE-METABOLISM; HYDROLASE ACTIVITY	Reduced lipolysis in hormone-sensitive lipase-deficient mice is associated with impaired glucose-stimulated insulin secretion (GSIS), suggesting that endogenous beta-cell lipid stores provide signaling molecules for insulin release. Measurements of lipolysis and triglyceride (TG) lipase activity in islets from HSL-/- mice indicated the presence of other TG lipase(s) in the beta-cell. Using real time-quantitative PCR, adipose triglyceride lipase (ATGL) was found to be the most abundant TG lipase in rat islets and INS832/13 cells. To assess its role in insulin secretion, ATGL expression was decreased in INS832/13cells(ATGL-knock-down (KD)) by small hairpin RNA. ATGL-KD increased the esterification of free fatty acid (FFA) into TG. ATGL-KD cells showed decreased glucose- or Gln + Leu-induced insulin release, as well as reduced response to KCl or palmitate at high, but not low, glucose. The K-ATP-independent/amplification pathway of GSIS was considerably reduced in ATGL-KD cells. ATGL(-/-) mice were hypoinsulinemic and hypoglycemic and showed decreased plasma TG and FFAs. A hyperglycemic clamp revealed increased insulin sensitivity and decreased GSIS and arginine-induced insulin secretion in ATGL(-/-) mice. Accordingly, isolated islets from ATGL(-/-) mice showed reduced insulin secretion in response to glucose, glucose + palmitate, and KCl. Islet TG content and FFA esterification into TG were increased by 2-fold in ATGL(-/-) islets, but glucose usage and oxidation were unaltered. The results demonstrate the importance of ATGL and intracellular lipid signaling for fuel-and nonfuel-induced insulin secretion.	[Joly, Erik; Madiraju, S. R. Murthy; Poitout, Vincent; Prentki, Marc] Univ Montreal, Ctr Rech, Ctr Hosp, Montreal Diabet Res Ctr, Montreal, PQ H1W 4A4, Canada; [Joly, Erik; Madiraju, S. R. Murthy; Poitout, Vincent; Prentki, Marc] Univ Montreal, Ctr Rech, Ctr Hosp, Mol Nutr Unit, Montreal, PQ H1W 4A4, Canada; [Poitout, Vincent; Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H1W 4A4, Canada; [Poitout, Vincent] Univ Montreal, Dept Med, Montreal, PQ H1W 4A4, Canada; [Ruderman, Neil B.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Ruderman, Neil B.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Ruderman, Neil B.] Boston Univ, Sch Med, Endocrinol Sect, Diabet Unit, Boston, MA 02118 USA; [Haemmerle, Guenter; Zechner, Rudolf] Karl Franzens Univ Graz, Inst Mol Biosci, A-8010 Graz, Austria	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Boston University; Boston University; Boston University; University of Graz	Prentki, M (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp, Montreal Diabet Res Ctr, Technopole Angus Rm 401,2901 Rachel E St, Montreal, PQ H1W 4A4, Canada.	marc.prentki@umontreal.ca	Guay, Claudiane/AAF-5381-2019	Ruderman, Neil/0000-0002-6589-6587; Zechner, Rudolf/0000-0001-5483-1182; Haemmerle, Guenter/0000-0001-9900-5896; Guay, Claudiane/0000-0002-6478-8744; Poitout, Vincent/0000-0002-6555-5053	National Institutes of Health; Canadian Diabetes Association; Canadian Institute of Health Research; Austrian Science Fund (FWF) [F 3002, Z 136] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Diabetes Association; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by a National Institutes of Health grant (to N.R., V. P., and M. P.). This work was also supported by grants from the Canadian Diabetes Association and the Canadian Institute of Health Research (to M. P.).	Akiyama M, 2007, MUSCLE NERVE, V36, P856, DOI 10.1002/mus.20869; Brun T, 2007, ONCOGENE, V26, P4261, DOI 10.1038/sj.onc.1210205; Chapman ER, 1996, BIOCHEM BIOPH RES CO, V225, P326, DOI 10.1006/bbrc.1996.1174; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8; Dobbins RL, 1998, J CLIN INVEST, V101, P2370, DOI 10.1172/JCI1813; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Fex M, 2004, ENDOCRINOLOGY, V145, P3746, DOI 10.1210/en.2003-1673; Fex M, 2009, DIABETOLOGIA, V52, P271, DOI 10.1007/s00125-008-1191-9; Fex M, 2006, DIABETES, V55, pS24, DOI 10.2337/db06-S004; Fischer J, 2007, M S-MED SCI, V23, P575, DOI 10.1051/medsci/20072367575; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; HAHN P, 1975, J LIPID RES, V16, P79; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HUTTON JC, 1983, BIOCHEM J, V210, P235, DOI 10.1042/bj2100235; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jensen MD, 2001, AM J PHYSIOL-ENDOC M, V281, pE789; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Koyama K, 1997, DIABETES, V46, P1276, DOI 10.2337/diabetes.46.8.1276; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lindvall H, 2004, J BIOL CHEM, V279, P3828, DOI 10.1074/jbc.M311365200; Masiello P, 2002, METABOLISM, V51, P110, DOI 10.1053/meta.2002.28969; Massa ML, 2001, J ENDOCRINOL, V171, P551, DOI 10.1677/joe.0.1710551; Mulder H, 2004, DIABETES, V53, P122, DOI 10.2337/diabetes.53.1.122; Mulder H, 1999, DIABETES, V48, P228, DOI 10.2337/diabetes.48.1.228; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; NEWSHOLME EA, 1976, BIOCH SOC S, V61, P109; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Olofsson CS, 2004, J PHYSIOL-LONDON, V557, P935, DOI 10.1113/jphysiol.2004.066258; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Roduit R, 2001, DIABETES, V50, P1970, DOI 10.2337/diabetes.50.9.1970; Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Schoenborn V, 2006, DIABETES, V55, P1270, DOI 10.2337/db05-1498; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Segall L, 1999, AM J PHYSIOL-ENDOC M, V277, pE521, DOI 10.1152/ajpendo.1999.277.3.E521; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Straub SG, 1998, DIABETES, V47, P758, DOI 10.2337/diabetes.47.5.758; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; VAUGHAN M, 1962, J BIOL CHEM, V237, P3354; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Watt MJ, 2008, MOL ENDOCRINOL, V22, P1200, DOI 10.1210/me.2007-0485; Wei EH, 2007, J BIOL CHEM, V282, P8027, DOI 10.1074/jbc.M605789200; Winzell MS, 2006, NUTR METAB CARDIOVAS, V16, pS11, DOI 10.1016/j.numecd.2005.11.006; Winzell MS, 2004, HORM METAB RES, V36, P795, DOI 10.1055/s-2004-826166; Winzell MS, 2001, DIABETES, V50, P2225, DOI 10.2337/diabetes.50.10.2225; Yaney GC, 2001, DIABETES, V50, P56, DOI 10.2337/diabetes.50.1.56; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	69	69	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16848	16859		10.1074/jbc.M109.006650	http://dx.doi.org/10.1074/jbc.M109.006650			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19389712	Green Published, hybrid			2022-12-27	WOS:000266962400021
J	Sun, XJ; Wei, L; Chen, Q; Terek, RM				Sun, Xiaojuan; Wei, Lei; Chen, Qian; Terek, Richard M.			HDAC4 Represses Vascular Endothelial Growth Factor Expression in Chondrosarcoma by Modulating RUNX2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTONE DEACETYLASES; VEGF EXPRESSION; BONE; CELLS; HEDGEHOG; CHEMOTHERAPY; RESISTANCE; PROMOTER; SARCOMA; GENES	Chondrosarcoma is a primary bone tumor with a dismal prognosis; most patients with this disease develop fatal pulmonary metastases, suggesting the need for a better systemic treatment. Anti-angiogenesis treatment may be useful, because angiogenesis is critical for both tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is the most potent pro-angiogenic factor and is regulated by pathways related to the normal physiologic response to hypoxia and genetic alterations related to the malignant phenotype. Our prior work has shown that VEGF is overexpressed in high grade chondrosarcoma and chondrosarcoma cell lines. Working on the premise that developmental pathways giving a selective growth advantage are often recapitulated in tumors, we investigated the regulation of VEGF by HDAC4 and Runx2 in chondrosarcoma. We tested the hypothesis that there is dysregulation of HDAC4/Runx2/VEGF gene expression and that decreased HDAC4 expression accounts for at least some of the increased VEGF expression seen in chondrosarcoma. We show that reduced expression of HDAC4 in chondrosarcoma cells increases expression of Runx2 leading to increased expression of VEGF and in vitro angiogenesis. Thus, both hypoxia and dysregulated expression of a developmental pathway are causes of increased VEGF expression in chondrosarcoma.	[Terek, Richard M.] Brown Univ, Warren Alpert Med Sch, Orthopaed Oncol Lab, Dept Orthopaed, Providence, RI 02903 USA; Rhode Isl Hosp, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Terek, RM (corresponding author), Brown Univ, Warren Alpert Med Sch, Orthopaed Oncol Lab, Dept Orthopaed, Coro W Bldg,Rm 402B,1 Hopping St, Providence, RI 02903 USA.	Richard_Terek@Brown.edu	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618; terek, richard/0000-0002-6322-6790	National Institutes of Health [AG014399, 1P20RR024484-01]; RIH Orthopaedic Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG014399, R01AG014399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIH Orthopaedic Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG014399 and Grant 1P20RR024484-01 from the NCRR. This work was also supported by the RIH Orthopaedic Foundation.	Asp J, 2005, INT J ONCOL, V27, P1577; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; BLOCK JA, 1991, J BONE JOINT SURG AM, V73A, P647, DOI 10.2106/00004623-199173050-00002; CAPANNA R, 1988, J BONE JOINT SURG AM, V70A, P60, DOI 10.2106/00004623-198870010-00010; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Huvos AG, 1991, CHONDROSARCOMA BONE, P343; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lee FY, 1999, J BONE JOINT SURG AM, V81A, P326, DOI 10.2106/00004623-199903000-00004; Lin CZ, 2004, J ORTHOP RES, V22, P1175, DOI 10.1016/j.orthres.2004.03.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCGOUGH RL, 2002, CLIN ORTHOP RELAT R, V397, P76; MCGOUGH RL, 2002, CLIN ORTHOP RELAT R, V397, P62; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Morioka H, 2003, CLIN CANCER RES, V9, P1211; Moussavi-Harami F, 2006, BIOCHEM BIOPH RES CO, V346, P379, DOI 10.1016/j.bbrc.2006.05.158; Osada H, 2004, INT J CANCER, V112, P26, DOI 10.1002/ijc.20395; Papachristou DJ, 2005, HISTOPATHOLOGY, V47, P565, DOI 10.1111/j.1365-2559.2005.02266.x; Park HR, 2007, PATHOL ONCOL RES, V13, P32, DOI 10.1007/BF02893438; Paroni G, 2004, MOL BIOL CELL, V15, P2804, DOI 10.1091/mbc.E03-08-0624; Rountree MR, 2001, ONCOGENE, V20, P3156, DOI 10.1038/sj.onc.1204339; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shao L, 2003, BIOCHEM PHARMACOL, V66, P2381, DOI 10.1016/j.bcp.2003.08.033; Sun LX, 2001, CANCER RES, V61, P4994; Terek RM, 1998, J ORTHOPAED RES, V16, P585, DOI 10.1002/jor.1100160510; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Velcheti V, 2007, J THORAC ONCOL, V2, P7, DOI 10.1097/JTO.0b013e31802c0276; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang LL, 2000, CANCER RES, V60, P3655; Zheng QP, 2005, AM J HUM GENET, V77, P305, DOI 10.1086/432261	38	51	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21881	21890		10.1074/jbc.M109.019091	http://dx.doi.org/10.1074/jbc.M109.019091			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19509297	Green Published, hybrid			2022-12-27	WOS:000268783700012
J	Nakayama, S; Murata, T; Murayama, K; Yasui, Y; Sato, Y; Kudoh, A; Iwahori, S; Isomura, H; Kanda, T; Tsurumi, T				Nakayama, Sanae; Murata, Takayuki; Murayama, Kazutaka; Yasui, Yoshihiro; Sato, Yoshitaka; Kudoh, Ayumi; Iwahori, Satoko; Isomura, Hiroki; Kanda, Teru; Tsurumi, Tatsuya			Epstein-Barr Virus Polymerase Processivity Factor Enhances BALF2 Promoter Transcription as a Coactivator for the BZLF1 Immediate-Early Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EBV DNA-POLYMERASE; BMRF1 GENE-PRODUCTS; EA-D; REPLICATION COMPARTMENTS; ACCESSORY PROTEIN; LYTIC CYCLE; HUMAN CYTOMEGALOVIRUS; BINDING PROTEIN; INSECT CELLS; IN-VITRO	The Epstein-Barr virus (EBV) BMRF1 protein is an essential replication protein acting at viral replication forks as a viral DNA polymerase processivity factor, where as the BALF2 protein is a single stranded DNA-binding protein that also acts at replication forks and is most abundantly expressed during viral productive replication. Here we document that the BMRF1 protein evidently enhances viral BZLF1 transcription factor-mediated transactivation of the BALF2 gene promoter. Mutagenesis and electrophoretic mobility shift assays demonstrated the BALF2 promoter to harbor two BZLF1 protein-binding sites (BZLF1-responsive elements). Direct binding of the BZLF1 protein to BZLF1-responsive elements and physical interaction between BZLF1 and BMRF1 proteins are prerequisite for the BMRF1 protein up-regulation of the BALF2 gene promoter. A monomeric mutant, C95E, which is defective in homodimerization, could still interact and enhance BZLF1-mediated transactivation. Furthermore although EBV protein kinase phosphorylates BMRF1 protein extensively, it turned out that phosphorylation of the protein by the kinase is inhibitory to the enhancement of the BZLF1-mediated transactivation of BALF2 promoter. Exogenous expression of BMRF1 protein augmented BALF2 expression in HEK293 cells harboring the EBV genome but lacking BMRF1 and BALF5 genes, demonstrating functions as a transcriptional regulator in the context of viral infection. Overall the BMRF1 protein is a multifunctional protein that cannot only act as a DNA polymerase processivity factor but also enhances BALF2 promoter transcription as a coactivator for the BZLF1 protein, regulating the expression level of viral single-stranded DNA-binding protein.	[Nakayama, Sanae; Murata, Takayuki; Yasui, Yoshihiro; Sato, Yoshitaka; Kudoh, Ayumi; Iwahori, Satoko; Isomura, Hiroki; Kanda, Teru; Tsurumi, Tatsuya] Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Murayama, Kazutaka] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Measurements & Diagnost, Sendai, Miyagi 9808575, Japan	Aichi Cancer Center; Tohoku University	Tsurumi, T (corresponding author), Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp	Murata, Takayuki/I-2621-2013; Sato, Yoshitaka/P-9728-2015; Kanda, Teru/J-7313-2019; Iwahori, Satoko/L-1948-2019	Murata, Takayuki/0000-0001-7228-0839; Sato, Yoshitaka/0000-0002-8541-6413; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Science, Sports, Culture and Technology of Japan [21022055, 20012056, 20390137]	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 21022055, 20012056, and 20390137 from the Ministry of Education, Science, Sports, Culture and Technology of Japan ( to T. T.).	Appleton BA, 2004, MOL CELL, V15, P233, DOI 10.1016/j.molcel.2004.06.018; Baumann M, 1999, EMBO J, V18, P6095, DOI 10.1093/emboj/18.21.6095; Chang PJ, 1998, J VIROL, V72, P5128, DOI 10.1128/JVI.72.6.5128-5136.1998; CHEN LW, 1995, VIROLOGY, V211, P593, DOI 10.1006/viro.1995.1443; Chen MR, 2000, J VIROL, V74, P3093, DOI 10.1128/JVI.74.7.3093-3104.2000; Chen XL, 2004, J BIOL CHEM, V279, P28375, DOI 10.1074/jbc.M400032200; CHIOU JF, 1985, P NATL ACAD SCI USA, V82, P5728, DOI 10.1073/pnas.82.17.5728; CHO MS, 1985, J VIROL, V56, P860, DOI 10.1128/JVI.56.3.860-866.1985; CRUTE JJ, 1989, J BIOL CHEM, V264, P19266; Daikoku T, 2006, J BIOL CHEM, V281, P11422, DOI 10.1074/jbc.M510314200; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; DECAUSSIN G, 1995, J VIROL, V69, P7309, DOI 10.1128/JVI.69.11.7309-7314.1995; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; FIXMAN ED, 1995, J VIROL, V69, P2998, DOI 10.1128/JVI.69.5.2998-3006.1995; FIXMAN ED, 1992, J VIROL, V66, P5030, DOI 10.1128/JVI.66.8.5030-5039.1992; FLEMINGTON EK, 1991, J VIROL, V65, P7073, DOI 10.1128/JVI.65.12.7073-7077.1991; Gershburg E, 2002, J VIROL, V76, P998, DOI 10.1128/JVI.76.3.998-1003.2002; Gershburg E, 2007, J VIROL, V81, P5407, DOI 10.1128/JVI.02398-06; HAMMERSCHMIDT W, 1988, CELL, V55, P427, DOI 10.1016/0092-8674(88)90028-1; Holley-Guthrie EA, 2005, J VIROL, V79, P745, DOI 10.1128/JVI.79.2.745-755.2005; Hung CH, 1999, J GEN VIROL, V80, P2747, DOI 10.1099/0022-1317-80-10-2747; Isomura H, 2004, J VIROL, V78, P12788, DOI 10.1128/JVI.78.23.12788-12799.2004; Isomura H, 2008, J VIROL, V82, P1638, DOI 10.1128/JVI.01917-07; KALLIN B, 1985, J VIROL, V54, P561, DOI 10.1128/JVI.54.2.561-568.1985; Kato K, 2003, J GEN VIROL, V84, P3381, DOI 10.1099/vir.0.19454-0; KIEHL A, 1991, VIROLOGY, V184, P330, DOI 10.1016/0042-6822(91)90849-7; KIEHL A, 1995, J VIROL, V69, P1669, DOI 10.1128/JVI.69.3.1669-1677.1995; KNIPE DM, 2002, FIELDS VIROLOGY, P2575; LI JS, 1987, J VIROL, V61, P2947, DOI 10.1128/JVI.61.9.2947-2949.1987; MCBRIDE AA, 1989, P NATL ACAD SCI USA, V86, P510, DOI 10.1073/pnas.86.2.510; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Ohashi M, 2007, MICROBES INFECT, V9, P150, DOI 10.1016/j.micinf.2006.11.001; PEARSON GR, 1983, J VIROL, V47, P193, DOI 10.1128/JVI.47.1.193-201.1983; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Randell JC, 2001, MOL CELL, V8, P911, DOI 10.1016/S1097-2765(01)00355-0; SCHEPERS A, 1993, EMBO J, V12, P3921, DOI 10.1002/j.1460-2075.1993.tb06070.x; TAKAGI S, 1991, VIROLOGY, V185, P309, DOI 10.1016/0042-6822(91)90778-A; Tsurumi T, 1996, VIROLOGY, V222, P352, DOI 10.1006/viro.1996.0432; TSURUMI T, 1993, J VIROL, V67, P1681, DOI 10.1128/JVI.67.3.1681-1687.1993; TSURUMI T, 1993, J VIROL, V67, P7648, DOI 10.1128/JVI.67.12.7648-7653.1993; Tsurumi T, 2001, CURR TOP MICROBIOL, V258, P65; Wang JT, 2005, J GEN VIROL, V86, P3215, DOI 10.1099/vir.0.81313-0; Yang PW, 2008, J GEN VIROL, V89, P884, DOI 10.1099/vir.0.83546-0; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Yokoyama N, 2000, BBA-GENE STRUCT EXPR, V1493, P119, DOI 10.1016/S0167-4781(00)00170-6; Yokoyama N, 1999, J GEN VIROL, V80, P2879, DOI 10.1099/0022-1317-80-11-2879; Zhang Q, 1999, J GEN VIROL, V80, P69, DOI 10.1099/0022-1317-80-1-69; Zhang Q, 1997, VIROLOGY, V230, P22, DOI 10.1006/viro.1997.8470; Zhang Q, 1996, J VIROL, V70, P5131, DOI 10.1128/JVI.70.8.5131-5142.1996; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	50	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21557	21568		10.1074/jbc.M109.015685	http://dx.doi.org/10.1074/jbc.M109.015685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19491105	Green Published, hybrid			2022-12-27	WOS:000268564400050
J	Gettins, PGW; Olson, ST				Gettins, Peter G. W.; Olson, Steven T.			Exosite Determinants of Serpin Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DEPENDENT-PROTEASE-INHIBITOR; PLASMINOGEN-ACTIVATOR INHIBITOR-1; HEPARIN-COFACTOR-II; FACTOR-XA; BINDING-SITE; PROTEINASE INHIBITION; RAPID INHIBITION; COVALENT COMPLEX; TERNARY COMPLEX; UROKINASE-TYPE	Serpins form an enormous superfamily of 40-60-kDa proteins found in almost all types of organisms, including humans. Most are one-use suicide substrate serine and cysteine proteinase inhibitors that have evolved to finely regulate complex proteolytic pathways, such as blood coagulation, fibrinolysis, and inflammation. Despite distinct functions for each serpin, there is much redundancy in the primary specificity-determining residues. However, many serpins exploit additional exosites to generate the exquisite specificity that makes a given serpin effective only when certain other criteria, such as the presence of specific cofactors, are met. With a focus on human serpins, this minireview examines use of exosites by nine serpins in the initial complex-forming phase to modulate primary specificity in either binary serpin-proteinase complexes or ternary complexes that additionally employ a protein or other cofactor. A frequent theme is down-regulation of inhibitory activity unless the exosite(s) are engaged. In addition, the use of exosites by maspin and plasminogen activator inhibitor-1 to indirectly affect proteolytic processes is considered.	[Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Gettins, Peter G. W.] Univ Illinois, Struct Biol Ctr, Chicago, IL 60612 USA; [Olson, Steven T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA.	pgettins@uic.edu; stolson@uic.edu			National Institutes of Health [HL49234, HL79430, HL39888, HL78827]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078827, R29HL039888, R01HL049234, R37HL039888, R01HL039888, R01HL079430, R37HL049234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49234 and HL79430 (to P. G. W. G.) and HL39888 and HL78827 (to S. T. O.).	Al-Ayyoubi M, 2007, J BIOL CHEM, V282, P19502, DOI 10.1074/jbc.M702445200; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Biliran H, 2001, CANCER RES, V61, P8676; Bouton MC, 2007, CIRC RES, V100, P1174, DOI 10.1161/01.RES.0000265066.92923.ee; Braud S, 2002, BIOCHEMISTRY-US, V41, P8478, DOI 10.1021/bi016069g; Chen VC, 2001, J BIOL CHEM, V276, P1276, DOI 10.1074/jbc.M005791200; Chen VC, 2000, J BIOL CHEM, V275, P40371, DOI 10.1074/jbc.M005691200; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; Degryse B, 2001, FEBS LETT, V505, P249, DOI 10.1016/S0014-5793(01)02797-1; Dekker RJ, 1999, J MOL BIOL, V293, P613, DOI 10.1006/jmbi.1999.3178; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Dobo J, 2006, J BIOL CHEM, V281, P38781, DOI 10.1074/jbc.M605151200; Frank PS, 2003, BIOCHEMISTRY-US, V42, P1078, DOI 10.1021/bi026917n; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Han X, 2000, BLOOD, V96, P3049; He L, 2008, BLOOD, V111, P4118, DOI 10.1182/blood-2007-12-127928; Hopkins PCR, 2000, J MOL EVOL, V51, P507, DOI 10.1007/s002390010114; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huntington JA, 2000, J BIOL CHEM, V275, P15377, DOI 10.1074/jbc.275.20.15377; Ibarra CA, 2004, J BIOL CHEM, V279, P3643, DOI 10.1074/jbc.M310601200; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Kamikubo Y, 2009, INT J BIOCHEM CELL B, V41, P578, DOI 10.1016/j.biocel.2008.07.006; Khalkhali-Ellis Z, 2007, CANCER RES, V67, P3535, DOI 10.1158/0008-5472.CAN-06-4767; Knauer DJ, 2000, J BIOL CHEM, V275, P37340, DOI 10.1074/jbc.M003909200; Law RHP, 2008, BLOOD, V111, P2049, DOI 10.1182/blood-2007-09-114215; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Rezaie AR, 2008, J BIOL CHEM, V283, P19922, DOI 10.1074/jbc.M802639200; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; Rezaie AR, 2003, P NATL ACAD SCI USA, V100, P12051, DOI 10.1073/pnas.2135346100; Steenbakkers PJM, 2008, MYCOL RES, V112, P999, DOI 10.1016/j.mycres.2008.01.021; Swanson R, 2007, J BIOL CHEM, V282, P2305, DOI 10.1074/jbc.M609546200; Tesch LD, 2005, PROTEIN SCI, V14, P533, DOI 10.1110/ps.041104905; Whisstock JC, 2000, J MOL BIOL, V301, P1287, DOI 10.1006/jmbi.2000.3982; Yang LK, 2003, J BIOL CHEM, V278, P37465, DOI 10.1074/jbc.M307243200; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	48	57	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20441	20445		10.1074/jbc.R800064200	http://dx.doi.org/10.1074/jbc.R800064200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19401470	Green Published, hybrid			2022-12-27	WOS:000268316100003
J	Belyi, Y; Stahl, M; Sovkova, I; Kaden, P; Luy, B; Aktories, K				Belyi, Yury; Stahl, Michael; Sovkova, Irina; Kaden, Peter; Luy, Burkhard; Aktories, Klaus			Region of Elongation Factor 1A1 Involved in Substrate Recognition by Legionella pneumophila Glucosyltransferase Lgt1 IDENTIFICATION OF Lgt1 AS A RETAINING GLUCOSYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; SORDELLII LETHAL TOXIN; NMR-SPECTROSCOPY; HIGH-RESOLUTION; PROTEIN; GLUCOSYLATION; VIRULENCE; COMPLEX; CONSEQUENCES; EXCITATION	Lgt1 is one of the glucosyltransferases produced by the Gram-negative bacterium Legionella pneumophila. This enzyme modifies eukaryotic elongation factor 1A (eEF1A) at serine 53, which leads to inhibition of protein synthesis and death of target cells. Here we studied the region of eEF1A, which is essential for substrate recognition by Lgt1. We report that the decapeptide (50)GKGSFKYAWV(59) of eEF1A is efficiently modified by Lgt1. This peptide covers the loop of the helix-loop-helix region formed by helices A* and A' of eEF1A and is part of the first turn of helix A'. Substitution of either serine 53, phenylalanine 54, tyrosine 56, or tryptophan 58 by alanine abolished or severely decreased glucosylation. Lgt1 modified the decapeptide (50)GKGSFKYAWV(59) with a higher glucosylation rate than full-length eEF1A purified from yeast, suggesting that a specific conformation of eEF1A is the preferred substrate of Lgt1. A GenBank (TM) search on the basis of the substrate decapeptide for similar peptide sequences retrieved heat shock protein 70 subfamily B suppressor 1 (Hbs1) as a target for glucosylation by Lgt1. Recombinant Hbs1 and the corresponding fragment ((303)GKASFAYAWV(312)) were glucosylated by Lgt1. NMR studies with the glucosylated eEF1A-derived decapeptide identified an alpha-anomeric structure of the glucose-serine 53 bond and characterize Lgt1 as a retaining glucosyltransferase.	[Stahl, Michael; Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Belyi, Yury; Sovkova, Irina] NF Gamalei Inst Epidemiol & Microbiol, Moscow 123098, Russia; [Kaden, Peter; Luy, Burkhard] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	University of Freiburg; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Technical University of Munich	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Albertstr 25, D-79104 Freiburg, Germany.	Klaus.Aktories@pharmakol.uni-freiburg.de	Belyi, Yury/AAU-8092-2020; Kaden, Peter/F-6716-2013; Aktories, Klaus/CAJ-5682-2022; Luy, Burkhard/I-1918-2013	Kaden, Peter/0000-0002-9414-2936; Aktories, Klaus/0000-0002-5397-0436; Luy, Burkhard/0000-0001-9580-6397	Bundesministerium fur Bildung und Forschung [05-1000004-7756]; Deutsche Forschungsgemeinschaft (DFG)	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported in part by the Bundesministerium fur Bildung und Forschung, International Association for the Promotion of Co-operation with Scientists (Project 05-1000004-7756 to Y.B. and K. A.) and the Deutsche Forschungsgemeinschaft (DFG, to K. A.).	Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, COLD SPRING HARB SYM, V66, P425, DOI 10.1101/sqb.2001.66.425; Belyi I, 2003, INFECT IMMUN, V71, P181, DOI 10.1128/IAI.71.1.181-186.2003; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Bitar DM, 2004, INT J MED MICROBIOL, V293, P519, DOI 10.1078/1438-4221-00286; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Cohen Y, 2005, ANGEW CHEM INT EDIT, V44, P520, DOI 10.1002/anie.200300637; DAVIS DG, 1985, J AM CHEM SOC, V107, P2820, DOI 10.1021/ja00295a052; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; EMSLEY L, 1990, CHEM PHYS LETT, V165, P469, DOI 10.1016/0009-2614(90)87025-M; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FREEMAN R, 1971, J CHEM PHYS, V54, P301, DOI 10.1063/1.1674608; Furrer J, 2004, J MAGN RESON, V166, P39, DOI 10.1016/j.jmr.2003.09.013; Geyer M, 2003, BIOCHEMISTRY-US, V42, P11951, DOI 10.1021/bi034529v; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; HAASNOOT CAG, 1980, TETRAHEDRON, V36, P2783, DOI 10.1016/0040-4020(80)80155-4; Hammer BK, 1999, MOL MICROBIOL, V33, P721, DOI 10.1046/j.1365-2958.1999.01519.x; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2006, J BIOL CHEM, V281, P19527, DOI 10.1074/jbc.M600863200; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Kramer F, 2001, J MAGN RESON, V149, P58, DOI 10.1006/jmre.2000.2271; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Lerm M, 1999, J BIOL CHEM, V274, P28999, DOI 10.1074/jbc.274.41.28999; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; OHBA M, 1994, FEBS LETT, V351, P263; STOTT K, 1995, J AM CHEM SOC, V117, P4199, DOI 10.1021/ja00119a048; Vetter IR, 2000, J MOL BIOL, V301, P1091, DOI 10.1006/jmbi.2000.4045; Wallrapp C, 1998, FEBS LETT, V440, P387, DOI 10.1016/S0014-5793(98)01492-6; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	40	29	34	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20167	20174		10.1074/jbc.M109.008441	http://dx.doi.org/10.1074/jbc.M109.008441			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19478083	hybrid, Green Published			2022-12-27	WOS:000268097400044
J	Chu, PY; Huang, LY; Hsu, CH; Liang, CC; Guan, JL; Hung, TH; Shen, TL				Chu, Pei-Yu; Huang, Ling-Ya; Hsu, Chun-Hua; Liang, Chun-Chi; Guan, Jun-Lin; Hung, Ting-Hsuan; Shen, Tang-Long			Tyrosine Phosphorylation of Growth Factor Receptor-bound Protein-7 by Focal Adhesion Kinase in the Regulation of Cell Migration, Proliferation, and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; SH2 DOMAIN; SIGNAL-TRANSDUCTION; CYCLE PROGRESSION; INSULIN-RECEPTOR; ADAPTER PROTEIN; GRB7 FAMILY; ASSOCIATION; EXPRESSION; IDENTIFICATION	We have previously reported that growth factor receptor-bound protein-7 (Grb7), an Src-homology 2 (SH2)-containing adaptor protein, enables interaction with focal adhesion kinase (FAK) to regulate cell migration in response to integrin activation. To further elucidate the signaling events mediated by FAK.Grb7 complexes in promoting cell migration and other cellular functions, we firstly examined the phosphorylated tyrosine site(s) of Grb7 by FAK using an in vivo mutagenesis. We found that FAK was capable of phosphorylating at least 2 of 12 tyrosine residues within Grb7, Tyr-188 and Tyr-338. Moreover, mutations converting the identified Tyr to Phe inhibited integrin-dependent cell migration as well as impaired cell proliferation but not survival compared with the wild-type control. Interestingly, the above inhibitory effects caused by the tyrosine phosphorylation-deficient mutants are probably attributed to their down-regulation of phospho-Tyr-397 of FAK, thereby implying a mechanism by competing with wild-type Grb7 for binding to FAK. Consequently, these tyrosine phosphorylation-deficient mutants evidently altered the phospho-Tyr-118 of paxillin and phosphorylation of ERK1/2 but less on phospho-Ser-473 of AKT, implying their involvement in the FAK.Grb7-mediated cellular functions. Additionally, we also illustrated that the formation of FAK.Grb7 complexes and Grb7 phosphorylation by FAK in an integrin-dependent manner were essential for cell migration, proliferation and anchorage-independent growth in A431 epidermal carcinoma cells, indicating the importance of FAK.Grb7 complexes in tumorigenesis. Our data provide a better understanding on the signal transduction event for FAK.Grb7-mediated cellular functions as well as to shed light on a potential therapeutic in cancers.	[Chu, Pei-Yu; Huang, Ling-Ya; Hung, Ting-Hsuan; Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 106, Taiwan; [Hsu, Chun-Hua] Natl Taiwan Univ, Dept Agr Chem, Taipei 106, Taiwan; [Liang, Chun-Chi; Guan, Jun-Lin] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Liang, Chun-Chi; Guan, Jun-Lin] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	National Taiwan University; National Taiwan University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shen, TL (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 106, Taiwan.	shentl@ntu.edu.tw	Liang, Chun-Chi/D-7986-2016; HSU, CHUN-HUA/W-4554-2019; Shen, Tang-Long/C-7460-2011; Liang, Richard Chun-Chi/C-6989-2013	Liang, Chun-Chi/0000-0002-8345-8564; HSU, CHUN-HUA/0000-0002-0008-7383; HUNG, TING-HSUAN/0000-0002-7790-4193; Shen, Tang-Long/0000-0001-6264-3608	National Science Council [NSC-96-2311B-002-023-MY3]; National Taiwan University [97R0343]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by National Science Council Grant NSC-96-2311B-002-023-MY3 and Frontier Research Grant of National Taiwan University 97R0343 (to T.- L. S.).	Akiyama N, 1997, CANCER RES, V57, P3548; An JJ, 2007, J BIOCHEM MOL BIOL, V40, P189; Bai T, 2008, CARCINOGENESIS, V29, P473, DOI 10.1093/carcin/bgm221; Chen DY, 2003, ONCOGENE, V22, P4348, DOI 10.1038/sj.onc.1206532; Chu Peter, 2003, J Biol, V2, P21, DOI 10.1186/1475-4924-2-21; Dahlberg PS, 2004, ANN THORAC SURG, V78, P1790, DOI 10.1016/j.athoracsur.2004.05.037; Daly RJ, 1998, CELL SIGNAL, V10, P613, DOI 10.1016/S0898-6568(98)00022-9; de Vet ECJM, 2003, BIOCHEM J, V375, P207, DOI 10.1042/BJ20030293; Fiddes RJ, 1998, J BIOL CHEM, V273, P7717, DOI 10.1074/jbc.273.13.7717; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Haran M, 2004, LEUKEMIA, V18, P1948, DOI 10.1038/sj.leu.2403512; Hitchins M P, 2002, J Med Genet, V39, pE13, DOI 10.1136/jmg.39.3.e13; Hodgson JG, 2005, CANCER RES, V65, P9695, DOI 10.1158/0008-5472.CAN-05-0755; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Itoh S, 2007, MOL CANCER RES, V5, P667, DOI 10.1158/1541-7786.MCR-06-0282; Jones N, 1999, J BIOL CHEM, V274, P30896, DOI 10.1074/jbc.274.43.30896; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kasus-Jacobi A, 2000, ONCOGENE, V19, P2052, DOI 10.1038/sj.onc.1203469; Keegan K, 1996, ONCOGENE, V12, P1537; Kim CW, 2006, J KOREAN MED SCI, V21, P478, DOI 10.3346/jkms.2006.21.3.478; Kishi T, 1997, BIOCHEM BIOPH RES CO, V232, P5, DOI 10.1006/bbrc.1997.6218; Leavey SF, 1998, AM J PHYSIOL-RENAL, V275, pF770, DOI 10.1152/ajprenal.1998.275.5.F770; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Li HB, 2005, ONCOGENE, V24, P4206, DOI 10.1038/sj.onc.1208591; Manser J, 1997, DEV BIOL, V184, P150, DOI 10.1006/dbio.1997.8516; MARGOLIS B, 1992, P NATL ACAD SCI USA, V89, P8894, DOI 10.1073/pnas.89.19.8894; Morrione A, 2000, INT J MOL MED, V5, P151; Pandey A, 1996, J BIOL CHEM, V271, P10607, DOI 10.1074/jbc.271.18.10607; Pero SC, 2007, BRIT J CANCER, V96, P1520, DOI 10.1038/sj.bjc.6603732; Pero SC, 2002, J BIOL CHEM, V277, P11918, DOI 10.1074/jbc.M111816200; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Reiske HR, 2000, FEBS LETT, V486, P275, DOI 10.1016/S0014-5793(00)02295-X; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Shen TL, 2001, FEBS LETT, V499, P176, DOI 10.1016/S0014-5793(01)02545-5; Shen TL, 2004, FRONT BIOSCI-LANDMRK, V9, P192, DOI 10.2741/1229; Shen TL, 2002, J BIOL CHEM, V277, P29069, DOI 10.1074/jbc.M203085200; Siamakpour-Reihani S, 2009, J MOL RECOGNIT, V22, P9, DOI 10.1002/jmr.916; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Skotheim RI, 2002, CANCER RES, V62, P2359; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Tanaka S, 2006, JNCI-J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Tsai NP, 2008, EMBO J, V27, P715, DOI 10.1038/emboj.2008.19; Tsai NP, 2007, EMBO J, V26, P1522, DOI 10.1038/sj.emboj.7601598; van Agthoven T, 2009, BREAST CANCER RES TR, V114, P23, DOI 10.1007/s10549-008-9969-5; Vayssiere B, 2000, FEBS LETT, V467, P91, DOI 10.1016/S0014-5793(99)01530-6; Walch A, 2004, INT J CANCER, V112, P747, DOI 10.1002/ijc.20411; Wojcik J, 1999, BIOCHEM BIOPH RES CO, V259, P113, DOI 10.1006/bbrc.1999.0727; Yokote K, 1996, J BIOL CHEM, V271, P30942, DOI 10.1074/jbc.271.48.30942; Yoon SW, 2005, PROTEOMICS, V5, P1987, DOI 10.1002/pmic.200401086	54	48	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20215	20226		10.1074/jbc.M109.018259	http://dx.doi.org/10.1074/jbc.M109.018259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19473962	Green Published, hybrid			2022-12-27	WOS:000268097400049
J	Ilien, B; Glasser, N; Clamme, JP; Didier, P; Piemont, E; Chinnappan, R; Daval, SB; Galzi, JL; Mely, Y				Ilien, Brigitte; Glasser, Nicole; Clamme, Jean-Pierre; Didier, Pascal; Piemont, Etienne; Chinnappan, Raja; Daval, Sandrine B.; Galzi, Jean-Luc; Mely, Yves			Pirenzepine Promotes the Dimerization of Muscarinic M1 Receptors through a Three-step Binding Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; FLUORESCENCE CORRELATION SPECTROSCOPY; RESONANCE ENERGY-TRANSFER; LIVING CELLS; LIVE CELLS; ACETYLCHOLINE-RECEPTORS; FLUCTUATION SPECTROSCOPY; COMPLEMENTARY SEQUENCE; CHOLINERGIC-RECEPTOR; NUCLEOCAPSID PROTEIN	Ligand binding to G protein-coupled receptors is a complex process that involves sequential receptor conformational changes, ligand translocation, and possibly ligand-induced receptor oligomerization. Binding events at muscarinic acetylcholine receptors are usually interpreted from radioligand binding studies in terms of two-step ligand-induced receptor isomerization. We report here, using a combination of fluorescence approaches, on the molecular mechanisms for Bodipypirenzepine binding to enhanced green fluorescent protein (EGFP)-fused muscarinic M1 receptors in living cells. Real time monitoring, under steady-state conditions, of the strong fluorescence energy transfer signal elicited by this interaction permitted a fine kinetic description of the binding process. Time-resolved fluorescence measurements allowed us to identify discrete EGFP lifetime species and to follow their redistribution upon ligand binding. Fluorescence correlation spectroscopy, with EGFP brightness analysis, showed that EGFP-fused muscarinic M1 receptors predominate as monomers in the absence of ligand and dimerize upon pirenzepine binding. Finally, all these experimental data could be quantitatively reconciled into a three-step mechanism, with four identified receptor conformational states. Fast ligand binding to a peripheral receptor site initiates a sequence of conformational changes that allows the ligand to access to inner regions of the protein and drives ligand-receptor complexes toward a high affinity dimeric state.	[Ilien, Brigitte; Daval, Sandrine B.; Galzi, Jean-Luc] Univ Strasbourg, Inst Rech, Dept Biotechnol Interact Mol, Ecole Biotechnol Strasbourg,FRE 3211, F-67412 Illkirch Graffenstaden, France; [Glasser, Nicole; Clamme, Jean-Pierre; Didier, Pascal; Piemont, Etienne; Chinnappan, Raja; Mely, Yves] Univ Strasbourg, Lab Biophoton & Pharmacol, UMR 7213, CNRS,Fac Pharm, F-67401 Illkirch Graffenstaden, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ilien, B (corresponding author), Univ Strasbourg, Inst Rech, Dept Biotechnol Interact Mol, Ecole Biotechnol Strasbourg,FRE 3211, Bvd S Brant BP 10413, F-67412 Illkirch Graffenstaden, France.	ilien@esbs.u-strasbg.fr			CNRS; INSERM; Universite de Strasbourg	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg	This work was supported in part by CNRS, INSERM, and the Universite de Strasbourg.	Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Avilov SV, 2008, NUCLEIC ACIDS RES, V36, P885, DOI 10.1093/nar/gkm1109; Azoulay J, 2003, J MOL BIOL, V326, P691, DOI 10.1016/S0022-2836(02)01430-4; Bernacchi S, 2002, J MOL BIOL, V317, P385, DOI 10.1006/jmbi.2002.5429; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Briddon SJ, 2007, TRENDS PHARMACOL SCI, V28, P637, DOI 10.1016/j.tips.2007.09.008; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Cezanne L, 2004, J BIOL CHEM, V279, P45057, DOI 10.1074/jbc.M404811200; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chen Y, 2005, BIOPHYS J, V88, P4366, DOI 10.1529/biophysj.105.059170; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; Clamme JP, 2003, BIOPHYS J, V84, P1960, DOI 10.1016/S0006-3495(03)75004-8; Clayton AHA, 2002, BIOPHYS J, V83, P1631, DOI 10.1016/S0006-3495(02)73932-5; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; ELLER M, 1988, NEUROCHEM INT, V12, P285, DOI 10.1016/0197-0186(88)90166-0; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Grant M, 2004, J BIOL CHEM, V279, P36179, DOI 10.1074/jbc.M407310200; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HEDLUND B, 1982, N-S ARCH PHARMACOL, V320, P3, DOI 10.1007/BF00499064; Heikal AA, 2001, CHEM PHYS, V274, P37, DOI 10.1016/S0301-0104(01)00486-4; HENIS YI, 1983, MOL PHARMACOL, V24, P357; Hermans E, 2003, PHARMACOL THERAPEUT, V99, P25, DOI 10.1016/S0163-7258(03)00051-2; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HIRSCHBERG BT, 1994, J BIOL CHEM, V269, P26127; Ilien B, 2003, J NEUROCHEM, V85, P768, DOI 10.1046/j.1471-4159.2003.01717.x; Jakubik J, 2000, J BIOL CHEM, V275, P18836, DOI 10.1074/jbc.M000112200; JARV J, 1979, J BIOL CHEM, V254, P5595; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; KLEIN WL, 1980, BIOCHEM BIOPH RES CO, V93, P1058, DOI 10.1016/0006-291X(80)90596-3; KLOOG Y, 1978, BRAIN RES, V144, P31, DOI 10.1016/0006-8993(78)90433-X; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Lecat S, 2002, J BIOL CHEM, V277, P42034, DOI 10.1074/jbc.M203606200; Li JH, 2007, J BIOL CHEM, V282, P26284, DOI 10.1074/jbc.M704875200; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Liu P, 2008, TRENDS ENDOCRIN MET, V19, P181, DOI 10.1016/j.tem.2008.02.004; Lohse MJ, 2007, ADV PROTEIN CHEM, V74, P167, DOI 10.1016/S0065-3233(07)74005-6; LUTHIN GR, 1984, MOL PHARMACOL, V26, P164; Ma AWS, 2007, BIOCHEMISTRY-US, V46, P7907, DOI 10.1021/bi6026105; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Palanche T, 2001, J BIOL CHEM, V276, P34853, DOI 10.1074/jbc.M104363200; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Park PSH, 2003, BIOCHEMISTRY-US, V42, P12960, DOI 10.1021/bi034491m; Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099; Pepperkok R, 1999, CURR BIOL, V9, P269, DOI 10.1016/S0960-9822(99)80117-1; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; POTTER LT, 1991, MOL PHARMACOL, V39, P211; Reich J. G., 1992, CURVE FITTING MODELL; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Tahtaoui C, 2004, J MED CHEM, V47, P4300, DOI 10.1021/jm040800a; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Weill C, 1999, J NEUROCHEM, V73, P791, DOI 10.1046/j.1471-4159.1999.0730791.x; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Ziessel R, 2007, NEW J CHEM, V31, P496, DOI 10.1039/b617972j	78	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19533	19543		10.1074/jbc.M109.017145	http://dx.doi.org/10.1074/jbc.M109.017145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19451648	Green Published, hybrid			2022-12-27	WOS:000267908300045
J	Silhan, J; Vacha, P; Strnadova, P; Vecer, J; Herman, P; Sulc, M; Teisinger, J; Obsilova, V; Obsil, T				Silhan, Jan; Vacha, Petr; Strnadova, Pavla; Vecer, Jaroslav; Herman, Petr; Sulc, Miroslav; Teisinger, Jan; Obsilova, Veronika; Obsil, Tomas			14-3-3 Protein Masks the DNA Binding Interface of Forkhead Transcription Factor FOXO4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LIGAND-BINDING; AFFINITY PURIFICATION; PHOSPHORYLATION; 14-3-3-PROTEINS; COMPLEX; DOMAIN; CONFORMATION; RECOGNITION; INHIBITION	The role of 14-3-3 proteins in the regulation of FOXO fork-head transcription factors is at least 2-fold. First, the 14-3-3 binding inhibits the interaction between the FOXO and the target DNA. Second, the 14-3-3 proteins prevent nuclear reimport of FOXO factors by masking their nuclear localization signal. The exact mechanisms of these processes are still unclear, mainly due to the lack of structural data. In this work, we used fluorescence spectroscopy to investigate the mechanism of the 14-3-3 protein-dependent inhibition of FOXO4 DNA-binding properties. Time-resolved fluorescence measurements revealed that the 14-3-3 binding affects fluorescence properties of 5-(((acetylamino) ethyl) amino) naphthalene-1-sulfonic acid moiety attached at four sites within the forkhead domain of FOXO4 that represent important parts of the DNA binding interface. Observed changes in 5-(((acetylamino) ethyl) amino) naphthalene-1-sulfonic acid fluorescence strongly suggest physical contacts between the 14-3-3 protein and labeled parts of the FOXO4 DNA binding interface. The 14-3-3 protein binding, however, does not cause any dramatic conformational change of FOXO4 as documented by the results of tryptophan fluorescence experiments. To build a realistic model of the FOXO4 center dot 14-3-3 complex, we measured six distances between 14-3-3 and FOXO4 using Forster resonance energy transfer time-resolved fluorescence experiments. The model of the complex suggests that the forkhead domain of FOXO4 is docked within the central channel of the 14-3-3 protein dimer, consistent with our hypothesis that 14-3-3 masks the DNA binding interface of FOXO4.	[Silhan, Jan; Vacha, Petr; Strnadova, Pavla; Obsil, Tomas] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Sulc, Miroslav] Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843, Czech Republic; [Vacha, Petr; Teisinger, Jan; Obsilova, Veronika; Obsil, Tomas] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague, Czech Republic; [Sulc, Miroslav] Acad Sci Czech Republic, Inst Microbiol, CR-14220 Prague, Czech Republic; [Vecer, Jaroslav; Herman, Petr] Charles Univ Prague, Fac Math & Phys, Inst Phys, CR-12116 Prague, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Obsil, T (corresponding author), Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic.	obsil@natur.cuni.cz	Obsil, Tomas/B-7142-2012; Sulc, Miroslav/K-1029-2014; Herman, Petr/A-2626-2008; Obsilova, Veronika/B-7116-2012; Teisinger, Jan/B-7122-2012	Obsil, Tomas/0000-0003-4602-1272; Sulc, Miroslav/0000-0002-2659-0489; Herman, Petr/0000-0001-6918-2576; Obsilova, Veronika/0000-0003-4887-0323; 	Grant Agency of the Czech Republic [204/06/0565]; Grant Agency of the Academy of Sciences of the Czech Republic Grant [IAA501110801]; Ministry of Education, Youth, and Sports of the Czech Republic Research Projects [MSM0021620857, MSM0021620835]; Centre of Neurosciences [LC554]; Academy of Sciences of the Czech Republic Research Project [AV0Z50110509]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic Grant(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic Research Projects(Ministry of Education, Youth & Sports - Czech Republic); Centre of Neurosciences; Academy of Sciences of the Czech Republic Research Project(Czech Academy of Sciences)	This work was supported by Grant Agency of the Czech Republic Grant 204/06/0565; Grant Agency of the Academy of Sciences of the Czech Republic Grant IAA501110801; Ministry of Education, Youth, and Sports of the Czech Republic Research Projects MSM0021620857 and MSM0021620835 and Centre of Neurosciences LC554; and Academy of Sciences of the Czech Republic Research Project AV0Z50110509.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Bridges D, 2004, SCI STKE, pre10; BROCHON JC, 1994, METHOD ENZYMOL, V240, P262; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BRYAN RK, 1990, EUR BIOPHYS J, V18, P165, DOI 10.1007/BF02427376; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; EFTINK MR, 1991, TOPICS FLUORESCENCE, V2, P55; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Kaestner KH, 2000, GENE DEV, V14, P142; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; Lakowicz J. R., 1983, PRINCIPLES FLUORESCE, P305; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mazet F, 2003, GENE, V316, P79, DOI 10.1016/S0378-1119(03)00741-8; MELHUISH WH, 1961, J PHYS CHEM-US, V65, P229, DOI 10.1021/j100820a009; Milne FC, 2002, BIOCHEM SOC T, V30, P379, DOI 10.1042/bst0300379; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsilova V, 2005, BIOCHEMISTRY-US, V44, P11608, DOI 10.1021/bi050618r; Obsilova V, 2004, J BIOL CHEM, V279, P4531, DOI 10.1074/jbc.M306939200; Obsilova V, 2008, BIOCHEMISTRY-US, V47, P1768, DOI 10.1021/bi7019468; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Sadilkova L, 2008, PROTEIN SCI, V17, P1834, DOI 10.1110/ps.035733.108; Silhan J, 2004, J BIOL CHEM, V279, P49113, DOI 10.1074/jbc.M408671200; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	41	51	52	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19349	19360		10.1074/jbc.M109.002725	http://dx.doi.org/10.1074/jbc.M109.002725			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19416966	hybrid, Green Published			2022-12-27	WOS:000267908300026
J	Luo, H; Hallen-Adams, HE; Walton, JD				Luo, Hong; Hallen-Adams, Heather E.; Walton, Jonathan D.			Processing of the Phalloidin Proprotein by Prolyl Oligopeptidase from the Mushroom Conocybe albipes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; ENDOPEPTIDASE; PROTEINS; PEPTIDE; IDENTIFICATION; PURIFICATION; BASIDIOMYCETE; SPECIFICITY; PATHWAY; LACTEA	The peptide toxins of poisonous Amanita mushrooms are bicyclic octapeptides (amatoxins) or heptapeptides (phallotoxins). In Amanita bisporigera, alpha-amanitin and phallacidin are synthesized as 35-and 34-amino acid proproteins, respectively, in which the amino acid sequences found in the mature toxins are flanked by conserved amino acid sequences. The presence of invariant Pro residues immediately upstream of the toxin regions and as the last predicted amino acid in the toxin regions themselves suggests that a Pro-specific peptidase is responsible for the initial post-translational processing of the Amanita toxin proproteins. We purified an enzyme from the phalloidin-producing mushroom Conocybe albipes that cleaves a synthetic 22-mer phalloidin peptide to release the mature toxin peptide (AWLATCP). Mass spectrometric analysis of the purified protein combined with isolation and sequencing of the encoding gene indicates that the responsible processing enzyme is a member of the prolyl oligopeptidase (POP) subfamily of proteases (EC 3.4.21.26). The processing enzyme was able to use the chromogenic POP substrate benzyloxycarbonyl-Gly-Pro-p-nitroanilide and was inhibited by the specific POP inhibitor benzyloxycarbonyl-Pro-prolinal. Both Pro bonds in the proprotein are cleaved by the same enzyme, with the C-terminal Pro bond cleaved first or much faster than the N-terminal Pro bond. Transient accumulation of the N-terminal intermediate indicates that cleavage is not strongly processive. A synthetic peptide representing the phallacidin proprotein was also cleaved by the POP of C. albipes, but a precursor of amanitin (which is not made by C. albipes) was cleaved inefficiently.	[Luo, Hong; Hallen-Adams, Heather E.; Walton, Jonathan D.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University	Walton, JD (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	walton@msu.edu			Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences; Office of Science, United States Department of Energy [DE-FG02-91ER20021]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088274] Funding Source: NIH RePORTER	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy Grant DE-FG02-91ER20021 (to the Plant Research Laboratory).	BRADY LR, 1975, LLOYDIA, V38, P172; Brandt I, 2007, CLIN CHIM ACTA, V377, P50, DOI 10.1016/j.cca.2006.09.001; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Craik DJ, 2007, CURR OPIN DRUG DISC, V10, P176; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; Duquesne S, 2007, CHEM BIOL, V14, P793, DOI 10.1016/j.chembiol.2007.06.004; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enjalbert F, 2004, MYCOLOGIA, V96, P720, DOI 10.2307/3762106; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Gass J, 2007, CELL MOL LIFE SCI, V64, P345, DOI 10.1007/s00018-006-6317-y; Hallen HE, 2003, MYCOL RES, V107, P969, DOI 10.1017/S0953756203008190; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Hutchison LJ, 1996, CAN J BOT, V74, P431, DOI 10.1139/b96-053; KOIDA M, 1976, J BIOL CHEM, V251, P7593; May JP, 2007, BIOPOLYMERS, V88, P714, DOI 10.1002/bip.20807; Milne BF, 2006, ORG BIOMOL CHEM, V4, P631, DOI 10.1039/b515938e; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; MORIYAMA A, 1988, J BIOCHEM, V104, P112, DOI 10.1093/oxfordjournals.jbchem.a122404; Muraoka S, 2000, J BIOSCI BIOENG, V89, P73, DOI 10.1016/S1389-1723(00)88053-6; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NOMURA K, 1986, FEBS LETT, V209, P235, DOI 10.1016/0014-5793(86)81118-8; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Qiu RD, 2005, J BIOL CHEM, V280, P16695, DOI 10.1074/jbc.M411372200; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; SATTAR AKMA, 1990, J BIOCHEM, V107, P256, DOI 10.1093/oxfordjournals.jbchem.a123035; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96; Wieland T., 1986, PEPTIDES POISONOUS A, P181; Williams RSB, 2005, PROG NEURO-PSYCHOPH, V29, P1029, DOI 10.1016/j.pnpbp.2005.03.020; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; YOSHIMOTO T, 1988, J BIOCHEM, V104, P622, DOI 10.1093/oxfordjournals.jbchem.a122522	41	32	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18070	18077		10.1074/jbc.M109.006460	http://dx.doi.org/10.1074/jbc.M109.006460			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19389704	Green Published, hybrid			2022-12-27	WOS:000267712400018
J	Tan, SH; Pal, M; Tan, MJ; Wong, MHL; Tam, FU; Teo, JWT; Chong, HC; Tan, CK; Goh, YY; Tang, MBY; Cheung, PCF; Tan, NS				Tan, Siew Hwey; Pal, Mintu; Tan, Ming Jie; Wong, Marc Hai Liang; Tam, Fong U.; Teo, Jamie Wei Ting; Chong, Han Chung; Tan, Chek Kun; Goh, Yan Yih; Tang, Mark Boon Yang; Cheung, Peter Ching For; Tan, Nguan Soon			Regulation of Cell Proliferation and Migration by TAK1 via Transcriptional Control of von Hippel-Lindau Tumor Suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-B-CHAIN; I-KAPPA-B; GROWTH-FACTOR; MEDIATED ACTIVATION; HUMAN KERATINOCYTES; SIGNALING PATHWAY; GENE-EXPRESSION; PPAR-BETA/DELTA; SKIN-DISEASE; KINASE TAK1	Skin maintenance and healing after wounding requires complex epithelial-mesenchymal interactions purportedly mediated by growth factors and cytokines. We show here that, for wound healing, transforming growth factor-Beta-activated kinase 1 (TAK1) in keratinocytes activates von Hippel-Lindau tumor suppressor expression, which in turn represses the expression of platelet-derived growth factor-B (PDGF-B), integrin beta 1, and integrin beta 5 via inhibition of the Sp1-mediated signaling pathway in the keratinocytes. The reduced production of PDGF-B leads to a paracrine-decreased expression of hepatocyte growth factor in the underlying fibroblasts. This TAK1 regulation of the double paracrine PDGF/hepatocyte growth factor signaling can regulate keratinocyte cell proliferation and is required for proper wound healing. Strikingly, TAK1 deficiency enhances cell migration. TAK1-deficient keratinocytes displayed lamellipodia formation with distinct microspike protrusion, associated with an elevated expression of integrins beta 1 and beta 5 and sustained activation of cdc42, Rac1, and RhoA. Our findings provide evidence for a novel homeostatic control of keratinocyte proliferation and migration mediated via TAK1 regulation of von Hippel-Lindau tumor suppressor. Dysfunctional regulation of TAK1 may contribute to the pathology of non-healing chronic inflammatory wounds and psoriasis.	[Tan, Siew Hwey; Pal, Mintu; Tan, Ming Jie; Wong, Marc Hai Liang; Tam, Fong U.; Teo, Jamie Wei Ting; Chong, Han Chung; Tan, Chek Kun; Goh, Yan Yih; Cheung, Peter Ching For; Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Tang, Mark Boon Yang] Natl Skin Ctr, Singapore 308205, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Skin Centre	Tan, NS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	nstan@ntu.edu.sg	Goh, Yan Yih/J-1926-2015; Cheung, Peter/A-2213-2011; Tan, Nguan Soon/A-2220-2011	Goh, Yan Yih/0000-0002-8922-9869; Tan, Nguan Soon/0000-0003-0136-7341	Ministry of Education, Singapore [ARC 8/06]; Nanyang Technological University, Singapore [RG 127/05, 158/06]	Ministry of Education, Singapore(Ministry of Education, Singapore); Nanyang Technological University, Singapore(Nanyang Technological University)	This work was supported in part by the Ministry of Education, Singapore (ARC 8/06) and Nanyang Technological University, Singapore ( Grants RG 127/05 and 158/06).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; ANSEL JC, 1993, J CLIN INVEST, V92, P671, DOI 10.1172/JCI116636; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CERVELLA P, 1993, J BIOL CHEM, V268, P5148; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; FUSENIG NE, 1994, KERATINOCYTE HDB, P71; IJpenberg A, 2004, EMBO J, V23, P2083, DOI 10.1038/sj.emboj.7600209; KRUEGER JG, 1990, J INVEST DERMATOL S, V94, P135; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Lederle W, 2006, AM J PATHOL, V169, P1767, DOI 10.2353/ajpath.2006.060120; Liu XY, 2008, FEBS LETT, V582, P4023, DOI 10.1016/j.febslet.2008.10.053; Lolkema MP, 2004, EXP CELL RES, V301, P139, DOI 10.1016/j.yexcr.2004.07.016; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; O'Toole EA, 2008, J CELL PHYSIOL, V214, P47, DOI 10.1002/jcp.21160; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Rafty LA, 2002, J CELL BIOCHEM, V85, P490, DOI 10.1002/jcb.10152; REUTERDAHL C, 1993, J CLIN INVEST, V91, P2065, DOI 10.1172/JCI116429; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tovar-Castillo LE, 2007, INT J DERMATOL, V46, P239, DOI 10.1111/j.1365-4632.2006.02962.x; Trouba KJ, 2002, ANTIOXID REDOX SIGN, V4, P665, DOI 10.1089/15230860260220175; VILLAGARCIA M, 1994, BLOOD, V83, P668, DOI 10.1182/blood.V83.3.668.bloodjournal833668; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Xia YP, 2001, J INVEST DERMATOL, V116, P50, DOI 10.1046/j.1523-1747.2001.00209.x; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zatyka M, 2002, J MED GENET, V39, P463, DOI 10.1136/jmg.39.7.463; Zia MK, 2007, INT J MOL MED, V20, P605	42	19	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18047	18058		10.1074/jbc.M109.002691	http://dx.doi.org/10.1074/jbc.M109.002691			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19419968	hybrid, Green Published			2022-12-27	WOS:000267712400016
J	Watanabe, J; Grijalva, V; Hama, S; Barbour, K; Berger, FG; Navab, M; Fogelman, AM; Reddy, ST				Watanabe, Junji; Grijalva, Victor; Hama, Susan; Barbour, Karen; Berger, Franklin G.; Navab, Mohamad; Fogelman, Alan M.; Reddy, Srinivasa T.			Hemoglobin and Its Scavenger Protein Haptoglobin Associate with ApoA-1-containing Particles and Influence the Inflammatory Properties and Function of High Density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; CORONARY HEART-DISEASE; CHOLESTEROL LEVELS; MIMETIC PEPTIDES; OXIDIZED PHOSPHOLIPIDS; PLASMA HEMOGLOBIN; FENTON REAGENT; RECEPTOR CD163; HEME UPTAKE; INHIBITS 3	Hemoglobin (Hb) uniquely associates with proinflammatory HDL in atherogenic mice and coronary heart disease (CHD) patients. In this paper, we report that Hb and its scavenger proteins, haptoglobin ( Hp) and hemopexin (Hx) are significantly increased in apoA-1-containing particles of HDL both in mouse models of hyperlipidemia and in CHD patients, when compared with wild type mice and healthy donors, respectively. We further demonstrate that the association of Hb, Hp, and Hx proteins with HDL positively correlates with inflammatory properties of HDL and systemic inflammation in CHD patients. Interestingly, HDL from Hp(-/-) mice under atherogenic conditions does not accumulate Hb and is anti-inflammatory, suggesting that(i) Hp is required for the association of Hb with HDL and (ii) Hb . Hp complexes regulate the inflammatory properties of HDL. Moreover, treatment of apoE(-/-) mice with an apoA-1 mimetic peptide resulted in significant dissociation of Hb.Hp complexes from HDL and improvement of HDL inflammatory properties. Our data strongly suggest that HDL can become proinflammatory via the Hb.Hp pathway in mice and humans, and dissociation of Hb.Hp.Hx complexes from apoA-1-containing particles of HDL may be a novel target for the treatment of CHD.	[Reddy, Srinivasa T.] Univ Calif Los Angeles, Dept Med Cardiol, CHS, Atherosclerosis Res Unit, Los Angeles, CA 90095 USA; [Reddy, Srinivasa T.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Barbour, Karen; Berger, Franklin G.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Reddy, ST (corresponding author), Univ Calif Los Angeles, Dept Med Cardiol, CHS, Atherosclerosis Res Unit, 650 Charles E Young Dr S,A8-131, Los Angeles, CA 90095 USA.	sreddy@mednet.ucla.edu			National Institutes of Health, NHLBI [HL-30568, 1R01HL082823]; Laubisch; Castera; UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL082823] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Laubisch; Castera; UCLA(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants HL-30568 (to A.M.F., M.N., and S.T.R.) and 1R01HL082823 (to S.T.R.). This work was also supported by the Laubisch, Castera, and M.K. Grey Funds at UCLA. M.N., S.T.R., and A.M.F. are principals in Bruin Pharma, and A.M.F. is an officer in Bruin Pharma.	Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; ALTRUDA F, 1985, NUCLEIC ACIDS RES, V13, P3841, DOI 10.1093/nar/13.11.3841; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Asleh R, 2008, DIABETES, V57, P2794, DOI 10.2337/db08-0450; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Cigliano L, 2001, STEROIDS, V66, P889, DOI 10.1016/S0039-128X(01)00124-6; Delanghe J, 1998, BLOOD, V91, P3524, DOI 10.1182/blood.V91.9.3524.3524_3524_3524; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; GARBY L, 1959, J CLIN INVEST, V38, P1479, DOI 10.1172/JCI103925; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Guetta J, 2007, ATHEROSCLEROSIS, V191, P48, DOI 10.1016/j.atherosclerosis.2006.04.032; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V205, P1072, DOI 10.1006/bbrc.1994.2775; Hunt RC, 1996, J CELL PHYSIOL, V168, P71, DOI 10.1002/(SICI)1097-4652(199607)168:1<71::AID-JCP9>3.0.CO;2-5; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; KEENE WR, 1965, BLOOD-J HEMATOL, V26, P705, DOI 10.1182/blood.V26.6.705.705; Kozak KR, 2003, P NATL ACAD SCI USA, V100, P12343, DOI 10.1073/pnas.2033602100; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; KUNITAKE ST, 1994, BIOCHEMISTRY-US, V33, P1988, DOI 10.1021/bi00174a003; Levy AP, 2007, ARTERIOSCL THROM VAS, V27, P134, DOI 10.1161/01.ATV.0000251020.24399.a2; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Mackness Michael I, 2004, Am J Cardiovasc Drugs, V4, P211, DOI 10.2165/00129784-200404040-00002; Navab M, 1997, J CLIN INVEST, V99, P2005, DOI 10.1172/JCI119369; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2000, J LIPID RES, V41, P1495; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1325, DOI 10.1161/01.ATV.0000165694.39518.95; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Navab M, 2004, CURR OPIN LIPIDOL, V15, P645, DOI 10.1097/00041433-200412000-00004; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; Navab M, 2001, J LIPID RES, V42, P1308; Navab M, 2001, ARTERIOSCL THROM VAS, V21, P481, DOI 10.1161/01.ATV.21.4.481; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Porta A, 1999, ZYGOTE, V7, P67, DOI 10.1017/S0967199499000416; PUPPO A, 1988, BIOCHEM J, V249, P185, DOI 10.1042/bj2490185; RADEMACHER BE, 1987, ANAL BIOCHEM, V160, P119, DOI 10.1016/0003-2697(87)90621-X; Ridker PM, 2002, CIRCULATION, V105, P2, DOI 10.1161/circ.105.1.2; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Spagnuolo MS, 2005, J BIOL CHEM, V280, P1193, DOI 10.1074/jbc.M411390200; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; Van Lenten BJ, 2007, J LIPID RES, V48, P2344, DOI 10.1194/jlr.M700138-JLR200; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Watanabe J, 2007, J BIOL CHEM, V282, P23698, DOI 10.1074/jbc.M702163200; WEINSTEIN MB, 1984, BIOCHEM BIOPH RES CO, V123, P489, DOI 10.1016/0006-291X(84)90257-2; Witztum JL, 2001, TRENDS CARDIOVAS MED, V11, P93, DOI 10.1016/S1050-1738(01)00111-6; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499	52	93	96	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18292	18301		10.1074/jbc.M109.017202	http://dx.doi.org/10.1074/jbc.M109.017202			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19433579	Green Published, hybrid			2022-12-27	WOS:000267712400042
J	Borland, G; Bird, RJ; Palmer, TM; Yarwood, SJ				Borland, Gillian; Bird, Rebecca J.; Palmer, Timothy M.; Yarwood, Stephen J.			Activation of Protein Kinase C alpha by EPAC1 Is Required for the ERK- and CCAAT/Enhancer-binding Protein beta-dependent Induction of the SOCS-3 Gene by Cyclic AMP in COS1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL BARRIER FUNCTION; EXCHANGE FACTOR; TRANSCRIPTION FACTORS; CAMP; RAP1; FAMILY; PHOSPHORYLATION; RECEPTOR; CADHERIN; HORMONE	We recently found that induction of the anti-inflammatory SOCS-3 gene by cyclic AMP occurs through novel cyclic AMP-dependent protein kinase-independent mechanisms involving activation of CCAAT/enhancer-binding protein (C/EBP) transcription factors, notably C/EBP beta, by the cyclic AMP GEF EPAC1 and the Rap1 GTPase. In this study we show that down-regulation of phospholipase (PL) C epsilon with small interfering RNA or blockade of PLC activity with chemical inhibitors ablates exchange protein directly activated by cyclic AMP (EPAC)-dependent induction of SOCS-3 in COS1 cells. Consistent with this, stimulation of cells with 1-oleoyl-2-acetyl-sn-glycerol and phorbol 12-myristate 13-acetate, both cell-permeable analogues of the PLC product diacylglycerol, are sufficient to induce SOCS-3 expression in a Ca2+-dependent manner. Moreover, the diacylglycerol- and Ca2+-dependent protein kinase C (PKC) isoform PKC alpha becomes activated following cyclic AMP elevation or EPAC stimulation. Conversely, down-regulation of PKC activity with chemical inhibitors or small interfering RNA-mediated depletion of PKC alpha or -delta blocks EPAC-dependent SOCS-3 induction. Using the MEK inhibitor U0126, we found that activation of ERK MAPKs is essential for SOCS-3 induction by either cyclic AMP or PKC. C/EBP beta is known to be phosphorylated and activated by ERK. Accordingly, we found ERK activation to be essential for cyclic AMP-dependent C/EBP activation and C/EBP beta-dependent SOCS-3 induction by cyclic AMP and PKC. Moreover, overexpression of a mutant form of C/EBP beta (T235A), which lacks the ERK phosphorylation site, blocks SOCS-3 induction by cyclic AMP and PKC in a dominant-negative manner. Together, these results indicate that EPAC mediates novel regulatory cross-talk between the cyclic AMP and PKC signaling pathways leading to ERK- and C/EBP beta-dependent induction of the SOCS-3 gene.	[Borland, Gillian; Bird, Rebecca J.; Palmer, Timothy M.; Yarwood, Stephen J.] Univ Glasgow, Div Mol & Cellular Biol, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Yarwood, SJ (corresponding author), Univ Glasgow, Div Mol & Cellular Biol, Fac Biomed & Life Sci, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	S.Yarwood@bio.gla.ac.uk	Palmer, Timothy/C-4975-2009; Palmer, Timothy/E-7290-2013	Palmer, Timothy/0000-0002-9803-7164; Yarwood, Stephen/0000-0001-9489-9253	Biotechnology and Biological Sciences Research Council [BB/D015324/1]; British Heart Foundation [PG/08/125]; BBSRC [BB/D015324/1] Funding Source: UKRI; British Heart Foundation [PG/08/125/26415] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported in part by Biotechnology and Biological Sciences Research Council Grant BB/D015324/1 (to S. J. Y. and T. M. P.) and British Heart Foundation Grant PG/08/125 (to T. M. P. and S. J. Y.).	BLUMBERG PM, 1988, CANCER RES, V48, P1; BORLAND G, 2009, BR J PHARM IN PRESS; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Engh RA, 2001, ADV ENZYME REGUL, V41, P121, DOI 10.1016/S0065-2571(00)00010-8; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; Gronning LM, 1999, ENDOCRINOLOGY, V140, P835, DOI 10.1210/en.140.2.835; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Islam D, 2009, AM J PHYSIOL-ENDOC M, V296, pE174, DOI 10.1152/ajpendo.90419.2008; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Wang CY, 2007, J PHYSIOL-LONDON, V584, P191, DOI 10.1113/jphysiol.2007.135616; Yarwood SJ, 2008, J BIOL CHEM, V283, P6843, DOI 10.1074/jbc.M710342200	30	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17391	17403		10.1074/jbc.M109.015370	http://dx.doi.org/10.1074/jbc.M109.015370			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19423709	hybrid, Green Published			2022-12-27	WOS:000267202500005
J	Calandria, JM; Marcheselli, VL; Mukherjee, PK; Uddin, J; Winkler, JW; Petasis, NA; Bazan, NG				Calandria, Jorgelina M.; Marcheselli, Victor L.; Mukherjee, Pranab K.; Uddin, Jasim; Winkler, Jeremy W.; Petasis, Nicos A.; Bazan, Nicolas G.			Selective Survival Rescue in 15-Lipoxygenase-1-deficient Retinal Pigment Epithelial Cells by the Novel Docosahexaenoic Acid-derived Mediator, Neuroprotectin D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; EXPRESSION; PHOTORECEPTORS; DISEASE; ROD; INFLAMMATION; APOPTOSIS; CALCIUM; BINDING; BRAIN	The integrity of the retinal pigment epithelial (RPE) cell is essential for the survival of rod and cone photoreceptor cells. Several stressors, including reactive oxygen species, trigger apoptotic damage in RPE cells preceded by an anti-inflammatory, pro-survival response, the formation of neuroprotectin D1 (NPD1), an oxygenation product derived from the essential omega-3 fatty acid family member docosahexaenoic acid. To define the ability of NPD1 and other endogenous novel lipid mediators in cell survival, we generated a stable knockdown human RPE (ARPE-19) cell line using short hairpin RNA to target 15-lipoxygenase-1. The 15-lipoxygenase-1-deficient cells exhibited 30% of the protein expression, and 15-lipoxygenase-2 remained unchanged, as compared with an ARPE-19 cell line control established using nonspecific short hairpin RNA transfected cells. NPD1 synthesis was stimulated by tumor necrosis factor alpha/H2O2-mediated oxidative stress in nonspecific cells (controls), whereas in silenced cells, negligible amounts of NPD1, 12(S)- and 15(S)-hydroxyeicosatetraenoic acid, and lipoxin A(4) were found under these conditions. Neither control nor the deficient cells showed an increase in 15-lipoxygenase-1 protein content after 16 h of oxidative stress, suggesting that the increased activity of 15-lipoxygenase-1 is due to activation of pre-existing proteins. 15-Lipoxygenase-silenced cells also displayed an exacerbated sensitivity to oxidative stress-induced apoptosis when compared with the control cells. NPD1 selectively and potently rescued 15-lipoxygenase-silenced cells from oxidative stress-induced apoptosis. These results demonstrate that 15-lipoxygenase-1 is activated by oxidative stress in ARPE-19 cells and that NPD1 is part of an early survival signaling in RPE cells.	[Calandria, Jorgelina M.; Marcheselli, Victor L.; Mukherjee, Pranab K.; Bazan, Nicolas G.] Louisiana State Univ, Neurosci Ctr Excellence, Hlth Sci Ctr, Sch Med, New Orleans, LA 70112 USA; [Uddin, Jasim; Winkler, Jeremy W.; Petasis, Nicos A.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Southern California	Bazan, NG (corresponding author), Louisiana State Univ, Neurosci Ctr Excellence, Hlth Sci Ctr, Sch Med, 2020 Gravier St, New Orleans, LA 70112 USA.	nbazan@lsuhsc.edu	Winkler, Jeremy/C-3198-2008; Bazan, Nicolas/AAN-4121-2020; Petasis, Nicos/B-3162-2009	Bazan, Nicolas/0000-0002-9243-5444; Petasis, Nicos/0000-0002-8864-4446	National Institutes of Health [R01 EY005121, P20 RR016816]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY005121 and P20 RR016816.	Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Bazan NG, 2007, INVEST OPHTH VIS SCI, V48, P4866, DOI 10.1167/iovs.07-0918; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bharti K, 2005, J INVEST DERMATOL, V125, pX, DOI 10.1111/j.0022-202X.2005.23876.x; BOK D, 1993, J CELL SCI, P189; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Brinckmann R, 1998, BLOOD, V91, P64, DOI 10.1182/blood.V91.1.64.64_64_74; Chang MS, 2005, INVEST OPHTH VIS SCI, V46, P849, DOI 10.1167/iovs.04-1166; Chen BL, 2006, J BIOL CHEM, V281, P18296, DOI 10.1074/jbc.M603484200; Engelhardt M, 2005, BRAIN RES, V1040, P98, DOI 10.1016/j.brainres.2005.01.075; Gan QF, 1996, J BIOL CHEM, V271, P25412, DOI 10.1074/jbc.271.41.25412; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1168, P73, DOI 10.1016/0005-2760(93)90268-E; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanning JL, 2005, J INVEST DERMATOL, V125, P805, DOI 10.1111/j.0022-202X.2005.23819.x; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Liang LN, 2008, INVEST OPHTH VIS SCI, V49, P4145, DOI 10.1167/iovs.07-1380; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; McKay BS, 2006, EXP NEUROL, V201, P234, DOI 10.1016/j.expneurol.2006.04.016; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13152, DOI 10.1073/pnas.0705949104; Organisciak DT, 1996, INVEST OPHTH VIS SCI, V37, P2243; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Walther M, 2004, J BIOL CHEM, V279, P3717, DOI 10.1074/jbc.M309564200	33	78	81	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17877	17882		10.1074/jbc.M109.003988	http://dx.doi.org/10.1074/jbc.M109.003988			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19403949	Green Published, hybrid			2022-12-27	WOS:000267202500053
J	Unal, ES; Zhao, RB; Chang, MH; Fiser, A; Romero, MF; Goldman, ID				Unal, Ersin Selcuk; Zhao, Rongbao; Chang, Min-Hwang; Fiser, Andras; Romero, Michael F.; Goldman, I. David			The Functional Roles of the His(247) and His(281) Residues in Folate and Proton Translocation Mediated by the Human Proton-coupled Folate Transporter SLC46A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; AMINO-ACID TRANSPORTER; METAL-ION TRANSPORTER; BRUSH-BORDER MEMBRANE; NOREPINEPHRINE TRANSPORTERS; CONFORMATIONAL FLEXIBILITY; HISTIDINE-RESIDUES; CHLORIDE TRANSPORT; ESCHERICHIA-COLI; LACTOSE PERMEASE	This report addresses the functional role of His residues in the proton-coupled folate transporter (PCFT; SLC46A1), which mediates intestinal folate absorption. Of ten His residues, only H247A and H281A mutations altered function. The folic acid influx K-t at pH 5.5 for H247A was down arrow 28.4-fold. Although wild type (WT)-PCFT K-i values varied among the folates, K-i values were much lower and comparable for H247-A, -R, -Q, or -E mutants. Homology modeling localized His(247) to the large loop separating transmembrane domains 6 and 7 at the cytoplasmic entrance of the translocation pathway in hydrogen-bond distance to Ser(172). The folic acid influx K-t for S172A-PCFT was decreased similar to H247A. His(281) faces the extracellular region in the seventh transmembrane domain. H281A-PCFT results in loss-of-function due to similar to 12-fold up arrow in the folic acid influx K-t. When the pH was decreased from 5.5 to 4.5, the WT-PCFT folic acid influx K-t was unchanged, but the K-t decreased 4-fold for H281A. In electrophysiological studies in Xenopus oocytes, both WT-PCFT- and H281A-PCFT-mediated folic acid uptake produced current and acidification, and both exhibited a low level of folate-independent proton transport (slip-page). Slippage was markedly increased for the H247A-PCFT mutant. The data suggest that disruption of the His(247) to Ser(172) interaction results in a PCFT conformational alteration causing a loss of selectivity, increased substrate access to a high affinity binding pocket, and proton transport in the absence of a folate gradient. The His(281) residue is not essential for proton coupling but plays an important role in PCFT protonation, which, in turn, augments folate binding to the carrier.	[Unal, Ersin Selcuk; Zhao, Rongbao; Goldman, I. David] Albert Einstein Canc Ctr, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Zhao, Rongbao; Goldman, I. David] Albert Einstein Canc Ctr, Dept Med, Bronx, NY 10461 USA; [Fiser, Andras] Albert Einstein Canc Ctr, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Fiser, Andras] Albert Einstein Canc Ctr, Dept Biochem, Bronx, NY 10461 USA; [Chang, Min-Hwang; Romero, Michael F.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Mayo Clinic	Goldman, ID (corresponding author), Albert Einstein Canc Ctr, Dept Mol Pharmacol, Chanin 2,1300 Morris Pk Ave, Bronx, NY 10461 USA.	igoldman@aecom.yu.edu			National Institutes of Health [CA-082621, EY-017732]; NATIONAL CANCER INSTITUTE [R01CA082621] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-082621 (to I. D. G.) and EY-017732 (to M. F. R.). Data in this report are from Ersin Selcuk Unal's thesis to be submitted in partial fulfillment of the requirements for the Degree of Doctor of Philosophy in the Graduate Division of Medical Sciences, Albert Einstein College of Medicine, Yeshiva University.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; Andrews NC, 2007, CELL METAB, V5, P5, DOI 10.1016/j.cmet.2006.12.004; Boll M, 2003, GENOMICS, V82, P47, DOI 10.1016/S0888-7543(03)00099-5; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Chang MH, 2008, J BIOL CHEM, V283, P18402, DOI 10.1074/jbc.M709819200; Chang MH, 2009, J MEMBRANE BIOL, V228, P125, DOI 10.1007/s00232-009-9165-5; Chen XZ, 1999, J BIOL CHEM, V274, P35089, DOI 10.1074/jbc.274.49.35089; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; COHEN LA, 1968, ANNU REV BIOCHEM, V37, P695, DOI 10.1146/annurev.bi.37.070168.003403; CRANE RK, 1977, REV PHYSIOL BIOCH P, V78, P99, DOI 10.1007/BFb0027722; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; Fairman WA, 1998, NAT NEUROSCI, V1, P105, DOI 10.1038/355; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fei YJ, 1997, BIOCHEMISTRY-US, V36, P452, DOI 10.1021/bi962058p; Fei YJ, 2000, J BIOL CHEM, V275, P9563, DOI 10.1074/jbc.275.13.9563; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Foltz M, 2005, BIOCHEM J, V386, P607, DOI 10.1042/BJ20041519; FRY DW, 1982, J BIOL CHEM, V257, P1890; Galic S, 2003, BIOCHEM J, V376, P413, DOI 10.1042/BJ20030799; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HORNE DW, 1992, ARCH BIOCHEM BIOPHYS, V298, P121, DOI 10.1016/0003-9861(92)90102-3; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meredith D, 2006, J MEMBRANE BIOL, V213, P79, DOI 10.1007/s00232-006-0876-6; Metzner L, 2008, BBA-BIOMEMBRANES, V1778, P1042, DOI 10.1016/j.bbamem.2007.12.026; Miles E W, 1977, Methods Enzymol, V47, P431; MULLERBERGER S, 1995, BIOCHEMISTRY-US, V34, P9325; MULLERBERGER S, 1995, BIOCHEMISTRY-US, V34, P9315; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P309, DOI 10.1016/S0006-2952(98)00306-2; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Rai BK, 2006, BIOINFORMATICS, V22, P2691, DOI 10.1093/bioinformatics/btl449; SAID HM, 1993, BIOCHEM J, V290, P237, DOI 10.1042/bj2900237; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHRON CM, 1985, J CLIN INVEST, V76, P2030, DOI 10.1172/JCI112205; SCHRON CM, 1991, J MEMBRANE BIOL, V120, P192, DOI 10.1007/BF01872403; Sharina IG, 2002, BIOCHEM PHARMACOL, V63, P1717, DOI 10.1016/S0006-2952(02)00955-3; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Steel A, 1997, J PHYSIOL-LONDON, V498, P563, DOI 10.1113/jphysiol.1997.sp021883; Tao Z, 2005, BIOCHEMISTRY-US, V44, P3466, DOI 10.1021/bi047812i; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Xu HX, 2004, PLOS BIOL, V2, P378, DOI 10.1371/journal.pbio.0020050; Yang HS, 2009, J BIOL CHEM, V284, P15970, DOI 10.1074/jbc.M109.001438; Yang J, 2007, J PHARMACOL EXP THER, V321, P462, DOI 10.1124/jpet.106.117648; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2009, J BIOL CHEM, V284, P4267, DOI 10.1074/jbc.M807665200	72	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17846	17857		10.1074/jbc.M109.008060	http://dx.doi.org/10.1074/jbc.M109.008060			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19389703	Green Published, hybrid			2022-12-27	WOS:000267202500050
J	Liu, YL; Zhao, Y; Dai, ZM; Chen, HM; Yang, WJ				Liu, Yu-Lei; Zhao, Yang; Dai, Zhong-Min; Chen, Han-Min; Yang, Wei-Jun			Formation of Diapause Cyst Shell in Brine Shrimp, Artemia parthenogenetica, and Its Resistance Role in Environmental Stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING PROTEIN; ENCYSTED EMBRYOS; CRYSTALLIN PROTEIN; CHAPERONE ACTIVITY; FRANCISCANA; TEMPERATURE; TERMINATION; EXPRESSION; MORTALITY; MEMBRANES	Artemia has attracted much attention for its ability to produce encysted embryos wrapped in a protective shell when subject to extremely harsh environmental conditions. However, what the cyst shell is synthesized from and how the formative process is performed remains, as yet, largely unknown. Over 20 oviparous specifically expressed genes were identified through screening the subtracted cDNA library enriched between oviparous and ovoviviparous Artemia ovisacs. Among them, a shell gland-specifically expressed gene (SGEG) has been found to be involved in the cyst shell formation. Lacking SGEG protein (by RNA interference) caused the cyst shell to become translucent and the chorion layer of the shell to become less compact and pultaceous and to show a marked decrease of iron composition within the shell. The RNA interference induced defective diapause cysts with a totally compromised resistibility to UV irradiation, extremely large temperature differences, osmotic pressure, dryness, and organic solvent stresses. In contrast, the natural cyst would provide adequate protection from all such factors. SGEG contains a 345-bp open reading frame, and its consequentially translated peptide consists of a 33-amino acid residue putative signal peptide and an 81-amino acid residue mature peptide. The results of Northern blotting and in situ hybridization indicate that the gene is specifically expressed in the cells of shell glands during the period of diapause cyst formation of oviparous Artemia. This investigation adds strong insight into the mechanism of cyst shell formation of Artemia and may be applicable to other areas of research in extremophile biology.	[Liu, Yu-Lei; Zhao, Yang; Dai, Zhong-Min; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Han-Min] Zhejiang Univ, Coll Life Sci, Equipment & Technol Serv Platform, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Wei-Jun] Minist Educ, State Conservat Ctr Gene Resources Wildlife, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Wei-Jun] Minist Educ, Key Lab Conservat Genet & Reprod Biol Wild Anim, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, WJ (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn		Yang, Wei-Jun/0000-0002-4591-8830; Dai, Zhong-Min/0000-0003-4083-1901	National Natural Sciences Foundation of China [40730212, 40876069];  [2007AA09Z426]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported by National Natural Sciences Foundation of China Grants 40730212 and 40876069 and 863 Program of China Grant 2007AA09Z426.	ADAMKOVA I, 1999, HATCHING QUALITY ART; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clegg JS, 2006, COMP BIOCHEM PHYS B, V145, P119, DOI 10.1016/j.cbpb.2006.04.014; Clegg James S., 2002, P129; CLEGG JS, 1978, J CELL PHYSIOL, V94, P123, DOI 10.1002/jcp.1040940202; Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715; CLEGG JS, 1995, EXP CELL RES, V219, P1, DOI 10.1006/excr.1995.1197; Clegg JS, 1997, J EXP BIOL, V200, P467; CLEGG JS, 1980, BRINE SHRIMP ARTEMIA, V2, P11; Criel Godelievre R.J., 2002, P1; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dattilo AM, 2005, INT J BIOMETEOROL, V49, P388, DOI 10.1007/s00484-005-0255-5; Drinkwater L.E., 1991, P93; DUTRIEU JANINE, 1960, ARCH ZOOL EXPTL ET GEN, V99, P1; FINAMORE FJ, 1969, CELL CYCLE GENE ENZY, P249; HAND SC, 1988, SCIENCE, V239, P1425, DOI 10.1126/science.239.4846.1425; HOFMANN GE, 1990, J EXP ZOOL, V253, P287, DOI 10.1002/jez.1402530308; Lavens P., 1987, P27; Liang P, 1997, J BIOL CHEM, V272, P19051, DOI 10.1074/jbc.272.30.19051; Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x; LIU FQ, 2002, ANIM SCI VET MED, V83, P10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRae TH, 2003, SEMIN CELL DEV BIOL, V14, P251, DOI 10.1016/j.semcdb.2003.09.019; MORRIS JE, 1967, J ULTRA MOL STRUCT R, V20, P244, DOI 10.1016/S0022-5320(67)90285-7; NAKANISHI Yu.H., 1962, ANNOT ZOOL JAPON, V35, P223; Nambu Z, 2004, J EXP ZOOL PART A, V301A, P542, DOI 10.1002/jez.a.80; Nambu Z, 2008, J EXP ZOOL PART A, V309A, P17, DOI 10.1002/jez.428; Oulton MM, 2003, EUR J BIOCHEM, V270, P4962, DOI 10.1046/j.1432-1033.2003.03898.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sugumar V, 2006, MICROSC RES TECHNIQ, V69, P957, DOI 10.1002/jemt.20371; Tanguay JA, 2004, J BIOSCIENCES, V29, P489, DOI 10.1007/BF02712121; VANDERLINDEN A, 1987, ARTEMIA RES ITS APPL, V2, P181; Versichele D., 1980, P231; Warner AH, 2004, ARCH BIOCHEM BIOPHYS, V424, P189, DOI 10.1016/j.abb.2004.02.022; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; YOSEFALI A, 1999, BIOTECHNOLOGICAL APP; ZHANG JS, 1994, J BIOL CHEM, V269, P3053; Zhu XJ, 2007, STRESS, V10, P53, DOI 10.1080/10253890601130773	40	35	36	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16931	16938		10.1074/jbc.M109.004051	http://dx.doi.org/10.1074/jbc.M109.004051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19395704	hybrid, Green Published			2022-12-27	WOS:000266962400030
J	Walters, KR; Pan, QF; Serianni, AS; Duman, JG				Walters, Kent R., Jr.; Pan, Qingfeng; Serianni, Anthony S.; Duman, John G.			Cryoprotectant Biosynthesis and the Selective Accumulation of Threitol in the Freeze-tolerant Alaskan Beetle, Upis ceramboides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD TOLERANCE; BOMBYX-MORI; POLYOL DEHYDROGENASES; ENZYMATIC PATHWAYS; DIAPAUSING EGG; BARK BEETLE; INSECTS; TREHALOSE; SILKWORM; GLYCEROL	Adult Upis ceramboides do not survive freezing in the summer but tolerate freezing to -60 degrees C in midwinter. The accumulation of two cryoprotective polyols, sorbitol and threitol, is integral to the extraordinary cold-hardiness of this beetle. U. ceramboides are the only animals known to accumulate high concentrations of threitol; however, the biosynthetic pathway has not been studied. A series of C-13-labeled compounds was employed to investigate this biosynthetic pathway using C-13{H-1} NMR spectroscopy. In vivo metabolism of C-13-labeled glucose isotopomers demonstrates that C-3-C-6 of glucose become C-1-C-4 of threitol. This labeling pattern is expected for 4-carbon saccharides arising from the pentose phosphate pathway. In vitro experiments show that threitol is synthesized from erythrose 4-phosphate, a C-4 intermediate in the PPP. Erythrose 4-phosphate is epimerized and/or isomerized to threose 4-phosphate, which is subsequently reduced by a NADPH-dependent polyol dehydrogenase and dephosphorylated by a sugar phosphatase to form threitol. Threitol 4-phosphate appears to be the preferred substrate of the sugar phosphatase(s), promoting threitol synthesis over that of erythritol. In contrast, the NADPH-dependent polyol dehydrogenase exhibits broad substrate specificity. Efficient erythritol catabolism under conditions that promote threitol synthesis, coupled with preferential threitol biosynthesis, appear to be responsible for the accumulation of high concentrations of threitol (250 mM) without concomitant accumulation of erythritol.	[Walters, Kent R., Jr.; Duman, John G.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Pan, Qingfeng; Serianni, Anthony S.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Pan, Qingfeng; Serianni, Anthony S.] Omicron Biochem Inc, South Bend, IN 46617 USA	University of Notre Dame; University of Notre Dame	Walters, KR (corresponding author), Univ Notre Dame, Dept Biol Sci, Galvin Biol Sci Bldg, Notre Dame, IN 46556 USA.	kwalter2@nd.edu			National Science Foundation [OPP-0117104, IOS-0618342]	National Science Foundation(National Science Foundation (NSF))	This study was supported by National Science Foundation Grants OPP-0117104 and IOS-0618342.	Bennett VA, 2005, J EXP BIOL, V208, P4467, DOI 10.1242/jeb.01892; BLOCK W, 1990, PHILOS T ROY SOC B, V326, P613, DOI 10.1098/rstb.1990.0035; CHINO H, 1960, J INSECT PHYSIOL, V5, P1, DOI 10.1016/0022-1910(60)90018-4; CHINO H, 1961, J INSECT PHYSIOL, V6, P231, DOI 10.1016/0022-1910(61)90067-1; CROWE JH, 1987, BIOCHEM J, V242, P1, DOI 10.1042/bj2420001; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Fields PG, 1998, J INSECT PHYSIOL, V44, P955, DOI 10.1016/S0022-1910(98)00055-9; GARRETT EC, 1990, CARBOHYD RES, V208, P23, DOI 10.1016/0008-6215(90)80082-E; GEHRKEN U, 1984, J INSECT PHYSIOL, V30, P421, DOI 10.1016/0022-1910(84)90100-8; HAYAKAWA Y, 1982, INSECT BIOCHEM, V12, P639, DOI 10.1016/0020-1790(82)90050-6; JONES RGW, 1981, PHYSL BIOCH DROUGHT, P172; KAGEYAMA T, 1973, INSECT BIOCHEM, V3, P373, DOI 10.1016/0020-1790(73)90071-1; Kostal V, 2007, J INSECT PHYSIOL, V53, P580, DOI 10.1016/j.jinsphys.2007.02.009; KUKAL O, 1988, J COMP PHYSIOL B, V158, P175, DOI 10.1007/BF01075831; Lee R.E. Jr, 1991, P17; LELOIR LF, 1957, METHOD ENZYMOL, V3, P840, DOI 10.1016/S0076-6879(57)03459-X; MILLER K, 1982, COMP BIOCHEM PHYS A, V73, P595, DOI 10.1016/0300-9629(82)90266-3; MILLER LK, 1978, J INSECT PHYSIOL, V24, P791, DOI 10.1016/0022-1910(78)90097-5; MILLER LK, 1975, NATURE, V258, P519, DOI 10.1038/258519a0; PITKANEN E, 1977, CLIN CHIM ACTA, V80, P49, DOI 10.1016/0009-8981(77)90262-5; Prade RA, 1996, BIOTECHNOL GENET ENG, V13, P101, DOI 10.1080/02648725.1996.10647925; Ramlov H, 1999, J COMP PHYSIOL B, V169, P224, DOI 10.1007/s003600050215; RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1; SERIANNI AS, 1979, BIOCHEMISTRY-US, V18, P1192, DOI 10.1021/bi00574a012; SHIMADA K, 1990, CRYO-LETT, V11, P243; Storey K.B., 1991, P64; STOREY KB, 1990, PHILOS T R SOC B, V326, P635, DOI 10.1098/rstb.1990.0036; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; TAKAHASHI SY, 1974, INSECT BIOCHEM, V4, P33, DOI 10.1016/0020-1790(74)90040-7; TERADA T, 1985, EUR J BIOCHEM, V148, P345, DOI 10.1111/j.1432-1033.1985.tb08845.x; WALUM E, 1982, ANAL BIOCHEM, V120, P8, DOI 10.1016/0003-2697(82)90310-4; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799	33	23	25	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16822	16831		10.1074/jbc.M109.013870	http://dx.doi.org/10.1074/jbc.M109.013870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19403530	Green Published, hybrid			2022-12-27	WOS:000266962400018
